2010”N“x –k—¢‘åŠwˆãŠw•”E‘åŠw•a‰@Œ€‹†‹ÆÑW(HTML”Å)

i’FŒŽ–{‚ÅŒäŠm”F‰º‚³‚¢j


‰ð–UŠw (ûŒŽ’PˆÊ)

[Šwp˜_•¶]

110001. [ŒŽ’˜] Expression of neuropeptide Y and agouti-related peptide in the hypothalamic arcuate
nucleus of newborn neurogenin3 null mutant mice. Arai Y1, Gradwohl G, Kameda Y: Cell Tissue Res
2010/4; 340 (1): 137-45. (Vˆä—Y‘Ÿ1: 1‰ð–U)

110002. [ŒŽ’˜] A Genetic Analysis of the Sakishima Islanders Reveals No Relationship with Taiwan
Aborigines but Shared Ancestry with Ainu and Main-island Japanese. Matsukusa H, Oota H1, Haneji
K, Toma T, Kawamura S, Ishida H: American Journal of Physical Anthropology 2010/6; 142 (2): 211-23.
(‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

110003. [ŒŽ’˜] Comparative studies of the Ainu, their ancestors, and neighbors: assessment based
on metric and nonmetric dental data. Kaburagi M, Ishida H, Goto M, Hanihara T1: Anthropological
Science 2010/8; 118 (2): 95-106. (ûŒŽP•F1: 1‰ð–U)

110004. [ŒŽ’˜] Nonmetric cranial variation of Jomon Japan: implications for the evolution of
eastern Asian diversity. Nakashima A, Ishida H, Shigematsu M, Goto M, Hanihara T1: American Journal
of Human Biology 2010/11-12; 22 (6): 782-90. (ûŒŽP•F1: 1‰ð–U)

120001. [ŒŽ’˜] ã‰º‘Bâ|‚Æ‘€•ûã‘€E‚̉ð–UŠw“IŒ€‹†. “à“c—YŠî, “L–ؐ³‹I, dŒ³m, ’dã@“Ö, –ì
ŒûMG, ŽR‰º‰À—Y, Œã“¡¹º, ûŒŽP•F1 (1‰ð–U): “ú–{Š{Šç–ʃCƒ“ƒvƒ‰ƒ“ƒgŠw‰ïŽ 2010/12; 9 (4):
147-53.

210001. [€ŒŽ’˜] How should we think about "population" in population genetics? Oota H1:
Proceeding of A Japan-based Global Study of Racial Representations 2010-2011: The Interface of
Humanities and Genomics 2011/3; p.70-6. (Proceeding of Grant-in-Aid by Japan Society of Promotion
of Science (S) (Principal Investigator: Yasuko Takezawa) Institute for Research in Humanities,
Kyoto University) (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

[’˜@‘]

610001. [Šwp‘] (•ª’SŽ·•M)yArch Lake Woman - Physical Anthropology and geoarchaeologyzOwsley
DW, Jodry MA, Stafford TW II, Haynes CV II, Stanford DJ, Jantz RL, Warnica JM, Hanihara T1, Dickenson
J, Bergstresser L, Macintyre IG, Logan MA, and Montgomery JL, Texas A&M University Press, 2010/9
”­s. (ûŒŽP•F1: 1‰ð–U)

610002. [Šwp‘] (•ª’SŽ·•M)yTrends in Physical Anthropology (Focus on Civilizations and
Cultures)zEstimate of divergence times for modern human populations based on craniometric variation,
p.154-76. Hanihara T1, Eds. Weiss KE, Nova Science Publisher, Inc., 2010/9”­s. (ûŒŽP•F1: 1
‰ð–U)

610003. [Šwp‘] (•ª’SŽ·•M)yPhylogeography: Concepts, Intraspecific Patterns and Speciation
Processes (Genetics - Research and Issues)zGene flow, genetic drift, and geographic variation
of the Ainu: an assessment based on nonmetric cranial traits, p.81-102. Hanihara T1, Eds. Rutgers
DS, Nove Science Publisher, 2011/1”­s. (ûŒŽP•F1: 1‰ð–U)

[Šw‰ïEŒ€‹†‰ï“™]

712001. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Geographic structure of dental variation and the
peopling of East/Southeast Asia and Pacific. Hanihara T1, Ishida H: American Association of
Physical Anthropologists (2010/4/16), New Mexico, USA. (ûŒŽP•F1: 1‰ð–U)

712002. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Alcohol dehydrogenase (ADH) gene cluster in
primates. Oota H1, Kaul R, Shibata H, Toyoda A, Fujiyama A, Speed WC, Kidd JR, Olson M, Kawamura
S, Kidd KK: International Primatological Society XXIII Congress Kyoto 2010 (2010/9/12-18), Kyoto.
(‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Dental metric variation among Late Paleoindian of Lagoa
Santa, Central Brazil. Nunes TL, Neves WA, Hanihara T1: Annual Meeting of the American Association
of Phsical Anthropologists (2010/4/17), Albuquerque. (ûŒŽP•F1: 1‰ð–U)

713002. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A study of functional differences between alleles in
P450 genes for medaka fish (Oryzias latipes). Katsumura T, Oda S, Mitani H, Kawamura S, Oota H1:
Genetics 2010: model organisms to human biology (2010/6/12-15), Boston, USA. (‘Ÿ“c”ŽŽ÷1: 1‰ð
–U)

713003. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) An evolutionary analysis of the NOD2 gene associated
with Crohn's disease. Nakagome S, Mano S, Kidd JR, Kidd KK, Kawamura S, Oota H1: The Society for
Molecular Biology and Evolution, Annual Meeting (2010/7/4-8), Lyon, France. (‘Ÿ“c”ŽŽ÷1: 1‰ð
–U)

713004. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Primate morphology, metabolism, and brain from an
evolution standpoint. Oota H1, Osada N2, Nakatsukasa M3, Chen F-C4, Khaitovich P5, Sumiyama K6
(2National Institute of Genetics, 3Kyoto University, 4National Health Research Institutes, Taiwan,
5Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese
Academy of Sciences, 6National Institute of Genetics): International Primatological Society XXIII
Congress Kyoto 2010 (2010/9/17), Kyoto. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U) ŠŠé‰æEŽåÃEŽi‰ïŽÒ‚Æ‚µ‚ÄŽQ‰Á

713005. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Toward deeper understanding color vision of howler
monkeys. Matsushita Y, Oota H1, Welker B, Kawamura S: International Primatological Society XXIII
Congress Kyoto 2010 (2010/9/12-18), Kyoto. (‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

722001. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) –쐶ƒƒ_ƒJW’c‚É‚š‚¯‚écytochrome P450ˆâ“`Žq‚̃AƒŒƒ‹ŠÔ
‹@”\·. Ÿ‘ºŒ[Žj, ”ö“c³“ñ, ŽO’JGŽu, ‰Í‘º³“ñ, ‘Ÿ“c”ŽŽ÷1 (1‰ð–U): “ú–{i‰»Šw‰ï‘å‰ï‘æ12‰ñ“Œ
‹ž‘å‰ï (2010/8/3), “Œ‹ž.

722002. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “Œ“ìƒAƒWƒAE“ŒƒAƒWƒA‚̐lX‚̕ψÙ, ‘œ—l«‚Æ‚»
‚Ì—R—ˆ. ûŒŽP•F (‰ð–U): ‘æ64‰ñ“ú–{l—ÞŠw‰ï‘‰ï (2010/10/2), ˆÉ’B, –kŠC“¹.

722003. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒAƒCƒk–¯‘°‚Ì“ªŠW‚š‚æ‚ÑŽ•Š¥Œ`‘Ԃ̕ψفE‘œ—l«
‚Æ‚»‚̐i‰». ûŒŽP•F (‰ð–U): ‘æ64‰ñ“ú–{l—ÞŠw‰ï‘‰ï (2010/10/3), ˆÉ’B, –kŠC“¹.

723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒqƒg‚Í‚È‚º•a‹C‚É‚È‚é‚Ì‚©?i‰»Šw‚Ì–Ú‚ÅŒ©‚éV‚œ‚ȃA
ƒvƒ[ƒ`?. ‘Ÿ“c”ŽŽ÷1, ’·’JìáÁ—Žq, ‘å‹Ž@‡, ’†žŽ Ž÷, ŠÔ–ìC•œ, ŽÄ“cO‹I (1‰ð–U): “ú–{i
‰»Šw‰ï‘å‰ï‘æ12‰ñ“Œ‹ž‘å‰ï (2010/8/4), “Œ‹ž. ŠŠé‰æEŽåÃEŽi‰ïŽÒ‚Æ‚µ‚ÄŽQ‰Á

723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž•Š¥Œv‘ª’l‚Æ”ñŒv‘ªƒf[ƒ^‚ÉŠî‚­ƒAƒCƒk‚Ƌߗ׏”W’c
‚Æ‚Ì”äŠrŒ€‹†. “L–ؐ³‹I, Î“c@”£, Œã“¡¹º, ûŒŽP•F1 (1‰ð–U): ‘æ64‰ñ“ú–{l—ÞŠw‰ï‘‰ï
(2010/10/3), ˆÉ’B, –kŠC“¹.

723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V¢ŠEƒUƒ‹ƒzƒGƒUƒ‹‘®‚É‚š‚¯‚éƒqƒgŒ^3FŒ^FŠo‰Œà‚Ì
ŒŸØ. Œ‰º—T, ‘Ÿ“c”ŽŽ÷1, Barbara WELKER, ‰Í‘º³“ñ (1‰ð–U): ‘æ64‰ñ“ú–{l—ÞŠw‰ï‘‰ï
(2010/10/3), ˆÉ’B, –kŠC“¹.

723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) …“c‚ÌŠgŽU‚ƃƒ_ƒJ‚̈ړ®. Ÿ‘ºŒ[Žj, ”ö“c³“ñ, ŽO’J
GŽu, ‰Í‘º³“ñ, ‘Ÿ“c”ŽŽ÷1 (1‰ð–U): ‘æ64‰ñ“ú–{l—ÞŠw‰ï‘‰ï (2010/10/3), ˆÉ’B, –kŠC“¹.

732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒqƒg‚̐i‰»‚ƃQƒmƒ€‘œ—l«. ‘Ÿ“c”ŽŽ÷
(‰ð–U): ‘æ20‰ñ“ú–{‰ð–UŠw‰ïŠÖ“ŒŽx•”§˜b‰ïw”äŠrŒ`‘ÔŠwŒ€‹†‚Ö‚ÌŠú‘Ò‚Æ–¢—ˆx(2010/5/22), “Œ‹ž.

733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒqƒgˆâ“`“I‘œŒ^‚Ì‹@”\‰ðÍŽÀŒ±ƒ‚ƒeƒ‹¶•š‚Æ
‚µ‚Ă̖쐶ƒƒ^ƒJW’c‚Ì—L—p«?cytochrome P450 ˆâ“`Žq‚É’…–Ú‚µ‚Ä?. Ÿ‘ºŒ[Žj, ”ö“c³“ñ, ŽO’JG
Žu, ‰Í‘º³“ñ, ‘Ÿ“c”ŽŽ÷1 (1‰ð–U): ¬Œ^‹›—ÞŒ€‹†‰ï‘æ16‰ñ‘å‰ï (2010/9/19), é‹Ê.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-110001. [ŒŽ’˜] An explicit signature of balancing selection for color vision variation
in New World monkeys. Hiwatashi T, Okabe Y, Tsutsui T, Hiramatsu C, Melin AD, Oota H1, Schaffner
CM, Aureli F, Fedigan LM, Innan H, Kawamura S: Molecular Biology Evolution 2010/2; 27 (2): 453-64.
(‘Ÿ“c”ŽŽ÷1: 1‰ð–U)

H21-110002. [ŒŽ’˜] Population-specific susceptibility to Crohn's disease and ulcerative
colitis; dominant and re cessive relative risks in the Japanese population. Nakagome S, Takeyama
Y, Mano S, Sakisaka S, Matsui T, Kawamura S, Oota H1: Ann Hum Genet 2010/3; 74 (2): 126-36. (‘Ÿ
“c”ŽŽ÷1: 1‰ð–U)

H21-120001. [ŒŽ’˜] Œ»‘ã“ú–{l‚̉ºŠ{œ•›ƒIƒgƒKƒCE‚Ì”­Œ»•p“x‚ÉŠÖ‚·‚錀‹†. dŒ³m, ‘º“c@
˜Ð, ŽR‰º‰À—Y, “L–ؐ³‹I, ûŒŽP•F1, Œã“¡¹º (1‰ð–U): “ú–{Œûo‰ÈŠw‰ïŽGŽ 2009/3; 58 (2): 50-5.

H21-520001. [‘à]y“ÁW1: i‰»l—ÞŠw‚ÌŒ»Ýz’j—‚ňقȂéˆÚZƒpƒ^[ƒ“‚ƃqƒgƒQƒmƒ€‘œ—l«.
‘Ÿ“c”ŽŽ÷ (‰ð–U): ˆâ“` 2010/3; 64 (2): 24-9.


‰ð–UŠw (ãã’PˆÊ)

[Šwp˜_•¶]

110005. [ŒŽ’˜] Development of the somatosensory cortex, the cerebellum, and the main olfactory
system in Semaphorin 3F knockout mice. Matsuda I, Fukaya M1, Nakao H, Nakao K, Matsumoto H, Mori
K, Watanabe M, Aiba A: Neurosci Res 2010/5; 66 (3): 321-9. ([’J¹O1: 1‰ð–U)

110006. [ŒŽ’˜] Impaired hippocampal neurogenesis and vascular formation in ephrin-A5-deficient
mice. Hara Y1, Nomura T, Yoshizaki K, FrisŽn J, Osumi N: STEM CELLS 2010/5; 28 (5): 974-83. (ŒŽ@
–FL1: 1‰ð–U)

110007. [ŒŽ’˜] USP9x-mediated deubiquitination of EFA6 regulates de novo tight junction assembly.
Thard D, Labarrade F, Partisani M, Milanini J, Sakagami H1, Fon EA, Wood SA, Franco M, Luton F:
EMBO JOURNAL 2010/5; 29 (9): 1499-509. (ãã—ms1: 1‰ð–U)

110008. [ŒŽ’˜] Activity-dependent localization in spines of the F-actin capping protein CapZ
screened in a rat model of dementia. Kitanishi T, Sakai J, Kojima S, Saitoh S, Inokuchi K, Fukaya
M1, Watanabe M, Matsuki N, Yamada MK: Genes Cells 2010/6; 15 (7): 737-47. ([’J¹O1: 1‰ð–U)

110009. [ŒŽ’˜] TARPs ƒÁ-2 and ƒÁ-7 are essential for AMPA receptor expression in the cerebellum.
Yamazaki M, Fukaya M1, Hashimoto K, Yamasaki M, Tsujita M, Itakura M, Abe M, Natsume R, Takahashi
M, Kano M, Sakimura K, Watanabe M: Eur J Neurosci 2010/6; 31 (12): 2204-20. ([’J¹O1: 1‰ð–U)

110010. [ŒŽ’˜] Oxidative stress in mature rat testis and its developmental changes. Sakai Y1,
Aminaka M, Takata A, Kudou Y2, Yamauchi H, Aizawa Y2, Sakagami H1: Dev Growth Differ 2010/9; 52
(7): 657-63. (ŽðˆäNO1, H“¡—Yˆê˜N2, ‘ŠàVDŽ¡2, ãã—ms1: 1‰ð–U, 2‰q¶EŒöO‰q¶)

110011. [ŒŽ’˜] Vezatin, a potential target for ADP-ribosylation factor 6, regulates the dendritic
formation of hippocampal neurons. Sanda M. Ohara N. Kamata A. Hara Y1, Tamaki H1, Sukegawa J,
Yanagisawa T, Fukunaga K, Kondo H, Sakagami H1: NEUROSCIENCE RESEARCH 2010/6; 67 (2): 126-36. (ŒŽ@
–FL1, ‹Ê–؉p–Ÿ1, ãã—ms1: 1‰ð–U)

110012. [ŒŽ’˜] Involvement of the Serum Response Factor Coactivator Megakaryoblastic Leukemia
(MKL) in the Activin-regulated Dendritic Complexity of Rat Cortical Neurons. Ishikawa M, Nishijima
N, Shiota J, Sakagami H1, Tsuchida K, Mizukoshi M, Fukuchi M, Tsuda M, Tabuchi A: J Biol Chem 2010/10;
285 (43): 32734-43. (ãã—ms1: 1‰ð–U)

110013. [ŒŽ’˜] Identification and characterization of PRG-1 as a neuronal calmodulin-binding
protein. Tokumitsu H, Hatano N, Tsuchiya M, Yurimoto S, Fujimoto T, Ohara N, Kobayashi R, Sakagami
H1: Biochem J 2010/10; 431 (1): 81-91. (ãã—ms1: 1‰ð–U)

110014. [ŒŽ’˜] NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in
postnatal life and following neurodegeneration. Kang SH, Fukaya M1, Yang JK, Rothstein JD, Bergles
DE: Neuron 2010/11; 68 (4): 668-81. ([’J¹O1: 1‰ð–U)

110015. [ŒŽ’˜] SynArfGEF is a guanine nucleotide exchange factor for Arf6 and localies
preferentially at post-synaptic specializations of inhibitory synapses. Fukaya M1, Kamata A, Hara
Y1, Tamaki H1, Katsumata O, Ito N, Takeda S, Hata Y, Suzuki T, Watanabe M, Harvey RJ, Sakagami
H1: J Neurochem 2011/3; 116 (6): 1122-37. ([’J¹O1, ŒŽ@–FL1, ‹Ê–؉p–Ÿ1, ãã—ms1: 1‰ð–U)

[Šw‰ïEŒ€‹†‰ï“™]

723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’ᕪŽq—ÊG’`”’Ž¿ARF6“ÁˆÙ“IƒOƒAƒjƒ“ƒkƒNƒŒƒIƒ`ƒhŒðŠ·
ˆöŽqGEP100/BRAG2‚̐_ŒoŒn‚É‚š‚¯‚é”­Œ»‚ÆŽ÷ó“Ë‹NŒ`¬‚Ö‚Ì‹@”\ŠÖ—^. ãã—ms1, ¬ŒŽ’ŒŽ÷ (1‰ð–U):
‘æ33‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2010/9/2), _ŒË.

723006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒXV¶Ž™‚̍˜‘‘OŠp‚Ì‚š‚¯‚éGABAì“®«ƒjƒ…[ƒƒ“
‚ÌŒ`‘ÔŠw“I“Á’¥. Š`è”ü‘ã, ãã—ms1, –öì‰Eç•v, ŒŠÛLŽj (1‰ð–U): ‘æ88‰ñ“ú–{¶—Šw‘å‰ï
(2011/3/28), ‰¡•l. Š“Œ“ú–{kÐ‚Ì‚œ‚ß, Journal of Physiological Science‚Å‚ÌŽãŠJÃ (p.1-370)

723007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Immuno-electronmicroscopic study for newly-formed
Golgi apparatus. ‹Ê–؉p–Ÿ1, ãã—ms1, ŽR‰È³•œ (1‰ð–U): ‘æ116‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘Šwp
W‰ï (2011/3/30), ‰¡•l. ŠkÐ‚Ì‚œ‚ß‘å‰ïŠJÃ’†Ž~

723008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The trafficking mode of AMPA-type glutamate
receptors in Bergmann glia. [’J¹O (‰ð–U): ‘æ29‰ñ“à“¡ƒRƒ“ƒtƒ@ƒŒƒ“ƒX ƒOƒŠƒAƒ[ƒ‹ƒh
(2010/10/6), Ã“썑Û‘ºƒZƒ“ƒ^[.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-110003. [ŒŽ’˜] VAV2 and VAV3 as Candidate Disease Genes for Spontaneous Glaucoma in Mice
and Humans. Fujikawa K, Iwata T, Inoue K, Akahori M, Kadotani H, Fukaya M1, Watanabe M, Chang
Q, Barnett EM, Swat W: PLoS One 2010/2; 5 (2): e9050. ([’J¹O1: 1‰ð–U)

H21-110004. [ŒŽ’˜] Comprehensive behavioral analysis of calcium/calmodulin-dependent
protein kinase IV knockout mice. Takao K, Tanda K, Nakamura K, Kasahara J, Nakao K, Katsuki M,
Nakanishi K, Yamasaki N, Toyama K, Adachi M, Umeda M, Araki T, Fukunaga K, Kondo H, Sakagami H1,
Miyakawa T: PLoS One 2010/3; 5 (3): e9460. (ãã—ms1: 1‰ð–U)


¶—Šw (ìã’PˆÊ)

[Šw‰ïEŒ€‹†‰ï“™]

712003. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Anti-tumor cell effects of excitation of acridine
orange with blue light. Hiruma H1: Symposium on Advanced Biotechnologies & Instrumentations (SABI)
2010 (2010/10/24), ãŠC. (”ä—¯ŠÔO”ü1: 1¶—)

722004. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Weak base-induced cytoplasmic vacuoles are
formed around individual lysosomes. ”ä—¯ŠÔO”ü1, •Ð‘q@—²1, ìã@—Ï1 (1¶—): ‘æ87‰ñ“ú–{
¶—Šw‰ï‘å‰ï (2010/5/20), ·‰ª

722005. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Exosomal secretion of FGF-1. ”ä—¯ŠÔO”ü1, ì
ã@—Ï1, ™]G–Ÿ1 (1¶—): ‘æ88‰ñ¶—Šw‰ï‘å‰ï (2011/3/28), ‰¡•l. ŠkÐ‚Ì‚œ‚ß‘å‰ïŠJÃ’†Ž~ (The
Journal of Physiological SciencesŽã‚Å”­•\)

723009. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Bioimaging study on intracellular localization of
synaptophysin in cultured rat hypothalamic supraoptic neurons. ˆé’†—¹1, ”ä—¯ŠÔO”ü1, •Ð‘q@
—²1, ìã@—Ï1 (1¶—): ‘æ87‰ñ“ú–{¶—Šw‰ï‘å‰ï (2010/5/19), ·‰ª.

723010. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The inhibitory effects of pentobarbital on axonal
transport in cultured rat cortical neurons. ™]G–Ÿ1, ”ä—¯ŠÔO”ü1, ìã@—Ï1 (1¶—): ‘æ87
‰ñ“ú–{¶—Šw‰ï‘å‰ï (2010/5/20), ·‰ª.

723011. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Non-phosphorylated neurofilaments are more vulnerable
to superoxide dismutase inhibition than phosphorylated neurofilaments in rat spinal neurons. ˆé
’†—¹1, ”ä—¯ŠÔO”ü1, ìã@—Ï1 (1¶—): Neuro2010 (2010/9/2), _ŒË.

723012. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Isolated neuroendocrine cells are capable of
spontaneous cell fusion during development. ”ä—¯ŠÔO”ü1, ˆé’†—¹1, ìã@—Ï1 (1¶—):
Neuro2010 (2010/9/4), _ŒË.

723013. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Inhibitory effects of bafilomycin A1 on weak
base-induced convulsion in mice. ™]G–Ÿ1, ”ä—¯ŠÔO”ü1, ìã@—Ï1 (1¶—): ‘æ88‰ñ“ú–{¶—
Šw‰ï‘å‰ï (2011/3/28), ‰¡•l. ŠkÐ‚Ì‚œ‚ß‘å‰ïŠJÃ’†Ž~ (The Journal of Physiological SciencesŽ
ã‚Å”­•\)

723014. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Fluorescence imaging of lipid peroxides in organelle
membranes. ˆé’†—¹1, ”ä—¯ŠÔO”ü1, •Ð‘q@—²1, ìã@—Ï1 (1¶—): ‘æ88‰ñ“ú–{¶—Šw‰ï‘å‰ï
(2011/3/30), ‰¡•l. ŠkÐ‚Ì‚œ‚ß‘å‰ïŠJÃ’†Ž~ (The Journal of Physiological Science Žã‚ÅŠJÃ)


¶—Šw (‰ÍŒŽ’PˆÊ)

[Šwp˜_•¶]

110016. [ŒŽ’˜] Localization of ATP-sensitive K+ channel subunits in rat submandibular gland. Zhou
M, He HJ, Hirano M, Sekiguchi M, Tanaka O, Kawahara K1, Abe H: J Histochem Cytochem 2010/6; 58
(6): 499-507. (‰ÍŒŽŽ‰ë1: 1¶—)

[’˜@‘]

620001. [Šwp‘] (•ª’SŽ·•M)y“ÁW: V‚µ‚¢ƒAƒ‹ƒhƒXƒeƒƒ“Šw‚Ì–‹ŠJ‚¯ (t‚Æ“§Í 68 (6))zƒAƒ‹ƒhƒX
ƒeƒƒ“‚ÌŠî‘b‰ÈŠw?ƒAƒ‹ƒhƒXƒeƒƒ“‚̐¶—ì—p‚ƃAƒ‹ƒhƒXƒeƒƒ“ƒGƒXƒP[ƒv?, p.973-6. ‰ÍŒŽŽ‰ë1,
ˆÀ‰ª—L‹IŽq1, ¬—ѐ‰À2 (1¶—, 2–ƒŒ), “Œ‹žˆãŠwŽÐ, 2010/6”­s.

620002. [Šwp‘] (•ª’SŽ·•M)y‘æ53‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï‹L”OŽ?t‘ŸŠw‚Ì—ðŽj‚ð’z‚¢‚œlXzt¶
—Šw‚ÌŒš‘¢ŽÒ, p.41-3. ‰ÍŒŽŽ‰ë (¶—), (ŽÐ) “ú–{t‘ŸŠw‰ï, “Œ‹ž, 2010/6”­s.

620003. [Šwp‘]y“ÁW: ƒŠƒ“‘ãŽÓˆÙí (t‚Æ“§Í 69 (2))z‘˜_: t‚ł̃Šƒ“—A‘—, p.155-9. ‰ÍŒŽŽ
‰ë (¶—), “Œ‹žˆãŠwŽÐ, 2010/8”­s.

620004. [Šwp‘]y”A×ŠÇŽŸŠ³‚̗Տ° (“ú–{t‘ŸŠw‰ïŽ53 (2))z•ªŽqƒŒƒxƒ‹‚©‚ç‚Ý‚œ”A×ŠÇ‹@”\,
p.136-41. ‰ÍŒŽŽ‰ë (¶—), (ŽÐ) “ú–{t‘ŸŠw‰ï, 2011/3”­s.

622001. [Šwp‘] (–|–ó)yƒMƒƒƒmƒ“ƒO¶—Šw@ŒŽ‘23”Łz‘æVIII•Ò ”A¶¬‚Æ”rŸ•@38. t‹@”\‚Æ”r”A,
p.741-70. 39. ×–EŠO‰t‚Ì‘g¬‚Æ—Ê‚Ì’²ß, p.771-87. ‰ÍŒŽŽ‰ë (¶—), ’˜ Kim E. Barrett, Susan M.
Barman, Scott Boitano, Heddwen L. Brooks, ŠÄ–ó ‰ª“c‘אL, ŠÛ‘P, “Œ‹ž, 2011/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713006. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The participation of testosterone in the retention of
the extinction memory of conditioned taste aversion learning in male mice. Suzuki E, Kawabe T,
Eda-Fujiwara H, Saito R, Satoh R1, Mmiyamoto T: The 20th Congress of the European Chemoreception
Research Organization (ECRO) 2010/9/19), Avignon, France. (²“¡—º•œ1: 1¶—)

713007. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Effect of testosterone on maturation process of brain
regions related to extinction memory retention of conditioned taste aversion learning. Suzuki
E, Kawabe T, Eda-Fujiwara H, Saito R, Satoh R1, Miyamoto T: The 8th International Symposium on
Molecular and Neural Mechanisms of Taste and Olfactory Perception (2010/11/6), Fukuoka, Japan.
(²“¡—º•œ1: 1¶—)

713008. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Sex differences in vocal behavior associated with pair
bonding in the budgerigar, a monogamous parrot. Eda-Fujiwara H, Hata Y, Inamura M, Watanabe A,
Satoh R1, Miyamoto T: 40th annual meeting of the Society for Neuroscience (2010/11/17), San Diego,
USA. (²“¡—º•œ1: 1¶—)

713009. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Mechanisms of Type 4 (Hyperkalemic) Renal Tubular
Acidosis. Hori K, Nagai T, Izumi Y, Nakayama Y, Hasuike Y, Nanami M, Yasuoka Y1, Otaki Y, Tanoue
A, Kawahara K1, Nakanishi T, Nonoguchi H: ‘æ43‰ñƒAƒƒŠƒJt‘ŸŠw‰ï‹c (2010/11/18), Denver, USA.
(ˆÀ‰ª—L‹IŽq1, ‰ÍŒŽŽ‰ë1: 1¶—)

713010. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Dislocation of mouse collecting duct aquaporin-2 by
metabolic acidosis: role of vasopressin V1a receptor. Yasuoka Y1, Kobayashi M2, Sato Y, Nonoguchi
H, Tanoue A, Kawahara K1: ‘æ43‰ñƒAƒƒŠƒJt‘ŸŠw‰ï‹c (2010/11/20), Denver, USA. (ˆÀ‰ª—L‹IŽq1, ¬
—ѐ‰À2, ‰ÍŒŽŽ‰ë1: 1¶—, 2–ƒŒ)

722006. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) A role of V1aR in acid-base balance. ˆÀ‰ª—L
‹IŽq1, ‰ÍŒŽŽ‰ë1 (1¶—): ‘æ87‰ñ“ú–{¶—Šw‰ï‘å‰ï (2010/5/20), ·‰ª.

723015. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Cellular Localization and Function of a Mutant of
Inwardly Rectifying K+ channel (Kir) 4.1. •Ÿ“c‰pˆê1, ‰ÍŒŽŽ‰ë1 (1¶—): ‘æ87‰ñ“ú–{¶—Šw‰ï
‘å‰ï (2010/5/19), ·‰ª.

723016. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Testosterone enhances retention of the extinction
memory of conditioned taste aversion learning in mice. —é–Øœš‰ë, ìç²‚Æ‚à‚±, “¡ŒŽGŽq, âV“¡—
‰À, ²“¡—º•œ1, ‹{–{•“T (1¶—): ‘æ87‰ñ“ú–{¶—Šw‰ï‘å‰ï (2010/5/19), ·‰ª.

723017. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒeƒXƒgƒXƒeƒƒ“‚̓}ƒEƒX‚Ì–¡ŠoŒ™ˆ«ŠwK‚̏Á‹Ž‹L‰¯•ÛŽ
‚𑝋­‚³‚¹‚é. —é–Øœš‰ë, ìç²‚Æ‚à‚±, “¡ŒŽGŽq, âV“¡—‰À, ²“¡—º•œ1, ‹{–{•“T (1¶—): ‘æ87‰ñ
“ú–{¶—Šw‰ï‘å‰ï (2010/5/19), ·‰ª.

723018. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Suger-preference genarated by alternative conditioning
procedure and its relationship with body weight under chronic food restriction in mice. ‹{–{
•“T, Yoshizawa H, Katazawa M, “¡ŒŽGŽq, ²“¡—º•œ1, Yasoshima Y (1¶—): ‘æ87‰ñ“ú–{¶—Šw‰ï
‘å‰ï (2010/5/19), ·‰ª.

723019. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) …ƒ`ƒƒƒlƒ‹AQP2‚̐tW‡ŠÇ×–E“à‹ÇÝ‚É‚š‚¯‚éƒAƒVƒh[
ƒVƒX‚̉e‹¿‚ƃoƒ\ƒvƒŒƒVƒ“V1aR‚Ì–ðŠ„. ˆÀ‰ª—L‹IŽq1, ¬—ѐ‰À2, ²“¡—Yˆê, –ìXŒû”ŽŽj, “cãºl,
‰ÍŒŽŽ‰ë1 (1¶—, 2–ƒŒ): ‘æ53‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2010/6/17), _ŒË.

723020. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”AŽ_—A‘—‰ßè”­Œ»ƒ}ƒEƒX‚ð—p‚¢‚œ”AŽ_—A‘—‚̉ðÍ. –Ø‘º@
“O, ’Ë“c@ˆ€, Amonpatumrat Sirirat, •Ÿ•yr”V, Jutabha Promusuk, Žs“cŒö”ü, ‰ÍŒŽŽ‰ë1, ‹àˆäDŽ,
ˆÀŒ®•F, ŸNˆä—T”V (1¶—): ‘æ53‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2010/6/17), _ŒË.

723021. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Spatial organization of song-activated neurons in the
caudomedial pallium of the budgerigar (Melopsittacus undulatus, a parrot). ²“¡—º•œ1, “¡ŒŽG
Žq, “n•Óˆ€Žq, ŽRèŽÌ•v, ‹{–{•“T (1¶—): ‘æ33‰ñ“ú–{_Œo‰ÈŠw‰ï‘å‰ï (2010/9/3), _ŒË.

723022. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒX‚Ì–¡ŠoŒ™ˆ«‹L‰¯‚̏Á‹Ž‹L‰¯•ÛŽ‚É‚š‚¯‚鐫·. ì
ç²‚Æ‚à‚±, —é–Øœš‰ë, “¡ŒŽGŽq, âV“¡—‰À, ²“¡—º•œ1, ‹{–{•“T (1¶—): “ú–{–¡‚Æ“õŠw‰ï‘æ44‰ñ‘å
‰ï (2010/9/10), –k‹ãB.

723023. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žö“ûŠúŽ“ƒ}ƒEƒX‚Ì–¡ŠoŒ™ˆ«ŠwK‚ƃIƒLƒVƒgƒVƒ“‚̉e‹¿.
‘匎‘Žq, Œ‰i’qŽÀ, ã–ìˆË—¢Žq, “¡ŒŽGŽq, ²“¡—º•œ1, ‹{–{•“T (1¶—): “ú–{–¡‚Æ“õŠw‰ï‘æ44‰ñ
‘å‰ï (2010/9/10), –k‹ãB.

723024. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆê•vˆêÈ‚̃ZƒLƒZƒCƒCƒ“ƒR‚ł͂‚ª‚¢‚ÌãJ‚ÉŠÖ‚í‚é”­ºs“®‚ɐ«·
‚ª‚ ‚é. “¡ŒŽGŽq, ”©@—R‰À, ˆîÀ‚Ü‚Ç‚©, “n•Óˆ€Žq, ²“¡—º•œ1, ‹{–{•“T (1¶—): “ú–{“®•šŠw‰ï
‘æ81‰ñ”NŽŸ‘å‰ï (2010/9/25), “Œ‹ž.

723025. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Prostaglandin E2 Stimulates the Expression of COX-2
in Mouse Macula Densa Cell Line. •Ÿ“c‰pˆê1, ‰ÍŒŽŽ‰ë1 (1¶—): ‘æ88‰ñ“ú–{¶—Šw‰ï‘å‰ï
(2011/3/28). ŠŠw‰ï’†Ž~‚Ì‚œ‚ß, ”­•\‚È‚µ‚ōûŽq‘Ì‚Ì‚Ý‚Å”­•\

733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t”A×ŠÇ‚ÌK{•ª”å‚ÆK{ƒ`ƒƒƒlƒ‹. ‰ÍŒŽŽ
‰ë (¶—): Œö‰và’c–@l ƒ\ƒ‹ƒgEƒTƒCƒGƒ“ƒXŒ€‹†à’c ‘æ22‰ñ•¬Œ€‹†”­•\‰ï (2010/7/20), “Œ‹ž.

733003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“E2‚̓}ƒEƒXƒ}ƒNƒ‰ƒfƒ“ƒT
×–EŠ” (NE-MD) ‚É‚š‚¯‚éCOX-2”­Œ»‚ðCü‚·‚é. •Ÿ“c‰pˆê1, ‰ÍŒŽŽ‰ë1 (1¶—): ‘æ40‰ñ“ú–{t‘ŸŠw
‰ï“Œ•”Šwp‘å‰ï (2010/9/25), ‰F“s‹{.

733004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tƒ}ƒNƒ‰ƒfƒ“ƒT×–E‚ÌPGE2ŽY¶Ž©ŒÈ’²ß‹@\.
•Ÿ“c‰pˆê1, ‰ÍŒŽŽ‰ë1 (1¶—): •œ¬22”N“x ¶—Œ€Œ€‹†‰ïuƒVƒOƒiƒ‹“`’B‚Ì“®“I—‰ð‚ð–ÚŽw‚·Ví—ªv
(2010/9/30), –ŒŒÃ‰® (‰ªè).

733005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒXtW‡ŠÇƒoƒ\ƒvƒŒƒVƒ“V1aR-AQP2Ž²: ŽÀ
Œ±“IƒAƒVƒh[ƒVƒX‚̉e‹¿. ˆÀ‰ª—L‹IŽq1, ¬—ѐ‰À2, ‰ÍŒŽŽ‰ë1 (1¶—, 2–ƒŒ): ¶—Œ€Œ€‹†‰ïw‹É
«×–E‚Ì•a‘Ԑ¶—‰ð–Ÿ‚ÉŒü‚¯‚œ‘œŠp“IƒAƒvƒ[ƒ`x(2010/11/4), ‰ªè.


¶‰»Šw

[Šwp˜_•¶]

110017. [ŒŽ’˜] TARPs g-2 and g-7 are essential for AMPA receptor expression in the cerebellum.
Maya Yamazaki, Masahiro Fukaya, Kouichi Hashimoto, Miwako Yamasaki, Itakura M1, Manabu Abe, Rie
Natsume, Takahashi M1, Masanobu Kano, Kenji Sakimura, Masahiko Watanabe: EUROPEAN JOURNAL OF
NEUROSCIENCE 2010/6; 31: 2204-22. (”‘q@œ1, ‚‹Ž³g1: 1¶‰»)

110018. [ŒŽ’˜] SNARE Protein recycling by ƒ¿SNAP and ƒÀSNAP supports synaptic vesicle priming.
Burgalossi A, Jung S, Meyer G, Jockusch WJ, Jahn O, Taschenberger H, O'Connor VM, Nishiki T,
Takahashi M1, Brose N, Rhee JS: Neuron 2010/11; 68: 473-87. (‚‹Ž³g1: 1¶‰»)

110019. [ŒŽ’˜] Interaction of calcium-dependent activator protein for secretion 1 (CAPS1) with
the class II ADP-ribosylation factor small GTPases is required for dense-core vesicle trafficking
in the trans-Golgi network. Sadakata T, Shinoda Y, Sekine Y, Saruta C, Itakura M1, Takahashi M1,
Furuichi T: J Biol Chem 2010/12; 285 (49): 38710-9. (”‘q@œ1, ‚‹Ž³g1: 1¶‰»)

110020. [ŒŽ’˜] PKC-dependent inhibition of CA2+-dependent exocytosis from astrocytes. Yasuda K,
Itakura M1, Aoyagi K, Sugaya T, Nagata E, Ihara H, Takahashi M1: Glia 2011/1; 59 (1): 143-51. (”Â
‘q@œ1, ‚‹Ž³g1: 1¶‰»)

120002. [ŒŽ’˜] ƒtƒ‰ƒOƒƒ“ƒg•ªŽq‹O“¹ (FMO) –@‚É‚æ‚鐅—n‰t’†‚̃gƒŒƒnƒ[ƒX‚Ɛ…•ªŽq‚Ì‘ŠŒÝì—p‚̉ð
Í. ÎˆäˆèŽq1, ŽP@F”V (1¶‰»): “ú–{Ž•‰È‘åŠw‹I—v 2011/3; 40: 35-9.

[Šw‰ïEŒ€‹†‰ï“™]

712004. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Input-specific spine entry of soma-derived
Vesl-1S protein conforms to synaptic tagging. Okada D1 (The 12th Magdeburg International
Neurobiological Symposium (2010/9/7), Magdeburg, Germany. (‰ª“c‘叕1: 1¶‰»)

713011. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Characterization of sialylated oligosaccharides in
mucin induced by parasitic nematode infection: analysis of epitope recognized by the monoclonal
antibody HCM31. Tsubokawa D, Goso Y1, Nakamura T2, Sato N, Kurihara M, Ishihara K: 25th
International Carbohydrate Symposium (2010/8/5), Tokyo. (ŒÜäzsM1, ’†‘º@Œ’2: 1¶‰», 2Šñ¶
’Ž)

722007. [Šw‰ï (‘S‘)] (•ªŽqE_Œo‰ñ˜H‰ÈŠwŠÖ˜Aƒ[ƒNƒVƒ‡ƒbƒv)yƒVƒiƒvƒX‚ƃXƒpƒCƒ“‚ðì‚éˆâ“`Žqz
‚È‚ºƒVƒiƒvƒXƒ^ƒO‚ÍŽ„‚ðŽä‚«‚‚¯‚œ‚Ì‚©. ‰ª“c‘叕 (¶‰»): •ïŠ‡Œ^”]‰ÈŠwŒ€‹†„iŽx‰‡ƒlƒbƒgƒ[ƒN
u‰Ä‚̃[ƒNƒVƒ‡ƒbƒvv(2010/7/29), ŽD–y.

723026. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Direct binding of calcineurin/PP2B to a specific region
in the intracellular C-terminal domain of ƒÁ-8. “n•Ó˜aò, ”‘q@œ1, ›’J’ËMŽq, ‚‹Ž³g1 (1
¶‰»): ‘æ53‰ñ“ú–{_Œo‰»Šw‰ïE‘æ33‰ñ“ú–{_Œo‰ÈŠw‰ïE‘æ20‰ñ“ú–{_Œo‰ñ˜HŠw‰ï‡“¯‘å‰ï (Neuro2010)
(2010/9/2), _ŒË.

723027. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Regulation of SNARE complex formation by 8-nitro-cGMP.
š Ž}P•º, ˆä“c’qÍ, àV@’q—T, Ô’rFÍ, ”‘q@œ1, ‚‹Ž³g1, ‹ŒŽ@G (1¶‰»): ‘æ53‰ñ“ú–{_
Œo‰»Šw‰ïE‘æ33‰ñ“ú–{_Œo‰ÈŠw‰ïE‘æ20‰ñ“ú–{_Œo‰ñ˜HŠw‰ï‡“¯‘å‰ï (Neuro2010) (2010/9/2), _ŒË.

723028. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒsƒƒJƒ‹ƒsƒ““Š—^‚É‚æ‚é‚Ä‚ñ‚©‚ñdÏ‚É‚æ‚Á‚Ĉø‚«‹N‚±
‚³‚ê‚é‰Â‹t“I‹y‚Ñ”ñ‰Â‹t“I‚ȏˆÙí‚̏oŒ». ‘å’ːM‘Ÿ˜N, ŽRX‘D1, “n•Ó@Ž , —é–؉f“ñ (1¶‰»):
‘æ53‰ñ“ú–{_Œo‰»Šw‰ïE‘æ33‰ñ“ú–{_Œo‰ÈŠw‰ïE‘æ20‰ñ“ú–{_Œo‰ñ˜HŠw‰ï‡“¯‘å‰ï (Neuro2010)
(2010/9/2), _ŒË.

723029. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒX‚Ì”]‚ÌSNAP-25‚̃Šƒ“Ž_‰»‚̓‚ƒmƒAƒ~ƒ“‚É‚æ‚è—}
§‚³‚ê‚é. ¬‹v•ÛGr, ŽRX‘D1, ”‘q@œ1, ”Ñ“c—@‹X, ‹{‰ª@“™2, ‚‹Ž³g1 (1¶‰», 2ž_):
‘æ53‰ñ“ú–{_‰»Šw‰ïE‘æ33‰ñ“ú–{_Œo‰»Šw‰ïE‘æ20‰ñ“ú–{_Œo‰ñ˜HŠw‰ï‡“¯‘å‰ï (Neuro2010)
(2010/9/2), _ŒË.

723030. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PKCˆË‘¶“I‚ÈSNAP-25‚̃Šƒ“Ž_‰»‚É‚æ‚éƒVƒiƒvƒgƒ][ƒ€
‚©‚ç‚̃h[ƒpƒ~ƒ“•úo‚Ì‘£i‹@\. ‚‹Ž³g1, ›–ì@‘ì, ŽRX‘D1, ”‘q@œ1 (1¶‰»): ‘æ53‰ñ
“ú–{_Œo‰»Šw‰ïE‘æ33‰ñ“ú–{_Œo‰ÈŠw‰ïE‘æ20‰ñ“ú–{_Œo‰ñ˜HŠw‰ï‡“¯‘å‰ï (Neuro2010) (2010/9/3),
_ŒË.

723031. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) TARPs ƒÁ-2 and ƒÁ-7 are functional components of
cerebellar AMPA receptor. ŽRè^–í, [’J¹O, ‹Ž–{_ˆê, ŽRè”ü˜aŽq, ”‘q@œ1, ‚‹Ž³g1, Žë
–ì•ûL, “n•Ó‰ë•F, è‘ºŒšŽi (1¶‰»): ‘æ53‰ñ“ú–{_Œo‰»Šw‰ïE‘æ33‰ñ“ú–{_Œo‰ÈŠw‰ïE‘æ20‰ñ“ú–{
_Œo‰ñ˜HŠw‰ï‡“¯‘å‰ï (Neuro2010) (2010/9/3), _ŒË.

723032. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶–ò (Œú–pE‘h—tE–؍) ‚̃‰ƒbƒgƒGƒ^ƒm[ƒ‹Žä‹N«ˆÝ
”S–ŒŠQ‚ɑ΂·‚éŒø‰Ê. ‹{ˆêŽÑ•c, Žsì‘ž•¶, ŒÜäzsM1, ÎŒŽ˜a•F (1¶‰»): ‘æ38‰ñ“ú–{’×ᇊw‰ï
(2010/11/20), ‘åã.

723033. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒbƒg‘å’°ƒ€ƒ`ƒ“‚ð–ƉuŒ¹‚Æ‚µ‚č쐬‚µ‚œƒ‚ƒmƒNƒ[ƒi
ƒ‹R‘̂̐«ó. ŒŽ“c@˜Ð, “c’†GŽ÷, ”Ñ“c‘׍L, ŒIŒŽ@œ, ŒÜäzsM1, ÎŒŽ˜a•F (1¶‰»): ‘æ83‰ñ“ú
–{¶‰»Šw‰ï‘å‰ï (2010/12/9), _ŒË.

723034. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Á‰»ŠÇŠñ¶ü’Ž‚ÌŠŽõ‚É‚æ‚郉ƒbƒg¬’°”S‰t‚̃€ƒ`ƒ““œ
œ‚̕ω». ’ؐì‘åŒå, ŒÜäzsM1, ’†‘º@Œ’2, ²“¡—ÏŽq, ŒIŒŽ@œ, ÎŒŽ˜a•F (1¶‰», 2Šñ¶’Ž): ‘æ
83‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (2010/12/9), _ŒË.

731001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒVƒiƒvƒXƒ^ƒO‰Œà‚ÌŽÀØ. ‰ª“c‘叕 (¶‰»): ž_‚ƍs
“®‚ÌŒ€‹†‰ï (2010/12/23), “Œ‹ž.


•ªŽqˆâ“`Šw

[Šwp˜_•¶]

110021. [ŒŽ’˜] Entire PTCH1 deletion is a common event in point mutation-negative cases with nevoid
basal cell carcinoma syndrome in Japan. Nagao K1, Fujii K, Saito K, Sugita K, Endo M, Motojima
T, Hatsuse H, Miyashita T1: Clin Genet 2011/2; 72 (2): 196-8. (’·”ö˜a‰E1, ‹{‰ºr”V1: 1•ªŽqˆâ
“`)

110022. [ŒŽ’˜] Multiple keratocystic odontogenic tumors associated with nevoid basal cell
carcinoma syndrome having distinct PTCH1 mutations: a case report. Sasaki R, Miyashita T1,
Matsumoto N, Fujii K, Saito K, Ando T: Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010/8;
110 (2): e41-6. (‹{‰ºr”V1: 1•ªŽqˆâ“`)

522001. [uÀ]y“ÁW: Œ©“Š‚µ‚Ä‚Í‚¢‚¯‚È‚¢‰Æ‘°«Žîᇁz–{–M‚É‚š‚¯‚é•ê”ÁŠî’ê×–EŠàÇŒóŒQ‚̈â“`Žq•Ï
ˆÙ‚ƗՏ°“I“Á’¥. ‹{‰ºr”V1, ‹Ë¶–ƒˆßŽq, âV“¡‰Á‘ãŽq, ™“cŽ¶, ‰““¡^”üŽq, “¡ˆäŽ‘¥ (1•ªŽqˆâ“`):
‰Æ‘°«Žîᇠ2011/1; 11 (1): 14-8.

[Šw‰ïEŒ€‹†‰ï“™]

713012. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical manifestations in Japanese Gorlin syndrome
patients. Miyashita T1, Endo M: 11th International Child Neurology Congress Meeting (2010/5/2),
Egypt. (‹{‰ºr”V1: 1•ªŽqˆâ“`)

713013. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Germline and somatic PTCH1 mutations in Japanese basal
cell nevus syndrome. Miyashita T1, Fujii K: 11th International Child Neurology Congress Meeting
(2010/5/2), Egypt. (‹{‰ºr”V1: 1•ªŽqˆâ“`)

722008. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –{–M‚É‚š‚¯‚é•ê”ÁŠî’ê×–EŠàÇŒóŒQ‚̈â“`Žq•ÏˆÙ
‚ƗՏ°“I“Á’¥. ‹{‰ºr”V1, ‰““¡^”üŽq, âV“¡‰Á‘ãŽq, ™“cŽ¶, “¡ˆäŽ‘¥ (1•ªŽqˆâ“`): ‘æ16‰ñ“ú–{
‰Æ‘°«Žîᇊw‰ïŠwpW‰ï (2010/7/10), VŠƒ.

723035. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PTCHˆâ“`ŽqˆÙí‚𔺂Á‚œŠî’ê×–E•ê”ÁÇŒóŒQ. ‹{‰ºr
”V1, ²X–Ø—º, âV“¡‰Á‘ãŽq, “n•Ó—ŠŸ, “¡ˆäŽ‘¥, [“cŒ’Ž¡, HŒŽŽí‚, ˆÀ“¡’q”Ž (1•ªŽqˆâ“`): ‘æ34
‰ñ“ú–{ˆâ“`ƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ïŠwpW‰ï (2010/5/28), “Œ‹ž.

723036. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ú–{l•ê”ÁŠî’ê×–EŠàÇŒóŒQ‚Ì16%‚ÍPTCH1ˆâ“`Žq‚Ì•Ð
ƒAƒŒƒ‹Œ‡‘¹‚Å”­Ç‚·‚é. ‹{‰ºr”V1, ’·”ö˜a‰E1, ‰““¡^”üŽq, –{“‡•q”T, âV“¡‰Á‘ãŽq, ™“cŽ¶, “¡ˆä
Ž‘¥ (1•ªŽqˆâ“`): ‘æ16‰ñ“ú–{‰Æ‘°«Žîᇊw‰ïŠwpW‰ï (2010/7/10), VŠƒ.

723037. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Sixteen percent of cases of basal cell carcinoma
syndrome patients in Japan carry an entire deletion of the PTCH1 gene. ’·”ö˜a‰E1, ‹Ë¶–ƒˆßŽq,
‚ŽR‹g‰i1, ‹{‰ºr”V1 (1•ªŽqˆâ“`): ‘æ69‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2010/9/22), ‘åã.

723038. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Characterization of a mouse monoclonal antibody raised
against human PTCH1 receptor protein. ‚ŽR‹g‰i1, ’·”ö˜a‰E1, ‹Ë¶–ƒˆßŽq, ‹{‰ºr”V1 (1•ªŽqˆâ
“`): ‘æ69‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2010/9/23), ‘åã.

723039. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 21-hydroxylase deficiency‚̐f’f‚É‚š‚¯‚éˆâ“`ŽqŒ^‚Æ
•\Œ»Œ^‚Ì–µ‚—á?PCR‚É‚š‚¯‚éallele dropout?. ‚ŽR‹g‰i1, ‹{‰ºr”V1, ˆÀ–{—Ž”n, ‘唚®Žq, ‚“c
Žj’j (1•ªŽqˆâ“`): l—Þˆâ“`Šw‰ï‘æ55‰ñ‘å‰ï (2010/10/29), ‘å‹{.

723040. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Characterization of a Mouse Monoclonal Antibody Raised
Against Human PTCH1 Receptor Protein. ‚ŽR‹g‰i1, Žu‘º«l, ’·”ö˜a‰E1, ‹Ë¶–ƒˆßŽq, ‹TŽRFŽO1,
‹{‰ºr”V1 (1•ªŽqˆâ“`): ‘æ33‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ïE‘æ83‰ñ“ú–{¶‰»Šw‰ï‘å‰ï ‡“¯‘å‰ï (2010/12/8),
_ŒË.

723041. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PTCH1 Mutations in Japanese Nevoid Basal Cell Carcinoma
Syndrome Patients. ’·”ö˜a‰E1, ‚ŽR‹g‰i1, ‹TŽRFŽO1, ‹{‰ºr”V1 (1•ªŽqˆâ“`): ‘æ33‰ñ“ú–{•ªŽq
¶•šŠw‰ï”N‰ïE‘æ83‰ñ“ú–{¶‰»Šw‰ï‘å‰ï ‡“¯‘å‰ï (2010/12/10), _ŒË.

732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) GorlinÇŒóŒQ‚ƈâ“`Žq•ÏˆÙ. ‹{‰ºr”V (•ªŽqˆâ“`):
‘æ1‰ñGorlinÇŒóŒQƒVƒ“ƒ|ƒWƒEƒ€ (2011/1/22), “Œ‹ž.

733006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •ê”ÁŠî’ê×–EŠàÇŒóŒQ‚Ì“ú–{lÇ—á16%‚É‚š
‚¢‚ÄPTCH1ˆâ“`Žq‚Ì‘SŒ‡Žž‚ªŒ©‚ç‚ê‚é. ’·”ö˜a‰E1, ²“¡[ˆê, ‹Ë¶–ƒˆßŽq, ‚ŽR‹g‰i1, ‹TŽRFŽO1, ‹{
‰ºr”V1 (1•ªŽqˆâ“`): ‘æ23‰ñ–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€ (2010/8/6), –k—¢‘åŠw+˜a“cƒLƒƒ
ƒ“ƒpƒX.

733007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –{–M‚É‚š‚¯‚éGorlinÇŒóŒQ157—á‚ÌŒŸ“¢?‰¢
•Ä‹‚Æ‚Ì‘Šˆá‚Ɛf’fŠî€‚ɂ‚¢‚Ä?. ‰““¡^”üŽq, …—ŽO”ü, “àì‰p‹I, “¡ˆäŽ‘¥, ‹{‰ºr”V1, âV“¡‰Á
‘ãŽq, ™“cŽ¶, ‰Í–ì—zˆê (1•ªŽqˆâ“`): ‘æ22‰ñç—tŒ§¬Ž™_Œo§˜b‰ï (2010/11/6), ç—t.

733008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) GorlinÇŒóŒQ‚É‚š‚¯‚鍜Œ`¬‚ÌŒŸ“¢?“®•šƒ‚
ƒfƒ‹‚ƍœ–§“x‚Æ‚ÌŠÖ˜A?. …—ŽO”ü, “¡ˆäŽ‘¥, ‹{‰ºr”V1, “A@—Yˆê, {ŽR–ƒˆßŽq, ‰““¡^”üŽq, “àì
‰p‹I, ‰Í–ì—zˆê (1•ªŽqˆâ“`): ‘æ22‰ñç—tŒ§¬Ž™_Œo§˜b‰ï (2010/11/6), ç—t.

733009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –{–M‚É‚š‚¯‚éGorlinÇŒóŒQ‚̗Տ°“IŒŸ“¢?Œú
˜JÈŒ€‹†”Ç‚Ì‘S‘’²ž‚æ‚è?. ‰““¡^”üŽq, “¡ˆäŽ‘¥, “àì‰p‹I, ‹{‰ºr”V1, âV“¡‰Á‘ãŽq, ™“cŽ¶ (1
•ªŽqˆâ“`): ‘æ115‰ñ¬Ž™ŒŒ‰tŽîᇍ§˜b‰ï (2011/1/21), “Œ‹ž.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H7-540001. [‚»‚Ì‘Œ (’Z•ñ)] XüƒtƒCƒ‹ƒ€—p”ñRIƒ}[ƒJ[. ŽÂ’ˏHŽq, ‚ŽR‹g‰i1, ŒÃ£—SŽq, Œ
–Šr”V, Â–؏Ÿ–€ (1•ªŽqˆâ“`): Isotope news 1995/12; 498: 30-1.

H21-110005. [ŒŽ’˜] Nevoid basal cell carcinoma syndrome with cleft lip and palate associated
with the novel PTCH gene mutations. Sasaki R, Saito K, Watanabe Y, Takayama Y1, Fujii K, Agawa
K, Miyashita T1, Ando T, Akizuki T: J Hum Genet 2009/7; 54 (7): 398-402. (‚ŽR‹g‰i1, ‹{‰ºr”V
1: 1•ªŽqˆâ“`)

–ò—Šw

[Šwp˜_•¶]

110023. [ŒŽ’˜] Microdose study of a P-glycoprotein substrate, fexofenadine, using a
non-radioisotope-labelled drug and LC/MS/MS. Yamazaki A, Kumagai Y1, Yamane N, Tozuka Z, Sugiyama
Y, Fujita T1, Yokota S2, Maeda M2: J Clin Pharm Ther 2010/4; 35 (2): 169-75. (ŒF’J—YŽ¡1, “¡“c
•üŒb1, ‰¡“cœÄˆê2, ‘O“cŽÀ‰Ô2: 1–ò—, 2“Œ•a‰@–òÜ•”)

110024. [ŒŽ’˜] mPGES-1-expressing bone marrow-derived cells enhance tumor growth and angiogenesis
in mice. Kamata H1, Hosono K2, Suzuki T2, Ogawa Y1, Kubo H1, Katoh H1, Ito Y, Uematsu S, Akira
S, Watanabe M1, Majima M2: Biomed Pharmacother 2010/7; 64 (6): 409-16. (Š™“cOŽ÷1, ×–ì‰Á“ÞŽq
2, —é–Ø—§‹I2, ¬ì‹±Žj1, ‹v•Û”CŽj1, ‰Á“¡@O1, “n粏¹•F1, ”n“ˆ³—²2: 1ŠO‰È, 2–ò—)

110025. [ŒŽ’˜] Roles of prostaglandin E2-EP1 receptor signaling in regulation of gastric motor
activity and emptying. Mizuguchi S1,2, Ohno T1,3, Hattori Y1, Ae T1,2, Minamino T1,2, Satoh T1,2,
Arai K, Saeki T, Hayashi I, Sugimoto Y, Narumiya S, Saigenji K1, Majima M2 (1Á‰»Ší“à, 2–ò—,
3ˆÉšŒŽ‹Š“¯): Am J Physiol Gastrointest Liver Physiol 2010/11; 299 (5): G1078-86. (…ŒûŸl1,2,
‘å–ì@—²1,3, •ž•”—fˆê˜Y1, ˆ¢]‘Ÿ‰ÀŽq1,2, “ì–ì@•×1,2, ²“Œäm1,2, ŒŒ³Ž›ŽâX1, ”n“ˆ³—²2)

110026. [ŒŽ’˜] Role of microsomal prostaglandin E synthase-1 in the facilitation of angiogenesis
and the healing of gastric ulcers. Ae T1,2, Ohno T1,3, Hattori Y1, Suzuki T2, Hosono K2, Minamino
T1, Sato T1, Uematsu S, Akira S, Koizumi W1, Majima M2 (1Á‰»Ší“à, 2–ò—, 3ˆÉšŒŽ‹Š“¯, 4‘åã
‘å ): Am J Physiol Gastrointest Liver Physiol 2010/11; 299 (5): G1139-46. (ˆ¢]‘Ÿ‰ÀŽq1,2, ‘å–ì@
—²1,3, •ž•”—fˆê˜Y1, —é–Ø—§‹I2, ×–ì‰Á“ÞŽq2, “ì–ì@•×1, ²“Œäm1, ¬ò˜aŽO˜Y1, ”n“ˆ³—²2)

110027. [ŒŽ’˜] Calcitonin gene-related peptide facilitates revascularization during hindlimb
ischemia in mice. Mishima T1, Ito Y1, Hosono K2, Tamura Y1, Uchida Y1, Hirata M1, Suzsuki T2,
Amano H3, Kato S4, Kurihara Y, Kurihara H, Hayashi I, Watanabe M1, Majima M2: Am J Physiol Heart
Circ Physiol 2011/2; 300 (2): 437-9. (”ü“‡—˜‘¥1, ˆÉ“¡‹`–ç1, ×–ì‰Á“ÞŽq2, “c‘ºK•ä1, “à“c‘׎Š
1, •œ“cŒõ”Ž1, —é–Ø—§‹I2, “V–ì‰pŽ÷3, ‰Á“¡L‘Ÿ˜Y4, ”n“ˆ³—²2: 1ŠO‰È, 2–ò—, 3ŒÄ‹zŠíŠO, 4zŠÂ
Ší“à)

110028. [ŒŽ’˜] The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial
tissues and angiogenesis in a mouse implantation model. Numao A1, Hosono K2, Suzuki T2, Hayashi
I, Uematsu S, Akira S, Ogino Y, Kawauchi H1, Unno N1, Majima M2: Biomed Pharmacother 2011/2; 65
(1): 77-84. (À”ö²Žq1, ×–ì‰Á“ÞŽq2, —é–Ø—§‹I2, ì“à”Žl1, ŠC–ìM–ç1, ”n“ˆ³—²2: 1ŽY•w, 2
–ò—)

110029. [ŒŽ’˜] Vascular endothelial growth factor receptor-1 signaling promotes liver repair
through restoration of liver microvasculature after acetaminophen hepatotoxicity. Kato T1, Ito
Y, Hosono K2, Suzuki, T2, Tamaki H3, Minamino T1, Kato S4, Sakagami H3, Shibuya M, Majima M2: Toxicol
Sci 2011/3; 120 (1): 218-29. (‰Á“¡“NŠó1, ×–ì‰Á“ÞŽq2, —é–Ø—§‹I2, ‹Ê–؉p–Ÿ3, “ì–ì@•×1, ‰Á“¡
L‘Ÿ˜N4, ãã—ms3, ”n“ˆ³—²2: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–ò—, 3‰ð–U, 4zŠÂŠí“à)

120003. [ŒŽ’˜] “ú–{lŒ’N¬l‚ð‘ΏۂƂµ‚œƒAƒvƒŒƒsƒ^ƒ“ƒg‹y‚уfƒLƒTƒƒ^ƒ]ƒ“•¹—pŽž‚É‚š‚¯‚éƒAƒUƒZ
ƒgƒƒ“‰–Ž_‰– (ƒZƒƒg[ƒ“ҐÒ‰t10 mg) ‚Ì–ò•š“®‘ÔŽŽŒ±. â“c”VŒP, â–{@Œc, ŒŽ@OŒõ, “ü]@L,
ŒF’J—YŽ¡1, ’r“c“ÄŽj, ¬‹Ž^–ç, Îì’qO, ”öèGŽ÷ (1–ò—): f—ÂƐV–ò 2010/12; 47 (12): 11-7.

220001. [€ŒŽ’˜]y“Á•ÊŠñezuŽ¡Œ±‚É‹‚ß‚ç‚ê‚éƒoƒCƒIƒ}[ƒJ[‚Æ‚µ‚Ä‚ÌPET‚ðl‚Š‚é‰ïv‚©‚ç‚Ì’ñŒŸ.
ˆÉ“¡Ÿ•F, A“c^ˆê˜Y, ŒF’J—YŽ¡1, K‘ºŽžl, Žu‰ê@„, ²“¡ŠxK, —«@¢‹Ê, ˆî–쏲—m, ”–Ø—˜ŽŸ, ’†
–ìds, ç“c“¹—Y, ’Ë“cG•v, ’¹ŽR—TŽi, “n糗TŽi (1–ò—): —Տ°–ò— 2010/5; 41 (5): 233-43.

510001. [‘à] Roles of calcitonin gene-related peptide in ehancement of angiogenesis. Majima
M1, Toda M2, Ito Y3, Ohno T4, Mishima T4, Suzuki T1, Hosono K1, Hayashi I: Inflammation and
Regeneration 2011/3; 31 (2): 146-50. (”n“ˆ³—²1, ŒË“c‰ë–ç2, ˆÉ“¡‹`–ç3, ‘å–ì@—²4, ”ü“‡—˜‘¥
3, —é–Ø—§‹I1, ×–ì‰Á“ÞŽq1: 1–ò—, 2–ƒŒ, 3ŠO‰È, 4Á‰»Ší“à)

510002. [‘à] Anti-tumor effects of prostaglandin D2 and its metabolites, 15-deoxy-ƒ¢12, 14-PGJ2,
by peroxisome proliferator-activated receptor (PPAR) ƒÁ-dependent and -independent pathways.
Nakamura M1, Yamaguchi S, Motoyoshi K, Negishi M, Saiti-Taki T, Matsumoto K2, Hayashi I, Majima
M3, Kitasato H: Inflammation and Regeneration 2011/3; 31 (2): 189-95. (’†‘º³Ž÷1, Œ–{˜a«2, ”n
“ˆ³—²3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2”å”AŠí, 3–ò—)

520001. [‘à]y2. ”ñ•WŽ¯‘̃}ƒCƒNƒƒh[ƒY—Տ°ŽŽŒ±‚ÌŽÀÛ‚Æ“W–]zLC/MS/MS‘ª’è‚É‚æ‚鎎Œ±‚ÌŽÀŽ{‚Æ
V‚œ‚ȉ”\«. ŒF’J—YŽ¡ (–ò—): —Տ°–ò— 2010/4; 41 (4): 123S-4S.

520002. [‘à]y‘æ6‰ñDIA“ú–{”N‰ïu‘Šú’Tõ“I—Տ°ŽŽŒ±‚ÌŒ»ó‚Ə«—ˆ“W–]vz‘Šú’Tõ“I—Տ°ŽŽŒ±‚Ì
“ú–{‚É‚š‚¯‚錻ó. ŒF’J—YŽ¡ (–ò—): —Տ°ˆã–ò 2010/5; 25 (5): 325-34.

520003. [‘à] “ú–{‚É‚š‚¯‚éS“d}QTŠÔŠu‚É‚æ‚éS‘ŸˆÀ‘S«•]‰¿. ŒF’J—YŽ¡ (–ò—): —Տ°•]‰¿
2010/6; 38 (1): 23-39.

520004. [‘à]y‘æ1‰ñDIAƒJ[ƒfƒBƒAƒbƒNEƒZƒCƒtƒeƒBEƒ[ƒNƒVƒ‡ƒbƒvu“ú–{‚Å‚ÌTQTŽŽŒ±ŽÀŽ{‚Ì–â
‘è“_vzQTŽŽŒ±‚Ì‚œ‚߂̗Տ°ŽŽŒ±ŽÀŽ{‚ÌŠÇ—. ŒF’J—YŽ¡ (–ò—): —Տ°ˆã–ò 2010/11; 26 (11): 27-38.

520005. [‘à]y“ÁW: ƒqƒXƒ^ƒ~ƒ“H1Žó—e‘̝hR–ò‚̗Տ°z–ò—Šw‚©‚ç‚Ý‚œƒCƒ“ƒyƒA[ƒhEƒpƒtƒH[ƒ}
ƒ“ƒX. ŒF’J—YŽ¡ (–ò—): ƒAƒŒƒ‹ƒM[‚̗Տ° 2010/12; 30 (4): 28-33.

[’˜@‘]

620005. [Šwp‘] (ŠÄCE•ª’SŽ·•M)y–ò•š«QT‰„’·ÇŒóŒQ?Šî‘b, ƒKƒCƒhƒ‰ƒCƒ“, —Տ°, ‘ª’èE•]‰¿, Ž–
—á?z‘æ1Í V–òŠJ”­‚É‚š‚¯‚é–ò•š«QT‰„’·ÇŒóŒQ. ‘æ6Í QT/QTc•]‰¿ŽŽŒ±ˆÈŠO‚̗Տ°ŽŽŒ±‚É‚š‚¯‚é
QT•]‰¿. ‘æ8Í QTŠÔŠu•â³. ŒF’J—YŽ¡1 (1–ò—), ŠÄC ŒF’J—YŽ¡1, ™ŽR@“Ä, î•ñ‹@\, “Œ‹ž, 2010/7
”­s.

620006. [Šwp‘] (•ª’SŽ·•M)y–òÜ‰uŠw‚ÌŠî‘b‚ÆŽÀ‘HzVI. ”Ì”„³”F‘O‚̗Տ°ŽŽŒ± (Ž¡Œ±) ‚ÆŽs”ÌŒã‚Ì
’²žEŽŽŒ±@2. ƒuƒŠƒbƒWƒ“ƒOE‘Û‹€“¯ŽŽŒ±, p.10-20. ŒF’J—YŽ¡ (–ò—), •Ò ŒiŽR@–Î, ‹v•Û“c@Œ‰,
ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, ‘åã, 2010/9”­s.

620007. [Šwp‘] (•ª’SŽ·•M)yƒ}ƒCƒNƒƒh[ƒY‚©‚çPET•ªŽqƒCƒ[ƒWƒ“ƒO‚Ö‚Ì“WŠJ@ˆâ“`ŽqˆãŠwMOOK•Ê
ûz‘æ3Í LC/MS/MS•ªÍ–@: V‚œ‚ȉ”\«‚ւ̃`ƒƒƒŒƒ“ƒW@‚Q. First in HumanŽŽŒ±‚ÌŠvV: 3‚‚̃}
ƒCƒNƒƒh[ƒYŽŽŒ±‚ÌŒoŒ±‚©‚ç. ŒF’J—YŽ¡ (–ò—), •Ò ™ŽR—Yˆê, ŽR‰ºL“ñ, ŒIŒŽçŠGŽq, ƒƒfƒBƒJƒ‹ƒh
ƒD, 2010/10”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712005. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Roles of leukotriene B4 recepter1 (BLT1) in
facilitation of tumor-associated angiogenesis. Majima M1: Keystone Symposium (2010/6/1), Kyoto.
(”n“ˆ³—²1: 1–ò—)

712006. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Future Asian Clinical Trial Network-Japan's
contribution. Kumagai Y1: NCCR (National Conference for Clinical Research) 2010, 13th NIH
Scientific Meeting (2010/6/2), KLuala Lumpur, Malaysia. (ŒF’J—YŽ¡1: 1–ò—)

712007. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) PG receptor signaling relevant to
lymphangiogenesis. Majima M1: GRC on lymphangiogenesis (2010/6/16), Borga, Italy. (”n“ˆ³—²1:
1–ò—)

712008. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Stromal PG receptor signaling relevant to
tumor-associated angiogenesis. Majima M1: ‘æ9‰ñ‘Û”÷¬zŠÂŠw‰ï (2010/8/11), Paris. (”n“ˆ³
—²1: 1–ò—)

712009. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Roles of leukotriene B4 recepter1 (BLT1) in
facilitation of tumor-associated angiogenesis. Majima M1: Tumor Microenvironment in ASCONA
(2010/10/28), Ascona, Swtwtzland. (”n“ˆ³—²1: 1–ò—)

712010. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) How to keep qualified CRCs. Kumagai Y1: DIA 2010
Korea Meeting (2010/11/10), Busan, Korea. (ŒF’J—YŽ¡1: 1–ò—)

712011. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Issues in FIM studies of new chemical entities
vs biologicals. Kumagai Y1: 6th Korea-Japan Joint symposium of Clinical Pharmacology and
Therapeutics 2010 (2010/11/11), Busan, Korea. (ŒF’J—YŽ¡1: 1–ò—)

712012. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Current Status of Clinical Trials and
Collaborative Research Proposal. Kumagai Y1 (The 2nd Catholic International Clinical Trial
Symposium (2011/1/4), Seoul, Korea. (ŒF’J—YŽ¡1: 1–ò—)

712013. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) PG receptor signaling relevant to
tumor-associated angiogenesis. Majima M1: Congress of Microcirculation (2011/2/21), Nagoya. (”n
“ˆ³—²1: 1–ò—)

713014. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Roles of prostaglandin E2-EP3/EP4 receptor signalings
in enhancement of lymphangiogenesis during inflammation. Hosono K1, Suzuki T1, Narumiya S, Majima
M1: 2010 Keystone Symposia Conference D2: Bioactive Lipids: Biochemistry and Diseases (2010/6/4),
‹ž“s. (×–ì‰Á“ÞŽq1, —é–Ø—§‹I1, ”n“ˆ³—²1: 1–ò—)

713015. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Recruitment of mast cells to the tumor microenvironment
via the high affinity leukotriene B4  receptor regulates tumor stromal profiles and
tumor-associated angiogenesis. Majima M1, Kosaka Y2, Suzuki T1, Hosono K1, Yokomizo T, Shimizu
T, Okamoto H2: 2010 Keystone Symposia Conference D2: Bioactive Lipids: Biochemistry and Diseases
(2010/6/5), ‹ž“s. (”n“ˆ³—²1, ¬âN°2, —é–Ø—§‹I1, ×–ì‰Á“ÞŽq1, ‰ª–{_Žk2: 1–ò—, 2–ƒŒ)

713016. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Phase 1 Study of the Safety, Pharmacokinetics and
Pharmacodynamics of Teneligliptin, a New DPP−IV Inhibitor, in Healthy Volunteers. Fujita
T1: American Diabetes Association's 70th Scientific Sessions (2010/6/28), Orlando, FL. (“¡“c•ü
Œb1: 1–ò—)

713017. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Type and prevalence of serious adverse events in phase
1 trials performed in Japan. Kumagai Y1, Monma T, Fukazawa I, Iijima H: WorldPharma 2010
(2010/7/20), Copenhagen, Denmark. (ŒF’J—YŽ¡1: 1–ò—)

722009. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Clinical approach for DILI; clarification of type
of liver dysfunction. ŒF’J—YŽ¡ (–ò—): ‘æ37‰ñ“ú–{ƒgƒLƒVƒRƒƒW[Šw‰ïŠwp”N‰ï (2010/6/18), ‹X
–ì˜pŽs, ‰«“ê.

722010. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) PG‚É‚æ‚郊ƒ“ƒpŠÇV¶‚̐§Œä. ”n“ˆ³—² (–ò—):
‘æ34‰ñ“ú–{ƒŠƒ“ƒpŠw‰ï‘‰ï (2010/6/25-27), “Œ‹ž.

722011. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‚ƈã–ò•i‚ÌŒ€‹†ŠJ”­?
¢ŠE“¯Žž‚ÌŠJ”­E\¿ERžE³”F‚ð‚ß‚Ž‚µ‚Ä?ˆã—ÊE‚©‚ç‚Ì’ñŒŸ. ŒF’J—YŽ¡ (–ò—): ‘æ1‰ñƒŒƒMƒ…ƒ‰
ƒgƒŠ[ƒTƒCƒGƒ“ƒXŠw‰ï (2010/10/4), “Œ‹ž.

722012. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒ^ƒ“ƒpƒNŽ¿Eƒyƒvƒ`ƒhR‘̈ã–ò•iŠJ”­‚É‚š‚¯‚é—Õ
°Œ€‹†. ŒF’J—YŽ¡ (–ò—): ‘æ25‰ñ“ú–{–ò•š“®‘ÔŠw‰ï”N‰ï (2010/10/9), é‹Ê.

722013. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “ú–{‚Å‚ÌQTŠÔŠu‚É‚æ‚éS‘ŸˆÀ‘S«•]‰¿‚ÌŽÀÛ. ’r
“cN•F, ŒF’J—YŽ¡1 (1–ò—): ‘æ31‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2010/12/1), ‹ž“s.

723042. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V‹KDPP-IV‘jŠQ–ò teneligliptin‚ÌŒ’N¬l‚É‚š‚¯‚é –ò
•š“®‘Ô‹y‚Ñ–ò—Šw“IŒø‰Ê. “¡“c•üŒb (–ò—): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ï (2010/5/27), ‰ªŽR.

723043. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”ñ—Տ°ƒf[ƒ^‚ƗՏ°S‘ŸˆÀ‘S«•]‰¿?Œ»ó‚Æ“W–]?. ŒF
’J—YŽ¡ (–ò—): ‘æ37‰ñ“ú–{ƒgƒLƒVƒRƒƒW[Šw‰ïŠwp”N‰ï (2010/6/16), ‰«“ê.

723044. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒJƒ‰ƒQƒjƒ“‹¹–Œ‰Šƒ‚ƒfƒ‹‚É‚š‚¯‚é–T‹¹‘BƒŠƒ“ƒpß‚É”­Œ»
‚µ‚œCOX-2‚Ì–ðŠ„. ì‘º“¹Žq1, ‘œ“c”üm, ”š’†@Œö1, ŒŽ“c–FÆ (1–ò—): ‘æ31‰ñ“ú–{‰ŠÇÄ¶ˆãŠw
‰ï (2010/8/5), “Œ‹ž.

723045. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«‘B«‰ŠÇ‘ƒ‚̃Šƒ“ƒpŠÇV¶‚É‚š‚¯‚éƒvƒƒXƒ^ƒOƒ‰
ƒ“ƒWƒ“E2-EP3/EP4Žó—e‘̃VƒOƒiƒŠƒ“ƒO‚Ì–ðŠ„. ×–ì‰Á“ÞŽq1, —é–Ø—§‹I1, ‹Ê–؉p–Ÿ2, ãã—ms2, ¬
‹{@Žü, ”n“ˆ³—²1 (1–ò—, 2‰ð–U): ‘æ31‰ñ“ú–{‰ŠÇEÄ¶ˆãŠw‰ï (2010/8/5), “Œ‹ž.

723046. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Տ°–ò—ŽŽŒ±ŽQ‰ÁŠó–]ŽÒ‚ÌŒŸžƒf[ƒ^‚Ì”NŽŸ’²ž1?ŒŒ
ŽZ?. “¡“c•üŒb (–ò—): ‘æ31‰ñ“ú–{—Տ°–ò—Šw‰ï (2010/12/1), ‹ž“s.

723047. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t”A×ŠÇ•ª”å‚Ì–Ê‚©‚ç‚Ý‚œ—L‹@ƒAƒjƒIƒ“«”A“ŏǎä‹N•š
Ž¿ƒCƒ“ƒhƒLƒVƒ‹—°Ž_‚ƃAƒ“ƒWƒIƒeƒ“ƒVƒ“•ÏŠ·y‘f‘jŠQ–ò‚Ƃ̐¶‘Ì“à‚Å‚Ì‘ŠŒÝì—p. “¡“c•üŒb1, ÎŒŽ˜a•F,
ˆÀ“cCˆê, ŒF’J—YŽ¡1, ”n“ˆ³—²1 (1–ò—): ‘æ31‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2010/12/2), ‹ž“s.

723048. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ’N¬l’j«‚ð‘ΏۂƂµ‚œƒcƒxƒ‹ƒNƒŠƒ“”œ‰ž‚ƃNƒHƒ“ƒe
ƒBƒtƒFƒƒ“ŒŸž‚Ì”äŠrŒŸ“¢. ŒK–”^—R”ü, ˜@À’qŽq, ‚•^Ž÷Žq, ¬—ѓށXŠG, Â–؈»Žq, –ΊїmŽq, X
ì”ü—R‹M, •Ÿ“‡ŽìŒb, Œ˜e^ŽÀŽq, ”Ñ“‡@”£, ŒF’J—YŽ¡1 (1–ò—): ‘æ31‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï
(2010/12/3), ‹ž“s

723049. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ú–{l‹y‚Ñ’†‘l (Š¿–¯‘°) ‚ð‘ΏۂƂµ‚œ1Ž{Ý‚É‚æ‚é
–ò•š“®‘Ô”äŠrŽŽŒ±‚ÌŽÀŽ{‘̐§‚ÌŒŸ“¢?Šé‰æE—§ˆÄ‚©‚çŽÀŽ{‚܂ł̉ۑè?. “¡“c•üŒb (–ò—): ‘æ31‰ñ“ú
–{—Տ°–ò—Šw‰ï (2010/12/3), ‹ž“s

723050. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RƒqƒXƒ^ƒ~ƒ“–ò‚Ì—LŠQ”œ‰ž‚̉ñ”ð?ƒCƒ“ƒyƒA[ƒhƒpƒtƒH
[ƒ}ƒ“ƒX‚𒆐S‚É?. ŒF’J—YŽ¡ (–ò—): ‘æ29‰ñŽš•@‰ÈƒAƒŒƒ‹ƒM[Šw‰ï (2011/2/19), ‘啪.

723051. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Characterization of cyclooxygenase-2 expressing cells
in draining lymph nodes during carrageenin-induced pleurisy. ”š’†@Œö1, ‘œ“c”üm, ì‘º“¹Žq1,
ŒŽ“c–FÆ (1–ò—): ‘æ84‰ñ“ú–{–ò—Šw‰ï”N‰ï (2011/3/23), ‰¡•l.

723052. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ŠÇ‘ƒ‚̋ߐڃŠƒ“ƒpß‚Åcyclooxygenase-2‚ð”­Œ»‚·‚é×
–E‚Ì“Á’¥. ì‘º“¹Žq1, ‘œ“c”üm, ”š’†@Œö1, ŒŽ“c–FÆ (1–ò—): ‘æ84‰ñ“ú–{–ò—Šw‰ï”N‰ï
(2011/3/23), ‰¡•l.

732003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‘Šú’Tõ“I—Տ°ŽŽŒ±‚ÌŽÀ—á‚Æ“W–]. ŒF
’J—YŽ¡ (–ò—): ‘æ12‰ñ—Տ°–ò—ŽŽŒ±Œ€‹†‰ï (2010/6/12), •Ÿ‰ª.

732004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ŒŒ¬”‚ƌŒŠÇV¶. ”n“ˆ³—² (–ò—):
‘æ31‰ñ“ú–{‰ŠÇEÄ¶ˆãŠw‰ï (2010/8/6), “Œ‹ž.

732005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –{–M‚É‚š‚¯‚鑁Šú—Տ°ŽŽŒ±‚ÌŒ»ó‚ƉÛ
‘è. ŒF’J—YŽ¡ (–ò—): ‘啪“Œv’k˜b‰ïE‘æ42‰ñ‘å‰ï (2010/10/22), ‘啪.

733010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Multidrug and toxin extrusion 1‘jŠQÜ
pyrimethamine‚Æmetformin‚Ì–ò•š‘ŠŒÝì—pŽŽŒ±. ˆÉ“¡Ÿl, “팎—m”V, ™ŽR—Yˆê, ŒF’J—YŽ¡1, é‰º—F
‹`, XŽR–F‘¥ (1–ò—): ‘æ18‰ñŠÌ•a‘Ԑ¶—Œ€‹†‰ï (2010/5/26), ŽRŒ`.

733011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) QTŽŽŒ±‚Ì‚œ‚߂̗Տ°ŽŽŒ±Ž{Ý‚ÌŠÇ—. ŒF’J
—YŽ¡ (–ò—): ‘æ1‰ñDIA Cardiac Safety Workshop in Japan (2010/5/26), “Œ‹ž.

733012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒCƒNƒƒh[ƒYEƒJƒZƒbƒg“Š—^ŽŽŒ±‚ð—p‚¢‚œ
ƒAƒgƒ‹ƒoƒXƒ^ƒ`ƒ“‚̊̂̃NƒŠƒAƒ‰ƒ“ƒX‚ÌŒˆ’è—vˆö‚̉ðÍ. ‹g“cŒ’‘Ÿ, ‘O“c˜aÆ, ™ŽR—Yˆê, ŒF’J—YŽ¡1,
‰Æ“üˆê˜Y, ŽRª®Œb (1–ò—): ‘æ18‰ñŠÌ•a‘Ԑ¶—Œ€‹†‰ï (2010/5/26), ŽRŒ`.

733013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘“à—Տ°ŽŽŒ±‚É‚š‚¯‚éS‘ŸˆÀ‘S«•]‰¿. ŒF’J
—YŽ¡ (–ò—): ˆÀ‘S«•]‰¿Œ€‹†‰ï (2010“~ƒZƒ~ƒi[) (2010/11/27), “Œ‹ž.

H21”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H21-712001. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Roles of angiotensin in
tumor-associated angiogenesis. Majima M1 (‘æ14‰ñ‘Û“à•ª”åŠw‰ï‹c ICE2010 (2010/3/26-30), Kyoto.
(”n“ˆ³—²1: 1–ò—)


”÷¶•šŠw

[Šwp˜_•¶]

110030. [ŒŽ’˜] A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and
immunodeficient animals: candidate strain for exclusion from select-agent lists. Propst KL, Mima
T1, Choi KH, Dow SW, Schweizer HP: Infect Immun 2010/7; 78 (7): 3136-43. (”üŠÔŒ’•F1: 1”÷¶•š)

110031. [ŒŽ’˜] The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role
in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a
broad-spectrum drug efflux system. Mima T1, Schweizer HP: Antimicrob Agents Chemother 2010/8;
54 (8): 3113-20. (”üŠÔŒ’•F1: 1”÷¶•š)

110032. [ŒŽ’˜] In vitro activity of cethromycin against Burkholderia pseudomallei and
investigation of mechanism of resistance. Mima T1, Schweizer HP, Xu ZQ: J Antimicrob Chemother
2011/1; 66 (1): 73-8. (”üŠÔŒ’•F1: 1”÷¶•š)

110033. [ŒŽ’˜] IL-10 controls Th2-type cytokine production and eosinophil infiltration in a mouse
model of allergic airway inflammation. Kosaka S, Tamauchi H1, Terashima M, Maruyama H, Habu S,
Kitasato H: Immunobiology 2011/7; 216 (7): 811-20. (‹Ê“àGˆê1: 1”÷¶•š)H23”N“x•ª

210002. [€ŒŽ’˜] Th2 Immune response plays a critical role in the development of Nickel-induced
allergic contact dermatitis. Tamauchi H1, Niiyama S2, Amoh Y2, Terashima M, Matsumura Y, Habu
S, Komotori, J, Katsuoka K2: Iinternational Immunology 2010/8; 22 (Suppl 1): iv109. (‹Ê“àGˆê
1, VŽRŽj˜N2, “V‰HN”V2, Ÿ‰ªŒ›¶2: 1”÷¶•š, 2”畆)

522002. [uÀ] –ƉuŠw‚ÌŠÏ“_‚©‚ç‚Ý‚œò‰»‘…‹Æ–±‚É‚©‚©‚í‚銎õÇ. ‹Ê“àGˆê (”÷¶•š): ò‰»‘…
2010/5; 409†: 4-11.

522003. [uÀ]y“ÁW: –Ɖu‚Æ‹@”\«H•izƒtƒRƒCƒ_ƒ“‚ƖƉu. ‹Ê“àGˆê1, ŠÛŽROŽq (1”÷¶•š):
Functional Food 2010/7; 4 (1).

540001. [‚»‚Ì‘Œ (Žž˜_)] Ž€¶ŠÏ‚©‚ç‚Ý‚œu‚¢‚Ì‚¿v?ˆãŠwŒŽ˜_‰‰K‚ðU‚è•Ô‚Á‚Ä?. ‹Ê“àGˆê (”÷¶
•š): “ú–{ˆãŽ–V•ñ 2010/11; 4516: 93-5.

[’˜@‘]

620008. [Šwp‘] (•ª’SŽ·•M)yŽ•‰È‚É‚š‚¯‚é‚­‚·‚è‚ÌŽg‚¢•û 2011-20114?–ò‚ª‚í‚©‚ê‚Î, f—ª•Ï‚í‚éz
ƒÀ-ƒ‰ƒNƒ^ƒ}[ƒ[ŽY¶‹Û?Šî‘b?. ‰ª–{—¹ˆê (”÷¶•š), •Ò ‹àŽq–ŸŠ°, ’Ŗ؈ê—Y, “VŠ}Œõ—Y, ²–ìŒöl, ì
•Ó—Ljê, ƒfƒ“ƒ^ƒ‹ƒ_ƒCƒ„ƒ‚ƒ“ƒhŽÐ, “Œ‹ž, 2010/11”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712014. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Collagen-anchoring: From bacterial toxin to drug.
Matsushita O1 (11th Joint Symposium Robert Koch Institute and The Kitasato Institute Kitasato
University (2010/10/26), Tokyo. (Œ‰º@Ž¡1: 1”÷¶•š)

713018. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Th2 immune response play a critical role in the
development of Nickel-induced allergic contact dermatitis. Tamauchi H1, Niiyama S2, Amoh S2,
Terashima M, Matsumura Y, Habu S, Komotori J, Katsuoka K2: 14th International congress of Immunology
(2010/8/26), Kobe. (‹Ê“àGˆê1, VŽRŽj˜N2, “V‰HN”V2, Ÿ‰ªŒ›¶2: 1”÷¶•š, 2”畆)

713019. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A novel parathyroid hormone fusion protein causes
sustained increases in bone mineral density in ovarectomized rats after monthly or single dosing.
Katikaneni, R PonnapakkamT, Bradford E, Pasala S, Matsushita O1, Sakon J, Gensure R: The 32nd
American Society of Bone and Mineral Research (ASBMR) Annual Meeting (2010/10/14), Montreal, Canada.
(Œ‰º@Ž¡1: 1”÷¶•š)

713020. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Prevention of chemotherapy-induced alopecia with a
novel parathyroid hormone fusion protein. Katikaneni R, Ponnapakkam T, Matsushita O1, Sakon J,
Gensure R: The 32nd American Society of Bone and Mineral Research (ASBMR) Annual Meeting
(2010/10/14), Montreal, Canada. (Œ‰º@Ž¡1: 1”÷¶•š)

713021. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Whole body autoradiography of a fusion protein
[35S]hPTH-CBD in mice. Gensure R, Miyata S, Matsushita O1, Sakon J, Uchida K, Komatsu Y, Suda
H: The 32nd American Society of Bone and Mineral Research (ASBMR) Annual Meeting (2010/10/14),
Toronto, Canada. (Œ‰º@Ž¡1: 1”÷¶•š)

722014. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒKƒX‰óás‹ÛŒQƒRƒ‰ƒQƒi[ƒ[‚̊Œ‹‡ƒhƒƒCƒ“‚Æ
Ä¶ˆã—Âւ̉ž—p. Œ‰º@Ž¡1, Œ@@–], ¬™“ú“o”ü, ¬o—²‹K, ˆÀ’B‰hŽ¡˜Y2, â–{ŒbŽq, •ž•”‰ëˆê,
‹{‰º•Œ›, X@@–], Jeffrey J Wilson, S T Leena Philominathan, Joshua Sakon (1”÷¶•š, 2‘åŠw‰@
ˆã—ÃŒnŒ€‹†‰È): ‘æ57‰ñƒgƒLƒVƒ“ƒVƒ“ƒ|ƒWƒEƒ€ (2010/7/16), ’·•l.

722015. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Ž„‚Í‚±‚Ì‚æ‚€‚ɍž“Ç‚·‚é?ž“ÇŽÒ‚Ì—§ê‚©‚ç?.
‰ª–{—¹ˆê (”÷¶•š): ‘æ26‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2011/2/18), ‰¡•l.

722016. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒjƒbƒPƒ‹ƒ`ƒ^ƒ“‡‹à‚ɑ΂·‚鐶‘Ì“K‡«•]‰¿Œn‚Ì
Ž÷—§. ‹Ê“àGˆê1, ŠâŸº˜a–ç2, Œ“ŒGs, ”ó”öŸ–ç (1”÷¶•š, 2–Ɖu): ‘æ161‰ñ“ú–{“S|‹Š‰ït‹Gu
‰‰‘å‰ï (2011/3/27), “Œ‹ž. Š“Œ“ú–{‘åkÐ‚É‚æ‚è‘å‰ï‚Í’†Ž~ (‹Š‰ï‘€‚æ‚è”­•\‚ðs‚Á‚œ‚±‚Æ‚É‚·‚éŽåŽ|
‚̘A—‚ª‰ïˆõ‚É’Ê’B‚³‚œ)

723053. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒjƒbƒPƒ‹ƒ`ƒ^ƒ“‡‹à‚̍ޗ¿“Á«‚Ɛ¶‘̂ւ̉e‹¿. ¬ìˆŸ
ŠóŽq, ‹Ê“àGˆê1, Œ“ŒGs, ”ó”öŸ–ç (1”÷¶•š): “S|‹Š‰ï‘æ160‰ñH‹G‘åu‰‰‰ï (2010/9/25), ŽD–y.

723054. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒbƒg‚É‚š‚¯‚éV‘fÞ‚ð—p‚¢‚œŒÛ–ŒÄ¶. ‹{‰º•Œ›, ˆî
–{—²•œ, ŒŒŽ‚ ‚¢, ‘å?NG, Œ@@–], Œ‰º@Ž¡1, ˆÀ’B‰hŽ¡˜Y2, X@@–] (1”÷¶•š, 2‘åŠw‰@ˆã—Ã
ŒnŒ€‹†‰È): ‘æ20‰ñ“ú–{Žš‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/10/9), ŒŽR.

723055. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ~ƒXƒ}ƒbƒ`PCR-RFLP–@‚É‚æ‚éƒtƒ‹ƒIƒƒLƒmƒƒ“Œn–òŠŽŽó
«f’f–@‚ÌŠJ”­. ’†–ì—³ˆê, ’†–ìÍ‘ã, ’·–ì‘¥”V, ˆ¢•””ü’mŽq, ‰ª–{—¹ˆê1 (1”÷¶•š): ‘æ22‰ñ“ú–{—Õ
°”÷¶•šŠw‰ï (2011/1/8), ‰ªŽR.

723056. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •a““àMRSA‚̊‹«“`”d‚̉ðÍ. VŽR“ށXŽq, ’†–ì—³ˆê,
ùŒŽ•Žu1 (1”÷¶•š): ‘æ26‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2011/2/18), ‰¡•l.

723057. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒVƒƒƒ[ƒwƒbƒh•ª—£ƒAƒVƒlƒgƒoƒNƒ^[‚̃oƒCƒIƒtƒBƒ‹ƒ€Œ`¬«. ‹e
–엝—¥Žq1, ùŒŽ•Žu2, “¡–Ø‚­‚ÉŽq3 (1(à) –k—¢ŠÂ‹«‰ÈŠwƒZƒ“ƒ^[, 2”÷¶•šŠw, 3ŠŽõŠÇ—Žº): ‘æ
26‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2011/2/19), ‰¡•l.

723058. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆã—ʋ«‚É‚š‚¯‚鈟‰”‚ÌŽE‹Û“Á«Šˆ—p‚ÉŠÖ‚·‚錟“¢. ùŒŽ•Žu1,
VŽR“ށXŽq, “¡–Ø‚­‚ÉŽq (1”÷¶•š): ‘æ26‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2011/2/19), ‰¡•l.

723059. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “º‚š‚æ‚Ñ“º‡‹à‚É‚æ‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX•sŠˆ‰»Œø
‰Ê‚ÌŒŸ“¢. ’†–ì—³ˆê, ùŒŽ•Žu1 (1”÷¶•š): ‘æ26‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2011/2/19), ‰¡•l.

723060. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “º‚š‚æ‚Ñ“º‡‹à‚É‚æ‚é•a‰@‚È‚¢×‹Û‰˜õ‚̒ጞ‰»?ˆã—Ê֘AŠŽõ‘Î
ô‚Ö“WŠJ?. ùŒŽ•Žu1, ‹e–엝—¥Žq2, VŽR“ށXŽq3, “¡–Ø‚­‚ÉŽq4 (1”÷¶•š, 2(à) –k—¢ŠÂ‹«‰ÈŠwƒZ
ƒ“ƒ^[, 3”畆, 4ŠŽõŠÇ—Žº): ‘æ26“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2011/2/19), ‰¡•l.

731002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒtƒRƒCƒ_ƒ“‚̃qƒg’°“à×‹Û‚É‚æ‚镪‰ð‚Ɛ¶—Šˆ«‚É ‚‚¢
‚Ä. ŠÛŽR OŽq, ‹Ê“àGˆê1, ìã•¶‹M, ˜@À—Ljê, ‹g‰iŒbŽq, ’‡–ì—²‹v, –k—¢‰p˜Y (1”÷¶•š): ‘æ13
‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[ (2010/8/6), \˜a“c, ‘æ13‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[u‰‰—vŽ| 2010; p.88.

733014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒKƒX‰óás‹ÛŒQƒRƒ‰ƒQƒi[ƒ[‚̊Œ‹‡ƒhƒƒC
ƒ“‚ƍжˆã—Âւ̉ž—p. ”üŠÔŒ’•F1, Œ@@–], ¬™“ú“o”ü, ¬o—²‹K, ˆÀ’B‰hŽ¡˜Y2, â–{ŒbŽq, •ž•”
‰ëˆê, ‹{‰º•Œ›, X@@–], Jeffrey J Wilson, S T Leena Philominathan, Joshua Sakon, Œ‰º@Ž¡1 (1
”÷¶•š, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ13‰ñ–k—¢”÷¶•šƒAƒJƒfƒ~[ (2010/8/6), \˜a“c.

733015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒKƒX‰óás‹ÛŒQƒRƒ‰ƒQƒi[ƒ[‚̊Œ‹‡ƒhƒƒC
ƒ“‚̍жˆã—Âւ̉ž—p. Œ‰º@Ž¡1, ”üŠÔŒ’•F1, Œˆäx—C, Œ@@–], ˆÀ’B‰hŽ¡˜Y2, â–{ŒbŽq, •ž•”
‰ëˆê, ‹{‰º•Œ›, X@@–] (1”÷¶•š, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ93‰ñ“ú–{×‹ÛŠw‰ïŠÖ“ŒŽx•”‘‰ï
(2010/10/21), “Œ‹ž.

733016. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒ‹ƒIƒƒLƒmƒƒ“Œn–ò‘ϐ«‹Û‚̃~ƒXƒ}ƒbƒ`
PCR-RFLP–@‚É‚æ‚év‘¬ŒŸo–@. ’†–ì—³ˆê, ’†–ìÍ‘ã, ’·–ì‘¥”V, ˆ¢•””ü’mŽq, ‰ª–{—¹ˆê1 (1”÷¶•š): ‘æ
57‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï (2010/10/21), “Œ‹ž.

H21”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H21-713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Treatment of chemotherapy-induced
osteoporosis and alopecia with a novel fusion protein. Katikaneni R, Ponnapakkam T, Mollaee M,
Miller E, Sakon J, Matsushita O1, Gensure R: The 31th American Society of Bone and Mineral Research
(ASBMR) Annual Meeting (2009/9/11), Denver, CO, USA. (Œ‰º@Ž¡1: 1”÷¶•š)


Šñ¶’ŽŠw

[Šw‰ïEŒ€‹†‰ï“™]

723061. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Changes in host intestinal mucus by Nippostrongylus
brasiliensis reinfection: effect of reduction in the period of primary infection. ’ؐì‘åŒå, ’†
‘º@Œ’1, ŒÜäzsM2, ’J“c•”•‡”ü, ÎŒŽ˜a•F (1Šñ¶’Ž, 2¶‰»): ‘æ79‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï
(2010/5/20-21), ˆ®ì.


•a—Šw

[Šwp˜_•¶]

110034. [ŒŽ’˜] Transcriptional regulation of pro-apoptotic Par-4 by NF-kappaB/p65 and its function
in controlling cell kinetics during early events in endometrial tumourigenesis. Saegusa M1,
Hashimura M, Kuwata T, Okayasu I1: J Pathol 2010/5; 221 (1): 26-36. (ŽOŽ}@M1, ‹Ž‘º”ü‹I, ŒK“c@
Œ’, ‰ªˆÀ@ŒM1: 1•a—)

110035. [ŒŽ’˜] Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked
to gallbladder carcinogenesis. Yanagisawa N1, Yamashita K2, Kuba T, Okayasu I1: Anticancer Res
2010/11; 30 (11): 4443-9. (–öàVM”V1, ŽR‰º˜a–ç2, ‹vê@Ž÷, ‰ªˆÀ@ŒM1: 1•a—, 2•a—•”)

110036. [ŒŽ’˜] Pin1 acts as amodulator of cell proliferation through alteration in NF-kB but not
beta-catenin/TCF4 siganaling in a subset of endometrial carcinoma cells. Saegusa M1, Hashimura
M2, Kuwata T: J Pathol 2010/12; 222 (4): 410-20. (ŽOŽ}@M1, ‹Ž‘º”ü‹I2, ŒK“c@Œ’: 1•a—, 2Œ`
‘ÔŒn)

110037. [ŒŽ’˜] CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in
response to butyric acid. Yoshida T1, Sekine T, Aisaki K, Mikami T1, Kanno J, Okayasu I1: J
Gastroenterol 2011/3; 46 (3): 339-49. (‹g“c@Œ÷1, ŽOã“N•v1, ‰ªˆÀ@ŒM1: 1•a—)

520006. [‘à]y“ÁW: ‚»‚±‚ª’m‚è‚œ‚¢Á‰»ŠÇŽîᇕa—z’×ᇐ«‘å’°‰ŠŠÖ˜AˆÙŒ`¬ (dysplasia) ‚̐f’f
‚ƍŋ߂̒mŒ©. ŽOã“N•v1, ‹g“c@Œ÷1, ¬—ѐŽ“T2, “¿ŽR@é1, r–؍‘ã, ‰ªˆÀ@ŒM1 (1•a—, 2Á
‰»Ší“à): •a—‚ƗՏ° 2010/6; 28 (6): 619-25.

[Šw‰ïEŒ€‹†‰ï“™]

713022. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Neural Network Approach for Histopathological
Diagnosis of Breast Diseases with Images. Hara A1 (19th International Conference on Computational
Statistics (2010/8/26), France. (ŒŽ@“ÖŽq1: 1•a—)

723062. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐ«‘å’°‰ŠŠÖ˜AŠà‚É‚š‚¯‚éMMP7, laminin5g2, sialyl
LewisX‚Ì”­Œ»: sporadicŒ^‘å’°Šà‚Æ‚Ì”äŠr. ŽOã“N•v1, À“c‰êŽq2, ‹g“c@Œ÷1, ‹e’n³b3, ’‡“c“T
L1, r–؍‘ã, “¿ŽR@é1, ”~‘ò“ÖŽq2, ‰ªˆÀ@ŒM1 (1•a—, 2Œ`‘ÔŒn, 3Á‰»Ší“à): ‘æ99‰ñ“ú–{•a—
Šw‰ï‘‰ï (2010/4/27), “Œ‹ž.

723063. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”xŠà‚É‚š‚¯‚éŽ÷—§‚µ‚œRBSGR‘Ì‚Ì—L—p«‚ɂ‚¢‚Ä. Î
“cœŽi, ŒiŽR‘וœ, Œ–{r‰p, ’·‰–@—º, Ó@¢ˆ®1, ‰ªˆÀ@ŒM1, ²“¡—Yˆê (1•a—): ‘æ99‰ñ“ú–{•a—
Šw‰ï‘‰ï (2010/4/27), “Œ‹ž.

723064. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –Ô—…“I‰ðÍ‚É‚æ‚Á‚Ä“Ÿ‚ç‚ê‚œolfactomedin4‚Ì’×ᇐ«‘å
’°‰Š‹y‚ÑŠÖ˜AŽîᇂɂš‚¯‚é–ðŠ„. ‹g“c@Œ÷1, ‹{‘OŒ‹‰Á, À“c‰êŽq, ’ß“c’qŽq, ŽOã“N•v1, ‰ªˆÀ@ŒM1 (1
•a—): ‘æ99‰ñ“ú–{•a—Šw‰ï‘‰ï (2010/4/27), “Œ‹ž.

723065. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒŠƒ“ƒpß‚ÉŒÀ‹Ç‚µ‚œLangerhans cell histiocytosis‚Ì
2Ç—á. ŠâŸºŒ[ˆê1, ŒŽ@“ÖŽq1, Š“cç”ü”T1, ‰ªˆÀ@ŒM1 (1•a—): ‘æ99‰ñ“ú–{•a—Šw‰ï‘‰ï
(2010/4/28), “Œ‹ž.

723066. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«‰©át‚ÌŒŽˆö‚ƍl‚Š‚ç‚ê‚œ‘’_ŠÇperibiliary cyst
‚̈ê–UŒŸ—á. ‚‹Ž”Ž”V1, ŽO—֏dŽ¡, –ì–{ˆê”Ž, —с@Lˆê, íŽRKˆê, ‚–ìN—Y (1•a—): ‘æ99‰ñ“ú–{
•a—Šw‰ï‘‰ï (2010/4/28), “Œ‹ž.

723067. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒ|ƒg[ƒVƒXŠÖ˜Aˆâ“`ŽqPar-4‚É‚æ‚éŽq‹{“à–Œ×–E“®‘Ô
’²ß‹@\‚Æ”­Šà. ŽOŽ}@M1, ‹Ž‘º”ü‹I, ŒK“c@Œ’, ‰ªˆÀ@ŒM1 (1•a—): ‘æ99‰ñ“ú–{•a—Šw‰ï‘‰ï
(2010/4/28), “Œ‹ž.

723068. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œ‘€—‘‘ƒ‚É”­¶‚µ‚œborderline endometrioid tumor‚Ì
ˆê—á. ŠâŸºŒ[ˆê (•a—): ‘æ32‰ñ•wl‰È•a—Šw‰ï (2010/6/5), “Œ‹ž.

723069. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’è—ÊRT-PCR–@‚ð—p‚¢‚œCTGF”­Œ»ŒŸõ‚É‚æ‚éŠÌüˆÛ‰»•]‰¿‚ÌŽŽ‚Ý.
‘å•”@œ1, ÎˆäŒ’ˆê˜Y2, •Ð‹ËŠ°”V2, “ú‚@‰›3 (1ˆã—Éq¶Šw•”, 2ŠO‰È, 3Á‰»Ší“à): ‘æ17‰ñ“ú–{
–å–¬ˆ³˜ŽiÇŠw‰ï‘‰ï (2010/9/9), •xŽR, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2010/8; 16 (2): 102.

723070. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) EICƒpƒ^[ƒ“‚ðŽŠ‚·Žq‹{‘Ì•”Serous adenocarcinoma‚Ì1
—á. ŠâŸºŒ[ˆê (•a—): ‘æ33‰ñ•wl‰È•a—Šw‰ï (2010/12/11), ‰ªŽR.

723071. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒeƒLƒXƒgƒ}ƒCƒjƒ“ƒO‚ð—p‚¢‚œ•a—f’f‹qŠÏ‰»‚ÌŽŽ‚Ý. ŒŽ@
“ÖŽq (•a—): ‘æ2‰ñ“ú–{ŒvŽZ‹@“ŒvŠw‰ï (ƒeƒLƒXƒgƒ}ƒCƒjƒ“ƒOƒXƒ^ƒfƒBƒOƒ‹[ƒvŒ€‹†‰ï) (2011/2/5), ŽD
–y.

733017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{Žîᇂ̈ê—á. –öàVM”V1, ŠâŸºŒ[ˆê1 (1
•a—): ‘æ91‰ñ_“ސ쌧•a—ˆã‰ï—á‰ï (2010/7/10), _“ސì.

733018. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒ‰ƒ“ƒ_ƒ€–Ɖu–@‚ð—p‚¢‚œ”xŠà“ÁˆÙ“IR‘̂̍쐻‚Æ‚»‚Ì—L
—p«‚ÌŒŸ“¢. ²“¡—Yˆê1,2, Œ–{r‰p1,2, ‰eŽR‘וœ1,2, “ì@@®1,2, Ó@¢ˆ®3, ˆÉ˜¬“c–Ÿ4, ²“¡
”Vr4, —Ž‰ØTˆê˜Y5, ‰v“c“TK5 (1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3•a—, 4ŒÄ‹zŠíŠO, 5ŒÄ‹z
Ší“à): ‘æ23‰ñ–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€ (2010/8/5), \˜a“cƒLƒƒƒ“ƒpƒX (V1†ŠÙ3ŠK103,
104Žº).

733019. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹’É‚ðŽå‘i‚ɃVƒ‡ƒbƒNó‘Ô‚É‚Ä—ˆ‰@‚µPCPS‚ð
‘}“ü‚·‚é‚à‹~–œ‚µ“Ÿ‚È‚©‚Á‚œˆê—á. ŒŽ@“ÖŽq (•a—): ‘æ217‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï
(2010/9/11), “Œ‹ž.

733020. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) f’f‚É‹ê—¶‚µ‚œG“’×ᇂÌ1—á. Š“cç”ü”T
1, ‹g“c@Œ÷1 (1•a—): ‘æ92‰ñ_“ސ쌧•a—ˆã‰ï (2011/1/8), _“ސì.

H21”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H21-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “]ŽÊˆöŽqEgr1‚É‚æ‚éŽq‹{“à–ŒŠà×–E‚̃À-ƒJƒe
ƒjƒ“ˆË‘¶«“]ˆÊ•ª‰»§Œä‹@\‚̉ð–Ÿ. ŽOŽ}@M1, ‹Ž‘º”ü‹I, ŒK“c@Œ’, ‰ªˆÀ@ŒM1 (1•a—): ‘æ98‰ñ
“ú–{•a—Šw‰ï‘‰ï (2009/5/1-3), ‹ž“s.


‰q¶ŠwEŒöO‰q¶Šw

[Šwp˜_•¶]

110038. [ŒŽ’˜] Cytotoxicity study of high temperature wool (HT Wool) by cell magnetomeric
evaluation. Kudo Y1, Kotani M1, Aizawa Y1: J Occup Health 2010; 52 (2): 106-14. (H“¡—Yˆê˜Y1,
¬’J@œ1, ‘ŠàVDŽ¡1: 1‰q¶EŒöO‰q¶)

110039. [ŒŽ’˜] Deterioration of renal function in ICR-derived glomerulonephritis (ICGN) mice by
sumacute administration of flioride in drinking water. Hosokawa M1, Asakawa H1, Tsuchiya T, Kaido
T1, Sugaya C1, Inoue Y, Tsunoda M1, Itai K, Kodama Y, Sugita-Konishi Y, Aizawa Y1: Fluoride 2010;
43 (1): 31-44. (×ì‚Ü‚äŽq1, óìG—Y1, ‹¬ŒËF–ç1, ›’J‚¿‚Š”ü1, Šp“c³Žj1, ‘ŠàVDŽ¡1: 1‰q¶E
ŒöO‰q¶)

110040. [ŒŽ’˜] Enhanced inhibitory effects of TBT chloride on the development of F1 rats. Asakawa
H1, Tsunoda M1, Kaido T1, Hosokawa M1, Sugaya C1, Inoue Y, Kudo Y1, Satoh T, Katagiri H, Akita
H, Saji M, Wakasa M, Negishi T, Tashiro T, Aizawa Y1: Arch Environ Contam Toxicol 2010/5; 58 (4):
1065-73. (óìG—Y1, Šp“c³Žj1, ‹¬ŒËF–ç1, ×ì‚Ü‚äŽq1, ›’J‚¿‚Š”ü1, H“¡—Yˆê˜Y1, ‘ŠàVDŽ¡
1: 1‰q¶EŒöO‰q¶)

110041. [ŒŽ’˜] Higher toxicity of dibutyltin and poly-L-lactide with a large amount of tin but
lower toxicity of poly-L-lactide of synthetic artificial dura mater exhibited on murine astrocyte
cell line. Tsuji M1, Inoue Y, Sugaya C1, Tsunoda M1, Sugaya T, Takahashi M, Yuba T, Tsuchiya T,
Aizawa Y1: Yakugaku Zasshi 2010/6; 130 (6): 847-55. (’ҁ@‰ë‘P1, ›’J‚¿‚Š”ü1, Šp“c³Žj1, ‘ŠàV
DŽ¡1: 1‰q¶EŒöO‰q¶)

110042. [ŒŽ’˜] An epidemiological analysis of severe cases of the influenza A (H1N1) 2009 virus
infection in Japan. Wada K1, Nishiura H, Kawana A: Influenza and Other Respiratory Viruses 2010/7;
4 (4): 179-86. (˜a“ckŽ¡1: 1‰q¶EŒöO‰q¶)

110043. [ŒŽ’˜] Interpersonal conflict and depression among Japanese workers with high or low
socioeconomic status: findings from the Japan Work Stress and Health Cohort Study. Inoue A,
Kawakami N, Aizawa Y1 (Japan Work Stress and Health Cohort Study Group): Soc Sci Med 2010/7; 71
(1): 173-80. (‘ŠàVDŽ¡1: 1‰q¶EŒöO‰q¶)

110044. [ŒŽ’˜] The validity of mass body temperature screening with ear thermometers in a warm
thermal environment. Suzuki T, Wada K1, Wada Y, Kagitani H, Arioka T, Maeda K, Kida K: Tohoku
J Exp Med 2010/9; 222 (2): 89-95. (˜a“ckŽ¡1: 1‰q¶EŒöO‰q¶)

110045. [ŒŽ’˜] Maintenance of influenza virus infectivty on the surfaces of personal orotective
equipment and clothing used in healthcare settings. Sakaguchi H1, Wada K1, Kajioka J, Watanabe
M, Nakano R, Hirose T, Ohta H1, Aizawa Y1: Environ Health Prev Med 2010; 15: 344-9. (ãŒû—mŽq
1, ˜a“ckŽ¡1, ‘Ÿ“c@Š°1, ‘ŠàVDŽ¡1: 1‰q¶EŒöO‰q¶)

110046. [ŒŽ’˜] Evaluation of hazardousness of refractory fibers by cell magnetometry. Kudo Y1,
Kotani M1, Aizawa Y1: J Toxicol Sci 2010/12; 35 (6): 807-15. (H“¡—Yˆê˜Y1, ¬’J@œ1, ‘ŠàVD
Ž¡1: 1‰q¶EŒöO‰q¶)

110047. [ŒŽ’˜] The alterations in cytokine mRNA expressions and productions by fluoride in a murine
macrophage cell line evaluated by real-tome PCR and ELISA. Hosokawa M1, Inoue Y2, Chen XF, Tsunoda
H, Ito K, Katagiri H, Tsunoda M1, Aizawa Y1: Trace Elements 2011; 22 (1): 27-33. (×ì‚Ü‚äŽq1,
ˆäã—tŽq2, Šp“c³Žj1, ‘ŠàVDŽ¡1: 1‰q¶EŒöO‰q¶, 2ˆã—Éq¶Šw•”)

110048. [ŒŽ’˜] Work-family conflict and prolonged fatigue among Japanese married male physicians.
Int Arch Occup Environ Health. Ohta H1, Wada K1, Kawashima M, Arimatsu M, Higashi T, Yoshikawa
T, Aizawa Y1: Int Arch Occup Environ Health 2011/1; published online DOI: 10.1007/s00420-011-0613-z.
(‘Ÿ“c@Š°1, ˜a“ckŽ¡1, ‘ŠàVDŽ¡1: 1‰q¶EŒöO‰q¶)

120004. [ŒŽ’˜] “Œ‹ž“s‚̈ã—Ë@ŠÖ‚É‚š‚¯‚é–\—Í‚ÌŒ»ó (‚»‚Ì1)?ŠÅŒìE‚ÆŽ––±E‚ªŒoŒ±‚µ‚œŠ³ŽÒ‚É‚æ‚é
–\—Í‚ÆŠ³ŽÒ“¯Žm‚Ì–\—Í?. ˜a“ckŽ¡1, ‘Ÿ“c@Š°1, L£’BŽq (1‰q¶EŒöO‰q¶)FˆÀ‘SˆãŠw 2010/10; 6
(2): 34-9.

120005. [ŒŽ’˜] VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU”­¶Žž‚Ì•ÛŒ’Š‚̑Ήž‚Æ–ðŠ„?‰“®‘Ήž‚Æ‚µ‚č‚Z¶“™W’c‚Ö‚Ì—\
–h“Š–ò?. ‚‰ª“¹—Y, ’r“c³•F, –ö£ŒúŽq, “¡àVM•v, ¡ˆäŠ²Ž}, “c’†‹žŽq, ²X–؏‰”ü, ¬—Ñ”Ž”V, ’ҁ@
‰ë‘P1, Šp“c³Žj1 (1‰q¶EŒöO‰q¶)F–k—¢ˆãŠw 2010/12; 40 (2): 89-99.

120006. [ŒŽ’˜] –k—¢‘åŠwˆãŠw•”•‘®—Տ°Œ€‹†ƒZƒ“ƒ^[Eƒ‰ƒ“ƒ_ƒ€‰»Š„•tŽ––±‹Ç‚ÌŒ»‹µ. ¯@‰À–F1, ‰€@
‘‹Õ2, â–{‘×—3, ˆíŒ©@Ž¡3, “V–ì‰pŽ÷, “c”šŒ’ˆê, ŽO‹{”ÍŽq, ²“¡r•F3, ‘ŠàVDŽ¡1 (1‰q¶EŒö
O‰q¶, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3—Տ°Œ€‹†EŠé‰æ): ƒwƒ‹ƒXƒTƒCƒGƒ“ƒXEƒwƒ‹ƒXƒPƒA 2010/12; 10 (2):
100-5.

120007. [ŒŽ’˜] Š{ŠÖßÇ‚̐f—ÃKƒCƒhƒ‰ƒCƒ“ì¬‚É‚š‚¯‚égPatient QuestionhŽûW‚Ì‚œ‚ß‚ÌŠ³ŽÒƒ{ƒ‰
ƒ“ƒeƒBƒA‚ɑ΂·‚éŒÂ•Ê–ʐڒ²ž. –Ø–ìEŽi, Šo“¹Œ’Ž¡, ™è³Žu, ¯@‰À–F1, “’óG“¹, Œ–FŽO, âV
“¡@‚, ŒŽR@‹Å (1‰q¶EŒöO‰q¶): “ú–{Š{ŠÖßŠw‰ïŽGŽ 2010/12; 22 (3): 151-7.

220002. [€ŒŽ’˜]yƒVƒ“ƒ|ƒWƒEƒ€: VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU”­¶‚É”õ‚Š‚œ‘—§•a‰@‹@\‚̑̐§zVŒ^ƒCƒ“ƒtƒ‹
ƒGƒ“ƒU‚Ì‚Ü‚ñ‰„Šú‚ð‘z’肵‚œf—ÃŒp‘±Œv‰æì‚è. ˜a“ckŽ¡ (‰q¶EŒöO‰q¶): ˆã—à 2010/10; 64 (10):
680a-3a.

510003. [‘à] Magnetometric evaluation of toxicities of chemicals to the lungs and cells. Aizawa
Y1, Kudo Y1: Environ Health Prev Med 2010/7; 15 (4): 197-202. (‘ŠàVDŽ¡1, H“¡—Yˆê˜Y1: 1‰q¶E
ŒöO‰q¶)

520007. [‘à]y•œíŽžEÐŠQŽž‚̉q¶‘΍ôzVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚©‚çŠw‚ԕ“I‚ÈŠŽõÇ‘΍ô. ˜a
“ckŽ¡1, ‘Ÿ“c@Š°1, ì“‡³•q1, ãŒû—mŽq1, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶)F •ÛŒ’ˆã—ÉȊw 2010/6;
59 (2); 94-9.

520008. [‘à] ˆã—Ë@ŠÖ‚É‹‚ß‚ç‚ê‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô?ŠŽõ‘΍ô‚Ɛf—ÃŒp‘±Œv‰æì‚è?. ˜a
“ckŽ¡ (‰q¶EŒöO‰q¶): ŠŽõE‰ŠÇE–Ɖu 2010/7; 40 (2); 157-65.

520009. [‘à] ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Æ”]‹@”\. Šp“c³Žj1, ‹{“‡]—¢Žq1, ŽO–ؖҐ¶1, ‘ŠàVDŽ¡1 (1
‰q¶EŒöO‰q¶): —Տ°–ƉuEƒAƒŒƒ‹ƒM[‰È 2010/9; 54 (3); 344-51.

520010. [‘à] ƒAƒXƒxƒXƒg‚ÌŒ’N‰e‹¿. H“¡—Yˆê˜N1, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘‡—Տ°
2010/9; 59 (9); 1997-8.

520011. [‘à] “­‚­‚ª‚ñŠ³ŽÒ‚ÌŒ»ó‚Æ•K—v‚ÈŽd‘g‚Ý. ˜a“ckŽ¡ (‰q¶EŒöO‰q¶): ˜J“­‚̉Ȋw
2010/12; 65 (12); 738-41.

520012. [‘à]y‚ª‚ñŠ³ŽÒ‚̏A˜JŽx‰‡ “­‚«‚È‚ª‚炪‚ñ‚ðŽ¡—Ã‚·‚éz(1) “­‚­‚ª‚ñŠ³ŽÒ‚ÌŒ»ó‚Æ•K—v‚ÈŽd
‘g‚Ý. ˜a“ckŽ¡ (‰q¶EŒöO‰q¶): ˜J“­‚̉Ȋw 2010/12; 65 (12); 738-41.

520013. [‘à] ‚킪‘‚̋Ζ±ˆã‚Ì‹i‰Œ, ˆùŽð, ‰^“®, HŽ–‚̏KŠµ‚ÌŒ»ó. ˜a“ckŽ¡1, ‹gì@“O, Œã“¡
—²‹v, •œˆäˆ€ŽR, Œ“‡‰p‰î, ’†“ˆ‹`•¶, Ô•ä—ŠG, –،˓¹Žq, •Ûâ@—² (1‰q¶EŒöO‰q¶): “úˆãŽGŽ
2011/1; 139 (9); 1894-9.

522004. [uÀ]yƒVƒ“ƒ|ƒWƒEƒ€: VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU”­¶‚É”õ‚Š‚œ‘—§•a‰@‹@\‚̑̐§zVŒ^ƒCƒ“ƒtƒ‹ƒG
ƒ“ƒUƒEƒCƒ‹ƒX”­¶Žž‚É‚š‚¯‚郏ƒNƒ`ƒ“‚Ì–ðŠ„. ˜a“ckŽ¡ (‰q¶EŒöO‰q¶): ‘—§ˆã—Êw‰ïŽ ˆã—Ã
2010/10; 64 (10): 680-3.

522005. [uÀ] ˆã—Ë@ŠÖ‚Å‚Ì–\—͑΍ô (‘æ1‰ñ)?ˆã—Ë@ŠÖ‚Å‚Ì–\—Í‚Í‘gD“I‚ÈŽæ‚è‘g‚݂ōŽ•ž‚·‚é?.
˜a“ckŽ¡ (‰q¶EŒöO‰q¶): Medical forum CHUGAI 2011/1; 15 (1): 2-8.

522006. [uÀ]yˆã—Ë@ŠÖ‚Å‚Ì–\—͑΍ô (‘æ2‰ñ)zŠ³ŽÒ‚©‚çˆã—Ï]Ž–ŽÒ‚Ö‚Ì–\—͂ɑ΂·‚é•ïŠ‡“I‚ȑ΍ô
ì‚è. ˜a“ckŽ¡ (‰q¶EŒöO‰q¶): Medical forumn CHUGAI 2011; 15 (2): 2-7.

540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yƒNƒŠ[ƒjƒ“ƒO‚ÆŒöO‰q¶‚ÉŠÖ‚·‚錀‹†•ñ‘zSHS (ƒVƒbƒNƒnƒEƒXÇŒó
ŒQ) ‚̐f’f‚ɂ‚¢‚ẲuŠw’²ž?ƒNƒŠ[ƒjƒ“ƒO‹Æ–±]Ž–ŽÒ‚ÌŒ’NŠÇ—‚ւ̉e‹¿?. ‘ŠàVDŽ¡1, ‹{“‡]—¢
Žq1 (1‰q¶EŒöO‰q¶): ƒNƒŠ[ƒjƒ“ƒO‚ÆŒöO‰q¶‚ÉŠÖ‚·‚錀‹†•ñ‘ (•œ¬21”N“x) 2010/4; p.19-23.

540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yƒNƒŠ[ƒjƒ“ƒO‚ÆŒöO‰q¶‚ÉŠÖ‚·‚錀‹†•ñ‘zƒhƒ‰ƒCƒNƒŠ[ƒjƒ“ƒO—p
Î–ûŒn—nÜ‹y‚уeƒgƒ‰ƒNƒƒƒGƒ`ƒŒƒ“‚Ì”|—{×–E‚ð—p‚¢‚œˆÀ‘S«•]‰¿‚ÌŽŽ‚Ý (2): ˆâ“`Žq”­Œ»•]‰¿. Šp
“c³Žj (‰q¶EŒöO‰q¶): ƒNƒŠ[ƒjƒ“ƒO‚ÆŒöO‰q¶‚ÉŠÖ‚·‚錀‹†•ñ‘ (•œ¬21”N“x) 2010/4;
p.29-32.

540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] ƒgƒi[‚ÌŽæ‚舵‚¢‚ÉŠÖ‚í‚錒N‰e‹¿’²ž. ‘ŠàVDŽ¡1, ²“¡•q•F2, Šp
“c³Žj1, H“¡—Yˆê˜N1, ˜a“ckŽ¡1, ‘Ÿ“c@Š°1, ì“‡³•q1 (1‰q¶EŒöO‰q¶, 2—Տ°Œ€‹†EŠé‰æ): ƒg
ƒi[‚ÌŽæ‚舵‚¢‚ÉŠÖ‚í‚錒N‰e‹¿’²ž@2009”N“x•ñ‘ 2010/7; p.1-.

540005. [‚»‚Ì‘Œ (–|–ó)]yˆã—Ïî•ñƒT[ƒrƒX Minds (ƒ}ƒCƒ“ƒY)^ˆã—Ã’ñ‹ŸŽÒŒü‚¯^ƒRƒNƒ‰ƒ“EƒŒƒrƒ…[z
…‚¬‚¹‚é‹Ö‰Œ‚Ì‚œ‚߂̉î“ü (2010 issue 3, Updated) (Citation: Maziak W, Ward KD, Eissenberg T.
Interventions for waterpipe smoking cessation. Cochrane Database of Systematic Reviews 2007,
Issue 4. Art. No.: CD005549. DOI: 10.1002/14651858.CD005549.pub2). –|–ó ¯@‰À–F1EŠÄ–ó û‰ª@
—²; JCOHR (1‰q¶EŒöO‰q¶): à’c–@l“ú–{ˆã—Ë@”\•]‰¿‹@\, Minds (“dŽqo”Å
http://minds.jcqhc.or.jp) 2010/7.
http://minds.jcqhc.or.jp/stc/0075/4/0075_G0000209_T0004171.html

540006. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] ˆÏˆõ‰ï•ñ (“ú–{ŒöO‰q¶Šw‰ï: ˆÏˆõ’·@‘ŠàVDŽ¡). ‘ŠàVDŽ¡1, ¬
—Ñ—õ‹B, ‘«—§ŒÈK, ‰““¡@–Ÿ, ŠÝ@—æŽq, ŽÂè‰p•v, ‚–쌒l, ’†Š_°’j, ’†ŒŽr—², ‘º“ˆK‘ã, ŽO‰Yé
•F, ã“‡OŽk, ›‰¬•¶•F (1‰q¶EŒöO‰q¶): ê–åE§“xŒŸ“¢ˆÏˆõ‰ï•ñ‘ 2010/8; p.1-88.

540007. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] ˆã—Ë@ŠÖ‚̉^‰c‚ðŽx‚Š‚éŽü•ÓŽY‹Æ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô?
ˆã–ò•i‰µ‚âMR, Ž‘|‹Æ, ˆã—ËƖ±‚È‚Ç‚ð‘Ώۂɂµ‚œ’²ž‚æ‚è?. ˜a“ckŽ¡1, ¬X—F‹M, ‹÷“c•üŽq (1‰q
¶EŒöO‰q¶): ŽY‹ÆˆãŠwU‹»à’c 2010/8; p.1-3.

540008. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] ƒgƒi[‚ÌŽæ‚舵‚¢‚ÉŠÖ‚í‚錒N‰e‹¿’²ž. ‘ŠàVDŽ¡1, ²“¡•q•F2, Šp
“c³Žj1, H“¡—Yˆê˜N1, ˜a“ckŽ¡1, ‘Ÿ“c@Š°1, ì“‡³•q1 (1‰q¶EŒöO‰q¶, 2—Տ°Œ€‹†EŠé‰æ): ƒg
ƒi[‚ÌŽæ‚舵‚¢‚ÉŠÖ‚í‚錒N‰e‹¿’²ž@2010”N“x•ñ‘ 2011/2; p.1-63.

540009. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬22”N“xŠÂ‹«È¿•‰‹Æ–± (‰»Šw•šŽ¿•]‰¿Œ€‹†‹@\)zŠù‘¶‚Ì’†“Å‚Ì
ŠT”O‚ƐEˆæ‚É‚š‚¯‚é”÷—ʂȉ»Šw•šŽ¿”˜˜I. ‘ŠàVDŽ¡1, Šp“c³Žj1 (1‰q¶EŒöO‰q¶): •œ¬22”N“xŠÂ
‹«’†‚Ì”÷—ʂȉ»Šw•šŽ¿‚É‚æ‚錒N‰e‹¿‚ÉŠÖ‚·‚éî•ñŽûW‹Æ–±•ñ‘ 2011/3; p.77-81.

540010. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬21”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à ˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹ÆuE
ˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‚‹Ž@Œª)vzEˆæ‚É‚š‚¯‚éV
Œ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ðŽx‰‡‚·‚éƒc[ƒ‹ì¬. ˜a“ckŽ¡ (‰q¶EŒöO‰q¶): •œ¬21”N“xŒú
¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à ˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹ÆuEˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i
‚ÉŠÖ‚·‚錀‹†v•œ¬21”N“x‘Š‡Œ€‹†•ñ‘ 2011/3; p.65-76.

540011. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬22”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹Æ)
uEˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹† ( Œ€‹†‘ã•\ŽÒ: ‚‹Ž@Œª)vzŠé‹Æ‚É‚š
‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (A/H1N1) ‚̑Ήž‚ÉŠÖ‚·‚é’²ž‚̃Œƒrƒ…[. ˜a“ckŽ¡ (‰q¶EŒöO‰q¶): •œ¬
22”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹Æ)uEˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô
‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x‘Š‡Œ€‹†•ñ‘ 2011/3; p.67-77.

540012. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)
uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vz‘S‘‰uŠw’²ž‚É‚æ‚éƒV
ƒbƒNƒnƒEƒXÇŒóŒQf’fŠî€‘Ó–«‚ÌŒŸ“¢. ‘ŠàVDŽ¡1, ¬‘q‰p˜Y, –Ø‘ºŒÜ˜Y, ŒF–ìGº, ’†‘º—zˆê, â•”@
v, ’·’JìáÁ‹I, X@ç—¢, ‹g–ì@”Ž, HŽRˆê’j, Šp“c˜a•F, Ž›‘ò­•F, –kžŠËŽq, …é‚Ü‚³‚Ý, ‹{“cŠ²
•v, Šp“c³Žj1, ¯@‰À–F1, ‰€@‘‹Õ2, ”ö“‡³K, ‹{“‡]—¢Žq1, ™‰Y—R”üŽq3, ¬Œ—T”ü, ¬‘ò@Šw (1
‰q¶EŒöO‰q¶, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3—\–hˆãŠwŒn): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@
ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x•ª’SŒ€‹†•ñ
‘ 2011/3; p.1-.

540013. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)
uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vzV’zZŽÉ‚É‚š‚¯‚éŠö”­
«—L‹@‰»‡•š‚ÌŽº“à”Z“x‘ª’è‚ƃVƒbƒNƒrƒ‹ÇŒóŒQ‚ÉŠÖ‚·‚鎩ŠoÇó’²ž. ‘ŠàVDŽ¡1, –،ˑž›’, â•”@
v, ˆÉ“¡r—m, Šp“c³Žj1, ¯@‰À–F1, ‹{“‡]—¢Žq1, ‰€@‘‹Õ2, Šâé‹`Œ[, ™‰Y—R”üŽq3, ¬Œ—T”ü
1, ¬‘ò@Šw, •Ð‹Ë—TŽj (1‰q¶EŒöO‰q¶, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3—\–hˆãŠwŒn): Œú¶˜J“­‰ÈŠwŒ€‹†
”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹†v
•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.21-9.

540014. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)
uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vz‘S‘‰uŠw’²ž‚É‚æ‚éƒV
ƒbƒNƒnƒEƒXÇŒóŒQf’fŠî€‘Ó–«‚ÌŒŸ“¢. ‘ŠàVDŽ¡1, ‹{“‡]—¢Žq1, ¬‘q‰p˜Y, –Ø‘ºŒÜ˜Y, ŒF–ìGº, ’†
‘º—zˆê, â•”@v, ’·’JìáÁ‹I, X@ç—¢, ‹g–ì@”Ž, HŽRˆê’j, Šp“c˜a•F, Ž›‘ò­•F, –kžŠËŽq, …é
‚Ü‚³‚Ý, ‹{“cŠ²•v, Šp“c³Žj1, ¯ ‰À–F1, ‰€@‘‹Õ2, ”ö“‡³K, ™‰Y—R”üŽq3, ¬Œ—T”ü1, ¬‘ò@Šw,
Šâé‹`Œ[, –،ˑž›’, ˆÉ“¡r—m (1‰q¶EŒöO‰q¶, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3—\–hˆãŠwŒn): Œú¶˜J“­
‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ
‚·‚錀‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.5-20.

540015. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)
uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vz‘S‘‰uŠw’²ž‚É‚æ‚éƒV
ƒbƒNƒnƒEƒXÇŒóŒQf’fŠî€‘Ó–«‚ÌŒŸ“¢ (‘‡Œ€‹†•ñ‘). ‘ŠàVDŽ¡1, ‹{“‡]—¢Žq1, ¬‘q‰p˜Y, –Ø
‘ºŒÜ˜Y, ŒF–ìGº, ’†‘º—zˆê, â•”@v, ’·’JìáÁ‹I, X@ç—¢, ‹g–ì@”Ž, HŽRˆê’j, Šp“c˜a•F, Ž›‘ò
­•F, –kžŠËŽq, …é‚Ü‚³‚Ý, ‹{“cŠ²•v, Šp“c³Žj1, ¯@‰À–F1, ‰€@‘‹Õ2, Šâé‹`Œ[, ™‰Y—R”üŽq
3, ¬Œ—T”ü1, ¬‘ò@Šw, –،ˑž›’1,ˆÉ“¡r—m (1‰q¶EŒöO‰q¶, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3—\–hˆã
ŠwŒn): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’f
Šî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹†v•œ¬21, 22”N“x‘‡Œ€‹†•ñ‘2011/3; p.9-24.

540016. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï (ŽŸ•aEáŠQ‘΍ôŒ€‹†•ª–ì zŠÂŠíŽŸŠ³E“œ”A•a“™
¶ŠˆKŠµ•a‘΍ô‘‡Œ€‹†)uŒûo•ÛŒ’‚ÆQOL‚ÌŒüã‚ÉŠÖ‚·‚鑍‡“IŒ€‹† (ƒVƒXƒeƒ}ƒeƒBƒbƒN (ƒRƒNƒ‰ƒ“) •ª
‰È‰ï)vz¯@‰À–F (‰q¶EŒöO‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï (ŽŸ•aEáŠQ‘΍ôŒ€‹†•ª–ì zŠÂŠíŽŸŠ³E“œ”A
•a“™¶ŠˆKŠµ•a‘΍ô‘‡Œ€‹†)uŒûo•ÛŒ’‚ÆQOL‚ÌŒüã‚ÉŠÖ‚·‚鑍‡“IŒ€‹† (ƒVƒXƒeƒ}ƒeƒBƒbƒN (ƒRƒNƒ‰
ƒ“) •ª‰È‰ï)v•œ¬22”N“x•ª’S•ñ‘ 2011/3; (in press).

540017. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)z1p36Œ‡ŽžÇ
ŒóŒQ‚ÌŽÀ‘Ô”cˆ¬‚ƍ‡•¹Çf—ÃKƒCƒhƒ‰ƒCƒ“ì¬. ŽR–{rŽŠ, •œàV‹±Žq, ‘OŠ_‹`O, Œ”ö^—, ²“¡Nm,
¯@‰À–F1 (1‰q¶EŒöO‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ) •œ¬22”N“x‘
Š‡Œ€‹†•ñ‘ 2011/3; p.1-11.

540018. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)z1p36Œ‡ŽžÇ
ŒóŒQ‚Ì‘æˆêŽŸ‘S‘’²žŒ‹‰Ê‚ƍ¡Œã‚ÌŠ³ŽÒ“o˜^‚É‚š‚¯‚é•ûj‚ÌŒŸ“¢. ¯@‰À–F1, ‰º“‡Œ\Žq, ²“¡Nm, ŽR
–{rŽŠ (1‰q¶EŒöO‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ) •ª’SŒ€‹†•ñ‘
2011/3; p.29-32.

540019. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ) (Œ€‹†‘ã•\
ŽÒ: ‘ŠàV@DŽ¡)zŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±E—Տ°Œ€‹†’†Šj‹’“_®”õ. ‘ŠàVDŽ¡1, ”n“ˆ³—²2, ˜aò@“O
3, ‰v“c“TK4, “n粏¹•F5, ²“¡•q•F6, ŒF’J—YŽ¡2, ’|“à³O, ¯@‰À–F1, ‰€@‘‹Õ7, ˆíŒ©@Ž¡6, â
–{‘×—6, Ä“¡Žj˜N, ŽŒŽ@~, ˆÉ“¡ Ÿ•F, Frank Arnold, •P–ìG•ã, “n粒B–ç, Œ‘ºGŒ› (1‰q¶EŒö
O‰q¶, 2–ò—, 3zŠÂŠí“à, 4ŒÄ‹zŠí“à, 5ŠO‰È, 6—Տ°Œ€‹†EŠé‰æ, 7’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): Œú¶˜J
“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ) •œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.1-5.

540020. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­
‚ðæ“±‚·‚鎡Œ±—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vz—Տ°Œ€‹†‚ÉŠÖ‚·‚鏉ŠwŽÒ
‚Ì‚œ‚ß‚Ì‹³ˆçƒvƒƒOƒ‰ƒ€‚Ì‚ ‚è•û‚ɂ‚¢‚Ä. ¯@‰À–F2, ‰€@‘‹Õ3, â–{‘×—1, ˆíŒ©@Ž¡1, ²“¡•q
•F1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶EŒöO‰q¶, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï
•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)u—Տ°Œ€‹†Žx‰‡‚ÉŠÖ‚·‚錟“¢v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘
2011/3; p.159-84.

[’˜@‘]

620009. [Šwp‘] (‹€’˜)yŒÄ‹z—p–hŒì‹ïƒtƒBƒbƒgƒeƒXƒgEƒgƒŒ[ƒjƒ“ƒOƒuƒbƒNz ˜a“ckŽ¡1, ‹gì@“O
(1‰q¶EŒöO‰q¶), ˜J“­‰ÈŠwŒ€‹†Šo”Å•”, “Œ‹ž, 2010/4”­s.

620010. [Šwp‘] (‹€’˜) ŒÄ‹z—p–hŒì‹ïƒtƒBƒbƒgƒeƒXƒgEƒgƒŒ[ƒjƒ“ƒOƒuƒbƒN. ˜a“ckŽ¡1, ‹gì@“O (1
‰q¶EŒöO‰q¶), ˜J“­‰ÈŠwŒ€‹†Šo”Å•”, 2010/4”­s.

620011. [Šwp‘] (•ª’SŽ·•M)y‚ª‚ñ‚ƈꏏ‚É“­‚±‚€I•KŒgCSRƒnƒ“ƒhƒuƒbƒNzp.89-103. ˜a“ckŽ¡ (‰q
¶EŒöO‰q¶), CSRƒvƒƒWƒFƒNƒg, “Œ‹ž, 2010/5”­s.

620012. [Šwp‘] (•ª’SŽ·•M)yŠŽõ‘΍ôƒGƒrƒfƒ“ƒXW{Œ»êŠˆ—pp (ƒCƒ“ƒtƒFƒNƒVƒ‡ƒ“ƒRƒ“ƒgƒ[ƒ‹@
2010”Nt‹G‘Š§)zŠŽõÇ‚Ü‚ñ‰„Žž‚̐f—ÃŒp‘±Œv‰æì‚è‚Ì‚·‚·‚ß, p.149. ˜a“ckŽ¡ (‰q¶EŒöO‰q¶), •Ò
–î–ì–M•v, XŒ“Œ[‘ŸƒƒfƒBƒJo”Å, “Œ‹ž, 2010/5”­s.

620013. [Šwp‘] (•ª’SŽ·•M)yˆãŠw‹³ˆç”’‘@2010”N”Å ('07?'10)zŽÐ‰ïˆãŠw‹³ˆç, p.25-29. –{‹Ž@
–L, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶), “ú–{ˆãŠw‹³ˆçŠw‰ï, ŽÂŒŽo”ŐVŽÐ, “Œ‹ž, 2010/7”­s.

620014. [Šwp‘] (•ª’SŽ·•M)yŠŽõ‘΍ôƒGƒrƒfƒ“ƒXW + Œ»êŠˆ—pp (ƒCƒ“ƒtƒFƒNƒVƒ‡ƒ“ƒRƒ“ƒgƒ[ƒ‹@
2010”Nt‹G‘Š§)zƒRƒ‰ƒ€@7 ŠŽõÇ‚Ü‚ñ‰„Žž‚̐f—ÃŒp‘±Œv‰æì‚è‚Ì‚·‚·‚ß, p.149. ˜a“ckŽ¡ (‰q¶E
ŒöO‰q¶), •Ò –î–ì–M•v, XŒ“Œ[‘Ÿ, ƒƒfƒBƒJo”Å, ‘åã, 2010/5”­s.

620015. [Šwp‘] (•ª’SŽ·•M)y—Տ°ˆã‚Ì‚œ‚߂̃pƒuƒŠƒbƒNƒwƒ‹ƒXzW’c‚ÌŒ’N‚ð‚Æ‚ç‚Š‚éŒöO‰q¶‚ÌŽ‹
“_, p.1-8. ˜a“ckŽ¡1 (1‰q¶EŒöO‰q¶), •Ò ‘Ÿ“c@Š°1, ˜a“ckŽ¡1, ŠÄC ‘ŠàVDŽ¡1, ’†ŠOˆãŠwŽÐ,
“Œ‹ž, 2010/10”­s.

620016. [Šwp‘] (•ª’SŽ·•M)y—Տ°ˆã‚Ì‚œ‚߂̃pƒuƒŠƒbƒNƒwƒ‹ƒXzƒRƒ‰ƒ€; ’m‚Á‚Ä‚š‚«‚œ‚¢ƒf[ƒ^ (1)
ˆã—Ï]Ž–ŽÒ”‚ƈã—Ôï, p.9-10. ‘Ÿ“c@Š°1, ˜a“ckŽ¡1 (1‰q¶EŒöO‰q¶), •Ò ‘Ÿ“c@Š°1, ˜a“ck
Ž¡1, ŠÄC ‘ŠàVDŽ¡1, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/10”­s.

620017. [Šwp‘] (•ª’SŽ·•M)y—Տ°ˆã‚Ì‚œ‚߂̃pƒuƒŠƒbƒNƒwƒ‹ƒXzŒ’NŠÇ—‚Æ‚Í?, p.11-21. ¯@‰À–F
1, •û—TŒõ (1‰q¶EŒöO‰q¶), •Ò ‘Ÿ“c@Š°1, ˜a“ckŽ¡1, ŠÄC ‘ŠàVDŽ¡1, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/10
”­s.

620018. [Šwp‘] (•ª’SŽ·•M)y—Տ°ˆã‚Ì‚œ‚߂̃pƒuƒŠƒbƒNƒwƒ‹ƒXzŽY‰ÈˆãŽt‚ÌŒž­‚ÆŽY‰Èˆã—Âð‹~‚€‚œ
‚߂̐§“xÝŒv. p.85-94. ‘Ÿ“c@Š°1 (1‰q¶EŒöO‰q¶), •Ò ‘Ÿ“c@Š°1, ˜a“ckŽ¡1, ŠÄC ‘ŠàVDŽ¡
1, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/10”­s.

620019. [Šwp‘] (•ª’SŽ·•M)y—Տ°ˆã‚Ì‚œ‚߂̃pƒuƒŠƒbƒNƒwƒ‹ƒXzƒRƒ‰ƒ€; ’m‚Á‚Ä‚š‚«‚œ‚¢ƒf[ƒ^ (2)
Š³ŽÒ‚ɂ‚¢‚Ä‚ÌŽå‚ȃf[ƒ^, p.114-5. ‘Ÿ“c@Š°1, ˜a“ckŽ¡1 (1‰q¶EŒöO‰q¶), •Ò ‘Ÿ“c@Š°1, ˜a
“ckŽ¡1, ŠÄC ‘ŠàVDŽ¡1, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/10”­s.

620020. [Šwp‘] (•ª’SŽ·•M)y—Տ°ˆã‚Ì‚œ‚߂̃pƒuƒŠƒbƒNƒwƒ‹ƒXzƒGƒrƒfƒ“ƒX‚ÉŠî‚­ŒöO‰q¶
(Evidence Based Public Health), p.116-25. ˜a“ckŽ¡1 (1‰q¶EŒöO‰q¶), •Ò ‘Ÿ“c@Š°1, ˜a“ck
Ž¡1, ŠÄC ‘ŠàVDŽ¡1, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/10”­s.

620021. [Šwp‘] (•ª’SŽ·•M)y—Տ°ˆã‚œ‚߂̃pƒuƒŠƒbƒNƒwƒ‹ƒXzƒRƒ‰ƒ€; •a‹C‚ÌŒˆ’è—vˆöuBIGGEMSv,
p.138. ˜a“ckŽ¡1 (1‰q¶EŒöO‰q¶), •Ò ‘Ÿ“c@Š°1, ˜a“ckŽ¡1, ŠÄC ‘ŠàVDŽ¡1, ’†ŠOˆãŠwŽÐ, “Œ
‹ž, 2010/10”­s.

620022. [Šwp‘] (•ª’SŽ·•M)y—Տ°ˆã‚Ì‚œ‚߂̃pƒuƒŠƒbƒNƒwƒ‹ƒXzƒRƒ‰ƒ€; ’m‚Á‚Ä‚š‚«‚œ‚¢ƒf[ƒ^ (3)
‘–¯‘S‘̂̃f[ƒ^, p.158-9. ‘Ÿ“c@Š°1, ˜a“ckŽ¡1 (1‰q¶EŒöO‰q¶), •Ò ‘Ÿ“c@Š°1, ˜a“ckŽ¡1,
ŠÄC ‘ŠàVDŽ¡1, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/10”­s.

620023. [Šwp‘] (•ª’SŽ·•M)y—Տ°ˆã‚Ì‚œ‚߂̃pƒuƒŠƒbƒNƒwƒ‹ƒXzŒöO‰q¶‚ð‚³‚ç‚ÉŠw‚ԏê?‘˜_,
p.160-2. ˜a“ckŽ¡1 (1‰q¶EŒöO‰q¶), •Ò ‘Ÿ“c@Š°1, ˜a“ckŽ¡1, ŠÄC ‘ŠàVDŽ¡1, ’†ŠOˆãŠwŽÐ, “Œ
‹ž, 2010/10”­s.

620024. [Šwp‘] (ŠÄCE•ÒW)y—Տ°ˆã‚Ì‚œ‚߂̃pƒuƒŠƒbƒNƒwƒ‹ƒXz‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶), •Ò
‘Ÿ“c@Š°1, ˜a“ckŽ¡1, ŠÄC ‘ŠàVDŽ¡1, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/10”­s.

620025. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚ÌŽ¡—ÃŽwj?Ž„‚Í‚±‚€Ž¡—µ‚Ä‚¢‚é, 2011”N”ŁzŠÂ‹«EE‹Æ«ˆöŽq
‚É‚æ‚鎟Š³?Å‹ß‚Ì“®Œü, p.884-6. ‘ŠàVDŽ¡ (‰q¶EŒöO‰q¶), ‘•ÒW ŽRŒû@“O, –kŒŽŒõ•v, •ŸˆäŽŸ
–î, ˆãŠw‘‰@, “Œ‹ž, 2011/1”­s.

620026. [Šwp‘] (•ÒW)y¡“ú‚ÌŽ¡—ÃŽwj?Ž„‚Í‚±‚€Ž¡—µ‚Ä‚¢‚é, 2011”N”ŁzŠÂ‹«EE‹Æ«ˆöŽq‚É‚æ
‚鎟Š³, p.884-95. ‘ŠàVDŽ¡ (‰q¶EŒöO‰q¶), ‘•ÒW ŽRŒû@“O, –kŒŽŒõ•v, •ŸˆäŽŸ–î, ˆãŠw‘‰@, “Œ
‹ž, 2011/1”­s.

620027. [Šwp‘] (‹€’˜)yŽY‹ÆˆãŠwŽÀ‘HŒ€CƒvƒƒOƒ‰ƒ€zŠé‹Æ‚É•K—v‚ȐVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô. ˜a“c
kŽ¡ (‰q¶EŒöO‰q¶), Œú¶˜J“­ÈˆÏ‘õuŽY‹Æˆã‚ÌŽÀ‘H“I”\—ÍŒüã‚Ì‚œ‚ß‚ÌŒ€CŽ–‹Æv, 2011”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712015. [Šw‰ï (‘Û)] (“Á•Ê•ñ) Introduction of exchange program between Universita "G. d'
Annunzio" and Kitasato University. Aizawa Y1, Di Gioacchino M: International Symposium on
Occupational and Environmental Allergy and Immune Disaeses 2010 (2010/4/8), Kyoto. (‘ŠàVDŽ¡1:
1‰q¶EŒöO‰q¶)

713023. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Immunotoxic effects of tributyltin on splenocytes and thymocytes
in female F1 rats ao 9 weeks of age after exposure via the placenta, their dams' milk, and/or
theis food. Tsunoda M1, Ikeuchi R1, Kaido T1, Hosokawa M1, Sugaya C1, Inoue Y1, Kudo Y1, Hayashi
K, Kosaka T, Takeuchi Y, Tashiro T, Aizawa Y1: International Symposium on Occupational and
Environmental Allergy and Immune Diseases 2010 (2010/4/9), kyoto, Abstract 2010; p.46. (Šp“c³
Žj1, ’r“à—Ž‘Ÿ˜Y1, ‹¬ŒËF–ç1, ×ì‚Ü‚äŽq1, ›’J‚¿‚Š”ü1, ˆäã—tŽq1, H“¡—Yˆê˜Y1, ‘ŠàVDŽ¡1: 1
‰q¶EŒöO‰q¶)

713024. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Effects of fluoride on the bones of rats evaluated by
microdensitometry after oral administration for two months. Tsunoda M1, Kido T1, Ikeuchi R1,
Sugaya C1, Tsuji M1, Zhang Y, Hosokawa M1, Inoue Y, Katagiri H, Itai K, Ohta H1, Aizawa Y1: XXXIX
International Coference of the International Society for Fluoraide Research (2010/12/2), India,
—\eW 2010; p.26. (Šp“c³Žj1, –،ˑž›’1, ’r“à—Ž‘Ÿ˜Y1, ›’J‚¿‚Š”ü1, ’ҁ@‰ë‘P1, ×ì‚Ü‚äŽq1,
‘Ÿ“c@Š°1, ‘ŠàVDŽ¡1: 1‰q¶EŒöO‰q¶)

713025. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The neurotoxic effects of tributyltin on male F1 rats by
continuous exposure from the fetus stage through their developing stages. Ikeuchi R1, Kido T1,
Sugaya C1, Tsunoda M1, Katagiri H, Uchimura A, Akita H, Saji M, Aizawa Y1: 2011 Society of Toxicology
50th Anniversary Meeting (2011/3/6), Washington DC. (’r“à—Ž‘Ÿ˜Y1, –،ˑž›’1, ›’J‚¿‚Š”ü1, Šp
“c³Žj1, ‘ŠàVDŽ¡1: 1‰q¶EŒöO‰q¶)

713026. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Fluoride in drinking water deteriorates renal damage in
ICR-derived glomerulonephritis (ICGN) mice. Hosokawa M1, Asakawa H1, Sugaya C1, Tsunoda M1, Itai
K, Kodama Y, Sugita-Konishi Y, Takata A, Yokoyama K, Aizawa Y1: 2011 Society of Toxicology 50th
Anniversary Meeting (2011/3/6), Washington DC. (×ì‚Ü‚äŽq1, óìG—Y1, ›’J‚¿‚Š”ü1, Šp“c³Žj
1, ‘ŠàVDŽ¡1: 1‰q¶EŒöO‰q¶)

713027. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) The effects of tributyltin (TBT) on splenocytes in F1 rats exposed
to TBT VIA placenta, their dam's milk, and/or food. Tsunoda M1, Kido T1, Ikeuchi R1, Kaido T1,
Hosokawa M1, Sugaya C1, Ohta H1, Katagiri H, Hayashi K, Kosaka T, Takeuchi Y, Tashiro T, Aizawa
Y1: 2011 Society of Toxicology 50th Anniversary Meeting (2011/3/6), Washington DC. (Šp“c³Žj1,
–،ˑž›’1, ’r“à—Ž‘Ÿ˜Y1, ‹¬ŒËF–ç1, ×ì‚Ü‚äŽq1, ›’J‚¿‚Š”ü1, ‘Ÿ“c@Š°1, ‘ŠàVDŽ¡1: 1‰q¶E
ŒöO‰q¶)

713028. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Changes in deep abdominal muscle thickness evaluated by
ultrasonography in adolescent female rhythmic gymnasts. Uchida Y, Hoshi K1, Yoshimoto M, Fujii
M, Kihara Y, Ashihara M, Nishimura M, Takahira N (‰q¶EŒöO‰q¶): Adobe (2011/3/27), Maui, Hawaii.
(¯@‰À–F1: 1‰q¶EŒöO‰q¶)

722017. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’†¬Šé‹Æ‚É‹‚ß‚ç‚ê‚éŒø‰Ê“I‚ȐVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô. ˜a“c
kŽ¡ (‰q¶EŒöO‰q¶): ‘æ83‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï(2010/5/27), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ‘): 181.

722018. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ˆãŠw•¶Œ£ŒŸõuÀ (2)?f’f‚ÌŒ€‹†˜_•¶Eî•ñ‚ðŽûW‚·‚é (“ü–å
•Ò)?. ¯@‰À–F (‰q¶EŒöO‰q¶): —Տ°Œ€‹†ƒZƒ“ƒ^[ƒZƒ~ƒi[ (2010/5/29), ‘Š–ÍŒŽ.

722019. [Šw‰ï (‘S‘)] (ƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€) ‡¬‹zŽû«lHd–Œ‚̈À‘S«•]‰¿‚ÉŠÖ‚·‚錀‹†; “®•šƒ‚ƒf
ƒ‹‚Ì2ƒ–ŒŽŠÏŽ@Œã‚Ì”]Še•”ˆÊ_Œo“`’B•šŽ¿‘ª’è. Šp“c³Žj1, ‹¬ŒËF–ç1, ’r“à—Ž‘Ÿ˜Y1, ×ì‚Ü‚äŽq1,
H“¡—Yˆê˜N1, “y‰®—˜], ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ21‰ñ“ú–{”÷—ÊŒ³‘fŠw‰ï(2010/7/3), ‹ž“s,
Biomed Res Trace Elements 2010; 21 (2): 100.

722020. [Šw‰ï (‘S‘)] (ƒ~ƒjƒVƒ“ƒ|ƒWƒEƒ€) ƒgƒŠƒuƒ`ƒ‹ƒXƒY‰»‡•š‚̈Ÿ–«ŒoŒû”˜˜I‚É‚æ‚é”DPƒ‰ƒbƒg
‚Ì”]Še•”ˆÊ‚̐_Œo“`’B•šŽ¿‹y‚ё̏d‚̕ω». ’r“à—Ž‘Ÿ˜Y1, ‹¬ŒËF–ç1, ×ì‚Ü‚äŽq1, ›’J‚¿‚Š”ü1, ˆä
ã—tŽq, H“¡—Yˆê˜N1, Šp“c³Žj1, ’|“à—T‹I, “c‘ã•üŽq, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ21‰ñ“ú–{
”÷—ÊŒ³‘fŠw‰ï(2010/7/3), ‹ž“s, Biomed Res Trace Elements 2010; 21 (2): 102.

722021. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) Web‚ð—p‚¢‚œî•ñ”­MEî•ñ—˜—p. ¯@‰À–F (‰q¶EŒöO‰q¶):
Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•ÛŒ’î•ñ—˜—pŠT˜_EuŽt (2010/12/9), ˜aŒõ (‘—§•ÛŒ’ˆã—ÉȊw‰@).

722022. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Œš’z•š‚ÆŒ’N–â‘è. Šp“c³Žj (‰q¶EŒöO‰q¶): ‘æ38‰ñŒš’z
•šŠÂ‹«‰q¶ŠÇ—‘S‘‘å‰ï(2011/1/21), “Œ‹ž, Environment and Building Services ƒrƒ‹‚Ɗ‹« 2011; 132:
23-7.

722023. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘@ˆÛó•šŽ¿Œ€‹†‹Š‹c‰ï‚ÌŠˆ“®“à—e. Šp“c³Žj (‰q¶EŒöO‰q
¶): ‘æ81‰ñ“ú–{‰q¶Šw‰ï(ŽãŠJÃ), “ú–{‰q¶ŠwŽGŽ 2011; 66 (2); 267-8.

723072. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒgƒŠƒuƒ`ƒ‹ƒXƒY“ñ¢‘㔘˜I‚Ì6T—ß, 9T—ß‚ÌF1ƒ‰ƒbƒg‚ɑ΂·‚é
prepulse inhibition test. ’r“à—Ž‘Ÿ˜Y1, Šp“c³Žj1, ›’J‚¿‚Š”ü1, ˆäã—tŽq1, ‘ŠàVDŽ¡1 (1‰q¶E
ŒöO‰q¶): ‘æ80‰ñ“ú–{‰q¶Šw‰ï‘‰ï (2010/5/10), å‘ä, “ú–{‰q¶ŠwŽGŽ 2010; 65 (2): 294.

723073. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒgƒŠƒuƒ`ƒ‹ƒXƒY“ñ¢‘㔘˜I (Œo‘Ù”Õ•ê“ûEÄ”˜˜I) ‚Ì‚æ‚é_Œo“`’B
•šŽ¿‚̕ω». Šp“c³Žj1, ŸÇìG—Y1, ’r“à—Ž‘Ÿ˜Y1, ‹¬ŒËF–ç1, ×ì‚Ü‚äŽq1, ›’J‚¿‚Š‚Ý1, ˆäã—t
Žq1, ’ҁ@‰ë‘P1, H“¡—Yˆê˜N1, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ80‰ñ“ú–{‰q¶Šw‰ï‘‰ï(2010/5/10),
å‘ä, “ú–{‰q¶ŠwŽGŽ 2010; 65 (2): 355.

723074. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒ}ƒEƒXƒ}ƒNƒƒtƒ@[ƒWŒn×–EJ774.1‚ÌŽ¥ŠE‘ª’è–@‚ð—p‚¢‚œsilicon
carbide ‚̓Ő«•]‰¿. ˆäã—tŽq1, ˆÉ“¡‹žŽq, H“¡—Yˆê˜N1, Šp“c³Žj1, ¬’J@œ1, ‘ŠàVDŽ¡1 (1‰q
¶EŒöO‰q¶): ‘æ80‰ñ“ú–{‰q¶Šw‰ï‘‰ï(2010/5/10), å‘ä, “ú–{‰q¶ŠwŽGŽ 2010; 65 (2): 365.

723075. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •@•”‹z“ü”˜˜IŽÀŒ±‚É‚æ‚郍ƒbƒNƒE[ƒ‹‚̈À‘S«•]‰¿. H“¡—Yˆê˜N
1, –Ζ؍¹ç‘ã1, ¬Œ—T”ü1, ‘å“c‰xŽq1, ¬ŽR”ü’q‘ã1, Šp“c³Žj1, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ
80‰ñ“ú–{‰q¶Šw‰ï‘‰ï(2010/5/11), å‘ä, “ú–{‰q¶ŠwŽGŽ 2010; 65 (2): 337.

723076. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 70ÎˆÈã‚̋Ζ±ˆã‚ª‹‚ß‚éˆã—Ë@ŠÖ‚ł̐EêŠÂ‹«‰ü‘P. ˜a“ckŽ¡
1, ‹gì@“O (1‰q¶EŒöO‰q¶): ‘æ83‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2010/5/26), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ
‘): 364.

723077. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Eˆæ’èŠúŒ’Nf’f‚ÌŒŸžŒ‹‰Ê‚ð“úí‚ÌŒ’NŠÇ—‚ÅŠˆ—p‚µ‚æ‚€‚Æ‚·‚é
˜J“­ŽÒ‚̃‚ƒ`ƒx[ƒVƒ‡ƒ“ˆöŽq. H“¡ˆÀŽj1, ‰ª“c[Žj1, Šp“c³Žj1, ²“¡•q•F2, ‘ŠàVDŽ¡1 (1‰q¶E
ŒöO‰q¶, 2—Տ°Œ€‹†EŠé‰æ): ‘æ83‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2010/5/27), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ‘):
397.

723078. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Eˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹† (‘æ
1•ñ)?Šé‹Æ‚̐VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚ÉŠÖ‚·‚鎿–â•[’²ž(Šî–{WŒvŒ‹‰Ê‚æ‚è)?. ¡ˆä“S•œ, ‚‹Ž@Œª,
“Œ@•qº, X@WŽ¢, ›ŽìŽR–±, ãŒŽ³“¹, ˜a“ckŽ¡1, XŒ“Œ[‘Ÿ, ŠÛŽR@’, Œ”WA‹KG, ‹{‘º‰ÀF (1
‰q¶EŒöO‰q¶): ‘æ83‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2010/5/27), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ‘): 403.

723079. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Eˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹† (‘æ
2•ñ)?Šé‹Æ‚̐VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚ÉŠÖ‚·‚éƒCƒ“ƒ^ƒrƒ…[’²ž?. ŠÛŽR@’, ¡ˆä“S•œ, ‹Ê‘㐚‚È‚È,
›ŽìŽR–±, ãŒŽ³“¹, ˜a“ckŽ¡1, XŒ“Œ[‘Ÿ, “Œ@•qº, ‚‹Ž@Œª, X@WŽ¢ (1‰q¶EŒöO‰q¶): ‘æ83
‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2010/5/27), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ‘): 404.

723080. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Eˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹† (‘æ
3•ñ)?]‹Æˆõ‚̃ŠƒXƒN‹y‚Ñ—\–hô‚ւ̈ӎ¯‚ÉŠÖ‚·‚鎿–â•[’²ž (Šî–{WŒvŒ‹‰Ê‚æ‚è)?. Œ”WA‹KG, ¡
ˆä“S•œ, ‚‹Ž@Œª, “Œ@•qº, X@WŽ¢, ›ŽìŽR–±, ãŒŽ³“¹, ˜a“ckŽ¡1, XŒ“Œ[‘Ÿ, ŠÛŽR@’, ‹{‘º
‰ÀF (1‰q¶EŒöO‰q¶): ‘æ83‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2010/5/27), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ‘): 404.

723081. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ú–{‚ÌŠù¥’j«ˆãŽt‚É‚š‚¯‚郏[ƒNEƒtƒ@ƒ~ƒŠ[EƒRƒ“ƒtƒŠƒNƒg‚Æ
–«”æ˜J‚ÌŠÖ˜A‚ɂ‚¢‚Ä. ‘Ÿ“c@Š°1, ˜a“ckŽ¡1, —LŒ‚Ü‚ä‚è, “Œ@•qº, ‹gì@“O, D“c@i, ‘ŠàV
DŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ83‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï(2010/5/27), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ‘): 409.

723082. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹Î–±ˆã‚ª–]‚ÞŒ’NŽx‰‡‚Ì‚œ‚߂̘J“­ðŒEEêŠÂ‹«‰ü‘Pƒj[ƒY‚Ì‘S
‘’²ž. ‹gì@“O, ˜a“ckŽ¡1, ¡‘º@‘ (1‰q¶EŒöO‰q¶): ‘æ83‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2010/5/27),
•Ÿˆä, ŽY‰qŽ 2010; 52(—Õ‘): 410.

723083. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 70ÎˆÈã‚̋Ζ±ˆã‚ª‹‚ß‚éˆã—Ë@ŠÖ‚ł̐EêŠÂ‹«‰ü‘P. ˜a“ckŽ¡
1, ‹gì@“O (1‰q¶EŒöO‰q¶): ‘æ83‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2010/5/27), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ
‘): 364.

723084. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) k‘åŠw•a‰@‚ɋΖ±‚·‚éŠÅŒìE‚ÌŽq‹{èò‚ª‚ñ‚ÉŠÖ‚·‚é’mŽ¯‚ÆŒŸfŽóf
‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä. ‹g–씪d1, ‘Ÿ“c@Š°1, ì“‡³•q1, Ž…‚Ý‚Ç‚è1, ˜a“ckŽ¡1, ‘ŠàVDŽ¡1 (1‰q
¶EŒöO‰q¶): ‘æ83‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2010/5/28), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ‘): 526.

723085. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) (ƒ|ƒXƒ^[) ’j«˜J“­ŽÒ‚̍s“®•Ï—e’iŠKƒ‚ƒfƒ‹‚É‚š‚¯‚é–³ŠÖS‚ÉŠÖ‚·
‚éƒAƒ“ƒP[ƒg’²ž. ‹{“‡]—¢Žq1, H“¡ˆÀŽj1, ‹ß“¡‚Š‚è1, Šp“c³Žj1, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶):
‘æ83‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2010/5/28), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ‘): 564.

723086. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ×–EŽ¥ŠE‘ª’è–@‚É‚š‚¯‚é Refractory Fiber‚̍זE“Ő«•]‰¿. H“¡
—Yˆê˜N1, –Ζ؍¹ç‘ã1, ¬Œ—T”ü1, ‘å“c‰xŽq1, ™‰Y—R”üŽq2, ¬’J@œ1, Šp“c³Žj1, ‘ŠàVDŽ¡1 (1
‰q¶EŒöO‰q¶, 2—\–hˆãŠwŒn): ‘æ83‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (2010/5/28), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ‘):
603.

723087. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’j«˜J“­ŽÒ‚É‚š‚¯‚閝«t‘Ÿ•a‚̊댯ˆöŽq‚ɂ‚¢‚Ä. ì“‡³•q1,
˜a“ckŽ¡1, ‘Ÿ“c@Š°1, Ž…‚Ý‚Ç‚è1, ‹g–씪d1, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ83‰ñ“ú–{ŽY‹Æ
‰q¶Šw‰ï (2010/5/28), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ‘): 610.

723088. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒgƒŠƒuƒ`ƒ‹ƒXƒY (TBT)“ñ¢‘㔘˜I‚É‚æ‚éF1ƒ‰ƒbƒg‚̍s“®‚ɑ΂·‚é‰e
‹¿; ƒI[ƒvƒ“ƒtƒB[ƒ‹ƒhŽŽŒ±‚É‚æ‚é•]‰¿. Šp“c³Žj1, ’r“à—Ž‘Ÿ˜Y1, ‹¬ŒËF–ç1, ×ì‚Ü‚äŽq1, ˆäã
—tŽq1, H“¡—Yˆê˜N1, •Ð‹Ë—TŽj, “c‘ã•üŽq, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ83‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï
(2010/5/28), •Ÿˆä, ŽY‰qŽ 2010; 52 (—Õ‘): 619.

723089. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒgƒŠƒuƒ`ƒ‹ƒXƒYŒo‘ٔՁEŒo•ê“û”˜˜I‚É‚æ‚éF1ƒ‰ƒbƒg6T—ߎž‚Ì‹¹‘B
ƒŠƒ“ƒp‹…ƒTƒuƒZƒbƒg‚̕ω». Šp“c³Žj1, ’r“à—Ž‘Ÿ˜Y1, ‹¬ŒËF–ç1, ×ì‚Ü‚äŽq1, ›’J‚¿‚Š”ü1, H“¡
—Yˆê˜N1, —с@Gˆê, ¬â’‰Ži, ’|“à—T‹I, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ41‰ñE‹ÆEŠÂ‹«ƒAƒŒƒ‹ƒM
[Šw‰ï (2010/7/16), ŒQ”n, E‹ÆEŠÂ‹«ƒAƒŒƒ‹ƒM[Ž 2010; 18 (1): 50.

723090. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒNƒŠ[ƒjƒ“ƒO—pÎ–ûŒn—nÜ‹y‚уeƒgƒ‰ƒNƒƒƒGƒ`ƒŒƒ“‚̃}ƒNƒƒtƒ@
[ƒWŒn×–E IL-12p40 ”­Œ»‚ɑ΂·‚é‰e‹¿. –،ˑž›’1, Šp“c³Žj1, ›’J‚¿‚Š”ü1, H“¡—Yˆê˜N1, ‘ŠàV
DŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ19‰ñ“ú–{—Տ°ŠÂ‹«ˆãŠw‰ïŠwpW‰ï (2010/7/2), “Œ‹ž, Ž˜^W 2010; p.63.

723091. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̗Տ°•ª—Þ‚É‚š‚¯‚鉻Šw•šŽ¿‹NˆöƒVƒbƒNƒnƒEƒX
ÇŒóŒQŠ³ŽÒ (2Œ^) ‚Ì”­Ç‘OŒã‚̉»Šw•šŽ¿•s‘ϐ«‚̕ω». ‹{“‡]—¢Žq1, ¬‘ò@Šw, ‰€@‘‹Õ2, ¯@‰À
–F1, Šp“c³Žj1, ‹{“cŠ²•v, â•”@v, ™‰Y—R”üŽq3, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶, 2—Տ°Œ€‹†EŠé
‰æ, 3—\–hˆãŠwŒn): ‘æ19‰ñ“ú–{—Տ°ŠÂ‹«ˆãŠw‰ïŠwpW‰ï (2010/7/3), “Œ‹ž, Ž˜^W 2010; 54.

723092. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒgƒŠƒuƒ`ƒ‹ƒXƒYŒo‘ٔՁEŒo•ê“û”˜˜I‚É‚æ‚郁ƒXF1ƒ‰ƒbƒg6T—ߎž‚Ì
äB‘ŸƒŠƒ“ƒp‹…ƒTƒuƒZƒbƒg‚̕ω». Šp“c³Žj1, –،ˑž›’1, ’r“à—Ž‘Ÿ˜Y1, ‹¬ŒËF–ç1, ×ì‚Ü‚äŽq1, ›
’J‚¿‚Š”ü1, H“¡—Yˆê˜N1, —с@Gˆê, ¬â’‰Ži, ’|“à—T‹I, “c‘ã•üŽq, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶):
‘æ17‰ñ“ú–{–Ɖu“Ő«Šw‰ïŠwp‘å‰ï (2010/9/9), ’}”g, u‰‰—vŽ|W 2010; p.124.

723093. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) WebƒAƒ“ƒP[ƒgì¬ƒVƒXƒeƒ€‚ÌŠJ”­: ƒVƒXƒeƒ€‚ÌŠT—v. ˆÀ
“¡—Yˆê, ¯@‰À–F1, ‹gŒ©ˆí˜Y, •û—TŒõ (1‰q¶EŒöO‰q¶): ‘æ68‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï
(2009/10/21), “Þ—Ç, “ú–{Œö‰qŽ 2009/10; 56 (10): 157.

723094. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì—¬s‰Šú‚É‚š‚¯‚é’â—¯‘[’u‚̈ӎuŒˆ’è‚ɍl—¶
‚·‚ׂ«—vˆö. ˜a“ckŽ¡1, ‘Ÿ“c@Š°1, ãŒû—mŽq1, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ69‰ñ“ú–{ŒöO‰q
¶Šw‰ï‘‰ï (2010/10/27), “Œ‹ž, “ú–{ŒöO‰q¶ŽGŽ 2010; 57 (10): 432.

723095. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’†¬‹K–Í•a‰@‚É‚š‚¯‚鏗«ŠÅŒì]Ž–ŽÒ‚̋ΘJˆÓ—~‚ÉŠÖ˜A‚·‚éE–±–ž
‘«“xˆöŽq. H“¡ˆÀŽj1, éŒËŽ —¢, ƒVƒFƒU[ƒh’M’Ë‚Ü‚¿Žq, Žu“c‹žŽq, ²“¡•q•F2, ‘ŠàVDŽ¡1 (1‰q¶E
ŒöO‰q¶, 2—Տ°Œ€‹†EŠé‰æ): ‘æ69‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï(2010/10/28), “Œ‹ž, “ú–{ŒöO‰q¶ŽGŽ.
2010; 57 (10): 486.

723096. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒŒƒZƒvƒg‚ð—p‚¢‚œ•v•wŠÔ‚É‚š‚¯‚é‚€‚•aWÏ«‚ÌŒŸ“¢.
¯@‰À–F1, ‰€@‘‹Õ2, â–{‘×—3, ²“¡•q•F3, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶, 2’nˆæŽüŽYŠúE‹~‹}ˆã
—Ã, 3—Տ°Œ€‹†EŠé‰æ): ‘æ69‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2010/10/28), “Œ‹ž, “ú–{ŒöO‰q¶ŽGŽ 2010/10;
57 (10): 476.

723097. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’èŠúŒ’Nf’fŽž‚Ì”AŒŸž‚É‚æ‚閝«t‘Ÿ•aƒXƒNƒŠ[ƒjƒ“ƒO‚̑Ó–«
‚ɂ‚¢‚Ä. ì“‡³•q1, ˜a“ckŽ¡1, ‘Ÿ“c@Š°1, Ž…‚Ý‚Ç‚è1, ‹g–씪d1, ãŒû—mŽq1, ‘ŠàVDŽ¡1 (1
‰q¶EŒöO‰q¶): ‘æ69‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2010/10/29), “Œ‹ž, “ú–{ŒöO‰q¶ŽGŽ 2010; 57 (10):
194.

723098. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ÐŠQ•œ‹»Žx‰‡Šˆ“® (ƒ~ƒƒƒ“ƒ}[) ‚ÅŒ@í‚µ‚œˆäŒË‚̐…Ž¿’²ž‹y‚ÑŒ»
’nŒp‘±ŠÇ—‚ÌŒŸ“¢. ’r“à—Ž‘Ÿ˜Y1, Šp“c³Žj1, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ69‰ñ“ú–{ŒöO‰q¶
Šw‰ï‘‰ï (2010/10/29), “Œ‹ž, “ú–{ŒöO‰q¶ŽGŽ 2010; 57 (10): 567.

723099. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŽÐˆõ‚ÌAdapt-Ability‚̓Rƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“”\—͈ȏã‚ɃXƒgƒŒƒX‚É
‰e‹¿‚µ‚Ä‚¢‚é. ‹TŽR»Žq, ‹àŽq‘œŽq, ŽÄ“c–«‹v, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ26‰ñ“ú–{ƒXƒgƒŒ
ƒXŠw‰ïŠwp‘‰ï (2010/11/5), •Ÿ‰ª, ƒXƒgƒŒƒX‰ÈŠw 2010; 25 (2): 137.

723100. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒXƒgƒŒƒbƒXƒ`ƒFƒbƒN‚Ì“Ÿ“_‚Í•K‚ž‚µ‚à•a‹C‚ðŽŠŽ‚µ‚È‚¢?Eê‚ÅŽÀ
Ž{‚·‚éƒXƒgƒŒƒXƒ`ƒFƒbƒN‚̉ʂœ‚·–ðŠ„?. ‹àŽq‘œŽq, ‹TŽR»Žq, ŽÄ“c–«‹v, ‘ŠàVDŽ¡1 (1‰q¶EŒöO
‰q¶): ‘æ26‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ïŠwp‘‰ï (2010/11/5), •Ÿ‰ª, ƒXƒgƒŒƒX‰ÈŠw 2010; 25 (2): 138.

723101. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”xŽ¥ŠE‘ª’è–@‚É‚æ‚éƒtƒ‰[ƒŒƒ“‚̉e‹¿•]‰¿. H“¡—Yˆê˜N1, ™‰Y—R
”üŽq2, –Ζ؍¹ç‘ã1, ¬ŽR”ü’q‘ã1, ‘å“c‰xŽq1, Šp“c³Žj1, ¬’J@œ1, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q
¶, 2—\–hˆãŠwŒn): ‘æ58‰ñ“ú–{E‹ÆEÐŠQˆãŠw‰ïŠwp‘å‰ï(2010/11/6), ç—t, “ú–{E‹ÆEÐŠQˆãŠw‰ï‰ï
Ž 2010; 58 (—Õ‘); 212.

723102. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Î–ûŒn—nÜ‚̃}ƒNƒƒtƒ@[ƒWIL-10‚ð—p‚¢‚œmRNA‚Ì”­Œ»‚ɑ΂·‚é‰e
‹¿. –،ˑž›’1, Šp“c³Žj1, H“¡—Yˆê˜N1, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ58‰ñ“ú–{E‹ÆEÐŠQˆã
Šw‰ïŠwp‘å‰ï (2011/11/6), ç—t, “ú–{E‹ÆEÐŠQˆãŠw‰ï‰ïŽ 2010; 58 (—Õ‘); 233.

723103. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒtƒb‘f‚É”˜˜I‚³‚ê‚œICR-derived glomerulonephritis (ICGN) ƒ}ƒE
ƒX‚Ì”A’†ƒ^ƒ“ƒpƒN. Šp“c³Žj1, –،ˑž›’1, ›’J‚¿‚Š”ü1, H“¡—Yˆê˜N1, ×ì‚Ü‚äŽq1, Ž™‹ÊK•v, ¬
Œ—ÇŽq, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): ‘æ81‰ñ“ú–{‰q¶Šw‰ï(ŽãŠJÃ), “ú–{‰q¶ŠwŽGŽ 2011; 66 (2);
407.

723104. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) lHd–Œ‚̎听•ª‚Å‚ ‚éƒ|ƒŠ“ûŽ_ƒ‰ƒNƒ`ƒh‚̃AƒXƒgƒƒTƒCƒgŒn×–E
‘B”\‚ւ̉e‹¿. ’ҁ@‰ë‘P1, ˆäã—tŽq1, ›’J‚¿‚Š”ü1, Šp“c³Žj1, ›’J’ËMŽq1, ‚‹Ž³g2, —Mê
rN, “y‰®—˜Œb, ‘ŠàVDŽ¡1, •Ÿ“‡“Nm (1‰q¶EŒöO‰q¶, 2¶‰»): ‘æ81‰ñ“ú–{‰q¶Šw‰ï (ŽãŠJÃ),
“ú–{‰q¶ŠwŽGŽ 2011; 66 (2); 408.

723105. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒNƒŠ[ƒjƒ“ƒO—nÜ‚É‚æ‚éƒ}ƒNƒƒtƒ@[ƒWŒn×–E‚̉ŠÇŒnƒTƒCƒgƒJƒC
ƒ“”­Œ»‚ɑ΂·‚錟“¢. –،ˑž›’1, Šp“c³Žj1, ›’J‚¿‚Š”ü1, H“¡—Yˆê˜N1, ‘ŠàVDŽ¡1 (1‰q¶EŒöO
‰q¶): ‘æ81‰ñ“ú–{‰q¶Šw‰ï (ŽãŠJÃ), “ú–{‰q¶ŠwŽGŽ 2011; 66 (2); 419.

723106. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆù—¿…ƒtƒb‘f‚É‚æ‚éICGNƒ}ƒEƒX‚̍œ‚ւ̉e‹¿. ×ì‚Ü‚äŽq1, ó
ìG—Y1, ›’J‚¿‚Š”ü1, –،ˑž›’1, Ž™‹ÊK•v, ¬Œ—ÇŽq, ‘Ÿ“c‹v‹g, Šp“c³Žj1, ‰¡ŽR˜am, ‘ŠàVDŽ¡
1 (1‰q¶EŒöO‰q¶): ‘æ81‰ñ“ú–{‰q¶Šw‰ï (ŽãŠJÃ), “ú–{‰q¶ŠwŽGŽ 2011; 66 (2); 460.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H17-521001. [‰ðà]y“ú–{‚̐f—ÃKƒCƒhƒ‰ƒCƒ“zf—ÃKƒCƒhƒ‰ƒCƒ“•‹y‚ÌŽŽ‚Ý. ¯@‰À–F (‰q¶E
ŒöO‰q¶): —Տ°Œ€‹†E¶•š“ŒvŒ€‹†‰ïŽ 2005/10; 25 (1): 23-6.

H19-120001. [ŒŽ’˜] Š{ŠÖßÇf—ÃKƒCƒhƒ‰ƒCƒ“‚É‚š‚¯‚égPatient Questionh‚Ì”cˆ¬‚ɃCƒ“ƒ^[ƒlƒbƒg
‚ð—˜—p‚·‚é‚œ‚ß‚Ì—\”õ’²ž. “’óG“¹, –Ø–ìEŽi, ¯@‰À–F1, ™è³Žu, Šo“¹Œ’Ž¡ (1‰q¶EŒöO‰q¶):
“ú–{Š{ŠÖßŠw‰ïŽGŽ 2007/12; 19 (3): 227-32.

H20-110001. [ŒŽ’˜] Maternity blues as predictor of postpartum depression: a prospective
cohort study among Japanese women. Watanabe M, Wada K1, Sakata Y, Aratake Y, Kato N, Ohta H1,
Tanaka K: J Psychosom Obstet Gynaecol 2008/9; 29 (3): 206-12. (˜a“ckŽ¡1, ‘Ÿ“c@Š°1: 1‰q¶E
ŒöO‰q¶)

H20-521001. [‰ðà]yÐŠQŽž‚É•ÛŒ’ˆã—Ï]Ž–ŽÒ‚͉œ‚ð‚·‚×‚«‚©@Šú‘Ò‚ÆŒ»ŽÀ‚ÌGapz ÐŠQ‚É‚š‚¯‚é
Ž•‰Èê–åE‚Ì–ðŠ„. ’†‹v–؍Nˆê, ¯@‰À–F1, ’ß“c, ‘ºˆä^‰î, ¬Žº‹MŽq, ŒËŒŽŒº, ¬é–ŸŽq, Ž›‰ª‰Á
‘ã (1‰q¶EŒöO‰q¶): •ÛŒ’ˆã—ÉȊw 2008/9; 57 (3): 225-33.

H20-521002. [‰ðà]y”ñ—ˆŠÙƒT[ƒrƒXz Œ’NŠë‹@ŠÇ—Žx‰‡ƒ‰ƒCƒuƒ‰ƒŠ[ƒVƒXƒeƒ€(H-CRISIS)‚É‚æ‚é
Œ’NŠë‹@î•ñ‚Ì’ñ‹Ÿ. ò@•ôŽq, ¯@‰À–F1, ˆé–ì@ˆÐ, ‘]ª’qŽj, •û—TŒõ (1‰q¶EŒöO‰q¶): ˆã
Šw}‘ŠÙ 2008/9; 55 (3): 220-3.

H20-540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­Èuƒrƒjƒ‹áŠQ‚Ì‹Æ–±ãŠO‚ÉŠÖ‚·‚錟“¢‰ïˆÏˆõ‰ïvz
‰–‰»ƒrƒjƒ‹ƒ‚ƒmƒ}[”˜˜Iì‹ÆŽÒ‚É‚š‚¯‚éŠÌ×–E‚ª‚ñ‚É‚æ‚鎀–S“™‚Ì”­¶•p“x‚ɂ‚¢‚ẲuŠw’²ž‚ð—p‚¢
‚œƒƒ^ƒAƒiƒŠƒVƒX‚ÉŠÖ‚·‚é•ñ‘. Ž…‰p—C, ‘ŠàVDŽ¡1, ’r“à—Ž‘Ÿ˜Y, ‰€@‘‹Õ2, ƒoƒbƒNƒXEƒŒƒIƒ“
3, ²“¡•q•F3 (1‰q¶EŒöO‰q¶, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3—Տ°Œ€‹†EŠé‰æ): Œú¶˜J“­Èuƒrƒjƒ‹á
ŠQ‚Ì‹Æ–±ãŠO‚ÉŠÖ‚·‚錟“¢‰ïˆÏˆõ‰ïv 2008/10.

H20-540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à’nˆæŒ’NŠë‹@ŠÇ—Œ€‹†Ž–‹ÆuƒOƒ
[ƒoƒ‹ŽÐ‰ï‚ɑΉž‚µ‚œŒ’NŠë‹@ƒT[ƒxƒCƒ‰ƒ“ƒXƒVƒXƒeƒ€: î•ñ•ªÍEƒOƒŒ[ƒfƒBƒ“ƒOŽè–@‚ÌŠJ”­‚Æ•]‰¿
(Žå”CŒ€‹†ŽÒ: ¡ˆä”Ž‹v)vzˆã–ò•iˆã—Ë@Ší“™ˆÀ‘S/ˆã—ÈÀ‘S‚Ì•ª–ì‚É‚š‚¯‚é‰ß‹Ž‚ÌŒ’NŠë‹@Ž–—á‚ƃOƒŒ[
ƒfƒBƒ“ƒO‚ɂ‚¢‚Ä‚ÌŒ€‹†. ¯@‰À–F1, ‘åŠâ—R”ü, ™‰Y‚³‚š‚è, ŽO‹{”ÍŽq, ²“¡—YŽ÷ (1‰q¶EŒöO‰q¶):
Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à’nˆæŒ’NŠë‹@ŠÇ—Œ€‹†Ž–‹ÆuƒOƒ[ƒoƒ‹ŽÐ‰ï‚ɑΉž‚µ‚œŒ’NŠë‹@ƒT[ƒxƒCƒ‰ƒ“
ƒXƒVƒXƒeƒ€:î•ñ•ªÍEƒOƒŒ[ƒfƒBƒ“ƒOŽè–@‚ÌŠJ”­‚Æ•]‰¿v•œ¬19-20”N“x‘‡Œ€‹†•ñ‘ 2009/3;
p.13-31.

H20-540003. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹àzŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘‡Œ€‹†
Ž–‹ÆuŒ’N“ú–{21‚Ì’†ŠÔ•]‰¿, “œ”A•a“™‚́u¡Œã‚̐¶ŠˆKŠµ•a‘΍ô‚̐„i‚ɂ‚¢‚Ä (’†ŠÔŽæ‚è‚Ü‚Æ‚ß) ‚ð
“¥‚Ü‚Š‚œ¡Œã‚̐¶ŠˆKŠµ•a‘΍ô‚Ì‚œ‚߂̃Gƒrƒfƒ“ƒX\’z‚ÉŠÖ‚·‚錀‹†vzWebƒAƒ“ƒP[ƒgì¬ƒVƒXƒeƒ€‚ÌŠJ
”­?ƒVƒXƒeƒ€‚ÌŠT—v‚Æ’²žŽ–—á‚̏Љî?. ˆÀ“¡—Yˆê, ¯@‰À–F1, ‹gŒ©ˆí˜Y, •û—TŒõ (1‰q¶EŒöO‰q
¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹àzŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘‡Œ€‹†Ž–‹ÆuŒ’N“ú–{21‚Ì’†ŠÔ•]‰¿, “œ”A•a
“™‚́u¡Œã‚̐¶ŠˆKŠµ•a‘΍ô‚̐„i‚ɂ‚¢‚Ä (’†ŠÔŽæ‚è‚Ü‚Æ‚ß) ‚𓥂܂Š‚œ¡Œã‚̐¶ŠˆKŠµ•a‘΍ô‚Ì‚œ‚ß
‚̃Gƒrƒfƒ“ƒX\’z‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2009/3; p.9-18.

H20-540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à‘æ3ŽŸ‘΂ª‚ñ‘‡í—ªŒ€‹†Ž–‹ÆuŠ³
ŽÒE‰Æ‘°E‘–¯‚ÌŽ‹“_‚É—§‚Á‚œ“KØ‚È‚ª‚ñî•ñ’ñ‹ŸƒT[ƒrƒX‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†vz‚ª‚ñî•ñ‚É‚š‚¯‚é
Š³ŽÒE‰Æ‘°E‘–¯‚ÌŽ‹“_‚ÉŠÖ‚·‚錀‹†. •û—TŒõ, ¯@‰À–F1 (1‰q¶EŒöO‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†
”ï•â•‹à‘æ3ŽŸ‘΂ª‚ñ‘‡í—ªŒ€‹†Ž–‹ÆuŠ³ŽÒE‰Æ‘°E‘–¯‚ÌŽ‹“_‚É—§‚Á‚œ“KØ‚È‚ª‚ñî•ñ’ñ‹ŸƒT[ƒrƒX
‚Ì‚ ‚è•û‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2009/3; p.15-9.

H20-540005. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹àzŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘‡Œ€‹†
Ž–‹Æu¡Œã‚Ì‚œ‚΂±‘΍ô‚̐„i‚ÉŠÖ‚·‚錀‹†vzu‚œ‚΂±‚ÆŒ’Nv‚ÉŠÖ‚·‚éî•ñ‚Ì–Ô—…“IŽûW^•]‰¿^“‡
^’ñ‹Ÿ‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ¯@‰À–F1, ¬“crs, ˆé–ì@ˆÐ, •û—TŒõ, ‹gŒ©ˆí˜Y, –]ŒŽ—F”üŽq, ŽO‹{”ÍŽq,
™‰Y‚³‚š‚è, Œ‘ºŒOŽq (1‰q¶EŒöO‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹àzŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘‡Œ€‹†
Ž–‹Æu¡Œã‚Ì‚œ‚΂±‘΍ô‚̐„i‚ÉŠÖ‚·‚錀‹†v•œ¬20”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2009/3; p.97-113.

H20-540006. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à’nˆæŒ’NŠë‹@ŠÇ—Œ€‹†Ž–‹ÆuƒOƒ
[ƒoƒ‹ŽÐ‰ï‚ɑΉž‚µ‚œŒ’NŠë‹@ƒT[ƒxƒCƒ‰ƒ“ƒXƒVƒXƒeƒ€:î•ñ•ªÍEƒOƒŒ[ƒfƒBƒ“ƒOŽè–@‚ÌŠJ”­‚Æ•]‰¿
(Žå”CŒ€‹†ŽÒ: ¡ˆä”Ž‹v )vzƒOƒ[ƒoƒ‹ŽÐ‰ï‚ɑΉž‚µ‚œŒ’NŠë‹@ƒT[ƒxƒCƒ‰ƒ“ƒXƒVƒXƒeƒ€: î•ñ•ªÍEƒO
ƒŒ[ƒfƒBƒ“ƒOŽè–@‚ÌŠJ”­‚Æ•]‰¿. ¡ˆä”Ž‹v, —é–؁@Œ³, ’JŒûŽF, •Ÿ“c‹gŽ¡, ¯@‰À–F1, ‹ß“¡‹v’õ, ’†
”ö—T”V, ”ª”Š—Tˆê˜Y (1‰q¶EŒöO‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à’nˆæŒ’NŠë‹@ŠÇ—Œ€‹†Ž–‹ÆuƒOƒ[
ƒoƒ‹ŽÐ‰ï‚ɑΉž‚µ‚œŒ’NŠë‹@ƒT[ƒxƒCƒ‰ƒ“ƒXƒVƒXƒeƒ€: î•ñ•ªÍEƒOƒŒ[ƒfƒBƒ“ƒOŽè–@‚ÌŠJ”­‚Æ•]‰¿v•œ
¬20”N“x‘Š‡Œ€‹†•ñ‘ 2009/3; p.1-4 .

H20-540007. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à’nˆæŒ’NŠë‹@ŠÇ—Œ€‹†Ž–‹ÆuƒOƒ
[ƒoƒ‹ŽÐ‰ï‚ɑΉž‚µ‚œŒ’NŠë‹@ƒT[ƒxƒCƒ‰ƒ“ƒXƒVƒXƒeƒ€:î•ñ•ªÍEƒOƒŒ[ƒfƒBƒ“ƒOŽè–@‚ÌŠJ”­‚Æ•]‰¿
(Žå”CŒ€‹†ŽÒ: ¡ˆä”Ž‹v)vzƒOƒ[ƒoƒ‹ŽÐ‰ï‚ɑΉž‚µ‚œŒ’NŠë‹@ƒT[ƒxƒCƒ‰ƒ“ƒXƒVƒXƒeƒ€: î•ñ•ªÍEƒO
ƒŒ[ƒfƒBƒ“ƒOŽè–@‚ÌŠJ”­‚Æ•]‰¿. ¡ˆä”Ž‹v, —é–؁@Œ³, ’JŒûŽF, •Ÿ“c‹gŽ¡, ¯@‰À–F1, ‹ß“¡‹v’õ, ’†
”ö—T”V, ”ª”Š—Tˆê˜Y (1‰q¶EŒöO‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à’nˆæŒ’NŠë‹@ŠÇ—Œ€‹†Ž–‹ÆuƒOƒ[
ƒoƒ‹ŽÐ‰ï‚ɑΉž‚µ‚œŒ’NŠë‹@ƒT[ƒxƒCƒ‰ƒ“ƒXƒVƒXƒeƒ€: î•ñ•ªÍEƒOƒŒ[ƒfƒBƒ“ƒOŽè–@‚ÌŠJ”­‚Æ•]‰¿v•œ
¬19-20”N“x‘‡Œ€‹†•ñ‘ 2009/3; p.1-7 .

H21-120002. [ŒŽ’˜] GRADEƒVƒXƒeƒ€‚É‚æ‚éŠ{ŠÖßÇ‰Šúf—ÃKƒCƒhƒ‰ƒCƒ“‚̍쐬. Šo“¹Œ’Ž¡, –Ø–ì
EŽi, ™è³Žu, “’óG“¹, Œ–FŽO, âV“¡@‚, ¯@‰À–F1 (1‰q¶EŒöO‰q¶): “ú–{Ž•‰ÈˆãŠw‰ïŽ
2010/3; 29: 52-6.

H21-520002. [‘à] ”ŠO‘‚É‚š‚¯‚éˆãŽt‚ÌŒ’NŽx‰‡‚Æ“ú–{‚Ì‘‡•a‰@‚Å‚Ì“WŠJ. ˜a“ckŽ¡ (‰q
¶EŒöO‰q¶): ‘‡•a‰@ž_ˆãŠw 2010/1; 22 (1); 7-13.

H21-520003. [‘à] ‚—ŽÐ‰ï‚ÆŒš’z•š‰q¶ŠÇ—. ‘ŠàVDŽ¡ (‰q¶EŒöO‰q¶): ƒrƒ‹‚Ɗ‹«
2010/3; (128): 15.

H21-522001. [uÀ]y“ÁW: ˆã—ÃŒ»ê‚É‚š‚¯‚é–\—͂ƃXƒgƒŒƒXzƒAƒNƒVƒ‡ƒ“ƒ`ƒFƒbƒNƒŠƒXƒg‚ðŠˆ—p
‚µ‚œˆã—Ë@ŠÖ‚Å‚Ì–\ŒŸE–\—͑΍ô. ˜a“ckŽ¡ (‰q¶EŒöO‰q¶)FƒXƒgƒŒƒX‰ÈŠw 2010/3; 24 (4): 239-45.

H21-540001. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘‡Œ€
‹†Ž–‹Æ)uŒûo•ÛŒ’‚Æ‘Sg‚ÌQOL‚ÌŠÖŒW‚ÉŠÖ‚·‚鑍‡Œ€‹†vzŒûo•ÛŒ’‚Æ‘Sg‚ÌQOL‚ÌŠÖŒW‚ÉŠÖ‚·‚鑍‡Œ€
‹†. ‰Ô“cMO, ˆÀ“¡—Yˆê”Ç (–k‘º‰ë•Û, âV“¡rs, ¯@‰À–F1, –쑺‹`–Ÿ, ‰Ô“cMO (1‰q¶EŒöO‰q¶):
Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘‡Œ€‹†Ž–‹Æ)uŒûo•ÛŒ’‚Æ‘Sg‚ÌQOL‚ÌŠÖŒW‚ÉŠÖ
‚·‚鑍‡Œ€‹†v•œ¬20”N“x‘Š‡Œ€‹†•ñ‘ 2009/4; p.1-14.

H21-540002. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘‡Œ€
‹†Ž–‹Æ)uŒûo•ÛŒ’‚Æ‘Sg‚ÌQOL‚ÌŠÖŒW‚ÉŠÖ‚·‚鑍‡Œ€‹†vz“œ”A•a‚ÆŽ•ŽüŽŸŠ³‚š‚æ‚ÑŽ•‚Ì‘rŽž‚Æ‚ÌŠÖ˜A?
•œ¬16”N‘–¯Œ’NE‰h—{’²žƒf[ƒ^‚É‚æ‚é‰ðÍ?. ˆÀ“¡—Yˆê, –쑺‹`–Ÿ, –k‘º‰ë•Û, âV“¡rs, ¯@‰À
–F1, ‰Ô“cMO (1‰q¶EŒöO‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘‡Œ€‹†Ž–‹Æ)
uŒûo•ÛŒ’‚Æ‘Sg‚ÌQOL‚ÌŠÖŒW‚ÉŠÖ‚·‚鑍‡Œ€‹†v•œ¬20”N“x‘Š‡Œ€‹†•ñ‘ 2009/4; p.141-52.

H21-540003. [‚»‚Ì‘Œ (ƒpƒ“ƒtƒŒƒbƒg)] (•ª’SŽ·•M)y–k—¢Œ€‹†Š@V•a‰@10Žü”N‹L”Oz“ÁF‚ ‚é“s
ŽsŒ^•a‰@‚Ì”­“W‚ð‹F‚Á‚Ä. ‘ŠàVDŽ¡ (‰q¶EŒöO‰q¶): –k—¢Œ€‹†Š@V•a‰@10Žü”N‹L”O (ŠwZ–@l–k
—¢Œ€‹†ŠE–k—¢‘åŠw–k—¢Œ€‹†Š•a‰@) 2010/2; p.13.

H21-540004. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬21”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (˜J“­ˆÀ‘S‰q¶‘‡
Œ€‹†Ž–‹Æ)uEˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹†: Œ€‹†‘ã•\ŽÒ@‚‹Ž@ŒªvzE
ˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô‚Ì’è’…‘£i‚ðŽx‰‡‚·‚éƒc[ƒ‹ì¬. ˜a“ckŽ¡ (‰q¶EŒöO‰q¶): •œ
¬21”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹Æ)uEˆæ‚É‚š‚¯‚éVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘Î
ô‚Ì’è’…‘£i‚ÉŠÖ‚·‚錀‹†@•œ¬21”N“x‘Š‡Œ€‹†•ñ‘ 2010/3; p.65-76.

H21-540005. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹Æ)u‚¶
‚ñ”xŒ’Nf’f‚É‚š‚¯‚éƒGƒbƒNƒXüƒfƒWƒ^ƒ‹ŽB‰e‰æ‘œ‚ÌŠˆ—p‚ÉŠÖ‚·‚錀‹†: Žå”CŒ€‹†ŽÒ@‘º“cŠì‘ãŽjvzƒf
ƒWƒ^ƒ‹‚¶‚ñ”x•W€ŽÊ^‚̍쐬‚ÉŠÖ‚·‚錟“¢. ‘ŠàVDŽ¡1, H“¡—Yˆê˜N1, ‘º“cŠì‘ãŽj, ‚‹Ž‰ëŽm, Žu“cŽõ
•v, R—ǐ³‘¥, â’JŒõ‘¥, ŠÝ–{‘ì–€, ‰Á“¡Ÿ–ç, “ú‰ºK‘¥, “c‘º‘Ÿ˜N, ›À¬•¶, “c’†—˜•F (1‰q¶EŒö
O‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹Æ)u‚¶‚ñ”xŒ’Nf’f‚É‚š‚¯‚éƒGƒbƒNƒXü
ƒfƒWƒ^ƒ‹ŽB‰e‰æ‘œ‚ÌŠˆ—p‚ÉŠÖ‚·‚錀‹†v•œ¬19?21”N“x‘‡Œ€‹†•ñ‘ 2010/3; 99-140.

H21-540006. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹Æ)u‚¶
‚ñ”xŒ’Nf’f‚É‚š‚¯‚éƒGƒbƒNƒXüƒfƒWƒ^ƒ‹ŽB‰e‰æ‘œ‚ÌŠˆ—p‚ÉŠÖ‚·‚錀‹† (Žå”CŒ€‹†ŽÒ: ‘º“cŠì‘ãŽj)vzƒf
ƒWƒ^ƒ‹‚¶‚ñ”x•W€ŽÊ^‚̍쐬‚ÉŠÖ‚·‚錟“¢. ‘º“cŠì‘ãŽj, ‘ŠàVDŽ¡1, ŠÝ–{‘ì–€, â’JŒõ‘¥, “ú‰ºK‘¥, Žu
“cŽõ•v (1‰q¶EŒöO‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹Æ)u‚¶‚ñ”xŒ’Nf’f
‚É‚š‚¯‚éƒGƒbƒNƒXüƒfƒWƒ^ƒ‹ŽB‰e‰æ‘œ‚ÌŠˆ—p‚ÉŠÖ‚·‚錀‹†v•œ¬21”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2010/3;
p.53-74.

H21-540007. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬20”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹àˆÏ‘õ˜J“­ˆÀ‘S‰q¶‘
‡Œ€‹†Ž–‹Æu‚¶‚ñ”xŒ’Nf’f‚É‚š‚¯‚éƒGƒbƒNƒXüƒfƒWƒ^ƒ‹ŽB‰e‰æ‘œ‚ÌŠˆ—p‚ÉŠÖ‚·‚錀‹† (Žå”CŒ€‹†ŽÒ: ‘º
“cŠì‘ãŽj)vzƒfƒWƒ^ƒ‹‚¶‚ñ”x•W€ŽÊ^‚̍쐬‚ÉŠÖ‚·‚錟“¢. ‘ŠàVDŽ¡1, H“¡—Yˆê˜N1 (1‰q¶EŒöO‰q
¶): •œ¬20”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹àˆÏ‘õ˜J“­ˆÀ‘S‰q¶‘‡Œ€‹†Ž–‹Æu‚¶‚ñ”xŒ’Nf’f‚É‚š‚¯‚éƒG
ƒbƒNƒXüƒfƒWƒ^ƒ‹ŽB‰e‰æ‘œ‚ÌŠˆ—p‚ÉŠÖ‚·‚錀‹†v•œ¬19?21”N“x‘‡Œ€‹†•ñ‘ 2010/3; p.99-140.

H21-540008. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] ŽY‹Æ•ÛŒ’ˆÏˆõ‰ï“š\ (“ú–{ˆãŽt‰ï). ‚“c@™Š, ‘ŠàVDŽ¡1,
“Œ@@v, š¢“¡‹áŽj, ¬ŽR@Ži, â–{•so•v, “‡@@Œå, ’|‘ºŒbŽj, “¹–Ÿ“¹O, –kžŠ@–«, –x]³’m, Œ
‰Y••F, ”‰ªM—T (1‰q¶EŒöO‰q¶): 2010/3; p.1-31.

H21-540009. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬21”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ
—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹† (Žå”CŒ€‹†ŽÒ: ‘ŠàVDŽ¡)vz
ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹†. ‘ŠàVDŽ¡ (‰q¶EŒöO‰q¶): •œ¬21”N“xŒú¶˜J
“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚É
ŠÖ‚·‚錀‹†v•œ¬21”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2010/3; p.1-5.

H21-540010. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬21”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ
—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹† (Žå”CŒ€‹†ŽÒ: ‘ŠàVDŽ¡)vz
ƒVƒbƒNƒnƒEƒXÇŒóŒQ‚Ì”íŠQŒW”‚ÉŠÖ‚·‚錀‹†. â•”@v, ‘ºãŽüŽO, ˆÉ‰êrŽ¡, ˆÉ’Ø“¿G, ¬“cØÌ,
–Ø‘º@÷, ‘ŠàVDŽ¡1 (1‰q¶EŒöO‰q¶): •œ¬21”N“xŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ
—‘΍ô‘‡Œ€‹†Ž–‹Æ)uƒVƒbƒNƒnƒEƒXÇŒóŒQ‚̐f’fŠî€‚ÌŒŸØ‚ÉŠÖ‚·‚錀‹†v•œ¬21”N“x‘Š‡E•ª’SŒ€‹†
•ñ‘ 2010/3; p. 45-51.

H21-540011. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’NˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€
‹†Ž–‹Æ) (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)zƒVƒbƒNƒnƒEƒXÇŒóŒQ‚ª‹^‚í‚ê‚銳ŽÒ‚Ì’²ž•[‚É‚æ‚éŽÀ‘Ô’²ž‚š‚æ‚ѐf
’f‚É—LŒø‚È–âfEŒŸž€–Ú‚ÌŒŸ“¢. ‘ŠàVDŽ¡1, â•”@v, ‹{“cŠ²•v, ¬‘q‰p˜Y, –Ø‘ºŒÜ˜Y, ŒF–ìGº, Šp
“c˜a•F, …é‚Ü‚³‚Ý, Ž›‘ò­•F, ’†‘º—zˆê, ’·’JìáÁ‹I, X@ç—¢, ‹g–ì@”Ž, HŽRˆê’j, ’|“à@³O, Šp
“c³Žj1, ¯@‰À–F1, ‰€@‘‹Õ2, ”ö“‡³K, ™‰Y—R”üŽq3, ¬Œ—T”ü1, ‹{“‡]—¢Žq1, ŒˆäFŽq, ¬
‘ò@Šw (1‰q¶EŒöO‰q¶, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3—\–hˆãŠwŒn): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (Œ’N
ˆÀ‘SEŠë‹@ŠÇ—‘΍ô‘‡Œ€‹†Ž–‹Æ)@•œ¬21”N“x•ª’SŒ€‹†•ñ‘ 2010/3.

H21-540012. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­ÈˆÏ‘õ (ŽY‹Æˆã‚ÌŽÀ‘H“I”\—ÍŒüã‚Ì‚œ‚ß‚ÌŒ€CŽ–
‹Æ) (Žå”CŒ€‹†ŽÒ: ‘º“cŠì‘ãŽj)zŽY‹ÆˆãŠwŽÀ‘HŒ€CƒvƒƒOƒ‰ƒ€: Šé‹Æ‚É•K—v‚ȐVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‘΍ô.
˜a“ckŽ¡ (‰q¶EŒöO‰q¶): ŽY‹ÆˆãŠwŽÀ‘HŒ€‹†ƒvƒƒOƒ‰ƒ€•ñ‘ 2010/3; p.241-55.

H21-540013. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘‡Œ€
‹†Ž–‹Æ)uw‚œ‚΂±E‹Ö‰Œ‚ÆŒ’Nx‚ÉŠÖ‚·‚éî•ñ‚ÌŽûW‚Æ’ñ‹Ÿ‚ɂ‚¢‚Ä‚ÌŒŸ“¢vz¡Œã‚Ì‚œ‚΂±‘΍ô‚̐„i
‚ÉŠÖ‚·‚錀‹†. –]ŒŽ—F”üŽq, •Ð–ì“ck‘Ÿ, ’†‘º³˜a, ‘]ª’qŽj, ¯@‰À–F1, ×–쏕”Ž (1‰q¶EŒöO‰q
¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘‡Œ€‹†Ž–‹Æ)uw‚œ‚΂±E‹Ö‰Œ‚ÆŒ’Nx‚ÉŠÖ
‚·‚éî•ñ‚ÌŽûW‚Æ’ñ‹Ÿ‚ɂ‚¢‚Ä‚ÌŒŸ“¢v‘Š‡E•ª’SŒ€‹†•ñ‘ 2010/3; p.3-8.

H21-540014. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘‡Œ€
‹†Ž–‹Æ)uw‚œ‚΂±E‹Ö‰Œ‚ÆŒ’Nx‚ÉŠÖ‚·‚éî•ñ‚ÌŽûW‚Æ’ñ‹Ÿ‚ɂ‚¢‚Ä‚ÌŒŸ“¢vz¯@‰À–F1, –]ŒŽ—F”üŽq, ‘]
ª’qŽj, “à“¡@“O, “ì‹œ‰hG, “ì‹œ—¢“Þ, œA“‡²•F, –L“‡‹`”Ž, ‰Ô“cMO, ¬“crs, ‰€@‘‹Õ2, â–{
‘×—3, œA£’BŽq, ŽO‹{”ÍŽq, ˆé–ì@ˆÐ, ò@•ôŽq, •û—TŒõ (1‰q¶EŒöO‰q¶, 2’nˆæŽüŽYŠúE‹~‹}ˆã
—Ã, 3—Տ°Œ€‹†EŠé‰æ): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘‡Œ€‹†Ž–‹Æ)uw‚œ‚΂±E
‹Ö‰Œ‚ÆŒ’Nx‚ÉŠÖ‚·‚éî•ñ‚ÌŽûW‚Æ’ñ‹Ÿ‚ɂ‚¢‚Ä‚ÌŒŸ“¢v‘Š‡E•ª’SŒ€‹†•ñ‘ 2010/3; p.70-95.

H21-540015. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹àu¡Œã‚Ì‚œ‚΂±‘΍ô‚̐„i‚ÉŠÖ‚·
‚錀‹† (Œ€‹†‘ã•\ŽÒ: –]ŒŽ—F”üŽq)vzƒŠƒT[ƒ`ƒ}ƒbƒsƒ“ƒO‚ÆŒ€‹†˜AŒg‘̐§‚̍\’z‚ÉŠÖ‚·‚錀‹†. ¯@‰À
–F1, –]ŒŽ—F”üŽq, ‰€@‘‹Õ2, ‚»‚Ì‘Œ (1‰q¶EŒöO‰q¶, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€
‹†”ï•â•‹àu¡Œã‚Ì‚œ‚΂±‘΍ô‚̐„i‚ÉŠÖ‚·‚錀‹†v•ª’S•ñ‘ 2010/3.

[’˜@‘]

H18-620001. [Šwp‘] (•ª’SŽ·•M)yˆã—Ë@ŠÖ‚Å‚ÌŽY‹Æ•ÛŒ’‚ÌŽèˆø‚«z—«‚̈ã—Ï]Ž–ŽÒ‚ɏA‹Æã•K
—v‚È”z—¶, p.203-8. “n•”^‹|, ‘Ÿ“c@Š°1 (1‰q¶EŒöO‰q¶), ŠÄC ‘ŠàVDŽ¡1, •Ò ˜a“ckŽ¡1, ŽÂ
ŒŽo”ŐVŽÐ, “Œ‹ž, 2006/5”­s.

H20-620001. [Šwp‘] (•ª’SŽ·•M)yƒCƒMƒŠƒX”­@ŽY‹Æ•ÛŒ’‚ÌABCz17Í ˆâ“`‚Ɛ¶B@ˆâ“`‚Ɛ¶B,
p.143-7. ‘ŠàVDŽ¡1, X@WŽ¢, ˜a“ckŽ¡1, ã’J‘¥Žq, ‘Ÿ“c@Š°1 (1‰q¶EŒöO‰q¶), ŠÄ–ó ‘ŠàVD
Ž¡1, X@WŽ¢, “ìŽR“°, “Œ‹ž, 2008”­s.

H21-620001. [Šwp‘] (•ÒW)y¡“ú‚ÌŽ¡—ÃŽwj?Ž„‚Í‚±‚€Ž¡—µ‚Ä‚¢‚é, 2011”N”ŁzŠÂ‹«EE‹Æ«
ˆöŽq‚É‚æ‚鎟Š³, p.753-62. ‘ŠàVDŽ¡ (‰q¶EŒöO‰q¶): ‘•ÒW ŽRŒû@“O, –kŒŽŒõ•v, •ŸˆäŽŸ–î, ˆã
Šw‘‰@, “Œ‹ž, 2011/1”­s.

H21-620002. [Šwp‘] (•ª’SŽ·•M)yŽÀ–±‘ÌŒn@ŽY‹Æ•ÛŒ’ƒKƒCƒhƒ‰ƒCƒ“, ‘æ9”Łz‘ŠàVDŽ¡ (‰q¶E
ŒöO‰q¶), ŽY‹ÆˆãŠwU‹»à’c, “Œ‹ž, 2009/7”­s.

H21-620003. [Šwp‘] (•ª’SŽ·•M)yˆã—Ï]Ž–ŽÒ‚Ì‚œ‚߂̐VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUA (H1N1) ‘΍ôŽÀ‘HƒK
ƒCƒh@’Ǖ┣zˆã—Ï]Ž–ŽÒ‚ðŠŽõ‚©‚çŽç‚é, p.30-44. ˜a“ckŽ¡1 (1‰q¶EŒöO‰q¶), •Ò ”яÀ‰ë˜N, ì
–Œ–Ÿ•F, ‚ŽR‹`_, “c‘ãáÁl, XŒ“Œ[‘Ÿ, ˜a“ckŽ¡1, ŠÄC “ú–{ˆãŽt‰ï, “ú–{ˆãŽt‰ï, “Œ‹ž, 2010/1”­
s.

H21-620004. [Šwp‘] (•ÒW)yƒXƒgƒŒƒX•S‰ÈŽ–“Tz ƒEƒCƒ‹ƒX“ŗ͂ƃXƒgƒŒƒX, p.137-43. ƒEƒ‹ƒg
ƒ‰ƒfƒBƒAƒ“ƒŠƒYƒ€ (’Ž“ú«ƒŠƒYƒ€), p.187-9. ‰h—{, p.207-9. ŠT“úƒŠƒYƒ€ (SŒŒŠÇŒn‚š‚æ‚Ñ‘Œ‚̃Xƒg
ƒŒƒXŠÖ˜AƒCƒxƒ“ƒg‚ւ̉e‹¿), p.273-7. ŠT“úƒŠƒYƒ€‚̈â“`Šw, p.278-82. ‹Gß“I•Ï“®, ƒXƒgƒŒƒX”œ‰ž‚É
‚š‚¯‚éŠT“úƒŠƒYƒ€‚̈â“`Šw, p.502-6. ‹Gß“IƒŠƒYƒ€, p.507-10. ‹à‘®EŽ_‰»ƒXƒgƒŒƒX‚Æ”]¶•šŠw,
p.629-31. Œð‘֐§‹Î–±, [–é, p.864-7. R‘Ì”œ‰ž, p.868-73. Ž_‰»ƒXƒgƒŒƒX, p.1020-3. Ž_‰»ƒXƒg
ƒŒƒX‚ƃAƒVƒh[ƒVƒX‚Ö‚Ì•ªŽq‰ž“š, p.1024-7. Ž_‰»ƒXƒgƒŒƒX‚ƉÁ—î, p.1028-30. Ž©ŒÈ–Ɖu, p.1077-82.
Žž‹Æ, ƒXƒgƒŒƒX, Œ’N, p.1134-9. EêƒXƒgƒŒƒX, p.1315-21. ‡–°, ‡–°áŠQ‚ƃXƒgƒŒƒX, p.1527-34.
”ì–ž‚ƃXƒgƒŒƒX, p.2284-5. •s–°, Žž·‚Ú‚¯, Œð‘֐§‹Î–±, p.2389-90. ƒ}ƒNƒƒtƒ@[ƒW, p.2544-9. ƒ}
ƒNƒƒtƒ@[ƒW‚̍RŽ_‹ÛŠˆ«‚ɑ΂·‚éƒXƒgƒŒƒX‚̉e‹¿, p.2550-4. ƒƒ^ƒ{ƒŠƒbƒNƒVƒ“ƒhƒ[ƒ€, p.2603-6.
—\–hÚŽí, p.2701-4. ƒ[ƒNEƒtƒ@ƒ~ƒŠ[Eƒoƒ‰ƒ“ƒX, p.2803-5. ‘ŠàVDŽ¡ (‰q¶EŒöO‰q¶), •Ò ƒX
ƒgƒŒƒX•S‰ÈŽ–“T–|–󊧍sˆÏˆõ‰ï, ŠÛ‘P, “Œ‹ž, 2010/1”­s.

H21-620005. [Šwp‘] (•ÒW)yƒXƒgƒŒƒX•S‰ÈŽ–“Tz ƒEƒ‹ƒgƒ‰ƒfƒBƒAƒ“ƒŠƒYƒ€ (’Ž“ú«ƒŠƒYƒ€),
p.187-9. ŽO–ؖҐ¶ (‰q¶EŒöO‰q¶), •Ò ƒXƒgƒŒƒX•S‰ÈŽ–“T–|–󊧍sˆÏˆõ‰ï, ŠÛ‘P, “Œ‹ž, 2010/1”­s.

H21-620006. [Šwp‘] (•ÒW)yƒXƒgƒŒƒX•S‰ÈŽ–“Tz ŠT“úƒŠƒYƒ€‚̈â“`Šw, p.278-82. Šp“c³Žj (‰q
¶EŒöO‰q¶), •Ò ƒXƒgƒŒƒX•S‰ÈŽ–“T–|–󊧍sˆÏˆõ‰ï, ŠÛ‘P, “Œ‹ž, 2010/1”­s.

H21-620007. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚ÌŽ¡—ÃŽwj 2010”N”Å?Ž„‚Í‚±‚€Ž¡—µ‚Ä‚¢‚éz17 ŠÂ‹«E
E‹Æ«ˆöŽq‚É‚æ‚鎟Š³@ŠÂ‹«EE‹Æ«ˆöŽq‚É‚æ‚鎟Š³‚Ì“®Œü, p.822-4. ‘ŠàVDŽ¡ (‰q¶EŒöO‰q¶), ‘
•ÒW ŽRŒû@“O, –kŒŽŒõ•v, •ŸˆäŽŸ–î, ˆãŠw‘‰@, “Œ‹ž, 2010/1”­s.

H21-620008. [Šwp‘] (ŠÄCE•ÒW)y¡“ú‚ÌŽ¡—ÃŽwj 2010”N”Å?Ž„‚Í‚±‚€Ž¡—µ‚Ä‚¢‚éz17 ŠÂ‹«E
E‹Æ«ˆöŽq‚É‚æ‚鎟Š³@ŠÂ‹«EE‹Æ«ˆöŽq‚É‚æ‚鎟Š³‚Ì“®Œü, p.822-33. ‘ŠàVDŽ¡ (‰q¶EŒöO‰q¶), ‘
•ÒW ŽRŒû@“O, –kŒŽŒõ•v, •ŸˆäŽŸ–î, ˆãŠw‘‰@, “Œ‹ž, 2010/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H19-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ÐŠQŽžŽ•‰È•ÛŒ’ˆã—Ñ̐§‚Ì’nˆæ•ÊŒŸ“¢. ’†‹v
–؍Nˆê, ‘ºˆä^‰î, ¯@‰À–F1, ’ß“c@, ¬Žº‹MŽq, Ž›‰ª‰Á‘ã (1‰q¶EŒöO‰q¶): ‘æ13‰ñ“ú–{W’c
ÐŠQˆãŠw‰ïƒZƒ~ƒi[ (2008/2/10-11), ‚‚­‚Î, “ú–{W’cÐŠQˆãŠw‰ïŽ 2008.12; 13 (3): 332.

H20-713001. [Šw‰ï (‘Û)] (ˆê”ʍu) Cancer Screening Guideline Information in Local
Government Office Web Sites in Japan. Hoshi K1, Hamashima C, Isono T, Izumi M, Ogata H: 5th
International G-I-N Conference (2008/10), Helsinki. (¯@‰À–F1: 1‰q¶EŒöO‰q¶j

H20-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œûo‚ƐH•i‚š‚æ‚щh—{ÛŽæ‚ÌŠÖ˜A@‘–¯Œ’NE
‰h—{’²ž‚̌•[ƒf[ƒ^‚É‚æ‚é‰ðÍ. ˆÀ“¡—Yˆê, –k‘º‰ë•Û, âV“¡rs, –쑺‹`–Ÿ, ¯@‰À–F1, ‰Ô“cMO (1
‰q¶EŒöO‰q¶): ‘æ57‰ñ“ú–{Œûo‰q¶Šw‰ï‘‰ïEŠwp‘å‰ï (2008/10/2-4), ‘å‹{, Œûo‰q¶Šw‰ïŽGŽ
2008/8; 58 (4): 300.

H20-723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å‹K–͍ЊQŽž‚É‚š‚¯‚é•a‰@Ž•‰È‚ÌŽ•‰È•ÛŒ’ˆã—Ã
‘̐§‚ÉŠÖ‚·‚éŽÀ‘Ô’²ž. ’†‹v–؍Nˆê, ‘ºˆä^‰î, ¯@‰À–F1, ’ß“c@, ¬Žº‹MŽq, Ž›‰ª‰Á‘ã (1‰q¶E
ŒöO‰q¶): ‘æ57‰ñ“ú–{Œûo‰q¶Šw‰ï‘‰ïEŠwp‘å‰ï (2008/10/2-4), ‘å‹{, Œûo‰q¶Šw‰ïŽGŽ 2008/8;
58 (4): 371.

H20-723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒCƒ“ƒ^[ƒlƒbƒg‚É‚æ‚é•ÛŒ’ˆã—Ïî•ñ’ñ‹Ÿ. ¯@‰À–F (‰q
¶EŒöO‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@EŒ€CEuŽt (2009/1/22), ˜aŒõ (‘—§•ÛŒ’ˆã—ÉȊw‰@).

H20-733001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ’NŠë‹@ŠÇ—e-learningŒ€C‚Ì•]
‰¿‚ÉŠÖ‚·‚é’²žŒ€‹†. ‹k‚Æ‚àŽq, ò@•ôŽq, ¯@‰À–F1, ‘]ª’qŽj, •‘º^Ž¡ (1‰q¶EŒöO‰q¶): ‘æ2
‰ñ•ÛŒ’ˆã—ÉȊwŒ€‹†‰ï (2008/9/19), é‹Ê, •ÛŒ’ˆã—ÉȊw 2008/12; 57 (4): 381.

H21-722001. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ‰ÈŠw“Iª‹’‚ÉŠî‚­•ÛŒ’î•ñ‚ÌŽûW ¯@‰À–F (‰q¶E
ŒöO‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•œ¬21”N“xê–å‰Û’ö‘I‘ð‰È–ځE•ÛŒ’î•ñ—˜—pŠT˜_EuŽt
(2009/9/15), ˜aŒõ (‘—§•ÛŒ’ˆã—ÉȊw‰@).

H21-722002. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) Web‚ð—p‚¢‚œî•ñ”­MEî•ñ—˜—p. ¯@‰À–F (‰q¶EŒö
O‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•œ¬21”N“xê–å‰Û’ö‘I‘ð‰È–ځE•ÛŒ’î•ñ—˜—pŠT˜_EuŽt
(2009/9/28), ˜aŒõ (‘—§•ÛŒ’ˆã—ÉȊw‰@).

H21-722003. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) Ž{ô‚ւ̃KƒCƒhƒ‰ƒCƒ“Šˆ—p. ¯@‰À–F (‰q¶EŒöO‰q
¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•œ¬21”N“x’nˆæ•ÛŒ’Žx‰‡‚Ì‚œ‚ß‚Ì•ÛŒ’î•ñˆ—‹ZpŒ€C (Ž{ô—§
ˆÄŽx‰‡ƒR[ƒXjuŽt (2009/12/1), ˜aŒõ (‘—§•ÛŒ’ˆã—ÉȊw‰@).

H21-722004. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ‰ÈŠw“Iª‹’‚ÉŠî‚­•ÛŒ’î•ñ‚ÌŽûW. ¯@‰À–F (‰q
¶EŒöO‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•ÛŒ’î•ñ—˜—pŠT˜_EuŽt (2010/12/7), ˜aŒõ (‘—§•Û
Œ’ˆã—ÉȊw‰@).

H21-722005. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ƒAƒ“ƒP[ƒg’²ž‰‰K (1) (2). ¯@‰À–F (‰q¶EŒöO
‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•œ¬21”N“x’nˆæ•ÛŒ’Žx‰‡‚Ì‚œ‚ß‚Ì•ÛŒ’î•ñˆ—‹ZpŒ€C (Ž{ô
—§ˆÄŽx‰‡ƒR[ƒX) uŽt (2009/12/8), ˜aŒõ (‘—§•ÛŒ’ˆã—ÉȊw‰@).

H21-722006. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ’nˆæ•ÛŒ’‚ÉŠÖ˜A‚µ‚œî•ñ‚ÌŽûW. ¯@‰À–F (‰q¶EŒö
O‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•œ¬21”N“x’nˆæ•ÛŒ’Žx‰‡‚Ì‚œ‚ß‚Ì•ÛŒ’î•ñˆ—‹ZpŒ€C (î
•ñŽûWEŠÇ—E”­MƒR[ƒX (2009), ˜aŒõ (‘—§•ÛŒ’ˆã—ÉȊw‰@).

H21-722007. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) Provision of health-related information through
internet. ¯@‰À–F (‰q¶EŒöO‰q¶): Œú¶˜J“­È‘—§•ÛŒ’ˆã—ÉȊw‰@E•œ¬21”N“xê–å‰Û’öII ‘Û
•ÛŒ’•ª–ì International Master of Public Health course/Special Lecture (2010/1/20), ˜aŒõ (‘—§
•ÛŒ’ˆã—ÉȊw‰@).

H21-722008. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ª‹’‚ÉŠî‚¢‚œ•ÛŒ’Žw“±‚ðŽÀ‘H‚·‚é‚œ‚ß‚É. ¯@‰À–F
(‰q¶EŒöO‰q¶): ç—tŽsŽ•‰È•ÛŒ’‹Æ–±Œ€C‰ï (2010/3/9), ç—tŽs•ÛŒ’Š.

H21-723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž•‰È‘åŠwEŽ•Šw•”, Ž•‰È‰q¶Žm—{¬Z, Ž•‰È‹Z
HŽm—{¬Z‚É‚š‚¯‚é‘å‹K–͍ЊQŽž‚ÌŽ•‰È•ÛŒ’ˆã—˳ˆç. ’ß“c@, ’†‹v–؍Nˆê, ¬Žº‹MŽq, ’r“c³b, Šâ
“ˆG–Ÿ, ‘ºˆä^‰î, ¯@‰À–F1, â–{—F‹I, Ž›‰ª‰Á‘ã (1‰q¶EŒöO‰q¶): ‘æ58‰ñ“ú–{Œûo‰q¶Šw‰ï‘
‰ïEŠwp‘å‰ï (2009/10/9-11), “Œ‹ž, Œûo‰q¶Šw‰ïŽGŽ 2009/8; 59 (4): 431.

H21-723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “œ”A•a‚ÆŽ•‚Ì•Û—Ló‹µ‚Æ‚ÌŠÖ˜A@•œ¬16”N‘
–¯Œ’NE‰h—{’²ž‚ð—p‚¢‚œ•ªÍ. ˆÀ“¡—Yˆê, –k‘º‰ë•Û, âV“¡rs, ¯@‰À–F1, –쑺‹`–Ÿ, ‰Ô“cMO, ŽO
‰YGŽq (1‰q¶EŒöO‰q¶): ‘æ58‰ñ“ú–{Œûo‰q¶Šw‰ï‘‰ïEŠwp‘å‰ï (2009/10/9-11), “Œ‹ž, Œûo‰q¶
Šw‰ïŽGŽ 2009/8; 59 (4): 329.

H21-723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) WebƒAƒ“ƒP[ƒgì¬ƒVƒXƒeƒ€‚ÌŠˆ—p—á:ƒKƒCƒhƒ‰ƒCƒ“ì¬E
•‹yŽž‚̃Rƒ“ƒZƒ“ƒTƒXŒ`¬. ¯@‰À–F1, ˆÀ“¡—Yˆê, ²“¡•q•F2, Œ–FŽO, âV“¡@‚, ŒŽR@‹Å, ‹gŒ©
ˆí˜Y, à_“‡‚¿‚³‚Æ, ÎŠ_çH, •û—TŒõ (1‰q¶EŒöO‰q¶, 2—Տ°Œ€‹†EŠé‰æ): ‘æ68‰ñ“ú–{ŒöO‰q¶
Šw‰ï‘‰ï (2009/10/21-23), “Þ—Ç, ‘æ68‰ñ“ú–{ŒöO‰q¶Šw‰ïŽ˜^W “ú–{ŒöO‰q¶ŽGŽ“Á•Ê•˜^2009/10;
56 (10): 157.

H21-731001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘“à‚Å‚Ì‚ª‚ñŒŸfƒKƒCƒhƒ‰ƒCƒ“ì¬‚Æ•‹yEŒ[
”­Šˆ“®‚ÌŒ»
¯@‰À–F (‰q¶EŒöO‰q¶): ‘æ20‰ñ“ú–{Œûo‰q¶Šw‰ï@‹ß‹EE’†‘EŽl‘’n•û‰ï‘‰ï (2009/6/21), L
“‡, Œûo‰q¶Šw‰ïŽGŽ 2009/10; 59 (5): 603-4.


–@ˆãŠw

[Šwp˜_•¶]

110049. [ŒŽ’˜] Analysis of the sarcomere protein gene mutation on cardiomyopathy -Mutations in
the cardiac troponin I gene. ‘ºãçŽq1, ’†‘º–Ίî1, ¬—ѐ³@2, ‘O“cˆê•ã2, “ü]@Â1, ˜a“c
•¶‘Ÿ2, —Ñ‚Ü‚¢Žq2, ²X–ؐçŽõŽq3, ’†ŠÛ®”ü3, ŒÃì—F1, ŒIŒŽŽ—R1 (1–@ˆã, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†
‰È, 3Œ`‘ÔŒn): Legal Medicine 2010; 12: 280-3.

220003. [€ŒŽ’˜] Mitochondrial DNA coding region‚̕ψِ«‚ÌŒŸ“¢‡T. ¬—ѐ³@1, ’†‘º–Ίî2, ‘º
ãçŽq2, ‘O“cˆê•ã1, “ü]@Â2, ˜a“c•¶‘Ÿ1, —Ñ‚Ü‚¢Žq1, ²X–ؐçŽõŽq3, ’†ŠÛ®”ü3, ŒÃì—F
2, ŒIŒŽŽ—R2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–@ˆã, 3Œ`‘ÔŒn): DNA‘œŒ^ 2010/5; 18: 250-4.

[Šw‰ïEŒ€‹†‰ï“™]

723107. [Šw‰ï (‘S‘)] (Œû‰‰) S‹ØÇ‚̈â“`Žq‰ðÍ‡]?ƒgƒƒ|ƒjƒ“\¬ˆâ“`Žq‚̕ψىðÍ?. ‘ºãç
Žq1, ’†‘º–Ίî1, ¬—ѐ³@2, ‘O“cˆê•ã2, “ü]@Â1, ˜a“c•¶‘Ÿ2, —Ñ‚Ü‚¢Žq2, ²X–ؐçŽõŽq3, ’†ŠÛ
®”ü3, ŒÃì—F1, ŒIŒŽŽ—R1 (1–@ˆã, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3Œ`‘ÔŒn): ‘æ94ŽŸ“ú–{–@ˆãŠw‰ïŠwp
‘S‘W‰ï (2010/6/24), “Œ‹ž, “ú–{–@ˆãŠwŽGŽ 2010/5, 64 (1): 54.

723108. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”ñŠO«¬’°úE‚ÌŒŽˆö„’è‚É‹ê—¶‚µ‚œ1–UŒŸ—á. ¬—ѐ³@1, “ü
]@Â2, ŒÃì—F2, ‘ºãçŽq2, ‘O“cˆê•ã1, —Ñ‚Ü‚¢Žq1, ²X–ؐçŽõŽq3, ’†ŠÛ®”ü3, ’†‘º–Ίî
2, ŒIŒŽŽ—R2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–@ˆã, 3Œ`‘ÔŒn): ‘æ94ŽŸ“ú–{–@ˆãŠw‰ïŠwp‘S‘W‰ï (2010/6/24),
“Œ‹ž, “ú–{–@ˆãŠwŽGŽ 2010, 64 (1): 70.

723109. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚”Z“x‚̃hƒXƒŒƒsƒ“‚ªŒŸo‚³‚ê‚œ‹}«ˆêŽ_‰»’Y‘f’†“ÅŽ€—á. ²X–Ø
çŽõŽq1, ŽÂ’Ë’B—Y2, ‘ºãçŽq2, “ü]@Â2, ¬—ѐ³@3, ‘O“cˆê•ã3, —Ñ‚Ü‚¢Žq3, ŒÃì—F2, ’†
‘º–Ίî2, ŒIŒŽŽ—R2 (1Œ`‘ÔŒn, 2–@ˆã, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): “ú–{–@’†“ÅŠw‰ï‘æ29”N‰ï
(2010/7/23-24), “Œ‹ž, “ú–{–@’†“ÅŠw‰ï‘æ29”N‰ïŽ˜^W 2010; p.142-3.

723110. [Šw‰ï (‘S‘)] (Œû‰‰) S‹ØÇ‚ÉŠî‚­“Ë‘RŽ€Ç—á‚É‚š‚¯‚émtDNAˆâ“`Žq‰ðÍ. ¬—ѐ³@1, ’†
‘º–Ίî2, ‘ºãçŽq2, ‘O“cˆê•ã1, “ü]@Â2, —Ñ‚Ü‚¢Žq1, ²X–ؐçŽõŽq3, ’†ŠÛ®”ü3, ŒÃì—F
2, ŒIŒŽŽ—R2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–@ˆã, 3Œ`‘ÔŒn) “ú–{DNA‘œŒ^Šw‰ï‘æ19‰ñŠwpW‰ï (2010/11/18),
ŽO“‡, “ú–{DNA‘œŒ^Šw‰ï‘æ19‰ñŠwpW‰ïŽ˜^W 2010, p.34.

723111. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Real-Time PCR‚ð—p‚¢‚œTaqMan Probe ABO genotyping II. ‘O“cˆê
•ã1, ‘ºãçŽq2, “ü]@Â2, ¬—ѐ³@1, —Ñ‚Ü‚¢Žq1, ²X–ؐçŽõŽq3, ’†ŠÛ®”ü3, ’†‘º–Ίî2, ŒÃ
ì—F2, ŒIŒŽŽ—R2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–@ˆã, 3Œ`‘ÔŒn): “ú–{DNA‘œŒ^Šw‰ï‘æ19‰ñŠwpW‰ï
(2010/11/18), ŽO“‡, “ú–{DNA‘œŒ^Šw‰ï‘æ19‰ñŠwpW‰ïŽ˜^W 2010, p.86.

733021. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Œû‰‰) Ž©ŽE—\–h‘΍ô‚ÌŒŸ“¢?ž_ŽŸŠ³‚ð—L‚·‚鎩ŽEŽÒ‚̃gƒ‰ƒCƒG[
ƒWŒŸžŒ‹‰Ê‚ɂ‚¢‚Ä?. —Ñ‚Ü‚¢Žq1, ‘ºãçŽq2, “ü]@Â2, ‘O“cˆê•ã1, ¬—ѐ³@1, ²X–ؐçŽõŽq
3, ’†‘º–Ίî2, ŒÃì—F2, ŒIŒŽŽ—R2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–@ˆã, 3Œ`‘ÔŒn): ‘æ79‰ñ“ú–{–@ˆãŠw
‰ïŠwpŠÖ“Œ’n•ûW‰ï (2010/10/30), “Œ‹ž, ‘æ79‰ñ“ú–{–@ˆãŠw‰ïŠwpŠÖ“Œ’n•ûW‰ïu‰‰—vŽ|W 2010;
p.19.

733022. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) Œ‹‘©ƒoƒ“ƒh‚ð—p‚¢‚œ“ÁˆÙ“I‚ÈŽ©iŽ€3—á. ‘O“cˆê•ã1, “ü
]@Â2, ‘ºãçŽq2, ¬—ѐ³@1, —Ñ‚Ü‚¢Žq1, ’†ŠÛ®”ü3, ²X–ؐçŽõŽq3, ’†‘º–Ίî2, ŒÃì—F
2, ŒIŒŽŽ—R2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2–@ˆã, 3Œ`‘ÔŒn): ‘æ79‰ñ“ú–{–@ˆãŠw‰ïŠwpŠÖ“Œ’n•ûW‰ï
(2010/10/30), “Œ‹ž, ‘æ79‰ñ“ú–{–@ˆãŠw‰ïŠwpŠÖ“Œ’n•ûW‰ïu‰‰—vŽ|W 2010; p.44.

733023. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) Š¥ó“®–¬áŽŒŒðÇ‚̈ê—á. “ü]@Â1, ‘ºãçŽq1, ¬
—ѐ³@2, ‘O“cˆê•ã2, —Ñ‚Ü‚¢Žq2, ’†ŠÛ®”ü3, ²X–ؐçŽõŽq3, ’†‘º–Ίî1, ŒÃì—F1, ŒIŒŽŽ—R1 (1
–@ˆã, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3Œ`‘ÔŒn): ‘æ79‰ñ“ú–{–@ˆãŠw‰ïŠwpŠÖ“Œ’n•ûW‰ï (2010/10/30), “Œ‹ž, ‘æ
79‰ñ“ú–{–@ˆãŠw‰ïŠwpŠÖ“Œ’n•ûW‰ïu‰‰—vŽ|W 2010; p.49.


ˆã—ÎЉïŠw


ˆã—pî•ñŠw


ŽÀŒ±“®•šŠw

[Šwp˜_•¶]

110050. [ŒŽ’˜] Abnormal epithelial cell polarity and ectopic epidermal growth factor receptor
(EGFR) expression induced in Emx2 KO embryonic gonads. Kusaka M, Katoh-Fukui Y, Ogawa H,
Miyabayashi K, Baba T, Shima Y, Sugiyama N, Sugimoto Y, Okuno Y, Kodama R, Iizuka-Kogo A, Senda
T, Sasaoka T1, Kitamura K, Aizawa S, Morohashi K: Endocrinology 2010/12; 151 (12): 5893-904. (ù
‰ªr–M1: 1ŽÀ“®)

530001. [‚»‚Ì‘Œ (’Z•ñ)] Microscopic structure of maxillary alveolar bone of small animals is easy
to form fistulas in orbital or nasal cavity by periapical abscess of the canine or molar. Morohoshi
Y1, Morita M: Bulletin de la Societe Franco-Japonaise des Sciences Veterinaires 2011/3; 22 (1-2):
23-6. (”¯N—Y1, X“c^•¶: 1ŽÀ“®)

[Šw‰ïEŒ€‹†‰ï“™]

713029. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) THE I2020T LRRK2-EXPRESSING TRANSGENIC MOUSE EXHIBITS
IMPAIRED LOCOMOTIVE ABILITY. Maekawa T, Mori S, Miyajima T, Sasaki Y, Komiya K, Azuma S1, Ohta
E, Obata F: The 10th International Conference on Alzheimer's and Parkinson's Disease AD/PD 2011
(2011/3/9-13), Barcelona, Spain. (“Œ@’åG1: 1ŽÀ“®)

723112. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’²ß‰Â”\‚ȃh[ƒpƒ~ƒ“D1Žó—e‘Ì”­Œ»Œn‚ð—L‚·‚éƒgƒ‰ƒ“ƒX
ƒWƒFƒjƒbƒNƒ}ƒEƒX‚̉^“®—ʉðÍ. ²“¡’©Žq1, Ÿ–ØŒ³–ç, ù‰ªr–M1 (1ŽÀ“®): ‘æ33‰ñ“ú–{_Œo‰ÈŠw‘å
‰ï (2010/9/2), _ŒË.

723113. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å”]Šî’êŠj“àî•ñ“`’B‚É‚š‚¯‚éƒh[ƒpƒ~ƒ“D1Žó—e‘Ì‚Ì‹@
”\. ’mŒ©‘”ü, ‘Ÿ“c@—Í, ²“¡’©Žq1, ù‰ªr–M1, Ÿ–ØŒ³–ç, •ì@M, “ì•”@“Ä (1ŽÀ“®): ‘æ33‰ñ
“ú–{_Œo‰ÈŠw‘å‰ï (2010/9/4), _ŒË.

723114. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) bó‘B‹@”\’ቺÇƒ‰ƒbƒgrdw‚̃wƒeƒ‘Ì‚ÌŒ`‘ÔŠw“I‰ðÍ.
ŒÃŠÚêˆê1, “Œ@’åG1 (1ŽÀ“®): ‘æ35‰ñ“ú–{”äŠr“à•ª”åŠw‰ï‘å‰ï‹y‚уVƒ“ƒ|ƒWƒEƒ€ (2010/11/18), Ã
‰ª.

723115. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒh[ƒpƒ~ƒ“D1Žó—e‘Ì‚Ì”­Œ»•Ï‰»‚ªˆø‚«‹N‚±‚·‰^“®—ʈُí.
²“¡’©Žq1, Ÿ–ØŒ³–ç, ù‰ªr–M1 (1ŽÀ“®): ‘æ33‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ï^‘æ83‰ñ“ú–{¶‰»Šw‰ï‘å‰ï
‡“¯‘å‰ï (2010/12/7), _ŒË.

723116. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) I2020T•ÏˆÙLRRK2ƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX‚̉ðÍ. ‘O
ì’B‘¥, ‘Ÿ“c‰x˜N, ²X–Ø—B, ‹{“‡”CŽi, “Œ@’åG1, ¬”Š•¶–í (1ŽÀ“®): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï
(2010/5/20-22), “Œ‹ž.

733024. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) I2020T•ÏˆÙLRRK2ƒgƒ‰ƒ“ƒXƒWƒFƒjƒbƒNƒ}ƒEƒX
‚É‚š‚¯‚é‰^“®‹@”\‰ðÍ. X¬•S‡, ‘Oì’B‘¥, ¬‹{‰ÀŸ, Œ`‰ë‘¥, H“c‹v’Œ, “Œ@’åG1, ¬”Š•¶–í (1
ŽÀ“®): ‘æ23‰ñ–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€Œ€‹†‰ï (2010/8/5), ÂX.

733025. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒEƒTƒM‹}«Š¥ÇŒóŒQ (ACS) ƒ‚ƒfƒ‹III-3, ¶
Š¥“®–¬•ÂÇŒã‚̐S“d},‹Â‰çˆÊ‚Æ‘€‰çˆÊ‚É‚š‚¯‚é“d‹É‘•’…•”ˆÊ‚ƐS“d}•Ï‰». ”¯N—Y1, ‹àˆäF•v, ’r
“cŒ›º, ’|“àº”Ž, ˆíŒ©@Ž¡2, ‹{ŒŽ‰p•v (1ŽÀ“®, 2—Տ°Œ€‹†EŠé‰æ): ‘æ26‰ñS“dî•ñˆ—ƒ[ƒNƒVƒ‡
ƒbƒv (2010/10/23), ’–•c‘ã, S“d} 2011; 31 (Suppl 1): S-1-3.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

S63-110001. [ŒŽ’˜] Highly sensitive assay for xanthine oxidase activity by high-performance
liquid chromatography with fluorescence detection. Sasaoka T1, Kaneda N, Nagatsu T: J Chromatogr
1988; 424: 392-7. (ù‰ªr–M1: 1ŽÀ“®)

S63-110002. [ŒŽ’˜] Analysis of salsolinol in human brain using high-performance liquid
chromatography with electrochemical detection. Sasaoka T1, Kaneda N, Niwa T, Hashizume Y, Nagatsu
T: J Chromatogr 1988; 428: 152-5. (ù‰ªr–M1: 1ŽÀ“®)

S63-110003. [ŒŽ’˜] Striatal dopamine release and metabolism in sinoaortic-denervated rats
by in vivo microdialysis. Alexander N, Nakahara D, Ozaki N, Kaneda N, Sasaoka T1, Iwata N, Nagatsu
T: Am J Physiol 1989/2; 254 (2 Pt 2): R396-9. (ù‰ªr–M1: 1ŽÀ“®)

H1-110001. [ŒŽ’˜] Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous
amine by use of gas chromatography-mass spectrometry. Niwa T, Takeda N, Sasaoka T1, Kaneda N,
Hashizume Y, Yoshizumi H, Tatematsu A, Nagatsu T: J Chromatogr 1989; 491: 397-403. (ù‰ªr–M1:
1ŽÀ“®)

H1-110002. [ŒŽ’˜] Structure of human phenylethanolamine N-methyltransferase gene: Existence
of two types of mRNA with different transcription initiation sites. Sasaoka T1, Kaneda N, Kurosawa
Y, Fujita K, Nagatsu T: Neurochem Int 1989; 15 (4): 555-65. (ù‰ªr–M1: 1ŽÀ“®)

H3-110001. [ŒŽ’˜] Tissue-specific and high-level expression of the human tyrosine
hydroxylase gene in transgenic mice. Kaneda N, Sasaoka T1, Kobayashi K, Kiuchi K, Nagatsu I,
Kurosawa Y, Fujita K, Yokoyama M, Nomura T, Katsuki M, Nagatsu T: Neuron 1991/4; 6 (4): 583-94.
(ù‰ªr–M1: 1ŽÀ“®)

H3-110002. [ŒŽ’˜] Primary structure of mouse tyrosine hydroxylase deduced from its cDNA.
Ichikawa S, Sasaoka T1, Nagatsu T: Biochem Biophys Res Commun 1991/5; 176 (3): 1610-6. (ù‰ªr
–M1: 1ŽÀ“®)

H3-110003. [ŒŽ’˜] Expression in brain sensory neurons of the transgene in transgenic mice
carrying human tyrosine hydroxylase gene. Nagatsu I, Yamada K, Karasawa N, Sakai M, Takeuchi T,
Kaneda N, Sasaoka T1, Kobayashi K, Yokoyama M, Nomura T, Katsuki M, Fujita K, Nagatsu T: Neurosci
Lett 1991/6; 127 (1): 91-5. (ù‰ªr–M1: 1ŽÀ“®)

H3-110004. [ŒŽ’˜] Enhanced expression of human tyrosine hydroxylase in the lower brainstem
of transgenic mice. Yamada K, Sakai M, Takeuchi T, Karasawa N, Kaneda N, Sasaoka T1, Kobayashi
K, Yokoyama M, Nomura T, Katsuki M, Fujita K, Nagatsu T Nagatsu I: Neurosci Lett 1991/12; 134 (1):
57-61. (ù‰ªr–M1: 1ŽÀ“®)

H3-110005. [ŒŽ’˜] Structure of the mouse tyrosine hydroxylase gene. Iwata N, Kobayashi K,
Sasaoka T1, Hidaka H, Nagatsu T: Biochem Biophys Res Commun 1992/1; 182 (1): 348-54. (ù‰ªr–M
1: 1ŽÀ“®)

H3-110006. [ŒŽ’˜] Genetic alteration of catecholamine specificity in transgenic mice.
Kobayashi K, Sasaoka T1, Morita S, Nagatsu I, Iguchi A, Kurosawa Y, Fujita K, Nomura T, Kimura
M, Katsuki M, Nagatsu T: Proc Natl Acad Sci U S A 1992/3; 89 (5): 1631-5. (ù‰ªr–M1: 1ŽÀ“®)

H4-110001. [ŒŽ’˜] Analysis of the human tyrosine hydroxylase gene promoter-chloramphenicol
acetyltransferase chimeric gene expression in transgenic mice. Sasaoka T1, Kobayashi K, Nagatsu
I, Takahashi R, Kimura M, Yokoyama M, Nomura T, Katsuki M, Nagatsu T: Brain Res Mol Brain Res 1992/12;
16 (3-4): 274-86. (ù‰ªr–M1: 1ŽÀ“®)

H4-110002. [ŒŽ’˜] Regulatory mechanism of dopamine biosynthesis in the striatum of
transgenic mice carrying human tyrosine hydroxylase gene. Kiuchi K, Kiuchi K, Kaneda N, Sasaoka
T1, Hidaka H, Nagatsu T: Neurosci Lett 1993/3; 151 (1): 55-8. (ù‰ªr–M1: 1ŽÀ“®)

H5-110001. [ŒŽ’˜] Normalization of tyrosine hydroxylase activity in vivo in the striatum
of transgenic mice carrying human tyrosine hydroxylase gene: a microdialysis study. Nakahara D,
Hashiguti H, Kaneda N, Sasaoka T1, Nagatsu T: Neurosci Lett 1993/8; 158 (1): 44-6. (ù‰ªr–M1:
1ŽÀ“®)

H6-110001. [ŒŽ’˜] Gene replacement of the p53 gene with the lacZ gene in mouse embryonic
stem cells and mice by using two steps of homologous recombination. Gondo Y, Nakamura K, Nakao
K, Sasaoka T1, Ito K, Kimura M, Katsuki M: Biochem Biophys Res Commun 1994/7; 202 (2): 830-7. (ù
‰ªr–M1: 1ŽÀ“®)

H7-110001. [ŒŽ’˜] Neural tube defects and abnormal brain development in F52-deficient mice.
Wu M, Chen DF, Sasaoka T1, Tonegawa S: Proc Natl Acad Sci U S A 1996/3; 93 (5): 2110-5. (ù‰ª
r–M1: 1ŽÀ“®)

H8-520001. [‘à]yƒW[ƒ“ƒ^[ƒQƒeƒBƒ“ƒOƒtƒ@ƒCƒ‹ -'97zƒh[ƒpƒ~ƒ“ƒŒƒZƒvƒ^[, ƒh[ƒpƒ~ƒ“ƒg
ƒ‰ƒ“ƒXƒ|[ƒ^[‚̃mƒbƒNƒAƒEƒgƒ}ƒEƒX. ù‰ªr–M (ŽÀ“®): ŽÀŒ±ˆãŠw 1996; 14 (‘Š§): 56-9.

H9-110001. [ŒŽ’˜] NMDA receptor-dependent refinement of somatotopic maps. Iwasato T,
Erzurumlu RS, Huerta PT, Chen DF, Sasaoka T1, Ulupinar E, Tonegawa S: Neuron 1997/12; 19 (6): 1201-10.
(ù‰ªr–M1: 1ŽÀ“®)

H9-520001. [‘à]yƒmƒbƒNƒAƒEƒgƒ}ƒEƒXƒf[ƒ^ƒuƒbƒNzF52, MARCKS-related protein (Mrp),
MacMARCKS. ù‰ªr–M (ŽÀ“®): Molecular Medicine 1997/12; 34 (—Õ‘): 165-6.

H9-520002. [‘à]yƒmƒbƒNƒAƒEƒgƒ}ƒEƒXƒf[ƒ^ƒuƒbƒNzHeme oxygenase-1, 2 (HO-1, HO-2). ù
‰ªr–M (ŽÀ“®): Molecular Medicine 1997/12; 34 (—Õ‘): 224.

H9-520003. [‘à]yƒmƒbƒNƒAƒEƒgƒ}ƒEƒXƒf[ƒ^ƒuƒbƒNzp53. ù‰ªr–M (ŽÀ“®): Molecular
Medicine 1997/12; 34 (—Õ‘): 385-6.

H9-520004. [‘à]yƒmƒbƒNƒAƒEƒgƒ}ƒEƒXƒf[ƒ^ƒuƒbƒNzras. ù‰ªr–M (ŽÀ“®): Molecular
Medicine 1997/12; 34 (—Õ‘): 435-6.

H11-110001. [ŒŽ’˜] Catecholamine synthesis is mediated by tyrosinase in the absence of
tyrosine hydroxylase. Rios M, Habecker B, Sasaoka T1, Eisenhofer G, Tian H, Landis S, Chikaraishi
D, Roffler-Tarlov S: J Neurosci 1999/5; 19 (9): 3519-26. (ù‰ªr–M1: 1ŽÀ“®)

H11-110002. [ŒŽ’˜] Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy
in beta-sarcoglycan-deficient mice. Araishi K, Sasaoka T1, Imamura M, Noguchi S, Hama H,
Wakabayashi E, Yoshida M, Hori T, Ozawa E: Hum Mol Genet 1999/9; 8 (9): 1589-98. (ù‰ªr–M1: 1
ŽÀ“®)

H12-110001. [ŒŽ’˜] Biochemical evidence for association of dystrobrevin with the
sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Yoshida M, Hama
H, Ishikawa-Sakurai M, Imamura M, Mizuno Y, Araishi K, Wakabayashi-Takai E, Noguchi S, Sasaoka
T1, Ozawa E: Hum Mol Genet 2000/4; 9 (7): 1033-40. (ù‰ªr–M1: 1ŽÀ“®)

H12-110002. [ŒŽ’˜] Dopamine D2 Long receptor-deficient mice display hypolocomotion and
reduced level of haloperidol-induced catalepsy. Wang Y, Xu R, Sasaoka T1, Tonegawa S, Kung MP,
Sankoorikal EB: J Neurosci 2000/11; 20 (22): 8305-14. (ù‰ªr–M1: 1ŽÀ“®)

H12-110003. [ŒŽ’˜] Caveolin-3 deficiency causes muscle degeneration in mice. Hagiwara Y,
Sasaoka T1, Araishi K, Imamura M, Yorifuji H, Nonaka I, Ozawa E, Kikuchi T: Hum Mol Genet 2000/12;
9 (20): 3047-54. (ù‰ªr–M1: 1ŽÀ“®)

H12-520001. [‘à]yƒmƒbƒNƒAƒEƒgƒ}ƒEƒXƒŠƒXƒgz‹Ø: ƒWƒXƒgƒƒtƒBƒ“Œ‹‡ƒ^ƒ“ƒpƒN. ù‰ªr–M (ŽÀ
“®): ¶‘̂̉Ȋw 2000; 51 (5): 395-7.

H13-110001. [ŒŽ’˜] Analysis of the spatial, temporal and tissue-specific transcription of
gamma-sarcoglycan gene using a transgenic mouse. Noguchi S, Wakabayashi-Takai E, Sasaoka T1, Ozawa
E: FEBS Lett 2001/4; 495 (1-2): 77-81. (ù‰ªr–M1: 1ŽÀ“®)

H14-110001. [ŒŽ’˜] Delivery of alpha- and beta-sarcoglycan by adeno-associated virus:
efficient rescue of muscle, but differential toxicity. Dressman D, Araishi K, Imamura M, Sasaoka
T1, Liu LA, Engvall E, Hoffman EP: Hum Gene Ther 2002/9; 13 (3): 1631-46. (ù‰ªr–M1: 1ŽÀ“®)

H14-110002. [ŒŽ’˜] Pathological analysis of muscle hypertrophy and degeneration in muscular
dystrophy in gamma-sarcoglycan-deficient mice. Sasaoka T1, Imamura M, Araishi K, Noguchi S, Mizuno
Y, Takagoshi N, Hama H, Wakabayashi-Takai E, Yoshimoto-Matsuda Y, Nonaka I, Kaneko K, Yoshida M,
Ozawa E: Neuromuscul Disord 2003/3; 13 (3): 193-206. (ù‰ªr–M1: 1ŽÀ“®)

H15-520001. [‘à] lHR‘̃eƒNƒmƒƒW[‚ÌŠî–{‚ƈãŠw‚ւ̉ž—p. “c’†“ЕF, ù‰ªr–M1 (1ŽÀ
“®): ¶‰»›{ 2003/12; 75 (12): 1551-5.

H16-110001. [ŒŽ’˜] Beta-Synemin localizes to regions of high stress in human skeletal
myofibers. Mizuno Y, Guyon JR, Watkins SC, Mizushima K, Sasaoka T1, Imamura M, Kunkel LM, Okamoto
K: Muscle Nerve 2004/9; 30 (3): 337-46. (ù‰ªr–M1: 1ŽÀ“®)

H16-520001. [‘à]yƒoƒCƒIƒeƒNƒmƒƒW[: Šî‘bŒ€‹†‚ƗՏ°‚ւ̉ž—p (9)zlHR‘̃eƒNƒmƒƒW[
‚ÌŠî‘b‚ƗՏ°‰ž—p‚̉”\«. “c’†“ЕF, “n•Ó‘¥K, ù‰ªr–M1 (1ŽÀ“®): ƒQƒmƒ€ˆãŠw 2004/8; 4 (4):
447-52.

H17-110001. [ŒŽ’˜] Unidirectional subcloning to generate more than 109 transformants from
1 microgram of vector DNA. Tanaka T, Watanabe N, Sasaoka T1: The Nihon University Journal of
Medicine 2005; 47 (2): 43-56. (ù‰ªr–M1: 1ŽÀ“®)

H17-510001. [‘à] Molecular and Cell Biology of the Sarcoglycan Complex. Ozawa E, Mizuno
Y, Hagiwara Y, Sasaoka T1, Yoshida M: Muscle Nerve 2005/11; 32 (5): 563-76. (ù‰ªr–M1: 1ŽÀ“®)

H18-110001. [ŒŽ’˜] Inactivation of aPKC lambda results in the loss of adherens junctions in
neuroepithelial cells without affecting neurogenesis in mouse neocortex. Imai F, Hirai S, Akimoto
K, Koyama H, Miyata T, Ogawa M, Noguchi S, Sasaoka T1, Noda T, Ohno S: Development 2006/5; 133
(9): 1735-44. (ù‰ªr–M1: 1ŽÀ“®)

H18-110002. [ŒŽ’˜] Mouse brains deficient in neuronal PDGF receptor-beta develop normally
but are vulnerable to injury. Ishii Y, Oya T, Zheng L, Gao Z, Kawaguchi M, Sabit H, Matsushima
T, Tokunaga A, Ishizawa S, Hori E, Nabeshima Y, Sasaoka T1, Fujimori T, Mori H, Sasahara M: J
Neurochem 2006/7; 98 (2): 588-600. (ù‰ªr–M1: 1ŽÀ“®)

H18-110003. [ŒŽ’˜] Caveolin-3 deficiency decreases the gene expression level of osteopontin
in mdx mouse skeletal muscle. Hagiwara Y, Fujita M, Imamura M, Noguchi S, Sasaoka T1: Acta Myol
2006/10; 25 (2): 53-61. (ù‰ªr–M1: 1ŽÀ“®)

H18-110004. [ŒŽ’˜] Cys669-Cys713 disulfide bridge formation is a key to dystroglycan cleavage
and subunit association. Watanabe N, Sasaoka T1, Noguchi S, Nishino I, Tanaka T: Genes Cells
2007/1; 12 (1): 75-88. (ù‰ªr–M1: 1ŽÀ“®)

H18-110005. [ŒŽ’˜] Cardiac arterial pole alignment is sensitive to FGF8 signaling in the
pharynx. Hutson MR, Zhang P, Stadt HA, Sato AK1, Li YX, Jarrett B, Creazzo TL, Kirby ML: Dev Biol
2006; 295: 486-97. (²“¡’©Žq1: 1ŽÀ“®)

H19-110001. [ŒŽ’˜] Platelet-derived growth factor (PDGF)-BB inhibits AMPA receptor-mediated
synaptic transmission via PDGF receptor-beta in murine nucleus tractus solitarius. Ohi Y, Ishii
Y, Haji A, Noguchi S, Sasaoka T1, Fujimori T, Nabeshima Y, Sasahara M, Hattori Y: Brain Res 2007/7;
1159: 77-85. (ù‰ªr–M1: 1ŽÀ“®)

H20-110002. [ŒŽ’˜] Ras signaling directs endothelial specification of VEGFR2+ vascular
progenitor cells. Kawasaki K, Watabe T, Sase H, Hirashima M, Koide H, Morishita Y, Yuki K, Sasaoka
T1, Suda T, Katsuki M, Miyazono K, Miyazawa K: J Cell Biol 2008/4; 181 (1): 131-41. (ù‰ªr–M
1: 1ŽÀ“®)

H21-110006. [ŒŽ’˜] Mouse prickle1, the homolog of a PCP gene, is essential for epiblast
apical-basal polarity. Tao H, Suzuki M, Kiyonari H, Abe T, Sasaoka T1, Ueno N: Proc Natl Acad
Sci U S A 2009/8; 106 (34): 14426-31. (ù‰ªr–M1: 1ŽÀ“®)

[’˜@‘]

H1-610001. [Šwp‘] (•ª’SŽ·•M)yBioinformaticszMolecular genetic approaches to the study
of human catecholamine-synthesizing enzymes, p281-8. Nagatsu T, Kaneda N, Kobayashi K, Ichinose
H, Sasaoka T1, Ishii A, Kiuchi K, Kurosawa Y, Fujita K, Eds. Hatase O, Wang JH, Elsevier Science
Publishers B. V., 1989”­s. (ù‰ªr–M1: 1ŽÀ“®)

H2-610001. [Šwp‘] (•ª’SŽ·•M)yAging of the brain: cellular and molecular aspects of brain
aging and Alzheimer's diseasezMolecular biological approaches to catecholamine neurotransmitters
and brain aging, p.53-66. Kaneda N, Kobayashi K, Ichinose H, Sasaoka T1, Ishii A, Kiuchi K, Kurosawa
Y, Fujita K, Nagatsu T, Eds. Osamu Hayaishi, S Karger Pub, 1991/3”­s. (ù‰ªr–M1: 1ŽÀ“®)

H3-610001. [Šwp‘] (•ª’SŽ·•M)yBasic, Clinical, and Therapeutic Aspects of Alzheimer's and
Parkinson's DiseaseszGenes of human catecholamine-synthesizing enzymes, p.481-6. Nagatsu T,
Kaneda N, Kobayashi K, Ichinose H, Sasaoka T1, Ishii A, Sumi C, Kiuchi K, Fujita K, Kurosawa Y,
Eds. Nagatsu T, et al, Plenum Pub Corp, New York, 1991/5”­s. (ù‰ªr–M1: 1ŽÀ“®)

H3-610002. [Šwp‘] (•ª’SŽ·•M)yParkinson's disease: From clinical aspects to molecular
basiszGenes of human catecholamine-synthesizing enzymes, p.19-38. Nagatsu T, Kaneda N, Kobayashi
K, Ichinose H, Sasaoka T1, Ishii A, Sumi C, Kiuchi K, Fujita K, Kurosawa Y, Eds. Nagatsu T,
Narabayashi H, Yoshida M, Springer-Verlag, Germany, 1991/10”­s. (ù‰ªr–M1: 1ŽÀ“®)

H5-610001. [Šwp‘] (•ª’SŽ·•M)yTyrosine Hydroxylase from discovery to cloning (Journal of
Neurochemistry)zNon-catecholaminergic neuronal expression of tyrosine hydroxylase in the brain
of transgenic mice with special reference to aromatic L-amino acid decarboxylase, p.37-57. Nagatsu
I, Yamada K, Karasawa N, Kaneda N, Sasaoka T1, Kobayashi K, Fujita K, Nagatsu T, Eds. Naoi M, Parvez
SH, VSP, Utrecht, The Netherlands, 1993/12”­s. (ù‰ªr–M1: 1ŽÀ“®)

H5-610002. [Šwp‘] (•ª’SŽ·•M)yTyrosine Hydroxylase from discovery to cloningzThe human
Tyrosine Hydroxylase gene, p.177-91. Nagatsu T, Kaneda N, Kobayashi K, Ichinose H, Sasaoka T1,
Kiuchi K, Fujita K, Kurosawa Y, Eds. Naoi M, Parvez SH, VSP, Utrecht, The Netherlands, 1993/12
”­s. (ù‰ªr–M1: 1ŽÀ“®)

H14-610001. [Šwp‘] (•ª’SŽ·•M)yCatecholamine Research: From Molecular Insights to Clinical
Medicine (Advances in Behavioral Biology Vol 53)zDopamine D2L receptor knockout mouse provides
a unique model system for studying the functions of D2L and D2S, p.175-8. Wang Y, Xu R, Sasaoka
T1, Sankoorikal E-B, Eds. Nagatsu T, Nabeshima T, McCarty R, Goldstein DS, Springer, 2002”­s.
(ù‰ªr–M1: 1ŽÀ“®)

[Šw‰ïEŒ€‹†‰ï“™]

H20-733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ³íƒ}ƒEƒX‚É‚š‚¯‚éLRRK2-mRNA‚Æ
ƒ^ƒ“ƒpƒNŽ¿‚Ì‘gD•ª•z‰ðÍ. ‘Oì’B‘¥, ‘Ÿ“c‰x˜N, Œ`‰ë‘¥, “Œ@’åG1, ¬”Š•¶–í (1ŽÀ“®): ‘æ21‰ñ
–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€Œ€‹†‰ï (2008/7/31), _“ސì.

H20-723003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒX‰^“®—ʂɑ΂·‚éD1ƒh[ƒpƒ~ƒ“Žó—e‘Ì‚Ì
”­Œ»•Ï‰»‚̉e‹¿. ²“¡’©Žq1, ù‰ªr–M1, rì-¬—Ñ‘Žq, X“c’qŽq, Ÿ–Ø–MŽq, Ÿ–ØŒ³–ç (1ŽÀ“®): ‘æ
31‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ï (2008/12/10), _ŒË.

H21-723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ³íƒ}ƒEƒX‚É‚š‚¯‚éLRRK2”­Œ»—ʂƉÁ—î‚ÌŠÖŒW.
‘Oì’B‘¥, ‘Ÿ“c‰x˜N, ‹v•Û@œ, ‘哹@•‘, ‰¡ŽRˆèŒb, “Œ@’åG1, ¬”Š•¶–í (1ŽÀ“®): ‘æ50‰ñ“ú–{_
ŒoŠw‰ï‘‰ï (2009/5/20-22), å‘ä.

H21-723006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”­Œ»§Œä‰Â”\‚ȃh[ƒpƒ~ƒ“D1Žó—e‘̂𓱓ü‚µ
‚œƒ}ƒEƒX‚ð—p‚¢‚œ‰^“®§Œä‹@\‚̉ðÍ. ²“¡’©Žq1, ù‰ªr–M1, rì‘Žq, X“c’qŽq, Ÿ–Ø–MŽq, Ÿ–Ø
Œ³–ç (1ŽÀ“®): ‘æ32‰ñ“ú–{_Œo‰ÈŠw‘å‰ï (2009/9/16), –ŒŒÃ‰®.

H21-723007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Locomotor control in transgenic mice harboring
tetracycline-regulated dopamine D1 receptor expression. ²“¡’©Žq1, Ÿ–ØŒ³–ç, ù‰ªr–M1 (1ŽÀ
“®): ‘æ32‰ñ“ú–{•ªŽq¶•šŠw‰ï”N‰ï (2009/12/10), ‰¡•l.


–ƉuŠw

[Šwp˜_•¶]

110051. [ŒŽ’˜] Nuclear factor-ƒÈB (NF-ƒÈB) inhibitor, Dehydroxymethylepoxyquinomicin (DHMEQ)
ameliorates experimental autoimmune uveoreitnitis (EAU) in mice. Iwata D, Kitaichi N, Ebihara
A, Iwabuchi K1, Yoshida K, Namba K, Ozaki M, Ohno S, Umezawa K, Yamashita K-i, Todo S, Ishida S,
Onoe K: Invest Ophthalmol Vis Sci 2010/4; 51 (4): 2077-84. (ŠâŸº˜a–ç1: 1–Ɖu)

110052. [ŒŽ’˜] Identification of a third variable lymphocyte receptor in the lamprey. Kasamatsu
J, Sutoh Y, Fugo K, Otsuka N, Iwabuchi K1, Kasahara M: Proc Natl Acad Sci U S A 2010/8; 107 (32):
14304-8. (ŠâŸº˜a–ç1: 1–Ɖu)

110053. [ŒŽ’˜] Developmental changes in the expression of SHP2-interacting transmembrane protein
(SIT) on T lineage cells. Shimizu N, Tsukagoshi Y, Eshima K1, Iizuka M2, Shinohara N1: The Kitasato
Medical Journal 2010/9; 40 (2): 107-13. (Ž…“Þ“Þ, ’ˉz—R, ]“‡k“ñ1, ”Ñ’Ë‚Ý‚³‚ð2, ŽÂŒŽMŒ«
1: 1–Ɖu, 2—\–hˆãŠwŒn)

110054. [ŒŽ’˜] Dendritic cell differentiation with prostaglandin E2 results in selective
attenuation of the ERK pathway and decreased interleukin-23 production. Hayashi F, Yanagawa Y,
Ono* K, Iwabuchi K1: Immunology. 2010/9; 131 (1): 67-76. (ŠâŸº˜a–ç1: 1–Ɖu)

110055. [ŒŽ’˜] LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular
activation. Kubo M, Kamiya Y, Nagashima R, Maekawa T, Eshima K1, Azuma S, Ohta E, Obata F: J
Neuroimmunol 2010/12; 229 (1-2): 123-8. (]“‡k“ñ1: 1–Ɖu)

110056. [ŒŽ’˜] Dendritic cell-derived TNF-ƒ¿ is responsible for development of IL-10-producing
CD4+ T cells. Hirata N, Yanagawa Y, Satoh M, Ogura H, Ebihara T, Noguchi M, Matsumoto M, Togashi
H, Seya T, Ono* K, Iwabuchi K1: Cell Immunol 2010; 261 (1): 37-41. (ŠâŸº˜a–ç1: 1–Ɖu)

110057. [ŒŽ’˜] Identification of INAM, a polyI:C-inducible membrane protein, that participates
in dendritic cell-mediated natural killer cell activation. Ebihara T, Azuma M, Oshiumi H,
Kasamatsu J, Iwabuchi K1, Matsumoto K, Saito H, Taniguchi T, Matsumoto M, Seya T: J Exp Med 2010/11;
207 (12): 2675-87. (ŠâŸº˜a–ç1: 1–Ɖu)

110058. [ŒŽ’˜] CSF-1-dependent red pulp macrophages regulate CD4 T cell responses. Kurotaki D,
Kon S, Bae K, Ito K, Matsui Y, Nakayama Y, Kanayama M, Kimura C, Narita Y, Nishimura T, Iwabuchi
K1, Mack M, van Rooijen N, Sakaguchi S, Uede T, Morimoto J: J Immunol 2011/2; 186 (4): 2229-37.
(ŠâŸº˜a–ç1: 1–Ɖu)

110059. [ŒŽ’˜] The role of tumor necrosis factor-ƒ¿ for interleukin-10 production by murine
dendritic cells. Hirata N, Yanagawa Y, Ogura H, Satoh M, Noguchi M, Matsumoto M, Togashi H, Onoe
K, Iwabuchi K1: Cell Immunol 2011; 266 (2): 165-71. (ŠâŸº˜a–ç1: 1–Ɖu)

510004. [‘à] Differential Enhancement of T Helper Type 1 (Th1)/Th2 Cytokine Production by Natural
Killer T Cells Through Negative Feedback Regulation with Cytokine-conditioned Dendritic Cells.
Iwabuchi K1, Yanagawa Y, Minami K, Mizuuchi K, Maeda M, Ogura H, Satoh M, Hayashi F, Obata Y, Ikeda
N, Iwata D, Hirata N, Iwabuchi C, Onoe K: Current Immunology Reviews 2010/5; 6 (2): 78-87. (Šâ
Ÿº˜a–ç1: 1–Ɖu)

[Šw‰ïEŒ€‹†‰ï“™]

713030. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ectopic expression of T-box transcription factor,
Eomesodermin, renders CD4+ Th2 cells cytotoxic by activating both perforin/granzyme- and FasL-Fas
pathways. Eshima K1, Chiba S, Kokubo K, Kobayashi H, Suzuki H, Shinohara N: 14th International
Congress of Immunology (2010/8/23), Kobe. (]“‡k“ñ1: 1–Ɖu)

713031. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MR1-restricted NKT cells exhibit beneficial role for
the development of atherosclerosis. Ogura H, Satoh M, Gilfillan S, Miyake S, Onoe K, Iwabuchi
K1: 14th International Congress of Immunology (2010/8/23), Kobe. (ŠâŸº˜a–ç1: 1–Ɖu)

713032. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Type II NKT cells operate diet-induced obesity. Satoh
M, Ogura H, Andoh Y, Nakayama, Tanihuchi M, Onoe K, Iwabuchi K1: 14th International Congress of
Immunology (2010/8/23), Kobe. (ŠâŸº˜a–ç1: 1–Ɖu)

713033. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The role of dendritic cell-produced TNF-ƒ¿ in
generation of IL-10-producing CD4+ T cells. Hirata N, Yanagawa Y, Iwabuchi K1, Satoh M, Ogura
H, Seya T, Onoe K, Noguchi M: 14th International Congress of Immunology (2010/8/24), Kobe. (Šâ
Ÿº˜a–ç1: 1–Ɖu)

713034. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Selective attenuation of the ERK pathway and decreased
interleukin-23 production in dendritic cells differentiated with prostaglandin E2. Hayashi F,
Yanagawa Y, Onoe K, Iwabuchi K1: 14th International Congress of Immunology (2010/8/25), Kobe. (Šâ
Ÿº˜a–ç1: 1–Ɖu)

713035. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Amelioration of experimental autoimmune uveoretinitis
by blockade of osteopontin with antibody or small interfering RNA. Iwabuchi K1, Iwata D, Kitamura
M, Kitaichi N, Kon S, Kitamei H, Namba K, Yoshida K, Ishida S, Ohno S, Rittling SR, Denhardt DT,
Uede T, Onoe K: 14th International Congress of Immunology (2010/8/27), Kobe. (ŠâŸº˜a–ç1: 1–Æ
‰u)

723117. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H‰a—U“±«”ì–ži“W‚É‚š‚¯‚éNKT×–E‚Ì–ðŠ„. ŠâŸº˜a–ç
1, ¬–ì]˜a‘¥ (1–Ɖu): ‘æ99‰ñ“ú–{•a—Šw‰ï‘‰ï (2010/4/29), “Œ‹ž.

723118. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶ŠˆKŠµ•aƒ}ƒEƒXƒ‚ƒfƒ‹‚É‚š‚¯‚éCD1dS‘©«‚ÆMR1S‘©
«NKT×–E‚̈قȂé‹@”\”­Œ». ŠâŸº˜a–ç1, ²“¡@‰ë, ¬‘q®Žq, ¬–ì]˜a‘¥, Susan Gilfillan, Luc Van
Kaer, “‡‘º“¹•v, ŽO‘îKŽq, ŽR‘º@—² (1–Ɖu): ‘æ20‰ñKyoto T Cell Conference (KTCC) 2010/6/5), ‹ž
“s.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-110007. [ŒŽ’˜] Prevention of experimental autoimmune uveoretinitis by blockade of
osteopontin with small interfering RNA. Iwata D, Kitamura M, Kitaichi N, Saito Y, Kon S, Namba
K, Morimoto J, Ebihara A, Kitamei H, Yoshida K, Ishida S, Ohno S, Uede T, Ono* K, Iwabuchi K1:
Exp Eye Res 2010/1; 90 (1): 41-8. (ŠâŸº˜a–ç1: 1–Ɖu)

H21-110008. [ŒŽ’˜] Natural killer T cells are involved in adipose tissue inflammation and
glucose intolerance in diet-induced obese mice. Ohmura K, Ishimori N, Ohmura Y, Tokuhara S, Nozawa
A, Horii S, Andoh Y, Fujii S, Iwabuchi K1, Onoe K, Tsutsui H: Arterioscler Thromb Vasc Biol 2010/2;
30 (2): 193-9. (ŠâŸº˜a–ç1: 1–Ɖu)


¶•šŠw


•š—Šw

[Šwp˜_•¶]

110060. [ŒŽ’˜] Modeling of radiative properties of Sn plasmas for extreme-ultraviolet source.
Sasaki A, Sunahara A, Furukawa H, Nishihara K, Fujioka S, Nishikawa T, Koike F1, Ohashi H, Tanuma
H: J Appl Phys 2010/6; 107 (11): 113303. (¬’r•¶”Ž1: 1•š—)

110061. [ŒŽ’˜] Isochoric heating of low-Z redused mass targets with high intensity laser pulse.
Ohshima S, Nishimura H, Batani D, Desai T, Veltcheva M, Nakamura H, Tanabe M, Fujiwara T, Kawamura
T, Koike F1, Mishra R, Sentoku Y, Mancini R, Hakel P, Mima K: J Phys: Conf Ser 2010; 244 (2): 022054.
(¬’r•¶”Ž1: 1•š—)

110062. [ŒŽ’˜] Energy transport and isochoric heating of a low Z reduced mass target irradiated
with a high intensity laser pulse. Nishimura H, Mishra, R Ohshima S, Nakamura H, Tanabe M, Fujiwara
T, Yamamoto N, Fujioka S, Batani D, Veltcheva M, Desai T, Jafer R, Kawamura T, Sentoku Y, Mancini
R, Hakel P, Koike F1, Mima K: Physics of Plasmas 2011/2; 18 (2): 022702. (¬’r•¶”Ž1: 1•š—)

110063. [ŒŽ’˜] Kƒ¿ radiation from low charge chlorine heated by an ion beam for cold dense plasma
diagnostics. Kawamura T, Horioka K, Koike F1: Laser and Particle Beams 2011; 29: 135-40. (¬
’r•¶”Ž1: 1•š—)

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-110009. [ŒŽ’˜] Identification of 4d-5p transitions in the spectra of Sn XV-Sn XIX recorded
from collisions between Sn ions and He. D'Arcy R, Ohashi H, Suda S, Tanuma H, Fujioka S, Nishimura
H, Nishihara K, Suzuki C, Kato T, Koike F1, O'Connor A, O'Sullivan G: J Phys B: At Mol Opt Phys
2009/8; 42 (16): 165207-12. (¬’r•¶”Ž1: 1•š—)

H21-110010. [ŒŽ’˜] Polarized Heƒ¿ Radiation by Anisotropic Fast Electron Transport in
Ultra-Intense Laser Produced Plasmas. Kawamura T, Kai T, Koike F1, Nakazaki S, Nishimura H,
Inubushi Y, Okano Y, Nagatomo H, Batani D, Morace A, Redaelli R, Fourment C, Santos J, Malka G,
Boscheron A, Casner A, Koenig M, Fujioka S, Nakamura T, Johzaki T, Mima K: AIP Conf Proc 2009/9;
1161 (1): 254-9. (¬’r•¶”Ž1: 1•š—)

H21-110011. [ŒŽ’˜] The atomic model of the Sn plasmas for the EUV source. Sasaki A, Sunahara
A, Nishihara K, Nishikawa T, Koike F1, Tanuma H: J Phys: Conf Ser 2009; 163: 012107. (¬’r•¶”Ž
1: 1•š—)

H21-110012. [ŒŽ’˜] Isotope shift calculations for open-shell atoms and ions: an extension
to the RATIP program. Fritzsche S, Dong CZ, Koike F1: Hyperfine Interactions 2010/2; 196 (1-3):
25-34. (¬’r•¶”Ž1: 1•š—)


¶‘̍HŠw


H•iŠŽõÇŠw


—Տ°‚€‚•aŠw

[’˜@‘]

620028. [Šwp‘]y¡“ú‚ÌŽ¡—ÃŽwj@2011”N”Å (Volune. 53)z16. ž_ŽŸŠ³@‚€‚•a«áŠQ, p.865-6.
‹{‰ª@“™ (ž_), ‘•ÒW ŽRŒû@“O, –kŒŽŒõ•v, •ŸˆäŽŸ–î, ˆãŠw‘‰@, 2011/1”­s.

620029. [‘à]y‚€‚•aŽ¡—Ãnƒ“ƒhƒuƒbƒN@f—ẪRƒcz‘æ‡U•” ‚€‚•aŠe˜_@ƒRƒ‰ƒ€: ”ñê–åˆã‚ª‚€‚Â
•a‚ðŽ¡—Ã‚·‚鎞‚Ì’ˆÓ, p.169-71. ‹{‰ª@“™1, ‘åÎ@’q1 (1ž_), •Ò ‘å–ì@—T, ‹à„o”Å, 2011/1
”­s.

[Šw‰ïEŒ€‹†‰ï“™]

731003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Disease mongeringŽž‘ã‚Ì‹C•ªáŠQŽ¡—Ã. ‹{‰ª@“™ (ž
_): ’nˆæž_•a‰@–òÜŽtŒ€‹†‰ï (2010/6/16), ’¬“c‚Ü‚¿‚­‚èŒöŽÐE‚Û‚Á‚Û’¬“c (’¬“cŽs).

731004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒvƒ‰ƒCƒ}ƒŠƒPƒA‚É‚š‚¯‚é‚€‚•aŽ¡—Ẩۑè. ‹{‰ª@“™
(ž_): ‚€‚•a‚Ì’nˆæ˜AŒg‚ðl‚Š‚é‰ï (2010/10/6), ‘Š–ÍŒŽŽs.

731005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)u‚€‚•a‚̍L‚ª‚è‚Ɛž_‰Èˆã‚É‹‚ß‚ç‚ê‚é‘Ήžv‚ɂ‚¢‚Ä.
‹{‰ª@“™ (ž_): •œ¬22”N“xŽ­ž‹Š‘OŠú‰@’·“™Œ€C‰ï (2010/10/22), Ž­Ž™“‡Žs.

731006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰“™) ”F’mÇ‚Æ–ò•š—Ö@EŠ³ŽÒ‰Æ‘°‘ΉžEŽü•ÓÇó‚ɂ‚¢‚Ä.
‘åÎ@’q (ž_): ’nˆæž_•a‰@–òÜŽtŒ€‹†‰ï (2010/11/17), ’¬“c‚Ü‚¿‚­‚èŒöŽÐE‚Û‚Á‚Û’¬“c (’¬“c
Žs).

732006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) Z’·‘Ώۃƒ“ƒ^ƒ‹ƒwƒ‹ƒXŒ€Cu‰‰. ‘åÎ@’q (ž_):
‘Š–ÍŒŽŽs‹³ˆçˆÏˆõ‰ï (2010/6/18), ‘Š–ÍŒŽŽs.

732007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Žs–¯ŒöŠJuÀ) Ž¡‚è‚â‚·‚¢‚€‚‚Ǝ¡‚è‚É‚­‚¢‚€‚Â. ‹{‰ª@“™ (ž
_): ‘Š–͏—Žq‘åŠw‰—tƒJƒ‹ƒ`ƒƒ[ƒZƒ“ƒ^[ (2010/6/24), ‘Š–͏—Žq‘åŠw (‘Š–ÍŒŽŽs).

732008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) S—Žm‚ɖ𗧂g‚€‚h‚Ì’mŽ¯?‚€‚•a‚Í–{“–‚É‘‚Š
‚œ‚Ì‚©H?. ‹{‰ª@“™ (ž_): _“ސ쌧—Տ°S—Žm‰ï@‘æ1‰ñŒ€C‰ïE‘‰ï (2010/7/4), ‰¡•lŽs.

732009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Šî’²u‰‰) ž_ˆã—©‚çwEê‚̃ƒ“ƒ^ƒ‹ƒwƒ‹ƒXx‚ð–â‚€. ‹{‰ª@“™
(ž_): ‘æ32‰ñƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘å‰ï (2010/9/2), “Œ‹ž“srì‹æ.

732010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) ‚€‚•a‚ð‚Ç‚€—‰ð‚·‚é‚©. ‹{‰ª@“™ (ž_): ‘Š–ÍŒŽŽs
Žs–¯‚R‹æ‡“¯ŒöŠJuÀ (2010/8/5), ‘Š–ÍŒŽŽs.

732011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ‹³“ª‘Ώۃƒ“ƒ^ƒ‹ƒwƒ‹ƒXŒ€Cu‰‰. ‘åÎ@’q (ž_):
‘Š–ÍŒŽŽs‹³ˆçˆÏˆõ‰ï (2010/11/16), ‘Š–ÍŒŽŽs.


’nˆæŽüŽYŠúE‹~‹}ˆã—ØAŒg‹³Žº

[Šwp˜_•¶]

540021. [‚»‚Ì‘Œ (–|–ó)]yˆã—Ïî•ñƒT[ƒrƒX Minds (ƒ}ƒCƒ“ƒY)^ˆã—Ã’ñ‹ŸŽÒŒü‚¯^ƒRƒNƒ‰ƒ“EƒŒƒrƒ…[z
‹Ö‰Œ‚Ì‚œ‚߂̍Ö°—Ö@ (2008 issue 4, Updated) (CitationFAbbot NC, Stead LF, White AR, Barnes J.
Hypnotherapy for smoking cessation. Cochrane Database of Systematic Reviews 1998, Issue 2. Art.
No.: CD001008. DOI: 10.1002/14651858.CD001008). –|–ó ‰€@‘‹Õ1, ¯@‰À–F2EŠÄ–ó û‰ª@—²GJCOHR
(1’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 2‰q¶EŒöO‰q¶): à’c–@l“ú–{ˆã—Ë@”\•]‰¿‹@\, Minds (“dŽqo”Å
http://minds.jcqhc.or.jp) 2010/7.
http://minds.jcqhc.or.jp/stc/0075/4/0075_G0000209_T0004164.html

[Šw‰ïEŒ€‹†‰ï“™]

723119. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ú–{‚̏¬Ž™‚É‚š‚¯‚鎟•a•‰’S‚ÆŠÖ˜A‚·‚éˆã—Ôï (Disease
burden and related medical cost for children in Japan). ‰€@‘‹Õ1, –ì“n³•F1, ¯@‰À–F2, ŠC
–ìM–ç3, â–{‘×—4, ²“¡•q•F4, ‘ŠàVDŽ¡2 (1’nˆæŽüŽYŠúE‹~‹}ˆã—à 2‰q¶EŒöO‰q¶, 3ŽY•w, 4
—Տ°Œ€‹†EŠé‰æ): ‘æ69‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (2010/10/28), “Œ‹ž, “ú–{ŒöO‰q¶ŽGŽ 2010/10; 57
(10): 476.

H21”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H18-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Genetic variations of MRF-2/ARID5B confers
risk of coronary alterosclerosis in the Japanese population. ‰€@‘‹Õ1, Watanabe M, Imai Y, et
al (1’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): The 71th Annual scientific meeting of the Japanese circulation society
(2007/3/15), Kobe.

H20-723004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Stability of the quality-effects model for
meta-analysis. ‰€@‘‹Õ1, Bax L2, Moons KGM, ²“¡•q•F2, ‘ŠàVDŽ¡3 (1’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 2
—Տ°Œ€‹†EŠé‰æ, 3‰q¶EŒöO‰q¶): The 19th annual scientific meeting of the Japan Epidemiological
association (2009/1/23-24), Kanazawa.


_ŒoÄ¶ˆã—Êw

[Šwp˜_•¶]

110064. [ŒŽ’˜] Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: a randomized,
controlled study. Mizuno Y1, Hasegawa K2, Kondo T3, Kuno S4, Yamamoto M5, Japanese Istradefylline
Study Group (1Department of Neurology, Juntendo Univeristy, 2National Sagamihara Hospital,
Department of Neurology, 3Wakayama Prefectural University, 4Dpearment of Neurology, National
Center for Neurology, 5Department of Neurology, Kagawa Prefectural Hospital): Mov Disord 2010/7/30;
25: 1437-43. (…–ì”ü–M1)

110065. [ŒŽ’˜] No evidence for pathogenic role of GIGYF2 mutation in Parkinson disease in Japanese
patients. Li L1, Funayama M1, Tomiyama H1, Li Y1, Yoshino H1, Sasaki R1, Kokubo Y1, Kuzuhara S1,
Mizuno Y1, Hattori N1 (1Dpeartment of Neurology, Juntendo University): Neurosci Lett 2010/8/2;
479 (3):245-8. (…–ì”ü–M1)

110066. [ŒŽ’˜] Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD
study. Schapira AH1, Albrecht S2, Barone P3, Comella CL4, McDermott MP5, Mizuno Y6, Poewe W7,
Rascol O8, Marek K9 (1Department of Clinical Neurosciences, Institute of Neurology, University
College London, London, United Kingdom, 2Boehringer Ingelheim GmbH, CD Medical Affairs CNS,
Ingelheim, Germany, 3Department of Neurological Sciences, University of Naples, Federico II and
IDC-Hermitage-Capodimonte, Naples, Italy, 4Department of Neurological Sciences, Rush University
Medical Center, Chicago, Illinois, USA, 5Department of Biostatistics and Computational Biology,
University of Rochester Medical Center, Rochester, New York, USA, 6Department of Neurology,
Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan, 7Department of Neurology,
Innsbruck Medical University, Innsbruck, Austria, 8Departments of Clinical Pharmacology and
Neurosciences, Clinical Investigation Center INSERM CIC9302, and INSERM UMR825, Toulouse
University Hospital, Toulouse, France, 9Institute for Neurodegenerative Disorders, New Haven,
Connecticut, USA): Mov Disord 2010/8/15; 25: 1627-32. (…–ì”ü–M6)

110067. [ŒŽ’˜] Efficacy, safety, and tolerability of overnight switching from immediate- to once
daily extended-release pramipexole in early Parkinson's disease. Rascol O1, Barone P2, Hauser
RA3, Mizuno Y4, Poewe W5, Schapira AH6, Salin L7, Sohr M8, Debieuvre C7; Pramipexole Switch Study
Group (1Departments of Clinical Pharmacology and Neurosciences, Toulouse University Hospital,
INSERM CIC9302-UMR825 Toulouse, France, 2Department of Neurological Sciences, University of Naples,
Naples, Italy, 3Department of Neurology, University of South Florida, Tampa, Florida, USA,
4Department of Neurology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan,
5Department of Neurology, Innsbruck Medical University, Innsbruck, Austria, 6University Department
of Clinical Neurosciences, Institute of Neurology, University College London, London, United
Kingdom, 7Clinical Research Department, Boehringer Ingelheim France S.A.S., Reims, France,
8Medical Division, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany): Mov
Disord 2010/10/30; 25: 2326-32. (…–ì”ü–M4)

110068. [ŒŽ’˜] Rapid screening of ATP13A2 variant with high-resolution melting analysis.
Funayama M1, Tomiyama H1, Wu RM1, Ogaki K1, Yoshino H1, Mizuno Y2, Hattori N1 (1Department of
Neurology, Juntendo University School of Medicine, 2Department of Neuroregenerative Medicine,
Kitasato University): Mov Disord 2010/10//30; 25 (14): 2434-7. (…–ì”ü–M2)

110069. [ŒŽ’˜] Randomized, double-blind, multicenter evaluation of pramipexole extended release
once daily in early Parkinson's disease. Hauser RA1, Schapira AH2, Rascol O3, Barone P4, Mizuno
Y5, Salin L6, Haaksma M7, Juhel N6, Poewe W8 (1Department of Neurology, University of South Florida,
Tampa, Florida, USA, 2University Department of Clinical Neurosciences, Institute of Neurology,
University College London, London, United Kingdom, 3Department of Clinical Pharmacology and
Neurosciences, Clinical Investigation Center, INSERM CIC-9203 and UMR-825, Toulouse University
Hospital, Toulouse, France, 4Department of Neurological Sciences, University of Naples, Federico
II and IDC-Hermitage-Capodimonte, Naples, Italy, 5Department of Neurology, Juntendo University
School of Medicine, Bunkyo-ku, Tokyo, Japan, 6Division of Medicine, Department of Clinical
Development, Boehringer Ingelheim France S.A.S., Reims, France, 7Medical Department, Boehringer
Ingelheim Pharma RCV GmbH & Co. KG, Vienna, Austria, 8Department of Neurology, Innsbruck Medical
University, Innsbruck, Austria): Mov Disord 2010/11/15; 25: 2542-9. (…–ì”ü–M5)

110070. [ŒŽ’˜] Ectopic expression of ƒ¿-synuclein affects the migration of neural stem cells in
mouse subventricular zone. Tani M1, Hayakawa H, Yasuda T, Nihira T, Hattori N1, Mizuno Y2,
Mochizuki H3 (1Department of Neurology, Juntendo University, 2Department of Neuroregenerative
Medicine, Kitasato University, 1Department of Neurology, Kitasato University): J Neurochem
2010/11; 115 (4): 854-63. (…–ì”ü–M2, –]ŒŽGŽ÷3)

520014. [‘à] ƒp[ƒLƒ“ƒ\ƒ“•a. …–ì”ü–M (‡“V“°‘åŠw”]_Œo“à‰È): ‘Ž‡—Õଠ2010; 59 (‘Š§†):
915-9.

520015. [‘à] ƒp[ƒLƒ“ƒ\ƒ“•aŽ¡—Âɂš‚¯‚鏙•ú«»Ü‚̈Ӌ`. …–ì”ü–M1, ŽR–{Œõ—˜2, ‹v–ì’åŽq3,
’·’JìˆêŽq4, •ž•”MF1 (1‡“V“°‘åŠw”]_Œo“à‰È, 2ìŒ§—§’†‰›•a‰@_Œo“à‰È, 3‘—§_Œož_ƒZƒ“
ƒ^[_Œo“à‰È, 4‘—§•a‰@‹@\‘Š–ÍŒŽ•a‰@_Œo“à‰È): V–ò—Տ° 2010; 59: 1819-33.

520016. [‘à] ƒp[ƒLƒ“ƒ\ƒ“•aŽ¡—Â̍¡: ƒp[ƒLƒ“ƒ\ƒ“•aŽ¡—ÃKƒCƒhƒ‰ƒCƒ“2011‚𓥂܂Š‚Ä. …–ì”ü
–M (_ŒoÄ¶ˆã—Ã): “à‰È 2011; 107: 767-72.

[’˜@‘]

610004. [’˜‘] The Enceyclopedia of Movement Disorders, Vol 2, Neuroimaging, Parkinson's Disease,
p.272-8. Mizuno Y (Department of Neurology, Juntendo University), Kompoliti K, Metman LV, edit.,
Academic Press, Oxford, 2010. (…–ì”ü–M)

610005. [’˜‘] The Enceyclopedia of Movement Disorders, Vol 3, Pallido-nigro-luysian atrophy,
p.363-5. Mizuno Y (Department of Neurology, Juntendo University), Kompoliti K, Metman LV, edit.,
Academic Press, Oxford, 2010. (…–ì”ü–M)

[Šw‰ïEŒ€‹†‰ï“™]

712016. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Nature and spread of Parkinson's disease. Mizuno Y (Department
of Neurology, Juntendo Unversity): Russian Academy of Sciences. Healthcare Department of the City
of Moscow-Movement Disorder Society (2010/4/15), Moscow. (…–ì”ü–M)

712017. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Clinical advantages of continuous drug delivery. Mizuno Y
(Department of Neurology, Juntendo University): 9th International Forum on Parkinson's Disease
(2010/4/30), Munich. (…–ì”ü–M)

712018. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Recent advances on the pathogenesisof Parkinson's disease.
Mizuno Y (Department of Neurology, Juntendo University): The 7th Chinese Congress on Parkinson's
Disease and Movment Disorders and 2010 Shanghai Jiao Tong Unviersity International Neurological
Disease (2010/5/26), Shanghai. (…–ì”ü–M)

712019. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Genetics, Autosomal recessive Parkinson's disease, Parkin.
Mizuno Y1, Nobutaka H2 (1Department of Neuroregenerative Medicine, Kitasato University,
2Department of Neurology, Juntendo University): 2nd World Parkinson Congress (2010/9/30), Glasgow,
Scottland, UK. (…–ì”ü–M1)

712020. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Various forms of Parkinson's Disease. Mizuno Y (Department of
Neuroregenerative Medicine): 5th International Expert Meeting on the Treatment of Parkinson's
Disease (2010/11/13), Tokyo. (…–ì”ü–M)

712021. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Non-motor symptoms in familial and sporadic Parkinson's disease.
Mizuno Y (Department of Neuroregenerative Medicine): 7th International Congress on Mental
Dysfunction in Parkinson's Disease and Related Disorders (2010/12/11), Barcelona. (…–ì”ü–M)

712022. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Nature and progress of Parkinson's disease. Mizuno Y
(Department of Neuroregenerative Medicine): 10th ADPD Conference (2011/3/12), Barcelona. (…–ì
”ü–M)

712023. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) When and how to start treatment? Mizuno Y (Department of
Neuroregenerative Medicine): 3rd Asian and Oceanian Parkinson's Disease and Movement Disorders
Congress (AOPMC) (2011/3/25), Taipei. (…–ì”ü–M)

712024. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) Etiopathogenesis of Parkinson's Disease. Mizuno Y (Department
of Neuroregenerative Medicine): 3rd Asian and Oceanian Parkinson's Disease and Movement Disorders
Congress (AOPMC) (2011/3/26), Taipei. (…–ì”ü–M)

722024. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒZƒ~ƒi[) ƒp[ƒLƒ“ƒ\ƒ“•a‚Ì”­Ç‹@˜‚ÆŽ¡—Ã?Å‹ß‚̘b‘è?. …–ì”ü
–M (_ŒoÄ¶ˆã—Ã): ‘æ63‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2010/10/23), ‰¡•l.

Á‰»Ší“à‰ÈŠw

[Šwp˜_•¶]

110071. [ŒŽ’˜] Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
Koizumi W1, Boku N, Yamaguchi K, Miyata Y, Sawaki A, Kato T, Toh Y, Hyodo I, Nishina T, Furuhata
T, Miyashita K, Okada Y (1Á‰»Ší“à): Ann Oncol 2010/4; 21 (4): 766-71. (¬ò˜aŽO˜Y1)

110072. [ŒŽ’˜] Therapeutic outcomes of endoscopic submucosal dissection of undifferentiated-type
intramucosal gastric cancer without ulceration and preoperatively diagnosed as 20 millimetres or
less in diameter. Yamamoto Y, Fujisaki J, Hirasawa T, Ishiyama A, Yoshimoto K, Ueki N, Chino A,
Tsuchida T, Hoshino E, Hiki N, Fukunaga T, Sano T, Yamaguchi T, Takahashi H, Miyata S, Yamamoto
N, Kato Y, Igarashi M1,2 (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Dig Endosc 2010/4; 22 (2): 112-8. (ŒÜ\
—’³L1,2)

110073. [ŒŽ’˜] Phase II study of S-1 as first-line treatment for elderly patients over 75 years
of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study. Koizumi W1, Akiya
T, Sato A, Sakuyama T, Sasaki E, Tomidokoro T, Hamada T, Fujimori M, Kikuchi Y, Shimada K, Mine
T, Yamaguchi K, Sasaki T, Kurihara M (1Á‰»Ší“à): Cancer Chemother Pharmacol 2010/5; 65 (6): 1093-9.
(¬ò˜aŽO˜Y1)

110074. [ŒŽ’˜] Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric
cancer (G-SOX study). Koizumi W1, Takiuchi H, Yamada Y, Boku N, Fuse N, Muro K, Komatsu Y, Tsuburaya
A (1Á‰»Ší“à): Ann Oncol 2010/5; 21 (5): 1001-5. (¬ò˜aŽO˜Y1)

110075. [ŒŽ’˜] Expansion of indications for endoscopic treatment of undifferentiated mucosal
gastric cancer: analysis of intramucosal spread in resected specimens. Sawada S, Fujisaki J,
Yamamoto N, Kato Y, Ishiyama A, Ueki N, Hirasawa T, Yamamoto Y, Tsuchida T, Tatewaki M, Hoshino
E, Igarashi M1,2, Takahashi H, Fujita R (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Dig Dis Sci 2010/5; 55 (5):
1376-80. (ŒÜ\—’³L1,2)

110076. [ŒŽ’˜] Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole
is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201
Study). Koizumi W1, Tanabe S1, Nakatani K1, Ishido K1, Nishimura K1, Azuma M1, Ae T1, Sasaki T1,
Higuchi K1, Katada C1, Nakayama N1, Saigenji K1 (1Á‰»Ší“à): J Clin Pharm Ther 2010/6; 35 (3):
303-7. (¬ò˜aŽO˜Y1, “c糁@‘1, ’†’JŒ€“l1, ÎŒËŒªŽŸ1, Œ‘º@Œ«1, “Œ@’q1, ˆ¢]‘Ÿ‰ÀŽq1, ²X
–Ø“O1, ”óŒûŸ•F1, Œ˜“ce—˜1, ’†ŽRž“T1, ŒŒ³Ž›ŽâX1)

110077. [ŒŽ’˜] Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation:
a review of 16 patients. Watanabe M1, Shibuya A2, Takada J1, Tanaka Y1, Okuwaki Y1, Minamino T1,
Hidaka H1, Nakazawa T1, Koizumi W1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): Eur J Intern Med 2010/8; 21 (4):
333-7. (“n粐^²1, a’J–Ÿ—²2, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “ì–ì@•×1, “ú‚@‰›1, ’†àV‹M
G1, ¬ò˜aŽO˜Y1)

110078. [ŒŽ’˜] Clinicopathological evaluation of duodenal well-differentiated endocrine tumors.
Ishido K1, Tanabe S1, Higuchi K1, Sasaki T1, Katada C1, Azuma M1, Naruke A1, Koizumi W1, Mikami
T2 (1Á‰»Ší“à, 2•a—): World J Gastroenterol 2010/9; 16 (36): 4583-8. (ÎŒËŒªŽŸ1, “c糁@‘1,
”óŒûŸ•F1, ²X–Ø“O1, Œ˜“ce—˜1, “Œ@’q1, ¬–с@“N1, ¬ò˜aŽO˜Y1, ŽOã“N•v2)

110079. [ŒŽ’˜] Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As
First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer. Doi T, Boku N, Kato
K, Komatsu Y, Yamaguchi K, Muro K, Hamamoto Y, Sato A, Koizumi W1, Mizunuma N, Takiuchi H (1Á
‰»Ší“à): Jpn J Clin Oncol 2010/10; 40 (10): 913-20. (¬ò˜aŽO˜Y1)

110080. [ŒŽ’˜] Current status in the occurrence of postoperative bleeding, perforation and
residual/local recurrence during colonoscopic treatment in Japan. Oka S, Tanaka S, Kanao H,
Ishikawa H, Watanabe T, Igarashi M1,2, Saito Y, Ikematsu H, Kobayashi K1, Inoue Y, Yahagi N, Tsuda
S, Simizu S, Iishi H, Yamano H, Kudo SE, Tsuruta O, Tamura S, Saito Y, Cho E, Fujii T, Sano Y,
Nakamura H, Sugihara K, Muto T (1Á‰»Ší“à, 2ŠàŒ€—L–Ÿ•a‰@): Dig Endosc 2010/10; 22 (4): 376-80.
(ŒÜ\—’³L1,2, ¬—ѐŽ“T1)

110081. [ŒŽ’˜] Reliability and validity of splenic volume measurement by 3-D ultrasound. Hidaka
H1, Nakazawa T1, Wang G2, Kokubu S1,3, Minamino T1, Takada J1, Tanaka Y1, Okuwaki Y1, Watanabe
M1, Shibuya A4, Koizumi W1 (1Á‰»Ší“à, 2—Տ°Œ€‹†EŠé‰æ, 3‡‘å—û”n•a‰@, 4ˆã—ÈÀ‘SEŠÇ—): Hepatol
Res 2010/10; 40 (10): 979-88. (“ú‚@‰›1, ’†àV‹MG1, ‰€@‘‹Õ2, š •ª–ΔŽ1,3, “ì–ì@•×1, ‚“c
Ž÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “n粐^²1, a’J–Ÿ—²4, ¬ò˜aŽO˜Y1)

110082. [ŒŽ’˜] Molecular predictors of combination targeted therapies (cetuximab, bevacizumab)
in irinotecan-refractory colorectal cancer (BOND-2 study). Zhang W, Azuma M1, Lurje G, Gordon
MA, Yang D, Pohl A, Ning Y, Bohanes P, Gerger A, Winder T, Hollywood E, Danenberg KD, Saltz L,
Lenz HJ (1Á‰»Ší“à): Anticancer Res 2010/10; 30 (10): 4209-17. (“Œ@’q1)

110083. [ŒŽ’˜] Diagnostic Peroral Video Cholangioscopy is an Accurate Diagnostic Tool for Patients
with Bile-duct Lesions. Itoi T, Osanai M, Igarashi Y, Tanaka K, Kida M1, Maguchi H, Yasuda K,
Okano N, Imaizumi H1, Yokoyama T, Itokawa F (1Á‰»Ší“à): Clin Gastroenterol Hepatol 2010/11; 8
(11): 934-8. (–Ø“cŒõL1, ¡ò@O1)

110084. [ŒŽ’˜] Pancreatobiliary reflux and the length of a common channel. Kamisawa T, Suyama
M, Fujita N, Maguchi H, Hanada K, Ikeda S, Igarashi Y, Itoi T, Kida M1, Honda G, Sai J, Horaguchi
J, Takahashi K, Sasaki T, Takuma K, Itokawa F, Ando H, Takehara H; The Committee of Diagnostic
Criteria of The Japanese Study Group on Pancreaticobiliary Maljunction (1Á‰»Ší“à): J Hepatobiliary
Pancreat Sci 2010/11; 17 (6): 865-70. (–Ø“cŒõL1)

110025. [ŒŽ’˜] Roles of prostaglandin E2-EP1 receptor signaling in regulation of gastric motor
activity and emptying. Mizuguchi S1,2, Ohno T1,3, Hattori Y1, Ae T1,2, Minamino T1,2, Satoh T1,2,
Arai K, Saeki T, Hayashi I, Sugimoto Y, Narumiya S, Saigenji K1, Majima M2 (1Á‰»Ší“à, 2–ò—,
3ˆÉšŒŽ‹Š“¯): Am J Physiol Gastrointest Liver Physiol 2010/11; 299 (5): G1078-86. (…ŒûŸl1,2,
‘å–ì@—²1,3, •ž•”—fˆê˜Y1, ˆ¢]‘Ÿ‰ÀŽq1,2, “ì–ì@•×1,2, ²“Œäm1,2, ŒŒ³Ž›ŽâX1, ”n“ˆ³—²2)

110026. [ŒŽ’˜] Role of microsomal prostaglandin E synthase-1 in the facilitation of angiogenesis
and the healing of gastric ulcers. Ae T1,2, Ohno T1,3, Hattori Y1, Suzuki T2, Hosono K2, Minamino
T1, Sato T1, Uematsu S, Akira S, Koizumi W1, Majima M2 (1Á‰»Ší“à, 2–ò—, 3ˆÉšŒŽ‹Š“¯, 4‘åã
‘å ): Am J Physiol Gastrointest Liver Physiol 2010/11; 299 (5): G1139-46. (ˆ¢]‘Ÿ‰ÀŽq1,2, ‘å–ì@
—²1,3, •ž•”—fˆê˜Y1, —é–Ø—§‹I2, ×–ì‰Á“ÞŽq2, “ì–ì@•×1, ²“Œäm1, ¬ò˜aŽO˜Y1, ”n“ˆ³—²2)

110085. [ŒŽ’˜] Risk factors for delayed bleeding after endoscopic submucosal dissection for
gastric neoplasm. Okada K, Yamamoto Y, Kasuga A, Omae M, Kubota M, Hirasawa T, Ishiyama A, Chino
A, Tsuchida T, Fujisaki J, Nakajima A, Hoshino E, Igarashi M1,2 (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Surg
Endosc 2011/1; 25 (1): 98-107. (ŒÜ\—’³L1,2)

110086. [ŒŽ’˜] Submucosal Fibrosis and Basic-Fibroblast Growth Factor-Positive Neutrophils
Correlate with Colonic Stenosis in Cases of Ulcerative Colitis. Yamagata M1, Mikami T2, Tsuruta
T2, Yokoyama K1, Sada M1, Kobayashi K1, Katsumata T1, Koizumi W1, Saigenji K1, Okayasu I2 (1Á
‰»Ší“à, 2•a—): Digestion 2011/2; 84 (1): 12-21. (ŽRãp@m1, ŽOã“N•v2, Tsuruta T2, ‰¡ŽR@ŒO
1, ²“c”ü˜a1, ¬—ѐŽ“T1, Ÿ–””º‰h1, ¬ò˜aŽO˜Y1, ŒŒ³Ž›ŽâX1, ‰ªˆÀ@ŒM2)

110087. [ŒŽ’˜] Protective effect of geranylgeranylacetone against loxoprofen sodium-induced small
intestinal lesions in rats. Iwai T1, Ichikawa T, Kida M1, Goso Y2, Kurihara M, Koizumi W1, Ishihara
K (1Á‰»Ší“à, 2¶‰»): Eur J Pharmacol 2011/2; 652 (1-3): 121-5. (Šâˆä’m‹v1, Žsì‘ž•¶, –Ø“cŒõ
L1, ŒÜäzsM2, ŒIŒŽ@œ, ¬ò˜aŽO˜Y1, ÎŒŽ˜a•F)

110088. [ŒŽ’˜] Endosonographic features of esophageal granular cell tumors using a high-frequency
catheter probe. Kim DU, Kim GH, Ryu DY, Lee DG, Cheong JH, Lee BE, Song GA, Park DY, Shin NR,
I H, Kida M1 (1Á‰»Ší“à): Scand J Gastroenterol 2011/2; 46 (2): 142-7. (–Ø“cŒõL1)

110089. [ŒŽ’˜] Sporadic nonampullary duodenal adenoma in the natumgl history of duodenal cancer:
a study of follow-up surveillance. Okada K, Fujisaki J, Kasuga A, Omae M, Kubota M, Hirasawa T,
Ishiyama A, Inamori M, Chino A, Yamamoto Y, Tsuchida T, Nakajima A, Hoshino E, Igarashi M1,2 (1
ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Am J Gastroenterol 2011/2; 106 (2): 357-64. (ŒÜ\—’³L1,2)

110090. [ŒŽ’˜] Basic studies of vascular images as seen with indocyanine green-guided ray
electronic endoscopy as compared with microangiography. Tanabe S1, Koizumi W1, Ishido K1, Katada
C1, Tahara K1, Ae T1, Naruke A1, Sato A1 (1Á‰»Ší“à): The Kitasato Medical Journal 2011/3; 41
(1): 63-8. (“c糁@‘1, ¬ò˜aŽO˜Y1, ÎŒËŒªŽŸ1, Œ˜“ce—˜1, “cŒŽ‹v”üŽq1, ˆ¢]‘Ÿ‰ÀŽq1, ¬–с@“N
1, ²“¡@•¶1)

110091. [ŒŽ’˜] Re-appearance of hepatitis B virus following therapy with rituximab for lymphoma
is not rare in Japanese patients with past hepatitis B virus infection. Watanabe M1, Shibuya A2,
Tsunoda Y3, Danbara M4, Ishii R4, Ohsaka M4, Takada J1, Tanaka Y1, Okuwaki Y1, Minamino T1, Hidaka
H1, Nakazawa T1, Horie R4, Higashihara M4, Koizumi W1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—, 3—AŒŒE×
–EˆÚA, 4ŒŒ‰t“à): Liver Int 2011/3; 31 (3): 340-7. (“n粐^²1, a’J–Ÿ—²2, Šp“c—TŽq3, ’hŒŽŠ²
¶4, Îˆä—²Ži4, ‘åâ@Šw4, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “ì–ì@•×1, “ú‚@‰›1, ’†àV‹MG
1, –x]—Ljê4, “ŒŒŽ³–Ÿ4, ¬ò˜aŽO˜Y1)

110092. [ŒŽ’˜] Endoscopic ultrasonography is valuable for identifying early gastric cancers
meeting expanded-indication criteria for endoscopic submucosal dissection. Okada K, Fujisaki J,
Kasuga A, Omae M, Yoshimoto K, Hirasawa T, Ishiyama A, Yamamoto Y, Tsuchida T, Hoshino E, Igarashi
M1,2, Takahashi H (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Surg Endosc 2011/3; 25 (3): 841-8. (ŒÜ\—’³L
1,2)

120008. [ŒŽ’˜] isŠÌ×–EŠà‚ɑ΂·‚éSorafenib‚Ì—LŒø«‚ƈÀ‘S«?Kanagawa Liver Study Group‚É‚æ
‚é‘œŽ{Ý‹€“¯Œ€‹†?. X–{@Šw1, À“c˜aŽi1, ‹ß“¡³W1, “ú‚@‰›2, ‚“cŽ÷ˆê2, a’J–Ÿ—²3, ‹{ì@
ŒO4, ‘åìLˆê4, ‰œ£çW5, “c’†Ž–Ÿ5 (1‰¡•lŽs—§‘åŠw•‘®Žs–¯‘‡ˆã—ÃZƒ“ƒ^[, 2Á‰»Ší“à, 3ˆã
—ÈÀ‘SEŠÇ—, 4_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 5¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw): ŠÌ‘Ÿ 2010/8; 51 (8): 411-7.

120009. [ŒŽ’˜] V‹KŠJ”­‚µ‚œRƒ‰ƒbƒg‘å’°ƒ€ƒ`ƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚ð—p‚¢‚œ‘å’°”S–ŒŠQ‚Ì•]‰¿‚ÉŠÖ
‚·‚錟“¢. •“c˜ÐŽq, Šâˆä’m‹v1, ²“¡‚©‚š‚è, Žsì‘ž•¶, ŒIŒŽ@œ, ŒÜäzsM2, ÎŒŽ˜a•F (1Á‰»Ší
“à, 2¶‰»): ’×ᇠ2010/9; 37 (2): 161-3.

210003. [€ŒŽ’˜] Preliminary experience of a prototype forward-viewing curved linear array
echoendoscope in a training phantom model. Imaizumi H1, Irisawa A (1Á‰»Ší“à): Dig Endosc 2010
/7; 22 (Suppl 1): S123-7. (¡ò@O1)

210004. [€ŒŽ’˜] Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis: a
Japanese nationwide randomized controlled trial. Watanabe T, Ajioka Y, Matsumoto T, Tomotsugu
N, Takebayashi T, Inoue E, Iizuka B, Igarashi M1,2, Iwao Y, Ohtsuka K, Kudo SE, Kobayashi K2, Sada
M2, Matsumoto T, Hirata I, Murakami K, Nagahori M, Watanabe K, Hida N, Ueno F, Tanaka S, Watanabe
M, Hibi T (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): J Gastroenterol 2011/1; 46 (Suppl 1): 11-6. (ŒÜ\—’³L
1,2, ¬—ѐŽ“T2, ²“c”ü˜a2)

310001. [Ç—á•ñ] Rapid Regression of Advanced Hepatocellular Carcinoma Associated with
Elevation of Des-Gamma-Carboxy Prothrombin after Short-Term Treatment with Sorafenib - A Report
of Two Cases. Nakazawa T1,2, Hidaka H1, Shibuya A3, Koizumi W1 (1Á‰»Ší“à, 2’†‘ò“à‰È, 3ˆã—Ã
ˆÀ‘SEŠÇ—): Case Rep Oncol 2010/8; 3: 298-303. (’†àV‹MG1,2, “ú‚@‰›1, a’J–Ÿ—²3, ¬ò˜aŽO
˜Y1)

310002. [Ç—á•ñ] Eosinophilic gastroenteritis associated with giant folds. Ishido K1, Tanabe
S1, Higuchi K1, Sasaki T1, Katada C1, Azuma M1, Koizumi W1, Saigenji K1, Niiyama S2, Mikami T3
(1Á‰»Ší“à, 2”畆, 3•a—): Dig Endosc 2010/10; 22 (4): 312-5. (ÎŒËŒªŽŸ1, “c糁@‘1, ”óŒûŸ
•F1, ²X–Ø“O1, Œ˜“ce—˜1, “Œ@’q1, ¬ò˜aŽO˜Y1, ŒŒ³Ž›ŽâX1, VŽRŽj˜N2, ŽOã“N•v3)

310003. [Ç—á•ñ] Rectal granular-cell tumor difficult to distinguish from carcinoid tumor.
Nakanome T1, Yokoyama K1, Takeuchi H1, Haruki S1, Sada M1, Kobayashi K1, Saigenji K1, Katsumata
T1, Hara A2, Okayasu I2 (1Á‰»Ší“à, 2•a—): Dig Endosc 2010/10; 22 (4): 325-8. (’†–Ú“N•œ1, ‰¡
ŽR@ŒO1, ’|“à@“µ1, t–Ø‘”ü1, ²“c”ü˜a1, ¬—ѐŽ“T1, ŒŒ³Ž›ŽâX1, Ÿ–””º‰h1, ŒŽ@“ÖŽq2, ‰ª
ˆÀ@ŒM2)

320001. [Ç—á•ñ] Crohn•aŠ³ŽÒ‚Ì‹·ó‚ɑ΂µƒoƒ‹[ƒ“Ž®¬’°“àŽ‹‹Ÿ (BE) ‚É‚æ‚éŠg’£p‚ª—L—p‚Å‚ ‚Á
‚œ1—á. ‰Á“¡@Ê1, ‰¡ŽR@ŒO1, ’†–Ú“N•œ1, Œ}@”üK1, •Ÿ“‡@“µ1, ²“c”ü˜a1, ¬—ѐŽ“T1, ¬ò
˜aŽO˜Y1 (1Á‰»Ší“à): Progress of Digestive Endoscopy 2010/6; 76 (2): 88-9 (5).

320002. [Ç—á•ñ] “àŽ‹‹ŸŠŒ©‚̉ü‘P‚ðŠm”F‚µ‚Š‚œCronkhite-CanadaÇŒóŒQ‚Ì3—á. Œ}@”üK1, ²
“c”ü˜a1, •Ÿ“‡@“µ1, ‰¡ŽR@ŒO1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1, ŽOŽ}@M2, ‰ªˆÀ@ŒM2 (1Á‰»Ší“à, 2
•a—): Progress of Digestive Endoscopy 2010/6; 76 (2): 114-5 (9).

520017. [‘à]yŒŒŠÇ‚ُ̈í‚ð‚«‚œ‚·Á‰»ŠÇŽŸŠ³zGastric antral vascular ectasia (GAVE) ‚̐f’f‚Æ
Ž¡—Ã. “c糁@‘1, Œ˜“ce—˜1, ²“¡@•¶1, ˆ¢]‘Ÿ‰ÀŽq1, ÎŒËŒªŽŸ1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): —Õ
°Á‰»Ší“à‰È 2010/4; 25 (5): 553-8.

520018. [‘à]y‘Šú‘å’°Šà2010z‘Šú‘å’°Šà‚̐ž–§‰æ‘œf’f?’Ž‰¹”g“àŽ‹‹Ÿ‚É‚æ‚é[’B“xf’f?. ¬
—ѐŽ“T1, –Ø“cŒõL1, Œ}@”üK1, •Ÿ“‡@“µ1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ˆÝ
‚Æ’° 2010/4; 45 (5): 811-21.

520019. [‘à]y‚â‚Á‚Ï‚è‘åØ, Šî–{Žè‹Zz¬’° [f’fEŽ¡—Ã]@ƒVƒ“ƒOƒ‹ƒoƒ‹[ƒ“¬’°“àŽ‹‹Ÿ‘}“ü–@‚Ì
Šî–{Žè‹Z. ²“c”ü˜a1, ¬—ѐŽ“T1, Œ}@”üK1, ‰¡ŽR@ŒO1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Á‰»Ší“àŽ‹
‹Ÿ 2010/4; 22 (4): 588-91.

520020. [‘à]y‚â‚Á‚Ï‚è‘åØ, Šî–{Žè‹Zz‰º•”Á‰»ŠÇ [f’f]@¶ŒŸ‚Ì—v”Û”»’è‚ÆŠî–{Žè‹Z. ŒÜ\—’³
L1,2, ç–쏻Žq1, ŠÝŒŽ‹Pm1, ¬ì‘åŽu1,2, ŠÝ@‹’‰1 (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Á‰»Ší“àŽ‹
‹Ÿ 2010/4; 22 (4): 624-6.

520021. [‘à]y‚â‚Á‚Ï‚è‘åØ, Šî–{Žè‹Zz’_äX [f’f]@ƒ‰ƒWƒAƒ‹Ž®EUS‰ð–UŠî–{Žè‹Z. –Ø“cŒõL1, ‹{
àVŽu˜N1, Šâˆä’m‹v1, ‹e’nG•F1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2010/4; 22 (4):
678-82.

520022. [‘à] •úŽËü«’°‰Š. ç–쏻Žq1, ›ÀF‹I1, ‰Yã®”V1, ŠÝŒŽ‹Pm1, ¬ì‘åŽu1,2, ŒÜ\
—’³L1,2 (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Gastroenterological Endoscopy 2010/5; 52 (5): 1381-92.

520023. [‘à]y“ÁW: •Ï‚í‚è‚ä‚­‘å’°‚ª‚ñ‰»Šw—Ö@?FOLFOX, FOLFIRI, ‚»‚µ‚ÄŽŸ‚Ì10”Nz—Տ°Å‘Oü
‚̈ãŽt‚©‚ç‚Ý‚œ‘å’°ŠàŽ¡—ÃKƒCƒhƒ‰ƒCƒ“?Ž^“¯‚Æ–â‘è’ñ‹N. ²X–Ø“O (Á‰»Ší“à): —Տ°Žîᇃvƒ‰ƒNƒeƒB
ƒX 2010/5; 6 (2): 182-5.

520024. [‘à]y¬’°E‘å’°“àŽ‹‹Ÿ@‚±‚ñ‚ÈŽž‚Ç‚€‚·‚é?ŒŸž•Òz‘å’°“àŽ‹‹Ÿ?‘}“ü¢“ï—á‚ւ̑Ώˆ@(1)
‘å’°‰ß’·‚É‚æ‚é‘}“ü¢“ï—á‚ɑ΂·‚é‘Ήž@a. SóŒ‹’°E‰¡sŒ‹’°‰ß’·—á‚ւ̑Ήž. ŒÜ\—’³L1,2 (1Šà
Œ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Intestine 2010/5; 14 (3): 233-8.

520025. [‘à]y¬’°E‘å’°“àŽ‹‹Ÿ@‚±‚ñ‚ÈŽž‚Ç‚€‚·‚é?ŒŸž•Òz‘å’°“àŽ‹‹Ÿ?‘}“ü¢“ï—á‚ւ̑Ώˆ@(2)
–ü’…E‹ü‹ÈEŒeŽº‚É‚æ‚é‘}“ü¢“ï—á‚ɑ΂·‚é‘Ήž@a. ŒŽˆö•Ê‘΍ô–@. ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ•a‰@,
2Á‰»Ší“à): Intestine 2010/5; 14 (3): 247-52.

520026. [‘à]y¬’°E‘å’°“àŽ‹‹Ÿ@‚±‚ñ‚ÈŽž‚Ç‚€‚·‚é?ŒŸž•Òz‘å’°“àŽ‹‹Ÿ?‘}“ü¢“ï—á‚ւ̑Ώˆ@(3)
—pŽè• •”ˆ³”—–@‚Ƒ̈ʕϊ·‚Ì—L—p«@a. “KØ‚È—pŽèˆ³”—‚Ƒ̈ʕϊ·‚É‚æ‚è‘}“ü–@‚ÌŒüã‚⎞ŠÔ’Zk‚ª‰Â
”\‚Æ‚È‚é. ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Intestine 2010/5; 14 (3): 261-4.

520027. [‘à]y’m‚Á‚Ä‚š‚­‚ׂ«‰ŠÇ«’°ŽŸŠ³z’Œ’°”S–Œ’EÇŒóŒQ. ‰¡ŽR@ŒO1, ¬—ѐŽ“T1, ’†–Ú“N•œ
1, ‰Á“¡@Ê1, Œ}@”üK1, ¬ì‘åŽu1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Á‰»Ší“à‰È 2010/6; 50
(6): 540-3.

520028. [‘à]yŒ©—Ž‚Æ‚·‚È, ‘Šúˆô“ªEH“¹ŠàzŒo•@E‹É×Œa“àŽ‹‹Ÿ‚É‚æ‚é’†‰ºˆô“ªŠàƒXƒNƒŠ[ƒjƒ“ƒO.
Œ˜“ce—˜1, “c糁@‘1, ˆ¢]‘Ÿ‰ÀŽq1, ³˜Ò@—²2, Œ—tG‹N2, ’†ŽR–Ÿm2, ÎŒËŒªŽŸ1, ’†’JŒ€“l1, “Œ@
’q1, ²X–Ø“O1, ”óŒûŸ•F1, ‰ª–{–ql2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2Žš•@): Á‰»Ší“àŽ‹‹Ÿ 2010/6;
22 (6): 931-9.

520029. [‘à]yQ&A‚ŒԂ郌ƒWƒfƒ“ƒgEƒm[ƒgzê–åˆã‚ª‚í‚©‚è‚â‚·‚­‰ðà (No.18)@“àŽ‹‹ŸŽ¡—Â̍‡
•¹Ç‚Ì•p“x‚Æ, ‡•¹Ç‚ð–h‚®ƒRƒc‚ð‹³‚Š‚ĉº‚³‚¢. ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): ‘å’°
ŠàFrontier 2010/6; 3 (2): 156-8.

520030. [‘à]y¬’°E‘å’°“àŽ‹‹Ÿ@‚±‚ñ‚ÈŽž‚Ç‚€‚·‚é?f’f•Òz‘å’°Žîᇐ«•a•Ï‚̐f’f@(3) ’Ž‰¹”g“à
Ž‹‹Ÿ•`o¢“ï•a•Ï‚ɑ΂·‚é‘Ήž@a. ŽOŽŸŒ³’Ž‰¹”g“àŽ‹‹Ÿ‚Ì—L—p«. ¬—ѐŽ“T1, Œ}@”üK1, ‰¡ŽR@ŒO
1, ²“c”ü˜a1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Intestine 2010/7; 14 (4): 369-74.

520031. [‘à]y’Œ’°ãè–å•”•a•Ï‚̊ӕʐf’f@ÅV‚Ì’mŒ©‚ðŠÜ‚߂āz’Œ’°ãè–å•”ŽŸŠ³‚ÌEUSf’f. ¬—Ñ
Ž“T1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ˆÝ
‚Æ’° 2010/7; 45 (8): 1381-6.

520032. [‘à]yŽè‹Z‚̉ðàzŽ¡—Í¢“ï—á‚ɑ΂·‚éƒ_ƒuƒ‹ƒXƒR[ƒvESD (ƒVƒ“ƒOƒ‹ƒgƒ‰ƒ“ƒXƒVƒXƒeƒ€). “c
糁@‘1, ”óŒûŸ•F1, ²X–Ø“O1, Œ˜“ce—˜1, “Œ@’q1, ÎŒËŒªŽŸ1, ’†’JŒ€“l1, ˆ¢]‘Ÿ‰ÀŽq1, ¬
ò˜aŽO˜Y1 (1Á‰»Ší“à): —Տ°Á‰»Ší“à‰È 2010/7; 25 (9): 1309-14.

520033. [‘à]y“àŽ‹‹ŸE“àŽ‹‹ŸŠO‰ÈŽ¡—ÍőOü?’áNPŽ¡—Â̐i•àz“àŽ‹‹ŸE“àŽ‹‹ŸŠO‰Èf—ËZp‚ÌŠJ
”­‚Ɛi•à?’Ž‰¹”g“àŽ‹‹Ÿ, ’Ž‰¹”g“àŽ‹‹Ÿ‰ºúŽhp‚̐i•à. –Ø“cŒõL1, r–ؐ³—Y1, ‹{àVŽu˜N1, ‹e’nG
•F1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à1): “ú–{—Տ° 2010/7; 68 (71): 1255-63.

520034. [‘à]y‘å’°“àŽ‹‹Ÿf’f‚̐i•àz‰ŠÇ«’°ŽŸŠ³f’fŠw‚̐i•à@6. ƒAƒ[ƒo«‘å’°‰Š‚Ì“àŽ‹‹Ÿf
’f. ŠÝŒŽ‹Pm1, ŒÜ\—’³L1,2, ç–쏻Žq1, ‰Yã®”V1, ŠÝ@‹’‰1, ›ÀF‹I, ¡ˆä, ¬ì‘åŽu
1,2 (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): Modern Physician 2010/7; 30 (7): 914-7.

520035. [‘à]y–å–¬ŒŒsˆÙí‚̐f’f, Ž¡—Âð‚ß‚®‚鏔–â‘èz–å–¬ˆ³˜ŽiÇ‚ÌŽ¡—Á@–å–¬ˆ³˜ŽiÇ‚ɑ΂·
‚é–ò•š—Ö@. “ú‚@‰› (Á‰»Ší“à): ŠÌE’_EäX 2010/8; 61 (2): 269-76.

520036. [‘à]y‰º•”Á‰»ŠÇ‚Ì‘OŠà•a•Ï, ‚”­Šàó‘Ô‚ð‚ß‚®‚Á‚āzAdenoma-carcinoma sequence‚ð‚ß‚®
‚Á‚Ä. ŒÜ\—’³L1,2, ç–쏻Žq2, ŠÝŒŽ‹Pm2, ŠÝ@‹¬2, ‰Yã®”V2 (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à):
—Տ°Á‰»Ší“à‰È 2010/8; 25 (10): 1325-32.

520037. [‘à]y‹~–œE‹~‹}‚Æ“àŽ‹‹ŸzÁ‰»ŠÇoŒŒ@oŒŒ«ƒVƒ‡ƒbƒN‚𔺂€Á‰»ŠÇoŒŒ‚ɑ΂·‚é“àŽ‹‹Ÿ‚Ì
–ðŠ„@—AŒŒ‚É‚æ‚Á‚ăVƒ‡ƒbƒN‚ª‰ü‘P‚·‚éê‡‚Ɖü‘P‚µ‚È‚¢ê‡, —AŒŒ‹‘”Û—á@‰º•”Á‰»ŠÇ. ¬—ѐŽ“T1,
Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2010/9; 22
(9): 1384-9.

520038. [‘à]y’_äXEUS@FNA‚̃Gƒrƒfƒ“ƒX2010zäX‰Œ«ùN–EE”^ᇃhƒŒƒi[ƒW@2010”NƒRƒ“ƒZƒ“ƒTƒX.
–Ø“cŒõL1, r–ؐ³—Y1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡
ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ’_‚ÆäX 2010/10; 31 (10): 1207-14.

520039. [‘à]yStenting BiblezƒXƒeƒ“ƒg‚ÌŠî‘b’mŽ¯‚ÆŠî–{“I‚È‘}“üŽè‹Z?ŠeŽíCovered Metallic Stent
(CMS) ‚Ì“Á’¥‚Æ‘I‘ð. –Ø“cŒõL1, ‹{àVŽu˜N1, ŽR“à_Žj1, ‰œ˜e‹»‰î1, Œ–{—Y‘Ÿ1, ŽR–{@‘n1, ²“Œ
äm1, Šâˆä’m‹v1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1
Á‰»Ší“à): ’_‚ÆäX 2010/10; 31 (—Õ‘“Á‘å): 939-45.

520040. [‘à]y“ÁWII: BŒ^ŠÌ‰ŠƒEƒCƒ‹ƒXÄŠˆ«‰»‚Ì–â‘è“_‚Ƒ΍ôzHBVÄŠˆ«‰»–hŽ~‚ÌŽŽ‚Ý?HBVŽ
‘±ŠŽõŠ³ŽÒ‚ɑ΂·‚éƒGƒ“ƒeƒJƒrƒ‹‚ÌŒø‰Ê. “n粐^² (Á‰»Ší“à): Á‰»Ší“à‰È 2010/10; 51 (4): 428-32.

520041. [‘à]y¡“ú‚̐ž_‰ÈŽ¡—ÃKƒCƒhƒ‰ƒCƒ“zž_‚š‚æ‚эs“®‚̏áŠQ‚É‚µ‚΂µ‚ΐ”º‚·‚é‘Œ‚̏áŠQ@6.
–ò•š«ŠÌáŠQ. “n粐^²1, a’J–Ÿ—²2 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ž_‰ÈŽ¡—Êw 2010/10; 25 (‘
Š§): 316-9.

520042. [‘à]yR‘̗Ö@‚̐V“WŠJ@V‚µ‚¢R‘̗Ö@zƒxƒoƒVƒYƒ}ƒu/ƒZƒcƒLƒVƒ}ƒu. ²X–Ø“O1, ¬ò
˜aŽO˜Y1 (1Á‰»Ší“à): ‰ŠÇ‚ƖƉu 2010/10; 18 (6): 608-13.

520043. [‘à]yÁ‰»Ší“àŽ‹‹Ÿf—Â̐i•à@ƒpƒ‰ƒ_ƒCƒ€ƒVƒtƒg‚Ö‚Ì‘Ù“®‚ðæL‚«‚Ý‚ézŽîᇐ«•a•Ï‚É‚š‚¯‚é
“àŽ‹‹Ÿf—Â̐i•à@“ªèò•”•\ÝŠà. Œ˜“ce—˜1, “c糁@‘1, ³˜Ò@—²2, ’†ŽR–Ÿm2, ‰ª–{–ql2, ¬ò
˜aŽO˜Y1 (1Á‰»Ší“à, 2Žš•@): “à‰È 2010/10; 106 (4): 615-21.

520044. [‘à]yStenting BiblezƒXƒeƒ“ƒgŽ¡—Ẫgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO?Covered Metallic Stent
‚̃gƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO (”²‹Ž¢“ï, ’_ùN‰Š, äX‰Š) (“®‰æ•t). ‹{àVŽu˜N1, –Ø“cŒõL1, Šâˆä’m‹v1,
‹e’nG•F1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ’_‚ÆäX 2010/10; 31 (—Õ‘“Á‘å): 1097-102.

520045. [‘à]yŠë‚È‚¢Ã–¬áŽoŒŒzI. Šë‚È‚¢H“¹EˆÝÃ–¬áŽoŒŒ@‡•¹ŽŸŠ³‚ð—L‚·‚éH“¹EˆÝÃ–¬áŽ
oŒŒ‚ւ̑Ήž?ŠÌ×–EŠà‡•¹—á. “ú‚@‰›1, “ì–ì@•×1, ’†àV‹MG1 (1Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ
2010/11; 22 (11): 1790-5.

520046. [‘à]y‰ŠÇ«’°ŽŸŠ³‚ւ̍¡“ú“IƒAƒvƒ[ƒ`z‰ŠÇ«’°ŽŸŠ³‚ւ̉h—{—Ö@‚Ì—L—p«‚Æ–â‘è“_. ¬
—ѐŽ“T (Á‰»Ší“à): ¬l•a‚Ɛ¶ŠˆKŠµ•a 2010/12; 40 (12): 1416-21.

520047. [‘à]yˆÝŠà‰»Šw—Ö@zisEÄ”­ˆÝŠà‚ɑ΂·‚éDocetaxel/Cisplatin/S-1—Ö@. ’†ŽRž“T1,2,
¬ò˜aŽO˜Y2 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): Á‰»Ší“à‰È 2011/1; 52 (1): 61-6.

520048. [‘à]yESD‚ÌŽÀÛ (15)zˆÝESD?Ž„‚̍H•v@‘ŠúˆÝŠàፍ­‡•¹—á‚ɑ΂·‚éDouble scope ESD
(single trans method). “c糁@‘1, ”óŒûŸ•F1, ²X–Ø“O1, Œ˜“ce—˜1, “Œ@’q1, ÎŒËŒªŽŸ1, ’†
’JŒ€“l1, ˆ¢]‘Ÿ‰ÀŽq1, ¬–с@Œ[1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Á‰»Ší‚̗Տ° 2011/2; 14 (1): 93-7.

520049. [‘à]yã•”Á‰»ŠÇŽŸŠ³‚ÌŽÀ’nf—Á@ÅV‚̐f’f‚Æ—LŒø‚ÈŽ¡—Â̂·‚ׂāzˆÝŠà‰»Šw—Ö@‚Ì—LŒø«.
”óŒûŸ•F1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): Medical Practice 2011/2; 28 (2): 313-4.

520050. [‘à]yu’Bl‚Ì‹Zv?¬’°E‘å’°z‘å’°“àŽ‹‹Ÿ@[’Bl‚̐f’fƒeƒNƒjƒbƒN]@’Ž‰¹”g“àŽ‹‹Ÿ: —Ç
‚¢‰æ‘œ‚ð“Ÿ‚é‚œ‚߂̃eƒNƒjƒbƒN?•`o¢“ï•a•Ï‚̉ðÍ‚Æ‘–ž–@‚̍H•v. ¬—ѐŽ“T (Á‰»Ší“à): Á‰»Ší“à
Ž‹‹Ÿ 2011; 23 (2): 259-62.

521001. [‰ðà]yQ&A@ê–åˆã‚É•·‚­IBDzNSAIDs‚âR‹ÛÜ‚ÍIBD‚Ì‘ˆ«ˆöŽq‚Æ‚È‚è‚Ü‚·‚©? ‰¡ŽR@ŒO
1, ¬—ѐŽ“T1 (1Á‰»Ší“à): IBD Research 2010/6; 4 (2): 132-5.

521002. [‰ðà]y—Տ°ŽŽŒ±Ð‰îzSPIRITSŽŽŒ±. ¬ò˜aŽO˜Y (Á‰»Ší“à): ˆÝ‚ª‚ñperspective 2010/6; 3
(2): 129-35.

522007. [uÀ]y‘å’°‚Ì’×ᇁ@‘åW‡z ‘˜_: ‘å’°‚Ì’×ᇐ«•a•Ï?f’f‚̃vƒƒZƒX‚ÆŠî–{?. Ÿ–””º‰h
1, ¬—ѐŽ“T1 (1Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2010/8; 22 (8): 1191-200.

522008. [uÀ]yŠª“ªƒAƒgƒ‰ƒX?‚±‚ñ‚È’×ᇂɏo‡‚Á‚œ‚ç ˆê–ڂŐf’f‚Å‚«‚Ü‚·‚©Hz‘˜_: ‘å’°‚Ì’×á‡
«•a•Ï?f’f‚̃vƒƒZƒX‚ÆŠî–{. Ÿ–””º‰h1, ¬—ѐŽ“T1 (1Á‰»Ší“à): Á‰»Ší“àŽ‹‹Ÿ 2010/8; 22 (8):
1191-200.

522009. [uÀ]yRound-table discussion: Ži‰ïzuˆÝŠàŽæˆµ‚¢‹K–ñv(‘æ14”Å) ‚̉ü’ù‚ÆTMN•ª—Þ. ²
–ì@•1, ‰Á“¡@—m, ¬ò˜aŽO˜Y2, ‰Ä‰zËŽŸ (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): ˆÝ‚ª‚ñperspective 2010/10;
3 (3): 149-57.

522010. [uÀ]yR‘̗Ö@‚̐V“WŠJ@V‚µ‚¢R‘̗Ö@z ƒxƒoƒVƒYƒ}ƒu/ƒZƒcƒLƒVƒ}ƒu. ²X–Ø“O1, ¬
ò˜aŽO˜Y1 (1Á‰»Ší“à): ‰ŠÇ‚ƖƉu 2010/10; 18 (6): 608-13.

522011. [uÀ]y“ÁW: ŠO‰Èˆã‚Ì‚œ‚ß‚Ì‘å’°Šà‚̐f’f‚ÆŽ¡—Áz2. ‘å’°Šà‚̐f’f@F‘f“àŽ‹‹Ÿ. ²“c”ü˜a
1, ¬—ѐŽ“T1, Œ}@”üK1, ‰¡ŽR@ŒO1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): —Տ°ŠO‰È 2010/10; 65 (11): 33-44.

522012. [uÀ]wˆÝŠàŽæˆµ‚¢‹K–ñx(‘æ14”Å) ‚̉ü’ù‚ÆTNM•ª—Þ. ²–ì@•1, ‰Á“¡@—m, ¬ò˜aŽO˜Y
2, ‰Ä‰zËŽŸ (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): ˆÝ‚ª‚ñperspective 2010/10; 3 (3): 149-57.

522013. [uÀ] “–‰@‚É‚š‚¯‚éØœ•s”\/Ä”­«ˆÝGIST‚ɑ΂·‚郁ƒ`ƒ‹Ž_ƒCƒ}ƒ`ƒjƒu‚ÌŽ¡—ЬÑ. ÎŒËŒª
ŽŸ1, “c糁@‘1, ”óŒûŸ•F1, “Œ@’q1, ²X–Ø“O1, Œ˜“ce—˜1, ¬–с@“N1, ¬ò˜aŽO˜Y1, ÷–{M
ˆê2, ŽOã“N•v3 (1Á‰»Ší“à, 2ŠO‰È, 3•a—): –k—¢ˆãŠw 2010/12; 40 (2): 125-31.

522014. [uÀ]y’_äXŽŸŠ³f—Â̍őOü?“ŽŸŠ³‚Ì‚æ‚è‚æ‚¢ƒ}ƒlƒWƒƒ“ƒg‚Ì‚œ‚ß‚É?zÀ’k‰ï: ’_äXŽŸ
Š³‚Ì“úíf—Ã?’_äXŠà‘Šú”­Œ©‚Æ’·Šú¶‘¶‚ðŒ©˜‚Š‚œƒXƒgƒ‰ƒeƒW[. ˆÉ’n’mG–Ÿ1, Žu‘ºŒªŽŸ, –Ø“cŒõL
2, ˆÉ²ŽR_’Ê (1“Œ‹ž‘åŠw, 2Á‰»Ší“à): “à‰È 2011/3; 107 (3): 505-19.

540022. [‚»‚Ì‘Œ (CPC)] —Տ°“I‚ɐisƒXƒLƒ‹ƒXˆÝŠà‚ð‹^‚€‚à2“x‚É‚í‚œ‚éˆÝ¶ŒŸ‚ň««×–E‚ðØ–Ÿ‚µ“Ÿ
‚È‚©‚Á‚œˆêÇ—á. ‹àŽq@‹œ1, “Œ@’q1, ‹g“c@Œ÷2 (1Á‰»Ší“à, 2•a—): –k—¢ˆãŠw 2010/12; 40 (2):
161-5.

[’˜@‘]

620030. [Šwp‘] (•ª’SŽ·•M)yƒXƒLƒ‹ƒAƒbƒv‘å’°“àŽ‹‹Ÿ@f’f•Òz‘æ9Í@’Ž‰¹”g“àŽ‹‹ŸŠÏŽ@, p.84-91.
¬—ѐŽ“T1, ‰¡ŽR@ŒO1, ²“c”ü˜a1 (1Á‰»Ší“à), •Ò “c’†MŽŸ, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/4”­s.

620031. [Šwp‘] (•ª’SŽ·•M)yÁ‰»Ší‚ª‚ñ–ò•š—Ö@2010z2. ˆÝ‚ª‚ñ‚ɑ΂·‚é–ò•š—Ö@, p.170-80. ¬
ò˜aŽO˜Y (Á‰»Ší“à), •Ò Žs‘q@—², Žsì@“x, “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2010/4/25”­s.

620032. [Šwp‘] (•ª’SŽ·•M)yƒNƒ[ƒ“•af—ÃKƒCƒhƒ‰ƒCƒ“zR‹Û–òEŒo’°‰h—{—Ö@EŒoÃ–¬‰h—{—Ö@.
•Ò, p.61-6. ¬—ѐŽ“T (Á‰»Ší“à), •Ò “ú–{Á‰»Ší•aŠw‰ï, “ì]“°, “Œ‹ž, 2010/4”­s.

620033. [Šwp‘] (•ª’SŽ·•M)yƒNƒ[ƒ“•af—ÃKƒCƒhƒ‰ƒCƒ“z“àŽ‹‹Ÿ“IŽ¡—Ã.•Ò, p.68. ¬—ѐŽ“T (Á
‰»Ší“à), •Ò “ú–{Á‰»Ší•aŠw‰ï, “ì]“°, “Œ‹ž, 2010/4”­s.

620034. [Šwp‘] (•ª’SŽ·•M)y‰æ‘œ‹­’²ŠÏŽ@‚É‚æ‚é“àŽ‹‹Ÿf’fƒAƒgƒ‰ƒXz’†E‰ºˆô“ª@Case3 ‰ºˆô“ª“û
“ªŽî, p.46. Œ˜“ce—˜ (Á‰»Ší“à), ŠÄC ’O‰HŠ°•¶, •Ò “cK‹v—Y, “c’†MŽ¡, ‰Á“¡Œ³Žk, Ä“¡@–L, “ú
–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2010/5”­s.

620035. [Šwp‘] (•ª’SŽ·•M)y‰æ‘œ‹­’²ŠÏŽ@‚É‚æ‚é“àŽ‹‹Ÿf’fƒAƒgƒ‰ƒXz’†E‰ºˆô“ª@Case5 ‰ºˆô“ª“û
“ªŽî, p.48-9. Œ˜“ce—˜ (Á‰»Ší“à), ŠÄC ’O‰HŠ°•¶, •Ò “cK‹v—Y, “c’†MŽ¡, ‰Á“¡Œ³Žk, Ä“¡@–L, “ú
–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2010/5”­s.

620036. [Šwp‘] (•ª’SŽ·•M)y‰æ‘œ‹­’²ŠÏŽ@‚É‚æ‚é“àŽ‹‹Ÿf’fƒAƒgƒ‰ƒXz’_EäX@Case132 IPMN (•ªŠò
Œ^), p.318-9. –Ø“cŒõL (Á‰»Ší“à), ŠÄC ’O‰HŠ°•¶, •Ò “cK‹v—Y, “c’†MŽ¡, ‰Á“¡Œ³Žk, Ä“¡@–L, “ú
–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2010/5”­s.

620037. [Šwp‘] (•ª’SŽ·•M)y‰æ‘œ‹­’²ŠÏŽ@‚É‚æ‚é“àŽ‹‹Ÿf’fƒAƒgƒ‰ƒXz’_EäX@Case133 IPMN (ŽåäX
ŠÇŒ^), p.320-1. –Ø“cŒõL (Á‰»Ší“à), ŠÄC ’O‰HŠ°•¶, •Ò “cK‹v—Y, “c’†MŽ¡, ‰Á“¡Œ³Žk, Ä“¡@–L,
“ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2010/5”­s.

620038. [Šwp‘] (•ª’SŽ·•M)y‰æ‘œ‹­’²ŠÏŽ@‚É‚æ‚é“àŽ‹‹Ÿf’fƒAƒgƒ‰ƒXz¬’°@‘˜_, p.323-5. ¬—Ñ
Ž“T1, ²“c”ü˜a1, –Ø“cŒõL1 (1Á‰»Ší“à), ŠÄC ’O‰HŠ°•¶, •Ò “cK‹v—Y, “c’†MŽ¡, ‰Á“¡Œ³Žk, Ä
“¡@–L, “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2010/5”­s.

620039. [Šwp‘] (•ª’SŽ·•M)y‰æ‘œ‹­’²ŠÏŽ@‚É‚æ‚é“àŽ‹‹Ÿf’fƒAƒgƒ‰ƒXz¬’°@Case136¬’°ƒ|ƒŠ[ƒv
(Peutz-JeghersÇŒóŒQ‚ɍ‡•¹), p.331. ¬—ѐŽ“T1, ²“c”ü˜a1, –Ø“cŒõL1 (1Á‰»Ší“à), ŠÄC ’O‰H
Š°•¶, •Ò “cK‹v—Y, “c’†MŽ¡, ‰Á“¡Œ³Žk, Ä“¡@–L, “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2010/5”­s.

620040. [Šwp‘] (•ª’SŽ·•M)y‰æ‘œ‹­’²ŠÏŽ@‚É‚æ‚é“àŽ‹‹Ÿf’fƒAƒgƒ‰ƒXz¬’°@Case137ƒNƒ[ƒ“•a (¬
’°Œ^), p.332. ¬—ѐŽ“T1, ²“c”ü˜a1, –Ø“cŒõL1 (1Á‰»Ší“à), ŠÄC ’O‰HŠ°•¶, •Ò “cK‹v—Y, “c’†
MŽ¡, ‰Á“¡Œ³Žk, Ä“¡@–L, “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2010/5”­s.

620041. [Šwp‘] (•ª’SŽ·•M)y‘å’°ŽŸŠ³f—ÂÌStrategyz‹•ŒŒ«‘å’°‰Š.•Ò, p.105-9. ¬—ѐŽ“T1, ‰¡
ŽR@ŒO1, ²“c”ü˜a1 (1Á‰»Ší“à), •Ò Ä“¡—T•ã, “c’†MŽ¡, “n粑–Ÿ, “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž,
2010/5”­s.

620042. [Šwp‘] (•ª’SŽ·•M)yÇ—á‚©‚çŠw‚ԁ@ƒEƒCƒ‹ƒXŠÌ‰Š‚ÌŽ¡—Ð헪z‘æ2•” Ç—á’掊@A BŒ^ŠÌ‰Š@
14 ŠÌ×–EŠàŽ¡—ÃŒã‚ÉŠjŽ_ƒAƒiƒƒOŽ¡—Âðs‚Á‚Ä‚¢‚œ‚É‚à‚©‚©‚í‚ç‚žŠÌŠà‚̍Ĕ­‚ª‚Ý‚ç‚ê‚œÇ—á, p.103-7.
’†àV‹MG1, š •ª–ΔŽ (1Á‰»Ší“à), •Ò H“¡³r, ò@•À–Ø, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2010/6”­s.

620043. [Šwp‘] (•ª’SŽ·•M)yŠÌ×–EŠà‚Ì•ªŽq•W“IŽ¡—ÁzŠe˜_@isŠÌ×–EŠà‚ɑ΂µƒ\ƒ‰ƒtƒFƒjƒu‚Ì’Z
Šú“Š—^‚É‚Ä‘tŒø‚µ‚œ1Ç—á, p.142-5. “ú‚@‰›1, ’†‘ò‹MG1, “ì–ì@•×1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ
˜e—T‰î1, “n粐^²1, a’J–Ÿ—²2, š •ª–ΔŽ1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—), •Ò H“¡
³r, ƒA[ƒNƒƒfƒBƒA, “Œ‹ž, 2010/8”­s.

620044. [Šwp‘] (•ª’SŽ·•M)y‰ŠÇ«’°ŽŸŠ³ŠÓ•Êf’fƒAƒgƒ‰ƒXz”xŒ‹Šj, p.64-9. ‹v•Û“c”ü˜a1, ¬—Ñ
Ž“T1 (1Á‰»Ší“à), •Ò ÔŒ‘׎Ÿ, Ä“¡—T•ã, Ž…œŽ¡, “ì]“°, “Œ‹ž, 2010/10”­s.

620045. [Šwp‘] (•ª’SŽ·•M)yEBM‚ª‚ñ‰»Šw—Ö@E•ªŽq•W“IŽ¡—Ö@2011-2012z1. Á‰»ŠÇ‚ª‚ñ@B. ˆÝ‚ª
‚ñ@3. Øœ•s”\isˆÝ‚ª‚ñ‚ɑ΂·‚é•W€‰»Šw—Ö@‚Í2Ü•¹—p‚©3Ü•¹—p‚©?, p.24-9. ²X–Ø“O (Á‰»
Ší“à), ŠÄC ŒžŠ’·G, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/11”­s.

620046. [Šwp‘] (•ª’SŽ·•M)yÁ‰»ŠíBook02@‰ŠÇ«’°ŽŸŠ³‚ð“úíf—ÂŐf‚é IBD‚Ƃ́H@‚»‚̐f’f‚Æ
Š³ŽÒ‚É‚ ‚킹‚œŽ¡—Áz‘æ3Í‰ŠÇ«’°ŽŸŠ³‚̐f’f@3) Xüf’f: ‰ŠÇ«’°ŽŸŠ³‚É‚š‚¯‚éXüf’f‚Ì–ðŠ„‚Æ
‚Í?, p.49-55. ‰¡ŽR@ŒO (Á‰»Ší“à), Šé‰æ “ú”ä‹I•¶, ‹vŒ—ˆê, —r“yŽÐ, “Œ‹ž, 2011/1/15”­s.

620047. [Šwp‘] (•ª’SŽ·•M)yˆã—Ë֊õƒ|ƒPƒbƒgƒ}ƒjƒ…ƒAƒ‹z¡ò@O (Á‰»Ší“à), Ó”C•ÒW •x–ìN
“úŒÈ, ˆãŽ•–òo”Å, “Œ‹ž, 2011/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712025. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Role of Forward-viewing Endosonography for
EUS-FNA. Kida M1, Araki M1: ‘æ79‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘ÛƒVƒ“ƒ|ƒWƒEƒ€ (2010/5/14), “Œ‹ž. (–Ø
“cŒõL1, r–ؐ³—Y1: 1Á‰»Ší“à)

712026. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Current management and outcome of upper GI
bleeding (nonvariceal). Tanabe S1 (‘æ9‰ñ“úŠØÁ‰»Ší“àŽ‹‹Ÿ‡“¯ƒVƒ“ƒ|ƒWƒEƒ€ (2010/5/15), “Œ‹ž.
(“c糁@‘1: 1Á‰»Ší“à)

712027. [Šw‰ï (‘Û)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) Clinical usefullness of EU-ME1 for EUS-FNA (V
ŠÏŽ@‘•’uEU-ME1‚̗Տ°‰ž—p). Kida M1: 10th International Symposium of Therapuetic Endoscopy (‘æ
10‰ñ‘ÛŽ¡—Ã“àŽ‹‹ŸEÁ‰»Ší•aŠwp‘å‰ï) (2010/6/11), ‘hB, ’†‘. (–Ø“cŒõL1: 1Á‰»Ší“à)

712028. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Live demonstration of EUS -FNA. Kida M1: 10th
International Symposium of Therapuetic Endoscopy (‘æ10‰ñ‘ÛŽ¡—Ã“àŽ‹‹ŸEÁ‰»Ší•aŠwp‘å‰ï)
(2010/6/11), ‘hB, ’†‘. (–Ø“cŒõL1: 1Á‰»Ší“à)

712029. [Šw‰ï (‘Û)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) The present status and future perspectives of
S-1 in gastric cancer - the present status in Japan and in other countries -The present status
in Japan Clinical oncology. Wasaburo Koizumi: 9th International Conference of the Asian Clinical
Oncology Society (2010/8/25), Gifu. (¬ò˜aŽO˜Y: Á‰»Ší“à)

712030. [Šw‰ï (‘Û)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) Stent management of Malignant biliary
obstruction. Kida M1: 2010 Hepatobiliary & Pancreatic Diseases International Summit Forum
(2010/9/16), YB, ’†‘. (–Ø“cŒõL1: 1Á‰»Ší“à)

712031. [Šw‰ï (‘Û)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) Combination Chemotherapy With Docetaxel,
Cisplatin, and S-1(DCS) for Advanced Gastric Cancer. Wasaburo Koizumi: International Society of
Gastrointestinal Oncology (2010/9/25), Philadelphia, USA. (¬ò˜aŽO˜Y: Á‰»Ší“à)

712032. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Stent management of malignant biliary
obstruction. Kida M1: The 4th Meeting of the Society of Gastrointestinal Intervention (SGI 2010)
2010/10/8), ƒ\ƒEƒ‹, ŠØ‘. (–Ø“cŒõL1: 1Á‰»Ší“à)

712033. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Recent Advancement of EUS-FNA: Specially with
Forward-Viewing Echoendoscope. Kida M1 (The 4th Meeting of the Society of Gastrointestinal
Intervention (SGI 2010) 2010/10/9), ƒ\ƒEƒ‹, ŠØ‘. (–Ø“cŒõL1: 1Á‰»Ší“à)

712034. [Šw‰ï (‘Û)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) Hands-on Training. Kobayashi Kiyonori: 17th
International Symposium on Endoscopic Ultrasonography (2010/11/12), Shanhai. (¬—ѐŽ“T: Á‰»Ší
“à)

712035. [Šw‰ï (‘Û)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) Benefical effects of angiotensin II type 1
receptor blocker olmesartan on portal pressure and hepatic fibrosis in selected patients with
cirrhosis. Hidaka H: Hepatobiliary Forum (2010/11), Shanghai. (“ú‚@‰›: Á‰»Ší“à)

712036. [Šw‰ï (‘Û)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) Future of EUS. –Ø“cŒõL (Á‰»Ší“à): 17th
International Symposium on Endoscopic Ultrasonography (2010/11/12), Shanhai.

712037. [Šw‰ï (‘Û)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) Hands-on Training. –Ø“cŒõL (Á‰»Ší“à): 17th
International Symposium on Endoscopic Ultrasonography (2010/11/12), Shanhai.

712038. [Šw‰ï (‘Û)] (µ‘ҍu‰‰EƒVƒ“ƒ|ƒWƒEƒ€“™) ‘å’°Žîᇐ«•a•Ï‚Ì“àŽ‹‹Ÿf’f?i’B“xf’f‚𒆐S
‚É?. ¬—ѐŽ“T (Á‰»Ší“à): 2011dŒcÁ‰»Ší“àŽ‹‹ŸƒtƒH[ƒ‰ƒ€ (2011/3/4-6), dŒc.

713036. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Relations between gastric atrophy and gastric cancer. Matsuda
K, Tanaka S, Oda T, Kida M1: American Digestive Diseases Weeks (2010/5/4), USA. (–Ø“cŒõL1: 1
Á‰»Ší“à)

713037. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) Narrow band imaging (NBI) for detecting superficial squamous cell
carcinoma of the head and neck in patients with esophageal squamous cell carcinoma. Katada C,
Tanabe S, Masaki T, Nakayama M, Ae T, Ishido K, Nakatani K, Azuma M, Sasaki T, Higuchi K, Okamoto
M, Koizumi W: The 9th Japan-Korea Joint Symposium on Gastrointestinal Endoscopy (2010/5/15), Tokyo.
(Œ˜“ce—˜1, “c糁@‘1, ³˜Ò@—²2, ’†ŽR–Ÿm2, ˆ¢]‘Ÿ‰ÀŽq1, ÎŒËŒªŽŸ1, ’†’JŒ€“l1, “Œ@’q1,
²X–Ø“O1, ”óŒûŸ•F1, ‰ª–{–ql2, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2Žš•@)

713038. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Narrow band imaging (NBI) for detecting superficial squamous cell
carcinoma of the head and neck in patients with esophageal squamous cell carcinoma. Katada C ,
Tanabe S, Higuchi K, Masaki T, Nakayama M, Okamoto M, Koizumi W: 12th World congress of the
international society for diseases of the esophagus (2010/9/3), Kagoshima. (Œ˜“ce—˜1, “c糁@‘
1, ”óŒûŸ•F1, ³˜Ò@—²2, ’†ŽR–Ÿm2, ‰ª–{–ql2, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2Žš•@)

713039. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Clinical Usefulness and Limitations of Cytapheresis in
Hospitalized Patients with Ulcerative Colitis. Kaoru Yokoyama, Kiyonori Kobayashi, Aya Kato,
Teppei Nakanome, Miyuki Mukae, Taishi Ogawa, Miwa Sada, Wasaburo Koizumi: The 5th Japan-Korea IBD
Symposium (2010/10/2), Seoul. (‰¡ŽR@ŒO1, ¬—ѐŽ“T1, ‰Á“¡@Ê1, ’†–Ú“N•œ1, Œ}@”üK1, ¬ì‘å
Žu1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

713040. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Endoscopic Assessment of Early Lesions of Ulcerative Colitis.
Miyuki Mukae, Kiyonori Kobayashi, Taishi Ogawa, Kaoru Yokoyama, Miwa Sada, Wasaburo Koizumi, Tetsuo
Mikami: The 5th Japan-Korea IBD Symposium (2010/10/2), Seoul. (Œ}@”üK1, ¬—ѐŽ“T1, ¬ì‘åŽu
1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1, ŽOã“N•v2: 1Á‰»Ší“à, 2•a—)

713041. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Clinical Usefulness of Endoscopic Balloon Dilatation for Lower
Gastrointestinal Strictures in Patients with Crohn's Disease. Aya Kato, Kaoru Yokoyama, Teppei
Nakanome, Miyuki Mukae, Taishi Ogawa, Miwa Sada, Kiyonori Kobayashi, Wasaburo Koizumi: The 5th
Japan-Korea IBD Symposium (2010/10/2), Seoul. (‰Á“¡@Ê1, ‰¡ŽR@ŒO1, ’†–Ú“N•œ1, Œ}@”üK1, ¬
ì‘åŽu1, ²“c”ü˜a1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

713042. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical Impacts of Newly Developed Forward Viewing
Convex EUS for Interventional FNA. Kida M1, Miyazawa S1, Ikeda H1, Takezawa M1, Araki M1, Watanabe
M1, Imaizumi H1, Kobayashi K1, Koizumi W1: United European Gastroenterological Week (2010/10/25),
Barcelona, Spain. (–Ø“cŒõL1, ‹{àVŽu˜N1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, r–ؐ³—Y1, “n粐^²1, ¡ò@
O1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

713043. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[ Clinical Impacts of "Removal" Covered Expamdable
Metallic Stent for Biliopancreatic Malignancy Patients. Kida M1, Miyazawa S1, Iwai T1, Ikeda H1,
Takezawa M1, Kikuchi H1, Watanabe M1, Imaizumi H1, Koizumi W1: United European Gastroenterological
Week (2010/10/26), Barcelona, Spain. (–Ø“cŒõL1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ’r“cOŽq1, ’|àVŽO‘ãŽq
1, ‹e’nG•F1, “n粐^²1, ¡ò@O1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

713044. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Endoscopic assistance as the safety technique of Percutaneous
Trans-Esophageal Gastrotubing (PTEG) for the patients who had difficulty with the Percutaneous
Endoscopic Gastrostomy (PEG) insertion. Masato Murakami1,2, Keiitirou Nishino1, Shigeto
Murakami1, Youko Takaoka1, Kousuke Mori1, Bonpei Murakami1, Satoshi Tanabe2, Mitsuhiro Kida2,
Wasaburou Koizumi2: UEGW2010 (‘æ18‰ñ‰¢BÁ‰»Ší•aTŠÔ) (2010/10/27), ƒoƒ‹ƒZƒƒi. (‘ºã‹§l1,2,
“c糁@‘2, –Ø“cŒõL2, ¬ò˜aŽO˜Y2: 1‘ºã‹L”O•a‰@, 2Á‰»Ší“à)

713045. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Clinical Usefulness and Limitations of Cytapheresis in
Hospitalized Patients. Yokoyama K, Kobayashi K, Kato A, Nakanome T, Mukae M, Ogawa T, Sada M,
Koizumi W: 2010 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National
Clinical & Research Conference (2010/12/10), Hollywood, Florida, Inflammatory Bowel Diseases
2011/1; 17 (Supplement 1): S66. (‰¡ŽR@ŒO1, ¬—ѐŽ“T1, ‰Á“¡@Ê1, ’†–Ú“N•œ1, Œ}@”üK1, ¬ì
‘åŽu1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à)

713046. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰Eƒ|ƒXƒ^[) Benefical effects of olmesartan medoxomil on portal
pressure and transforming growth factor 1 (TGR-ƒÀ1) in selected patients with cirrhosis. Hidaka
H, Nakazawa T, Minamino T, Takada J, Tanaka Y, Okuwaki Y, Watanabe M, Shibuya A, Koizumi W: The
61 AASLD The Liver Meeting 2010, (2010/9/2), Boston. (“ú‚@‰›1, ’†àV‹MG1, “ì–ì@•×1, ‚“cŽ÷
ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “n粐^²1, a’J–Ÿ—²2, ¬ò˜aŽO˜Y1: 1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—)

722025. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’×ᇐ«‘å’°‰Š‚É‚š‚¯‚闝‘z“I‚È“àŽ‹‹ŸƒT[ƒxƒCƒ‰ƒ“ƒX‚ð–ÚŽw‚µ
‚Ä ’×ᇐ«‘å’°‰Š‡•¹‘å’°Žîá‡‚Ì“àŽ‹‹Ÿ‚É‚æ‚éƒT[ƒxƒCƒ‰ƒ“ƒX–@‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ¬—ѐŽ“T1, ²“c”ü˜a
1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ96‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2010/4/23), VŠƒ, “ú–{Á‰»Ší•aŠw‰ïŽG
Ž 2010/3; 107 (—Õ‘‘‰ï): A88.

722026. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ˆÝŠà‰»Šw—Ö@@Å‹ß‚Ì’mŒ© isEÄ”­ˆÝŠà‚ɑ΂·‚é
docetaxel/cisplatin/S-1 (DCS) —Ö@‚Ì‘æII‘ŠŽŽŒ± (KDOG0601 P2) ÅIŒ‹‰Ê•ñ. ¬ò˜aŽO˜Y1, ”óŒû
Ÿ•F1, ’†ŽRž“T1,2 (1Á‰»Ší“à, 2_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[): ‘æ96‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï
(2010/4/24), VŠƒ, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2010/3; 107 (—Õ‘‘‰ï): A112.

722027. [Šw‰ï (‘S‘)] (Šw•”Šw¶ŽŠà) H“¹‚ª‚ñp‘O¶ŒŸ‘gD‚ð—p‚¢‚œp53ˆâ“`Žq•ÏˆÙ‚ÌŒŸõ. ŠÖ’JŒ³
Š²1, •Ð“c‰Ä–ç2, “c糁@‘3, ‰ªˆÀ@ŒM4, ‘å•”@œ5 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È¶‘̍\‘¢ˆã‰ÈŠwŒQ×–EE
‘gD•a—Šw, 2ŠO‰È, 3Á‰»Ší“à, 4•a—, 5ˆã—Éq¶Šw•”): ‘æ99‰ñ“ú–{•a—Šw‰ï‘‰ï (2010/4/29), “Œ
‹ž, “ú–{•a—Šw‰ï‰ïŽ 2010/3; 99 (1): 368.

722028. [Šw‰ï (‘S‘)] (ƒrƒfƒIƒVƒ“ƒ|ƒWƒEƒ€)yÁ‰»ŠÇÃ–¬áŽ‚ÌŽ¡—Ð헪z•W€Ž¡—ÂƐV‚µ‚¢“WŠJ EVL
Œã‚ÌPPI“Š—^‚É‚æ‚éoŒŒ—\–h‚ð–Ú“I‚Æ‚µ‚œ–³ìˆ×”äŠrŽŽŒ±?ƒ_ƒuƒ‹ƒ^ƒCƒvƒI[ƒo[ƒ`ƒ…[ƒu‚ÌŽg—pŒoŒ±‚à
“¥‚Ü‚Š‚Ä?. “ú‚@‰› (Á‰»Ší“à): ‘æ79‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/5/13), “Œ‹ž,
Gastroenterological Endoscopy 2010/4; 52 (Suppl 1): 820.

722029. [Šw‰ï (‘S‘)] (ƒrƒfƒIƒVƒ“ƒ|ƒWƒEƒ€)yã•”Á‰»ŠÇESD‚ÌŽè‹Z‚ƍH•vz‘ŠúˆÝŠàŽ¡—Í¢“ï—á‚É‘Î
‚·‚éDouble scope ESD(single trans method)‚Ì—L—p«. ”óŒûŸ•F1, “c糁@‘1, “Œ@’q1 (1Á‰»Ší
“à): ‘æ79‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/5/14), “Œ‹ž, Gastroenterological Endoscopy 2010/4; 52
(Suppl 1): 826.

722030. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y“àŽ‹‹Ÿ‚̈À‘SŠÇ—z“àŽ‹‹ŸŽ¡—Âɂš‚¯‚émidazolam
‚Æpropofol‚Ì–³ìˆ×‰»‘OŒü‚«—Տ°‘æII‘ŠŽŽŒ±. ²X–Ø“O1, “Œ@’q1, “c糁@‘1 (1Á‰»Ší“à): ‘æ
79‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/5/13), “Œ‹ž, Gastroenterological Endoscopy 2010/4; 52 (Suppl
1), 853.

722031. [Šw‰ï (‘S‘)] (“Á•ÊƒVƒ“ƒ|ƒWƒEƒ€)y’_“¹ƒXƒeƒ“ƒg‚Ì“K‰ž‚Æ‘I‘ðz•W€‰»‚ð–ÚŽw‚µ‚Ä ’†‰º•”’_
“¹‹·ó‚ɑ΂·‚éCovered Wall stent‚ÌŠJ‘¶¬Ñ‚ƕnjã‚̑Ήž. ‹{àVŽu˜N1, –Ø“cŒõL1, ¡ò@O1 (1
Á‰»Ší“à): ‘æ79‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/5/14), “Œ‹ž, Gastroenterological Endoscopy
2010/4; 52 (Suppl 1): 763.

722032. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yPEG‘¢ÝEŒðŠ·‚ÌŽè‹Z‚ƍH•vz‚“xŒÄ‹z‹@”\áŠQ—á
‚ɑ΂·‚éNPPV•¹—pPEG‚Ì—L—p«. ‹à@–Ÿ“N1, ”óŒûŸ•F1, ‰¬–ì”üŒbŽq2 (1Á‰»Ší“à, 2_Œo“à): ‘æ
79‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/5/14), “Œ‹ž, Gastroenterological Endoscopy 2010/4; 52 (Suppl
1): 901.

722033. [Šw‰ï (‘S‘)] (“Á•ÊƒVƒ“ƒ|ƒWƒEƒ€)y‘ŠúˆÝŠàESD‚Ì“K‰ž‚ð‚ß‚®‚é–â‘èz–¢•ª‰»Œ^Šà‚ð—L‚·‚鑁
ŠúˆÝŠà‚É‚š‚¯‚éESD‚Ì“K‰žŠg‘å. “Œ@’q1, “c糁@‘1, ÷–{Mˆê2 (1Á‰»Ší“à, 2ŠO‰È): ‘æ79‰ñ“ú
–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/5/15), “Œ‹ž, Gastroenterological Endoscopy 2010/4; 52 (Suppl 1):
780.

722034. [Šw‰ï (‘S‘)] (ƒrƒfƒIƒVƒ“ƒ|ƒWƒEƒ€)y“àŽ‹‹ŸŽ~ŒŒ‚ÌŽ¡—ÑI‘ðz‘å’°oŒŒ«•a•Ï‚ɑ΂·‚é“àŽ‹‹Ÿ
“IŽ~ŒŒ–@‚ÌŽ¡—ЬÑ. Œ}@”üK1, ²“c”ü˜a1, ¬—ѐŽ“T1 (1Á‰»Ší“à): ‘æ79‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw
‰ï‘‰ï (2010/5/15), “Œ‹ž, Gastroenterological Endoscopy 2010/4; 52 (Suppl 1): 840.

722035. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y‘Sg«ŽŸŠ³‚Æ‚µ‚Ă̊̍d•ÏÇz‡•¹Ç‚̐V‚µ‚¢Ž¡—à ŠÌd•Ï
Š³ŽÒ‚É‚š‚¢‚ÄOlmesartan Medoxomil‚ÍTGF-ƒÀ1‚ÌŽY¶‚ð—LˆÓ‚É—}§‚·‚é. “ú‚@‰›1, ’†‘ò‹MG1, “ì
–ì@•×1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “n粐^²1, a’J–Ÿ—²2, š •ª–ΔŽ1,3, ¬ò˜aŽO˜Y1 (1
Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—, 3‡‘å—û”n•a‰@): ‘æ46‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (2010/5/27), ŽRŒ`, ŠÌ‘Ÿ
2010/4; 51 (Suppl 1): A52.

722036. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŠÌ‰æ‘œf’f‚É‚š‚¯‚éEOB MRI‚Ì—L—p«‚ƉۑèzGd-EOB-DTPA
‘¢‰eMRI‚Ì‘¢‰eŒø‰Ê‚ÆŠÌ—\”õ”\‚Æ‚ÌŠÖ˜A. Ž…—T‹M1, ‚“cŽ÷ˆê1, ’†àV‹MG1, “ú‚@‰›1, ‰œ˜e—T‰î
1, “c’†Œ«–Ÿ1, “n粐^²1, a’J–Ÿ—²2 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ46‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï
(2010/5/28), ŽRŒ`, ŠÌ‘Ÿ 2010/4; 51 (Suppl 1): A88.

722037. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y’Ž‰¹”g“àŽ‹‹Ÿ‚̐V“WŠJzV‚µ‚¢’ŒŽ‹Œ^ƒRƒ“ƒxƒbƒNƒX
ƒXƒR[ƒv‚É‚æ‚éEUS-FNA‚̐¬Ñ. r–ؐ³—Y1,2, –Ø“cŒõL2, ‹{àVŽu˜N2, Šâˆä’m‹v2, ‹e’nG•F2, ’|àV
ŽO‘ãŽq2, ¡ò@O2, ¬ò˜aŽO˜Y2 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ83‰ñ“ú–{’Ž‰¹”gˆãŠw‰ï
(2010/5/30), ‹ž“s, ’Ž‰¹”gˆãŠw 2010/4; 37 (Suppl): S229.

722038. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y‘Š‡”­ŒŸz• •”ŽŸŠ³‚ɑ΂·‚é’Ž‰¹”gŒŸž. –Ø“cŒõL (Á‰»Ší
“à): ‘æ83‰ñ“ú–{’Ž‰¹”gˆãŠw‰ï (2010/5/30), ‹ž“s, ’Ž‰¹”gˆãŠw 2010/4; 37 (Suppl): S229.

722039. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yH“¹ŽŸŠ³‚ɑ΂·‚é‘OŒü‚«”äŠrŽŽŒ±, ‘œŽ{ÝŒ€‹†, ‘S‘“o˜^•ñz
H“¹ŠàEMR/ESDÇ—á‚̃ˆ[ƒh•sõ‘Ñ‚ðƒoƒCƒIƒ}[ƒJ[‚É‚µ‚œ”­Šà‚ÉŠÖ‚·‚éƒRƒz[ƒgŒ€‹†. Œ˜“ce—˜1,2,
•“¡@Šw1, ‹àŽq˜aO1, ¬“cˆê˜Y1, Ž…—Eˆê1, “c糁@‘1,2, ¬’r’qK1, “yŽRŽõŽu1, ‰¡ŽR“OŽ¢1, Î
ìGŽ÷1 (1Œú¶˜J“­È‰^‰c”ïŒð•t‹à‚ª‚ñŒ€‹†ŠJ”­”ïuƒAƒ‹ƒR[ƒ‹‘ãŽÓy‘f‚ƐH“¹‘œ”­‚ª‚ñE‘Œ‘ŸŠíd•¡
‚ª‚ñ‚Æ‚ÌŠÖ˜A«‚š‚æ‚Ñ”­Ç—\–h‚ÉŠÖ‚·‚錀‹†”ǁv, 2Á‰»Ší“à): ‘æ64‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï
(2010/8/31), •Ÿ‰ª, ‘æ64‰ñ“ú–{H“¹Šw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010/8; p.90.

722040. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yH“¹ŽŸŠ³‚ɑ΂·‚é‘OŒü‚«”äŠrŽŽŒ±, ‘œŽ{ÝŒ€‹†, ‘S‘“o˜^•ñz
cStage II/III (nonT4) H“¹Šà‚ɑ΂·‚é5-FU/CDDP+•úŽËü(50.4 Gy) (mRTOG)‚̗Տ°‘æII‘ŠŽŽŒ±. ‰Á“¡@
Œ’1, ’†“‡‹MŽq, ˆÉ“¡–F‹I, “¿‰iL–ç, ’r“c—TŽq, Œ˜“ce—˜2, ÎŽR”ŽžŠ3, L’†Gˆê, ‹Ž–{‹M”V (1‘—§
‚ª‚ñƒZƒ“ƒ^[’†‰›•a‰@, 2Á‰»Ší“à, 3•úŽËü (Žîá‡)): ‘æ64‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2010/8/31), •Ÿ
‰ª, ‘æ64‰ñ“ú–{H“¹Šw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010/8; p.93.

722041. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yStage IVa (T4, M0) H“¹Šà‚ÌŽ¡—ÁzŽèp‚Í•K—v‚©?@T4H
“¹Šà‚ɑ΂·‚éDocetaxel/CDDP/5-FU/•úŽËü“¯Žž•¹—p—Ö@(DCF-R)‚ÌŽ¡—ЬÑ. ”óŒûŸ•F1, ¬ò˜aŽO˜Y1,
“c糁@‘1, ²X–Ø“O1, Œ˜“ce—˜1, “Œ@’q1, ¬’J³Žq2, •Ð“c‰Ä–ç3, ª–{¹”V3, ŽÄ“c’q—²3 (1
Á‰»Ší“à, 2•úŽËü (Žîá‡), 3ŠO‰È): ‘æ64‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2010/9/1), •Ÿ‰ª, ‘æ64‰ñ“ú–{H
“¹Šw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010/8; p.129.

722042. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yH“¹ˆÝÃ–¬áŽŽ¡—Â̗˜_‚ÆŽÀ‘HzPPI‚ð—p‚¢‚œEVLŒã‚̏oŒŒ—\
–h–Ú“I‚Ì”ñ–ÓŒŸ–³ìˆ×”äŠrŽŽŒ±. “ú‚@‰›1, ‰œ˜e—T‰î1, “ì–ì@•×1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, “n粐^
²1, ’†àV‹MG1, a’J–Ÿ—²2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ17‰ñ“ú–{–å–¬ˆ³˜Ži
ÇŠw‰ï‘‰ï (2010/9/9), •xŽR, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2010/8; 16 (2): 49.

722043. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŠÌ×–EŠàŽ¡—Â̂±‚ê‚©‚ç‚Ì“WŠJz–å–¬Žîá‡ð‚š‚æ‚ъ̐Ö¬Žîá‡
ð‡•¹ŠÌ×–EŠà‚ɑ΂·‚é•úŽËü—Ö@‚Ì—L—p«. “c’†Œ«–Ÿ1, ’†àV‹MG1, “ú‚@‰›1 (1Á‰»Ší“à): ‘æ14
‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (2010/10/13), ‰¡•l, ŠÌ‘Ÿ 2010/9; 51 (Suppl 2): A429.

722044. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y–å–¬ˆ³˜ŽiÇ‚Ì•a‘Ô‚ÆŽ¡—Ázƒ‰ƒxƒvƒ‰ƒ][ƒ‹10 mg‚Ì1“ú1
‰ñ“Š—^‚Í, “àŽ‹‹Ÿ“IÃ–¬áŽŒ‹ãFp (EVL) Œã‚̍ďoŒŒ‚ð—LˆÓ‚É—}§‚·‚é. “ú‚@‰›1, ‰œ˜e—T‰î1, ¬ò
˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ14‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (2010/10/14), ‰¡•l, ŠÌ‘Ÿ 2010/9; 51 (Suppl 2): A515.

722045. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yESD‚É‚š‚¯‚éŽè‹Z‚̍H•vzˆÝsƒrƒfƒIt ‘ŠúˆÝŠàፍ­‡•¹
—á‚ɑ΂·‚éDouble scope ESD (single trans method) ‚Ì—L—p«. “c糁@‘1, ”óŒûŸ•F1, “Œ@’q1 (1
Á‰»Ší“à): ‘æ80‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/10/15), ‰¡•l, Gastroenterological Endoscopy
2010/9; 52 (Suppl 2): 2338.

722046. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yH“¹Šà‚ÌŽ¡—Ð헪 (•\ÝŠà‚©‚çisŠà‚Ü‚Å)z
T4/M1LYMH“¹Šà‚ɑ΂·‚éDocetaxel/CDDP/5-FU/•úŽËü“¯Žž•¹—p—Ö@ (DCF-R) ‚ÌŽ¡—ЬÑ. ”óŒûŸ•F1,
¬ò˜aŽO˜Y1, “c糁@‘1 (1Á‰»Ší“à): ‘æ52‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (2010/10/15), ‰¡•l, “ú–{Á‰»
Ší•aŠw‰ïŽGŽ 2010/9; 107 (—Õ‘‘å‰ï ): A628.

722047. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yEMR, ESD‚̉ۑèzˆÀ‘SŠmŽÀ‚È“àŽ‹‹Ÿˆã—Â̒ñ‹Ÿ‚ÉŒü‚¯‚Ä ESD
‚É‚š‚¯‚éRŒŒð—Ö@‚ÌŽæ‚舵‚¢‚Æ–â‘è“_?EGMRŒ€‹†‰ïƒAƒ“ƒP[ƒg’²žŒ‹‰Ê?. ²X–Ø“O1, “c糁@‘1,
Œõ‰i@“Ä2 (1Á‰»Ší“à, 2“Œ‹ž—Žqˆã‘å): ‘æ80‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/10/15), ‰¡•l,
Gastroenterological Endoscopy 2010/9; 52 (Suppl 2): 2250.

722048. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y¬’°Žîᇐ«•a•Ï‚Ö‚Ì“àŽ‹‹Ÿ“IƒAƒvƒ[ƒ`z¬’°Žîᇂ̐f’f‚É
‚š‚¯‚é“àŽ‹‹ŸŒŸž‚Ì–ðŠ„‚Æ’Ž‰¹”g“àŽ‹‹Ÿf’f‚Ì—L—p«. Œ}@”üK1, ¬—ѐŽ“T1 (1Á‰»Ší“à): ‘æ80‰ñ
“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/10/16), ‰¡•l, Gastroenterological Endoscopy 2010/9; 52 (Suppl 2):
2388

722049. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y’Z’°ÇŒóŒQ‚ÌŽ¡—ÁzÝ‘î’†SÃ–¬‰h—{–@‚̉ۑè‚Ƒ΍ô Ý‘î
’†SÃ–¬‰h—{—Ö@‚ðŒp‘±‚µ‚Ä‚¢‚鉊Ç«’°ŽŸŠ³Š³ŽÒ‚É‚š‚¯‚錌’†”÷—ÊŒ³‘f”Z“x‚̐„ˆÚ‚ɂ‚¢‚Ä‚ÌŒŸ“¢.
‰Á“¡@Ê1, ¬—ѐŽ“T1, Ÿ–””º‰h1 (1Á‰»Ší“à): ‘æ52‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (2010/10/16), ‰¡•l,
“ú–{Á‰»Ší•aŠw‰ïŽGŽ 2010/9; 107 (—Õ‘‘å‰ï): A755.

722050. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yH“¹‚ª‚ñ‚ɑ΂·‚éWŠw“IŽ¡—Â̐V“WŠJzT4/M1LYMH“¹Šà‚É‘Î
‚·‚éDCF‚É‚æ‚鉻Šw•úŽËü—Ö@ (DCF-R) ‚Ì‘æII—Տ°‘ŠŽŽŒ± (’†ŠÔ‰ðÍ). ”óŒûŸ•F1, ¬ò˜aŽO˜Y1, “c
糁@‘1, ²X–Ø“O1, Œ˜“ce—˜1, “Œ@’q1, ¬’J³Žq2, ‘ì˜ad2, ª–{¹”V3, •Ð“c‰Ä–ç3 (1Á
‰»Ší“à, 2•úŽËü (Žîá‡), 3ŠO‰È): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/28), ‹ž“s, “ú–{ŠàŽ¡—Ã
Šw‰ïŽ 2010/9; 45 (2): 320.

722051. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y‘ŠúˆÝ‚ª‚ñ‚ɑ΂·‚é”S–Œ”—£pz“K‰ž‚ÆŒÀŠE –¢•ª
‰»Œ^¬‡‘ŠúˆÝŠà‚ɑ΂·‚éESD“K‰žŠg‘å. “c糁@‘1, “Œ@’q1, •@‰ª@ž1, ŽOã“N•v2, ¬ò˜aŽO
˜Y1 (1Á‰»Ší“à, 2•a—): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/29), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ
2010/9; 45 (2): 453.

722052. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y‘ŠúˆÝ‚ª‚ñ‚ɑ΂·‚é”S–Œ”—£pz“K‰ž‚ÆŒÀŠE?•ª‰»
Œ^‘ŠúˆÝŠà‚ɑ΂·‚éESD‚̃ŒƒgƒƒXƒyƒNƒeƒBƒu‚Ȑ¬Ñ‚Æ‘OŒü‚«ŽŽŒ±‚Ö‚Ì’ñŒŸ?. ¬“cˆê˜Y1, “‡’ÑŸˆê
1, ¬–ì—T”V, “c糁@‘2, ”ѐ΍_N, ‹ß“¡@m, “ñ‹{ŠîŽ÷ (1‘—§‚ª‚ñŒ€‹†ƒZƒ“ƒ^[’†‰›•a‰@, 2Á‰»Ší
“à): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/29), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2010/9; 45 (2): 452.

722053. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yIBD“EdÇ—á‚ÌŽ¡—Ð헪z’×ᇐ«‘å’°‰Š“ü‰@—á‚É‚š‚¯‚錌
‹…¬•ª‹z’…œ‹Ž—Ö@‚Ì—LŒø«‚ÆŒÀŠE. ‰¡ŽR@ŒO1, ¬—ѐŽ“T1, ²“c”ü˜a1 (1Á‰»Ší“à): ‘æ65‰ñ“ú–{
‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2010/11/27), •lŒ, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2010/9; 63 (9): 568.

722054. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰“™) ‘Šú‘å’°Šà‚̐[’B“xf’f‚É‚š‚¯‚éNBI‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢.
Œ}@”üK1, ¬—ѐŽ“T1, ²“c”ü˜a1 (1Á‰»Ší“à): ‘æ28‰ñ“ú–{‘å’°ŒŸžŠw‰ï (2010/11/27-28), “Œ‹ž, “ú
–{‘å’°ŒŸžŠw‰ïŽGŽ 2011/1; 27 (2): 56.

722055. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ’×ᇐ«‘å’°‰Š“ü‰@—á‚É‚š‚¯‚錌‹…¬•ª‹z’…œ‹Ž—Ö@‚Ì—LŒø«
‚ÆŒÀŠE. ‰¡ŽR@ŒO1, ¬—ѐŽ“T1 (1Á‰»Ší“à): ‘æ7‰ñ“ú–{Á‰»ŠÇŠw‰ï‘‰ïŠwpW‰ï (2011/2/18), ‹ž“s.

722056. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) isEÄ”­ˆÝ‚ª‚ñ‚ɑ΂·‚édocetaxel/cisplatin/S-1 (DCS) —Ã
–@ (KDOG0601 P2): ’·Šú‰ðÍŒ‹‰Ê. ’†ŽRž“T1,2, ¬ò˜aŽO˜Y2, ”óŒûŸ•F2, Œ‘º@Œ«1,2, ²X–Ø“O
2, “c糁@‘2, ‚–ؐžˆê1,2, “Œ@’q2, Œ˜“ce—˜2, ’†’JŒ€“l2, ÎŒËŒªŽŸ2, –ö“c’Œ‹B1, –{‹Ž@C
1,2 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ83‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2011/3/4), ÂX.

722057. [Šw‰ï (‘S‘)] (ƒrƒfƒIƒ[ƒNƒVƒ‡ƒbƒv) ‘ŠúˆÝŠàፍ­‡•¹—á‚ɑ΂·‚éDouble scope ESD (single
trans method) ‚Ì—L—p«. “c糁@‘1, ”óŒûŸ•F1, “Œ@’q1, ²X–Ø“O1 (1Á‰»Ší“à): ‘æ83‰ñ“ú–{
ˆÝŠàŠw‰ï‘‰ï (2011/3/5): ÂX.

723120. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŒŽƒyƒvƒVƒmƒQƒ“I/II”䏜‹Û‘OŒã‚̕ω»—Š (PG•Ï‰»—Š–@) ‚É‚æ‚é
ƒwƒŠƒRƒoƒNƒ^[EƒsƒƒŠœ‹Û”»’è–@. ›ÀF‹I1, t“úÍ—Ç1, ‰ª“c˜a‹v1, ‘å‘O‰ë”ü1, ¡ˆä1, ŠÝ@
‹’‰1, ŠÝŒŽ‹Pm1, ‹g–{˜am1, •œàVr–Ÿ1, ÎŽRW¢Žu1, ¬ì‘åŽu1,2, ç–쏻Žq1, ŽR–{—Š³1, ‰Y
ã®”V1, “y“c’mG1, “¡è‡Žq1, ŒÜ\—’³L1,2, ¯–ìŒb’Õv1, ‚‹Ž@Š°1, ŽO–؈ꐳ1 (1ŠàŒ€—L–Ÿ
•a‰@, 2Á‰»Ší“à): ‘æ96‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2010/4/22), VŠƒ, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2010/3;
107 (—Õ‘‘‰ï): A351

723121. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰º•”’Œ’°isŠà‚̏p‘O‰»Šw•úŽËü—Ö@‚ɑ΂·‚é“àŽ‹‹Ÿ“IŒø‰Ê”»’è‚Ì
—L—p«. ¬ì‘åŽu1,2, ‘å–î‰ë•q1, ŠÝŒŽ‹Pm1, ŠÝ@‹’‰1, ç–쏻Žq1, ‰Yã®”V1, “¡–{‰À–ç1, •
–ö—m–í1, ã–ì‰ëŽ‘1, ŒÜ\—’³L1,2, •“¡“Oˆê˜Y1 (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): ‘æ96‰ñ“ú–{Á‰»
Ší•aŠw‰ï‘‰ï (2010/4/22), VŠƒ, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2010/3; 107 (—Õ‘‘‰ï): A360

723122. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠO‰È“IØœ•s”\äXŠà‚ɑ΂·‚égemcitabine+TS-1•¹—p‰»Šw—Ö@. ‹e
’nG•F1, –Ø“cŒõL1, ‘剪³•œ1, ŽR–{@‘n1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ˆÀ“¡@‹1, ’r“cOŽq1, ’|àV
ŽO‘ãŽq1, r–ؐ³—Y1, ŽRèDŠì1, “n•Ó–€–ç1, –Ø“c–FŽ÷1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ
96‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2010/4/23), VŠƒ, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2010/3; 107 (—Õ‘‘‰ï): A282.

723123. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚—p—ʃƒgƒƒjƒ_ƒ][ƒ‹‚ƃIƒƒvƒ‰ƒ][ƒ‹‚Ì“ñÜ‚ɂďœ‹Û‚µ“Ÿ‚œ“Á
”­«ŒŒ¬”ÂŒž­«Ž‡”Á•a‡•¹, ƒAƒ[ƒo«ŠÌ”^ᇂ̈ê—á. ¬–ìO“ñ1,2, –î–ì‹MŽj1,2, —Ž@‹M—T1,2, ‘O
àV@”J1,2, ‘å–ì@—²1,2 (1ˆÉšŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ96‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (2010/4/24),
VŠƒ, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2010/3; 107 (—Õ‘‘‰ï): A454.

723124. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) EUS-FNA‚É‚š‚¯‚éúŽhjŒa‚É‚æ‚éf’f”\‚ÌŒŸ“¢. r–ؐ³—Y1,2, –Ø
“cŒõL1, ‰œ˜e‹»‰î1, ‘剪³•œ1, ²“¡äm1, ‹{àVŽj˜N1, Šâˆä’m‹v1, ˆÀ“¡@‹1,3, ’r“cOŽq1, ‹e
’nG•F1, ’|àVŽO‘ãŽq1, ‰F’Ö؋±Žq1, ŽRèDŠì1,3, “n•Ó–€–ç1, –Ø“c–FŽ÷1, ¡ò@O1, ŽR“cŽŠl
1, ¬ò˜aŽO˜Y1 (1‘Š–ÍŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à, 3•œ’Ë‹€Ï•a‰@): ‘æ79‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï
(2010/5/14), “Œ‹ž, Gastroenterological Endoscopy 2010/4; 52 (Suppl 1): 1042.

723125. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‚ÅŒoŒ±‚µ‚œäX‰Œ«ùN–E‚ɑ΂·‚é“àŽ‹‹ŸŽ¡—Â̌Ÿ“¢. ‘剪³•œ
1, “¡ˆä@Š]2, ¡ò@O1, ‹{àVŽj˜N1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1 (1Á‰»
Ší“à, 2•úŽËü (‰æ‘œ)): ‘æ79‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/5/14), “Œ‹ž, Gastroenterological
Endoscopy 2010/4; 52 (Suppl 1): 1045.

723126. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘¢‰eÜ‚̈Ⴂ‚É‚æ‚é’_`EäX‰t×–Ef‚Ì—z«—Š‚ÌŒŸ“¢. “¿‰iŽüŽq
1, –Ø“cŒõL1, ŽR–{@‘n1, ‘剪³•œ1, Šâˆä’m‹v1, ‹{àVŽu˜N1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, “n•Ó–€–ç
1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ79‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/5/14), “Œ‹ž,
Gastroenterological Endoscopy 2010/4; 52 (Suppl 1): 1047.

723127. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ×Œa‘å’°“àŽ‹‹ŸPCF-Y0005‚ÌŽg—pŒoŒ±. ç–쏻Žq1, ŒÜ\—’³L1,2,
‰Á“¡@ŒO1, ¡ˆä•ä1, ŠÝ@‹’‰1, ŠÝŒŽ‹Pm1, ¬ì‘åŽu1,2, ‰Yã®”V1, “¡“c—Í–ç1 (1ŠàŒ€—L–Ÿ•a
‰@, 2Á‰»Ší“à): ‘æ79‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/5/14), “Œ‹ž, Gastroenterological Endoscopy
2010/4; 52 (Suppl 1): 1072.

723128. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) š\ႍ׋۔|—{‚É‚š‚¢‚Ä’Ž‘ÌŒŸo‚³‚ê‚œ•³ü’ŽÇ‚Ì1—á. –x–с@‘
1, ”‹ŒŽ‹IŽq1, Š}ŒŽ–ÎŽq1, r”Š@“Ä1, ›À@“O1, ŠÖ‚ê‚¢‚µ1, ¬–ìO“ñ1,2 (1ˆÉšŒŽ‹Š“¯•a‰@, 2
Á‰»Ší“à): ‘æ59‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2010/5/22-23), _ŒË, ˆãŠwŒŸž 2010/4; 59 (4): 565.

723129. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –«CŒ^ŠÌ‰Š‚ɑ΂·‚éƒyƒOƒCƒ“ƒ^[ƒtƒFƒƒ“ƒ¿2aEƒŠƒoƒrƒŠƒ“Eƒt
ƒ‹ƒoƒXƒ^ƒ`ƒ“•¹—p“Š—^ŽŽŒ± (pilot study). ‚“cŽ÷ˆê1, ’†àV‹MG1, “ú‚@‰›1, “n•Ó^²1, ‰œ˜e—T
‰î1, “c’†Œ«–Ÿ1, “ì–ì@•×1, a’J–Ÿ—²2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ46‰ñ“ú–{
ŠÌ‘ŸŠw‰ï‘‰ï (2010/5/27), ŽRŒ`, ŠÌ‘Ÿ 2010/4; 51 (Suppl 1): A293.

723130. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘å’°“àŽ‹‹ŸŒŸž‚Ì‹U‰A«Šà‚ÌŒŸ“¢. ŠÝŒŽ‹Pm1, ŒÜ\—’³L1,2, ›
ÀF‹I1, ¡ˆä1, ŠÝ@‹’‰1, ¬ì‘åŽu1,2, ‰Yã®”V1, ç–쏻Žq1, ‰Á“¡@ŒO1, “y“c’mG1 (1
ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): ‘æ49‰ñ“ú–{Á‰»Ší‚ª‚ñŒŸfŠw‰ï‘‰ï (2010/6/11), ‰«“ê, “ú–{Á‰»Ší‚ª‚ñ
ŒŸfŠw‰ïŽGŽ 2010/5; 48 (3): 72.

723131. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žl‰–‰»’Y‘f—U”­‹}«ŠÌáŠQŒã‚̊̍ж‰ß’ö‚É‚š‚¯‚éƒgƒƒ“ƒ{ƒLƒTƒ“
‚Ì–ðŠ„. “ì–ì@•×1,2, ˆÉ“¡‹`–ç1,3, ˆÉ“¡‘s•œ4, ‰Á“¡“NŠó1, ¬ò˜aŽO˜Y2, ”n“ˆ³—²1 (1–ò—, 2
Á‰»Ší“à, 3ŠO‰È, 4–ƒŒ): ‘æ31‰ñ“ú–{‰ŠÇEÄ¶ˆãŠw‰ï (2010/8/5), “Œ‹ž, Inflammation and
Regeneration 2010/7: 30 (4): 326.

723132. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) isH“¹Šà‚ɑ΂·‚ép‘O/“±“üDocetaxel, Cisplatin, 5FU•¹—p—Ö@
‚ÌŠÇ—•û–@‚ÉŠÖ‚·‚錟“¢. Œ˜“ce—˜1, •Ð“c‰Ä–ç2, ’·£’Ê—², ×’JD‘¥, •l–{N•v, Ž…Gº, Œ‰º®
”V, ×ì@•à, “ˆ“c@—T, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ŠO‰È ): ‘æ64‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2010/8/31),
•Ÿ‰ª, ‘æ64‰ñ“ú–{H“¹Šw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010/8; p.210.

723133. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) lŠÔƒhƒbƒN‚Å”­Œ©‚³‚ê‚œˆ««ŽîᇂƃtƒHƒ[ƒAƒbƒv‚ɂ‚¢‚Ä. “ü]
‡Žq1, Šp–ìÆ‘ã, Ä“¡ˆŸ–îŽq, 傖Œ—Ï–€, Œ“c—BŽj, ’|àVŽO‘ãŽq2, ‰ª“c@ƒ3 (1–k—¢Œ€‹†Š•a‰@, 2
Á‰»Ší“à, 3Œ’NŠÇ—ƒZ): ‘æ51‰ñ“ú–{lŠÔƒhƒbƒNŠw‰ïŠwpW‰ï (2010/8/26-27), ˆ®ì, lŠÔƒhƒbƒN
2010/8; 25 (2): 345.

723134. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[)y—v–]‰‰‘èzOlmesartan’·Šú“Š—^‚É‚æ‚éTGF-ƒÀ1ŽY¶—}
§‚Æ–å–¬~ˆ³Œø‰Ê‚ɂ‚¢‚Ä‚ÌŒŸ“¢. “ú‚@‰›1, ’†‘ò‹MG1, ‰œ˜e—T‰î1, “ì–ì@•×1, “c’†Œ«–Ÿ1, ‚“c
Ž÷ˆê1, “n粐^²1, a’J–Ÿ—²2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ17‰ñ“ú–{–å–¬ˆ³˜Ž
iÇŠw‰ï‘‰ï (2010/9/10), •xŽR, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2010/8; 16 (2): 90.

723135. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è)y—v–]‰‰‘èzˆ««’_“¹‹·ó‚ɑ΂·‚éMetallic stent‚É‚æ‚é“àŽ‹‹Ÿ“I
’_“¹ƒhƒŒƒi[ƒWp‚Ì•û–@. ‹{àVŽu˜N1, –Ø“cŒõL1, Šâˆä’m‹v1, ’r“cOŽq1, ‹e’nG•F1, ’|àVŽO‘ãŽq
1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ46‰ñ“ú–{’_“¹Šw‰ïŠwpW‰ï
(2010/9/25), L“‡, ’_“¹ 2010/8; 24 (3): 416.

723136. [Šw‰ï (‘S‘)] (ˆê”ʉ‰‘è)y—v–]‰‰‘èz“–‰@‚É‚š‚¯‚éŠÌŠO’_ŠÇŠà‚̏p‘Of’f‚ÉŠÖ‚·‚錟“¢. Šâ
ˆä’m‹v1, –Ø“cŒõL1, ‹{àVŽu˜N1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡
ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ46‰ñ“ú–{’_“¹Šw‰ïŠwpW‰ï (2010/9/25), L“‡, ’_“¹ 2010/8;
24 (3): 422.

723137. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)y—v–]‰‰‘è: ‘’_ŠÇŒ‹ÎŽ¡—Â̌»ó‚Æ–â‘è“_zÄ”­ƒƒJƒjƒYƒ€‚Æ‚»‚Ì
‘΍ô?’_ŠÇŒ‹Î‚ɑ΂·‚éESTEEPBD‚Ì’·Šú—\ŒãEÄ”­‚ւ̑΍ô?. ’r“cOŽq1, –Ø“cŒõL1, ¬ò˜aŽO˜Y
1 (1Á‰»Ší“à): ‘æ46‰ñ“ú–{’_“¹Šw‰ïŠwpW‰ï (2010/9/25), L“‡, ’_“¹ 2010/8; 24 (3): 341

723138. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‚É‚š‚¯‚é’×ᇐ«‘å’°‰Š‚ɑ΂·‚錌‹…¬•ªœ‹Ž—Ö@‚ÌŒ»ó‚Æ—L—p
«. ‰ÍŒèû‘Ÿ˜Y1, •ìŒ«ˆê˜Y1, ‹e’n³b1,2, ˆÀ“¡@‹1,2, •ž•”—fˆê˜Y1,2, —¢“¹“N•F1,2, à_–Œr
–ç1, ŽRèDŠì1,2, –ì“o@œ1,2 (1•œ’Ë‹€Ï•a‰@, 2Á‰»Ší“à): ‘æ59‰ñ‹€ÏˆãŠw‰ï (2010/9/30), ŽD
–y, ‹€Ïˆã•ñ 2010/9; 59 (Suppl): 119.

723139. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‹~–œ‹~‹}ƒZƒ“ƒ^[‚É‚š‚¯‚éoŒŒ«Á‰»«’×ᇎ¡—Â̌»‹µ. ’†’J
Œ€“l1,2, ‹{àVŽu˜N1,2, ŽÄ“c^—RŽq1, _œä’m“¹1, Š~Œ©•¶Ž}1, •Ð‰ª—Sˆê1, ŒŠª@”Ž1, ¬ò˜aŽO˜Y
2, ‘Š”nˆêˆå1 (1‹~–œ, 2Á‰»Ší“à): ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (2010/10/10), ‰¡•l, “ú–{‹~‹}ˆãŠw‰ï
ŽGŽ 2010/8; 21 (8): 585.

723140. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) isEÄ”­ˆÝŠà‚ɑ΂·‚édocetaxel/cisplatin/S-1 (DCS) —Ö@
(KDOG0601 P2) Updated Results. ’†ŽRž“T1,2, ¬ò˜aŽO˜Y2, Œ‘º@Œ«1,2, ”óŒûŸ•F2, ²X–Ø“O2,
“c糁@‘2, ‚–ؐžˆê1, “Œ@’q2, Œ˜“ce—˜2, ’†’JŒ€“l2, ÎŒËŒªŽŸ2, –ö“c’Œ‹B1,2, –{‹Ž@C1,2
(1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ52‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (2010/10/13), ‰¡•l, “ú–{Á
‰»Ší•aŠw‰ïŽGŽ 2010/9; 107 (—Õ‘‘å‰ï): A786.

723141. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚ɂĐf’f‚µ‚œH“¹ŠàpŒãÄŒšˆÝŠÇŠà21Ç—á32•a•Ï‚ÌŒŸ“¢. –ö
“c’Œ‹B1, –{‹Ž@C1,2, Œ‘º@Œ«1,2, ’†ŽRž“T1,2, ‚–ؐžˆê1, ²–ìG–í1,2, “ìoƒ“ñ1, ÂŽR–@•v
1 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ52‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (2010/10/13), ‰¡•l, “ú–{
Á‰»Ší•aŠw‰ïŽGŽ 2010/9; 107 (—Õ‘‘å‰ï): A794.

723142. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Crohn•a‚ɑ΂·‚éInfliximabˆÛŽ—Ö@‚Ì—L—p«‚Æ–â‘è“_. ‰¡ŽR@ŒO
1, ¬—ѐŽ“T1, Œ}@”üK1, •Ÿ“‡@“µ1, ²“c”ü˜a1 (1Á‰»Ší“à): ‘æ52‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï
(2010/10/14), ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2010/9; 107 (—Õ‘‘å‰ï): A868.

723143. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) NBIŠg‘å“àŽ‹‹Ÿ‚ÅŠÏŽ@‚µ‚œIrregular microvessels (IMV) ‚É‚æ‚éA
“ª•a•Ï‚ÌŠàE”ñŠà‚̊ӕʐf’f‚ÉŠÖ‚·‚錟“¢. Œ˜“ce—˜1, “c糁@‘1, ³˜Ò@—²2, ’†ŽR–Ÿm2, ‰ª–{–q
l2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2Žš•@): ‘æ80‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/10/14), ‰¡•l,
Gastroenterological Endoscopy 2010/9; 52 (Suppl 2): 2409.

723144. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –¢•ª‰»Œ^Šà‚ð—L‚·‚鑁ŠúˆÝŠà‚É‚š‚¯‚éESD‚Ì“K‰žŠg‘å. “Œ@’q
1, “c糁@‘1, ÷–{Mˆê2 (1Á‰»Ší“à, 2ŠO‰È): ‘æ80‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/10/14), ‰¡
•l, Gastroenterological Endoscopy 2010/9; 52 (Suppl 2): 2437.

723145. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚̐isŠÌŠà‚ɑ΂·‚éƒ\ƒ‰ƒtƒFƒjƒu“Š—^‚̐¬Ñ. ‚“cŽ÷ˆê1, “ú
‚@‰›1, ’†àV‹MG1, ‰œ˜e—S‰î1, “c’†Œ«–Ÿ1, “ì–ì@•×1, “n•Ó^²1, a’J–Ÿ—²2, ¬ò˜aŽO˜Y1 (1
Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ14‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (2010/10/14), ‰¡•l, ŠÌ‘Ÿ 2010/9; 51 (Suppl
2): A622.

723146. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) CŒ^ŠÌ‰ŠƒEƒCƒ‹ƒX‚ɑ΂·‚éV‚µ‚¢RƒEƒCƒ‹ƒXÜƒXƒNƒŠ[ƒjƒ“ƒOŒn‚Ì
ŠJ”­. ’r“c³“¿1, X@‹žŽq1, ’†àV‹MG2, —LŠCN—Y1, ’c”—_•û1, ‰Á“¡é”V1 (1‰ªŽR‘åŠw, 2Á‰»
Ší“à): ‘æ14‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘å‰ï (2010/10/14), ‰¡•l, ŠÌ‘Ÿ 2010/9; 51 (Suppl 2): A586.

723147. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) f’f‚É‹ê—¶‚µ”]Žº‰Š‚𕹔­‚µ‚œ•³ü’ŽÇ‚̈ê—á. ¬–ìO“ñ1,2, ”ä
—¯ì—•1, –î–ì‹MŽj1,2, —Ž@‹M—T1,2, ‘OàV@”J1,2, ‘å–ì@—²1,2 (1ˆÉšŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ
52‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (2010/10/14), ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽGŽ 2010/9; 107 (—Õ‘‘å‰ï): A878.

723148. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘ŠúˆÝŠà‚ɑ΂·‚éESD‚ÌŽ¡—ЬÑ. ÎŒËŒªŽŸ1, “c糁@‘1, ²X
–Ø“O1, ”óŒûŸ•F1, Œ˜“ce—˜1, “Œ@’q1, ¬–с@“N1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ80‰ñ“ú–{Á‰»
Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/10/15), ‰¡•l, Gastroenterological Endoscopy 2010/9; 52 (Suppl 2): 2447.

723149. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é’_ŠÇƒJƒjƒ…ƒŒ[ƒVƒ‡ƒ“‚ÌŽÀÛ. Šâˆä’m‹v1, –Ø“cŒõL
1, ‹{àVŽu˜N1, ˆÀ“¡@‹1, ’r“cOŽq1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡ò@O
1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ80‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/10/16), ‰¡•l,
Gastroenterological Endoscopy 2010/9; 52 (Suppl 2): 2540.

723150. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 20 mmˆÈã‚Ì‘å’°Žîᇂɑ΂·‚é“àŽ‹‹ŸŽ¡—ÃŽè‹Z‚Ì‘I‘ð. ²“c”ü˜a1,
¬—ѐŽ“T1, Œ}@”üK1, •Ÿ“‡@“µ1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ¬ò˜aŽO˜Y1, ‰ªˆÀ@ŒM2 (1Á‰»Ší“à, 2
•a—): ‘æ80‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï (2010/10/16), ‰¡•l, Gastroenterological Endoscopy 2010/9;
52 (Suppl 2): 2509.

723151. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) isEÄ”­ˆÝŠà‚ɑ΂·‚éDCS—Ö@ (KDOG 0601) ‚̌㎡—Â̌Ÿ“¢. ’†
ŽRž“T1,2, ¬ò˜aŽO˜Y2, ”óŒûŸ•F2, ²X–Ø“O2, Œ‘º@Œ«1,2, “c糁@‘2, ‚–ؐžˆê1,2, “Œ@’q
2, Œ˜“ce—˜2, ’†’JŒ€“l2, –ö“c’Œ‹B1, –{‹Ž@C1,2 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ48
‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/28), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2010/9; 45 (2): 523.

723152. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Øœ•s”\ˆÝŠà‚ɑ΂·‚éƒtƒb‰»ƒsƒŠƒ~ƒWƒ“ŒnRŠàÜ•s‰žŒã‚̍RŠàÜŽ¡
—Ã. Œ‘º@Œ«1,2, ’†ŽRž“T1,2, ‚–ؐžˆê1, –ö“c’Œ‹B1, –{‹Ž@C1,2 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2
Á‰»Ší“à): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/28), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2010/9; 45 (2):
529.

723153. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “ñ“_ŒÅ’èESD‚É‚æ‚é’Œ’°ESD. –{‹Ž@C1,2, Œ‘º@Œ«1,2, ‚–Ø
žˆê1, ²–ìG–í1,2, ’†ŽRž“T1,2, –ö“c’Œ‹B1 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»Ší“à): ‘æ48‰ñ“ú
–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/28), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2010/9; 45 (2): 544.

723154. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‚—îŽÒisEÄ”­‘å’°Šà‚ɑ΂·‚éŽOŽŸŽ¡—Èȍ~‚ÌCetuximab}
Irinotecan—Ö@‚ÌŽ¡—ЬÑ. “ˆ“c@Œ°1, ˆÉ“Œ—FO1, ‘ꐌˆÀ—²1, ª–{@—m, ‘]“c@‹Ï, “ú”䌒Žu, Ô
’Ë‘s‘Ÿ˜Y, —L‰ª@m, ]ì’q‹v, ’·“ˆ@“Ö, ŒšŽŠxŽj, ŽRŽº@“n, ²X–Ø“O2, “Œ@’q2, ¬ò˜aŽO˜Y2
(1º˜a‘åŠw‰¡•lŽs–k•”•a‰@, 2Á‰»Ší“à): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/28), ‹ž“s, “ú–{
ŠàŽ¡—Êw‰ïŽ 2010/9; 45 (2): 567.

723155. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) isH“¹G•œã”çŠà‚ɑ΂·‚ép‘O/“±“üDCF—Ö@‚ÌŠÇ—•û–@‚ÉŠÖ‚·‚é
‘œŽ{Ý’²ž. Œ˜“ce—˜1, •Ð“c‰Ä–ç2, ’·£’Ê—², ×’JD‘¥, •l–{N•v, Ž…Gº, Œ‰º®”V, ×ì@•à,
“ˆ“c@—T, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ŠO‰È ): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/30), ‹ž“s, “ú
–{ŠàŽ¡—Êw‰ïŽ 2010/9; 45 (2): 991.

723156. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ’Œ’°—ǐ«ƒŠƒ“ƒpàh–E«ƒ|ƒŠ[ƒv‚Ì“àŽ‹‹Ÿf’f‚ɂ‚¢‚Ä‚ÌŒŸ“¢. Œ}@
”üK1, ¬—ѐŽ“T1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ65‰ñ“ú–{‘å’°
ãè–å•aŠw‰ïŠwpW‰ï (2010/11/26), •lŒ, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2010/9; 63 (9): 645

723157. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ’Œ’°ƒJƒ‹ƒ`ƒmƒCƒh‚̗Տ°•a—Šw“I“Á’¥‚Æ“àŽ‹‹ŸŽ¡—Â̓K‰ž‚ɂ‚¢‚Ä
‚ÌŒŸ“¢. ²“c”ü˜a1, ¬—ѐŽ“T1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ¬ò˜aŽO˜Y1, ²“¡•˜Y2 (1
Á‰»Ší“à, 2ŠO‰È): ‘æ65‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2010/11/27), •lŒ, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ
2010/9; 63 (9): 688.

723158. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŒeŽºoŒŒ‚ÌŒŸ“¢. Œ}@”üK1, ¬—ѐŽ“T1, ¬ì‘åŽu1, ‰¡ŽR@ŒO
1, ²“c”ü˜a1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ64‰ñ“ú–{Á‰»ŠÇŠw‰ï (2011/2/19), ‹ž“s.

723159. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘ŠúˆÝŠà‚Ì“¯Žž«EˆÙŽž«‘œ”­•a•Ï‚ÉŠÖ‚·‚錟“¢. ÎŒËŒªŽŸ1, “c
糁@‘1, ”óŒûŸ•F1, ²X–Ø“O1, “Œ@’q1, ¬–с@“N1, Œ˜“ce—˜1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ
83‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2011/3/4), ÂX.

731007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) isˆÝŠà‰»Šw—Ö@‚ÌŒ»ó‚Ə«—ˆ“W–]?ŒÂ•Ê‰»Ž¡—Ẩ”\
«?. ¬ò˜aŽO˜Y (Á‰»Ší“à): ŽR‰ADIFŒ€‹†‰ï (2011/2/18), •ÄŽq.

732012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ƒVƒ“ƒOƒ‹ƒoƒ‹[ƒ“¬’°“àŽ‹‹Ÿ‘}“ü–@•W€‰»‚ÌŽæ‘g. ¬
—ѐŽ“T (Á‰»Ší“à): ‘æ27‰ñÁ‰»Ší“àŽ‹‹Ÿ„i˜A—‰ï‘‰ï (2010/5/12), “Œ‹ž.

732013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ‘å’°Šà‚Ì“àŽ‹‹Ÿ‚É‚æ‚é[’B“xf’f‚ÆŽ¡—Ã?‘ŠúŠà‚ð’†
S‚É?. ¬—ѐŽ“T (Á‰»Ší“à): ‘æ12‰ñé“ŒÁ‰»ŠÇŽŸŠ³Œ€‹†‰ï (2010/6/9), “Œ‹ž.

732014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv) äX’_“¹ŽŸŠ³‚ɑ΂·‚é“àŽ‹‹ŸŽ¡—Â̌»ó‚ÆŒÀŠE?äX
‰Œ«ùN–E‚ɑ΂·‚é“àŽ‹‹ŸŽ¡—Â̌»ó‚ÆŒÀŠE?. Šâˆä’m‹v1, –Ø“cŒõL1, ‹{àVŽu˜N1, ˆÀ“¡@‹1, ’r“c
OŽq1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ
90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2010/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2010/6; 77
(1): 63.

732015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) isˆÝŠà‚ɑ΂·‚é•W€“I‰»Šw—Ö@‚ÌŠm—§‚ð–Ú
Žw‚µ‚Ä. ¬ò˜aŽO˜Y (Á‰»Ší“à), ‘æ46‰ñÁ‰»Ší•aŠw‰ïbM‰zŽx•”—á‰ï (2010/6/12), b•{.

732016. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€)yESD/EMR‚Ì’·Šú¬Ñz‘œ‚­‚̃‚ƒ_ƒŠƒeƒB[‚Æ‚Ì”äŠr
‚ðŠÜ‚ß ‘ŠúˆÝŠà‚ɑ΂·‚é“àŽ‹‹ŸŽ¡—Â̎è‹Z•ÊŒŸ“¢?ESD‚Ə]—ˆ–@‚Ì”äŠr?. ÎŒËŒªŽŸ1, “c糁@‘1,
²X–Ø“O1, ”óŒûŸ•F1, Œ˜“ce—˜1, “Œ@’q1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹
‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2010/6/12), “Œ‹ž, Progress of Digestive Endoscopy 2010/6; 77 (1): 60.

732017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) “à‰Èˆã‚Ì—§ê‚©‚ç?Early Stage. ¬ò˜aŽO˜Y (Á‰»
Ší“à): “Œ‹žˆÝŠà‰»Šw—Ö@u‰‰‰ï (2011/6/17), “Œ‹ž (‚“c”nê).

732018. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) Á‰»ŠÇˆ««Žîá‡‚Ì“àŽ‹‹Ÿ“If’fŽ¡—Â̐i•à?ESD¢
“ïÇ—á‚ɑ΂·‚éƒ}ƒ‹ƒ`ƒxƒ“ƒfƒBƒ“ƒOƒXƒR[ƒv‚Ì—L—p«?. ÎŒËŒªŽŸ1, “c糁@‘1, ²X–Ø“O1, ”óŒûŸ
•F1, ˆ¢]‘Ÿ‰ÀŽq1, “Œ@’q1, Œ˜“ce—˜1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): _“ސ쌧Á‰»Ší•aˆãŠw‰ï‘æ54
‰ñŒ€‹†‰ï (2010/6/27), _“ސì, _“ސìˆãŠw‰ïŽGŽ 2010/1; 37 (1): 72-3.

732019. [Šw‰ï (Œ€‹†‰ïE’n•û‰ï)] (‹³ˆçu‰‰“™) Interventional EUS‚ÌŒ»ó‚Ə«—ˆ. –Ø“cŒõL (Á‰»
Ší“à): “ú–{“àŽ‹‹ŸŠw‰ï’†‘’n•û‰ï (2010/6/27), ‰ªŽR.

732020. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) “ªèò•”•\ÝŠà‚̐f’f‚ÆŽ¡—à ?Å‹ß‚Ì“®Œü?. Œ˜“ce—˜
(Á‰»Ší“à): ‘æ26‰ñ‘Š–͏Á‰»Ší•aŒ€‹†‰ï (2010/7/1), _“ސì.

732021. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) isˆÝŠà‚ɑ΂·‚é•W€“I‰»Šw—Ö@‚ÌŠm—§‚ð–ÚŽw‚µ‚Ä.
¬ò˜aŽO˜Y (Á‰»Ší“à): ‰¡{‰êˆãŽt‰ïŠwpW‰ï (2010/7/6), ‰¡{‰ê.

732022. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) ˆÝŠà‰»Šw—Ö@‚Ì•W€“IŽ¡—Â̊m—§. ¬ò˜aŽO˜Y (Á‰»Ší
“à): ‘æ2‰ñÁ‰»Ší‰ÈŽŸŠ³ (2010/7/14), ‘Š–ÍŒŽ“상ƒfƒBƒJƒ‹ƒZƒ“ƒ^[.

732023. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) isˆÝŠà‚ɑ΂·‚鉻Šw—Ö@‚ÌŒ»ó‚Æ“W–]. ¬ò˜aŽO˜Y
(Á‰»Ší“à): ‘åãÁ‰»ŠÇ‚ª‚ñ‰»Šw—Ö@Œ€‹†‰ï2010”N‰Ä‹GƒZƒ~ƒi[ (2010/8/7), _ŒË.

732024. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) ˆÝŠà‰»Šw—Ö@‚ÌŒ»ó‚Æ“W–]. ¬ò˜aŽO˜Y (Á‰»Ší“à): ‘æ
10‰ñ–kŠC“¹–k—¢ˆãŠw‰ï (2010/8/21), ŽD–y.

732025. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yˆã—ÖòŠwuÀzŽŸ•a‚Ì•a‘Ô‚ÆŽ¡—Ã?ˆÝ‚ª‚ñ‚Ì•a‘Ô‚Æ–ò
•š—Ö@?. ¬ò˜aŽO˜Y (Á‰»Ší“à): •œ¬22”N“x¶ŠU‹³ˆçƒZƒ~ƒi[ (2010/9/11), “Œ‹ž.

732026. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ˆÝŠà‰»Šw—Ö@‚̐i•à?•W€Ž¡—Â̊m—§‚ð–ÚŽw‚µ‚Ä?.
¬ò˜aŽO˜Y (Á‰»Ší“à): ‘æ35‰ñ—Տ°ˆãŠwŒ€CuÀ (2010/9/18), ‘Š–Í‘å–ì.

732027. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) Á‰»ŠÇ•ÂÇ‚ɑ΂·‚éƒTƒ“ƒhƒXƒ^ƒ`ƒ“‚É‚æ‚邪‚ñŽ¡—Ðí
—ª. ¬ò˜aŽO˜Y (Á‰»Ší“à): ‘æ2‰ñFACTSZ@Webcastu‰‰‰ï (2010/10/5), •Ÿ‰ª.

732028. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ƒKƒCƒhƒ‰ƒCƒ“‚Ə«—ˆ‚Ö‚Ì“W–] (2)@ˆÝ‚ª‚ñ@1. –ò•š—Ã
–@‚ÌŒ»ó. ¬ò˜aŽO˜Y (Á‰»Ší“à): The 10ThƒIƒ“ƒRƒƒW[ƒZƒ~ƒi[ (2010/10/9), “Œ‹ž (ç‘ã“c‹æ).

732029. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) isˆÝŠà‰»Šw—Ö@‚ÌŒ»‹µ‚Ə«—ˆ“W–]?ƒI[ƒ_[ƒƒCƒh
Ž¡—Ẩ”\«?. ¬ò˜aŽO˜Y (Á‰»Ší“à): ‘æ22‰ñé“ìÁ‰»ŠíŽŸŠ³§˜b‰ï (2010/10/22), –ڍ•.

732030. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) H. pylori œ‹Û‚Ì“K‰žŠg‘å‚ɂ‚¢‚Ä. ¬ò˜aŽO˜Y (Á
‰»Ší“à): _“ސìƒwƒŠƒRƒoƒNƒ^[EƒsƒƒŠ ƒtƒH[ƒ‰ƒ€ (2010/10/27), ‘Š–Í‘å–ì.

732031. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) IBD‚Ƃ̂‚«‚ ‚¢•û?ˆãŽt‚Ì—§ê‚©‚ç?. ¬—ѐŽ“T (Á
‰»Ší“à): NPO–@l“ú–{‰ŠÇ«’°ŽŸŠ³‹Š‰ïŽåÃ (2010/10/30), “Œ‹ž.

732032. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ƒNƒ[ƒ“•a‚ɑ΂·‚é‰h—{—Ö@‚̈Ӌ`. ¬—ѐŽ“T (Á‰»
Ší“à): ‘æ12‰ñƒƒbƒhƒLƒ…[ƒuENSTŒ€‹†‰ï (2010/11/6), “Œ‹ž.

732033. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•ÊŠé‰æ) ŠÏŒŒ“IŽ¡—ÁEŒŸž‚̈À‘S‚ðŽx‰‡‚·‚é’Ž‰¹”gŒŸž‚̃mƒEƒn
ƒE ‘åŒ^ŽîᇂÆS1Žîᇂɑ΂·‚éRFA. ¬–ìO“ñ1,2, “ú‚@‰›2, ’†àV‹MG2, š •ª–ΔŽ2,3 (1ˆÉšŒŽ‹Š
“¯•a‰@, 2Á‰»Ší“à, 3‡‘å—û”n•a‰@): “ú–{’Ž‰¹”gˆãŠw‰ï‘æ21‰ñŠÖ“ŒbM‰z’n•û‰ï (2010/11/7), “Œ‹ž,
’Ž‰¹”gˆãŠw 2010/3; 37 (2): 167.

732034. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ˆÝŠà‰»Šw—Ö@‚ÌŒ»ó‚Æ“W–]?“Á‚ÉDCS—Ö@‚ɂ‚¢‚Ä?.
¬ò˜aŽO˜Y (Á‰»Ší“à): ²‰êˆÝŠà‰»Šw—Ö@Šwpu‰‰‰ï (2010/11/19), ²‰ê.

732035. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ˆÝŠà‰»Šw—Ö@‚̐i•à. ¬ò˜aŽO˜Y (Á‰»Ší“à): ‘æ36
‰ñ–k—¢ˆãŠw‰ï‘‰ï (2010/11/20), ‘Š–Í‘å–ì.

732036. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv)y–å–¬ˆ³˜ŽiÇ‚̉摜f’f, ‹@”\‰æ‘œf’fz3D’Ž
‰¹”g‚ð—p‚¢‚œäB—eÏ‘ª’è‚ÌReliability‚ÆValidity‚ɂ‚¢‚Ä‚ÌŒŸ“¢. “ú‚@‰›1, ’†‘ò‹MG1, a’J–Ÿ
—²2 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ38‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (2010/12/2), “Œ‹ž, ŠÌ‘Ÿ 2010/10; 51
(Suppl 3): A696.

732037. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŠÌŠà‚̉摜f’f‚Ɛf—Âւ̃Cƒ“ƒpƒNƒgz
Gd-EOB-DTPA‘¢‰eMRI‚̊̍זE‘Š‚Å’áM†‚ð’æ‚·‚é–RŒŒ«ŠÌŽîᇂ̌oŽž“I•Ï‰»‚ÉŠÖ‚·‚錟“¢. “c’†Œ«–Ÿ
1, ’†àV‹MG1, “ú‚@‰›1 (1Á‰»Ší“à): ‘æ38‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (2010/12/2), “Œ‹ž, ŠÌ‘Ÿ 2010/10;
51 (Suppl 3): A700.

732038. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŠÌ×–EŠà‚ɑ΂·‚镪Žq•W“IŽ¡—Öò‚Ì–ðŠ„zisŠÌ
×–EŠà‚ɑ΂·‚éƒ\ƒ‰ƒtƒFƒjƒuŽ¡—Ã?PIVKA-II‚Ì•Ï‘J‚ÆŽ¡—ÃŒø‰Ê‚Æ‚ÌŒŸ“¢?. ’†àV‹MG1, “ú‚@‰›1, a
’J–Ÿ—²2 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ38‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (2010/12/3), “Œ‹ž, ŠÌ‘Ÿ (2010/10),
51 (Suppl 3): A713.

732039. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv)yIBDz“àŽ‹‹Ÿ“I”S–ŒŽ¡–ü‚̈Ӌ`?’×ᇐ«‘å’°‰Š‚Ì
Š°‰ð“±“üŽž‚Ì“àŽ‹‹ŸŠŒ©‚É‚æ‚éÄ”­‚Ì—\‘ª?. ‰¡ŽR@ŒO1, ¬—ѐŽ“T1 (1Á‰»Ší“à): ‘æ91‰ñ“ú–{Á‰»
Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2010/12/10), “Œ‹ž, Progress of Digestive Endoscopy 2010/12; 78 (1): 72.

732040. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒrƒfƒIƒ[ƒNƒVƒ‡ƒbƒv)yERCPzƒJƒjƒ…ƒŒ[ƒVƒ‡ƒ“‚ÌŠî–{‚ƍH•v?“–
‰@‚É‚š‚¯‚é’_ŠÇƒJƒjƒ…ƒŒ[ƒVƒ‡ƒ“‚ÌŠî–{‚ƍH•v?. Šâˆä’m‹v1, –Ø“cŒõL1, ‹{àVŽu˜N1, ’r“cOŽq1, ˆÀ
“¡@‹1, ’|àVŽO‘ãŽq1, ‹e’nG•F1, r–ؐ³—Y1, “n•Ó–€–ç1, ¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à):
‘æ91‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2010/12/11), “Œ‹ž, Progress of Digestive Endoscopy
2010/12; 78 (1): 76.

732041. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ’Tõ“I—Տ°Œ€‹† (äXEˆÝ‚ª‚ñ‚ð‘ΏÛ). ¬ò˜aŽO˜Y (Á
‰»Ší“à): NEDO Start-up Meeting (2010/12/16), “Œ‹ž (Žsƒ–’J).

732042. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘ŠúˆÝŠàፍ­‡•¹—á‚ɑ΂·‚éDouble scope ESD
(single trans method) ‚Ì—L—p«. ”óŒûŸ•F1, “c糁@‘1, ²X–Ø“O1, “Œ@’q1, ÎŒËŒªŽŸ1, Œ˜“c
e—˜1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ39‰ñ_“ސìˆÝŠàŽ¡—ÃŒ€‹†‰ï (2010), ‰¡•l.

732043. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ‘Šú’Œ’°Šà‚ɑ΂·‚鎡—Ö@‚Ì‘I‘ð‚ÆŽ¡—ЬÑ. ²“c”ü
˜a1, ¬—ѐŽ“T1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ¬ò˜aŽO˜Y1, ²“¡•˜Y2, “n粏¹•F2, ŽOŽ}@M
3 (1Á‰»Ší“à, 2ŠO‰È, 3•a—): ‘æ74‰ñ‘å’°ŠàŒ€‹†‰ï (2011/1/21), •Ÿ‰ª.

732044. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ‘å’°”ñã”琫Žîᇂ̐f’f‰ß’ö‚Æ’Ž‰¹”g“àŽ‹‹Ÿf’f‚̈Ó
‹`. Œ}@”üK1, ¬—ѐŽ“T1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1, ²“¡•
˜Y2, ŽOã“N•v3 (1Á‰»Ší“à, 2ŠO‰È, 3•a—): ‘æ75‰ñ‘å’°ŠàŒ€‹†‰ï (2011/1/21), •Ÿ‰ª, ƒvƒƒOƒ‰ƒ€E
Ž˜^W 2011/1; p.49.

732045. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ˆÝŠà‰»Šw—Ö@?¡Šm‚©‚ȃGƒrƒfƒ“ƒX?.
¬ò˜aŽO˜Y (Á‰»Ší“à): Tokyou Symposium of Gastric Cancer 2011 (2011/2/19), “Œ‹ž(ŠÛ‚Ì“à).

732046. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ‘å’°ŒeŽºoŒŒ‚Ì“àŽ‹‹Ÿf’f‚ÆŽ¡—Ã. ²“c”ü˜a1, ¬—Ñ
Ž“T1, Œ}@”üK1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ¬ò˜aŽO˜Y1, ²“¡•˜Y2, “n粏¹•F2 (1Á‰»Ší“à, 2ŠO
‰È): ‘æ47‰ñ_“ސì‘å’°ŽŸŠ³Œ€‹†‰ï (2011/2/24), ‰¡•l.

733026. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) BCAA»Ü‚ð—p‚¢‚œŠÌd•Ï‚ÌQOL‰ü‘P‚ÖŒü‚¯‚œŽæ‚è‘g‚Ý?
ƒŠ[ƒoƒNƒg‚ð—p‚¢‚œ‘œŽ{Ý‹Š“¯Œ€‹†‚ɂ‚¢‚Ä?. “ú‚@‰›1, “ì–ì@•×1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “n
粐^²1, ’†‘ò‹MG1, a’J–Ÿ—²2, ¬ò˜aŽO˜Y1, ŒBŠ|L“ñ1,3, ŽRèDŠì1,4, ”üŒŽÃ1,5, Â–Ø‚¢‚Ã
‚Ý6, ‘å’ˏr˜a1,7, “y‹Ž@Œ’1,8, ’†–ìŽj˜Y1,9, ²“¡‘ˆê˜Y10, ó—té”V11, ‘å–ì@—²1,12 (1Á‰»
Ší“à, 2ˆã—ÈÀ‘SEŠÇ—, 3ŒBŠ|ƒNƒŠƒjƒbƒN, 4•œ’Ë‹€Ï•a‰@, 5‘Š–Í–ì•a‰@, 6“ŒŽÅ—ÑŠÔ•a‰@, 7’Ëvˆä
Ô\Žš•a‰@, 8‚‚¿‚Í‚µƒNƒŠƒjƒbƒN, 9Šp’†ƒNƒŠƒjƒbƒN, 10²“¡ˆã‰@, 11‚ ‚³‚Γà‰ÈEÁ‰»Ší‰ÈƒNƒŠƒjƒb
ƒN, 12ˆÉšŒŽ‹Š“¯•a‰@): ‘æ2‰ñWŠw“IÃ–¬áŽŽ¡—ÃŒ€‹†‰ï (2010/5/15), “Œ‹ž, Gastroenterological
Endoscopy 2010/4; 52 (Suppl 1): 1138.

733027. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰ NBIŠÏŽ@‚µ‚Š‚œ’ᕪ‰»Œ^‘ŠúŠà‚̈ê—á. ŠÝŒŽ‹Pm1, ç–ì
»Žq1, ›ÀF‹I1, ¡ˆä1, ŠÝ@‹’‰1, ‰Yã®”V1, ¬ì‘åŽu1,2, ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ•a
‰@, 2Á‰»Ší“à): ‘æ5‰ñ‘å’°Šg‘å“àŽ‹‹ŸŒ€‹†‰ï (2010/5/15), “Œ‹ž, Gastroenterological Endoscopy
2010/4; 52 (Suppl 1): 1151.

733028. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŠÌd•ÏŠ³ŽÒ‚É‚š‚¢‚ÄOlmesartan Medoxomil‚ÍTGF-ƒÀ1‚Ì
ŽY¶‚ð—LˆÓ‚É—}§‚·‚é. “ú‚@‰›1, ’†àV‹MG1, “ì–ì@•×1, “c’†Œ«–Ÿ1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “n
粐^²1, a’J–Ÿ—²2, š •ª–ΔŽ1,3, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—, 3‡‘å—û”n•a‰@): ‘æ
41‰ñŠÌŠàÇ—ጟ“¢‰ï (2010/5/15), “Œ‹ž.

733029. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) •úŽËü {ƒ\ƒ‰ƒtƒFƒjƒu•¹—p—Ö@‚ª—LŒø‚Å‚ ‚Á‚œ‚“x–¬ŠÇ
ŽîᇐZ‚𔺂Á‚œis‹‘åŠÌ×–EŠà‚Ì1—á. ’†àV‹MG1, “ú‚@‰›1, ‰œ˜e—T‰î1, ‚“cŽ÷ˆê1, “c’†Œ«
–Ÿ1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ41‰ñŠÌŠàÇ—ጟ“¢‰ï (2010/5/15), “Œ‹ž.

733030. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) TAEŽ¡—Õs”\‚ÌVEGF–ƉuõF—z«‚̊̍זEŠà‚ɑ΂µ–ñ2
TŠÔ‚̃\ƒ‰ƒtƒFƒjƒu“Š—^‚ɂĉ摜ã‚Ì’˜Œø‚ª“Ÿ‚ç‚ê‚œ1—á. “c’†Œ«–Ÿ1, “ú‚@‰›1, ‘å•”@œ2, ’|“à
“ÖŽq1, “ì–ì@•×1, ‚“cŽ÷ˆê1, ‰œ˜e—T‰î1, “n粐^²1, ’†àV‹MG1, a’J–Ÿ—²3, ¬ò˜aŽO˜Y1 (1Á
‰»Ší“à, 2ˆã—Éq¶Šw•”, 3ˆã—ÈÀ‘SEŠÇ—): ‘æ41‰ñŠÌŠàÇ—ጟ“¢‰ï (2010/5/15), “Œ‹ž.

733031. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) –«CŒ^ŠÌ‰Š‚ɑ΂·‚éƒyƒOƒCƒ“ƒ^[ƒtƒFƒƒ“ƒ¿2aEƒŠƒo
ƒrƒŠƒ“Eƒtƒ‹ƒoƒ`ƒXƒ^ƒ“•¹—p“Š—^ŽŽŒ± (pilot study). ‚“cŽ÷ˆê1, ’†àV‹MG1, “ú‚@‰›1, “n粐^²
1, ‰œ˜e—T‰î1, “c’†Œ«–Ÿ1, “ì–ì@•×1, a’J–Ÿ—²2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ
41‰ñŠÌŠàÇ—ጟ“¢‰ï (2010/5/15), “Œ‹ž.

733032. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) •úŽËü+ƒ\ƒ‰ƒtƒFƒjƒu•¹—p—Ö@‚ª—LŒø‚Å‚ ‚Á‚œ‚“x–¬ŠÇŽî
ᇐZ‚𔺂Á‚œis‹‘åŠÌ×–EŠà‚Ì1—á. “ì–ì@•×1, ’†àV‹MG1, “ú‚@‰›1, ‰œ˜e—S‰î1, ‚“cŽ÷ˆê
1, “c’†Œ«–Ÿ1, ŽR–{@‘n1, “n粐^²1, a’J–Ÿ—²2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ
309‰ñÁ‰»Ší•aŠw‰ïŠÖ“ŒŽx•”‰ï (2010/5/22), “Œ‹ž.

733033. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒJƒbƒ^[ƒiƒCƒt‚Ì“Eo‚ÉŽ©‰Æ»æ’[ƒt[ƒh‚ª—LŒø‚Å‚ ‚Á
‚œ1—á. ’†–Ú“N•œ1, “c糁@‘1, ‹à@–Ÿ“N1, ‘剪³•œ1, ŽR–{@‘n1, ²“¡@•¶1, ÎŒËŒªŽŸ1, ˆ¢]
‘Ÿ‰ÀŽq1, “Œ@’q1, ’†’JŒ€“l1, ”óŒûŸ•F1, ²X–Ø“O1, Œ˜“ce—˜1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ
90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2010/6/1), “Œ‹ž, Progress of Digestive Endoscopy 2010/6; 77
(1): 84.

733034. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) isˆÝŠà‚Æ‚ÌŠÓ•Ê‚É‹ê—¶‚µ‚œˆÝ”~“ł̈ê—á. ²“¡@•¶
1, ²X–Ø“O1, “c糁@‘1, ÎŒËŒªŽŸ1, “Œ@’q1, Œ˜“ce—˜1, ”óŒûŸ•F1, ¬ò˜aŽO˜Y1 (1Á‰»Ší
“à): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2010/6/11), “Œ‹ž, Progress of Digestive Endoscopy
2010/6; 77 (1): 85.

733035. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚—îŽÒ‚Ì‘’_ŠÇŒ‹ÎÇ‚ɑ΂·‚é“àŽ‹‹ŸŽ¡—Ã. ‰œ˜e‹»‰î
1, –Ø“cŒõL1, ’r“cOŽq1, ‘剪³•œ1, ²“Œäm1, ‹{àVŽu˜N1, Šâˆä’m‹v1, ˆÀ“¡@‹1,2, ‹e’rG•F
1, ’|àVŽO‘ãŽq1, r–ؐ³—Y1,3, ‰F’Ö؋±Žq1,4, ŽRèDŠì1,2, Ž­ŠÔM–Ÿ1, “n•Ó–€–ç1,3, –Ø“c–FŽ÷1,
¡ò@O1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2•œ’Ë‹€Ï•a‰@, 3‘Š–ÍŒŽ‹Š“¯•a‰@, 4•£–ì•Ó‘‡•a‰@): ‘æ90
‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2010/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2010/6; 77
(1): 95.

733036. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’Œ’°GIST‚ÌŠm’èf’f‚É’Ž‰¹”g“àŽ‹‹Ÿ‰ºúŽh‹zˆø×–Ef/
¶ŒŸ‚ª—L—p‚Å‚ ‚Á‚œ2—á. Œ}@”üK1, ¬—ѐŽ“T1, •Ÿ“‡@“µ1, ¬ì‘åŽu1, ‰¡ŽR@ŒO1, ²“c”ü˜a1, –Ø
“cŒõL1, ¬ò˜aŽO˜Y1, ²“¡•˜Y2, “n粏¹•F2, ŽOã“N•v3, ‰ªˆÀ@ŒM3 (1Á‰»Ší“à, 2ŠO‰È, 3•a—):
‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2010/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2010/6;
77 (1): 96.

733037. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’×ᇐ«‘å’°‰ŠŒo‰ß’†‚Ɉ««ƒŠƒ“ƒpŽî‚ð‡•¹‚µ‚œ1—á. –î
–ì‹MŽj1, ‰¡ŽR@ŒO1, ’†–Ú“N•œ1, ‰Á“¡@Ê1, Œ}@”üK1, •Ÿ“‡@“µ1, ²“c”ü˜a1, ¬—ѐŽ“T1, ¬ò
˜aŽO˜Y1, ŒŽ@“ÖŽq2, ‰ªˆÀ@ŒM2, ’dŒŽŠ²¶3 (1Á‰»Ší“à, 2•a—, 3ŒŒ‰t“à): ‘æ90‰ñ“ú–{Á‰»Ší“àŽ‹
‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2010/6/11), “Œ‹ž, Progress of Digestive Endoscopy 2010/6; 77 (1): 98.

733038. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ˆÝ‰ßŒ`¬ƒ|ƒŠ[ƒv‚©‚çŠà‰»‚ð”F‚ß‚ç‚ê‚œÇ—á. ŽOŽ}—zˆê
1,2, ”üŒŽÃ1,2, ’|‰º’me1,2, ‰HœAŒ’m1, ŠøŽè˜a•F11, ‹g“c@‹I1, ŒŒ³Ž›ŽâX1,2, ‘åˆä“c³l
1,2 (1ŽÐ•Û‘Š–Í–ì•a‰@, 2Á‰»Ší“à): ‘æ55‰ñ_“ސ쌧Á‰»Ší•aŒ€‹†‰ï (2010/6/19), ‰¡•l.

733039. [Šw‰ï (Œ€‹†‰ïE’n•û‰ï)] (ˆê”ÊŒû‰‰) ¬l’°‰ñ“]ˆÙíÇ‚̈ê—á. –kì”Ž”V1,2, –î–ì‹MŽj1,2,
—Ž@‹M—T1,2, ‘OàV@”J1,2, ¬–ìO“ñ1,2, ‘å–ì@—²1,2, Œ‰ª“¹l1, ‰LìŽl˜Y1 (1ˆÉšŒŽ‹Š“¯•a‰@, 2
Á‰»Ší“à): ‘æ55‰ñ_“ސ쌧Á‰»Ší•aŒ€‹†‰ï (2010/6/19), ‰¡•l.

733040. [Šw‰ï (Œ€‹†‰ïE’n•û‰ï)] (ˆê”ʍu‰‰) isˆÝŠàŽ¡—Âɂš‚¯‚éS-1‚ð—p‚¢‚œŒÂ•Ê‰»ˆã—Âւ̓W–]
?5FU‘ãŽÓŠÖ˜Ay‘f‚𒆐S‚É?. “Œ@’q1, ¬–с@“N1, ÎŒËŒªŽŸ1, Œ˜“ce—˜1, ²X–Ø“O1, ”óŒûŸ
•F1, “c糁@‘1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ12‰ñ_“ސìÁ‰»ŠíŠà‰»Šw—Ö@ƒJƒ“ƒtƒ@ƒŒƒ“ƒX
(2010/6/25), ‰¡•l.

733041. [Šw‰ï (Œ€‹†‰ïE’n•û‰ï)] (ˆê”ÊŒû‰‰) ’†’°Ž²”P“]Ç‚𔺂Á‚œ¬l’°‰ñ“]ˆÙíÇ‚̈ê—á. –kì
”Ž”V1,2, —Ž@‹M—T1,2, ‘OàV@”J1,2, ¬–ìO“ñ1,2, ‘å–ì@—²1,2, Œ‰ª“¹l1, ‰LìŽl˜Y1 (1ˆÉšŒŽ
‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ10‰ñŒ_“ސìÁ‰»ŠíƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/7/7), Œú–Ø.

733042. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Hemosuccus pancreaticus‚ª‹^‚í‚ê‚œã•”Á‰»ŠÇoŒŒ‚Ì1
—á. “n•ÓWŽ¯1, ’†’JŒ€“l1, ”óŒûŸ•F1, ÎŒËŒªŽŸ1, “Œ@’q1, Œ˜“ce—˜1, ²X–Ø“O1, “c糁@‘
1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ310‰ñÁ‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï (2010/7/10), “Œ‹ž.

733043. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) AŒ^ˆÝ‰Š‚ɍ‡•¹‚µ‚œˆÝƒJƒ‹ƒ`ƒmƒCƒh‚É“àŽ‹‹ŸŽ¡—ÂðŽ{s
‚µ‚œ1—á. –ö“c’Œ‹B1, Œ‘º@Œ«1,2, ’†ŽRž“T1,2, –{‹Ž@C1,2 (1_“ސ쌧—§‚ª‚ñƒZƒ“ƒ^[, 2Á‰»
Ší“à): ‘æ574‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2010/7/11), “Œ‹ž.

733044. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰Eƒ|ƒXƒ^[) ’_äX“àŽ‹‹Ÿ‚ÌŠî–{Žè‹Z?EUS-FNA?. ¡ò@O
1, –Ø“cŒõL1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ17‰ñ_“ސ쌧Á‰»Ší“àŽ‹‹Ÿ§’k‰ï (2010/8/26), ‰¡•l.

733045. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) BCAAè÷—±»Ü‚ð—p‚¢‚œŠÌd•Ï‚ÌQOL‰ü‘P‚É‚Â
‚¢‚Ä?‘œŽ{Ý‹Š“¯Œ€‹†‚É‚æ‚éŽæ‚è‘g‚Ý?. “ú‚@‰›1, ŒBŠ|L“ñ1,2, ŽRèDŠì1,3, ”üŒŽÃ1,4, Â
–Ø‚¢‚ÂÝ5, ‘å’ˏr˜a1,6, “y‹Ž@Œ’1,7, ’†–ìŽj˜Y1,8, ²“¡‘ˆê˜Y9, ó—té”V10, ‘å–ì—²1,11 (1Á
‰»Ší“à, 2ŒBŠ|ˆã‰@, 3•œ’Ë‹€Ï•a‰@, 4‘Š–Í–ì•a‰@, 5“ŒŽÅ—ÑŠÔ•a‰@, 6’ËvˆäÔ\Žš•a‰@, 7‚‚¿‚Í‚µ
ƒNƒŠƒjƒbƒN, 8Šp’†ƒNƒŠƒjƒbƒN, 9²“¡ˆã‰@, 10‚ ‚³‚Γà‰ÈEÁ‰»ŠíƒNƒŠƒjƒbƒN, 11ˆÉšŒŽ‹Š“¯•a‰@): ‘æ
12‰ñŠÌ•s‘SŽ¡—ÃŒ€‹†‰ï (2010/9/10), •xŽR, “ú–{–å–¬ˆ³˜ŽiÇŠw‰ïŽGŽ 2010/8; 16 (2): 142.

733046. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) \“ñŽw’°“û“ª•”¶ŒŸ‚ªf’f‚̈ꏕ‚Æ‚È‚Á‚œŽ©ŒÈ–Ɖu«äX
‰Š‚Ì1—á. ‹àŽq@‹œ1, ‹e’nG•F1, –Ø“cŒõL1, Šâˆä’m‹v1, ‹{àVŽu˜N1, ’|àVŽO‘ãŽq1, ¡ò@O1, ¬
ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ311‰ñÁ‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï (2010/9/11), “Œ‹ž.

733047. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐ«‘å’°‰Š‚ɑ΂·‚éV‹KŽ¡—Ã?RTNF-ƒ¿R
‘̐»Ü?. ‰¡ŽR@ŒO1, ¬—ѐŽ“T1 (1Á‰»Ší“à): ‘æ2‰ñTNF-ƒ¿‘jŠQÜ‚̃ƒJƒjƒYƒ€‚ðl‚Š‚é‰ï
(2010/9/16), “Œ‹ž.

733048. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Long segmental stenosis‚ð’悵‚œ, ‹t—¬«H“¹‰Š‚ªŒŽ
ˆö‚ÆŽv‚í‚ê‚éH“¹‹·ó‚Ì1—á. ŽR“à_Žj1,2, ˆîŠ_‘דl1, ç“c«”n1, ŠÖªŠG—œŽq1, ‰œ˜e‹»‰î1,2, ‰Í
Œèû‘Ÿ˜Y1, ¬–с@“N1,2, ˆÀ“¡@‹1,2, •ž•”—fˆê˜Y1,2, —¢“¹“N•F1,2, à_–Œr–ç1, ŽRèDŠì1,2, –ì
“o@œ1,2 (1•œ’Ë‹€Ï•a‰@, 2Á‰»Ší“à): _“ސ쌧Á‰»Ší•aˆãŠw‰ï‘æ42‰ñ‘‰ï (2010/10/10), _“ސì,
_“ސìˆãŠw‰ïŽGŽ 2010/7; 37 (2): 259.

733049. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒJƒbƒ^[ƒiƒCƒt‚Ì“Eo‚ÉŽ©‰Æ»æ’[ƒt[ƒh‚ª—LŒø‚Å‚ ‚Á
‚œ1—á. ’†–Ú“N•œ1, “c糁@‘1, ‹à@–Ÿ“N1, ²“¡@•¶1, ÎŒËŒªŽŸ1, ˆ¢]‘Ÿ‰ÀŽq1, “Œ@’q1, ’†
’JŒ€“l1, ”óŒûŸ•F1, ²X–Ø“O1, Œ˜“ce—˜1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ43‰ñ_“ސ쌧Á‰»Ší•a
ˆãŠw‰ï (2010/11/6), ‰¡•l.

733050. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‚IgG4ŒŒÇ‚𔺂€ŠÌ‰ŠÇ«‹UŽîᇠ(IPT) ‚Æ”x‘œ”­Z
‰e‚ð’悵‚œƒAƒ‹ƒR[ƒ‹«ŠÌd•Ï‚Ì1—á. ˜a“c‘ñ–ç1, “n粐^²1, ‹àŽq@‹œ1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ
˜e—T‰î1, “ú‚@‰›1, a’J–Ÿ—²2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ576‰ñ“ú–{“à‰ÈŠw
‰ïŠÖ“Œ’n•û‰ï (2010/11/13), “Œ‹ž, ‘æ576‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010/11; p.40.

733051. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “ªèò•”•\ÝŠà‚ÌŽ¡—Ð헪?“àŽ‹‹Ÿ“I”S–ŒØœp (EMR) ‚Ì
—§ê‚©‚ç?. Œ˜“ce—˜1, ’†ŽR–Ÿm2, ³˜Ò@—²2, Œ—tG‹N2, ‰ª–{—·l2, ‰ª–{–ql2, “c糁@‘1, ¬
ò˜aŽO˜Y1 (1Á‰»Ší“à, 2Žš•@): ‘æ8‰ñ“ªèò•”•\ÝŠàŒ€‹†‰ï (2010/11/27), ç—t.

733052. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŠÌd•Ï‚Ɗ̍זEŠà‚ÅŒo‰ßŠÏŽ@’†‚É’_”XoŒŒ‚ð‚«‚œ‚µ‚œˆê
—á. ‹àŽq@‹œ1, “ú‚@‰›1, ‚‹ŽW•F1, ‚“cŽ÷ˆê1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “n糐^²1, a’J–Ÿ—²
2, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ38‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (2010/12/2), “Œ‹ž, ŠÌ
‘Ÿ 2010/10; 51 (Suppl 3): A728.

733053. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Gd-EOB-DTPA‘¢‰eMRI‚É‚æ‚éŠÌ×–EŠà‰æ‘œf’f‚É‚š‚¯‚é
ŠgŽU‹­’²‰æ‘œ•¹—p‚̈Ӌ`. ‰œ˜e—T‰î1, ’†àV‹MG1, “ú‚@‰›1 (1Á‰»Ší“à): ‘æ38‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ
•”‰ï (2010/12/2), “Œ‹ž, ŠÌ‘Ÿ 2010/10; 51 (Suppl 3): A769.

733054. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’×ᇐ«‘å’°‰Š‚ÌŒo‰ßŠÏŽ@’†‚ɈôŒã”^á‡, ’†“a‹Ø”^ᇂð‚«
‚œ‚µ‚œ1—á. ‹àŽq@‹œ1, ²“c”ü˜a1, Œ}@”üK1, ‰¡ŽR@ŒO1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à):
‘æ312‰ñÁ‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï (2010/12/4), “Œ‹ž.

733055. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž¡—Âɓïa‚·‚écollagenous colitis‚Ì1—á. ‰œ˜e‹»‰î
1, ‰¡ŽR@ŒO1, Œ}@”üK1, ¬ì‘åŽu1, ²“c”ü˜a1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1, ŒŽ@“ÖŽq2 (1Á‰»Ší
“à, 2•a—): ‘æ91‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2010/12/10), “Œ‹ž, Progress of Digestive
Endoscopy 2010/12; 78 (1): 96.

733056. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “ÁˆÙ“I‚È“àŽ‹‹Ÿ‘œ‚ð’悵, ƒvƒŒƒhƒjƒ]ƒƒ“ (PSL) ‚ª’˜Œø
‚µ‚œCollagenous colitis‚̈ê—á. ‹gàV“Þ’ÃŽq1,2, ç–쏻Žq1, ¡ˆä1, ŒE“c@Šw1, ŠÝ@‹’‰1, ŠÝ
ŒŽ‹Pm1, —с@—TŽq1, ‰Yã®”V1, ŒÜ\—’³L1,2 (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): ‘æ91‰ñ“ú–{Á‰»Ší
“àŽ‹‹ŸŠw‰ïŠÖ“Œ’n•û‰ï (2010/12/10), “Œ‹ž, Progress of Digestive Endoscopy 2010/12; 78 (1): 96.

733057. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰Eƒ|ƒXƒ^[) RŒŒð—Ö@‚Ə㕔Á‰»ŠÇoŒŒ. ¡ò@O1, “c
糁@‘1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): —Տ°ŒŒðEŽ~ŒŒƒtƒH[ƒ‰ƒ€2011 (2011/1/13), _“ސì.

733058. [Šw‰ï (Œ€‹†‰ïE’n•û‰ï)] (ˆê”ʍu‰‰) isˆÝŠàŽ¡—Âɂš‚¯‚éS-1‚ð—p‚¢‚œŒÂ•Ê‰»ˆã—Âւ̓W–]
?5FU‘ãŽÓŠÖ˜Ay‘f‚𒆐S‚É?. “Œ@’q1, ¬–с@“N1, ÎŒËŒªŽŸ1, Œ˜“ce—˜1, ²X–Ø“O1, ”óŒûŸ
•F1, “c糁@‘1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ20‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€ (2011/1/28), ‘Š–ÍŒŽ.

733059. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) “–‰@‚É‚š‚¯‚éƒAƒ‹ƒR[ƒ‹«ƒPƒgƒAƒVƒh[ƒVƒX‚̗Տ°“I“Á
’¥. ’†’JŒ€“l1,2, ‹{àVŽu˜N1,2, ŽÄ“c^—RŽq1, ãžŠ‹gl1, ‘Š”nˆêˆå1 (1‹~–œ, 2Á‰»Ší“à): ‘æ61
‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2011/2/5), ‰¡•l.

733060. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’Œ’°úE‚É‚æ‚éúE«• –Œ‰Š‚𓯎ž”­Ç‚µ‚œŠÌŒŒŠÇ“÷Žî
”j—ô‚̈ê—á. “n粍WŽ¯1, ‹{àVŽu˜N1,2, ’†’JŒ€“l1,2, ŽÄ“c^—RŽq2, Š~Œ©•¶Ž}2, ƒEƒbƒhƒnƒ€ƒX—æŽq
3, •Ð‰ª—Sˆê2, ŒŠª@”Ž2, ‘Š”nˆêˆå2 (1Á‰»Ší“à, 2‹~–œ, 3•úŽËü (‰æ‘œ)): ‘æ61‰ñ“ú–{‹~‹}ˆãŠw
‰ïŠÖ“Œ’n•û‰ïŠwpW‰ï (2011/2/5), ‰¡•l.

733061. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) äX“ª•”‚Æ”ö•”‚Ì2‰ÓŠ‚ÉŽî᎑œ‚ð”F‚ß‚œŽ©ŒÈ–Ɖu«äX‰Š
‚Ì1—á. ’r“c@”™1, ‹e’nG•F1, –Ø“cŒõL1, Šâˆä’m‹v1, ‹{àVŽu˜N1, ’|àVŽO‘ãŽq1, ¡ò@O1, ¬
ò˜aŽO˜Y1 (1Á‰»Ší“à): ‘æ578‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2011/2/12), “Œ‹ž, ‘æ578‰ñ“ú–{“à‰ÈŠw‰ï
ŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/2; p.37.

733062. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒAƒ[ƒo«ŠÌ”^ᇂ̎¡—Ã’†, “ñÜ‚݂̂ɂďœ‹Û‚ɐ¬Œ÷‚µ
“Á”­«ŒŒ¬”ÂŒž­«Ž‡”Á•a‚àŽ¡–ü‚µ‚œ1—á. ¬–ìO“ñ1,2, –kì”Ž”V1,2, —Ž@‹M—T1,2, ‘OàV@”J1,2,
‘å–ì@—²1,2 (1ˆÉšŒŽ‹Š“¯•a‰@, 2Á‰»Ší“à): ‘æ578‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2011/2/12), “Œ‹ž, ‘æ
578‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/2; p.43.

733063. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) CŒ^ŠÌd•Ï‚ɍ‡•¹‚µ‚œŠÌƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. “ú‚@
‰›1, ‚“cŽ÷ˆê1, “ì–ì@•×1, “c’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “n粐^²1, ’†àV‹MG1, a’J–Ÿ—²2, ¬ò˜aŽO
˜Y1 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ—): ‘æ313‰ñÁ‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï (2011/2/26), “Œ‹ž.

733064. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) œ‹Û—Ö@‚ª‘tŒ÷‚µ‚œˆÝ‹‘吗åüÇ‚Ì1—á. ¬–с@“N1, “c
糁@‘1, ÎŒËŒªŽŸ1, “Œ@’q1, ²X–Ø“O1, ”óŒûŸ•F1, ¬ò˜aŽO˜Y1, ’†’JŒ€“l1, Œ˜“ce—˜1 (1
Á‰»Ší“à): ‘æ313‰ñÁ‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï (2011/2/26), “Œ‹ž.

733065. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒyƒOƒCƒ“ƒ^[ƒtƒFƒƒ“EƒŠƒoƒrƒŠƒ“—Ö@’†‚É–Ô–Œ“®–¬•ª
Ž}•ÂÇÇ (BRAO)E–Ô–Œ’†SÃ–¬•ÂÇÇ (CRVO) ‚𗈂µ‚œˆê—á. ‚‹ŽW•F1, “n粐^²1, ‚“cŽ÷ˆê1, “c
’†Œ«–Ÿ1, ‰œ˜e—T‰î1, “ú‚@‰›1, ’†àV‹MG1, ¬ò˜aŽO˜Y1, a’J–Ÿ—²2 (1Á‰»Ší“à, 2ˆã—ÈÀ‘SEŠÇ
—): ‘æ313‰ñÁ‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ï 2011/2/26), “Œ‹ž, ‘æ313‰ñÁ‰»Ší•aŠw‰ïŠÖ“ŒŽx•”—á‰ïƒvƒƒO
ƒ‰ƒ€ 2011/2; p.8.

733066. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž¡—Âɋꗶ‚µ‚œ¬’°‹·óÇ—á‚Ì1—á. ‰Á“¡@Ê
1, ‰¡ŽR@ŒO1, Œ}@”üK1, ¬ì‘åŽu1, ‹v•Û“c”ü˜a1, ¬—ѐŽ“T1, ¬ò˜aŽO˜Y1 (1Á‰»Ší“à): _“ސì
Œ§‰ŠÇ«’°ŽŸŠ³u‰‰‰ï (2011/3/4), ‰¡•l.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-520003. [‘à]y‰Æ‘°«‘å’°Šàf—Âɂš‚¯‚é•W€‰»‚̈Ӌ`‚ƉۑèzLynchÇŒóŒQ‚̃T[ƒxƒCƒ‰ƒ“
ƒX‚É‚š‚¯‚é‘å’°“àŽ‹‹Ÿ‚š‚æ‚я㕔Á‰»ŠÇ“àŽ‹‹Ÿ‚É‚æ‚é•a•Ï‚Ì”­Œ©•p“x‚Æ•a—Šw“IŠŒ©‚ÉŠÖ‚·‚錟“¢. V
ˆä³”ü, ¬ì‘åŽu1,2, ç–쏻Žq1, ‘q‰ªŒ«•ã, ŽR–{—Š³, “¡è‡Žq, ŒÜ\—’³L1,2, ã–ì‰ëŽ‘, “¡–{‰À
–ç, •–ö—m–í, ‘å–•q, ”äŠé’ŒŽ÷, •Ÿ‰i@“N, ‘åŽR”ɘa, ²–ì@•1, ‰Á“¡@ŒO, “y“c’mG, Œ³ˆä‹IŽq,
Ž­Žæ³“¹, ŽR–{’q—Žq, ‰Á“¡@—m, Îì—Yˆê, ŽRŒûr°, •“¡“Oˆê˜Y (1ŠàŒ€—L–Ÿ•a‰@, 2Á‰»Ší“à): ‰Æ
‘°«Žîᇠ2010/1; 10 (1): 32-8.

H21-520004. [‘à]y–å–¬‚ÆäB‘Ÿ‚Ìup datezI. –å–¬@3. –å–¬ˆ³˜ŽiÇ‚ɑ΂·‚é–ò•š—Ö@?H“¹Ã
–¬áŽ‚𒆐S‚É?. “ú‚@‰› (Á‰»Ší“à): ŠO‰È 2010/1; 72 (1): 13-7.

[’˜@‘]

H21-620009. [Šwp‘] (•ª’SŽ·•M)y‰ŠÇ«’°ŽŸŠ³zCTEMRIf’f, p.74-7. ¬—ѐŽ“T (Á‰»Ší“à),
•Ò “ú”ä‹I•¶, ˆãŠw‘‰@, “Œ‹ž, 2010/1”­s.

H21-620010. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚̐f’fŽwjzŽŸŠ³•Ò@H“¹Ã–¬áŽ, p.696-9. “ú‚@‰› (Á
‰»Ší“à), ‘•ÒW ‹ààVˆê˜Y, ‰iˆä—ÇŽO, ˆãŠw‘‰@, “Œ‹ž, 2010/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H21-733001. [Šw‰ï (Œ€‹†‰ïE’n•û‰ï)] (µ‘ҍu‰‰) “ªèò•”•\ÝŠà‚̐f’f‚ÆŽ¡—Ã. Œ˜“ce—˜ (Á‰»
Ší“à): ‘æ6‰ñ‹S“{ìƒtƒH[ƒ‰ƒ€ (2010/3/6), “È–Ø.


zŠÂŠí“à‰ÈŠw

[Šwp˜_•¶]

110093. [ŒŽ’˜] Importance of Morphological Changes in T-U waves During Bepridil Therapy as a
Predictor of Ventricular Arrhythmic Event. Kurokawa S, Niwano S1, Kiryu M, Murakami M, Ishikawa
S, Yumoto Y1, Moriguchi M, Niwano H1, Kosukegawa T, Izumi T1: Circ J 2010/5; 74 (5): 876-84. (•
ì‘–, ’ë–ìTˆê1, ‹Ë¶“T˜N, ‘ºã‰ë”ü, Îì®Žq, “’–{‰ÀG1, XŒû¹O, ’ë–ì—TŒb1, ¬•ì’mŽq,
˜aò@“O1: 1zŠÂŠí“à)

110094. [ŒŽ’˜] Vascular response to overlapping everolimus-eluting stents - Comparison with
paclitaxel-eluting stents. Otake H, Honda Y, Yamasaki M, Tsujino I, Shimohama T1, Sakurai R,
Hasegawa T, Waseda K, Ako J, Fitzgerald PJ: Circ J 2010/5; 74 (5): 1023-5. (‰º•lF˜Y1: 1zŠÂ
Ší“à)

110095. [ŒŽ’˜] Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are
associated with metabolic components in high-risk patients with cardiovascular disease.
Yamaoka-Tojo M1, Tojo T2, Takahira N1, Matsunaga A1, Aoyama N2, Masuda T1, Izumi T2: Cardiovasc
Diabetol 2010/5; 14: 17. (“ŒžŠ”ü“ÞŽq1, “ŒžŠ‘å‹P2, ‚•œ®L1, Œ‰i“Ä•F1, ÂŽR’Œ‘P2, ‘“c@‘ì
1, ˜aò@“O2: 1ˆã—Éq¶Šw•”, 2zŠÂŠí“à)

110096. [ŒŽ’˜] Myocardial infarction in a premenopausal woman with a decreased serum estrogen level
due to leuprorelin acetate. Sasaki T, Kurosawa T, Yamaguchi H, Yanagisawa T, Arikawa A, Takemura
H, Ikeda Y, Izumi T1: Journal of Cardiology Cases 2010/6; 1 (3): 171-5. (˜aò@“O1: 1zŠÂŠí“à)

110097. [ŒŽ’˜] Preventive Effect of Amiodarone on VT/VF Events in ICD Patients with Structural
Heart Diseases. Kiryu M1, Niwano S1, Kishihara J, Aoyama Y, Ishikawa S, Murakami M, Kurokawa S,
Yumoto Y1, Imaki R2, Fukaya H1, Niwano H1, Izumi T1: Journal of Arrhythmia 2010/6; 26 (4): 250-8.
(‹Ë¶“T˜N1, ’ë–ìTˆê1, ŠÝŒŽ@~, ÂŽR—S–ç, Îì®Žq, ‘ºã‰ë”ü, •ì‘–, “’–{‰ÀG1, ¡–Ø—²
‘Ÿ2, [’J‰p•œ1, ’ë–ì—TŒb1, ˜aò@“O1: 1zŠÂŠí“à, 2‹~–œ)

110098. [ŒŽ’˜] Systemic acidosis in acute myocardial ischemia--cause or result of
life-threateningventricular arrhythmia? Niwano S1, Tojo T1: Circ J 2010/9; 74 (9): 1794-5. (’ë
–ìTˆê1, “ŒžŠ‘å‹P1: 1zŠÂŠí“à)

110099. [ŒŽ’˜] SPIRIT III JAPAN versus SPIRIT III USA: A Comparative Intravascular Ultrasound
Analysis of the Everolimus-Eluting Stent. Shimohama T1, Ako J, Yamasaki M, Otake H, Tsujino I,
Hasegawa T, Nakatani D, Sakurai R, Chang H, Kusano H, Waseda K, Honda Y, Stone GW, Saito S, Fitzgerald
PJ, Sudhir K: Am J Cardiol 2010/7; 106 (1): 13-7. (‰º•lF˜Y1: 1zŠÂŠí“à)

110100. [ŒŽ’˜] Comparison of everolimus- versus paclitaxel-eluting stents implanted in patients
with diabetes mellitus as evaluated by three-dimensional intravascular ultrasound analysis. Otake
H, Ako J, Yamasaki M, Tsujino I, Shimohama T1, Hasegawa T, Sakurai R, Waseda K, Honda Y, Sood P,
Sudhir K, Stone GW, Fitzgerald PJ: Am J Cardiol 2010/8; 106 (4): 492-7. (‰º•lF˜Y1: 1zŠÂŠí“à)

110101. [ŒŽ’˜] Incidence of diffuse and focal chronic stent recoil after implantation of current
generation bare-metal and drug-eluting stents. Koo BK, Waseda K, Ako J, Hasegawa T, Shimohama
T1, Nakatani D, Otake H, Yamasaki M, Sakurai R, Tsujino I, Honda Y, Fitzgerald PJ: Int J Cardiol
2010/9; 144 (1): 132-4. (‰º•lF˜Y1: 1zŠÂŠí“à)

110102. [ŒŽ’˜] A National Survey on Myocarditis Associated With the 2009 Influenza A (H1N1)
Pandemic in Japan. Ukimura A, Izumi T1, Matsumori A: Circ J 2010/10; 74 (10): 2193-9. (˜aò@“O
1: 1zŠÂŠí“à)

110103. [ŒŽ’˜] Prognostic value of gated myocardial perfusion imaging for asymptomatic patients
with type 2 diabetes: the J-ACCESS 2 investigation. Yamasaki Y, Nakajima K, Kusuoka H, Izumi T1,
Kashiwagi A, Kawamori R, Shimamoto K, Yamada N, Nishimura T: Diabetes Care 2010/11; 33 (11): 2320-6.
(˜aò@“O1: 1zŠÂŠí“à)

110104. [ŒŽ’˜] Risks and Benefits of Combined Use of Bucolome and Warfarin in Anticoagulation
Therapy. Hatakeyama Y1, Niwano S1, Niwano H1, Kosukegawa T1, Izumi T1: Int Heart J 2010/11; 51
(6): 399-403. (”©ŽR—SŽq1, ’ë–ìTˆê1, ’ë–ì—TŒb1, ¬•ì’mŽq1, ˜aò@“O1: 1zŠÂŠí“à)

110105. [ŒŽ’˜] Combined effects of up- and downstream therapies on atrial fibrillation in a canine
rapid stimulation model. Fukaya H1, Niwano S1, Niwano H1, Masaki Y, Kiryu M1, Hirasawa S1, Sato
D1, Moriguchi M, Izumi T1: Int J Cardiol 2010/12; [Epub ahead of print]. ([’J‰p•œ1, ’ë–ìTˆê
1, ’ë–ì—TŒb1, ^è‹`•F, ‹Ë¶“T˜Y1, •œàV³ŽŸ1, ²“¡‘å•ã1, XŒû¹•F, ˜aò@“O1: 1zŠÂŠí“à)

110106. [ŒŽ’˜] Preventive Effect of Amiodarone on VT/VF Events in ICD Patients with Structural
Heart Diseases. Kiryu M1, Niwano S1, Kishihara J2, Aoyama Y1, Ishikawa S2, Murakami M2, Kurokawa
S2, Yumoto Y1, Imaki R3, Fukaya H1, Niwano H1, Izumi T1: Journal of Arrhythmia 2010; 26 (4): 250-8.
(‹Ë¶“T˜Y1, ’ë–ìTˆê1, ŠÝŒŽ@~2, ÂŽR—S–ç2, Îì®Žq2, ‘ºã‰ë”ü2, •ì‘–2, “’–{‰ÀG1,
¡–Ø—²‘Ÿ3, [’J‰p•œ1, ’ë–ì—TŒb1, ˜aò@“O1: 1zŠÂŠí“à, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‹~–œ

110107. [ŒŽ’˜] Prognostic significance of right ventricular dimension on acute decompensation in
chronic left-sided heart failure. Maekawa E1, Inomata T1, Watanabe I, Yanagisawa T1, Mizutani
T, Shinagawa H, Koitabashi T1, Takeuchi I2, Tokita N, Inoue Y3, Izumi T1: Int Heart 2011/3; 52
(2): 119-26. (‘OìŒb”ü1, ’––”FŒ³1, –öàV’q‹`1, ¬”‹Žr”ü1, ’|“àˆê˜Y2, ˆäã—D‰î3, ˜aò@“O
1: 1zŠÂŠí“à, 2‹~–œ, 3•úŽËü (‰æ‘œ))

110108. [ŒŽ’˜] Circulating interleukin-18: A specific biomarker for atherosclerosis-prone
patients with metabolic syndrome. Yamaoka-Tojo M1, Tojo T2, Wakaume K, Kameda R, Nemoto S, Takahira
N1, Masuda T1, Izumi T2: Nutr Metab (Lond) 2011/1; 8: 3. (“ŒžŠ”ü“ÞŽq1, “ŒžŠ‘å‹P2, ‚•œ®L1, ‘
“c@‘ì1, ˜aò@“O2: 1ˆã—Éq¶Šw•”, 2zŠÂŠí“à)

110109. [ŒŽ’˜] N-acetylcysteine suppresses the progression of ventricular remodeling in acute
myocarditis. Niwano S1, Niwano H1, Sasaki S1, Fukaya H1, Yuge M1, Imaki R2, Machida Y, Izumi T1:
Circ J 2011/3; 75 (3): 662-71. (’ë–ìTˆê1, ’ë–ì—TŒb1, ²X–؎щh1, [’J‰p•œ1, ‹|í@‘å1, ¡
–Ø—²‘Ÿ2, ’¬“c—z“ñ, ˜aò@“O1: 1zŠÂŠí“à, 2‹~–œ)

120010. [ŒŽ’˜] ƒCƒkS–[×“®ƒ‚ƒfƒ‹‚É‚š‚¯‚éRAŒn—}§–ò‚̍ì—p‹@˜. ’ë–ìTˆê (zŠÂŠí“à): S“d}
2010/5; 30 (2): 178-80.

120011. [ŒŽ’˜] ƒxƒvƒŠƒWƒ‹—LŒø—á–³Œø—á‚É‚š‚¯‚é‘Ì•\–ʐS“d}T”g•Ï‰»‚ÌŒŸ“¢. •ì‘–1, ’ë–ìT
ˆê2, ‹Ë¶“T˜Y2, [’J‰p•œ2, ”©ŽR—SŽq1, “’–{‰ÀG2, XŒû¹•F, ˜aò@“O2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2
zŠÂŠí“à): S“d} 2010/5; 30 (Supll 1): S1-8.

320003. [Ç—á•ñ] –Ɖu—}§—Ö@–¢Ž{s‚ÌŒo‰ß’†‚ÉŒy‰õ‚Æ‘ˆ«‚𗈂µ‚œS‘ŸƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á.
–öàV’q‹`1, ’––”FŒ³1, ¬”‹Žr”ü1, ÂŽR’Œ‘P1, Ž›è•¶¶, ˜aò@“O1 (1zŠÂŠí“à): ŒÄ‹z‚ƏzŠÂ
2010/4; 58 (4): 435-40.

320004. [Ç—á•ñ] S–[•p”‚̏Ď܂ÉCARTO merge‚ª—L—p‚Å‚ ‚Á‚œƒtƒ@ƒ[Žl’¥ÇpŒã‚Ì1—á. ”©ŽR—S
Žq1, “’–{‰ÀG2, •ì‘–1, ‹Ë¶“T˜Y2, ¡–Ø—²‘Ÿ3, ’ë–ìTˆê2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí
“à, 3‹~–œ): S‘Ÿ 2010/12; 42 (Supll 4): 44-9.

320005. [Ç—á•ñ] ‘m–X•ÙŒ`¬p‚š‚æ‚э¶ŽºŒ`¬p‚ɂăJƒeƒRƒ‰ƒ~ƒ“ˆË‘¶«S•s‘S‚©‚ç—£’E‚µ“Ÿ‚œŽˆ‘Ñ
Œ^‹ØƒWƒXƒgƒƒtƒB[S‹ØÇ‚̈ê—á. ²“¡@—z1, ’––”FŒ³2, ¬”‹Žr”ü2, ˆé‘º@³, ÂŽR’Œ‘P2, •i
ì–íl2, ŒˆäŠîŒp2, ˜aò@“O2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2zŠÂŠí“à): ŒÄ‹z‚ƏzŠÂ 2010/8; 58 (8):
843-7.

510005. [‘à] Ezetimibe and reactive oxygen species. Yamaoka-Tojo M1, Tojo T2, Takahira N1,
Masuda T1, Izumi T2: Curr Vasc Pharmacol 2011/1; 9 (1): 109-20. (“ŒžŠ”ü“ÞŽq1, “ŒžŠ‘å‹P2, ‚•œ
®L1, ‘“c@‘ì1, ˜aò@“O2: 1ˆã—Éq¶Šw•”, 2zŠÂŠí“à)

520051. [‘à]yÀ’k‰ïzS–[×“®Š³ŽÒ‚É‚š‚¯‚éR‹ÃŒÅ—Ö@‚̏d—v«. ‘ŠàV‹`–[, ‚ŒŽœŽi, ¥P”VG,
’ë–ìTˆê1 (1zŠÂŠí“à): Pharma Medica 2010/9; 28 (9): 89-94.

520052. [‘à]y˜b‘è‚Ì‚­‚·‚èzƒAƒŠƒXƒLƒŒƒ“ƒtƒ}ƒ‹Ž_‰–. ÂŽR’Œ‘P (zŠÂŠí“à): “ú–{•a‰@–òÜŽt‰ïŽG
Ž 2010/8; 46 (8): 1153-7.

521003. [‰ðà] S‹Ø‰Š‚É‚š‚¯‚éSŽº«•s®–¬‚ɑ΂·‚éR•s®–¬–ò‚Ì“Š—^‚Í, ƒKƒCƒhƒ‰ƒCƒ“‚É”œ‚·‚ésˆ×
‚Æ‚µ‚ĉߌë‚Æ‚Ý‚È‚³‚ê‚é‚©. ÂŽR’Œ‘P (zŠÂŠí“à): ˆã—Ô»—á‰ðà 2010/6; 26: 115-7.

521004. [‰ðà]yƒgƒsƒbƒNƒXz‰ŠÇ‚ƐS–[×“®. ’ë–ìTˆê (zŠÂŠí“à): ÅVˆãŠw 2010/6; 65 (7): 125-9.

521005. [‰ðà] “ú–{zŠÂŠíŠw‰ïê–åˆãŽŽŒ±‰ðà. ’|Î‹±’m, ŒŽ@˜aO, Šy–؍GŽÀ, ”ö’ҁ@–L, ì‘º—Sˆê
˜Y, ’ë–ìTˆê1 (1zŠÂŠí“à): zŠÂŠíê–åˆã 2010/9; 18 (2, •Êû): 374-80.

521006. [‰ðà] ˆãŠw‚ƈã—Â̍őOü?dÇS•s‘S‚̏WŠw“IŽ¡—Ã?. dÇS•s‘S‚̏WŠw“IŽ¡—Ã. ˜aò@
“O (zŠÂŠí“à): “ú–{“à‰ÈŠw‰ïŽGŽ 2010/10; 99 (10): 2558-70.

521007. [‰ðà]yŽ¿‹^‰ž“šzS–[×“®E‘e“®‚Ì•\‹L. ’ë–ìTˆê (zŠÂŠí“à): “ú–{ˆãŽ–V•ñ 2010/12; 4521:
77-8.

521008. [‰ðà]y¡†‚̃nƒCƒ‰ƒCƒg‡BzS‹Ø‰Šf’f‚É‚š‚¯‚éS‘ŸMRI. ’––”FŒ³ (zŠÂŠí“à): “ú–{W’†
Ž¡—ÈãŠw‰ïŽGŽ 2011/1; 18 (1): 8-10.

522015. [uÀ]y’–ڂ̈ã—ÍőOüzS•s‘S‚Ì‹}«Šú‚©‚疝«Šú‚ÉŽŠ‚鎟•aŠÇ—. ’m——r˜Y, ’––”FŒ³
1 (1zŠÂŠí“à): ƒi[ƒVƒ“ƒOƒgƒDƒfƒC 2010/5; 25 (6): 54-5.

522016. [uÀ]y“ÁW: “«S•s‘S‚ɑ΂·‚é”ñ–ò•š—Ö@‚̍őOüz[f‚é] 1. “«S•s‘S‚ÌOverview.
…’J’m‘×, ˜aò@“O1 (1zŠÂŠí“à): Heart View 2010/6; 14 (6): 8-13.

522017. [uÀ]y“ÁW: “«S•s‘S‚ɑ΂·‚é”ñ–ò•š—Ö@‚̍őOüz[Ž¯‚é] 6. “«S•s‘S‚Ɋׂé•a‘Ô
‚ðŽ¯‚é@c. S‹Ø‰Š. ’––”FŒ³ (zŠÂŠí“à): Heart View 2010/6; 14 (6): 54-9.

522018. [uÀ]y“ÁW: ‹~‹}f—Âɂš‚¯‚éS“d}f’fzIII. ŽŸŠ³‚©‚ç‚Ý‚éS“d}ˆÙí@4. S–Œ‰Š, S‹Ø
‰Š, ”xŒŒðÇðÇ, ”x‚ŒŒˆ³‚ð‹^‚€S“d}. ’––”FŒ³ (zŠÂŠí“à): ‹~‹}ˆãŠw 2010/6; 34 (6): 677-82.

522019. [uÀ]yzŠÂŠí–ò?ŒÂ•Ê‚ɉž‚¶‚œ“KØ‚ÈŽg—p–@zŠe–òÜ‚Ì“KØ‚ÈŽg—p–@@ƒWƒMƒ^ƒŠƒX. ’––”F
Œ³ (zŠÂŠí“à): f’f‚ÆŽ¡—à 2010/6; 98 (6): 925-8.

522020. [uÀ]y“ÁW: Common Disease‚Æ‚µ‚Ă̐S–[×“®‚̐f‚©‚œz S–[×“®‚ÌŒŸžEŽ¡—Ẫtƒ[?
‰f‚©‚çê–åˆãÐ‰î‚Ü‚Å (5)@–ò•šŽ¡—Ẫ|ƒCƒ“ƒg?ÄfŽž@RŒŒð—Ö@‚Ì’²®‚ƃŠƒYƒ€ƒRƒ“ƒgƒ[ƒ‹.
’ë–ìTˆê (zŠÂŠí“à): “ú–{ˆãŽ–V•ñ 2010/7; 4501: 38-42.

522021. [uÀ]y“ÁW: zŠÂŠíŽŸŠ³‚Ì‹tƒŠƒ‚ƒfƒŠƒ“ƒOzS•s‘S‚É‚š‚¯‚é‹tƒŠƒ‚ƒfƒŠƒ“ƒO. ’––”FŒ³ (z
ŠÂŠí“à): ŒÄ‹z‚ƏzŠÂ 2010/7; 58 (7): 683-8.

522022. [uÀ]y“ÁW: ‚±‚±‚܂Ői‚ñ‚Ÿ •s®–¬Œ€‹†‚̍ŐV“®Œü?S–[×“®‚ð‚ß‚®‚éV“WŠJzS–[×“®?
ƒAƒbƒvƒXƒgƒŠ[ƒ€Ž¡—Â̗Տ°“IˆÓ‹`?. ’ë–ìTˆê (zŠÂŠí“à): ˆãŠw‚Ì‚ ‚ä‚Ý 2010/8; 234 (6): 678-84.

522023. [uÀ]y“ÁW: S‹ØÇES‹Ø‰Š?Šî‘b‚ƗՏ°‚̍őOü2010z’–Ú‚³‚ê‚éS‹Ø‰Š?Œ€ÇŒ^S‹Ø‰Š
?. ‘OìŒb”ü1, ˜aò@“O1 (1zŠÂŠí“à): ‘Ž‡—Õଠ2010/8; 59 (8): 1760-65.

522024. [uÀ]y“ÁW: S‹ØÇES‹Ø‰Š?Šî‘b‚ƗՏ°‚̍őOü2010z’–Ú‚³‚ê‚éS‹Ø‰Š?DŽ_‹…«S‹Ø
‰Š?. ’––”FŒ³ (zŠÂŠí“à): ‘Ž‡—Õଠ2010/8; 59 (8): 1772-5.

522025. [uÀ] S•s‘S‚Æ•nŒŒ, ‚»‚µ‚Ä“SŒ‡–R. ˜aò@“O (zŠÂŠí“à): MMJ 2010/9; 9ŒŽ†: 363.

522026. [uÀ] S“d}ƒNƒCƒY. ’ë–ìTˆê (zŠÂŠí“à): S“d} 2010/10; 30 (4): 327-33.

522027. [uÀ]y“ÁW: ‹}«S•s‘Sz6. ‹}«S•s‘S‚É‚š‚¯‚éƒoƒCƒIƒ}[ƒJ[@(2) ‚±‚ê‚©‚ç‚̃gƒƒ|ƒj
ƒ“‚̉ʂœ‚·‚ׂ«–ðŠ„, ‚»‚µ‚ÄBNP‚Æ‚Ì”äŠr. ’––”FŒ³ (zŠÂŠí“à): INTENSIVIST 2010/10; 2 (4): 709-14.

522028. [uÀ]y“ÁW: Šg’£ŠúS•s‘S‚ÌŽ¡—Âɂš‚¯‚éEBM?Œ»ó‚ƍ¡Œã‚Ì“W–]?zŠg’£ŠúS•s‘S‚ÌŽ¡—à (‹}
«Šú). ’––”FŒ³ (zŠÂŠí“à): CIRCULATION Up-to-Date 2010/10; 5: 39-44.

522029. [uÀ]y“ÁW: zŠÂŠí–ò‚ÌŽg‚¢•û?ƒRƒc‚Æ—Ž‚Æ‚µŒŠ?z1. zŠÂŠíŽŸŠ³‚Ì–ò•šŽ¡—Ã?Overview?@
b. –«S•s‘S. …’J’m‘×, ˜aò@“O1 (1zŠÂŠí“à): Heart View 2010/11; 14 (12): 14-23.

522030. [uÀ]y“ÁW: zŠÂŠí–ò‚ÌŽg‚¢•û?ƒRƒc‚Æ—Ž‚Æ‚µŒŠ?z3. zŠÂŠí–ò‚ÌŽg‚¢•û‚ƃRƒc@b. •s®–¬
Ž¡—Á@1 IŒQR•s®–¬–ò. ’ë–ìTˆê (zŠÂŠí“à): Heart View 2010/11; 14 (12): 162-6.

522031. [uÀ]y“ÁW: zŠÂŠí–ò‚ÌŽg‚¢•û?ƒRƒc‚Æ—Ž‚Æ‚µŒŠ?z5. ƒgƒsƒbƒNƒX@b. ƒoƒ]ƒvƒŒƒVƒ“V2Žó
—e‘̝hR–ò/ƒgƒ‹ƒoƒvƒ^ƒ“. ’––”FŒ³ (zŠÂŠí“à): Heart View 2010/11; 14 (12): 266-70.

522032. [uÀ]y“ÁW: AED‚ðŒŸØ‚·‚ézS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚É‚š‚¯‚éAED. –ì“cçt1, ˜aò@“O
1 (1zŠÂŠí“à): ŒÄ‹z‚ƏzŠÂ 2010/11; 58 (11): 1121-5.

522033. [uÀ]y“ÁW: “úíf—ÂŐf‚銎õÇ?‚±‚ÌŽŸŠ³‚ðŒ©—Ž‚Æ‚·‚ȁzf’f‚Ì’x‚ꂪ’vŽ€“I‚ɂȂ銎õ
Ç?‹}«S‹Ø‰ŠESŠO–Œ‰Š?. ’––”FŒ³ (zŠÂŠí“à): “à‰È 2010/11; 106 (5): 800-5.

522034. [uÀ]yzŠÂŠíŽŸŠ³‚Ì•a‘ԂƐf’fEŽ¡—à (II)zS‹Ø[Ç. ‰––ì•û–Ÿ, ˜aò@“O1 (1zŠÂŠí“à):
ˆãŠw‚Æ–òŠw 2010/12; 64 (6): 829-33.

522035. [uÀ]y“ÁW: “à‰ÈŽ¡—ÃsƒbƒgƒtƒH[ƒ‹zII. zŠÂŠí@S•s‘S. ’––”FŒ³ (zŠÂŠí“à): “à‰È
2010/12; 106 (6): 1002-6.

522036. [uÀ]y“ÁW: ‹}«S•s‘SÇŒóŒQŠÇ—‚̃pƒ‰ƒ_ƒCƒ€ƒVƒtƒgz‹}«S•s‘SÇŒóŒQ‚̌ċzŠÇ—. …
’J’m‘×, ’––”FŒ³1 (1zŠÂŠí“à): ICU‚ÆCCU 2011/1; 35 (1): .43-50.

522037. [uÀ]y˜AÚ: EBM Hot FlashzCIBIS-ELD. ’––”FŒ³ (zŠÂŠí“à): CARDIAC PRACTICE 2011/1;
22 (1): 83-5.

522038. [uÀ]y“ÁW: –«ŽŸŠ³‚Ì‹}«‘ˆ«@•a‘Ô‚Ì—‰ð‚ÆŽ¡—Â̎ÀÛz1. –«S•s‘S‚Ì‹}«‘ˆ«. ’–
–”FŒ³ (zŠÂŠí“à): ‹~‹}ˆãŠw 2011/1; 35 (1): 3-6.

522039. [uÀ]y“ÁW: S•s‘S‚ɑ΂·‚éS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚ÌŽÀÛzS•s‘S‚ɑ΂·‚é•W€“I–ò•šŽ¡—Ã.
–ì“cçt1, ˜aò@“O1 (1zŠÂŠí“à): zŠÂŠí“à‰È 2011/3; 69 (3): 203-9.

530002. [‚»‚Ì‘Œ (Comment)] Cardiac-troponin-guided heart failure management: is it possible in
clinical practice? Inomata T: Circ J 2011/3; 75 (3): 542-3. (’––”FŒ³: zŠÂŠí“à)

540023. [‚»‚Ì‘Œ (Editorial Comment)] “cè˜_•¶‚ɑ΂·‚éEditorial Comment?Œ€ÇŒ^S‹Ø‰Š‚ł̕⏕
zŠÂ?‚¢‚©‚ɐ؂萷‚è‚·‚é‚©. ’––”FŒ³ (zŠÂŠí“à): S‘Ÿ 2010/11; 42 (11): 1498-9.

540024. [‚»‚Ì‘Œ (‘Î’k)]yƒwƒ‹ƒV[ƒg[ƒNzŒ€ÇŒ^S‹Ø‰Š‚©‚ç‰ñ•œul¶ŠÏ‚ª•Ï‚í‚è‚Ü‚µ‚œv (ŽR–{—z
ˆê (”o—D) vs. ˜aò@“O). ˜aò@“O (zŠÂŠí“à): •é‚µ‚ÆŒ’N 2010/12; 2011”N2ŒŽ†: 47-52.

540025. [‚»‚Ì‘Œ] ‚±‚ê‚©‚ç‚̐SƒŠƒnŠw‰ï‚ÉŠú‘Ò‚·‚邱‚Æ. ˜aò@“O (zŠÂŠí“à): S‘ŸƒŠƒnƒrƒŠƒe[ƒV
ƒ‡ƒ“ 2011/2; 16 (1): 3-4.

[’˜@‘]

620048. [Šwp‘] (•ª’SŽ·•M)y—Տ°ˆã‚Ì‚œ‚߂̏zŠÂŠíf—Áz–«S•s‘S‚ÌŽ¡—Ã?‚±‚±‚ª’m‚è‚œ‚¢?–«
S•s‘SƒKƒCƒhƒ‰ƒCƒ“…Žç‚Ɖ^—pã‚Ì’ˆÓ“_, p.18-22. ¬”‹Žr”ü1, ˜aò@“O1 (1zŠÂŠí“à), ‹Š˜aŠé
‰æ, “Œ‹ž, 2010/4”­s.

620049. [Šwp‘] (•ª’SŽ·•M)yƒzƒ‹ƒ^[S“d}‹L˜^’†‚Ì“Ë‘RŽ€—áz‹}«S‹Ø[Ç p.84-6. “’–{‰ÀG1,
’ë–ìTˆê1 (1zŠÂŠí“à), •Ò “c粍W‹v, “ú–{ƒzƒ‹ƒ^[ƒmƒ“ƒCƒ“ƒxƒCƒVƒuS“dŠwŒ€‹†‰ï, 2010/6”­s.

620050. [Šwp‘] (•ª’SŽ·•M)yzŠÂŠíƒTƒsƒA 8@S•s‘S‚Ì‹}«Šú‘Ήžz2Í: S•s‘S‹}«Šú‚ÌŽ¡—Öò‚ð
Žg‚¢‚±‚È‚·@D. CahR–ò, p.80-3. ’––”FŒ³ (zŠÂŠí“à), ‘•ÒW ‰iˆä—ÇŽO, Ó”C•ÒW –k•—­Žj, •Ò
W‹Š—Í ‹à@’q—², ’†ŽR‘“X, “Œ‹ž, 2010/6”­s.

620051. [Šwp‘] (•ª’SŽ·•M)yƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“@Šî–{‚©‚çÅVŽ¡—Â܂Š‰ü’ù2”ŁzƒKƒCƒhƒ‰
ƒCƒ“‚ÉŠî‚­ƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“, p.102-7. ’ë–ìTˆê (zŠÂŠí“à, •Ò ‘ŠàV‹`–[, ‰œ‘º@Œª,
Medical ViewŽÐ, “Œ‹ž, 2010/7”­s.

620052. [Šwp‘] (•ª’SŽ·•M)yŠ³ŽÒŽ˜^‚Å‹†‚ß‚ézŠÂŠí•aƒVƒŠ[ƒY3@S•s‘Sz‘æ‚SÍ Š³ŽÒ‚ÉŠw‚ԐS•s
‘S‚̐f’f‚ÆŽ¡—Á@3. “Á’èS‹ØÇ@1. ‹}«S‹Ø‰Š, p.165-74. –öàV’q‹`1, ˜aò@“O1 (1zŠÂŠí“à), •Ò
“›ˆä—T”V, —r“yŽÐ, “Œ‹ž, 2010/9”­s.

620053. [Šwp‘] (•ª’SŽ·•M)yzŠÂŠíƒi[ƒX‚Ì‚œ‚ß‚Ì•s®–¬Ž¡—ÂƃPƒA (ƒn[ƒgƒi[ƒVƒ“ƒO2010”NH‹G
‘Š§)z1Í •s®–¬‚Æ‚Í?@•s®–¬‚̏Ǐó‚ƏŠŒ©, p.28-32. ’ë–ìTˆê (zŠÂŠí“à), ŠÄC ÔÎ@œ, ƒƒf
ƒBƒJo”Å, ‘åã, 2010/10”­s.

620054. [Šwp‘] (•ª’SŽ·•M)yzŠÂŠíê–åˆãŒ€CƒeƒLƒXƒgzŽŸŠ³•Ò@8. S‹ØŽŸŠ³@a. S‹Ø‰Š, p..250-2.
’––”FŒ³ (zŠÂŠí“à), ŠÄC ‹gìƒˆê, •Ò “n•ÓO”V, ‘å–å‰ë•v, •¶Œõ“°, 2011/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

711001. [Šw‰ï (‘Û)] (“Á•Êu‰‰) The role of beta blockers in the treatment of heart failure
-Learning from clinical practice-. Inomata T1: The 14th Scentific Session of the Society of
Cardiovascular Endocrinology and Metabolism (2010/4/1), Nara. (’––”FŒ³1: 1zŠÂŠí“à)

711002. [Šw‰ï (‘Û)] (“Á•Êu‰‰) Real World Experience of SES in complex cases. Shiono T1, Saito
S: GIGS2010 (2010/6/12), ŒcB, ŠØ‘. (‰––ì•û–Ÿ1: 1zŠÂŠí“à)

712039. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Risk stratification and Treatment Approaches in
Acute Heart Failure. Inomata T1 (The 5th Asian Pacific Congress of Heart Failure (2010/4/16),
ƒvƒTƒ“, ŠØ‘. (’––”FŒ³1: 1zŠÂŠí“à)

713047. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Immunomodulatory effects of amiodarone to ameliorate
rat autoimmune myocarditis. Inomata T1, Izumi T1: XX World Congress ISHR 2010 Kyoto (2010/5/13),
Kyoto. (’––”FŒ³1, ˜aò@“O1: 1zŠÂŠí“à)

713048. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Role of experimental autoimmune myocarditis on
green-fluorescent-protein-expressing T cells. Inomata T1, Izumi T1: XX World Congress ISHR 2010
Kyoto (2010/5/13), Kyoto. (’––”FŒ³1, ˜aò@“O1: 1zŠÂŠí“à)

713049. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Transradial Renal Angioplasty for Fibromuscular
Dysplasia (FMD) of young female. Shiono T1, Izumi T1: TCTAP2010 (2010/5/29), ƒ\ƒEƒ‹, ŠØ‘. (‰–
–ì•û–Ÿ1, ˜aò@“O1: 1zŠÂŠí“à)

713050. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Patient Selection and Therapeutic Strategy for
Emergency Percutaneous Cardiopulmonary System in Cardiopulmonary Arrest Patients. Aoyama N1, Imai
H2, Kono K1, Kato S1 Nishinari, M, Fukuda N, Kurosawa T, Soma K2, Izumi T1: World Congress of
Cardiology Scientific Sessions 2010 (2010/6/18), Beijing, China. (ÂŽR’Œ‘P1, ¡ˆä@Š°2, ‰Í–ì@
Œ’1, ‰Á“¡L‘Ÿ˜N1, ‘Š”nˆêˆå2, ˜aò@“O1: 1zŠÂŠí“à, 2‹~–œ)

713051. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Anti-inflammatory effects of pentraxin 3 in human
visceral adipocytes by reducing reactive oxygen species production. Yamaoka-Tojo M, Tojo T1: ESC
Congress 2010 (2010/8/29), Stockholm, Sweden. (“ŒžŠ‘å‹P1: 1zŠÂŠí“à)

713052. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Up-regulations of Extracellular Matrix Genes in Atrial
Fibrillation. -A Global mRNA Profiling in the Canine Experimental Atrial Fibrillation Model-.
Kishihara J, Niwano S1, Niwano H1, Fukaya H1, Masaki Y, Kiryu M1, Kurokawa S, Aoyama Y1, Izumi
T1: ESC Congress 2010 (2010/8/29), Stockholm, Sweden. (’ë–ìTˆê1, ’ë–ì—TŒb1, [’J‰p•œ1, ‹Ë¶
“T˜Y1, ÂŽR’Œ‘P1, ˜aò@“O1: 1zŠÂŠí“à)

713053. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Atorvastatin suppresses the up-regulation of
connective tissue growth factor (CTGF) and atrial tissue fibrosis in canine model of atrial
fibrillation. Kiryu M1, Niwano S1, Niwano H1, Fukaya H1, Masaki Y, Kishihara J, Aoyama Y1, Kurokawa
S, Izumi T1: ESC Congress 2010 (2010/8/31), Stockholm, Sweden. (‹Ë¶“T˜Y1, ’ë–ìTˆê1, ’ë–ì—T
Œb1, [’J‰p•œ1, ÂŽR’Œ‘P1, ˜aò@“O1: 1zŠÂŠí“à)

713054. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Primary Oxidative Stress Causes Electrical Remodeling
in Ventricular Myocardium in Heart/Muscle-specific Hyper-oxidative Mice Model. Kurokawa S, Niwano
S1, Niwano H1, Kosukegawa T, Masaki Y, Murakami M, Ishikawa S, Noda Y, Shimizu T, Izumi T1: ESC
Congress 2010 (2010/9/1), Stockholm, Sweden. (’ë–ìTˆê1, ’ë–ì—TŒb1, ˜aò@“O1: 1zŠÂŠí“à)

713055. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Prognostic Significance of the Right Ventricular
Dimension on Acute@Decompensation in Chronic Left-Sided Heart Failure. Maekawa E1, Inomata T1,
Koitabashi T1, Izumi T1: Ameraican Heart Association Scientific Meeting 2010 in Chicago
(2010/11/16), Chicago, USA. (‘OìŒb”ü1, ’––”FŒ³1, ¬”‹Žr”ü1, ˜aò@“O1: 1zŠÂŠí“à)

713056. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Judgement. ‰––ì•û–Ÿ (zŠÂŠí“à): ùì“ú’†—FDŒ€‹†”­
•\‰ï (2010/11/26), –k‹ž.

721001. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‹}«S‹Ø[Ç‚É•¹”­‚·‚éSƒ|ƒ“ƒv•s‘S‚Ö‚Ì‹}«Šú‘Ήž. ’––”FŒ³
(zŠÂŠí“à): ‘æ19‰ñ“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“Ž¡—Êw‰ïŠwpW‰ï (2010/8/22), å‘ä.

721002. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) Œ»‹µ‚̐S•s‘SŠÇ—ŽÀ‘H–@?ƒAƒEƒgƒJƒ€‚ð‚¢‚©‚ÉŒ©˜‚Š‚é‚©? ’––”F
Œ³ (zŠÂŠí“à): “ú–{—Տ°–ƒŒŠw‰ï‘æ30‰ñ‘å‰ï (2010/11/4), “¿“‡.

722058. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S–[×“®‚Ì–ò•šŽ¡—Á@ƒAƒbƒvƒXƒgƒŠ[ƒ€‚Ö‚Ì’§í.
’ë–ìTˆê (zŠÂŠí“à): ‘æ49‰ñ•¶ŒŽ‰ï‘‰ï (2010/7/3), “Œ‹ž.

722059. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –«S•s‘SŽ¡—Âɂš‚¯‚éƒÀŽÕ’f–òƒJƒ‹ƒxƒWƒ[ƒ‹
‚Ì”ï—p‘ÎŒø‰Ê. ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ58‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2010/9/17), “Œ
‹ž.

722060. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) •¹”­‚·‚éÒ’ŒŊԔ‰Š‚ªŽŠŽ‚·‚銎õ«S“à–Œ‰Š
‚ÌŒ»ó‚Ɖۑè. ’––”FŒ³1, ‘OìŒb”ü1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ58‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï
(2010/9/19), “Œ‹ž.

722061. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S•s‘S‚É‚š‚¯‚é•s®–¬‚̐f—Ã: S•s‘S‚Ì•s®–¬Šî
Ž¿Œ`¬. ’ë–ìTˆê (zŠÂŠí“à): ‘æ14‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ïƒVƒ“ƒ|ƒWƒEƒ€1 (2010/10/7), “Œ‹ž.

722062. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) S•s‘SŠÇ—‚É‚š‚¯‚é–ò•š—Ö@‚ð‚Ç‚€ˆÊ’u‚¯‚é‚©. ’––”
FŒ³ (zŠÂŠí“à): ‘æ14‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[ (2010/10/7), “Œ‹ž.

722063. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Clinical Impact of Corticosteroid Therapy on
Eosinophilic Myocarditis. –öàV’q‹`1, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ14‰ñ“ú–{S•s‘SŠw
‰ïŠwpW‰ï (2010/10/8), “Œ‹ž.

722064. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒgƒ‹ƒoƒvƒ^ƒ“ (ƒoƒ]ƒvƒŒƒVƒ“V2Žó—e‘̝hR–ò).
’––”FŒ³ (zŠÂŠí“à): ‘æ14‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2010/10/8), “Œ‹ž.

722065. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S•s‘S‚É”º‚€•s®–¬‚̃AƒbƒvƒXƒgƒŠ[ƒ€Ž¡—Ã. ’ë
–ìTˆê (zŠÂŠí“à): ‘æ27‰ñ“ú–{S“dŠw‰ïŠwpW‰ïŠwpŽ–âˆÏˆõ‰ï’ñŒŸƒVƒ“ƒ|ƒWƒEƒ€ (2010/10/8), ‘啪.

723160. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒo[ƒ`ƒƒƒ‹‘Ì•\–Ê‘œ‹ÉS“d}‚É‚æ‚éBrugadaŒ^S“d}Ç
—á‚ÌST•Ï‰»•ª•z‚ÌŒŸ“¢. Îì®Žq, ’ë–ìTˆê1, ¡–Ø—²‘Ÿ2, ŠÝŒŽ@~, ÂŽR—T–ç1, ‘ºã‰ë”ü1, •ì
‘–1, ‹Ë¶“T˜Y1, [’J‰p•œ1, ”©ŽR—SŽq1, “’–{‰ÀG1, ’ë–ì—TŒb1, ˜aò@“O1 (1zŠÂŠí“à, 2‹~
–œ): ‘æ25‰ñ“ú–{•s®–¬Šw‰ïŠwpW‰ï (2010/6/11), –ŒŒÃ‰®.

723161. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒxƒvƒŠƒWƒ‹“Š—^‚É‚æ‚éS–[×“®”gŽüŠú’· (FCL) ‚̕ω»‚ð
ƒXƒyƒNƒgƒ‰ƒ€‰ðÍ‚É‚æ‚Á‚ÄŒoŽž•]‰¿‚Å‚«‚œ’·ŠúŽ‘±«S–[×“®‚Ì1—á. ÂŽR—T–ç1, ’ë–ìTˆê1, •ì‘
–1, ŠÝŒŽ@~, Îì®Žq, ‘ºã‰ë”ü1, ‹Ë¶“T˜Y1, [’J‰p•œ1, ”©ŽR—SŽq1, “’–{‰ÀG1, ’ë–ì—TŒb
1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ25‰ñ“ú–{•s®–¬Šw‰ïŠwpW‰ï (2010/6/11), –ŒŒÃ‰®.

723162. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒxƒvƒŠƒWƒ‹“à•žÇ—á‚É‚š‚¯‚錌’†ƒxƒvƒŠƒWƒ‹”Z“x‚ÆQTŠÔ
Šu‚š‚æ‚Ñ‘Ì•\–ʐS“d}T”gŒ`‘ԕω»‚ÌŒŸ“¢. •ì‘–1, ’ë–ìTˆê1, ÂŽR—T–ç1, [’J‰p•œ1, “’–{
‰ÀG1, ’ë–ì—TŒb1, ã–ì˜as, ˜aò@“O1, ²‹Ž‹v”üŽq, ‹{“à˜a”ü (1zŠÂŠí“à): ‘æ25‰ñ“ú–{•s®–¬Šw
‰ïŠwpW‰ï (2010/6/11), –ŒŒÃ‰®.

723163. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) R‹ÃŒÅ—Ö@ERŒŒ¬”—Ö@•¹—p‚É‚æ‚éoŒŒ«•›ì—p”­Œ»
•p“x‚Ɗ댯ˆöŽq‚ÌŒŸ“¢. ”©ŽR—SŽq1, ’ë–ìTˆê1, ’ë–ì—TŒb1, ÂŽR—T–ç1, Îì®Žq, ŠÝŒŽ@~, ‘ºã
‰ë”ü1, •ì‘–1, ‹Ë¶“T˜Y1, “’–{‰ÀG1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ25‰ñ“ú–{•s®–¬Šw‰ïŠwp
W‰ï (2010/6/11), –ŒŒÃ‰®.

723164. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚Žü”gƒTƒ“ƒvƒŠƒ“ƒOƒfƒWƒ^ƒ‹ƒzƒ‹ƒ^[S“dŒv‚É‚æ‚è•s®
–¬‚ƐSŽº’x‰„“dˆÊ‚Ì“ú“à•Ï“®‚ð•]‰¿‚Å‚«‚œ–«S•s‘S‹}«‘ˆ«‚Ì1—á. ‘ºã‰ë”ü1, ’ë–ìTˆê1, ¡–Ø—²
‘Ÿ2, ŠÝŒŽ@~, ÂŽR—T–ç1, Îì®Žq, ‹Ë¶“T˜Y1, •ì‘–1, [’J‰p•œ1, ’ë–ì—TŒb1, ˜aò@“O1
(1zŠÂŠí“à, 2‹~–œ): ‘æ25‰ñ“ú–{•s®–¬Šw‰ïŠwpW‰ï (2010/6/11), –ŒŒÃ‰®.

723165. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇS•s‘SŠù‰Ç—á‚É‚š‚¯‚é’vŽ€“I•s®–¬ƒCƒxƒ“ƒg—\‘ª
ˆöŽq‚ÌŒŸ“¢. ŠÝŒŽ@~, ’ë–ìTˆê1, ÂŽR—T–ç1, Îì®Žq, ‘ºã‰ë”ü1, ‹Ë¶“T˜Y1, •ì‘–1, [
’J‰p•œ1, ”©ŽR—SŽq1, “’–{‰ÀG1, ’ë–ì—TŒb1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ25‰ñ•s®–¬Šw‰ïŠwpW‰ï
(2010/6/11), –ŒŒÃ‰®.

723166. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) S–[×“®ƒ‚ƒfƒ‹Œ¢‚É‚š‚¯‚éƒAƒgƒ‹ƒoƒXƒ^ƒ`ƒ“‚̍\‘¢“IƒŠ
ƒ‚ƒfƒŠƒ“ƒO‚ɑ΂·‚錟“¢. ‹Ë¶“T˜Y1, ’ë–ìTˆê1, ŠÝŒŽ@~, ÂŽR—T–ç1, •ì‘–1, [’J‰p•œ1, ²
“¡‘å•ã, ’ë–ì—TŒb1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ25‰ñ“ú–{•s®–¬Šw‰ïŠwpW‰ï (2010/6/11), –ŒŒÃ‰®.

723167. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A case of coronary artery aneurysm in Kawasaki disease
-Insights from OCT imaging-. ‰º•lF˜Y1, Œ¬^‹Õ, “ŒžŠ‘å‹P1, ÂŽR’Œ‘P1, Îˆä³_2, •àV—˜˜Y,
XŒû¹•F, •Ÿ“c’Œl, ˜aò@“O1 (1zŠÂŠí“à, 2¬Ž™): ‘æ19‰ñ“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“Ž¡—Êw‰ï
ŠwpW‰ï (2010/8/24), å‘ä.

723168. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒJƒ‹ƒVƒEƒ€hR–ò“à•ž’†‚Å‚ ‚è‚È‚ª‚çƒeƒjƒX’†‚ÉVf‚Æ‚È
‚Á‚œ‰^“®—U”­«“«Š¥¹k‚̈ê—á. ¬™—Œb1, ’––”FŒ³1, ’ë–ìTˆê1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ
58‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2010/9/17), “Œ‹ž.

723169. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚킪‘‚É‚š‚¢‚Ä‚àS•s‘S’Ž‹}«Šú‚Å‚Å‚ÌClinical
Scenario‚Í’Ê—p‚·‚é‚©. “n•Óˆê˜Y, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ58‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwp
W‰ï (2010/9/17), “Œ‹ž.

723170. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹•”Žó’ŒŒã‚ÉŒ°Ý‰»‚µ“Ÿ‚È‚©‚Á‚œS‹Ø—ô‚̈ê—á. ‘O
ìŒb”ü1, ’––”FŒ³1, ’|“àˆê˜Y2, ˆäãMK3, ˜aò@“O1 (1zŠÂŠí“à, 2‹~–œ, 3S‘ŸŒŒŠÇŠO): ‘æ58
‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2010/9/17), “Œ‹ž.

723171. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[ S“à–Œ‰ºS‹Ø‹•ŒŒ‚ðŽŠŽ‚·‚鏉”­’›Œó‚ÆMRIŠŒ©‚ð’悵,
“ÁˆÙ‚ÈŒo‰ß‚ð’H‚Á‚œSƒAƒ~ƒƒCƒh[ƒVƒX‚̈ê—á. Šâ–{ŽO˜a1, •iì–íl1, ’––”FŒ³1, ˜aò@“O1 (1z
ŠÂŠí“à): ‘æ58‰ñ“ú–{S‘Ÿ•aŠw‰ïŠwpW‰ï (2010/9/17), “Œ‹ž.

723172. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ŠúÄŸó—¬—Ö@‚ðs‚Á‚œ‹}«S‹Ø[Ç—á‚É‚š‚¯‚éŒoŽž“I
¶ŽºƒŠƒ‚ƒfƒŠƒ“ƒO‚ÌŒŸ“¢. …’J’m‘×, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ58‰ñ“ú–{S‘Ÿ•aŠw‰ïŠw
pW‰ï (2010/9/18), “Œ‹ž.

723173. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) BrugadaÇŒóŒQ‚É‚š‚¯‚éAž‚ÝŒ^œ×“®Ší (ICD) Až‚Ý
ƒKƒCƒhƒ‰ƒCƒ“…Žç—Š‚ÌŒŸ“¢. ‹Ë¶“T˜Y1, ’ë–ìTˆê1, ŠÝŒŽ@~, ÂŽR—S–ç1, Îì®Žq, ‘ºã‰ë”ü1, •
ì‘–1, ”©ŽR—TŽq1, “’–{‰ÀG1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ27‰ñ“ú–{S“dŠw‰ïŠwpW‰ï (2010/10/8),
‘啪.

723174. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒgƒ‹ƒoƒvƒ^ƒ“‚̐S«•‚ŽîŠ³ŽÒ‚ð‘ΏۂƂµ‚œ—Տ°–ò—ŽŽŒ±.
’––”FŒ³ (zŠÂŠí“à): ‘æ14‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2010/10/8), “Œ‹ž.

723175. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[ ŒŽŒoŽüŠú‚ª•s®–¬oŒ»‚ÉŠÖ˜A‚µ‚œ‚Ɛ„Ž@‚³‚ê, f’f‚š‚æ‚Ñ
Ž¡—Âɓïa‚µ‚œ1—á. ”©ŽR—TŽq1, “’–{‰ÀG1, ²“¡@—z, ÂŽR—S–ç1, Îì®Žq, ŠÝŒŽ@~, ‘ºã‰ë”ü
1, ‹Ë¶“T˜Y1, •ì‘–1, ’ë–ìTˆê1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ27‰ñ“ú–{S“dŠw‰ïŠwpW‰ï
(2010/10/8), ‘啪.

723176. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚Žü”gƒTƒ“ƒvƒŠƒ“ƒOƒfƒWƒ^ƒ‹ƒzƒ‹ƒ^[S“dŒv‚É‚æ‚è•s®
–¬Šî”Õ‚ÌŒoŽž•Ï‰»‚ð•]‰¿‚Å‚«‚œ–«S•s‘S‚Ì1—á. ‘ºã‰ë”ü1, ’ë–ìTˆê1, ¡–Ø—²‘Ÿ2, ²“¡@—z, ŠÝ
ŒŽ@~, ÂŽR—S–ç1, Îì®Žq, ‹Ë¶“T˜Y1, •ì‘–1, [’J‰p•œ1, ’ë–ì—TŒb1, ˜aò@“O1 (1zŠÂ
Ší“à, 2‹~–œ): ‘æ27‰ñ“ú–{S“dŠw‰ïŠwpW‰ï (2010/10/8), ‘啪.

723177. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽOë•Ù—Ö‚š‚æ‚Ñ•ªŠE—ä‚É‹NŒ¹‚ð—L‚·‚éfocal atrial
tachycardia‚ð‡•¹‚µ‚œ1—á. “’–{‰ÀG1, ²“¡@—z, ÂŽR—S–ç1, Îì®Žq, ŠÝŒŽ@~, ‘ºã‰ë”ü1, ‹Ë
¶“T˜Y1, •ì‘–1, ”©ŽR—TŽq1, ’ë–ìTˆê1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ27‰ñ“ú–{S“dŠw‰ïŠwp
W‰ï (2010/10/8), ‘啪.

723178. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž‘±“IS–[×“®‚É‚š‚¯‚éƒxƒvƒŠƒWƒ‹“Š—^‚É‚æ‚é×“®”gŽü
Šú’· (FCL) •Ï‰»‚Æ“Ž’²—¥‰»—\‘ª. ÂŽR—S–ç1, ’ë–ìTˆê1, ’ë–ì—TŒb1, •ì‘–1, ²“¡@—z, ŠÝŒŽ@
~, Îì®Žq, ‘ºã‰ë”ü1, ‹Ë¶“T˜Y1, [’J‰p•œ1, ”©ŽR—TŽq1, “’–{‰ÀG1, ˜aò@“O1 (1zŠÂŠí“à):
‘æ27‰ñ“ú–{S“dŠw‰ïŠwpW‰ï (2010/10/8), ‘啪.

723179. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž‘±“IS–[×“®‚ɑ΂·‚éƒAƒ“ƒCƒIƒeƒ“ƒVƒ“Žó—e‘ÌŽÕ’f–ò
‚ÌŒø‰Ê?×“®”gŽüŠú’·‚ð—p‚¢‚œƒŠƒ‚ƒfƒŠƒ“ƒO—}§ì—p•]‰¿?. ŠÝŒŽ@~, ’ë–ìTˆê1, ÂŽR—S–ç1, Îì
®Žq, ²“¡@—z, ‘ºã‰ë”ü1, ‹Ë¶“T˜Y1, •ì‘–1, ”©ŽR—TŽq1, “’–{‰ÀG1, [’J‰p•œ1, ˜aò@“O
1 (1zŠÂŠí“à): ‘æ27‰ñ“ú–{S“dŠw‰ïŠwpW‰ï (2010/10/8), ‘啪.

723180. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ãŽº«ŠúŠOŽûk (APC) ‚̏Ď܂ÉNon-contact mapping
(EnSite)‚ª—L—p‚Å‚ ‚Á‚œ1—á. ²“¡@—z, “’–{‰ÀG1, ÂŽR—S–ç1, Îì®Žq, ŠÝŒŽ@~, ‘ºã‰ë”ü1, ‹Ë
¶“T˜Y1, •ì‘–1, ”©ŽR—TŽq1, ’ë–ìTˆê1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ27‰ñ“ú–{S“dŠw‰ïŠwp
W‰ï (2010/10/8), ‘啪.

723181. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘Ì•\–Ê‘œ‹ÉS“dŒv‚É‚æ‚éBrugadaŒ^S“d}Ç—á‚̃ŠƒXƒN
‘w•Ê‰»‚ÌŒŸ“¢. Îì®Žq, ’ë–ìTˆê1, ÂŽR—S–ç1, ŠÝŒŽ@~, ‘ºã‰ë”ü1, •ì‘–1, ‹Ë¶“T˜Y1, [
’J‰p•œ1, ”©ŽR—TŽq1, ¡–Ø—²‘Ÿ2, “’–{‰ÀG1, ’ë–ì—TŒb1, ˜aò@“O1 (1zŠÂŠí“à, 2‹~–œ): ‘æ27‰ñ
“ú–{S“dŠw‰ïŠwpW‰ï (2010/10/8), ‘啪.

723182. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«‚€‚ÁŒŒ«S•s‘S‚É‚š‚¯‚éCardiac Power Index‚Ì—\
Œã“IˆÓ‹`. …’J’m‘×1, ’––”FŒ³1, (1zŠÂŠí“à): ‘æ14‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2010/10/8), “Œ
‹ž.

723183. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H1N1Œ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUS‹Ø‰Š‚ð‡•¹‚µ‚œŠŽõ«S“à–Œ‰Š
‚É‚æ‚è‹}«S•s‘S‚𗈂µ‚œˆê—á. –k—¢—œŽÑ1, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ14‰ñ“ú–{S•s
‘SŠw‰ïŠwpW‰ï (2010/10/9), “Œ‹ž.

723184. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) S‘ŸÄ“¯Šú—Ö@‚ªˆê‰ß«¶‹rƒuƒƒbƒN‚É”º‚€S•s‘S‘ˆ«
‚Ì”œ•œ‚ð‰ñ”ð‚³‚¹‚œˆê—á. “n•Óˆê˜Y, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ14‰ñ“ú–{S•s‘SŠw‰ïŠw
pW‰ï (2010/10/9), “Œ‹ž.

731008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠÇ—‚ð‚Ç‚€l‚Š‚é‚©?CRT‚ÆOptivol‚©‚ç‚Ý‚œŒ»
ó‚Ɖۑè. ’––”FŒ³ (zŠÂŠí“à): ¬“cŒŽS•s‘S“Á•Êu‰‰‰ï (2010/4/13), ¬“cŒŽ.

731009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S‘ŸÄ“¯Šú—Ö@(CRT)‚Ɖ“Šuƒ‚ƒjƒ^ƒŠƒ“ƒO. ’––”FŒ³ (z
ŠÂŠí“à): ‘Š–ÍŒŽzŠÂŠíƒ~[ƒeƒBƒ“ƒO (2010/5/10), ‘Š–ÍŒŽ.

731010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Œn“—§‚ĂĐg‚ɂ‚¯‚éS•s‘SŠÇ—. ’––”FŒ³ (zŠÂŠí
“à): ¬–qŽs–¯•a‰@Œ€C‹³ˆçˆÏˆõ‰ïuÀ (2010/5/14), ˆ€’m.

731011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠÇ—‚É‚š‚¯‚éBNP‘ª’è?‚»‚Ì‹•‚ÆŽÀ. ’––”FŒ³
(zŠÂŠí“à): ‘æ10‰ñ”ª”ŠzŠÂŠíˆã—ØAŒg‰ï (2010/5/28), •Ÿ‰ª.

731012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽÀ’nS•s‘SŽ¡—©‚ç•R‰ð‚­ƒÀŽÕ’f–ò‚Ì–ðŠ„?ŽÀ‘H•Ò. ’–
–”FŒ³ (zŠÂŠí“à): ‘æ11‰ñ‰F“s‹{ˆã—ØAŒgŒ€‹†‰ï (2010/6/8), ‰F“s‹{.

731013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) pEF‚ɉe‹¿‚ð‹y‚Ú‚·SŠO“I—vˆö. ’––”FŒ³ (zŠÂŠí“à):
‘æ6‰ñ‹}«S•s‘SŒ€‹†‰ï (2010/6/26), “Œ‹ž.

731014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠÇ—‚É‚š‚¯‚éBNP‘ª’è?‚»‚Ì‹•‚ÆŽÀ. ’––”FŒ³
(zŠÂŠí“à): ‘æ1‰ñ–ŒŒÃ‰®S•s‘SƒhƒNƒ^[ƒY (2010/6/26), –ŒŒÃ‰®.

731015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠÇ—‚É‚š‚¯‚éBNP‘ª’è?‚»‚Ì‹•‚ÆŽÀ. ’––”FŒ³
(zŠÂŠí“à): ‘æ7‰ñ“Œ˜aSŽŸŠ³—Տ°•a‰@˜AŒg‰ï (2010/7/1), “V—.

731016. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) [ÇŒãS•s‘S‚ɃÀŽÕ’f–ò‚ð‚Ç‚€¶‚©‚·‚©. ’––”FŒ³ (z
ŠÂŠí“à): ˆÉšèS•s‘SUpdateƒtƒH[ƒ‰ƒ€ (2010/7/2), ŒQ”n.

731017. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠÇ—‚É‚š‚¯‚éBNP‘ª’è?‚»‚Ì‹•‚ÆŽÀ. ’––”FŒ³
(zŠÂŠí“à): ‘æ3‰ñ‘åãcardiac medical careƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/7/30), ‘åã.

731018. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) WPWÇŒóŒQ‚̃AƒuƒŒ[ƒVƒ‡ƒ“. ’ë–ìTˆê (zŠÂŠí“à): EP
ƒTƒ}[ƒZƒ~ƒi[2010 (2010/7/31), “Œ
‹ž.

731019. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”­ì«ãŽº•p”‚ÆWPWÇŒóŒQ. ’ë–ìTˆê (zŠÂŠí“à): ˆã
Šw¶ƒTƒ}[ƒZƒ~ƒi[ (2010/8/18), “Œ‹ž.

731020. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) BNP‚ð‚¢‚©‚ÉŽg‚¢‚±‚È‚·‚©?S•s‘Sf—Âɂš‚¯‚éˆÊ’u•t
‚¯‚Æ‚Í. ’––”FŒ³ (zŠÂŠí“à): Žñ“sŒ—ƒV[ƒƒ“ƒXHCDƒZƒ~ƒi[ (2010/8/21), “Œ‹ž.

731021. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠÇ—‚É‚š‚¯‚éBNP‘ª’è?‚»‚Ì‹•‚ÆŽÀ. ’––”FŒ³
(zŠÂŠí“à): ŽsìzŠÂŠíƒZƒ~ƒiƒŠƒI (2010/9/7), Žsì.

731022. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠÇ—‚É‚š‚¯‚éBNP‘ª’è?‚»‚Ì‹•‚ÆŽÀ. ’––”FŒ³
(zŠÂŠí“à): –«S•s‘Suptodate (2010/9/9), “Œ‹ž.

731023. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡‚³‚ç•·‚¯‚È‚¢!? HOW TO S•s‘SƒÀŽÕ’f–òŽ¡—Ã. ’––”F
Œ³ (zŠÂŠí“à): ƒÀŽÕ’f–òƒ†[ƒU[ƒYƒ~[ƒeƒBƒ“ƒO (2010/9/22), ’·‰ª.

731024. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) SƒCƒxƒ“ƒg‹}«Šú‚É‚š‚¯‚éƒÀŽÕ’f–ò‚Ì–ðŠ„. ’––”FŒ³
(zŠÂŠí“à): ŽüpŠúƒÀ1ŽÕ’f–òƒZƒ~ƒi[ (2010/9/24), ‰¡•l.

731025. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠ³ŽÒ‚ɑ΂·‚鎡—Â̎ÀÛ(1) (2). ’––”FŒ³ (z
ŠÂŠí“à):uS•s‘S‚ɑ΂·‚闝Šw—Ö@vuK‰ï (2010/9/25), ‘Š–ÍŒŽ.

731026. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠÇ—‚É‚š‚¯‚éBNP‘ª’è?‚»‚Ì‹•‚ÆŽÀ. ’––”FŒ³
(zŠÂŠí“à): •Ÿ“‡zŠÂŠíŽŸŠ³ƒAƒJƒfƒ~[ (2010/9/30), •Ÿ“‡

731027. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰ ƒAƒEƒgƒJƒ€‚ðˆÓŽ¯‚µ‚œS•s‘SŠÇ—?–Ú‚ÉŒ©‚Š‚鎡—Ã, –Ú‚É
Œ©‚Š‚È‚¢Ž¡—Ã?. ’––”FŒ³ (zŠÂŠí“à): ‘æ8‰ñzŠÂŠí˜AŒgƒpƒXŒ€‹†‰ï (2010/10/7), ä.

731028. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®Ž¡—Âɂš‚¯‚éƒAƒ~ƒIƒ_ƒƒ“‚̈ʒu‚¯. ’ë–ìT
ˆê (zŠÂŠí“à): ƒAƒ~ƒIƒ_ƒƒ“ƒeƒŒƒtƒHƒ“u‰‰‰ï (2010/10/9), “Œ‹ž.

731029. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡‚³‚ç•·‚¯‚È‚¢!? HOW TO S•s‘SƒÀŽÕ’f–òŽ¡—Ã. ’––”
FŒ³ (zŠÂŠí“à): SAGAMI HF FORUM (2010/10/25), ˆÉšŒŽ.

731030. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽÀ’nS•s‘SŽ¡—©‚ç•R‰ð‚­ƒÀŽÕ’f–ò‚Ì–ðŠ„?ŽÀ‘H•Ò. ’–
–”FŒ³ (zŠÂŠí“à): ŽO“‡ƒrƒ\ƒvƒƒ[ƒ‹u‰‰‰ï (2010/10/28), ŽO“‡.

731031. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Œ»‹µ‚̐S•s‘SŽ¡—©‚çl‚Š‚éSt˜AŠÖ‚ƍ¡Œã‚̉ۑè‚É‚Â
‚¢‚Ä. ’––”FŒ³ (zŠÂŠí“à): ‘æ2‰ñJapan AKI Summit (2010/10/30), “Œ‹ž.

731032. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) [ÇŒãS•s‘S‚ɃÀŽÕ’f–ò‚ð‚Ç‚€¶‚©‚·‚©. ’––”FŒ³ (z
ŠÂŠí“à): ‘æ8‰ñ•ŸˆäŠ¥ŽŸŠ³‚ðl‚Š‚é‰ï (2010/11/5), •Ÿˆä.

731033. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠÇ—‚É‚š‚¯‚éBNP‘ª’è?‚»‚Ì‹•‚ÆŽÀ. ’––”FŒ³
(zŠÂŠí“à): ‘æ5‰ñŒ§‰›zŠÂŠí§˜b‰ï (2010/11/12), ‰ŽOð.

731034. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰ Œn“—§‚Ä‚œS•s‘SŠÇ—?–Ú‚ÉŒ©‚Š‚鎡—Ã, –Ú‚ÉŒ©‚Š‚È‚¢Ž¡
—Ã. ’––”FŒ³ (zŠÂŠí“à): ‘æ14‰ñt“úˆäzŠÂŠíŒ€‹†‰ï (2010/11/27), ˆ€’m.

731035. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘‡—Í‚ª–â‚í‚ê‚éS•s‘Sf—Â̌»‹µ. ’––”FŒ³ (zŠÂŠí
“à): ƒfƒBƒIƒoƒ“ù”­”„10Žü”N‹L”Ou‰‰‰ïin Yokohama (2010/12/2), ‰¡•l.

731036. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) [ÇŒãS•s‘S‚ɃÀŽÕ’f–ò‚ð‚Ç‚€¶‚©‚·‚©. ’––”FŒ³ (z
ŠÂŠí“à): z–KS•s‘SForum (2010/12/6), z–K.

731037. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S–[×“®‚Ì–ò•šŽ¡—Ã?ƒAƒbƒvƒXƒgƒŠ[ƒ€Ž¡—Â̐¥”ñ?.
’ë–ìTˆê (zŠÂŠí“à): ‘æ6‰ñ‘O‹Ž’n‹æ“à‰Èƒ~[ƒeƒBƒ“ƒO (2010/12/17), ‘O‹Ž.

731038. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) SŽºŠúŠOŽûk‚Ì–ò•šŽ¡—Ã. ’ë–ìTˆê (zŠÂŠí“à): “ú–{
S“dŠw‰ï‹³ˆçƒZƒ~ƒi[F•s®–¬–ò•š—Ö@‚ÌUp to date 2010 (2010/12/23), ‰¡•l.

731039. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) R•s®–¬–ò‚ÌŒ÷ß@R•s®–¬–ò‚Ìpit-falls. ’ë–ìTˆê
(zŠÂŠí“à): _“ސì•a‰@–òÜŽt‰ï (2011/1/20), ‰¡•l.

731040. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŽ¡—Âɂš‚¯‚é—˜”A–ò‚Ì–ðŠ„. ’––”FŒ³ (zŠÂŠí
“à): S•s‘S‚ƃoƒ]ƒvƒŒƒVƒ“u‰‰‰ï (2011/1/21), À’Ã.

731041. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Œn“—§‚Ä‚œS•s‘Sf—Ã‚ð‚¢‚©‚É“WŠJ‚·‚é‚©. ’––”FŒ³
(zŠÂŠí“à): hANPƒtƒH[ƒ‰ƒ€inŒVh (2011/1/24), “Œ‹ž.

731042. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘‡—Í‚ª–â‚í‚ê‚éS•s‘Sf—Â̌»‹µ. ’––”FŒ³ (zŠÂŠí
“à): S•s‘S—\–h‚ÆŽ¡—ÃŽÀ‘HƒtƒH[ƒ‰ƒ€ (2011/1/25), Ã‰ª.

731043. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Œn“—§‚Ä‚œS•s‘Sf—Ã‚ð‚¢‚©‚É“WŠJ‚·‚é‚©. ’––”FŒ³
(zŠÂŠí“à): ‘æ3‰ñzŠÂŠíŽáŽèƒZƒ~ƒi[ (2011/2/2), –ŒŒÃ‰®.

731044. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡‚¢‚©‚ɐS•s‘S‚Ɛ킀‚©?ŽÀ‘Hƒ}ƒjƒ…ƒAƒ‹. ’––”FŒ³
(zŠÂŠí“à): DSzŠÂŠíƒVƒ“ƒ|ƒWƒEƒ€-S•s‘Sup-to-date- (2011/2/3), “Œ‹ž.

731045. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽÀ’nS•s‘SŽ¡—©‚ç•R‰ð‚­ƒÀŽÕ’f–ò‚Ì–ðŠ„?ŽÀ‘H•Ò. ’–
–”FŒ³ (zŠÂŠí“à): ‘æ133‰ñŠw‚Ú‚€‰ï (2011/2/16), `–ì.

731046. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¡‚¢‚©‚ɐS•s‘S‚Ɛ킀‚©?ŽÀ‘Hƒ}ƒjƒ…ƒAƒ‹. ’––”FŒ³
(zŠÂŠí“à): DSzŠÂŠíƒVƒ“ƒ|ƒWƒEƒ€2011é‹Ê (2011/3/1), ‘å‹{.

731047. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SƒÀŽÕ’f–ò—Ö@‚ÌŒ»‹µ‚Ɖۑè. ’––”FŒ³ (zŠÂŠí
“à): Opinion Learders Academy in Osaka (2011/3/4), ‘åã.

731048. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SƒÀŽÕ’f–ò—Ö@‚ÌŒ»‹µ‚Ɖۑè. ’––”FŒ³ (zŠÂŠí
“à): ŒQ”nƒÀ blocker seminar (2011/3/7), ‘O‹Ž.

732047. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) •s®–¬‚̃AƒbƒvƒXƒgƒŠ[ƒ€Ž¡—Â̈Ӌ`.
’ë–ìTˆê (zŠÂŠí“à): é‹ÊƒAƒ~ƒIƒ_ƒƒ“Œ€‹†‰ï (2010/7/2), é‹Ê.

732048. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S‹Ø[ÇŒã¶ŽºƒŠƒ‚ƒfƒŠƒ“ƒO‚É‚Ç‚€‘Î
›³‚·‚ׂ«‚©. ’––”FŒ³ (zŠÂŠí“à): DSzŠÂŠíƒtƒH[ƒ‰ƒ€2010?S•s‘SUp-to-date? (2010/7/24), “Œ
‹ž.

732049. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) S•s‘SƒCƒxƒ“ƒg—}§‚ÌŠÏ“_‚©‚ç‚Ý‚œS
–[×“®ƒRƒ“ƒgƒ[ƒ‹‚̈Ӌ`. ’ë–ìTˆê (zŠÂŠí“à): ‘æˆêŽO‹€zŠÂŠíƒtƒH[ƒ‰ƒ€ (2010/12/11), “Œ‹ž.

732050. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)u”x…Žî‚ð‹É‚ß‚évPart I. •a‘ԁEf’fE
•]‰¿@6. Swan-GanzƒJƒe[ƒeƒ‹. ’––”FŒ³ (zŠÂŠí“à): ‘æ7‰ñ‹}«S•s‘SŒ€‹†‰ï (2011/1/15), “Œ‹ž.

733067. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) CARTOƒ}ƒbƒsƒ“ƒO‚ª‹NŒ¹“¯’è‚É—L—p‚Å‚ ‚Á‚œ
ƒtƒ@ƒ[Žl’¥ÇpŒãS–[•p”‚Ì1—á. ”©ŽR—SŽq1, “’–{‰ÀG1, ‹Ë¶“T˜Y1, •ì‘–1, ’ë–ìTˆê1, ˜a
ò@“O1 (1zŠÂŠí“à): ‘æ22‰ñ—Տ°•s®–¬Œ€‹†‰ï (2010/1/9), “Œ‹ž.

733068. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇS•s‘S‚ð’悵‚œ‘å“®–¬“ñë•Ù‚̈ê—á. ‘O
ìŒb”ü1, ¬”‹Žr”ü1, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ47‰ñ“Œ‹žSƒGƒR[}Œ€‹†‰ï (2010/5/22),
“Œ‹ž.

733069. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) S–[’†Šu•Âœp‚š‚æ‚ÑŠ¥“®–¬ƒoƒCƒpƒXpŒã‚É
‘ˆ«‚µ‚œ”x‚ŒŒˆ³Ç‚̈ê—á. ¬™—Œb1, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ11‰ñ”x‚ŒŒˆ³ÇŽ¡
—ÃŒ€‹†‰ï (2010/6/5), “Œ‹ž.

733070. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •s®–¬ƒCƒxƒ“ƒg‚É‚Ä”­Ç‚µ‚œ‰EŽºáŠQ—DˆÊ‚Ì
S‘ŸƒTƒ‹ƒRƒCƒh[ƒVƒX‚̈ê—á. ²“¡F“T1, ’––”FŒ³1, ²“¡‘å•ã1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ572
‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2010/6/12), “Œ‹ž.

733071. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒCƒ”EƒRƒƒ“ƒe[ƒ^[. ‰––ì•û–Ÿ (zŠÂŠí
“à): Tokyo Live Demonstration 2011 CVITŠÖ“ŒbM‰z’n•û‰ï (2010/10/22), “Œ‹ž.

733072. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) LAD•a•Ï‚ɑ΂·‚éCypher stent (SES) —¯’uŒã
‚Éstent fracture‚𔺂€VLST‚ðŒJ‚è•Ô‚µ‚œÇ—á. ‹T“c@—Ç, ‰º•lF˜Y1, “ŒžŠ‘å‹P1, Œ¬^‹Õ, XŒû
¹•F, •Ÿ“c’Œl, •àV—˜˜Y, ˜aò@“O1 (1zŠÂŠí“à): ‘æ37‰ñ“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“Ž¡—Êw‰ï
ŠÖ“ŒbM‰z’n•û‰ï (ŠÖ“ŒbM‰zCVIT) (2010/10/23), “Œ‹ž.

733073. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) CypherƒXƒeƒ“ƒg‚Ìfracture•”ˆÊ‚É’x”­«ƒX
ƒeƒ“ƒgŒŒðÇ‚ðŒJ‚è•Ô‚µ‚œ1—á. ‹T“c@—Ç, ‰º•lF˜Y1, “ŒžŠ‘å‹P1, Œ¬^‹Õ, ˜aò@“O1 (1zŠÂŠí
“à): ‘æ2‰ñŒ§‰›zŠÂŠíŽ¡—ÃŒ€‹†‰ï (2010/10/25), _“ސì.

733074. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PTRA¬Œ÷Œã‚É‹}‘¬‚ɐt•s‘S‚ªis‚µ‚œˆê—á. ‹T
“c@—Ç, ‰––ì•û–Ÿ1, ‰º•lF˜Y1, “ŒžŠ‘å‹P1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ13‰ñ_“ސìPTAŒ€‹†‰ï
(2010/11/5), _“ސì.

733075. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[ S“à–Œ‰ºS‹Ø‹•ŒŒ‚ðŽŠŽ‚·‚鏉”­’›Œó‚ð’悵, “Á
ˆÙ‚ÈŒo‰ß‚ð’H‚Á‚œSƒAƒ~ƒƒCƒh[ƒVƒX‚̈ê—á. ŠâŒ³ŽO˜a1, •iì–íl1, ’––”FŒ³1, –k—¢—œŽÑ1, ¬™
—Œb1, “n•Óˆê˜Y1, ‘OìŒb”ü1, –öàV’q‹`1, …’J’m‘×1, ¬”‹Žr”ü1, ’|“àˆê˜Y2, ˜aò@“O1 (1z
ŠÂŠí“à, 2‹~–œ): ‘æ32‰ñS‹Ø¶ŒŸŒ€‹†‰ï (2010/11/27), “Œ‹ž.

733076. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚킪‘‚ł̐S•s‘S’Ž‹}«Šúf—ÂÉClinical
Scenario‚Í’Ê—p‚·‚é‚©? “n•Óˆê˜Y1, ’––”FŒ³1, ˜aò@“O1 (1zŠÂŠí“à): ‘æ23‰ñ_“ސìS•s‘SŒ€‹†
‰ï (2011/2/26), ‰¡•l.

H21”N“xˆÈ‘O•ª

[’˜@‘]

H21-620011. [Šwp‘] (•ª’SŽ·•M)yzŠÂŠíŒ€Cƒm[ƒgz‘æ4Í ŠeŽŸŠ³‚Ì‚Ý‚©‚œ‚ƑΉž@C S•s‘S@
9. S•s‘S‚É‚š‚¯‚éŒÄ‹zŠÇ—. ÂŽR’Œ‘P (zŠÂŠí“à), ‘ŠÄC ‰iˆä—ÇŽO, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2010/3”­
s.

[Šw‰ïEŒ€‹†‰ï“™]

H21-722009. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ‹•ŒŒ«SŽŸŠ³‚É‚š‚¯‚éƒoƒCƒIƒ}[ƒJ[‚ÌŒ»ó. ÂŽR’Œ‘P
(zŠÂŠí“à): ‘æ20‰ñ¶•šŽŽ—¿•ªÍ‰ÈŠw‰ï”NŽŸŠwpW‰ï (2010/3/13), “Œ‹ž.

H21-731002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S•s‘SŠÇ—‚É‚š‚¯‚éBNP‘ª’è?‚»‚Ì‹•‚ÆŽÀ. ’–
–”FŒ³ (zŠÂŠí“à): ŽsìzŠÂŠíƒZƒ~ƒiƒŠƒI (2009/9/7), Žsì.


_Œo“à‰ÈŠw

[Šwp˜_•¶]

110110. [ŒŽ’˜] Induction of parkinsonism-related proteins in the spinal motor neurons of
transgenic mouse carrying a mutant SOD1 gene. Morimoto N, Nagai M1, Miyazaki K, Ohta Y, Kurata
T, Takehisa Y, Ikeda Y, Matsuura T, Asanuma M, Abe K: J Neurosci Res 2010/6; 88 (8): 1804-11. (‰i
ˆä^‹MŽq1: 1_Œo“à)

110111. [ŒŽ’˜] Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term
observational study. Iizuka T1, Yoshii S, Kan S2, Hamada J1, Dalmau J, Sakai F, Mochizuki H1:
J Neurol 2010/10; 257 (10): 1686-91. (”ђˍ‚_1, à_“cˆê1, ›@Mˆê2, –]ŒŽGŽ÷1: 1_Œo“à, 2
•úŽËü (‰æ‘œ))

110112. [ŒŽ’˜] The effect of orexin-A on the pathological mechanism in the rat focal cerebral
ischemia. Kitamura E1, Hamada J1, Kanazawa N, Yonekura J1, Masuda R1, Sakai F, Mochizuki H1:
Neurosci Res 2010/10; 68 (2): 154-7. (–k‘º‰p“ñ1, à_“cˆê1, •Ä‘qƒŽq1, ‘“c@—ã1, –]ŒŽGŽ÷1:
1_Œo“à)

120012. [ŒŽ’˜] –ò•š“®‘ÔŠw“I‚š‚æ‚Ñ–ò—Šw“Iƒvƒƒtƒ@ƒCƒ‹‚©‚ç‚Ý‚œƒiƒ‰ƒgƒŠƒvƒ^ƒ“‚̈Ӌ`. à_“cˆê
(_Œo“à): PROGRESS IN MEDICINE 2010/9; 30 (9): 2437-42.

320006. [Ç—á•ñ] Pure motor isolated finger palsy‚ð’悵‚œ”][Ç‚Ì1—á. –k‘º‰p“ñ1, à_“cˆê
1, —é–؍N•ã1, ˆ¢‹v’Óñ•v1, ›@Mˆê2, –]ŒŽGŽ÷1 (1_Œo“à, 2•úŽËü (‰æ‘œ)): —Տ°_ŒoŠw 2010/8;
50 (8): 572-7.

510006. [‘à] The regulatory role of alpha-synuclein and parkin in neuronal cell apoptosis;
possible implications for the pathogenesis of Parkinson's disease. Yasuda T, Mochizuki H1:
Apoptosis 2010/11; 15 (11): 1312-21. (–]ŒŽGŽ÷1: 1_Œo“à)

520053. [‘à]yALSŠ³ŽÒ‚̍ݑîˆã—ÁzŠÉ˜aƒPƒA (áu’ɑ΍ô). ‰¬–ì”üŒbŽq (_Œo“à): —Տ°ƒŠƒn 2010/5;
19 (5): 484-8.

520054. [‘à]y¡ŒŽ‚ÌŽå‘è: ŒÄ‹z•s‘S‚̐f—ÁzŒÄ‹z•s‘S‚ðµ‚­ŽŸŠ³@_Œo‹ØŽŸŠ³. ‰¬–ì”üŒbŽq (_Œo
“à): medicina 2010/8; 47 (8): 1420-3.

522040. [uÀ]y“ÁW: –TŽîᇐ«_Œo‹ØŽŸŠ³updatezRNMDAŽó—e‘Ì”]‰Š‚ÉŠÖ‚·‚éÅV‚Ì’mŒ©. ”ђˍ‚
_1, âˆä•¶•F, –]ŒŽGŽ÷1 (1_Œo“à): BRAIN and NERVE?_ŒoŒ€‹†‚̐i•à 2010/4; 62 (4): 331-8.

522041. [uÀ]y_Œo“à‰È‚Ì•a‹C‚Ì‚·‚ׂāzƒRƒ‰ƒ€: ƒ~ƒgƒRƒ“ƒhƒŠƒA”]‹ØÇ. ”ђˍ‚_ (_Œo“à): ‚©‚ç
‚Ÿ‚̉Ȋw 2010/5; 265: 196-7.

522042. [uÀ]y“ÁW: –Ɖu«_ŒoŽŸŠ³?V‚œ‚ÈŽ¡—Ð헪‚ÉŒü‚¯‚āzƒgƒsƒbƒNƒX: Ž©ŒÈ–Ɖu«”]‰Š. ”Ñ
’ˍ‚_1, –]ŒŽGŽ÷1 (1_Œo“à): “à‰È 2010/5; 105 (5): 858-63.

522043. [uÀ]y“ÁW: ‘ÌŠOŽ®—z‰Aˆ³Ž®lHŒÄ‹zz‹ØˆÞk«‘€õd‰»Ç. ‰¬–ì”üŒbŽq (_Œo“à): lHŒÄ
‹z 2010/5; 27 (1): 30-3.

522044. [uÀ]y“ÁW: _Œo“à‰È‚Ì•a‹C‚Ì‚·‚ׂāzART. 4 ‰^“®ƒjƒ…[ƒƒ“ŽŸŠ³E_ŒoŒnŠŽõÇ@‹ØˆÞk
«‘€õd‰»Ç. ‰¬–ì”üŒbŽq (_Œo“à): ‚©‚ç‚Ÿ‚̉Ȋw 2010/6; 265: 113-7.

[’˜@‘]

620055. [Šwp‘] (•ª’SŽ·•M)yÇ—á‚©‚çŠw‚ÔNPPV?ƒ`[ƒ€ˆã—Ã‚Ì–ðŠ„•ª’S?II ˆŸ‹}«‚©‚疝«ŽŸŠ³‚Ì
ê‡@1. ƒGƒrƒfƒ“ƒXƒŒƒxƒ‹‚̍‚‚¢ŽŸŠ³@_Œo‹ØŽŸŠ³?‹ØˆÞk«‘€õd‰»Ç‚𒆐S‚É?, p.105-18. ‰¬–ì
”üŒbŽq1, ‰Z¶Lˆê, ‘å‰i—¢”ü, ìã@—B, ˆÉš“c–ŸŽq, —é–ؐg˜aŽq, ²“¡Žu•Û, ²“¡‚Ý‚³‚ð (1_Œo“à),
•Ò’˜ ’±–Œ—Ñ’Œ•F, Žœ“°o”Å, “Œ‹ž, 2010/5”­s.

620056. [Šwp‘] (•ª’SŽ·•M)yÇ—á‚©‚çŠw‚Ԑ헪“I•Ð“ª’ɐf’fEŽ¡—Áz‚šŽY‚µ‚œŒã‚Ђǂ¢“ª’É‚É”Y‚Ü‚³
‚ê‚é—á, p.270?8. à_“cˆê (_Œo“à), •Ò •œ“cKˆê, ŒÜ\—’‹v‰À, Ž…r•F, ’|“‡‘œ‰ê•v, “ìŽR“°, “Œ
‹ž, 2010/12”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712040. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Pathogenesis of stroke-like episodes in MELAS@
A role of neuron-astrocyte uncoupling in neuronal hyperexcitability. Iizuka T1, Sakai F, Hamada
J1, Michizuki H1: The 7th Conference of Asian Society for Mitochondrial Research and Medicine
(ASMRM) and the 10th Conference of Japanese Society of Mitochondrial Research and Medicine (J-mit)
(2010/12/18), Fukuoka. (”ђˍ‚_1, à_“cˆê1, –]ŒŽGŽ÷1: 1_Œo“à)

713057. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Glycine receptor antibodies in immune-mediated
movement disorders: progressive encephalomyelitis with rigidity and myoclonus,
opsoclonus-myoclonus syndrome, and ocular flutter syndrome. Iizuka T1, Urano Y1, Miyakawa S1,
Hamada J1, Leite I, Vincent A, Sakai F, Mochizuki H1: The 62nd American Academy of Neurology
(2010/4/21), Toronto, Canada. (”ђˍ‚_1, ‰Y–ì‹`Í1, ‹{ì¹D1, à_“cˆê1, –]ŒŽGŽ÷1: 1_Œo
“à)

713058. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Influence of the renal excretion of
anti-parkinsonian drugs in patients with Parkinson's disease associated with chronic kidney disease.
Ryo M1, K Akiyama, Mochizuki H1, F Yoshii: The 14th Congress of the European Federation of
Neurological Societies (EFNS) (2010/9/28), Geneve Switzerlamd. (—À@³•£1, –]ŒŽGŽ÷1: 1_Œo“à)

713059. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical perspective on pathophysiology of stroke-like
episodes in MELAS. Iizuka T1, Sakai F, Hamada M1, Mochizuki H1: 29th International Congress of
Clinical Neurophysiology (2010/10/29), Kobe. (”ђˍ‚_1, à_“cˆê1, –]ŒŽGŽ÷1: 1_Œo“à)

722066. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) •Ð“ª’É‚Ì•a‘Ԑ¶—‚É‚š‚¯‚é’†•_ŒoŒn‚ÌŠÖ—^?•Ð
“ª’É‚Ìgenerator?. à_“cˆê (_Œo“à): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2010/5/22), “Œ‹ž.

722067. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Diverse Pathophysiology of Prolonged Aura in FHM2.
”ђˍ‚_ (_Œo“à): Migraine Future Research Perspectives: from the Newest Research in Japan (‘æ
38‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï) (2010/11/20), Tokyo.

722068. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€2)y•Ð“ª’É‚Ì•a‘ԁEŽ¡—Â̍őOüz•Ð“ª’É‚É‚š‚¯‚é_ŒoŒŽ«‰ŠÇ.
à_“cˆê (_Œo“à): ‘æ38‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2010/11/20), “Œ‹ž.

723185. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]’ê“®–¬•ÂÇÇ‚É‚š‚¯‚é”]’ê“®–¬‚ÌFLAIR‰æ‘œ‚É‚æ‚錟
“¢. ˆ¢‹v’Óñ•v1, Ž‰ÆKŽq1, –S•œ1, —Rˆäi‘Ÿ˜Y, —é–؍N•ã, ˆäorŒõ2, ‘êŽR—eŽq1, ”ђˍ‚_
1, à_“cˆê1, –]ŒŽGŽ÷1 (1_Œo“à, 2‹~–œ): ‘æ35‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï (2010/4/15), ·‰ª.

723186. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒbƒg’†‘å”]“®–¬•ÂÇƒ‚ƒfƒ‹‚É‚š‚¯‚éghrelinÃ–¬“à“Š
—^‚ÌŒŸ“¢. –k‘º‰p“ñ1, •Ä‘qƒŽq1, ‹ààV’Œ”ü, ‘“c@—ã1, à_“cˆê1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ35
‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï (2010/4/17), ·‰ª.

723187. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽO³_ŒoØ’fp‚̓‰ƒbƒg‚̔玿Šg‰„«—}§‚ðŒž­‚³‚¹‚é.
‘“c@—ã1, à_“cˆê1, •Ä‘qƒŽq1, –k‘º‰p“ñ1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ35‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï
(2010/4/17), ·‰ª.

723188. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Olmesartan‚Íangiotensin II‚É‚æ‚é”玿Šg‰„«—}§‚Ì
‘‰Á‚ð—\–h‚·‚é. ‘“c@—ã1, à_“cˆê1, •Ä‘qƒŽq1, –k‘º‰p“ñ1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ51‰ñ“ú
–{_ŒoŠw‰ï‘‰ï (2010/5/20), “Œ‹ž.

723189. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒp[ƒLƒ“ƒ\ƒ“•a‚É‚š‚¯‚鎋°‰ºŠj”][•”ŽhŒƒ—Ö@‚Ì”F’m‹@”\‚ɑ΂·
‚é’·Šú“I‰e‹¿. ‘êŽR—eŽq1, ²“¡Ÿl2, ‰¬–ì@—T1, ‰¬–ì”üŒbŽq1, âE–{–Ÿ•F3, –]ŒŽGŽ÷1 (1_Œo“à,
2”]ŠO, 3ž_): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2010/5/20), “Œ‹ž.

723190. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Orexin-1Žó—e‘̝hR–ò‚Ì“Š—^—ʕω»‚É‚æ‚郉ƒbƒg”玿Šg
‰„«—}§‚ɑ΂·‚éŒø‰Ê‚Ì‘ŠˆÙ. •Ä‘qƒŽq1, à_“cˆê1, –k‘º‰p“ñ1, ‘“c@—ã1, –]ŒŽGŽ÷1, âˆä•¶•F
(1_Œo“à): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2010/5/20), “Œ‹ž.

723191. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«t‘Ÿ•a (Chronic Kideny Disease: CKD) ‚𔺂€ƒp[
ƒLƒ“ƒ\ƒ“•aŠ³ŽÒ‚É‚š‚¯‚ét”rŸ•«–ò•š“Š—^‚É‚š‚¯‚é‰e‹¿. —À@³•£1, HŽRŽ“¿, –]ŒŽGŽ÷1, ‹gˆä•¶‹Ï
(1_Œo“à): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2010/5/21), “Œ‹ž.

723192. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —}§«_Œo“`’BáŠQ‚ª„‘ª‚³‚ê‚Ä‚¢‚é_Œo–ƉuŽŸŠ³‚É‚š
‚¯‚éRƒOƒŠƒVƒ“Žó—e‘̍R‘̂̈Ӌ`. ”ђˍ‚_1, Leite Maria, Vincent Angela, ‰Y–ì‹`Í1, âˆä•¶•F,
–]ŒŽGŽ÷1 (1_Œo“à): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï (2010/5/21), ‰¡•l.

723193. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Š£á‚ÆŒŒŠÇáŠQ. ˆ¢‹v’Óñ•v1, –S•œ1, “à–쏲Žq
1, ‰Y–ì‹`Í1, à_“cˆê1, –]ŒŽGŽ÷1, Œü–ì@“N2 (1_Œo“à, 2”畆): ‘æ51‰ñ“ú–{_ŒoŠw‰ï‘‰ï
(2010/5/22), “Œ‹ž.

723194. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒp[ƒLƒ“ƒ\ƒ“•a‚ÌŽ‹°‰ºŠj”][•”ŽhŒƒp‚É‚æ‚é’·Šú“I”F’m‹@”\•Ï‰».
‘êŽR—eŽq1, ²“¡Ÿl2, ‰¬–ì@—T1, ‰¬–ìŒb”üŽq1, ˆé–{–Ÿ•F3, –]ŒŽGŽ÷1 (1_Œo“à, 2”]ŠO, 3ž_):
‘æ4‰ñƒp[ƒLƒ“ƒ\ƒ“•aE‰^“®áŠQŽŸŠ³ƒRƒ“ƒOƒŒƒX (2010/10/7), ‹ž“s.

723195. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒp[ƒLƒ“ƒ\ƒ“•a‚ÌŽ‹°‰ºŠj”][•”ŽhŒƒp‚É‚æ‚é’·Šú“I”F
’m‹@”\•Ï‰». ‘êŽR—eŽq1, ²“¡Ÿl2, ‰¬–ì@—T1, ‰¬–ì”üŒbŽq1, âE–{–Ÿ•F3, –]ŒŽGŽ÷1 (1_Œo“à, 2
”]ŠO, 3ž_): ‘æ4‰ñƒp[ƒLƒ“ƒ\ƒ“•a‰^“®áŠQŽŸŠ³ƒRƒ“ƒOƒŒƒX (2010/10/8), ‹ž“s.

723196. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Angiotensin IIŽó—e‘Ì‘jŠQÜ‚ª•Ð“ª’Ƀ‚ƒfƒ‹ƒ‰ƒbƒg‚É‹y
‚Ú‚·ì—p‚ÌŒŸ“¢. ‘“c@—ã1, à_“cˆê1, •Ä‘qƒŽq1, –k‘º‰p“ñ1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ38‰ñ“ú
–{“ª’ÉŠw‰ï‘‰ï (2010/11/19), “Œ‹ž.

723197. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ã–¬“àorexin-A“Š—^Œã‚̃‰ƒbƒg”]ŒŒ—¬‚ɑ΂·‚é‰e‹¿. •Ä
‘qƒŽq1, à_“cˆê1, –k‘º‰p“ñ1, ‘“c@—ã1, –]ŒŽGŽ÷1, âˆä•¶•F (1_Œo“à): ‘æ38‰ñ“ú–{“ª’ÉŠw
‰ï‘‰ï (2010/11/19), “Œ‹ž.

723198. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ª’ÉŠO—ˆ‚É‚š‚¯‚éƒgƒŠƒvƒ^ƒ“»Ü‘I‘ð‚ÌŒ»ó. ¬ì‰Ê—Ñ
1, à_“cˆê1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ38‰ñ“ú–{“ª’ÉŠw‰ï‘‰ï (2010/11/20), “Œ‹ž.

723199. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒbƒg’†‘å”]“®–¬•ÂÇƒ‚ƒfƒ‹“®•š‚É‚š‚¯‚éghrelin”]•Û
ŒìŒø‰Ê‚ÌŒŸ“¢. –k‘º‰p“ñ1, à_“cˆê1, ‹ààV’Œ”ü, •Ä‘qƒŽq1, ‘“c@—ã1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ
22‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï (2010/11/26), ‘åã.

723200. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PARK8 Sagamihara‰ÆŒn‚Ì”ñ‰^“®Çó‚ÌŒŸ“¢1: ”F’m‹@”\,
‚€‚‚𒆐S‚É. —À@³•£1, ‰¬–ì@—T1, ‘“c@—ã1, Ž‰ÆKŽq1, ŒÃàV‰p–Ÿ1, …–ì”ü–M, ’·’JìˆêŽq
1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ52‰ñ“ú–{_ŒoŠw‰ïŠwp‘å‰ï (2011/5/20), –ŒŒÃ‰®.

731049. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a‚Ì–³“®Ç‚ɂ‚¢‚Ä. –]ŒŽGŽ÷ (_Œo“à):
‘æ12‰ñ•Ÿ‰ª_Œo“à‰ÈŽŸŠ³Œ€‹†‰ï (2010/4/23), •Ÿ‰ª.

731050. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]‰ŠE”]Ç‚ðl‚Š‚é: RNMDAŽó—e‘Ì”]‰Š‚𒆐S‚Æ‚·‚鎩
ŒÈ–Ɖu«”]‰Š‚̗Տ°‘œ‚Æ•a‘Ô. ”ђˍ‚_ (_Œo“à): ‘æ17‰ñ‚‚«‚¶•úŽËüƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/4/24),
“Œ‹ž.

731051. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a‚Ì–³“®Ç‚ɂ‚¢‚Ä. –]ŒŽGŽ÷ (_Œo“à):
‘æ5‰ñYokohama kawasaki Neurologic Workshop (2010/5/7), _“ސì.

731052. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) —Տ°ˆã‚ª’m‚Á‚Ä‚š‚«‚œ‚¢ƒp[ƒLƒ“ƒ\ƒ“•a‚̐f’f‚ÆŽ¡—Ã.
–]ŒŽGŽ÷ (_Œo“à): ‘æ484‰ñŒŽ—ጀ‹†‰ï (2010/5/7), _“ސì.

731053. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a?ÅV‚̘b‘è?. –]ŒŽGŽ÷ (_Œo“à (‘æ
2‰ñÂXƒp[ƒLƒ“ƒ\ƒ“•aŠwpu‰‰‰ï): 2010/6/3), ÂX.

731054. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a?Å‹ß‚̘b‘è. –]ŒŽGŽ÷ (_Œo“à): ‘æ
6‰ñWestern Chiba Neurological Seminar (W-CNS) (2010/6/23), ç—t.

731055. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•aup to date. –]ŒŽGŽ÷ (_Œo“à): •xŽm
ƒp[ƒLƒ“ƒ\ƒ“•aƒtƒH[ƒ‰ƒ€2010 (2010/6/25), Ã‰ª.

731056. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) RNMDAŽó—e‘Ì”]‰Š‚Æ‚»‚ÌŽü•ÓŽŸŠ³. ”ђˍ‚_ (_Œo“à):
‘æ13‰ñ•ºŒÉ_ŒoƒZƒ~ƒi[ (2010/7/24), _ŒË.

731057. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) orexin‚Ì”]zŠÂ‚É‚š‚¯‚é–ðŠ„?•Ð“ª’ɁE”]‹•ŒŒ‚ɑ΂·‚é
ŠÖ—^?. à_“cˆê (_Œo“à): ‘æ37‰ñŠÖ“Œ’n‹æ”]ŒŒŠÇáŠQ§˜b‰ï (2010/10/19), “Œ‹ž.

731058. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •Ð“ª’É‚Ì•a‘Ԑ¶—?Orexin‚Ì–ðŠ„?. à_“cˆê (_Œo
“à): ‘æ19‰ñ–kŠC“¹“ª’ɕ׋­‰ï (2010/10/22), ŽD–y.

732051. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒ‰ƒbƒg’†‘å”]“®–¬•ÂÇƒ‚ƒfƒ‹“®•š‚É‚š
‚¯‚éorexin-A‚Ì”­Œ». –k‘º‰p“ñ1, •Ä‘qƒŽq1, ‹ààV’Œ”ü, ‘“c@—ã1, à_“cˆê1, âˆä•¶•F, –]ŒŽG
Ž÷1 (1_Œo“à): ‘æ37‰ñŠÖ“Œ’n‹æ”]ŒŒŠÇáŠQ§˜b‰ï (2010/10/19), “Œ‹ž.

733077. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ÁˆÙ‚ÈŒo‰ß‚ð‚œ‚Ç‚Á‚œ‰º‚‘Ì‘²’†‚̈ê—á. –î
S•œ1, ˆä“‡‘å•ã1, ‰Y–ì‹`Í1, ²“Œ^‹|1, ‘êŽR—eŽq1, —Rˆäi‘Ÿ˜Y, ‘“c@—ã1, ”ђˍ‚_1, ˆ¢‹v
’Óñ•v1, à_“cˆê1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ9‰ñ“Œ‹žstrokeƒtƒƒ“ƒeƒBƒA (2010/4/9), “Œ‹ž.

733078. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ã–¬“ŽŒŒðÇE‘–Œ‰Š‚ð‡•¹‚µ, ƒXƒeƒƒCƒh
‚ª‘tŒ÷‚µ‚œŠáâ|æ’[•”ƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ‚̈ê—á. ‘êŽR—eŽq1, ‹àŽq~‘Ÿ˜Y1, ‰Y–ì‹`Í1, ²“Œ–ƒ‹|1, –]
ŒŽGŽ÷1 (1_Œo“à): ‘æ193‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï (2010/6/5), “Œ‹ž.

733079. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PD‘ŠúŽ¡—Â̎ÀÛ. ‘êŽR—eŽq (_Œo“à): Žá
Žè_Œo“à‰Èˆã‚Ì‚œ‚ß‚ÌPDf—ÃŽÀ‘Hƒ[ƒNƒVƒ‡ƒbƒv (2010/6/15), _“ސì.

733080. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “àèò“®–¬‹·óÇ‚É”º‚€”]—ÀoŒŒ‚̈ê—á. ‘“c@
—ã1, ‹àŽq~‘Ÿ˜Y1, “à–쏲Žq1, à_“cˆê1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ12‰ñ Neurovascular Conference
(2010/6/18), ’¬“c.

733081. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[ Orofacial dyskinesias, pseudo-piano playing
motions‚š‚æ‚Ñcatalepsy‚ð’悵‚œRNMDAŽó—e‘Ì”]‰Š‚Ì1—á. ”ђˍ‚_1, “à–쏲Žq1, ‰Y–ì‹`Í1, ‘ê
ŽR—eŽq1, à_“cˆê1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ25‰ñ“ú–{‘å”]Šî’êŠjŒ€‹†‰ï (2010/7/31), •Ÿ“‡.

733082. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ALS‚̃PƒAƒ}ƒlƒWƒƒ“ƒg. ‰¬–ì”üŒbŽq (_Œo
“à): ‘æ9‰ñ“ú–{ƒPƒAƒ}ƒlƒWƒƒ“ƒg‘å‰ï (2010/8/28), é‹Ê.

733083. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯‚¶Çó‚ðŒJ‚è•Ô‚µ‚œˆê‰ß«”]‹•ŒŒ”­ìŒã‚Ì
”][Ç‚̈ê—á. ˆ¢‹v’Óñ•v1, à_“cˆê1, –]ŒŽGŽ÷1 (1_Œo“à): ‘æ13‰ñƒjƒ…[ƒƒoƒXƒLƒ…ƒ‰[ƒJƒ“
ƒtƒ@ƒŒƒ“ƒX (2010/11/12), ‘Š–ÍŒŽ.

733084. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[ áz¹dÏ‚Å”­Ç‚µ, L”͈͂ÈMRIˆÙíŠŒ©‚ð’æ
‚µ‚œRNMDAŽó—e‘Ì”]‰Š‚Ì17Î’j«. ‹àŽq~‘Ÿ˜Y1, ”ђˍ‚_1, “à–쏲Žq1, à_“cˆê1, –]ŒŽGŽ÷1 (1
_Œo“à): ‘æ195‰ñ“ú–{_ŒoŠw‰ïŠÖ“ŒEbM‰z’n•û‰ï (2010/11/27), “Œ‹ž.

H21”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H21-540016. [‚»‚Ì‘Œ (Œ€‹†•ñ‘“™)yŒú¶˜J“­È“x“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶
Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŽ¿‚ÌŒüã‚ÉŠÖ‚·‚錀‹†vzƒXƒRƒ|ƒ‰ƒ~ƒ““îp‚Ì—L—p«. ‰¬–ì”üŒbŽq1,
‹{ì¹D1, ‘O“cŽÀ‰Ô2, •ŽR­ˆê2, –]ŒŽGŽ÷1 (1_Œo“à, 2“Œ•a‰@–òÜ•”): Œú¶˜J“­È“x“«ŽŸŠ³
Ž•žŒ€‹†Ž–‹Æu“Á’莟Š³Š³ŽÒ‚̐¶Šˆ‚ÌŽ¿ (Quality of life, QOL) ‚ÌŽ¿‚ÌŒüã‚ÉŠÖ‚·‚錀‹†v•œ¬21”N
“xŒ€‹†•ñ‰ïƒvƒƒOƒ‰ƒ€ 2009/12; p.34.


ŒŒ‰t“à‰ÈŠw

[Šwp˜_•¶]

110113. [ŒŽ’˜] Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia: results of
a prospective study in Japan. Nagai T, Takeuchi J, Dobashi N, Kanakura Y, Taniguchi S, Ezaki K,
Nakaseko C, Hiraoka A, Miyazaki Y, Higashihara M1, Tsukamoto N, Kiyoi H, Nakao S, Shinagawa K,
Ohno R, Naoe T, Ohnishi K, Usui N: Int J Hematol 2010/7; 92 (1): 111-7. (“ŒŒŽ³–Ÿ1: 1ŒŒ‰t“à)

110114. [ŒŽ’˜] Clinical efficacy and safety of biapenem for febrile neutropenia in patients with
underlying hematopoietic diseases: a multi-institutional study. Nakagawa Y, Suzuki K, Hirose T,
Chou T, Fujisawa S, Kida M, Usuki K, Ishida Y, Taniguchi S, Kouzai Y, Tomoyasu S, Miyazaki K1,
Higashihara M1, Ando K, Aoki S, Arai A, Akiyama N, Hatake K, Okamoto S, Dan K, Ohyashiki K, Urabe
A: J Infect Chemother 2011/2; 17 (1): 58-67. (‹{è_“ñ1, “ŒŒŽ³–Ÿ1: 1ŒŒ‰t“à)

110115. [ŒŽ’˜] Inhibition of active HIV-1 replication by NF-kappaB inhibitor DHMEQ. Miyake A,
Ishida T, Yamagishi M, Hara T, Umezawa K, Watanabe T, Horie R1: Microbes Infect 2010/5; 12 (5):
400-8. (–x]—Ljê1: 1ŒŒ‰t“à)

110116. [ŒŽ’˜] The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target
for nuclear factor-kappaB inhibitors in Hodgkin's lymphoma. Nakashima M, Ishii Y, Watanabe M,
Togano T1, Umezawa K, Higashihara M1, Watanabe T, Horie R1: Cancer Sci 2010/11; 101 (11): 2490-6.
(’Ì–ì•x‹P1, “ŒŒŽ³–Ÿ1, –x]—Ljê1: 1ŒŒ‰t“à)

320007. [Ç—á•ñ] ƒpƒ‹ƒ{ƒEƒCƒ‹ƒXB19ŠŽõ‚É‚æ‚鍜‘–³Œ`¬ƒNƒŠ[ƒ[‚𗈂·‚à–³Ž–oŽY‚µ“Ÿ‚œŽ©ŒÈ–Æ
‰u«—nŒŒ«•nŒŒ‡•¹‘o‘Ù”D•w‚̈ê—á. Î“c@—²1, ‹{è_“ñ1, ‰¥@‘cœ1, Š™“c_–«1, –Ø‘º—T˜a1, •Ð
ŽR‘쎢, Îˆä—²Ži1, ‘åâ@Šw1, ’hŒŽŠ²¶1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): “ú–{“à‰ÈŠw‰ïŽGŽ 2010/10; 99 (10):
2539-41.

320008. [Ç—á•ñ] ’×ᇐ«‘å’°‰Š‚ɍ‡•¹‚µ‚œ, ‚Ñ‚Ü‚ñ«‘å×–EŒ^B×–EƒŠƒ“ƒpŽî‚Ì1Ç—á. ¬ˆä–Ÿ‰Ø
1, Š™“c_–«1, ‰¥@‘cœ1, –Ø‘º—T˜a1, Â–Ø‘ì–€, •ÐŽR‘쎢, Îˆä—²Ži1, ’Ì–ì•x‹P1, —é–Ø—TŽq2, ‘å
â@Šw1, ‹{è_“ñ1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à, 2—AŒŒE×–EˆÚA): _“ސ쌌‰t
Œ€‹†‰ïŽ 2010; 30: 39-41.

320009. [Ç—á•ñ] —Ü‘BŒŽ”­‚Ñ‚Ü‚ñ«‘å×–EŒ^B×–EƒŠƒ“ƒpŽî‚Ì1Ç—á. ŽáV•‡”ü, ‘åâ@Šw1, ‰¥@‘c
œ1, Š™“c_–«1, –Ø‘º—T˜a1, Â–Ø‘ì–€, •ÐŽR‘쎢, Îˆä—²Ži1, ’Ì–ì•x‹P1, ‹{è_“ñ1, ’hŒŽŠ²¶1, –x
]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): _“ސ쌌‰tŒ€‹†‰ïŽ 2010; 30: 73-4.

[’˜@‘]

620057. [Šwp‘] (•ª’SŽ·•M)yˆã–ò•i•›ì—pƒnƒ“ƒhƒuƒbƒN?‘æ2”Å?z‹ÃŒÅáŠQ, p.375-80. “ŒŒŽ³–Ÿ
1, Â–Ø‘ì–€ (1ŒŒ‰t“à), ŠÄC ø‹‹Ž—²ˆê, “ú–{—Õ଎Ð, ‘åã, 2010/5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713060. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Evaluation of romiplostim in a randomized
placebo-controlled Phase 3 study of a Japanese population with chronic immune thrombocytopenia
(ITP). Miyazaki K1, Shirasugi Y, Ando K, Tomiyama Y, Okamoto S, Kurokawa M, Kirito K, Yonemura
Y, Mori S, Usuki K, Iwato K, Hashino S, Wei H, Lizambri R: 52th Annual Meeting of the American
Society of Hematology (2010/12/6), USA. (‹{è_“ñ1: 1ŒŒ‰t“à)

722069. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y•œŠŠ‹Ø‚É‚š‚¯‚éƒVƒOƒiƒ‹“`’BŒ€‹†‚̃JƒbƒeƒBƒ“ƒOƒGƒbƒWzƒ~ƒI
ƒVƒ“Œyœ (MYL9) ‚ÌT×–E”’ŒŒ•aŠ”‚É‚š‚¯‚éCD3”­Œ»—U“±‚Ö‚ÌŠÖ—^. Â–Ø‘ì–€1, “n粐^—Žq, ‹{è_“ñ
1, ’hŒŽŠ²¶1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ52‰ñ“ú–{•œŠŠ‹ØŠw‰ï‘‰ï (2010/7/2), å‘ä.

723201. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) æ“V«‹‘匌¬”ǂɂš‚¯‚éV‹KGPIIb•ÏˆÙ‚Ì“¯’è. š 
“‡LŽ¡, ŽR‘ºŠì”ü, “¡X—S‘œ, ‹{è_“ñ1, ”–؍_˜a, •yŽR‰Àº, âV“¡‰p•F (1ŒŒ‰t“à): ‘æ11‰ñ“ú–{ŒŸ
žŒŒ‰tŠw‰ï‘‰ï (2010/7/24), “Œ‹ž.

723202. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘¢ŒŒŠ²×–EˆÚA8”NŒã‚Égranulocytic sarcoma‚Æ‚µ‚čÄ
”­‚µ‚œ‚ª, œ‘‚Íintact‚Å‚ ‚Á‚œAML (M2). ‰¥@‘cœ1, Š™“c_–«1, –Ø‘º—T˜a1, Œ‰ª˜aº1, ‘åâ@Šw
1, Îˆä—²Ži1, ‹{è_“ñ1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ72‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ï
(2010/9/24), ‰¡•l.

723203. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MYL9 is involved in the expression of the CD3 complex
in T cell leukemia cells. Â–Ø‘ì–€1, Watanabe M, ‹{è_“ñ1, ’hŒŽŠ²¶1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à):
‘æ72‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ï (2010/9/25), ‰¡•l.

723204. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐ«‘å’°‰Š‚ɍ‡•¹‚µ‚œ‚Ñ‚Ü‚ñ«‘å×–EŒ^B×–EƒŠƒ“ƒp
Žî. Š™“c_–«1, ¬ˆä–Ÿ‰Ø1, Î“c@—²1, ‰¥@‘cœ1, –Ø‘º—T˜a1, Œ‰ª˜aº1, Îˆä—²Ži1, •ÐŽR‘쎢
1, ‘åâ@Šw1, ’Ì–ì•x‹P1, ‹{è_“ñ1, ’hŒŽŠ²¶1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ72‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ï
(2010/9/25), ‰¡•l.

733085. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŽ”­«—Œ‘€«•›tDLBCL. —§‰Ô‹MŽj, ‰Ôèr
•ã1, Œ‰ª˜aº1, Â–Ø‘ì–€1, •ÐŽR‘쎢1, Š™“c_–«1, ‰¥@‘cœ1, Îˆä—²Ži1, ‘åâ@Šw1, ‹{è_“ñ
1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ62‰ñ_“ސ쌌‰tŒ€‹†‰ï (2010/9/4), ‰¡•l.

733086. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) æ“V«‘æVˆöŽqŒ‡–RÇ2—á. HŽRŒ[•ã1, Œ
‰ª˜aº1, Š™“c_–«1, ‰¥@‘cœ1, Îˆä—²Ži1, ‘åâ@Šw1, ‹{è_“ñ1, ’hŒŽŠ²¶1, “ŒŒŽ³–Ÿ1 (1ŒŒ
‰t“à): ‘æ62‰ñ_“ސ쌌‰tŒ€‹†‰ï (2010/9/4), ‰¡•l.

733087. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«œ‘’P‹…«”’ŒŒ•a‚É‘œ”­«œ‘Žî‚ð‡•¹
‚µ‚Ä”­Ç‚µ‚œ1—á. ã–ì‰Ì“ÞŽq, ‹{è_“ñ1, Œ‰ª˜aº1, Š™“c_–«1, ‰¥@‘cœ1, Îˆä—²Ži1, ‘åâ@Šw
1, ’hŒŽŠ²¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ574‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2010/9/4), “Œ
‹ž.

733088. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Ž‹û«—Þ“Vávጂɍ‡•¹‚µ‚œŒã“V«ŒŒ—F•aA‚Ì
1—á. Žª“c^ˆê1, Œ‰ª˜aº1, Š™“c_–«1, ‰¥@‘cœ1, Îˆä—²Ži1, ‘åâ@Šw1, ‹{è_“ñ1, ’hŒŽŠ²
¶1, –x]—Ljê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ62‰ñ_“ސ쌌‰tŒ€‹†‰ï (2010/9/4), ‰¡•l.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-110013. [ŒŽ’˜] Clinical significance of detection of immature platelets: comparison
between percentage of reticulated platelets as detected by flow cytometry and immature platelet
fraction as detected by automated measurement. Koike Y, Miyazaki K1, Higashihara M1, Kimura E,
Jona M, Uchihashi K, Masuda A, Kandabashi K, Kurokawa M, Yatomi Y: Eur J Haematol 2010/2; 84 (2):
183-4. (‹{è_“ñ1, “ŒŒŽ³–Ÿ1: 1ŒŒ‰t“à)

[Šw‰ïEŒ€‹†‰ï“™]

H21-723008. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) …áv«—Þ“Vávጂɍ‡•¹‚µ‚œŒã“V«ŒŒ—F•aA. ’r
“c—S‹B, ‹{è_“ñ1, –Ø‘º—T˜a1, ‰¥@‘cœ1, Š™“c_–«1, Îˆä—²Ži1, ‘åâ@Šw1, ’hŒŽŠ²¶1, –x]—Ç
ˆê1, “ŒŒŽ³–Ÿ1 (1ŒŒ‰t“à): ‘æ164‰ñ“ú–{ŒŒ‰tŠw‰ï—á‰ï (2010/2/6), “Œ‹ž.


ŒÄ‹zŠí“à‰ÈŠw

[Šwp˜_•¶]

110117. [ŒŽ’˜] Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell
lung cancer. Ono A, Naito T, Murakami H, Takahashi T, Nakamura Y, Tsuya A, Kaira K, Igawa S1,
Shukuya T, Tamiya A, Kaira R, Endo M, Yamamoto N: Int J Clin Oncol 2010/4; 15 (2): 161-5. (ˆä
ì@‘1: 1ŒÄ‹zŠí“à)

110118. [ŒŽ’˜] Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small
cell lung cancer. Kaira K, Naito T, Takahashi T, Ayabe E, Shimoyama R, Kaira R, Ono A, Igawa S1,
Shukuya T, Murakami H, Tsuya A, Nakamura Y, Endo M, Yamamoto N: Lung Cancer 2010/4; 68 (1): 99-104.
(ˆäì@‘1: 1ŒÄ‹zŠí“à)

110119. [ŒŽ’˜] Comparison of chemotherapy for unresectable pulmonary high-grade non-small cell
neuroendocrine carcinoma and small-cell lung cancer. Igawa S1, Watanabe R, Ito I, Murakami H,
Takahashi T, Nakamura Y, Tsuya A, Kaira K, Naito T, Endo M, Yamamoto N, Kameya T: Lung Cancer 2010/6;
68 (3): 438-45. (ˆäì@‘1: 1ŒÄ‹zŠí“à)

110120. [ŒŽ’˜] Phase I and pharmacologic study of weekly bolus topotecan for advanced
non–small-cell lung cancer. Masuda N1, Matsui K, Negoro S, Takeda K, Kudoh S, Nakagawa K,
Mukaiyama A, Arase H, Yoshida P, Ijima T, Takada M, Fukuoka M: Clin Lung Cancer 2010/7; 11 (4):
271-9. (‰v“c“TK1: 1ŒÄ‹zŠí“à)

110121. [ŒŽ’˜] Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced
non-small cell lung cancer: Thoracic oncology research group study 0502. Seto T, Yamanaka T, Wasada
I, Seki N, Okamoto H, Ogura T, Shibuya M, Takiguchi Y, Shinkai T, Masuda N1, Ichinose Y, Eguchi
K, Watanabe K: Lung Cancer 2010/8; 69 (2): 213-7. (‰v“c“TK1: 1ŒÄ‹zŠí“à)

110122. [ŒŽ’˜] Evaluation of amrubicin for treatment of elderly patients with small-cell lung
cancer. Igawa S1, Otani S1, Katono K1, Takakura A1, Maki S1, Mitsufuji H1, Kubota M1, Masuda N1:
The Kitasato Med J 2010/9; 40 (2): 144-9. (ˆäì@‘1, ‘å’JçŽq1, ã‰“–쌒1, ‚‘q@W1, ^–Ø
K‘ã1, ŽO“¡@‹v1, ‹v•Û“cŸ1, ‰v“c“TK1: 1ŒÄ‹zŠí“à)

110123. [ŒŽ’˜] Actual status of adjuvant chemotherapy for non-small-cell lung cancer at one
Japanese cancer center: the need for increased cooperation between medical oncologists and surgeons.
Shukuya T, Takahashi T, Tamiya A, Ono A, Igawa S1, Nakamura Y, Tsuya A, Murakami H, Endo M, Ohde
Y, Nakagawa K, Okumura T, Kondo H, Yamamoto N: Medical Oncology 2010/9; 27 (3): 932-7. (ˆäì@‘
1: 1ŒÄ‹zŠí“à)

110124. [ŒŽ’˜] Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer.
Igawa S1, Ryuge S1, Fukui T1, Otani S1, Kimura Y, Katono K1, Takakura A1, Kubota M1, Mitsufuji
H1, Katagiri M2, Yanase N3, Masuda N1: Int J Clin Oncol 2010/10; 15 (5): 447-52. (ˆäì@‘1, —Ž
‰ØTˆê˜Y1, •Ÿˆä•ü–ç1, ‘å’JçŽq1, ã‰“–쌒1, ‚‘q@W1, ‹v•Û“cŸ1, ŽO“¡@‹v1, •Ð‹Ë^l2, –î
“ߐ£M—Y3, ‰v“c“TK1: 1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3ŠÅŒìŠw•”)

110125. [ŒŽ’˜] Randomized Phase II Trial of Irinotecan with Paclitaxel or Gemcitabine for Non-small
Cell Lung Cancer: Association of UGT1A1*6 and UGT1A1*27 with Severe Neutropenia. Nakamura Y, Soda
H, Oka M, Kinoshita A, Fukuda M, Fukuda M, Takatani H, Nagashima S, Soejima Y, Kasai T, Nakatomi
K, Masuda N1, Tsukamoto K, Kohno S: J Thorac Oncol 2011/1; 6 (1): 121-7. (‰v“c“TK1: 1ŒÄ‹zŠí
“à)

110126. [ŒŽ’˜] Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with
advanced non-small cell lung cancer. Masuda N1, Negoro S, Hausheer F, Nakagawa K, Matsui K, Kudoh
S, Takeda K, Yamamoto N, Yoshimura N, Ohashi Y, Fukuoka M: Cancer Chemother Pharmacol 2011/3; 67
(3): :533-42. (‰v“c“TK1: 1ŒÄ‹zŠí“à)

320010. [Ç—á•ñ] Carboplatin, Paclitaxel•¹—p—Ö@‚Å•aš§Œä‚ª“Ÿ‚ç‚ê‚œŠùŽ¡—˹‘BŠà‚Ì1—á. ˆä
ì@‘1, –öàVM”V2, Žª“c^ˆê, ”Ñ“c—Sˆê˜Y, ^–؍K‘ã1, –Ø‘º—[, ‘å’JçŽq1, —с@L[1, ‚‘q@W
1, ã‰“–쌒1, ¬–ì“cŽ1, ŽR–{—ÏŽq1, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2•a—): Šà‚Ɖ»Šw—Ö@ 2010/11; 37
(11): 2161-3.

521009. [‰ðà] ŒÄ‹z‹@”\‚Æ‘ÌŒ^. ‹v•Û“cŸ1, ¬—эO—S2 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”): ŒÄ‹zŠí“à‰È
2010/6; 17 (6): 565-9.

522045. [uÀ]y‹É‚ß‚æ‚€ŒÄ‹z‹@”\ŒŸžz3. S‘©«”xŽŸŠ³‚ƌċz‹@”\ŒŸž. ‹v•Û“cŸ1, ¬—эO—S2 (1
ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”): Medical Technology 2010/7; 38 (7): 674-8.

522046. [uÀ]yŒÄ‹z•s‘S‚̐f—ÁzŒÄ‹z•s‘S‚ðµ‚­ŽŸŠ³?–òÜ«”x‰Š. ŽO“¡@‹v (ŒÄ‹zŠí“à): Medicina
2010/8; 47 (8): 1404-1408

[’˜@‘]

620058. [Šwp‘] (•ª’SŽ·•M)y‚ª‚ñ•ªŽq•W“IŽ¡—à (8 (2))zMeeting Report: ‘æ50‰ñ”xŠàŠw‰ï‘‰ï,
p.149-53. ˆäì@‘ (ŒÄ‹zŠí“à), , ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, ‘åã, 2010/4”­s.

620059. [Šwp‘] (•ª’SŽ·•M)yƒIƒ“ƒRƒƒWƒXƒg‚Í‚±‚€Ž¡—µ‚Ä‚¢‚é@”x‚ª‚ñf—ÂƉ»Šw—Ö@z2. ”x‚ª‚ñ
‚ÆŠmf‚µ‚œ‚ç?Ž¡—Â̐i‚ß•û‚Æ“K‰žÇ—á@3 ¬×–E”xŠà‚ÌŽ¡—Õûj, p.45-52. ˆäì@‘1 (1ŒÄ‹zŠí“à),
ŠÄC â“c@—D, •Ò ‰v“c“TK1, ƒ”ƒ@ƒ“ƒƒfƒBƒJƒ‹, “Œ‹ž, 2011/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713061. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Impact of Obesity on Lung Volumes in Japanese.
Katono K1, Kubota M1, Kimura Y, Onoda S1, Igawa S1, Hataishi R1, Yanase N2, Masuda N1, Kobayashi
H3: European Respiratory Society Barcelona 2010 Congress (2010/9/19), Barcelona, Spein. (ã‰“
–쌒1, ‹v•Û“cŸ1, ¬–ì“cŽ1, ˆäì@‘1, ”šÎ—²Ž¡1, –î“ߐ£M—Y2, ‰v“c“TK1, ¬—эO—S3: 1
ŒÄ‹zŠí“à, 2ŠÅŒìŠw•”, 3ˆã—Éq¶Šw•”)

713062. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Impact of body weight on lung volumes in patients with
pulmonary diseases. Kubota M1, Katono K1, Otani S1, Takakura A1, Yamamoto M1, Hataishi R1, Yokoba
M2, Mitsufuji H1, Masuda N1, Kobayashi H2: European Respiratory Society Barcelona 2010 Congress
(2010/9/21), Barcelona, Spein. (‹v•Û“cŸ1, ã‰“–쌒1, ‘å’JçŽq1, ‚‘q@W1, ŽR–{—ÏŽq1, ”šÎ
—²Ž¡1, ‰¡ê³“T2, ŽO“¡@‹v1, ‰v“c“TK1, ¬—эO—S2: 1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”)

713063. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Prognostic significance of Nestin in resected non-small
cell lung cancer. Ryuge S1, Sato Y, Wang G, Yokoba M2, Katagiri M2, Masuda N1: European Respiratory
Society Annual Congress 2010 (2010/9/21), Barcelona, Spein. (—Ž‰ØTˆê˜Y1, ‰¡ê³“T2, •Ð‹Ë^l
2, ‰v“c“TK1: 1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”)

713064. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Quantitative assessment of pulmonary rehabilitation
by using of Impulse Oscillometry. Yokoba M1, Wada M2, Kubota M2, Katono K2, Takakura A2, Hamazaki
N, Koike T, Masuda N2, Katagiri M1: 15th Congress of the APSR 2010 (2010/11/24), Manila, Philippine.
(‰¡ê³“T1, ˜a“c^—RŽq2, ‹v•Û“cŸ2, ã‰“–쌒2, ‚‘q@W2, à_è‚Ì‚Ô‚ ‚«, ¬’r‚Æ‚à‚œ‚©, ‰v“c“T
K2, •Ð‹Ë^l1: 1ˆã—Éq¶Šw•”, 2ŒÄ‹zŠí“à)

723205. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Impulse Oscillometry (IOS) –@‚É‚æ‚éŒÄ‹zƒŠƒnƒrƒŠƒe[
ƒVƒ‡ƒ“‚É‚š‚¯‚é‰^“®—Ö@‚Ì’è—Ê“I•]‰¿‚ÌŒŸ“¢. ‰¡ê³“T1, •Ð‹Ë^l1, ŒˆäNl2, ‚‘q@W2, Šâ›œ
–ƒˆßŽq2, ã‰“–쌒2, ”šÎ—²Ž¡2, ‹v•Û“cŸ2, ‰v“c“TK2 (1ˆã—Éq¶Šw•”, 2ŒÄ‹zŠí“à): ‘æ50‰ñ“ú–{
ŒÄ‹zŠíŠw‰ïŠwpu‰‰‰ï (2010/4/23), ‹ž“s.

723206. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒQƒtƒBƒ`ƒjƒu“Š—^‚É‚æ‚èPR‚ª3”NˆÈãŽ‘±‚µ‚œÇ—á‚ÌŒŸ
“¢. ‘å’JçŽq1, ŽO“¡@‹v1, —с@L[1, ^–؍K‘ã1, –Ø‘º—[, ã‰“–쌒1, ‚‘q@W1, ŒˆäNl1,
—Ž‰ØTˆê˜Y1, ˆäì@‘1, ¬–ì“cŽ1, ‰¡ê³“T2, ”šÎ—²Ž¡1, ‹v•Û“cŸ1, •Ð‹Ë^l2, ¬—эO—S
2, –î“ߐ£M—Y3, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3ŠÅŒìŠw•”): ‘æ50‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠwpu
‰‰‰ï (2010/4/23), ‹ž“s.

723207. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚—îŽÒ–¢Ž¡—Ði“WŒ^¬×–E”xŠà‚É‚š‚¯‚鉖Ž_ƒAƒ€ƒ‹ƒrƒV
ƒ“‚ÌŽg—pŒoŒ±. ˆäì@‘1, ã‰“–쌒1, ‚‘q@W1, ‘å’JçŽq1, •Ð‹Ë^l2, –î“ߐ£M—Y3, ¬—эO—S
2, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3ŠÅŒìŠw•”): ‘æ50‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠwpu‰‰‰ï (2010/4/23),
‹ž“s.

723208. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) is”ñ¬×–E”xŠà‚ɑ΂·‚éƒGƒ‹ƒƒ`ƒjƒu‚Ì—LŒø«‚š‚æ‚Ñ
ˆÀ‘S«‚ÉŠÖ‚·‚é‘œŽ{Ý‹€“¯Œ€‹†. Â–Ø‘ô–ç, ˆäì@‘1, ŒÃ‰®’ŒŽ÷, •Ð‹Ë^l2, ˆî‘º‹§‹I, ‹ß“¡—S‰î, “c
K‚³‚­‚çŽq, ’[ŽR’ŒŽ÷, ‰Y–ì“NÆ, ‹{àV‹Pb, ‰v“c“TK1, ˆ¢•”@’Œ (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”): ‘æ
50‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠwpu‰‰‰ï (2010/4/23-25), ‹ž“s.

723209. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”ì–ž‚ª”x‹C—Ê•ª‰æ‚É‹y‚Ú‚·‰e‹¿?’j—•Ê‰ðÍ?. ã‰“–ì
Œ’1, ‹v•Û“cŸ1, ”’ˆäŠx“ñ, Œ—t—TŽq1, ‰i“‡—YŽŸ˜Y1, —с@L[1, ^–؍K‘ã1, –Ø‘º—[, ‘å’JçŽq
1, ’©ŒG–ƒˆßŽq, ˜a“c^—RŽq1, ‰HØT‘Ÿ˜Y1, ŽR–{—ÏŽq1, –î“àŒŽ’qŽq1, ‰v“c“TK1, ¬—эO—S2 (1ŒÄ
‹zŠí“à, 2ˆã—Éq¶Šw•”): ‘æ50‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠwpu‰‰‰ï (2010/4/24), ‹ž“s.

723210. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”ñ¬×–E”xŠà‚É‚š‚¯‚éNestin”­Œ»‚̗Տ°•a—Šw“IŒŸ“¢.
—Ž‰ØTˆê˜Y1, ²“¡—Yˆê, —с@L[1, ^–؍K‘ã1, –Ø‘º—[, ‰HØT‘Ÿ˜Y1, ‰¡ê³“T2, ª’ÃŒ«Ži3, ˆÉ
˜¬“c–Ÿ3, ²“¡”Vr3, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3ŒÄ‹zŠíŠO): ‘æ50‰ñ“ú–{ŒÄ‹zŠíŠw‰ï
Šwpu‰‰‰ï (2010/4/25), ‹ž“s, “ú–{ŒÄ‹zŠw‰ïŽGŽ 2010; 48 (‘Š§†): 939.

723211. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”xŠàŠ³ŽÒŒŒŽ’†‚ÌŽîᇊ֘AŽ©ŒÈR‘Ì‚Ì–Ô—…“I’Tõ. ¬—с@
M, Œ–{r‰p, ŒiŽR‘וœ, —Ž‰ØTˆê˜Y1, Ó@¢ˆ®2, ‰ªˆÀ@ŒM2, ²“¡—Yˆê (1ŒÄ‹zŠí“à, 2•a—): ‘æ
99‰ñ“ú–{•a—Šw‰ï‘‰ï (2010/4/27), “Œ‹ž.

723212. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”xŠàŠ³ŽÒŒŒŽ’†‚ÌŽîᇊ֘AŽ©ŒÈR‘Ì‚Ì–Ô—…“I’Tõ. ¬—с@
M, Œ–{r‰p, ŒiŽR‘וœ, —Ž‰ØTˆê˜Y1, Ó@¢ˆ®2, ‰ªˆÀ@ŒM2, ²“¡—Yˆê (1ŒÄ‹zŠí“à, 2•a—): ‘æ
99‰ñ“ú–{•a—Šw‰ï‘‰ï (2010/4/27), “Œ‹ž.

723213. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _Œo“à•ª”å”xŠà‚É‚š‚¯‚éHu mRNA‚š‚æ‚у^ƒ“ƒpƒNŽ¿‚Ì”­
Œ». Œ–{r‰p1, ŒiŽR‘וœ1, ¬—с@M1, —Ž‰ØTˆê˜Y2, Ó@¢ˆ®3, ‰ªˆÀ@ŒM3, ²“¡—Yˆê4 (1‘åŠw
‰@ˆã—ÃŒnŒ€‹†‰È, 2ŒÄ‹zŠí“à, 3•a—, 4ˆã—Éq¶Šw•”): ‘æ99‰ñ“ú–{•a—Šw‰ï‘‰ï (2010/4/27), “Œ‹ž.

723214. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚—îŽÒ‹ÇŠis”ñ¬×–E”xŠà‚ɑ΂·‚éƒrƒmƒŒƒ‹ƒrƒ“ + ‹¹
•”•úŽËü•¹—p—Ö@‚Ì‘æ1‘ŠŽŽŒ±. ˆäì@‘1, •Ð‹Ë^l2, ˜a“c^—RŽq1, ‰v“c“TK1, —Ž‰ØTˆê˜Y1 (1
ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/30), ‹ž“s.

723215. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠùŽ¡—Ðis”ñ¬×–E”xŠà‚ɑ΂·‚éTS-1’PÜ—Ö@‚Ì‘æ2‘Š
ŽŽŒ±. ˜a“c^—RŽq1, ŽR–{—ÏŽq1, —Ž‰ØTˆê˜Y1, ÎŒŽ–¢ŠóŽq1, Š}“‡^Žu1, –Ø‘º”ü’qŽq1, “ú‹gNO1,
‘å’JçŽq1, ã‰“–쌒1, ‚‘q@W1, •Ÿˆä•ü–ç1, ¬–ì“cŽ1, ˆäì@‘1, –î“àŒŽ’qŽq1, ‰¡ê³“T
2, ”šÎ—²Ž¡1, ŽO“¡@‹v1, ‹v•Û“cŸ1, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”): ‘æ51‰ñ“ú–{”xŠàŠw
‰ï‘‰ï (2010/11/3), L“‡, ”xŠà 2010; 50 (5): 497.

723216. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) is”ñ¬×–E”xŠà‚ɑ΂·‚é3rd-lineˆÈ~‚É‚š‚¯‚éƒyƒƒg
ƒŒƒLƒZ[ƒg‚ÌŽ¡—ÃŒoŒ±. ˆäì@‘1, •Ð‹Ë^l2, ¬—эO—S2, –î“ߐ£M—Y3, ŽO“¡@‹v1, ‹v•Û“cŸ1, ‰v
“c“TK1 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3ŠÅŒìŠw•”): ‘æ51‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2010/11/3), L“‡.

723217. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) is”ñ¬×–E”xŠà‚ɑ΂·‚éƒGƒ‹ƒƒ`ƒjƒu‚Ì—LŒø«‚š‚æ‚Ñ
ˆÀ‘S«‚̃ŒƒgƒƒXƒyƒNƒeƒBƒu‚ÈŒŸ“¢. ŒÃ‰®’ŒŽ÷, Â–Ø‘ô–ç, ˆäì@‘1, •õ‰º¹“¹, ˆ¢•”@’Œ, ‰v“c“TK
1, ‹{àV‹Pb (1ŒÄ‹zŠí“à): ‘æ51‰ñ“ú–{”xŠàŠw‰ï‘‰ï (2010/11/4), L“‡.

723218. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠùŽ¡—Ðis”ñ¬×–E”xŠà‚ɑ΂·‚éƒyƒƒgƒŒƒLƒZƒh’PÜ‚Ì
Ž¡—ÃŒoŒ±. ˆäì@‘1, ’©ŒG–ƒˆßŽq, ‰¡ê³“T2, –î“ߐ£M—Y3, •Ð‹Ë^l2, ¬—эO—S2 (1ŒÄ‹zŠí“à, 2
ˆã—Éq¶Šw•”, 3ŠÅŒìŠw•”): ‘æ9‰ñ“ú–{—Տ°Žîᇊw‰ïŠwpW‰ï (2011/7/22), ‰¡•l.

733089. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ”xŠàžž’†‚É‹ô‘R”­Œ©‚³‚ê‚œ‹CŠÇŽxè÷—±×–EŽî‚Ì1—á.
—с@L[1, ã‰“–쌒1, “ú‹gNO1, –Ø‘º”ü’qŽq1, ÎŒŽ–¢ŠóŽq1, ‰i“‡—YŽŸ˜Y1, ^–؍K‘ã1, ‘å’JçŽq
1, ‹v•Û“cŸ1, •Ð‹Ë^l1, –î“ߐ£M—Y1, Ó@¢ˆ®2, ‹v˜N’Ï®”ü3, ²“¡”Vr3, ‰v“c“TK1 (1ŒÄ‹z
Ší“à, 2•a—, 3ŒÄ‹zŠíŠO): ‘æ134 ‰ñ“ú–{ŒÄ‹zŠí“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”‰ï (2010/9/11), “Œ‹ž (ƒAƒXƒeƒ‰ƒX
–{ŽÐ).

733090. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒãcŠu‰A‰e‚ð”F‚ß‚œIgG4ŠÖ˜AŽŸŠ³‚Ì1—á. ^
–؍K‘ã1, ‚‘q@W1, ÎŒŽ–¢ŠóŽq1, –Ø‘º”ü’qŽq1, “ú‹gNO1, —с@L[1, ‰i“‡—YŽŸ˜Y1, ‘å’JçŽq
1, ã‰“–쌒1, —Ž‰ØTˆê˜Y1, ¬–ì“cŽ1, ˆäì@‘1, ”šÎ—²Ž¡1, ‰¡ê³“T2, ŽO“¡@‹v1, ‹v•Û“c
Ÿ1, ¬—эO—S2, –î“ߐ£M—Y3, •Ð‹Ë^l2, ‰v“c“TK1 (1ŒÄ‹zŠí“à, 2ˆã—Éq¶Šw•”, 3ŠÅŒìŠw•”): ‘æ
192‰ñ“ú–{ŒÄ‹zŠíŠw‰ïŠÖ“Œ’n•û‰ï (2010/11/20), “Œ‹ž, “ú–{ŒÄ‹zŠíŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W
2010; p.18.

733091. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) …‘fEˆêŽ_‰»’‚‘f“¯Žž‹z“ü‚É‚æ‚éƒ}ƒEƒXS‹Ø
‹•ŒŒÄŸó—¬ŠQ‚ÌŒyŒžŒø‰Ê. ”šÎ—²Ž¡ (ŒÄ‹zŠí“à): ‘æ19‰ñƒoƒCƒIƒtƒBƒWƒIƒƒW[Œ€‹†‰ï (2011/2/26),
‹ž“s.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-110014. [ŒŽ’˜] Randomized phase III trial of trastuzumab monotherapy followed by
trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients
with HER2-positive metastatic breast cancer: the JO17360 Trial Group. Inoue K, Nakagami K,
Mizutani M, Hozumi Y, Fujiwara Y, Masuda N1, Tsukamoto F, Saito M, Miura S, Eguchi K, Shinkai T,
Ando M, Watanabe T, Masuda N1, Ohashi Y, Sano M, Noguchi S: Breast Cancer Res Treat 2010/1; 119
(1): 127-36. (‰v“c“TK1: 1ŒÄ‹zŠí“à)

H21-110015. [ŒŽ’˜] Phase II study of erlotinib in Japanese patients with advanced non-small
cell lung cancer. Takahashi T, Yamamoto N, Nukiwa T, Mori K, Tsuboi M, Horai T, Masuda N1, Eguchi
K, Mitsudomi T, Yokota S, Segawa Y, Ichinose Y, Fukuoka M, Saijo N: Anticancer Res 2010/2; 30 (2):
557-63. (‰v“c“TK1: 1ŒÄ‹zŠí“à)

H21-110016. [ŒŽ’˜] Efficacy chemotherapy with carboplatin and paclitaxel for unresectable
thymic carcinoma. Igawa S1, Murakami H, Takahashi T, Nakamura Y, Tusya A, Naito T, Kaira K, Ono
A, Shukuya T, Tamiya A, Endo M, Yamamoto N: Lung Cancer 2010/2; 67 (2): 194-7. (ˆäì@‘1: 1
ŒÄ‹zŠí“à)


“à•ª”å‘ãŽÓ“à‰ÈŠw

[Šwp˜_•¶]

110127. [ŒŽ’˜] Detrended fluctuation analysis is considered to be useful as a new indicator for
short-term glucose complexity. Yamamoto N, Kubo Y, Ishizawa K, Kim G, Moriya T, Yamanouchi T,
Otsuka K: Diabetes Technol Ther 2010; 12: 775-83. (Žç‰®’B”ü: “à•ª”å‘ãŽÓ“à)

110128. [ŒŽ’˜] Release of salusin-ƒÀ from human monocytes/macrophages. Sato K, Fujimoto K,
Koyama T, Shichiri M: Regulatory Peptides 2010/6; 162 (1-3): 68-72. (Žµ—¢áÁ‹`: “à•ª”å‘ãŽÓ“à)

110129. [ŒŽ’˜] Serum levels and urinary excretion of salusin-ƒ¿ in renal insufficiency. Kimoto
S, Sato K, Watanabe T, Suguro T, Koyama T, Shichiri M: Regulatory Peptides 2010/6; 162 (1-3): 129-32.
(Žµ—¢áÁ‹`: “à•ª”å‘ãŽÓ“à)

110130. [ŒŽ’˜] Chronic infusion of salusin-ƒ¿ and -ƒÀ exerts opposite effects on atherosclerotic
lesion development in apolipoprotein E-deficient mice. Nagashima M, Watanabe T, Shiraishi Y,
Morita R, Terasaki M, Arita S, Hongo S, Sato K, Shichiri M, Miyazaki A, Hirano T: Atherosclerosis
2010; 212: 70-7. (Žµ—¢áÁ‹`: “à•ª”å‘ãŽÓ“à)

110131. [ŒŽ’˜] Upregulation of CDKN2A and suppression of cyclin D1 gene expressions in
ACTH-secreting pituitary adenomas. Tani Y, Inoshita N, Sugiyama T, Kato M, Yamada S, Shichiri
M, Hirata Y: European Journal of Endocrinology 2010; 163: 523-9. (Žµ—¢áÁ‹`: “à•ª”å‘ãŽÓ“à)

110132. [ŒŽ’˜] Hepatocyte-protective and anti-oxidant effects of rifampicin on human chronic
hepatitis C and murine acute hepatocyte disorder. Kataoka K, Kono Y, Sugimoto M, Furuichi Y,
Shichiri M, Tanaka Y: Experimental Therapeutic Medicine 2010; 1: 1041-7. (Žµ—¢áÁ‹`: “à•ª”å‘ãŽÓ
“à)

110133. [ŒŽ’˜] Distinct systemic distribution of salusin-ƒ¿ and salusin-ƒÀ in the rat. Suzuki
N, Shichiri M, Tateno T, Sato K, Hirata Y: Peptides 2011; 32: 805-10. (Žµ—¢áÁ‹`: “à•ª”å‘ãŽÓ“à)

110134. [ŒŽ’˜] The (pro)renin receptor is cleaved by ADAM19 in the Golgi leading to its secretion
into extracellular space. Yoshikawa A, Aizaki Y, Kusano K, Kishi F, Susumu T, Iida S, Ishiura
S, Nishimura S, Shichiri M, Senbonmatsu T: Hypertens Res 2011; 34: 599-605. (Žµ—¢áÁ‹`: “à•ª”å
‘ãŽÓ“à)

110135. [ŒŽ’˜] Beneficial effects of L- and N-type calcium channel blocker on glucose and lipid
metabolism and renal function in patients with hypertension and type II diabetes mellitus. Masuda
T, Ogura MN, Moriya T, Takahira N, Matsumoto T, Kutsuna T, Hara M, Aiba N, Noda C, Izumi T: Cardiovasc
Ther 2011; 29: 46-53. (Žç‰®’B”ü1, –ì“cçt2, ˜aò@“O2: 1“à•ª”å‘ãŽÓ“à, 2zŠÂŠí“à)

110136. [ŒŽ’˜] Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese
type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS). Katayama S, Moriya
T, Tanaka S, Tanaka S, Yajima Y, Sone H, Iimuro S, Ohashi Y, Akanuma Y, Yamada N, Japan Diabetes
Complications Study Group: Diabetologia 2011; 54: 1025-31. (Žç‰®’B”ü: “à•ª”å‘ãŽÓ“à)

110137. [ŒŽ’˜] Effects of multiple factorial intervention on ambulatory BP profile and renal
function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study. Kanaoka
T, Tamura K, Moriya T1, Tanaka K, Konno Y, Kondoh S, Toyoda M, Umezono T, Fujikawa T, Ohsawa M,
Dejima T, Maeda A, Wakui H, Haku S, Yanagi M, Mitsuhashi H, Ozawa M, Okano Y, Ogawa N, Yamakawa
T, Mizushima S, Suzuki D, Umemura S: Clin Exp Hypertens. 2011/1; 33 (4): 255-63. (Žç‰®’B”ü1: 1
“à•ª”å‘ãŽÓ“à)

120013. [ŒŽ’˜] ‘Ï“œ”\áŠQ‚ð—L‚·‚é”D•w‚̃Gƒlƒ‹ƒM[‘ãŽÓ‚Í‚Ç‚Ì‚æ‚€‚ɕω»‚·‚é‚©?Resting energy
expenditure (REE) ‚ðŽw•W‚Æ‚µ‚œŒŸ“¢?. Žsì—‹Žt1, Žç‰®’B”ü1, lŒ©–ƒ”üŽq, ìã—IŽq, ’†“ˆ‚Æ‚µ‚Ý,
“c’†Œ[Ži1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): “œ”A•a‚Æ”DP 2010; 10 (1): 118-22.

120014. [ŒŽ’˜] “œ”A•a‡•¹”DP‚É‚š‚¯‚écontinuous glucose monitoring (CGM) ‚Ì—L—p«‚ÌŒŸ“¢. —с@
“N”Í1, Žç‰®’B”ü1, —é–Ø‹M”Ž1, ¬ìŒ°Žj1, ‹ß“¡’qŽq1, —é–Ø’qŽq1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): “œ
”A•a‚Æ”DP 2010; 10 (1): 92-6.

320011. [Ç—á•ñ] “œ”A•a«ƒPƒgƒAƒVƒh[ƒVƒX‚É”ñ•ÂÇ«’°ŠÇ‹•ŒŒÇ‚ð‡•¹‚µ‚œ2Œ^“œ”A•a‚Ì1—á. Žs
ì—‹Žt1, Žç‰®’B”ü1, •Ûâ’CŽ÷1, •ŸŒ’qŽq1, ‰«ø“iˆê˜Y1, ¬ìŒ°Žj1, —é–Ø‹M”Ž1, ŒŒŽ‚Ü‚Ç‚©2, ‚
“c“NG1, “c’†Œ[Ži1, “¡“c–F–M1 (1“à•ª”å‘ãŽÓ“à, 2—ÕŒŸŠw): “œ”A•a 2010; 53 (7): 495-500.

320012. [Ç—á•ñ] ƒ`[ƒ€ˆã—Âɂæ‚èt‹@”\’ቺ‚ª—}§‚³‚ê‚œ“œ”A•a«tÇ . Žç‰®’B”ü (“à•ª”å‘ãŽÓ
“à): “ú–{ˆãŽ–V•ñ 2010; 4479: 82-7.

320013. [Ç—á•ñ] ’˜–Ÿ‚ȍDŽ_‹…Z‚𔺂€ŠÌ‰Š‘œ‚ð’悵‚œDŽ_‹…‘‰ÁÇŒóŒQ (HES) ‚Ì1—á. ’†àV“Ä
l, ‹Êˆä”ŽC, —с@“N”Í1, ‚–؉pŒb, ˆÉ“¡‘å•ã, ‘å‘]ªN•v, HŒŽ“NŽj (1“à•ª”å‘ãŽÓ“à): “ú–{“à‰ÈŠw
‰ïŽGŽ 2010; 99: 822-4.

520055. [‘à] ˆã—Ч“x‰üŠv‚Ì“W–]. Žµ—¢áÁ‹` (“à•ª”å‘ãŽÓ“à): t‚Æ“§Í 2010; 69: 531-2.

520056. [‘à] CKD (–«t‘Ÿ•a) ‚ƐtÇ?SEt˜AŠÖ‚Æ‚Í?@“œ”A•aŠ³ŽÒ‚É‚š‚¯‚étÇ‚ƐSŒŒŠÇŽŸŠ³‚É
ŠÖ‚·‚éŠÖŒW‚ɂ‚¢‚Ä‹³‚Š‚Ä‚­‚Ÿ‚³‚¢. ‘å’ë˜al1, ‰«ø“iˆê˜Y1, Žç‰®’B”ü1 (1“à•ª”å‘ãŽÓ“à): Q&A‚Å
‚í‚©‚é”ì–ž‚Æ“œ”A•a 2011/1; 10 (1): 66-9.

522047. [uÀ] yÀ’k‰ïzƒGƒrƒfƒ“ƒX‚ÉŠî‚­~ˆ³–ò‚Ì•¹—p: ‡Ü‚Ì—L—p‚ÈŽg‚¢•ª‚¯•û. ˆÀ“ŒŽ”V, •x
ŽR”ŽŽj, ‰F“s‹{•Û“T, ·“cr‰î, •Ÿ“c@ž, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): Pharma Medica 2010/11; 28 (11):
55-60.

[’˜@‘]

620060. [Šwp‘] (•ª’SŽ·•M)y“œ”A•a«×¬ŒŒŠÇÇ (‘æ2”Å) (“ú–{—Õଠ68 (‘Š§))z”­ÇEi“W§Œä
‚̍őOü@“œ”A•a«tÇ@ŒŸžƒ}[ƒJ[‚Æ‚»‚̈Ӌ`@ƒVƒXƒ^ƒ`ƒ“C, p.419-25. ‰«ø“iˆê˜Y1, Žç‰®’B”ü
1 (1“à•ª”å‘ãŽÓ“à), “ú–{—Õ଎Ð, 2010/11”­s.

620061. [Šwp‘] (•ª’SŽ·•M)y•a‘Ԑ¶—ƒrƒWƒ…ƒAƒ‹ƒ}ƒbƒv 1z‘ãŽÓŽŸŠ³@4 ‚”AŽ_ŒŒÇ (’É•—), p.31-6.
ŸN“c–ƒ–ë, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à), •Ò ²“¡çŽj, ˆäã’qŽq, ˆãŠw‘‰@, “Œ‹ž, 2011/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

723219. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 2Œ^“œ”A•aŠ³ŽÒ‚ɑ΂·‚éƒrƒ‹ƒ_ƒOƒŠƒvƒ`ƒ“‚Ì’·Šú“Š—^‚Å‚Ì•]‰¿?’P
“Æ52TŠÔ“Š—^‚ł̈À‘S«ŽŽŒ±?. ‰F“s‹{ˆê“T, ‹e’r•û—˜, Žç‰®’B”ü1, Ž›”öVŽi, –k˜e“N“ñ, ŽOXMK (1
“à•ª”å‘ãŽÓ“à): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2010/5/27-29), ‰ªŽR, “œ”A•a 2010; 53: S-127.

723220. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Detrended fluctuation analysis‚ð—p‚¢‚œ˜A‘±ŒŒ“œ‘ª’èƒf[ƒ^‚Ì”ñ
üŒ`‰ðÍ. ŽR–{’Œ@, ‹v•Û@–L, ÎàV–ì, ‹à@Œõ‰F, Žç‰®’B”ü1, ŽR“àrˆê, ‘å’Ë–M–Œ (1“à•ª”å‘ãŽÓ
“à): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2010/5/27-29), ‰ªŽR, “œ”A•a 2010; 53: S-127.

723221. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Տ°‰Â”\‚ȃoƒCƒIƒ}[ƒJ[’Tõ‚ð–Ú“I‚Æ‚µ‚œ, “œ”A•aŠ³ŽÒ‚ÌŒŒŽƒv
ƒƒeƒI[ƒ€‰ðÍ. ‚“c“NG1, •œ“ˆ—EŽm1, ŒŒŽ‚Ü‚Ç‚©2, ‘åÎ³“¹, ¬Ž›‹`’j, ‘O“c’‰Œv, “¡“c–F–M1,
Žç‰®’B”ü1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2—ÕŒŸŠw): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2010/5/27-29),
‰ªŽR, “œ”A•a 2010; 53: S-176.

723222. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 2Œ^“œ”A•aŠ³ŽÒ‚É‚š‚¯‚é”A’†ƒVƒXƒ^ƒ`ƒ“C‚Ì‘ª’èˆÓ‹`. ‘å’ë˜al1,
Žç‰®ç”ü1, ¬›žŽu•ä, ^ŽÄVˆê, ‰«ø“iˆê˜Y1, —с@“N”Í1, ¬ìŒ°Žj1, “c’†Œ[Ži1, Žµ—¢áÁ‹`1 (1“à
•ª”å‘ãŽÓ“à): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2010/5/27-29), ‰ªŽR, “œ”A•a 2010; 53: S-219.

723223. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠO—ˆ‚É‚š‚¯‚éContinuous glucose monitoring (CGM) ‚Ì—L—p«. ¬
ìŒ°Žj1, Žç‰®’B”ü1, —é–Ø‹M”Ž1, ‹ß“¡’qŽq1, —é–Ø’qŽq1, —с@“N”Í1, “c’†Œ[Ži1, Žµ—¢áÁ‹`1 (1“à
•ª”å‘ãŽÓ“à): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2010/5/27-29), ‰ªŽR, “œ”A•a 2010; 53: S-239.

723224. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “œ”A•a«tÇ“§ÍÇ—á‚É‚š‚¯‚éCGM‚̉ðÍ‚š‚æ‚Ñ‚»‚ÌŒã‚ÌHbA1c‚Ì
ŒŸ“¢. —с@“N”Í1, Žç‰®’B”ü1, —é–Ø‹M”Ž1, ‹ß“¡’qŽq1, —é–Ø’qŽq1, ‘å’ë˜al1, ¬ìŒ°Žj1, ‰«èi
ˆê˜Y1, “c’†Œ[Ži1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2010/5/27-29),
‰ªŽR, “œ”A•a 2010; 53: S-261.

723225. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 2Œ^“œ”A•a‚É‚š‚¯‚ét‹@”\‚Ì—\Œã‚Ì‚œ‚ß‚É‚Í”AƒAƒ‹ƒuƒ~ƒ“‚Ɛ³Šm‚È
GFR‚Ì‘ª’è‚ð. Žç‰®’B”ü1, ˜a“c—R”üŽq1, ‘å’ë˜al1, —с@“N”Í1, ‰«ø“iˆê˜Y1, “c’†Œ[Ži1, Žµ—¢áÁ
‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2010/5/27-29), ‰ªŽR, “œ”A•a 2010; 53:
S-261.

723226. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰¢•Äl‚ÌŒŒŽƒVƒXƒ^ƒ`ƒ“C‚É‚æ‚éeGFR‚Í“ú–{l2Œ^“œ”A•a‚É“K—p‚Å
‚«‚é‚©? ‰«ø“iˆê˜Y1, Žç‰®’B”ü1, ‘å’ë˜al1, —с@“N”Í1, ¬ìŒ°Žj1, “c’†Œ[Ži1, Žµ—¢áÁ‹`1 (1
“à•ª”å‘ãŽÓ“à): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2010/5/27-29), ‰ªŽR, “œ”A•a 2010; 53: S-261.

723227. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ú–{l1Œ^‹y‚Ñ2Œ^“œ”A•a³íƒAƒ‹ƒuƒ~ƒ“”AŠú‚̐t‘gDE‹@”\˜AŠÖ
‚͈قȂé? ‘å’ë˜al1, Žç‰®’B”ü1, —с@“N”Í1, “n•Ó“¹Žq1, ‰«ø“iˆê˜Y1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ
“à): ‘æ53‰ñ“ú–{t‘ŸŠw‰ï”NŽŸŠwpW‰ï (2010/6/18-20), _ŒË, “ú–{“§ÍˆãŠw‰ïŽGŽ 2010; 43 (1): 286.

723228. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˜A‘±ŒŒ“œ‘ª’è‚É‚æ‚é“œ”A•a“§ÍŠ³ŽÒ‚ÌŒŒ“œ“®‘Ԃ̏ڍ×. ¬ìŒ°Žj
1, Žç‰®’B”ü1, —с@“N”Í1, —é–Ø‹M”Ž1, ‹ß“¡’qŽq1, —é–Ø’qŽq1, ‘å’ë˜al1, ‰«ø“iˆê˜Y1, Žµ—¢áÁ‹`
1 (1“à•ª”å‘ãŽÓ“à): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/18-20), _ŒË, “ú–{“§ÍˆãŠw‰ïŽGŽ 2010;
43 (1): 507.

723229. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[ ”­Ç9ƒ–ŒŽŒã‚É—‘‘ƒŽîᇐ؏œp‚ƖƉu—Ö@‚ðs‚¢, ˆÓŽ¯á
ŠQ‚ª‹}‘¬‚ɉü‘P‚µ‚œRNMDAŽó—e‘Ì”]‰Š‚̈ê—á. ‹ß“¡’qŽq1, ”ђˍ‚_2, “à–쏲Žq2, ‰Y–ì‹`Í2, ˆ¢‹v
’Óñ•v2, à_“cˆê2, –]ŒŽGŽ÷2 (1“à•ª”å‘ãŽÓ“à, 2_Œo“à): ‘æ28‰ñ“ú–{_ŒoŽ¡—Êw‰ï‘‰ï (2010/7/15),
‰¡•l.

723230. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”DP“œ”A•a‚š‚æ‚Ñ“œ”A•a”DP—×{‚ւ̐æi“IŽæ‚è‘g‚Ý “œ”A•a‡•¹”D
P‚É‚æ‚éContinuous Glucose Monitoring (CGM) ‚ÌŽg—p‚É‚æ‚蕪‚©‚邱‚Æ. Žç‰®’B”ü (“à•ª”å‘ãŽÓ“à): ‘æ
26‰ñ“ú–{“œ”A•aE”DPŠw‰ïŠwpW‰ï (2010/11/26-27), ‚³‚¢‚œ‚ÜŽs, “œ”A•a‚Æ”DP 2010; 10 (2): S-40.

723231. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Continuous Glucose Monitoring (CGM) ‚É‚æ‚é“œ”A•a‡•¹”DP‚̐H
ŒãŒŒ“œpeakŽžŠÔ‚ÌŒŸ“¢. Žá‘q‰‘”ü1, Žç‰®’B”ü1, —с@“N”Í1, ³–ØŽkl1, ŠÖªŠG—œŽq1, ¬ìŒ°•¶1,
Žsì—‹Žt1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ26‰ñ“ú–{“œ”A•aE”DPŠw‰ïŠwpW‰ï (2010/11/26-27), ‚³
‚¢‚œ‚ÜŽs, “œ”A•a‚Æ”DP 2010; 10 (2): S-76.

723232. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “œ”A•a‡•¹”DP‚É‚š‚¯‚écontinuous glucose monitoring (CGM) ‚Ì
—L—p«‚ÌŒŸ“¢. —с@“N”Í1, Žç‰®’B”ü1, —é–Ø‹M”Ž1, ¬ìŒ°Žj1, ‹ß“¡’qŽq1, —é–Ø’qŽq1, Žµ—¢áÁ‹`1 (1
“à•ª”å‘ãŽÓ“à): ‘æ26‰ñ“ú–{“œ”A•aE”DPŠw‰ïŠwpW‰ï (2010/11/26-27), ‚³‚¢‚œ‚ÜŽs, “œ”A•a‚Æ”DP
2010; 10 (1): 92-6.

723233. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘Ï“œ”\áŠQ‚ð—L‚·‚é”D•w‚̃Gƒlƒ‹ƒM[‘ãŽÓ‚Í‚Ç‚Ì‚æ‚€‚ɕω»‚·‚é‚©
?Resting energy expenditure (REE) ‚ðŽw•W‚Æ‚µ‚œŒŸ“¢?. Žsì—‹Žt1, Žç‰®’B”ü1, lŒ©–ƒ”üŽq2, ì
ã—IŽq2, ’†“ˆ‚Æ‚µ‚Ý2, “c’†Œ[Ži1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à, 2‰h—{•”): ‘æ26‰ñ“ú–{“œ”A•aE”D
PŠw‰ïŠwpW‰ï (2010/11/26-27), ‚³‚¢‚œ‚ÜŽs, “œ”A•a‚Æ”DP 2010; 10 (1): 118-22.

733092. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹C‚É‚µ‚Ä‚Ü‚·‚©!?@HŒãŒŒ“œ’l. —с@“N”Í (“à•ª”å‘ãŽÓ
“à): ‘æ15‰ñ_“ސ쓜”A•aƒEƒH[ƒNƒ‰ƒŠ[ (2010/9/26), ‰¡•l.

733093. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) CGM (Continuous Glucose Monitoring) ‚É‚æ‚錌“œƒvƒ
ƒtƒ@ƒCƒ‹‚̉ðÍ‚É‚æ‚è—ǍD‚ÈŒŒ“œ“®‘Ô‚Æ‚È‚Á‚œBOT‚̈êÇ—á. ³–ØŽkl1, ‚“c“NG1, Žá‘q‰‘”ü1, •œ
“ˆ—EŽm1, ‘å’ë˜al1, —с@“N”Í1, ¬ìŒ°Žj1, ‰«ø“iˆê˜Y1, Žsì—‹Žt1, Š™“c—T“ñ1, Žç‰®’B”ü1, Žµ
—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): _“ސ쓜”A•aŒ€‹†‰ï (2010/9), ‰¡•l.

733094. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¶‘̃ŠƒYƒ€‚ÆŽ©—¥_Œo Ž‘±”牺ŒŒ“œ‘ª’è (Continuous
Glucose Monitoring) ‚ÆŽ©—¥_Œo‹@”\. ŽR–{’Œ@, ‹v•Û@–L, ÎàV–ì, ‹à@Œõ‰F, Žç‰®’B”ü1, ŽR“àr
ˆê, ‘å’Ë–M–Ÿ (1“à•ª”å‘ãŽÓ“à)F ‘æ63‰ñ“ú–{Ž©—¥_ŒoŠw‰ïŠwpW‰ï (2010/10/22-23), ‰¡•l, “ú–{Ž©—¥
_ŒoŠw‰ïŽ 2010; 63: 115.

733095. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Œo’±Œ`œ“Ž“I‰º‚‘ÌŽîᇓEopŒã‚Ì–ò•šŽ¡—Âɓïa‚µ‚Ä
‚¢‚éAcromegaly‚Ì1—á. Žsì—‹Žt1, “n•Ó“¹Žq1, ³–ØŽkl1, ŠÖªŠG—œŽq1, Žá‘q‰‘”ü1, •œ“ˆ—EŽm1,
—с@“N”Í1, Š™“c—T“ñ1, ‰«ø“iˆê˜Y1, ¬ìŒ°Žj1, ‚“c“NG1, Žç‰®’B”ü1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ
“à): ‘æ15‰ñ_“ސìŠÔ”]‰º‚‘̃Jƒ“ƒtƒ@ƒŒƒ“ƒX (2010/11/24), ‰¡•l.

733096. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “œ”A•a«tÇ“§Í—á‚ÌŒŒ“œ“®‘Ô‚Ì”cˆ¬‚ÉCGM‚Í—L—p‚Å‚ 
‚é. —с@“N”Í1, —é–Ø‹M”Ž1, ‹ß“¡’qŽq1, —é–Ø’qŽq1, ¬ìŒ°Žj1, ‰«ø“iˆê˜Y1, “c’†Œ[Ži1, Žç‰®’B
”ü1 (1“à•ª”å‘ãŽÓ“à): ‘æ22‰ñ“œ”A•a«tÇŒ€‹†‰ï (2010/12/4-5), “Œ‹ž, Diabetes Frontier 2010; 21
(5): 625.

733097. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒ`[ƒ€ˆã—Ã: “œ”A•a«tÇ‚ÌŽ¡—Â͓ú–{“œ”A•a—×{Žw“±
Žm (CDEJ) ‚É‚æ‚éƒ`[ƒ€ˆã—ÂÅ?Time to Act?. Žç‰®’B”ü1, —é–Ø’qŽq1, ‘å’ë˜al1, —с@“N”Í1, ‰«
ø“iˆê˜Y1, ¬ìŒ°Žj1, —é–Ø‹M”Ž1, “c’†Œ[Ži1 (1“à•ª”å‘ãŽÓ“à): ‘æ22‰ñ“œ”A•a«tÇŒ€‹†‰ï
(2010/12/4-5), “Œ‹ž, Diabetes Frontier 2010; 21 (6): 737.

733098. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒCƒ“ƒXƒŠƒ“—Ö@‚©‚çGLP-1ƒAƒiƒƒO»Ü‚ɕύX‚µŒo‰ßŠÏ
Ž@’†‚Ì“œ”A•a«“§ÍŠ³ŽÒ‚Ì1—á. ˆÉ“¡—zŽq, XŒû‚¢‚Ô‚«, ¬—Ñ’Œ”V, ŒË’J‹`K, ”~‘º@•q, Š™“c—T“ñ1, Žç
‰®’B”ü1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ48‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/1/29), “Œ‹ž.

733099. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆÙíƒwƒ‚ƒOƒƒrƒ“Ç‚𔺂Á‚œ2Œ^“œ”A•a‚Ì1—á. ŠÖªŠG
—œŽq1, Žsì—‹Žt1, ³–ØŽkl1, Žá‘q‰‘”ü1, •œ“ˆ—EŽm1, —с@“N”Í1, ‰«ø“iˆê˜Y1, ¬ìŒ°Žj1, ‚“c
“NG1, Žç‰®’B”ü1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ48‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/1/29),
“Œ‹ž.

733100. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “‡Žž’²Ç‚ð‡•¹‚µ‚œ1Œ^“œ”A•a‡•¹”D•w‚̗×{Žw“±.
”‹ŒŽºŽq, Žsì—‹Žt1, •œ—Ñ“Þ•c, Žç‰®’B”ü1 (1“à•ª”å‘ãŽÓ“à): ‘æ48‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û
‰ï (2011/1/29), “Œ‹ž.

733101. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) CGM‚É‚æ‚茌“œƒvƒƒtƒ@ƒCƒ‹‚š‚æ‚ÑŒŒ“œ•Ï“®‚̉ü‘P‚ªŠm
”F‚³‚ê‚œBOT‚̈êÇ—á. ³–ØŽkl1, ‚“c“NG1, ŠÖªŠG—œŽq1, Žá‘q‰‘”ü1, •œ“ˆ—EŽm1, —с@“N”Í1, ¬
ìŒ°Žj1, ‰«ø“iˆê˜Y1, Žsì—‹Žt1, Žç‰®’B”ü1, Žµ—¢áÁ‹`1 (1“à•ª”å‘ãŽÓ“à): ‘æ48‰ñ“ú–{“œ”A•aŠw
‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/1/29), “Œ‹ž.

H21”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H21-72309. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —L’ɐ«—«‰»“û–[‚𔺂Á‚œGraves•a‚̈ê—á. —с@“N”Í1,
Š™“c—T“ñ1, ˜a“c—R”üŽq1, ŒŒŽ‚Ü‚Ç‚©2, ‚“c“NG1, “c’†Œ[Ži1, Žç‰®’B”ü1 (1“à•ª”å‘ãŽÓ“à, 2—ÕŒŸ
Šw): ‘æ83‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï (2010/3/25-28), ‹ž“s, “ú–{“à•ª”åŠw‰ïŽGŽ 2010; 86: 131.

H21-723010. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) propylthiouracil (PTU) Žg—pŒã‚ɍ‚“x‰©át‚ª‘J
‰„‚µ‚œƒoƒZƒhƒE•a‚Ì1—á. “n•Ó“¹Žq1, Žsì—‹Žt1, ¬ìŒ°Žj1, ‰«ø“iˆê˜Y1, —é–Ø‹M”Ž1, Š™“c—T“ñ
1, “c’†Œ[Ži1, Žç‰®’B”ü1 (1“à•ª”å‘ãŽÓ“à): ‘æ83‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï (2010/3/25-28), ‹ž“s, “ú
–{“à•ª”åŠw‰ïŽGŽ 2010; 86: 131.

H21-733002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) CGM (Continuous Glucose Monitoring) ‚É‚ÄŒŒ
“œƒvƒƒtƒ@ƒCƒ‹‚ðŠÏŽ@‚µ‚œBOT2Ç—á. ‘å’ë˜al1, ŒŒŽ‚Ü‚Ç‚©2, —é–Ø’qŽq1, —с@“N”Í1, ¬ìŒ°Žj1,
‰«ø“iˆê˜Y1, Žsì—‹Žt1, —é–Ø‹M”Ž1, ‚“c“NG1, “c’†Œ[Ži1, Žç‰®’B”ü1 (1“à•ª”å‘ãŽÓ“à, 2—ÕŒŸ
Šw): ‘æ47‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2010/1/30), ‘å‹{,“œ”A•a 2010; 53 (8): 670.

H21-733003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒWƒAƒ]ƒLƒVƒh‚ªŒø‘t‚µ‚œ, ‚ƒCƒ“ƒXƒŠƒ“ŒŒ«’á
ŒŒ“œÇ‚Ì1Ç—á. •œ“ˆ—EŽm1, ‚“c“NG1, —é–Ø’qŽq1, ¬ìŒ°Žj1, ‰«ø“iˆê˜Y1, Žsì—‹Žt1, —é–Ø‹M
”Ž1, Š™“c—T“ñ1, ŒŒŽ‚Ü‚Ç‚©2, “c’†Œ[Ži1, Žç‰®’B”ü1 (1“à•ª”å‘ãŽÓ“à, 2—ÕŒŸŠw): ‘æ47‰ñ“ú–{“œ”A
•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2010/1/30), ‘å‹{, “œ”A•a 2010; 53 (8): 666.

H21-733004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)y–«‡•¹Ç‚̗Տ° (tÇ)z”A’†ƒAƒ‹ƒuƒ~ƒ“‘ª
’è‚Æ‚»‚̗Տ°“IˆÓ‹`?‚Æ‚É‚©‚­ŠmŽÀ‚È‘ª’è‚ð (‰ðà)?. Žç‰®’B”ü (“à•ª”å‘ãŽÓ“à): ‘æ44‰ñ“œ”AŠw‚̐i
•à (2010/3/5-6), ‘åã, “œ”A•aŠw‚̐i•à 2010; 44: 267-71.


t‘Ÿ“à‰ÈŠw

[Šwp˜_•¶]

110138. [ŒŽ’˜] Antigen binding abilities of anti-nephrin antibody are prescribed by signal
sequence of expression vector in genetic immunization. Naito S1, Kamata K1, Aoyama T1, Yamanaka
N2, Okamoto T1, Tazaki H1: Kitasato Med J 2011/3; 41 (1): 31-41. (“à“¡³‹g1, Š™“cvšæ1, ÂŽR
“ŒŒÜ1, ŽR’†@–]2, ‰ª–{’qŽq1, “cèq”ü1: 1t‘Ÿ“à, 2–h‰qˆã‰È‘åŠwZŠO‰ÈŠw)

110139. [ŒŽ’˜] Nephrin signal peptide sequence cDNA in expression vector determined antibody
characteristics reacting on native or glycosilation-disturbed nephrin protein in genetic
immunization. Naito S1, Aoyama T1, Kamata K1: Kitasato Med J 2011/3; 41 (1): 31-41. (“à“¡³‹g
1, ÂŽR“ŒŒÜ1, Š™“cvšæ1: 1t‘Ÿ“à)

110140. [ŒŽ’˜] Passive Heymann nephritis induced by genetic immunization using megalin cDNA
fragments. Tazaki H1, Kamata K1, Naito S1, Okamoto T1, Kobayashi K1, Yamanaka N2, Aoyama T1:
Kitasato Med J 2011/3; 41 (1): 69-75. (“cèq”ü1, Š™“cvšæ1, “à“¡³‹g1, ‰ª–{’qŽq1, ¬—с@Œ\
1, ŽR’†@–]2, ÂŽR“ŒŒÜ1: 1t‘Ÿ“à, 2–h‰qˆã‰È‘åŠwZŠO‰ÈŠw)

120015. [ŒŽ’˜] ƒGƒ|ƒGƒ`ƒ“ƒ¿‚ƃGƒ|ƒGƒ`ƒ“ƒÀ‚̔牺“Š—^Žž‚Ì’É‚Ý‚Ì”äŠrŒŸž. –q–앐Žu1, ˆÀ“¡@q
2,3, ’·ê@‘×1, “‡“c@”£1, Š™“cvšæ4, ¬‹{ŽR‹MŽq2,3 (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@t‘Ÿ“à
‰È, 2–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@–òÜ•”, 3–òŠw•”—Տ°–òŠwŒ€‹†E‹³ˆçƒZƒ“ƒ^[, 4t‘Ÿ“à): “§
Í‰ïŽ 2010; 43 (9): 795-800.

320014. [Ç—á•ñ] ˆ««‹¹‘BŽî‹¹–Œ”dŽí‚Ö‚Ì•úŽËüŽ¡—Âɂæ‚芰‰ð‚ð“Ÿ‚œ“«”÷¬•Ï‰»Œ^ƒlƒtƒ[ƒ[
ÇŒóŒQ‚Ì1—á. ‰ª–{’qŽq1, ²–ì@—²1, Žáˆä—zŠó2, ‘º–쏇–ç1, “c’†@Œ\1, “cèq”ü1, ¬—с@Œ\1,
“à“¡³‹g1, ‹Ž–{ƒqƒƒR1, “¡“c˜aŒÈ1, ÂŽR“ŒŒÜ1, â–{®“o1, ŒŽ@“ÖŽq3, Œ‰iŒh“ñ4, Š™“cvšæ1 (1
t‘Ÿ“à, 2‰¡•l‘æˆê•a‰@, 3•a—, 4•úŽËü‰È): “ú–{t‘ŸŠw‰ïŽ 2010/5; 52 (4): 515-22.

320015. [Ç—á•ñ] RGBMR‘Ì‚ÆMPO-ANCA‚ª‹€‚É—z«‚ðŽŠ‚µ‚œ”ŒŒŽ‘ÌŒ`¬«Ž…‹…‘̐t‰Š‚Ì1—á. ‹àŒõ
•ôŽq1,2, ²–ì@—²2, “à“¡³‹g2, ÂŽR‰ë‘¥2, ‹Ž–{ƒqƒƒR2, ’†–ì‘fŽq2, ÂŽR“ŒŒÜ2, ’·ê@‘×2,3, ’|
“àN—Y2, Žç‰®—˜‰À4, â–{®“o2, Š™“cvšæ2 (1‹e–Œ‹L”O•a‰@tEäPŒŽ•aƒZƒ“ƒ^[, 2t‘Ÿ“à, 3–k—¢Œ€
‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 4ˆãŠw‹³ˆç): –k—¢ˆãŠw 2010/6; 40 (1): 33-8.

320016. [Ç—á•ñ] is«‚ÌŽ‹—͒ቺ‚ƃlƒtƒ[ƒ[ÇŒóŒQ‚ð’悵‚œŒ‹ß«Ž…‹…‘̍d‰»Ç‚Ì1—á. ŒÃ’J¹
Žq1, ²–ì@—²1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, Š™“c^—Žq1, —Ñ‚Ý‚ä‚«1, ‘º–쏇–ç1, “à“¡³‹g1, “à“c–ž
”üŽq1, â–{®“o1, Š™“cvšæ1 (1t‘Ÿ“à): t‰ŠÇ—ጀ‹† 2011/2; 27: 100-12.

520057. [‘à] ’`”’”A”­Œ»‹@˜‚É‚Ý‚ét‹@”\áŠQi“W—}§‚Ö‚Ì“W–]. “¡“c•q˜Y1, Š™“cvšæ2 (1“Œ‹ž
‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰È, 2t‘Ÿ“à): Pharme Medica 2010/6; 28 (6): 113-6.

520058. [‘à] Glomerular thrombosis (DICtÇ). ²–ì@—²1, Š™“cvšæ1 (1t“à): ˆãŠw‚Æ–òŠw
2011/3; 65 (3): 335-8.

522048. [uÀ]y“ÁW: “±“üŠî€‚©‚ç’·Šú‡•¹Ç‚Ü‚Å ‰p—ªŒê‚ÅŠî‘b‚ª‚í‚©‚é! “§Í—Ö@‚ÌABCz18 1-3 NS@
ƒlƒtƒ[ƒ[ÇŒóŒQ. ²–ì@—² (t‘Ÿ“à): “§ÍƒPƒA 2011/2; 17 (2): 18.

522049. [uÀ]y“ÁW: “±“üŠî€‚©‚ç’·Šú‡•¹Ç‚Ü‚Å ‰p—ªŒê‚ÅŠî‘b‚ª‚í‚©‚é! “§Í—Ö@‚ÌABCz19 1-4 RPGN@
‹}‘¬is«Ž…‹…‘̐t‰Š. ²–ì@—² (t‘Ÿ“à): “§ÍƒPƒA 2011/2; 17 (2): 19.

522050. [uÀ]y“ÁW: “±“üŠî€‚©‚ç’·Šú‡•¹Ç‚Ü‚Å ‰p—ªŒê‚ÅŠî‘b‚ª‚í‚©‚é! “§Í—Ö@‚ÌABCz20 1-5 AKI@
‹}«táŠQ. ²–ì@—² (t‘Ÿ“à): “§ÍƒPƒA 2011/2; 17 (2): 20-1.

522051. [uÀ]y“ÁW: “±“üŠî€‚©‚ç’·Šú‡•¹Ç‚Ü‚Å ‰p—ªŒê‚ÅŠî‘b‚ª‚í‚©‚é! “§Í—Ö@‚ÌABCz22 1-6 CGN.
24 1-7 IgAtÇ. “à“c–ž”üŽq (t‘Ÿ“à): “§ÍƒPƒA 2011/2; 17 (2): 22-6.

522052. [uÀ]yŒ€‹†Ž{ÝÐ‰îz–k—¢‘åŠwˆãŠw•”t‘Ÿ“à‰È. Š™“cvšæ (t“à): Nephrology Frontier
2011/3; 10 (1): 87-91.

[’˜@‘]

620062. [Šwp‘]y“§Í—Ö@ƒlƒNƒXƒg Xz“ÁWw–³|Ž_“§Í‰t‚̉ۑè‚Æ“W–]x“§Í‰t‚ƏzŠÂ“®‘Ô, p.34-43.
ŽR’†@–], Š™“cvšæ1 (1t‘Ÿ“à), •Ò H—t@—², HàV’‰’j, ˆãŠw}‘o”Å, “Œ‹ž, 2010/5”­s.

620063. [Šwp‘]yƒseries ƒ‚ƒfƒ‹“®•š—˜—pƒ}ƒjƒ…ƒAƒ‹„ŽŸŠ³ƒ‚ƒfƒ‹‚̍쐻‚Æ—˜—p?zŠÂŠíŽŸŠ³z‘æ‚S
Í tŽŸŠ³@‘æ‚Qß tŽŸŠ³ì»ƒ‚ƒfƒ‹@‘æ2€ Ž…‹…‘̏áŠQƒ‚ƒfƒ‹@(3) Heymannt‰Š, p.301-6. Š™“cv
šæ (t‘Ÿ“à), •Ò –k@@“O, ‘Œ, ƒGƒ‹EƒAƒCEƒV[, “Œ‹ž, 2010/8/30”­s.

620064. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚ÌŽ¡—ÃŽnŽwj 2011”N“x”Å?Ž„‚Í‚±‚€Ž¡—µ‚Ä‚¢‚éz’áƒiƒgƒŠƒEƒ€
ŒŒÇ, p.561-2. Š™“cvšæ (t‘Ÿ“à), ‘•ÒW ŽRŒû@“O, –kŒŽŒõ•v, •ŸˆäŽŸ–î, ˆãŠw‘‰@, “Œ‹ž, 2011/1
”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722070. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) y“Á•ÊŠé‰æ3: ‚æ‚­‚í‚©‚éƒVƒŠ[ƒY4zƒlƒtƒ[ƒ[ÇŒóŒQ (Šî‘b. Š™
“cvšæ (t‘Ÿ“à): ‘æ53‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2010/06/18), _ŒË, “ú–{t‘ŸŠw‰ïŽ 2010/5; 52 (3):
244.

722071. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) yƒZƒ“ƒgƒ‰ƒ‹“§Í‰t‹Ÿ‹‹ƒVƒXƒeƒ€ (CDDS) ‚É‚š‚¯‚铧Í‰tE•â
[‰t‚ÌŒŸØz“§Í‰t‚̌ċzŠíŒn‚ւ̉e‹¿. ŽR’†@–]1, Š™“c’qG2, ‰i‰ª@—²2, Š™“cvšæ3 (1–h‰qˆã‰È
‘åŠwZŠO‰ÈŠw, 2‘Š–ÍŒŽƒNƒŠƒjƒbƒN, 3t‘Ÿ“à): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/20), _ŒË, “§
Í‰ïŽ 2010/5; 43 (S1): 297.

723234. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆÛŽŒŒ‰t“§ÍŠ³ŽÒ‚É‚š‚¯‚鎉Ž¿’l‚Æèò“®–¬ƒGƒR[ŠŒ©?”ñ“œ”A•aŒQ
‚Å‚Ì”äŠr?. XŒû‚¢‚Ô‚«1, ¬—Ñ’Œ”V1, “à“¡³‹g2, ¬—с@Œ\2, ’|“àN—Y2, ‘å‹v•Û[l1, Š™“cvšæ
2 (1‘Š•‘äƒj[ƒŒƒ“ƒNƒŠƒjƒbƒN, 2t‘Ÿ“à): ‘æ53‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2010/06/16), _ŒË, “ú–{
t‘ŸŠw‰ïŽ 2010/5; 52 (3): 290.

723235. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) is‚µ‚œCKDÇ—á‚Ö‚ÌACEI, ARB’P“Æ‚š‚æ‚Ñ•¹—p“Š—^‚ÌŒø‰Ê?
Kanagawa Valsartan Trial (KVT) ‚æ‚è?. ˆÀ“c@—²1, ‹g‘ºŒáŽu•v2, ”~‘º@•q3, ‰““¡³”V4, Š™“cv
šæ5, –Ø‘ºŒ’“ñ˜Y1 (1¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠwt‘ŸE‚ŒŒˆ³“à‰È, 2º˜a‘åŠw“¡‚ª‹u•a‰@Et‘Ÿ“à‰È, 3‰¡
•lŽs—§‘åŠw‘åŠw‰@ˆãŠwŒ€‹†‰ÈzŠÂŠíEt‘Ÿ“à‰ÈŠw, 4“ŒŠC‘åŠwˆãŠw•”tE“à•ª”åE‘ãŽÓ“à‰È, 5t‘Ÿ“à): ‘æ
53‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ï (2010/06/17), _ŒË, “ú–{t‘ŸŠw‰ïŽ 2010/5; 52 (3): 294.

723236. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)y‘æ54‰ñ“ú–{t‘ŸŠw‰ïŠwp‘‰ïE‰ï’·ÜzƒJƒ‹ƒVƒEƒ€ƒCƒIƒmƒtƒFƒA
‚É‚æ‚é“œœŒ‹‡áŠQƒlƒtƒŠƒ“‚Ì‘‰Á‚ƍזE“à¬–E‘̃XƒgƒŒƒX. “à“¡³‹g1, ÂŽR“ŒŒÜ1, ŽR’†@–]2, ‰ª
–{’qŽq1, “cèq”ü1, ¬—с@Œ\1, Š™“cvšæ1 (1t‘Ÿ“à, 2–h‰qˆã‰È‘åŠwZŠO‰ÈŠw): ‘æ53‰ñ“ú–{t‘Ÿ
Šw‰ïŠwp‘‰ï (2010/06/16), _ŒË, “ú–{t‘ŸŠw‰ïŽ 2010/5; 52 (3): 343.

723237. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) LDL‹z’…‚©‚çDEPP (DFƒT[ƒ‚) ‚֕ύXŒã‘ÌŠOzŠÂŽž‚Ì•›ì—p‚ªŒyŒž
‚Å‚«‚œ1—á. VˆäŽÀ‰„1, ‚‹Ž”Ž‹v1, ‘“cŽ”ü2, –q–앐Žu3, ’·ê@‘×3, “‡“c@”£3 (1–k—¢Œ€‹†Š
ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@tƒZƒ“ƒ^[, 2“¯ŠÅŒì•”, 3“¯t‘Ÿ“à‰È): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï
(2010/6/18), _ŒË, “§Í‰ïŽ 2010/5; 43 (S1): 447.

723238. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) dÇ‹•ŒŒŽèŽw‚ւ̃PƒA. ‘“cŽ”ü1, •Ÿ‰ª”ü—R‹I1, –Ø‘º‰xŽq1, Žº
‰ª‘œŠìŽq1, –q–앐Žu2, ’·ê@‘×2, “‡“c@”£2 (1–k—¢‘åŠw–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@ŠÅŒì•”,
2“¯t‘Ÿ“à‰È): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/19), _ŒË, “§Í‰ïŽ 2010/5; 43 (S1): 464.

723239. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒGƒŠƒXƒƒ|ƒGƒ`ƒ“ (EPO) ”牺“Š—^Žž‚̐»ÜŠÔ‚Å‚Ì’É‚Ý‚Ì”äŠr’²ž.
–q–앐Žu1, ˆÀ“¡@q2, ’·ê@‘×1, “‡“c@”£1, Š™“cvšæ3, ¬‹{ŽR‹MŽq4 (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZ
ƒ“ƒ^[•a‰@t‘Ÿ“à‰È, 2“¯–òÜ•”, 3t‘Ÿ“à, 4–òÜ•”): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/19), _
ŒË, “§Í‰ïŽ 2010/5; 43 (S1): 517.

723240. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆÛŽŒŒ‰t“§ÍŠ³ŽÒ‚Ì“]“|‚ÉŠÖ—^‚·‚éˆöŽq‚ÌŒŸ“¢. ‚‹ŽºO1, ˆ¢•”
‹`Žj2, ˆíŒ©–[‘ã2, š“ߏrŽ÷2, Œ‰i“Ä•F2, ‚‹Ž”ÍŽq1, ²–ì‹IŽq1, ‚–؁@—T1, –{‹Ž²’mŽq1, Î‹Ž
”ü¶1, ’|“àN—Y3, Š™“cvšæ3, ‹g“c@àˆ1 (1‚³‚ª‚ݏzŠÂŠíƒNƒŠƒjƒbƒN, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3t‘Ÿ
“à): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/20), _ŒË, “§Í‰ïŽ 2010/5; 43 (S1): 581.

723241. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’á‰h—{‚ðŒ_‹@‚ÉACTH’P“ÆŒ‡‘¹Ç‚Ɛf’f‚³‚ê‚œŒŒ‰t“§ÍŠ³ŽÒ‚̈ê—á.
‰«èŠGˆß1, ã@@‘1, “c‘º_ŽO1, Ž…Œ’Žj2, â–{®“o2, Š™“cvšæ2 (1ãƒNƒŠƒjƒbƒN“à‰È, 2t‘Ÿ
“à): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/18), _ŒË, “§Í‰ïŽ 2010/5; 43 (S1): 674.

723242. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬’°“àŽ‹‹Ÿ‚ÅŒJ‚è•Ô‚·Á‰»ŠÇoŒŒ‚̐f’f‚ÆŽ¡—Âɐ¬Œ÷‚µ‚œˆÛŽŒŒ‰t
“§ÍŠ³ŽÒ‚̈ê—á. “c’†@Œ\1, ÂŽR“ŒŒÜ1, ŽðˆäŒ’Žj2, ¬—ѐŽ“T3, ”üŒŽ@Ã1, Š™“c^—Žq2, Š™“cv
šæ2 (1‘Š–Í–ì•a‰@t‘Ÿ“à‰È, 2t‘Ÿ“à, 3–k—¢‘åŠw“Œ•a‰@Á‰»Ší“à‰È): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï@
(2010/6/19), _ŒË, “§Í‰ïŽ 2010/5; 43 (S1): 725.

723243. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) • •”‘å“®–¬áŽpŒã‚É‘Sg‘ŸŠí‚ɃRƒŒƒXƒeƒ[ƒ‹Çð‚𗈂œ‚µ‚œˆê—á.
ŒÃ’J¹Žq1, ²–ì@—²1, Š™“c^—Žq1, “n‰ï—œŽÑŽq1, ‰¥çŽq, ÂŽR‰ë‘¥1, ’†–ì‘fŽq1, “à“c–ž”üŽq
1, â–{®“o1, Š™“cvšæ1 (1t‘Ÿ“à): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/19), _ŒË, “§Í‰ïŽ
2010/5; 43 (S1): 765.

723244. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŒ‰t“§ÍŠ³ŽÒ‚É‚š‚¯‚é–òÜ—no«ƒXƒeƒ“ƒg‚ÌŽ¡—ЬÑ. “cèq”ü
1, Ž…Œ’Žj1, ‰ª–{’qŽq1, ¬—с@Œ\1, “à“¡³‹g1, â–{®“o1, ‰º•lF˜Y2, ’|“àˆê˜Y2, XŒû¹•F2,
Š™“cvšæ1 (1t‘Ÿ“à, 2zŠÂŠí“à): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/19), _ŒË, “§Í‰ïŽ
2010/5; 43 (S1): 769.

723245. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) lH’YŽ_ò—‚ª“§ÍŒø—Š‚É‹y‚Ú‚·‰e‹¿?‘æ“ñ•ñ?. VˆäŽÀ‰„1, ‚
‹Ž”Ž‹v1, ‘“cŽ”ü2, –q–앐Žu3, ’·ê@‘×3, “‡“c@”£3 (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@tƒZ
ƒ“ƒ^[, 2“¯ŠÅŒì•”, 3“¯t‘Ÿ“à‰È): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/20), _ŒË, “§Í‰ïŽ
2010/5; 43 (S1): 564.

723246. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “àƒVƒƒƒ“ƒg‘n•”ŠŽõ‚©‚犎õ«‹¹•”‘å“®–¬áŽ‚ð‚«‚œ‚µ‚œŒŒ‰t“§ÍŠ³
ŽÒ‚̈ê—á. Š™“c^—Žq1, “à“c–ž”üŽq1, ŒÃ’J¹Žq1, “n‰ï—œŽÑŽq1, ‰¥çŽq1, ÂŽR‰ë‘¥1, ’†–ì‘fŽq
1, ²–ì@—²1, â–{®“o1, Š™“cvšæ1 (1t‘Ÿ“à): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/20), _
ŒË, “§Í‰ïŽ 2010/5; 43 (S1): 793.

723247. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆÛŽŒŒ‰t“§Í (HD) Š³ŽÒ‚É‚š‚¯‚éƒOƒŠƒRƒAƒ‹ƒuƒ~ƒ“ (GA), HbA1C, ƒy
ƒ“ƒgƒVƒWƒ“ (Pent) ‚ÌŠÖ˜A‚ɂ‚¢‚Ä. ¬—с@Œ\1, ’|“àN—Y1, “à“¡³‹g1, “n•Óm”ü2, XŒû‚¢‚Ô‚«2, ¬
—Ñ’Œ”V2, ‘å‹v•Û[l2, Š™“cvšæ1, ›ŒŽßŽq3, ÎŒŽ˜a•F3 (1t‘Ÿ“à, 2‘Š•‘äƒj[ƒŒƒ“ƒNƒŠƒjƒbƒN, 3
ˆã—Éq¶Šw•”): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/20), _ŒË, “§Í‰ïŽ 2010/5; 43 (S1): 800.

723248. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ºŒ‡–R‚É‚æ‚é”ÄŒŒ‹…Œž­Ç‚ð‚«‚œ‚µ‚œˆÛŽŒŒ‰t“§ÍŠ³ŽÒ‚̈ê—á. ’†
–ì‘fŽq1, ŽðˆäŒ’Žj1, ŒÃ’J¹Žq1, Š™“c^—Žq1, “n‰ï—œŽÑŽq1, ‰¥çŽq1, ÂŽR‰ë‘¥1, ²–ì@—²1, “à
“c–ž”üŽq1, âV“¡@‹B2, ŸNˆäŒ’Ž¡2, â–{®“o1, Š™“cvšæ1 (1t‘Ÿ“à, 2‹Ž–{ƒNƒŠƒjƒbƒN)F ‘æ55‰ñ
“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/20), _ŒË, “§Í‰ïŽ 2010/5; 43 (S1): 808.

731059. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –«t‘Ÿ•a‚Ì•a‘Ô‚ÆŽ¡—Ã. Š™“cvšæ (t‘Ÿ“à): ‰¡•lŽs
‰h‹æˆãŽt‰ïŠwpu‰‰‰ï (2010/5/19), ‰¡•l.

731060. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “úíf—ɺ‚Å‚ÌCKD‚ÌŽ¡—Ð헪. Š™“cvšæ (t‘Ÿ“à): z
ŠÂŠím (2010/6/2), …ŒË.

731061. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ANCAŠÖ˜AŒŒŠÇ‰ŠEt‰Š‚̗Տ°. Š™“cvšæ (t‘Ÿ“à): ŒF
–{Œ§t‘ŸŠwpu‰‰‰ï (2010/7/20), ŒF–{.

731062. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) CKDf—Â̍ŋ߂̘b‘è. Š™“cvšæ (t‘Ÿ“à): ‘æ2‰ñ‚³
‚ª‚ÝCKDƒlƒbƒgƒ[ƒN (2010/10/7), ‘Š–ÍŒŽ.

731063. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –«t‘Ÿ•a (CKD) ‚Ì•a‘Ô‚ÆŽ¡—Âɂ‚¢‚Ä. Š™“cvšæ (t
‘Ÿ“à): ’¬“cŽs–¯•a‰@“à‰Èu‰‰‰ï (2010/11/2), “Œ‹ž.

731064. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒlƒtƒ[ƒ[ÇŒóŒQ‚ÌŠî‘b‚ƗՏ°. Š™“cvšæ (t‘Ÿ“à): ‘æ
4‰ñ‘啪t‰ŠŒ€‹†‰ï (2010/11/25), ‘啪.

731065. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “úíf—ÂłÌCKD‚ÌŽ¡—Ð헪. Š™“cvšæ (t‘Ÿ“à): –
«t‘Ÿ•a‚ƐSŒŒŠÇŒn‡•¹Çu‰‰‰ï (¬ŽR’n‹æˆãŽt‰ï) (2010/12/7), “È–ØŒ§¬ŽR.

731066. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰–•ªÛŽæ‚Æ–«t‘Ÿ•a. Š™“cvšæ (t‘Ÿ“à): ‘æ12‰ñ_
“ސ쌧Œ§‰›tŽŸŠ³•afƒZƒ~ƒi[ (2011/2/10), ‘Š–ÍŒŽ

733102. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)y‘æ79‰ñ_“ސìtŒ€‹†‰ï—DG‰‰‘èÜz“ºŒ‡–R‚É‚æ‚èrHuEpo
’ïR«•nŒŒ‚ƔČŒ‹…Œž­Ç‚ð’悵‚œˆÛŽŒŒ‰t“§ÍŠ³ŽÒ‚̈ê—á. Š™“c^—Žq1, ’†–ì‘fŽq1, ŽáV•‡”ü1, Žð
ˆäŒ’Žj1, ŒÃ’J¹Žq1, “n‰ï—œ¹Žq1, ‰¥ç‰êŽq1, ‘º–쏇–ç1, “à“¡³‹g1, ²–ì@—²1, “à“c–ž”üŽq1, â
–{®“o1, âV“¡@‹B2, ŸNˆäŒ’Ž¡2, Š™“cvšæ1 (1t‘Ÿ“à, 2‹Ž–{ƒNƒŠƒjƒbƒN): ‘æ79‰ñ_“ސìtŒ€‹†‰ï
(2010/5/15), ‰¡•l.

733103. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) is«‚ÌŽ‹—͒ቺ‚ƃlƒtƒ[ƒ[ÇŒóŒQ‚ð’悵‚œŒ‹ß«Ž…
‹…‘̍d‰»Ç‚̈ê—á. ŒÃ’J¹Žq1, ²–ì@—²1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, —Ñ‚Ý‚ä‚«1, Š™“c^—Žq1, ‘º–ì
‡–ç1, “à“¡³‹g1, “à“c–ž”üŽq1, â–{®“o1, Š™“cvšæ1 (1t‘Ÿ“à): ‘æ54‰ñ_“ސìt‰ŠŒ€‹†‰ï
(2010/9/18), ‰¡•l.

733104. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬‡«Œ‹‡‘gD•a (MCTD) ‚̉Á—Ã’†‚ÉANCA‰A«‚̉󎀐«
Ž…‹…‘̐t‰Š‚ð‡•¹‚µ‚œˆê—á. —Ñ‚Ý‚ä‚«1, “à“¡³‹g1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, Š™“c^—Žq1, ŒÃ’J¹Žq
1, ‰¥çŽq1, ’†–ì‘fŽq1, ‘º–쏇–ç1, ²–ì@—²1, “à“c–ž”üŽq1, â–{®“o1, Š™“cvšæ1 (1t‘Ÿ“à):
‘æ40‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2010/9/25), ‰F“s‹{, “ú–{t‘ŸŠw‰ïŽ 2010/8; 52 (6): 688.

733105. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹}‘¬is«t‰ŠÇŒóŒQ‚Å”­Ç‚µ, ‘œÊ‚ȏǏó‚ð’悵‚œ
Churg?StraussÇŒóŒQ (CSS) ‚̈ê—á. –q–앐Žu1, ‹g“c@G1, ’·ê@‘×1, L£—²ˆê1, “‡“c@”£1, Š™
“cvšæ2 (1–k—¢‘åŠw–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2t‘Ÿ“à): ‘æ40‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï
(2010/9/25), ‰F“s‹{, “ú–{t‘ŸŠw‰ïŽ 2010/8; 52 (6): 689.

733106. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)@’†Žš‰Š, S‹Ø[Ç‚ð‡•¹‚µ‚œMPO?ANCA—z«Œ°”÷‹Ÿ“I‘œ
”­ŒŒŠÇ‰Š‚̈ê—á. ŒÃ’J¹Žq1, ²–ì@—²1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, Š™“c^—Žq1, —Ñ‚Ý‚ä‚«1, ‘º–쏇
–ç1, “à“¡³‹g1, “à“c–ž”üŽq1, â–{®“o1, Š™“cvšæ1 (1t‘Ÿ“à): ‘æ40‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å
‰ï (2010/9/24), ‰F“s‹{, “ú–{t‘ŸŠw‰ïŽ 2010/8; 52 (6): 708.

733107. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒVƒNƒƒXƒ|ƒŠƒ“‚É‚æ‚é‰Â‹t«”’Ž¿”]Ç‚ð‡•¹‚µ‚œƒlƒtƒ
[ƒ[ÇŒóŒQ‚̈ê—á. Š™“c^—Žq1, ²–ì@—²1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, ŒÃ’J¹Žq1, —Ñ‚Ý‚ä‚«1, ‰¥ç
Žq1, “n‰ï—œŽÑŽq1, ÂŽR‰ë‘¥1, ‘º–쏇–ç1, “à“¡³‹g1, ’†–ì‘fŽq1, “à“c–ž”üŽq1, â–{®“o1, Š™
“cvšæ1 (1t‘Ÿ“à): ‘æ40‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2010/9/25), ‰F“s‹{, “ú–{t‘ŸŠw‰ïŽ 2010/8;
52 (6): 720.

733108. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –Œ«tÇ‚É•¹”­‚µ‚œMPO-, PR3-ANCA‹€‚É—z«‚ÌŒ°”÷‹Ÿ“I
‘œ”­ŒŒŠÇ‰Š‚̈ê—á. ŽðˆäŒ’Žj1, “à“c–ž”üŽq1, ŽáV•‡”ü1, —Ñ‚Ý‚ä‚«1, ŒÃ’J¹Žq1, Š™“c^—Žq1, ‘º
–쏇–ç1, “à“¡³‹g1, ²–ì@—²1, â–{®“o1, Š™“cvšæ1 (1t‘Ÿ“à): ‘æ40‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp
‘å‰ï (2010/9/25), ‰F“s‹{, “ú–{t‘ŸŠw‰ïŽ 2010/8; 52 (6): 722.

733109. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) tŽîᎂð’悵‚œMPO-ANCA—z«Wegener“÷‰èŽîÇ‚̈ê—á.
ŽáV•‡”ü1, ²–ì@—²1, ŽðˆäŒ’Žj1, Š™“c^—Žq1, ŒÃ’J¹Žq1, —Ñ‚Ý‚ä‚«1, ‰¥çŽq1, “n‰ï—œŽÑŽq
1, ‘º–쏇–ç1, ÂŽR‰ë‘¥1, “à“¡³‹g1, ’†–ì‘fŽq1, “à“c–ž”üŽq1, â–{®“o1, Š™“cvšæ1 (1t‘Ÿ“à):
‘æ40‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2010/9/25), ‰F“s‹{, “ú–{t‘ŸŠw‰ïŽ 2010/8; 52 (6): 723.

733110. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆÛŽ“§ÍŒo‰ß’†‚ɐtŽüˆÍoŒŒ‚𗈂µ‚œ2—á. ’·ê@‘×
1, –q–앐Žu1, ¢‘ò’BŽO2, “‡“c@”£1, Š™“cvšæ3 (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2–k–{‘æˆê
ƒNƒŠƒjƒbƒN, 3t‘Ÿ“à): ‘æ40‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2010/9/25), ‰F“s‹{, “ú–{t‘ŸŠw‰ïŽ
2010/8; 52 (6): 728.

733111. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)y—Տ°‘̉tŒ€‹†‰ï—DG‰‰‘èÜzH“¹Šà‚̉»Šw—Ö@’†‚É“d‰ð
Ž¿ˆÙí‚𔺂¢áz¹dÏ”­ì‚𐶂¶‚œ1Ç—á. —Ñ‚Ý‚ä‚«1, ‘º–쏇–ç1, ‰¡“c˜aŽq2, ŽðˆäŒ’Žj1, ŒÃ’J¹
Žq1, Š™“c^—Žq1, Œ˜“ce—˜2, “à“¡³‹g1, “à“c–ž”üŽq1, ²–ì@—²1, â–{®“o1, Š™“cvšæ1 (1t
‘Ÿ“à, 2Á‰»Ší“à): ‘æ42‰ñ—Տ°‘̉tŒ€‹†‰ï (2010/10/23), “Œ‹ž, —Տ°‘̉tŒ€‹†‰ïŽ 2010/10; 42: 15.

733112. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’á”AŽ_ŒŒÇ«‰^“®Œã‹}«t•s‘S‚̈ê—á‚Æ•a‘Ԃɂ‚¢‚Ä‚Ì
ŒŸ“¢. —Ñ‚Ý‚ä‚«1, ‘º–쏇–ç1, ŽáV•‡”ü1, ŽðˆäŒ’Žj1, Š™“c^—Žq1, ŒÃ’J¹Žq1, “à“¡³‹g1, ²–ì@
—²1, “à“c–ž”üŽq1, â–{®“o1, Š™“cvšæ1 (1t‘Ÿ“à): ‘æ80‰ñ_“ސìtŒ€‹†‰ï (2010/11/28), ‰¡•l.

733113. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ°”÷‹Ÿ“I‘œ”­ŒŒŠÇ‰Š‚ÌŽ¡—Ã. “à“c–ž”üŽq1, “à
“¡³‹g1, ²–ì@—²1, Š™“cvšæ1 (1t‘Ÿ“à): ‘æ1‰ñ–k—¢ŒŒŠÇƒtƒH[ƒ‰ƒ€ (2010/12/6), ‘Š–ÍŒŽ.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-522002. [uÀ] •œ¬21”N“x_“ސ쌧tŽŸŠ³‘‡ˆã—ÃZƒ“ƒ^[Šˆ“®•ñ. Š™“cvšæ (t“à): _
“ސ쌧“§ÍŽ{Ý˜A—‹Š‹c‰ï•ñ 2010/3; 25: 21-2.

H21-540017. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] (•ª’S)y•¶•”‰ÈŠwÈuƒnƒCƒeƒNƒŠƒT[ƒ`EƒZƒ“ƒ^[Ý”õŽ–‹Æv
‘I’èƒvƒƒWƒFƒNƒg (2006-2010)z‘̉tƒzƒƒIƒXƒ^ƒVƒX”j’]‚̐t–hŒä‹@\. â–{®“o (t‘Ÿ“à): •¶•”‰ÈŠw
ÈuƒnƒCƒeƒNƒŠƒT[ƒ`EƒZƒ“ƒ^[Ý”õŽ–‹Æv‘I’èƒvƒƒWƒFƒNƒg (2006-2008) •ñ‘, 2009/5; p.30-1.


äPŒŽ•aEŠŽõ“à‰ÈŠw

[Šwp˜_•¶]

110141. [ŒŽ’˜] Identification of autoantigens specific for systemic lupus erythematosus with
central nervous system involvement. Iizuka N1, Okamoto K, Matsushita R1, Kimura M1, Nagai K, Arito
M, Kurokawa MS, Masuko K, Suematsu N, Hirohata S1, Kato T: Lupus 2010/5; 19 (6): 717-26. (”Ñ’Ë
iŽq1, Œ‰º—çŽq1, –Ø‘º”ü•Û1, œA”šr¬1: 1äPŒŽ•a¥ŠŽõ“à)

110142. [ŒŽ’˜] Anti-ribosomal P protein antibody induces Th1 responses by enhancing the production
of IL-12 in activated monocytes. Nagai T1, Yanagida T, Hirohata S1: Mod Rheumatol 2011/2; 21 (1):
57-62. (‰iˆä—§•v1, œA”šr¬1: 1äPŒŽ•a¥ŠŽõ“à)

310004. [Ç—á•ñ] An attack of acute neuro-Behet's disease during the course of chronic
progressive neuro-Behet's disease: report of two cases. Matsui T1, Ishida T, Tono T1, Yoshida
T, Sato S, Hirohata S1: Mod Rheumatol 2010/12; 20 (6): 621-6. (Œˆär’Ê1, “Œ–ì‹IŽq1, œA”šr¬
1: 1äPŒŽ•a¥ŠŽõ“à)

522053. [uÀ]y“ÁW: Ž©ŒÈR‘Ì‚ÅŽ©ŒÈ–ƉuŽŸŠ³‚Ì–{‘Ô‚É”—‚ézCNSƒ‹[ƒvƒX‚ÉŠÖŒW‚·‚鎩ŒÈR‘͉̂œ‚©.
œA”šr¬ (äPŒŽ•a¥ŠŽõ“à): •ªŽqƒŠƒEƒ}ƒ`Ž¡—à 2010/4; 3 (1): 21-5.

522054. [uÀ]y“ÁW: äPŒŽ•a?•a‘Ԃւ̐V‚œ‚ȃAƒvƒ[ƒ`‚ÆŽ¡—ÓWŠJ?z[äPŒŽ•a‚Ì•ªŽq•W“I‚Ɛ§Œä‚Ö
‚̃Aƒvƒ[ƒ`]@ƒx[ƒ`ƒFƒbƒg•a‚Ì•ªŽq•W“I‚Ɛ§Œä. œA”šr¬ (äPŒŽ•a¥ŠŽõ“à): ÅVˆãŠw 2010/5; 65
(5): 1007-12.

522055. [uÀ]yƒTƒCƒgƒJƒCƒ“‚ÆŽŸŠ³?‚ ‚ç‚œ‚È•a‘Ôƒ‚ƒfƒ‹‚©‚玡—ÂÖ?zŽ¡—Âւ̉ž—p@RTNF-ƒ¿R
‘Ì‚ÆBehet•a. œA”šr¬ (äPŒŽ•a¥ŠŽõ“à): ˆãŠw‚Ì‚ ‚ä‚Ý 2010/7; 234 (5): 593-7.

522056. [uÀ]y“ÁW: äPŒŽ•a‚É”º‚€_ŒoE‹ØáŠQ?f’f‚ÆŽ¡—Â̐i•àzEditorial äPŒŽ•a‚É”º‚€_ŒoE
‹ØáŠQ. œA”šr¬ (äPŒŽ•a¥ŠŽõ“à): “ú“à‰ïŽ 2010/8; 99 (8): 1751-3.

522057. [uÀ]y“ÁW: äPŒŽ•a‚É”º‚€_ŒoE‹ØáŠQ?f’f‚ÆŽ¡—Â̐i•àzäPŒŽ•a‚É‚š‚¯‚é_ŒoáŠQ‚̃}[
ƒJ[. ‰iˆä—§•v1, œA”šr¬1 (1äPŒŽ•a¥ŠŽõ“à): “ú“à‰ïŽ 2010/8; 99 (8): 1858-64.

522058. [uÀ]yŠÖß‰Š‚̊ӕʐf’f‚ÆŽ¡—Â̐i•àz6. Behet•a. œA”šr¬ (äPŒŽ•a¥ŠŽõ“à): “ú“à‰ï
Ž 2010/10; 99 (10): 2427-31.

522059. [uÀ]y“ÁW: ”x‚ŒŒˆ³Ç‚̗Տ°‚É‚š‚¯‚éÅV–ò•šŽ¡—ÁzäPŒŽ•aê–åˆã‚ªf‚é”x‚ŒŒˆ³Ç@3. ƒ{
ƒZƒ“ƒ^ƒ“’ljÁ“Š—^‚ª—LŒø‚Å‚ ‚Á‚œŒŽ”­«RƒŠƒ“Ž‰Ž¿R‘̏njóŒQ‚ɍ‡•¹‚µ‚œ–«ŒŒðÇð«”x‚ŒŒˆ³Ç‚Ì1
—á. ‰““¡•œm, “c’†Z–Ÿ1 (1äPŒŽ•a¥ŠŽõ“à): Modern Physician 2010/10; 30 (—ÕŽž‘Š§†): 10-2.

522060. [uÀ]yƒVƒ“ƒ|ƒWƒEƒ€: ”x‚ŒŒˆ³ÇŽ¡—Âɂš‚¯‚éPGI2ŒoŒû–ò‚̈ʒu•t‚¯z4. äPŒŽ•a«”x“®–¬«
”x‚ŒŒˆ³ÇŽ¡—Âɂš‚¯‚éPGI2ŒoŒû–ò‚̈ʒu•t‚¯. “c’†Z–Ÿ1, ¯@Œ’‘Ÿ1, œA”šr¬1 (1äPŒŽ•a¥ŠŽõ
“à): Therapeutic Research 2010/10; 31 (10): 1439-41.

522061. [uÀ]yäPŒŽ•a?‚»‚Ì“ü‚èŒû‚©‚疝«Šú‚܂ŁzŠe˜_?f’f‚ÆŽ¡—Â̎ÀÛ@Behet•a. œA”šr
¬ (äPŒŽ•a¥ŠŽõ“à): f’f‚ÆŽ¡—à 2010/10; 98 (10): 1641-6.

522062. [uÀ]y˜AÚ: ŽŸ¢‘ã‚̐¶•šŠw“I»Ü [‘æ11‰ñ]zƒGƒtƒ@ƒŠƒYƒ}ƒu. ‰iˆä—§•v (äPŒŽ•a¥ŠŽõ“à):
•ªŽqƒŠƒEƒ}ƒ`Ž¡—à 2010/11; 3 (4): 204-6.

522063. [uÀ]y“ÁW: ”xzŠÂE”x‚ŒŒˆ³‚ðŽ¯‚é?f’fEŽ¡—Â̌»Ý?z[Ž¡‚·]@14. [Expertise] V‹K
Ž¡—Öò‚ÌPotential@b. soluble guanylate cyclaseŽhŒƒ–ò. “c’†Z–Ÿ1, ¯@Œ’‘Ÿ1 (1äPŒŽ•a¥ŠŽõ“à):
Heart View 2010/12; 15 (1): 95-8.

522064. [uÀ]y“ÁW: ŠÖßƒŠƒEƒ}ƒ`f—Â̐V“WŠJzf’f‚ւ̃Aƒvƒ[ƒ`@ŠÖßƒŠƒEƒ}ƒ`‚Ì•a‘Ô‚©‚ç‚Ý‚œ
f’f‚ւ̃Aƒvƒ[ƒ`. ‰iˆä—§•v (äPŒŽ•a¥ŠŽõ“à): ¬l•a‚Ɛ¶ŠˆKŠµ•a 2011/1; 41 (1): 17-22.

522065. [uÀ]y“ÁW: ŠÖßƒŠƒEƒ}ƒ`‚ð‹^‚Á‚œ‚ç?f’fEŽ¡—ÂÌUpdate‚ÆŠÓ•Ê‚·‚ׂ«äPŒŽ•azŠÖßƒŠƒE
ƒ}ƒ`‚ÆŠÓ•Ê‚ª•K—v‚ÈŽŸŠ³‚Æ‚»‚Ì“Á’¥@[Žá”N?’†”N‚Å‘œ‚¢ŽŸŠ³]@Behet (ƒx[ƒ`ƒFƒbƒg) •a. “c’†Z–Ÿ
1, ¯@Œ’‘Ÿ1, œA”šr¬1 (1äPŒŽ•a¥ŠŽõ“à): Medicina 2011/2; 48 (2): 214-7.

522066. [uÀ]y“ÁW: ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚̐f’f‚ÆŽ¡—Â̐i•àzSLE‚Ì’†•_ŒoÇó‚ÉŠÖ˜A‚·‚鎩
ŒÈR‘Ì. ‰iˆä—§•v (äPŒŽ•a¥ŠŽõ“à): ƒŠƒEƒ}ƒ`‰È 2011/3; 45 (3): 241-7.

[’˜@‘]

610006. [Šwp‘] (•ª’SŽ·•M)yBehet's syndromezBehet's syndrome and the nervous system, p.95-113.
Siva A, Hirohata S1, Eds. Yazici, Yusuf; Yazici, Hasan, Springer, 2010”­s. (œA”šr¬1: 1äPŒŽ
•a¥ŠŽõ“à)

620065. [Šwp‘] (•ª’SŽ·•M)yÅVˆãŠw •Êû V‚µ‚¢f’f‚ÆŽ¡—ÂÌABC 67/–Ɖu6@‘Sg«ƒGƒŠƒeƒ}ƒg[
ƒfƒXz‘æ2Í •a—E•a‘Ԑ¶—@‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ì•a‘Ԑ¶—, p.48-57. œA”šr¬ (äPŒŽ•a¥ŠŽõ
“à), •Ò ’|“à@‹Î, ÅVˆãŠwŽÐ, ‘åã, 2010/5”­s.

620066. [Šwp‘] (•ª’SŽ·•M)y®Œ`ŠO‰È Knack & Pitfalls@ƒŠƒEƒ}ƒ`f—Â̗v“_‚Æ–Ó“_zII. Œø—Š“I‚È
ƒŠƒEƒ}ƒ`«ŽŸŠ³f’f‚̎菇@7. ’ˆÓ‚·‚ׂ«ƒŠƒEƒ}ƒ`‡•¹Ç‚Ənjó, p.41-3. œA”šr¬ (äPŒŽ•a¥ŠŽõ“à),
•Ò –Ø‘º—FŒú, •¶Œõ“°, “Œ‹ž, 2010/5”­s.

620067. [Šwp‘] (•ª’SŽ·•M)y“ú–{—Õ଑Š§†@ŠÖßƒŠƒEƒ}ƒ` (‘æ2”Å)?Š°‰ð‚ð–ÚŽw‚·Ž¡—Â̐VŽž‘ã?z
III. ŠÖßƒŠƒEƒ}ƒ`‚̐¬ˆö‚Æ•a‘Ԑ¶—@4. ‰ŠÇƒƒfƒCƒG[ƒ^[@4) Ú’…•ªŽq, p.189-93. œA”šr¬ (äP
ŒŽ•a¥ŠŽõ“à), “ú–{—Õ଎Ð, ‘åã, 2010/5”­s.

620068. [Šwp‘] (•ª’SŽ·•M)yEBM‚ÉŠî‚­”]_ŒoŽŸŠ³‚ÌŠî–{“IŽ¡—ÃŽwj ‰ü’ù‘æ3”Łz7. ‘€“ª“®–¬‰Š
‚ƃŠƒEƒ}ƒ`«‘œ”­‹Ø’ɏÇ, 8. äPŒŽ•a‚Ì’†•_ŒoÇó, p.422-7. œA”šr¬ (äPŒŽ•a¥ŠŽõ“à), •Ò “c‘º@
W, Œ’J‰ë¶, Ž…‹P•v, Medical ViewŽÐ, “Œ‹ž, 2010/6”­s.

620069. [Šwp‘] (•ª’SŽ·•M)yGUIDELINE äPŒŽ•aEƒŠƒEƒ}ƒ` ‰ü’ù‘æ‚Q”Å?Ž¡—ÃKƒCƒhƒ‰ƒCƒ“‚ð‚Ç‚€“Ç‚Þ
‚©?zBehcet•a, p.90-6. œA”šr¬ (äPŒŽ•a¥ŠŽõ“à), •Ò ¬’r—²•v, Z“cF”V, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž,
2010/8”­s.

620070. [Šwp‘] (•ª’SŽ·•M)yƒŠƒEƒ}ƒ`EäPŒŽ•a“à‰ÈƒNƒŠƒjƒJƒ‹ƒXƒ^ƒ“ƒ_[ƒhzIII. ŽŸŠ³‚Æ‚»‚ÌŽ¡—ÂÌ
ŽÀÛ@12. ƒx[ƒ`ƒFƒbƒg•a, p.179-88. œA”šr¬ (äPŒŽ•a¥ŠŽõ“à), •Ò ŽOXŒo¢, •¶Œõ“°, “Œ‹ž, 2010/8
”­s.

620071. [Šwp‘] (•ª’SŽ·•M)yƒŠƒEƒ}ƒ`•aŠwƒeƒLƒXƒgzK. ‚»‚Ì‘Œ‚ÌŽŸŠ³@1. Behet•a, p.396-403. œA
”šr¬ (äPŒŽ•a¥ŠŽõ“à), •Ò “ú–{ƒŠƒEƒ}ƒ`Šw‰ï, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2010/9”­s.

620072. [Šwp‘] (•ª’SŽ·•M)y˜Z’ù”Å ‰Æ’ëˆãŠw‘å‘S‰Èz29 äPŒŽ•a‚ÆŒŽˆö•s–Ÿ‚Ì‘SgŽŸŠ³@‘Sg«ƒGƒŠ
ƒeƒ}ƒg[ƒfƒX, p.2655-7. œA”šr¬ (äPŒŽ•a¥ŠŽõ“à), ‘‡ŠÄC ‚‹vŽj–›, ‰Ž“c‹’j, –k‘º‘yˆê˜Y, •Ÿ
ˆäŽŸ–î, –@Œ€, “Œ‹ž, 2010/10”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713065. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Characteristic changes in histopathogy of synovial
tissues from patients with rheumatoid arthritis treated with TNF inhibitors. Hirohata S1, Tomita
T, Yoshikawa H: EULAR 2010 (2010/6/16-19), Roma, Italy. (œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713066. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Neuro-Behcet's disease in Japan: a multicenter
retrospective survey. Hirohata S1, Kikuchi H, Sawada S, Nagafuchi H, Kuwana M, Takeno M,
Ishigatsubo Y: 14th International Conference on Behcet's disease (2010/7/7-11), London, UK. (œA
”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713067. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Role of immature plasmacytoid dendritic cells of the
bone marrow in the pathogenesis of rheumatoid arthritis. Hirohata S1, Tomita T, Yoshikawa H: 14th
International Congress of Immunology (2010/8/22-27), Kobe, Japan. (œA”šr¬1: 1äPŒŽ•aEŠŽõ“à)

713068. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical features of Behcetfs disease with vascular
nvolvement. Kikuch H, Asako K, Takayama M, Kono H, Hirohata S1, Ono Y: 74th Annual Scientific
Meeting, American College of Rheumatology (2010/11/6-11), Atlanta, USA. (œA”šr¬1: 1äPŒŽ•aE
ŠŽõ“à)

713069. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Determination of the Accurate Incidence of pulmonary
arterial hypertension in patients with Systemic Sclerosis, Mixed Connective Tissue disease and
Systemic Lupus Erythematosus by Prospective Study for 3-Years. Tanaka S1, Hoshi K1, Tanaka J1,
Wada T2, Matsui T1, Nagai T1, Okada J3, Hirohata S1: 74th ACR/ARHP Annual Scientific Meeting
(2010/11/6-11), Atlanta, USA. (“c’†Z–Ÿ1, ¯@Œ’‘Ÿ1, “c’†~ˆê1, ˜a“c’B•F2, Œˆär’Ê1, ‰iˆä—§
•v1, ‰ª“c@ƒ3, œA”šr¬1: 1äPŒŽ•aEŠŽõ“à, 2‘‡f—Ã, 3Œ’NŠÇ—ƒZ)

713070. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Efficacy of cerebrospinal fluid testing and magnetic
resonance imaging for diagnosis of Neuro-Behcet's disease: a multicenter retrospective analysis.
Hirohata S1, Kikuchi H, Sawada S, Nagafuchi H, Kuwana M, Takeno M, Ishigatsubo Y: 74th Annual
Scientific Meeting, American College of Rheumatology (2010/11/6-11), Atlanta, USA. (œA”šr¬1:
1äPŒŽ•aEŠŽõ“à)

713071. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[ TNF inhibitors induce the hyalinization in deep lining
layers of the synovium with degeneration, vacuolization, and detachment of synoviocytes in
rheumatoid arthritis. Hirohata S1, Tomita T, Yoshikawa H, Kyogoku M: 74th Annual Scientific
Meeting, American College of Rheumatology (2010/11/6-11), Atlanta, USA. (œA”šr¬1: 1äPŒŽ•aE
ŠŽõ“à)

722072. [Šw‰ï (‘S‘)] (Meet the Exports) ƒx[ƒ`ƒFƒbƒg•a. œA”šr¬ (äPŒŽ•a¥ŠŽõ“à): ‘æ54‰ñ“ú
–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï^‘æ19‰ñ‘ÛƒŠƒEƒ}ƒ`ƒVƒ“ƒ|ƒWƒEƒ€ (2010/4/23), _ŒË.

722073. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ƒx[ƒ`ƒFƒbƒg•a‚ɑ΂·‚éRTNFƒ¿R‘̗Ö@. œA”šr¬
(äPŒŽ•aEŠŽõ“à): ‘æ54‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï^‘æ19‰ñ‘ÛƒŠƒEƒ}ƒ`ƒVƒ“ƒ|ƒWƒEƒ€
(2010/4/22), _ŒË.

722074. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) äPŒŽ•a«”x‚ŒŒˆ³Ç‚ɑ΂·‚éƒvƒƒXƒ^ƒTƒCƒNƒŠƒ“
—Ö@. “c’†Z–Ÿ (äPŒŽ•aEŠŽõ“à): ‘æ54‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï ‘æ19‰ñ‘ÛƒŠƒEƒ}ƒ`ƒV
ƒ“ƒ|ƒWƒEƒ€ (2010/4/23), _ŒË.

722075. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒ“ƒ|ƒWƒEƒ€2zŒ©‚Š‚Ä‚«‚œVŽ¡—Âɂæ‚é‰î“ü@1. _Œoƒx[
ƒ`ƒFƒbƒg•a‚ɑ΂·‚éf’fEŽ¡—Â̐i•à. œA”šr¬ (äPŒŽ•aEŠŽõ“à): ‘æ15‰ñ“ú–{_Œož_ˆãŠw‰ï
(2010/12/4), “Œ‹ž.

723249. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒx[ƒ`ƒFƒbƒg•a‚̓«‚Ô‚Ç‚€–Œ‰Š‚ɑ΂·‚éƒCƒ“ƒtƒŠƒL
ƒVƒ}ƒu‚ÌŒø‰Ê. “Œ–ìr—m, “Œ–ì‹IŽq1, Žè“ˆ’qŽq, “c’†~ˆê1, ˜a“c’B•F2, Œˆär’Ê1, ‰iˆä—§•v1, “c
’†Z–Ÿ1, Îì@Í1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à, 2‘‡f—Ã): ‘æ54‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠw
pW‰ï ‘æ19‰ñ‘ÛƒŠƒEƒ}ƒ`ƒVƒ“ƒ|ƒWƒEƒ€ (2010/4/22), _ŒË.

723250. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RƒŠƒ{ƒ\[ƒ€PR‘Ì‚ÍŠˆ«‰»’P‹…‚ÌIL-12ŽY¶‚𘎐i‚·
‚邱‚Æ‚É‚æ‚èTh1”œ‰ž‚ð—U“±‚·‚é. ‰iˆä—§•v1, –ö“c‚œ‚ÝŽq, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ54‰ñ
“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï ‘æ19‰ñ‘ÛƒŠƒEƒ}ƒ`ƒVƒ“ƒ|ƒWƒEƒ€ (2010/4/22), _ŒË.

723251. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚鐬lƒXƒ`ƒ‹•a46—á‚̏‰ŠúŽ¡—ÃŒã‚̍Ĕ­ó‹µ
‚ÌŒŸ“¢. “Œ–ì‹IŽq1, “Œ–ìr—m, “c’†Z–Ÿ1, “c’†~ˆê1, Œˆär’Ê1, ‰iˆä—§•v1, œA”šr¬1 (1äPŒŽ
•aEŠŽõ“à): ‘æ54‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï ‘æ19‰ñ‘ÛƒŠƒEƒ}ƒ`ƒVƒ“ƒ|ƒWƒEƒ€ (2010/4/23),
_ŒË.

723252. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«ŠÔŽ¿«t‰Š‚ð‡•¹‚µ‚œƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. ˆÀ
•”Šw˜N1, ¯ŽR—²s1, ‹Ë¶–ƒˆßŽq, “Œ–ì‹IŽq1, Žè“ˆ’qŽq, “Œ–ìr—m, “c’†~ˆê1, Œˆär’Ê1, ‰iˆä—§
•v1, “c’†Z–Ÿ1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ54‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï ‘æ19‰ñ‘
ÛƒŠƒEƒ}ƒ`ƒVƒ“ƒ|ƒWƒEƒ€ (2010/4/23), _ŒË.

723253. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) SLE‚ÉDemyelinating syndrome‚ð‡•¹‚µ‚œ‚ƍl‚Š‚ç‚ê‚é
1—á. ¯ŽR—²s1, ˆÀ•”Šw˜N1, ‹Ë¶–ƒˆßŽq, “Œ–ì‹IŽq1, “Œ–ìr—m, “c’†~ˆê1, Œˆär’Ê1, ‰iˆä—§•v
1, “c’†Z–Ÿ1, Îì@Í1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ54‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï ‘æ
19‰ñ‘ÛƒŠƒEƒ}ƒ`ƒVƒ“ƒ|ƒWƒEƒ€ (2010/4/24), _ŒË.

723254. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖßƒŠƒEƒ}ƒ`Š³ŽÒ‚É‚š‚¯‚éŒ`Ž¿×–E—lŽ÷ó×–E. “c’†~
ˆê1, Œˆär’Ê1, ‰iˆä—§•v1, “c’†Z–Ÿ1, Îì@Í1, œA”šr¬1 (1äPŒŽ•a¥ŠŽõ“à): ‘æ54‰ñ“ú–{ƒŠ
ƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï ‘æ19‰ñ‘ÛƒŠƒEƒ}ƒ`ƒVƒ“ƒ|ƒWƒEƒ€ (2010/4/24), _ŒË.

723255. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”x‚ŒŒˆ³Ç‡•¹‚Ì‹­”çÇŒo‰ß’†‚ɐtƒNƒŠ[ƒ[‚𔭏ǂµ‚œ
1—á. “Œ–ì‹IŽq1, ŽRŒû—TŽq1, ‹Ë¶–ƒˆßŽq, “Œ–ìr—m, Žè“ˆ’qŽq, ¬ì‰p—C1, “c’†Z–Ÿ1, Îì@Í
1, ‰““¡•œm, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ54‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï ‘æ19‰ñ‘ÛƒŠ
ƒEƒ}ƒ`ƒVƒ“ƒ|ƒWƒEƒ€ (2010/4/24), _ŒË.

723256. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äPŒŽ•a«”x“®–¬«”x‚ŒŒˆ³Ç‚É‚š‚¯‚éEpoprostenolŽ‘±
Ã’Ž¡—Â̐¬Ñ. “c’†Z–Ÿ1, ‘‘@M”Ž1, “Œ–ì‹IŽq1, “Œ–ìr—m, ˜a“c’B•F2, ‰iˆä—§•v1, œA”šr¬1
(1äPŒŽ•aEŠŽõ“à, 2‘‡f—Ã): ‘æ54‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï ‘æ19‰ñ‘ÛƒŠƒEƒ}ƒ`ƒVƒ“ƒ|
ƒWƒEƒ€ (2010/4/24), _ŒË.

723257. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PRES (Posterior Reversible Encephalopathy Syndrome)
‚ÆRCVS (Reversible Cerebral Vasocostriction Syndrome) ‚ð‡•¹‚µ‚œSjšgrenÇŒóŒQ‡•¹SLE‚Ì1—á.
H“¡—Y‘å1, “c’†~ˆê1, ŒŽ@—º—S1, ¬ì‰p—C1, ¯@Œ’‘Ÿ1, ‰iˆä—§•v1, “c’†Z–Ÿ1, Îì@Í1, œA
”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ25‰ñ“ú–{—Տ°ƒŠƒEƒ}ƒ`Šw‰ï (2010/11/27), “Œ‹ž.

723258. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RƒŠƒ{ƒ\[ƒ€PR‘Ì‚ÌŠÖ—^‚ªŽŠŽ‚³‚ê‚œƒ‹[ƒvƒXt‰Š‚Ì
ˆê—á. Žè“ˆ’qŽq, ŽO“‡Fm, ŒŽ@—º—S1, H“¡—Y‘å1, ¬ì‰p—C1, ¯@Œ’‘Ÿ1, “c’†~ˆê1, ‰iˆä—§•v
1, “c’†Z–Ÿ1, Îì@Í1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ25‰ñ“ú–{—Տ°ƒŠƒEƒ}ƒ`Šw‰ï (2010/11/27),
“Œ‹ž.

723259. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]Š²‚̈ޏk‚ðŽŠ‚µ‚œRƒŠƒ{ƒ\[ƒ€PR‘Ì—z«SLE‚Ì1—á.
ŒŽ@—º—S1, ‰iˆä—§•v1, H“¡—Y‘å1, ¬ì‰p—C1, Žè“ˆ’qŽq, ¯@Œ’‘Ÿ1, “c’†~ˆê1, “c’†Z–Ÿ1, Îì@
Í1, ‰ª“c@ƒ2, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à, 2Œ’NŠÇ—ƒZ): ‘æ25‰ñ“ú–{—Տ°ƒŠƒEƒ}ƒ`Šw‰ï
(2010/11/27), “Œ‹ž.

732052. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰7) RƒŠƒ{ƒ\[ƒ€PR‘Ì‚ÆSLE‚Ì‘ŸŠíáŠQ. œA”šr¬ (äP
ŒŽ•aEŠŽõ“à): ‘æ40‰ñ“ú–{t‘ŸŠw‰ï“Œ•”Šwp‘å‰ï (2010/9/24), ‰F“s‹{.

733114. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t“®–¬áŽ‚ð‡•¹‚µ‚œANCAŠÖ˜AŒŒŠÇ‰Š‚̈êÇ—á.
H“¡—Y‘å1, ‰iˆä—§•v1, “Œ–ìr—m, ¬ì‰p—C1, ŒŽ@—º—S1, Žè“ˆ’qŽq, ¯@Œ’‘Ÿ1, “c’†~ˆê1, “c’†
Z–Ÿ1, Îì@Í1, œA”šr¬1, “Œ–ì‹IŽq1, ¯ŽR—²s1 (1äPŒŽ•aEŠŽõ“à): ‘æ62‰ñ_“ސ샊ƒEƒ}ƒ`
ˆã‰ï (2010/7/17), ‰¡•l.

733115. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PRES (Posterior Reversible Encephalopathy
Syndrome) ‚ÆRCVS (Reversible Cerebral Vasocostriction Syndrome) ‚ð‡•¹‚µ‚œSjšgrenÇŒóŒQ‡•¹
SLE‚Ì1—á. H“¡—Y‘å1, “c’†~ˆê1, ¬ì‰p—C1, ŒŽ@—º—S1, ¯@Œ’‘Ÿ1, ‰iˆä—§•v1, “c’†Z–Ÿ1, Î
ì@Í1, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à): ‘æ575‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2010/10/2), “Œ‹ž.

733116. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]Š²‚̈ޏk‚ðŽŠ‚µ‚œ’†•_Œoƒ‹[ƒvƒX‚Ì1—á.
ŒŽ@—º—S1, ‰iˆä—§•v1, H“¡—Y‘å1, ¬ì‰p—C1, ¯@Œ’‘Ÿ1, “c’†~ˆê1, “c’†Z–Ÿ1, Îì@Í1, ‰ª
“c@ƒ2, œA”šr¬1 (1äPŒŽ•aEŠŽõ“à, 2Œ’NŠÇ—ƒZ): ‘æ576‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (2010/11/13),
“Œ‹ž.

ŠO‰ÈŠw

[Šwp˜_•¶]

110143. [ŒŽ’˜] Is total mesorectal excision always necessary for T1-T2 lower rectal cancer?.
Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, Saito Y, Watanabe M1, Morita T,
Hida J, Ueno M, Ono M, Yasuno M, Sugihara K: Ann Surg Oncol 2010/4; 17 (4): 973-80. (“n粏¹•F
1: 1ŠO‰È)

110144. [ŒŽ’˜] Technique of esophagojejunostomy using transoral placement of the pretilted anvil
head after laparoscopic gastrectomy for gastric cancer. Sakuramoto S1, Kikuchi S1, Futawatari
N1, Moriya H1, Katada N1, Yamashita K1, Watanabe M1: Surgery 2010/5; 147 (5): 742-7. (÷–{Mˆê
1, ‹e’rŽj˜Y1, “ñ“nM]1, X’JGŒõ1, •Ð“c‰Ä–ç1, ŽR‰ºŒpŽj1, “n粏¹•F1: 1ŠO‰È)

110145. [ŒŽ’˜] Appropriateness of splenectomy for advanced cancer located in the upper third of
the stomach. Sakuramoto S1, Yamashita K1, Watanabe M1: Surg Endsc 2010/5; 24 (5): 1219-20. (÷
–{Mˆê1, ŽR‰ºŒpŽj1, “n粏¹•F1: 1ŠO‰È)

110146. [ŒŽ’˜] Potential utility of HOP homeobox gene promoter methylation as a marker of tumor
aggressiveness in gastric cancer. Ooki A1, Yamashita K1, Kikuchi S1, Sakuramoto S1, Katada N1,
Kokubo K, Kobayashi H, Kim MS, Sidransky D, Watanabe M1: Oncogene 2010/6; 29 (22): 3263-75. (‘å
–؁@‹Å1, ŽR‰ºŒpŽj1, ‹e’rŽj˜Y1, ÷–{Mˆê1, •Ð“c‰Ä–ç1, ¬—эO—S, “n粏¹•F1: 1ŠO‰È)

110024. [ŒŽ’˜] mPGES-1-expressing bone marrow-derived cells enhance tumor growth and angiogenesis
in mice. Kamata H1, Hosono K2, Suzuki T2, Ogawa Y1, Kubo H1, Katoh H1, Ito Y, Uematsu S, Akira
S, Watanabe M1, Majima M2: Biomed Pharmacother 2010/7; 64 (6): 409-16. (Š™“cOŽ÷1, ×–ì‰Á“ÞŽq
2, —é–Ø—§‹I2, ¬ì‹±Žj1, ‹v•Û”CŽj1, ‰Á“¡@O1, “n粏¹•F1, ”n“ˆ³—²2: 1ŠO‰È, 2–ò—)

110147. [ŒŽ’˜] Phosphate of regenerating liver-3 as a convergent therapeutic target for lymph node
metastasis in esophageal squamous cell carcinoma. Ooki A1, Yamashita K1, Kikuchi S1, Sakuramoto
S1, Katada N1, Watanabe M1: Int J Cancer 2010/8; 127 (3): 543-54. (‘å–؁@‹Å1, ŽR‰ºŒpŽj1, ‹e’r
Žj˜Y1, ÷–{Mˆê1, •Ð“c‰Ä–ç1, “n粏¹•F1: 1ŠO‰È)

110148. [ŒŽ’˜] FANCD2 mRNA overexpression is a bona fide indicator of lymph node metastasis in
human colorectal cancer. Ozawa H1, Iwatsuki M, Mimori K, Sato T1, Johansson F, Toh H, Watanabe
M1, Mori M: Ann Surg Oncol. 2010 Sep;17(9): 2010/9; 17 (9): 2341-8. (¬àV•œ‘Ÿ1, ²“¡•˜Y1, “n
粏¹•F1: 1ŠO‰È)

110149. [ŒŽ’˜] Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan
(FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3
non-inferiority study (FIRIS study). Muro K, Boku N, Shimada Y, Tsuji A, Sameshima S, Baba H,
Satoh T, Denda T, Ina K, Nishina T, Yamaguchi K, Takiuchi H, Esaki T, Tokunaga S, Kuwano H, Komatsu
Y, Watanabe M1, Hyodo I, Morita S, Sugihara K: Lancet Oncol 2010/9; 11 (9): 853-60. (“n粏¹•F
1: 1ŠO‰È)

110150. [ŒŽ’˜] Immunomodulation of monocyte-derived dendritic cells through ligation of
tumor-produced mucins to Siglec-9. Ohta M, Ishida A, Toda M, Akita K, Inoue M, Yamashita K1,
Watanabe M1, Murata T, Usui T, Nakada H: Biochem Biophys Res Commun 2010/11; 402 (4): 663-9. (ŽR
‰ºŒpŽj1, “n粏¹•F1: 1ŠO‰È)

110151. [ŒŽ’˜] Medium-term results of neoadjuvant systemic chemotherapy using irinotecan,
5-florouracil, and leucovorin in patients with locally advanced rectal cancer. Ishii Y, Hasegawa
H, Endo T, Okabayashi K, Ochiai H, Moritani K, Watanabe M1, Kitagawa Y: Eur J Surg Oncol 2010/11;
36 (11): 1061-5. (“n粏¹•F1: 1ŠO‰È)

110152. [ŒŽ’˜] Anastomotic leakage contributes to the risk for systemic recurrence in stage II
colorectal cancer. Katoh H1, Yamashita K1, Wang G2, Sato T1, Nakamura T1, Watanabe M1: J
Gastrointest Surg 2011/1; 15 (1): 120-9. (‰Á“¡@O1, ŽR‰ºŒpŽj1, ‰€@‘‹Õ2, ²“¡•˜Y1, ’†‘º—²
r1, “n粏¹•F1: 1ŠO‰È, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã)

110153. [ŒŽ’˜] Genetic alterations of K-ras may reflect prognosis in stage III colon cancer
patients below 60 years of age. Onozato W1, Yamashita K1, Kuba T, Katoh H1, Nakamura T1, Sato
T1, Ihara A, Okayasu I2, Watanabe M1: J Surg Oncol 2011/1; 103 (1): 25-33. (¬–ì—¢q1, ŽR‰ºŒp
Žj1, ‰Á“¡@O1, ’†‘º—²r1, ²“¡•˜Y1, ‰ªˆÀ@ŒM2, “n粏¹•F1: 1ŠO‰È, 2•a—)

110154. [ŒŽ’˜] Genomic and epigenetic profiles of gastric cancer:Potential diagnostic and
therapeutic applications. Yamashita K1, Sakuramoto S1, Watanabe M1: Surg Today 2011/1; 41 (1):
24-38. (ŽR‰ºŒpŽj1, ÷–{Mˆê1, “n粏¹•F1: 1ŠO‰È)

110027. [ŒŽ’˜] Calcitonin gene-related peptide facilitates revascularization during hindlimb
ischemia in mice. Mishima T1, Ito Y1, Hosono K2, Tamura Y1, Uchida Y1, Hirata M1, Suzsuki T2,
Amano H3, Kato S4, Kurihara Y, Kurihara H, Hayashi I, Watanabe M1, Majima M2: Am J Physiol Heart
Circ Physiol 2011/2; 300 (2): 437-9. (”ü“‡—˜‘¥1, ˆÉ“¡‹`–ç1, ×–ì‰Á“ÞŽq2, “c‘ºK•ä1, “à“c‘׎Š
1, •œ“cŒõ”Ž1, —é–Ø—§‹I2, “V–ì‰pŽ÷3, ‰Á“¡L‘Ÿ˜Y4, ”n“ˆ³—²2: 1ŠO‰È, 2–ò—, 3ŒÄ‹zŠíŠO, 4zŠÂ
Ší“à)

110155. [ŒŽ’˜] A Phase II trial of neoadjuvant preoperative chemoradiotherapy with S-1 plus
irinotecan and radiation in patients with locally advanced rectal cancer: clinical feasibility
and response rate. Sato T1, Ozawa H1, Hatate K1, Onosato W1, Naito M1, Nakamura T1, Ihara A, Koizumi
W2, Hayakawa K3, Okayasu I4, Yamashita K1, Watanabe M1: Int J Radiat Oncol Biol Phys 2011/3; 79
(3): 677-83. (²“¡•˜Y1, ¬àV•œ‘Ÿ1, ŠøŽè˜a•F1, ¬–ì—¢q1, “à“¡³‹K1, ’†‘º—²r1, ˆäŒŽ@Œú, ¬
ò˜aŽO˜Y2, ‘ì˜ad3, ‰ªˆÀ@ŒM4, ŽR‰ºŒpŽj1, “n粏¹•F1: 1ŠO‰È, 2Á‰»Ší“à, 3•úŽËü (Žîá‡), 4
•a—)

120016. [ŒŽ’˜] Á‰»«’×ᇐúE‚ÌŽ¡—Ã?• o‹ŸŽèp“K‰ž‚ÌŠg‘å‚ÉŒü‚¯‚Ä?. ‰Í–{@Œ’, ’|–{ˆÀG, ¬â
–ùŒ«1, ’r“c@“Ä1, –Ø’ë—YŽŠ, ‘呺FŽu, ²“¡ŒõŽj, ‚‹Ž•é, ¬‘ò³K (1ŠO‰È): ‘œ–€Á‰»ŠíƒVƒ“ƒ|
ƒWƒEƒ€Ž 2010/4; 24 (1): 40-3.

120017. [ŒŽ’˜] ’Œ’°‚Ìendluminal surgery. ‹à•œ‰i“ñ, ‰–àV–M‹v, ‹{“à–M_, ŒI“c@~1, ’@–ЖP, ã
–쑏ˆê˜Y (1ŠO‰È): ˆÝ‚Æ’° 2010/4/30; 45 (5): 899-905.

120018. [ŒŽ’˜] “àƒVƒƒƒ“ƒg’É‚ð–ü’…_Œo”—£‚ÅŽ¡–ü‚³‚¹‚Š‚œ1Ç—á. ‹v–Ø“c˜a‹u, ŒÃˆäG“T, “y‹Žœˆê
˜Y1, ’Ócˆê˜Y, ”Ñ“cˆê, –x]@‘ì, ¬–쎛ˆê•F, â“c”Ž”ü, ‹Ê’u@“§, –ڍ•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ
•v (1ŠO‰È): t‚Æ“§Í 2010/4; 68 (•Êû) t•s‘SŠO‰È2010: 69-71.

120019. [ŒŽ’˜] “–‰@‚É‚š‚¯‚éØœ•s”\isÄ”­‘å’°Šà‚ɑ΂·‚éFOLFIRI, FOLFOX (}bevacizumab) —Ö@
‚ÌŒŸ“¢. ×“c@Œj1, Â–ؐ^•F, éŒË@Œ[, ‰Ä‹Ñ@ŒŸ, “c‘º@Œõ, ¬“‡³•v, ‰J‹{@“N, Š›Žu“c• (1ŠO
‰È): Šà‚Ɖ»Šw—Ö@ 2010/5; 37 (5): 841-5.

120020. [ŒŽ’˜] “ûŠà‚É‚š‚¯‚ép‘O‰»Šw—Ö@ŒãƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpß¶ŒŸ‚ÌŒŸ“¢. åÎ‹I•F1, ¬â–ùŒ«1,
—с@‹žŽq1, ‰Á“¡@O1, ‹ß“¡NŽj1, ‰|–{‘ñ–Î1, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È): –k—¢ˆãŠw 2010/6; 40
(1): 7-11.

120021. [ŒŽ’˜] ˆãŒŽ«‰Œ«“®–¬áŽ‚ɑ΂·‚éƒoƒ‹[ƒ“•ÂÇ‰ºŒo”ç“Iƒgƒƒ“ƒrƒ“’“ü—Ö@‚̈Ӌ`. “c‘ºK
•ä1, •œ“cŒõ”Ž1, ŒŠª@”Ž2, ƒEƒbƒhƒnƒ€ƒX—æŽq2, ”ü“‡—˜º1, ‘å‹v•Û”Ž¢1, “n粏¹•F1 (1ŠO‰È, 2
•úŽËü): –k—¢ˆãŠw 2010/6; 40 (1): 13-8.

120022. [ŒŽ’˜] o¶‘Of’f‚³‚ê‚œ—‘‘ƒùN–E‚ɑ΂·‚鎡—Õûj. “c’†@Œ‰1, •“cŒ›Žq1, “n粏¹•F1, ŠC
–ìM–ç2, “V–ì@Š®2, ‹àˆä—Y“ñ2 (1ŠO‰È, 2ŽY•w): “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2010/12; 46 (4):
1208-11.

220004. [€ŒŽ’˜] ƒ`[ƒ€ˆã—Âðl‚Š‚é?MDƒAƒ“ƒ_[ƒ\ƒ“‚ª‚ñƒZƒ“ƒ^[‚ðŒ©Šw‚µ‚Ä?. ™ŽR’ŒŽq1, ‚“‡
~¶, ‹Ž–{_L, ‘å—¢—mˆê, –kŽR‚³‚ä‚è, ²“¡m”ü, Naoto T. Ueno (1ŠO‰È): Šà‚Ɖ»Šw—Ö@ 2010; 37:
753-7.

310005. [Ç—á•ñ] Laparoscopy-Assisted Distal Gastrectomy for Early Gastric Cancer with Complete
Situs. Futawatari N1, Kikuchi S1, Watanabe M1: Inversus: Report of a Case. Surgery Today 2010;
40: 64-7. (“ñ“nM]1, ‹e’rŽj˜Y1, “n粏¹•F1: 1ŠO‰È)

320017. [Ç—á•ñ] ’Ž‚Žîᇂð‹^‚¢• o‹Ÿ‰ºŽèp‚ðŽ{s‚µ‚œ’Ž‚ŒeŽºÇ‚Ì1—á. ŽÄ“c’q—²1, ”Ž­r•F,
‹e’r’š”V, –ìŒû@„ (1ŠO‰È): “ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ïŽGŽ 2010/4; 15 (2): 231-5.

320018. [Ç—á•ñ] •³”A‚É‚Ä”­Ç‚µ‚œ—«‚ÌSóŒ‹’°Šà‚̈ê—á. ×“c@Œj1, “c‘º@Œõ, ¬“‡³•v, ‰J
‹{@“N (1ŠO‰È): ŠO‰ÈŽ¡—à 2010/4; 102 (4): 419-21.

320019. [Ç—á•ñ] Ã–¬d‰»«’°‰Š‚Ì1—á. ’†ŽRLˆê1, ¬“‡ˆêl, ˆ¢‘]˜a“N, –ìèŽ¡d (1ŠO‰È): “ú
–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ 2010/7; 43 (7): 736-40.

320020. [Ç—á•ñ] FDG-PET/CT‚ª—L—p‚Å‚ ‚Á‚œ’Œ’°Šà• –Œ“]ˆÚÇ—á. ¬›žŒc‘Ÿ1, “à“¡³‹K1, ²“¡•
˜Y1, ¬àV•œ‘Ÿ1, ’r“c@“Ä1, ’†‘º—²r1, ¬–ì—¢q1, Œ‹{—mŽj, ˆäŒŽ@Œú, “n粏¹•F1 (1ŠO‰È): _
“ސìˆãŠw‰ïŽGŽ 2010/7; 37 (2): 264.

320021. [Ç—á•ñ] ”÷¬“û“ª\‘¢‚ðŽŠ‚µ‚œ• –ŒŒŽ”­Ÿ÷‰t«“û“ª‘BŠà‚Ì1—á. ”’ÎœAÆ1, “c“‡@O1, ˆÀ
•””üŠ°, Œ@”ªŽk1, ”ª\ì—v•œ1, –{‹@‹§ (1ŠO‰È): “ú–{—Տ°ŠO‰ÈŠw‰ïŽGŽ 2010; 71 (9): 248-52.

320022. [Ç—á•ñ] ˆÝ“]ˆÚ‚Å”­Œ©‚³‚ê’·Šú¶‘¶‚µ‚œis«“ûŠà‚Ì1—á. —с@‹žŽq1, åÎ‹I•F1, ¬â
–ùŒ«1, ‰|–{‘ñ–Î1, Š“cç”ü”T2, ‹ß“¡NŽj, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È, 2•a—): Šà‚Ɖ»Šw—Ö@
2010/11; 37 (12): 2756-9.

512001. [uÀ] Changes of telomere length with aging. Takubo K, Aida J, Izumiyama-Shimomura N,
Ishikawa N, Sawabe M, Kurabayashi R, Shiraishi H1, Arai T, Nakamura K-I: Geriatr Gerontol Int 2010/7;
10 (Supp 1): S197-206. (”’ÎœAÆ1: 1ŠO‰È)

521010. [‰ðà] ‚ª‚ñ‚Ì’áNP«Ž¡—Âɂ‚¢‚ā@2. “ûŠàf—Âɂš‚¯‚é’áNPƒAƒvƒ[ƒ`‚ÌŒ»ó. ‘ •À@
Ÿ (ŠO‰È): _“ސìˆãŠw‰ïŽGŽ 2010/7; 37 (2): 182-6.

521011. [‰ðà/“ÁW]y“àŽ‹‹ŸE“àŽ‹‹ŸŠO‰ÈŽ¡—ÍőOü?’áNPŽ¡—Â̐i•à?z IV. “àŽ‹‹ŸŠO‰ÈŽ¡—Â̐i
•à@1. Á‰»Ší—̈æ@2) ‰º•”Á‰»ŠÇ?• o‹Ÿ‰º‘å’°Øœp‚̐i•à?. ²“¡•˜Y1, “à“¡³‹K1, ’r“c@“Ä
1, ¬‘q’Œl1, “n粏¹•F1 (1ŠO‰È): “ú–{—Õଠ2010/7; 68 (7): 1334-8.

521012. [‰ðà]y‚í‚©‚è‚â‚·‚¢ƒL[ƒ[ƒh‰ðàzp‘O‰»Šw•úŽËü—Ö@. ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È):
ƒRƒ“ƒZƒ“ƒTƒXŠàŽ¡—à 2010/8; 9 (3): 166-7.

521013. [‰ðà]y‚í‚©‚è‚â‚·‚¢ƒL[ƒ[ƒh‰ðàzƒ}ƒCƒNƒRNA. ¬â–ùŒ«1, “n粏¹•F1 (1ŠO‰È): ƒRƒ“
ƒZƒ“ƒTƒXŠàŽ¡—à 2010/8; 9 (3): 168.

522067. [uÀ]y“ÁW: ‘Šú‘å’°Šà 2010z7. ‘Šú‘å’°Šà‚ÌŽ¡—Á@5) • o‹Ÿ‰ºØœp. ¬–ì—¢q1, ’†
‘º—²r1, “à“¡³‹K1, ’r“c@“Ä1, ¬àV•œ‘Ÿ1, ²“¡•˜Y1, ˆäŒŽ@Œú, “n粏¹•F1 (1ŠO‰È): ˆÝ‚Æ’° 2010/4;
45 (5): 915-21.

522068. [uÀ]y“ÁW: ŠO‰È“–’Œˆã•KŒgzII. •a““–’Œˆã•KŒg@1. pŒã‡•¹Ç‚Ƒ΍ô@12 ‘å’°ŠàŽèp@(5)
• ‰ï‰AŽ®’Œ’°Ø’fp. ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): Á‰»ŠíŠO‰È 2010/4; 33 (5): 821-2.

522069. [uÀ]y“ÁW: Žèp‹@Ší‚ÌŽg‚¢•û?Šî–{‚Ɖž—p?zII. ‹ŸŽ‹‰ºŽèp—p‹@Ší@3. ƒgƒƒJ[ƒ‹. ŽO
d–ì_˜N1, ÷–{Mˆê1, •Ð“c‰Ä–ç1, ŽR‰ºŒpŽj1, ª–{¹”V1, ŽÄ“c’q—²1, “n粏¹•F1 (1ŠO‰È): Žèp
2010/5; 64 (6): 829-32.

522070. [uÀ]y“§Íˆã—Âɂš‚¯‚éƒKƒCƒhƒ‰ƒCƒ“ƒGƒbƒZƒ“ƒXzŠ³ŽÒŠÇ—?ƒoƒXƒLƒ…ƒ‰[ƒAƒNƒZƒX‚Ì‘I‘ð‚Æ
ŠÇ—?. ‹v–Ø“c˜a‹u, ŒÃˆäG“T, “y‹Žœˆê˜Y1, ’Ócˆê˜Y, ”Ñ“cˆê, ŽO‰Y³‹`, –x]@‘ì, ¬–쎛ˆê•F,
â“c”Ž”ü, ‹Ê’u@“§, –ڍ•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO‰È): t‚Æ“§Í 2010/4; 68 (4): 474-8.

522071. [uÀ]y“ÁW: “àŽ‹‹ŸE“àŽ‹‹ŸŠO‰ÈŽ¡—ÍőOü?“àŽ‹‹ŸŠO‰ÈŽ¡—Â̐i•à?zVI. “àŽ‹‹ŸŠO‰ÈŽ¡—Ã
‚̐i•à@1. Á‰»Ší—̈æ@2) ‰º•”Á‰»ŠÇ?• o‹Ÿ‰º‘å’°Øœp‚̐i•à?. ²“¡•˜Y1, “à“¡³‹K1, ’r“c@
“Ä1, ¬‘q’Œl, “n粏¹•F1 (1ŠO‰È): “ú–{—Õଠ2010/7; 68 (7): 1334-8.

522072. [uÀ]yƒVƒ“ƒ|ƒWƒEƒ€: ’·Šú—¯’uƒJƒe[ƒeƒ‹‚Ì“K³Žg—p‚ðl‚Š‚éz“–‰@‚É‚š‚¯‚é’·Šú—¯’uŒ^ƒJƒe
[ƒeƒ‹‚Ì“K‰ž‚ƍ‡•¹Ç‚ÌŒ»‹µ. â“c”Ž”ü, ‹v–Ø“c˜a‹u, ˆÉ“¡@ŒO, ˆ¢•”@”Ž, “y‹Žœˆê˜Y1, ŽO‰Y³‹`, ’Ã
“cˆê˜Y, ”Ñ“cˆê, –x]@‘ì, ¬–쎛ˆê•F, ŒÃˆäG“T, ‹Ê’u@“§, –ڍ•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO
‰È): t‚Æ“§Í 2010/7; 69 (•ÊûƒAƒNƒZƒX2010): 38-40.

522073. [uÀ]y•K“ǁ@‰ŠÇ«ŽŸŠ³Žèpz ˆÝH“¹‹t—¬Ç‚ɑ΂·‚é• o‹Ÿ‰ºŽèp. ŽÄ“c’q—²1, •Ð“c‰Ä–ç
1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, “n粏¹•F1 (1ŠO‰È): Žèp 20107; 64 (8): 1083-8.

522074. [uÀ]y“ÁW: Á‰»ŠÇÄŒš–@?‡•¹Çƒ[ƒ‚ւ̍H•v?zII. ˆÝØœŒãÄŒš–@@12. ˆÝ‘S“EŒãRoux-Y
ÄŒš?ŒoŒûƒAƒ“ƒrƒ‹–@. ÷–{Mˆê1, •Ð“c‰Ä–ç1, ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, ‹e’rŽj˜Y1, “n粏¹•F1 (1
ŠO‰È): Žèp 2010/9; 64 (10): 1461-7.

522075. [uÀ]y“ÁW: ŠO‰Èˆã‚Ì‚œ‚ß‚Ì‘å’°Šà‚̐f’f‚ÆŽ¡—Áz5. ‘å’°Šà‚ÌŠO‰ÈŽ¡—Ák• o‹Ÿ‰ºŽèpl‘å
’°‘S“Ep?’×ᇐ«‘å’°‰Š, ‰Æ‘°«‘å’°‘BŽîÇ. “à“¡³‹K1, ²“¡•˜Y1, ¬àV•œ‘Ÿ1, ’r“c@“Ä1, ¬‘q
’Œl1, ¬–ì—¢q1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): —Տ°ŠO‰È 2010/10; 65 (11): 359-63.

522076. [uÀ]y“ÁW: ƒŠƒ“ƒpßŠsŽ; Å‹ß‚̃Rƒ“ƒZƒvƒgz8 ’Œ’°Šà‚ɑ΂·‚郊ƒ“ƒpßŠsŽ. ¬–ì—¢q
1, ’†‘º—²r1, ‘å–؁@‹Å1, Š™“cOŽ÷1, ¬‘q’Œl1, “à“¡³‹K1, ’r“c@“Ä1, ²“¡•˜Y1, “n粏¹•F1 (1
ŠO‰È): Á‰»ŠíŠO‰È 2010/12; 33 (13): 1995-2001.

522077. [uÀ]y“ÁW: ‹ŸŽ‹‰ºŽèp?p’†ƒgƒ‰ƒuƒ‹‘Ώˆz 8. ’áˆÊ‘O•ûØœp. ’r“c@“Ä1, ²“¡•˜Y
1, ’†‘º—²r1, ¬‘q’Œl1, ¬–ì—¢q1, “à“¡³‹K1, “n粏¹•F1 (1ŠO‰È): ŠO‰È 2011/1; 73 (1): 39-44.

522078. [uÀ]y“ÁW: ‰ŠÇ«’°ŽŸŠ³?Å‹ß‚Ì“®Œü?z‰ŠÇ«’°ŽŸŠ³‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚̃Gƒrƒfƒ“ƒX.
“à“¡³‹K1, “n粏¹•F1 (1ŠO‰È): ŠO‰ÈŽ¡—Ã2011/1; 104 (1): 52-6.

[’˜@‘]

620073. [Šwp‘] (•ª’SŽ·•M)y‘Šú‘å’°Šà2010 (ˆÝ‚Æ’° 45 (5-‘Š§†))z7. ‘Šú‘å’°Šà‚ÌŽ¡—Á@• o
‹Ÿ‰ºØœp, p.915-21. ¬–ì—¢q1, ’†‘º—²r1, “à“¡³‹K1, ’r“c@“Ä1, ¬àV•œ‘Ÿ1, ²“¡•˜Y1, ˆä
ŒŽ@Œú1, “n粏¹•F1 (1ŠO‰È), ˆãŠw‘‰@, “Œ‹ž, 2010/4”­s.

620074. [Šwp‘] (•ª’SŽ·•M)yDS NOW 9@‰º•”Á‰»ŠÇ‚Ì• o‹Ÿ‰ºŽèp?³Šm‚ÈŽèp‚ðs‚€‚œ‚߂̃Rƒc?z
• o‹Ÿ‰ºSóŒ‹’°Øœp‚̏pŽ®, p.56-69. ’†‘º—²r1 (1ŠO‰È), •Ò “n粏¹•F1, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ
‹ž, 2010/7”­s.

620075. [Šwp‘] (•ª’SŽ·•M)y¬Ž™‰È—Տ°ƒsƒNƒVƒX21@¬Ž™ŠO—ˆ‚Ŗ𗧂ŠO‰È“Iˆ’uz3Í ’m‚Á‚Ä‚š‚«
‚œ‚¢‹~‹}ŽŸŠ³‚Əˆ’u@‹¹•”ŠO, p.198-9. “c’†@Œ‰ (ŠO‰È), ê–å•ÒW —¢Œ©@º, ’†ŽR‘“X, “Œ‹ž,
2010/10”­s.

620076. [Šwp‘] (•ª’SŽ·•M)yŠO‰Èˆã‚Ì‚œ‚ß‚Ì‘å’°Šà‚̐f’f‚ÆŽ¡—à (—Տ°ŠO‰È 65 (11-‘Š§†))z5. ‘å
’°Šà‚ÌŠO‰ÈŽ¡—Á@[• o‹Ÿ‰ºŽèp]@‘å’°‘S“Ep?’×ᇐ«‘å’°‰Š, ‰Æ‘°«‘å’°‘BŽîÇ, p.359-63. “à“¡³‹K
1, ²“¡•˜Y1, ¬àV•œ‘Ÿ1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È), ˆã
Šw‘‰@, “Œ‹ž, 2010/10”­s.

620077. [Šwp‘] (•ª’SŽ·•M)y‘æ43‰ñ“ú–{—Տ°tˆÚAŠw‰ï‹L˜^W: tˆÚAÇ—áW2010z–kŠC“¹‚É‚š‚¯
‚錣tˆÚA‚̐¬Ñ‚Æ“EoŽž‚Ì–â‘è“_, p.224-6. ”Ñ“cˆê, ŒŽ“c@_, X“c@Œ€, Ž­–ì@P, “y‹Žœˆê˜Y
1, ŽO‰Y³‹`, ‹Ê’u@“§ (1ŠO‰È), •Ò ‚‹ŽŒö‘Ÿ, –xŒ©’‰Ži, ŠÄC “ú–{—Տ°tˆÚAŠw‰ï, “ú–{ˆãŠwŠÙ, “Œ
‹ž, 2010/10”­s.

620078. [Šwp‘] (•ª’SŽ·•M)y•Êû V—̈æ•ÊÇŒóŒQƒVƒŠ[ƒY: ŠÌE’_“¹ŒnÇŒóŒQ (‘æ2”Å) III@ŠÌŠO
’_“¹•Ò?‚»‚Ì‘Œ‚̊́E’_“¹ŒnŽŸŠ³‚ðŠÜ‚ß‚Ä?zII. ’_ùN@2. Žîá‡, —³‹K§•a•Ï@1) Žîᇃ}[ƒJ[ŽY¶’_
ùNŠà (CEAEAFPECA19-9Esialy1), p.246-8. ŒÃ“cˆê“¿1, •Ð‹ËŠ°”V1, ÎˆäŒ’ˆê˜Y1, ‚‹Ž’õl1 (1ŠO
‰È), “ú–{—Õ଎Ð, ‘åã, 2011/2”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712041. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Present Status of Laparoscopic Surgery for Rectal
Cancer in Japan. Watanabe M1: Digestive Disease Week 2010 (2010/5/1-5), USA. (“n粏¹•F1: 1ŠO
‰È)

712042. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Standard procedure of Sigmoidetomy. Watanabe
M1: ASIA-IRCAD TAIWAN: Advanced Course in Colorectal Surgery (2010/9/10), Taiwan. (“n粏¹•F1: 1
ŠO‰È)

712043. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Surgical anatomy and technique of Laparoscopic
TME. Watanabe M1: ASIA-IRCAD TAIWAN: Advanced Course in Colorectal Surgery (2010/9/11), Taiwan.
(“n粏¹•F1: 1ŠO‰È)

713072. [Šw‰ï(‘Û)] (ƒ|ƒXƒ^[) Homeobox gene HOPX is epigenetically silenced cancer-specifically
in colorectal cancer and predicts poor prognosis in stage III colorectal cancer. Katoh H1,
Yamashita K1, Ooki A1, Waraya M2, Watanabe M1: American Association for Cancer Research 101st Annual
Meeting (2010/4/17-21), Washington DC, USA. (‰Á“¡@O1, ŽR‰ºŒpŽj1, ‘å–؁@‹Å1, ˜m’J”ü“Þ2, “n
粏¹•F1: 1ŠO‰È, 2ˆã—ÃŒnŒ€‹†‰È)

713073. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The efficacy of pull-through method for biliary
interventions. Bekku E1, Aramaki T: 9th Asian-Pacific Congress of Cardio-vascular Interventional
Radiology (2010/6/1-4), Seoul. (•Ê‹{ŠG”ü^1: 1ŠO‰È)

713074. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Transhiatal migration of the stomach following laparoscopic
Heller myotomy and Dor fundoplication for achalasia. Shibata T1,õKatada N1, Nemoto M1,õMieno
H1,õYamashita K1,õSakuramoto S1,õKikuchi S1, Watanebe M1: 12th World Congress of the
International Society for Disease of the Esophagus (2010/9/2-5), Kagoshima. (ŽÄ“c’q—²1, •Ð“c‰Ä
–ç1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1: 1ŠO‰È)

713075. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Protective roles of calcitonin gene-related peptide
in experimentally DSS-induced colitis. Takeda-kawashima N1, Tanaka K1, Watanabe M1, Majima M2:
XXIII International Symposium on Paediatric Surgical Research (2010/9/13), Tokyo. (•“cŒ›Žq1, “c
’†@Œ‰1, “n粏¹•F1, ”n“ˆ³—²2: 1ŠO‰È, 2–ò—)

713076. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A Case of Perforation of the Sigmoid Colon due to an
Incarcerated Inguinal Hernia with Acute Coronary Syndrome: A Multi-disciplinary Approach during
the Perioperative period. Yamaguchi R1, Fujita T, Sakamoto T: ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwp
W‰ï (‘æ4‰ñ“úŠØ‡“¯ƒZƒbƒVƒ‡ƒ“) (2010/10/9-11), “Œ‹ž. (ŽRŒû‚é‚ÂŽq1: 1ŠO‰È)

713077. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Protective roles of calcitonin gene-related peptide in
experimentally DSS-induced colitis. Takeda-kawashima N1, Tanaka K1, Watanabe M1, Majima M2: 3rd
World Congress of Pediatric Surgery (2010/10/21), New Delhi, India. (•“cŒ›Žq1, “c’†@Œ‰1, “n
粏¹•F1, ”n“ˆ³—²2: 1ŠO‰È, 2–ò—)

713078. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Sentinel lymph node biopsy for breast cancer patients
after primary systemic therapy. Kosaka Y1, Sengoku N1, Hayashi K1, Katoh H1, Kondo Y1, Enomoto
T1, Kuranami M1, Watanabe M1: The 7th International Sentinel Node Society Meeting (2010/11/20),
Yokohama. (¬â–ùŒ«1, åÎ‹I•F1, —с@‹žŽq1, ‰Á“¡@O1, ‹ß“¡NŽj1, ‰|–{‘ñ–Î1, ‘ •À@Ÿ1, “n
粏¹•F1: 1ŠO‰È)

713079. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) Mesenteric panniculitis after colon surgery four cases report
and a review of the literture in Japan. Naito M1, Sato T1, Ikeda A1, Ogura N1, Onozato W1, Kojyo
K1, Nakamura T1, Watanabe M1: 12th China-Japan-Korea Colorectal Symposium (2010/12/4-5), Shanghai,
China. (“à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ŒÃé@Œ›1, ’†‘ºr—²1, “n粏¹
•F1: 1ŠO‰È)

721003. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) • o‹Ÿ‰º‘å’°Øœp‚É‚š‚¯‚éƒtƒŒƒLƒVƒuƒ‹ƒXƒR[ƒv‚Ì—L—p«?ˆÀ‘S
‚È”—£EŽö“®‚ÆŠsŽ?. “n粏¹•F (ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/19), ‰¡•l.

721004. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ACTS-GCŽŽŒ±‚Ì5”NŽž‚̃tƒHƒ[ƒAƒbƒvƒf[ƒ^. ÷–{Mˆê (ŠO‰È):
‘æ83‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2011/3/4), ŽO‘ò.

722076. [Šw‰ï (‘S‘)] (ƒrƒfƒIƒVƒ“ƒ|ƒWƒEƒ€)y1.1. ˆÀ‘S‚È‹ŸŽ‹‰ºŽèp‚ðs‚€‚œ‚߂̉äX‚̍H•v: H“¹E
ˆÝŽèpzVD1.1-2 ˆÀ‘S‚ÅŠmŽÀ‚È• o‹Ÿ‰ºH“¹ƒAƒJƒ‰ƒVƒAŽèp‚ð–ÚŽw‚µ‚Ä. ŽÄ“c’q—²1, •Ð“c‰Ä–ç1, ª–{
¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ35‰ñ“ú–{ŠO‰ÈŒn˜A
‡Šw‰ïŠwpW‰ï (2010/6/17), ‰YˆÀ, “ú–{ŠO‰ÈŒn˜A‡‰ïŽGŽ 2010; 35: 363.

722077. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) o¶‘Of’f‚³‚ê‚œ—‘‘ƒùN–E‚ɑ΂·‚鎡—Õûj. “c
’†@Œ‰1, •“cŒ›Žq1, “n粏¹•F1, ŠC–ìM–ç2, “V–ì@Š®2, ‹àˆä—Y“ñ2 (1ŠO‰È, 2ŽY•w): ‘æ48‰ñ“ú–{
ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŠwpW‰ï (2010/7/11), _ŒË.

722078. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Žîᇐ苒•”ˆÊ, ’_ùNŠOi“WˆöŽq‚š‚æ‚эĔ­Œ`Ž®‚©
‚ç‚Ý‚œSS’_ùNŠà‚ɑ΂·‚鎡—Õûj. •Ð‹ËŠ°”V1, ’†‘º˜a“¿, ‰Í–”@Š°, ˜m’J”ü“Þ1, ÎˆäŒ’ˆê˜Y1, ‚‹Ž
’õl1, ŒÃ“cˆê“¿, “n粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2010/7/15), ‰ºŠÖ.

722079. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) pCR‚͏p‘O‰»Šw•úŽËü—Ö@‚Å“Ÿ‚ç‚ê‚é–³Ä”­¶‘¶‚̃TƒƒQ[ƒg
ƒ}[ƒJ[‚É‚È‚é‚©? ²“¡•˜Y1, ¬àV•œ‘Ÿ1, ’r“c@“Ä1, “à“¡³‹K1, ’†‘ºr—²1, ¬–ì—¢q1, “›ˆä“Ö
Žq1, ŽO‰YŒ[Žõ1, Œ‹{—mŽj, ˆäŒŽ@Œú, “n粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï
(2010/7/14-16), ‰ºŠÖ.

722080. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) SŽŸŠ³‚š‚æ‚ьċzŠíŽŸŠ³‡•¹Ç—á‚ɑ΂·‚é• o‹Ÿ‰º
‘å’°Øœp‚̑Ó–«. ¬–ì—¢q1, ’†‘ºr—²1, “à“¡³‹K1, ’r“c@“Ä1, ¬àV•œ‘Ÿ1, ²“¡•˜Y1, ˆäŒŽ@
Œú, “n粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2010/7/14-16), ‰ºŠÖ.

722081. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) • o‹Ÿ‰ºˆÝ‘S“E‚š‚æ‚Ñ•¬–å‘€Øœ‚É‚š‚¯‚é•«‡‚Ì
H•v. •Ð“c‰Ä–ç1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ŽÄ“c’q—²1, ª–{¹”V1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO
‰È): ‘æ65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2010/7/14-16), ‰ºŠÖ.

722082. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) • o‹Ÿ‰º’Œ’°ŠàŽèp‚ÌŽèpŽè‹Z‚Ì’èŒ^‰»‚ð–ÚŽw‚µ‚Ä.
’†‘ºr—²1, ¬–ì—¢q1, “à“¡³‹K1, ’r“c@“Ä1, ²“¡•˜Y1, ¬àV•œ‘Ÿ1, ˆäŒŽ@Œú1, “n粏¹•F1 (1
ŠO‰È): ‘æ65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2010/7/14-16), ‰ºŠÖ.

722083. [Šw‰ï(‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) COX-2‚š‚æ‚уvƒƒXƒ^ƒOƒ‰ƒ“ƒfƒBƒ“EP3/EP4ƒVƒOƒiƒ‹‚Í
CXCL12/CXCR4ƒPƒ‚ƒJƒCƒ“ƒVƒXƒeƒ€‚ð‰î‚µ‚ÄŽîᇔ÷¬ŠÂ‹«‚𐧌䂷‚é. ‰Á“¡@O1, —é–Ø—§‹I2, ×–ì‰Á“Þ
Žq2, ¬ì‹±Žj1, ‹v•Û”CŽj1, Š™“cOŽ÷1, “n粏¹•F1, ”n“ˆ³—²2 (1ŠO‰È, 2–ò—): ‘æ31‰ñ“ú–{‰ŠÇE
Ä¶ˆãŠw‰ï (2010/8/5-6), “Œ‹ž.

722084. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) • o‹Ÿ‰ºƒAƒJƒ‰ƒVƒAŽèp‚É‚š‚¯‚é”S–Œ‘¹: ”­¶
‚̃ƒJƒjƒYƒ€‚ƑΏˆ–@. •Ð“c‰Ä–ç1, ŽÄ“c’q—²1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e
’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ64‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2010/8/31), ‹v—¯•Ä.

722085. [Šw‰ï(‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) Homeobox only protein X (HOPX) is epigenetically and
cancer-specifically silenced tumor suppressor gene candidates in colorectal cancer (CRC). Katoh
H1, Yamashita K1, Ooki A1, Waraya M2, Watanabe M1: ‘æ69‰ñ“ú–{ŠàŠw‰ïŠwp‘‰ï (2010/9/22-24), ‘å
ã. (‰Á“¡@O1, ŽR‰ºŒpŽj1, ‘å–؁@‹Å1, ˜m’J”ü“Þ2, “n粏¹•F1: 1ŠO‰È, 2ˆã—ÃŒnŒ€‹†‰È)

722086. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ‘å’°Šà. “n粏¹•F (ŠO‰È): ‘æ80‰ñ“ú–{Á‰»Ší“àŽ‹‹ŸŠw‰ï‘‰ï
(2010/10/13-16), ‰¡•l.

722087. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv4)yH“¹—ǐ«ŽŸŠ³Žèp‚̃Rƒc‚Æ’·Šú¬Ñz• o‹Ÿ‰ºH“¹ƒAƒJƒ‰
ƒVƒAŽèpŒã‚Ì’·Šú¬Ñ. ŽÄ“c’q—²1, •Ð“c‰Ä–ç1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e
’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/19), ‰¡•l.

722088. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv4)yH“¹—ǐ«ŽŸŠ³Žèp‚̃Rƒc‚Æ’·Šú¬ÑzGERD‚ɑ΂·‚é• o‹Ÿ
‰ºŽèp?H“¯“¹‹@”\•]‰¿‚©‚ç‚Ý‚œNissen–@, Toupet–@‚Ì“Á«‚ÆŽèp‚̃Rƒc3?. •Ð“c‰Ä–ç1, ‹e’rŽj˜Y
1, ‘Œ (1ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/19), ‰¡•l.

722089. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€8)yÀ’·z• o‹Ÿ‰º‘å’°ŠàŽèp‚ɑ΂·‚éÅV‚̍H•v. “n粏¹•F
(ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/20), ‰¡•l.

722090. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) • o‹Ÿ‰º‘å’°ŠàŽèp‚ɑ΂·‚éÅV‚̍H•v?ä`ÄŒ`
¬p‚ðŽ{‚µ‚œä`¬ØŠJ‚É‚æ‚é• o‹Ÿ‰º‘å’°Øœp‚ÌŒŸ“¢?. “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q
’Œl1, ¬–ì—¢q1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/18-20),
‰¡•l.

722091. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ä`ÄŒ`¬p‚ðŽ{‚µ‚œä`¬ØŠJ‚É‚æ‚é• o‹Ÿ‰º‘å’°Øœp‚ÌŒŸ“¢.
“à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ’†‘º—²r1, “n粏¹•F1 (1ŠO‰È): ‘æ23
‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/18-20), ‰¡•l.

722092. [Šw‰ï (‘S‘)] (‹³ˆçƒVƒ“ƒ|ƒWƒEƒ€1) ‚—îŽÒ‚ÌŠàŽèp. “n粏¹•F (ŠO‰È): ‘æ48‰ñ“ú–{ŠàŽ¡—Ã
Šw‰ïŠwpW‰ï (2010/10/29), ‹ž“s.

722093. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y‰º•”’Œ’°‚ª‚ñŽèpzp‘O‰»Šw•úŽËü—Ö@‚Æãè–å‹@”\: p‘O‰»
Šw•úŽËü—Ö@‚ŋǏŠEœ”Õ“àÄ”­‚Í0%‚É‚Å‚«‚é‚©? ²“¡•˜Y1, “à“¡³‹K1, ’r“c@“Ä1, ¬‘q’Œl1, ¬
–ì—¢q1, ‘å–؁@‹Å1, ’†‘º—²r1, ˆäŒŽ@Œú, “n粏¹•F1 (1ŠO‰È): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï
(2010/10/28-30), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2010; 45 (1): 162.

722094. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y‰ŠÇ«’°ŽŸŠ³‚ɑ΂·‚éQOL‚ÌŒüã‚©‚ç‚Ý‚œŽ¡—Ö@‚Ì
‘I‘ðz’×ᇐ«‘å’°‰Š‚ɑ΂·‚é• o‹Ÿ‰º‘å’°‘S“Ep‚Ì“K‰ž‚Ɖۑè. ¬àV•œ‘Ÿ1, ’r“c@“Ä1, “à“¡³‹K1, ²
“¡•˜Y1, ¬‘q’Œl1, ¬–ì—¢q1, ’†‘º—²r1, ˆäŒŽ@Œú, “n粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{‘å’°ãè–å
•aŠw‰ïŠwpW‰ï (2010/11/26-27), •lŒ, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2010/9; 63 (9): 581.

722095. [Šw‰ï (‘S‘)] (ƒNƒŠƒjƒJƒ‹ƒJƒ“ƒtƒ@ƒŒƒ“ƒX) ŠO‰È•Ò: ‹ÇŠis’Œ’°Šà. ²“¡•˜Y1, “n粏¹•F
1 (1ŠO‰È): ‘æ65‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2010/11/26-27), •lŒ.

722096. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŒŒŠÇ“àƒJƒe[ƒeƒ‹ŠÖ˜AŠŽõ‚ÉŠÖ‚í‚éV‚œ‚ÈŽæ‚è‘g‚݂Ɖۑèz–„
‚ߍž‚ÝŒ^CVƒ|[ƒg‚Ì“K‰ž‚ÆŠÇ—. ‘ •À@Ÿ1, åÎ‹I•F1, —с@‹žŽq1, ¬â–ùŒ«1, ¬–ì—¢q1, ’†‘º
—²r1, “n粏¹•F1, ²“¡‹vŽq, ”ԏ ÍŽq, ‚é—R”üŽq, rˆä—L”ü (1ŠO‰È): ‘æ26‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘
‰ï (2011/2/19), ‰¡•l.

723260. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “àƒVƒƒƒ“ƒg’ɂɑ΂·‚éŠO‰È“IŽ¡—Ö@. ‹v–Ø“c˜a‹u, ŒÃˆäG“T, “y‹Ž
œˆê˜Y1, ’Ócˆê˜Y, ”Ñ“cˆê, –x]@‘ì, ¬–쎛ˆê•F, â“c”Ž”ü, ‹Ê’u@“§, –ڍ•‡ˆê, •ÄìŒ³Ž÷, ì
‘º–Ÿ•v (1ŠO‰È): ‘æ26‰ñ“ú–{ˆãHŠwŽ¡—Êw‰ïŠwp‘å‰ï (2010/4/2-4), “Œ‹ž, ˆãHŠwŽ¡—à 2010. 07; 22
(2): 127.

723261. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹·ó”•Ê‚É‚æ‚éƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“‚ÌŽ¡—ЬÑ. ’Ócˆê˜Y, ‹v–Ø“c
˜a‹u, “y‹Žœˆê˜Y1, ”Ñ“cˆê, –x]@‘ì, â“c”Ž”ü, ŒÃˆäG“T, ¬–쎛ˆê•F, ‹Ê’u@“§, –ڍ•‡ˆê, •Ä
ìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO‰È): ‘æ26‰ñ“ú–{ˆãHŠwŽ¡—Êw‰ïŠwp‘å‰ï (2010/4/2-4), “Œ‹ž, ˆãHŠwŽ¡—à 2010.
07; 22 (2): 133.

723262. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) cStage II/IIIH“¹Šà‚ɑ΂·‚ép‘O•â•—Ö@‚Æ‚µ‚Ä‚Ì
JCOG9907ƒŒƒWƒƒ“‚Ì•]‰¿. ª–{¹”V1, •Ð“c‰Ä–ç1, ŽÄ“c’q—²1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê
1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8), –ŒŒÃ‰®.

723263. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Stage IV‚ɑ΂·‚éDocetaxel + CDDP + S-1 (DCS) —Ö@
Œã‚Ìadjuvant surgery. ŽOd–ì_˜N1, ÷–{Mˆê1, ŽÄ“c’q—²1, ª–{¹”V1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, ‹e
’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8), –ŒŒÃ‰®.

723264. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒJƒ‹ƒVƒgƒjƒ“ˆâ“`ŽqŠÖ˜Aƒyƒvƒ`ƒh (CGRP) ‚É‚æ‚éƒfƒLƒXƒgƒ‰ƒ“—°Ž_
ƒiƒgƒŠƒEƒ€ (DSS) —U”­’°‰Š‚ւ̉ŠÇ—}§Œø‰Ê?‘æ2•ñ?. •“cŒ›Žq1, “c’†@Œ‰1, “n粏¹•F1, ”n“ˆ³
—²2 (1ŠO‰È, 2–ò—): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8), –ŒŒÃ‰®.

723265. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) bó‘BŽèp‚É‚š‚¯‚éHarmonic FOCUS‚Ì—L—p«. ‰|–{‘ñ–Î1, —с@‹ž
Žq1, åÎ‹I•F1, ¬â–ùŒ«1, ™ŽR’ŒŽq1, ‹ß“¡NŽj1, ‘å‹v•Û”Ž¢, M‘ŸºŽq1, ŒàVL‹±1, •ŸŒ‘ô^,
“ï”gF“¿, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8), –ŒŒÃ‰®, “ú
–{ŠO‰ÈŠw‰ïŽGŽ 2010; 111 (—Õ‘2): 282.

723266. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘OŒŒŽCA19-9’l‰A«—áäXŠÇŠà‚É‚š‚¢‚ďp‘OŒŒŽ
DU-PAN-2/SPan-1‚͕⏕“I—\ŒãˆöŽq‚É‚È‚é. ˜m’J”ü“Þ1, ŽR‰ºŒpŽj1, –k‘º^Ž÷, •Ð‹ËŠ°”V1, ÎˆäŒ’ˆê
˜Y1, ‚‹Ž’õl1, ŒÃ“cˆê“¿, “n粏¹•F1 (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8), –Œ
ŒÃ‰®.

723267. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V‚µ‚¢ƒfƒoƒCƒXgHarmonic FOCUSh‚ð—p‚¢‚œ“ûŠà’áNPŽèp. —с@‹ž
Žq1, ¬â–ùŒ«1, åÎ‹I•F1, •ŸŒ‘ô^, ŒàVL‹±1, ‘å‹v•Û”Ž¢, ™ŽR’ŒŽq1, ‹ß“¡NŽj1, ‰|–{‘ñ–Î
1, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È) : ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8), –ŒŒÃ‰®, “ú–{ŠO
‰ÈŠw‰ïŽGŽ 2010; 111 (—Õ‘2): 281.

723268. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ŠúˆÝŠà‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚̈ʒu‚¯. ÷–{Mˆê
1, •Ð“c‰Ä–ç1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ª–{¹”V1, ŽÄ“c’q—²1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ
110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8), –ŒŒÃ‰®.

723269. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’_“¹E\“ñŽw’°“û“ª•”ˆ««Žîᇂɑ΂·‚éŽèp¬Ñ‚Æ—\Œã
•s—LjöŽq. ‰Í–”@Š°, ŽR‰ºŒpŽj1, –k‘º^Ž÷, ˜m’J”ü“Þ1, •Ð‹ËŠ°”V, ÎˆäŒ’ˆê˜Y1, ‚‹Ž’õl1, ŒÃ“c
ˆê“¿, “n粏¹•F1 (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8), –ŒŒÃ‰®.

723270. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Epigenics‚ÆGlycomics‚ð—p‚¢‚œ•ªŽq¶•šŠw‚ÌŠO‰ÈŒŸ‘Ì
‚ւ̉ž—p. ŽR‰ºŒpŽj1, ‘å–؁@‹Å1, ‰Á“¡@O1, ˜m’J”ü“Þ1, •Ð“c‰Ä–ç1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n
粏¹•F1 (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/9), –ŒŒÃ‰®.

723271. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹ƒAƒJƒ‰ƒVƒA‚ɑ΂·‚é“àŽ‹‹Ÿ‰ºŽèp‚Í•W€“IŽ¡—ÂƂÈ
‚è‚€‚é‚©? •Ð“c‰Ä–ç1, ŽÄ“c’q—²1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n
粏¹•F1 (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/9), –ŒŒÃ‰®.

723272. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒXƒeƒŒƒIƒKƒCƒh‰º‹zˆøj¶ŒŸ‚ðs‚Á‚œƒJƒeƒSƒŠ[3ÎŠD‰»Ç—á‚ÌMRI
‰æ‘œ‚É‚æ‚錟“¢. åÎ‹I•F1, ™ŽR’ŒŽq1, ¬â–ùŒ«1, —с@‹žŽq1, ‰|–{‘ñ–Î1, ‘ •À@Ÿ1, ”Œ“cŠì”ü
–ç2, ƒEƒbƒhƒnƒ€ƒX—æŽq3, “n粏¹•F1 (1ŠO‰È, 2‘—§‘Š–ÍŒŽ•a‰@ŠO‰È, 3•úŽËü (‰æ‘œ)): ‘æ110‰ñ“ú
–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8-10), –ŒŒÃ‰®, “ú–{ŠO‰ÈŠw‰ïŽGŽ 2010/3; 111 (2, —ÕŽž‘nŠ§†): 579.

723273. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘Sg‡•¹Ç (American Society of Anesthesiologists (ASA) •ª—Þ
Class 3ˆÈã) ‚ð—L‚·‚éÇ—á‚ɑ΂·‚é• o‹Ÿ‰º‘å’°Øœp‚ÌŒŸ“¢. ¬–ì—¢q1, ’†‘º—²r1, “à“¡³‹K1,
’r“c@“Ä1, ¬àV•œ‘Ÿ1, ²“¡•˜Y1, ˆäŒŽ@Œú1, “n粏¹•F1 (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwp
W‰ï (2010/4/8-10), –ŒŒÃ‰®, “ú–{ŠO‰ÈŠw‰ïŽGŽ 2010/3; 111 (—Õ‘2): 608.

723274. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) • o‹Ÿ‰ºƒAƒJƒ‰ƒVƒApŒã‚Ì’·Šú¬Ñ. ŽÄ“c’q—²1, •Ð“c‰Ä–ç1, ª
–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰È
Šw‰ï’èŠúŠwpW‰ï (2010/4/8-10), –ŒŒÃ‰®, “ú–{ŠO‰ÈŠw‰ïŽ 2010; 111 (—Õ‘2): 585.

723275. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠO‰È‚Ì‘²‘OE‘²Œã‹³ˆç‚Ì–â‘è“_‚Æ‚»‚̑΍ô. ˆäŒŽ@Œú, ¬–ì—¢q
1, ’†‘º—²r1, ¬â–ùŒ«1, ’r“c@“Ä1, “à“¡³‹K1, ¬àV•œ‘Ÿ1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ
110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8-10), –ŒŒÃ‰®, “ú–{ŠO‰ÈŠw‰ïŽGŽ 2010/3; 111 (—Õ‘2): 642.

723276. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Øœ•s”\EÄ”­‘å’°Šà‚ɑ΂·‚鉻Šw—Ö@‚Ì–â‘è“_. ²“¡•˜Y1, ¬
àV•œ‘Ÿ1, ’r“c@“Ä1, “à“¡³‹K1, ’†‘ºr—²1, ¬–ì—¢q1, “›ˆä“ÖŽq1, ŽO‰YŒ[Žõ1, Œ‹{—mŽj, ˆäŒŽ@Œú
1, “n粏¹•F1 (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8-10), –ŒŒÃ‰®, “ú–{ŠO‰ÈŠw‰ïŽ
2010; 111 (—Õ‘2): 330.

723277. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ’×ᇐ«‘å’°‰Š‚̏pŒã‚É”­¶‚µ‚œstomal volvulus‚ÌŒŸ“¢. ’r“c@“Ä
1, ¬àV•œ‘Ÿ1, “à“¡³‹K1, ²“¡•˜Y1, ¬–ì—¢q1, ’†‘º—²r1, ˆäŒŽ@Œú1, “n粏¹•F1 (1ŠO‰È): ‘æ
110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8-10), –ŒŒÃ‰®, “ú–{ŠO‰ÈŠw‰ïŽGŽ 2010/3; 111 (—Õ‘2): 426.

723278. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‚É‚š‚¯‚é‘å’°Šà• –Œ“]ˆÚ‚ɑ΂·‚鎡—ÃŽwj‚ÌŒŸ“¢. “à“¡³‹K
1, ²“¡•˜Y1, ¬àV•œ‘Ÿ1, ’r“c@“Ä1, ’†‘º—²r1, ¬–ì—¢q1, ˆäŒŽ@Œú1, “n粏¹•F1 (1ŠO‰È): ‘æ
110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8-10), –ŒŒÃ‰®, “ú–{ŠO‰ÈŠw‰ïŽGŽ 2010/3; 111 (—Õ‘2): 500.

723279. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ûŠàœ‘‚É‚š‚¯‚émicroRNA 34a/p53”­Œ»‚̗Տ°“IˆÓ‹`‚ɂ‚¢‚Ä. ¬
â–ùŒ«1, ‰¡–x••F, ŽOXŒ÷Žm, H‹gŽ•S‡, ‘ •À@Ÿ1, “n粏¹•F1, X@³Ž÷ (1ŠO‰È) : ‘æ110‰ñ“ú
–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8-10), –ŒŒÃ‰®, “ú–{ŠO‰ÈŠw‰ïŽGŽ 2010; 111 (—Õ‘2): 225.

723280. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠÌ‹•ŒŒÄŸó—¬áŠQ‚É‚š‚¯‚éToll-like receptor 4 (TLR4) ƒVƒOƒiƒ‹
“`’BŒo˜H‚ÆHeme Oxygenase (HO)-1‚Ì–ðŠ„. “y‹Žœˆê˜Y1, ‹Ê’u@“§, ’Ócˆê˜Y, ”Ñ“cˆê, â“c”Ž”ü, –x
]@‘ì, ŒÃˆäG“T, ¬–쎛ˆê•F, ‹v–Ø“c˜a‹u, –ڍ•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ•v, Yuan Zhai,
Kupiec-Weglinski Jerzy W (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8-10), –ŒŒÃ‰®, “ú
–{ŠO‰ÈŠw‰ïŽGŽ 2010/3; 111 (—Õ‘2): 200.

723281. [Šw‰ï(‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[)isEÄ”­‘å’°Šà‚ɑ΂·‚éƒxƒoƒVƒYƒ}ƒu•¹—p‰»Šw—Ö@‚ÌŽ¡
—ЬÑ. ŠC’ËMŽj1, “c“‡@O1, ˆÀ•””üŠ°, ”’ÎœAÆ1, “ñ“nM]1, ‹ß“¡NŽj1, _’J‹I‹P, ’r‰i@œ,
Œ@”ªŽk, ”ª\ì—v•œ, –ì–{ˆŸ‹IŽq (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8-10), –ŒŒÃ
‰®, “ú–{ŠO‰ÈŠw‰ïŽGŽ 2010/3; 111 (—Õ‘2): 331.

723282. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “§ÍŠ³ŽÒ‚Ì‹•ŒŒ«’°ŽŸŠ³ (Abdominal Angina, ‰óŽ€Œ^‹•ŒŒ«’°‰Š, ã
’°ŠÔ–Œ“®–¬ŒŒðÇ) ‚Ə㒰ŠÔ–Œ“®–¬ÎŠD‰». ¬–쎛ˆê•F, ‹v–Ø“c˜a‹u, “y‹Žœˆê˜Y1, ’Ócˆê˜Y, ”Ñ“c
ˆê, –x]@‘ì, â“c”Ž”ü, ŒÃˆäG“T, ‹Ê’u@“§, –ڍ•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO‰È): ‘æ110‰ñ“ú–{
ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/8-10), –ŒŒÃ‰®, “ú–{ŠO‰ÈŠw‰ïŽGŽ 2010/3; 111 (—Õ‘2): 355.

723283. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) • o‹Ÿ‰ºŒ‹’°ŠàŽèp‚Ì’·Šú—\Œã‚ÌŒŸ“¢. ’†‘º—²r1, ¬–ì—¢q1, “à
“¡³‹K1, ’r“c@“Ä1, ²“¡•˜N1, ¬àV•œ‘Ÿ1, ˆäŒŽ@Œú, “n粏¹•F1 (1ŠO‰È): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï
’èŠúŠwpW‰ï (2010/4/8-10), –ŒŒÃ‰®, “ú–{ŠO‰ÈŠw‰ïŽGŽ 2010/3; 111 (—Õ‘2): 609.

723284. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹‚ª‚ñp‘O‰»Šw—Ö@Œø‰Ê”»’è‚Ì‚œ‚ß‚Ì•ªŽq•a—Šw“IŽè
–@‚̉ž—p. ²“¡’q‘ã, X’JGŒõ1, •Ð“c‰Ä–ç1, “c糁@‘2, ‰ªˆÀ@ŒM3, ‘å•”@œ4 (1ŠO‰È, 2Á‰»Ší
“à, 3•a—, 4ˆã—Éq¶Šw•”): ‘æ99‰ñ“ú–{•a—Šw‰ï‘‰ï (2010/4/27-29), “Œ‹ž.

723285. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰ÈIPMNŽèpÇ—á‚©‚ç‚Ý‚œ•¶Ž}äXŠÇŒ^IPMN‚ÌŽèp“K‰ž.
ÎˆäŒ’ˆê˜Y1, ˜m’J”ü“Þ,1 ‰Í–”@Š°, •Ð‹ËŠ°”V1, ‚‹Ž’õl1, ŒÃ“cˆê“¿, “n粏¹•F1 (1ŠO‰È): ‘æ22‰ñ
“ú–{ŠÌ’_äXŠO‰ÈŠw‰ïEŠwpW‰ï (2010/5/26), å‘ä.

723286. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÀ‘S‚È• o‹Ÿ‰º’_ùN“Eop‚ðs‚€‚œ‚ß‚Ì‹³ˆçVIDEOì¬
‚ÌŽŽ‚Ý. ‚‹Ž’õl1, ŒÃ“cˆê“¿, ’†‘º˜a“¿, ‰Í–”@Š°, –k‘º@^Ž÷, ˜m’J”ü“Þ1, ×’J@’q, •Ð‹ËŠ°”V1,
ÎˆäŒ’ˆê˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ22‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ïEŠwpW‰ï (2010/5/27), å‘ä.

723287. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºäXØœp‚ÌŽè‹Z‚Ɛ¬Ñ. •Ð‹ËŠ°”V1, ŒÃ“cˆê“¿,
ÎˆäŒ’ˆê˜Y1, ‚‹Ž’õl1, ˜m’J”ü“Þ1, ×’J@’q, ‰Í–”@Š°, ’†‘º˜a“¿, “n粏¹•F1 (1ŠO‰È): ‘æ22‰ñ
“ú–{ŠÌ’_äXŠO‰ÈŠw‰ïEŠwpW‰ï (2010/5/27), å‘ä.

723288. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ºsŒ‹’°ŠàEMR 6”NŒã‚ɐ؏œ‚µ‚œäX“]ˆÚ‚Ì1—á. ‚–ì“N
˜Y, ‚‹Ž’õl1, ’†‘º˜a“¿, ‰Í–”@Š°, –k‘º^Ž÷, ˜m’J”ü“Þ1, ×’J@’q, •Ð‹ËŠ°”V1, ÎˆäŒ’ˆê˜Y1, ŒÃ
“cˆê“¿, “n粏¹•F1 (1ŠO‰È): ‘æ22‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ïEŠwpW‰ï (2010/5/28), å‘ä.

723289. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äXŠÑ’Ê–§’…–D‡–@‚ÌŽè‹Z‚Æ’ZŠú¬Ñ. •Ð‹ËŠ°”V1, ŒÃ“c
ˆê“¿, ÎˆäŒ’ˆê˜Y1, ‚‹Ž’õl1, ˜m’J”ü“Þ1, ×’J@’q, ‰Í–”@Š°, ’†‘º˜a“¿, “n粏¹•F1 (1ŠO‰È): ‘æ
22‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ïEŠwpW‰ï (2010/5/28), å‘ä.

723290. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Single incision laparoscopic surgery‚É‚æ‚é’_ùN“Eop‚Ì“±“ü‚Æ
‰Šú¬Ñ‚ÌŒŸ“¢. â–{—FŒ©Žq1, –Ø‘º@“O, ‹à“cŒå˜Y (1ŠO‰È): ‘æ22‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ïEŠwpW‰ï
(2010/5/26-28), ‹{é, ‘æ22‰ñ“ú–{ŠÌ’_äXŠO‰ÈŠw‰ïEŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010/5; p.344.

723291. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) p‘Of’f‚ª‰Â”\‚Å‚ ‚Á‚œ”ñ”Œ‰ñ‰ºˆô“ª_Œo‚̈ê—á. “c’†r“¹1, ‰|
–{‘ñ–Î1, ‰Á“¡@O1, —с@‹žŽq1, ¬â–ùŒ«1, åÎ‹I•F1, ‘ •À@Ÿ1, ‹ß“¡NŽj1, Š“cç”ü”T2, “n
粏¹•F1 (1ŠO‰È, 2•a—): ‘æ22‰ñ“ú–{“à•ª”åŠO‰ÈŠw‰ï‘‰ï (2010/6/11-12), ‘åã.

723292. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ûŠàœ“]ˆÚ‚ɑ΂·‚éŽðÎŽ_’ïR«Ž_ƒzƒXƒtƒ@ƒ^[ƒ[œŒ^ƒAƒCƒ\ƒUƒC
ƒ€ (TRACP-5b) ‘ª’è‚Ì—L—p«‚ÌŒŸ“¢. •äâ”üŽ÷1, åÎ‹I•F1, ‰Á“¡@O1, ¬â–ùŒ«1, —с@‹žŽq1, ‰|
–{‘ñ–Î1, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È): ‘æ22‰ñ“ú–{“à•ª”åŠO‰ÈŠw‰ï‘‰ï (2010/6/11-12), ‘åã.

723293. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒJƒ‹ƒVƒgƒjƒ“ˆâ“`ŽqŠÖ˜Aƒyƒvƒ`ƒh (CGRP) ‚É‚æ‚éƒfƒLƒXƒgƒ‰ƒ“—°Ž_
ƒiƒgƒŠƒEƒ€ (DSS) —U”­‘å’°‰Š‚ւ̉ŠÇ—}§Œø‰Ê?‘æ3•ñ?. •“cŒ›Žq1, “c’†@Œ‰1, “n粏¹•F1, ”n“ˆ
³—²2 (1ŠO‰È, 2–ò—): ‘æ47‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠwpW‰ï (2010/6/17), –ŒŒÃ‰®.

723294. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÙŽž«‚ɏoŒ»‚µ‚œ‘œ”­«ƒŠƒ“ƒpŠÇŽî‚Ì1—á. ŒàVL‹±
1, “c’†@Œ‰1, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È): ‘æ47‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠwpW‰ï (2010/6/17), –Œ
ŒÃ‰®

723295. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÌ’_“¹ƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚É‚Ä”rŸ•‚ð”F‚ß‚È‚©‚Á‚œ”ñ’_“¹
•ÂœÇ‚ÌŒŸ“¢. “c’†@Œ‰1, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È): ‘æ47‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠwpW‰ï
(2010/6/17), –ŒŒÃ‰®

723296. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’°œÃ–¬ˆ³”—ÇŒóŒQ‚ɑ΂·‚éƒXƒeƒ“ƒg—¯’up‚Ì—L—p«. “c‘ºK•ä
1, •œ“cŒõ”Ž1, ŒŠª@”Ž2,3, “à“c‘׎Š1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, “n粏¹•F1 (1ŠO‰È, 2•úŽËü (‰æ‘œ), 3
‹~–œ): ‘æ30‰ñ“ú–{Ã–¬Šw‰ï‘‰ï (2010/6/17-18), ‹{è, Ã–¬Šw 2010; 21: 219.

723297. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) AVFEAVG•ÂÇ‚ɑ΂·‚éŽèp¬Ñ‚ÌŒŸ“¢. ŒÃˆäG“T, ‹v–Ø“c˜a‹u, ¬
–쎛ˆê•F, ÀàV—ŠG, àV‘º—Sˆê, “y‹Žœˆê˜Y1, ’Ócˆê˜Y, ”Ñ“cˆê, –x]@‘ì, â“c”Ž”ü, ‹Ê’u@“§, –Ú
•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO‰È): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/18-20), _ŒË, “ú
–{“§ÍˆãŠw‰ïŽGŽ 2010/5; 43 (Suppl.1): 372.

723298. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V‹K“§Í“±“üŠ³ŽÒ‚̃oƒXƒLƒ…ƒ‰[EƒAƒNƒZƒX‚Ì•Ï‘J. ”Ñ“cˆê, ‹v
–Ø“c˜a‹u, ˆÀ•””üŠ°, “y‹Žœˆê˜Y1, ŽO‰Y³‹`, ’Ócˆê˜Y, ÀàV—ŠG, àV‘º—Sˆê, â“c”Ž”ü, ŒÃˆäG“T, –x
]@‘ì, ¬–쎛ˆê•F, ‹Ê’u@“§, –ڍ•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO‰È): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwp
W‰ïE‘‰ï (2010/6/18-20), _ŒË, “ú–{“§ÍˆãŠw‰ïŽGŽ 2010/5; 43 (Suppl.1): 372.

723299. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “§ÍŠ³ŽÒ‚̐lHŒÄ‹zŠÇ—‚ÉŠÖ‚·‚錟“¢. ÀàV—ŠG, ’†”öN•v, ‹v–Ø
“c˜a‹u, ”Ñ“cˆê, ’Ócˆê˜Y, “y‹Žœˆê˜Y1, –x]@‘ì, â“c”Ž”ü, ¬–쎛ˆê•F, ŒÃˆäG“T, ‹Ê’u@“§, –Ú
•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO‰È):‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/18-20), _ŒË, “ú
–{“§ÍˆãŠw‰ïŽGŽ 2010/5; 43 (Suppl.1): 482.

723300. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ––œŒŒŠ²×–EˆÚA‚É‚æ‚錌ŠÇÄ¶Ž¡—Ẫ‰ƒ“ƒ_ƒ€‰»”äŠrŽŽŒ±. –x]@
‘ì, “y‹Žœˆê˜Y1, ’Ócˆê˜Y, ”Ñ“cˆê, â“c”Ž”ü, ¬–쎛ˆê•F, ŒÃˆäG“T, ‹Ê’u@“§, ‹v–Ø“c˜a‹u, –Ú
•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO‰È): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/18-20), _ŒË, “ú
–{“§ÍˆãŠw‰ïŽGŽ 2010/5; 43 (Suppl.1): 570.

723301. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ûŠàŽèp‚É‚š‚¯‚éV‚µ‚¢ƒfƒoƒCƒXHarmonic FOCUS‚Ì—L—p«. —с@‹ž
Žq1, ¬â–ùŒ«1, åÎ‹I•F1, ‰|–{‘ñ–Î1, ‹ß“¡NŽj1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, V•”@÷3, Š“cç”ü”T
4, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È, 2•úŽËü (‰æ‘œ), 3•úŽËü (Žîá‡), 4•a—): ‘æ18‰ñ“ú–{“ûŠàŠw‰ï
Šwp‘‰ï (2010/6/24-25), ŽD–y, ‘æ18‰ñ“ú–{“ûŠàŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2010; p.275.

723302. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) WŠw“IŽ¡—ÂÅPCR‚ª“Ÿ‚ç‚ê‚œ“û–[ŒŽ”­G•œã”çŠà‚Ì1—á. ‰Í–ì—uŽq,
åÎ‹I•F1, ‰Á“¡@O1, ¬â–ùŒ«1, —с@‹žŽq1, ‰|–{‘ñ–Î1, Š“cç”ü”T2, ‘ •À@Ÿ1, “n粏¹•F1 (1
ŠO‰È, 2•a—): ‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï (2010/6/24-25), ŽD–y, ‘æ18‰ñ“ú–{“ûŠàŠw‰ï‘‰ïƒvƒƒO
ƒ‰ƒ€Ž˜^W 2010; p.451.

723303. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚é“û–[‰·‘¶pŽž‚̍Čš•û–@‚ÌŒŸ“¢. åÎ‹I•F1, ‰Á“¡@
O1, ¬â–ùŒ«1, ”Ñ’Ë”ü1, —с@‹žŽq1, ‰|–{‘ñ–Î1, ’†ŒF‘žŽm, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È): ‘æ
18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï (2010/6/24-25), ŽD–y, ‘æ18‰ñ“ú–{“ûŠàŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2010;
p.462.

723304. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒAƒiƒXƒgƒƒ][ƒ‹“Š—^Š³ŽÒ‚É‚š‚¯‚鍜–§“x‚̕ω». ™ŽR’ŒŽq1, ¬
â–ùŒ«1, —с@‹žŽq1, åÎ‹I•F1, ‰|–{‘ñ–Î1, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È): ‘æ18‰ñ“ú–{“ûŠàŠw‰ï
Šwp‘‰ï (2010/6/24-25), ŽD–y, ‘æ18‰ñ“ú–{“ûŠàŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2010; p.498.

723305. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) isÄ”­Š³ŽÒ‚Ö‚ÌLapatinib“Š—^‚Ì—LŒø«‚Æ‚»‚̈À‘S«‚ɂ‚¢‚Ä.
¬â–ùŒ«1, ‰Á“¡@O1, ‹ß“¡NŽj1, Š“cç”ü”T2, —с@‹žŽq1, ‰|–{‘ñ–Î1, åÎ‹I•F1, ‘ •À@Ÿ1, “n
粏¹•F1 (1ŠO‰È, 2•a—): ‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ï (2010/6/24-25), ŽD–y, ‘æ18‰ñ“ú–{“ûŠàŠw‰ï
‘‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2010; p.606.

723306. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) f’f‚É“ïa‚µ‚œ“û–[‰·‘¶pŒã‚É”­¶‚µ‚œ•úŽËüŽ¡—Ì㌌ŠÇ“÷Žî‚̈ê
—á. M‘ŸºŽq1, —с@‹žŽq1, ¬â–ùŒ«1, åÎ‹I•F1, ‰|–{‘ñ–Î1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, ‘ì˜ad3, V
•”@Œì3, Š“cç”ü”T4, ŠâŸºŒ[ˆê4, ‹ß“¡NŽj, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È, 2•úŽËü (‰æ‘œ), 3
•úŽËü (Žîá‡), 4•a—): ‘æ18‰ñ“ú–{“ûŠàŠw‰ï‘‰ï (2010/6/24-25), ŽD–y, ‘æ18‰ñ“ú–{“ûŠàŠw‰ï‘‰ïƒv
ƒƒOƒ‰ƒ€Ž˜^W 2010/5; p.650.

723307. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) o¶‘Of’f‚³‚ê‚œ•›tŒŽ”­ùN–E«_Œo‰èŽî‚Ì1—á. ¬–ì
è’q”V1, “c’†@Œ‰1, •“cŒ›Žq1, “n粏¹•F1, ‹àˆä—Y“ñ2 (1ŠO‰È, 2ŽY•w): ‘æ46‰ñ“ú–{ŽüŽYŠúEV¶
Ž™ˆãŠw‰ïŠwpW‰ï (2010/7/11), _ŒË

723308. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚“xisˆÝŠà‚ɑ΂·‚éDocetaxel + CDDP + S-1 (DCS) —Ã
–@Œã‚Ìsalvage surgery. ŽOd–ì_˜N1, ÷–{Mˆê1, ŽÄ“c’q—²1, ª–{¹”V1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1,
‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2010/7/15), ‰ºŠÖ.

723309. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÀ‘SŠmŽÀ‚È‹¹o‹Ÿ‰ºH“¹ŠàŽèp‚ð–ÚŽw‚µ‚Ä. •Ð“c‰Ä–ç
1, ª–{¹”V1, ŽÄ“c’q—²1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ
65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2010/7/16), ‰ºŠÖ.

723310. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰äX‚ÌŠíŠB–D‡Ší‚ðŽg—p‚µ‚œäX‘Ì”ö•”Øœ–@. ‚‹Ž’õl
1, ’†‘º˜a“¿, ‰Í–”@Š°, –k‘º^Ž÷, ˜m’J”ü“Þ1, ×’J@’q, •Ð‹ËŠ°”V, ÎˆäŒ’ˆê˜Y1, ŒÃ“cˆê“¿, “n粏¹
•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2010/7/16), ‰ºŠÖ.

723311. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰ñ’°ˆÙŠ«äX‚̈ê—á. ”’ÎœAÆ1, “c“‡@O1, “ñ“nM]1, ŠC’Ã
‹MŽj1, ‹ß“¡NŽj1, –{‹@‹§, Œ@”ªŽk, ”ª\ì—v•œ (1ŠO‰È): ‘æ65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï
(2010/7/16), ‰ºŠÖ.

723312. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ˆÀ‘S‚È‘å’°‹ŸŽ‹‰ºŽèp‚Ì‚œ‚ß‚Ì‘¢‰eCT‚É‚æ‚錌ŠÇ‘–s‚Ì•]‰¿. ’r
“c@“Ä1, ²“¡•˜Y1, ¬àV•œ‘Ÿ1, “à“¡³‹K1, ¬–ì—¢q1, ’†‘ºr—²1, ˆäŒŽ@Œú, “n粏¹•F1 (1ŠO‰È):
‘æ65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2010/7/14-16), ‰ºŠÖ.

723313. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘å’°ŠàŽèp‚É‚š‚¯‚鎊“K‚ȕ‘nŽè‹Z‚ÌŒŸ“¢. “à“¡³‹K1, ²“¡•˜Y
1, ¬àV•œ‘Ÿ1, ’r“c@“Ä1, ’†‘ºr—²1, ¬–ì—¢q1, ˆäŒŽ@Œú, “n粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{Á‰»
ŠíŠO‰ÈŠw‰ï‘‰ï (2010/7/14-16), ‰ºŠÖ.

723314. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚鏬’°, ‘å’°GIST‚ɑ΂·‚éf’f, Ž¡—Â̑Ó–
«‚ÌŒŸ“¢. “›ˆä“ÖŽq1, ²“¡•˜Y1, ¬àV•œ‘Ÿ1, ’r“c@“Ä1, “à“¡³‹K1, ¬–ì—¢q1, ’†‘º—²r1, ˆä
ŒŽ@Œú, “n粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2010/7/14-16), ‰ºŠÖ.

723315. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”S–Œ‘¹‚ð‚«‚œ‚³‚È‚¢ˆÀ‘S‚È• o‹Ÿ‰ºƒAƒJƒ‰ƒVƒAŽèp. ŽÄ“c’q—²
1, •Ð“c‰Ä–ç1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ
65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2010/7/14-16), ‰ºŠÖ.

723316. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 80ÎˆÈã‚̍‚—îŽÒ‘å’°ŠàÇ—á‚ɑ΂·‚é• o‹Ÿ‰º‘å’°Øœ
p‚Ì—L—p«. ˆäŒŽ@Œú, ¬–ì—¢q1, ’†‘º—²r1, ’r“c@“Ä1, “à“¡³‹K1, ¬àV•œ‘Ÿ1, ²“¡•˜Y1, “n
粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (2010/7/14-16), ‰ºŠÖ.

723317. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚éˆÝŠà‚ɑ΂·‚é• o‹Ÿ‰ºˆÝØœp‚ÌŒ»‹µ. •œˆä˜a–í1,
¬ì‹±Žj1, ŸNˆä‰ë”V, ª–{ˆê•F, ’|’†°”V, –x]˜aL (1ŠO‰È): ‘æ65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï
(2010/7/14-16), ‰ºŠÖ.

723318. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) H“¹Šà‚ÌŽüpŠúŠÇ—‚̍H•v. X’JGŒõ1, ª–{¹”V2, ŽÄ
“c—²’q2, ŽOd–ì_˜N2, •Ð“c‰Ä–ç2, ÷–{Mˆê2, ‹e’rŽj˜Y2, “n粏¹•F1 (1‘Š–ÍŒŽ•a‰@, 2ŠO‰È): ‘æ
64‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2010/8/31), ‹v—¯•Ä.

723319. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ž_ŽŸŠ³‚Æ‚µ‚Ä‚ÌŽ¡—×ð‚ð—L‚·‚éH“¹ƒAƒJƒ‰ƒVƒAÇ—á‚ÌŒŸ“¢. ŽÄ“c
’q—²1, •Ð“c‰Ä–ç1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO
‰È): ‘æ64‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2010/8/31-9/1), ‹v—¯•Ä.

723320. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ä”­«‰¡Šu–ŒãŒeŽº‚̈ê—á. ˜a“c@Ž¡1, ’†ìŠîl, ‹à
ˆä•q—Y (1ŠO‰È): ‘æ64‰ñ“ú–{H“¹Šw‰ïŠwpW‰ï (2010/8/31), ‹v—¯•Ä.

723321. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰E”w•”‚ƉEä\•”Žh‘n‚Ì1—á. ŽRŒû‚é‚ÂŽq1, “¡“c@®, â
–{“N–ç (1ŠO‰È): ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïEŠwpW‰ï (2010/10/9-11), “Œ‹ž.

723322. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ•â•‰ºˆÝ‘S“Ep‚̃Rƒc‚Æ•W€‰». ÷–{Mˆê1, •Ð
“c‰Ä–ç1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ŽÄ“c’q—²1, ª–{¹”V1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ8
‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘å‰ï (2010/10/15), ‰¡•l.

723323. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Rabeprazole‚É‚æ‚éStevens-JohnsonÇŒóŒQ‚ª‹^‚í‚ê‚œúE«\“ñ
Žw’°’×ᇂÌ1—á. Œì@Œc, X’JGŒõ1, “V–ì^—Žq1, ¬‘q’Œl1, â–{—FŒ©Žq1, ”Œ“cŠì”ü–ç, ‹ààV
G‹I, –Ø‘º@“O, ‹à“cŒå˜Y (1ŠO‰È): ‘æ52‰ñ “ú–{Á‰»Ší•aŠw‰ï‘å‰ï (2010/10/13-16), ‰¡•l, “ú–{Á‰»
Ší•aŠw‰ïŽGŽ 2010/9; 107 (—Õ‘): A811.

723324. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶‘’°œÃ–¬ˆ³”—ÇŒóŒQ‚𕹔­‚·‚éL”͈͌^‚̐[•”Ã–¬
ŒŒðÇ‚ɑ΂·‚éW–ñ“IŒŒðœ‹Žp‚ª—LŒø‚Å‚ ‚Á‚œˆê—á. •œ“cŒõ”Ž1, “c‘ºK•ä1, ŒŠª@”Ž2, “à“c‘׎Š
1, ƒEƒbƒhƒnƒ€ƒX—æŽq3, ”ü“‡—˜º1, ‘å‹v•Û”Ž¢, “n粏¹•F1 (1ŠO‰È, 2‹~–œ, 3•úŽËü (‰æ‘œ)): ‘æ51
‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï (2010/10/14-16), ˆ®ì, –¬ŠÇŠw 2010; 50: S269.

723325. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹o‹Ÿ‰ºH“¹‚ª‚ñŽèp (VATS-E): Ž„‚Í‘€‰çˆÊ‚ð‘I‚Ô. ª
–{¹”V1, ‹e’rŽj˜Y1 (1ŠO‰È), ‘Œ: ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/18), ‰¡•l.

723326. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™“àŽ‹‹ŸŽèp: –k—¢‘åŠwŠO‰È‚Å‚ÌŒoŒ±. “c’†@Œ‰1, “n
粏¹•F1, •Ð“c‰Ä–ç1, ŒÃ“cˆê“¿, •“cŒ›Žq1, ‚ˆÀ@”£1 (1ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï
(2010/10/18), ‰¡•l.

723327. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºˆÝ‘S“E‚É‚š‚¯‚éÄŒš‚Ì•W€‰»‚ÉŒü‚¯‚Ä. ÷–{M
ˆê1, •Ð“c‰Ä–ç1, ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, ª–{¹”V1, ŽÄ“c’q—²1, “ñ“nM]1, X’JGŒõ1, •œˆä˜a
–í1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/19), ‰¡•l.

723328. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚—îŽÒ‘å’°Šà‚ɑ΂·‚é• o‹Ÿ‰ºŽèp‚̃ŠƒXƒNƒ}ƒl[ƒWƒ
ƒ“ƒg. ’†‘º—²r1, ¬–ì—¢q1, ²“¡•˜Y1, “à“¡³‹K1, ’r“c@“Ä1, ¬‘q’Œl1, “n粏¹•F1 (1ŠO‰È):
‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/18-20), ‰¡•l.

723329. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘O‚ɃƒVƒ‹Ž_ƒCƒ}ƒ`ƒjƒu‚ð“Š—^‚µ• o‹Ÿ‰º“àãè–劇–ñ
‹ØØœ (ISR) ‚Ő؏œ‚µ‚œ’Œ’°GIST‚Ì1—á. ×“c“ÄŽu1, ¬–ì—¢q1, ’†‘º—²r1, ‘å–؁@‹Å1, Š™“cO
Ž÷1, ¬‘q’Œl1, “à“¡³‹K1, ’r“c@“Ä1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw
‰ï‘‰ï (2010/10/18-20), ‰¡•l.

723330. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘O•â•‰»Šw—Ö@Œã‚É‹ŸŽ‹‰ºŽèp‚ðŽ{s‚µ‚œ’Œ’°Šà‚Ì1
—á. ¬‘q’Œl1, ¬–ì—¢q1, “à“¡³‹K1, ’r“c@“Ä1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ
23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/18-20), ‰¡•l.

723331. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) SE”x‡•¹Ç‚ð—L‚·‚éÇ—á‚ɑ΂·‚é• o‹Ÿ‰º‘å’°Øœp
‚Ì“K‰ž‚ɂ‚¢‚Ä?SŽŸŠ³‚š‚æ‚ьċzŠíŽŸŠ³‡•¹Ç—á‚ɑ΂·‚é• o‹Ÿ‰º‘å’°Øœp‚̑Ó–«?. ¬–ì—¢q
1, ’†‘º—²r1, ‘å–؁@‹Å1, Š™“cOŽ÷1, ¬‘q’Œl1, “à“¡³‹K1, ’r“c@“Ä1, ²“¡•˜Y1, “n粏¹•F1 (1
ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/18-20), ‰¡•l.

723332. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐ«‘å’°‰Š‚ɑ΂·‚é• o‹Ÿ‰º‘å’°‘S“Ep‚̍H•v. ¬àV
•œ‘Ÿ1, ’r“c@“Ä1, “à“¡³‹K1, ¬‘q’Œl1, ²“¡•˜Y1, ¬–ì—¢q1, ’†‘º—²r1, ˆäŒŽ@Œú, “n粏¹•F
1 (1ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/18-20), ‰¡•l.

723333. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “àŽ‹‹ŸŠO‰Èˆãˆç¬‚̍œK‰»‚ð–ÚŽw‚µ‚Ä. ²“¡•˜Y1, ’†
‘º—²r1, ¬–ì—¢q1, “à“¡³‹K1, ’r“c@“Ä1, ¬‘q’Œl1, “n粏¹•F1 (1ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO
‰ÈŠw‰ï‘‰ï (2010/10/18-20), ‰¡•l.

723334. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚é’PEŽ®• o‹Ÿ‰º’_ùN“Eop‚̍H•v. â–{—FŒ©Žq1, ‹à
“cŒå˜Y, “V–ì^—Žq1, X’JGŒõ1, ŽO‰YŒ[Žõ1, ˆäã€l, ŠC’ËMŽj1, ‹à‘òG‹I (1ŠO‰È): ‘æ23‰ñ“ú
–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/18-20), ‰¡•l.

723335. [‘S‘(Šw‰ï)] (ˆê”ʍu‰‰) •¬–å•”ˆÝ”S–Œ‰ºŽîᇂɑ΂·‚é“àŽ‹‹ŸŠO‰ÈŽèp?out-side or in-side?
?. ŒI“c@~1, ‹à•œ‰i“ñ, ‰–àV–M‹v, ”Ñ’Ë”ü1, ’†ŒF‘žŽm, ‹{“à–M_ (1ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹Ÿ
ŠO‰ÈŠw‰ï‘‰ï (2010/10/18-20), ‰¡•l.

723336. [‘S‘(Šw‰ï)] (ˆê”ʍu‰‰) ‘å‘Úƒwƒ‹ƒjƒA‹UŠÒ”[‚É‚æ‚éiN«ƒCƒŒƒEƒX‚ɑ΂µ‚Ä• o‹Ÿ‰ºŽèp‚ðŽ{
s‚µ‚œ1—á. ]ŠÔ@—æ1, ŠøŽè˜a•F1, ‰HœAŒ’m1, ‹g“c@‹I, “n粏¹•F1 (1ŠO‰È): ‘æ23‰ñ“ú–{“àŽ‹‹Ÿ
ŠO‰ÈŠw‰ï‘‰ï (2010/10/18-20), ‰¡•l, “ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ïŽGŽ 2010; 15: 684.

723337. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) tˆÚAŒãƒXƒeƒƒCƒh‘Šú—£’E—Ö@‚Ì’†ŠÔ¬Ñ. ŽO‰Y³‹`, ŒŽ“c@_,
‰º“c’Œ•F, ˆÉ“¡—m•ã, “y‹Žœˆê˜Y1, •Ÿ‘òM”V, –x“c‹L¢•F, ŠâŒ©‘åŠî, X“c@Œ€, –ìX‘ºŽ–ç, ‹Ê’u@“§
(1ŠO‰È): ‘æ46‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2010/10/20-22), ‹ž“s, ˆÚA2010/10; 45 (‘‰ï—ÕŽž†): 237.

723338. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘å‘Ú“®–¬‚Ö‚Ì’EŒŒƒJƒe[ƒeƒ‹‚Ì—¯’u–@‚Æ—L—p«. ”Ñ“cˆê, “y‹Žœ
ˆê˜Y1, ŽO‰Y³‹`, ‹Ê’u@“§ (1ŠO‰È): ‘æ46‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2010/10/20-22), ‹ž“s, ˆÚA2010/10;
45 (‘‰ï—ÕŽž†): 245.

723339. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) tˆÚAŒã‘Šú•nŒŒ‚ÌŒŸ“¢. ŽO‰Y³‹`, ŒŽ“c@_, –x“c‹L¢•F, ‰º“c
’Œ•F, •Ÿ‘òM”V, ŠâŒ©‘åŠî, X“c@Œ€, ˆÉ“¡—m•ã, “y‹Žœˆê˜Y1, –ìX‘ºŽ–ç, ‹Ê’u@“§ (1ŠO‰È): ‘æ46
‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2010/10/20-22), ‹ž“s, ˆÚA2010/10; 45 (‘‰ï—ÕŽž†): 258.

723340. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆÚA15”NŒã‚ÉClass IIDQR‘Ì—z«‚Æ‚È‚Á‚œŠù‘¶R‘Ì—z«tˆÚA—á.
²“¡@šá1, ‹Ê’u@“§1, “y‹Žœˆê˜Y1, ŽO‰Y³‹`, ”Ñ“cˆê (1ŠO‰È): ‘æ46‰ñ“ú–{ˆÚAŠw‰ï‘‰ï
(2010/10/20-22), ‹ž“s, ˆÚA2010/10; 45 (‘‰ï—ÕŽž†): 306.

723341. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚ł̃Oƒ‰ƒZƒvƒ^[‚É‚æ‚étˆÚA“±“ü–Ɖu—}§–@‚ÌŒoŒ±. “y‹Žœ
ˆê˜Y1, ‹Ê’u@“§, ŽO‰Y³‹`, ”Ñ“cˆê, ²“¡@šá, ˆÉ“¡—m•ã, •ÄìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO‰È): ‘æ46‰ñ
“ú–{ˆÚAŠw‰ï‘‰ï (2010/10/20-22), ‹ž“s, ˆÚA2010/10; 45 (‘‰ï—ÕŽž†): 316.

723342. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒTƒCƒgƒƒKƒƒEƒCƒ‹ƒXR‘Ì—z«ƒŒƒVƒsƒGƒ“ƒg‚É‚š‚¯‚é–Ɖu—}§–@•Ê
‚ÌŠŽõ•p“x‚ÌŒŸ“¢. ŽO‰Y³‹`, ŒŽ“c@_, –x“c‹L¢•F, “y‹Žœˆê˜Y1, ˆÉ“¡—m•ã, ŠâŒ©‘åŠî, •Ÿ‘òM”V, ‰º
“c’Œ•F, X“c@Œ€, –ìX‘ºŽ–ç, ‹Ê’u@“§ (1ŠO‰È): ‘æ46‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2010/10/20-22), ‹ž“s,
ˆÚA2010/10; 45 (‘‰ï—ÕŽž†): 338.

723343. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œã• –Œ‹Ÿ‰ºƒhƒi[t“Eop‚É‚š‚¯‚éƒhƒŒ[ƒ“—¯’u‚ÌŒŸ“¢. ŽO‰Y³‹`,
–x“c‹L¢•F, •Ÿ‘òM”V, “y‹Žœˆê˜Y1, ŒŽ“c@_, ˆÉ“¡—m•ã, ‹Ê’u@“§ (1ŠO‰È): ‘æ46‰ñ“ú–{ˆÚAŠw‰ï
‘‰ï (2010/10/20-22), ‹ž“s, ˆÚA2010/10; 45 (‘‰ï—ÕŽž†): 342.

723344. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) isˆÝŠà‚É‚É‚š‚¯‚éƒNƒŒƒXƒ`ƒ““Š—^‚ÆŒŒŸ÷TGF-beta”Z“x
‚̒ቺ (ŒŸõ“IRCT). ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, ª–{¹”V1, ŽÄ“c’q—²1, ÷–{Mˆê1, •Ð“c‰Ä–ç1, ‹e
’rŽj˜N1, “n粏¹•F1 (1ŠO‰È): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/30), ‹ž“s.

723345. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éAvastin“Š—^Ç—á‚ÌŒŸ“¢. ×“c@Œj1, Œ
“c@—@, ’¹ŠC³”Ž, •œ–ì‘å•ã, ŒÃé@Œ›1, ‰Í“‡r•¶, Â–ؐ^•F, éŒË@Œ[, “c‘º@Œõ, ¬“‡³•v, ‰J‹{@
“N, Š›Žu“c• (1ŠO‰È): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/28-30), ‹ž“s.

723346. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “–‰@‚É‚š‚¯‚é‘å’°Šà• –Œ“]ˆÚÇ—á‚ɑ΂·‚鎊“K‚ÈŽ¡—Õûj‚ÌŒŸ“¢.
“à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ‘å–؁@‹Å1, ’†‘º—²r1, “n粏¹•F1 (1
ŠO‰È): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/28-30), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2010; 45 (1): 118.

723347. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰»Šw—Ö@Žž‚Ì’†SÃ–¬ƒ|[ƒg‚É‹Nˆö‚·‚éƒCƒ“ƒVƒfƒ“ƒg‚Ì•ªÍ‚ƈÀ‘S
‚ȉ^—p. ‘ •À@Ÿ1, åÎ‹I•F1, —с@‹žŽq1, ¬â–ùŒ«1, ¬–ì—¢q1, ’†‘º—²r1, “n粏¹•F1, ²“¡
‹vŽq, ”ԏ ÍŽq, rˆä—L”ü (1ŠO‰È): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwp‘‰ï (2010/10/28-30), ‹ž“s, “ú–{Šà
Ž¡—Êw‰ïŽ 2010; 45 (1): 225.

723348. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é‘å’°Šà• –Œ“]ˆÚÇ—á‚ɑ΂·‚鎊“K‚ÈŽ¡—Õû
j‚ÌŒŸ“¢. “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ‘å–؁@‹Å1, ’†‘º—²r1, “n
粏¹•F1 (1ŠO‰È): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/28-30), ‹ž“s.

723349. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘å’°ŠàpŒã‘nŠŽõ‚̊댯ˆöŽq‚̉ðÍ. ’†‘º—²r1, ¬–ì—¢q1, ˆä
ŒŽ@Œú1, “à“¡³‹K1, ’r“c@“Ä1, ¬àV•œ‘Ÿ1, ²“¡•˜N1, “n粏¹•F1 (1ŠO‰È): ‘æ23‰ñ“ú–{ŠO‰ÈŠŽõ
ÇŠw‰ïŠwpW‰ï (2010/11/18-19), “Œ‹ž, ŠŽõÇŠwŽGŽ 2010/7; 84 (4): 552.

723350. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚ł̃^ƒNƒƒŠƒ€ƒX™•úÜ‚É‚æ‚étˆÚA“±“ü–Ɖu—}§–@‚ÌŒoŒ±.
ŽO‰Y³‹`, “y‹Žœˆê˜Y1, ²“¡@šá, ˆÉ“¡—m•ã, ‹Ê’u@“§ (1ŠO‰È): ‘æ37‰ñ“ú–{‘ŸŠí•Û‘¶¶•šˆãŠw‰ï’è
ŠúŠwpW‰ï (2010/11/19-20),VŠƒ, Organ Biology 2010/11; 17 (2): 204.

723351. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠÌ‹•ŒŒÄŸó—¬áŠQ‚É‚š‚¯‚éTLR4ƒVƒOƒiƒ‹“`’BŒo˜H‚ÆHO-1‚Ì–ðŠ„.
“y‹Žœˆê˜Y1, ‹Ê’u@“§, ”Ñ“cˆê, ‹v–Ø“c˜a‹u, –ڍ•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ•v, ŽO‰Y³‹`, Yuan Zhai,
Kupiec-WeglinskiJerzy W (1ŠO‰È): ‘æ37‰ñ“ú–{‘ŸŠí•Û‘¶¶•šˆãŠw‰ï’èŠúŠwpW‰ï (2010/11/19-20),V
Šƒ, Organ Biology 2010/11; 17 (2): 227.

723352. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‚“xisˆÝŠà‚ɑ΂·‚ép‘O‰»Šw—Ö@Docetaxel{CDDP{S-1
(NAC-DCS) Œã‚̐؏œ¬Ñ. ŽOd–ì_˜N1, ÷–{Mˆê1, ŽÄ“c’q—²1, ª–{¹”V1, ”óŒûŸ•F2, •Ð“c‰Ä–ç
1, ‹e’rŽj˜Y1, ¬ò˜aŽO˜Y2, “n粏¹•F1 (1ŠO‰È, 2Á‰»Ší“à): ‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï
(2010/11/21), ‰¡•l, “ú–{—Տ°ŠO‰ÈŠw‰ïŽGŽ 2010/10; 71 (‘Š§): 503.

723353. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{‚š‚æ‚Ñ•t‘®Ší‚Ì’Eo‚µ‚œê‹Œaƒwƒ‹ƒjƒA2—á‚ÌŒoŒ±.
‚ˆÀ@”£1, “c’†@Œ‰1, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È): ‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2010/11/21),
‰¡•l.

723354. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘lŒaƒwƒ‹ƒjƒA›Æ“ÚŒã‚ɐž‘ƒˆÞk‚ð”F‚ß‚œ3Ç—á. “c’†@
Œ‰1, ‚ˆÀ@”£1, •“cŒ›Žq1, “n粏¹•F1 (1ŠO‰È): ‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2010/11/21), ‰¡•l.

723355. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ^«’°Î‚𔺂Á‚œ¬lƒƒbƒPƒ‹ŒeŽºúE‚Ì1—á. M‘ŸºŽq1, ¬â
–ùŒ«1, ‘å‹v•Û”Ž¢, Š™“cOŽ÷1, ¬–ì—¢q1, ’†‘º—²r1, Š“cç”ü”T2, “n粏¹•F1 (1ŠO‰È, 2•a—):
‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2010/11/22), ‰¡•l, “ú–{—Տ°ŠO‰ÈŠw‰ïŽGŽ 2010; 71 (‘Š§): 678.

723356. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Œ‘å˜a•a‰@‚É‚š‚¯‚é’Ž‚”S‰tùN–E«•a•Ï‚Ì9—á‚̗Տ°•a
—Šw“IŒŸ“¢. ŠÝ–{ˆê˜Y, ‰Í–{@Œ’, ’|–{ˆÀO, –Ø’ë—YŽŠ, ‘呺FŽu, ²“¡ŒõŽj, ¬â–ùŒ«1 (1ŠO‰È): ‘æ
72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2010/11/23), ‰¡•l.

723357. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) • o‹Ÿ‰ºƒAƒJƒ‰ƒVƒAŽèp‚É‚š‚¯‚ép’†‰œ–‹‘¹Ç—á‚ÌŒŸ“¢. ŽÄ“c’q
—²1, •Ð“c‰Ä–ç1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È):
‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2010/11/23), ‰¡•l, “ú–{—Տ°ŠO‰ÈŠw‰ïŽGŽ 2010; 71: 545.

723358. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹‘åŒã• –ŒŽ‰–b“÷Žî‚Ì1Øœ—á. ‘å‹v•Û”Ž¢, ‚‹Ž’õl1, ¬â–ù
Œ«1, M‘ŸºŽq1, “c’†r“¹1, •œ“cŒõ”Ž1, “n粏¹•F1 (1ŠO‰È): ‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï
(2010/11/23), ‰¡•l, “ú–{—Տ°ŠO‰ÈŠw‰ïŽGŽ 2010; 71 (‘Š§): 799.

723359. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹o‹Ÿ‰º‚ɐ؏œ‚µ‚œH“¹ˆ««•FŽî‚̈ê—á. ¬›žŒc‘Ÿ
1, ª–{¹”V1, Îˆä@’q1, ŽOd–ì_˜N1, ŽÄ“c’q—²1, •Ð“c‰Ä–ç1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F
1 (1ŠO‰È): ‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2010/11/23), ‰¡•l.

723360. [‘S‘(Šw‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • •”‘å“®–¬áŽƒXƒeƒ“ƒhƒOƒ‰ƒt‚Æ‘}“ü‚Æ• o‹Ÿ‰ºSóŒ‹’°Ø
œ‚𓯎ž‚ÉŽ{s‚µ‚Š‚œˆê—á. Š™“cOŽ÷1, ’†‘º—²r1, •œ“cŒõ”Ž1, ŒÜ\—’rŽO, ¬–ì—¢q1, ¬‘q’Œl
1, “à“¡³‹K1, ’r“c@“Ä1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï
(2010/11/21-23), ‰¡•l.

723361. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹}«‰ºŽˆ‹•ŒŒ‚𗈂œ‚µ‚œŠO«‘‘å‘Ú“®–¬‘¹‚̈ê—á.
“à“c‘׎Š1, •œ“cŒõ”Ž1, •ž•”@, “c‘ºK•ä1, ‘å‹v•Û”Ž¢, ŒÜ\—’ˆê°, ‘åò—z‰î, “n粏¹•F1 (1ŠO
‰È): ‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2010/11/21-23), ‰¡•l “ú–{—Տ°ŠO‰ÈŠw‰ïŽGŽ 2010; 71 (‘Š§†):
652.

723362. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’PEŽ®• o‹Ÿ‰º’_ùN“Eop‚Ì“±“ü. â–{—FŒ©Žq1, ‹à“cŒå˜Y, “V–ì
^—Žq1, X’JGŒõ1, ŽO‰YŒ[Žõ1, ˆäã€l, ŠC’ËMŽj1, ‹à‘òG‹I (1ŠO‰È): ‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw
‰ï‘‰ï (2010/11/21-23), ‰¡•l.

723363. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝØœRoux-en YÄŒšŒã‚É”º‚€’ʉߏáŠQ‚ÌŒŸ“¢. •Ê‹{ŠG
”ü^1, ì‘º‘׈ê (1ŠO‰È):‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2010/11/21-23), ‰¡•l.

723364. [‘S‘(Šw‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p’†ˆÙí‚ŒŒˆ³‚ɂĐf’f‚µ‚Š‚œ•›tŠOŠŒF×–EŽî‚Ì1—á.
ŒàVL‹±1, ÎˆäŒ’ˆê˜Y1, •äâ”üŽ÷1, ’†‘º˜a“¿, ‰Í–”@Š°2, ˜m’J”ü“Þ2, Š™“cOŽ÷1, •Ð‹ËŠ°”V1, ŒG
Œ³—Y‰î1, ŒÃ“cˆê“¿1 “n粏¹•F1 (1ŠO‰È, 2ˆã—ÃŒnŒ€‹†‰È): ‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï
(2010/11/21-23), ‰¡•l.

723365. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Acute COronary Syndrome‚ð‡•¹‚µ‚œ‚ªŠJ• p‚ƏWŠw“I
Ž¡—Âɂæ‚è‹~–œ‚µ‚œ¶ê‹Œaƒwƒ‹ƒjƒA›Æ“Ú‚É‚æ‚éSóŒ‹’°úE‚Ì1—á. ŽRŒû‚é‚ÂŽq1, “¡“c@®, â–{“N–ç
(1ŠO‰È): ‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2010/11/21-23), ‰¡•l.

723366. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°ŠàpŒãPET-CT‚É‚Ä”­Œ©‚³‚ê‚œŠÌ”öó—t“]ˆÚ‚Ì‚QØœ
—á. ˜a“c@Ž¡1, ‹àˆä•q—Y (1ŠO‰È): ‘æ72‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2010/11/21-23), ‰¡•l.

723367. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒNƒŠƒjƒJƒ‹ƒpƒX‚ð—p‚¢‚œ‘å’°ŠàŽèp‚É‚š‚¯‚é“ü‰@ŠúŠÔ‚Ì
‘Ó–«‚Ə”–â‘è‚ÌŒŸ“¢. ¬‘q’Œl1, ¬–ì—¢q1, “à“¡³‹K1, ’r“c@“Ä1, ’†‘º—²r1, ²“¡•˜Y1, “n
粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï (2010/11/26-27), •lŒ, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ
2010/9; 63 (9): 618.

723368. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒNƒ[ƒ“•apŒã•«‡•”Šà‚Ì1—á. ’r“c@“Ä1, ¬àV•œ‘Ÿ1, ¬‘q’Œ
l1, ¬–ì—¢q1, “à“¡³‹K1, ’†‘ºr—²1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{‘å’°ãè–å•aŠw
‰ïŠwpW‰ï (2010/11/26-27), •lŒ, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2010/9; 63 (9): 735.

723369. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) lHãè–å‘¢Ýp‚ɑ΂·‚é•W€‰»‚ÌŒŸ“¢?“–‰@‚É‚š‚¯‚élHãè–å‘¢Ý
p‚ÌŒ»ó?. “à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ‘å–؁@‹Å1, ’†‘º—²r1, “n
粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2010/11/26-27), •lŒ, “ú–{‘å’°ãè–å•aŠw‰ï
ŽGŽ 2010/9; 63 (9): 707.

723370. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) • o‹Ÿ‰º’Œ’°ŠàŽèpŽè‹Z‚Ì’èŒ^‰»‚ð‚ß‚Ž‚µ‚Ä. ’†‘º—²r1, ¬–ì—¢
q1, “à“¡³‹K1, ’r“c@“Ä1, ²“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï
(2010/11/26-27), •lŒ, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2010/9; 63 (9): 651.

723371. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Stage II‘å’°Šà‚̍Ĕ­ŠëŒ¯ˆöŽq‚̗Տ°•a—Šw“IŒŸ“¢. ¬‘q’Œl1,
‹ààVG‹I, “V–ì^—Žq1, ‚‹Ž”ü’qŽq, â–{—FŒ©Žq1, X’JGŒõ1, ”Œ“cŠì”ü–ç, ˆäã€l, –Ø‘º@“O, ‹à
“cŒå˜Y (1ŠO‰È): ‘æ65‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2010/11/26-27), •lŒ, “ú–{‘å’°ãè–å•aŠw‰ïŽG
Ž 2010/9; 63 (9): 305.

723372. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Stage 3‘å’°Šà‚Ì—\ŒãˆöŽq‚ÌŒŸ“¢. ¬‘q’Œl1, ‹ààVG‹I, “V–ì^
—Žq1, â–{—FŒ©Žq1, X’JGŒõ1, ”Œ“cŠì”ü–ç, ˆäã€l, –Ø‘º@“O, ‹à“cŒå˜Y (1ŠO‰È): ‘æ65‰ñ“ú–{
‘å’°ãè–å•aŠw‰ïŠwpW‰ï (2010/11/26-27), •lŒ, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2010/9; 63 (9): 462.

723373. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‰ŠÇ«’°ŽŸŠ³‚ɑ΂·‚éQOL‚ÌŒüã‚©‚ç‚Ý‚œŽ¡—Ö@‚Ì‘I‘ð?’×ᇐ«‘å
’°‰Š‚ɑ΂·‚é• o‹Ÿ‰º‘å’°‘S“Ep‚Ì“K‰ž‚Ɖۑè?. ¬àV•œ‘Ÿ1, ’r“c@“Ä1, “à“¡³‹K1, ²“¡•˜Y1, ¬
‘q’Œl1, ¬–ì—¢q1, ’†‘º—²r1, ˆäŒŽ@Œú, “n粏¹•F1 (1ŠO‰È): ‘æ65‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW
‰ï (2010/11/26-27), •lŒ, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2010/9; 63 (9): 581.

723374. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é• o‹Ÿ•â•‰º‘å’°ŠàŽèp“±“üŒã‚ÌŽ¡—ЬÑ
‚ÌŒŸ“¢. ×“c@Œj1, ŒÃé@Œ›1, “c‘º@Œõ (1ŠO‰È): ‘æ65‰ñ“ú–{‘å’°ãè–å•aŠw‰ïŠwpW‰ï
(2010/11/26-27), •lŒ, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2010/9; 63 (9): 650.

723375. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ä”­‚𗈂µ‚œãŠ{‘̂̈ê—á. ‚ˆÀ@”£1, “c’†@Œ‰1, •
“cŒ›Žq1, “n粏¹•F1, ’†ŠÚ®–ç2 (1ŠO‰È, 2¬Ž™): ‘æ26‰ñ“ú–{¬Ž™‚ª‚ñŠw‰ïŠwpW‰ï (2010/12/17), ‘å
ã.

723376. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ž_ŽŸŠ³‚ª‹^‚í‚ê‚œH“¹ƒAƒJƒ‰ƒVƒA‚Ì2—á. ŽÄ“c’q—²1, •Ð“c‰Ä–ç
1, ª–{¹”V1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ÷–{Mˆê1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ6‰ñ“ú–{Á
‰»ŠÇŠw‰ï‘‰ïŠwpW‰ï (2010/12/19-20), •Ÿ‰ª.

723377. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 80ÎˆÈã‚—îŽÒˆÝŠà‚ɑ΂·‚é‹ŸŽ‹‰ºŽèp. ‹e’rŽj˜Y1, ‘Œ
(1ŠO‰È): ‘æ83‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2011/3/5), ŽO‘ò.

723378. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒoŒûƒAƒ“ƒrƒ‹‚ð—p‚¢‚œ• o‹Ÿ‰º•¬–å‘€ˆÝØœp‚É‚š‚¯‚é
ÄŒš–@. ‹e’rŽj˜Y1, ‘Œ (1ŠO‰È): ‘æ83‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2011/3/5), ŽO‘ò.

731067. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘å’°ŠàŽ¡—Ã?Å‹ß‚̘b‘è?. “n粏¹•F (ŠO‰È): —Œ–Ñ’n
‹æ‘å’°Šàu‰‰‰ï (2010/5/26), “È–Ø.

731068. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘å’°Šà‚ɑ΂·‚é•â•‰»Šw—Ö@‚ÌŒ»ó‚Æ“W–]. “n粏¹•F
(ŠO‰È): ‘æ1‰ñŒcœäƒIƒ“ƒRƒƒW[ƒtƒH[ƒ‰ƒ€ (2010/5/29), “Œ‹ž.

731069. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) • o‹Ÿ‰º‘å’°Øœ‚Ì‚·‚ׂÄ. “n粏¹•F (ŠO‰È): ‘æ28‰ñ
_“ސìpŒã‘ãŽÓ‰h—{Œ€‹†‰ï (2010/7/10), _“ސì.

731070. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ˆÝŠà‚ɑ΂·‚é• o‹Ÿ‰ºˆÝØœp‚ÌŽÀÛ. ÷–{Mˆê (ŠO
‰È): ‘æ39‰ñ–k—€“àŽ‹‹ŸŠO‰ÈŒ€‹†‰ï (2010/9/11), ‹à‘ò.

731071. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘å’°Šà‚ɑ΂·‚é•â•‰»Šw—Ö@‚ÌŒ»ó‚Æ“W–]. “n粏¹•F
(ŠO‰È): ‘å’°ŠàƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/11/12), –ŒŒÃ‰®.

731072. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘å’°ŠàŽ¡—Â̐i•à. “n粏¹•F (ŠO‰È): ‘æ5‰ñ‘å’°ŽŸŠ³
•ª‰È‰ï (2010/12/1), ‘åã.

732053. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) • o‹Ÿ‰ºˆÝ‘S“EŒã‚̍Čš–@?Orvil‚ð
—p‚¢‚œdouble stapling technique?. ÷–{Mˆê1, •Ð“c‰Ä–ç1, ŽOd–ì_˜N1, ŽR‰ºŒpŽj1, ŽÄ“c’q—²
1, ª–{¹”V1, ‹e’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ18‰ñŠÖ“Œ• o‹Ÿ‰ºˆÝØœŒ€‹†‰ï (2010/11/6), “Œ
‹ž.

732054. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “ûŠà–ò•š—Ö@‚ÌŒ»ó‚ɂ‚¢‚Ä?PST,
Ajuvant, MBC‚ÌŠÏ“_‚©‚ç?. —с@‹žŽq1, ’†ŒF‘žŽm1, â–{‚¢‚ÂÝ1, ŒŽ@@‰p, ‹ß“¡NŽj1 (1ŠO‰È): –k
—¢‘åŠwŠO‰ÈŽîᇊwŒ€‹†‰ï (KSOA) (2011/3/5), Vh.

733117. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝ“]ˆÚ‚Å”­Œ©‚³‚ê’·Šú¶‘¶‚µ‚œis«“ûŠà‚Ì
1—á. —с@‹žŽq1, åÎ‹I•F1, –x]‘Ÿ˜N, ¬â–ùŒ«1, ‰|–{‘ñ–Î1, Š“cç”ü”T2, ‘ •À@Ÿ1, “n糏¹
•F1 (1ŠO‰È, 2•a—): ‘æ32‰ñ“ú–{Šà‹ÇŠ—Ö@Œ€‹†‰ï (2010/6/11), “Þ—Ç.

733118. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŠO’°œƒOƒ‰ƒtƒg‚Őt“®–¬Œ`¬‚µŠO’°œ“®–¬‹·ó•”’uŠ·‚µ
‚œŒ£tˆÚA—á. “y‹Žœˆê˜Y1, ‹Ê’u@“§, ŽO‰Y³‹`, ”Ñ“cˆê, ’Ócˆê˜Y, –x]@‘ì, â“c”Ž”ü, ¬–쎛
ˆê•F, ŒÃˆäG“T, ‹v–Ø“c˜a‹u, –ڍ•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO‰È): ‘æ26‰ñtˆÚAEŒŒŠÇŠO‰ÈŒ€‹†
‰ï (2010/6/25-26), –ŒŒÃ‰®.

733119. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆÚA‘OR‘̏œ‹Ž—Ö@‚É‚š‚¯‚écryofiltration‚Ì—L—p«.
ŽO‰Y³‹`, “y‹Žœˆê˜Y1, ”Ñ“cˆê, ‹Ê’u@“§, ŒŽ“c@_, ŠâŒ©‘åŠî, ‰º“c’Œ•F (1ŠO‰È): ‘æ26‰ñtˆÚ
AEŒŒŠÇŠO‰ÈŒ€‹†‰ï (2010/6/25-26), –ŒŒÃ‰®.

733120. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’EŒŒ—pƒJƒe[ƒeƒ‹‚Ì‘å“®–¬—¯’u–@‚ɂ‚¢‚Ä. ”Ñ“cˆê,
‹Ê’u“§, “y‹Žœˆê˜Y1, ŽO‰Y³‹`, •ÄìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO‰È): ‘æ26‰ñtˆÚAEŒŒŠÇŠO‰ÈŒ€‹†‰ï
(2010/6/25-26), –ŒŒÃ‰®.

733121. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Stentgraft—¯’uŽž‚É—Œ‘€t“®–¬•ÂÇ‚𗈂œ‚µ
‚œ1—á. ‘å‹v•Û”Ž¢, “c‘ºK•ä1, •œ“cŒõ”Ž1, “à“c‘׎Š1, “n粏¹•F1 (1ŠO‰È): ‘æ145‰ñŒŒŠÇŠO‰ÈÇ
—ጟ“¢‰ï (2010/6), Žsì.

733122. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žá”NŒ‹’°Šà‚É‚š‚¯‚éK-rasˆâ“`Žq‚̕ψق̈Ó
‹`. ¬–ì—¢q1, ŽR‰ºŒpŽj1, ’†‘º—²r1, ‘å–؁@‹Å1, Š™“cOŽ÷1, ¬‘q’Œl1, “à“¡³‹K1, ’r“c@“Ä
1, ¬àV•œ‘Ÿ1, ²“¡•˜Y1, ˆäŒŽ@Œú, “n粏¹•F1 (1ŠO‰È): ‘æ73‰ñ‘å’°ŠàŒ€‹†‰ï (2010/7/2), ‰‚”ü‘å
“‡.

733123. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°Šà‚ÌOncologic Emergency; “–‰@‚Å‚ÌŒo
Œ±‚ƃAƒ‹ƒSƒŠƒYƒ€. ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, “à“¡³‹K1, ’†‘º—²r1, ²“¡•˜Y1, “n粏¹
•F1 (1ŠO‰È): ‘æ73‰ñ‘å’°ŠàŒ€‹†‰ï (2010/7/2), ‰‚”ü‘哇.

733124. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å’°Šà“¯Žž«ŠÌ“]ˆÚ‚ɑ΂·‚鎡—Ð헪‚ÌŒŸ“¢.
“à“¡³‹K1, ²“¡•˜Y1, ’r“c@“Ä1, ¬‘q’Œl1, ¬–ì—¢q1, ‘å–؁@‹Å1, ’†‘º—²r1, “n粏¹•F1 (1
ŠO‰È): ‘æ73‰ñ‘å’°ŠàŒ€‹†‰ï (2010/7/2), ‰‚”ü‘哇.

733125. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ABO•s“K‡tˆÚAŒã‚Ì‹}«R‘ÌŠÖ˜AŒ^‹‘â”œ‰ž‚É‘±”­‚µ
‚œis«‚ÌTMA‚É‚æ‚葁Šú‚ɈڐAt‹@”\‘rŽž‚µ‚œ1—á. ŽO‰Y³‹`, “y‹Žœˆê˜Y1, ‰º“c’Œ•F, [àV—Yˆê˜Y,
—é–؁@º, “¡“c—T”ü, ‹v•Û“c‰À“ÞŽq, ˆÉ“¡—m•ã, ‹Ê’u@“§ (1ŠO‰È): ˆÚAt•a—Œ€‹†‰ï‘æ14‰ñŠwpW‰ï
(2010/7/17), “Œ‹ž.

733126. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”ö‘€äXØœ‚É‚š‚¯‚鎩“®–D‡Ší‚ð—p‚¢‚œŠÉ™
ˆ³”—–@‚É‚æ‚éäXØ—£. ÎˆäŒ’ˆê˜Y1, ’†‘º˜a“¿1, ‰Í–”@Š°, ˜m’J”ü“Þ1, Š™“cOŽ÷1, •Ð‹ËŠ°”V1, ŒGŒ³
—Y‰î1, “n粏¹•F1, ‚‹Ž’õl1, ŒÃ“cˆê“¿ (1ŠO‰È): ‘æ37‰ñ“ú–{äXØŒ€‹†‰ï (2010/8/28), ŽOd.

733127. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —‘‰©ùNŠà‚Æ‚µ‚čĔ­‚µ‚œãŠ{‘Ì‚Ì1—á. “c’†@
Œ‰1, ‚ˆÀ@”£1, •“cŒ›Žq1, “n粏¹•F1, ’†ŠÚ®–ç2 (1ŠO‰È, 2¬Ž™): ‘æ53‰ñ_“ސ쏬Ž™Žîᇌ€‹†‰ï
(2010/9/11), ‰¡•l.

733128. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “EoŽž‚ɍH•v‚µ‚œ‹‘å—‘‘ƒ”S‰t«ùN–E‘BŽî‚Ì
ˆê—á. ‰¡“c˜aŽq1, ‚ˆÀ@”£1, “c’†@Œ‰1, “n粏¹•F1 (1ŠO‰È): ‘æ818‰ñŠO‰ÈW’k‰ï (2010/9/18), “Œ
‹ž.

733129. [Šw‰ï(‘S‘)] (ˆê”ʍu‰‰) ‘å’°Šà‚É‚š‚¯‚é Homeobox only protein (HOP) ”­Œ»—}§‚É‚æ‚鈫«
“xŠl“Ÿ‚ÆŠà“ÁˆÙ“IHOPƒvƒƒ‚[ƒ^[DNAƒƒ`ƒ‹‰»‚̗Տ°“IˆÓ‹`. ‰Á“¡@O1, ŽR‰ºŒpŽj1, ‘å–؁@‹Å1, ˜m
’J”ü“Þ2, “n粏¹•F1 (1ŠO‰È, 2ˆã—ÃŒnŒ€‹†‰È): ‘æ30‰ñ“ú–{•ªŽqŽîᇃ}[ƒJ[Œ€‹†‰ï (2010/9/21), ‘å
ã.

733130. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚«‚í‚ß‚Ä‹H‚ȏ¬Ž™’_ùNŽîᇂÌ1—á. “c’†r“¹
1, “c’†@Œ‰1, •“cŒ›Žq1, ‚ˆÀ@”£1, •Ð‹ËŠ°”V1, ‚‹Ž’õl1, “n粏¹•F1, ¡ò@O2 (1ŠO‰È, 2Á
‰»Ší“à): ‘æ45‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2010/10/8), “Œ‹ž.

733131. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) f’f‚É“ïa‚µ‚œœ”Õ“àƒŠƒ“ƒpŠÇŠg’£Ç‚Ì1—á.
•“cŒ›Žq1, “c’†@Œ‰1, –ì—Ç”Ž, •“c’B•v, XìMs, “c’†G–Ÿ, “¡–ì–Ÿ_, —é“Œ¹–ç, Œ“c@—@, ŽR
ª—T‰î, “n粏¹•F1 (1ŠO‰È): ‘æ45‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2010/10/8), “Œ‹ž.

733132. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’°œ“®–¬•ÂÇ‚ɑ΂·‚éEVT’†‚ÌŒŒŠÇ‘¹‚É‘Î
‚µ‚Ä, EVT‚ł̏C•œ‚ª‘tŒ÷‚µ‚œ 2—á. ‘å‹v•Û”Ž¢, “c‘ºK•ä1, •œ“cŒõ”Ž1, “à“c‘׎Š1, “n粏¹•F1 (1
ŠO‰È): ‘æ18‰ñŒŒŠÇŠO‰ÈŠÖ“ŒbM‰z’n•û‰ï (2010/10/30), ŽO‘é.

733133. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶‘å‘ڐÖ¬‚̍‚“xˆ³”r‚ð’æ‚·‚é‘lŒa•”‘œ–[«
‚Ì‚€–E«ŽîᎂÌ1—á. ‘å‹v•Û”Ž¢, “c‘ºK•ä1, •œ“cŒõ”Ž1, “à“c‘׎Š1, “n粏¹•F1 (1ŠO‰È): ‘æ146
‰ñŒŒŠÇŠO‰ÈÇ—ጟ“¢‰ï (2010/10), ‘œ–€.

733134. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œð’ÊŽ–ŒÌ‚É‚æ‚é‹ó’°Š®‘S’f—ô‚ð”F‚ß‚œ1—á. ‹v
•Û”CŽj1, Œ@”ªŽk, “c“‡@O1, ”’ÎœAÆ1, “ñ“nM]1, ‹ß“¡NŽj1, ‚‹Ž’õl1, ”ª\ì—v•œ (1ŠO‰È):
‘æ28‰ñé‹ÊŒ§ŠO‰ÈW’k‰ï (2010/11/27), ‚³‚¢‚œ‚Ü.

733135. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ²S’áŒ`¬ÇŒóŒQ‚ð‡•¹‚µNorwoodpŒã‚ÉŠJ
• p‚ðŽ{s‚µ‚œIcystŒ^’_“¹•ÂœÇ‚Ì1—á. ‚ˆÀ@”£1, “c’†@Œ‰1, •“cŒ›Žq1, ‹{’n@ŠÓ2, ©@L
–ç3, ŒÏè‰ëŽq3, “n粏¹•F1 (1ŠO‰È, 2S‘ŸŒŒŠÇŠO, 3¬Ž™): ‘æ37‰ñ“ú–{’_“¹•ÂœÇŒ€‹†‰ï (2010/12/11),
“Œ‹ž.

733136. [Šw‰ï (’n•ûEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚é’PEŽ®‹ŸŽ‹‰ºƒwƒ‹ƒjƒAC•œp. â–{—FŒ©Žq
1, ‹à“cŒå˜Y, “V–ì^—Žq1, X’JGŒõ1, ŽO‰YŒ[Žõ1, ˆäã€l, ŠC’ËMŽj1, ‹à‘òG‹I (1ŠO‰È): ‘æ2
‰ñ_“ސìƒwƒ‹ƒjƒAŒ€‹†‰ï (2010/12/11), V‰¡•l.

733137. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å‘̃wƒ‹ƒjƒA‹UŠÒ”[‚É‚æ‚éiN«ƒCƒŒƒEƒX‚É
‘΂µ‚Ä• o‹Ÿ‰ºŽèp‚ðŽ{s‚µ‚œ1—á. ]ŠÔ@—æ1, ŠøŽè˜a•F1, ‰HœAŒ’m1, ‹g“c@‹I, “n粏¹•F1 (1ŠO
‰È): ‘æ2‰ñ_“ސìƒwƒ‹ƒjƒAŒ€‹†‰ï (2010/12/11), V‰¡•l.

733138. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆóŠÂŒ^ŽîᇍזE‚ðŠÜ‚Þ“û‘BZ«¬—tŠà‚Ì1
—á. ¬–ìè’q”V1, ¬â–ùŒ«1, “c’†r“¹1, ‰Á“¡@O1, —с@‹žŽq1, åÎ‹I•F1, ‰|–{‘ñ–Î1, ‘ •À@Ÿ
1, “n粏¹•F1 (1ŠO‰È): ‘æ129‰ñ_“ސ쌧—Տ°ŠO‰ÈˆãŠw‰ïW’k‰ï (2010/12/18), ‰¡•l.

733139. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) pŒã‚É‹}‘¬‚ÈŒo‰ß‚ð‚œ‚Ç‚Á‚œ’_ùNŽîᇂÌ1—á.
]ŠÔ@—æ1, ‹g“c@‹I, ŠøŽè˜a•F1, ‰HœAŒ’m1, ’|‰º’me2, ŽOŽ}—zˆê2, ”üŒŽÃ2, ‘åˆä“c³l, Œ
Œ³Ž›ŽâX2 (1ŠO‰È, 2Á‰»Ší“à): ‘æ34‰ñ–k—¢ŠÌ’_äXŽŸŠ³Œ€‹†‰ï (2010), ’¬“c.

733140. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆóŠÂŒ^ŽîᇍזE‚ðŠÜ‚Þ“û‘BZ«¬—tŠà‚Ì1—á. ¬–ìè
’q”V1, ¬â–ùŒ«1, “c’†r“¹1, ‰Á“¡@O1, —с@‹žŽq1, åÎ‹I•F1, ‰|–{‘ñ–Î1, ‘ •À@Ÿ1, “n粏¹
•F1 (1ŠO‰È): ‘æ129‰ñ_“ސ쌧—Տ°ŠO‰ÈˆãŠw‰ïW’k‰ï (2010), ‰¡•l.

733141. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) \“ñŽw’°GIST‚ɑ΂µäX‰·‘¶\“ñŽw’°•ªßØœ
‹y‚ÑRoux-en-YÄŒš‚ðs‚Á‚œÇ—á. •Ê‹{ŠG”ü^1, Ž›“‡‰ë“T (1ŠO‰È): ‘æ217‰ñÃ‰ªŒ§ŠO‰Èˆã‰ïW’k‰ï
(2010), •lŒ.

733142. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) p‘O‰»Šw•úŽËü—Ö@‚ð—p‚¢‚œis’Œ’°Šà‚É‘Î
‚·‚鎡—Ð헪. ²“¡•˜Y1, ’†‘º—²r1, ’r“c@“Ä1, ¬–ì—¢q1, “à“¡³‹K1, ¬‘q’Œl1, ‘å–؁@‹Å1,
“n粏¹•F1 (1ŠO‰È): ‘æ74‰ñ‘å’°ŠàŒ€‹†‰ï (2011/1/21), •Ÿ‰ª.

733143. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) L”͈͖喬ZäXŠà‚ɑ΂µp‘O‰»Šw•úŽËü—Ã
–@‚ª‘tŒ÷‚µR0Žèp‚ðŽ{s‚µ“Ÿ‚œ1—á. “c“‡@O1, ‹v•Û”CŽj1, ”’ÎœAÆ1, “ñ“nM]1, ‹ß“¡NŽj1, ‚
‹Ž’õl1, Œ@”ªŽk, ”ª\ì—v•œ (1ŠO‰È): ‘æ14‰ñ–k—¢‘åŠwŠO‰ÈŽîᇊwŒ€‹†‰ï (KSOA) (2011/3/5), V
h.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-110017. [ŒŽ’˜] Minimally invasive straight laparoscopic total proctocolectomy for
ulcerateve coliti. Ozawa H1, Kokuba Y, Nakamura T1, Naito M1, Sato T1, Hatate K1, Onozato W1,
Miura H1, Tsutsui A, Ikeda A1, Ihara A, Watanabe M1: Asian J Endosc Surg 2010/2; 3 : 24-7. (¬
àV•œ‘Ÿ1, ’†‘º—²r1, “à“¡³‹K1, ²“¡•˜Y1, ŠøŽè˜a•F1, ¬–ì—¢q1, ŽO‰YŒ[Žõ1, ’r“c@“Ä1, “nç²
¹•F1: 1ŠO‰È)

H21-110018. [ŒŽ’˜] Neurofilament heavy polypeptide regulates the Akt-beta catenin pathway
in human esophageal squamous cell carcinoma. Kim MS, Xiaofei C, Cyunthia L, Nagpal JK, Lee J,
Huang Y, Yamashita K1, Trink B, Ratovitski EA, Sidransky D: PLoS One 2010/2; 5 (2): e9003. (ŽR
‰ºŒpŽj1: 1ŠO‰È)

H21-120003. [ŒŽ’˜] “]ˆÚ«‘å’°Šà‚ɑ΂·‚éƒZƒcƒLƒVƒ}ƒu‚Ì—LŒø«. ²“¡•˜Y1, ¬–ì—¢q1, ’r“c@
“Ä1, “à“¡³‹K1, ¬àV•œ‘Ÿ1, ’†‘º—²r1, ˆäŒŽ@Œú1, “n粏¹•F1 (1ŠO‰È): V–ò‚ƗՏ° 2010/1; 59 (1):
74-81.

H21-320001. [Ç—á•ñ] isÄ”­Šà‚ɑ΂µ‚Ċɘa“IÝ‘îˆã—Âðs‚Á‚œ˜Z—á. ã–쑏ˆê˜Y, ‹{“à–M
_, ’†ŒF‘žŽm, r–q@’Œ, ”Ñ’Ë”ü1, ŒI“c@~, ‰–àV–M‹v, ‘“c—Yˆê, ’†–ì‘׊°, ¬£ä–ë, åÎ‹I•F
1, ‘ •À@Ÿ1, “n粏¹•F1 (1ŠO‰È): Šà‚Ɖ»Šw—Ö@ 2009/12; 36 (Suppl I): 78-80.

H21-320002. [Ç—á•ñ] TS-1/PTX—Ö@‚ª‘tŒø‚µQOL‚̉ü‘P‚ª“Ÿ‚ç‚ê‚œ—Œ‘€“ûŠà, “]ˆÚ«ˆÝŠà, Šà«
• –Œ‰Š‚̈ê—á. ’†ŒF‘žŽm, r–q@’Œ, ”Ñ’Ë”ü1, ŠâèŒ«‘Ÿ˜Y, •œˆär’j, ‰–àV–M‹v, ŒI“c@~, ‹{“à–M
_, ã–쑏ˆê˜Y, ’·“cG–€, åÎ‹I•F1, ‘ •À@Ÿ1 (1ŠO‰È): The Kitakanto Medical Journal 2010/2;
60 (1): 83-4.

H21-522003. [uÀ]y“ÁW: –D‡Ž…‚ÆŠŽõz‘å’°ŠàpŒã‘nŠŽõ‚̊댯ˆöŽq‚ÌŒŸ“¢. ’†‘º—²r1, “n
粏¹•F1 (1ŠO‰È): “ú–{ŠO‰ÈŠŽõÇŠw‰ïŽGŽ 2009/8; 6 (4): 277-81.

H21-522004. [uÀ]y“ÁW: Žîᇐis‚É”º‚€oncologic emergency; ‹~‹}Žº‚ł̑Ήžƒ}ƒjƒ…ƒAƒ‹zf
’f‚ÆŽ¡—Á@(1) Á‰»ŠíŒn‚Ìoncologic emergency. ’r“c@“Ä1, “n粏¹•F1 (1ŠO‰È): ƒRƒ“ƒZƒ“ƒTƒXŠàŽ¡
—Ã 2010/2; 9 (1): 4-9.

H21-522005. [uÀ]y“ÁW: ƒGƒLƒXƒp[ƒg‚ª“`‚Š‚é Á‰»ŠíŠàŽèp‚Ì—¬‚ê‚ÆŽèp•Žè‚̐S“Ÿz“àŽ‹‹Ÿ
‰º‘å’°ŠàŽèp‚Ì—¬‚ê‚ÆŽèp•Žè‚̐S“Ÿ. ¬–ì—¢q1, ’†‘º—²r1, “à“¡³‹K1, ’r“c@“Ä1, ¬àV•œ‘Ÿ1, ²
“¡•˜Y1, “n粏¹•F1 (1ŠO‰È): —Տ°ŠO‰È 2010/3; 65 (3): 364-71.

[’˜@‘]

H21-620012. [Šwp‘] (•ª’SŽ·•M)y‰ŠÇ«’°ŽŸŠ³z• o‹Ÿ‰ºŽèp. ¬àV•œ‘Ÿ1, “n粏¹•F1 (1ŠO
‰È), •Ò “ú”ä‹I•¶, ˆãŠw‘‰@, “Œ‹ž, 2010/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H21-723011. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œ£tˆÚAŒã‚ɃEƒCƒ‹ƒXŠŽõ (CMVˆÝ‰Š, ‘яóáv]) ‚ðŒJ‚è
•Ô‚µ‚œˆê—á. “y‹Žœˆê˜Y1, ‹Ê’u@“§, ”Ñ“cˆê, ’Ócˆê˜Y, –x]@‘ì, â“c”Ž”ü, ¬–쎛ˆê•F, ŒÃˆäG
“T, ‹v–Ø“c˜a‹u, –ڍ•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO‰È): ‘æ43‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2010/1/28-30),
‚’m.

H21-723012. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –kŠC“¹‚ÌŒ£tˆÚAƒhƒi[‚ւ̃Jƒjƒ…ƒŒ[ƒVƒ‡ƒ“‚Ɛt“Eo–@
‚̉ü‘P“_. ”Ñ“cˆê, ‹Ê’u@“§, “y‹Žœˆê˜Y1, ’Ócˆê˜Y, –x]@‘ì, â“c”Ž”ü, ¬–쎛ˆê•F, ŒÃˆäG“T,
‹v–Ø“c˜a‹u, –ڍ•‡ˆê, •ÄìŒ³Ž÷, ì‘º–Ÿ•v (1ŠO‰È): ‘æ43‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2010/1/28-30), ‚
’m.

H21-723013. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚éˆÝ”S–Œ‰ºŽîᇂɑ΂·‚é• o‹Ÿ‰ºŽèp‚ÌŒŸ“¢.
ŽÄ“c’q—²1, ÷–{Mˆê1, ŽOd–ì_˜N1, ª–{¹”V1, ŽR‰ºŒpŽj1, •Ð“c‰Ä–ç1, ‹e’rŽj˜Y1, “n粏¹•F1 (1
ŠO‰È): ‘æ82‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2010/3/3-5), VŠƒ.

H21-723014. [Šw‰ï (Šw‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical outcome of laparoscopic gastrectmy
for gastric cancer. ÷–{Mˆê1, •Ð“c‰Ä–ç1, ŽR‰ºŒpŽj1, ŽOd–ì_˜N1, ª–{¹”V1, ŽÄ“c’q—²1, ‹e
’rŽj˜Y1, “n粏¹•F1 (1ŠO‰È): ‘æ82‰ñ“ú–{ˆÝŠàŠw‰ï‘‰ï (2010/3/5), VŠƒ.

H21-731003. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’Œ’°ŠàŽ¡—Â̐V‚œ‚È“WŠJ “n粏¹•F (ŠO‰È):
’Œ’°Šà‚ɑ΂·‚é–Ɖu‰»Šw—Ö@u‰‰‰ï (2010/2/5), ‰Y˜a.

H21-731004. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘å’°Šà‚̐V‚µ‚¢Ž¡—Ð헪. “n粏¹•F (ŠO‰È): ‘œ
–€ƒA[ƒrƒ^ƒbƒNƒX“K³Žg—pƒZƒ~ƒi[ (2010/2/19), “Œ‹ž.

H21-731005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘å’°Šà‚ɑ΂·‚é“àŽ‹‹ŸŠO‰È‚ÌŽÀÛ. “n粏¹•F
(ŠO‰È): ‘æ17‰ñVideo Forum for Surgeons in Osaka (2010/2/26), ‘åã.

H21-732001. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ¬Ž™‚É‚š‚¯‚éˆÝᑂ̓K‰ž‚ÆŠÇ—. •“cŒ›Žq (ŠO
‰È): PEDƒhƒNƒ^[ƒYƒlƒbƒgƒ[ƒN (2010/1/30), ‘Š–ÍŒŽ.

H21-732002. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) H“¹ŒeŽºÄ”­‚̈ê—á. ˜a“c@Ž¡ (ŠO‰È): •œ’Ë
ŽsˆãŽt‰ï (2010/2), •œ’ËŽs.

H21-732003. [Šw‰ï (‘S‘)] (ƒZƒ~ƒi[) ‘å’°‚ª‚ñ‚̐f’f‚ÆŽ¡—»‚µ‚Ä—\–h. “n粏¹•F (ŠO‰È): “ú
–{R‰Á—îˆãŠw‰ï Seminer 2010@Šî‘b•Ò/Žóu—puK‰ï (2010/3/7), “Œ‹ž.

H21-733005. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”A–ŒŠÇŠà‚Ì1—á. â–{—FŒ©Žq1, ‹à“cŒå˜Y, “V
–ì^—Žq1, ¬‘q’Œl1, X’JGŒõ1, ”Œ“cŠì”ü–ç, ‹ààVG‹I, ˆäã€l, –Ø‘º@“O, Ö“¡¶˜N (1ŠO‰È):
‘æ814‰ñŠO‰ÈW’k‰ï (2009/9/12), “Œ‹ž.

H21-733006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Œ‹’°Šà‚É‚š‚¯‚é“]ˆÚ—z«ƒŠƒ“ƒpßŒÂ”‚Æ—\Œã‚Ì
ŒŸ“¢. “à“¡³‹K1, ²“¡•˜Y1, ¬àV•œ‘Ÿ1, ’†‘º—²r1, ’r“c@“Ä1, ¬–ì—¢q1, ˆäŒŽ@Œú1, “n粏¹
•F1 (1ŠO‰È): ‘æ72‰ñ‘å’°ŠàŒ€‹†‰ï (2010/1/15), ‹v—¯•Ä, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ 2010/7; 63 (7): 450.

H21-733007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ‹’°Šà‚É‚š‚¯‚é“]ˆÚ—z«ƒŠƒ“ƒpßŒÂ
”‚Æ—\Œã‚ÌŒŸ“¢. “à“¡³‹K1, ²“¡•˜Y1, ¬àV•œ‘Ÿ1, ’†‘º—²r1, ’r“c@“Ä1, ¬–ì—¢q1, ˆäŒŽ@Œú,
“n粏¹•F1 (1ŠO‰È): ‘æ72‰ñ‘å’°ŠàŒ€‹†‰ï (2010/1/15), ‹v—¯•Ä.

H21-733008. [Šw‰ï (’n•ûEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚é’PEŽ®‹ŸŽ‹‰ºŽèp. â–{—FŒ©Žq1, ‹à
“cŒå˜Y, “V–ì^—Žq1, X’JGŒõ1, ŽO‰YŒ[Žõ1, ˆäã€l, ŠC’ËMŽj1, ‹à‘òG‹I (1ŠO‰È): ‘æ127‰ñ_
“ސ쌧—Տ°ŠO‰ÈˆãŠw‰ïW’k‰ï (2010/2/27), ‰¡•l.


S‘ŸŒŒŠÇŠO‰ÈŠw

[Šwp˜_•¶]

110156. [ŒŽ’˜] Ebstein anomaly associated with double-orifice tricuspid valve. ”Â’JŒcˆê1, ‹{
’n@ŠÓ2, ˆäãMK2, ¬ŒŽ–M‹`3 (1“Œ‹ž‘åŠw, 2S‘ŸŒŒŠÇŠO, 3ŠC˜V–Œ‘‡•a‰@): J Thorac Cardiovasc
Surg 2010/6: 139 (6): 131-3.

110157. [ŒŽ’˜] The effectiveness of prestorage leukocyte-reduced red blood cell transfusion on
perioperative inflammatory response with a miniaturized biocompatible bypass system. ‹{’n@ŠÓ
1, ‹{–{—²Ži2, ŒÃ•œ@‘3, ”Â’JŒcˆê4, —F•Û‹M”Ž5, ²“¡@Œ³4, ¬ŒŽ–M‹`6 (1S‘ŸŒŒŠÇŠO, 2ŒQ”nŒ§
—§¬Ž™ˆã—ÃZƒ“ƒ^[, 3MEƒZ, 4“Œ‹ž‘åŠw, 5‹~–œ, 6ŠC˜V–Œ‘‡•a‰@): J Thorac Cardiovasc Surg 2010/6;
139 (6): 1561-7.

110158. [ŒŽ’˜] Regional high-flow cerebral perfusion improves both cerebral and somatic tissue
oxygenation in aortic arch repair. ‹{’n@ŠÓ1, ‹{–{—²Ži2, ŒÃ•œ@‘3, ”Â’JŒcˆê4, —F•Û‹M”Ž5, ˆä
ãMK1, ¬ŒŽ–M‹`6 (1S‘ŸŒŒŠÇŠO, 2ŒQ”nŒ§—§¬Ž™ˆã—ÃZƒ“ƒ^[, 3MEƒZ, 4“Œ‹ž‘åŠw, 5‹~–œ, 6ŠC˜V
–Œ‘‡•a‰@): Ann Thorac Surg 2010/8; 90 (2): 593-9.

110159. [ŒŽ’˜] Miniaturized biocompatible cardiopulmonary bypass for the Fontan procedure. ”Â
’JŒcˆê1, ‹{’n@ŠÓ2, ‹{–{—²Ži3, ˆäãMK2, —F•Û‹M”Ž4, ŒÃ•œ@‘5, ²“¡@Œ³1, ¬ŒŽ–M‹`6 (1“Œ
‹ž‘åŠw, 2S‘ŸŒŒŠÇŠO, 3ŒQ”nŒ§—§¬Ž™ˆã—ÃZƒ“ƒ^[, 4‹~–œ, 5MEƒZ, 6ŠC˜V–Œ‘‡•a‰@): Surg Today
2010/11; 40 (11): 1040-5.

521014. [‰ðà]y‚Ü‚¢E‚Ä‚­‚É‚Á‚­z‰æ‘œf’fQ•A. ’¹ˆäWŽO1, ¬ŒŽ–M‹`2 (1S‘ŸŒŒŠÇŠO, 2ŠC˜V–Œ
‘‡•a‰@): ‹¹•”ŠO‰È 2010/9; 63 (10): 886-91.

521015. [‰ðà]y‚Ü‚¢E‚Ä‚­‚É‚Á‚­zV¶Ž™E“ûŽ™‚̐Ö¬ƒJƒjƒ…ƒŒ[ƒVƒ‡ƒ“‚̍H•v. ‹{’n@ŠÓ (S‘ŸŒŒ
ŠÇŠO): ‹¹•”ŠO‰È 2011/2; 64 (2): 114.

[Šw‰ïEŒ€‹†‰ï“™]

723379. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”N—î‚ɉž‚¶‚œ‘å“®–¬“ñë•ÙÇ—á‚ɑ΂·‚éŠO‰ÈŽ¡—Â̌Ÿ“¢. ’¹ˆäW‘¢
1, ¬ŒŽ–M‹`2, {“¡‹±ˆê1, ŽÄ“c@u1, ˆäãMK1, ”g—¢—z‰î1, ‹{’n@ŠÓ1, —F•Û‹M”Ž1, ”Â’JŒcˆê1,
“c’†—C‹M1 (1S‘ŸŒŒŠÇŠO, 2ŠC˜V–Œ‘‡•a‰@): ‘æ111‰ñ“ú–{ŠO‰ÈŠw‰ï (2010/4/9), –ŒŒÃ‰®, “ú–{ŠO‰ÈŠw
‰ïŽGŽ 2010/3; 111 (2): 561.

723380. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) FontanzŠÂ‚É‚š‚¯‚éV‚œ‚ÈŽw•W‚Ì‘n‘¢@ˆ³—¬—Ê“¯ŽžŒv‘ª‚ÉŠî‚­ƒG
ƒlƒ‹ƒM[‘¹Žž, wave intensity‚̉ðÍ. ”Â’JŒcˆê1, ‹{’n@ŠÓ1, –{“c@’2, “c’†—C‹M1, ”g—¢—z‰î1,
’†”š–퐶2, {“¡‹±ˆê1, ˆäãMK1, —F•Û‹M”Ž3, ¬ŒŽ–M‹`4, Îˆä³_2 (1S‘ŸŒŒŠÇŠO, 2¬Ž™, 3‹~
–œ, 4ŠC˜V–Œ‘‡•a‰@): ‘æ46‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï (2010/7/6-9), ‰YˆÀ, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ
2010/6; 26: 372.

723381. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The relationship between regional cereberal flow and
somatic tissue oxygenetion in Norwood stage I palliation. ‹{’n@ŠÓ1, ”Â’JŒcˆê1, —F•Û‹M”Ž2, “c
’†—C‹M1, ”g—¢—z‰î1, ’¹ˆäW‘¢1, ŽÄ“c@u1, {“¡‹±ˆê1, ˆäãMK1, ¬ŒŽ–M‹`1 (1S‘ŸŒŒŠÇŠO, 2
‹~–œ): ‘æ46‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (2010/7/6-9), ‰YˆÀ.

723382. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) SuturelessC•œ6TŒã‚ɍĔj—ô‚ð‚«‚œ‚µA‹Ù‹}Žèp‚Å‹~
–œ‚µ‚œ‰º•Ç[Ç‚Ì1—á. ’¹ˆäW‘¢1, ¬ŒŽ–M‹`1, {“¡‹±ˆê1, ŽÄ“c@u1, ˆäãMK1, ”g—¢—z‰î1, ‹{
’n@ŠÓ1, —F•Û‹M”Ž2, ”Â’JŒcˆê1, “c’†—C‹M1 (1S‘ŸŒŒŠÇŠO, 2‹~–œ): ‘æ15‰ñ“ú–{Š¥“®–¬ŠO‰ÈŠw‰ïŠw
p‘å‰ï (2010/7/30), ‘åã.

723383. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘å“®–¬“ñë•ÙÇ—á‚É‚š‚¯‚éãs‘å“®–¬Šg’£‚ɑ΂·‚éAo Wrappingp
‚ÌŒŸ“¢. ’¹ˆäW‘¢1, ‹{’n@ŠÓ1, {“¡‹±ˆê1, ŽÄ“c@u1, ˆäãMK1, “c‘º’q‹I1, ‹gˆä@„1, —F•Û
‹M”Ž2, ùŒŽ‘–L1 (1S‘ŸŒŒŠÇŠO, 2‹~–œ): ‘æ51‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï (2010/10/14), –kŠC“¹, –¬ŠÇŠw
2010/9; 50: 183.

723384. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) S‘ŸŒŒŠÇŠO‰È—̈æ‚É‚š‚¯‚é“àŽ‹‹Ÿ‰ºŽèp‚ÌŒ»ó‚ƍ¡Œã: “–‰@‚É‚š‚¯
‚é“àŽ‹‹Ÿ“I“®–¬ŠÇ•Âœp (VATS-PDA) “±“ü‚Ö‚ÌŒoˆÜ‚Ɛ¬Ñ‚ɂ‚¢‚Ä. ‹{–{—²Ži1, ‹g–{–Ÿ_2, ”öèWˆê
1, •Šâ@ŽÀ1, ‹{’n@ŠÓ3 (1ŒQ”nŒ§—§¬Ž™ˆã—ÃZƒ“ƒ^[S‘ŸŒŒŠÇŠO‰È, 2ˆÇ—Ñ‘åŠwS‘ŸŒŒŠÇŠO‰ÈŠw, 3S
‘ŸŒŒŠÇŠO): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/18-20), ‰¡•l, “ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ïŽGŽ 2010/10;
15 (7): 246.

723385. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) S‘ŸŒŒŠÇŠO‰È—̈æ‚É‚š‚¯‚é“àŽ‹‹Ÿ‰ºŽèp‚ÌŒ»ó‚ƍ¡Œã: æ“V«SŽŸ
Š³‚̐S“àC•œ‚É‚š‚¯‚é“àŽ‹‹Ÿ‰ºŽèp‚ÌŒ»ó. ‹{’n@ŠÓ1, ‹gˆä@„1, —F•Û‹M”Ž2 (1S‘ŸŒŒŠÇŠO, 2‹~–œ):
‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/18-20), ‰¡•l, “ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ïŽGŽ 2010/10; 15 (7):
246.

723386. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬l‚É‚š‚¯‚鐶‘Ì•Ù‚ðŽg—p‚µ‚œŽOë•Ù’P•Ù’uŠ·p‚ÌŒŸ“¢. “c‘º’q‹I
1, ’¹ˆäW‘¢1, ˆäãMK1, ŽÄ“c@u1, {“¡‹±ˆê1, ùŒŽ‘–L1, —F•Û‹M”Ž2, ‹gˆä@„, ‹{’n@ŠÓ1 (1
S‘ŸŒŒŠÇŠOS, 2‹~–œ): ‘æ48‰ñ“ú–{lH‘ŸŠíŠw‰ï (2010/11/20), å‘ä, lH‘ŸŠí 2010/11; 39 (2): 150.

723387. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹·¬‘å“®–¬•Ù—ւ𔺂€IAA/CoA complex‚ɑ΂·‚鎡—Õû
j‚ÌŒŸ“¢. ‹gˆä@„1, ‹{’n@ŠÓ1, —F•Û‹M”Ž2, ùŒŽ‘–L1, ’¹ˆäW‘¢1, ŽÄ“c@u1, {“¡‹±ˆê1, ˆä
ãMK1, “c‘º’q‹I1 (1S‘ŸŒŒŠÇŠO, 2‹~–œ): ‘æ41‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2011/2/23), ‰Y
ˆÀ.

723388. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™ŠJSp’†‚̑劲‹y‚щºŽˆ‹ÇŠŽ_‘f–O˜a“x(rSO2)‘ª’è
‚̈Ӌ`. ‹gˆä@„1, ‹{’n@ŠÓ1, ŒÃ•œ@‘2, —F•Û‹M”Ž3, ùŒŽ‘–L1, ’¹ˆäW‘¢1, ŽÄ“c@u1, {“¡
‹±ˆê1, ˆäãMK1, “c‘º’q‹I1 (1S‘ŸŒŒŠÇŠO, 2MEƒZ, 3‹~–œ): ‘æ41‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwp‘
‰ï (2011/2/23), ‰YˆÀ.

723389. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) FontanŽèp‚ð–ÚŽw‚µ‚œŽ¡—Ð헪-‘ŠúŽèp‰î“ü‚É‚æ‚é’i
ŠK“IFontanŽèp. ùŒŽ‘–L1, ‹{’n@ŠÓ1, ‹gˆä@„1, —F•Û‹M”Ž2, “c‘º’q‹I1, ˆäãMK1, ŽÄ“c@u
1, {“¡‹±ˆê1, ’¹ˆäWŽO1 (1S‘ŸŒŒŠÇŠO, 2‹~–œ): ‘æ41‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwp‘‰ï (2011/2/24),
‰YˆÀ.

723390. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ãs‘å“®–¬(Ao) Šg‘å‚𔺂€“ñë•ÙÇ—á‚ÌŠO‰ÈŽ¡—Â̌Ÿ“¢
?Wrappingp‚Ì—LŒø«‚ɂ‚¢‚Ä?. ’¹ˆäWŽO1, ‹{’n@ŠÓ1, ŽÄ“c@u1, {“¡‹±ˆê1, ˆäãMK1, “c
‘º’q‹I1, ‹gˆä@„1, —F•Û‹M”Ž2, ùŒŽ‘–L1 (1S‘ŸŒŒŠÇŠO, 2‹~–œ): ‘æ41‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ï
Šwp‘‰ï (2011/2/25), ‰YˆÀ.

733144. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒtƒ@ƒ[Žl’¥Ç, ”x“®–¬•Âœ, Žå—v‘Ì”x‘€•›ŒŒs‚ɑ΂µ
ˆêŠú“I‚É”x“®–¬W‡‰»‚ðs‚Á‚œ1—á. ”Â’JŒcˆê1, ‹{’n@ŠÓ1, “c’†—C‹M1, ”g—¢—z‰î1, ’¹ˆäW‘¢1, ŽÄ
“c@u1, {“¡‹±ˆê1, ˆäãMK1, —F•Û‹M”Ž2 (1S‘ŸŒŒŠÇŠO, 2‹~–œ): ‘æ153‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“Œ
bM‰z’n•û‰ï (2010/6/5), ‘å‹{, “ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2010/6; 153‰ñ: 7.

733145. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž©ŒÈS–Œƒpƒbƒ`Šg‘åp‚ð—p‚¢‚œ”xÃ–¬‹·ó‚Ì1—á. ùŒŽ
‘–L1, ‹{’n@ŠÓ1, ‹gˆä@„1, —F•Û‹M”Ž2, ’¹ˆäWŽO1, {“¡‹±ˆê1, ŽÄ“c@u1, ˆäãMK1, “c‘º’q
‹I1 (1S‘ŸŒŒŠÇŠO, 2‹~–œ): ‘æ154‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2010/11/13), “Œ‹ž, “ú–{‹¹
•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2010/11; 154‰ñ: 16.

733146. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘å“®–¬“ñë•Ù‚ÉIE‚ƐVŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUS‹Ø‰Š‚ð‡•¹‚µ
‚œÇ—á. “c‘º’q‹I1, ’¹ˆäWŽO1, ùŒŽ‘–L1, —F•Û‹M”Ž2, ‹gˆä@„1, ˆäãMK1, {“¡‹±ˆê1, ŽÄ“c@
u1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2‹~–œ): ‘æ154‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2010/11/13), “Œ
‹ž, “ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2010/11; 154‰ñ: 21.

733147. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’ZŠúŠÔ‚ɐlH•Ù‹@”\•s‘S‚ðŒJ‚è•Ô‚µ‚œDŽ_‹…‘‘œÇ‚Ì1
—á. ùŒŽ‘–L1, ’¹ˆäWŽO1, ŽÄ“c@u1, {“¡‹±ˆê1, ˆäãMK1, “c‘º’q‹I1, ‹gˆä@„1, ‹{’n@ŠÓ
1 (1S‘ŸŒŒŠÇŠO): ‘æ155‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/3/5), ‰¡•l, “ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ
“ŒbM‰z’n•û‰ï—vŽ|W 2011/3; 155‰ñ: 6.

733148. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ^o’ŒÚ‘—ŒŒ‚É‚Ä‘—ŒŒ˜H‚ðŠm•Û‚µ‚œAŒ^‹}«‘å“®–¬‰ð—£
‚Ì1—á. ”g—¢—z‰î1, æс@³Šî1, ŽR–{Ms2, ¬ŒŽ–M‹`2, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ŠC˜V–Œ‘‡•a
‰@): ‘æ155‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/3/5), ‰¡•l, “ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û
‰ï—vŽ|W 2011/3; 155‰ñ: 16.

733149. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰E”x“®–¬˜r“ª“®–¬‹NŽnÇE‘å“®–¬kóÇ‚̈ê—á. “c‘º’q
‹I1, ‹{’n@ŠÓ1, ‹gˆä@„1, —F•Û‹M”Ž2, ’¹ˆäWŽO1, ŽÄ“c@u1, {“¡‹±ˆê1, ˆäãMK1, ùŒŽ‘–L
1 (1S‘ŸŒŒŠÇŠO, 2‹~–œ): ‘æ155‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/3/5), ‰¡•l, “ú–{‹¹•”ŠO
‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W 2011/3; 155‰ñ: 17.

ŒÄ‹zŠíŠO‰ÈŠw

[Šwp˜_•¶]

110160. [ŒŽ’˜] Discriminant model for cytologic distinction of large cell neuroendocrine carcinoma
from small cell carcinoma of the lung. Hoshi R1, Furuta N1, Horai T2, Ishikawa Y3, Migita S3,
Satoh Y4 (1ŠàŒ€‹†‰ï—L–Ÿ•a‰@×–Ef’f•”, 2ŠàŒ€‹†‰ï—L–Ÿ•a‰@ŒÄ‹zŠí“à‰È, 3ŠàŒ€‹†‰ïŠàŒ€‹†Š•a—•”, 4
ŒÄ‹zŠíŠO): J Thorac Oncol 2010/4; 5 (4): 472-8. (²“¡”Vr4)

110161. [ŒŽ’˜] Role of insulin-like growth factor binding protein 2 in lung adenocarcinoma:
IGF-independent antiapoptotic effect via caspase-3. Migita T1, Narita T, Asaka R, Miyagi E, Nagano
H, Nomura K, Matsuura M, Satoh Y2, Okumura S, Nakagawa K, Seimiya H, Ishikawa Y (1The Cancer Institute,
2ŒÄ‹zŠíŠO): Am J Pathol 2010/4; 176 (4): 1756-66. (²“¡”Vr2)

110162. [ŒŽ’˜] Impact of positive pleural lavage cytology on survival in patients having lung
resection for non-small-cell lung cancer: An international individual patient data meta-analysis.
Lim E1, Clough R1, Goldstraw P1, Edmonds L1, Aokage K1, Yoshida J1, Nagai K1, Shintani Y1, Ohta
M1, Okumura M1, Iwasaki T1, Yasumitsu T1, Okada M1, Mimura T1, Tsubota N1, Nakagawa T1, Okumura
N1, Satoh Y1,2, Okumura S1, Nakagawa K1, Higashiyama M1, Kodama K1, Riquet M1, Vicidomini G1, Santini
M1, Kotoulas C1, Hsu JY1, Chen CY1 (1International Pleural Lavage Cytology Collaborators, 2΀
‹zŠíŠO): J Thorac Cardiovasc Surg 2010/6; 139 (6): 1441-6. (²“¡”Vr1,2)

110163. [ŒŽ’˜] Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas. Nagashio
Ryo, Sato Y, Matsumoto T, Kageyama T, Satoh Y1, Ryuge S2, Masuda N2, Goshima N, Jiang SX3, Okayasu
I3 (1ŒÄ‹zŠíŠO, 2ŒÄ‹zŠí“à, 3•a—): Lung Cancer 2010/7; 69 (1): 54-9. (²“¡”Vr1, —Ž‰ØTˆê˜Y2,
‰v“c“TK2, Ó@¢ˆ®3, ‰ªˆÀ@ŒM3)

110164. [ŒŽ’˜] Predictors of postoperative survival in patients with locally advanced non-small
cell lung carcinoma. Iyoda A1, Hiroshima K2 , Moriya Y2, Yoshida S2, Suzuki M2, Shibuya K2, Yoshino
I2 (1ŒÄ‹zŠíŠO, 2ç—t‘åŠwŒÄ‹zŠíŠO‰ÈŠw): Surg Today 2010/8; 40 (8): 725-8. (ˆÉ˜¬“c–Ÿ1)

110165. [ŒŽ’˜] Combined Effect of Anti-Angiogentic Agens, Angiotensin Type 1 Receptor Antagonists
and Radiation Therapy. Amano H1, Ohnuma Y2, Niibe Y2, Hyakawa K2, Satoh Y1, Majima M3 (1ŒÄ‹z
ŠíŠO, 2•úŽËü(Žîá‡), 3–ò—): Current signal transduction therapy 2010/9; 5 (3): 206-11. (“V–ì
‰pŽ÷1, ‘åÀ—Yˆê˜Y2, V•”@÷2, ‘ì˜ad2, ²“¡”Vr1, ”n“ˆ³—²3)

110166. [ŒŽ’˜] Activation status of receptor tyrosine kinase downstream pathways in primary lung
adenocarcinoma with reference of KRAS and EGFR mutations. Hiramatsu M1, Ninomiya H, Inamura K,
Nomura K, Takeuchi K, Satoh Y2, Okumura S, Nakagawa K, Yamori T, Matsuura M, Morikawa T, Ishikawa
Y (1ŠàŒ€‹†Š, 2ŒÄ‹zŠíŠO): Lung Cancer 2010/10; 70 (1): 94-102. (²“¡”Vr2)

310006. [Ç—á•ñ] Thymic large cell neuroendocrine carcinoma: report of a resected case - a case
report. Ogawa F1, Iyoda A1, Amano H1, Nezu K1, Jiang SX2, Okayasu 2, Satoh Y1 (1ŒÄ‹zŠíŠO, 2
•a—): Journal of cardiothoracic surgery 2010/11; 5: 115-9. (¬ìŽj—m1, ˆÉ˜¬“c–Ÿ1, “V–ì‰pŽ÷1,
ª’ÃŒ«Ži1, Ó@¢ˆ®2, ‰ªˆÀ@ŒM2, ²“¡”Vr1)

320023. [Ç—á•ñ] ‡•¹‚·‚é“Á”­«ŠÔŽ¿«”x‰Š‚Ì‹}«‘ˆ«‚̍ŏ¬‰»‚ð–ÚŽw‚µ‚œ”xŠàŽèp‚̏p’†ŠÇ—.
’·’ˍs—Y, ”–ؐ­Œ›, –Dâ‰À@, ŒŽ@‰p‘¥1, ’|‰º@Œ[ (1ŒÄ‹zŠíŠO): —Տ°–ƒŒ 2010/7; 34 (7): 1191-2.

[’˜@‘]

620079. [Šwp‘] (•ª’SŽ·•M)yƒIƒ“ƒRƒƒWƒXƒg‚Í‚±‚€Ž¡—µ‚Ä‚¢‚é@”x‚ª‚ñf—ÂƉ»Šw—Ö@z2. ”x‚ª‚ñ
‚ÆŠmf‚µ‚œ‚ç?Ž¡—Â̐i‚ß•û‚Æ“K‰žÇ—á@4 ”ñ¬×–E”xŠà‚ÌŽ¡—Õûj, p.56-8. ˆÉ˜¬“c–Ÿ1, ²“¡”Vr1
(1ŒÄ‹zŠíŠO), ŠÄC â“c@—D, •Ò ‰v“c“TK2 (2ŒÄ‹zŠí“à), ƒ”ƒ@ƒ“ƒƒfƒBƒJƒ‹, “Œ‹ž, 2011/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712044. [Šw‰ï (‘Û)] (ƒ[ƒNƒVƒ‡ƒbƒv) Cytology of adenocarcinoma of the lung: peripheral
non-invasive lesions and impact of micropapillary clusters on lung cancer treatment. Satoh Y1,
Hosh R2, Horai T3, Okumura S3, Nakagawa K3, Ishikawa Y4, Miyata S5 (1ŒÄ‹zŠíŠO, 2ŠàŒ€—L–Ÿ•a‰@
×–Ef’f•”, 3ŠàŒ€—L–Ÿ•a‰@ŒÄ‹zŠíƒZƒ“ƒ^[, 4ŠàŒ€—L–Ÿ•a‰@•a—•”, 5ŠàŒ€—L–Ÿ•a‰@ƒQƒmƒ€ƒZƒ“ƒ^[):
17th International Congress of Cytology(‘æ17‰ñ‘Û×–EŠw‰ï‹c) (2010/5/19), Edinburgh, Scotland,
UK. (²“¡”Vr1)

712045. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Angiogenesis enhanced by TP signaling-mediated platelet
adhesion to neovasculized endothelial cells with VEGFR1+CXCR4+mobilization during hindlimb
ischemia. Amano H1, Matsui Y1, Ito Y2, Nezu K1, Ogaawa F1, Kurohzu N1, Iyoda A1, Kato S3, Satoh
Y1, Majima M4 (1ŒÄ‹zŠíŠO, 2ŠO‰È, 3zŠÂŠí“à, 4–ò—): ‘æ9‰ñ¢ŠE”÷¬zŠÂŠw‰ï (2010/9/28), ƒtƒ‰
ƒ“ƒXEƒpƒŠ. (“V–ì‰pŽ÷1, ŒˆäŒ[•v1, ˆÉ“¡‹`–ç2, ª’ÃŒ«Ži1, ¬ìŽj—m1, ‹v˜N’Ï®”ü1, ˆÉ˜¬“c–Ÿ1,
‰Á“¡V‘Ÿ˜Y3, ²“¡”Vr1, ”n“ˆ³—²4)

713080. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Circulating tumor cells in peripheral venous blood of primary
lung cancer patients: detection using adenovirus GFP-labeling. Satoh1 Y, Matsui Y1, Ogawa F1,
Amano H1, Hara H1, Nezu K1, Iyoda A1, Yoshimura H1, Fukui T2, Igawa S2, Katagiri M2, Masuda N2,
Masago A3, Tsujino Y3 (1ŒÄ‹zŠíŠO, 2ŒÄ‹zŠí“à, 3ƒVƒXƒƒbƒNƒX (Š”)): AACR 101st (‘æ101‰ñ•Ä‘Šà
Šw‰ï)(2010/4/19), USA Washington, DC. (²“¡”Vr1, ŒˆäŒ[•v1, ¬ìŽj—m1, “V–ì‰pŽ÷1, ŒŽ@‰p‘¥
1, ª’ÃŒ«Ži1, ˆÉ˜¬“c–Ÿ1, ‹g‘º”Ž–M1, •Ÿˆä•ü–ç2, ˆäì@‘2, ‰v“c“TK2)

713081. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Correlation between cytomorphology and therapeutic
responses to EGFR-TKI with lung adenocarcinomas. Hoshi R, Furuta N, Horai T, Ishikawa Y, Hirai
Y, Satoh Y1: 17th International Congress of Cytology (2010/5/18), Edinburgh, Scotland, UK. (²
“¡”Vr1: 1ŒÄ‹zŠíŠO)

713082. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Cytological Characteristics of Pulmonary Large Cell
Neuroendocrine Carcinoma. Satoh Y1: Lung neuroendocrine tumor meeting in Tokyo 2010 (2010/7/23),
Tokyo. (²“¡”Vr1: 1ŒÄ‹zŠíŠO)

713083. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) Is surgical resection a safe and effective treatment for
non-small cell lung cancer patients over 75-years-old? Ogawa F1, Wang G2, Hoshi K3, Matsui Y1,
Amano H1, Kurohzu N1, Hara H1, Nezu K1, Iyoda A1, Satoh Y1 (1ŒÄ‹zŠíŠO, 2—Տ°Œ€‹†EŠé‰æ, 3‰q¶E
ŒöO‰q¶): 4th Asia Pacific Lung Cancer Conference (2010/12/3), Seoul, South Korea. (¬ìŽj—m
1, ‰€@‘‹Õ2, ¯@‰À–F3, ŒˆäŒ[•v1, “V–ì‰pŽ÷1, ‹v˜N’Ï®”ü1, ŒŽ@‰p‘¥1, ª’ÃŒ«Ži1, ˆÉ˜¬“c–Ÿ
1, ²“¡”Vr1)

722097. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yÀ’·z”x‘BŒnˆÙŒ^×–E‚ð‚æ‚Þ: —ǐ«‚©‚ç‘BŠà‚Ü‚Å. ²“¡”V
r (ŒÄ‹zŠíŠO): ‘æ51‰ñ“ú–{—Տ°×–EŠw‰ï‘‰ïtŠú‘å‰ï (2010/5/30), ‰¡•l.

722098. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) Žîᇔx“]ˆÚ‚É‚š‚¯‚éAT1aƒVƒOƒiƒŠƒ“ƒO‚̃ƒJƒjƒYƒ€‚̉ðÍ.
“V–ì‰pŽ÷1, ŒˆäŒ[•v1, ˆÉ“¡‹`–ç2, ª’ÃŒ«Ži1, ¬ìŽj—m1, ‹v˜N’Ï®”ü1, ˆÉ˜¬“c–Ÿ1, ‰Á“¡V‘Ÿ˜Y
3, ²“¡”Vr1, ”n“ˆ³—²4 (1ŒÄ‹zŠíŠO, 2ŠO‰È, 3zŠÂŠí“à, 4–ò—): ‘æ31‰ñ“ú–{‰ŠÇEÄ¶ˆãŠw‰ï
(2010/8/5), “Œ‹žEVh‹ž‰€ƒvƒ‰ƒUƒzƒeƒ‹, ‘æ31‰ñ“ú–{‰ŠÇEÄ¶ˆãŠw‰ïEƒvƒƒOƒ‰ƒ€—\eW 2010/7; 30
(4): 312.

722099. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yÀ’·z”x_Œo“à•ª”åŠà‚ÌŠî‘b‚ƗՏ°. ²“¡”Vr (ŒÄ‹zŠíŠO):
‘æ51‰ñ“ú–{”xŠàŠw‰ï (2010/11/4), L“‡, “ú–{”xŠàŠw‰ïŽ 2010/10; 50 (5): 66.

722100. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ”x‘å×–E_Œo“à•ª”åŠà‚ɑ΂·‚镪Žq•W“IŽ¡—Âð–Ú“I‚Æ‚µ‚œˆâ
“`Žq•ÏˆÙ, ’`”’”­Œ»‰ðÍ. ˆÉ˜¬“c–Ÿ1, Ó@¢ˆ®2, ª’ÃŒ«Ži1, ¬ìŽj—m1, ŒˆäŒ[•v1, “V–ì‰pŽ÷1, ŒŽ@
‰p‘¥1, ‹v˜N’Ï®”ü1, ‰v“c“TK3, ‘ì˜ad4, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2•a—, 3ŒÄ‹zŠí“à, 4•úŽËü(Žî
á‡)): ‘æ51‰ñ“ú–{”xŠàŠw‰ï (2010/11/4), L“‡, “ú–{”xŠàŠw‰ïŽ 2010/10; 50 (5): 468.

722101. [Šw‰ï (‘S‘)] (ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‚±‚̏Ǘá‚ð‚Ç‚€‚·‚é3 (”x). ª’ÃŒ«Ži (ŒÄ‹zŠíŠO): ‘æ72
‰ñ“ú–{—Տ°ŠO‰ÈŠw‰ï‘‰ï (2010/11/21), ‰¡•lEƒpƒVƒtƒBƒR‰¡•l, “ú–{—Տ°ŠO‰ÈŠw‰ïŽGŽ 2010/10; 71 (‘
Š§†): 75.

722102. [Šw‰ï (‘S‘)] (‹L”Ou‰‰) 2009”NÅ—DG˜_•¶Ü‹L”Ou‰‰. ²“¡”Vr (ŒÄ‹zŠíŠO): ‘æ49‰ñ“ú
–{—Տ°×–EŠw‰ï‘‰ïHŠú‘å‰ï (2010/11/21), _ŒË.

722103. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·z”xŠà‚É‚š‚¯‚é‘gD‘œE×–E‘œ‚ƈâ“`Žq•Ï‰». ²“¡”Vr
(ŒÄ‹zŠíŠO): ‘æ49‰ñ“ú–{—Տ°×–EŠw‰ï‘‰ïHŠú‘å‰ï (2010/11/22), _ŒË.

723391. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰)yÀ’·z”x@Šî‘b-2. ²“¡”Vr (ŒÄ‹zŠíŠO): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï
’èŠúŠwpW‰ï (2010/4/10), –ŒŒÃ‰®.

723392. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ”xŠàŽ¡—ẪXƒ^ƒ“ƒ_[ƒh?ŠO‰È—Ö@‚ƕ⏕—Ö@‚Ì‘g‚ݍ‡‚킹?”x‘å
×–E_Œo“à•ª”åŠà‚ÌŽ¡—ÃŒoŒ±‚©‚ç. ˆÉ˜¬“c–Ÿ1, ŒˆäŒ[•v1, ¬ìŽj—m1, “V–ì‰pŽ÷1, ŒŽ@‰p‘¥1, ª’Ã
Œ«Ži1, Ó@¢ˆ®2, ‰ªˆÀ@ŒM2, ‘ì˜ad3, ‹g‘º”Ž–M1, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2•a—, 3•úŽËü(Žî
á‡)): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/10), –ŒŒÃ‰®, “ú–{ŠO‰ÈŠw‰ïŽGŽ 2010/2; 111 (2):
650.

723393. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “]ˆÚ«”xŽîᇌ`¬‚É‚š‚¯‚éAT1aŽó—e‘̂̃ƒJƒjƒYƒ€‚̉ðÍ. “V–ì
‰pŽ÷1, ˆÉ“¡‹`–ç2, ŒˆäŒ[•v1, ¬ìŽj—m1, ŒŽ@‰p‘¥1, ª’ÃŒ«Ži1, ˆÉ˜¬“c–Ÿ1, ”n“ˆ³—²3, ²“¡”V
r1 (1ŒÄ‹zŠíŠO, 2ŠO‰È, 3–ò—): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/10), –ŒŒÃ‰®, “ú–{ŠO
‰ÈŠw‰ïŽGŽ 2010/2; 111 (2): 655.

723394. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠÔŽ¿«”x‰Š‡•¹”xŠà‚É‚š‚¯‚épŒã‹}«‘ˆ«ŠÖ˜AˆöŽq‚ÌŒŸ“¢. ˆÉ˜¬“c
–Ÿ1, HŽRŒ[•ã1, ¬ìŽj—m1, ˆÉ“¡—@Žq1, ŒˆäŒ[•v1, “V–ì‰pŽ÷1, ŒŽ@‰p‘¥1, ª’ÃŒ«Ži1, ‹g‘º”Ž–M
1, ²“¡”Vr1 (1ŒÄ‹zŠíŠO): ‘æ27‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï‘‰ï (2010/5/13), å‘ä, “ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï
ŽGŽ 2010/4; 24 (3): 194.

723395. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 75ÎˆÈã‚—îŽÒ”ñ¬×–E”xŠà‚ɑ΂·‚éŽèpŽ¡—Â̌Ÿ“¢. ¬ìŽj—m
1, ŒˆäŒ[•v1, “V–ì‰pŽ÷1, ŒŽ@‰p‘¥1, ª’ÃŒ«Ži1, ˆÉ˜¬“c–Ÿ1, ‰€@‘‹Õ2, Leon Bax2, ²“¡•q•F2, ‹g
‘º”Ž–M1, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2—Տ°Œ€‹†EŠé‰æ): ‘æ27‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï‘‰ï (2010/5/13), å
‘ä, “ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ïŽGŽ 2010/4; 24 (3): 303.

723396. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ”xŠO‰ÈŽèpŠ³ŽÒ‚̏pŒã•p–¬«•s®–¬‚ɑ΂·‚鉖Ž_ƒ‰ƒ“ƒWƒIƒ[ƒ‹‚Ì
—}§Œø‰Ê‚ÌŒŸ“¢. ª’ÃŒ«Ži1, ¬ìŽj—m1, ŒˆäŒ[•v1, “V–ì‰pŽ÷1, ŒŽ@‰p‘¥1, ˆÉ˜¬“c–Ÿ1, ‹g‘º”Ž–M
1, ²“¡”Vr1 (1ŒÄ‹zŠíŠO): ‘æ27‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï‘‰ï (2010/5/14), å‘ä, “ú–{ŒÄ‹zŠíŠO‰ÈŠw‰ï
ŽGŽ 2010/4; 24 (3): 181.

723397. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹CŠÇŽxè÷—±×–EŽî‚Ì2—á. —é–ؓޏŽq, ¯@—˜—Ç, ŒÃ“c
‘¥s, •œˆäN•v, ²“¡”Vr1, Œ³ˆä‹IŽq, •ó—ˆ@ˆÐ, Îì—Yˆê (1ŒÄ‹zŠíŠO): ‘æ51‰ñ“ú–{—Տ°×–EŠw‰ï
‘‰ï (2010/5/30), ‰¡•l.

723398. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”x‘BŒnˆÙŒ^×–E‚̍זEŠw“IŠÓ•Ê“_‚ÌŒŸ“¢: ”x––œ¬Œ^‘B
Šà‚̍זE‘œ‚𒆐S‚É. ¯@—˜—Ç, ŒÃ“c‘¥s, •œˆäN•v, •ó—ˆ@ˆÐ, Œ³ˆä‹IŽq, Îì—Yˆê, ²“¡”Vr1 (1
ŒÄ‹zŠíŠO): ‘æ51‰ñ“ú–{—Տ°×–EŠw‰ï‘‰ï (2010/5/30), ‰¡•l.

723399. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·zŒÄ‹zŠí‡B. ˆÉ˜¬“c–Ÿ (ŒÄ‹zŠíŠO): ‘æ51‰ñ“ú–{—Տ°×–EŠw
‰ï‘‰ïtŠú‘å‰ï (2010/5/30), ‰¡•l.

723400. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žîᇓ]ˆÚŒ`¬‚É‚š‚¯‚éAT1aŽó—e‘Ì‚Ì–ðŠ„. “V–ì‰pŽ÷1, ŒˆäŒ[•v
1, ˆÉ“¡‹`–ç2, ª’ÃŒ«Ži1, ¬ìŽj—m1, ‹v˜N’Ï®”ü1, ˆÉ˜¬“c–Ÿ1, […º‹g3, ”n“ˆ³—²4, ²“¡”Vr
1 (1ŒÄ‹zŠíŠO, 2ŠO‰È, 3’}”g‘åŠw, 4–ò—): ‘æ31‰ñ“ú–{ŠàŠw‰ï (2010/9/22), ‘åãEƒŠ[ƒKƒƒCƒ„ƒ‹
ƒzƒeƒ‹.

723401. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Molecular allelo-karyotyping of pulmonary
adenocarcinoma using single nucleotide polymorphism genomic array. Ninomiya H, Kato M, Nomura
K, Nagano Y, Mun M, Sakao Y1, Okumura S, Satoh Y, Ogawa S, Ishikawa Y: ‘æ69‰ñ“ú–{ŠàŠw‰ïŠwp‘
‰ï (2010/9/23), ‘åã. (²“¡”Vr1: 1ŒÄ‹zŠíŠO)

723402. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ”x‘å×–E_Œo“à•ª”åŠàØœÇ—á‚É‚š‚¯‚épŒãÄ”­‚ÌŒŸ“¢. ˆÉ˜¬“c–Ÿ
1, ¬ìŽj—m1, ŒˆäŒ[•v1, “V–ì‰pŽ÷1, ŒŽ@‰p‘¥1, ‹v˜N’Ï®”ü1, ª’ÃŒ«Ži1, ‹g‘º”Ž–M1, ²“¡”Vr
1 (1ŒÄ‹zŠíŠO): ‘æ63‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/10/27), ‘åã, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽ
2010/9; 58 (supplement): 447.

723403. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŒŽ”­«”ñ¬×–E”xŠà‚É‚š‚¯‚錌’†zŠÂŽîᇍזE‚̍‚ŠŽ“xŒŸo–@‚̈Ó
‹`. ²“¡”Vr1, ¬ìŽj—m1, ŒˆäŒ[•v1, “V–ì‰pŽ÷1, ŒŽ@‰p‘¥1, ‹v˜N’Ï®”ü1, ª’ÃŒ«Ži1, ˆÉ˜¬“c
–Ÿ1, ‰v“c“TK2 (1ŒÄ‹zŠíŠO, 2ŒÄ‹zŠí“à): ‘æ51‰ñ“ú–{”xŠàŠw‰ï (2010/11/3), L“‡, “ú–{”xŠàŠw‰ïŽ
2010/10; 50 (5): 508.

723404. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŒŽ”­«”xŠà‚É‚š‚¯‚é×–Ef‚Å‚Ì—\Œã‚̐„‘ª‚ÉŠÖ‚·‚錟“¢. ¯@—˜—Ç
1, •ó—ˆ@ˆÐ1,2, •¶@•qŒi2, â”öK‘¥2, ‰œ‘º@‰h2, ’†ì@Œ’2, –x’n@“Ä2, ‘å–ö•¶‹`2, Œ”öœl
2, Œ³ˆä‹IŽq1,3 Îì—Yˆê3, ‹{“c@•q4, ²“¡”Vr5 (1ŠàŒ€—L–Ÿ•a‰@×–Ef’f•”, 2ŠàŒ€—L–Ÿ•a‰@ŒÄ‹z
ŠíƒZƒ“ƒ^[, 3ŠàŒ€—L–Ÿ•a‰@•a—•”, 4ŠàŒ€—L–Ÿ•a‰@ƒQƒmƒ€ƒZƒ“ƒ^[, 5ŒÄ‹zŠíŠO): ‘æ51‰ñ“ú–{”xŠàŠw‰ï
(2010/11/3), L“‡, “ú–{”xŠàŠw‰ïŽ 2010/10; 50 (5): 533.

723405. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŒŽ”­«”xŠàŽèpŠ³ŽÒ‚̏pŒã•p–¬«•s®–¬‚ɑ΂·‚鉖Ž_ƒ‰ƒ“ƒWƒIƒ[
ƒ‹‚Ì—}§Œø‰Ê‚ÌŒŸ“¢. ª’ÃŒ«Ži1, ¬ìŽj—m1, ŒˆäŒ[•v1, “V–ì‰pŽ÷1, ŒŽ@‰p‘¥1, ‹v˜N’Ï®”ü1, ˆÉ
˜¬“c–Ÿ1, ²“¡”Vr1 (1ŒÄ‹zŠíŠO): ‘æ51‰ñ“ú–{”xŠàŠw‰ï (2010/11/4), L“‡, “ú–{”xŠàŠw‰ïŽ 2010/10;
50 (5): 567.

723406. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·zŠî‘bŒ€‹†‡A. ˆÉ˜¬“c–Ÿ (ŒÄ‹zŠíŠO): ‘æ49‰ñ“ú–{—Տ°×–E
Šw‰ï‘‰ïHŠú‘å‰ï (2010/11/21), _ŒË.

731073. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”xŠàf—Âɂš‚¯‚éŒÄ‹zŠí×–Ef: Œ»ó‚Æ“W–]. ²“¡”Vr
(ŒÄ‹zŠíŠO): “ú–{—Տ°×–EŠw‰ï–k—€˜A‡‰ï (2010/9/23), •ŸˆäŒ§Ä¶‰ï•a‰@Œ€Cu“°.

732055. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Žs–¯ŒöŠJuÀ) ‚à‚Á‚Æ’m‚è‚œ‚¢, ”x‚ª‚ñÅ‘Oü. ²“¡”Vr (ŒÄ‹zŠí
ŠO): ‘æ24‰ñ“ú–{—Տ°×–EŠw‰ïŠÖ“Œ˜A‡ŠwpW‰ï (2010/9/18), Œyˆä‘ò.

732056. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€)y‘‡Ži‰ïzƒVƒ“ƒ|ƒWƒEƒ€ II: ×–E“¯’è‚␄’è•a•Ï
‚ÉŽ©M‚Ì‚ ‚é1–‡‚̎ʐ^. ²“¡”Vr (ŒÄ‹zŠíŠO): ‘æ24‰ñ“ú–{—Տ°×–EŠw‰ïŠÖ“Œ˜A‡ŠwpW‰ï
(2010/9/18), Œyˆä‘ò.

733150. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Bjork•Ï–@pŒã‚ɐis‚µ‚œ”x“®Ã–¬á‘‚ɑ΂µTCPC
conversionŒã‚ɉE”x‰º—tØœ‚ðs‚Á‚œ1—á. ª’ÃŒ«Ži1, ‹{’n@ŠÓ2, ¬ìŽj—m1, “V–ì‰pŽ÷1, ˆÉ˜¬“c
–Ÿ1, ˆäãMK2, ’†”š–퐶3, ²“¡”Vr1 (1ŒÄ‹zŠíŠO, 2S‘ŸŒŒŠÇŠO, 3¬Ž™ (‘æ153‰ñ“ú–{‹¹•”ŠO‰ÈŠw
‰ïŠÖ“ŒbM‰z’n•û‰ï (2010/6/5), ‘å‹{ƒ\ƒjƒbƒNƒVƒeƒBƒrƒ‹, “ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï—vŽ|W
2010/6; 153‰ñ: 8.

733151. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) —Œ‘€–ԏó‰A‰e‚ɑ΂µ‹¹o‹Ÿ‰º”x•”•ªØœp‚ðŽ{s‚µf’f
‚³‚ê‚œ”xDŽ_«“÷Žî‚̈ê—á. Îˆä@‘å1, ¬ìŽj—m1, ŒˆäŒ[•v1, “V–ì‰pŽ÷1, ŒŽ@‰p‘¥1, ‹v˜N’Ï®”ü
1, ª’ÃŒ«Ži1, ˆÉ˜¬“c–Ÿ1, ‹g‘º”Ž–M1, ŽOŽ}@M2, ‰ªˆÀ@ŒM2, ‰v“c“TK3, ²“¡”Vr1 (1ŒÄ‹zŠíŠO,
2•a—, 3ŒÄ‹zŠí“à): ‘æ133‰ñ“ú–{ŒÄ‹zŠí“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”‰ï (2010/7/10), “Œ‹ž (ƒAƒXƒeƒ‰ƒX–{ŽÐ).

733152. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‹¹o‹Ÿ‚𕹗p‚µ, 1Šú“I‚ÉŽèp‚ðŽ{s‚µ‚œDumbbellŒ^_
ŒoâŽî‚Ì1—á. Îˆä@‘å1, “V–ì‰pŽ÷1, ˆÉ˜¬“c–Ÿ1, ¬ìŽj—m1, ŒˆäŒ[•v1, ŒŽ@‰p‘¥1, ‹v˜N’Ï®”ü
1, ª’ÃŒ«Ži1, ‹g‘º”Ž–M1, Ž…@ú2, “¡ˆäŽF2, ŒŽ@“ÖŽq3, ŽOã“N•v3, ŽOŽ}@M3, ²“¡”Vr1 (1
ŒÄ‹zŠíŠO, 2”]ŠO, 3•a—): ‘æ134 ‰ñ“ú–{ŒÄ‹zŠí“àŽ‹‹ŸŠw‰ïŠÖ“ŒŽx•”‰ï (2010/9/11), “Œ‹ž (ƒAƒXƒeƒ‰ƒX
–{ŽÐ).


”]_ŒoŠO‰ÈŠw

[Šwp˜_•¶]

110167. [ŒŽ’˜] Expression of Hydroxyindole-O-Methyltransferase Enzyme in the Human Central
Nervous System and in Pineal Parenchymal Cell Tumors. Fukuda T1, Akiyama N2, Ikegami M2, Takahashi
H3, Sasaki A4, Oka H5, Komori T6, Tanaka Y7, Nakazato Y7, Akimoto J8, Tanaka M9, Okada Y9, Saito
S2 (1“Œ‹žŽœŒb‰ïˆã‰È‘åŠw_Œo•a—Šw, 2“¯•ªŽq–ƉuŠw, 3VŠƒ‘åŠw•a—, 4é‹Êˆã‰È‘åŠw•a—, 5”]ŠO, 6
“s—§_ŒoŒ€‹†Š•a—, 7ŒQ”n‘åŠw‘æˆê•a—, 8“Œ‹žˆã‰È‘åŠw”]_ŒoŠO‰È, 9“Œ‹ž—Žqˆã‰È‘åŠw”]_ŒoŠO‰È):
J Neuropathol Exp Neurol 2010/5; 69 (5): 498-510. (•Ÿ“c—²_1, HŽR’šä2, ’rã‰ë”Ž2, ‚‹Ž@‹Ï
3, ²X–؏~4, ‰ª@GG5, ¬X—²Ži6, “c’†—DŽq7, ’†—¢—mˆê7, HŒ³Ž¡˜N8, “c’†³•F9, ‰ª“c–F˜a9,
Ä“¡ŽO˜Y2)

110168. [ŒŽ’˜] Soluble Guanylate Cyclase ƒ¿1ƒÀ1Limits Stroke Size and Attenuates Neurological
Injury. Atochin DN1, Yuzawa I2, Li Q1, Rauwerdink KM1, Malhotra R1, Chang J1, Brouckaert P3, Ayata
C1, Moskowitz MA1, Bloch KD1, Huang PL1, Buys ES1 (1MGH, 2”]ŠO, 3Ghent University): Stroke 2010/8;
41: 1815-9. (“’àV@ò2)

110169. [ŒŽ’˜] PDGFRA gene rearrangements are frequent genetic evemts in PDGFRA-amplified
glioblastomas. Ozawa, T1, Cameron W Brennan2, Lu Wang3, Massimo Squatrito2, Takashi Sasayama4,
Mitsutoshi Nakada5, Jason T Huse2, Alicia Pedraza2, Utsuki S1, Yasui Y6, Adesh Tandon7, Elena I
Fomchenko2, Oka H1, Ross L Levine3, Fujii K1, Marc Ladanyi3, Eric C Holland2 (1”]ŠO, 2Brain Tumor
Center, Sloan-Kettering Cancer Center, 3Dept. of Pathology and Human Oncology, Pathogenesis Program,
SKCC, 4_ŒË‘åŠw”]_ŒoŠO‰È, 5‹à‘ò‘åŠw”]_ŒoŠO‰È, 6Œ`‘ÔŒn, 7Department of Neurosurgery, The Albert
Einstein College of Nedicine): Genes & Development 2010/10; 24 (19): 2205-18. (¬àV’B–ç1, ‰F’Ã
–Ø‘1, ˆÀˆä”ü]6, ‰ª@GG1, “¡ˆäŽF1)

110170. [ŒŽ’˜] Neurocysticercosis: Assessing Where the Infection was Acquired From. Yanagida T1,
Yuzawa I2, Joshi DD1, Sako Y1, Nakao M1, Nakatani K3, Kawano N2, Oka H2, Fujii K2, Ito A1 (1ˆ®
ìˆã‰È‘åŠwŠñ¶’ŽŠw, 2”]ŠO, 3ˆ®ìˆã‰È‘åŠw“¯“®•šŠw): J Travel Med 2010/5-6; 17 (3): 206-8. (–ö
“c“N–î1, “’àV@ò2, Joshi DD1, ”—@Nm1, ’†”ö@–«1, ’†’J˜aG3, ì–ìM”V2, ‰ª@GG2, “¡ˆä
ŽF2, ˆÉ“¡@—º1)

110171. [ŒŽ’˜] Linear Fractures Occult on Skull Radiographs: A Pitfall at Radiological Screening
for Mild Head Injury. Nakahara K1, Shimizu S1, Utsuki S1, Oka H1, Kitahra T2, Kan S3, Fujii K1
(1”]ŠO, 2‹~–œ, 3•úŽËü (‰æ‘œ)): J Trauma 2011/1; 70 (1): 180-2. (’†ŒŽ–M»1, Ž…@ú1, ‰F’Ã
–Ø‘1, ‰ª@GG1, –kŒŽF—Y2, ›@Mˆê3, “¡ˆäŽF1)

110172. [ŒŽ’˜] Cerebral autosomal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy syndrome mutations increase susceptibility to spreading depression.
Eikermann-Haerter K, Yuzawa I1, Dilekoz E, Moskowitz MA, Ayata C: Ann Neurol 2011/2; 69 (2): 413-8.
(“’‘ò@ò1: 1”]ŠO)

110173. [ŒŽ’˜] Outcomes Analysis of Ruptured Distal Anterior Cerebral Artery Aneurysms Treated
by Endosaccular Embolization and clipping. Suzuki S1, Kurata A1, Yamada M1, Iwamoto K1, Nakahara
K1, Sato K1, Niki J1, Sasaki M1, Kitahara T2, Fujii K1, Kan S3 (1”]ŠO, 2‹~–œ, 3•úŽËü (‰æ‘œ)):
Intervent Neuroradiol 2011/3; 17 (1): 49-57. (—é–؏ː¶1, ‘q“c@²1, ŽR“c@Ÿ1, Šâ–{˜a‹v1, ’†
ŒŽ–M»1, m–؁@~1, ²“¡Œör1, ²X–Ø—º1, –kŒŽF—Y2, “¡ˆäŽF1, ›@Mˆê3)

120023. [ŒŽ’˜] ‘OŒãŠg’£‚ ‚é‚¢‚ÍŒãŠg’£Žè‹Z‚ðs‚í‚È‚¢èò“®–¬ƒXƒeƒ“ƒg—¯’up: pŒã‚ÌŒoŽž“I‚ÈŒŒŠÇ“à
o‚̕ω». —é–؏ː¶1, ‘q“c@²1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, m–؁@~1, ‹{è•üŽq1, ŽR“c@Ÿ1, ‰ª@
GG1, “¡ˆäŽF1, ›@Mˆê2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): Journal of Neuroendovascular Therapy 2010/5;
4 (1): 16-9.

120024. [ŒŽ’˜] ”F’mÇÇó‚ð’æ‚·‚éd–Œ“®Ã–¬á‘‚Ì•a‘Ô. —é–؏ː¶1, ‘q“c@²1, ‰F’Öؑ1, ’†ŒŽ
–M»1, Šâ–{˜a‹v1, ŽR“c@Ÿ1, “¡ˆäŽF1, ›@Mˆê2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): Dementia Japan
2010/6; 24 (2): 184-90.

120025. [ŒŽ’˜] •sŠ®‘S‚ȃNƒŠƒbƒsƒ“ƒO‚É‚æ‚èŽc‘¶‚µ‚œ”]“®–¬áŽ‚ɑ΂·‚é”]ŒŒŠÇ“àŽèp‚Ì—L—p«. m–؁@
~1, —é–؏ː¶1, ‘q“c@²1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, ²“¡Œör1, ŽR“c@Ÿ1, –kŒŽF—Y2, “¡ˆäŽF
1, ›@Mˆê3 (1”]ŠO, 2‹~–œ, 3•úŽËü (‰æ‘œ)): Journal of Neuroendvascular Therapy 2010/12; 4 (3):
140-5.

120026. [ŒŽ’˜] ‹‘å“®–¬áŽ‚ɑ΂·‚é᎓àÇðp‚̕ꌌŠÇŽ©‘R•ÂÇ‚ɂ‚¢‚Ä. —é–؏ː¶1, ‘q“c@²1, Šâ
–{˜a‹v1, ’†ŒŽ–M»1, m–؁@~1, ˆ¢•”Ž’q1, Œ¢Ž”@‰~1, ŽR“c@Ÿ1, “¡ˆäŽF1, ›@Mˆê2 (1”]
ŠO, 2•úŽËü (‰æ‘œ)): –k—¢ˆãŠw 2010/6; 40 (1): 1-6.

210005. [€ŒŽ’˜] Optic nerve germinoma - neurohypophyseal germinoma‚Æ‚Ì‘Šˆá. ‰F’Öؑ1, ‰ª@G
G1, –Ø“‡çq1, ‹{è•üŽq1, “¡ˆäŽF1 (1”]ŠO): ‘æ20‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ïproceeding 2010/6;
86 (Suppl): 51-3.

220005. [€ŒŽ’˜] “«‰ºŽˆ’É‚ð’悵‚œ˜’ʼn©FèÕ‘Ñ“àŒŒŽî‚Ì1—á. ‘åàV¬”V1, ë“à—²—Y1, ¬—шè
•v1, “¡ˆäŽF1 (1”]ŠO): “ú–{Ò‘áŠQˆãŠw‰ïŽ 2010/5; 23 (1): 120-1.

220006. [€ŒŽ’˜] èò’Å‘OcèՑэœ‰»Ç‚Æ‹‘å‘O•ûœž™‚É‚æ‚èš‹‰ºáŠQ‚𗈂œ‚µ‚œ1—á. ë“à—²—Y1, ‘å
àV¬”V2, L£—²ˆê3, “¡ˆäŽF2 (1KMC•a‰@, 2”]ŠO, 3_Œo“à): “ú–{Ò‘áŠQˆãŠw‰ïŽ 2010/5; 23 (1):
86-7.

220007. [€ŒŽ’˜] ‹¹’ōd–ŒŠO• ‘€‚É”­¶‚µ‚œŠC–ȏ󌌊ǎî‚Ì1—á. ë“à—²—Y1, ‘åàV¬”V2, L£—²ˆê
3, “¡ˆäŽF2 (1KMC•a‰@, 2”]ŠO, 3_Œo“à): “ú–{Ò‘áŠQˆãŠw‰ïŽ 2010/5; 23 (1): 98-9.

220008. [€ŒŽ’˜] ƒp[ƒLƒ“ƒ\ƒ“•aŠ³ŽÒ‚É‚š‚¯‚鐳’†_ŒoŽhŒƒŒã‚ÌŽ‹°VimŠj“à‚̃V[ƒ^‘шæƒRƒq[ƒŒƒ“
ƒX‚̕ω»‚š‚æ‚Ñ–ðŠ„‚É‚Â‚¢‚Ä. “n•ÓŽ¬1, ²“¡Ÿl2, ’†“ˆ@„3, •œŒË­Žj1, D–{—T•œ1, ‘å]çœA
4 (1ŒQ”n‘åŠwˆãŠw•””]_ŒoŠO‰È, 2”]ŠO, 3“Œ‹ž—Žqˆã‰È‘åŠw”]_ŒoŠO‰È, 4“ú‚•a‰@‹@”\”]ŠO‰ÈEƒKƒ“
ƒ}ƒiƒCƒtƒZƒ“ƒ^[): ‹@”\“I”]_ŒoŠO‰È 2010/6; 49 (1): 20-1.

220009. [€ŒŽ’˜] ƒ‰ƒgƒPùN–EpŒã‚̐Z“§ˆ³«’E‘ÇŒóŒQ‚ð‚«‚œ‚µ‚œˆê—á. Œ¢Ž”@‰~1, ‰ª@GG1, ²
“¡Ÿl1, ‰F’Öؑ1, “¡ˆäŽF1 (1”]ŠO): ‘æ20‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ïproceeding 2010/6; 86
(Suppl): 54-6.

220010. [€ŒŽ’˜] Optic nerve germinoma?neurohypophyseal germinoma‚Æ‚Ì‘Šˆá. ‰F’Öؑ1, ‰ª@G
G1, –Ø“‡çq1, ŠÖŒû•üŽq1, “¡ˆäŽF1 (1”]ŠO): ‘æ20‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ïProceeding 2010/6;
86 (Suppl): 51-3.

220011. [€ŒŽ’˜] MTX‘å—ʗÖ@Žž‚ÌŽÄ—è“’‚É‚æ‚ét‹@”\•ÛŒìì—p. ‰F’Öؑ1, ‰ª@GG1, –Ø“‡çq
1, —é–؏ː¶1, ²“¡Ÿl1, ‹{“‡—Ç‹P1, “¡ˆäŽF1 (1”]ŠO): ”]_ŒoŠO‰È‚ÆŠ¿•û 2010/8; 18: 31-3.

220012. [€ŒŽ’˜] VA-PICA “®–¬áŽ‚ɑ΂·‚錌ŠÇ“àÇðp‚Ì—LŒø«. —é–؏ː¶1, ‘q“c@²1, Šâ–{˜a‹v
1, ’†ŒŽ–M»1, m–؁@~1, ²“¡Œör1, ²X–Ø—º1, Œ¢Ž”@‰~1, ŽR“c@Ÿ1, “¡ˆäŽF1, ›@Mˆê2,
–kŒŽF—Y3 (1”]ŠO, 2•úŽËü (‰æ‘œ), 3‹~–œ): Journal of Neuroendvascular Therapy 2010/11; 4 (4):
245.

220013. [€ŒŽ’˜] ŠC–ȐÖ¬“Ž‚ւ̐V‚µ‚¢ŒoÃ–¬ƒAƒvƒ[ƒ`ƒ‹[ƒg. Œ¢Ž”@‰~1, ‘q“c@²1, —é–؏ː¶
1, Šâ–{˜a‹v1, m–؁@~1, ’†ŒŽ–M»1, ²“¡Œör1, ŽR“c@Ÿ1, “¡ˆäŽF1, ›@Mˆê2, ‘响ä’m1,
¬àV@m3 (1”]ŠO, 2•úŽËü (‰æ‘œ), 3Ž¬“c‘‡•a‰@”]_ŒoŠO‰È): Journal of Neuroendvascular Therapy
2010/11; 4 (4): 270.

220014. [€ŒŽ’˜] ‰ð—£«’ōœ“®–¬áŽ‚Ì•a‘Ԃɂ‚¢‚Ä, ŒŒs—ÍŠw“IŒŸ“¢. m–؁@~1, ‘q“c@²1, —é–Ø
Ë¶1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, ²X–Ø—º1, ²“¡Œör1, ˆ¢•”Ž’q1, Œ¢Ž”@‰~1, ŽR“c@Ÿ1, “¡ˆäŽ
F1, ›@Mˆê2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): Journal of Neuroendvascular Therapy 2010/11; 4 (4): 339.

220015. [€ŒŽ’˜] ”]“®–¬áŽÇðp‚É‚š‚¯‚éáŽ“à–¬ˆ³‘ª’è‚̈Ӌ`‚Æ—L—p«. ²“¡Œör1, ‘q“c@²1, —é
–؏ː¶1, m–؁@~1, ²X–Ø—º1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, ŽR“c@Ÿ1, “¡ˆäŽF1, ›@Mˆê2 (1”]
ŠO, 2•úŽËü(‰æ‘œ)): Journal of Neuroendvascular Therapy 2010/11; 4 (3): 329.

310007. [Ç—á•ñ] Primary central nervous system large B-cell lymphoma with prolific, mixed
T-cell and macrophage infiltrates, mimicking multiple sclerosis. Utsuki S1, Oka H1, Miyazaki T1,
Yamazaki T1, Yasui Y2, Fujii K1, Kawano N1, Tokuyama W3, Iwabuchi K3, Okayasu I3, Yagishita S4
(1”]ŠO, 2Œ`‘ÔŒn, 3•a—, 4_“ސ샊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[•a—): Brain Tumor Pathol 2010/4; 27
(1): 59-63. (‰F’Öؑ1, ‰ª@GG1, ‹{è•üŽq1, ŽRè—F–ç1, ˆÀˆä”ü]2, “¡ˆäŽF1, ì–ìM”V1, “¿
ŽR@é3, ŠâŸºŒ[ˆê3, ‰ªˆÀ@ŒM3)

310008. [Ç—á•ñ] Foramen magnum meningioma with arterial supply from the odontoid arterial
sysytem. Miyazaki T1, Suzuki S1, Kurata A1, Iwamoto K1, Shimizu S1, Oka H1, Fujii K1, Kan S2 (1
”]ŠO, 2•úŽËü (‰æ‘œ)): Kitasato Med J 2010/9; 40 (2): 154-7. (‹{è•üŽq1, —é–؏ː¶1, ‘q“c@²
1, Šâ–{˜a‹v1, Ž…@ú1, ‰ª@GG1, “¡ˆäŽF1, ›@Mˆê2)

310009. [Ç—á•ñ] A Case of Non-Traumatic Subgaleal Hematoma Effecitvely Treated with
Endovascular Surgery. Koizumi H1, Suzuki S1, Utsuki S1, Nakahara K1, Niki J1, Mabuchi I1, Kurata
A1, Fujii K1 (1”]ŠO): Intervent Neuroradiol 2010/9; 16 (3): 317-21. (¬òŠ°”V1, —é–؏ː¶1, ‰F
’Öؑ1, ’†ŒŽ–M»1, m–؁@~1, ”nŸºˆêŽ÷1, ‘q“c@²1, “¡ˆäŽF1)

310010. [Ç—á•ñ] Effectiveness of interferon-beta therapy for recurrent glioblastoma: a case
report. Utsuki S1, Oka H1, Miyajima Y1, Sato K1, Shimizu S1, Suzuki S1, Fujii K1 (1”]ŠO): Tumori
2011/1-2; 97 (1): 119-22. (‰F’Öؑ1, ‰ª@GG1, ‹{“‡—Ç‹P1, ²“¡Œör1, Ž…@ú1, —é–؏ː¶
1, “¡ˆäŽF1)

310011. [Ç—á•ñ] Subependymal giant cell astrocytoma with oncocytic change. Utsuki S1, Oka H1,
Kijima C1, Yasui M2, Fujii K1, Kawano N3, Yagishita S4 (1”]ŠO, 2Œ`‘ÔŒn, 3ˆé•”ƒNƒŠƒjƒbƒN, 4_
“ސ샊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[•a—): Brain Tumor Pathol 2011/2; 28 (1): 53-7. (‰F’Öؑ1, ‰ª@G
G1, –Ø“‡çq1, ˆÀˆä”ü]2, “¡ˆäŽF1, ì–ìM”V3, –ö‰ºŽO˜Y4)

310012. [Ç—á•ñ] Primary central nervous system lymphoma in acquired immune deficiency syndrome
mimicking toxoplasmosis. Utsuki S1, Oka H1, Abe K1, Ohsawa S1, Yamazaki T1, Yasui Y2, Fujii K1
(1”]ŠO, 2Œ`‘ÔŒn): Brain Tumor Pathol 2011/2; 28 (1): 83-7. (‰F’Öؑ1, ‰ª@GG1, ˆ¢•”Ž’q1,
‘åàV¬”V1, ŽRè—F–ç1, ˆÀˆä”ü]2, “¡ˆäŽF1)

320024. [Ç—á•ñ] Ž‹°“à‹ÃŒÅ•”ˆÊ‚Ì‘Šˆá‚É‚æ‚鏑ŽšUí‚̉ü‘PŒø‰Ê‚ɂ‚¢‚Ä: Ò‘¬”]•Ï«Ç‚Ì1—á.
²“¡Ÿl1, ‘å]çœA2, “n•ÓŽ¬3, ’†“‡@„4, “¡–{Œ’ˆê5 (1”]ŠO, 2“ú‚•a‰@‹@”\”]ŠO‰ÈEƒKƒ“ƒ}ƒi
ƒCƒtƒZƒ“ƒ^[, 3ŒQ”n‘åŠwˆãŠw•””]_ŒoŠO‰È, 4“Œ‹ž—Žqˆã‰È‘åŠw”]_ŒoŠO‰È, 5Ž©Ž¡ˆã‰È‘åŠw_Œo“à‰È):
‹@”\“I”]_ŒoŠO‰È 2010/6; 49 (1): 64-5.

320025. [Ç—á•ñ] èò“®–¬ƒXƒeƒ“‚Æ—¯’upŒã‚ɉߟ󗬏njóŒQ‚ð’悵‚œÇ—á‚ÌŒŸ“¢. ’†ŒŽ–M»1, —é–؏Ë
¶1, ‘q“c@²1, Šâ–{˜a‹v1, m–؁@~1, ²X–Ø—º1, ²“¡Œör1, ŽR“c@Ÿ1, “¡ˆäŽF1, ›@Mˆê
2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): Journal of Neuroendvascular Therapy 2010/11; 4 (4): 352.

320026. [Ç—á•ñ] ”F’mÇÇó‚Őf’f‚³‚ê‚œ–«d–Œ‰ºŒŒŽî‚ÌŠO‰ÈŽ¡—ÃŒø‰Ê. —é–؏ː¶1, ’†ŒŽ–M»1,
‰F’Öؑ1, ‘q“c@²1, ŽR“c@Ÿ1, “¡ˆäŽF1 (1”]ŠO): Dementia Japan 2011/3; 24 (4): 479-83.

510007. [‘à] Current Signal Transduction Therapy for Brain Tumors Review Article. Oka H1, Niibe
Y2, Utsuki S1, Hayakawa K2, Fujii K1 (1”]ŠO, 2•úŽËü (Žîá‡)): Current Signal Transduction Therapy
2010/9; 5 (3): 223-30. (‰ª@GG1, V•”@÷2, ‰F’Öؑ1, ‘ì˜ad2, “¡ˆäŽF1)

511001. [‰ðà] (Technical Note) Depth-Adjustable Fixation of External Ventricular Drains to
Counteract Obstruction in Tight Ventricles. Shimizu S1, Hagiwara H1, Nakayama K1, Yamamto I2,
Fujii K1 (1”]ŠO, 2‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È): Neurol Med Chir (Tokyo) 2010/7; 50 (7):
611-3. (Ž…@ú1, ”‹ŒŽG”V1, ’†ŽRŒ«Ži1, ŽR–{—E•v2, “¡ˆäŽF1)

511002. [‰ðà] (Technical Note) Preventive stitching for migration of a peritoneal catheter into
the abdominal wall after ventriculoperitoneal shunting. Nakahara K1, Shimizu S1, Oka H1, Utsuki
S1, Fujii K1 (1”]ŠO): Neurol Med Chir (Tokyo) 2010/7; 50 (7): 614-5. (’†ŒŽ–M»1, Ž…@ú1, ‰ª@
GG1, ‰F’Öؑ1, “¡ˆäŽF1)

511003. [‰ðà] (Technical Note) Anchoring of Methylmethacrylate Filler to the Calvarium. Shimizu
S1, Kondo K1, Yamazaki T1, Nakayama K1, Yamamoto I2, Fujii K1 (1”]ŠO, 2‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“
ƒ^[•a—): Neurol Med Chir (Tokyo) 2011/2; 51 (2): 167-9. (Ž…@ú1, ‹ß“¡GŽ¡1, ŽRè—F–ç1, ’†
ŽRŒ«Ži1, “¡ˆäŽF1)

511004. [‰ðà] (Technical Note) Inclined Foot Switches for Surgical Microscopes: A Comfortable
Desigh for Seated Surgeons. Shimizu S1, Tanaka O2, Kondo K1, Yamazaki T1, Nakayama K1, Yamamoto
I2, Fujii K1 (1”]ŠO, 2‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“ƒ^[•a—): Neurol Med Chir (Tokyo) 2011/3; 51 (3):
260-2. (Ž…@ú1, “c’†@C2, ‹ß“¡GŽ¡1, ŽRè—F–ç1, ’†ŽRŒ«Ži1, ŽR–{—E•v2, “¡ˆäŽF1)

520059. [‘à] VŽž‘ã‚Ì”]Žîᇊw?f’fEŽ¡—Â̍őOü?. ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): “ú–{—Õ
° 2010/12; 68 (10): 188-92.

522079. [uÀ] ‚à‚â‚à‚â•a. ŽR“c@Ÿ (”]ŠO): BRAIN NURSING 2010/4; 26 (4): 30-1.

522080. [uÀ]y“ÁW: ‘æ18‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€z¬Ž™Atypical Teratoid/Rhabdoid Tumor‚̉»Šw•ú
ŽËü—Ö@. ‰ª@GG1, ‰F’Öؑ1, –Ø“‡çq1, V•”@÷2, ‘ì˜ad2, “¡ˆäŽF1 (1”]ŠO, 2•úŽË
ü (Žîá‡)): –k—¢ˆãŠw 2010/6; 40 (1): 47-52.

522081. [uÀ]y”]ŠO‰ÈQ&Az‘æ4‰ñ–Ÿ‚é‚¢‚È‚â‚Ý‘Š’kŽº?ƒeƒNƒjƒbƒN‚Ì•œ˜a—˜—p?. ‰F’Öؑ (”]ŠO):
”]_ŒoŠO‰È‘¬•ñ 2010/6; 20 (6): 701.

522082. [uÀ]y“ÁW1: _Œo“ï•a‚̍ŐVŽ¡—Ö@z‘æ2•”@ƒp[ƒLƒ“ƒ\ƒ“•a‚Ì’èˆÊ“IŽ‹°Žèp—Ö@. ²
“¡Ÿl1, “¡ˆäŽF1 (1”]ŠO): “ï•a‚ƍݑîƒPƒA 2010/9; 16 (6): 10-2.

522083. [uÀ]y”]ŠO‰ÈQ•Az‘æ8‰ñ–Ÿ‚é‚¢‚È‚â‚Ý‘Š’kŽº. ‰ª@GG (”]ŠO): ”]_ŒoŠO‰È‘¬•ñ 2010/10;
20 (10): 1205.

522084. [uÀ] “Œ‹ž”]Žîᇌ€‹†‰ï‚̐¶‚¢—§‚¿‚ÆŒ»ó: ‘æ100‰ñ“Œ‹ž”]Žîᇌ€‹†‰ï‹L”Ou‰‰‚ðŒ}‚Š‚Ä. ‰ª@
GG (”]ŠO): Neuro-Oncology‚̐i•à 2010/12; 19 (1): 84-8.

522085. [uÀ]y“ÁW: ‘æ19‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€z”]_ŒoŠO‰È—̈æ‚É‚š‚¯‚镪Žq•W“IŽ¡—ÂƂ̊ւí‚è
?“]ˆÚ«”]ŽîᇏǗႩ‚ç?. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, –Ø“‡çq1, ˆ¢•”Ž’q
1, “¡ˆäŽF1 (1”]ŠO): –k—¢ˆãŠw 2010/12; 40 (2): 111-7.

522086. [uÀ] CSPS-II‚ÉŠî‚­”][ÇŽ¡—Âɂ‚¢‚Ä: ”]ŽîᇁE”]‘²’†‚Ì—ŒŽÒ‚ÉŒg‚í‚é—§ê‚Å. ‰ª@G
G (”]ŠO): Medical Tribune 2010. http://www.medical-tribune.co.jp/

540026. [‚»‚Ì‘Œ (’Z•ñE‘¬•ñ)] Ž„‚Ì‚š‚·‚·‚߂̈êû, ˆê–‡, ˆêŒ¬uƒ`ƒ“‚µ‚ă`ƒbƒvƒXv. ‰F’Öؑ (”]
ŠO): ”]_ŒoŠO‰È‘¬•ñ 2010/5; 20 (5): 604.

540027. [‚»‚Ì‘Œ]y“ÁW: ‘æ100‰ñ‹L”O‘å‰ï ‹ß‹E”]Žîᇕa—ŒŸ“¢‰ï‹L˜^z“Œ‹ž”]Žîᇌ€‹†‰ï‚̐¶‚¢—§‚¿
‚ÆŒ»ó?‘æ100‰ñ“Œ‹ž”]Žîᇌ€‹†‰ï‹L”Ou‰‰‰ï‚ðŒ}‚Š‚Ä?. ‰ª@GG (”]ŠO): Neuro-Oncology‚̐i•à
2010; 19 (1): 84-8.

540028. [‚»‚Ì‘Œ (’Z•ñE‘¬•ñ)] —ðŽj‚ÉŠw‚Ñ, ŒŽ“_‚É‹A‚ë‚€. “¡ˆäŽF (”]ŠO): ”]_ŒoŠO‰È 2011/1; 39
(1): 3-4.

[’˜@‘]

620080. [Šwp‘] (•ª’SŽ·•M)y‘‡f—Ã}ƒjƒ…ƒAƒ‹z”]ŽÀŽ¿‚ÌŽŸŠ³, p.663-6. ²“¡Ÿl1, –kŒŽF—Y2
(1”]ŠO, 2‹~–œ), •Ò ãŒŽæ£Žu•v3, ‘å—ÑŠ®ƒj4, ‹÷’JŒìl5, ‰vŽq–M—m6, Œ‰ª”Žº7 (3‹€—§—Žq‘åŠw
‹³Žö, 4‘å—Ñ“à‰Èˆã‰@‰@’·, 5Œ³“Œ‹ž‹€Ï•a‰@•a‰@’·, 6“ú–{ˆã‰È‘åŠwç—t–k‘•a‰@, 7‰F“s‹{’†‰›•a‰@•a
‰@’·), ‹à–F“°, ‹ž“s, 2010/7”­s.

620081. [Šwp‘] (•ª’SŽ·•M)y”]_ŒoŠO‰È—Տ°ƒ}ƒjƒ…ƒAƒ‹@‰ü’ù4 ”Å‘æIIIŠªzXII. Žèp‚ÉŠÖ‚·‚鎖
€@”]Žº‚Ö‚Ì“ž’B–@, p. 1691-9. ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO), ŠÄC ’[@˜a•v, ƒVƒ…ƒvƒŠƒ“ƒK[, “Œ
‹ž, 2010/7”­s.

620082. [Šwp‘] (•ª’SŽ·•M)yƒrƒWƒ…ƒAƒ‹”]_ŒoŠO‰È1@‘O“ª—tE“ª’ž—tzŽèp‚É•K—v‚È’†‘å”]“®–¬‚Æ
‚»‚Ì•ªŽ}‚Ì”÷¬‰ð–U, p.38-47. ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO), •Ò •ÐŽR—eˆê2, •y‰i’î“ñ3, Ä“¡‰„
l4 (2“ú–{‘åŠwˆãŠw•””]_ŒoŠO‰È, 3“Œ–k‘åŠwˆãŠw•””]_ŒoŠO‰È, 4“Œ‹ž‘åŠwˆãŠw•””]_ŒoŠO‰È), ƒƒW
ƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2010/10”­s.

620083. [Šwp‘] (•ª’SŽ·•M)yEBM ”]_ŒoŠO‰ÈŽŸŠ³‚ÌŽ¡—Ã2011-2012zII. Žîᇁ@13. “ªŠWˆô“ªŽî: Žè
pƒAƒvƒ[ƒ`‚ð‚Ç‚Ì‚æ‚€‚É‘I‘ð‚·‚é‚©?, p.182-8. ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO), •Ò ‹{–{@‹2, V
ˆä@ˆê3, —é–Ø—Ï•Û4, aˆä‘sˆê˜Y5, ’†£—T”V6 (2‹ž“s‘åŠw”]_ŒoŠO‰È‹³Žö, 3‡“V“°‘åŠw”]_ŒoŠO‰È
‹³Žö, 4ŽRŒû‘åŠw”]_ŒoŠO‰È‹³Žö, 5‘—§‚ª‚ñƒZƒ“ƒ^[‰È’·, 6“Þ—ÇŒ§—§ˆã‰È‘åŠw‹³Žö), ’†ŠOˆãŠwŽÐ, “Œ
‹ž, 2010/10”­s.

620084. [Šwp‘] (•ª’SŽ·•M)y”]ŽîᇎÀ‘HƒP[ƒXƒXƒ^ƒfƒB‘æ2Šªz“ªŠWŠOL“W‚ðŽŠ‚µ‚œã‰º_ŒoâŽî‚É
‘΂·‚éŽèpƒAƒvƒ[ƒ`. p.39-42. ‰ª@GG (”]ŠO), •Ò HŒ³Ž¡˜N, “c’†@‘, (Š”) ƒGƒTƒbƒv, “Œ‹ž,
2010/12”­s.

620085. [Šwp‘] (•ª’SŽ·•M)y”]ŽîᇎÀ‘HƒP[ƒXƒXƒ^ƒfƒB‘æ2Šªz‹‘哪ŠWˆô“ªŽî‚ÌŽèpƒAƒvƒ[ƒ`,
p.43-6. ‰ª@GG (”]ŠO), •Ò HŒ³Ž¡˜N, “c’†@‘, (Š”) ƒGƒTƒbƒv, “Œ‹ž, 2010/12”­s.

620086. [Šwp‘] (•ª’SŽ·•M)y”]ŽîᇎÀ‘HƒP[ƒXƒXƒ^ƒfƒB‘æ2Šªz’˜–Ÿ‚È“÷‰èŽî—l•Ï‰»‚𔺂Á‚œˆÆã•”
•a•Ï, p.111-3. ‰F’Öؑ (”]ŠO), •Ò HŒ³Ž¡˜N, “c’†@‘, (Š”) ƒGƒTƒbƒv, “Œ‹ž, 2010/12”­s.

620087. [Šwp‘] (•ª’SŽ·•M)y”]ŽîᇎÀ‘HƒP[ƒXƒXƒ^ƒfƒB‘æ2ŠªzŠÔ”]E‰º‚‘ÌŽîá‡?ƒ‰ƒPƒgùN–E‚Æ“ª
ŠWˆô“ªŽî‚Æ‚ÌŠÖŒW, p.114-7. ‰ª@GG (”]ŠO), •Ò HŒ³Ž¡˜N, “c’†@‘, (Š”) ƒGƒTƒbƒv, “Œ‹ž, 2010/12
”­s.

620088. [Šwp‘] (•ª’SŽ·•M)yƒCƒ‰ƒXƒgƒŒƒCƒeƒbƒh”]ŽîᇊO‰ÈŠwzC-VI. ŠeŽí”]Žîᇂ̎èp@2. ‘–ŒŽî@
‘å”]Š™‘–ŒŽî, p.132-5. “¡ˆäŽF1 (1”]ŠO), •Ò ‰Í–{Œ\Ži2, –{‹œˆê”Ž3, ŒI²@ŒO4 (2ŠÖŒˆã‰È‘å
Šw”]_ŒoŠO‰È‹³Žö, 3MB‘åŠw”]_ŒoŠO‰È‹³Žö, 4L“‡‘åŠw‘åŠw‰@”]_ŒoŠO‰È‹³Žö), ˆãŠw‘‰@, “Œ‹ž,
2011/3”­s.

621001. [‚»‚Ì‘Œ (‹L”OŽ)] (•ª’SŽ·•M)y“ú–{”]_ŒoŠO‰ÈŠw‰ï—ˆã‰ï@‘n—§20Žü”N‹L”O†@20”N‚Ì•à
‚݁EEEz‘n—§20Žü”N‚ðj‚µ‚Ä, p.86. “¡ˆäŽF (”]ŠO), “ú–{”]_ŒoŠO‰ÈŠw‰ï—ˆã‰ï, 2010”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712046. [Šw‰ï (‘Û)] (‹³ˆçu‰‰) Atypical Teratoid/Rhabdoid Tumor. Oka H1, Utsuki S1, Kijima C1,
Fujii K1 (1”]ŠO): Bit's Annual World Cancer Congress (2010/6/23), Singapore. (‰ª@GG1, ‰F’Ã
–Ø‘1, –Ø“‡çq1, “¡ˆäŽF1)

712047. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) Significance of porphyrins in blood and urine of brain
tumor patients that underwent 5-ALA administration. Utsuki S1, Oka H1, Fujii K1, Miyoshi N (1
”]ŠO): 2010 International Chemical Congress of Pacific Basin Societies (2010/12/20), Honolulu.
(‰F’Öؑ1, ‰ª@GG1, “¡ˆäŽF1)

713084. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Autocrine mortility factor mRNA and its receptor
expression in human pituitary adenomas. Oka H1, Utsuki S1, Kijima C1, Tanizaki Y1, Miyajima Y1,
Yasui Y, Fujii K1: The EANS Annual Meeting 2010 (2010/4/26), Groningen, Netherlands. (‰ª@GG
1, ‰F’Öؑ1, –Ø“‡çq1, ’Jè‹`“¿1, ‹{“‡—Ç‹P1, “¡ˆäŽF1: 1”]ŠO)

713085. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Change in MGMT expression after chemotherapy for malignant
gliomas. Utsui S1, Oka H1, Kijima C1, Suzuki S1, Sato S1, Miyajima Y1, Hagiwara H1, Fujii K1 (1
”]ŠO): The 7th Meeting of the Asian Society for Neuro-Oncology (ASNO) (2010/6/12), ƒ\ƒEƒ‹. (‰F
’Öؑ1, ‰ª@GG1, –Ø“‡çq1, —é–؏ː¶1, ²“¡Ÿl1, ‹{“‡—Ç‹P1, ”‹ŒŽG”V1, “¡ˆäŽF1)

713086. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Tianium Bridge Watertight Closure. Kusumi M (”]ŠO): Advanced
Skull Base Microanatomy and Hands-On Dissection Workshop (2010/11/18), Florida. (‹v{”ü^—)

713087. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Jugular Bulb Translocation Technique. Kusumi M (”]ŠO): Advanced
Skull Base Microanatomy and Hands-On Dissection Workshop (2010/11/19), Florida. (‹v{”ü^—)

721005. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) d–Œ“®Ã–¬˜KŽ¡—Â̌»ó 1. ŠC–ȐÖ¬“Ž•”d–Œ“®Ã–¬˜K‚ɑ΂·‚鎡
—Ð헪. ‘q“c@² (”]ŠO): ‘æ30‰ñ”]_ŒoŠO‰ÈƒRƒ“ƒOƒŒƒX‘‰ï (2010/5/9), ‰¡•l.

721006. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‘€”]ŽºŽîᇎèp‚É•K—v‚È”÷¬‰ð–U‚ÆŠO‰ÈŽ¡—Ã. ‰ª@GG1, “¡ˆäŽ
F1, Rhoton AL Jr (1”]ŠO): ‘æ30‰ñ“ú–{”]_ŒoŠO‰ÈƒRƒ“ƒOƒŒƒX (2010/5/9), ‰¡•l.

722104. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) ”]Žîᇂɂš‚¯‚éphotodynamic diagnosis‚ÌŒ»ó‚ƍ¡Œã‚Ì“W–].
‰F’Öؑ1, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/28), ·‰ª.

722105. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) Low Flow Bypass ‚ÌŠî–{Žè‹Z. ŽR“c@Ÿ (”]ŠO): ‘æ30‰ñ“ú–{”]_
ŒoŠO‰ÈƒRƒ“ƒOƒŒƒX‘‰ï (2010/5/8), ‰¡•l.

722106. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) Ž‹°E’†”]‚̉ð–U‚ÆŠO‰ÈŽ¡—Ã. ‰ª@GG1, “¡ˆäŽF1, ƒAƒ‹ƒo[
ƒgEƒ[ƒgƒ“Jr2 (1”]ŠO, 2ƒtƒƒŠƒ_‘åŠw”]_ŒoŠO‰È): ‘æ30‰ñ“ú–{”]_ŒoŠO‰ÈƒRƒ“ƒOƒŒƒX‘‰ï (2010/5/9),
‰¡•l.

722107. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) ‰º‚‘Ì‘BŽî‚É‚š‚¯‚éAMFmRNA‚š‚æ‚ÑŽó—e‘ÌmRNA”­Œ»‚̈Ӌ`;
ŠC–ȐÖ¬“ŽNd, Žîᇌ^‚ƈâ“`Žq”­Œ»‚ÌŠÖ˜A. ‰ª@GG1, ’Jè‹`“¿1, ‰F’Öؑ1, –Ø“‡çq1, ‹{
“‡—Ç‹P1, ”‹ŒŽG”V1, “¡ˆäŽF1 (1”]ŠO): ‘æ28‰ñ“ú–{”]Žîᇕa—Šw‰ï (2010/5/21), ‘åã.

722108. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) “ªŠWˆô“ªŽî‚̐_Œo“àŽ‹‹ŸŽèp: ‚»‚Ì—˜“_‚ÆŒÀŠE. ‰ª@GG
1, ƒyƒ‹ƒlƒcƒL[EƒAƒNƒZƒ‹2, “¡ˆäŽF1 (1”]ŠO, 2ƒ}ƒCƒ“ƒc‘åŠw”]_ŒoŠO‰È): ‘æ22‰ñ“ú–{“ªŠW’êŠO
‰ÈŠw‰ï (2010/7/15), ‹v—¯•Ä.

722109. [Šw‰ï (‘S‘)] (‹L”Ou‰‰) Microsurgical and endoscopic anatomy of the vidian canal. ‘å
àV¬”V (”]ŠO): ‘æ22‰ñ“ú–{“ªŠW’êŠO‰ÈŠw‰ï (2010/7/15), ‹v—¯•Ä.

722110. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) _Œo“àŽ‹‹ŸŽx‰‡“ªŠWˆô“ªŽîŽèp: Š³ŽÒ‚É“K‚µ‚œ—Õ‹@‰ž•Ï‚ÈŽè
pƒAƒvƒ[ƒ`. ‰ª@GG1, “¡ˆäŽF1, ƒyƒ‹ƒlƒcƒL[EƒAƒNƒZƒ‹2 (1”]ŠO, 2ƒ}ƒCƒ“ƒc‘åŠw): ‘æ15‰ñ
“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2010/10/2), ‘åã.

722111. [Šw‰ï (‘S‘)] (Žw’èƒRƒƒ“ƒg)yŽs–¯ŒöŠJuÀu”]Žîᇂɗ§‚¿Œü‚©‚€vz¬l”]Žîᇂ̎¡—Õûj
‚ɂ‚¢‚Ä. “¡ˆäŽF (”]ŠO): ‘æ15‰ñ“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2010/10/3), ‘åã.

722112. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ‘€“ªœ: Mastoidectomy‚É•K—v‚È”÷¬‰ð–U‚ÆŽÀÛ. ‰ª@GG1, “¡
ˆäŽF1, Rhoton, AL, Jr2 (1”]ŠO, 2ƒtƒƒŠƒ_‘åŠw”]_ŒoŠO‰È): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ69‰ñŠwp‘‰ï
(2010/10/27), •Ÿ‰ª.

722113. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) “ªŠWˆô“ªŽî‚ÌŽ¡—Ð헪: _Œo“àŽ‹‹ŸŽx‰‡—Õ‹@‰ž•ÏŽèpƒAƒvƒ
[ƒ`. ‰ª@GG1, “¡ˆäŽF1, ƒyƒ‹ƒlƒcƒL[EƒAƒNƒZƒ‹2 (1”]ŠO, 2ƒ}ƒCƒ“ƒc‘åŠw”]_ŒoŠO‰È): “ú–{
”]_ŒoŠO‰ÈŠw‘æ69‰ñŠwp‘‰ï (2010/10/28), •Ÿ‰ª.

722114. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ”]Žº“àŽîᇂɑ΂·‚é”÷¬ŠO‰È‰ð–U‚ÆŽèpƒAƒvƒ[ƒ`. ‰ª@GG1,
“¡ˆäŽF1, Rhoton, AL, Jr2, Perneczky, A3 (1”]ŠO, 2ƒtƒƒŠƒ_‘åŠw”]_ŒoŠO‰È, 3ƒ}ƒCƒ“ƒc‘åŠw”]_
ŒoŠO‰È): “ú–{”]_ŒoŠO‰ÈŠw‰ï‘æ69‰ñŠwp‘‰ï (2010/10/29), •Ÿ‰ª.

722115. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) ”]Žîᇂɂš‚¯‚éPDD‚Æ”A’†ƒ|ƒ‹ƒtƒBƒŠƒ“‚Æ‚ÌŠÖŒW. ‰F’Öؑ
1, ‰ª@GG1, –Ø“‡çq1, ˆ¢•”Ž’q1, “¡ˆäŽF1 (1”]ŠO): ‘æ31‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘‰ï
(2010/11/14), –ŒŒÃ‰®.

722116. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) –k—¢‘åŠw‚É‚š‚¯‚é_Œo“àŽ‹‹ŸƒgƒŒ[ƒjƒ“ƒO‚Æ‹Zp”F’èŽæ“ŸƒZ
ƒ~ƒi[. ‰ª@GG1, ƒyƒ‹ƒlƒcƒL[EƒAƒNƒZƒ‹2, ‹ß“¡GŽ¡1, ’†ŒŽ–M»1, ¬òŠ°”V1, ‘åàV¬”V1, ‰F
’Öؑ1, Ž…@ú1, “¡ˆäŽF1 (1”]ŠO, 2ƒ}ƒCƒ“ƒc‘åŠw”]_ŒoŠO‰È): ‘æ17‰ñ“ú–{_Œo“àŽ‹‹ŸŠw‰ï
(2010/12/10), ç—t.

722117. [Šw‰ï (‘S‘)] (ƒhƒŠƒ‹ƒnƒ“ƒYƒIƒ“ƒR[ƒX) ‘€“ªœ: Mastoidectomy‚É•K—v‚È”÷¬‰ð–U‚ÆŽÀÛ.
‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): ‘æ69‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠwp‘‰ï (2010/12/27), •Ÿ‰ª.

722118. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) ŠÔ”]‰º‚‘̗̈æ‚ÌŽî᎐«•a•Ï‚É‚š‚¯‚éIgG4–Ɖu‘gDŠw“IŒŸ“¢.
–Ø“‡çq1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ˆÀˆä”ü]2, ì–ìM”V1, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘Ô
Œn): ‘æ21‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2011/3/12), “Œ‹ž.

722119. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) _Œo“àŽ‹‹Ÿ•¹—p‚É‚æ‚铪ŠWˆô“ªŽî‚Ì‹@”\‰·‘¶Žèpí—ª: ‰º‚
‘Ì•¿‰·‘¶‚Æ”A•öÇ‚Ì”­¶. ‰ª@GG1, ƒyƒ‹ƒlƒcƒL[EƒAƒNƒZƒ‹2, ‰F’Öؑ1, Ž…@ú1, ’†ŒŽ–M»
1, ²“¡Œör1, ‘åàV¬”V1, ‹{“‡—Ç‹P1, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO, 2ƒ}ƒCƒ“ƒc‘åŠw”]_ŒoŠO‰È): ‘æ
21‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2011/3/12), “Œ‹ž.

723407. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚à‚â‚à‚â•a‚É‚š‚¯‚éMRI FLAIR‰æ‘œivy sign‚̗Տ°“Id
—v«. ŽR“c@Ÿ1, —é–؏ː¶1, ²“¡Œör1, ‹{è•üŽq1, ”nŸºˆêŽ÷1, ‘q“c@²1, “¡ˆäŽF1, ›@M
ˆê2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): ‘æ39‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï (2010/4/15), ·‰ª.

723408. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]“®–¬áŽÇðp‚É‚š‚¯‚éáŽ“à–¬ˆ³‘ª’è‚̈Ӌ`‚Æ—L—p«. ²“¡Œör
1, —é–؏ː¶1, ‘q“c@²1, ’†ŒŽ–M»1, Šâ–{˜a‹v1, m–؁@~1, ŽR“c@Ÿ1, “¡ˆäŽF1, ›@Mˆê2,
–kŒŽF—Y3 (1”]ŠO, 2•úŽËü (‰æ‘œ), 3‹~–œ): ‘æ39‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï (2010/4/16), ·‰ª.

723409. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]Žº“àoŒŒ‚ðŒJ‚è•Ô‚µ‚œ‘O–¬—‘p“®–¬‰“ˆÊ•”ŒŒŠÇŠïŒ`‚̈ê—á. ŽRè
—F–ç1, Ž…@ú1, ‰ª@GG1, ‹ß“¡GŽ¡1, ’†ŽRŒ«Ži1, ŽR–{—E•v2, “¡ˆäŽF1 (1”]ŠO, 2‰¡•lŽs—§
”]ŒŒŠÇˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È): ‘æ39‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï (2010/4/16), ·‰ª.

723410. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰ð—£«’ōœ“®–¬áŽ‚Ì•a‘Ԃɂ‚¢‚Ä?ŒŒs—ÍŠw“IŒŸ“¢?. ‘q“c@²
1, —é–؏ː¶1, Šâ–{˜a‹v1, ²“¡Œör1, ˆ¢•”Ž’q1, Œ¢Ž”@‰~1, ‹{è•üŽq1, ’†ŒŽ–M»1, ŽR“c@Ÿ1,
“¡ˆäŽF1 (1”]ŠO): ‘æ35‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï (2010/4/16), ·‰ª.

723411. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Primary Stenting ‚š‚æ‚ÑŒãŠg’£‚ðs‚í‚È‚¢èò“®–¬ƒXƒeƒ“ƒg—¯’up‚Ì
¬Ñ?pŒãŒoŽž“I‚ÈŒŒŠÇ“ào‚̕ω»‚ɂ‚¢‚Ä?. —é–؏ː¶1, ‘q“c@²1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, m
–؁@~1, ²“¡Œör1, ‰F’Öؑ1, ŽR“c@Ÿ1, “¡ˆäŽF1, ›@Mˆê2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): ‘æ
35‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï (2010/4/17), ·‰ª.

723412. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŒŠÇáŠQ‚É‚š‚¯‚é_Œo“àŽ‹‹Ÿ Keyhole Surgery ‚ÌŒ»ó‚Æ“W–]: ‚»‚Ì
—˜“_‚ÆŒ‡“_. ‰ª@GG1, “¡ˆäŽF1, Axel Perneczky2 (1”]ŠO, 2ƒ}ƒCƒ“ƒc‘åŠw”]_ŒoŠO‰È): ‘æ39‰ñ
“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï (2010/4/17), ·‰ª.

723413. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŒŠÇ•«‡‚ÌŠî–{Žè‹Z. ŽR“c@Ÿ (”]ŠO): ‘æ30‰ñ“ú–{”]_ŒoŠO‰ÈƒR
ƒ“ƒOƒŒƒX‘‰ï (2010/5/6), ‰¡•l.

723414. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) tˆÚAŠ³ŽÒ‚É”­¶‚µ‚œ’†•_ŒoŒnpost-transplant
lymphoproliferative disorder. ‰F’Öؑ1, ‰ª@GG1, ‹{è•üŽq1, ˆÀˆä”ü]2, “¡ˆäŽF1, “¿ŽR@‹X
3, ŒŽ@“ÖŽq3, ŽOã“N•v3, ‰ªˆÀ@ŒM3, ‹g“cˆê¬4 (1”]ŠO, 2Œ`‘ÔŒn, 3•a—, 4”å”AŠí): ‘æ28‰ñ“ú
–{”]Žîᇕa—Šw‰ï (2010/5/21), ‘åã.

723415. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ªŠW’ê“]ˆÚ‚ð”F‚ß‚œd•¡ŽîᇂÌ1–UŒŸ—á. ”nŸºˆêŽ÷1, ‰ª@GG1,
‰F’Öؑ1, –Ø“‡çq1, “¡ˆäŽF1, “¿ŽR@‹X2, ‰ªˆÀ@ŒM2 (1”]ŠO, 2•a—): ‘æ28‰ñ“ú–{”]Žîᇕa—
Šw‰ï (2010/5/21), ‘åã.

723416. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’†•_Œo“]ˆÚ‚ð‚«‚œ‚µ‚œ”畆T×–EƒŠƒ“ƒpŽî‚Ì1—á. –Ø“‡çq1, ‰ª@
GG1, ‰F’Öؑ1, ’†ŒŽ–M»1, ˆÀˆä”ü]2, “¿ŽR@‹X3, ‰ªˆÀ@ŒM3, “ŒŒŽ³–Ÿ4, “¡ˆäŽF1 (1”]ŠO,
2Œ`‘ÔŒn, 3•a—, 4ŒŒ‰t“à): ‘æ28‰ñ“ú–{”]Žîᇕa—Šw‰ï (2010/5/21), ‘åã.

723417. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ž‹Œð·‚É”­¶‚µ‚œganglioglioma‚Ì1—á. ’Jè‹`“¿1, ‰ª@GG1,
“¡ˆäŽF1, ‰F’Öؑ1, Jin L2, Sheithauer B W2, Lloyd R V2 (1”]ŠO, 2Mayo Clinic College of Medicine):
‘æ28‰ñ“ú–{”]Žîᇕa—Šw‰ï (2010/5/21), ‘åã.

723418. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ò‘¬”]•Ï«Ç‚É”º‚€Uí‚ɑ΂µŽ‹°Žèp‚ðs‚Á‚œ1—á. ²“¡Ÿl
1, ‘å]çœA2, “n•ÓŽ¬3, ’†“ˆ@„4, “¡–{Œ’ˆê5 (1”]ŠO, 2“ú‚•a‰@‹@”\”]ŠO‰ÈEƒKƒ“ƒ}ƒiƒCƒtƒZƒ“
ƒ^[, 3ŒQ”n‘åŠwˆãŠw•””]_ŒoŠO‰È, 4“Œ‹ž—Žqˆã‰È‘åŠw”]_ŒoŠO‰È, 5Ž©Ž¡ˆã‰È‘åŠw_Œo“à‰È): ‘æ51‰ñ
“ú–{_ŒoŠw‰ï‘‰ï (2010/5/21), “Œ‹ž.

723419. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’†•_ŒoŒnŒŽ”­‚Ì‚Ñ‚Ü‚ñ«‘å×–EŒ^B×–EƒŠƒ“ƒpŽî‚É‚š‚¯‚éT cell
Z‚ƗՏ°‘œ‚Æ‚ÌŠÖŒW. ‰F’Öؑ1, ‰ª@GG1, ‹{“‡—Ç‹P1, –Ø“‡çq1, ’Jè‹`“¿1, ”‹ŒŽG”V1, ˆÀ
ˆä”ü]2, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ28‰ñ“ú–{”]Žîᇕa—Šw‰ï (2010/5/21), ‘åã.

723420. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Atypical choroid plexus papilloma ‚Ì1—á. ‹{è•üŽq1, ‰ª@G
G1, ‰F’Öؑ1, –Ø“‡çq1, ’Jè‹`“¿1, ‹{“‡—Ç‹P1, ”‹ŒŽG”V1, Œ¢Ž”@‰~1, ˆÀˆä”ü]2, “¡ˆäŽF
1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ28‰ñ“ú–{”]Žîᇕa—Šw‰ï (2010/5/21), ‘åã.

723421. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) _Œo“àŽ‹‹Ÿ‚É‚æ‚é“Eop‚ª—LŒø‚Å‚ ‚Á‚œƒRƒƒCƒhùN–E‚Ì1—á. –Ø“‡
çq1, ‰ª@GG1, ‰F’Öؑ1, ’†ŒŽ–M»1, ‹{è•üŽq1, ˆÀˆä”ü]2, “¿ŽR@‹X3, ‰ªˆÀ@ŒM3, “¡ˆäŽ
F1 (1”]ŠO, 2Œ`‘ÔŒn, 3•a—): ‘æ28‰ñ“ú–{”]Žîᇕa—Šw‰ï (2010/5/21), ‘åã.

723422. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “û—cŽ™_ŒoŒð³/Ž‹°‰º•””­¶pilmyxiod astorocytoma‚Ì•a—‘gD
‘œ‚ÆŽ¡—Ã?’·ŠúŒo‰ßŠÏŽ@—á‚ÌŒŸ“¢‚©‚ç?. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ˆÀˆä”ü]2, “¡ˆäŽF1
(1”]ŠO, 2Œ`‘ÔŒn): ‘æ28‰ñ“ú–{”]Žîᇕa—Šw‰ï (2010/5/21), ‘åã.

723423. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ÎŠD‰»‚𔺂Á‚œ”]Žº“àŽîᇂÌ1—á. ‰F’Öؑ1, ‰ª@GG1, ”nŸº
ˆêŽ÷1, –Ø“‡çq1, ˆÀˆä”ü]2, “¡ˆäŽF1, “¿ŽR@‹X3, ‰ªˆÀ@ŒM3, ì–ìM”V4, –ö‰ºŽO˜Y5 (1”]ŠO,
2Œ`‘ÔŒn, 3•a—, 4ˆé•”ƒNƒŠƒjƒbƒN, 5_“ސ쑍‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[•a—•”): ‘æ28‰ñ“ú–{”]
Žîᇕa—Šw‰ï (2010/5/21), ‘åã.

723424. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) P53 gene mutations in pituitary carcinomas. ’Jè‹`
“¿1, ‰ª@GG1, “¡ˆäŽF1, ‰F’Öؑ1, Jin L, Scheithauer BW, Lloyd RV (1”]ŠO): ‘æ28‰ñ“ú–{”]
Žîᇕa—Šw‰ï (2010/5/21), ‘åã.

723425. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “û—cŽ™‚ÌŽ‹_ŒoŒð³/Ž‹°‰º•”‚É”­¶‚µ‚œpilomyxoid astrocytoma
‚Ì“Á’¥?’·ŠúŒo‰ßŠÏŽ@—á‚ÌŒŸ“¢‚©‚ç?. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, “¡ˆäŽF1 (1”]ŠO): ‘æ
38‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2010/6/4), •xŽR.

723426. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Atypical choroid plexus papilloma‚Ì1—á. ‹{è•üŽq1, ‰ª@G
G1, ‰F’Öؑ1, ’†ŒŽ–M»1, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO): ‘æ38‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2010/6/4),
•xŽR.

723427. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) _Œo“àŽ‹‹Ÿ‚É‚æ‚éŽîᇓEop‚ÌŒ»ó‚Æ–â‘è“_. ‰ª@GG1, ƒyƒ‹ƒl
ƒcƒL[EƒAƒNƒZƒ‹2, “¡ˆäŽF1 (1”]ŠO, 2ƒ}ƒCƒ“ƒc‘åŠw”]_ŒoŠO‰È): ‘æ38‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï
(2010/6/4), •xŽR.

723428. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™ˆÆã•”germinoma‚ÌŽ‹—͏áŠQ‚Æ”A•öÇ‚Ìoutcome. ‰F’Öؑ1,
‰ª@GG1, –Ø“‡çq1, ‹{è•üŽq1, ’†ŒŽ–M»1, “¡ˆäŽF1 (1”]ŠO): ‘æ38‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï
(2010/6/4), •xŽR.

723429. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) œ«human tail‚𔺂Á‚œPfeifferÇŒóŒQ‚̈ê—á. Œ¢Ž”@‰~1, ’†
ŒŽ–M»1, ‰ª@GG1, ‰F’Öؑ1, “¡ˆäŽF1 (1”]ŠO): ‘æ38‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2010/6/5), •x
ŽR.

723430. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™‚à‚â‚à‚â•a‚̐f’fEŽ¡—Âɂš‚¯‚éMRI FLAIR‰æ‘œ‚̏d—v«. ŽR
“c@Ÿ1, —é–؏ː¶1, ’†ŒŽ–M»1, ²“¡Œör1, Œ¢Ž”@‰~1, –Ø“‡çq1, ˆ¢•”Ž’q1, “¡ˆäŽF1 (1”]
ŠO): ‘æ38‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2010/6/5), •xŽR.

723431. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™‚É‚š‚¢‚Ä’Pˆê‰æ‘œŒŸž‚Å•`o‚³‚ê‚È‚¢“ªŠWœüóœÜƒpƒ^[ƒ“
‚ÌŒŸ“¢. ’†ŒŽ–M»1, Ž…@ú1, ‰ª@GG1, ‰F’Öؑ1, ŽR“c@Ÿ1, ›@Mˆê2, “¡ˆäŽF1 (1”]
ŠO, 2•úŽËü (‰æ‘œ)): ‘æ38‰ñ“ú–{¬Ž™_ŒoŠO‰ÈŠw‰ï (2010/6/5), •xŽR.

723432. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘åEŒžˆ³pŒã‚ɏnj󐫍d–Œ‰º…Žî‚Ì”­¶‚µ‚œ1—á. ŽO“‡‘å“¿1, z
–K’m–ç1, ŽOˆäŒö•F1 (1”]ŠO): ‘æ25‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2010/6/10), –ŒŒÃ‰®.

723433. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ÇŒó«èò’Å‘OcèՑэœ‰»Ç‚Ì1—á. ë“à—²—Y1, ‘åàV¬”V1, œA£
—²ˆê2, “¡ˆäŽF1 (1”]ŠO, 2–k—¢‘åŠw–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@_Œo“à‰È): ‘æ25‰ñ“ú–{Ò‘
ŠO‰ÈŠw‰ï (2010/6/10), –ŒŒÃ‰®.

723434. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “«‰ºŽˆ’É‚ð’悵‚œ˜’ʼn©FèÕ‘Ñ“àŒŒŽî‚Ì1—á. ‘åàV¬”V1, ë
“à—²—Y1, “茎G”V1, “¡ˆäŽF1 (1”]ŠO): ‘æ25‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï (2010/6/10), –ŒŒÃ‰®.

723435. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŽèŠÖß¶‹üˆÊ‚É‚š‚¯‚é‚‚܂ݓ®ì¢“ï‚ðŽå‘i‚Æ‚µ‚œŽèªŠÇÇŒóŒQ‚Ì
2—á. Ž…@ú1, ‹k@Ž ‘2, “¡ˆäŽF1 (1”]ŠO, 2Œ“‡•a‰@”]_ŒoŠO‰È): ‘æ25‰ñ“ú–{Ò‘ŠO‰ÈŠw‰ï
(2010/6/10), –ŒŒÃ‰®.

723436. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 5-ƒAƒ~ƒmƒŒƒuƒŠƒ“Ž_ (ALA) “Š—^Žž‚̃|ƒ‹ƒtƒBƒŠƒ“—Ê‘ª’è‚É‚æ‚éŠàf
’f‚̉”\«. Î’ˏ¹G1, ¬‘qrˆê˜Y2, Š—’r—˜Í2, ‹ß“¡‰ë—Y3, ‰F’Öؑ4, ‘å‘qˆê˜Y2 (1ƒRƒXƒ‚Î
–û (Š”) ALAŽ–‹ÆƒZƒ“ƒ^[, 2“Œ‹žHŠw‘åŠw, 3“Œ‹ž“sŽs‘åŠw, 4”]ŠO): ‘æ20‰ñ“ú–{Œõü—ÍŠwŠw‰ï
(2010/6/12), •Ÿˆä.

723437. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œã“ª‰º³’†ƒAƒvƒ[ƒ`‚É‚š‚¯‚épŒãáu’É‚ðŒž‚¶‚é‘n“WŠJ: €•”‹Ø‚Æ
‘åŒã“ª_Œo‚Ö‚Ì”z—¶. Ž…@ú1, ŽRè—F–ç1, ‹ß“¡GŽ¡1, ’†ŽRŒ«Ži1, ŽR–{—E•v2, ‰ª@GG1, “¡ˆä
ŽF1 (1”]ŠO, 2‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È): ‘æ22‰ñ“ú–{“ªŠW’êŠO‰ÈŠw‰ï (2010/7/15), ‹v
—¯•Ä.

723438. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Diamond T-saw‚ð—p‚¢‚œƒeƒ“ƒgãŠJ“ª: ®—e“I‚©‚ˆÀ‰¿‚ȍœ•ÙŒÅ’è.
Ž…@ú1, ‹ß“¡GŽ¡1, ŽRè—F–ç1, ’†ŽRŒ«Ži1, ŽR–{—E•v2, “¡ˆäŽF1 (1”]ŠO, 2‰¡•lŽs—§”]ŒŒŠÇˆã
—ÃZƒ“ƒ^[”]_ŒoŠO‰È): ‘æ22‰ñ“ú–{“ªŠW’êŠO‰ÈŠw‰ï (2010/7/15), ‹v—¯•Ä.

723439. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘€“ª—t‚š‚æ‚ÑŠáâ|“à‚ÌŒŽ”­«ˆ««•FŽî‚̈ê—á. –Ø“‡çq1, ‰ª@
GG1, ‰F’Öؑ1, ˆÀˆä”ü]2, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ22‰ñ“ú–{“ªŠW’êŠO‰ÈŠw‰ï (2010/7/16),
‹v—¯•Ä.

723440. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Actrocytoma‚É‚š‚¯‚éDJ-1‚ÌŠj“à”­Œ»‚̒ቺ‚ÆŠ³ŽÒ—\Œã‚Æ‚ÌŠÖ˜A«
‚ɂ‚¢‚Ä. ‹{“‡—Ç‹P1, ²“¡—Yˆê2, ‰ª@GG1, ‰F’Öؑ1, ‹ß“¡GŽ¡1, ’Jè‹`“¿1, ’·‰–@—º2, “¡
ˆäŽF1 (1”]ŠO, 2ˆã—Éq¶Šw•”): ‘æ11‰ñ“ú–{•ªŽq”]_ŒoŠO‰ÈŠw‰ï (2010/8/28), å‘ä.

723441. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Hemangioblastoma ‚Ì“Eo‚ɑ΂·‚é5-ALA ‚ð—p‚¢‚œp’†ŒuŒõf’f‚Ì
—L—p«. ‰F’Öؑ1, ‰ª@GG1, –Ø“‡çq1, ‹{“‡—Ç‹P1, ”‹ŒŽG”V1, “¡ˆäŽF1 (1”]ŠO): ‘æ15‰ñ
“ú–{”]Žîᇂ̊O‰ÈŠw‰ï (2010/10/2), ‘åã.

723442. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ACLS-EP (Experienced Provider) ƒR[ƒX‚̈Ӌ`. ²X–؏rÆ1, ‘
“c‘äŽj2, Œˆä’ŒŽ÷3, ‘响ä’m4, ŒR_³—²5, “c’†s•v5, ‹g–ì“Đl6, Â–؏dŒ›7 (1Œ§Œ•”•lŒˆã—Ã
ƒZƒ“ƒ^[‹~‹}‰È, 2‘åŽè’¬ƒAƒrƒGƒXƒNƒŠƒjƒbƒN, 3”Ö“cŽs—§‘‡ˆã—ÃZƒ“ƒ^[, 4”]ŠO, 5“Œ‹ž‘åŠw‹~‹}ˆã
Šw, 6•lŒˆã‰È‘åŠwˆãŠw•”‹~‹}ˆãŠwuÀ, 7Â–؃NƒŠƒjƒbƒN): ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (2010/10/10),
“Œ‹ž.

723443. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ò’ŒŠÇ”w‘€‚É’Eo‚µ‚œ˜’ŒŊԔƒwƒ‹ƒjƒA‚Ì1—á. ‘åàV¬”V1, ë
“à—²—Y1, ‹{è•üŽq1, “¡ˆäŽF1 (1”]ŠO): ‘æ45‰ñ“ú–{Ò‘áŠQˆãŠw‰ï (2010/10/22), Œ–{.

723444. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Š¥“®–¬ŽŸŠ³, Ž‰Ž¿‘ãŽÓˆÙí‚ð”O“ª‚É‚š‚¢‚œCAS‚ÌŒŸ“¢. ¬àV@m
1, ‘q“c@²2, —é–؏ː¶2, ›@Mˆê3, ²X–Ø—º1, ŽR“à’B–ç1, ŒE‘qF“¹1, Šâ–{˜a‹v2 (1Ž¬“c‘‡
•a‰@”]ŒŒŠÇáŠQƒZƒ“ƒ^[”]_ŒoŠO‰È, 2”]ŠO, 3•úŽËü(‰æ‘œ)): “ú–{”]_ŒoŠO‰ÈŠw‘æ69‰ñŠwp‘‰ï
(2010/10/28), •Ÿ‰ª.

723445. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘æ2¢‘ãƒZƒ‹ƒTƒCƒgƒRƒCƒ‹‚Ì, ŽÀŒ±“I”]“®–¬áŽ‚ð—p‚¢‚œŽ¡—ÃŒø‰Ê‚É
‚‚¢‚Ä‚Ì•a—Šw“IŒŸ“¢. Šâ–{˜a‹v1, ‘q“c@²1, ‘响ä’m1, —é–؏ː¶1, ²“¡Œör1, ’†ŒŽ–M»1, ŽR
“c@Ÿ1, “¡ˆäŽF1, ˆÀˆä”ü]2, ŠâŸºŒ[ˆê3 (1”]ŠO, 2Œ`‘ÔŒn, 3•a—): “ú–{”]_ŒoŠO‰ÈŠw‘æ69‰ñŠw
p‘‰ï (2010/10/28), •Ÿ‰ª.

723446. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–Ž{Ý‚É‚š‚¯‚épilomyxoid astrocytoma ‚Ì“Á’¥: pilocytic
astrocytoma‚Ì”äŠr‚Æ‚Æ‚à‚É. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, “¡ˆäŽF1 (1”]ŠO): “ú
–{”]_ŒoŠO‰ÈŠw‘æ69‰ñŠwp‘‰ï (2010/10/28), •Ÿ‰ª.

723447. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Epstein-Barr virus —z«’†•_ŒoŒnŒŽ”­ƒŠƒ“ƒpŽî‚ÌŒŸ“¢. ‰F’ÖØ
‘1, ‰ª@GG1, ‹{“‡—Ç‹P1, –Ø“‡çq1, ”‹ŒŽG”V1, —é–؏ː¶1, ²“¡Ÿl1, “¡ˆäŽF1 (1”]ŠO): “ú
–{”]_ŒoŠO‰ÈŠw‘æ69‰ñŠwp‘‰ï (2010/10/28), •Ÿ‰ª.

723448. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œã“ª‰º³’†ƒAƒvƒ[ƒ`‚É‚š‚¯‚épŒãáu’É‚ðŒž‚¶‚é‘n“WŠJ: €•”‹Ø‚Æ
‘åŒã_Œo‚Ö‚Ì”z—¶. Ž…@ú1, ŽRè—F–ç1, ‹ß“¡GŽ¡1, ‰F’Öؑ1, ‰ª@GG1, ’†ŽRŒ«Ži1, ŽR–{—E
•v2, “¡ˆäŽF1 (1”]ŠO, 2‰¡•lŽs—§”]ŒŒŠÇˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È): “ú–{”]_ŒoŠO‰ÈŠw‘æ69‰ñŠwp‘
‰ï 82010/10/28), •Ÿ‰ª.

723449. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ªŠW“àˆ³–¢”j—ô“àèò“®–¬áŽ‚ɑ΂µ‚Äflow alteration/reversal‚ð—p
‚¢‚ÄŽ¡—µ‚œ1—á. ²“¡Œör1, ˆ¢•”Ž’q1, –Ø“‡çq1, Œ¢Ž”@‰~1, ‹{“‡—Ç‹P1, ”‹ŒŽG”V1, —é–؏Ë
¶1, ²“¡Ÿl1, ‰F’Öؑ1, ‰ª@GG1, ŽR“c@Ÿ1, ‘q“c@²1, “¡ˆäŽF1 (1”]ŠO): “ú–{”]_Œo
ŠO‰ÈŠw‘æ69‰ñŠwp‘‰ï (2010/10/28), •Ÿ‰ª.

723450. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”xÇðÇ‚ð‡•¹‚µ‚œ–¢”j—ô•”•ªŒŒð‰»‹‘å‘OŒð’Ê“®–¬áŽ‚ÌŽèpŒoŒ±.
ë“à—²—Y1, ‘åàV¬”V1, ‹{è•üŽq1, œA£—²ˆê2, “¡ˆäŽF1 (1”]ŠO, 2–k—¢‘åŠw–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹
ƒZƒ“ƒ^[•a‰@_Œo“à‰È): “ú–{”]_ŒoŠO‰ÈŠw‘æ69‰ñŠwp‘‰ï (2010/10/29), •Ÿ‰ª.

723451. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒgƒ‹ƒRˆÆ“à‚š‚æ‚шƏ㕔•a•Ï‚̉摜f’f‚ÆIgG4–Ɖu‘gDŠw“IŒŸ“¢.
–Ø“‡çq1, ‰ª@GG1, ‰F’Öؑ1, ˆÀˆä”ü]2, ì–ìM”V1, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): “ú–{”]
_ŒoŠO‰ÈŠw‘æ69‰ñŠwp‘‰ï (2010/10/29), •Ÿ‰ª.

723452. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) xanthogranuloma‚𔺂Á‚œƒ‰ƒgƒPùN–E‚Ì•a—Šw“IŒŸ“¢. ‹{“‡—Ç‹P1,
‰ª@GG1, ‰F’Öؑ1, ‹ß“¡GŽ¡1, ‘åàV¬”V1, “¡ˆäŽF1 (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‘æ69‰ñŠwp
‘‰ï (2010/10/29), •Ÿ‰ª.

723453. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ò’ŒŠÇ”w‘€‚É’Eo‚µ‚œ˜’ŒŊԔƒwƒ‹ƒjƒA‚Ì1—á. ‘åàV¬”V1, ë
“à—²—Y1, ‹{è•üŽq1, “¡ˆäŽF1 (1”]ŠO): “ú–{”]_ŒoŠO‰ÈŠw‘æ69‰ñŠwp‘‰ï (2010/10/29), •Ÿ‰ª.

723454. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”]Žº“àŒŽ”­ùN–E‚ɑ΂·‚é_Œo“àŽ‹‹ŸŽ¡—Ã. ’†ŒŽ–M»1, Žt“cMl2,
‰ª@GG1, ˆäŒŽ@“N3, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO, 2‘—§¬ˆçˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È, 3’}”g‘å
Šw”]_ŒoŠO‰È): “ú–{”]_ŒoŠO‰ÈŠw‘æ69‰ñŠwp‘‰ï (2010/10/29), •Ÿ‰ª.

723455. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™‚à‚â‚à‚â•a‚̏nj󉻂ð—\‚·‚éivy sign‚̏oŒ». ŽR“c@Ÿ1,
—é–؏ː¶1, ²“¡Œör1, ˆ¢•”Ž’q1, Œ¢Ž”@‰~1, –Ø“‡çq1, ‘q“c@²1, “¡ˆäŽF1 (1”]ŠO): “ú–{
”]_ŒoŠO‰ÈŠw‘æ69‰ñŠwp‘‰ï (2010/10/29), •Ÿ‰ª.

723456. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠC–ȐÖ¬“Ž‚ւ̐V‚µ‚¢ŒoÃ–¬“IƒAƒvƒ[ƒ`ƒ‹[ƒg. ‘q“c@²1, —é
–؏ː¶1, Šâ–{˜a‹v1, m–؁@~1, ’†ŒŽ–M»1, ²“¡Œör1, ˆ¢•”Ž’q1, Œ¢Ž”@‰~1, –Ø“‡çq1, ŽR“c@
Ÿ1, “¡ˆäŽF1, ›@Mˆê2, ‘响ä’m1, ¬àV@m3, ²X–Ø—º3 (1”]ŠO, 2•úŽËü (‰æ‘œ), 3Ž¬“c‘
‡•a‰@”]_ŒoŠO‰È): “ú–{”]_ŒoŠO‰ÈŠw‘æ69‰ñŠwp‘‰ï (2010/10/29), •Ÿ‰ª.

723457. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) CASŽüpŠú‚É‚š‚¯‚錌¬”‹ÏW”\ƒ‚ƒjƒ^ƒŠƒ“ƒO‚Ì—L—p«. ²X–Ø—º
1, —é–؏ː¶1, ‘q“c@²1, “¡ˆäŽF1, ¬àV@m1, ‹e’n@Œh2, ŽR“à’B–ç2, ŒE‘qF“¹2 (1”]ŠO, 2Ž¬
“c‘‡•a‰@”]_ŒoŠO‰È): ‘æ26‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2010/11/18), ¬‘q.

723458. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]“®–¬áŽÇðp‚É‚š‚¯‚éáŽ“à–¬ˆ³‘ª’è‚̈Ӌ`‚Æ—L—p«. ²“¡Œör
1, ‘q“c@²1, —é–؏ː¶1, m–؁@~1, ²X–Ø—º1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, ŽR“c@Ÿ1, “¡ˆäŽF1,
›@Mˆê2 (1”]ŠO, 2•úŽËü(‰æ‘œ)): ‘æ26‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2010/11/19), ¬‘q.

723459. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ᎍǐðp‚ÅŽ¡—µ‚œ”j—ô––œ«‘O‰º¬”]“®–¬áŽ‚Ì1—á. ¬òŠ°”V
1, —é–؏ː¶1, ‘q“c@²1, “c’†ç•F1, ‹{â‰À’j1, “¡ˆäŽF1 (1”]ŠO): ‘æ26‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡
—Êw‰ïŠwp‘‰ï (2010/11/19), ¬‘q.

723460. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) VA-PICA“®–¬áŽ‚ɑ΂·‚錌ŠÇ“àÇðp‚Ì—LŒø«. —é–؏ː¶1, ‘q“c@
²1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, m–؁@~1, ²“¡Œör1, ²X–Ø—º1, Œ¢Ž”@‰~1, ŽR“c@Ÿ1, “¡ˆäŽF
1, ›@Mˆê2, –kŒŽF—Y3 (1”]ŠO, 2•úŽËü (‰æ‘œ), 3‹~–œ): ‘æ26‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp
‘‰ï (2010/11/19), ¬‘q.

723461. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘æ2¢‘ãƒZƒ‹ƒTƒCƒgƒRƒCƒ‹‚ð—p‚¢‚œŽ¡—ÃŒø‰Ê‚ɂ‚¢‚Ä‚Ì•a—Šw“IŒŸ
“¢. Šâ–{˜a‹v1, ‘q“c@²1, ‘响ä’m1, —é–؏ː¶1, ²“¡Œör1, ’†ŒŽ–M»1, ŽR“c@Ÿ1, “¡ˆäŽF
1, ˆÀˆä”ü]2 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ26‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2010/11/19), ¬‘q.

723462. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠC–ȐÖ¬“Ž‚ւ̐V‚µ‚¢ŒoÃ–¬“IƒAƒvƒ[ƒ`ƒ‹[ƒg. Œ¢Ž”@‰~1, ‘q
“c@²1, —é–؏ː¶1, Šâ–{˜a‹v1, m–؁@~1, ’†ŒŽ–M»1, ²“¡Œör1, ŽR“c@Ÿ1, “¡ˆäŽF1, ›@M
ˆê2, ‘响ä’m1, ¬àV@m3 (1”]ŠO, 2•úŽËü (‰æ‘œ), 3Ž¬“c‘‡•a‰@”]_ŒoŠO‰È): ‘æ26‰ñ“ú–{”]_
ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2010/11/19), ¬‘q.

723463. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‰ð—£«’ōœ“®–¬áŽ‚Ì•a‘Ԃɂ‚¢‚Ä, ŒŒs—ÍŠw“IŒŸ“¢. m–؁@~1, ‘q
“c@²1, —é–؏ː¶1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, ²X–Ø—º1, ²“¡Œör1, ˆ¢•”Ž’q1, Œ¢Ž”@‰~1, ŽR“c@
Ÿ1, “¡ˆäŽF1, ›@Mˆê2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): ‘æ26‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï
(2010/11/19), ¬‘q.

723464. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) èò“®–¬ƒXƒeƒ“ƒg—¯’up‚ɉߟ󗬏njóŒQ‚ð’悵‚œÇ—á‚ÌŒŸ“¢. ’†ŒŽ–M
»1, —é–؏ː¶1, ‘q“c@²1, Šâ–{˜a‹v1, m–؁@~1, ²X–Ø—º1, ²“¡Œör1, ŽR“c@Ÿ1, “¡ˆäŽF
1, ›@Mˆê2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): ‘æ26‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï (2010/11/19), ¬
‘q.

723465. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Š¥“®–¬ŽŸŠ³, Ž‰Ž¿‘ãŽÓˆÙí‚ð”O“ª‚É‚š‚¢‚œCAS‚ÌŒŸ“¢. ¬àV@m
1, ‘q“c@²2, —é–؏ː¶2, Šâ–{˜a‹v2, “¡ˆäŽF2, ²X–Ø—º2, ›@Mˆê3 (1Ž¬“c‘‡•a‰@”]_ŒoŠO
‰È, 2”]ŠO, 3•úŽËü (‰æ‘œ)): ‘æ26‰ñ“ú–{”]_ŒoŒŒŠÇ“àŽ¡—Êw‰ïŠwp‘‰ï 8201011/19), ¬‘q.

723466. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 5-ALA “Š—^Œã‚ÌgliomaŠ³ŽÒ‚Ì”A’†ƒ|ƒ‹ƒtƒBƒŠƒ“‘ª’è. ‰F’Öؑ1,
‰ª@GG1, –Ø“‡çq1, ‹{“‡—Ç‹P1, ”‹ŒŽG”V1, ²“¡Œör1, —é–؏ː¶1, ²“¡Ÿl1, “¡ˆäŽF1 (1
”]ŠO): ‘æ28‰ñ“ú–{”]Žîᇊw‰ïŠwpW‰ï (2010/11/28), Œyˆä‘ò.

723467. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Astrocytoma‚É‚š‚¯‚éDJ-1‚ÌŠj“à”­Œ»‚̒ቺ‚ÆŠ³ŽÒ—\Œã‚Æ‚ÌŠÖ˜A«
‚ɂ‚¢‚Ä. ‹{“‡—Ç‹P1, ²“¡—Yˆê2, ‰ª@GG1, ‰F’Öؑ1, ‹ß“¡GŽ¡1, ’Jè‹`“¿1, ’·‰–@—º2, “¡
ˆäŽF1 (1”]ŠO, 2ˆã—Éq¶Šw•”): ‘æ28‰ñ“ú–{”]Žîᇊw‰ïŠwpW‰ï (2010/11/28), Œyˆä‘ò.

723468. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) HER-2—z«“û‚ª‚ñ‚ɑ΂·‚镪Žq•W“I–ò‚Æ”]“]ˆÚ‚ÌŠÖ˜A«. ”‹ŒŽG”V
1, ¬â–ùŒ«2, ‰ª@GG1, ‰F’Öؑ1, ‘ •À@Ÿ2, “¡ˆäŽF1, “n粏¹•F2 (1”]ŠO, 2ŠO‰È): ‘æ28
‰ñ“ú–{”]Žîᇊw‰ïŠwpW‰ï (2010/11/29), Œyˆä‘ò.

723469. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”]Žîᇎèp‚ł̃}ƒNƒŽÊ^‚ð—p‚¢‚œŽèp‹L˜^‚Ì—L—p«‚ɂ‚¢‚Ä. ”n
ŸºˆêŽ÷1, ‰ª@GG1, “¡ˆäŽF1, Šâ–{˜a‹v1, “c’†@—m2 (1”]ŠO, 2Šƒ–èŽs—§•a‰@”]_ŒoŠO‰È): ‘æ
28‰ñ“ú–{”]Žîᇊw‰ïŠwpW‰ï (2010/11/29), Œyˆä‘ò.

723470. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Atypical Teratoid/Rhabdoid Tumor: “ú–{‘S‘’²žÅI•ñ. ‰ª@
GG1, “¡ˆäŽF1, “ú–{”]Žîᇊw‰ï‘ÙŽ™«ŽîᇑS‘’²ž”Ç2 (1”]ŠO, 2“ú–{”]Žîᇊw‰ï‘ÙŽ™«’†•_Œo
ŒnŽîᇑS‘’²žŒ€‹†”Ç): ‘æ28‰ñ“ú–{”]Žîᇊw‰ïŠwpW‰ï (2010/11/29), Œyˆä‘ò.

723471. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ž‹Œð³‚É”­¶‚µ‚œ, ganglioglioma‚Ì1—á. ’Jè‹`“¿1, ”Ñ“cG•v
1, ‰ª@GG1, ì–ìM”V1, “¡ˆäŽF1 (1”]ŠO): ‘æ28‰ñ“ú–{”]Žîᇊw‰ïŠwpW‰ï (2010/11/29), Œyˆä
‘ò.

723472. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Keyhole surgery‚Ì‚œ‚߂̐_Œo“àŽ‹‹ŸŽx‰‡Žèp: ‚»‚̃gƒŒ?ƒjƒ“ƒO
‚ÆŽÀÛ. ‰ª@GG1, Perneczky A2, “¡ˆäŽF1 (1”]ŠO, 2ƒ}ƒCƒ“ƒc‘åŠw”]_ŒoŠO‰È): ‘æ17‰ñ“ú–{_
Œo“àŽ‹‹ŸŠw‰ï (2010/12/10), ç—t.

723473. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŽ”­«”]Žº“àùN–E‚ɑ΂·‚é_Œo“àŽ‹‹ŸŽ¡—Ã. ’†ŒŽ–M»1, Žt“cMl
2, ‰ª@GG1, ˆäŒŽ@“N3, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO, 2‘—§¬ˆçˆã—ÃZƒ“ƒ^[”]_ŒoŠO‰È, 3’}
”g‘åŠw—Տ°ˆãŠwŒn”]_ŒoŠO‰È): ‘æ17‰ñ“ú–{_Œo“àŽ‹‹ŸŠw‰ï (2010/12/11), ç—t.

723474. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«‚Ä‚ñ‚©‚ñŽ¡—Âɂš‚¯‚郉ƒ‚ƒgƒŠƒMƒ“ (ƒ‰ƒ~ƒNƒ^[
ƒ‹) ‚ÌŽg—pŒoŒ±. ˆ¢•”Ž’q1, ‰ª@GG1, ‰F’Öؑ1, ²“¡Ÿl1, ²“¡Œör1, ”‹ŒŽG”V1, ‹{“‡—Ç‹P
1, “¡ˆäŽF1 (1”]ŠO): ‘æ34‰ñ“ú–{‚Ä‚ñ‚©‚ñŠO‰ÈŠw‰ï (2011/1/20), L“‡.

723475. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‚¢‚¶‚ß‚ðŒ_‹@‚É”­Ç‚µ‚œ‘áz‚É”º‚€Uí‚Ì1—á. ²“¡Ÿl1, ‘å]
çœA2, “n•ÓŽ¬3, ‰ª@GG1, ŽR“c@Ÿ1, “¡ˆäŽF1 (1”]ŠO, 2“ú‚•a‰@‹@”\”]ŠO‰ÈEƒKƒ“ƒ}ƒiƒCƒt
ƒZƒ“ƒ^[, 3ŒQ”n‘åŠwˆãŠw•””]_ŒoŠO‰È): ‘æ50‰ñ“ú–{’èˆÊE‹@”\_ŒoŠO‰ÈŠw‰ï (2011/1/22), L“‡.

723476. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž‹°‰ºŠj“à‚Ì•Ó‰Œn—̈æƒjƒ…[ƒƒ“‚̐_Œo¶—Šw“I“Á’¥. ²“¡Ÿl
1, ’mŒ©‘”ü2, “¡ˆäŽF1, “ì•”@“Ä2 (1”]ŠO, 2Ž©‘R‰ÈŠwŒ€‹†‹@\¶—ŠwŒ€‹†Š¶‘̃VƒXƒeƒ€Œ€‹†•”–å):
‘æ50‰ñ“ú–{’èˆÊE‹@”\_ŒoŠO‰ÈŠw‰ï (2011/1/22), L“‡.

723477. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬”]äP‰èŽî¬l—á‚ÌŒŸ“¢. ‰F’Öؑ1, ‰ª@GG1, –Ø“‡çq1, ”‹
ŒŽG”V1, ‹{“‡—Ç‹P1, “¡ˆäŽF1 (1”]ŠO): ‘æ34‰ñ“ú–{”]_ŒoCI Šw‰ï‘‰ï (2011/2/4), •ÄŽq.

723478. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒvƒƒ‰ƒNƒ`ƒm[ƒ}‚ÌŽèp“Eo‚Å“à•žŽ¡—Â𒆎~‰Â”\‚©H?‹“Ž™Šó
–]EªŽ¡ŽèpŠó–]—á‚𒆐S‚É?. ‹{“‡—Ç‹P1, ‰ª@GG1, ‰F’Öؑ1, Ž…@ú1, ”‹ŒŽG”V1, ‹ß“¡G
Ž¡1, ‘åàV¬”V1, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO): ‘æ21‰ñ“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2011/3/11), “Œ
‹ž.

723479. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”A•öÇ‚Å”­Ç‚µ‚œErdheim Cheater Disease‚̈ê—á: ’·ŠúŠÏŽ@‚©‚ç.
”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ˆÀˆä”ü]2, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ21‰ñ
“ú–{ŠÔ”]‰º‚‘ÌŽîᇊw‰ï (2011/3/11), “Œ‹ž.

723480. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –¢”j—ô“®–¬áŽ‚ɑ΂·‚éÇðpŒã‚Ì’·ŠúŒo‰ßŠÏŽ@Œ‹‰Ê‚ÌŒŸ
“¢. —é–؏ː¶1, ‘q“c@²1, Šâ–{˜a‹v1, ’†ŒŽ–M»1, m–؁@~1, ²X–Ø—º1, ²“¡Œör1, ŽR“c@Ÿ
1, “¡ˆäŽF1, ›@Mˆê2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): ‘æ40‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŠw‰ï (2011/3/25), “Œ
‹ž.

731074. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]_ŒoŠO‰È—̈掟Š³‚Æ‚Ä‚ñ‚©‚ñŽ¡—ÁF‚Ä‚ñ‚©‚ñŠO‰È‚ÆŽ¡
—Öò. ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): ƒOƒ‰ƒNƒ\ƒXƒ~ƒXƒNƒ‰ƒCƒ““Á•Êu‰‰‰ï (2010/8/4), ’¬“c.

731075. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “Œ‹ž”]Žîᇌ€‹†‰ï‚̐¶‚¢—§‚¿‚ÆŒ»ó: ‘æ100‰ñ“Œ‹ž”]Žî
ᇌ€‹†‰ï“Á•Êu‰‰‰ï‚Ì•ñ‚ðŠÜ‚ß. ‰ª@GG1, “¡ˆäŽF1, ì–ìM”V1 (1”]ŠO): ‘æ100‰ñ‹ß‹E”]Žîá‡
•a—ŒŸ“¢‰ï‹L”O“Á•Êu‰‰‰ï (2010/10/23), ‘åã.

731076. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]_ŒoŠO‰È—̈æ‚É‚š‚¯‚é_Œo“àŽ‹‹ŸŽèp‚ÌŒ»ó‚Æ“W–]: _
Œo“àŽ‹‹ŸŽx‰‡Žèp‚©‚çKeyhole surgery. ‰ª@GG1, “¡ˆäŽF1, Rhoton AL Jr2, Perneczky A3 (1”]
ŠO, 2ƒtƒƒŠƒ_‘åŠw”]_ŒoŠO‰È, 3ƒ}ƒCƒ“ƒc‘åŠw”]_ŒoŠO‰È): ‘æ10‰ñŒú–ؐ_ŒoŠO‰Èˆã‰ï“Á•Êu‰‰‰ï
(2010/11/10), ΜЯ.

731077. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]_ŒoŠO‰Èˆã‚Æ‹³ˆç. “¡ˆäŽF (”]ŠO): ‘æ238‰ñŽR—œ
”]_ŒoƒZƒ~ƒi[ (2010/11/16), b•{.

731078. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]_ŒoŠO‰È—̈æ‚É‚š‚¯‚éæ’[Žèp?“Á‚ɐ_Œo“àŽ‹‹ŸŽèp
‚ɂ‚¢‚Ä?. ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): –k—¢‘åŠw•a‰@ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”“Á•Êu‰‰‰ï
(2010/11/28), ‘Š–ÍŒŽ.

731079. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]_ŒoŠO‰Èˆã‚Æ‹³ˆç. “¡ˆäŽF (”]ŠO): ‘æ37‰ñ•Ÿ‰ª‘å
ŠwˆãŠw•””]_ŒoŠO‰ÈŠJu‹L”O‰ïŠwpu‰‰‰ï (2010/12/4), •Ÿ‰ª.

732057. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ”]_ŒoŠO‰È—̈æ‚Æ‚Ä‚ñ‚©‚ñŽ¡—Ã: ‚Ä‚ñ‚©‚ñŠO‰È‚ÆŽ¡—Öò.
‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): ƒOƒ‰ƒNƒ\ƒXƒ~ƒXƒNƒ‰ƒCƒ“‹³ˆçu‰‰‰ï (2010/8/4), ’¬“c.

732058. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) CSPS-IIŠî‚­”]dÇŽ¡—Âɂ‚¢‚Ä: ”]ŽîᇁE”]‘²’†‚Ì
—ŒŽÒ‚ÉŒg‚í‚é—§ê‚Å. ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): ƒvƒŒƒ^[ƒ‹Šwp‹³ˆçu‰‰‰ï (2010/9/6), ‰¡•l.

732059. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) ”]_ŒoŠO‰ÈŽŸŠ³‚Ì‚Ä‚ñ‚©‚ñŽ¡—Ã: –ò•šŽ¡—ÂƎèpŽ¡—Ã. ‰ª@GG
1, “¡ˆäŽF1 (1”]ŠO): ƒOƒ‰ƒNƒ\ƒXƒ~ƒXƒNƒ‰ƒCƒ“»–ò‹³ˆçu‰‰‰ï (2011/1/28), ’¬“c.

733153. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒp[ƒLƒ“ƒ\ƒ“•aŠ³ŽÒ‚̐Uí‚É‚æ‚Á‚ÄŽ‹°Vim
Šj“à‚ɐ¶‚¶‚é“Ë‘R‚Ì“¯ŠúŠˆ“®‚ɂ‚¢‚Ä. “n•ÓŽ¬1, ²“¡Ÿl2, •œŒË­Žj1, D–{—T•œ1, ’†“ˆ@„3, áÁ
–Ø“ñ—t4, ‘å]çœA5 (1ŒQ”n‘åŠw”]_ŒoŠO‰È‹@”\“I”]_ŒoŠO‰Èƒ`[ƒ€, 2”]ŠO, 3“Œ‹ž—Žqˆã‰È‘åŠw”]_
ŒoŠO‰È, 4¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw_Œo“à‰È, 5“ú‚•a‰@‹@”\ŠO‰ÈƒZƒ“ƒ^[): ‘æ30‰ñŠÖ“Œ‹@”\“I”]ŠO‰ÈƒJ
ƒ“ƒtƒ@ƒŒƒ“ƒX (2010/4/3), “Œ‹ž.

733154. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒNƒŠƒbƒsƒ“ƒOpŒã18”N–Ú‚É‚­‚à–Œ‰ºoŒŒ‚Å”­
Ç‚µ‚œˆãŒŽ«‹U«”]“®–¬áŽ‚Ì1—á. ë“à—²—Y1, ‘åàV¬”V1, L£‚Žm2, –{@‹§3, “¡ˆäŽF1 (1”]
ŠO, 2–k—¢‘åŠw–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@_Œo“à‰È, 3“¯•a—): ‘æ111‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ
“ŒŽx•”‰ï (2010/4/10), “Œ‹ž.

733155. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’†•_Œo“]ˆÚ‚ð‚«‚œ‚µ‚œ”畆T×–EƒŠƒ“ƒpŽî
‚̈ê—á. –Ø“‡çq1, ‰ª@GG1, ‰F’Öؑ1, ’†ŒŽ–M»1, ˆÀˆä”ü]2, “¡ˆäŽF1, “¿ŽR@é3, ‰ªˆÀ@
ŒM3, “ŒŒŽ³–Ÿ4 (1”]ŠO, 2Œ`‘ÔŒn, 3•a—, 4ŒŒ‰t“à): ‘æ111‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“ŒŽx•”‰ï
(2010/4/10), “Œ‹ž.

733156. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Anterior condylar vein‚𗬏oÃ–¬‚Æ‚µ‚œ
Posterior fossa dural AVF‚Ì1—á. Šâ–{˜a‹v1, —é–؏ː¶1, ‘q“c@²1, –Ø“‡çq1, ’†ŒŽ–M»1, ˆ¢
•”Ž’q1, ŽR“c@Ÿ1, “¡ˆäŽF1 (1”]ŠO): ‘æ44‰ñ_“ސì”]ŒŒŠÇ“àŽèp§˜b‰ï (2010/5/17), ‰¡•l.

733157. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]Žº“àŒŽ”­«ùN–E‚ɑ΂·‚é_Œo“àŽ‹‹ŸŽ¡—Ã. ’†
ŒŽ–M»1, Žt“cMl2, ‰ª@GG1, ˆäŒŽ@“N1, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO, 2‘—§¬ˆçˆã—ÃZƒ“ƒ^
[”]_ŒoŠO‰È): ‘æ11‰ñWaterfront Neurosurgical Conference (2010/5/30), “Œ‹ž.

733158. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯ŽžŠú‚Égastrointestinal stromal tumor‚Æ
¬”]Žîᇂðf’f‚µ‚œ‚P—á: GIST‚Í”]‚É“]ˆÚ‚·‚éŽîᇂȂ̂©. ”‹ŒŽG”V (”]ŠO): ‘æ101‰ñ“Œ‹ž”]Žîᇌ€‹†
‰ï (2010/7/3), “Œ‹ž.

733159. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) optic pathway-hypotalamic pilomyxoid
astrocytoma‚̈ê—á: ’·Šú“IŠÏŽ@Ç—á‚©‚ç. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ˆÀˆä”ü]
2, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ20‰ñ“Œ‹ž”]Žîᇎ¡—ͧ˜b‰ï (2010/7/9), “Œ‹ž.

733160. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ[ƒ`[ƒA‚̃tƒ@[ƒXƒgƒ‰ƒCƒ““Š—^‚É‚š‚¯‚éŒø
‰Ê‚ÌŒŸ“¢?Preliminary Report?. ‘q“c@² (”]ŠO): ƒ[ƒ`[ƒAù”­”„3Žü”N‹L”OŠwpu‰‰‰ï
(2010/7/22), ‘Š–ÍŒŽ.

733161. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]_ŒoŠO‰È—̈æ‚É‚š‚¯‚镪Žq•W“IŽ¡—ÂƂ̊Ö
‚í‚è?“]ˆÚ«”]ŽîᇏǗႩ‚ç?. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ˆÀˆä”ü]2, “¡ˆäŽ
F1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ19‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€ (2010/7/23), ‘Š–ÍŒŽ.

733162. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒTƒ‹‚Ì•Ó‰”玿ŽhŒƒ‚ɑ΂·‚鎋°‰ºŠj‚̃jƒ…[ƒƒ“‰ž“š.
²“¡Ÿl1, ’mŒ©‘”ü2, “¡ˆäŽF1, “ì•”@“Ä2 (1”]ŠO, 2¶—ŠwŒ€‹†ŠE¶‘̃VƒXƒeƒ€): ‘æ25‰ñ“ú
–{‘å”]Šî’êŠjŒ€‹†‰ï (2010/8/1), •Ÿ“‡.

733163. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚¢‚¶‚ß‚ðŒ_‹@‚É”­Ç‚µ‚œ‘ŽšUí‚É, Vim
thalamotomy‚ª’˜Œø‚µ‚œ1—á. ²“¡Ÿl1, ‘å]çœA2, “n•ÓŽ¬3, ‰¬–ì@—T4, “¡ˆäŽF1 (1”]ŠO, 2
“ú‚•a‰@‹@”\”]ŠO‰ÈEƒKƒ“ƒ}ƒiƒCƒtƒZƒ“ƒ^[, 3ŒQ”n‘åŠw”]_ŒoŠO‰È, 4“ŒŽÅ—ÑŠÔ•a‰@_Œo“à‰È): ‘æ31
‰ñŠÖ“Œ‹@”\“I”]_ŒoŠO‰ÈƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/9/4), “Œ‹ž.

733164. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹}‘¬‚Ȉ««“]‰»‚ð‚«‚œ‚µ‚œƒOƒŠƒI[ƒ}‚̈ê—á:
”DPEoŽY‚Æ‚ÌŠÖ˜A«. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, –Ø“‡çq1, ˆ¢•”Ž’q1, ˆÀ
ˆä”ü]2, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ20‰ñ_“ސì”]ŽîᇃtƒH[ƒ‰ƒ€ (2010/9/10), ‰¡•l.

733165. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ªŠW“à–¢”j—ô“àèò“®–¬áŽ‚ɑ΂µ‚Äflow
alteration/reversal‚ð—p‚¢‚ÄŽ¡—µ‚œ1—á. ²“¡Œör1, ˆ¢•”Ž’q1, ‹{è•üŽq1, —é–؏ː¶1, ²“¡Ÿ
l1, ‰ª@GG1, ŽR“c@Ÿ1, ‘q“c@²1, “¡ˆäŽF1 (1”]ŠO): ‘æ112‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“ŒŽx•”
ŠwpW‰ï (2010/9/11), “Œ‹ž.

733166. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ð—£«’ōœ“®–¬áŽ?•a‘Ô‚ÆŽ¡—Ã?. ‘q“c@²
(”]ŠO): ‘æ4‰ñ_“ސì”]_Œo‰Èˆã‰ïŠwpW‰ï (2010/9/15), ‰¡•l.

733167. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) èò•”èò“®–¬‹·óÇ‚̃Gƒrƒfƒ“ƒX. ²“¡Œör (”]
ŠO): 2010”N“x–k—¢”]_ŒoŠO‰È”÷¬‰ð–U‰ÄŠúƒZƒ~ƒi[ (2010/9/18), ‘Š–ÍŒŽ.

733168. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Cadaver dissection‚ð’Ê‚¶‚œŠwK–@?ŒŸ‘̏€
”õ‚©‚ç3DŽÊ^ŽB‰eEŠÓÜ•û–@‚ɂ‚¢‚Ä?. ‘åàV¬”V (”]ŠO): 2010”N“x–k—¢”]_ŒoŠO‰È”÷¬‰ð–U‰ÄŠúƒZ
ƒ~ƒi[ (2010/9/19), ‘Š–ÍŒŽ.

733169. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “®–¬áŽŽèp‚Ì‚œ‚ß‚Ì“ªŠW’êŠO‰È‰ð–U. aãN
Ž¡ (”]ŠO): 2010”N“x–k—¢”]_ŒoŠO‰È”÷¬‰ð–U‰ÄŠúƒZƒ~ƒi[ (2010/9/19), ‘Š–ÍŒŽ.

733170. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬”]‹ŽŠp•”‹ß–T‚Ì“ªŠW•a•Ï‚ÌŽèp‚É•K—v‚ÈŠO
‰È‰ð–U?Lateral suboccipital approach‚̉ð–U‚Æ‘O’ë_ŒoâŽîŽèp?. ‰ª@GG (”]ŠO): 2010”N“x–k
—¢”]_ŒoŠO‰È”÷¬‰ð–U‰ÄŠúƒZƒ~ƒi[ (2010/9/19), ‘Š–ÍŒŽ.

733171. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) flow alteration‚É‚æ‚é”]“®–¬Ž¡—Ã. ŽR“c@Ÿ
(”]ŠO): 2010”N“x–k—¢”]_ŒoŠO‰È”÷¬‰ð–U‰ÄŠúƒZƒ~ƒi[ (2010/9/19), ‘Š–ÍŒŽ.

733172. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 1) ”÷¬ŠO‰È‰ð–Uintroduction@2) ‚Ü‚Æ‚ß. “¡
ˆäŽF (”]ŠO): 2010”N“x–k—¢”]_ŒoŠO‰È”÷¬‰ð–U‰ÄŠúƒZƒ~ƒi[ (2010/9/19), ‘Š–ÍŒŽ.

733173. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]ŠjˆãŠwŒŸž‚ð‚¢‚©‚É‚µ‚ÄŠˆ—p‚·‚é‚©?”]_
ŒoŠO‰È—̈æ?. ŽR“c@Ÿ (”]ŠO): ‘æ27‰ñ_“ސìPETESPECTŒ€‹†‰ï (2010/10/2), ‰¡•l.

733174. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹}‘¬‚È‘‘åŒXŒü‚ð”F‚ß‚œŽîᇗގ—«•a•Ï‚̈ê
—á. ”nŸºˆêŽ÷1, ‰ª@GG1, ‰F’Öؑ1, ²–ìm—E2, “¡ˆäŽF1 (1”]ŠO, 2Šƒ–èŽs—§•aˆö—Տ°ŒŸž
•a—): ‘æ102‰ñ“Œ‹ž”]Žîᇌ€‹†‰ï (2010/11/3), “Œ‹ž.

733175. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”A•öÇ‚Å”­Ç‚µ‚œ“÷‰èŽî«•a•Ï‚̈ê—á. ”‹ŒŽ
G”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ˆÀˆä”ü]2, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ15‰ñ‚©‚È
‚ª‚íŠÔ”]‰º‚‘ÌŽŸŠ³ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/11/24), ‰¡•l.

733176. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï) (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Epstein-Barr virus—z«’†•_ŒoŒnŒŽ”­ƒŠƒ“
ƒpŽî‚ÌŽ¡—ЬÑ. ‰F’Öؑ1, ‰ª@GG1, ‹{“‡—Ç‹P1, –Ø“‡çq1, ”‹ŒŽG”V1, —é–؏ː¶1, ²“¡Ÿl
1, “¡ˆäŽF1 (1”]ŠO): ‘æ40‰ñƒjƒ…[ƒEƒIƒ“ƒRƒƒWƒB‚̉ï (2010/12/4), “Œ‹ž.

733177. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œ”­«”]Žîᇂ̊ӕʐf’f‚Ì—¯ˆÓ“_. ”‹ŒŽG”V
1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ˆÀˆä”ü]2, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ21‰ñ“Œ‹ž”]Žî
ᇎ¡—ͧ˜b‰ï (2010/12/17), “Œ‹ž.

733178. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éƒGƒ“ƒ^[ƒvƒ‰ƒCƒY‚ÌŽg—pŒoŒ±. —é
–؏ː¶1, ‘q“c@²1, ²X–Ø—º1, Šâ–{˜a‹v1, m–؁@~1, ²“¡Œör1, ¬òŠ°”V1, ŽR“c@Ÿ1, “¡ˆä
ŽF1, ›@Mˆê2 (1”]ŠO, 2•úŽËü (‰æ‘œ)): ‘æ7‰ñ“Œ‹ž, _“ސì”]ŒŒŠÇŽ¡—ͧ˜b‰ï (2011/1/22), “Œ
‹ž.

733179. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •a—f’f‚É“ïa‚µ‚œ‘–ŒŽî‚̈ê—á. ‹{“‡—Ç‹P
1, ‰ª@GG1, ‰F’Öؑ1, ”‹ŒŽG”V1, Œ¢Ž”@‰~1, –Ø“‡çq1, “¡ˆäŽF1 (1”]ŠO): ‘æ21‰ñ_“ސì
”]ŽîᇃtƒH[ƒ‰ƒ€ (2011/1/28), ‰¡•l.

733180. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’†•_ŒoŒnŒŽ”­ˆ««ƒŠƒ“ƒpŽî‚ɑ΂·‚é•W€Ž¡
—ÂƂ»‚ÌŒÀŠE: ¡Œã‚Ö‚Ì“W–]‚ð‚Ó‚Ü‚Š‚Ä. ”‹ŒŽG”V1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ˆÀˆä”ü]
2, “¡ˆäŽF1 (1”]ŠO, 2Œ`‘ÔŒn): ‘æ20‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€ (2011/1/28), ‘Š–ÍŒŽ.

733181. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •a—f’f‚É“ïa‚µ‚œ‘–ŒŽî‚̈ê—á. ‹{“‡—Ç‹P
(”]ŠO): ‘æ103‰ñ“Œ‹ž”]Žîᇌ€‹†‰ï (2011/2/19), “Œ‹ž.

733182. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚—îŽÒ”]ŽÀŽ¿“à‚É”­¶‚µ‚œ“û“ªóŽîᇂ̈ê—á.
–Ø“‡çq1, ‰ª@GG1, ‰F’Öؑ1, ‹{“‡—Ç‹P1, ”‹ŒŽG”V1, ²“¡Œör1, “¡ˆäŽF1 (1”]ŠO): ‘æ14
‰ñ”]_ŒoŠO‰ÈŽŸŠ³‚̗Տ°‚Æ•a—‚ÌJOINT CONFERENCE (2011/2/26), “Œ‹ž.

733183. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ªŠW“à–¢”j—ô“àèò“®–¬áŽ‚ɑ΂µ‚Äflow
alteration/reversal‚ð—p‚¢‚ÄŽ¡—µ‚œˆê—á. ²“¡Œör1, ŽR“c@Ÿ1, “¡ˆäŽF1 (1”]ŠO): ‘æ22‰ñ_
“ސìStroke Forum (2011/3/4), ‰¡•l.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-110019. [ŒŽ’˜] Cerebral autosomal dominamt arteriopathy with subcortical infarcts and
leukoencephalopathy ayndrome mutations increase susceptibility to spreading depression.
Eikermann-Haerter K1, Yuzawa I2, Dilekoz E1, Joutel A1, Moskowitz MA1, Ayata C1 (1MGH, 2”]ŠO):
Ann Neurol 2010/2; 69 (2): 413-8. (“’àV@ò2)

H21-320003. [Ç—á•ñ] ”’Ž¿”]Ç‚É‚æ‚é”F’mÇ‚ÆŒëf‚³‚ê‚é”]Žîá‡?ŒŒŠÇ“à‘å×–EŒ^B×–E«ƒŠƒ“
ƒpŽî?. ‰F’Öؑ1, —é–؏ː¶1, ’†ŒŽ–M»1, ²“¡Ÿl1, ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): Dementia
Japan 2010/3; 24 (1): 57-64.

H21-540018. [‚»‚Ì‘Œ (’Z•ñE‘¬•ñ)] Ž„‚Ì‚š‚·‚·‚߂̈êû, ˆê–‡, ˆêŒ¬uŒ³’¬”~—сv. ‰F’Öؑ (”]
ŠO): ”]_ŒoŠO‰È‘¬•ñ 2010/1; 20 (1): 111.

H21-540019. [‚»‚Ì‘Œ (’Z•ñE‘¬•ñ)] Ž„‚Ì‚š‚·‚·‚߂̈êû, ˆê–‡, ˆêŒ¬uˆâŒŸ‘ƒLƒbƒgv. ‰F’ÖØ
‘ (”]ŠO): ”]_ŒoŠO‰È‘¬•ñ 2010/3; 20 (3): 360.

[’˜@‘]

H21-621001. [‚»‚Ì‘Œ (u‰‰˜^)] (•ª’SŽ·•M)y‚©‚È‚ª‚í“ï•a‘Š’kEŽx‰‡ƒZƒ“ƒ^[ˆã—Íu‰‰‰ï@u‰‰
˜^No.10z‚à‚â‚à‚â•a (ƒEƒBƒŠƒX“®–¬—֕ǏÇ) ‚̏Ǐó‚ÆŽ¡—Âɂ‚¢‚Ä, p.1-24. “¡ˆäŽF (”]ŠO), ‚©
‚È‚ª‚í“ï•a‘Š’kEŽx‰‡ƒZƒ“ƒ^[, _“ސì, 2010/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H21-731006. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]_ŒoŠO‰È—̈æ‚É‚š‚¯‚éæ’[ŠO‰ÈŽ¡—ÂƖò•šŽ¡
—Ã. ‰ª@GG1, “¡ˆäŽF1 (1”]ŠO): ‘å’ː»–ò“Á•Êu‰‰‰ï (2010/3/28), Œú–Ø.

H21-731007. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”]‘²’†‚ÌŠO‰È“IŽ¡—Ã. “¡ˆäŽF (”]ŠO): ’ߊª
’n‹æƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“§˜b‰ï (2010/1/28), `–ì.

H21-733009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]_ŒoŠO‰Èˆã‚É•K{‚ÌŠO‰È‰ð–U@ŠT
à. “¡ˆäŽF (”]ŠO): ‘æ15‰ñ–k—¢”]_ŒoŠO‰È”÷¬‰ð–UƒZƒ~ƒi[ (2010/3/13), ‘Š–ÍŒŽ.


¬Ž™‰ÈŠw

[Šwp˜_•¶]

110174. [ŒŽ’˜] Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for
Stenotic Lesions after Kawasaki Disease. Muta H, Îˆä³_1 (1¬Ž™): The Journal of Pediatrics
2010/7; 157 (1): 120-6.

110175. [ŒŽ’˜] Blood concentrations of midazolam in status epilepticus using an appropriate
condition of HPLC. Šâèr”V1, –ìX“c–L1, Îˆä³_1, Osawa M (1¬Ž™): Pediatrics International
2010/8; 52 (4): 513-9.

110176. [ŒŽ’˜] Interictal EEG findings in 12 cases of neonatal seizures after asphyxia. Šâè
r”V1, –ìX“c–L1, –ì“n³•F1, Îˆä³_1 (1¬Ž™): Kitasato Medical Journal 2010/9; 40 (2): 114-21.

120027. [ŒŽ’˜] Japanese Pediatric Asthma Control Program (JPAC), ¬Ž™šb‘§ƒRƒ“ƒgƒ[ƒ‹ƒeƒXƒg
(Childhood Asthma Control Test: C-ACT)‚ƌċz‹@”\, ŒÄ‹CˆêŽ_‰»’‚‘f‚ÌŒoŽž“I•Ï‰»‚ÌŒŸ“¢. ˆéè@~
1, ì–ì@–L1, ³“c“N—Y1, ŽO‘º@®1, ¬ì—ÏŽj2, –ìŠÔ@„2, ‰Í–ì“O–ç1, ’†‘º—zˆê1 (1‰¡•lŽs—§
‚݂ȂƐԏ\Žš•a‰@, 2¬Ž™): ƒAƒŒƒ‹ƒM[ 2010/7; 59 (7): 822-30.

310013. [Ç—á•ñ] Kikuchi-Fujimoto disease developed into autoimmune disease: A report of two
cases. •û¹•œ1, â“Œ—R‹I1, âV“¡“T[2, Ÿ‰ªŒ›¶2, Îˆä³_1 (1¬Ž™, 2”畆): Modern
Rheumatology 2010/6; 20 (3): 301-5.

320027. [Ç—á•ñ] ƒVƒvƒƒtƒƒLƒTƒVƒ“‚ª—LŒø‚Å‚ ‚Á‚œƒTƒ‹ƒ‚ƒlƒ‰‘–Œ‰Š‚̐V¶Ž™—á. ŒŽ@^l1, “¡
•‹`l1,4, “‡ŠÑ@ˆè1, –ìXŽRŸl2, »ìŒc‰î3, Îˆä³_4 (1–k—¢Œ€‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@,
2ŠC˜V–Œ‘‡•a‰@, 3–k—¢¶–œ‰ÈŠwŒ€‹†Š, 4¬Ž™): “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2010/4; 114 (4): 699-705.

520060. [‘à]y¬læ“V«SŽŸŠ³z Š®‘S‘匌ŠÇ“]ˆÊÇ. –Ø‘ºƒl1, Îˆä³_1 (1¬Ž™): SƒGƒR[
2010/8; 11 (8): 754-9.

520061. [‘à] ƒwƒ‹ƒp[T×–Eƒpƒ‰ƒ_ƒCƒ€?Th17×–E‚ÆTreg×–E‚É‚æ‚鎟Š³Œ`¬‚Ɛ§Œä?. –ìŠÔ@„
(¬Ž™): “ú–{—Տ°–ƉuŠw‰ï‰ïŽ 2010/10; 33 (5): 262-71.

522087. [uÀ]y‘Î’kz“ú–{‚̏zŠÂŠí•aŠw‚ÌŒ¹—¬?ìè•a. ìè•xì1, Îˆä³_2 (1“ú–{ìè•aŒ€‹†
ƒZƒ“ƒ^[, 2¬Ž™): ŒÄ‹z‚ƏzŠÂ 2010/9; 58 (9): 945-52.

522088. [uÀ]y“ÁW: ”ì–žÇupdatez ”ì–ž‚É”º‚€”–â‘è?•a‘Ô‚ÆŽ¡—Á@¬Ž™‚̔얞Ç. ‹k“cˆê‹P1,2,
Îˆä³_2, ‘åŠÖ••F1 (1•lŒˆã‰È‘åŠw, 2¬Ž™): ‘Ž‡—Տ° 2010/9; 59 (9): 1942-8.

[’˜@‘]

620089. [Šwp‘] (•ª’SŽ·•M)yzŠÂŠí•aŠw@Šî‘b‚ƗՏ°C‘æ1”Łz5Í Š¥“®–¬ŽŸŠ³@“®–¬d‰»ˆÈŠO‚̐¬
ˆö‚É‚æ‚銥“®–¬ŽŸŠ³?ìè•a, p.752-7. Îˆä³_ (¬Ž™), •Ò ì–Œ³•q, –k•—­Žj, ¬Žºˆê¬, ŽºŒŽ–L
–Ÿ, ŽRè —Í, Œ‘º‘“X, “Œ‹ž, 2010/7”­s.

620090. [Šwp‘] (•ª’SŽ·•M)yŒŒŠÇƒGƒR[ƒp[ƒtƒFƒNƒgƒKƒCƒh?“®–¬d‰»‚Ì‘Šú”­Œ© (zŠÂŠí—Տ°ƒTƒs
ƒA 9)z3Í ŒŒŠÇƒGƒR[‚ð‹ìŽg‚µ‚œ“ÁŽêŒŸž@¬Ž™‰È—̈æ‚É‚š‚¯‚錌ŠÇƒGƒR[, p.219-26. Îˆä³_ (¬
Ž™), ‘•ÒW ‰iˆä—ÇŽO, Ó”C•ÒW ŽºŒŽ–L–Ÿ, •ÒW‹Š—Í –ìoFˆê, ’†ŽR‘“X, “Œ‹ž, 2010/8”­s.

620091. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚ÌŽ¡—ÃŽnŽwj 2011”N“x”Å?Ž„‚Í‚±‚€Ž¡—µ‚Ä‚¢‚éz23 ¬Ž™‰ÈŽŸŠ³@
SŽŸŠ³‚ð‚à‚“û—cŽ™‚Ì“úí¶Šˆ‚ÌŠÇ—‚ÆŽw“±, p.1173-4. Îˆä³_ (¬Ž™), ‘•ÒW ŽRŒû@“O, –kŒŽŒõ
•v, •ŸˆäŽŸ–î, ˆãŠw‘‰@, “Œ‹ž, 2011/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712048. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Stress test and quality of life in long-term after kawasaki.
Îˆä³_ (¬Ž™): Association for European pediatric cardiology (2010/5/26-29), Innsbruck,
Austria.

713088. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Quantitative evaluation of cardiac function in
onochorionic diamniotic twin patients: Tissue Doppler Study. –Ø‘ºƒl1, ’†”š–퐶1, ‘å˜a“c‰Ä
Žq1, ˆÀ“¡@Žõ1,Îˆä³_1 (1¬Ž™): ‘æ46‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï^The 3rd Congress of
Asia-Pacific Pediatric Cardiac Society (2010/7/7), ç—t, The 3rd Congress of Asia-Pacific
Pediatric Cardiac Society, abstract book, 2010; p.282.

713089. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The Efficacy@And Safety Of New Strategy Kawasaki
Disease: A Clinical Trial In Single Institution. Îˆä³_1, •û¹•œ1, –{“c@’1, îŒŽ‹`l
1, –Ø‘ºƒl1, ’†”š–퐶1 (1¬Ž™): American Heart Association Scientific Sessions 2010 (2010/11/15),
Chicago.

722120. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) Percutaneous Coronary Intervention for Kawasaki
Disease. Îˆä³_1, –Ž“cLŽÀ2 (1¬Ž™, 2”Ñ’ËŽs–¯•a‰@): ‘æ46‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW
‰ï (2010/7/7), ç—t, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2010/6; 26 (Suppl): 154.

722121. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y“«ìè•a‚ÌŽ¡—Ð헪zIVIG •s‰ž‚ɑ΂·‚鎡—ÃvƒƒgƒR[
ƒ‹: “–‰@‚É‚š‚¯‚é–ƉuƒOƒƒuƒŠƒ“•s‰ž—á‚ɑ΂·‚鎡—Ð헪. îŒŽ‹`l1, •û¹•œ1, –{“c@’1, –Ø‘º
ƒl1, ’†”š–퐶1, Îˆä³_1 (1¬Ž™): ‘æ30‰ñ“ú–{ìè•aŠw‰ïŠwpW‰ï (2010/10/11), ‹ž“s.

722122. [Šw‰ï (‘S‘)] (ƒ~ƒjƒ[ƒNƒVƒ‡ƒbƒv)y¬Ž™Á‰»ŠÇƒAƒŒƒ‹ƒM[zV¶Ž™E“ûŽ™Á‰»ŠÇƒAƒŒƒ‹ƒM[
Š³Ž™‚Ì”S–Œ‚ð—p‚¢‚œ•a‘Ԃ̉ðÍ. ‘å’Ë‹Xˆê1, “¡•‹`l2, _•ÛŒ\—S1, ˆî–щp‰î1, ”nê—m‰î1, X@^
—1, ŽRì—zŽq1, Â–ö@—z1, “¡ˆä@“O1, H“¡FL1, —é–Ø—³—m1, Ž…r–Ÿ1 (1‡“V“°‘åŠw, 2¬Ž™):
‘æ60‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ïH‹GŠwp‘å‰ï (2010/11/26), “Œ‹ž, ƒAƒŒƒ‹ƒM[ 2010/10; 59 (9-10): 1358.

722123. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒNƒŠƒjƒJƒ‹ƒAƒ[: ¬Ž™‚©‚琬l‚ւ̃gƒ‰ƒ“ƒWƒVƒ‡ƒ“2z“œ”A
•a: ¬Ž™Šú”­Ç1Œ^“œ”A•aŠ³ŽÒ‚Ì“à‰È‚ւ̈ڍs?–k—¢‘åŠw‚É‚š‚¯‚錻ó‚Æ–â‘è?. ‘å’Ь”V (¬Ž™):
‘æ20‰ñ—Տ°“à•ª”å‘ãŽÓUpdate (2011/1/28), ŽD–y, “ú–{“à•ª”åŠw‰ïŽGŽ 2010/12; 86 (3): 655.

723481. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒpƒŠƒrƒYƒ}ƒu“Š—^‚ÍRSV‹}«×‹CŠÇŽx‰Š‚Ì“ü‰@‚ðŒž­‚³
‚¹‚œ‚©? —с@‰1, ã“cN‹v1, •Ÿ“‡’‹`2, ŒŽ@^l1,3, ”~ŒŽ@ŽÀ4, Îˆä³_1 (1¬Ž™, 2•Ÿ“‡
¬Ž™‰Èˆã‰@, 3‘Š–Í–ì•a‰@, 4‚€‚߂͂炱‚Ç‚àƒNƒŠƒjƒbƒN): ‘æ113‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2010/4/23),
·‰ª, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2010/2; 114 (2): 309.

723482. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«ìè•a‚ɑ΂·‚éƒXƒeƒƒCƒhƒpƒ‹ƒX•¹—p—Ö@?ƒ}ƒC
ƒNƒƒAƒŒƒC‰ðÍ‚É‚æ‚錟“¢?. •û¹•œ1, â“Œ—R‹I1, îŒŽ‹`l1, ‹àŽq’‰O1, HŽR˜a­1, ©@L–ç
1, ²“¡‰Á‘ãŽq1, –Ø‘ºƒl1, ’†”š–퐶1, Îˆä³_1 (1¬Ž™): ‘æ113‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï
(2010/4/24), ·‰ª, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2010/2; 114 (2): 220.

723483. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]«–ƒáƒ‚É”º‚€‘±”­«œ‘e頏ǂ̒†’·Šú“I—\Œã. Šâèr
”V1, –ìX“c–L1, Îˆä³_1 (1¬Ž™): ‘æ113‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2010/4/24), ·‰ª, “ú–{¬
Ž™‰ÈŠw‰ïŽGŽ 2010/2; 114 (2): 361.

723484. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒxƒr[ƒXƒŠƒ“ƒOŽg—p’†‚ÉCPA‚Æ‚È‚Á‚œ2ƒ•ŒŽ—Ž™—á. ‚
—œ@Šw1, ã“cN‹v1, HŽR˜a­1, ‹àŽq’‰O1, –ìX“c–L1, —с@‰1,2, Îˆä³_1, “c‘º—Ll2, ¡
ˆä@Š°2, ‘Š”nˆêˆå2 (1¬Ž™, 2‹~–œ): ‘æ113‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2010/4/24), ·‰ª, “ú–{¬
Ž™‰ÈŠw‰ïŽGŽ 2010/2; 114 (2): 369.

723485. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽŸ¢‘ãƒV[ƒNƒGƒ“ƒT[‚É‚æ‚éìè•a‚ÌŒŽˆö‹†–Ÿ. •“c@
œ1, ŠÖ’ˍ„Žj1, ŒŠŠª‹ÅŽq1, ²“¡œˆê2, ‘åê–MO2, •l“c—m’Ê3, Ž›ˆä@Ÿ3, •û¹•œ4, Îˆä³_
4, X@‰ë—º5, ‰¡“cr•œ5, …’J“N–ç1 (1‘—§ŠŽõÇŒ€‹†Š, 2VŠƒŽs–¯, 3“Œ‹ž—Žqˆã‘å, 4¬Ž™, 5
‰¡•lŽs‘å): ‘æ113‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2010/4/25), ·‰ª, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2010/2; 114 (2):
242.

723486. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒEƒCƒ‹ƒX‚Ì–Ô—…“I‰ðÍ‚É‚æ‚éìè•a‚ÌŒŽˆö‹†–Ÿ. …’J“N
–ç1, •“c@œ1, ŠÖ’ˍ„Žj1, ‘åê–MO2, ŒŠŠª‹ÅŽq1, •û¹•œ3, Îˆä³_3, X@‰ë—º4, ‰¡“cr•œ
4 (1‘—§ŠŽõÇŒ€‹†Š, 2Œö—§º˜a•a‰@, 3¬Ž™, 4‰¡•lŽs‘å): ‘æ113‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï
(2010/4/25), ·‰ª, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2010/2; 114 (2): 242.

723487. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”r”AŽžäNã÷”A“¹‘¢‰eŒŸž‚É‚š‚¯‚é”r”A‘£i‚ɂ͉œ‚ª—LŒø
‚©? Šâ”g’Œ”ü1, ’†‘ºM–ç2, “Y“c—RŠóŽq1, ‰z–ì_]4, Žç‰®r‰î5, ”э‚Šì‹v—Y3, ‰ÍŒ‹Iº2, Îˆä
³_2 (1ŠC˜V–Œ‘‡•a‰@, 2¬Ž™, 3–kŒ€ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 4‰z–쏬Ž™‰È, 5Ã“ìƒLƒbƒYƒNƒŠƒj
ƒbƒN): ‘æ113‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (2010/4/25), ·‰ª, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ 2010/2; 114 (2): 380.

723488. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “û—cŽ™“«šb–‚ɂš‚¯‚éHRCT‚É‚æ‚é‹CŠÇŽx•Ç‚ÌŒú‚³‚Ì
‘ª’è. ŽO‘º@®1, ˆéè@~1, ³“c“N—Y1, ¬ì—ÏŽj2, –ìŠÔ@„2, ì–ì@–L1, ‰Í–ì“O–ç1, ’†‘º—z
ˆê1, Œ‰ª@Ž1 (1‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 2¬Ž™): ‘æ22‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Տ°‘å‰ï
(2010/5/8), ‹ž“s, ƒAƒŒƒ‹ƒM[ 2010/4; 59 (3-4): 401.

723489. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒCƒRƒgƒŠƒGƒ“Žó—e‘̝hR–ò (ƒvƒ‰ƒ“ƒ‹ƒJƒXƒgEK) “Š—^
‚É‚æ‚鏬Ž™šb‘§”­Ç—\–h‚ÉŠÖ‚·‚錀‹† (ˆê•ñ). ’r•”•qŽs1,11, ì–ì@–L2,11, –ÚàVŒ›ˆê3,11, ‰ª–ì—T
“ñ4,11, ¯‰ª@–Ÿ5,11, ¬ì—ÏŽj6,11, Šâ“c@•q7,11, ‘åŽÄW—m8,11, ŽRŒûŒöˆê9,11, –ìŠÔ@„10,11
(1’r•”¬Ž™‰ÈƒAƒŒƒ‹ƒM[‰È, 2‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 3‚ß‚Ž‚킱‚Ç‚àƒNƒŠƒjƒbƒN, 4‚š‚©‚̏¬Ž™‰È
ƒAƒŒƒ‹ƒM[‰È, 5ç—tŒ§‚±‚Ç‚à•a‰@, 6ç—tˆ€—F‰ï‹L”O•a‰@, 7Šâ“c¬Ž™‰È, 8“Œ‹žŒú¶”N‹à•a‰@, 9“¯ˆ€
‹L”O•a‰@, 10¬Ž™, 11¬Ž™ƒAƒŒƒ‹ƒM[‰ŠúŽ¡—ÃŒ€‹†‰ï): ‘æ22‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Տ°‘å‰ï
(2010/5/8), ‹ž“s, ƒAƒŒƒ‹ƒM[ 2010/4; 59 (3-4): 404.

723490. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) JPAC‚ð—˜—p‚µ‚œ¬Ž™‹CŠÇŽxšb‘§’nˆæ˜AŒgƒpƒX‚Ì’ZŠúƒpƒX
•]‰¿. ˆéè@~1, ŽO‘º@®1, ³“c“N—Y1, ¬ì—ÏŽj2, –ìŠÔ@„2, ì–ì@–L1, ‰Í–ì“O–ç1, ’†‘º—z
ˆê1, Œ‰ª@Ž1 (1‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 2¬Ž™): ‘æ22‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Տ°‘å‰ï
(2010/5/8), ‹ž“s, ƒAƒŒƒ‹ƒM[ 2010/4; 59 (3-4): 405.

723491. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU—¬sŠú‚É‚š‚¯‚é“–‰@’ʉ@’†‚Ìšb‘§Š³
Ž™‚ւ̉e‹¿. ³“c“N—Y1, ˆéè@~1, ŽO‘º@®1, ¬ì—ÏŽj2, –ìŠÔ@„2, ì–ì@–L1, ‰Í–ì“O–ç1, ’†
‘º—zˆê1, Œ‰ª@Ž1 (1‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 2¬Ž™): ‘æ22‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Տ°‘å‰ï
(2010/5/8), ‹ž“s, ƒAƒŒƒ‹ƒM[ 2010/4; 59 (3-4): 415.

723492. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]“®Ã–¬ŠïŒ`oŒŒŒã‚ɏoŒ»‚µ‚œáz«ŽÎèò‚ɑ΂µ‚ÄAŒ^ƒ{
ƒcƒŠƒkƒX“Å‘f‚ª—LŒø‚Ÿ‚Á‚œ1—á. –ìX“c–L1, Šâèr”V1, ×“c‚Ì‚Œ‚Ý1,2, ”’ˆäGK1,3, Îˆä³_1 (1
¬Ž™, 2‘Š–ÍŒŽ—È牀, 3‘Š–Í‘ä•a‰@)‘æ52‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï (2010/5/20), ‹v—¯•Ä, ”]‚Æ”­’B
2010/5; 42 (Suppl): S396.

723493. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒûŠWƒ~ƒIƒNƒ[ƒkƒX‚ð’悵‚œ“ûŽ™Œ^Alexander•a‚Ì1—á.
²X–ؐªs1, –ìX“c–L1,2, åŒŽ’•¶1, ²‹vŠÔŒ[1, {ŠLŒ€Ži1 (1‘—§ž_E_ŒoƒZƒ“ƒ^[•a‰@, 2¬
Ž™): ‘æ52‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï (2010/5/22), ‹v—¯•Ä, ”]‚Æ”­’B 2010/5; 42 (Suppl): S323.

723494. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™1Œ^“œ”A•a‚É‚š‚¯‚é”ì–ž‚ÆŽ‰Ž¿‘ãŽÓ‚ÉŠÖ‚·‚錟“¢.
‹k“cˆê‹P1, “c‹v•ÛŒ›s1, ‰º•l^—Žq1, ‘å’Ь”V1, •—’£áÁ—R”ü1, ‰¡“csŽj2, Îˆä³_1 (1¬Ž™, 2
‘Š–ÍŒŽ‹Š“¯•a‰@): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2010/5/27), ‰ªŽR, “œ”A•a 2010/4; 53 (Suppl
1): S-101.

723495. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •êŽq‚Æ‚à‚ɐ¶Œã1”NˆÈ“à‚É”­Ç‚µ‚œ1Œ^“œ”A•a—á. —é–Ø
“Þ’ÃŽq1, “¡‰ªŽO—é1, “c’†GŽ÷1, ‘åXˆÀŒb1, ‘åì—¹ƒV‹ã1, “c‹v•ÛŒ›s2 (1ŠC˜V–Œ‘‡•a‰@, 2¬Ž™):
‘æ53‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2010/5/27), ‰ªŽR, “œ”A•a 2010/4; 53 (Suppl 1): S-137.

723496. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ãO–Ñ–Œ“ñ—r«‘o‘ق̐S‹@”\•]‰¿?SƒGƒR[‚ÆŒŒŽŠw“IŒŸ
ž‚ð—p‚¢‚œŒŸ“¢?. –Ø‘ºƒl1, ’†”š–퐶1, ‘å˜a“c‰ÄŽq1, ˆÀ“¡@Žõ1, Îˆä³_1 (1¬Ž™): ‘æ21‰ñ
“ú–{SƒGƒR[}Šw‰ïŠwpW‰ï (2010/5/13-15), ŽD–y

723497. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŽ”­«d‰»«’_ŠÇ‰Š (PSC) ‚ɑ΂·‚éŠÌˆÚAŒã, ’×ᇐ«‘å
’°‰Š (UC) ‚©‚ç‚Ì‘å—ʏoŒŒ‚É‚æ‚è‘å’°ˆŸ‘S“Ep‚ðŽ{s‚µ‚œ1—á. â“Œ—R‹I1, “c’†@Œ‰2, ŒÃ“cˆê“¿2, Î
ˆäŒ’ˆê˜Y2, •“cŒ›Žq2, “n粏¹•F2 (1¬Ž™, 2ŠO‰È): ‘æ47‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠwpW‰ï (2010/6/17-19),
–ŒŒÃ‰®.

723498. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’m“IáŠQŠ³ŽÒ‚Ö‚Ì• –Œ“§Í“±“ü‚ɂ‚¢‚Ä?“–‰@‚Å‚ÌŒoŒ±
?. ©@L–ç1, ’†‘ºM–ç1, “Y“c—RŠóŽq2, Šâ”g’Œ”ü2, ‰z–ì_]1, Žç‰®r‰î1, ”э‚Šì‹v—Y1, ‰ÍŒ
‹Iº1, Îˆä³_1 (1¬Ž™, 2ŠC˜V–Œ‘‡•a‰@): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/20), _
ŒË, “ú–{“§ÍˆãŠw‰ïŽGŽ 2010/5; 43 (Suppl 1): 819.

723499. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) æ“V«‘’_ŠÇùNŽî‚ð‡•¹‚µ‚œíõF‘Ì—ò«‘œ”­«ùN–Et
(ARPKD) ‚̏—Ž™—á. ˆîŠ_@“µ1, ’†‘ºM–ç1, “Y“c—RŠóŽq2, Šâ”g’Œ”ü2, ‰z–ì_]3, Žç‰®r‰î4, ”э‚
Šì‹v—Y5, ‰ÍŒ‹Iº1, Îˆä³_1 (1¬Ž™, 2ŠC˜V–Œ‘‡•a‰@, 3‰z–쏬Ž™‰È, 4Ã“ìƒLƒbƒYƒNƒŠƒjƒbƒN, 5
–kŒ€ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@): ‘æ45‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ïŠwpW‰ï (2010/7/3), ‘åã, “ú–{¬Ž™t‘Ÿ
•aŠw‰ïŽGŽ 2010/6; 23 (1-Suppl): 189.

723500. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠJSpŒã‚ÌŠ³ŽÒŠÇ—: ×–E«–Ɖu”\‚ÌŒŸ“¢. ’†”š–퐶
1, •û¹•œ1, ‘å˜a“c‰ÄŽq1, –Ø‘ºƒl1, ˆÀ“¡@Žõ1, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO
‰È): ‘æ46‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ïEŠwpW‰ï (2010/7/9), ç—t, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ 2010/6; 26
(Suppl): 374.

723501. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V‚œ‚È‘ª’è–@‚É‚æ‚éä`‘Ñ“®–¬ŒŒ‚Ìcortisol, cortisone
”Z“x‚Ì‘ª’è‚Æ‘ª’茋‰Ê‚ÌŒŸ“¢. ’·’Jì‹1, ‰Íˆä¹•F1, –ì“n³•F2, Šâ‰ibŒß˜Y1, ŽO‘îŽjŽq1, “¹˜a•S
‡1, Œ‘q@’1, ŽÄ“c@ŽÀ1, ’O‰H–[Žq1, •œ‰Ær’j1 (1‹ž“s‘åŠw, 2¬Ž™): ‘æ46‰ñ“ú–{ŽüŽYŠúEV¶
Ž™ˆãŠw‰ï (2010/7/12), _ŒË, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2010/6; 46 (2): 728.

723502. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éSGA«’ág’·‚ɑ΂·‚éƒtƒHƒ[ƒAƒbƒv‚ÌŒ»
ó. HŽR˜a­1, “c‹v•ÛŒ›s1, ‰¡ŠÖ—Sˆê˜Y1,2, ˆÉ“¡®Žu1, ŒÏè‰ëŽq1, ˆÉâ‰ës1,2, çݎ@Šw1, ‘å
’Ь”V1, –ì“n³•F1, Îˆä³_1 (1¬Ž™, 2‘Š–Í–ì•a‰@): ‘æ46‰ñ“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï (2010/7/13),
_ŒË, “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2010/6; 46 (2): 608.

723503. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V¶Ž™TSHEFT4“¯Žž‘ª’è‚É‚æ‚éƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒO‚Å
”­Œ©‚³‚ê‚œd“xæ“V«Ž‹°‰º•”«bó‘B‹@”\’ቺÇ‚Ì2—á. ‹k“cˆê‹P1, Œ‰YM•v2, ]”gŒËF•ã1, “c
‹v•ÛŒ›s1, ‘å’Ь”V1, ŽÄŽRŒ[Žq1, ‰¡“csŽj1, ¬’r‚ ‚¯‚Ý3, •ŸŽm@Ÿ4, –{ŠÔ‚©‚š‚è4, ŽRã—SŽŸ
5, –ŠCŠoŽu6, Îˆä³_1 (1¬Ž™, 2¹“¿‘åŠw, 3¬’r‚±‚Ç‚àƒNƒŠƒjƒbƒN, 4ŽD–yŽs‰q¶Œ€‹†Š, 5_“Þ
ìŒ§—\–hˆãŠw‹Š‰ï, 6Œcœä‹`m‘åŠw): ‘æ37‰ñ“ú–{ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ï (2010/8/29), ‰¡•l, “ú–{
ƒ}ƒXEƒXƒNƒŠ[ƒjƒ“ƒOŠw‰ïŽ 2010/7; 20 (2): 169.

723504. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •¡‡Œ^‰º‚‘Ì‹@”\’ቺÇ(CPHD)‚Ɛf’f‚µ‚œ4Ç—á‚̗Տ°
“IŒŸ“¢. ‚—œ@Šw1,2, “c‹v•ÛŒ›s1,3, HŽR˜a­1,3, ‹k“cˆê‹P1, ˆÉ“¡®Žu1, ‘å’Ь”V1, ‰¡“csŽj
2, ˆÉ’B–ؐŸl4, •û@‹Î4, Îˆä³_1 (1¬Ž™, 2‘Š–ÍŒŽ‹Š“¯•a‰@, 3–kŒ€ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 4
¬ˆçˆã—ÃZƒ“ƒ^[): ‘æ44‰ñ“ú–{¬Ž™“à•ª”åŠw‰ïŠwpW‰ï (2010/10/8), ‘åã ‘æ44‰ñ“ú–{¬Ž™“à
•ª”åŠw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010; p.85.

723505. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™1Œ^“œ”A•aŠ³ŽÒ‚É‚š‚¯‚錌’†ƒPƒgƒ“‘ÌŽ©ŒÈ‘ª’è‚Ì—L
—p«‚ÌŒŸ“¢. ¬—э_Ži1, Œüˆä“¿’j2, ŒÜ\—’—T3, ‰Yã’B•F4, “c‹v•ÛŒ›s5, ‹e’rMs6, ‹e’r@“§7,
Œ‰YM•v8, ì‘º’qs9, ‰J‹{@L10 (1ŽR—œ‘å, 2ˆ®ìˆã‘å, 3ŒÜ\—’¬Ž™‰È, 4x‰Í‘ä“ú‘å•a‰@, 5¬
Ž™, 6‰¡•lŽs‘å, 7VŠƒ‘å, 8¹“¿‘å, 9‘åãŽs‘å, 10é‹Êˆã‘å): ‘æ44‰ñ“ú–{¬Ž™“à•ª”åŠw‰ïŠwpW‰ï
(2010/10/8), ‘åã, ‘æ44‰ñ“ú–{¬Ž™“à•ª”åŠw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010; p.141.

723506. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éSGA(Small for Gestational Age) Ž™‚É‘Î
‚·‚éƒtƒHƒ[ƒAƒbƒv‘̐§‚ÌŒ»ó. HŽR˜a­1,2, “c‹v•ÛŒ›s1,2, ‹k“cˆê‹P1, ˆÉ“¡®Žu1, ‰º•l^—¢Žq
1, ‘å’Ь”V1, •—’£áÁ—R”ü1, ‰¡“csŽj3, Îˆä³_1 (1¬Ž™, 2–kŒ€ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 3‘Š–Í
ŒŽ‹Š“¯•a‰@): ‘æ44‰ñ“ú–{¬Ž™“à•ª”åŠw‰ïŠwpW‰ï (2010/10/8), ‘åã, ‘æ44‰ñ“ú–{¬Ž™“à•ª”åŠw‰ïŠw
pW‰ï@ƒvƒƒOƒ‰ƒ€EŽ˜^W 2010; p.161.

723507. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«ìè•a‚ɑ΂·‚鎡—Ð헪: ƒƒ`ƒ‹ƒvƒŒƒhƒjƒ“ƒpƒ‹
ƒX•¹—p—Ö@‚Ì—L—p«. •û¹•œ1, îŒŽ‹`l1, –{“c@’1, –Ø‘ºƒl1, ’†”š–퐶1, Îˆä³_1 (1¬
Ž™): ‘æ30‰ñ“ú–{ìè•aŠw‰ïŠwpW‰ï (2010/10/10), ‹ž“s.

723508. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Ž•s‘SÇŒóŒQ‚ð‚«‚œ‚µ‚œFontanŽèpŒã‚̐ìè•a‚̈ê—á.
–{“c@’1, ’†”š–퐶1, îŒŽ‹`l1, ‹àŽq’‰O1, –Ø‘ºƒl1, •û¹•œ1, Îˆä³_1 (1¬Ž™): ‘æ30
‰ñ“ú–{ìè•aŠw‰ïŠwpW‰ï (2010/10/10), ‹ž“s.

723509. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹…’™—¯‚ð‡•¹‚µ‚œìè•a5—á: ŒŒ’†VEGF‚É‚æ‚錟“¢.
îŒŽ‹`l1, •û¹•œ1, –{“c@’1, –Ø‘ºƒl1, ’†”š–퐶1, Îˆä³_1 (1¬Ž™): ‘æ30‰ñ“ú–{ìè•a
Šw‰ïŠwpW‰ï (2010/10/10), ‹ž“s.

723510. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒNƒ[ƒ“•a‚É‚š‚¯‚錌ŽƒTƒCƒgƒJƒCƒ“’l‚š‚æ‚Ñ’°ŠÇ”S–Œ
‚̃VƒOƒiƒ‹“`’B•ªŽq”­Œ»‚ÌŒŸ“¢. “¡•‹`l1,2, ‘å’Ë‹Xˆê1, Šô£@Œ\1, ‘å’JŽF1, Â–ö@—z1, “¡ˆä@
“O1, H“¡FL1, Ž…r–Ÿ1 (1‡“V“°‘åŠw, 2¬Ž™): ‘æ37‰ñ“ú–{¬Ž™‰h—{Á‰»ŠíŠÌ‘ŸŠw‰ï
(2010/10/9-10), ‚Œ, “ú–{¬Ž™‰h—{Á‰»ŠíŠÌ‘ŸŠw‰ïŽGŽ 2010/9; 24 (Suppl): 133.

723511. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Microarray‚ð—p‚¢‚œ¬Ž™Šú‰ŠÇ«’°ŽŸŠ³‚Ì•a‘Ô‚ÌŒŸ“¢.
‘å’Ë‹Xˆê1, ŸNˆä—R”üŽq1, “¡•‹`l1,2, ˆî–щp‰î1, Šô£@Œ\1, ”nê—m‰î1, —é–ØŒõK1, Â–ö@—z
1, “¡ˆä@“O1, H“¡FL1, Ž…r–Ÿ1 (1‡“V“°‘åŠw, 2¬Ž™): ‘æ37‰ñ“ú–{¬Ž™‰h—{Á‰»ŠíŠÌ‘ŸŠw‰ï
(2010/10/9-10), ‚Œ, “ú–{¬Ž™‰h—{Á‰»ŠíŠÌ‘ŸŠw‰ïŽGŽ 2010/9; 24 (Suppl): 132.

723512. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰È‚ÅŒoŒ±‚µ‚œ¬Ž™Šú”x‘S“EÇ—á‚ÌŒŸ“¢. ‹àŽq’‰O1, ã
“cN‹v1, —с@‰1, •Ÿ“‡’‹`1, ŒŽ@^l1, ”~ŒŽ@ŽÀ2, –ì“n³•F1, Îˆä³_1 (1¬Ž™, 2‚€‚ß‚Í
‚炱‚Ç‚àƒNƒŠƒjƒbƒN): ‘æ43‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ï (2010/10/29), •Ÿ‰ª, “ú–{¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ï
ŽGŽ 2010/9; 21 (Suppl): 83.

723513. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚“x‚È‹CŠÇ‹·ó‚𔺂€‰E”x–³Œ`¬‚̈êV¶Ž™—á. ©@L
–ç1, ã“cN‹v1, ‹àŽq’‰O1, —с@‰1, •Ÿ“‡’‹`1, ŒŽ@^l1, ”~ŒŽ@ŽÀ2, –ì“n³•F1, Îˆä³_
1 (1¬Ž™, 2‚€‚߂͂炱‚Ç‚àƒNƒŠƒjƒbƒN): ‘æ43‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ï (2010/10/29), •Ÿ‰ª, “ú–{
¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ïŽGŽ 2010/9; 21 (Suppl): 92.

723514. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™ŒÄ‹záŠQÇ—á‚ɑ΂·‚é—z‰Aˆ³‘ÌŠOŽ®lHŒÄ‹z–@‚Ì“K
‰ž‚ÆŒÀŠE. —с@‰1,2 ã“cN‹v1, ‹àŽq’‰O1, •Ÿ“‡’‹`1, ŒŽ@^l1, ”~ŒŽ@ŽÀ3, Îˆä³_1 (1
¬Ž™, 2Ã‰ªŒ§—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[, 3‚€‚߂͂炱‚Ç‚àƒNƒŠƒjƒbƒN): ‘æ43‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ï
(2010/10/29), •Ÿ‰ª, “ú–{¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ïŽGŽ 2010/9; 21 (Suppl): 101.

723515. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒpƒ“ƒfƒ~ƒbƒNA/H1N1‚É‚æ‚éPlastic bronchitis‚Ì9Î
’jŽ™—á?”ñ‘}ŠÇ‰º‚Å‚ÌŠÇ—?. •ô”öŒb—œ1, ã“cN‹v1, ‹àŽq’‰O1, —с@‰1, •Ÿ“‡’‹`1, ŒŽ@^l
1, ”~ŒŽ@ŽÀ2, Îˆä³_1 (1¬Ž™, 2‚€‚߂͂炱‚Ç‚àƒNƒŠƒjƒbƒN): ‘æ43‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ï
(2010/10/30), •Ÿ‰ª, “ú–{¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ïŽGŽ 2010/9; 21 (Suppl): 105.

723516. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹CŠÇŽxšb‘§ŠÇ—Š³Ž™‚É‚š‚¯‚éŒÄ‹z‹@”\, FENO‚Ì‹Gß•Ï“®
‚ÌŒŸ“¢. ˆéè@~1, ŽO‘º@®1, ¬ì—ÏŽj2, –ìŠÔ@„2, ì–ì@–L1, ‰Í–ì“O–ç1, ’†‘º—zˆê1, Œ‰ª@
Ž1 (1‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 2¬Ž™): ‘æ60‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ïH‹GŠwp‘å‰ï (2010/11/25), “Œ
‹ž, ƒAƒŒƒ‹ƒM[ 2010/10; 59 (9-10): 1443.

723517. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹CŠÇŽxšb‘§Š³Ž™‚É‚š‚¯‚éIOS (Mostgraph) ‚̍Č»«‚ÌŒŸ
“¢. ŽO‘º@®1, ˆéè@~1, ¬ì—ÏŽj2, –ìŠÔ@„2, ì–ì@–L1, ‰Í–ì“O–ç1, ’†‘º—zˆê1, Œ‰ª@Ž
1 (1‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 2¬Ž™): ‘æ60‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ïH‹GŠwp‘å‰ï (2010/11/25), “Œ
‹ž, ƒAƒŒƒ‹ƒM[ 2010/10; 59 (9-10): 1444.

723518. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ{—‘ƒAƒŒƒ‹ƒM[Š³ŽÒ‚ÌŒoŒû•‰‰×ŽŽŒ±‚̍ČŸ“¢ (‘æ1•ñ)
?Çó”­Œ»Œ^‚ÆIgE RASTƒXƒRƒA‚̘AŠÖ?. ¬ì—ÏŽj1, ŽOãŒ’‘Ÿ˜Y1, ì–ì@–L2, ˆéè@~2, ‘åŽÄW
—m3, –ìŠÔ@„4 (1ç—tˆ€—F‰ï‹L”O•a‰@, 2‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 3“Œ‹žŒú¶”N‹à•a‰@, 4¬Ž™): ‘æ
60‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ïH‹GŠwp‘å‰ï (2010/11/26), “Œ‹ž, ƒAƒŒƒ‹ƒM[ 2010/10; 59 (9-10): 1444.

723519. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ{—‘ƒAƒŒƒ‹ƒM[Š³ŽÒŒoŒû•‰‰×ŽŽŒ±‚̍ČŸ“¢@‘ŠŽžŒ^‚ÉŒp
‘±‚·‚é’x”­’x‰„Çó‚Æ—‘”’IgE RASTƒXƒRƒA‚̘AŠÖ. ŽOãŒ’‘Ÿ˜Y1, ¬ì—ÏŽj1,2, ‘åŽÄW—m3, ˆéè@~
4, ì–ì@–L4, –ìŠÔ@„2 (1ç—tˆ€—F‰ï‹L”O•a‰@, 2¬Ž™, 3“Œ‹žŒú¶”N‹à•a‰@, 4‰¡•lŽs—§‚݂ȂƐԏ\
Žš•a‰@): ‘æ60‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ïH‹GŠwp‘å‰ï (2010/11/27), “Œ‹ž, ƒAƒŒƒ‹ƒM[ 2010/10; 59
(9-10): 1421.

723520. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •êŽq‚Æ‚à‚ɐ¶Œã1”NˆÈ“à‚Ì“ûŽ™Šú‚É”­Ç‚µ‚œ1Œ^“œ”A•a
Ç—á. —é–Ø“Þ’ÃŽq1, “¡‰ªŽO—é1, “c’†GŽ÷1, ‘åXˆÀŒb1, “c‹v•ÛŒ›s2 (1ŠC˜V–Œ‘‡•a‰@, 2¬Ž™): ‘æ
27‰ñ“ú–{“œ”A•aE”DPŠw‰ï”NŽŸŠwpW‰ï (2010/11/26), ‚³‚¢‚œ‚Ü, “œ”A•a‚Æ”DP 2010/10; 10 (2): S-56.

723521. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚“x‚È‹CŠÇ‹·ó‚𔺂€‰E”x–³Œ`¬‚̈êV¶Ž™—á. ©@L
–ç1, –ì“n³•F1, ‰¡ŠÖ—Sˆê˜Y1, ˆÉ“¡®Žu1, ŒÏè‰ëŽq1, ˆÉâ‰ës1, Îˆä³_1 (1¬Ž™): ‘æ55‰ñ“ú
–{–¢nŽ™V¶Ž™Šw‰ïEŠwpW‰ï (2010/11/5-7), _ŒË, “ú–{–¢nŽ™V¶Ž™Šw‰ïŽGŽ 2010/10; 22 (3): 596.

723522. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒoŒûProstaglandinE1»Ü‚É‚æ‚èÝ‘îŠÇ—‰Â”\‚Æ‚È‚Á‚œ
13ƒgƒŠƒ\ƒ~[‚Ì1—á. “yŠò@•œ1, HŽR˜a­1, ‰¡ŠÖ—Sˆê˜Y1, ˆÉ“¡®Žu1, ŒÏè‰ëŽq1, ˆÉâ‰ës1, çÝ
Ž@Šw1, –ì“n³•F1, Îˆä³_1 (1¬Ž™): ‘æ55‰ñ“ú–{–¢nŽ™V¶Ž™Šw‰ïEŠwpW‰ï (2010/11/5-7), _
ŒË, “ú–{–¢nŽ™V¶Ž™Šw‰ïŽGŽ 2010/10; 22 (3): 607.

723523. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚ÅŒoŒ±‚µ‚œ‘ÙŽ™•ê‘ÌŠÔ—AŒŒÇŒóŒQ‚Ì3—á. ‰¡ŠÖ—Sˆê
˜Y1, Îˆä³_1, –ì“n³•F1, çݎ@Šw1, ˆÉâ‰ës1, ŒÏè‰ëŽq1, ˆÉ“¡®Žu1 (1¬Ž™): ‘æ55‰ñ“ú–{
–¢nŽ™V¶Ž™Šw‰ïEŠwpW‰ï (2010/11/5-7), _ŒË, “ú–{–¢nŽ™V¶Ž™Šw‰ïŽGŽ 2010/10; 22 (3): 663.

723524. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ{—‘ƒAƒŒƒ‹ƒM[f’f‚É‚š‚¯‚éŒoŒû•‰‰×ŽŽŒ±‚̐¶—‘‚ƉÁ”M
—‘‚Å‚Ì”äŠrŒŸ“¢. ŽOãŒ’‘Ÿ˜Y1, ¬ì—ÏŽj1,2, ‘åŽÄW—m3, ˆéè@~4, ì–ì@–L4, –ìŠÔ@„2 (1ç
—tˆ€—F‰ï‹L”O•a‰@, 2¬Ž™, 3“Œ‹žŒú¶”N‹à•a‰@, 4‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@): ‘æ47‰ñ“ú–{¬Ž™ƒAƒŒƒ‹
ƒM[Šw‰ï (2010/12/4), ‰¡•l, “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ 2010/11; 24 (4): 591.

723525. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) šb–”­ì‚Å“ü‰@‚µ‚œ“û—cŽ™‚̗Տ°”wŒi‚É‚æ‚éƒNƒ‰ƒXƒ^[
•ªÍ. ˆéè@~1, ŽO‘º@®1, ¬ì—ÏŽj2, –ìŠÔ@„2, ì–ì@–L1, ’†‘º—zˆê1 (1‰¡•lŽs—§‚݂ȂƐÔ
\Žš•a‰@, 2¬Ž™): ‘æ47‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï (2010/12/4), ‰¡•l, “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ
2010/11; 24 (4): 611.

723526. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰È‚É‚š‚¯‚éƒGƒsƒyƒ“ˆ•û‚ÌŒoŒ±. ŽO‘º@®1, ˆéè@~
1, ¬ì—ÏŽj2, –ìŠÔ@„2, ì–ì@–L1, ’†‘º—zˆê1 (1‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 2¬Ž™): ‘æ47‰ñ“ú
–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï (2010/12/4), ‰¡•l, “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ 2010/11; 24 (4): 614.

723527. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒgƒVƒ‹Ž_ƒXƒvƒ‰ƒ^ƒXƒgƒhƒ‰ƒCƒVƒƒbƒv‚̏¬Ž™‹CŠÇŽxšb‘§
”­Ç‚Ö‚Ì—L—p«‚ÌŒŸ“¢. ¬ì—ÏŽj1,2, ŽOãŒ’‘Ÿ˜Y1, ‘åŽÄW—m3, ˆéè@~4, ì–ì@–L4, ²”Œ•q—º
2, –ìŠÔ@„2 (1ç—tˆ€—F‰ï‹L”O•a‰@, 2¬Ž™, 3“Œ‹žŒú¶”N‹à•a‰@, 4‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@): ‘æ
47‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ï (2010/12/5), ‰¡•l, “ú–{¬Ž™ƒAƒŒƒ‹ƒM[Šw‰ïŽ 2010/11; 24 (4): 620.

723528. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) FontanpŒã‚Ì”x“®Ã–¬á‘‚ɑ΂µ‚Ä”x—tØœ‚ðs‚Á‚œ1—á.
’†”š–퐶1, –Ø‘ºƒl1, ˆÀ“¡@Žõ1, –{“c@’1, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒŠÇŠO‰È): ‘æ
13‰ñ“ú–{¬læ“V«SŽŸŠ³Šw‰ï (2011/1/9), •Ÿ‰ª.

723529. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œ‘€“®–¬ŠÇŠJ‘¶‚ð‡•¹‚µ‚œ‘å“®–¬kóÇ‚Ì1—á. ’†”š–í
¶1, •x“c@‰p2, –Ø‘ºƒl1, ˆÀ“¡@Žõ1, –{“c@’1, ‹{’n@ŠÓ3, Îˆä³_1 (1¬Ž™, 2º˜a‘å, 3
S‘ŸŒŒŠÇŠO): ‘æ22‰ñ“ú–{Pediatric Intervention CardiologyŠw‰ïŠwpW‰ï (2011/1/21), ‰ªŽR.

723530. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’·Šú“ü‰@‚È‚ç‚Ñ‚É“ü‘Þ‰@‚ðŒJ‚è•Ô‚µ‚œdÇSgáŠQŽ™10
—á‚̉h—{•]‰¿. Šâèr”V1, “©ŽR‹IŽq2, ‰““¡¬Žq3, Vˆä–œ—¢Žq4, ²X–Ø”ü˜aŽq5, –îàV^Ž}5, ‘å’Ã
¬”V1, Îˆä³_1 (1¬Ž™, 2‰h—{•”, 3—Տ°ŒŸž•”, 4–òÜ•”, 5ŠÅŒì•”): ‘æ14‰ñ“ú–{•a‘Ô‰h—{Šw‰ï”N
ŽŸŠwpW‰ï (2011/1/15-16), ‰¡•l, “ú–{•a‘Ô‰h—{Šw‰ïŽ 2010/11; 13 (5): 175.

723531. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™‚ÌECMO: ¬Ž™‚Ì‹}«S‹Ø‰Š‚ɑ΂·‚éECMO‚Ì—L—p«.
ˆÀ“¡@Žõ1,2, ŽÂŒŽ^Žj1, ’†ì@‘1, ˜ZŽÔ@’1, ‹v‰äC“ñ1, –â“cç»1, ¡‘ºšæG1, ˆäŽèŒ’‘Ÿ˜Y1
(1‘—§¬ˆçˆã—ÃŒ€‹†ƒZƒ“ƒ^[, 2¬Ž™): ‘æ38‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï (2011/2/24-26), ‰¡•l, “ú
–{W’†Ž¡—ÈãŠw‰ïŽGŽ 2011/1; 18 (Suppl): 189.

731080. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬Ž™‚Ì1Œ^“œ”A•a?—Տ°Œ»ê‚Å‚Ì‚³‚Ü‚Ž‚܂ȏǗá‚ð’Ê‚µ
‚ÄŠŽ‚¶‚œ‚±‚Æ, ‹C‚¢‚œ‚±‚Æ?. “c‹v•ÛŒ›s (¬Ž™): ‘æ4‰ñˆ€’m¬Ž™“à•ª”åƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/7/3),
–ŒŒÃ‰® (ƒmƒ{ŽÐ).

731081. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ìè•a‹}«Šú‚š‚æ‚щ“ŠuŠú‚̏”–â‘è Îˆä³_ (¬Ž™):
‘æ6‰ñ‰ªŽRìè•aŒ€‹†‰ï (2010/10/30), ‰ªŽR.

732060. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Žs–¯ŒöŠJuÀ) ìè•a‚É‚©‚©‚Á‚œŽq‚Ç‚à‚̐¬lŠú‚Ì–â‘è‚ƑΉž. Î
ˆä³_ (¬Ž™):yŽs–¯ŒöŠJuÀz¬Ž™Šú‚Ì–«S‘ŸŽŸŠ³‚͐¬l‚Æ‚È‚è‚Ç‚€‚È‚é‚©?¬læ“VŽŸŠ³‚Ì–â‘è“_
‚ƑΉž? (2010/7/10), ç—t.

732061. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) –«ŽŸŠ³‚ð‚à‚ÂŽq‚Ç‚à‚Ö‚Ì—{Œì‹³—@‚Æ‚µ‚Ä‚Ì‚©‚©‚í‚è?
“œ”A•a‚Ɣ얞Ž™“¶‚ւ̑Ήž‚𒆐S‚Æ‚µ‚Ä?. “c‹v•ÛŒ›s (¬Ž™): “Œ‹žŠwZ•ÛŒ’Œ€‹†‰ï
(2010/8/18), ã–ì.

732062. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ¬Ž™ŽvtŠú“œ”A•a‚̐SgˆãŠw. ‘å’Ь”V (¬Ž™): ‘æ16
‰ñç—t¬Ž™“œ”A•aE“à•ª”匀‹†‰ï (2010/9/14), ç—t (ƒmƒ{ŽÐ).

732063. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) ìè•a‚̍ŐV‚Ì’mŒ©: •aˆö, Ž¡—Ã, ‰“ŠuŠú‚̏”–â‘è. Î
ˆä³_ (¬Ž™): ‘æ1‰ñìèŽs–k•”¬Ž™‰Èˆã‚̉ï (2010/11), _“ސì.

733184. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘SgŒ^JIA‚Æ‚µ‚ÄŽ¡—Ã’†‚Ì2—Ž™—á. â“Œ—R
‹I1, •û¹•œ1, ª–{•¶Žq, Îˆä³_1 (1¬Ž™): ‘æˆê‰ñ“ú–{¬Ž™JIAŒ€‹†‰ï (2010/5), _“ސì.

733185. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) H1N1Œ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚É‚æ‚邯‚¢‚ê‚ñdÏŒã‚É‘€“ª—t•a
•ÏE‚Ä‚ñ‚©‚ñ‚𔭏ǂµ‚œˆê—á. –ìX“c–L1, Šâèr”V1, ×“c‚Ì‚Œ‚Ý1,2, ”’ˆäGK1,3, Îˆä³_1 (1
¬Ž™, 2‘Š–ÍŒŽ—È牀, 3‘Š–Í‘ä•a‰@): ‘æ46‰ñ_“ސ쏬Ž™_Œo§˜b‰ï (2010/7/10), ‰¡•l.

733186. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žá”N”­Ç2Œ^“œ”A•a‚É‚š‚¯‚éS—“I–â‘è‚ÌŒŸ“¢. ‘å’Ь
”V1, ‰º•l^—Žq1, “c‹v•ÛŒ›s1, •—’£áÁ—R”ü1, ‰¡“csŽj2, Îˆä³_1 (1¬Ž™, 2‘Š–ÍŒŽ‹Š“¯•a‰@):
‘æ16‰ñ¬Ž™¥ŽvtŠú“œ”A•aƒVƒ“ƒ|ƒWƒEƒ€ (2010/7/11), ‘åã (ƒmƒ{ŽÐ).

733187. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒNƒƒoƒUƒ€“à•ž‚ƃtƒFƒmƒoƒ‹ƒrƒ^[ƒ‹Ã–¬“à“Š—^‚ª‘tŒ÷
‚µ‚œ‘å“cŒŽÇŒóŒQ‚Ì1—á. –{“c@’1, Šâèr”V1, ‹àŽq’‰O1, –ìX“c–L1, Îˆä³_1 (1¬Ž™): ‘æ
66‰ñ_“ސì‚Ä‚ñ‚©‚ñ§˜b‰ï (2010/7/17), ‰¡•l, _“ސ쌧ž_ˆãŠw‰ïŽ 2011/3; 60: 73.

733188. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚éSGA (Small for Gestational Age) Ž™‚É‘Î
‚·‚éƒtƒHƒ[ƒAƒbƒv‘̐§‚ÌŒŸ“¢. HŽR˜a­1, “c‹v•ÛŒ›s1, ‹k“cˆê‹P1, ˆÉ“¡®Žu1, ‰º•l^—¢Žq1, ‘å
’Ь”V1, •—’£áÁ—R”ü1, ‰¡“csŽj2, Îˆä³_1 (1¬Ž™, 2‘Š–ÍŒŽ‹Š“¯•a‰@): ‘æ24‰ñ¬Ž™¬’·Œ€‹†‰ï
(2010/7/31), “Œ‹ž.

733189. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’PS–[’PSŽº‚ɑ΂µSŠO“±ŠÇ‚ð—p‚¢‚œFontanp‚ðŽ{s‚µ
pŒã‰“ŠuŠú‚ÉŠŽõ‚É‚æ‚铱ŠÇ•Âœ‚𗈂œ‚µ‚œˆê—á. ‘剪–ƒ—1, ’†”š–퐶1, –Ø‘ºƒl1, ‘å˜a“c‰ÄŽq1,
ˆÀ“¡@Žõ1, Îˆä³_1 (1¬Ž™): ‘æ6‰ñ_“ސ쏬Ž™zŠÂŠíŒ€‹†‰ï (2010/9/25), ‰¡•l.

733190. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÌ“àŠO’_ŠÇŠg’£‚Ɗ̐üˆÛÇ‚ð‡•¹‚µ‚œíõF
‘Ì—ò«‘œùN–Et (ARPKD) ‚̏—Ž™—á. ˆîŠ_@“µ1,’†‘ºM–ç1, “Y“c—RŠóŽq1, Šâ”g’Œ”ü1, ‘剪–ƒ—1, 
•û¹•œ1, “¡•‹`l1, â“Œ—R‹I1, Îˆä³_1, •“cŒ›Žq2, “c’†@Œ‰2 (1¬Ž™, 2ŠO‰È): ‘æ22‰ñ_“Þ
ì¬Ž™ŠÌŽŸŠ³Œ€‹†‰ï (2010/9), _“ސì.

733191. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”­’BáŠQ‚Æ‚Ä‚ñ‚©‚ñ‚ɍ‡•¹‚µ‚œ’áƒÁƒOƒƒuƒŠ
ƒ“ŒŒÇ‚̏—Ž™. â“Œ—R‹I1, ²“¡T‘Ÿ˜Y1, ‘剪–ƒ—1, ©@L–ç1, •û¹•œ1, îŒŽ‹`l1, •ˆäŒ€“ñ,
Îˆä³_1 (1¬Ž™): ‘æˆê‰ñŠÖ“Œb‰z–Ɖu•s‘SÇŒ€‹†‰ï (2010/9), “Œ‹ž.

733192. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚ŏo¶‚µ‚œSGA‚ɑ΂·‚éƒtƒHƒ[ƒAƒbƒv‚ÌŒã•ûŽ‹“I
ŒŸ“¢. HŽR˜a­ (¬Ž™): ‘æ9‰ñ–k—¢Pediatrics Seminar (2010/10/14), ‘Š–ÍŒŽ.

733193. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Drop attack‚ª•p”­‚·‚éÇŒó«‹ÇÝŠÖ˜A«‚Ä
‚ñ‚©‚ñ‚Ì1—á. ŽRŒûˆ»”T1, Šâèr”V1, –ìX“c–L1, Îˆä³_1 (1¬Ž™): ‘æ52‰ñ“ú–{¬Ž™_ŒoŠw‰ïŠÖ
“Œ’n•û‰ï (2010/11/3), “Œ‹ž.

733194. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) 2009”NH1N1pdm ƒCƒ“ƒtƒ‹ƒGƒ“ƒU”]Ç‚Ì‚Ü‚Æ‚ß?’á‘̉·—Ã
–@‚ÌŽŽ‚Ý?. –ìX“c–L (¬Ž™): ‘æ342‰ñ ‘Š–ÍŒŽŽs¬Ž™‰Èˆã‰ïŒŽ—፧˜b‰ï (2010/11/17), ‘Š–ÍŒŽ


733195. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@¬Ž™‰È: ƒLƒƒƒŠ[ƒI[ƒo[‚ÌŒ»ó‚Ɖۑè?
“à•ª”åE‘ãŽÓŠO—ˆ‚Å‚ÌŒ»ó?. ‘å’Ь”V (¬Ž™): ‘æ342‰ñ‘Š–ÍŒŽŽs¬Ž™‰Èˆã‰ïŒŽ—፧˜b‰ï (2010/11/17),
‘Š–ÍŒŽ.

733196. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒPƒgƒAƒVƒh[ƒVƒX‚Å“œ”A•a‚𔭏ǂµ‚œ13ƒgƒŠƒ\ƒ~[ÇŒó
ŒQ‚Ì1—á. ²“¡T‘Ÿ˜Y1, ‘å’Ь”V1, ‰i·—T‰ÀŽq1, ©@L–ç1, –ì“n³•F1, Îˆä³_1 (1¬Ž™): ‘æ
16‰ñ_“ސ쏬Ž™“œ”A•aŒ€‹†‰ï (2010/11/24), ‰¡•l.

733197. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹}«Ž…‹…‘̐t‰Š‚Æ—n˜A‹ÛŠŽõŒã”œ‰ž«ŠÖß‰Š‚ð‡•¹‚µ‚œ
1—á. ‘剪–ƒ—1, ’†‘ºM–ç1, îŒŽ‹`l1, “Y“c—RŠóŽq1, Šâ”g’Œ”ü1, â“Œ—R‹I1, ‰ÍŒ‹Iº1, Îˆä
³_1 (1¬Ž™): ‘æ307‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï (2010/11/20), ‰¡•l.

733198. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹Ø’ɂƍ‚CKŒŒÇ‚ÌŒo‰ß‚©‚çWilson•a‚Ɛf’f‚³‚ê‚œˆê—á.
–ìX“c–L1, Šâèr”V1, ×“c‚Ì‚Œ‚Ý1,2, ”’ˆäGK1,3, Îˆä³_1 (1¬Ž™, 2‘Š–ÍŒŽ—È牀, 3‘Š–Í‘ä
•a‰@): ‘æ47‰ñ_“ސ쏬Ž™_Œo§˜b‰ï (2011/1/22), ‰¡•l.

733199. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Gabapentin‚ª—LŒø‚Å‚ ‚Á‚œ•”•ª”­ì20—á‚Æ–³Œø10—á‚É
‚š‚¯‚錌’†”Z“x‚Ì”äŠr. Šâèr”V1, –ìX“c–L1, ×“c‚Ì‚Œ‚Ý1,2, Îˆä³_1 (1¬Ž™, 2‘Š–ÍŒŽ—È牀. ):
‘æ67‰ñ_“ސì‚Ä‚ñ‚©‚ñ§˜b‰ï (2011/1/29), ‰¡•l.

733200. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) upd (11) pat‚Őf’f‚³‚ê‚œBechwith-WiedemannÇŒóŒQ
(BWS) ‚Ì1Ç—á. “c‹v•ÛŒ›s1,2, ‹k“cˆê‹P2, ‰¡ŠÖ—Sˆê˜Y2,3, HŽR˜a­1,2, ˆÉ“¡®Žu2, ŒÏè‰ëŽq
2, ‘å’Ь”V2, •—’£áÁ—R”ü2, –ì“n³•F2, ‰¡“csŽj4, •“cŒ›Žq5, “c’†@Œ‰5, Îˆä³_2 (1–kŒ€ƒ
ƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2¬Ž™, 3‘Š–Í–ì•a‰@, 4‘Š–ÍŒŽ‹Š“¯•a‰@, 5ŠO‰È): ‘æ20‰ñ—Տ°“à•ª”å‘ãŽÓUpdate
(2011/1/28), ŽD–y, “ú–{“à•ª”åŠw‰ïŽGŽ 2010/12; 86 (3): 703.

733201. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹¹•ÇŠO‚ɐL“W‚µ‚œŽ‰–b‰èŽî‚Ì1—á. Œ–{“TŽq
1, “c’†@Œ‰2, ‚ˆÀ@”£2, “n粏¹•F2 (1¬Ž™, 2ŠO‰È): ‘æ54‰ñ_“ސ쏬Ž™Žîᇌ€‹†‰ï (2011/3/5), _
“ސì.

733202. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒPƒgƒAƒVƒh[ƒVƒX‚Å“œ”A•a‚𔭏ǂµ‚œ13ƒgƒŠƒ\ƒ~[ÇŒó
ŒQ‚Ì1—á. ‰i·—T‰ÀŽq1, ²“¡T‘Ÿ˜Y1, –{“c@’1, ©@L–ç1, –Ø‘ºƒl1, –ìX“c–L1, ‘å’Ь”V1,
–ì“n³•F1, Îˆä³_1 (1¬Ž™): ‘æ309‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï^‘æ28‰ñ_“ސ쏬Ž™‰Èˆã‰ïE
‘‰ï (2011/3/19), ‰¡•l.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-110020. [ŒŽ’˜] Health-Related Quality of life in Adolescents and Young Adults with a
History of Kawasaki Disease. Muta H, Îˆä³_1, Iemura M, Matsuishi T (1¬Ž™): The Journal of
Pediatrics 2010/3; 156 (3): 439-43.

H21-320004. [Ç—á•ñ] Asperger syndrome‚ð‡•¹‚µ‚œöˆö«‹ÇÝŠÖ˜A«‚Ä‚ñ‚©‚ñ‚Ì1—á. Šâèr
”V1, –ìX“c–L1, ×“c‚Ì‚Œ‚Ý1, Îˆä³_1 (1¬Ž™): _“ސ쌧ž_ˆãŠw‰ïŽGŽ 2010/3; 59: 85.

H21-320005. [Ç—á•ñ] ƒm[ƒxƒ‹ƒo[ƒ‹‚ÌŒp‘±“I‚ȐÖ¬“à“Š—^‚ª—LŒø‚Å‚ ‚Á‚œ“‚ȏnj󐫋Ǎ݊Ö
˜A«‚Ä‚ñ‚©‚ñ‚Ì1—á. Œì‹ÅŽq1, ‹àŽq’‰O1, Šâèr”V1, –ìX“c–L1, Îˆä³_1 (1¬Ž™): _“ސì
Œ§ž_ˆãŠw‰ïŽGŽ 2010/3; 59: 87.

[’˜@‘]

H21-620013. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚̐f’fŽwj ‘æ6”Łz23 ¬Ž™ŽŸŠ³@¬Ž™‚̐S‹Ø‰Š, p.1860-2.
Îˆä³_ (¬Ž™), ‘•ÒW ‹ààVˆê˜Y, ‰iˆä—ÇŽO, ˆãŠw‘‰@, “Œ‹ž, 2010/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H21-723015. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œ‘€“®–¬ŠÇŠJ‘¶‚ð‡•¹‚µ‚œ‘å“®–¬kóÇ‚Ì1—á.
’†”š–퐶1, •x“c@‰p, –Ø‘ºƒl1, ˆÀ“¡@Žõ1, –{“c@’1, ‹{’n@ŠÓ2, Îˆä³_1 (1¬Ž™, 2S‘ŸŒŒ
ŠÇŠO): ‘æ22‰ñ“ú–{Pediatric Intervention CardiologyŠw‰ïŠwpW‰ï (2010/1/21), ‰ªŽR.

H21-733010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Nasal DPAPŽ{s’†‚É”­Ç‚µ‚œPIE
(Pulmonaryinterstitial emphysema) ‚Ì2—á. ˆÉâ‰ës1, ‰¡ŠÖ—Sˆê˜Y1, ˆÉ“¡®Žu1, ŒÇè‰ëŽq1, ™š
Ž@Šw1, ’·’Jì‹1, –ì“n³•F1, Îˆä³_1 (1¬Ž™): ‘æ299‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“ސ쌧’n•û‰ï
(2009/6/13), ‰¡•l, _“ސìˆãŠw‰ïŽGŽ 2010/1; 37 (1): 53.


ŽY•wl‰ÈŠw

[Šwp˜_•¶]

110177. [ŒŽ’˜] Effect of the interval between onset of sustained fetal bradycarsia snd cesarean
delivery on long-term neonata neurologic prognosis. Kamoshita E, Amano K1, Kanai Y1, Mochizuki
J1, Ikeda Y1, Kikuchi S1, Tani A1, Shoda T1, Okutomi T2, Nowatari M3, Unno N1: Int J Gynaecol Obstet
2010/10; 111 (1): 23-7. (“V–ì@Š®1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ’r“c‘×—T1, ‹e’nMŽO1, ’J@º”Ž1, ¯
“c@—²1, ‰œ•xr”V2, –ì“n³•F3, ŠC–ìM–ç1: 1ŽY•w, 2–ƒŒ, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã)

110028. [ŒŽ’˜] The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial
tissues and angiogenesis in a mouse implantation model. Numao A1, Hosono K2, Suzuki T2, Hayashi
I, Uematsu S, Akira S, Ogino Y, Kawauchi H1, Unno N1, Majima M2: Biomed Pharmacother 2011/2; 65
(1): 77-84. (À”ö²Žq1, ×–ì‰Á“ÞŽq2, —é–Ø—§‹I2, ì“à”Žl1, ŠC–ìM–ç1, ”n“ˆ³—²2: 1ŽY•w, 2
–ò—)

120028. [ŒŽ’˜] Žq‹{‘ÌŠàŽ¡—Â̌µ‚µ‚³: “–‰@‚É‚š‚¯‚éŽq‹{‘ÌŠà‚ÌŽ¡—ЬÑ?IŒ^‘ÌŠà, IIŒ^‘ÌŠà‚Ì—\Œã
ˆöŽq‚Ì”äŠr?. Šp“cV•œ1, Vˆä³G1, Vˆä@“w1, ìŒû”ü˜a1, ¬–ìd–ž1, À“c@Ê1, ¡ˆä@ˆ€1,
ã–V•qŽq, ‘ –{”Žs, ŠC–ìM–ç1 (1ŽY•w): “ú–{•wl‰ÈŽîᇊw‰ïŽGŽ 2010/10; 28 (4): 511-23.

120029. [ŒŽ’˜] Žq‹{“à–ŒŠÔŽ¿“÷Žî18—á‚̗Տ°•a—Šw“IŒŸ“¢. ‘匎@Ž÷1, ¬—Ñ—zˆê1, —é–؁@’Œ1, –Ø
Œûˆê¬1, Vˆä³G2, Šp“cV•œ2, ã–V•qŽq, •œàV@–Ò3, ‘ºŒr¬3, ŽOãŠ²’j3 (1¹ƒ}ƒŠƒAƒ“ƒiˆã‰È
‘åŠw, 2ŽY•w, 3“ŒŠC‘å): “ú–{•wl‰ÈŽîᇊw‰ïŽGŽ 2010/4; 28 (2): 144-9.

120030. [ŒŽ’˜] ”DP’†‚ÌD-dimer‘ª’è’l‚Ɛ[•”Ã–¬ŒŒðÇ (DVT). ‹e’nMŽO1, ‘同—fŽq1, À”ö²Žq
1, ‰Í–ìÆŽq1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ¯“c@—²1, ’J@º”Ž1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w): “ú
–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ 2010/4; 46 (1): 17-21.

120031. [ŒŽ’˜] ‘I‘ð“I•ª•Ø—U”­E‹æˆæ–ƒŒ‚É‚æ‚éSŽŸŠ³‡•¹”DP‚Ì•ª•ØŠÇ—. À“c@Ê1, ‹e’nMŽO1,
–]ŒŽƒŽq1, ‹àˆä—Y“ñ1, ¯“c@—²1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w): “ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ
2010/8; 46 (3): 775-9.

220016. [€ŒŽ’˜] ‘O’u–ü’…‘Ù”Õ‚ÌŠÇ—‚ÉŠÖ‚·‚é‘O•ûŽ‹“IŒŸ“¢. ‘同—fŽq1, “V–ì@Š®1, ŠC–ìM–ç1 (1
ŽY•w): “ú–{ŽY•wl‰ÈEV¶Ž™ŒŒ‰tŠw‰ïŽ 2010/6; 20 (1): S59-60.

310014. [Ç—á•ñ] Long-distance Relay Transportation of a Patient with Twin-Twin Transfusion
Syndrome Requiring Early Delivery by Doctor-Helicopters. Nakagawa Y, Inokuchi S, Morita S, Ohtsuka
H, Akieda K, Mochizuki J1, Okada K: Tokai J Exp Clin Med 2010/7; 35 (3): 118-21. (–]ŒŽƒŽq1: 1
ŽY•w)

520062. [‘à] ‘ÙŽ™f’f‚©‚ç‘ÙŽ™Ž¡—ÂÖ. “V–ì@Š® (ŽY•w): _“ސì•ê«‰q¶Šw‰ïŽ 2010; 14: 1-5.

522089. [uÀ]y“ÁW: ŽY•wl‰È‹~‹}‚Ì‚·‚ׂāzA. ‘˜_@ŽY‰È‹~‹}‚©‚ç‚Ý‚œoŒŒ«ƒVƒ‡ƒbƒN. “V–ì@Š®
(ŽY•w): ŽY•wl‰ÈŽ¡—à 2010/4; 100 (‘Š§): 477-83.

522090. [uÀ]y“ÁW: ˆÀŠy‚È‚šŽY‚Ö‚Æ“±‚­Žè‹Z‚ƃ|ƒCƒ“ƒg ŽY’Ɋɘa–@‚ð‹É‚ß‚éz8 ˆã—ÃŽ{Ý‚Å‚ÌŽÀ‘H
—á@(5) d–ŒŠO–ƒŒ (’Á’É–@). “V–ì@Š® (ŽY•w): ƒy‚èƒlƒCƒ^ƒ‹ƒPƒA 2010/6; 6: 44-6.

522091. [uÀ]yƒVƒ“ƒ|ƒWƒEƒ€: ŽY‰È‚É‚š‚¯‚éoŒŒ‘΍ôz•ª•ØŒãoŒŒ‚ɑ΂·‚éinterventional radiology.
“V–ì@Š® (ŽY•w): “ú–{ŽY•wl‰ÈEV¶Ž™ŒŒ‰tŠw‰ïŽ 2010/6; 20 (1): S41-2.

522092. [uÀ]y“ÁW‘˜_z”DP«ŽŸŠ³‚ɑ΂·‚éMTXŽ¡—Ã. ì“à”Žl (ŽY•w): “ú–{ŽY‰È•wl‰ÈŠÖ“Œ˜A‡
’n•û•”‰ïŽ 2010/11; 47 (4): 457-8.

522093. [uÀ]y“ÁW: ÅVî•ñ‚©‚ç‚Ý‚œŽq‹{“à–ŒÇ‚Æ‚»‚̑΍ôzŽq‹{“à–ŒÇ«ùN–E‚Æ‚»‚̑΍ô. ‰¬–ì
‹|ŠóŽq1, ì“à”Žl1, À”ö²Žq1, ŠC–ìM–ç1 (1ŽY•w): ŽY•wl‰ÈŽ¡—à 2011/3; 102 (3): 255.

522094. [uÀ]y“ÁW: ŽY•wl‰È@‹~‹}ƒ}ƒjƒ…ƒAƒ‹zŽY‰È—̈æ@17. ŽY‰È–ƒŒŽž‚̃gƒ‰ƒuƒ‹. “V–ì@Š®
(ŽY•w): ŽY‰È‚Æ•wl‰È 2011/3; 78 (‘Š§): 131-8.

[’˜@‘]

620092. [Šwp‘]@(•ª’SŽ·•M)y’鉀ØŠJp@Šî–{‚Ɖž—p‚܂邲‚ƃ}ƒXƒ^[zŒÃ“T“I’鉀ØŠJp, p.42-7.
“V–ì@Š® (ŽY•w), •Ò ’|“c@È, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2010/8”­s.

620093. [Šwp‘] (•ª’SŽ·•M)y‚±‚ê‚Ÿ‚¯‚Í’m‚Á‚Ä‚š‚«‚œ‚¢! ŽY‰È–ƒŒQ&A (–ƒŒ‰ÈŠwƒŒƒNƒ`ƒƒ[ 2 (2))z
II. ’鉀ØŠJ‚Ì–ƒŒ: ‘˜_@Q12. ‹ÇŠZ–ƒŒ. “V–ì@Š® (ŽY•w), •Ò ÆˆäŽ¶, ‘‡ˆãŠwŽÐ, “Œ‹ž,
2010/6”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722124. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) •ª•ØŒãoŒŒ‚ɑ΂·‚éinterventional radiology.
“V–ì@Š® (ŽY•w): ‘æ20‰ñ“ú–{ŽY•wl‰ÈEV¶Ž™ŒŒ‰tŠw‰ï (2010/6/23), •lŒ.

722125. [Šw‰ï (‘S‘)] (ƒ~ƒjƒ[ƒNƒVƒ‡ƒbƒv) ‹ÇŠisŽq‹{èòŠà‚ɑ΂·‚鍂ü—Ê—Šo“àÆŽË‚É‚æ‚铯Žž
‰»Šw•úŽËü—Ö@‚Ì‘œŽ{Ý‘æII‘ŠŽŽŒ± (JGOG1066). Šì‘œì—º, ŒË”F•¶, à_–ì“S‘Ÿ˜Y, ”n‰®ŒŽŒ’Ži, •œ
“ˆ‘×”V, Â–Ø—zˆê, “c”š¹“¹, Šp“cV•œ1, ‘ºã–ŸO, ‘ëàV@Œ› (1ŽY•w): ‘æ48‰ñ“ú–{•wl‰ÈŽîᇊw‰ï
(2010/7/9), ‚‚­‚΍‘Û‰ï‹cê, “ú–{•wl‰ÈŽîᇊw‰ïŽGŽ 2010; 28 (3): 291.

722126. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‚±‚ê‚©‚ç‚Ì”D•wŒ’f‘̐§‚ðl‚Š‚é. ŠC–ìM–ç (ŽY•w): ‘æ51‰ñ
“ú–{•ê«‰q¶Šw‰ï (2010/11/6), ÎìŒ§—§‰¹Šy“°.

722127. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’鉀ØŠJpŒã’Á’É–@‚Æ‚µ‚Ä‚Ì• ‰¡‹Ø–Œ–ʃuƒƒbƒN‚Ì—L—p«. ‘å
Œ—fŽq1, ‰œ•xr”V2, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w, 2–ƒŒ): “ú–{ŽüŽYŠú
V¶Ž™ˆãŠw‰ï (‘æ29‰ñŽüŽYŠúƒVƒ“ƒ|ƒWƒEƒ€) (2010/1/15), ‚Ç‚ñ‚®‚葺X‚̃Rƒ“ƒT[ƒgƒz[ƒ‹ (²‰êŒ§).

722128. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) neuraxial analgesia‚É‚æ‚é–³’É•ª•Ø‚Å‚ÌŽ™“ª‰ñùˆÙí”­¶—Š
‚ɂ‚¢‚Ä?–ƒŒ–@‚É‚æ‚é”­¶—Š‚̕ω»‚ÌŒŸ“¢?. ‰ª“c®Žq, “V–ì@Š®1, ‰œ•xr”V2, –]ŒŽƒŽq1, ŠC–ì
M–ç1 (1ŽY•w, 2–ƒŒ): “ú–{ŽüŽYŠúV¶Ž™ˆãŠw‰ï (‘æ29‰ñŽüŽYŠúƒVƒ“ƒ|ƒWƒEƒ€) (2010/1/15), ‚Ç‚ñ‚®
‚葺X‚̃Rƒ“ƒT[ƒgƒz[ƒ‹ (²‰êŒ§).

723532. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒoƒJƒe[ƒeƒ‹“®–¬ŠŠðp (TAE) ‚̃ŠƒXƒN‚Æ”DP—\Œã‚ÉŠÖ‚·‚錟“¢.
“‡‰ª‹¶1, ŽR“c‹¿Žq1, ‚–؈»Žq1, Œ@”——Ç, ŠÖŒû˜aŠé1, ‹e’nMŽO1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY
•w): ‘æ62‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï (2010/4/23), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€.

723533. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) LINEAR ARRAY HPV Genotyping Test‚ð—p‚¢‚œHPV genotyping‚ÆŽq
‹{èò•”•a•Ï‚Æ‚ÌŠÖ˜A‚ÌŒŸ“¢. Š‹‰ª”ü’Õä1, À“c@Ê1, ¬–ìd–ž1, Vˆä@“w1, ìŒû”ü˜a1, Vˆä³G
1, “n糁@ƒ, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY•w): ‘æ62‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï (2010/4/23), “Œ‹ž‘Ûƒt
ƒH[ƒ‰ƒ€.

723534. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ’鉀ØŠJpŒã’Á’É–@‚Æ‚µ‚Ä‚Ì• ‰¡‹Ø–Œ–ʃuƒƒbƒN‚Ì—LŒø«. ‘同—f
Žq1, ˆ¢•”ˆè”ü1, “cŽG—L‹I1, ŒàVW‘ã1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w): ‘æ62‰ñ“ú–{ŽY‰È•wl‰ÈŠw
‰ï (2010/4/23), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€.

723535. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰È‚ÅŒoŒ±‚µ‚œŽq‹{‘Ì•”Šà“÷Žî‚̗Տ°•a—Šw“IŒŸ“¢. ¬–ìd–ž1,
Vˆä³G1, Vˆä@“w1, ìŒû”ü˜a1, À“c@Ê1, “n糁@ƒ, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY•w): ‘æ62‰ñ
“ú–{ŽY‰È•wl‰ÈŠw‰ï (2010/4/24), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€.

723536. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Endometrial intrapithelial carcinoma (EIC) ‚Æ‘ŠúŽq‹{‘Ì•”Ÿ÷‰t
«‘BŠà. À“c@Ê1, Vˆä³G1, Vˆä@“w1, ìŒû”ü˜a1, ¬–ìd–ž1, ˆ¢•”ˆè”ü1, “n糁@ƒ, Šp“cV
•œ1, ŠC–ìM–ç1 (1ŽY•w): ‘æ62‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï (2010/4/24), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€.

723537. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éŽq‹{‘Ì•”Ÿ÷‰t«‘BŠà‚ÌŒŸ“¢. “cŽG—L‹I1, ìŒû”ü˜a1,
Vˆä³G1, Vˆä@“w1, ¬–ìd–ž1, À“c@Ê1, “n糁@ƒ, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY•w): ‘æ62‰ñ
“ú–{ŽY‰È•wl‰ÈŠw‰ï (2010/4/24), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€.

723538. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —‘ŠÇŠà‚ÆŽq‹{‘ÌŠà‚ÌŸ÷‰t«‘BŠà‚̗Տ°•a—Šw“I”äŠrŒŸ“¢. Vˆä³G
1, ìŒû”ü˜a1, Vˆä@“w1, ¬–ìd–ž1, À“c@Ê1, ‚–؈»Žq1, “n糁@ƒ, Šp“cV•œ1, ŠC–ìM–ç1 (1
ŽY•w): ‘æ62‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï (2010/4/24), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€.

723539. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰È‚É‚š‚¯‚éŽq‹{“à–ŒÇ«‚Ì‚€–EÇ—á‚ÌŽ¡—ЬÑ?GnRHa-ŒoäTúŽh
“à—eœ‹Ž?• o‹Ÿ‰ºŽèp–@‚𒆐S‚É. ‰¬–ì‹|ŠóŽq1 , ì“à”Žl1, Îì‰ëˆê1, À”ö²Žq1, ‘å—ÞŒb
”üŽq1, •ˆä‰p—¢Žq, ŠC–ìM–ç1 (1ŽY•w): ‘æ62‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï (2010/4/24), “Œ‹ž‘ÛƒtƒH[ƒ‰
ƒ€.

723540. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘Ù”Õ‚É‘œ‚Ì‚€–Eƒpƒ^[ƒ“‚ð”F‚ß‚œÇ—á‚ÌŠÇ—. –]ŒŽƒŽq1, “cŽG—L
‹I1, ¯“c@—²1, ‹àˆä—Y“ñ1, ‰Í–ìÆŽq1, ‘同—fŽq1, “c‘ã^Šó, Vˆä³G1, “n糁@ƒ, “V–ì@Š®1, ŠC
–ìM–ç1 (1ŽY•w): ‘æ62‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï (2010/4/24), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€.

723541. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{‘Ì•”–Ÿ×–E‘BŠà‚̗Տ°•a—Šw“IŒŸ“¢. Vˆä@“w1, À“c@Ê1,
¬–ìd–ž1, ìŒû”ü˜a1, Vˆä³G1, ŽR“c‹¿Žq1, “n糁@ƒ, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY•w): ‘æ62‰ñ
“ú–{ŽY‰È•wl‰ÈŠw‰ï (2010/4/24), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€.

723542. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _“ސ쌧‰º‚É‚š‚¯‚éŽq‹{“à–ŒÇf—Â̌»ó (‘æˆê•ñ)@ƒW
ƒFƒmƒQƒXƒg‚ɂ‚¢‚Ä. ó–ì—ÁŽq, åŒŽG–ç, ˜aòrˆê˜Y, —é–Ø—²O, ì“à”Žl1, ’†–ì^²’j, ˆäã—T”ü,
“c‘º‚Ý‚Ç‚è, ¬“c@—Í, Îì‰ë•F (1ŽY•w): ‘æ62‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠwpu‰‰‰ï (2010/4/23-25). “Œ
‹ž, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2010/2; 62 (2): 569, “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ 2010/2; 62 (2): 569.

723543. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·zGroup75@Žq‹{‘Ì•”ˆ««Žîá‡7. Šp“cV•œ (ŽY•w): ‘æ62‰ñ
“ú–{ŽY‰È•wl‰ÈŠw‰ï (2010/4/24), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€.

723544. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·zGrroup113 ‡•¹Ç”DP8. “V–ì@Š® (ŽY•w): ‘æ62‰ñ“ú
–{ŽY‰È•wl‰ÈŠw‰ï (2010/4/25), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€.

723545. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰)yÀ’·z‚“Ÿ“_‰‰‘è12@ŽüŽYŠú. ŠC–ìM–ç (ŽY•w): ‘æ62‰ñ“ú–{ŽY
‰È•wl‰ÈŠw‰ï (2010/4/25), “Œ‹ž‘ÛƒtƒH[ƒ‰ƒ€.

723546. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{‘B‹ØÇ‚æ‚è”­¶‚µ‚œŽq‹{‘ÌŠà‚Ì1—á. ŒàVW‘ã1, Vˆä@“w1,
À“c@Ê1, ¬–ìd–ž1, “cŽG—L‹I1, ìŒû”ü˜a1, Vˆä³G1, “n糁@ƒ, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY
•w): ‘æ51‰ñ“ú–{—Տ°×–EŠw‰ï (tŠú) (2010/5/31), ƒpƒVƒtƒBƒR‰¡•l.

723547. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) p‘O×–Ef‚ÅŽq‹{‘Ì•”Šà“÷Žî‚Ɛf’f‚³‚ê‚œ3—á‚̍זEŠw“IŒŸ“¢. ¬
–ìd–ž1, À“c@Ê1, Vˆä@“w1, ìŒû”ü˜a1, Vˆä³G1, “n糁@ƒ, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY•w):
‘æ51‰ñ“ú–{—Տ°×–EŠw‰ï (tŠú) (2010/5/31), ƒpƒVƒtƒBƒR‰¡•l.

723548. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z‹{‘Ì•”‡E. Šp“cV•œ (ŽY•w)): ‘æ51‰ñ“ú–{—Տ°×–EŠw‰ï (t
Šú) (2010/5/29-31), ƒpƒVƒtƒBƒR‰¡•l.

723549. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘O’u–ü’…‘Ù”Õ‚ÌŠÇ—‚ÉŠÖ‚·‚é‘O•ûŽ‹“IŒŸ“¢. ‘同—fŽq
1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w): ‘æ20‰ñ“ú–{ŽY•wl‰ÈEV¶Ž™ŒŒ‰tŠw‰ï (2010/6/26), •lŒ.

723550. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —‘‘ƒŽîᇂð“Eo‚·‚邱‚ƂŗǍD‚ÈŒo‰ß‚ð‚Æ‚Á‚œRNMDAŽó—e‘Ì”]‰Š‚Ì
2—á. “‡‰ª‹¶1, Vˆä³G1, À“c@Ê1, ¬–ìd–ž1, Vˆä@“w1, ìŒû”ü˜a1, Šp“cV•œ1, ŠC–ìM
–ç1 (1ŽY•w): ‘æ48‰ñ“ú–{•wl‰ÈŽîᇊw‰ï (2010/7/8-10), ‚‚­‚΍‘Û‰ï‹cê, “ú–{•wl‰ÈŽîᇊw‰ïŽG
Ž 2010; 28 (3): 314.

723551. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) AFP‚ª‚’l‚ðŽŠ‚µ‚œƒZƒ‹ƒgƒŠEŠÔŽ¿×–EŽîᇂ̈ê—á. À“c@Ê1, V
ˆä³G1, Vˆä@“w1, ìŒû”ü˜a1, ¬–ìd–ž1, “n糁@ƒ, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY•w): ‘æ48‰ñ“ú
–{•wl‰ÈŽîᇊw‰ï (2010/7/8-10), ‚‚­‚΍‘Û‰ï‹cê, “ú–{•wl‰ÈŽîᇊw‰ïŽGŽ 2010; 28 (3): 315.

723552. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Lipoleiomysarcoma‚Ì1—á. “cŽG—L‹I1, ìŒû”ü˜a1, À“c@Ê1, ¬
–ìd–ž1, Vˆä@“w1, Vˆä³G1, “n糁@ƒ, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY•w): ‘æ48‰ñ“ú–{•wl‰ÈŽî
ᇊw‰ï (2010/7/8-10), ‚‚­‚΍‘Û‰ï‹cê, “ú–{•wl‰ÈŽîᇊw‰ïŽGŽ 2010; 28 (3): 344.

723553. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŽYåñ”À‘—Ç—á‚ÌŽÀó. ‰Í–ìÆŽq1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ¯“c@
—²1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w): ‘æ46‰ñ“ú–{ŽüŽYŠúEV¶Ž™Šw‰ï (2010/7/12), _ŒË‘Û‰ï‹cê.

723554. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘ÙŽ™Šút᱊g’£—á‚Ì’·Šú—\Œã. –]ŒŽƒŽq1, ‹àˆä—Y“ñ1, ‰Í–ìÆŽq
1, ‘同—fŽq1, ¯“c@—²1, –ì“n³•F2, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): ‘æ
46‰ñ“ú–{ŽüŽYŠúEV¶Ž™Šw‰ï (2010/7/12), _ŒË‘Û‰ï‹cê.

723555. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 18ƒgƒŠƒ\ƒ~[‚Ì‘ÙŽ™S””ƒpƒ^[ƒ“‚ÆŽüŽYŠú—\Œã. ‘同—fŽq1, ‹à
ˆä—Y“ñ1, –]ŒŽƒŽq1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w): ‘æ46‰ñ“ú–{ŽüŽYŠúEV¶Ž™Šw‰ï (2010/7/13),
_ŒË‘Û‰ï‹cê.

723556. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”DP’†‚ÌD-dimer‘ª’è’l‚Ɛ[•”Ã–¬ŒŒðÇ (DVT). ‹e’nMŽO1, ‘å
Œ—fŽq1, À”ö²Žq1, ‰Í–ìÆŽq1, ‹àˆä—Y“ñ1, –]ŒŽƒŽq1, ¯“c@—²1, ’J@º”Ž1, “V–ì@Š®1, ŠC–ì
M–ç1 (1ŽY•w): ‘æ46‰ñ“ú–{ŽüŽYŠúEV¶Ž™Šw‰ï (2010/7/11-13), _ŒË‘Û‰ï‹cê.

723557. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰È‚ÅŒoŒ±‚µ‚œŽq‹{‘Ì•”Šà“÷Žî‚Æ—Þ“à–Œ‘BŠàƒOƒŒ[ƒh3‚̗Տ°Šw“I
”äŠrŒŸ“¢. ¬–ìd–ž1, À“c@Ê1, Vˆä@“w1, ìŒû”ü˜a1, Vˆä³G1, Šp“cV•œ1, ŠC–ìM–ç1 (1
ŽY•w): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/30), ‘—§‹ž“s‘Û‰ïŠÙ.

723558. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žá”NŽq‹{èòŠàŠ³ŽÒ‚Ì•Ï‘J. À“c@Ê1, ¬–ìd–ž1, Vˆä@“w1, ì
Œû”ü˜a1, “cŽG—L‹I1, Vˆä³G1, Šp“cV•œ1, V•”@÷2, ‘ –{”Žs, ‘ì˜ad2, ŠC–ìM–ç1 (1ŽY•w,
2•úŽËü (Žîá‡)): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/30), ‘—§‹ž“s‘Û‰ïŠÙ.

723559. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) èòŠàpŒã–T‘å“®–¬ƒŠƒ“ƒpß (PAN) Ä”­—á‚̉ðÍ. M“c­Žq, À“c@
Ê1, Vˆä³G1, Šp“cV•œ1, —é–؁@’Œ, ¬—Ñ—zˆê, …Œûˆê¬, ¬‹{ŽRTˆê, ’·’JìŽŽu, ‰F“cìN”Ž, ‘º
Œr¬, ŽOãŠ²’j (1ŽY•w): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/30), ‘—§‹ž“s‘Û‰ïŠÙ.

723560. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) œŒ`¬•s‘SÇ5Ç—á‚Ì”DPŒo‰ß. –]ŒŽƒŽq1, “‡‰ª‹¶
1, “V–ì@Š®1, ŠC–ìM–ç1, ‚“cŽj’j (1ŽY•w): ‘æ55‰ñ“ú–{l—Þˆâ“`Šw‰ï (2010/10/27-30), ‘å‹{.

723561. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{èò•”ã”ç“à‘BŠà‚̐f’f‚É‹ê—¶‚µ‚œˆê—á. À“c@Ê1, ‚–؈»Žq
1, “cŽG—L‹I1, ¬–ìd–ž1, Vˆä@“w1, ìŒû”ü˜a1, Vˆä³G1, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY•w): ‘æ
49‰ñ“ú–{—Տ°×–EŠw‰ïHŠú‘å‰ï (2010/11/21), _ŒËƒ|[ƒgƒsƒAƒzƒeƒ‹.

723562. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) f’f‚É‹ê—¶‚µ‚œäTŒŽ”­–³F‘f«ˆ««•FŽî‚Ì1—á. “‡‰ª‹¶1, V
ˆä³G1, ˆ¢•”ˆè”ü1, ŽR“c‹¿Žq1, À“c@Ê1, ¬–ìd–ž1, Vˆä@“w1, ìŒû”ü˜a1, Šp“cV•œ1, ŠC–ì
M–ç1 (1ŽY•w): ‘æ49‰ñ“ú–{—Տ°×–EŠw‰ïHŠú‘å‰ï (2010/11/22), _ŒËƒ|[ƒgƒsƒAƒzƒeƒ‹.

723563. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) žŽq“€Œ‹•Û‘¶17”N‚ÌŒoŒ±. ì“à”Žl1, ‰ÍˆäŽ‰À, À
”ö²Žq1, ‰¬–ì‹|ŠóŽq1, Îì‰ëˆê1, ŠC–ìM–ç1 (1ŽY•w): ‘æ55‰ñ“ú–{¶BˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï
(2010/11/11-12), “¿“‡.

723564. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ÙŽ™Ž¡—Âðs‚Á‚œ‘ÙŽ™bó‘BŽî‚Ì1—á. ‹àˆä—Y“ñ1, “c
ŽG—LŠó, ‘同—fŽq1, –]ŒŽƒŽq1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w): ‘æ8‰ñ“ú–{‘ÙŽ™Ž¡—Êw‰ï (2010/11/13),
é‹Ê.

723565. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚镪•ØŽž’Á’É–@‚Ì•Ï‘J‚ÆŒ»ó. “V–ì@
Š® (ŽY•w): ‘æ114‰ñ“ú–{ŽY‰È–ƒŒ‰ÈŠw‰ï (2010/12/4), ‰¡•l.

723566. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) AFP‚ª‚’l‚ðŽŠ‚µ‚œƒZƒ‹ƒgƒŠEŠÔŽ¿×–EŽîᇂ̈ê—á. À“c@Ê1, V
ˆä³G1, Vˆä@“w1, ìŒû”ü˜a1, ¬–ìd–ž1, “n糁@ƒ, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY•w): ‘æ49‰ñ“ú
–{•wl‰ÈŽîᇊw‰ï (2010/12/4-5), ²‰êŽs•¶‰»‰ïŠÙ.

723567. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Lipoleimyosarcoma‚Ì1—á. “cŽG—L‹I1, ìŒû”ü˜a1, À“c@Ê1, ¬
–ìd–ž1, Vˆä@“w1, Vˆä³G1, “n糁@ƒ, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY•w): ‘æ49‰ñ“ú–{•wl‰ÈŽî
ᇊw‰ï (2010/12/4-5), ²‰êŽs•¶‰»‰ïŠÙ.

723568. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —‘‘ƒŽîᇂð“Eo‚·‚邱‚ƂŗǍD‚ÈŒo‰ß‚ð‚Æ‚Á‚œRNMDAŽó—e‘Ì”]‰Š‚Ì
2—á. “‡‰ª‹¶1, Vˆä³G1, À“c@Ê1, ¬–ìd–ž1, Vˆä@“w1, ìŒû”ü˜a1, Šp“cV•œ1, ŠC–ìM
–ç1 (1ŽY•w): ‘æ49‰ñ“ú–{•wl‰ÈŽîᇊw‰ï (2010/12/4-5), ²‰êŽs•¶‰»‰ïŠÙ.

723569. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘O’u–ü’…‘ٔՂ̒鉀ØŠJŽž‚̍H•v. ‘同—fŽq1, “V–ì@Š®
1, ŠC–ìM–ç1 (1ŽY•w): ‘æ33‰ñ“ú–{ŽY•wl‰ÈŽèpŠw‰ï (2011/2/13), ‰ªŽR.

731082. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽüŽYŠúˆã—ƒnˆæˆã—ØAŒg. ŠC–ìM–ç (ŽY•w): ‘æ23‰ñ
…ŒËŽüŽYŠú§˜b‰ï (2010/5/23), ˆïéŒ§ˆãŽt‰ïŠÙ.

731083. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –k—¢‘åŠw‚É‚š‚¯‚é”_ˆã˜AŒg‹³ˆç‚ÌŽŽ‚Ý. ì“à”Žl (ŽY
•w): ‘æ12‰ñ‰¡•lARTŒ€‹†‰ï (2010/8/29), _“ސì.

732064. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) u‰‰‰ïŠJÃÓ”CŽÒ (ƒCƒ“ƒXƒgƒ‰ƒNƒ^[‘ã•\). –]ŒŽƒ
Žq (ŽY•w): _“ސ쌧ŽY‰È•wl‰Èˆã‰ï‘æ3‰ñV¶Ž™‘h¶–@uK‰ï (2010/5/22), _“ސì.

732065. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Šñ•tuÀ) Šñ•uÀ‚ÌŠT—v•ñ. ŠC–ìM–ç (ŽY•w): –k—¢‘åŠwˆãŠw
•”^_“ސ쌧Šñ•uÀu’nˆæŽüŽYŠúE‹~‹}ˆã—ØAŒg‹³ˆçvŠJÝ‹L”Ou‰‰‰ï (2010/11/25), –k—¢‘åŠwˆãŠw
•”M6†ŠÙ‡“¯u‹`Žº.

733203. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žq‹{‘B‹ØÇ‚æ‚è”­¶‚µ‚œ—Þ“à–Œ‘BŠà‚Ì1—á. ‚–؈»Žq
1, Vˆä@“w1, À“c@Ê1, ¬–ìd–ž1, ìŒû”ü˜a1, Vˆä³G1, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY•w): ‘æ
12‰ñ_“ސì•wl‰ÈŽîᇌ€‹†‰ïŠwpu‰‰‰ï (2010/5/22), ƒuƒŠ[ƒYƒxƒCƒzƒeƒ‹.

733204. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”DP’†‚ɏoŒ»‚µ, ‹}Œƒ‚É‘‘債‚œ“]ˆÚ«—‘‘ƒŠà‚Ì1—á. Œ
àVW‘ã1, –ì“c–Fl, ª–{—æŽq, “cŒû@–Ÿ, ‹gŒŽ@ˆê1, –]ŒŽˆ€˜N1, ‘å–ì@“w, ã–V•qŽq (1ŽY•w): ‘æ
12‰ñ_“ސì•wl‰ÈŽîᇌ€‹†‰ïŠwpu‰‰‰ï (2010/5/22), ƒuƒŠ[ƒYƒxƒCƒzƒeƒ‹.

733205. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) f’fAŽ¡—Âɋꗶ‚µ‚œŸ÷‰t«‘BŠà‚Ì1—á. ŠÖŒû˜aŠé1, ŠÖ
–{—É•œ, ª–{‘‘ˆê, ’F@‰pŽ÷1, ‘åX’qŽq, ‘ëì­˜a, –x“cˆ»Žq, âV“¡¶˜N (1ŽY•w): ‘æ12‰ñ_“ސì•w
l‰ÈŽîᇌ€‹†‰ïŠwpu‰‰‰ï (2010/5/22), ƒuƒŠ[ƒYƒxƒCƒzƒeƒ‹.

733206. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Œ§‰›–k‘Š’n‹æŽüŽYŠú‹~‹}ŒŸ“¢‰ï@‡@•œ¬21”NŽüŽYŠú‹~‹}
Ç—á‚̂܂Ƃ߂ƏǗá•ñ, ‡AŽYåñ”À‘—‚ÌŽÀó. ‰Í–ìÆŽq (ŽY•w): ‘Š–ÍŒŽŽsŽY•wl‰Èˆã‰ïŠwpu‰‰‰ï
(2010/5/26), ‘Š–ÍŒŽ“상ƒfƒBƒJƒ‹ƒZƒ“ƒ^[.

733207. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰)yÀ’·zŒ§‰›–k‘Š’n‹æŽüŽYŠú‹~‹}ŒŸ“¢‰ï@‡@•œ¬21”NŽü
ŽYŠú‹~‹}Ç—á‚̂܂Ƃ߂ƏǗá•ñ, ‡AŽYåñ”À‘—‚ÌŽÀó. “V–ì@Š® (ŽY•w): ‘Š–ÍŒŽŽsŽY•wl‰Èˆã‰ïŠwpu
‰‰‰ï (2010/5/26), ‘Š–ÍŒŽ“상ƒfƒBƒJƒ‹ƒZƒ“ƒ^[.

733208. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·z•wl‰È‚ª‚ñ‚Ì—\–h?ƒsƒ‹‚ƃƒNƒ`ƒ“?. Vˆä³
G (ŽY•w): ‘Š–ÍŒŽŽsŽY•wl‰Èˆã‰ïŠwpu‰‰‰ï (2010/6/9), ‘Š–ÍŒŽ“상ƒfƒBƒJƒ‹ƒZƒ“ƒ^[.

733209. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 18ƒgƒŠƒ\ƒ~[‚Ì‘ÙŽ™S””}ŠŒ©. ‘同—f
Žq1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w): ‘æ35‰ñ“ú–{•ª•ØŠÄŽ‹Œ€‹†‰ï (2010/6/12), “Œ‹ž.

733210. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆêãO–Ñ–Œˆê—r–Œ‘o‘Ù‚ÌŠÇ—. ŽR“c‹¿Žq1, ‘同—fŽq1, V
ˆä‰r”ü1, ¯“c@—²1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w): ‘æ119‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï
(2010/6/13), “sŽsƒZƒ“ƒ^[ƒzƒeƒ‹, “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ïŽ 2010; 47 (2): 216.

733211. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘ٕ֐«• –Œ‰Š‚Ì4Ç—á. ‚–؈»Žq1, ‹àˆä—Y“ñ1, –]ŒŽ
ƒŽq1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w): ‘æ119‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï (2010/6/13),
“sŽsƒZƒ“ƒ^[ƒzƒeƒ‹, “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ïŽ 2010; 47 (2): 245.

733212. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚édÇŽq‹{“à–ŒÇÇ—á‚ɑ΂·‚鎡—Â̍H•v.
ŽR“c‹¿Žq1, ‰¬–ì‹|ŠóŽq1, À”ö²Žq1, ì“à”Žl1, ŠC–ìM–ç1 (1ŽY•w): ‘æ363‰ñŽl…‰ï (2010/6/23),
•¶‹žƒVƒrƒbƒNƒZƒ“ƒ^[EƒXƒJƒCƒz[ƒ‹.

733213. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zì“à”Žl (ŽY•w): ƒfƒBƒiƒQƒXƒgŒ€‹†‰ï (2010/7/2),
¬“c‹}ƒzƒeƒ‹ƒZƒ“ƒ`ƒ…ƒŠ[‘Š–Í‘å–ì.

733214. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘ÙŽ™Ž¡—Âðs‚Á‚œ‘ÙŽ™bó‘BŽî‚̈ê—á. ì“à‰ëŽq, “cŽG
—L‹I1, ‹àˆä—Y“ñ1, “V–ì@Š®1, ŠC–ìM–ç1 (1ŽY•w): ‘æ390‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“ސì’n•û•”‰ï
(2010/7/3), _“ސ쌧‘‡ˆã—ÉïŠÙ.

733215. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ØŽîŠjop4”NŒã‚É”­Ç‚µ‚œˆÙŠ«Žq‹{‹ØŽî
‚Ì1—á. ŒàVW‘ã1, Vˆä@“w1, Œ”—@—Ç1, À“c@Ê1, ¬–ìd–ž1, ìŒû”ü˜a1, Vˆä³G1, Šp“c
V•œ1, ì“à”Žl1, ŠC–ìM–ç1 (1ŽY•w): “ú–{ŽY‰È•wl‰ÈŠw‰ï_“ސì’n•û•”‰ï (2010/7/25), _“ސì.

733216. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) •ª•ØŽžoŒŒ‚̑Ήžô. “V–ì@Š® (ŽY•w): ‘Š–ÍŒŽŽsŽY•w
l‰Èˆã‰ïŠwpu‰‰‰ï (2010/7/25), ¬“c‹}ƒzƒeƒ‹ƒZƒ“ƒ`ƒ…ƒŠ[‘Š–Í‘å–ì.

733217. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘å—ʏoŒŒ‚É‚æ‚è‹Ù‹}Žèp‚Æ‚È‚Á‚œŽq‹{ŒeŽº‚Ì1—á. ’†˜e
[Í, À“c@Ê1, Vˆä@“w1, ¬–ìd–ž1, ìŒû”ü˜a1, Vˆä³G1, ì“à”Žl1, “V–ì@Š®1, Šp“cV•œ
1, ŠC–ìM–ç1 (1ŽY•w): ‘æ391‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“ސì’n•û•”‰ï (2010/9/25), ìè“úqƒzƒeƒ‹.

733218. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) 2009”NŽY‰È‹~‹}•ñ. Îì_Žj, ÎŽR‚ß‚®‚Ý, ˆä’ƐT
ˆê˜Y, Î’Ë•¶•œ, –ŒŒÃ’Žj, âV“¡Žõˆê˜Y, “c–쓇”üé, ‰œ“c”ü‰Á, ‚‹ŽP—Y, ‰Á“¡—ÇŽ÷, ‹ß“¡Žé‰¹, Î–{
lŽm, –]ŒŽƒŽq1, “V–ì@Š®1, ŠC–ìM–ç1, •œ’m—Y (1ŽY•w): ‘æ391‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“ސì’n
•û•”‰ï (2010/9/25), ìè“úqƒzƒeƒ‹.

733219. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žq‹{èòŠàƒŠƒ“ƒpß“]ˆÚ‚É‚š‚¯‚éÄ”­Ç—á‚ÌŒŸ“¢. À“c@
Ê1, Vˆä@“w1, ìŒû”ü˜a1, Vˆä³G1, Šp“cV•œ1, ŠC–ìM–ç1 (1ŽY•w): ‘æ28‰ñ_“ސì3‘åŠwƒIƒ“
ƒRƒƒWƒXƒg‚̉ï (2010/11/12), ƒzƒeƒ‹ƒZƒ“ƒ`ƒ…ƒŠ[‘Š–Í‘å–ì.

733220. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žq‹{èò‚ª‚ñ‚Í—\–h‚Å‚«‚é? ìŒû”ü˜a (ŽY•w): ‘æ41‰ñ–k
—¢‘åŠw“¯‘‹‰ïu‰‰‰ï (2010/11/20), ƒzƒeƒ‹ƒZƒ“ƒ`ƒ…ƒŠ[‘Š–Í‘å–ì.

733221. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŽüŽYŠú‹~‹}?‹~–œ‹~‹}ˆã—ÂƂ̘AŒg?. ŽR“c‹¿Žq (ŽY
•w): ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2011/2/5), ƒpƒVƒtƒBƒR‰¡•l.

733222. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘å—ʏoŒŒ‚ð‚«‚œ‚µ‚œŽq‹{ŒeŽº‚Ì1—á. Vˆä@“w (ŽY•w):
‘Š–ÍŒŽŽsŽY•wl‰Èˆã‰ïŠwpu‰‰‰ï (2011/2/16), ‘Š–ÍŒŽ“상ƒfƒBƒJƒ‹ƒZƒ“ƒ^[.

733223. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) 1) •œ¬21”N“x‚É‚š‚¯‚éŽq‹{‚ª‚ñŒŸfÇ—á“™‚ɂ‚¢‚Ä, 2)
•s“K³•W–{‚ɂ‚¢‚Ä. Šp“cV•œ (ŽY•w): ‘Š–ÍŒŽŽsŽY•wl‰Èˆã‰ï@Žq‹{‚ª‚ñŒŸfŠwpu‰‰‰ï‚š‚æ‚яǗጀ
C‰ï (2011/2/22), ‘Š–ÍŒŽ“상ƒfƒBƒJƒ‹ƒZƒ“ƒ^[.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-522006. [uÀ]y“ÁW: ‚—î”DP‚ðl‚Š‚éz12. ‚—î”DP‚̒鉀ØŠJ. ‘同—fŽq1, “V–ì@Š®
1, ŠC–ìM–ç1 (1ŽY•w): ŽY•wl‰È‚ÌŽÀÛ 2010/2; 59 (2): 221-7.

[Šw‰ïEŒ€‹†‰ï“™]

H21-731008. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –³’É•ª•Ø‚Ì•Ï‘J‚ÆŒ»ó. “V–ì@Š® (ŽY•w): ‰¡
•lŽY•wl‰Èˆã‰ï (2010/3), ‰¡•l.


®Œ`ŠO‰ÈŠw

[Šwp˜_•¶]

110178. [ŒŽ’˜] Quality of life, knee function, and physical activity in Japanese elderly women
with earlystage knee osteoarthritis. Watanabe H1, Urabe K2, Takahira N1, Ikeda N, Fujita M2, Obara
S, Hendona T3, Aikawa J2, Itoman M2: J Orthop Surg (Hong Kong) 2010/4; 18 (1): 31-4. (“n粗T”V
1, è•”@Œ›2, ‚•œ®L1, “¡“c@Œì2, •Ó“y–Œ—²3, ‘Šì@~2, Ž…–ž·Œ›2: 1ˆã—Éq¶Šw•”, 2®ŠO,
3ƒŠƒnƒrƒŠ•”)

110179. [ŒŽ’˜] Discrepancy between anatomical axis and stem position of various femoral components
in Japanese. Ueno M1, Urabe K1, Fujita M1, Aikawa J1, Kobayashi A, Itoman M1: J Orthop Surg 2010/4;
18 (1): 11-4. (ã–쐳Šì1, è•”@Œ›1, “¡“c@Œì1, ‘Šì@~1, Ž…–ž·Œ›1: 1®ŠO)

110180. [ŒŽ’˜] Can the caudal extent of fusion in the surgical treatment of scoliosis in Duchenne
muscular dystrophy be stopped at lumbar 5. Takaso M1, Nakazawa T1, Imura T1, Ueno M1, Saito W1,
Shintani R1, Takahashi K, Yamazaki M, Ohtori S, Okamoto M2, Masaki T2, Okamoto H3, Okutomi T3,
Ishii K, Ueda Y: Eur Spine J 2010/5; 19 (5): 787-96. (‚‘Š»Žm1, ’†àVr”V1, ˆä‘º‹M”V1, ã–쐳
Šì1, âV“¡@˜j1, V’J‚è‚å‚€‰î1, ‰ª–{–ql2, ³˜Ò@—²2, ‰ª–{_Žk3, ‰œ•xr”V3: 1®ŠO, 2Žš•@, 3
–ƒŒ)

110181. [ŒŽ’˜] Change in Modic type 1 and 2 signals after posterolateral fusion surgery. Ohtori
S, Yamashita M, Yamauchi K, Inoue G, Koshi T, Suzuki M, Orita S, Eguchi Y, Ochiai N, Kishida S,
Takaso M1, Kuniyoshi K, Ishikawa T, Arai G, Miyagi M, Kamoda H, Nakamura J, Aoki Y, Takahashi K:
Spine (Phila Pa 1976) 2010/5; 35 (12): 1231-5. (‚‘Š»Žm1: 1®ŠO)

110182. [ŒŽ’˜] Surgical management of severe scoliosis with high risk pulmonary dysfunction in
Duchene muscular dystrophy: patient function, quality of life and satisfaction. Takaso M1,
Nakazawa T1, Imura T1, Okada T1, Fukushima K1, Ueno M1, Takahira N2, Takahashi K, Yamazaki M, Ohtori
S, Okamoto H3, Okutomi T3, Okamato M4, Masaki T4, Uchinuma E5, Sakagami H6: Int Orthop 2010/6;
34 (5): 685-702. (‚‘Š»Žm1, ’†àVr”V1, ˆä‘º‹M”V1, ‰ª“c‹M[1, •Ÿ“‡Œ’‰î1, ã–쐳Šì1, ‚•œ®
L2, ‰ª–{_Žk3, ‰œ•xr”V3, ‰ª–{–ql4, ³˜Ò@—²4, “àÀ‰hŽ÷5, ãã—ms6: 1®ŠO, 2ˆã—Éq¶Šw
•”, 3–ƒŒ, 4Žš•@, 5Œ`¬E”üŠO, 6‰ð–U)

110183. [ŒŽ’˜] Prolonged endochondral bone healing in senescence is shortened by low-intensity
pulsed ultrasound in a manner dependent on COX-2. Naruse K1, Sekiya H, Harada Y, Iwabuchi S, Kozai
Y, Kawamata R, Kashima I, Uchida K1, Urabe K1, Seto K, Itoman M1, Mikuni-Takagaki Y: Ultrasound
Med Biol 2010/7; 36 (7): 1098-108. (¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, è•”@Œ›1, Ž…–ž·Œ›1: 1®ŠO)

110184. [ŒŽ’˜] Surgical correction of spinal deformity in patients with congenital muscular
dystrophy. Takaso M1, Nakazawa T1, Imura T1, Okada T1, Ueno M1, Saito W1, Takahashi K, Yamazaki
M, Ohtori S: J Orthop Sci 2010/7; 15 (4): 493-501. (‚‘Š»Žm1, ’†àVr”V1, ˆä‘º‹M”V1, ‰ª“c‹M[
1, ã–쐳Šì1, âV“¡@˜j1: 1®ŠO)

110185. [ŒŽ’˜] Reattachment of the greater trochanter in total hip arthroplasty: the pin-sleeve
system compared with the Dall-Miles cable grip system. Takahira N1, Itoman M2, Uchiyama K2,
Takasaki S2, Fukushima K2: Int Orthop 2010/8; 34 (6): 793-7. (‚•œ®L1, Ž…–ž·Œ›2, “àŽRŸ•¶
2, ‚èƒF2, •Ÿ“‡Œ’‰î2: 1ˆã—Éq¶Šw•”, 2®ŠO)

110186. [ŒŽ’˜] Autogenous iliac crest bone graft versus banked allograft bone in scoliosis surgery
in patient with Dushenne muscular dystrophy. Nakazawa T1, Takaso M1, Imura T1, Adachi K, Fukushima
K1, Saito W1, Miyajima G, Minatani A, Shinntani R1, Itoman M1, Takahashi K, Yamazaki M, Ohtori
S, Sasaki A: Int Orthop 2010/8; 34 (6): 855-61. (’†àVr”V1, ‚‘Š¹Žm1, ˆä‘º‹M”V1, ˆÀ’B@Œö, •Ÿ
“‡Œ’‰î1, âV“¡@˜j1, ‹{“‡Œº—z, “ì’J@~, V’J‚è‚å‚€‰î1, Ž…–ž·Œ›1, ‚‹Ž˜a‹v, ŽRè³Žu, ‘å’¹ž
Ži, ²X–؏~: 1®ŠO)

110187. [ŒŽ’˜] Surgical versus nonsurgical treatment of selected patients with discogenic low back
pain: A Small-Sized Randomized Trial. Ohtori S, Takahashi K, Orita S, Takaso M1: Spine 2010/10.
(‚‘Š»Žm1: 1®ŠO)

110188. [ŒŽ’˜] Clinical applications of diffusion magnetic resonance imaging of the lumbar
foraminal nerve root entrapment. Eguchi Y, Ohtori S, Yamashita M, Yamauchi K, Suzuki M, Orita
S, Kamoda H, Arai G, Ishikawa T, Miyagi M, Ochiai N, Kishida S, Masuda Y, Ochi S, Kikawa T, Takaso
M1, Aoki Y, Toyone T, Suzuki T, Takahashi K: Eur Spine J 2010/11; 19 (11): 1874-82. (‚‘Š»Žm
1: 1®ŠO)

110189. [ŒŽ’˜] Radiological evaluation of allograft reconstruction in acetabulum with Ganz
reinforcement ring in revision total hip replacement. Uchiyama K1, Takahira N2, Fukushima K1,
Yamamoto T1, Moriya M1, Itoman M1: J Orthop Sci 2010/11; 15 (6): 764-71. (“àŽRŸ•¶1, ‚•œ®L
2, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, X’JŒõr1, Ž…–ž·Œ›1: 1®ŠO, 2ˆã—Éq¶Šw•”)

110190. [ŒŽ’˜] Umbilical cord blood-derived mesenchymal cell fate after mouse umbilical cord blood
transplantation. Uchida K1, Urabe K1, Naruse K1, Itoman M1: Transplantation 2010/11; 90 (9):
1037-9. (“à“cŒ’‘Ÿ˜Y1, è•”@Œ›1, ¬£NŽ¡1, Ž…–ž·Œ›1: 1®ŠO)

110191. [ŒŽ’˜] Repeated freeze-thaw cycles reduce the survival rate of osteocytes in bone-tendon
constructs without affecting the mechanical properties of tendons. Suto K1, Urabe K1, Naruse K1,
Uchida K1, Matsuura T1, Mikuni-Takagaki Y, Suto M1, Nemoto N, Kamiya K2, Itoman M1: Cell Tissue
Bank. 2010 Nov 30. [Epub ahead of print] ({“¡D1, è•”@Œ›1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, Œ‰Y
W³1, ‚Š_—TŽq, {“¡Œõ•q1, ª–{@[, _’JŒ’‘Ÿ˜Y2, Ž…–ž·Œ›1: 1®ŠO, 2ƒŠƒnƒrƒŠ•”)

110192. [ŒŽ’˜] A 5-year epidemiological study on the prevalence rate of idiopathic scoliosis in
Tokyo: school screening of more than 250,000 children. Ueno M1, Takaso M1, Nakazawa T1, Imura
T1, Saito W1, Shintani R1, Uchida K1, Fukuda M2, Takahashi K, Ohtori S, Kotani T, Minami S: J Orthop
Sci 2011/1; 16 (1): 1-6. (ã–쐳Šì1, ‚‘Š»Žm1, ’†àVr”V1, ˆä‘º‹M”V1, âV“¡@˜j1, V’J‚è‚å‚€
‰î1, “à“cŒ’‘Ÿ˜Y1, •Ÿ“c—Ï–ç2: 1®ŠO, 2ˆã—Éq¶Šw•”)

110193. [ŒŽ’˜] Less invasive and less technically demanding decompressive procedure for lumbar
spinal stenosis-appropriate for general orthopaedic surgeons?-. Takaso M1, Nakazawa T1, Imura
T1, Okada T1, Fukushima K1, Ueno M1, Saito W1, Shintani R1, Sakagami H2, Takahashi K, Yamazaki
M, Ohtori S, Kotani T: Int Orthop 2011/1; 35 (1): 67-73. (‚‘Š»Žm1, ’†àVr”V1, ˆä‘º‹M”V1, ‰ª
“c‹M[1, •Ÿ“‡Œ’‰î1, ã–쐳Šì1, âV“¡@˜j1, V’J‚è‚å‚€‰î1, ãã—ms2: 1®ŠO, 2‰ð–U)

110194. [ŒŽ’˜] Influence of internal fixator stiffness on murine fracture healing: two types of
fracture healing lead to two different cellular events and growth factor expressions. Ueno M1,
Urabe K1, Naruse K1, Uchida K1, Minehara H1, Yamamoto T1, Steck R, Gregory L, Wullschleger ME,
Schuetz MA, Itoman M1: Exp Anim 2011/1; 60 (1): 79-87. (ã–쐳Šì1, è•”@Œ›1, ¬£NŽ¡1, “à“c
Œ’‘Ÿ˜Y1, •ôŒŽG¹1, ŽR–{‹–Ÿ1, Steck R, Gregory L, Wullschleger ME, Schuetz MA, Ž…–ž·Œ›1: 1
®ŠO)

110195. [ŒŽ’˜] Surgical treatment of scoliosis using allograft bone from a regional bone bank.
Takaso M1, Nakazawa T1, Imura T1, Ueno M1, Saito W1, Shintani R1, Fukushima K1, Toyama M1, Sukegawa
K1, Okada T, Fukuda M: Arch Orthop Trauma Surg 2011/2; 131 (2): 149-55. (‚‘Š»Žm1, ’†àVr”V
1, ˆä‘º‹M”V1, ã–쐳Šì1, âV“¡@˜j1, V’J‚è‚å‚€‰î1, •Ÿ“‡Œ’‰î1, “hŽR³G1, •ì_Žm1, •Ÿ“c—Ï
–ç2: 1®ŠO, 2ˆã—Éq¶Šw•”)

110196. [ŒŽ’˜] Inactivity but Not Ovariectomy Determines the mechanical property and quality of
Bone in the Hind Limbs of Aged Female Rats. Suto M1, Naruse K1, Uchida K1, Yamamoto T1, Suto K1,
Urabe K1, Mikuni-Takagaki Y, Itoman M1: The Kitasto Medical Journal 2011/3; 41 (1): 76-83. ({
“¡Œõ•q1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, ŽR–{‹–Ÿ1, {“¡D1, è•”@Œ›1, ‚Š_—TŽq, Ž…–ž·Œ›1: 1®
ŠO)

120032. [ŒŽ’˜] “Œ‹ž“s‚É‚š‚¯‚é“Á”­«‘€œ^Ç‚ÌŠwZŒŸf?2007”N‚ÌŒ‹‰Ê. ’†àVr”V1, ‚‘Š»Žm1, ˆä
‘º‹M”V1, ã–쐳Šì1, V’J‚è‚å‚€‰î1, âV“¡@˜j1, “hŽR³G1 (1®ŠO): J Spine Res 2010/11; 1 (11):
1947-51.

120033. [ŒŽ’˜] lH•GŠÖß’uŠ·pŒãŠŽõ‚ɑ΂·‚é•GŠÖßŒÅ’èp‚ÌŽ¡—ÃŒoŒ±. “hŽR³G1, “¡“c@Œì1, ‘Š
ì@~1, è•”@Œ›1, Ž…–ž·Œ›1 (1®ŠO): “ú–{lHŠÖßŠw‰ïŽ 2010/12; 40: 254-5.

120034. [ŒŽ’˜] lHŒÒŠÖßƒXƒeƒ€‚̃Zƒƒ“ƒgƒŒƒXŒÅ’è‚É‚š‚¯‚é‘Å‚¿ž‚ݗ͂̐„’è. Žðˆä—˜“Þ1, ‚‹Ž—º
Žq1, ‚•œ®L1, “àŽRŸ•¶2, ŽR–{‹–Ÿ2, •Ÿ“‡Œ’‰î2, X’JŒõr2, “à“cŒ’‘Ÿ˜Y2, ‚‘Š»Žm2, Ž…–ž·
Œ›2, ”nŸºŽŽ‘1 (1ˆã—Éq¶Šw•”, 2®ŠO): ƒoƒCƒIƒƒJƒjƒYƒ€Šw‰ïŽ 2011/2; 35 (1): 52-7.

220017. [€ŒŽ’˜] ’ZŽžŠÔ‚ÅŒø—Š“I‚ȍœ‘¬•ªœ‹Ž•û–@‚ÌŒŸ“¢. Œ”ö@¹1, è•”@Œ›2, ¬£NŽ¡2, “à
ŽRŸ•¶2, “à“cŒ’‘Ÿ˜Y2, Ž…–ž·Œ›2, ”nŸºŽŽ‘3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2®ŠO, 3ˆã—Éq¶Šw•”): ˆÚ
A 2010/6; 45 (3): 303-4.

310015. [Ç—á•ñ] Low-intensity pulsed ultrasound to repair insufficiency fracture occurred
adjacent to osteonecrosis caused by long-term steroid administration. Suto K1, Urabe K1, Naruse
K1, Ueno M1, Uchida K1, Suto M1, Yamamoto T1, Itoman M1: The Kitasato Medical Journal 2011/3; 41
(1): 90-6. ({“¡D1, è•”@Œ›1, ¬£NŽ¡1, ã–쐳Šì1, “à“cŒ’‘Ÿ˜Y1, {“¡Œõ•q1, ŽR–{‹–Ÿ1, Ž…
–ž·Œ›1: 1®ŠO)

320028. [Ç—á•ñ] qí«Š£áŠ³ŽÒ‚ɐ¶‚¶‚œŒÒŠÖßÇ‚ɑ΂µ‚ĐlHŒÒŠÖß’uŠ·p‚ðŽ{s‚µ‚œ1—á. •õŠÝ
—mŽŸ˜Y1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ‚•œ®L2, “ì’J@~1, Ž…–ž·Œ›1 (1®ŠO, 2ˆã—Éq¶Šw•”): ŠÖ
“Œ®Œ`ÐŠQŠO‰ÈŠw‰ïŽGŽ 2010/8; 41 (4): 171-6.

320029. [Ç—á•ñ] ˆŸ’E‰P«ŒÒŠÖßÇ‚ɑ΂·‚é‘å‘ڍœ“]ŽqŠÔœ^‹È“à”œœØ‚èp‚̍H•v. “hŽR³G1, •Ÿ
“‡Œ’‰î1, “àŽRŸ•¶1, ‰Í‘º@’Œ1, Ž…–ž·Œ›1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): Hip Jiont 2010/10;
36: 607-9.

320030. [Ç—á•ñ] ‚—«‚ɐ¶‚¶‚œŒÒŠÖßŠŠ–Œ«“ŽîÇ‚Ì1—á. “ì’J@~1, •Ÿ“‡Œ’‰î1, “àŽRŸ
•¶1, ‚•œ®L2, “hŽR³G1, Ž…–ž·Œ›1 (1®ŠO, 2ˆã—Éq¶Šw•”): ŠÖ“Œ®Œ`ÐŠQŠO‰ÈŠw‰ïŽGŽ 2010/12;
41 (6): 374-7.

521016. [‰ðà] STR/OrtCrljƒ}ƒEƒX‚Ì•a‘Ô‚Æ‚»‚Ì•]‰¿. “à“cŒ’‘Ÿ˜Y1, è•”@Œ›1, ¬£NŽ¡1, ‚‘Š»
Žm1, Ž…–ž·Œ›1 (1®ŠO): CRJ Letters 2010/12; 19 (1): 1-10.

521017. [‰ðà] ƒ}ƒEƒXä`‘ÑŒŒˆÚAƒ‚ƒfƒ‹. “à“cŒ’‘Ÿ˜Y1, è•”@Œ›1, ¬£NŽ¡1, ‚‘Š»Žm1, Ž…–ž·
Œ›1 (1®ŠO): CRJ Letters 2010/12; 19 (1): 11-5.

521018. [‰ðà] Œ‹Šj«Ò’ʼnŠ. ‚‘Š»Žm1, ã–쐳Šì1, ’†àVr”V1, ˆä‘º‹M”V1, Ä“¡@˜j1, ˆäã‰ë
r (1®ŠO): J Spine Res 2011/1; 2 (1): 27-34.

522095. [uÀ]y“ÁW: ƒCƒ“ƒvƒ‰ƒ“ƒgŠŽõ?‚»‚Ì—\–h‚Ƒ΍ô?zTHAŠŽõ?lHŒÒŠÖß’uŠ·pŠŽõ‚ɑ΂·
‚éR‹Û–òŠÜ—LƒZƒƒ“ƒgƒXƒy[ƒT[‚ðŽg—p‚µ‚œ“ñŠú“IÄ’uŠ·p. “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, Ž…
–ž·Œ›1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ®Œ`EÐŠQŠO‰È 2010/4; 53 (5): 569-78.

522096. [uÀ]y“ÁW: ƒCƒ“ƒvƒ‰ƒ“ƒgŠŽõ?‚»‚Ì—\–h‚Ƒ΍ô?zTKAŠŽõ?ƒŠƒ“Ž_ƒJƒ‹ƒVƒEƒ€œƒZƒƒ“ƒg
‚ð—p‚¢‚œR‹Û–ò‚Ìdrug delivery system‚ƃRƒ“ƒ|[ƒlƒ“ƒg‚ð‰·‘¶‚µ‚œlH•GŠÖß‘S’uŠ·pŒãŠŽõ‚ÌŽ¡—Ã.
è•”@Œ›1, ¬£NŽ¡1, ‘Šì@~1, “¡“c@Œì1, “à“cŒ’‘Ÿ˜Y1, Ž…–ž·Œ›1 (1®ŠO): ®Œ`EÐŠQŠO‰È
2010/4; 53 (5): 603-10.

522097. [uÀ]yŒÒŠÖßŽŸŠ³‚ÌŽ¡—Ã?up-to-datezI. ¬Ž™ŒÒŠÖßŽŸŠ³‚ÌŽ¡—Á@‘å‘ڍœ“ª‚·‚ׂèÇ‚ɑ΂·
‚éfemoroacetabular impingement‚ð‰ñ”ð‚·‚é‚œ‚߂̍œ“ª‰ºèò•”ž¶óœØ‚èp. “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1,
ŽR–{‹–Ÿ1, Ž…–ž·Œ›1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): •Êû®Œ`ŠO‰È 2010/4; 57: 32-5.

522098. [uÀ]yŒÒŠÖßŽŸŠ³‚ÌŽ¡—Ã?up-to-datezII. ¬lŒÒŠÖß•Ï«ŽŸŠ³‚ÌŽ¡—Á@1. •ÏŒ`«ŒÒŠÖßÇ@
1) œØ‚èp@Â‘s”NŠú‚̐isŠú‚š‚æ‚Ñ––Šú•ÏŒ`«ŒÒŠÖßÇ‚ɑ΂·‚é‘å‘ڍœŠO”œ‹ü‹ÈœØ‚èp‚Ì—L—p«.
‚èƒF1, “àŽRŸ•¶1, Ž…–ž·Œ›1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): •Êû®Œ`ŠO‰È 2010/4; 57:
47-50.

522099. [uÀ]yŒÒŠÖßŽŸŠ³‚ÌŽ¡—Ã?up-to-datezII. ¬lŒÒŠÖß•Ï«ŽŸŠ³‚ÌŽ¡—Á@5. Femoroacetabular
impingement@Femoraoacetabular impingement‚ɑ΂·‚ésurgical dislocation–@‚ÌŽèpŽè‹Z. •Ÿ“‡Œ’‰î
1, Ž…–ž·Œ›1, “àŽRŸ•¶1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): •Êû®Œ`ŠO‰È 2010/4; 57: 109-12.

522100. [uÀ]yŒÒŠÖßŽŸŠ³‚ÌŽ¡—Ã?up-to-datezII. ¬lŒÒŠÖß•Ï«ŽŸŠ³‚ÌŽ¡—Á@6. lHŠÖßŒã‚Ì’o
‚Ý, ŠŽõ@‹‘å‹ßˆÊ‘å‘ڍœœŒ‡‘¹‚ɑ΂·‚ésegmental allograft composite‚ð—p‚¢‚œÄŒš–@. •Ÿ“‡Œ’‰î
1, “àŽRŸ•¶1, ‚•œ®L2, è•”@Œ›1, Ž…–ž·Œ›1 (1®ŠO, 2ˆã—Éq¶Šw•”): •Êû®Œ`ŠO‰È 2010/4; 57:
126-9.

522101. [uÀ]y“ÁW: ŠŽõlHŠÖß‚ÌŽ¡—ÁzŠŽõlHŒÒŠÖßŒã‚̍œŒ‡‘¹‚ɑ΂·‚铯Žíœ‚É‚æ‚éÄŒš–@.
“àŽRŸ•¶1, Ž…–ž·Œ›1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): Monthly Book Orthopaedics 2010/4; 23
(4): 77-85.

522102. [uÀ]y“ÁW: ‘å‘ڍœèò•”/“]Žq•”œÜ‚ð‚ß‚®‚鏔–â‘èz‘å‘ڍœèò•”/“]Žq•”œÜ‚É‚š‚¯‚éÃ–¬ŒŒ
ðEÇðÇ‚Ì”­¶—Š‚Æ‚»‚Ì—\–h. ‚•œ®L1, “àŽRŸ•¶2, •Ÿ“‡Œ’‰î2, ‰Í‘º@’Œ2, “à–쐳—²2, Ž…–ž·
Œ›2 (1ˆã—Éq¶Šw•”, 2®ŠO): ®Œ`¥ÐŠQŠO‰È 2010/7; 53 (8): 953-8.

522103. [uÀ]y“ÁW: revision THA‚É‚š‚¯‚錻‹µ‚ƉۑèzII. ƒXƒeƒ€‘€@Wagner SLƒXƒeƒ€‚É‚æ‚élH
ŒÒŠÖß’uŠ·p?‹ßˆÊ‘å‘ڍœœŒ‡‘¹‚ɑ΂·‚铯ŽíœˆÚA‚Ì•¹—p?. “àŽRŸ•¶1, ‚•œ®L2, è•”@Œ›1, •Ÿ
“‡Œ’‰î1, ŽR–{‹–Ÿ1, X’JŒõr1, ‚èƒF1, Ž…–ž·Œ›1 (1®ŠO, 2ˆã—Éq¶Šw•”): ŠÖßŠO‰È 2010/10;
29 (10): 68-75.

522104. [uÀ]yÇ—á‚©‚çŠw‚Ô Š³ŽÒ‚̏ó‘Ô•Ê lHŒÒŠÖßÄ’uŠ·p‚ƃPƒAzŠe˜_: lHŒÒŠÖßƒXƒeƒ€Žü•Ó
œÜ‚É‚æ‚èÄŒšp‚Æ‚È‚Á‚œÇ—áE•ªßó”玿œ‚Ì“¯Žíœ‚ð—p‚¢‚œƒZƒƒ“ƒgƒŒƒXƒXƒeƒ€‚ł̍Čšp. ‚•œ
®L1, “àŽRŸ•¶2, •Ÿ“‡Œ’‰î2, ‰Í‘º@’Œ2, X’JŒõr2 (1ˆã—Éq¶Šw•”, 2®ŠO): ®Œ`ŠO‰ÈŠÅŒì 2011/2;
16 (2): 142-9.

540029. [‚»‚Ì‘Œ (Ð‰î)] Ã–¬ŒŒðÇðÇ—\–h‚Ì‚œ‚߂̃ŠƒXƒNƒŒƒxƒ‹‚ɉž‚¶‚œ—\–h’²ž•[. ‚•œ®L1,
“àŽRŸ•¶2, ‚‘Š»Žm2, “¡“c@Œì2, “à–쐳—²2, ‰ª“c‹M[2, •Ÿ“‡Œ’‰î2, ’†àVr”V2, ˆä‘º‹M”V2, ‘Š
ì@~2, è•”@Œ›2, Ž…–ž·Œ›2 (1ˆã—Éq¶Šw•”, 2®ŠO): —Տ°®Œ`ŠO‰È 2010/7; 45 (7): 603-7.

540030. [‚»‚Ì‘Œ]yPersonal ViewzŠO‰Èˆã‚̍˔\? ‚‘Š»Žm (®ŠO): ®Œ`EÐŠQŠO‰È 2011/2; 54 (2).

[’˜@‘]

620094. [Šwp‘] (•ª’SŽ·•M)yˆÚA‚Ì‚œ‚ß‚Ì‘ŸŠí“Eo‚Æ•Û‘¶zˆÚA‘gD‚Ì“Eo‚Æ•Û‘¶. ¬£NŽ¡1, è
•”@Œ›1, Ž…–ž·Œ›1 (1®ŠO), •Ò ó–앐G, •Ÿ›ž‹³ˆÌ, Œ•Ž@Œh, ŠG–ì‘òL, ƒVƒ…ƒvƒŠƒ“ƒK[EƒWƒƒƒp
ƒ“Š”Ž®‰ïŽÐ, “Œ‹ž, 2010”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713090. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Abnormal tibial torsion may cause an earliest
detectable deformity in STR/OrtCrlj osteoarthritis mouse model. Naruse K1, Urabe K1, Uchida K1,
Toyama M1, Itoman M1: 9th World Congress of the International Cartilage Repair Society (2010/9/29),
Barcelona, Spein. (¬£NŽ¡1, è•”@Œ›1, “à“cŒ’‘Ÿ˜Y1, “hŽR³G1, Ž…–ž·Œ›1: 1®ŠO)

713091. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Investigation of hyperlipidemic property in STR/Ort
mice. Uchida K1, Naruse K1, Itoman M1, Urabe K1: 9th World Congress of the International Cartilage
Repair Society (2010/9/29), Barcelona, Spein. (“à“cŒ’‘Ÿ˜Y1, ¬£NŽ¡1, Ž…–ž·Œ›1, è•”@Œ›1:
1®ŠO)

713092. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Mesenchymal cell fate after mice cord blood
transplantation. Uchida K1, Naruse K1, Urabe K1, Itoman M1: 7th Combined Meeting of the Orthopaedic
Research Societies (2010/10/16), Kyoto. (“à“cŒ’‘Ÿ˜Y1, ¬£NŽ¡1, è•”@Œ›1, Ž…–ž·Œ›1: 1®ŠO)

713093. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Low intensity pulse ultrasound accelerate endochondral
ossification in aged mouse fracture model. Naruse K1, Urabe K1, Uchida K1, Suto K1, Mikuni-Takagaki
Y, Itoman M1: 13th International Conference of Asia Pacific Association of Surgical Tissue Bank
(APASTB) (2010/10/29), Bukittinggi, Indonesia. (¬£NŽ¡1, è•”@Œ›1, “à“cŒ’‘Ÿ˜Y1, {“¡D
1, ‚Š_—TŽq, Ž…–ž·Œ›1: 1®ŠO)

713094. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Effect of allogenic serum addition to University of
Wisconsin solution for prolonged cold preservation of osteochondral allograft. Onuma K1, Urabe
K1, Naruse K1, Uchida K1, Itoman M1: 13th International Conference of Asia Pacific Association
of Surgical Tissue Bank (APASTB) (2010/10/26-30), Bukittinggi, Indonesia. (¬ÀŒ«Ž¡1, è•”@Œ›
1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, Ž…–ž·Œ›1: 1®ŠO)

713095. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The current status and issue of advanced medical
treatment for allogenic bone ligamentous tissue in JAPAN. Urabe K1, Naruse K1, Uchida K1, Itoman
M1: 13th International Conference of Asia Pacific Association of Surgical Tissue Banks (APASTB),
(2010/10/28), Bukittinggi, Indonesia. (è•”@Œ›1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, Ž…–ž·Œ›1: 1®ŠO)

722129. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “ú–{‚É‚š‚¯‚é, FAI‚̐f’f‚Æ•p“x?XüŠw“IÄŒŸ“¢
‚©‚ç?. •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, X’JŒõr1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ83‰ñ“ú–{®Œ`
ŠO‰ÈŠw‰ïŠwp‘‰ï (2010/5/28), “Œ‹ž.

722130. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ŠŽõlHŒÒŠÖßŒã‚̍œŒ‡‘¹‚ɑ΂·‚铯ŽíˆÚAœ‚É
‚æ‚éÄŒšp. “àŽRŸ•¶1, ‚•œ®L2, ‚èƒF1, •Ÿ“‡Œ’‰î1, è•”@Œ›1, ŽR–{‹–Ÿ1, X’JŒõr1, “ì
’J@~1, ‹{“‡Œº—z1, Ž…–ž·Œ› (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ37‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2010/10/2),
•Ÿ‰ª, ‘æ37‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2010; p.153, ‘æ37‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï
ƒvƒƒOƒ‰ƒ€Ž˜^W 2010; p.153.

722131. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‰^“®Ší×–E‘ãŽÓ‚É‚š‚¯‚郁ƒJƒjƒJƒ‹ƒXƒgƒŒƒX‚Ì—˜
“_‚ÆŒ‡“_ ’áo—Í’Ž‰¹”gƒpƒ‹ƒX (LIPUS) ‚É‚æ‚鍜ÜŽ¡–ü‘£iŒø‰Ê‚Ì‹@˜. ¬£NŽ¡1, è•”@Œ›1, “à“c
Œ’‘Ÿ˜Y1, ‚Š_—TŽq, Ž…–ž·Œ› (1®ŠO): ‘æ25‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2010/10/14), ‹ž“s.

722132. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒtƒHƒ“ƒ_ƒpƒŠƒkƒNƒX‚ ‚é‚¢‚̓GƒmƒLƒTƒpƒŠƒ“Žg—p
‰º‚ł̐lHŒÒŠÖßÄ’uŠ·p‚É‚š‚¯‚é[•”Ã–¬ŒŒðÇ‚Ì”­¶•p“x. ‰Í‘º@’Œ1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X
’JŒõr1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ41‰ñ“ú–{lHŠÖßŠw‰ï (2011/2/26), “Œ
‹ž.

723570. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯Žíœ“‘gD‚Ì‚æ‚è“KØ‚Ȓቷ•Û‘¶‚Ì‚œ‚ß‚Ì‘gD•Û‘¶
‰t‚ÌŠJ”­. ¬ÀŒ«Ž¡1, è•”@Œ›1, ¬£NŽ¡1, –p@W³1, “à“cŒ’‘Ÿ˜Y1, Ž…–ž·Œ›1 (1®ŠO): ‘æ
23‰ñ“ú–{“‘ãŽÓŠw‰ï (2010/4/2), Ž­Ž™“‡.

723571. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶•šŠw“I»Ü“Š—^’†‚̊֐߃ŠƒEƒ}ƒ`Š³ŽÒ‚ɑ΂·‚鐮Œ`ŠO
‰ÈŽèp‚ÌŒŸ“¢. “¡“c@Œì, è•”@Œ›1, ‘Šì@~1, “àŽRŸ•¶1, Îì@Í2, “c’†Z–Ÿ2, ‰ª“c@ƒ3, œA
”šr¬2, Ž…–ž·Œ› (®ŠO, 2äPŒŽ•aEŠŽõ“à, 3Œ’NŠÇ—ƒZ): ‘æ54‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï
(2010/4/24), _ŒË.

723572. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œ‘€isŠúE––Šú•ÏŒ`«ŒÒŠÖßÇ‚ɑ΂µ‚Ä—Œ‘€‚ÉŽ{s‚µ
‚œ‘å‘ڍœŠO”œœØ‚èp‚̐¬Ñ. “àŽRŸ•¶1, ‚•œ®L2, ‚èƒF1, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, Ž…–ž·Œ›
1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ83‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwp‘‰ï (2010/5/29), “Œ‹ž.

723573. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚—«‚É”­Ç‚µ, ŒÒŠÖß‹ŸŽ‹‰º‚ÉŽ¡—µ‚Š‚œŠŠ–Œ«“î
œŽí‚Ì2—á. •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, “ì’J@~1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ2‰ñ“ú–{
ŠÖß‹Ÿ, •G, ƒXƒ|[ƒc®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (2010/7/2), ‰«“ê.

723574. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) œƒZƒƒ“ƒg‚ƃŠƒ“Ž_ƒJƒ‹ƒVƒEƒ€ƒy[ƒXƒg‚𕹗p‚µ‚œŠŽõ
lH•GŠÖß‚ÌŽ¡—à (‰ï‹c˜^). ‘Šì@~1, è•”@Œ›1, “¡“c@Œì1, “ì’J@~1, •Ÿ“‡Œ’‰î1, •ôŒŽG¹
1, Šâ£@‘å1, Ž…–ž·Œ›1 (1®ŠO): JOSKAS2010 (2010/7/2-4), ‰«“ê.

723575. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lH•GŠÖßÄ’uŠ·pŒãŠŽõ‚ɑ΂µ“¯Žíœ‚ð—p‚¢‚Ä•GŠÖß
ŒÅ’èp‚ðs‚Á‚œ5—á. “hŽR³G1, “¡“c@Œì1, ‘Šì@~1, è•”@Œ›1, Ž…–ž·Œ›1 (1®ŠO): JOSKAS2010
(2010/7/2-4), ‰«“ê.

723576. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lH•GŠÖß‘S’uŠ·p‚̏pŒãXü•]‰¿. “¡“c@Œì1, è•”@
Œ›1, ‘Šì@~1, Ž…–ž·Œ›1 (1®ŠO): JOSKAS2010 (2010/7/2-4), ‰«“ê.

723577. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚±‚ê‚©‚ç‚ÌŽ„‚œ‚¿?¡, œØ‚èp‚ÉŽv‚€‚±‚Æ?. “àŽRŸ
•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, X’JŒõr1, ŽR–{‹–Ÿ1, ‚èƒF1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ18‰ñ
Hip Forum 2010 (2010/7/24), ’¹‰H.

723578. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) æiˆã—Áu”ñ¶‘̃hƒi[‚É‚æ‚é“€Œ‹•Û‘¶“¯ŽíœEx‘Ñ‘g
Dv‚ÌŒ»ó‚Æ–â‘è“_. è•”@Œ›1, –I’J—T“¹, ¬£NŽ¡1, •Ÿ“‡Œ’‰î1, “à“cŒ’‘Ÿ˜Y1, ˆäàV_”V, Š}ŒŽ
‚Ý‚Ç‚è, ¬—ѐçŒb, Ž…–ž·Œ› (1®ŠO): ‘æ9‰ñ“ú–{‘gDˆÚAŠw‰ï‘‰ïEŠwpW‰ï (2010/8/28), •Ÿ“‡.

723579. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯Ží“‘gD‚Ì‚æ‚è“KØ‚Ȓቷ•Û‘¶‚Ì‚œ‚ß‚Ì‘gD•Û‘¶‰t
‚ÌŠJ”­. ¬ÀŒ«Ž¡1, è•”@Œ›1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, –p@W³1, Ž…–ž·Œ› (1®ŠO): ‘æ9‰ñ
“ú–{‘gDˆÚAŠw‰ï‘‰ïEŠwpW‰ï (2010/8/28), •Ÿ“‡.

723580. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •ÏŒ`«ŒÒŠÖßÇ‚ɑ΂·‚é“à”œœØ‚èp‚Ì“K‰ž. X’JŒõr
1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ‚•œ®L2, ŽR–{‹–Ÿ1, è•”@Œ›1, Ž…–ž·Œ›, ‚‘Š»Žm1 (1®ŠO, 2ˆã
—Éq¶Šw•”): ‘æ37‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2010/10/2), •Ÿ‰ª, ‘æ37‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ïƒv
ƒƒOƒ‰ƒ€Ž˜^W 2010; p.337.

723581. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éCurved Periacetabular Osteotomy?2005
”N‚©‚ç‚Ì’ZŠú¬Ñ?. “àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, X’JŒõr1, ‹{“‡Œº—z1, “ì’J@
~1, •õŠÝ—mŽŸ˜Y1, è•”@Œ›1, Ž…–ž·Œ› (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ37‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï
(2010/10/2), •Ÿ‰ª, ‘æ37‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2010; p.341.

723582. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒCƒ“ƒvƒ‰ƒ“ƒgŠE–Ê‚ÉŽc—¯‚·‚é’èí‰×d‚̍œ‘gD‚ւ̉e‹¿.
”nŸºŽŽ‘, –òŽt_G, Žðˆä—˜“Þ, “à“cŒ’‘Ÿ˜Y1, ¬£NŽ¡1 (1®ŠO): ‘æ37‰ñ“ú–{—Տ°ƒoƒCƒIƒƒJƒjƒNƒX
Šw‰ï (2010/11/1), ‹ž“s.

723583. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lH•IŠÖß‘S’uŠ·pŒã‚ɏã˜rŽO“ª‹ØäF‰„’·p‚ð—v‚µ‚œŠÖ
ßƒŠƒEƒ}ƒ`•I•ÏŒ`‚Ì1—á. “¡“c@Œì1, è•”@Œ›1, ‘Šì@~1, ¬ÀŒ«Ž¡1, Ž…–ž·Œ›1 (1®ŠO): ‘æ
38‰ñ“ú–{ŠÖß•aŠw‰ï (2010/11/18-19), ‹ž“s.

723584. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖß•a‚ɑ΂·‚éãŽˆlHŠÖß’uŠ·p@ŠÖßƒŠƒEƒ}ƒ`Š³ŽÒ
‚Ì•I•ÏŒ`‚ɑ΂·‚锌S‘©Œ^lH•IŠÖß‘S’uŠ·p‚ÌŽ¡—ÃŒoŒ±. “¡“c@Œì1, è•”@Œ›1, ‘Šì@~1, ¬À
Œ«Ž¡1, Ž…–ž·Œ›1 (1®ŠO): ‘æ38‰ñ“ú–{ŠÖß•aŠw‰ï (2010/11/18-19), ‹ž“s.

723585. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lH•GŠÖß‘S’uŠ·pŒã‚š‚æ‚эĒuŠ·pŒã‚Éãøœ‘e–ʍœ‚«
‚è‚ðs‚È‚Á‚œÇ—á‚ÌŒŸ“¢. “¡ŠªŽõŽq1, è•”@Œ›1, ‘Šì@~1, “ì’J@~1, ‚–쏞‘Ÿ˜Y1, –Œ‘q’Œd1
(1®ŠO): ‘æ38‰ñ“ú–{ŠÖß•aŠw‰ï (2010/11/18-19), ‹ž“s.

723586. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å‘ڍœ‚̊֐ߊO•ÏŒ`‚ð—L‚·‚é•ÏŒ`«•GŠÖßÇ‚ɑ΂µ‚Đl
H•GŠÖß‘S’uŠ·p‚ðŽ{s‚µ‚œ3—á. “ì’J@~1, ‘Šì@~1, è•”@Œ›1, “¡“c@Œì1, Šâ£@‘å1, ‚‘Š
»Žm1 (1®ŠO): ‘æ41‰ñ“ú–{lHŠÖßŠw‰ï (2011/2/25), “Œ‹ž.

723587. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒeƒƒCƒh«‘å‘ڍœ“ª‰óŽ€Ç‚ɑ΂·‚élHœ“ª’uŠ·p‚Í
—L—p‚©? X’JŒõr1, “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, ‚•œ®L2, ‰Í‘º@’Œ1, ŽR–{‹–Ÿ1, ‚èƒF1, Ž…–ž
·Œ›, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ41‰ñ“ú–{lHŠÖßŠw‰ï (2011/2/26), “Œ‹ž, ‘æ41‰ñ“ú
–{lHŠÖßŠw‰ïŽ˜^W 2011; p.329.

723588. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lHŒÒŠÖßÄ’uŠ·p‚É‚š‚¯‚é‹ßˆÊ‘å‘ڍœ‹‘卜Œ‡‘¹‚É‘Î
‚·‚éallograft-prosthesis composite‚̏pŒã¬Ñ. “àŽRŸ•¶1, ‚•œ®L2, •Ÿ“‡Œ’‰î1, ŽR–{‹–Ÿ1, X
’JŒõr1, è•”@Œ›1, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ41‰ñ“ú–{lHŠÖßŠw‰ï (2011/2/26), “Œ
‹ž.

723589. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒXä`‘ÑŒŒˆÚAŒã‚ɍœ‘‚ɐ¶’…‚µ‚œ×–E‚͍œÜŽ¡–ü‚É
ŠÖ—^‚·‚é. “à“cŒ’‘Ÿ˜Y1, è•”@Œ›1, ¬£NŽ¡1, ã–쐳Šì1, Ž…–ž·Œ›, ‚‘Š»Žm1 (1®ŠO): ‘æ10
‰ñ“ú–{Ä¶ˆã—Êw‰ï‘‰ï (2011/3/1), “Œ‹ž, ‘æ10‰ñ“ú–{Ä¶ˆã—Êw‰ï‘‰ïŽ˜^W 2011; p.215.

723590. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •ÏŒ`«•GŠÖßÇŽ©‘R”­Çƒ}ƒEƒX STR/Ort‚É‚š‚¯‚鎉Ž¿‘ã
ŽÓˆÙí. “à“cŒ’‘Ÿ˜Y1, è•”@Œ›1, ¬£NŽ¡1, {“¡Œõ•q1, {“¡D1, ã–쐳Šì1, ŽR–{‹–Ÿ1, “ˆ
“cçˆÀ‹I1, Ž…–ž·Œ›, ‚‘Š»Žm1 (1®ŠO): ‘æ24‰ñ“ú–{“‘ãŽÓŠw‰ï (2011/3/5), •Ÿ‰ª, ‘æ24‰ñ“ú–{
“‘ãŽÓŠw‰ïŽ˜^W 2011; p.156.

731084. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ò’ŃCƒ“ƒXƒgƒDƒ‹ƒƒ“ƒe[ƒVƒ‡ƒ“‚ÌŽÀÛ. ‚‘Š»Žm (®
ŠO): _“ސ쐮Œ`ŠO‰Èˆã‰ïŠwpu‰‰‰ï (2010/11/20), ‰¡•l.

731085. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) œ‰P‰ñ“]œØ‚èp‚É‚š‚¯‚éÅ¬NPŽèp?Curved
Periacetabular Osteotomy‚ÌŽèpŽè‹Z?. “àŽRŸ•¶1, •Ÿ“‡Œ’‰î1, X’JŒõr1, ‚•œ®L2, Ž…–ž·Œ› (®
ŠO, 2ˆã—Éq¶Šw•”): ‘æ26‰ñ_“ސ쐮Œ`ŽèpŽè‹ZŒ€‹†‰ï (2010/6/11), ‰¡•l.

731086. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ò’Œ•ÏŒ`‚̍ŋ߂̎¡—Ã. ‚‘Š»Žm (®ŠO): ç—tŒ§®Œ`
ŠO‰Èˆã‰ï (2011/2/17), ç—t.

732066. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –k—¢‘åŠw‚É‚š‚¯‚鐮Œ`ŠO‰Èˆãˆç¬‚Ì‚œ
‚ß‚ÌŽŽ‚݂ƍ¡Œã‚̉ۑè. “àŽRŸ•¶1, è•”@Œ›1, “à–쐳—²1, ‰ª“c‹M[1, •ôŒŽG¹1, ¬£NŽ¡1, ’†
àVr”V1, ‚•œ®L2, ‚‘Š»Žm1 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ140‰ñ_“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ï
(2010/10/23), ‰¡•l, _“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ïŽGŽ 2010/10; 23 (2): 49.

732067. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‹ØƒWƒXƒgƒƒtƒB[‚É”º‚€Ò’Œ•ÏŒ`Ž¡—Ã
‚ÌŽÀÛ. ‚‘Š»Žm1, ’†àVr”V1, ˆä‘º‹M”V1, âV“¡@˜j1 (1®ŠO): Œú¶˜J“­È‹ØƒWƒXƒgƒƒtƒB[Œ€‹†
”ljï‹c (2010/12/4), “Œ‹ž.

733224. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œ‘€lH•GŠÖß’uŠ·pŒãMRSAŠŽõ‚ɑ΂µ‚čR
‹Û–òŠÜ—LƒŠƒ“Ž_ƒJƒ‹ƒVƒEƒ€ƒy[ƒXƒg‚ƃZƒƒ“ƒgƒXƒy[ƒT[‚𕹗p‚µŽ¡—µ‚œ1—á. •õŠÝ—mŽŸ˜Y1, è•”@
Œ›1, ‘Šì@~1, “ì’J@~1, ‹{“‡Œº—z1, âV“¡@˜j1 (1®ŠO): ‘æ139‰ñ_“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ï
(2010/6), ‰¡•l.

733225. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å‘ڍœ“ª‚·‚ׂèÇpŒã‚É”­¶‚µ‚œ‘å‘ڍœ“ª‰ó
Ž€Ç‚ɑ΂µ‚Ä‘å‘ڍœ“ªŒã•û‰ñ“]œØ‚èp‚ðŽ{s‚µ‚œ2—á. ‰Í‘º@’Œ1, ‚•œ®L2, “àŽRŸ•¶1, •Ÿ“‡Œ’
‰î1, X’JŒõr1, Ž…–ž·Œ› (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ59‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2010/9/17), ·
‰ª.

733226. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) lH•GŠÖß‘S’uŠ·pŒã‚ɐ¶‚¶‚œpatellofemoral synovial
hyperplasia‚Ì1—á. ‘Šì@~1, è•”@Œ›1, “ì’J@~1, ‹{“‡Œº—z1, âV“¡@˜j1, Šâ£@‘å1, Ž…–ž
·Œ›1 (1®ŠO): ‘æ59‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2010/9/17-18), ·‰ª.

733227. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –ƒáƒ«“à”œë‘«‚ɑ΂µƒCƒŠƒUƒƒt‘nŠOŒÅ’èŠí‚ð—p‚¢‚Ä‘«
ŠÖß‘SŒÅ’èp‚ðŽ{s‚µ‚œ1—á. •ì_Žm1, è•”@Œ›1, ‘Šì@~1, •Ÿ“‡Œ’‰î1, “ì’J@~1, âV“¡@˜j
1, Ž…–ž·Œ›1 (1®ŠO): ‘æ59‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2010/9/17-18), ·‰ª.

733228. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Engelmann•a‚Ì1—á. “¡“c@Œì1, ‘Šì@~1, è•”@Œ›
1, Ž…–ž·Œ›1 (1®ŠO): ‘æ59‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2010/9/17-18), ·‰ª.

733229. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒXä`‘ÑŒŒˆÚAŒã‚ÌŠÔ—tŒn×–E‚Ì“®‘Ô. “à
“cŒ’‘Ÿ˜Y1, è•”@Œ›1, ¬£NŽ¡1, Ž…–ž·Œ›1 (1®ŠO): ‘æ29‰ñ“ú–{‰^“®ŠíˆÚAEÄ¶ˆãŠwŒ€‹†‰ï
(2010/9/25), ‹ž“s.

733230. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —â“€E‰ð“€‚ÌŒJ‚è•Ô‚µ‚É‚æ‚鍜Ex‘Ñ‘gD’†
‚̐¶‘¶×–Eœ‹Ž. {“¡D1, è•”@Œ›1, ¬£NŽ¡1, “à“cŒ’‘Ÿ˜Y1, –p@W³1, {“¡Œõr1, Ž…–ž·
Œ›1 (1®ŠO): ‘æ29‰ñ“ú–{‰^“®ŠíˆÚAEÄ¶ˆãŠwŒ€‹†‰ï (2010/9/25), ‹ž“s.

733231. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) œÜ•”•sˆÀ’萫‘J‰„–ü‡ƒ‚ƒfƒ‹‚ɑ΂µ‚Ä’áo
—Í’Ž‰¹”gƒpƒ‹ƒX‚ª–³Œø‚Å‚ ‚é‹@˜‚ÌŒŸ“¢. ¬£NŽ¡1, è•”@Œ›1, ‚Š_—TŽq, “à“cŒ’‘Ÿ˜Y1, “à–쐳—²
1, Ž…–ž·Œ›, ‚‘Š»Žm1 (1®ŠO): ‘æ14‰ñ’Ž‰¹”gœÜŽ¡—ÃŒ€‹†‰ï (2011/1/22), “Œ‹ž.

733232. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V‚µ‚¢‘å‘ڍœ—p‰~“›Œ^‘“à“BMadonna‚ÌŽ¡—Ã
¬Ñ. –Œ‘q’Œd1, “à–쐳—²1, •ôŒŽG¹1, –p@W³1, “àŽRŸ•¶1, è•”@Œ›1, Ž…–ž·Œ› (1®ŠO): ‘æ
141‰ñ_“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ï (2011/3/5), ‰¡•l.

733233. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å‘ڍœèò•”œŽîᇑ~àŠŒã‚ÉStrut bone allograft
‚ð—p‚¢‚čČš‚ð‚š‚±‚È‚Á‚œ2—á. “¡ŠªŽõŽq1, •Ÿ“‡Œ’‰î1, “àŽRŸ•¶1, X’JŒõr1, è•”@Œ›1, ¬£N
Ž¡1, ‚‘Š»Žm1, ‚•œ®L2 (1®ŠO, 2ˆã—Éq¶Šw•”): ‘æ141‰ñ_“ސ쐮Œ`ÐŠQŠO‰ÈŒ€‹†‰ï (2011/3/5),
‰¡•l.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-521001. [‰ðà] ‰»”^«Ò’ʼnŠ ‚‘Š»Žm1, ã–쐳Šì1 (1®ŠO): J Spine Res 2010/2; 1 (2):
174-81.

[Šw‰ïEŒ€‹†‰ï“™]

H21-723016. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “¯ŽíœEx‘Ñ‘gD‚ÉŠÜ‚Ü‚ê‚鐶‘¶×–Eœ‹Ž•û–@
‚ÌŒŸ“¢. {“¡D1, è•”@Œ›1, ¬£NŽ¡1, –p@W³1, “à“cŒ’‘Ÿ˜Y1, {“¡Œõ•q1, ã–쐳Šì1, ŽR
–{‹–Ÿ1, Ž…–ž·Œ› (1®ŠO): ‘æ30‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ (2010/3/13), •Ÿ‰ª.


Œ`¬ŠO‰ÈE”ü—eŠO‰ÈŠw

[Šwp˜_•¶]

110197. [ŒŽ’˜] Significance of CD271 in Bone Marrow Mesenchymal Stem Cells -Changes by
Cryopreservation-. Aoyagi K1, Yamazaki Y1, Matsuo A1, Shimakura Y1, Takeda A1, Uchinuma E1: J
Craniofac Surg 2010/5; 21 (3): 666-78. (Â–ö˜a–ç1, ŽRèˆÀ°1, Œ”ö‚ ‚š‚¢1, “‡‘qNl1, •“c@Œ[
1, “àÀ‰hŽ÷1: 1Œ`¬E”üŠO)

110198. [ŒŽ’˜] Hes1 regulates formations of the hypophyseal pars tuberalis and the hypothalamus.
H–{•ôŽ1, Nishimaki T, Vˆä—Y‘Ÿ2, “àÀ‰hŽ÷1, Yamauchi H, Kameda Y (1Œ`¬E”üŠO, 2‰ð–U): Cell
and Tisue Research 2010/6; 340: 509-21.

110199. [ŒŽ’˜] Hes1 is required for the development of craniofacial structures derived from
ectomesenchymal neural crest cells. H–{•ôŽ1, Kameda Y, Vˆä—Y‘Ÿ2, ŽO‰Y³–Ÿ2, Nishimaki T, •
“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO, 2‰ð–U): The Journal of Craniofacial Surgery 2010/9; 21 (5):
1443-9.

110200. [ŒŽ’˜] Differing effects of allogenic, heterologous sera and scaffold structures on the
bone forming ability of undifferentiated mesenchymal stem cells. Takase C1, Yamazaki Y1, Matsuo
A1, Aoyagi K1, Takeda A1, Uchinuma E1: The Kitasato Medical Journal 2010/9; 40 (2): 122-8. (‚
£@Å1, ŽRèˆÀ°1, Œ”ö‚ ‚š‚¢1, Â–ö˜a–ç1, •“c@Œ[1, “àÀ‰hŽ÷1: 1Œ`¬E”üŠO)

110201. [ŒŽ’˜] Human Body Fat Transplant to Nude Mice. “잊º—Y1, •“c@Œ[2, “àÀ‰hŽ÷2 (1–k
—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2Œ`¬E”üŠO): The Kitasato Med J 2011/3; 41 (1): 57-62.

120035. [ŒŽ’˜] OŠ{—ôÇ—á‚ɑ΂·‚鑁ŠúŠ{—ô•”œˆÚA‚Ì•]‰¿. ŽRèˆÀ°1, ’†‹v–؍Nˆê, Î“n–õ•v, £
èWˆê˜Y1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): “ú–{ŒûoŠO‰ÈŠw‰ïŽGŽ 2010/5; 56 (5): 305-12.

120036. [ŒŽ’˜] d“xŽlŽˆŠJ•úœÜ‚ɑ΂·‚éfree flap‚ð—p‚¢‚œ‘ŠúÄŒš. ª–{@[1, Â–ö˜a–ç1, ”
–ؐT–ç1, H–{•ôŽ1, ÎìS‰î1, ŒFàVŒ›ˆê, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘n 2010/7; 1 (2): 74-80.

120037. [ŒŽ’˜] ŠÌ”Á‚ÌŽ¡—Õû–@. ŽR‰º—ŠG1,2 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): “ú–{”ü—e”畆‰È
Šw‰ïŽ 2010; 20: 357-67.

210006. [€ŒŽ’˜] Potential of regenerative medicine of bone tissue using the autologous umbilical
cord and umbilical cord blood. ”nêŽq1, ŽRèˆÀ°1, Â–ö˜a–ç1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`
¬E”üŠO): 20th Congress of the European Association of Cranio-Maxillp-Facial Surgery 2010/9;
p.359-63.

210007. [€ŒŽ’˜] Proliferative and differentialpotentials of human bone marrow-derived
mescenchymal cells cultured with autologous serum. ŽRèˆÀ°1, •“c@Œ[1, ”nêŽq1, “àÀ‰hŽ÷
1 (1Œ`¬E”üŠO): 20th Congress of the European Association of Cranio-Maxillp-Facial Surgery 2010/9;
p.377-82.

310016. [Ç—á•ñ] Medical Treatment for Burn Patients with Eating Disorders: A Case Report. H
–{•ôŽ1, •“c@Œ[1, ‰i“‡˜a‹M1, ãŒŽ—Œb1, ª–{@[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): Plastic Surgery
International 2011; 2011: 4 pages.

320031. [Ç—á•ñ] ŽèŽw––œ“®–¬‚É”­Ç‚µ‚œ“®–¬áŽ‚Ì2—á. ƒTƒŠƒoƒ““Þ’ÃŽq1, ŽR“c’Œl1, “àÀ‰hŽ÷
1 (1Œ`¬E”üŠO): Œ`¬ŠO‰È 2010/5; 53 (5): 559-64.

320032. [Ç—á•ñ] ÎŠD—°‰©‡Ü‚É‚æ‚鉻Šw”M?áŠQ‚Ì–hŽ~‚ð‹‚ß‚Ä?. ‰i”ü‘åŽu, ‘å’J’˱”V1,
‰Á“¡ŒŠ], ‘O“‡•¶•v, ŒŠ_—Ç•v, ‰ÄìŽü‰î (1Œ`¬E”üŠO): “ú–{”_‘ºˆãŠw‰ïŽGŽ 2010; 59 (1): 44-9.

320033. [Ç—á•ñ] _ŒoâŽî‚©‚爫«“]‰»‚𐶂¶‚œ‰º‘ÚŒŽ”­ˆ««––œ_ŒoâŽîᇂÌ1—á. ‹ß“¡ŒªŽi1,
ŽR‰º—ŠG1,2 (1Ã“슙‘q‘‡•a‰@, 2Œ`¬E”üŠO): “ú–{Œ`¬ŠO‰ÈŠw‰ïŽ 2010/11; 30: 626-32.

320034. [Ç—á•ñ] Á‰»ŠÇúE‚ð‚«‚œ‚µ‚œ”M‚Ì1—á. ‹{àV—Œb, ª–{@[1, H–{•ôŽ1, ™–{F”V
1, ‘Š”nˆêˆå2, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO, 2‹~–œ): ”M 2010/6; 36 (2): 83-9.

420001. [—Տ°ŽŽŒ±] ƒqƒAƒ‹ƒƒ“Ž_‚ƃRƒ‰[ƒQƒ“‚ðŠîÞ‚Æ‚µ‚œƒ}ƒgƒŠƒbƒNƒX‚ɃqƒgüˆÛ‰è×–E‚ð‘g‚ݍž‚ñ
‚Ÿ“¯Ží”|—{^”ç‚ÌŠJ”­. •–ö”\Œõ, ‹v•ÛŒ’‘Ÿ˜Y, ŽR“c’Œl1 (1Œ`¬E”üŠO): lH‘ŸŠí 2010/6; 39 (1):
36-7.

520063. [‘à]yŒ`¬ŠO‰ÈŽŸŠ³update2010z”畆ŽŸŠ³”ž—±Žî, èŗ±Žî. “‡‘qNl1, “àÀ‰hŽ÷1 (1Œ`¬E
”üŠO): Œ`¬ŠO‰È 2010/10; 53 (‘): 38.

520064. [‘à]yŒ`¬ŠO‰ÈŽŸŠ³update2010z”畆ŽŸŠ³‰©FŽî. “‡‘qNl1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO):
Œ`¬ŠO‰È 2010/10; 53 (‘): 39.

520065. [‘à] 100Î‚Ü‚Å‚¢‚«‚é‚œ‚ß‚Ì–{. ŽR‰º—ŠG1,2 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): “ú–{
R‰Á—îˆãŠw‰ïŽGŽ 2010; 16: 110-1.

522105. [uÀ]y“ÁW: ƒAƒ“ƒ`ƒGƒCƒWƒ“ƒO”ü—eˆã—à Å‘OüzƒLƒŒ[ƒVƒ‡ƒ“EƒTƒvƒŠƒƒ“ƒg‚É‚æ‚éR‰Á—î
Ž¡—Ã. ŽR‰º—ŠG1,2 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): PEPARS 2010/9; 45: 9-16.

[’˜@‘]

620095. [Šwp‘]y”ü—eˆã—Ẫ{ƒcƒŠƒkƒXŽ¡—Áz‘æ7Í ”畆Žá•Ô‚莡—Âɂš‚¯‚éƒ{ƒcƒŠƒkƒX‚Ì—˜—p (ƒR
ƒ“ƒrƒl[ƒVƒ‡ƒ“Ž¡—Ã), p.88-98. ŽR‰º—ŠG1,2 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@), ‘ŠÄC Š@—Ž™Z,
ŠÄC Ž›–{@ƒ, –ڍ荂L, •Ò ”g—˜ˆäŽ‹I, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2010”­s.

620096. [Šwp‘]yŒ`¬ŠO‰ÈADVANCEƒVƒŠ[ƒYII-5@“û–[E“û“ª‚̍Čš‚Ɛ®—e: Å‹ß‚̐i•à (‰ü’ù‘æ2
”Å)zII “û–[‚Ì”ü—eŠO‰È@23 “û–[k¬p, p.224-33. ’r–{”ɍO1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO), ŠÄC ”g
—˜ˆäŽ‹I, •Ò –î–쌒“ñ, Žœ“°o”Å, “Œ‹ž, 2010”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712049. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Reconstruction of nasal defects after skin cancer resection.
•“c@Œ[1, ™–{‰À, H–{•ôŽ1, ª–{@[1, Naohiko Sakai, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): The 20th
China-Japan Joint Congress on Plastic Surgery (2010/8/25-27), Shanghai.

712050. [Šw‰ï (‘Û)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yRhinoplasty IIzImmediate nasal reconstruction
after removal of foreign body using diced cartilage wrapped with temporal fascia. •“c@Œ[1,
Nobuaki Nakakita, Nobutaka Furuyama, Tomoyuki Matsukura, Kazuhiro Hayashi, “‡‘qNl1, “àÀ‰hŽ÷
1 (1Œ`¬E”üŠO): 12th International Congress of Oriental Society of Aesthetic Plastic Surgery
(2010/11/1-3), “Œ‹ž.

713096. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Long-term evaluation of 11 cases who underwent dental
implant treatment in bone-grafted alveolar cleft. Yamazaki Y1, Nakakuki K, Ozeki M, Sezaaki K1,
Takeda A1, Uchinuma E1: 6th congress of the international cleft palate foundation (2010/6/10),
Seoul, Korea. (ŽRèˆÀ°1, £èWˆê˜Y1, •“c@Œ[1, “àÀ‰hŽ÷1: 1Œ`¬E”üŠO)

713097. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) One-stage reconstruction of full thickness alar defect using
folded nasalabial flap combined with redundant skin turn-over flap. •“c@Œ[1, “‡‘qNl1, ª
–{@[1, H–{•ôŽ1, –p@Œ\ˆê1, V”ü—T‘Ÿ1, ‰i“‡˜a‹M1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): The 10th
Korea-Japan Congress of Plastic and Reconstructive Surgery (2010/6/16-18), Busan (Korea).

713098. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The Examination of the Complications Case of the Blepharoptosis
Surgery in Our Institution. “‡‘qNl1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): The 10th Korea-Japan
Congress of Plastic and Reconstructive Surgery (2010/6/16), Busan (Korea).

713099. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Melasam Treatment utilizing 1064nm Q-switced Nd. ŽR‰º—ŠG1,2,
Yuki Matsuo, Makiko Tokuda, Kenji Kondo, Tetsuhiko Toyama, Tadashi Sakai (1Œ`¬E”üŠO, 2Ã“ì
Š™‘q‘‡•a‰@): YAG Laser IMCAS Asia (2010/7/11), Hong-Kong.

713100. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) Development of Wound Dressing Composed of Hyaluronic Acid and
Collagen Spongy Sheet with Epidermal Growth Factor. ˜°‚ ‚©‚Ë1, Akiko Yamamoto, •“c@Œ[1, “à
À‰hŽ÷1, •–ö”\Œõ (1Œ`¬E”üŠO): The 20th China-Japan Joint Congress on Plastic Surgery
(2010/8/25-27), Shanghai.

713101. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) Potential of regenerative medicine of bone tissue using the
autologous umbilical cord and umbilical cord blood. ”nêŽq1, ŽRèˆÀ°1, Â–ö˜a–ç1, •“c@Œ[
1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO (20th Congress of the European Association of Cranio-Maxillp-Facial
Surgery (2010/9/14-17), Bruges (Belgium).

713102. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Proliferative and differential potentials of human bone
marrow-derived mescenchymal cells cultured with autologous serum. ŽRèˆÀ°1, •“c@Œ[1, ”nê
Žq1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): 20th Congress of the European Association of Cranio-Maxillp-Facial
Surgery (2010/9/14-17), Bruges (Belgium).

713103. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Low-fluence Qswitced Nd: YAGLaser treatment of Aging Complex
Pigmentation (ACP). ŽR‰º—ŠG1,2, Yuki Matsuo, Makiko Tokuda, Kenji Kondo, Tetsuhiko Toyama,
Tadashi Sakai, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): 12th International Congress of Oriental
Society of Aesthetic Plastic Surgery (2010/11/3), “Œ‹ž.

713104. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Potential of UCB-derived Plasma as the source of regenerative
medicine. ”nêŽq1, •“c@Œ[1, ŽRèˆÀ°1, Â–ö˜a–ç1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): 12th
International Congress of Oriental Society of Aesthetic Plastic Surgery (2010/11/3), “Œ‹ž.

713105. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) Skin Banking System for Allogeneic Cultured Dermal Substitute
Composed of Hyaluronic Acid and Collagen Spongy Matrix Containing Fibroblasts. ˜°‚ ‚©‚Ë1, Akiko
Hashimoto, Kentaro Kubo, ŽR“c’Œl1, “àÀ‰hŽ÷1, •–ö”\Œõ (1Œ`¬E”üŠO): BIT's 3rd annual congress
of regenerative medicine & stem cells 2010 (2010/12/4-7), Shanghai.

713106. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Low-fluence Qswitced Nd:YAGLaser treatment of Aging Complex
Pigmentation (ACP). ŽR‰º—ŠG1,2, Yuki Matsuo, Makiko Tokuda, Kenji Kondo, Tetsuhiko Toyama,
Tadashi Sakai, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): IMCAS. Paris (2011/1/7), Paris.

713107. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Clinical Benefits of Eyelash Growth ProductgLatisseTMh. ŽR
‰º—ŠG1,2, Yuki Matsuo, Makiko Tokuda, Kenji Kondo, Tetsuhiko Toyama, Tadashi Sakai, “àÀ‰hŽ÷
1 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): IMCAS. Paris (2011/1/7), Paris.

721007. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ãŠááق̌`¬ŠO‰È. ²“¡‰p–Ÿ1, –Ñ—˜–ƒ—¢, –î‘òŒcŽj, ‰F’ÖؗŽˆê,
“àÀ‰hŽ÷2 (1–k—¢Œ€‹†Š•a‰@, 2Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/9), ‹à
‘ò.

722133. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šááَèp‚̍‡•¹Ç‚Æ‚»‚̏C³. ²“¡‰p–Ÿ, –Ñ—˜–ƒ—¢, –î‘òŒcŽj,
“àÀ‰hŽ÷1 (1Œ`¬E”üŠO): “ú–{”ü—eˆã—ËŠ‰ï‘æ41‰ñuK‰ï (2010/5/29), “Œ‹ž.

722134. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”ü—eˆãŠw‚ł̃Aƒ“ƒ`ƒGƒCƒWƒ“ƒOŽ¡—Ã: UP DATE. ŽR‰º—ŠG1,2,
Œ”ö—R‹I, ˆÀâV_Žq, “‚mŒŽ—zŽq, ‚‹Ž”Ž”ü (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ10‰ñ“ú–{R‰Á—î
ˆãŠw‰ï‘‰ï (2010/6/13), ‹ž“s.

722135. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) QƒXƒCƒbƒ`ƒ‹ƒr[‚š‚æ‚у„ƒOƒŒ[ƒU[‚ðŽg—p‚µ‚œƒVƒ~, ŠÌ”Á;
Aging Complex Pigmentation (ACP)‚ÌŽ¡—Ã. ŽR‰º—ŠG1,2 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ10
‰ñ“ú–{R‰Á—îˆãŠw‰ï‘‰ï (2010/6/13), ‹ž“s.

722136. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Short Interval Toning (SIT) Laser vs IPL. ŽR‰º—ŠG1,2, Œ
”ö—R‹I, “¿“c^‹IŽq, ‹ß“¡ŒªŽi, ‰“ŽR“N•F, ”’•Ç¹ˆŸ, Žðˆä@‹K (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ
33ƒŒ[ƒU[Ž¡—Êw‰ï (2010/6/26), ‰¡•l.

722137. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”û–сEáʖт̃Aƒ“ƒ`ƒGƒCƒWƒ“ƒO: áʖшç–э܁uLatisseTMv‚ÌŽg
—pŒoŒ±. ŽR‰º—ŠG1,2 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): “ú–{”ü—eŠO‰ÈŠw‰ï (2010/6/28), “Œ‹ž.

722138. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”ü—eˆãŠw‚ƃAƒ“ƒ`ƒGƒCƒWƒ“ƒO: ”ü—e”畆‰È‚É•K—v‚ȃeƒNƒjƒbƒN
‚ƃIƒvƒVƒ‡ƒ“. ŽR‰º—ŠG1,2 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ10‰ñ“ú–{”ü—e”畆‰ÈŠw‰ï‘‰ï
(2010/8/1), “Œ‹ž.

722139. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŠç‚ÌŽá•Ô‚è‚»‚ê‚Œ‚ê‚ÌŽè–@?‚»‚Ì“K‰ž‚Ɖ”\«?z1. ’“ü—Ã
–@?‚»‚ÌŒÀŠE‚Ɖ”\«?. ²“¡‰p–Ÿ (–k—¢Œ€‹†Š•a‰@): ‘æ28‰ñ“ú–{”ü—e”畆‰ÈŠw‰ï‘‰ïEŠwp‘å‰ï
(2010/8/8), “Œ‹ž.

722140. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒVƒ~EŠÌ”Á‚ÌIPL Toning‚ÌŽÀÛ. ŽR‰º—ŠG1,2 (1Œ`¬E”üŠO,
2Ã“슙‘q‘‡•a‰@): ‘æ33‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (‘æ109‰ñŠwpW‰ï) (2010/10/7), ‹ž“s.

722141. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’áNP“IŽ‰–b—Z‰ð. ŽR‰º—ŠG1,2, Œ”ö—R‹I, “¿“c^‹IŽq, ‹ß
“¡ŒªŽi, ‰“ŽR“N•F, ”’•Ç¹ˆŸ, Žðˆä@‹K, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ33‰ñ“ú–{
”ü—eŠO‰ÈŠw‰ï‘‰ï (2010/10/8), ‹ž“s.

722142. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yäF–ŒŒÅ’è–@‚»‚Ì‘Œz—Œ‘€‚ÉŠááىº‚‚ð—L‚·‚銳ŽÒ‚̕Б€‹“‹ØäF
–ŒŒÅ’èŽèp. “‡‘qNl1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): “ú–{”ü—eŠO‰ÈŠw‰ï‘æ110‰ñŠwpW‰ï
(2011/1/15), “Œ‹ž.

722143. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) pŒã•s–ž—vˆö‚Æ‚»‚̑΍ô?ãŠááَèp‚݂̂ʼn”\‚È‚Ì‚©?. ²
“¡‰p–Ÿ, –Ñ—˜–ƒ—¢, –î‘òŒcŽj, ‰F’ÖؗŽˆê, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ110‰ñ“ú–{”ü—eŠO‰ÈŠw‰ïŠwp
W‰ï (2011/1/15), “Œ‹ž.

722144. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ˜Vl«äF–Œ«Šááىº‚ÇŒóŒQ‚Å‚Í‹“‹Ø•s‘SÇ‚ÆŠá—֋؍SkÇ‚É
‘΂·‚éf’f‚ÆŽ¡—ªd—v. ‰F’ÖؗŽˆê, ‰Í–ì‘Ÿ˜Y, ²“¡‰p–Ÿ1, “àÀ‰hŽ÷2 (1–k—¢Œ€‹†Š•a‰@, 2Œ`¬E
”üŠO): ‘æ110‰ñ“ú–{”ü—eŠO‰ÈŠw‰ïŠwpW‰ï (2011/1/15), “Œ‹ž.

722145 . [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒ“ƒ|ƒWƒEƒ€3zäF–ŒŒÅ’è–@‚»‚Ì‘Œ: —Œ‘€‚ÉŠááىº‚‚ð—L‚·‚é
Š³ŽÒ‚̕Б€‹“‹ØäF–ŒŒÅ’èŽèp. “‡‘qNl1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): “ú–{”ü—eŠO‰ÈŠw‰ï@
‘æ110‰ñŠwpW‰ï (2011/1/15), “Œ‹ž.

723591. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”畆ˆÚApƒpƒX‚̃oƒŠƒAƒ“ƒX•ªÍ. ‘Ÿ“cçq, ’¹‹”ŽŽq1, —§ÎÊ
”T, Žðˆä’mŒb”ü, ˆêŽr¢, ‚–ì–õŒå (1Œ`¬E”üŠO): ‘æ11‰ñ“ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ïŠwpW‰ï
(2010/3-4), ŒŽR.

723592. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) d“x‚̉ºŠ{“ª‹zŽû‚𔺂Á‚œ¬l¬‰ºŠ{Ç‚̈êÇ—á. é‰º@W1, ŽR
èˆÀ°1, ’r–{”ɍO1, Â–ö˜a–ç1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW
‰ï (2010/4/7), ‹à‘ò.

723593. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠO‘lŒ€C¶‚ç‚É•p”­‚µ‚Ä‚¢‚éŽè•”ŠO. ’†‘º@Œ’1, ‘å’J’˱”V
1, ƒTƒŠƒoƒ““Þ’ÃŽq1, —ŒŠp’qŽq (1Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/7-9),
‹à‘ò.

723594. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) bFGF»Ü‚É’ïR‚ðŽŠ‚µ‚œ“«’×ᇂɑ΂·‚铯Ží”|—{^”ç‚ÌŽg—pŒo
Œ±. ŽR“c’Œl1, ŽOD@G, “àÀ‰hŽ÷1, •–ö”\Œõ (1Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠw
pW‰ï (2010/4/7-9), ‹à‘ò.

723595. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Facial rejuvenation:V‹@Šíƒtƒ‰ƒNƒVƒ‡ƒiƒ‹RF‚ÌŽ¡—ÃŒoŒ±. ŽR‰º
—ŠG1,2, Œ”ö—R‹I, “¿“c^‹IŽq, ‹ß“¡ŒªŽi, ‰“ŽR“N•F, Žðˆä@‹K (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@):
‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/7-9), ‹à‘ò.

723596. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Žá”NŽÒ‚Ì•@o‚æ‚è”­¶‚µ‚œ‘B—lùN–EŠà‚Ì1—á. Î•‹§Žj, Œ”ö‚ ‚š
‚¢1, ‹g’|r—T, ”nêŽq1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïE
ŠwpW‰ï (2010/4/7-9), ‹à‘ò.

723597. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) œ]‹È’ÜŽèp‚É‚š‚¯‚é‘€’ÜŠs‚Ö‚ÌDernmal fat graft‚É‚æ‚éÄœ]‹È—\
–h‚ɂ‚¢‚Ä. “잊º—Y1, Š–ì^Žq2 (1–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`
¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/7-9), ‹à‘ò.

723598. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œo”ç“IƒGƒŒƒNƒgƒƒ|[ƒVƒ‡ƒ“–@ (“d‹CúEŒo”瓱“ü–@) ‚̗Տ°Œø‰Ê.
Š–ì^Žq1, “잊º—Y2 (1Œ`¬E”üŠO, 2–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïE
ŠwpW‰ï (2010/4/7-9), ‹à‘ò.

723599. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”A–ŒŠÇˆâŽcÇ8—á‚ÌŒŸ“¢. ”nêŽq1, ’¹‹”ŽŽq1, ‹{àV—Œb, •
“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/7-9), ‹à‘ò.

723600. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Œ‘€Œœ‚«ãüâ|•›“û‚Ì1—á. •–ö”ü—¢1, ‘“c—³Ž™1, “àÀ‰hŽ÷1 (1
Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/7-9), ‹à‘ò.

723601. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “û‘B“û“ª•”‘BŽî‚̈ê—á. ‘“c—³Ž™1, •–ö”ü—¢1, ”nê‹Is, “àÀ
‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/7-9), ‹à‘ò.

723602. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Furlow•Ï–@‚É‚æ‚鏉‰ñŒûŠWŒ`¬p‚̏pŒã¬Ñ. ’r–{”ɍO1, £èW
ˆê˜Y, ŽRèˆÀ°1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï
(2010/4/7-9), ‹à‘ò.

723603. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) DeHaan•Ï–@‚É‚æ‚é—Œ‘€ŒûOŒ`¬Žž‚̐ԐOŒ`¬‚ɑ΂·‚éH•v. £è
Wˆê˜Y1, ’r–{”ɍO1, ŽRèˆÀ°1, ‰i“‡˜a‹M1, –p@Œ\ˆê1, V”ü—T‘Ÿ1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`
¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/7-9), ‹à‘ò.

723604. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) œŠi«‰ºŠ{‘O“ˏNJ³ŽÒ‚ÆŒ’íŽÒ‚̉ºŠ{œ‘̐ϔäŠr. Â–ö˜a–ç1, ’r
–{”ɍO1, ŽRèˆÀ°1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW
‰ï (2010/4/7-9), ‹à‘ò.

723605. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆ««Žîᇐ؏œŒã”ö—ƒa•”‘S‘wŒ‡‘¹‚ɑ΂·‚é‹ÇŠhinge-flap•¹—p‚É‚æ
‚éÄŒš. •“c@Œ[1, V”ü—T‘Ÿ1, –p@Œ\ˆê1, ‰i“‡˜a‹M1, H–{•ôŽ1, ”–ؐT–ç, ª–{@[1, “àÀ‰h
Ž÷1 (1Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/7-9), ‹à‘ò.

723606. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šááَèp‚É‚š‚¯‚鏕Žè‚Ì–ðŠ„‚É‚Â‚¢‚Ä. –î‘òŒcŽj, –Ñ—˜–ƒ—¢, ²“¡
‰p–Ÿ, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/7-9), ‹à‘ò.

723607. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) áʖшç–э܁uLatisseTMv‚̗Տ°Œø‰Ê‚ÌŒŸ“¢. Œ”ö—R‹I, ŽR‰º—ŠG
1,2, “¿“c^‹IŽq, ‹ß“¡ŒªŽi, ‰“ŽR“N•F, Žðˆä@‹K (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ53‰ñ“ú–{Œ`
¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/9), ‹à‘ò.

723608. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰Aˆ³•Âœ—Ö@: •a‘Ô•ÊŒø‰Ê‚ÌŒŸ“¢. ‰“ŽR“N•F, ŽR‰º—ŠG1,2, Œ”ö
—R‹I, “¿“c^‹IŽq, ‹ß“¡ŒªŽi, Žðˆä@‹K (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw
‰ï‘‰ïEŠwpW‰ï (2010/4/9), ‹à‘ò.

723609. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šç–ʂɐ¶‚¶‚œŠî’ê×–Eã”çŽî‚ɑ΂·‚éØœ”͈͂̌Ÿ“¢‚Ɖۑè. “¿“c
^‹IŽq, ŽR‰º—ŠG1,2, Œ”ö—R‹I, ‰“ŽR“N•F, ‹ß“¡ŒªŽi, Žðˆä@‹K (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@):
‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/9), ‹à‘ò.

723610. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Žá‚­, ‚«‚ê‚¢‚Å‚¢‚é‚œ‚߂̂̃Aƒ“ƒ`ƒGƒCƒWƒ“ƒOˆã—Ã. ŽR‰º—ŠG1,2
(1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/9), ‹à‘ò.

723611. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒûOŒûŠW—ô‚ð‡•¹‚µ‚œ—r–Œ”j—ôƒV[ƒNƒGƒ“ƒX‚Ì2—á. •XŒ©˜a–€1, £
èWˆê˜Y1, ŽRèˆÀ°1, ’r–{”ɍO1, é‰º@W1, XŽRŒc‘Ÿ1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO):
‘æ53‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2010/4/9), ‹à‘ò.

723612. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) d”M‚É‚š‚¯‚éŽèŽw”M‚ɑ΂·‚鑁Šú|üŽh“ü‚Əp‘O‘Œ“®ŒP—û.
ª–{@[1, ”–ؐT–ç, H–{•ôŽ1, ŒF‘òŒ›ˆê, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ53‰ñ“ú–{ŽèŠO‰ÈŠw‰ïŠwp
W‰ï (2010/4/15-17), VŠƒ.

723613. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Œ‘€OŠ{ŒûŠW—ô‚ÌŒûŠWŒ`¬Žž‚É—p‚¢‚œ•@’†Šu‰º’[•Ù‚̏pŒãŒo‰ß. £
èWˆê˜Y1, ’r–{”ɍO1, ŽRèˆÀ°1, Â–ö˜a–ç1, “‡‘qNl1, ’†‹v–؍Nˆê, –p@Œ\ˆê1, XŽRŒc‘Ÿ1, “à
À‰hŽ÷1, Î“n–õ•v (1Œ`¬E”üŠO): ‘æ34‰ñ“ú–{ŒûŠW—ôŠw‰ï‘‰ïEŠwpW‰ï (2010/5/27-28), “Œ‹ž.

723614. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Š{—ô•”œˆÚA‚ðs‚Á‚œ•Ð‘€OŠ{ŒûŠW—ôŠ³ŽÒ‚Ì’·Šú—Տ°“I•]‰¿. ŽRè
ˆÀ°1, ’†‹v–؍Nˆê, Î“n–õ•v, ’r–{”ɍO1, £èWˆê˜Y1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ34‰ñ“ú–{Œû
ŠW—ôŠw‰ï‘‰ïEŠwpW‰ï (2010/5/27-28), “Œ‹ž.

723615. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “d‹C‰Î‚ª”M‚ÌŽå‘Ì‚Å‚ ‚Á‚œdÇ“dŒ‚‚̈ê—á. ‘å’J’˱”V1,
’†‘º@Œ’1, ‰ª“c–M•F, V”ü—T‘Ÿ1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ36‰ñ“ú–{”MŠw‰ï
(2010/6/4-5), ‰¡•l.

723616. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) áʖт̃Aƒ“ƒ`ƒGƒCƒWƒ“ƒO: ˆç–ÑŽ¡—Ã. Œ”ö—R‹I, ŽR‰º—ŠG1,2, ˆÀ
âV_Žq, “‚mŒŽ—zŽq, ‚‹Ž”Ž”ü (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ10‰ñ“ú–{R‰Á—îˆãŠw‰ï‘‰ï
(2010/6/12), ‹ž“s.

723617. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) œŠi«‰ºŠ{‘O“ˏǂɂš‚¯‚éŠ{‹ž³Žèp‘OŒã‚̈ô“ª•”‹C“¹Œ`‘Ԃ̕ω»
‚ɂ‚¢‚Ä. ’r–{”ɍO1, Â–ö˜a–ç1, ŽRèˆÀ°1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ20‰ñ“ú–{
Š{•ÏŒ`ÇŠw‰ï‘‰ï (2010/6/15-16), ŽD–y.

723618. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–ƒZƒ“ƒ^[‚É‚š‚¯‚éƒtƒ‰ƒNƒVƒ‡ƒiƒ‹ƒŒ[ƒU[Ž¡—Â̌oŒ±‚ɂ‚¢‚Ä.
–î‘òŒcŽj, ²“¡‰p–Ÿ, –Ñ—˜–ƒ—¢, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ28‰ñ“ú–{”ü—e”畆‰ÈŠw‰ï‘‰ïEŠwp‘å
‰ï (2010/8/7), “Œ‹ž.

723619. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Q-switched Nd-YAG Laser‚É‚æ‚郌[ƒU[ƒs[ƒŠƒ“ƒO‚Ì’·ŠúŒø‰Ê. –Ñ
—˜–ƒ—¢, ²“¡‰p–Ÿ, –î‘òŒcŽj, ŽRŒû–ƒŽq, ¬–ì’Ë‘•c1, ‰F’ÖؗŽˆê, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ28
‰ñ“ú–{”ü—e”畆‰ÈŠw‰ï‘‰ïEŠwp‘å‰ï (2010/8/7), “Œ‹ž.

723620. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ{ƒgƒbƒNƒXƒrƒXƒ^Eƒnƒ“ƒYƒIƒ“ƒZƒ~ƒi[. ²“¡‰p–Ÿ (–k—¢Œ€‹†Š•a
‰@): ‘æ28‰ñ“ú–{”ü—e”畆‰ÈŠw‰ï‘‰ïEŠwp‘å‰ï (2010/8/7), “Œ‹ž.

723621. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚éƒtƒ‰ƒNƒVƒ‡ƒiƒ‹ƒŒ[ƒU[Ž¡—Â̌oŒ±‚ɂ‚¢‚Ä. –î‘òŒc
Žj, –Ñ—˜–ƒ—¢, ²“¡‰p–Ÿ, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ28‰ñ“ú–{”ü—e”畆‰ÈŠw‰ïEŠwp‘å‰ï (2010/8/7-8),
“Œ‹ž.

723622. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‚—îŽÒŽš‰îˆ««Žîá‡: QOL‚Ì‚œ‚ß‚ÉŽš‰î‘SØœ‚ð‚Ç‚€l‚Š‚é‚©? ŽR
‰º—ŠG1,2, Œ”ö—R‹I, Œ”ö—R‹I, “¿“c^‹IŽq, ‹ß“¡ŒªŽi, ‰“ŽR“N•F, Žðˆä@‹K (1Œ`¬E”üŠO, 2Ã“슙
‘q‘‡•a‰@): ‘æ25‰ñ“ú–{”畆ŠO‰ÈŠw‰ï (2010/9/4), ‘啪.

723623. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •@•”‚ɐ¶‚¶‚œ”畆ˆ««Žîᇂ̐؏œÄŒš‚ÌŒŸ“¢. Œ”ö—R‹I, ŽR‰º—ŠG
1,2, “¿“c^‹IŽq, ‹ß“¡ŒªŽi, ‰“ŽR“N•F, Žðˆä@‹K (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ25‰ñ“ú–{”ç
•†ŠO‰ÈŠw‰ï (2010/9/4), ‘啪.

723624. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ä`‘Ñ—R—ˆŠÔ—tŒnŠ²×–E‚Æä`‘ÑŒŒ‚ð—p‚¢‚œœ‘gD‚̍ж. ”nêŽq
1, •“c@Œ[1, ŽRèˆÀ°1, Â–ö˜a–ç1, ‘]ª—R”üŽq, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ19‰ñ“ú–{Œ`¬ŠO‰È
Šw‰ïŠî‘bŠwpW‰ï (2010/9/16-17), ‰¡•l.

723625. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’mŠoáŠQ—̈æ‚Ì‘n‚ɑ΂·‚é_ŒoˆöŽq‹ÇŠ“Š—^‚̉e‹¿. ÎìS‰î
1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ19‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2010/9/16-17), ‰¡
•l.

723626. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒqƒAƒ‹ƒƒ“Ž_‚ƃRƒ‰[ƒQƒ“‚ðŠîÞ‚Æ‚µ‚œEGFŠÜ—L”í•¢Þ‚ÌŠJ”­: ü
ˆÛ‰è×–E‚Ö‚ÌŒŒŠÇV¶ˆöŽqŽY¶‘£iŒø‰Ê. ˜°‚ ‚©‚Ë1, ŽR–{ºŽq, ‰F’ÃŒŽÍO, ŠÛŽRˆŸ—R”ü, •“c Œ[
1, “àÀ‰hŽ÷1, •–ö”\Œõ (1Œ`¬E”üŠO): ‘æ19‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (2010/9/16-17), ‰¡
•l.

723627. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒpƒ‹ƒXƒ‰ƒCƒgÆŽË‚É‚æ‚èƒXƒeƒƒCƒh‹ÇŠ’“ü—Ö@‚Ő¶‚¶‚œŠ×‰š•a•Ï
‚Ì‘Šú‰ü‘P‚ð‚Ý‚œ2Ç—á. “잊º—Y1, Š–ì^Žq2, “àÀ‰hŽ÷2 (1–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@, 2Œ`¬E
”üŠO): ‘æ33‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (‘æ109‰ñŠwpW‰ï) (2010/10/7-8), ‹ž“s.

723628. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒƒ\ƒ|ƒŒ[ƒVƒ‡ƒ“‹@Ší(MesoActhysÒ) ‚Ì”ü”§Œø‰Ê‚ÌŒŸ“¢. Š–ì^
Žq1, “잊º—Y2 (1Œ`¬E”üŠO, 2–k—¢ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@): ‘æ33‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (‘æ109
‰ñŠwpW‰ï) (2010/10/7-8), ‹ž“s.

723629. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šç‚̈óÛ?–Ú‚à‚Æ?. ²“¡‰p–Ÿ, –Ñ—˜–ƒ—¢, –î‘òŒcŽj, ‰F’ÖؗŽˆê,
“àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ33‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (‘æ110‰ñŠwpW‰ï) (2010/10/7), ‹ž“s.

723630. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰»Šw•šŽ¿‰ß•qÇ‚ƃXƒLƒ“ƒPƒA. –î‘òŒcŽj, ²“¡‰p–Ÿ, –Ñ—˜–ƒ—¢, ‰F
’ÖؗŽˆê, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ33‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (‘æ110‰ñŠwpW‰ï) (2010/10/7),
‹ž“s.

723631. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒûŠpŽüˆÍ‚ɑ΂·‚鎡—Ã. ²“¡‰p–Ÿ, –Ñ—˜–ƒ—¢, –î‘òŒcŽj, ‰F’ÖؗŽ
ˆê, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ33‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (‘æ110‰ñŠwpW‰ï) (2010/10/8), ‹ž“s.

723632. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒŒ[ƒU[ƒs[ƒŠƒ“ƒO‚É‚æ‚锧‚ÌŽc—¯‹à‘®‚É‚æ‚锜‰ž. –Ñ—˜–ƒ—¢, ²
“¡‰p–Ÿ, –î‘òŒcŽj, ‰F’ÖؗŽˆê, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ33‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (‘æ110‰ñ
ŠwpW‰ï) (2010/10/8), ‹ž“s.

723633. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) áʖшç–э܁uLatisseTMv‚̗Տ°Šw“IŒŸ“¢. Œ”ö—R‹I, ŽR‰º—ŠG1,2,
“¿“c^‹IŽq, ‹ß“¡ŒªŽi, ‰“ŽR“N•F, ”’•Ç¹ˆŸ, Žðˆä@‹K (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ33‰ñ
“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (2010/10/8), ‹ž“s.

723634. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠÌ”ÁŽ¡—Âɂš‚¯‚éƒXƒLƒ“ƒPƒA‚̏d—v«. “c’†‘•c1, “àÀ‰hŽ÷2 (1
ƒXƒNƒGƒAƒNƒŠƒjƒbƒN, 2Œ`¬E”üŠO): ‘æ33‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (‘æ110‰ñŠwpW‰ï) (2010/10/7-8),
‹ž“s.

723635. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ãŒûOŒ`‘Ԃɉe‹¿‚ð—^‚Š‚éŠ{œ—vˆö‚ÌŒŸ“¢. ’r–{”ɍO1, Â–ö˜a–ç
1, ŽRèˆÀ°1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ33‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (‘æ110‰ñŠwp
W‰ï) (2010/10/7-8), ‹ž“s.

723636. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ}ƒXƒN‚É‚æ‚éˆóÛ‚̕ω»‚ɂ‚¢‚Ä. ²“¡‰p–Ÿ (–k—¢Œ€‹†Š•a‰@):
‘æ10‰ñ“ú–{ŠçŠw‰ï‘å‰ïƒtƒH[ƒ‰ƒ€ŠçŠw (2010/10/23), “Œ‹ž.

723637. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ï‹É“I•Û‘¶—Ö@‚ðs‚Á‚œ—cŽ™‰ºŠ{œœÜ‚Ì1—á. Â–ö˜a–ç1, ’r–{
”ɍO1, ŽRèˆÀ°1, £èWˆê˜Y1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ28‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO
‰ÈŠw‰ïŠwpW‰ï (2010/10/28-29), ‹ž“s.

723638. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹}‘¬‚È‘‘åŒXŒü‚ðŽŠ‚µ‚œ¬Ž™‘€“ª•”ŽîᎂÌ1—á. •XŒ©˜a
–€1, ˜°‚ ‚©‚Ë1, ÎìS‰î1, ‹g’|r—T1, é‰º@W1, ’r–{”ɍO1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E
”üŠO): ‘æ28‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï (2010/10/28-29), ‹ž“s.

723639. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “Ë‘R‚Ì•@ˆôo•Âœ‹@”\•s‘S‚É‚æ‚è”­Œ©‚³‚ê‚œ¬l—á”S–Œ‰ºŒûŠW—ô‚Ì
Ž¡—ÃŒoŒ±. ’r–{”ɍO1, £èWˆê˜Y1, ŽRèˆÀ°1, •“c@Œ[1, “àÀ‰hŽ÷1, ³˜Ò@—²2 (1Œ`¬E”üŠO,
2Žš•@): ‘æ28‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï (2010/10/28-29), ‹ž“s.

723640. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰ºŠ{œŒã•ûˆÚ“®‚É”º‚€èò’ňʒu‚̕ω»‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ’r–{”ɍO
1, Â–ö˜a–ç1, ŽRèˆÀ°1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ28‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠw
pW‰ï (2010/10/28-29), ‹ž“s.

723641. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž•‰È‹ž³Ž¡—ÃŒã‚ÉŠç–Ê‚Ì—ÖŠs•s’²˜a‚ð‘i‚Š‚銳ŽÒ‚ɑ΂µ‚ÄŠ{‹ž³Žè
p‚ƃfƒ“ƒ^ƒ‹ƒCƒ“ƒvƒ‰ƒ“ƒg‚ðŽ{s‚µ‚œ3Ç—á. ’†‹v–؍Nˆê, ŽRèˆÀ°1, Â–ö˜a–ç1, ’r–{”ɍO1, •“c@
Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ28‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï (2010/10/28-29), ‹ž“s.

723642. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) œŠi«‰ºŠ{‘O“ˏǂɂš‚¯‚éŠ{‹ž³Žèp‘OŒã‚Ì‹C“¹Œ`‘ԂƐ㍜ˆÊ’u‚Ì
•Ï‰»‚ɂ‚¢‚Ä. ’r–{”ɍO1, Â–ö˜a–ç1, ŽRèˆÀ°1, £èWˆê˜Y1, “‡‘qNl1, •“c@Œ[1, “àÀ‰hŽ÷
1 (1Œ`¬E”üŠO): ‘æ28‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï (2010/10/28-29), ‹ž“s.

723643. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ôòÜ‚É‚æ‚é‘«”w•”ƒAƒ‹ƒJƒŠ‘¹‚Ì1—á. Î•‹§Žj, Œ”ö‚ ‚š‚¢
1, ‰i“‡˜a‹M1, ÎìS‰î1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ58‰ñ“ú–{E‹ÆEÐŠQˆãŠw‰ïŠwp
W‰ï (2010/11/6), ‰YˆÀ.

723644. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠO‘lŒ€Cˆã‚ç‚É‚æ‚Á‚Ä•p”­‚µ‚Ä‚¢‚éŽè•”ŠO. ’†‘º@Œ’1, ‘å’J
’˱”V1, ƒTƒŠƒoƒ““Þ’ÃŽq1 (1Œ`¬E”üŠO): ‘æ59‰ñ“ú–{”_‘ºˆãŠw‰ïŠwpW‰ï (2010/11/12), ·‰ª.

723645. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) d“xŽlŽˆŠJ•úœÜ‚ɑ΂·‚鑁Šú—V—£”ç•ÙˆÚAp. ª–{@[1, Â–ö
˜a–ç1, ”–ؐT–ç, H–{•ôŽ1, “à–쐳—²2, ÎìS‰î1, •ôŒŽG¹3, ‘åì@F, “àÀ‰hŽ÷1 (1Œ`¬E”ü
ŠO, 2®ŠO, 3‹~–œ): ‘æ37‰ñ“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ïŠwpW‰ï (2010/11/18-19), –ŒŒÃ‰®.

723646. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ã–¬ˆÚA‚𕹗p‚µ‚œ—V—£”ç•ÙˆÚA—á‚ÌŒŸ“¢. ª–{@[1, ŒF‘òŒ›ˆê,
ÎìS‰î1, ”–ؐT–ç, H–{•ôŽ1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ37‰ñ“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ï
ŠwpW‰ï (2010/11/18-19), –ŒŒÃ‰®.

723647. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Platysmal band‚ÌŽ¡—Ö@‚ɂ‚¢‚Ä. ²“¡‰p–Ÿ (–k—¢Œ€‹†Š•a‰@): ‘æ
29‰ñ“ú–{—Տ°”畆ŠO‰ÈŠw‰ïŠwp‘å‰ï (2011/2/25), ‰«“ê.

723648. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠO•@•”‚ÌŠî’ê×–EŠà‚ɑ΂·‚éÄŒšpŽ®‚ÌŒŸ“¢. •“c@Œ[, ™–{‰À,
H–{•ôŽ1, ÎìS‰î1, ŽÄ“c’m‹`1, ª–{@[1, Žðˆä’Œ•F, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ16‰ñ“ú–{
—Տ°–Ñ”¯Šw‰ï^‘æ29‰ñ“ú–{—Տ°”畆ŠO‰ÈŠw‰ï‡“¯ŠwpW‰ï in ‰«“ê (2011/2/25-26), ‰«“ê.

723649. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ä`‘ÑŒŒ—R—ˆfibrin‚ÌŽ©‰Æ‘gDscaffold‚Æ‚µ‚Ẳ”\«. ”nêŽq
1, ŽRèˆÀ°1, •“c@Œ[1, ‘]ª—R”üŽq, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ10‰ñ“ú–{Ä¶ˆã—Êw‰ï‘‰ï
(2011/3/1-2), “Œ‹ž.

723650. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž©ŒÈŒŒŽ”|—{‰º‚É‚š‚¯‚éƒqƒgœ‘—R—ˆŠÔ—tŒn×–E‚Ì‘B”\‚Æ•ª‰»”\.
ŽRèˆÀ°1, •“c@Œ[1, ”nêŽq1, ‘]ª—R”üŽq, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ10‰ñ“ú–{Ä¶ˆã—Êw
‰ï‘‰ï (2011/3/1-2), “Œ‹ž.

732068. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ŽÀ‘H: ƒ{ƒgƒbƒNƒXƒrƒXƒ^: ‰ž—p•Ò. ŽR‰º—ŠG1,2 (1Œ`
¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): AŒ^ƒ{ƒcƒŠƒkƒX“Å‘fŽ{pƒZƒ~ƒi[ (2010/4/4), “Œ‹ž.

732069. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ‚É‚«‚Ñ‚ÌŽ¡—Ã. ŽR‰º—ŠG1,2 (1Œ`¬E”üŠO, 2Ã“슙
‘q‘‡•a‰@): ‘æ6‰ñMSCS (2010/4/18), “Œ‹ž.

732070. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ”ü—eˆãŠw‚ł̃Aƒ“ƒ`ƒGƒCƒWƒ“ƒOŽ¡—ÃUpdate. ŽR‰º—ŠG
1,2 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‰«“ê—\–hˆãŠwŒ€‹†‰ï (2010/6/19), ‰«“ê.

732071. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) Ý‘îåñጂ̌©•û. ‘å’J’˱”V (Œ`¬E”üŠO): ‘æ4‰ñz
–KÝ‘îˆãŠw§˜b‰ï (2010/6/19), z–K.

732072. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJE‹³ˆçu‰‰) ”ü—eˆã—Â̐¬Œ÷Ž–—áEƒVƒ~EŠÌ”ÁŽ¡—Ã. ŽR‰º—ŠG
1,2 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ1‰ñƒAƒ“ƒ`ƒGƒCƒWƒ“ƒOƒZƒ~ƒi[ in –ŒŒÃ‰® (2010/7/25), –Œ
ŒÃ‰®.

732073. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) ¡‚³‚ç•·‚¯‚È‚¢, ¡•·‚«‚œ‚¢QƒXƒCƒbƒ`YAGƒŒ[ƒU
[‚ÌŠî‘b‚ƗՏ°. ŽR‰º—ŠG1,2 (1Œ`¬E”üŠO, 2Ã“슙‘q‘‡•a‰@): MBF (2010/9/5), “Œ‹ž.

732074. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) Oncology of Plastic Surgery. ŽR‰º—ŠG1,2 (1Œ`¬E
”üŠO, 2Ã“슙‘q‘‡•a‰@): ‘æ7‰ñMSCS (2010/10/9), ‹ž“s.

732075. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒVƒ~Ž¡—Ã. ŽR‰º—ŠG1,2 (1Œ`¬E”üŠO, 2Ã“슙
‘q‘‡•a‰@): ‘æ15‰ñƒXƒLƒ“ƒPƒAŒ€‹†‰ï (2010/10/30), “Œ‹ž.

732076. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ŒöŠJuÀ) Qswitced Laser. ŽR‰º—ŠG1,2 (1Œ`¬E”üŠO, 2Ã“ì
Š™‘q‘‡•a‰@): ‘æ1‰ñŽR‰ºm (2010/11/21), –ŒŒÃ‰®.

732077. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•ÊuÀ) ”’ŒŒ‹…‚É‚æ‚鎩ŒÈ‘gD‚ւ̏áŠQ«?Œ`¬ŠO‰Èˆã‚©‚ç‚Ý‚œ
-. ‘å’J’˱”V (Œ`¬E”üŠO): ‘æ3‰ñ’†‰›é‹Ê‘nŽ¡–üŒ€‹†‰ï (2011/2/26), ã”ö.

733234. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‘å‘Ú•”–Iâ|D‰Š. ‹{àV—Œb, ’¹‹”ŽŽq1, ”nêŽq1, •
“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): _“ސìÇ—ጟ“¢‰ï (2010/5/15), ‰¡•l.

733235. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Žèp“K‰ž‚É‹ê—¶‚µ‚œ Žš‰º‘B•”Žîᎂ̈ê—á. X@Žé¢, X
ŽRŒc‘Ÿ1, é‰º@W1, ‹{àV—Œb, Â–ö˜a–ç1, ª–{@[1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): _
“ސìÇ—ጟ“¢‰ï (2010/5/15), ‰¡•l.

733236. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “û–[ƒy[ƒWƒFƒbƒg•a‚Ì1—á. ’†‘º@Œ’1, ‘å’J’˱”V1,
ƒTƒŠƒoƒ““Þ’ÃŽq1 (1Œ`¬E”üŠO): ‘æ5‰ñ“ŒM’n‹æ”畆‰ÈŒ`¬ŠO‰È˜A—‰ï‹c (2010/5/22), ²‹v.

733237. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) •GŠÖßSk‚Æåñጔ­¶‚Æ‚ÌŠÖŒW‚ɂ‚¢‚Ä‚ÌŒ€‹†?‚»‚Ì1:
Œ’íŽÒ‚É‚š‚¯‚é‹ü‹ÈŠp“x‚Ƒ̈³‚ÌŠÖŒW‚ɂ‚¢‚Ä. ’†“‡•¶, ‰¬ŒŽ«ˆê, ’†‘º@Œ’1, ‘å’J’˱”V1 (1Œ`
¬E”üŠO): ‘æ7‰ñ“ú–{åñጊw‰ïŠÖ“ŒbM‰z’n•û‰ï (2010/5/29), ’·–ì.

733238. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Symmetrical Peripheral Gangrene‚Ì1—á. Š}ŒŽN•œ, –k
‘º—ŠGŽq1, –öàV³”V1, ™–{F”V1, âV“¡çq1 (1Œ`¬E”üŠO): ‘æ16‰ñ‰¡•lŒ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€
(2010/6/1), ‰¡•l.

733239. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”’ŒŒ‹…‚É‚æ‚鎩ŒÈ‘gD‚ւ̏áŠQ«. ‘å’J’˱”V (Œ`¬E
”üŠO): ‘æ12‰ñMB—Տ°‹~‹}§˜b‰ï (2010/6/19), z–K.

733240. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ã‰ºŠááىŽîᇐ؏œ‚É‚š‚¯‚鏬H•v. ’†‘º@Œ’1, ‘å’J
’˱”V1, ƒTƒŠƒoƒ““Þ’ÃŽq1 (1Œ`¬E”üŠO): “ú–{Œ`¬ŠO‰ÈŠw‰ï’†•”Žx•”MB’n•û‰ï‘æ60‰ñ—á‰ï
(2010/6/26), Œ–{.

733241. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žš‰º‘BŽîᇂ̈ê—á. ¬–ìy•œ1, ‚‹ŽŽkŽ¡1, –p@Œ\ˆê
1 (1Œ`¬E”üŠO): MB’n•û‰ï (2010/6/29), ’·–ì.

733242. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Š×“ü’܂ɑ΂·‚éƒAƒNƒŠƒ‹lH’ܗÖ@‚ÌŽg—pŒoŒ±. ŽOD@
G, ŽR“c’Œl1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ262‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï“Œ‹ž’n•û‰ï (2010/7/3), “Œ‹ž.

733243. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ã‰ºŠááَîᇐ؏œ‚É‚š‚¯‚鏬H•v. ’†‘º@Œ’1, ‘å’J’Ã
‹±”V1, ƒTƒŠƒoƒ““Þ’ÃŽq1 (1Œ`¬E”üŠO): ‘æ45‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï’†•”Žx•”ŠwpW‰ï (2010/7/10), •l
Œ.

733244. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒXƒvƒŒ[ŠÊ‚É‚æ‚é”M‚Ì3Ç—á. Žç’JˆŸŠóŽq1, •–ö”ü
—¢1, V”ü—T‘Ÿ1, ŒFàVŒ›ˆê, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ18‰ñVh”MƒtƒH[ƒ‰ƒ€ (2010/9/3), “Œ
‹ž.

733245. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚鉻Šw”M‚ÌŒŸ“¢. ’†‘º@Œ’1, ‘å’J’˱”V
1, ƒTƒŠƒoƒ““Þ’ÃŽq1 (1Œ`¬E”üŠO): ‘æ23‰ñ“ú–{”MŠw‰ïbM’n•û‰ï (2010/9/4), b•{.

733246. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Š×“ü’܂̐V‚µ‚¢Ž¡—Õû–@. ŽOD@G, ‚ŽR“ÖŽq1, ŽR“c
’Œl1 (1Œ`¬E”üŠO): ‘æ135‰ñ‰¡•l“ì‹€Ï•a‰@—Տ°W’k‰ï (2010/10/1), ‰¡•l.

733247. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Non-surgical patterns of practice : Lower face. ²
“¡‰p–Ÿ (–k—¢Œ€‹†Š•a‰@): Japanese Facial Aesthetics Council (2010/10/10), “Œ‹ž.

733248. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚éåñጎüpŠúŠÇ—–@. ’†‘º@Œ’1, ‘å’J’˱
”V1, ƒTƒŠƒoƒ““Þ’ÃŽq1 (1Œ`¬E”üŠO): ‘æ7‰ñ’·–쌧åñግ§˜b‰ï (2010/10/17), Œ–{.

733249. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “«åñጂð—L‚·‚éÒ‘‘¹Š³ŽÒ‚ւ̈êŠÑ‚µ‚œƒPƒA‚ð–Ú
Žw‚µ‚Ä. ¬ŠÔ‘ò”üç, ¯–ì–ŸŽq, “‡“cŒ[Žu, “A@^“¿, ’†‘º@Œ’1, ‘å’J’˱”V1, ƒTƒŠƒoƒ““Þ’ÃŽq1 (1
Œ`¬E”üŠO): ‘æ7‰ñ’·–쌧åñግ§˜b‰ï (2010/10/17), Œ–{.

733250. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’܏°‘¹‚ɑ΂µ¢•t‚¯’Ü£‚ð—p‚¢‚œŽ¡—ÃŒoŒ±. ŽR“c’Œl
1, ‚ŽR“ÖŽq1, ŽOD@G (1Œ`¬E”üŠO): ‘æ13‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2010/11/6), ‰¡•l.

733251. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) f’f‚É‹ê—¶‚µ‚œŒŒŠÇ•a•Ï‚Ì2Ç—á. ‹Ž–{­•q1, ‘º‰ºˆê
W (1Œ`¬E”üŠO): ‘æ13‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2010/11/6), ‰¡•l.

733252. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‹~–œ‚µ‚Š‚œ‰óŽ€«‹Ø–Œ‰Š‚Ì1—á. ˆêŽr¢, ’¹‹”ŽŽq
1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ13‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2010/11/6), ‰¡•l.

733253. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) •s³oŒ‡‚ðŒJ‚è•Ô‚·ä`•”Žîᎂ̈ê—á. ‹Tˆäç—T1, ’B•x
—S‰î, ‘“c—³Ž™1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ13‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2010/11/6), ‰¡•l.

733254. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) º‘щ¡Šu–ŒÇ‚Ì1—á. âV“¡çq1, –k‘º—ŠGŽq1, ™–{
F”V1, ¬Œ@ˆ€, óˆä‘ñ—Y, —é–؈ê‰ë (1Œ`¬E”üŠO): ‘æ13‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2010/11/6),
‰¡•l.

733255. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’Ž‰¹”g‚𕹗p‚µ‚œ’Žk¬”çØ‚É‚æ‚éŽèªŠÇŠJ•úp‚̏pŒã
¬Ñ. Š–ì^Žq1, “잊º—Y2, ë“à—²•v2, ‘åàV¬”V2, ‹{è•üŽq2 (1Œ`¬E”üŠO, 2–k—¢Œ€‹†Šƒƒf
ƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@): ‘æ13‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2010/11/6), ‰¡•l.

733256. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒqƒAƒ‹ƒƒ“Ž_‚ƃRƒ‰[ƒQƒ“‚ðŠîÞ‚Æ‚µ‚œEGFŠÜ—L”í•¢Þ
‚ÌŠJ”­: üˆÛ‰è×–E‚Ö‚ÌŒŒŠÇV¶ˆöŽqŽY¶‘£iŒø‰Ê. ˜°‚ ‚©‚Ë1, ŽR–{ºŽq, ‰F’ÃŒŽÍO, ŠÛŽRˆŸ—R”ü, •
“c Œ[1, “àÀ‰hŽ÷1, •–ö”\Œõ (1Œ`¬E”üŠO): ‘æ13‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2010/11/6), ‰¡•l.

733257. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) MRSAtÇ‚ð‡•¹‚µ‚œ‰º‘ړ«’×ᇂÌ1—á. ‹g’|r—T
1, ª–{@[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): ‘æ13‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€ (2010/11/6), ‰¡•l.

733258. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’áNP“I@Ž‰–b‚ɑ΂·‚鎡—Ã. ŽR‰º—ŠG1,2 (1Œ`¬E
”üŠO, 2Ã“슙‘q‘‡•a‰@): Œ©‚œ–ڂ̃Aƒ“ƒ`ƒGƒCƒWƒ“ƒO (2010/11/6), “Œ‹ž.

733259. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŽY•wl‰È‚Æ‹Š—Í‚µ‚ÄŽ¡—Âðs‚Á‚œ1—á. ˆêŽr¢, ’¹‹
”ŽŽq1, ‘å‰z@“Ö, •—ŠÔ‹Å’j, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): _“ސìÇ—ጟ“¢‰ï (2010/11/13),
‘Š–ÍŒŽ.

733260. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’‹Œ«–jœœÜ‚É”º‚€áu’ɐ«áŠQ‚Ì1—á. ‹Ž–{ˆê‹P, ™
–{F”V1, âV“¡çq1, ŽR–{^‹›, –k‘º—ŠGŽq1 (1Œ`¬E”üŠO): _“ސìÇ—ጟ“¢‰ï (2010/11/13), ‘Š–Í
ŒŽ.

733261. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŠO‘lŒ€C¶‚ç‚É‚æ‚Á‚Ä•p”­‚µ‚Ä‚¢‚éŽè•”ŠO?‘æ2•ñ:
‚»‚ÌŒã‚Ç‚€‚È‚Á‚œ??. ‘å’J’˱”V1, ’†‘º@Œ’1, ƒTƒŠƒoƒ““Þ’ÃŽq1 (1Œ`¬E”üŠO): “ú–{Œ`¬ŠO‰ÈŠw
‰ï’†•”Žx•”MB’n•û‰ï‘æ61‰ñ—á‰ï (2010/12/4), ’·–ì.

733262. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”_‹Æ‚ɏ]Ž–‚·‚éŠO‘l—¯Šw¶‚ç‚É•p”­‚µ‚œŽè•”ŠO. ’†
‘º@Œ’ (Œ`¬E”üŠO): ²‹vˆãŽt‰ï (2011/1/13), ²‹v.

733263. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”_‹Æ‚ɏ]Ž–‚·‚éŠO‘l—¯Šw¶‚ç‚É•p”­‚µ‚œŽè•”ŠO. ’†
‘º@Œ’ (Œ`¬E”üŠO): ‘æ44‰ñ¬”–k²‹vˆãŠw‰ï (2011/2/13), ¬”.

733264. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) šk_Œo‰è×–EŽî‚Ì2—á. X”ü•äŽq, ‘åè­ŠC, ”ì“c@C,
”ì“c˜aŒb, ’†“‡³ŒÈ, –؉ºTŒá, ŒŽ@–rŽq, “¿‰i‰h‹g, ––Ÿ•F, Î•‹§Žj1, ’·“cG–€2 (1Œ`¬E”üŠO,
2ã”ö’†‰›‘‡•a‰@): ‘æ48‰ñé‹ÊŒ§ˆãŠw‰ï (2011/2/20), ‚³‚¢‚œ‚Ü.

733265. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šááىº‚Žèp—á‚ÌŒŸ“¢. Î•‹§Žj1, Œ”ö‚ ‚š‚¢1, ‰i
“‡˜a‹M1, ã–쑏ˆê˜Y2 (1Œ`¬E”üŠO, 2ã”ö’†‰›‘‡•a‰@): ‘æ48‰ñé‹ÊŒ§ˆãŠw‰ï (2011/2/20), ‚³‚¢
‚œ‚Ü.

733266. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‡ŽwÇpŒã‚̐F‘f’Ÿ’…‚ɑ΂µ (ŽèŠÖß•”‚©‚ç‚Ì) ‘S‘wA
”ç‚É‚æ‚è’£‘Ö‚Š‚ðs‚¢—ǍD‚ÈŒ‹‰Ê‚ð“Ÿ‚œˆê—á. ‘å’J’˱”V1, ’†‘º@Œ’1, ƒTƒŠƒoƒ““Þ’ÃŽq1 (1Œ`¬E
”üŠO): ‘æ12‰ñ“Œ–kMŒ`¬ŠO‰È§˜b‰ï (2011/2/25), ’·–ì.

733267. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) —LŒs‘å‘Ú‹Ø–Œ’£‹Ø”ç•Ù‚É‚æ‚é• •ÇÄŒš‚ÌŒoŒ±. –p@Œ\ˆê
1, ˆÉ“¡GŒ›1, ‚‹ŽŽk–Ÿ1 (1Œ`¬E”üŠO): ‘æ12‰ñ“Œ–kMŒ`¬ŠO‰È§˜b‰ï (2011/2/25), ’·–ì.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-320006. [Ç—á•ñ] ŠÖßƒŠƒEƒ}ƒ`‚É‚æ‚鐬lœ«Š{ŠÖß‹­’ŒÇŠ³ŽÒ‚ÌŽ¡—ÃŒoŒ±. Â–ö˜a–ç1,
ŽRèˆÀ°1, ’r–{”ɍO1, “àÀ‰hŽ÷1, ‰““¡•œm, Î“n–õ•v (1Œ`¬E”üŠO): “ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŽ
2009/9; 25 (3): 295-302.

H21-520006. [‘à]y“ª•”EŠç–Ê‚ÌŒ`¬ŠO‰Èzœá°p. “‡‘qNl1, Žðˆä’Œ•F1, “àÀ‰hŽ÷1 (1Œ`
¬E”üŠO): Œ`¬ŠO‰È 2009/10; 52 (‘Š§): S203-11.

H21-522007. [uÀ]yŽ„‚ÌŽèp‚ƍ‡•¹Ç‰ñ”ð‚̃Rƒc (‘æ32‰ñ)zŽš‰º‘BŽîᇂɑ΂·‚éŽèp. ª–{@[
1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): Œ`¬ŠO‰È 2009/8; 52 (8): 939-46.

H21-522008. [uÀ]y“ÁW: Šááىº‚Ç‚ÌŽ¡—Ð헪zŠááىº‚ÇŽèp‚̍‡•¹Ç‚Æ‚»‚̑΍ô. “‡‘qN
l1, Â–ö˜a–ç1, “àÀ‰hŽ÷1 (1Œ`¬E”üŠO): Œ`¬ŠO‰È 2010/1; 53 (1): 57-63.

[Šw‰ïEŒ€‹†‰ï“™]

H17-723001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ª”ç‚ðCARRIER‚Æ‚µ‚œ—LŒsó‘€“ª‹Ø–Œ•Ù‚Æ•ª‘w
A”ç‚É‚æ‚菬ŽšÇÄŒšŽš‰î‚̔畆Œ‡‘¹•”‚ð”í•¢‚µ‚œ1—á. Â–ö˜a–ç1, ’†–kMº (1Œ`¬E”üŠO): ‘æ48
‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ïEŠwpW‰ï (2005/4/13-15), “Œ‹ž.

H19-723002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) œ‘ŠÔ—tŒnŠ²×–E‚Ì“€Œ‹•Û‘¶‚Ì—L–³‚É‚æ‚鐫Ž¿
”äŠr. Â–ö˜a–ç1, ŽRèˆÀ°1 (1Œ`¬E”üŠO): ‘æ7‰ñ“ú–{Ä¶ˆã—Êw‰ï‘‰ï (2008/3/31), –ŒŒÃ‰®.

H20-723005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆ««ŠÖßƒŠƒEƒ}ƒ`‚É‚æ‚鐬lœ«Š{ŠÖß‹­’ŒÇ
Š³ŽÒ‚ÌŽ¡—ÃŒoŒ±. Â–ö˜a–ç1, ŽRèˆÀ°1, ’r–{”ɍO1 (1Œ`¬E”üŠO): ‘æ18‰ñ“ú–{Š{•ÏŒ`ÇŠw‰ï‘‰ï
(2008/6/17-18), –ŒŒÃ‰®.

H20-723006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ãŠ{ŽO•ªŠ„œØ‚è‚Å™ù‡‰ü‘P‚ðs‚Á‚œ1—á. Â
–ö˜a–ç1, ŽRèˆÀ°1, ’r–{”ɍO1 (1Œ`¬E”üŠO): ‘æ26‰ñ“ú–{“ªŠWŠ{Šç–ÊŠO‰ÈŠw‰ïŠwpW‰ï
(2008/10/16-17), ·‰ª.

H21-713001. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical features of arterial injuries to the
upper extremity. Nemoto M1, Aoyagi K1, Kashiwagi S1, Akimoto M1, Kumazawa K, Ishikawa S1, Uchinuma
E1: The 8th congress of the asian pacific federation of societies for surgery of the hand
(2009/11/13), Kaohsung, Taiwan. (ª–{@[1, Â–ö˜a–ç1, ”–ؐT–ç1, H–{•ôŽ1, ÎìS‰î1, “àÀ
‰hŽ÷1: 1Œ`¬E”üŠO)

H21-713002. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Reconstruction for a deep burn wound of the
elbow in extensive burn patients. Nemoto M1, Akimoto M1, Sugimoto T1, Ishikawa S1, Uchinuma E1:
5th congress of the world society for reconstructive microsurgery (2009/6/25), Okinawa. (ª–{@
[1, H–{•ôŽ1, ™–{F”V1, ÎìS‰î1, “àÀ‰hŽ÷1: 1Œ`¬E”üŠO)

H21-713003. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Selection of vessels of free tissue transfer
for open fractures to a lower extremity. Nemoto M1, Aoyagi K1, Kashiwagi S1, Akimoto M1, Uchinuma
E1: 5th congress of the world society for reconstructive microsurgery (2009/6/25), Okinawa. (ª
–{@[1, Â–ö˜a–ç1, ”–ؐT–ç1, H–{•ôŽ1, “àÀ‰hŽ÷1: 1Œ`¬E”üŠO)

H21-723017. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠŽõ«S“à–Œ‰Š‚𕹔­‚µ‚œ”M‚Ì2—á. V”ü
—T‘Ÿ1, ª–{@[1, ÎìS‰î1, ™–{F”V1, H–{•ôŽ1, ”–ؐT–ç1, “àÀ‰hŽ÷1, ‘Š”nˆêˆå2 (1Œ`¬E
”üŠO, 2‹~–œ): ‘æ35‰ñ“ú–{”MŠw‰ïŠwpW‰ï (2009/6/4), “Œ‹ž.

H21-723018. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) L”͈͔MŒãፍ­Sk‚ÌŽ¡—ÃŒoŒ±. ª–{@[
1, V”ü—T‘Ÿ1, é‰º@W1, XŽRŒc‘Ÿ1, •ŽRhŽq (1Œ`¬E”üŠO): ‘æ12‰ñ–k—¢Œ`¬ŠO‰ÈƒtƒH[ƒ‰ƒ€
(2009/11/28), ‰¡•l.

H21-733011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚Õ‚é‚Õ‚é‚Ì‚š”§‚ð‚ß‚Ž‚µ‚Ä, ƒVƒ~ƒVƒ‚ÌŒŽˆö, Ž¡
—Ã, —\–h. ƒTƒŠƒoƒ““Þ’ÃŽq (Œ`¬E”üŠO): ²‹v•ä’¬Œ’NƒtƒH[ƒ‰ƒ€ (2009/7/15), ’·–ì.

H21-733012. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@”MŠ³ŽÒ‚É‚š‚¯‚éåñጔ­¶—vˆö
‚ÌŒŸ“¢. •ÐŽRˆŸŽ÷, Šâ‘º‹M”ü, AŒŽ”ü•ä, ˆêŽr¢, ª–{@[1, “àÀ‰hŽ÷1, ‘Š”nˆêˆå2 (1Œ`¬E”ü
ŠO, 2‹~–œ): ‘æ18‰ñ“ú–{”MŠw‰ïŠÖ“Œ’n•û‰ï (2010/1/30), “Œ‹ž.

H21-733013. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™Šáâ|’êüóœÜ‚ɑ΂·‚鉺’Œ‹Ø
ŽüˆÍ”—£p‚ÌŒoŒ±. ™–{‰À, ’r–{”ɍO1, ™–{F”V1, ª–{@[1, •“c@Œ[1, “àÀ‰hŽ÷1 (1Œ`¬E
”üŠO): ‘æ261‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠÖ“ŒŽx•”“Œ‹ž’n•û‰ï (2010/3/6), “Œ‹ž.Š’ù³ÄŒfÚ


”畆‰ÈŠw

[Šwp˜_•¶]

110202. [ŒŽ’˜] Antibodies against cyclic citrullinated peptide in psoriatic arthritis of Japanese
patients. Maejima H1, Aki R1, Watarai A1, Shirai K, Hamada Y2, Katsuoka K1: J Dermatol 2010/4;
37 (4): 339-45. (‘O“‡‰pŽ÷1, ˆÀåY—Ljê1, “n‰ï@W1, ”’ˆä‹ž”ü, •l“c—SŽq2, Ÿ‰ªŒ›¶1: 1”畆, 2
•a‘ԁEf—ÃŒn)

110203. [ŒŽ’˜] Prognostic significance of the hair follicle stem cell marker nestin in patients
with malignant melanoma. Tanabe K1, Amoh Y1, Kanoh M, Takasu H1, Sakai N, Sato Y, Katsuoka K1:
Eur J Dermatol 2010/5-6; 20 (3): 283-8. (“c•ÓŒ’ˆê1, “V‰HN”V1, ‚{@”Ž1, Ÿ‰ªŒ›¶1: 1”畆)

110204. [ŒŽ’˜] The analysis of the clinical, radiological and laboratory variables in psoriatic
arthritis, 25 Japanese patients. Maejima H1, Taniguchi T1, Watarai A1, Aki R1, Katsuoka K1: J
Dermatol 2010/7; 37 (7): 647-56. (‘O“‡‰pŽ÷1, ’JŒû—F‘¥1, “n‰ï@W1, ˆÀåY—Ljê1, Ÿ‰ªŒ›¶1: 1
”畆)

110205. [ŒŽ’˜] The nail diseases in psoriatic arthritis with Japanese patients by using modefied
nail psoriasis severity index scores. Maejima H1, Taniguchi T1, Watarai A1, Katsuoka K1: Int J
Dermatol 2010/8; 49 (8): 901-6. (‘O“‡‰pŽ÷1, ’JŒû—F‘¥1, “n‰ï@W1, Ÿ‰ªŒ›¶1: 1”畆)

110206. [ŒŽ’˜] Th2 Immune Response Plays a Critical Role in the Development of Nickel -Induced
Allergic Contact Dermatitis. Niiyama S1, Tamauchi H2, Amoh Y1, Terashima M, Matsumura Y, Kanoh
M, Habu S, Komotori J, Katsuoka K1: Int Arch Allergy Immunol 2010/9; 153 (10): 303-14. (VŽRŽj
˜N1, ‹Ê“àGˆê2, “V‰HN”V1, Ÿ‰ªŒ›¶1: 1”畆, 2”÷¶•š)

110207. [ŒŽ’˜] Hyper IgE syndrome diagnosed in early infancy by gene analysis of STAT3 mutation.
Watarai A1, Niiyama S1, Morita M1, Bando Y2, Minegishi Y, Katsuoka K1: Eur J Dermatol 2011/3; 21
(2): 254-5. (“x‰ï@W1, VŽRŽj˜N1, X“c”ü•ä1, â“Œ—R‹I2, Ÿ‰ªŒ›¶1: 1”畆, 2¬Ž™)

120038. [ŒŽ’˜] ˆ««Žîá‡‚ð‡•¹‚µ‚œ”畆‹Ø‰Š‚̗Տ°“IŒŸ“¢. Vˆä@’B1, “í@@•‘, ŒKŒŽTŽ¡1, ’JŒû
—F‘¥1, X“c”ü•ä1, ]“¡GŒõ1, ŽOˆäƒá1, Ÿ‰ªŒ›¶1 (1”畆): “ú–{”畆‰ÈŠw‰ïŽGŽ 2010/5; 120 (6):
1197-202.

210008. [€ŒŽ’˜] Sarcoidosis expressing as four distinct cutaneous lesions. Maejima H1, Nakahara
C, Watarai A1, Katsuoka K1: Eur J Dermatol 2010/7-8; 20 (4): 505-6. (‘O“‡‰pŽ÷1, “n‰ï@W1, Ÿ
‰ªŒ›¶1: 1”畆)

210009. [€ŒŽ’˜] Cholesterol embolism associated with MPO-ANCA. Maejima H1, Noguchi T, Tanei R:
Eur J Dermatol 2010/7-8; 20 (4): 539-40. (‘O“‡‰pŽ÷1: 1”畆)

210010. [€ŒŽ’˜] Superficial mycosis of the breast caused by Curvularia inaequalis. Tanabe K1,
Seino M, Senda S: Eur J Dermatol 2010/9-10; 20 (5): 658-9. (“c•ÓŒ’ˆê1: 1”畆)

320035. [Ç—á•ñ] ãüˆÛŽî. “c•ÓŒ’ˆê (”畆): Visual Dermatology 2011/1; 10 (1): 56-57

320036. [Ç—á•ñ] ‘å‚«‚È’×ᇂ𔺂Á‚œAcquired Reactive Perforating Collagenosis. ’†ŒŽç•ÛŽq
1, VŽRŽj˜N1, Ÿ‰ªŒ›¶1 (1”畆): ”畆‰È‚̗Տ° 2010/6; 52 (6): 869-72.

520066. [‘à] ¬Ž™‚ÌŒŒŠÇ‰Š. Ÿ‰ªŒ›¶1, “n‰ï@W1 (1”畆): “ú–{¬Ž™”畆‰ÈŠw‰ïŽGŽ 2011/2; 30:
9-13.

521019. [‰ðà] ‰~Œ`’E–яǎ¡—Âɂš‚¯‚éƒZƒtƒ@ƒ‰ƒ“ƒ`ƒ“‚Ì–ðŠ„. ꎓ¡“T[ (”畆): ƒAƒ‹ƒJƒƒCƒhŒ€‹†
‰ï‰ïŽ 2010/7; 36: 17-23.

522106. [uÀ]y“ÁW: ¬Ž™”畆f—à ƒp[ƒtƒFƒNƒgƒKƒCƒhzI. “úí“I‚É‚Ý‚ç‚ê‚鏬Ž™‚̔畆ŽŸŠ³@’Ü‚Ì
ˆÙí. ꎓ¡“T[ (”畆): Monthly Book Derma 2010/4; 164 (‘Š§): 56-9.

522107. [uÀ]y“ÁW: Œõü‚Ɣ畆z—Տ°—á: ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX. Vˆä@’B1, ‘àV^ŽÀŽq1, “í@@
•‘, Ÿ‰ªŒ›¶1, à_Œû‘Ÿ‘¢ (1”畆): ”畆•af—à 2010/4; 32 (4): 393-6.

522108. [uÀ]y“ÁW: Œõü‚Ɣ畆z—Տ°—á: amyopathic dermatomyositis?”畆Çó‚ª“úŒõ”˜˜I‚É‚æ‚è
Ä”R‚µ‚œ¬Ž™Šú”­Ç—á?. Vˆä@’B1, Ÿ‰ªŒ›¶1, •y“c¹G (1”畆): ”畆•af—à 2010/4; 32 (4):
401-4.

522109. [uÀ]yå@–ƒ]—lŒŒŠÇ‰Šz‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX (SLE) Š³ŽÒ‚ɐ¶‚¶‚œ—á. Vˆä@’B (”畆):
ˆã–ò‚Ì–å 2010/4; 50 (4): 112-3.

522110. [uÀ]yMondor•az‹¹•””牺‚ÉŒ¡ˆø’ɂ𔺂€õódŒ‹‚Æ‚µ‚悶‚œ—á. ²“¡’ŒÆ (”畆): ˆã
–ò‚Ì–å 2010/5; 50: 154-5.

522111. [uÀ]y“ÁW: ƒtƒbƒgƒPƒAŽÀ‘HƒKƒCƒhz‡@‘«’Ü”’á. Vˆä@’B (”畆): ŠÅŒì‹Zp 2010/11; 56
(3): 32-3.

522112. [uÀ]y“ÁW: ƒtƒbƒgƒPƒAŽÀ‘HƒKƒCƒhz‡CŒ{Šá, äEãñ. Vˆä@’B (”畆): ŠÅŒì‹Zp 2010/11; 56
(13): 38-9.

522113. [uÀ]y”sŒŒÇ]vHenoch-SchoenleinŽ‡”Á•a‚ÌŒo‰ß’†‚ɐ¶‚¶‚œ—á. ꎓ¡“T[ (”畆): ˆã–ò‚Ì
–å 2011/1; 50 (6): 92-3.

530003. [‚»‚Ì‘Œ (ƒŒƒ^[)] Efficacy of tacrolimus against Churg-Strauss syndrome in a patient with
myasthenia gravis. Niiyama S1, Amoh Y1, Suzuki K, Wada T2, Katsuoka K1: Rheumatology International
2010/4; 30 (6): 847-8. (VŽRŽj˜N1, “V‰HN”V1, ˜a“c’B•F2, Ÿ‰ªŒ›¶1: 1”畆, 2‘Ž‡f—Ã)

530004. [‚»‚Ì‘Œ (’Z•ñ)] Non-pigmenting Fixed Drug Eruption Induced by Sorafenib. Tanabe K1, Amoh
Y1, Mii S1, Eto H1, Iwamura M2, Katsuoka K1: Acta Derm Venereol 2010/5; 90 (3): 307. (“c•ÓŒ’ˆê
1, “V‰HN”V1, ŽOˆäƒá1, ]“¡GŒõ1, Šâ‘º³Žk2, Ÿ‰ªŒ›¶1: 1”畆, 2”å”AŠí)

530005. [‚»‚Ì‘Œ (Letters to the Editor)] Intractable leg ulcer associated with gouty tophi:
Treatment with allogeneic culture dermal substitute. Tanabe K1, Amoh Y1, Katsuoka K1, Kuroyanagi
Y: J Dermatol 2010/11; 37 (11): 998-9. (“c•ÓŒ’ˆê1, “V‰HN”V1, Ÿ‰ªŒ›¶1: 1”畆)

530006. [‚»‚Ì‘Œ (Letters to the Editor)] Erythroderma induced by morphine sulfate. Arai S1, Mukai
H: J Dermatol 2011/3; 38 (3): 288-9. (Vˆä@’B1: 1”畆)

540031. [‚»‚Ì‘Œ]yƒ}ƒ‹ƒz”畆‰ÈƒZƒ~ƒi[@No.205zŒŒŠÇ‰ŠEŒŒŠÇáŠQƒKƒCƒhƒ‰ƒCƒ“. Ÿ‰ªŒ›¶ (”畆):
ƒ‰ƒWƒINIKKEI 2010/5.

540032. [‚»‚Ì‘Œ] “Œ‹žŽx•”Šwp‘å‰ï‚֍s‚Á‚œ‚È‚ç. Ÿ‰ªŒ›¶ (”畆): ƒfƒ‹ƒ}‹äŠy•” 2010/9; p.11-2.

540033. ‚»‚Ì‘Œ [(Mini Report)] pŒã8”N–Ú‚É‘œ”­“]ˆÚ‚𐶂¶‚œˆ««•FŽî‚Ì1—á. ’JŒû—F‘¥1, Ÿ‰ª
Œ›¶1 (1”畆): ”畆‰È‚̗Տ° 2010/12; 52 (13): 2080-1.

[’˜@‘]

620097. [Šwp‘] (•ª’SŽ·•M)yWHAT'S New in ”畆‰ÈŠw@2010-2011zWHAT'S NEW in —Տ°”畆‰ÈŠw@äP
ŒŽ•aEŒŒŠÇ‰Š@2. ŒŒŠÇ‰ŠEŒŒŠÇáŠQƒKƒCƒhƒ‰ƒCƒ“‚̃GƒbƒZƒ“ƒX, p.130-1. Ÿ‰ªŒ›¶ (”畆), •Ò ‹{’n
—ÇŽ÷, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ, 2010/4”­s.

620098. [Šwp‘] (•ª’SŽ·•M)y‚ ‚œ‚炵‚¢ŠwZ•ÛŒ’”畆‰Èƒ}ƒjƒ…ƒAƒ‹zPart3 Šw“¶ŠúEŽvtŠú‚É‚æ‚­‚Ý
‚ç‚ê‚é”畆ŽŸŠ³@N –Ñ”¯ˆÙí, p.133-5. ꎓ¡“T[ (”畆), •Ò’˜ ”nê’ŒŽq, f’f‚ÆŽ¡—ÃŽÐ, 2010/9”­s.

620099. [Šwp‘] (•ª’SŽ·•M)y”畆ŽŸŠ³ÅV‚ÌŽ¡—Ã2011-2012zVII äPŒŽ•a‚š‚æ‚Ñ—ÞŽ—ŽŸŠ³@2 –«‰~
”óƒGƒŠƒeƒ}ƒg[ƒfƒX (DLE), p.90. Ÿ‰ªŒ›¶ (”畆), •ÒW ‘ëì‰ë_, “n•ÓWˆê, “ì]“°, “Œ‹ž,
2011/1”­s.

620100. [Šwp‘] (•ª’SŽ·•M)y¬Ž™—Տ°‰h—{Šwz‘æ5Í ÇŒó‚Ɗӕʐf’f@K –Ñ”¯E’܂ُ̈í, p.150-2.
ꎓ¡“T[ (”畆), •Ò Ž™‹Ê_Žq, ‹Êˆä@_, Ž…r–Ÿ, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 2011/1”­s.

620101. [Šwp‘] (•ª’SŽ·•M)y”畆Çó‚©‚ç‚Ý‚œŒŒŠÇ‰Šf’f‚ÌŽèˆø‚« (‘æ1”Å)z‘æ1•” f’f•Ò@‘˜_
ƒŒŒŠÇ‰Šf—Â̊T—v„7. ŒŒŠÇ‰Š‚ÌŒŒ‰t, ”AŒŸž, p.24-5. Vˆä@’B (”畆), •Ò Œú¶˜J“­È“«ŒŒŠÇ
‰Š‚ÉŠÖ‚·‚é’²žŒ€‹†”Ç, ‹àŒŽo”Å, “Œ‹ž, 2011/3”­s.

620102. [Šwp‘] (•ª’SŽ·•M)y”畆Çó‚©‚ç‚Ý‚œŒŒŠÇ‰Šf’f‚ÌŽèˆø‚« (‘æ1”Å)z‘æ1•” f’f•Ò@Še˜_
ƒ’†ŒŒŠÇ‚ÌŒŒŠÇ‰Š„3-1. Œ‹ß«‘œ”­“®–¬‰Š, p.48-50. ꎓ¡“T[ (”畆), •Ò Œú¶˜J“­È“«ŒŒŠÇ‰Š
‚ÉŠÖ‚·‚é’²žŒ€‹†”Ç, ‹àŒŽo”Å, “Œ‹ž, 2011/3”­s.

620103. [Šwp‘] (•ª’SŽ·•M)y”畆Çó‚©‚ç‚Ý‚œŒŒŠÇ‰Šf’f‚ÌŽèˆø‚« (‘æ1”Å)z‘æ1•” f’f•Ò@Še˜_
ƒ’†ŒŒŠÇ‚ÌŒŒŠÇ‰Š„3-2. ”畆Œ^Œ‹ß«‘œ”­“®–¬‰Š, p.51-2. ꎓ¡“T[ (”畆), •Ò Œú¶˜J“­È“«ŒŒ
ŠÇ‰Š‚ÉŠÖ‚·‚é’²žŒ€‹†”Ç, ‹àŒŽo”Å, “Œ‹ž, 2011/3”­s.

620104. [Šwp‘] (•ª’SŽ·•M)y”畆Çó‚©‚ç‚Ý‚œŒŒŠÇ‰Šf’f‚ÌŽèˆø‚« (‘æ1”Å)z‘æ1•” f’f•Ò@Še˜_
ƒŒŒŠÇ‚ÌŒŒŠÇ‰Š„8. Henoch-SchonleinŽ‡”Á•a, p.75-7. ꎓ¡“T[ (”畆), •Ò Œú¶˜J“­È“«ŒŒŠÇ‰Š
‚ÉŠÖ‚·‚é’²žŒ€‹†”Ç, ‹àŒŽo”Å, “Œ‹ž, 2011/3”­s.

620105. [Šwp‘] (•ª’SŽ·•M)y”畆Çó‚©‚ç‚Ý‚œŒŒŠÇ‰Šf’f‚ÌŽèˆø‚« (‘æ1”Å)z‘æ1•” f’f•Ò@Še˜_
ƒ‚»‚Ì‚Ù‚©‚ÌŒŒŠÇáŠQ„10. å@–ƒ]—lŒŒŠÇ‰Š, p.81-2. Vˆä@’B (”畆), •Ò Œú¶˜J“­È“«ŒŒŠÇ‰Š
‚ÉŠÖ‚·‚é’²žŒ€‹†”Ç, ‹àŒŽo”Å, “Œ‹ž, 2011/3”­s.

620106. [Šwp‘] (•ª’SŽ·•M)y”畆Çó‚©‚ç‚Ý‚œŒŒŠÇ‰Šf’f‚ÌŽèˆø‚« (‘æ1”Å)z‘æ2•” Ç—á•Ò (CD-ROM
ŽûÚ)@”畆ŒŒŠÇ‰Š‚ÆŒŒŠÇáŠQ@Mondor•a. ²“¡’ŒÆ (”畆), •Ò Œú¶˜J“­È“«ŒŒŠÇ‰Š‚ÉŠÖ‚·‚é’²ž
Œ€‹†”Ç, ‹àŒŽo”Å, “Œ‹ž, 2011/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712051. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Reduced expression of dermcidin, a peptide active
against Propionibacterium acnes, in the sweat of acne vulgaris patients. Fujimura T1: 9th meeting
of the German-Japanese society of dermatology (2010/6/12), Weimar. (“¡‘º‹¿’j1: 1”畆)

713108. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Reduced expression of dermicidin, a peptide active
against Propionibacterum acnes, in the sweat of acne vulgaris patients. Yoshino T, Fujimura T1,
Mukuno A1, Sato N1, Nakano T1, Takahashi M, Suzuki T, Matsukuma S, Katsuoka K1: The 70th Annual
meeting for the society for investigative dermatology (2010/5/7), Atlanta, Georgia, USA. (“¡‘º
‹¿’j1, Œü–ì@“N1, ²“¡’ŒÆ1, ’†–ì•q–Ÿ1, Ÿ‰ªŒ›¶1: 1”畆)

713109. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Microscopic polyangiitis accompaniied by septic
vasculitis and Henoch-Schoenlein purpura. Niiyama S1: ‘æ9‰ñ“ú“Ɣ畆‰ÈŠw‰ï (2010/6/9), Weimar,
Germany. (VŽRŽj˜N1: 1”畆)

713110. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Histological Examination About Localization of Hair
Follicle Stem Cell. Saito N1, Amoh Y1, Katsuoka K1, Niiyama S1, Nemoto N2: 6th WORLD CONGRESS
FOR HAIR RESEARCH (2010/6/17), Cairns, Australia. (ꎓ¡“T[1, “V‰HN”V1, Ÿ‰ªŒ›¶1, VŽRŽj˜N
1, ª–{“TŽq2: 1”畆, 2ƒoƒCƒIƒCƒ[ƒWƒ“ƒOŒ€‹†ƒZ)

722146. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒŠƒxƒhŽŸŠ³‚ÌŽ¡—Ã. ‘àVŠ²’j (”畆): ‘æ109‰ñ
“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï (2010/4/17), ‘åã.

722147. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ŒŒŠÇ“÷Žî: V‚µ‚¢Ž¡—Ð헪. ‘àVŠ²’j (”畆): ‘æ
109‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï (2010/4/17), ‘åã.

722148. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ¬Ž™‚ÌŒŒŠÇ‰Š. Ÿ‰ªŒ›¶ (”畆): ‘æ34‰ñ“ú–{¬
Ž™”畆‰ÈŠw‰ï‘‰ïŠwp‘å‰ï (2010/7/3), ˆ€•Q.

722149. [Šw‰ï (‘S‘)] (ƒ~ƒjƒŒƒNƒ`ƒƒ[) ŠÖßÇ«Š£á‚̐f’f‚ÆŽ¡—Ã. ‘O“‡‰pŽ÷1, Ÿ‰ªŒ›¶1 (1”ç
•†): ‘æ25‰ñ“ú–{Š£áŠwp‘å‰ï (2010/9/4), ‰F•”.

722150. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ’j«Œ^’E–яǐf—ÃKƒCƒhƒ‰ƒCƒ“‚̃|ƒCƒ“ƒg. ꎓ¡
“T[ (”畆): ‘æ33‰ñ“ú–{”ü—e”畆ŠO‰ÈŠw‰ï‘‰ï (2010/10/8), ‹ž“s.

722151. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒRƒ‰[ƒQƒ“ƒyƒvƒ`ƒhŠÜ—LH•iÛŽæ‚É‚æ‚é–Ñ”¯‚ÌŒ’
N‘i. ꎓ¡“T[ (”畆): ‘æ74‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”Šwp‘å‰ï (2011/2/12), “Œ‹ž.

723651. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) f’f‚É“ïa‚µ‚œ–¬ŠÇŒnŽîᇂ̈ê—á. —шŸ–îŽq, “c‘ã‚ ‚©
‚è, ’†ŒŽ„Žu, “à@”ŽŽj, Žtˆä—mˆê, ŒÃ]‘—², ‹Ë¶”ü–›, ‘àVŠ²’j1, Šâè@G (1”畆): ‘æ26‰ñ“ú
–{”畆ˆ««Žîᇊw‰ïŠwp‘å‰ï (2010/6/4), “Œ‹ž.

723652. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”x“]ˆÚ‚ª‹}‘¬‘ˆ«‚µ‚œ“ª•”ŒŒŠÇ“÷Žî?–UŒŸ—á?. ‘àV^
ŽÀŽq1, ŒKŒŽTŽi1, ‘àVŠ²’j1, ꎓ¡“T[1, Ÿ‰ªŒ›¶1, Œ‰ªWO (1”畆): ‘æ26‰ñ“ú–{”畆ˆ««Žî
ᇊw‰ïŠwp‘å‰ï (2010/6/4), “Œ‹ž.

723653. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) DŽ_‹…Z‚𔺂Á‚œŽá”N«‰©F“÷‰èŽî?“–‰ÈŒoŒ±—á‚ÌŒŸ
“¢‚ð‰Á‚Š‚Ä?. ꎓ¡“T[1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ34‰ñ“ú–{¬Ž™”畆‰ÈŠw‰ï (2010/7/3), ˆ€•Q.

723654. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Direct transplantation of upper part of hair follicle
containing hair follicle stem cell area (hfPSA) promote the recovery of peripheral nerve injury.
“V‰HN”V1, ˆÀåY—Ljê1, ‰ÍŒŽŽ‰ë2, •l“c—SŽq3, Robert M Hoffman, Ÿ‰ªŒ›¶1 (1”畆, 2¶—, 3•a
‘ԁEf—ÃŒn): “ú–{Œ€‹†”畆‰ÈŠw‰ï ‘æ35‰ñ”NŽŸŠwp‘å‰ïE‘‰ï (The 35th Annual Meeting of the Japanese
Society for Investigative Dermatology), (2010/12/3), ˜a‰ÌŽR.

723655. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Histological examination about localization of hair
follicle stem cell. ꎓ¡“T[1, “V‰HN”V1, VŽRŽj˜N1, ª–{“TŽq2, Ÿ‰ªŒ›¶1 (1”畆, 2ƒoƒCƒI
ƒCƒ[ƒWƒ“ƒOŒ€‹†ƒZ): “ú–{Œ€‹†”畆‰ÈŠw‰ï ‘æ35‰ñ”NŽŸŠwp‘å‰ïE‘‰ï (The 35th Annual Meeting of the
Japanese Society for Investigative Dermatology), (2010/12/3), ˜a‰ÌŽR.

723656. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) áy]‹u]‚ª‘œ”­‚µ‚œ–Ø‘º•a‚Ì1—á. Vˆä@’B1, ‘P‰Æ—R
—, ŠŒŽ•üŒb, •S£—tŽq, ’†–ì•q–Ÿ1, ‰q“¡@Œõ, Œã“¡—T”ü (1”畆): ‘æ74‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx
•”Šwp‘å‰ï (2011/2/11), “Œ‹ž.

731087. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒAƒŒƒ‹ƒM[«”畆ŽŸŠ³‚̐f’f‚ÆŽ¡—Ẫ|ƒCƒ“ƒg?å@–ƒ]
‚ƃAƒgƒs[«”畆‰Š‚𒆐S‚É?. Vˆä@’B (”畆): Œ§‰›3Žs“à‰Èˆã‰ïŠwpu‰‰‰ï (2010/7/9), ŠC˜V–Œ.

731088. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “à‰Èˆã‚̐f‚é”畆ŽŸŠ³. Ÿ‰ªŒ›¶ (”畆): Four Season's
Conference (2010/5/11), ‘Š–ÍŒŽŽs.

731089. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”畆‰È‚©‚ç‚Ý‚œŒŒŠÇ‰Š. Ÿ‰ªŒ›¶ (”畆): ‘æ2‰ñŒŠÖ
“ŒŒŒŠÇ‰ŠƒtƒH[ƒ‰ƒ€ (2010/11/5), “Œ‹ž.

731090. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”ç]‚̐f•ûA“Á‚ɃŠƒxƒh‚ɂ‚¢‚Ä. Ÿ‰ªŒ›¶ (”畆): ‘æ
74‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”Šwp‘å‰ï (2011/2/11), “Œ‹ž.

731091. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ¬Ž™‚ÌŒŒŠÇ‰Š. Ÿ‰ªŒ›¶ (”畆): ƒ}ƒ‹ƒz”畆‰ÈƒZƒ~ƒi
[ (2011/3/1), “Œ‹ž.

732078. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Epithelial cell entry activity of
Mycobacterium leprae depends on a specific sequence within mce1A. “¡‘º‹¿’j (”畆): ‘æ11‰ñƒ
[ƒxƒ‹ƒgƒRƒbƒzŒ€‹†Š^–k—¢Œ€‹†ŠE–k—¢‘åŠw‡“¯ƒVƒ“ƒ|ƒWƒEƒ€ (2010/10/26), “Œ‹ž.

732079. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‰~Œ`’E–яǂ̎¡—Âɂš‚¯‚éƒZƒtƒ@ƒ‰ƒ“
ƒ`ƒ“‚Ì–ðŠ„. ꎓ¡“T[ (”畆): ‘æ36‰ñƒAƒ‹ƒJƒƒCƒhŒ€‹†‰ï (2010/6/26), “Œ‹ž.

732080. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‰~Œ`’E–яǎ¡—Â̌»ó‚ƍ¡Œã‚Ì“W–]?
Š³ŽÒ‚³‚ñ‚ðf—µ‚È‚ª‚çŽv‚€‚±‚Æ?. ꎓ¡“T[ (”畆): ‘æ34‰ñ‰~Œ`’E–яǂðl‚Š‚é‰ï (2010/7/17), “Œ
‹ž.

732081. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‘æ74‰ñ“Œ‹žŽx•”Šwp‘å‰ï‚ɂ‚¢‚Ä. Ÿ
‰ªŒ›¶ (”畆): ƒfƒ‹ƒ}‹äŠy•” (2010/9/7), ‘Š–ÍŒŽ.

732082. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ˆÞk«’E–Ñ(pseudopelade). ꎓ¡“T[
(”畆): ‘æ74‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”Šwp‘å‰ï (2011/2/11), “Œ‹ž.

732083. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ŠÖßÇ«Š£á‚̐f’f‚ÆŽ¡—Ã. ‘O“‡‰pŽ÷
(”畆): ‘æ74‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•” (2011/2/11), “Œ‹ž.

732084. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒnƒ“ƒZƒ“•a‚ÌŠŽõ—lŽ®?‚ç‚¢‹Û‚Ì•@”S
–Œã”ç×–E‚ւ̐N“ü‹@\?. ²“¡’ŒÆ (”畆): ‘æ74‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”Šwp‘å‰ï (2011/2/12),
“Œ‹ž.

732085. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) äPŒŽ•a‚Ì•a‘Ô‚ÆŽ¡—Ã?”畆‹Ø‰Š. Vˆä@
’B (”畆): ‘æ74‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹žŽx•”Šwp‘å‰ï (2011/2/12), “Œ‹ž.

733268. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ\ƒ‰ƒtƒFƒjƒu (ƒlƒNƒTƒo[ƒ‹Ò) ‚É‚æ‚é–ò]‚Ì
4—á. “c•ÓŒ’ˆê1, ŽOˆäƒá1, ]“¡GŒõ1, Ÿ‰ªŒ›¶1, Šâ‘º³Žk2 (1”畆, 2”å”AŠí): ‘æ830‰ñ“ú–{
”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2010/6/19), _“ސì

733269. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Curvularia inaequalis‚É‚æ‚é•\Ý«^‹ÛÇ
‚Ì1—á. “c•ÓŒ’ˆê1, Ž–ì‚Ý‚«, å“c»Žq, Ÿ‰ªŒ›¶1 (1”畆): ‘æ61‰ñ“ú–{”畆‰ÈŠw‰ï’†•”Žx•”Šwp
‘å‰ï (2010/9/11), ‘åã.

733270. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒvƒŒƒhƒjƒ]ƒƒ““Š—^’†‚Ƀjƒ…[ƒ‚ƒVƒXƒ`ƒX”x
‰Š‚𔭏ǂµ‚œŽ©ŒÈ–Ɖu«…ávÇ‚Ì1—á. “Œ‹V“ß’ÃŽq1, ã“c‹ªŽm1, ]“¡GŒõ1, ‘àV^ŽÀŽq1, ²“¡’Œ
Æ1, Ÿ‰ªŒ›¶1 (1”畆): “ú–{”畆‰ÈŠw‰ï‘æ832‰ñ“Œ‹ž’n•û‰ï (2010/9/11), ‰¡•l.

733271. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹Ç–ÊŒ^ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. ‘O“‡‰pŽ÷
1, Ÿ‰ªŒ›¶1 (1”畆): “ú–{”畆‰ÈŠw‰ï‘æ832‰ñ“Œ‹ž’n•û‰ï (2010/9/11), ‰¡•l.

733272. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž‘±‰Aˆ³ôò—Ö@‚ª—LŒø‚Å‚ ‚Á‚œ”w•””牺”^
ᇂÌ1—á. Š‰Y’qŽk1, ã“c‹ªŽm1, ‹{àV—ŒbŽq, VŽRŽj˜N1, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1 (1”畆): “ú–{
”畆‰ÈŠw‰ï‘æ832‰ñ“Œ‹ž’n•û‰ï (2010/9/11), ‰¡•l.

733273. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “û–[ŠO (ãè–åŽüˆÍ) Paget•a‚Ì1—á. ¬ŒŽG
Æ1, ã“c‹ªŽm1, Š‰Y’qŽk1, ’†ŒŽç•ÛŽq1, ‘àV^ŽÀŽq1, ŽOˆäƒá1, “V‰HN”V1, ²“¡’ŒÆ1, âV“¡
“T[1, Ÿ‰ªŒ›¶1, ‘å–؁@˜a (1”畆): “ú–{”畆‰ÈŠw‰ï‘æ832‰ñ“Œ‹ž’n•û‰ï (2010/9/11), ‰¡•l.

733274. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒCƒ“ƒtƒŠƒLƒVƒ}ƒu‚ðŽg—p‚µ‚œ”^áv«Š£á‚Ì1
—á. ‘O“‡‰pŽ÷1, •ÐŽR’qŒbŽq1, ã“c‹ªŽm1, “n‰ï@W1, Ÿ‰ªŒ›¶1 (1”畆): ‘æ2‰ñ_“ސ슣ᝎ¡—Ã
Œ€‹†‰ï (2010/9/18), ‰¡•l.

733275. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶‘€• •”‚É’×ᇂ𐶂¶‚œ—á. ꎓ¡“T[ (”畆):
‘æ4‰ñ_“ސì—Տ°”畆•a—‘gDŒŸ“¢‰ï (2010/11/13), ’¬“c.

733276. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒVƒNƒƒrƒ‹”]Ç‚ð‚«‚œ‚µ‚œ…“—‚Ì1—á. ¬
ŒŽGÆ1, ã“c‹ªŽm1, Vˆä@’B1, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1, –]ŒŽ‘ˆê˜Y (1”畆): “ú–{”畆‰ÈŠw‰ï‘æ833
‰ñ“Œ‹ž’n•û‰ï (2010/11/20), ‰¡•l.

733277. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒ€ƒV™ù‚Ì1—á. ã“c‹ªŽm1, X“c”ü•ä1,
“c•ÓŒ’ˆê1, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1, ÎìS‰î (1”畆): “ú–{”畆‰ÈŠw‰ï‘æ833‰ñ“Œ‹ž’n•û‰ï
(2010/11/20), ‰¡•l.

733278. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “÷‰èŽî«ŠááىŠ‚Ì1—á. Vˆä@’B1, ‘P‰Æ—R
—, •S£—tŽq, ’†–ì•q–Ÿ1, ‰q“¡@Œõ (1”畆): ‘æ74‰ñ“ú–{”畆‰ÈŠw‰ï“Œ•”Žx•”Šwp‘å‰ï (2010/11/20),
å‘ä.

733279. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Epithelioid hemangioendothelioma‚Ì1—á. ‚
{@”Ž1, ã“c‹ªŽm1, ŽOˆäƒá1, ꎓ¡“T[1, ‘àVŠ²’j1, Ÿ‰ªŒ›¶1, •XŒ©˜a–€2, •“c@Œ[2 (1”ç
•†, 2Œ`¬E”üŠO): “ú–{”畆‰ÈŠw‰ï‘æ834‰ñ“Œ‹ž’n•û‰ï (2010/12/18), ìè.

733280. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒnƒCƒhƒƒLƒVƒEƒŒƒA‚É‚æ‚é“«‰º‘Ú’×ᇂÌ
1—á. •ÐŽR’qŒbŽq1, ã“c‹ªŽm1, ’·‹Ž”ü‰À, “n‰ï@W1, ²“¡’ŒÆ1, Ÿ‰ªŒ›¶1 (1”畆): “ú–{”畆‰È
Šw‰ï‘æ834‰ñ“Œ‹ž’n•û‰ï (2010/12/18), ìè.

733281. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’WgFŒ‹ß‚ª‘œ”­‚µ‚œ“ª•”ƒŠƒ“ƒpŠÇ“÷Žî (LAS)
‚Ì1—á. Š‰Y’qŽk1, ã“c‹ªŽm1, ’†ŒŽç•ÛŽq1, ‘àV^ŽÀŽq1, ²“¡’ŒÆ1, âV“¡“T[1, ‘àVŠ²’j1, Ÿ
‰ªŒ›¶1, “”I@‹B (1”畆): “ú–{”畆‰ÈŠw‰ï‘æ835‰ñ“Œ‹ž’n•û‰ï (2011/1/15), ‰¡•l.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H20-110003. [ŒŽ’˜] Human and mouse hair follicles contain both multipotent and monopotent
stem cells. Amoh Y1, Kanoh M, Niiyama S1, Kawahara K2, Sato Y, Katsuoka K1, Hoffman RM: Cell Cycle
2009/1; 8 (1): 176-7. (“V‰HN”V1, VŽRŽj˜N1, ‰ÍŒŽŽ‰ë2, ²“¡—Yˆê, Ÿ‰ªŒ›¶1: 1”畆, 2¶—)

H21-520007. [‘à]y”畆‰ÈV“üˆã‹Çˆõ‚Ì‚œ‚ß‚Ì”ç]‚ÌŒ©•ûE‹LÚ–@@”畆‰È‚Ì‹€’ÊŒŸŒê‚ðŠw‚Ú‚€z
Part.1 “÷ŠáŠŒ©‚ÌŒ©•û, ‹LÚ–@@‘à04 ”畆‰È“Á—L‚Ì”­]–Œ. Ÿ‰ªŒ›¶ (”畆): Visual Dermatology
2010/3; 4ŒŽ†: 346-50.


”å”AŠí‰ÈŠw

[Šwp˜_•¶]

110208. [ŒŽ’˜] ƒ¿1,2-Fucosylated and ƒÀ-N-acetylgalactosaminylated prostate specific antigen as
an efficient marker of prostatic cancer. •Ÿ“‡ŒcŽq, ²“¡ˆÐ•¶1, ”nêŽu˜Y1, ŽR‰ºŽŽq (1”å”AŠí):
GLYCOBIOLOGY 2010/4; 20 (4): 452-60.

110209. [ŒŽ’˜] Dasatinib Is Preclinically Active against Src-Overexpressing Human Transitional
Cell Carcinoma of the Urothelium with Activated Src Signaling. Jonathan M Levitt, ŽR‰º‰p”V1,
Weiguo Jian, Seth P Lemer, Guru Sonpavde (1”å”AŠí): Molecular Cancer Therapeutics 2010/5; 9 (5):
1128-35.

110210. [ŒŽ’˜] Nomogram to predict seminal vesicle invasion using the status of cancer at the base
of the prostate on systematic biopsy. ‘å–x@—, Michael W Kattan, Changhong Yu, Œ–{˜a«1, ²
“¡ˆÐ•¶1, Îˆä~ˆê˜Y1, ‹{ìˆºŽq, “ü]@Œ[1, Šâ‘º³Žk1, ‹k@­º (1”å”AŠí): International Journal
of Urology 2010/6; 17 (6): 534-40.

110211. [ŒŽ’˜] Dietary Administration of Mushroom Mycelium Extracts in Patients with Early Stage
Prostate Cancers Managed Expectantly: A Phase II Study. Z‹g‹`Œõ, ‹ŽªŸ‘P, ⚁@‘Ps, ‹g‘ºk
Ž¡, ²“¡ˆÐ•¶1, ŽÔ@‰pr, •À–؏rˆê, ŽÂŒŽM—Y (1”å”AŠí): Japanese Journal of Clinical Oncology
2010/6; 40 (10): 967-72.

110212. [ŒŽ’˜] Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma
of the Upper Urinary Tract: An International Validation Study. Giacomo Novara, Œ–{˜a«1, Wassim
Kassouf, Thomas J Walton, Hans-Martin Fritsche, Patric J Bastian, Juan I Martinez-Salamanca,
Christian Seitz, R John Lemberger, Maximilian Burger, Assaad El-Hakim, ”nêŽu˜Y1, Guida Martignoni,
Amit Gupta, Pierre I Karakiewicz, Vincenzo Ficarra, Shahrokh F Shariat (1”å”AŠí): EUROPEAN UROLOGY
2010/6; 57 (6): 1064-71.

110213. [ŒŽ’˜] Proteomic Study of Sera from Patients with Bladder Cancer: Usefulness of S100A8
and S100A9 Proteins. Sho Minami, Yuichi Sato, Toshihide Matsumoto, Taihei Kageyama, Yusuke
Kawashima, ¬Ž›‹`’j, Îˆä~ˆê˜Y1, Œ–{˜a«1, Ryo Nagashio, ‰ªˆÀ@ŒM2 (1”å”AŠí, 2•a—): CANCER
GENOMICS & PROTEOMICS 2010/7; 7 (4): 181-90.

110214. [ŒŽ’˜] Morphology of hypoxia following cryoablation in a prostate cancer murine model:
Its relationship to necrosis, apoptosis and, microvessel density. –Ø‘º«‹M1, Zahid Rabbani,
Vladimir Mouraviev, Matvey Tsivian, Zeljko Vujaskovic, ²“¡ˆÐ•¶1, ”nêŽu˜Y1, John M Baust, John
G Baust, Thomas J Polascik (1”å”AŠí): CRYOBIOLOGY 2010/8; 61 (1): 148-54.

110215. [ŒŽ’˜] Role of Vitamin D3 as a Sensitizer to Cryoablation in a Murine Prostate Cancer Model:
Preliminary In Vivo Study. –Ø‘º«‹M1, Zahid Rabbani, Vladimir Mouraviev, Matvey Tsivian, Jorge
Caso, ²“¡ˆÐ•¶1, ”nêŽu˜Y1, Zeljko Vujaskovic, John M Baust, John G Baust, Thomas J Polascik (1
”å”AŠí): UROLOGY 2010/9; 76 (3): 764.e14-e20.

110216. [ŒŽ’˜] Analysis of Urinary Function Using Validated Instruments and Uroflowmetry After
Primary and Salvage Prostate Cryoablation. –Ø‘º«‹M1, Vladimir Mouraviev, Matvey Tsivian, Daniel
M Moreira, Janice M Mayes, Thomas J Polascik (1”å”AŠí): UROLOGY 2010/11; 76 (5): 1258-65.

110217. [ŒŽ’˜] Association of Tumor Necrosis With Pathological Features and Clinical Outcome in
754 Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An
International Validation Study. Christian Seitz, Amit Gupta, Shahrokh F Shariat, Œ–{˜a«1,
Wassim Kassouf, Thomas J Walton, Hans-Martin Fritsche, Wolfgang Otto, Stefan Tritschler, Patrick
J Bastian, Joaquin Carballido, Vincenzo Ficarra, Pierre I Karakiewicz, Walter Artibani, Guido
Mazzoleni, Giacomo Novara (1”å”AŠí): JOURNAL OF UROLOGY 2010/11; 184 (5): 1895-900.

110218. [ŒŽ’˜] Profilin 1 overexpression in renal cell carcinoma. “ì“c@—@1, Šâ‘º³Žk2, ¬Ž›
‹`’j, Yusuke Kawashima, ’r“cŸb1, ‘呐@—m2, “¡“c“N•v2, ‘O“c’‰Œv, ”nêŽu˜Y2 (1‘åŠw‰@ˆã—ÃŒn
Œ€‹†‰È, 2”å”AŠí): International Journal of Urology 2011/1; 18 (1): 63-71.

110219. [ŒŽ’˜] Assessment of immunological biomarkers in patients with advanced cancer treated
by personalized peptide vaccination. Noguchi M, Mine T, Komatsu N, Suekane S, Moriya F, Matsuoka
K, Yutani S, Shichijo S, Yamada A, Toh U, Kawano K, Azuma K, Uemura H, Okuno K, Œ–{˜a«1, Yanagimoto
H, Yamanaka R, Oka M, Todo S, Sasada T, Itoh K (1”å”AŠí): Cancer BIOLOGY & THERAPY 2011/1; 10 (12):
1266-79.

110220. [ŒŽ’˜] Feasibility Study of an Intensity-Modulated Radiation Model for the Study of
Erectile Dysfunction. Bridget F Koontz, MD, Hui Yan, PhD, –Ø‘º«‹M1, Zeljko Vujaskovic, MD, PhD,
Craig Donatucci, MD, Fang-Fang Yin, PhD (1”å”AŠí): Journal of Sexual Medicine 2011/2; 8 (2): 411-8.

110221. [ŒŽ’˜] Pelvimetric Dimensions do not Impact upon Nerve Sparing or Erectile Function
Recovery in Patients Undergoing Radical Retropubic Prostatectomy. Christian von Bodman, Mika P
Matikainen, Ricardo L.Favaretto, Œ‰ºˆêm1, John P Mulhall, James A.Eastham, Peter T Scardino,
Oguz Akin, Farhang Rabbani (1”å”AŠí): Journal of Sexual Medicine 2011/2; 8 (2): 567-74.

110222. [ŒŽ’˜] Angiolymphoid hyperplasia with eosinophilia on penile skin in a 7-year-old child.
Nishi M1, Matsumoto K1, Fujita T1, Satoh T1, Iwabuchi K2, Iwamura M1, Baba S1 (1”å”AŠí, 2•a—):
JOURNAL OF PEDIATRIG SURGERY 2011/3; 46 (3): 559-61. (Œ@·G1, Œ–{˜a«1, “¡“c“N•v1, ²“¡ˆÐ
•¶1, ŠâŸºŒ[ˆê2, Šâ‘º³Žk1, ”nêŽu˜Y1)

120039. [ŒŽ’˜] “–‰@‚É‚š‚¯‚éTUL‚ÌŽ¡—ЬÑ. Îì@–í1, ŠÛ@“T•v, •œˆäËŽi, ŽR“c‘׎j1, ‰¡“cáÁ
“ñ, “y“c–š”ü1, Œ@·G1, “c”šŒ’ˆê1, ”nêŽu˜Y1 (1”å”AŠí): Japanese Journal of Endourology and
ESWL 2010/4; 23 (1): 116-21.

120040. [ŒŽ’˜] Morcellation‚É‚š‚¯‚éhand-piece”œ“]–@‚Ì—L—p«‚ÌŽÀØ. •œŽR‹M”Ž1, ÝŠy•q–ç, “¡
“c“N•v1, ‹v•Û¯ˆê, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): Japanese Journal of Endourology and ESWL
2010/4; 23 (1): 133-7.

120041. [ŒŽ’˜] ”A‚̃vƒƒeƒI?ƒ€‰ðÍ–@ŠJ”­‚©‚çf’fƒ}[ƒJ[Šl“Ÿ‚ÉŒü‚¯‚Ä. ¬Ž›‹`’j, ‘呐@—m1 (1
”å”AŠí): “ú–{t‘ŸŠw‰ïŽ 2010/5; 52 (4): 480-4.

120042. [ŒŽ’˜] ƒ^ƒ_ƒ‰ƒtƒBƒ‹‚Ì—LŒø«‚ƈÀ‘S«‚ÌŒŸ“¢‚š‚æ‚ÑŠ³ŽÒS—‚ւ̉e‹¿. ŽR–{Œ’˜Y, ²X–؏t–Ÿ,
X“c@‡, –ƒ¶‘Ÿs, Â–ØŒcˆê˜Y, ‘Ÿ“c“¹–ç, Žu‘º@“N, aŒûG”V1, Œã“¡—²‘Ÿ, [àV@—§, ÎìŒö—f (1
”å”AŠí): “ú–{«‹@”\Šw‰ïŽGŽ 2010/6; 25 (1): 29-36.

120043. [ŒŽ’˜] “ûŽ™–³ÇŒó«…tÇŠ³ŽÒ‚ɑ΂·‚é”A˜HŠŽõÇƒŠƒXƒNƒtƒ@ƒNƒ^[‚ÌŒŸ“¢. Œ@·G1, Œ
–ì‘å•ã, ”’–öŒc”V, ŽRè—Yˆê˜Y (1”å”AŠí): “ú–{¬Ž™”å”AŠí‰ÈŠw‰ïŽGŽ 2010/6; 19 (1): 10-3.

120044. [ŒŽ’˜] ƒnƒCƒŠƒXƒN‘O—§‘BŠà‚ɑ΂·‚é“à•ª”å—Ö@•¹—p‚É‚æ‚éHDR brachytherapy‚ÌŒŸ“¢. ²“¡ˆÐ
•¶1, ÎŽR”ŽžŠ2, “c”šŒ’ˆê1, –k–ì‰ëŽj, •ÊŠ‰pŽ¡1, “ì“c@—@3, –Ø‘º«‹M1, “¡“c“N•v1, Œ–{˜a«
1, ¬’J³Žq2, ã‘O•ôŽq, ‰oì@W, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3‘åŠw‰@ˆã
—ÃŒnŒ€‹†‰È): ”å”AŠíŠO‰È 2010/8; 23 (8): 1181-2.

120045. [ŒŽ’˜] œ“]ˆÚ‚ª‚ñŠ³ŽÒ‚ɑ΂·‚éEORTC QOL’²žƒ‚ƒWƒ…[ƒ‹?EORTC QLQ-BM22“ú–{Œê”Å‚ÌŠJ”­
?. ²“¡ˆÐ•¶1, ¬—э‘•F, –x@‘×—S, ”Ñ“c^‰î, ²“¡@‰·, Î•@—m, Edward Chow, ‰ºÈW“ñ˜Y (1
”å”AŠí): Šà‚Ɖ»Šw—Ö@ 2010/8; 37 (8): 1507-12.

120046. [ŒŽ’˜] –¢ŒoŒ±pŽÒ‚ªHoLEP (Holmium Laser Enucleation of the Prostate) ‚É‘ŠúKn‚·‚é‚œ
‚ß‚Ì’ñˆÄ. •œŽR‹M”Ž1, ÝŠy•q–ç, “¡“c“N•v1, Šâ‘º³Žk1, ‹v•Û¯ˆê, ”nêŽu˜Y1 (1”å”AŠí) ”å”AŠí‰È
‹I—v 2010/8; 56 (8): 431-4.

120047. [ŒŽ’˜] –«ŒŒ‰t“§ÍŠ³ŽÒ‚É‚š‚¯‚郁ƒ^ƒ{ƒŠƒbƒNƒVƒ“ƒhƒ[ƒ€‚ÌŒŸ“¢. •œ—Ç—²•Û, •º“¡@“§, ‹g
“cˆê¬1, ”nêŽu˜Y1, ‰–ìÊŽq, ’|‘º@“O, ç—t“N’j, “ú‘ä‰p—Y, •œ–ì@•× (1”å”AŠí): ”å”AŠíŠO‰È
2010/10; 23 (10): 1453-8.

220018. [€ŒŽ’˜] ‘O—§‘BŠà‚ɑ΂·‚é–§••¬üŒ¹—Ö@?LDR, HDR?. ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, “c”šŒ’ˆê
1, “ì“c@—@3, ù–{Ž¡Žq1, ¬’J³Žq2, –k–ì‰ëŽj, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡),
3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ36‰ñ”A˜Hˆ««Žîᇌ€‹†‰ï‹L˜^ 2010/5; p.59-65.

220019. [€ŒŽ’˜] ƒAƒWƒA‚©‚ç‚Ý‚œ“ú–{‚̐t‘ã‘֗Ö@‚ɂ‚¢‚Ä. ‹g“cˆê¬ (”å”AŠí): t‚Æ“§Í 2010/6;
68 (6): 953-4.

220020. [€ŒŽ’˜]u_“ސìtˆÚAƒŒƒVƒsƒGƒ“ƒgƒR[ƒfƒBƒl[ƒ^[‚̉ïv‚Ì—§‚¿ã‚°‚Æ“W–]. ’r“c¬]1,
–ìŒû•¶”T, ’†–ڐ^—Žq, ã–ì˜a”ü, ¬âŽu•Û, ‹g“cˆê¬1, Îˆä‘å•ã1, —͐ΒC–ç, ²X–؏G˜Y, ŠÛˆä—S
“ñ (1”å”AŠí): tˆÚAÇ—áW2010 (‘æ43‰ñ“ú–{—Տ°tˆÚAŠw‰ï‹L˜^W) 2010/9; p.389-90.

220021. [€ŒŽ’˜] ’YŽ_ƒ‰ƒ“ƒ^ƒ“…˜a•š“Š—^6ƒPŒŽŠÔ‚Å‚ÌŠ¥“®–¬ÎŠD‰»Žw”‚̕ω». •º“¡@“§, Šp“c—²r,
ŽR–{ƒXƒ~Žq, Žáˆä—zŠó1, Îˆä‘å•ã1, “ú‘ä‰p—Y, Žðˆä@‹Š1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí) Nephrology
Frontier‘Š§† (‘æ21‰ñ“ú–{t«œÇŒ€‹†‰ï‹L˜^W) 2010/11; p.45-7.

320037. [Ç—á•ñ] ‚IgG4ŒŒÇ‚ð”F‚ß‚œŒÀ‹Ç«Œã• –ŒüˆÛÇ. •ÊŠ‰pŽ¡1, ‘OŽR—Ç‘Ÿ1, “c‰ª‰ÀŒ›, Â@
‹Pº, –{@‹§ (1”å”AŠí): —Տ°”å”AŠí‰È 2010/4; 64 (5): 337-40.

320038. [Ç—á•ñ] R‹ÃŒÅ–òŒp‘±‰º‚ÉŽ{s‚µ‚œHoLEP (Holmium Laser Enucleation of the Prostate) ‚Ì
ŒoŒ±. •œŽR‹M”Ž1, ÝŠy•q–ç, “¡“c“N•v1, Šâ‘º³Žk1, ‹v•Û¯ˆê, ”nêŽu˜Y1 (1”å”AŠí): “ú–{”å”AŠí
‰ÈŠw‰ïŽGŽ 2010/5; 101 (7): 754-7.

320039. [Ç—á•ñ] t‰Š‚É”AŠÇ‹·ó‚ð‡•¹‚µƒXƒeƒƒCƒhŽ¡—ÂŌy‰õ‚µ7”NŒã‚ɍĔ­‚𗈂œ‚µ‚œ‚ªÄ“x“¯
—Ö@‚ÅŒy‰õ‚µ‚œÇ—á. ¬—ÑŒ’‘Ÿ˜Y1, Îˆä‘å•ã1, –]ŒŽN•œ1, ø‹Œû@‘å, ‘OŽR—Ç‘Ÿ1, “c”šŒ’ˆê1, “¡“c
“N•v1, Šâ‘º³Žk1, ‹g“cˆê¬1, ”nêŽu˜Y1, ’|“àN—Y2 (1”å”AŠí, 2t‘Ÿ“à): _“ސìˆãŠw‰ïŽGŽ 2011/1;
38 (1): 82-3.

520067. [‘à]y”å”AŠí‰ÈŒŸž‚Ì‚±‚±‚ªƒ|ƒCƒ“ƒgzCT‚âMRI, “àŽ‹‹ŸŒŸž‚̐f’f‹Zp‚ªŒüã‚µ‚œŒ»Ý, i
s«t᱑¢‰e‚Ì“K‰ž, •û–@‚̃Rƒc, Šî–{“I“lje–@‚ɂ‚¢‚Ä‹³‚Š‚Ä‚­‚Ÿ‚³‚¢. ŽR‰º‰p”V1, ‰z“c’|˜N, ‘å“Œ
‹MŽu, rì@F (1”å”AŠí): —Տ°”å”AŠí‰È (‘Š§†) 2010/4; 64 (4): 161-4.

520068. [‘à]y”å”AŠí‰ÈŒŸž‚Ì‚±‚±‚ªƒ|ƒCƒ“ƒgzŒo”ç“I‡s«t᱑¢‰e‚Ì“K‰ž, •û–@, Šî–{“I“lje–@‚É
‚‚¢‚Ä‹³‚Š‚Ä‚­‚Ÿ‚³‚¢. ‰z“c’|˜N1, ŽR‰º‰p”V1, ‘å“Œ‹MŽu, rì@F (1”å”AŠí): —Տ°”å”AŠí‰È (‘Š§
†) 2010/4; 64 (4): 165-6.

520069. [‘à] ”å”AŠí‘̍o‹ŸŽèp‚É—p‚¢‚é‹ÃŒÅEŽ~ŒŒ‘•’u?‰œ‚ð, ‚Ç‚±‚Å, ‚Ç‚€Žg‚€‚©?. Šâ‘º³Žk1
(1”å”AŠí): Japanese Journal of Endourology and ESWL 2010/4; 23 (1): 10-8.

520070. [‘à] ¬Ž™‚̐t᱔AŠÇˆÚs•”•ÂÇ‚ɑ΂·‚é• o‹Ÿ‰ºt᱌`¬p. Šâ‘º³Žk1, Œ@·G1, ”n
êŽu˜Y1 (1”å”AŠí): Japanese Journal of Endourology and ESWL 2010/4; 23 (1): 37-45.

520071. [‘à] Suprahiatul repair–@ (Politano-Leadbetter–@) ‚É‚æ‚é‹CäNã÷‰º”AŠÇäNã÷V•«‡p.
‘v@¬_, Œ@·G1, Šâ‘º³Žk1, ”nêŽu˜Y1, “’–{‹v—Y, ‰ª“c@O (1”å”AŠí): Japanese Journal of
Endourology and ESWL 2010/4; 23 (1): 58-61.

520072. [‘à] T1t×–EŠà‚ɑ΂·‚é• o‹Ÿ‰ºªŽ¡“It“Eœp‚Ì’·Šú—\Œã‚ɂ‚¢‚Ä. “¡“c“N•v1, Šâ‘º³
Žk1, ù–{Ž¡Žq1, Œ“c‘å‰î1, “c”šŒ’ˆê1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): Japanese Journal of
Endourology and ESWL 2010/4; 23 (1): 64-7.

520073. [‘à] ‚ü—Ê—Š‘gD“àÆŽË—Ö@. ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, –k–ì‰ëŽj, ‘ì˜ad2, ”nêŽu˜Y1
(1”å”AŠí, 2•úŽËü (Žîá‡)) Urology View 2010/4; 8 (2): 64-7.

520074. [‘à] ‹Ø‘w”ñZ«äNã÷Šà‚ÌäNã÷“à’“ü—Ö@. Œ–{˜a« (”å”AŠí): —Տ°”å”AŠí‰È 2010/8; 64
(9): 647-52.

522114. [uÀ] t᱔AŠÇˆÚs•”’ʉߏáŠQ‚ɑ΂·‚é• o‹Ÿ‰ºt᱌`¬p‚̃KƒCƒhƒ‰ƒCƒ“. Šâ‘º³Žk (”å
”AŠí): 2010”N‘²Œã‹³ˆçƒeƒLƒXƒg (‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï) 2010/4; 15 (1): 352-6.

522115. [uÀ]y“ÁW: ‘æ18‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€zŒŽ”­‘ƒ‚ ‚é‚¢‚͍Ĕ­‘ƒ‚ɑ΂µ‚ĉ»Šw—Ö@E•úŽËü
—Ö@‚ª‘tŒø‚µ’·Šú¶‘¶‚µ‚Š‚œZ«äNã÷Šà‚Ì2—á. Œ@·G1, Œ–{˜a«1, •ÊŠ‰pŽ¡1, ’r“cŸb2, “¡
“c“N•v1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, V•”@÷3, ‘ì˜ad3, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†
‰È, 3•úŽËü (Žîá‡)): –k—¢ˆãŠw 2010/6; 40 (1): 53-6.

522116. [uÀ] Ž~ŒŒŠí‹ï‚̈À‘SŽg—pŠî–{Žè‹Z. Šâ‘º³Žk (”å”AŠí): 2010”N‘²Œã‹³ˆçƒeƒLƒXƒg (“ú–{”å
”AŠí‰ÈŠw‰ï“Œ•”E’†•”EŒ“ú–{‘‰ï) 2010/8; 15 (2): 126-31.

522117. [uÀ]y“ÁW: ‘æ19‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€zis«t×–EŠà‚ɑ΂·‚ésorafenib‚É‚æ‚é”­]?
‘œŒ`g”Á‚ɂ‚¢‚Ä?. ’r“cŸb1, Šâ‘º³Žk2, ŽOˆäƒá3, “c”šŒ’ˆê2, “¡“c“N•v2, “c•ÓŒ’ˆê2, ”n
êŽu˜Y2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2”å”AŠí, 3”畆): –k—¢ˆãŠw 2010/12; 40 (2): 133-5.

522118. [uÀ]y“ÁW: ‘æ19‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€zis«t×–EŠà‚ɑ΂·‚éƒXƒjƒ`ƒjƒuŽ¡—Â̌Ÿ“¢. “¡
“c“N•v1, Šâ‘º³Žk1, “y‹Ž³l1, ’r“cŸb2, “c”šŒ’ˆê1, Îˆä‘å•ã1, Œ–{˜a«1, ²“¡ˆÐ•¶1, ‹g“c
ˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): –k—¢ˆãŠw 2010/12; 40 (2): 137-40.

530007. [‚»‚Ì‘Œ (’²ž•ñ)] Genomic expression and single-nucleotide polymorphism profiling
discriminates chromophobe renal cell carcinoma and oncocytoma. Min-Han Tan, Chin Fong Wong, Hwei
Ling Tan, Ximing J Yang, Jonathon Ditlev, Œ“c‘å‰î1, Sok Kean Khoo, Jun Sugimura, “¡‰ª’mº, Kyle
A Furge, Eric Kort, Sophie Giraud, Sophie Ferlicot, Philippe Vielh, Delphine Amsellem-Ouazana,
Bernard Debre, Thierry Flam, Nicolas Thiounn, Marc Zerbib, Gerard Benoit, Stephane Droupy, Vincent
Molinie, Annick Vieillefond, Puay Hoon Tan, Stephane Richard, Bin Tean Teh (1”å”AŠí): BMC Cancer
2010/5; 10: 196.

530008. [‚»‚Ì‘Œ (’Z•ñ)] Non-pigmenting Fixed Drug Eruption Induced by Sorafenib. “c•ÓŒ’ˆê1, “V
‰HN”V2, ŽOˆäƒá2, Hiromitsu Eto, Šâ‘º³Žk1, Ÿ‰ªŒ›¶2 (1”å”AŠí, 2”畆): ACTA
DERMATO-VENEREOLOGICA 2010/5; 90 (3): 307.

540034. [‚»‚Ì‘Œ] tˆÚA‚ðŠó–]‚·‚éŠF—l‚Ö. ‹g“cˆê¬1, Žáˆä—zŠó1, “ú‘ä‰p—Y (1”å”AŠí): ‚߂΂Š
2010/7; 84†.

540035. [‚»‚Ì‘Œ] Œcœä‹`m•’Ê•”@3”N¶ƒR[ƒX•ÊŽö‹Æ. ‹g“cˆê¬1, Žáˆä—zŠó1, “ú‘ä‰p—Y (1”å”A
Ší): ‘æ13‰ñ–Ú˜H‚Í‚é‚©‹³Žº 2010/11.

540036. [‚»‚Ì‘Œ] tˆÚA‚ÉŠÖ‚·‚é’²ž (•œ¬21”N“x) ‚Ì•ªÍŒ‹‰Ê‚ɂ‚¢‚Ä. ‹g“cˆê¬1, Žáˆä—zŠó1, “ú
‘ä‰p—Y (1”å”AŠí): _“ސ쌧“§ÍŽ{Ý˜A—‹Š‹c‰ï•ñ 2010/11; 25: 17-20.

540037. [‚»‚Ì‘Œ] ”å”AŠí‰È—̈æ‚É‚š‚¯‚é• o‹ŸŽèp‚ÌŒ»ó‚Ə«—ˆ“W–]. Šâ‘º³Žk (”å”AŠí): ‚Í‚¿‚Ì‚Ö
ˆãŽt‰ï‚Ì‚€‚²‚« 2011/1; 499 (Vt“ÁW†): 32.

540038. [‚»‚Ì‘Œ (ƒpƒ“ƒtƒŒƒbƒg)]y“ú–{‚̈ã—ËZp‚Í—D‚ê‚Ä‚¢‚é!!?ƒf[ƒ^‚Å—§Ø‚³‚ê‚œ“ú–{‚̈ã—ËZ
pz”å”AŠí• o‹ŸŽèp‚ÌŠJ”­‚Æ‹Zp”F’è^“ú–{”å”AŠí‰ÈŠw‰ï, p.14. Œ“cŒöŽu, ”nêŽu˜Y1 (1”å”AŠí),
•Ò ŠO‰ÈŒnŠw‰ïŽÐ‰ï•ÛŒ¯ˆÏˆõ‰ï˜A‡, ƒG[ƒUƒC (Š”), “Œ‹ž, 2011/2”­s.

540039. [‚»‚Ì‘Œ] ‚—p—ʃ~ƒ]ƒŠƒrƒ“•¹—p–Ɖu—}§—Ö@? —ǍD‚ȗՏ°Œ‹‰Ê‚ðŠm”F?. ‹g“cˆê¬1, Žáˆä
—zŠó1, “ú‘ä‰p—Y (1”å”AŠí) Medical Tribune 2011/3; 44 (12): 11.

[’˜@‘]

610007. [Šwp‘] (•ª’SŽ·•M)yBladder CancerzINVESTIGATION OF MOLECULAR PROTEINS FOR UROTHELIAL
CARCINOMA IN THE URINARY BLADDER, p.1-15. Œ–{˜a«1, Œ@·G1, ’r“cŸb1, “¡“c“N•v1, ²“¡
ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí), Nova Science Publishers, 2010/4”­s.

620107. [Šwp‘] (•ª’SŽ·•M)ytE”å”AŠíŠà?Šî‘bE—Տ°Œ€‹†‚̃Aƒbƒvƒf[ƒg? (“ú–{—Õଠ68Šª‘Š§
†4)zII. äNã÷Šà@3. “Á˜_@1) Œo”A“¹“IŽèp‚̍ۂ̃‰ƒ“ƒ_ƒ€¶ŒŸ, p.353-6. Œ–{˜a«1, ”nêŽu˜Y1 (1
”å”AŠí), “ú–{—Õ଎Ð, ‘åã, 2010/4”­s.

620108. [Šwp‘]y‘ŸŠí•s‘S‚ð—L‚·‚éŽèpEŠÇ—?f’f‚ÆŽ¡—ẪRƒc‚Æ—Ž‚Æ‚µŒŠ?zùN–EtŠŽõ‚ÌŠO‰È“I
Ž¡—Ö@, p.10-3. ‹g“cˆê¬ (”å”AŠí), COSMOF 2010, 2010/11”­s.

620109. [Šwp‘] (•ª’SŽ·•M)yƒGƒŒƒNƒgƒƒjƒNƒXƒVƒŠ[ƒY: ŽŸ¢‘ãŒõˆã—Ã?ƒŒ[ƒU[‹Zp‚̗Տ°‚Ö‚Ì‹Ž
“n‚µ?z‘æ9Í@”å”AŠí‰È‚É‚š‚¯‚郌[ƒU[Ž¡—Ã, p.100-10. Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí), ƒV[
ƒGƒ€ƒV[o”Å, 2010/11”­s.

620110. [Šwp‘] (•ª’SŽ·•M)yƒi[ƒX‚Ì‚œ‚ß‚Ì ”A˜HŒ‹ÎÇ ‚Ü‚é‚í‚©‚èuÀ (”å”AŠíƒPƒA Vol.15
No.11)z5. ‘ÌŠOÕŒ‚”gÓÎp (ESWL) ‚ƃNƒŠƒjƒJƒ‹ƒpƒX, p.32-9. rì@F, ‰z“c’|˜N, ŽR‰º‰p”V1, ‘å
“Œ‹MŽu, ‰z‚N—T, V–ì^”ü], ‹Ž–{‹PŽq, ‘Š”n‹IŽq, ²“¡‚«‚æŽq, Vˆäçt (1”å”AŠí), ƒƒfƒBƒJo”Å,
2010/11”­s.

620111. [Šwp‘]y—Տ°ƒi[ƒX‚Ì‚œ‚ß‚ÌBasic & Standard: ”å”AŠí‰ÈŠÅŒì‚Ì’mŽ¯‚ÆŽÀÛz”å”AŠí‰ÈŽèp
‚É•K—v‚ȉð–U‚ÆŽŸŠ³‚Ì’mŽ¯@4. ‘O—§‘B‚Ì‚Í‚œ‚ç‚«‚ÆŽŸŠ³, p.32-9. ²“¡ˆÐ•¶ (”å”AŠí), •Ò ⚁@‘Ps,
ƒƒfƒBƒJo”Å, 2010/12”­s.

620112. [Šwp‘] (•ª’SŽ·•M)yTODAY'S THERAPY 2011 Volume 53z19. ”å”AŠí‰ÈŽŸŠ³: tˆÚAŠ³ŽÒ‚̃P
ƒA, p.1004-5. ‹g“cˆê¬ (”å”AŠí),@ˆãŠw‘‰@, 2011/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712052. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Neoadjuvant In Situ Gene Therapy for Prostate Cancer:
Kitasato Trial. ²“¡ˆÐ•¶ (”å”AŠí): ƒAƒWƒAƒ“ƒXƒ^ƒfƒB‰ªŽR'11 (2011/2/17), ‰ªŽR.

713111. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) VALIDATION OF TUMOUR ARCHITECTURE IS AN INDEPENDENT
PREDICTOR OF OUTCOMES AFTER RADICAL NEPHROURETERECTOMY. Fritsche HM, Novara G, Gupta A, Œ–{
˜a«1, Kassouf W, Walton T, Burger M, Tritschler S, ”nêŽu˜Y1, Bastian PJ, Carballido J, Seitz
C, Otto W, Karakiewicz PI, Ficarra V, Shariat SF (1”å”AŠí): 25th Anniversary Congress of the European
Association of Urology (2010/4/17), Balcerona, Spain, EUROPEAN UROLOGY SUPPLEMENTS 2010; 9 (2):
45.

713112. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) LYMPHOVASCULAR INVASION IS A PATHOLOGIC FEATURE OF
BIOLOGICALLY AGGRESSIVE DISEASE IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT:AN
INTERNATIONAL EXTERNAL VALIDATION STUDY. Novara G, Œ–{˜a«1, Kassouf W, Walton JT, Fritsche HM,
Bastian JP, Martinez-Salamanca JI, Seitz C, Lemberger RJ, Burger M, El-Hakim A, ”nêŽu˜Y1,
Martignoni G, Gupta A, Karakiewicz PI, Ficarra V, Shariat SF (1”å”AŠí): 25th Anniversary Congress
of the European Association of Urology (2010/4/17), Balcerona, Spain, EUROPEAN UROLOGY SUPPLEMENTS
2010; 9 (2): 46.

713113. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) THE COMBINED INVESTIGATION OF MOLECULAR PROTEINS
PREDICTS CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER.
Œ–{˜a«1, Satoh Y, ²“¡ˆÐ•¶1, “c”šŒ’ˆê1, “¡“c“N•v1, Šâ‘º³Žk1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å
”AŠí): 25th Anniversary Congress of the European Association of Urology (2010/4/19), Balcerona,
Spain, EUROPEAN UROLOGY SUPPLEMENTS 2010; 9 (2): 291.

713114. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ONCOLOGICAL OUTCOMES FOR OPEN AND LAPAROSCOPIC
NEPHROURETERECTOMY:A MULTI-INSTITUTIONAL EXTERNAL VALIDATION STUDY FROM THE UPPER TRACT UROTHELIAL
CARCINOMA COLLABORATION. Novara G, Walton T, Gupta A, Œ–{˜a«1, Bastian P, Kassouf W, Fritsche
HM, Martinez-Salamanca JI, Seitz C, Ficarra V, Karakiewicz PI, Shariat SF (1”å”AŠí): 25th
Anniversary Congress of the European Association of Urology (2010/4/19), Balcerona, Spain, EUROPEAN
UROLOGY SUPPLEMENTS 2010; 9 (2): 321.

713115. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) LYMPHOVASCULAR INVASION IS A PATHOLOGIC FEATURE OF
BIOLOGICALLY AGGRESSIVE DISEASE IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT:
AN INTERNATIONAL EXTERNAL VALIDATION STUDY. Giacomo Novara, Œ–{˜a«1, Wassim Kassouf, Thomas
J Walton, Hans-Martin Fritsche, Patrick J Bastian, Juan I Martínez-Salamanca, Christian
Seitz, R John Lemberger, Maximilian Burger, Assaad El-Hakim, ”nêŽu˜Y1, Guido Martignoni, Amit
Gupta, Pierre I Karakiewicz, Vincenzo Ficarra, Shahrokh F Shariat (1”å”AŠí): American Urological
Asociation Annual Meeting 2010 (2010/5/30), San Francisco, USA, The Journal of Urology 2010; 183
(4, Supplement): e64.

713116. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ¿1,2-FUCOSYLATED AND ƒÀ-N-ACETYLGALACTOMINYLATED
PROSTATE SPECIFIC ANTIGEN AS AN EFFICIENT MARKER OF PROSTATE CANCER. ²“¡ˆÐ•¶1,•Ÿ“‡ŒcŽq, ŽR‰º
ŽŽq, ˆÉ“Œˆê˜Y, “c”šŒ’ˆê1, Œ–{˜a«1, ”nêŽu˜Y1 (1”å”AŠí): American Urological Asociation Annual
Meeting 2010 (2010/5/30), San Francisco, USA, The Journal of Urology 2010; 183 (4, Supplement):
e150-e151.

713117. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PROGNOSTIC VALUE OF CONCOMITANT CARCINOMA IN SITU IN
PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA. Wolfgang
Otto, Hans-Martin Fritsche, Giacomo Novara, Amit Gupta, Œ–{˜a«1, Wassim Kassouf, Tom Walton,
Maximilian Burger, Stefan Tritschler, ”nêŽu˜Y1, Patrick J Bastian, Juan I Martinez-Salamanca,
Christian Seitz, Pierre I Karakiewicz, Vincenzo Ficarra, Shahrokh F Shariat (1”å”AŠí): American
Urological Asociation Annual Meeting 2010 (2010/5/30), San Francisco, USA, The Journal of Urology
2010; 183 (4, Supplement): e164.

713118. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PROGNOSTIC SIGNIFICANCE OF TUMOR LOCATION IN UPPER
TRACT UROTHELIAL CARCINOMA. Faysal A Yafi, Shahrokh F Shariat, Giacomo Novara, Amit Gupta, Œ
–{˜a«1, Thomas J Walton, Hans-Martin Fritsche, Patrick J Bastian, Juan I Martinez-Salamanca,
Christian Seitz, Vincenzo Ficarra, Pierre I Karakiewicz, Wassim Kassouf (1”å”AŠí): American
Urological Asociation Annual Meeting 2010 (2010/5/30), San Francisco, USA, The Journal of Urology
2010; 183 (4, Supplement): e165.

713119. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) INFLUENCE OF BODY MASS INDEX IN LAPAROSCOPIC RADICAL
NEPHRECTOMY: THE CORRELATION WITH PERIRENAL OR SUBCUTANEOUS FAT THICKNESS. “¡“c“N•v1, Šâ‘º³
Žk1, ’ѺGN1, Œ“c‘å‰î1, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): American Urological
Asociation Annual Meeting 2010 (2010/5/31), San Francisco, USA, The Journal of Urology 2010; 183
(4, Supplement): e388.

713120. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) PROTEOMIC RESEARCH FOR DIAGNOSTIC MARKERS: INCREASED
EXPRESSION OF S100A8/9 IS ASSOCIATED WITH DISEASE PROGRESSION AND CANCER-SPECIFIC SURVIVAL IN
BLADDER CANCER. Œ–{˜a«1, ²“¡—Yˆê2, ²“¡ˆÐ•¶1, “c”šŒ’ˆê1, Sho Minami, “¡“c“N•v1, Šâ‘º³Žk
1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2ˆã—Éq¶Šw•”): American Urological Asociation Annual Meeting
2010 (2010/5/31), San Francisco, USA, The Journal of Urology 2010; 183 (4, Supplement): e442.

713121. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) THE COMBINED INVESTIGATION OF MOLECULAR PROTEINS
PREDICTS CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER.
Œ–{˜a«1, ²“¡ˆÐ•¶1, “c”šŒ’ˆê1, “¡“c“N•v1, ²“¡—Yˆê2, Šâ‘º³Žk1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1
”å”AŠí, 2ˆã—Éq¶Šw•”): American Urological Asociation Annual Meeting 2010 (2010/5/31), San
Francisco, USA, The Journal of Urology 2010; 183 (4, Supplement): e446.

713122. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RESULT OF SECOND BIOPSY IS IMPORTANT FOR DECISION MAKING
BEFORE ENTERING ACTIVE SURVEILLANCE PROTOCOL FOR LOW RISK PROSTATE CANCER. Ari Adamy, David S.
Yee, Œ‰ºˆêm1, Angel M Cronin, Alexandra C Maschino, Bertrand Guillonneau, Peter T Scardino, James
A Eastham (1”å”AŠí): American Urological Asociation Annual Meeting 2010 (2010/6/2), San Francisco,
USA, The Journal of Urology 2010; 183 (4, Supplement): e789.

713123. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Influence of body mass index in laparoscopic radical
nephrectomy. “¡“c“N•v1, Šâ‘º³Žk1, “c”šŒ’ˆê1, Îˆä‘å•ã1, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1
”å”AŠí): 7th East Asian Society of Endourology Meeting (2010/6/19), Korea, The Korean Journal of
Endourology 2010; 9 (Supplement 1): 137.

713124. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Importance of enlightenment to the local citizens about
renal transplantation procurement. ’r“c¬]1, ‹g“cˆê¬1, Îˆä‘å•ã1, ˆ°Š ~‘Ÿ˜Y, ‚‹Ž@Œb, “ü
—ˆ‹GŒb, –ìŒû•¶”T, ŠC˜V‘ò‰ÀŽq, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí): XXIII International Congress of The
Transplantation Society (2010/8/16), Vancouver, Canada.

713125. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Pharmacokinetics of Once-Daily Tacrolimus Extended
Release (TER) in de novinduction immunotherapy. ‹g“cˆê¬1, ¬—я¹G2, Îˆä‘å•ã1, ’|“àN—Y3,
Žáˆä—zŠó1, ‘OŽR—Ç‘Ÿ1, ‚Œû@‘å1 –îŒã˜a•v2, ”nêŽu˜Y1 (1”å”AŠí, 2–òÜ•”, 3t‘Ÿ“à): XXIII
International Congress of The Transplantation Society (2010/8/16), Vancouver, Canada.

713126. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The therapy for tumoral calcinosis in CAPD patients.
•º“¡@“§, Žáˆä—zŠó1, Takayasu Taira, “ú‘ä‰p—Y, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): The 13th Congress
of the Internatiol Society for peritoneal Dialysis (2010/8/23), Mexico City, Mexico.

713127. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Immune responses in prostate cancer patients received in situ
gene therapy of repeated HSV-tk injection and ganciclovir administration. Makoto Kubo, ²“¡ˆÐ
•¶1, “c”šŒ’ˆê1, Œ–{˜a«1, ”nêŽu˜Y1, ¬”Š•¶–í2 (1”å”AŠí, 2ˆã—Éq¶Šw•”): 14th International
Congress of Immunology (2010/8/26), _ŒË.

713128. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Novel CO2 laser partial nephrectomy: pilot study in
a porcine model. Tsivian M, Caso JR, –Ø‘º«‹M1, Madden JF, Polascik TJ, Mouraviev VA (1”å”A
Ší): 28th World Congress of Endourology and SWL (WCE 2010) (2010/9/1-4), Chicago, IL, USA.

713129. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Synergistic Effects of Combination therapy with
GLIPR1TM Protein and Docetaxel in Prostate Cancer. •âáÁ“ñ1, ²“¡ˆÐ•¶1, Œ–{˜a«1, “c”šŒ’ˆê
1, “¡“c“N•v1, Timothy C Thompson, ”nêŽu˜Y1 (1”å”AŠí): The 27th Japan-korea Urological Congress
(2010/9/11), ‹ž“s.

713130. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Systemic T-cell activation following in situ gene
therapy in prostate cancer patients. •âáÁ“ñ1, ²“¡ˆÐ•¶1, Makoto Kubo, “c”šŒ’ˆê1, Œ–{˜a«
1, ¬”Š•¶–í2, “ߐ{•Û—F, Žáˆä—zŠó1, Œö•¶—T–€, Malcolm K Brenner, Timothy C Thompson, ”nêŽu˜Y1
(1”å”AŠí, 2ˆã—Éq¶Šw•”): The Fourth China-Japan urological association annual meeting
(2010/10/16), Xian, China.

713131. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) DEVELOPMENT OF THE JAPANESE VERSION OF THE HRQOL INSTRUMENT FOR
PATIENTS WITH BONE METASTASES: EORTC QLQ-BM22. Kojiro Shimozuma, ²“¡ˆÐ•¶1, Kunihiko Kobayashi,
Taisuke Hori, Shinsuke Iida, Atsushi Sato, Hiroshi Ishiguro, Takeru Shiroiwa, Shinya Saito, Edward
Chow (1”å”AŠí): 18th International Society for Quality of Life Research Annual Conference
(2010/10/29), Denver, USA.

713132. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A Modern Animal Model of Radiation-Induced Erectile
Dysfunction. –Ø‘º«‹M1, Bridget F Koontz, Hui Yan, Zahid Rabbani, ²“¡ˆÐ•¶1, ”nêŽu˜Y1, Fang-fang
Yin, Craig F Donatucci, Thomas J Polascik, Zeljko Vujaskovic (1”å”AŠí): 52nd ASTRO annual meeting
(2010/11/1), San Diego, CA, USA.

713133. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Erectile function of rat after radiotherapy for
prostate cancer: innovative technique mimicking IMRT treatment. –Ø‘º«‹M1, Hui Yan, Zahid Rabbani,
Fang-Fang Yin, Thomas Polascik, Craig F Donatucci, Zeljko Vujaskovic, Bridget Koontz (1”å”AŠí):
2010 Sexual Medicine Society of North America (SMSNA) Annual Meeting (2010/11/13), Miami Beach,
FL, USA.

713134. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) On-demand use of erectile aids in men with severe
preoperative erectile function treated by prostate cryoablation. –Ø‘º«‹M1, Matvey Tsivian, Jorge
Caso, Daniel M Moreira, Vladimir Mouraviev, Craig F Donatucci, Thomas J Polascik (1”å”AŠí): 2010
Sexual Medicine Society of North America (SMSNA) Annual Meeting (2010/11/13), Miami Beach, FL,
USA.

713135. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) A phase l study of personalized peptide vaccination for advanced
urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and
cisplatin. Œ–{˜a«1, M Noguchi, ²“¡ˆÐ•¶1, “c”šŒ’ˆê1, “¡“c“N•v1, A.yamada, N Komatsu, ‹g“c
ˆê¬1, K Itoh, ”nêŽu˜Y1 (1”å”AŠí): 26th Annual Congress of the European Association of Urology
(2011/3/20), Vienna, Austria.

713136. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Synergistic Effects of Combination therapy with GLIPR1TM Protein
and Docetaxel in Prostate Cancer. •âáÁ“ñ1, Ryuta Tanimoto, Timmoty C Thomoson, ”nêŽu˜Y1 (1
”å”AŠí): 26th Annual Congress of the European Association of Urology (2011/3/21), Vienna, Austria.

721008. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‘O—§‘B‚ª‚ñ?¡Œã‚Ì•úŽËüŽ¡—Ẩʂœ‚·–ðŠ„. Eric Klein, ‹ŽªŸ
‹`, ²“¡ˆÐ•¶1, ‹g‰ª–õ¶ (1”å”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/27), ·‰ª, “ú”å”A‰ïŽ
2010; 101 (2): 56.

721009. [Šw‰ï (‘S‘)] (“Á•Êu‰‰)y‘²Œã‹³ˆçƒvƒƒOƒ‰ƒ€z”å”AŠí• o‹ŸŽèpƒKƒCƒhƒ‰ƒCƒ“. “c’†³—˜
1, —é–ؘa—Y, Šâ‘º³Žk1 (1”å”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/30), ·‰ª.

721010. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ƒJƒ“ƒ{ƒWƒAE“ú–{—FDŒŒ‰tò‰»ƒZƒ“ƒ^[‚ÌŠJÝ•ñ. Žáˆä—zŠó (”å
”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/18), _ŒË, “§Í‰ïŽ 2010; 43 (Supplement 1):
57.

721011. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) •W€“I• –ŒƒJƒe[ƒeƒ‹‘}“ü–@. ‹g“cˆê¬1, Žáˆä—zŠó1, Îˆä‘å•ã
1 (1”å”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/20), _ŒË, “§Í‰ïŽ 2010; 43 (Supplement
1): 348.

721012. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ŠÖ˜AŠw‰ï‚Æ‚ÌŠÖ‚í‚è•û. Šâ‘º³Žk1, ŽÂŒŽM—Y, ‰Í‡O“ñ, Œüˆä®
ˆê˜Y (1”å”AŠí): “ú–{”å”AŠí‰ÈŠw‰ï‹³ˆçƒ[ƒNƒVƒ‡ƒbƒv (2010/8/19), •Ÿ‰ª.

721013. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‘O—§‘BŠàf—Âɂš‚¯‚éADTIBL‚ɑ΂·‚é‘Ήž. ²“¡ˆÐ•¶ (”å”AŠí):
ZENITH Meeting-JAPAN 2010 (2010/8/21), “Œ‹ž.

721014. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) Prostate Cancer Update 2010. ²“¡ˆÐ•¶ (”å”AŠí): THE Best of AUA
in Japan 2010 (2010/10/16), “Œ‹ž.

721015. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) • o‹Ÿ‰º‘O—§‘B“Eœp‚ÌŠî–{Žè‹Z?‚±‚ê‚©‚çŽn‚ß‚él‚Ì‚œ‚ß‚ÌStep
by Step?. Šâ‘º³Žk (”å”AŠí): ‘æ24‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï (2010/10/22), ‹ž“s, Japanese
Journal of Endourology and ESWL 2010; 23 (3): 26.

721016. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) mCRPC (“]ˆÚE‹Žš’ïR«‘O—§‘B‚ª‚ñ) ‚ɑ΂·‚鎡—Ð헪‚Ɖۑè. ²
“¡ˆÐ•¶ (”å”AŠí): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/28), ‹ž“s.

721017. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‘O—§‘BŠàf—Âɂš‚¯‚ébone health ?ƒ]ƒŒƒhƒƒ“Ž_‚Ì“Š—^ƒ^ƒCƒ~ƒ“
ƒO?. ²“¡ˆÐ•¶ (”å”AŠí): Urology Bone Metastasis Forum 2011 (2011/1/20), –ŒŒÃ‰®.

722152. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) • o‹Ÿ‰ºt•”•ªØœp‚Ì‹Zp“I–â‘è“_‚Æ‹ß–¢—ˆ‘œ. Šâ‘º³Žk
1, “¡“c“N•v1, ù–{Ž¡Žq1, Œ“c‘å‰î1, Îˆä‘å•ã1, ‰©@‰p–Î1, ‘º–{«r, ìã’B‰›, Š‹Œ@ŒM, ”nê
Žu˜Y1 (1”å”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/30), ·‰ª “ú”å”A‰ïŽ 2010; 101 (2): 86.

722153. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ƒŠƒ“‹z’…Ü‚̉h—{ŠÇ—‚Ö‚ÌŒø‰Ê. •º“¡@“§, ²“¡Œb”üŽq, ì
ãƒŽq, ‹g“cˆê¬1 (1”å”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/19), _ŒË, “§Í‰ïŽ
2010; 43 (Supplement 1): 304.

722154. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) • o‹Ÿ‰ºt᱌`¬p. Šâ‘º³Žk1, Œ@·G1, ”nêŽu˜Y1 (1
”å”AŠí): ‘æ19‰ñ“ú–{¬Ž™”å”AŠí‰ÈŠw‰ï‘‰ï (2010/7/2), ŽD–y, “ú–{¬Ž™”å”AŠí‰ÈŠw‰ïŽGŽ 2010; 19
(2): 46.

722155. [Šw‰ï (‘S‘)] (ƒrƒfƒIƒfƒBƒXƒJƒbƒVƒ‡ƒ“) • o‹Ÿ‰ºt᱌`¬pFŒo• –Œ“IƒAƒvƒ[ƒ`‚É‚æ‚é
Anderson-Hynes–@‚ÌŽèpŽè‹Z. Šâ‘º³Žk (”å”AŠí): ‘æ24‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï
(2010/10/22), ‹ž“s, Japanese Journal of Endourology and ESWL 2010; 23 (3): 22.

722156. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) CRPC‚ɑ΂·‚éˆâ“`ŽqE×–EŽ¡—Â̌»ó‚Æ“WŠJ. ²“¡ˆÐ•¶1, “c
”šŒ’ˆê1, Œ–{˜a«1, •âáÁ“ñ1, “¡“c“N•v1, ‹v•Û@œ, –öàVM”V2, ¬”Š•¶–í3, ‰ªˆÀ@ŒM2, “ߐ{•Û
—F, Œö•¶—T›ß, ”nêŽu˜Y1 (1”å”AŠí, 2•a—, 3ˆã—Éq¶Šw•”): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï
(2010/10/28), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2010; 45 (2): 333.

722157. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) œ“]ˆÚ‚ª‚ñŠ³ŽÒ‚ɑ΂·‚éEORTC QOL’²žƒ‚ƒWƒ…[ƒ‹:
EORTC QLQ-BM22“ú–{Œê”Å‚ÌŠJ”­. ²“¡ˆÐ•¶1, ¬—э‘•F, –x@‘×—S, ”Ñ“c^‰î, ²“¡@‰·, Î•@—m, Chow
Edward, ‰ºÈW“ñ˜Y (1”å”AŠí): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/29), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ï
Ž 2010; 45 (2): 446.

722158. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)
ƒ^ƒNƒƒŠƒ€ƒX™•ú–ò‚É‚æ‚é–Ɖu—}§“±“ütˆÚA‚Å‚ÌTDM‚ƗՏ°Œ‹‰Ê. ‹g“cˆê¬ (”å”AŠí): ‘æ44‰ñ“ú–{
—Տ°tˆÚAŠw‰ï (2011/1/27), •ºŒÉ.

723657. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ô‰è‹…ᔂɂš‚¯‚éŒoŒûƒLƒŒ[ƒgÜƒGƒNƒWƒFƒCƒh“Š—^Œã‚Ì
ŠeŽí“§Í—Ö@‚É‚æ‚é“Sœ‹Ž—Ê‚Ì”äŠr. ‘Ÿ“c¹–M, •º“¡@“§, –]ŒŽç‰êŽq, ‰ÍŒŽƒŽq, ‰ÁìN_, ŒIŒŽ³
ŒÈ, –{ŠÔ@’, ‘呐@—m1, “c”šŒ’ˆê1, Œ–{˜a«1, Îˆä‘å•ã1, ‹g“cˆê¬1, ”nêŽu˜Y1, Žðˆä@‹Š1, “ú
‘ä‰p—Y (1”å”AŠí): ‘æ26‰ñ“ú–{ˆãHŠwŽ¡—Êwp‘å‰ï (2010/4/3), “Œ‹ž.

723658. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) is«‘O—§‘BŠà‚ɑ΂·‚éNeoadjuvant
Estramustine/Paclitaxel•¹—pHDR brachytherapy‚ÌŒŸ“¢. ’†ªŽu•Û1, ²“¡ˆÐ•¶1, ‰oì@W, –k–ì‰ë
Žj, “c”šŒ’ˆê1, ÎŽR”ŽžŠ2, ù–{Ž¡Žq1, –Ø‘º«‹M1, Œ–{˜a«1, ‰¡ŽR‰p“ñ, ‘ì˜ad2, ”nêŽu˜Y1 (1
”å”AŠí, 2•úŽËü (Žîá‡)): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/27), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2):
205

723659. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) I-125‘O—§‘BŠà‰i‹v‘}“ü–§••¬üŒ¹—Ö@ (LDR) Œã‚̉º•”
”A˜HÇó (LUTS) ‚ɑ΂·‚鉖Ž_ƒ^ƒ€ƒXƒƒVƒ“, ƒiƒtƒgƒsƒWƒ‹‚š‚æ‚уVƒƒhƒVƒ“‚Ì”äŠrŒŸ“¢. ’ѺGN1,
²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, “c”šŒ’ˆê1, •ÊŠ‰pŽ¡1, “¡“c“N•v1, Œ–{˜a«1, ²“¡ŠG—¢“Þ, ¬’J³Žq2, –k
–ì‰ëŽj, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡)): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/27),
·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 209.

723660. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œ”­«ùN–EtÇ (PKD) ‚Å‚Ì“Eot‚É‚š‚¯‚étŠà‚ÌŒŸ“¢.
Îˆä‘å•ã1, ‹g“cˆê¬1, ø‹Œû@‘å1, ‘åŽR“N•œ1, “y“c–š”ü1, “c”šŒ’ˆê1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1
”å”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/27), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 218.

723661. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Thromboxane A2 Synthase‚ð—p‚¢‚œƒ}ƒEƒXäNã÷Šà×–E—Ö@‚ÌŒŸ“¢. Œ
–{˜a«1, ˆäã—æ”ü, –k—¢‰p˜Y2, ’ѺGN1, ˆÉ“Œˆê˜Y, ‰F“s‹{‘ñŽ¡, ‚‹Ž—Tˆê˜Y, “¡“c“N•v1, ²“¡ˆÐ
•¶1, Šâ‘º³Žk1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2ˆã—Éq¶Šw•”): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï
(2010/4/27), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 349.

723662. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žá”N”­¶äNã÷Šà‚̗Տ°“IŒŸ“¢. ŽR“c‘׎j1, Œ–{˜a«1, ŠÛ@“T•v,
•œˆäËŽi, Îì@–í, •ÊŠ‰pŽ¡1, “¡“c“N•v1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ98
‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/27), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 367.

723663. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) PSAŒ‹‡“œœ‚ÌŠà«•Ï‰»‚ð‰ž—p‚µ‚œV‹KƒoƒCƒIƒ}[ƒJ[‚ÌŒŸ“¢. ²
“¡ˆÐ•¶1, •Ÿ“‡ŒcŽq, ŽR‰ºŽŽq, ˆÉ“Œˆê˜Y, ²“¡ŠG—¢“Þ, “c”šŒ’ˆê1, Œ–{˜a«1, Šâ‘º³Žk1, ”nêŽu˜Y
1 (1”å”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/28), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 154.

723664. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) R‹ÃŒÅ–ò”ñ‹x–ò‰º‚Å‚ÌHoLEP (Holmium Laser enucleation of the
prostate) ‚ÌŒoŒ±. •œŽR‹M”Ž1, ÝŠy•q–ç, ™“c‰ÀŽq1, “¡“c“N•v1, Šâ‘º³Žk1, ‹v•Û¯ˆê, ‰¡ŽR‰p“ñ,
^‰ºß•v, ”nêŽu˜Y1 (1”å”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/28), ·‰ª, “ú”å”A‰ïŽ 2010;
101 (2): 394.

723665. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘O—§‘BŠàƒzƒ‹ƒ‚ƒ“—Ö@‚É‚æ‚鍜–§“x’ቺ‚ɑ΂·‚éŒoŒûƒA
ƒŒƒ“ƒhƒƒl[ƒg‚Ì—L—p«‚ÌŒŸ“¢. Žá“c•”—zŽi1, “ü]@Œ[1, ‘ºã‘אŽ1, Îˆä~ˆê˜Y1, —äˆä’èŽk1, Ž
ŒŽ@~, “n粒B–ç, ‚“ˆ—Í–í, ‚‹Ž—Sˆê˜Y, –å˜e˜ab (1”å”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï
(2010/4/29), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 260.

723666. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) is«t×–EŠà‚ɑ΂·‚éSorafenib‚É‚æ‚é”畆Çó‚Ì—Õ
°•a—Šw“IŒŸ“¢. ’r“cŸb1, Šâ‘º³Žk2, ŽOˆäƒá3, “c”šŒ’ˆê2, “¡“c“N•v2, “c•ÓŒ’ˆê2, Ÿ‰ªŒ›¶
2, ”nêŽu˜Y2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2”å”AŠí, 3”畆): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/29),
·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 272.

723667. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚ÌŒ£tˆÚA‚É‚š‚¯‚鍂—îŽÒƒhƒi[‚̐¬Ñ. ø‹Œû@‘å
1, ‹g“cˆê¬1, Îˆä‘å•ã1, ‘åŽR“N•œ1, –ìŒû•¶”T, ’r“c¬], •ÊŠ‰pŽ¡1, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å
”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/29), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 295.

723668. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œo’Œ’°“I‘O—§‘B¶ŒŸ‚É‚š‚¯‚édeep apical biopsy: T1c‘O—§‘BŠà‚É
‘΂·‚é—LŒø«‚ÌŒŸ“¢. ‘OŽR—Ç‘Ÿ1, ²“¡ˆÐ•¶1, Œ–{˜a«1, “c”šŒ’ˆê1, ŽR‰º‰p”V1, •ÊŠ‰pŽ¡1, ’r“c
Ÿb2, Šâ‘º³Žk1, –öàVM”V3, ‰ªˆÀ@ŒM3, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3•a—): ‘æ
98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/29), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 406.

723669. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒnƒCƒŠƒXƒN‘O—§‘BŠà‚ɑ΂·‚é“à•ª”å—Ö@•¹—p‚É‚æ‚éHDR
brachytherapy‚ÌŽ¡—ЬÑ. ‘åŽR“N•œ1, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, “c”šŒ’ˆê1, –k–ì‰ëŽj, ù–{Ž¡Žq1, •Ê
Š‰pŽ¡1, ‘呐@—m1, Œ–{˜a«1, “¡“c“N•v1, ¬’J³Žq2, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽË
ü (Žîá‡)): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/29), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 419.

723670. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) t×–EŠà‚ɑ΂·‚é• o‹Ÿ‰ºªŽ¡“It“Eœp‚É‚š‚¯‚é’·Šú—\Œã‚ÌŒŸ“¢.
Œ“c‘å‰î1, Šâ‘º³Žk1, “¡“c“N•v1, ù–{Ž¡Žq1, “c”šŒ’ˆê1, ìã’B‰›, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å
”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/29), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 422.

723671. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒnƒCƒŠƒXƒN‘O—§‘BŠà‚ɑ΂·‚éƒlƒIƒAƒWƒ…ƒoƒ“ƒgˆâ“`ŽqŽ¡
—Â̌Ÿ“¢. •ÊŠ‰pŽ¡1, ²“¡ˆÐ•¶1, ‹v•Û@œ, –öàVM”V2, “c”šŒ’ˆê1, Œ–{˜a«1, ²“¡ŠG—¢“Þ, Šâ‘º
³Žk1, ¬”Š•¶–í3, ‰ªˆÀ@ŒM2, “ߐ{•Û—F, Œö•¶—T›ß, ”nêŽu˜Y1 (1”å”AŠí, 2•a—, 3ˆã—Éq¶Šw•”):
‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/30), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 300.

723672. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Žîᇌa‚ƗՏ°f’f‚ª• o‹Ÿ‰º•›t“Eœp‚̗Տ°•a—Œ‹‰Ê
‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä. ù–{Ž¡Žq1, Šâ‘º³Žk1, “¡“c“N•v1, “y‹Ž³l1, “ì“c@—@2, ’r“cŸb2, •Ê
Š‰pŽ¡1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï
(2010/4/30), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 317.

723673. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒãŠú‚—îŽÒ‚È‚ç‚Ñ‚É’Ž‚—îŽÒ‚É‚š‚¯‚鐫‹@”\‚ÌŒŸ“¢. –Ø
‘º«‹M1, ™“c@“Ö1, ²“¡ˆÐ•¶1, Žu‘º@“N, ™“c‰ÀŽq, ø‹Œû@‘å1, ‘OŽR—Ç‘Ÿ1, “y‹Ž³l1, ”nêŽu
˜Y1 (1”å”AŠí: )‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/30), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 318.

723674. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒCƒ“ƒtƒ‹ƒGƒ“ƒU—\–h‚Ì‚œ‚ß‚Ì•sD•zƒ}ƒXƒNŽg—p‚̃Gƒrƒfƒ“ƒX (ŒŒ‰t
“§Í—á‚Å‚ÌŒŸ“¢). •º“¡@“§, Žáˆä—zŠó1, ‘呐@—m1, “c”šŒ’ˆê1, Œ–{˜a«1, ’|ìŸŽ¡, Îˆä‘å•ã1,
‹g“cˆê¬1, “à“c–Lº, Žðˆä@‹Š1, “ú‘ä‰p—Y, ”nêŽu˜Y1 (1”å”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï
(2010/4/30), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 461.

723675. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) is«t×–EŠà‚ɑ΂·‚éƒ\ƒ‰ƒtƒFƒjƒuEƒXƒjƒ`ƒjƒuŒð‘֗Ö@‚ÌŒŸ“¢.
“¡“c“N•v1, Šâ‘º³Žk1, ’r“cŸb2, ù–{Ž¡Žq1, “c”šŒ’ˆê1, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1
”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/30), ·‰ª, “ú”å”A‰ïŽ 2010; 101
(2): 479.

723676. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆÙ‚È‚é‘gDŒ^‚ð’悵‚œ“¯‘€“¯Žž«t×–EŠà‚Ì3—á. “¿ŽR‰ÀŽq1, “¡
“c“N•v1, ‘OŽR—Ç‘Ÿ1, ™“c@“Ö1, “y‹Ž³l1, “c”šŒ’ˆê1, Œ–{˜a«1, Šâ‘º³Žk1, ‹g“cˆê¬1, ”nê
Žu˜Y1 (1”å”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/30), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 480.

723677. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éstage I”ñƒZƒ~ƒm[ƒ}‚̗Տ°ŒŸ“¢. “c”šŒ’ˆê1, ’r“c
Ÿb2, •ÊŠ‰pŽ¡1, “y‹Ž³l1, Îˆä‘å•ã1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@
ˆã—ÃŒnŒ€‹†‰È): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/30), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 487.

723678. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ž‘ƒ¬n‚Ì‚€–EŠïŒ`Žî‚̈««“]‰»‚Ì1—á. ‰œ–ì‹I•F1, –{“c’ŒN (1
”å”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/30), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 488.

723679. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Structual maintenance of chromsomes 3‚ÌäNã÷ŠàV‹KŽîᇃ}[ƒJ
[‚Æ‚µ‚Ä‚Ì—L—p«‚ÌŒŸ“¢. ‘呐@—m1, Œ–{˜a«1, •ž•”@Šw, ¬Ž›‹`’j, “ì“c@—@2, ‘å‹Ž˜a–ç, ì“‡
—S‰î, ²“¡ŠG—¢“Þ, “¡“c“N•v1, Šâ‘º³Žk1, ‘åÎ³“¹, ‘O“c’‰Œv3, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@ˆã
—ÃŒnŒ€‹†‰È, 3—Šw•”): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (2010/4/30), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2):
491.

723680. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ä”­“«ëŒ\ƒRƒ“ƒWƒ[ƒ}‚ÉŠÖ‚·‚镪Žq¶•šŠw“I‰ðÍ. ™“c@“Ö
1, Œ–{˜a«1, –k—¢‰p˜Y2, àV‘º³”V, ŒŽ@˜a–î, Œ@·G1, ‘呐@—m1, “¡é‹M‹³1, “¡“c“N•v1, ²
“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí‰È, 2ˆã—Éq¶Šw•”): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï
(2010/4/30), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 491.

723681. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) äNã÷‘gD‚É‚š‚¯‚éVEGF-C‚š‚æ‚ÑVEGFR-3”­Œ»‚ÉŠÖ‚·‚錟“¢. ²“¡
ŠG—¢“Þ, Œ–{˜a«1, ’r“cŸb2, “ì“c@—@2, “y‹Ž³l1, “c”šŒ’ˆê1, Ÿ“c^s1, •º“¡@“§, “¡“c“N
•v1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw
‰ï‘‰ï (2010/4/30), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 494.

723682. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “û—cŽ™”A˜HŒ‹ÎÇ‚ɑ΂·‚é”jÓŽ¡—ÃŒø‰Ê‚ÌŒŸ“¢. Œ@·G1, ŠÛ@
“T•v, •œˆäËŽi, Îì@–í1, “y‹Ž³l1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ98‰ñ“ú–{”å”AŠí‰ÈŠw
‰ï‘‰ï (2010/4/30), ·‰ª, “ú”å”A‰ïŽ 2010; 101 (2): 502.

723683. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Žîᇌa‚ƗՏ°f’f‚ª• o‹Ÿ‰º•›t“Eœp‚̗Տ°•a—Œ‹‰Ê‚É‹y‚Ú‚·‰e
‹¿‚ɂ‚¢‚Ä. ù–{Ž¡Žq1, Šâ‘º³Žk1, “¡“c“N•v1, ŽR“c‘׎j1, “ì“c@—@2, ‹g“cˆê¬1, ”nêŽu˜Y1 (1
”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ22‰ñ“ú–{“à•ª”åŠO‰ÈŠw‰ï‘‰ï (2010/6/11), ‘åã.

723684. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’YŽ_ƒ‰ƒ“ƒ^ƒ““Š—^6ƒJŒŽŠÔ‚Å‚ÌŠ¥“®–¬ÎŠD‰»Žw”‚̕ω».
•º“¡@“§, “ú‘ä‰p—Y, Žáˆä—zŠó1, •œ—Ç—²•Û, Šp“c—²r, ‹g“cˆê¬1, ”nêŽu˜Y1, Žðˆä@‹Š1 (1”å”AŠí):
‘æ53‰ñ“ú–{t‘ŸŠw‰ïŠwpW‰ïE‘‰ï (2010/6/16), _ŒË.

723685. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) HDŠ³ŽÒ‚É‚š‚¯‚é‚€‚•aƒXƒNƒŠ[ƒjƒ“ƒOƒc[ƒ‹BDI-2 (Beck
Depression Inventory) ‚ÆCES-D (the Center for Epidemiologic Studies Depression Scale) ‚Æ‚Ì‘ŠŠÖ.
ŽR–{ƒXƒ~Žq, •º“¡@“§, ’|‘º@“O, Žáˆä—zŠó1, •œ—Ç—²•Û, ‹g“cˆê¬1, ”nêŽu˜Y1, “ú‘ä‰p—Y, Žðˆä@‹Š
1, ‰ª”ü’q‘ã (1”å”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/18), _ŒË, “§Í‰ïŽ 2010; 43
(Supplement 1): 360.

723686. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) HDŠ³ŽÒ‚É‚š‚¯‚é‚€‚•aƒXƒNƒŠ[ƒjƒ“ƒOƒc[ƒ‹Beck
Depression Inventory (BDI-2) ‚ÌŒoŽž•Ï‰»‚ÌŠÏŽ@. ŽR–{ƒXƒ~Žq, •º“¡@“§, ’|‘º@“O, —Lˆä’B˜Y, ùì@
¬, “y“c–š”ü1, {“¡—˜—Y1, Ÿ“c^s1, ‚“ˆ—Í–í1, ’؈ärŽ÷1, ‰““¡’‰—Y, “à“c–Lº, ‹g“cˆê¬1, ”n
êŽu˜Y1, “ú‘ä‰p—Y, ‰ª”ü’q‘ã (1”å”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/18), _ŒË,
“§Í‰ïŽ 2010; 43 (Supplement 1): 360.

723687. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œ”­«ùN–EtÇ (PKD) ‚Å‚Ì“Eot‚É‚š‚¯‚étŠà‚ÌŒŸ“¢.
Îˆä‘å•ã1, ‹g“cˆê¬1, ‘OŽR—Ç‘Ÿ1, “¿ŽR‰ÀŽq1, ‘åŽR“N•œ1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ
55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/18), _ŒË, “§Í‰ïŽ 2010; 43 (Supplement 1): 370.

723688. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’YŽ_ƒ‰ƒ“ƒ^ƒ“‚̐HŽ–’†‚ƐH’ŒŒã“Š—^‚É‚š‚¯‚郊ƒ“‹z’…Œø
‰Ê‚Ì”äŠr. •º“¡@“§, X@—²Ži, –Ø‘º«‹M1, ²“¡ˆÐ•¶1, Žu‘º@“N, •œŽR‹M”Ž1, “¡“c“N•v1, ŽR‰º‰p
”V1, ’|ìŸŽ¡, ‹g“cˆê¬1, “à“c–Lº, ”nêŽu˜Y1 (1”å”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï
(2010/6/18), _ŒË, “§Í‰ïŽ 2010; 43 (Supplement 1): 383.

723689. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _“ސìtˆÚAƒŒƒVƒsƒGƒ“ƒgƒR[ƒfƒBƒl[ƒ^[‚̉ïv‚Ì—§
‚¿ã‚°‚ɂ‚¢‚Ä. ’r“c¬], –ìŒû•¶”T, ’†–ڐ^—Žq, ¬âŽu•Û, ã–ì˜a”ü, ‹g“cˆê¬1, Îˆä‘å•ã1, —Í
Î’C–ç, ²X–؏G˜Y, ŠÛˆä—S“ñ (1”å”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/18), _ŒË,
“§Í‰ïŽ 2010; 43 (Supplement 1): 441.

723690. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “§ÍH’†‚Ì’`”’Ž¿1 g‚̓Šƒ“15 mg‚É‘Š“–‚·‚é‚ÉŠÖ‚·‚éŠe‘‚ÌŒ£—§
W‚©‚ç‚Ì•¶Œ£“IŒ€‹†. ìãƒŽq, •º“¡@“§, ›‰Æ@K, ²“¡Œb”üŽq, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí):
‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/18), _ŒË, “§Í‰ïŽ 2010; 43 (Supplement 1): 658.

723691. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) •Û‘¶Šú–«t•s‘S‚É‚š‚¯‚鍂”Z“xH•š‘@ˆÛŠÜ—L’á’`”’ƒNƒbƒL[
(RKF-1) ‚ª—L—p‚Å‚ ‚Á‚œ1Ç—á (28ƒ–ŒŽŠÔ‚ÌŠÏŽ@). ²“¡Œb”üŽq, •º“¡@“§, •œ—Ç—²•Û, ç—t“N’j, ‹g“c
ˆê¬1, Žðˆä@‹Š1, ”nêŽu˜Y1, “ú‘ä‰p—Y (1”å”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/18),
_ŒË, “§Í‰ïŽ 2010; 43 (Supplement 1): 658

723692. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –«ŒŒ‰t“§ÍŠ³ŽÒ‚ÌŽ‰Ž¿‘ãŽÓˆÙí‚ɑ΂·‚éƒGƒ[ƒ`ƒ~ƒu‚ÌŒø‰Ê. •œ—Ç
—²•Û, •º“¡@“§, Žáˆä—zŠó1, ç—t“N’j, “ú‘ä‰p—Y, •œ–ì@•× (1”å”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwp
W‰ïE‘‰ï (2010/6/18), _ŒË, “§Í‰ïŽ 2010; 43 (Supplement 1): 687.

723693. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ô‰è‹…ᔂɂš‚¯‚éŒoŒûƒLƒŒ[ƒgÜƒGƒNƒWƒFƒCƒh“Š—^Œã‚ÌŠeŽí“§Í—Ã
–@‚É‚æ‚é“Sœ‹Ž—Ê‚Ì”äŠr. –]ŒŽç‰êŽq, •º“¡@“§, ‘Ÿ“c¹–M, ‰ÍŒŽƒŽq, ‰ÁìN_, ŒIŒŽ³ŒÈ, –{ŠÔ@’,
‘呐@—m1, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1, Žðˆä@‹Š1, “ú‘ä‰p—Y (1”å”AŠí): ‘æ55‰ñ“ú–{“§Í
ˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/18), _ŒË, “§Í‰ïŽ 2010; 43 (Supplement 1): 695.

723694. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒvŽZŽ®‚©‚狁‚ß‚œƒJƒŠƒEƒ€, ƒŠƒ“, ‰–•ªÛŽæ—ʂƐHŽ–‹L
˜^‚Ƃ̍·‚ðl‚Š, ¡Œã‚̉h—{•]‰¿í—ª‚ɑ΂·‚éˆêlŽ@. ²“¡Œb”üŽq, •º“¡@“§, •œ—Ç—²•Û, ç—t“N’j, ‹g
“cˆê¬1, ŽR–{ƒXƒ~Žq, “n•Ó‹žŽq, Žðˆä@‹Š1, ‚‹Žˆê‘Ÿ˜Y, ìãƒŽq, ”nêŽu˜Y1, “ú‘ä‰p—Y (1”å”AŠí):
‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/20), _ŒË, “§Í‰ïŽ 2010; 43 (Supplement 1): 588.

723695. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œo• –Œ“I• o‹Ÿ‰ºt“EœpŒã‚É• –Œ“§ÍÄ“±“ü‰Â”\‚Å‚ 
‚Á‚œ1—á. ‘OŽR—Ç‘Ÿ1, ø‹Œû@‘å1, Îˆä‘å•ã1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ55‰ñ“ú–{“§Í
ˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/20), _ŒË, “§Í‰ïŽ 2010; 43 (Supplement 1): 602.

723696. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŒ‰t“§ÍŠ³ŽÒ‚̔畆@áyÇ‚ɑ΂·‚éƒiƒ‹ƒtƒ‰ƒtƒBƒ“‰–Ž_‰– (ƒŒƒ~ƒb
ƒ`ƒJƒvƒZƒ‹Ò) ‚ÌŒø‰Ê. ²“¡’Œ”V, •º“¡@“§, ŽR–{ƒXƒ~Žq, Žáˆä—zŠó1, •œ—Ç—²•Û, ‹g“cˆê¬1, ”nêŽu
˜Y1, Žðˆä@‹Š1 (1”å”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/20), _ŒË, “§Í‰ïŽ 2010;
43 (Supplement 1): 781.

723697. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) IVŒ^ƒ_ƒCƒAƒ‰ƒCƒUPES-21Eƒ¿‚ÆVŒ^ƒ_ƒCƒAƒ‰ƒCƒUPES-17Sƒ¿‚̗Տ°
«”\”äŠr. Â–Ø–ÎŽ÷, ‚‹Ž—Tˆê˜Y, –ìŒû•¶”T, ’r“c¬], ‘OŽR—Ç‘Ÿ1, “¿ŽR‰ÀŽq1, Îˆä‘å•ã1, ‹g“cˆê
¬1, ‚‹Ž_—Y, ‹{–{‰Ã‘×, —é–؁@‘å, Šp“c—²r (1”å”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï
(2010/6/20), _ŒË, “§Í‰ïŽ 2010; 43 (Supplement 1): 789.

723698. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒpƒ“ƒfƒ~ƒbƒN‰º‚ł̃}ƒXƒN‘•’…—Š, ŠŽ–`Çó”­
Œ»—Š, v‘¬f’fƒLƒbƒg—z«—Š‚ÌŒŸ“¢. ²“¡’Œ”V, •º“¡@“§, ŽR–{ƒXƒ~Žq, Žáˆä—zŠó1, •œ—Ç—²•Û, ‹g“cˆê
¬1, ”nêŽu˜Y1, Žðˆä@‹Š1 (1”å”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/20), _ŒË, “§
Í‰ïŽ 2010; 43 (Supplement 1): 807.

723699. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŒ‰t“§ÍŠ³ŽÒ‚É‚š‚¯‚éŽct‹@”\‚̈Ӌ`. ‰ÍŒŽƒŽq, •º“¡@“§, –]ŒŽ
ç‰êŽq, ‘Ÿ“c¹–M, ‹à‰ªNs, ŒIŒŽ³ŒÈ, –{ŠÔ@’, “c”šŒ’ˆê1, Îˆä‘å•ã1, ‹g“cˆê¬1, ”nêŽu˜Y1, Žð
ˆä@‹Š1, “ú‘ä‰p—Y (1”å”AŠí): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/6/20), _ŒË, “§Í‰ïŽ
2010; 43 (Supplement 1): 813.

723700 [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) t᱔AŠÇˆÚs•”‚Ì”AŠÇƒ|ƒŠ[ƒv‚ɑ΂µ‚Ä• o‹Ÿ‰ºt᱌`¬p‚ðŽ{s
‚µ‚œ2—á. Œ@·G1, Šâ‘º³Žk1, ”nêŽu˜Y1, ‘v@¬_ (1”å”AŠí): ‘æ19‰ñ“ú–{¬Ž™”å”AŠí‰ÈŠw‰ï
‘‰ï (2010/7/2), ŽD–y, “ú–{¬Ž™”å”AŠí‰ÈŠw‰ïŽGŽ 2010; 19 (2):112.

723701. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ^ƒ_ƒ‰ƒtƒBƒ‹‚Ì—LŒø«‚ƈÀ‘S«‚ÌŒŸ“¢‚š‚æ‚ÑŠ³ŽÒS—‚Ö
‚̉e‹¿. ŽR–{Œ’˜Y, ²X–؏t–Ÿ, Žu‘º@“N, Œã“¡—²‘Ÿ, [àV@—§, ÎìŒöN, aŒûG”V1, X“c@‡, –ƒ
¶‘Ÿs, Â–ØŒcˆê˜Y, ‘Ÿ“c“¹–ç (1”å”AŠí): “ú–{«‹@”\Šw‰ï‘æ21‰ñŠwp‘‰ï (2010/8/29), –ŒŒÃ‰®, “ú
–{«‹@”\Šw‰ïŽGŽ 2010; 25 (2): 226-7.

723702. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —«œ”Õ’êŽèp‚É‚š‚¯‚éƒoƒŠƒAƒ“ƒX•ªÍ. {è^ŽÀ, â
–{”ü‰À, ”ä—¯ŠÔ‚ ‚ä‚Ý, ˆäã‰pŽq, “ú‹Ž‰fŽq, ‘åì‚ ‚³Žq, Œ“c‘å‰î1, ìã’B‰› (1”å”AŠí): ‘æ17‰ñ
“ú–{”r”A‹@”\Šw‰ï (2010/9/30), ŽR—œ, “ú–{”r”A‹@”\Šw‰ïŽ 2010; 21 (1): 216.

723703. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _Œo‰·‘¶• o‹Ÿ‰º‘O—§‘B‘S“EpŽ{sÇ—á‚Ì•a—Šw“IŒŸ“¢.
‘å“Œ‹MŽu, ‰z“c’|˜N, ŽR‰º‰p”V1, rì@F (1”å”AŠí): ‘æ23‰ñ“ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ï‘‰ï (2010/10/19),
‰¡•l, “ú–{“àŽ‹‹ŸŠO‰ÈŠw‰ïŽGŽ 2010; 15 (7): 452.

723704. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ¶‘̐tˆÚAŒã10”N–Ú‚É”]‚ɐ¶‚¶‚œLymphomatoid granulomatosis‚Ì
1—á. Îˆä‘å•ã1, ‹g“cˆê¬1, –]ŒŽN•œ1, ‘OŽR—Ç‘Ÿ1, “y‹Ž³l1, ø‹Œû@‘å1, Žáˆä—zŠó1, ’|“àN
—Y2, ”nêŽu˜Y1, Šp“c—TŽq3, ‰F’Öؑ4 (1”å”AŠí, 2t‘Ÿ“à, 3—AŒŒE×–EˆÚA, 4”]ŠO): ‘æ46‰ñ“ú
–{ˆÚAŠw‰ï‘‰ï (2010/10/22), ‹ž“s, “ú–{ˆÚAŠw‰ïŽGŽ 2010; 45: 304.

723705. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) _“ސìtˆÚAƒŒƒVƒsƒGƒ“ƒgˆÚAƒR[ƒfƒBƒl[ƒ^[ (RTC) ‚̉ï‚ð’Ê‚¶
‚Ă̈ڐA’nˆæˆã—Â̋Š—͑̐§‚­‚è. ’r“c¬], –ìŒû•¶”T, ’†–ڐ^—Žq, ã–ì˜a”ü, ¬âŽu•Û, ‹g“cˆê
¬1, Îˆä‘å•ã1, —͐ΒC–ç, ²X–؏G˜Y, ŠÛˆä—S“ñ (1”å”AŠí): ‘æ46‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2010/10/22),
‹ž“s, “ú–{ˆÚAŠw‰ïŽGŽ 2010; 45: 346.

723706. [Šw‰ï (‘S‘)] (ƒrƒfƒI) HoLEP; ‰ð–U‚ðˆÓŽ¯‚µ‚œŠjo–@. ÝŠy•q–ç, •œŽR‹M”Ž1, Žá“c•”—zŽi
1, ‹v•Û¯ˆê, Îì—²‘Ÿ, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ24‰ñ“ú–{EndourologyEESWL
Šw‰ï‘‰ï (2010/10/22), ‹ž“s, Japanese Journal of Endourology and ESWL 2010; 23 (3): 147.

723707. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢Œ€‹†Š•a‰@‚É‚š‚¯‚éESWL (DornierŽÐ»Delta II) Œã
‚̐t”í–Œ‰ºŒŒŽî, tŽüˆÍŒŒŽîÇ—á‚ÌŒŸ“¢. —äˆä’èŽk1, “y‹Ž³l1, ‘ºã‘אŽ1, Žá“c•”—zŽi1, Îˆä~
ˆê˜Y1, “ü]@Œ[1, —äˆä’è‹I (1”å”AŠí): ‘æ24‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï (2010/10/22), ‹ž
“s, Japanese Journal of Endourology and ESWL 2010; 23 (3): 160.

723708. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚é• o‹Ÿ‰ºªŽ¡“I‘O—§‘B“Eœp; 10
”NŠÔ‚̗Տ°¬Ñ. “c”šŒ’ˆê1, Šâ‘º³Žk1, ²“¡ˆÐ•¶1, Œ@·G1, “y‹Ž³l1, ¬—ÑŒ’‘Ÿ˜Y1, •ÊŠ‰p
Ž¡1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ24‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï (2010/10/22), ‹ž“s, Japanese
Journal of Endourology and ESWL 2010; 23 (3): 186.

723709. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) HoLEP (Holmium Laser enucleation of the prostate) pŒã”A“¹‹·
óÇ‚ɑ΂·‚éŽèpŽè‹Z‚ÌŒŸ“¢. Žá“c•”—zŽi1, ÝŠy•q–ç, •œŽR‹M”Ž1, “¡“c“N•v1, Šâ‘º³Žk1, ‹v•Û¯
ˆê, ”nêŽu˜Y1 (1”å”AŠí): ‘æ24‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï (2010/10/22), ‹ž“s, Japanese
Journal of Endourology and ESWL 2010; 23 (3): 214.

723710. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) åœ•\–Ê“d‹CŽhŒƒ (ssTES) ‚É‚æ‚é• o‹Ÿ‰ºªŽ¡“I‘O—§‘B“EœpŒã‚Ì
• ˆ³«”AŽž‹Ö‘Šú‰ü‘PŒø‰Ê‚ÌŒŸ“¢. Œ@·G1, Šâ‘º³Žk1, “c”šŒ’ˆê1, ²“¡ˆÐ•¶1, Œ–{˜a«1, “¡“c
“N•v1, Îˆä‘å•ã1, ’r“cŸb2, •ÊŠ‰pŽ¡1, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ24‰ñ“ú
–{EndourologyEESWLŠw‰ï‘‰ï (2010/10/22), ‹ž“s, Japanese Journal of Endourology and ESWL 2010;
23 (3): 232.

723711. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “§ÍŠ³ŽÒ‚É‚š‚¯‚鋐‘åùN–Et‚Ì• o‹Ÿ‰ºt“Eœp‚ÌŒŸ“¢.
Îˆä‘å•ã1, ‹g“cˆê¬1, –]ŒŽN•œ1, ¬—ÑŒ’‘Ÿ˜Y1, “c”šŒ’ˆê1, “¡“c“N•v1, Œ@·G1, Šâ‘º³Žk1, ”n
êŽu˜Y1 (1”å”AŠí): ‘æ24‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï (2010/10/23), ‹ž“s, Japanese Journal
of Endourology and ESWL 2010; 23 (3): 166.

723712. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚ł̃ˆƒE‘f125‰i‹v‘}“ü–§••¬üŒ¹—Ö@‚É‚š‚¯‚ép
‘O“à•ª”å—Ö@‚̉e‹¿. ’ѺGN1, ²“¡ˆÐ•¶1, “c”šŒ’ˆê1, “¡“c“N•v1, Œ–{˜a«1, ÎŽR”ŽžŠ2, ¬’J
³Žq2, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡)): ‘æ24‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï
(2010/10/23), ‹ž“s, Japanese Journal of Endourology and ESWL 2010; 23 (3): 204.

723713. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠOÆŽËÄ”­‘O—§‘BŠà‚ɑ΂·‚éFocal Salvage HDR
brachytherapy‚ÌŒŸ“¢. ²“¡ˆÐ•¶1, “c”šŒ’ˆê1, –Ø‘º«‹M1, •ÊŠ‰pŽ¡1, Œ–{˜a«1, –k–ì‰ëŽj, ÎŽR
”ŽžŠ2, ¬’J³Žq2, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡)): ‘æ24‰ñ“ú–{EndourologyE
ESWLŠw‰ï‘‰ï (2010/10/23), ‹ž“s, Japanese Journal of Endourology and ESWL 2010; 23 (3): 204.

723714. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) • o‹Ÿ‰ºªŽ¡“It“Eœp‚É‚š‚¯‚é•a—•aŠú‚̉e‹¿. “¡“c“N•v1, Šâ
‘º³Žk1, “y‹Ž³l1, Îˆä‘å•ã1, “c”šŒ’ˆê1, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ24
‰ñ“ú–{EndourologyEESWLŠw‰ï‘‰ï (2010/10/23), ‹ž“s, Japanese Journal of Endourology and ESWL 2010;
23 (3): 240.

723715. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MVAC‘ϐ«isäNã÷Šà‚ɑ΂·‚éƒe[ƒ‰[ƒƒCƒhŠàƒyƒvƒ`ƒh
ƒƒNƒ`ƒ“—Ö@?Phase I study. Œ–{˜a«1, –ìŒû³“T, ²“¡ˆÐ•¶1, “c”šŒ’ˆê1, “¡“c“N•v1, Šâ‘º³Žk
1, ŽR“c@—º, ¬Œœ˜a, ”nêŽu˜Y1, ˆÉ“Œ‹±Œå (1”å”AŠí): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/29),
‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2010; 45 (2): 510.

723716. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) is«t×–EŠà‚ɑ΂·‚éƒXƒjƒ`ƒjƒu“Š—^‚ÌŒŸ“¢. “¡“c“N•v1, Šâ‘º
³Žk1, ’r“cŸb2, “c”šŒ’ˆê1, Îˆä‘å•ã1, Œ–{˜a«1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@
ˆã—ÃŒnŒ€‹†‰È): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/29), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2010; 45 (2):
930.

723717. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) is«äNã÷Šà‚ɑ΂·‚éM-VAC•¹—p‰»Šw•úŽËü—Ö@‚ÌŒŸ“¢. ’r“cŸb
1, Œ–{˜a«2, V•”@÷3, “c”šŒ’ˆê2, ²“¡ˆÐ•¶2, Šâ‘º³Žk2, ÎŽR”ŽžŠ3, ¬’J³Žq3, ‘ì˜ad3,
”nêŽu˜Y2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2”å”AŠí, 3•úŽËü (Žîá‡)): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï
(2010/10/30), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2010; 45 (2): 1046.

723718. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) tˆÚAŒã‚̍ē±“ü‚É• –Œ“§Í‚ð‘I‘ð‚µ‚œÇ—á‚ÌŒŸ“¢. Îˆä‘å•ã1,
‹g“cˆê¬1, –]ŒŽN•œ1, ¬—ÑŒ’‘Ÿ˜Y1, ‘OŽR—Ç‘Ÿ1, “y‹Ž³l1, •âáÁ“ñ1, “c”šŒ’ˆê1, ‰““¡’‰—Y, ”n
êŽu˜Y1 (1”å”AŠí): ‘æ16‰ñ“ú–{• –Œ“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/11/6), ‘啪.

723719. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) • o‹Ÿ‰ºt“EœpŒã‚É• –Œ“§ÍÄ“±“ü‚ð‰Â”\‚Å‚ ‚Á‚œˆê
Ç—á. Îˆä‘å•ã1, ‹g“cˆê¬1, ‘OŽR—Ç‘Ÿ1, ¬—ÑŒ’‘Ÿ˜Y1, •âáÁ“ñ1, Œ@·G1, “¡“c“N•v1, Šâ‘º
³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ16‰ñ“ú–{• –Œ“§ÍˆãŠw‰ïŠwpW‰ïE‘‰ï (2010/11/6), ‘啪.

723720. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éŒo”A“¹“IäNã÷Žîᇐ؏œpƒNƒŠƒjƒJƒ‹ƒpƒX‚Ì
—L—p«‚ÌŒŸ“¢. ‘呐@—m1, “¡é‹M‹³1, ™“c@“Ö1, ‘OŽR—Ç‘Ÿ1, Œã“¡O], ²“¡•ä, ‚–ì–õŒå (1”å
”AŠí): ‘æ11‰ñ“ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ï (2010/12/3), ŒŽR.

723721. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚épreemtivetˆÚAÇ—á‚ÌŒŸ“¢. Îˆä‘å•ã
1, ‹g“cˆê¬1, ¬—ÑŒ’‘Ÿ˜Y1, –]ŒŽN•œ1, “y‹Ž³l1, •âáÁ“ñ1, Žáˆä—zŠó1, ’|“àN—Y2, ‰““¡’‰—Y,
”nêŽu˜Y1 (1”å”AŠí, 2t‘Ÿ“à): ‘æ44‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2011/1/27), •ºŒÉ.

723722. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’†•_ŒoŒn‚ɏoŒ»‚µ‚œPTLD‚Ì3—á. •âáÁ“ñ1, Îˆä
‘å•ã1, ŽR“c‘׎j1, ‹àŽqŽu•Û1, ’r“cŸb2, –ìŒû•¶”T, ’|“àN—Y3, ‹g“cˆê¬1, ‰““¡’‰—Y, ”nêŽu˜Y1
(1”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3t‘Ÿ“à): ‘æ44‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2011/1/27), •ºŒÉ.

723723. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@tˆÚAŠ³ŽÒ‰ï‚Ƃ̈ê”ÊŽs–¯‚Ö‚Ì‘ŸŠíˆÚA•
‹yŒ[”­Šˆ“®. ’r“c¬], ‹g“cˆê¬1, Îˆä‘å•ã1, –ìŒû•¶”T, ‚‹Ž@Œb, rì–@Žq, ’[ŽR˜a”ü, “ü–Ø‹GŒb,
‘ì˜ad2, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡)): ‘æ44‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2011/1/27),
•ºŒÉ.

723724. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RTC‚É‚æ‚éˆÚAŠÅŒìEŠ³ŽÒŽx‰‡‚Ì’nˆæ“à‹€’ʉ»‚ÌŽŽ‚Ý. –ì
Œû•¶”T, ’r“c¬], “c’†”üŽ÷, ¯–ì^ƒ, ¬âŽu•Û, ‹g“cˆê¬1 (1”å”AŠí): ‘æ44‰ñ“ú–{—Տ°tˆÚAŠw
‰ï (2011/1/28), •ºŒÉ.

723725. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tˆÚA‚É‚š‚¯‚鍂—p—ʃ~ƒ]ƒŠƒrƒ“‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢
(‘æ3•ñ). ‹g“cˆê¬1, ’†ì@Œ’, ¯’·Ž—², ‘Šì@Œú, Ž³ŒËŽˆê˜Y, ‘åé‹g‘¥, ŸÇ–ì—F•F, ‘ºˆä@Ÿ, ’·
’Jìº (1”å”AŠí): ‘æ44‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2011/1/28), •ºŒÉ.

731092. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒ}ƒEƒXtˆÚAƒ‚ƒfƒ‹‚ÌŠm—§‚Æ‚»‚̍R‘ÌŠÖ˜AŒ^‹‘â”œ‰ž.
Îˆä‘å•ã (”å”AŠí): ‘æ19‰ñ_“ސìEˆÚAt•a—‚ð•×‹­‚·‚é‰ï (2010/5/22), ‰¡•l.

731093. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) t×–EŠà–ò•š—Ö@?ŽÀ—Տ°‰º‚Å‚ÌŽg—pŒoŒ±?. “¡“c“N•v
(”å”AŠí): ‘æ3‰ñ‚ª‚ñê–å–òÜŽtƒZƒ~ƒi[ (2010/6/25), ‰¡•l.

731094. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”å”AŠí‰È• o‹Ÿ‰ºŽèp: •›t“EœpEt“Eœp‚ÌŽŸ‚ð–Ú
Žw‚µ‚Ä. Šâ‘º³Žk (”å”AŠí): ‘æ28‰ñŠò•Œ”å”AŠí• o‹Ÿ‰ºƒvƒƒOƒ‰ƒ€ (2010/7/24), Šò•Œ.

731095. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –k—¢‘åŠw•a‰@‚ɉ—‚¯‚錣tˆÚA‚Æ‚»‚ÌŽx‰‡ƒVƒXƒeƒ€. ‹g
“cˆê¬1, Žáˆä—zŠó1, Îˆä‘å•ã1 (1”å”AŠí): ‘æ2‰ñ–k“Œ–ktˆÚA•×‹­‰ï (2010/8/7), O‘O.

731096. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘O—§‘BŽîá‡: ƒfƒ…ƒ^ƒXƒeƒ‰ƒCƒh‚̐V‚œ‚ȃAƒvƒ[ƒ`. ²
“¡ˆÐ•¶ (”å”AŠí): ƒAƒ{ƒ‹ƒu”­”„1Žü”N‹L”Ou‰‰‰ïin‘Š–ÍŒŽŒ§‰›’n‹æ (2010/9/22), ‘Š–ÍŒŽ.

731097. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Œ»Ý‚̐tˆÚAŽ–î?ˆÚA–@ˆÄ‰ü³‘OŒã?. ‹g“cˆê¬1, Žá
ˆä—zŠó1, Îˆä‘å•ã1 (1”å”AŠí): ‘æ21‰ñŒ”Z“§Í§˜b‰ï (2010/9/25), Šò•Œ.

731098. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”å”AŠí‰ÈŽèp‚Ì•Ï‘J‚Æ“W–]. Šâ‘º³Žk (”å”AŠí): ‘æ206
‰ñ”ªŒË”å”AŠí‰È’k˜b‰ïŠwpu‰‰‰ï (2010/10/1), ”ªŒË.

731099. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) tŠà?Œ»ó‚ƐV‚µ‚¢Ž¡—Â̒a¶?. Œ“c‘å‰î (”å”AŠí):
‘æ144‰ñ‘å˜a‰ïŒöŠJˆãŠwuÀ (2010/10/2), “Œ‘å˜a.

731100. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”å”AŠí‰È‚É‚š‚¯‚é’nˆæ˜AŒgƒNƒŠƒjƒJƒ‹ƒpƒX?Kitasato
Prostate Cancer Network: KP-Net‚̉^—p?. ²“¡ˆÐ•¶ (”å”AŠí): ”å”AŠí‚ª‚ñŽ¡—ÃZƒ~ƒi[ (2010/10/7),
L“‡.

731101. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘O—§‘BŠàŽ¡—Ã?Bone Health‚ւ̑Ήž. ²“¡ˆÐ•¶ (”å”A
Ší): •lŒ”å”AŠí‰ÈŠàœ“]ˆÚƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX (2010/10/15), •lŒ.

731102. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) —Տ°Œ€‹†No.1ÅI•ñ. Œ–{˜a« (”å”AŠí): ‘æ‚W‰ñ_
“ސì”å”AŠí‰ÈŠwŒ€‹†‰ï (2010/11/18), ‰¡•l.

731103. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘O—§‘BŠàf—Âɂš‚¯‚ébone health. ²“¡ˆÐ•¶ (”å”AŠí):
”å”AŠí‰È‚ª‚ñŠwpu‰‰‰ï (2010/12/9), Šò•Œ.

731104. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) G’m•s”\‘O—§‘BŠà (T1c) ‚̍čl. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ
1‰ñ‚¿‚ΐV¢‹I”å”AŠí‰ÈƒZƒ~ƒi[ (2011/1/12), ç—t.

731105. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‘O—§‘BŠàŽ¡—Â̍őOü. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ17‰ñ_
“ސì”å”AŠí‰Èf—ÏŠ§˜b‰ï (2011/2/26), ‰¡•l.

731106. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰ü³‘ŸŠíˆÚA–@ˆÄ‚Ì‘O‚ÆŒã?‰œ‚ª•Ï‚í‚è, ‰œ‚ª•Ï‚í‚Á‚Ä
‚¢‚È‚¢‚Ì‚©?. ‹g“cˆê¬1, Žáˆä—zŠó1, Îˆä‘å•ã1 (1”å”AŠí): ‘æ15‰ñ (•œ¬22”N“x) _“ސ쌧tŽŸ
Š³‘‡ˆã—ÃZƒ“ƒ^[E–k—¢‘åŠw•a‰@ŒŒ‰tò‰»ƒZƒ“ƒ^[‡“¯Œ€‹†‰ï (2011/2/27), ‘Š–ÍŒŽ.

732086. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) Œo‰ßŠÏŽ@E‡•¹Ç. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ12‰ñƒˆ
ƒE‘f125ƒV[ƒhüŒ¹‰i‹v‘}“ü‚É‚æ‚é‘O—§‘BŠà–§••¬üŒ¹—Ö@‹ZpuK‰ï (2010/6/12), “Œ‹ž.

732087. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ‘ŠúŽ€–S‘Ήž‚É‚š‚¯‚éƒKƒCƒhƒ‰ƒCƒ“‰ð
à. ²“¡ˆÐ•¶1, Â–؁@Šw, ‰oì@W, Ä“¡Žj˜Y, ²•ûŽü–V, a’J@‹Ï, ™‰Ya”V, ‚‹Ž@–L, ’†‘º@÷,
Œ‘º“N•v, •l“c’B“ñ, ŽO–؍PŽ¡, ŽR‰º@F, ŽR’†‰pšæ, ä݁@“ÄŒ›, “yŠí‰®‘ìŽu (1”å”AŠí): ‘æ7‰ñ‘O—§‘B
Šà–§••¬üŒ¹‰i‹v‘}“üŽ¡—ÃŒ€‹†‰ï (2010/7/18), “Œ‹ž.

732088. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Žs–¯ŒöŠJuÀ) ‘gD“àÆŽË‚ª—Ç‚¢—§ê‚©‚ç. ²“¡ˆÐ•¶ (”å”AŠí): Žs
–¯ŒöŠJuÀ‚ƃRƒ“ƒT[ƒg‚Ö‚Ì‚š—U‚¢ (2010/8/7), ‚è.

732089. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) EORTC-QLQ-BM22‚ÉŠÖ‚µ‚Ä. ²“¡ˆÐ•¶ (”å”AŠí): _“ސì
”å”AŠí‰ÈŠwŒ€‹†‰ï (‘O—§‘BŠàœ“]ˆÚáu’ÉŠÇ—‚É‚š‚¯‚錟“¢‰ï) (2010/9/30), ‰¡•l.

732090. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‘²Œã‹³ˆçƒvƒƒOƒ‰ƒ€) ”å”AŠí• o‹ŸŽèp‚ÌŠî–{Žè‹Z. Ž›’n•q˜Y, ì
Šì“c–rŽi, Šâ‘º³Žk1 (1”å”AŠí): ‘æ62‰ñ“ú–{”å”AŠí‰ÈŠw‰ïŒ“ú–{‘‰ï (2010/11/6), Ž­Ž™“‡.

732091. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Žs–¯ŒöŠJuÀ)u‘ŸŠí’ñ‹ŸEˆÚA‚ðl‚Š‚é_“ސì‚̉ïvŽåÃ Žs–¯Œö
ŠJuÀ2010‚ÌŠJÃ‚ÉŠñ‚¹‚Ä. ‹g“cˆê¬1, Žáˆä—zŠó1, Îˆä‘å•ã1 (1”å”AŠí):u‘ŸŠí’ñ‹ŸEˆÚA‚ðl‚Š
‚é_“ސì‚̉ïvŽåÃŽs–¯ŒöŠJuÀ2010 (2010/11/20), ‰¡•l.

732092. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) œ“]ˆÚ‚ɑ΂·‚é–ò•š—Ö@: bone health
‚ðŒ©˜‚Š‚œ‘Ήž. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ26‰ñ‘O—§‘BƒVƒ“ƒ|ƒWƒEƒ€ (2010/12/12), •iì.

732093. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™)u‘O—§‘BŠà¬üŒ¹—Ö@Œã1”NˆÈ“àŽ€–SŽž
‚̑Ήžƒ}ƒjƒ…ƒAƒ‹‰ü’èvVer1.2‚̉ðà. ²“¡ˆÐ•¶ (”å”AŠí): ‘æ6‰ñJ-POPS’†ŠÔ•ñ‰ï (2011/1/22), “Œ
‹ž.

732094. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) PSA (PSAƒoƒEƒ“ƒX, PSA’l•Ï“®). ²
“¡ˆÐ•¶ (”å”AŠí): ‘æ6‰ñJ-POPS’†ŠÔ•ñ‰ï (2011/1/22), “Œ‹ž.

732095. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Žs–¯ŒöŠJuÀ) tˆÚA‚̍ŐVŽ–î. Îˆä‘å•ã (”å”AŠí): “ú–{—Տ°
”å”AŠí‰Èˆã‰ï_“ސ암‰ï (2011/1/29), ‘Š–ÍŒŽ.

732096. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Žs–¯ŒöŠJuÀ) •p”A‚Ì‚š‚Í‚È‚µ. “¡é‹M‹³ (”å”AŠí): “ú–{—Տ°”å
”AŠí‰Èˆã‰ï_“ސ암‰ï (2011/1/29), ‘Š–ÍŒŽ.

732097. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] Žs–¯ŒöŠJuÀ) ‘O—§‘BŠà‚̍ŐVŽ–î. “c”šŒ’ˆê (”å”AŠí): “ú–{—Տ°
”å”AŠí‰Èˆã‰ï_“ސ암‰ï (2011/1/29), ‘Š–ÍŒŽ.

733282. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t‰Š‚É”AŠÇ‹·ó‚ð‡•¹‚µƒXƒeƒƒCƒhŽ¡—ÂŌy
‰õ‚µ7”NŒã‚ɍĔ­‚𗈂œ‚µ‚œ‚ªÄ“x“¯—Ö@‚ÅŒy‰õ‚µ‚œÇ—á. ¬—ÑŒ’‘Ÿ˜Y1, Îˆä‘å•ã1, –]ŒŽN•œ1, ø‹
Œû@‘å1, ‘OŽR—Ç‘Ÿ1, “c”šŒ’ˆê1, “¡“c“N•v1, Šâ‘º³Žk1, ‹g“cˆê¬1, ”nêŽu˜Y1, ’|“àN—Y2 (1”å
”AŠí, 2t‘Ÿ“à): ‘æ78‰ñ_“ސ쌧”å”AŠí‰Èˆã‰ï (2010/6/12), ìè.

733283. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶tŽüˆÍ‚æ‚è”­¶‚µ‚œ’E•ª‰»Œ^Ž‰–b“÷Žî‚̈ê
—á. ŽR‰º‰p”V1, ‰z“c’|˜N, rì@F, ‘å“Œ‹MŽu (1”å”AŠí): ‘æ602‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï
(2010/6/17), “Œ‹ž.

733284. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ\ƒ‰ƒtƒFƒjƒu (ƒlƒNƒTƒo[ƒ‹Ò) ‚É‚æ‚é–ò]‚Ì
‚S—á. “c•ÓŒ’ˆê1, ŽOˆäƒá2, ]“¡GŒõ, Ÿ‰ªŒ›¶2, Šâ‘º³Žk1 (1”å”AŠí, 2”畆): ‘æ830‰ñ“ú–{
”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï_“ސì (2010/6/19), _“ސì.

733285. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¶‘̐tˆÚAƒhƒi[‚É‚š‚¯‚épŒã’·Šú¬Ñ‚ÌŒŸ
“¢. ‘OŽR—Ç‘Ÿ1, Îˆä‘å•ã1, ø‹Œû@‘å1, “¡“c“N•v1, ’|“àN—Y2, –ìŒû•¶”T, Šâ‘º³Žk1, ‹g“cˆê¬1,
”nêŽu˜Y1 (1”å”AŠí, 2t‘Ÿ“à): ‘æ26‰ñtˆÚAEŒŒŠÇŠO‰ÈŒ€‹†‰ï (2010/6/26), Œ¢ŽR (ˆ€’m.

733286. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚鍪Ž¡“I‘O—§‘B“Eœp: 15
”N¬Ñ‚ÌŒŸ“¢. “c”šŒ’ˆê1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1, ‰oì@W, “à“c–Lº (1”å”AŠí): ‘æ
27‰ñ_“ސ쌧‘O—§‘BŽîᇌ€‹†‰ï (2010/7/3), ‰¡•l.

733287. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) T3CtŠà‚ɑ΂µ‚ÄNeoadjuvant‚Æ‚µ‚ăX[ƒe
ƒ“ƒg‚ð—p‚¢‚œÇ—á. ù–{Ž¡Žq (”å”AŠí): ‘æ1‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2010/7/16), ‘Š–ÍŒŽ.

733288. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒ\ƒ‰ƒtƒFƒjƒu‚É‚æ‚è’°ŠÇúE‚𗈂œ‚µ‚œˆêÇ
—á. Žá“c•”—zŽi (”å”AŠí): ‘æ1‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2010/7/16), ‘Š–ÍŒŽ.

733289. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹ŸŽ‹‰ºŽèp‚É‚š‚¯‚ép‘OŒŸž‚̏d—v«. Œ“c
‘å‰î (”å”AŠí): ‘æ1‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2010/7/16), ‘Š–ÍŒŽ.

733290. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tŠà‚̃vƒƒeƒI[ƒ€‰ðÍ. “ì“c@—@ (”å”AŠí):
‘æ1‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2010/7/16), ‘Š–ÍŒŽ.

733291. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t×–EŠà‚ɑ΂·‚镪Žq•W“IŽ¡—Ã. “¡“c“N•v (”å
”AŠí): ‘æ1‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2010/7/16), ‘Š–ÍŒŽ.

733292. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “§Ít‚É”­Ç‚µ‚œùN–E«tŠà‚ɑ΂·‚鎡—ÂÉ
‚‚¢‚Ä. ’؈ärŽ÷ (”å”AŠí): ‘æ1‰ñ–k—¢”å”AŠí‰È§˜b‰ï (2010/7/16), ‘Š–ÍŒŽ.

733293. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[)yˆÝŠà‚É‚š‚¯‚éf’fEŽ¡—ÁEŽèp‹y‚Ñ’¿‚µ‚¢Ç
—á‚ÌFREE DISCUSSIONzt•”•ªØœŒã‚ÉŠÌ“]ˆÚ‚𗈂œ‚µ‚œˆê—á. •œˆäËŽi (”å”AŠí): ‘æ1‰ñ–k—¢”å”AŠí
‰È§˜b‰ï (2010/7/16), ‘Š–ÍŒŽ.

733294. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”]‘²’†Š³ŽÒ‚É‚š‚¯‚é‰ßŠˆ“®äNã÷‚ɑ΂·‚éƒCƒ~
ƒ_ƒtƒFƒiƒVƒ“‚ÌŒø‰Ê‚ÉŠÖ‚·‚錟“¢. “c”šŒ’ˆê (”å”AŠí): ¬–ì–ò•iH‹Æ (Š”) ŽåÃŠwpu‰‰‰ï
(2010/7/16), ‰¡•l.

733295. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒˆƒE‘f125‰i‹v‘}“ü–§••¬üŒ¹—Ö@‚É‚š‚¯‚é
p‘O“à•ª”å—Ö@: pŒã”r”AáŠQ‚ÉŠÖ‚·‚錟“¢. ’ѺGN1, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, ¬’J³Žq2, “c”š
Œ’ˆê1, •ÊŠ‰pŽ¡1, “¡“c“N•v1, Œ–{˜a«1, ²“¡ŠG—¢“Þ, –k–ì‰ëŽj, ‘Ÿ“cK—˜, ã‘O•ôŽq3, ‘ì˜ad
2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3•úŽËü•”): ‘æ7‰ñ‘O—§‘BŠà–§••¬üŒ¹‰i‹v‘}“üŽ¡—ÃŒ€‹†
‰ï (2010/7/18), “Œ‹ž.

733296. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) is«t×–EŠà‚ɑ΂·‚éƒXƒjƒ`ƒjƒuŽ¡—Â̌Ÿ
“¢. “¡“c“N•v1, Šâ‘º³Žk1, “y‹Ž³l1, ’r“cŸb2, “c”šŒ’ˆê1, Îˆä‘å•ã1, Œ–{˜a«1, ²“¡ˆÐ•¶
1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ19‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€ (2010/7/23),
‘Š–ÍŒŽ.

733297. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) is«t×–EŠà‚ɑ΂·‚éSorafenib‚É‚æ‚é‘œ
Œ`g”Á‚̗Տ°•a—Šw“IŒŸ“¢. ’r“cŸb1, Šâ‘º³Žk2, ŽOˆäƒá3, “c”šŒ’ˆê2, “¡“c“N•v2, “c•ÓŒ’ˆê
2, Ÿ‰ªŒ›¶3, ”nêŽu˜Y2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2”å”AŠí, 3”畆): ‘æ19‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€
(2010/7/23), ‘Š–ÍŒŽ.

733298. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tˆÚAŒã‚ÉŠO‰È“IC•œp‚ð—v‚µ‚œ”A˜H‡•¹Ç
‚ÌŒŸ“¢. Îˆä‘å•ã1, ‹g“cˆê¬1, –]ŒŽN•œ1, ø‹Œû@‘å1, ‘OŽR—Ç‘Ÿ1, “y“c–š”ü1, Œ@·G1, “c”š
Œ’ˆê1, Šâ‘º³Žk1, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí): ‘æ19‰ñ“ú–{t•s‘SŠO‰ÈŒ€‹†‰ï (2010/7/24), ŒK
–Œ (ŽOd).

733299. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) mouseIL-4‚ð—p‚¢‚œäNã÷Šà×–EŽ¡—Â̌Ÿ“¢. ‘O
‰ÔË‘Ÿ˜Y, —é–؉h—, ’†‘º³Ž÷, Œ–{˜a«1, –k—¢‰p˜Y2 (1”å”AŠí, 2ˆã—Éq¶Šw•”): ‘æ23‰ñu–k—¢
‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€vŒ€‹†‰ï (2010/8/6), ÂX.

733300. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠeŽíäNã÷Šà×–EŠ”‚É‚š‚¯‚éperiplakinˆâ“`Žq
”­Œ»—Ê‚Ì”äŠr‚Æperiplakinˆâ“`Žq“±“ü‚É‚æ‚éäNã÷ŠàŽ¡—Â̌Ÿ“¢. ‘åàV‘ñ–ç, ’†‘º³Ž÷, Œ–{˜a«1, ˆÉ
“Œˆê˜Y, –k—¢‰p˜Y2 (1”å”AŠí, 2ˆã—Éq¶Šw•”): ‘æ23‰ñu–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€vŒ€‹†
‰ï (2010/8/6), ÂX.

733301. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RŽîᇐ«ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“ŽY¶×–E‚ð—p‚¢
‚œäNã÷Šàƒ‚ƒfƒ‹ƒ}ƒEƒX‚ɑ΂·‚é×–E—Ö@‚ÌŒŸ“¢. ’†‘º³Ž÷, ŽRŒûãĕœ, Œ³‹gŽ–Ÿ, Œ–{˜a«1, ”n“ˆ³—²
2, –k—¢‰p˜Y (1”å”AŠí, 2–ò—): ‘æ23‰ñu–k—¢‘åŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€vŒ€‹†‰ï (2010/8/6),
ÂX.

733302. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) úŽhjƒQ[ƒW”•ÏX‚É‚æ‚éƒNƒŠƒAƒ‰ƒ“ƒXƒMƒƒƒbƒv‚̕ω».
‘Ÿ“c¹–M, ‰ÍŒŽƒŽq, •º“¡@“§, ‹à‰ª‘׍s, ‰ÁìN_, ŒIŒŽ³ŒÈ, –{ŠÔ@’, ‹g“cˆê¬1, ”nêŽu˜Y1 (1
”å”AŠí): ‘æ5‰ñƒNƒŠƒAƒ‰ƒ“ƒXƒMƒƒƒbƒvŒ€‹†‰ïŠwpW‰ï (2010/8/28), ‰ªŽR.

733303. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) HoLEP‚ðŒ_‹@‚É‘Sg”dŽí‚𗈂µ‚œ‘O—§‘B‚̈ê
—á. ™“c@“Ö1, Œ@·G1, ÝŠy•q–ç, ‘ºã‘אŽ1, ŽR“c‘׎j1, ¬—ÑŒ’‘Ÿ˜Y1, –]ŒŽN•œ1, Šâ‘º³Žk
1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ42‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“ސì’n•û‰ï (2010/9/9), V‰¡•l, ”å”AŠíŠO‰È 2010;
23 (11): 1672.

733304. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) œ“]ˆÚ‚ª‚ñŠ³ŽÒ‚ɑ΂·‚éEORTC QOL’²žƒ‚ƒW
ƒ…[ƒ‹: EORTC QLQ-BM22“ú–{Œê”Å‚ÌŠJ”­. ²“¡ˆÐ•¶1, ¬—э‘•F, –x@‘×—S, ”Ñ“c^‰î, ²“¡@‰·, Î
•@—m, Edward Chow, ‰ºÈW“ñ˜Y (1”å”AŠí): ‘æ75‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2010/9/16), “È–Ø, ”å
”AŠíŠO‰È 2011; 24 (—ÕŽž): 504.

733305. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚鍪Ž¡“I‘O—§‘B“Eœp: 15
”N¬Ñ‚ÌŒŸ“¢. “c”šŒ’ˆê1, ²“¡ˆÐ•¶1, ’r“cŸb2, Îˆä‘å•ã1, “y‹Ž³l1, “ì“c@—@2, ¬—ÑŒ’‘Ÿ˜Y
1, –]ŒŽN•œ1, Šâ‘º³Žk1, ‰oì@W, “à“c–Lº, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ75
‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2010/9/16), “È–Ø, ”å”AŠíŠO‰È 2011; 24 (—ÕŽž): 506.

733306. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒãŠú‚—îŽÒ‚È‚ç‚Ñ‚É’Ž‚—îŽÒ‚É‚š‚¯‚鐫‹@”\
‚ÌŒŸ“¢. ™“c@“Ö1, –Ø‘º«‹M1, ²“¡ˆÐ•¶1, Žu‘º@“N, ™“c‰ÀŽq1, ø‹Œû@‘å1, ‘OŽR—Ç‘Ÿ1, “y‹Ž³
l1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ75‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2010/9/16), “È–Ø, ”å”A
ŠíŠO‰È 2011; 24 (—ÕŽž): 513.

733307. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t“ñŽŸˆÚAŒã‚Éhypotonic bladder‚Æ”AŠÇäN
ã÷‹t—¬Ç‚ð‡•¹‚µ”A˜HŠŽõ‚ðŒJ‚è•Ô‚µ‚œ1Ç—á. ŽR“c‘׎j1, Îˆä‘å•ã1, –]ŒŽN•œ1, ¬—ÑŒ’‘Ÿ˜Y1, ‹à
ŽqŽu•Û1, –ìŒû•¶”T, Žáˆä—zŠó1, ‹g“cˆê¬1, ‰““¡’‰—Y, ”nêŽu˜Y1 (1”å”AŠí): ‘æ75‰ñ“ú–{”å”AŠí‰È
Šw‰ï“Œ•”‘‰ï (2010/9/16), “È–Ø, ”å”AŠíŠO‰È 2011; 24 (—ÕŽž): 516.

733308. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) Structual maintenance of chromsomes 3‚ÌäNã÷ŠàV‹K
Žîᇃ}[ƒJ[‚Æ‚µ‚Ä‚Ì—L—p«‚ÌŒŸ“¢. ‘呐@—m1, Œ–{˜a«1, •ž•”@Šw, ¬Ž›‹`’j, ²“¡ŠG—¢“Þ, “ì“c@
—@2, ²“¡ˆÐ•¶1, ‘O“c’‰Œv3, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3—Šw•”): ‘æ75‰ñ“ú–{”å
”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2010/9/16), “È–Ø, ”å”AŠíŠO‰È 2011; 24 (—ÕŽž): 529.

733309. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) _Œo‰·‘¶‘̍o‹Ÿ‰º‘O—§‘B‘S“Eœp‚ðs‚Á‚œÇ—á‚ɑ΂·‚é
•a—Šw“IŒŸ“¢. ŽR‰º‰p”V1, ‰z“c’|˜N, rì@F, ‘å“Œ‹MŽu (1,”å”AŠí): ‘æ75‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”
‘‰ï (2010/9/16), “È–Ø, ”å”AŠíŠO‰È 2011; 24 (—ÕŽž): 539.

733310. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) –k—¢‘åŠw‚É‚š‚¯‚é‰AŒsŠàÇ—á‚̗Տ°“IŒŸ“¢. ‘OŽR—Ç‘Ÿ
1, Œ–{˜a«1, Œ@·G1, ŒŽ@˜a–î, “y‹Ž³l1, “¡“c“N•v1, ²“¡ˆÐ•¶1, Šâ‘º³Žk1, –k—¢‰p˜Y2, ”n
êŽu˜Y1 (1”å”AŠí, 2ˆã—Éq¶Šw•”): ‘æ75‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2010/9/16), “È–Ø, ”å”AŠíŠO
‰È 2011; 24 (—ÕŽž): 545.

733311. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒˆƒE‘f125‰i‹v‘}“ü–§••¬üŒ¹—Ö@‚É‚š‚¯‚é
p‘O“à•ª”å—Ö@: pŒã”r”AáŠQ‚ÉŠÖ‚·‚錟“¢. ’ѺGN1, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, “c”šŒ’ˆê1, •ÊŠ
‰pŽ¡1, “¡“c“N•v1, Œ–{˜a«1, ²“¡ŠG—¢“Þ, ¬’J³Žq2, –k–ì‰ëŽj, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí,
2•úŽËü (Žîá‡)): ‘æ75‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2010/9/17), “È–Ø, ”å”AŠíŠO‰È 2011; 24 (—Õ
Žž): 521.

733312. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) is«t×–EŠà‚ɑ΂·‚éˆêŽŸŽ¡—ÂƂµ‚ẴXƒjƒ`ƒjƒu“Š
—^‚ÌŒŸ“¢. “¡“c“N•v1, Šâ‘º³Žk1, “y‹Ž³l1, ’r“cŸb2, “c”šŒ’ˆê1, Îˆä‘å•ã1, Œ–{˜a«1, ‹g
“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ75‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2010/9/17),
“È–Ø, ”å”AŠíŠO‰È 2011; 24 (—ÕŽž): 550.

733313. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) is«äNã÷Šà‚ɑ΂·‚éM-VAC•¹—p‰»Šw•úŽËü—Ö@‚ÌŒŸ“¢.
’r“cŸb1, Œ–{˜a«2, V•”@÷3, “c”šŒ’ˆê2, ²“¡ˆÐ•¶2, Šâ‘º³Žk2, ÎŽR”ŽžŠ3, ¬’J³Žq3, ‘
ì˜ad3, ”nêŽu˜Y2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2”å”AŠí, 3•úŽËü (Žîá‡)): ‘æ75‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ
•”‘‰ï (2010/9/17), “È–Ø, ”å”AŠíŠO‰È 2011; 24 (—ÕŽž): 555.

733314. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) is«äNã÷Šà‚̉“Šu“]ˆÚ‚ɑ΂µUroplakin3‚ªf’f‚É—LŒø
‚Ÿ‚Á‚œ1—á. –]ŒŽN•œ1, Œ–{˜a«1, •ÊŠ‰pŽ¡1, ŽR“c‘׎j1, “y‹Ž³l1, Îˆä‘å•ã1, “¡“c“N•v1, ²
“¡ˆÐ•¶1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ75‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (2010/9/17), “È–Ø, ”å
”AŠíŠO‰È 2011; 24 (—ÕŽž): 558.

733315. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒzƒ‹ƒ‚ƒ“’ïR«‘O—§‘BŠà‚ɑ΂·‚éƒhƒZƒ^ƒLƒZ
ƒ‹‚ÌŽ¡—ÃŒoŒ±. “c”šŒ’ˆê (”å”AŠí): ‘O—§‘BŠà‰»Šw—Ö@‚ÉŠÖ‚·‚éÀ’k‰ï (2010/10/2), ‘Š–ÍŒŽ.

733316. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) I-125‘O—§‘BŠà‰i‹v‘}“ü–§••¬üŒ¹—Ö@ (LDR)
Œã‚̉º•””A˜HÇó (LUTS) ‚ɑ΂·‚鉖Ž_ƒ^ƒ€ƒXƒƒVƒ“, ƒiƒtƒgƒsƒWƒ‹‚š‚æ‚уVƒƒhƒVƒ“‚Ì”äŠrŒŸ“¢. ’Ã
‘ºGN1, ²“¡ˆÐ•¶1, ÎŽR”ŽžŠ2, “c”šŒ’ˆê1, “ì“c@—@3, •ÊŠ‰pŽ¡1, “¡“c“N•v1, Œ–{˜a«1, ²“¡
ŠG—¢“Þ, ¬’J³Žq2, –k–ì‰ëŽj, ‘ì˜ad2, ”nêŽu˜Y1 (1”å”AŠí, 2•úŽËü (Žîá‡), 3‘åŠw‰@ˆã—ÃŒnŒ€
‹†‰È): ‘æ6‰ñ”å”AŠíŽîᇕúŽËüŒ€‹†‰ï (2010/10/16), “Œ‹ž.

733317. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Œ£tÌŽæƒ`[ƒ€Šˆ“®‚Ì—¬‚ê‚ƃTƒ|[ƒgƒVƒXƒe
ƒ€?DVDŽ‹’®‚Æà–Ÿ?. ‹g“cˆê¬ (”å”AŠí): ‘æ5‰ñŒ“ú–{Žx•”ˆÚAŽ{Ý‰ï‹c (2010/10/23), ‘åã.

733318. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘œ”­«ùN–EtÇ‚Ì“Eot‚É‚š‚¯‚étŠà‚ÌŒŸ“¢.
Îˆä‘å•ã1, ‹g“cˆê¬1, ¬—ÑŒ’‘Ÿ˜Y1, “y‹Ž³l1, “c”šŒ’ˆê1, “¡“c“N•v1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1
”å”AŠí): ‘æ18‰ñùN–E«tŽŸŠ³Œ€‹†‰ï (2010/10/31), “Œ‹ž.

733319. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) äNã÷ŠàNested Variant‚̈ê—á. Œ“c‘å‰î1,
‘åì‚ ‚³Žq, ‰©@‰p–Î1, —äˆä’èŽk1, ŒK”ö’èm, ìã’B‰› (1”å”AŠí): ‘æ62‰ñ“ú–{”å”AŠí‰ÈŠw‰ïŒ“ú–{
‘‰ï (2010/11/5), Ž­Ž™“‡, Œ“ú–{”å”AŠí‰È 2010; 72 (‘Š§†): 116.

733320. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) G-CSFŽY¶t×–EŠà‚Ì1—á. —äˆä’èŽk1, Žá“c•”—zŽi1,
Îˆä~ˆê˜Y1, “ü]@Œ[1, —äˆä’è‹I1 (1”å”AŠí): ‘æ62‰ñ“ú–{”å”AŠí‰ÈŠw‰ïŒ“ú–{‘‰ï (2010/11/5), Ž­
Ž™“‡, Œ“ú–{”å”AŠí‰È 2010; 72 (‘Š§†): 148.

733321. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) is«t×–EŠà‚ɑ΂·‚éƒXƒjƒ`ƒjƒuŽ¡—Âɂš‚¯‚é—LŠQŽ–
Û‚ÌŒŸ“¢. “y‹Ž³l1, “¡“c“N•v1, Šâ‘º³Žk1, ŽR“c‘׎j1, Îˆä‘å•ã1, “c”šŒ’ˆê1, ‹g“cˆê¬1, ”n
êŽu˜Y1 (1”å”AŠí): ‘æ62‰ñ“ú–{”å”AŠí‰ÈŠw‰ïŒ“ú–{‘‰ï (2010/11/5), Ž­Ž™“‡, Œ“ú–{”å”AŠí‰È 2010;
72 (‘Š§†): 151.

733322. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Z«äNã÷Šà‚ɑ΂µ‚ĉ»Šw—Ö@E•úŽËü—Ö@
‚ª‘tŒ÷‚µ’·Šú¶‘¶‚µ‚œ2—á. Œ@·G (”å”AŠí): ‘æ8‰ñ_“ސì”å”AŠí‰ÈŠwŒ€‹†‰ï (2010/11/18), V‰¡
•l.

733323. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •\Ý«äNã÷Šà‹y‚ÑäNã÷ã”ç“àŠà‚ɑ΂·‚éBCG
äNã÷“à“Š—^‚ÌŒŸ“¢. Œ–{˜a« (”å”AŠí): ‘æ8‰ñ_“ސì”å”AŠí‰ÈŠwŒ€‹†‰ï (2010/11/18), V‰¡•l.

733324. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒwƒ‚ƒ_ƒCƒ„ƒtƒBƒ‹ƒ^[ABH-P‚ÆABH-F‚ÌHDF
‚É‚š‚¯‚鐫”\•]‰¿‚Ì”äŠr. ’©“ú‘åŽ÷, ŠÛŽR’ŒŽq, ×’JLŠC, ŽR“à•‡”ü, âV“¡@‹B ŸNˆäŒ’Ž¡, Îˆä‘å•ã1,
ŽR‰º–Ÿ‘× (1”å”AŠí): ‘æ16‰ñ“ú–{HDFŒ€‹†‰ïŠwpW‰ïE‘‰ï (2010/11/20), _ŒË.

733325. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘OŠóŽßHDF‚ÆŒãŠóŽßHDF, ‚Ç‚¿‚炪¶‘Ì‚É—D
‚µ‚¢‚Ì‚Ÿ‚ë‚€‚©? ×’JLŠC, âV“¡@‹B, ’©“ú‘åŽ÷, ŠÛŽR’ŒŽq, ŽR“à•‡”ü, ¬‹v•ÛŒªˆê, ŸNˆäŒ’Ž¡, Îˆä
‘å•ã1 (1”å”AŠí): ‘æ16‰ñ“ú–{HDFŒ€‹†‰ïŠwpW‰ïE‘‰ï (2010/11/20), _ŒË.

733326. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒŠƒo[ƒXƒŠƒ^[ƒ“•ûŽ®‚É‚æ‚鐞»…‹Ÿ‹‹”zŠÇ
‚̍쐻. ‘Ÿ“c¹–M, •º“¡@“§, ‰ÍŒŽƒŽq, ‹à‰ª‘׍s, ‰ÁìN_, ŒIŒŽ³ŒÈ, –{ŠÔ@’, Îˆä‘å•ã1, ‹g“c
ˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ16‰ñ“ú–{HDFŒ€‹†‰ïŠwpW‰ïE‘‰ï (2010/11/20), _ŒË.

733327. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) f’f‚É‹ê—¶‚µ‚œŒã• –ŒGanglioneuroma‚̈ê—á.
’†‘º@Œ›, Îˆä‘å•ã1, ¬—ÑŒ’‘Ÿ˜Y1, “y‹Ž³l1, •âáÁ“ñ1, “c”šŒ’ˆê1, “¡“c“N•v1, Œ–{˜a«1, ²
“¡ˆÐ•¶1, Šâ‘º³Žk1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ79‰ñ_“ސ쌧”å”AŠí‰Èˆã‰ï (2010/11/27),
‰¡•l.

733328. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«t•s‘SŠ³ŽÒ‚Ì‹‘åùN–Et‚ɑ΂·‚éŠJ• pE
• o‹ŸŽèp‚Ì”äŠrŒŸ“¢. “y‹Ž³l1, ‹g“cˆê¬1, Îˆä‘å•ã1, ¬—ÑŒ’‘Ÿ˜Y1, ŽR“c‘׎j1, Šâ‘º³Žk1, ”n
êŽu˜Y1 (1”å”AŠí): ‘æ7‰ñ‘ŸŠí•s‘SŠ³ŽÒ‚ɑ΂·‚éŠO‰ÈEŠÇ—Œ€‹†‰ï (2010/11/27), “Œ‹ž.

733329. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒNƒŠƒWƒ“ƒIƒŒƒ“ƒW‚𕉉ׂµ‚œäNã÷Šà×–E‚Ì
ÂFŒõŠŽŽó«?V‚µ‚¢äNã÷ŠàŽ¡—Â̒Tõ‚ƍ\’z‚ÉŒü‚¯‚œŠî‘b“IŒ€‹†?. Œ@·G1, ù–{Ž¡Žq1, ”ä—¯ŠÔ
O”ü2, Šâ‘º³Žk1, ìã@—Ï2, ”nêŽu˜Y1 (1”å”AŠí, 2¶—): ‘æ2‰ñƒAƒNƒŠƒWƒ“ƒIƒŒƒ“ƒWŽ¡—ÃŒ€‹†‰ï
(2010/12/4), ‹ž“s.

733330. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) œ“]ˆÚ‚ª‚ñŠ³ŽÒ‚ɑ΂·‚éEORTC QOL’²žƒ‚ƒW
ƒ…[ƒ‹: EORTC QLQ-BM22“ú–{Œê”Å‚ÌŠJ”­. ²“¡ˆÐ•¶1, ¬—э‘•F, –x@‘×—S, ”Ñ“c^‰î, ²“¡@‰·, Î
•@—m, Edward Chow, ‰ºÈW“ñ˜Y (1”å”AŠí): ‘æ26‰ñ‘O—§‘BƒVƒ“ƒ|ƒWƒEƒ€ (2010/12/12), •iì.

733331. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒŠƒXƒN•ª—Þ‚ð—p‚¢‚œ‘O—§‘BŠà‚É‚š‚¯‚éŒÂ•Ê‰»
Ž¡—ÃXƒgƒ‰ƒeƒW[. ²“¡ˆÐ•¶1, “c”šŒ’ˆê1, Šâ‘º³Žk1, “ì“c@—@2, ’r“cŸb2, “¡“c“N•v1, Œ–{˜a
«1, ÎŽR”ŽžŠ3, ¬’J³Žq3, –k–ì‰ëŽj, ‘“c@Ši, V•”@÷3, ‘ì˜ad3, ”nêŽu˜Y1 (1”å”AŠí, 2
‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3•úŽËü (Žîá‡)): ‘æ20‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€ (2011/1/28), ‘Š–ÍŒŽ.

733332. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –T”A“¹•œŠŠ‹ØŽî‚̈ê—á. ‘OŽR—Ç‘Ÿ1, •œ–ìC
•œ, ‘呐@—m1, “¡é‹M‹³1, “c”šŒ’ˆê1, ÝŠy•q–ç, ^‰ºß•v, ”nêŽu˜Y1 (1”å”AŠí): ‘æ43‰ñ“ú–{”å
”AŠí‰ÈŠw‰ï_“ސì’n•û‰ï (2011/2/10), V‰¡•l, ”å”AŠíŠO‰È 2011; 24 (4): 699.

733333. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) f’f‚É‹ê—¶‚µ‚œŒã• –ŒGanglioneuroma‚̈ê—á.
–]ŒŽN•œ1, Šâ‘º³Žk1, Œ@·G1, ¬—ÑŒ’‘Ÿ˜Y1, “y‹Ž³l1, •âáÁ“ñ1, “c”šŒ’ˆê1, “¡“c“N•v1, Œ
–{˜a«1, ²“¡ˆÐ•¶1, ‹g“cˆê¬1, ”nêŽu˜Y1 (1”å”AŠí): ‘æ43‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“ސì’n•û‰ï
(2011/2/10), V‰¡•l, ”å”AŠíŠO‰È 2011; 24 (4): 699.

733334. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —Œ‘€”AŠÇŠàpŒã“§Í“±“ü‚µ‚œÇ—á‚ÉGN—Ö@‚ð
Ž{s‚µ‘tŒ÷‚µ‚œˆê—á. ™“c‰ÀŽq1, •œˆäËŽi, Îì@–í1, ŠÛ@“T•v, Ž…Œ’Žj2, ‰¡“cáÁ“ñ, Œ@·G
1, Šâ‘º³Žk1, ”nêŽu˜Y1 (1”å”AŠí, 2t‘Ÿ“à): ‘æ43‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“ސì’n•û‰ï (2011/2/10),
V‰¡•l, ”å”AŠíŠO‰È 2011; 24 (4): 700.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H20-540008. [‚»‚Ì‘Œ]y“ÁW: “ú–{‚̈ã—ËZp‚Í—D‚ê‚Ä‚¢‚é!! PART IIIz”å”AŠí• o‹ŸŽèp‚ÌŠJ”­
‚Æ‹Zp”F’è. Œ“cŒöŽu, ”nêŽu˜Y1 (1”å”AŠí): ŠO•Û˜Aƒjƒ…[ƒX 2008/11; 10: 2.

H21-110021. [ŒŽ’˜] Role of TNFƒ¿ in Early Chemokine Production and Leukocyte Infiltration
into Heart Allografts. Îˆä‘å•ã1, A D Schenk, ”nêŽu˜Y1, Fairchild RL (1”å”AŠí): AMERICAN JOURNAL
OF TRANSPLANTATION 2010/1; 10 (1): 59-68.

H21-220001. [€ŒŽ’˜] •\Ý«äNã÷Šà‚ɑ΂·‚éBCGäNã÷“à’“ü—Ö@‚ÌŒŸ“¢?“±“üEˆÛŽ—Ö@‚ÉŠÖ‚·‚é
‘œŽ{Ý‹€“¯Œ€‹†?. Œ–{˜a«1, ”nêŽu˜Y1, ŒE“c‹gM, ’†_‹`ŽO (1”å”AŠí): ”å”AŠíŠO‰È 2010/2; 23
(2): 207-11.

H21-530001. [‚»‚Ì‘Œ] What is CKD? “ú‘ä‰p—Y, Žáˆä—zŠó1, ‹g“cˆê¬1 (1”å”AŠí): Cambodia TV
2010/3.

H21-530002. [‚»‚Ì‘Œ] What is hemodialysis? Žáˆä—zŠó1, ‹g“cˆê¬1, “ú‘ä‰p—Y (1”å”AŠí):
Cambodia TV 2010/3.

H21-530003. [‚»‚Ì‘Œ] What is renal transplantation? ‹g“cˆê¬1, Žáˆä—zŠó1, “ú‘ä‰p—Y (1”å
”AŠí): Cambodia TV 2010/3.

[Šw‰ïEŒ€‹†‰ï“™]

H21-713004. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Cryotherapy Increases Intratumoral Hypoxia
and Necrosis in a Mouse Prostate Cancer Model: Its Relationship with Microvessel Density and
Apoptosis. –Ø‘º«‹M1, Vladimir Mouraviev, Zahid Rabbani, Matvey Tsivian, Zeljko Vujaskovic, and
Thomas J Polascik (1”å”AŠí): 3rd international symposium on focal therapy and imaging of prostate
and kidney cancer (2010/2/24), Washington DC, USA.

H21-713005. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Biopsy accuracy in identifying unilateral
prostate cancer depends on prostate weight. Tsivian M, Moreira DM, Sun L, Mouraviev V, –Ø‘º«
‹M1, Moul JW, Polascik TJ (1”å”AŠí): 74th Annual Meeting of the Southeastern Section of the AUA
(2010/3/11-14), Miami Beach, FL, USA.

H21-713006. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Tumor size and endophytic growth pattern
affect recurrence rates after laparoscopic renal cryoablation. Tsivian M, Lyne C, Mayes JM,
Mouraviev V, –Ø‘º«‹M1, Polascik TJ (1”å”AŠí): 74th Annual Meeting of the Southeastern Section
of the AUA (2010/3/11-14), Miami Beach, FL, USA.

H21-731009. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) MVAC‘ϐ«isEÄ”­äNã÷Šà‚ɑ΂·‚éƒe[ƒ‰[ƒ
ƒCƒhŠàƒyƒvƒ`ƒhƒƒNƒ`ƒ“—Ö@‚ÌŒoŒ±. Œ–{˜a« (”å”AŠí): ‘æ10‰ñ”’‹àŠwpu‰‰‰ï (2010/1/21), “Œ‹ž.


Šá‰ÈŠw

[Šwp˜_•¶]

110223. [ŒŽ’˜] Evaluation of pupil diameter after posterior chamber phakic intraocular lens
implantation. _’J˜aF1, Ž…Œö–ç1, ŒÜ\—’ÍŽj1, Îì@‹Ï2 (1Šá‰È, 2ˆã—Éq¶Šw•”): Eye 2010/4;
24 (4): 588-94.

110224. [ŒŽ’˜] Relationship between ciliary sulcus diameter and anterior chamber diameter and
corneal diameter. ìŽç“c‘ñŽu1, ‹›—¢@”Ž1, _’J˜aF2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): J
Cataract Refract Surg 2010/4; 36 (4): 617-24.

110225. [ŒŽ’˜] Effect of Pupil Size on Visual Acuity in a Laboratory Model of Pseudophakic
Monovision. ìŽç“c‘ñŽu1, ‹›—¢@”Ž1, ”Œ“c’m–ç1, ˆÉ“¡”ü¹ŠG1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá
‰È): Journal of refractive surgery 2010/5; 26 (5): 378-80.

110226. [ŒŽ’˜] Posterior Chamber Phakic Implantable Collamer Lens: Changes in Vault During 1 Year.
¬“‡—²Ži1, ‘O“cªG2, ‹g“c—zŽq1, ’†‘º—Fº2, ŒŽ@CÆ1, Žsìˆê•v1,3 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È, 2
–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 3Šá‰È): J Refractive Surgery 2010/5; 26 (5): 327-32.

110227. [ŒŽ’˜] Limbal relaxing incision during cataract extraction versus photoastigmatic
keratectomy after cataract extraction in controlling pre-existing corneal astigmatism. Fouda S1,
_’J˜aF2, ‘ŠàV‘å•ã2, Ž…Œö–ç2 (1Zagazig Uviversity (Egypt), 2Šá‰È): Graefes Arch Clin Exp
Ophthalmol 2010/7; 248 (7): 1029-35.

110228. [ŒŽ’˜] Influence of Refractive Correction on Ocular Dominance . ’†ŽR“ށX”ü1, ìŽç“c
‘ñŽu2, ‹›—¢@”Ž2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): Optical Review 2010/8; 17(4): 421-4.

110229. [ŒŽ’˜] Optical performances of implantable collamer lenses with and without a central
perforation. ‘å–{•¶Žq1, Ž…Œö–ç1, ‹›—¢@”Ž2, ìŽç“c‘ñŽu2, ‰F‰ê–ÎŽO2 (1Šá‰È, 2ˆã—Éq¶Šw•”):
Kitasato Medical Journal 2010/9.; 40 (2): 150-3.

110230. [ŒŽ’˜] Changes in vaulting and the effect on refraction after phakic posterior chamber
intraocular lens implantation. _’J˜aF1, Ž…Œö–ç1, ìŽç“c‘ñŽu2 (1Šá‰È, 2ˆã—Éq¶Šw•”): J
Cataract Refract Surg 2010/9; 35 (9): 1582-6.

110231. [ŒŽ’˜] Usefulness of Anterior Chamber Depth Measurement for Efficacy Assessment of Steroid
Pulse Therapy in Patients with Vogt-Koyanagi-Harada Disease. ‘å’Î’qG1, Ž…Œö–ç1, ŒÜ\—’Í
Žj1, _’J˜aF1 (1Šá‰È): Jpn J Ophthalmol 2010/9; 54 (5): 396-400.

110232. [ŒŽ’˜] Time course of corneal biomechanical parameters after phacoemulsification with
intraocular lens implantation. _’J˜aF1, Ž…Œö–ç1, ‘å–{•¶Žq1, “V–엝Œb1 (1Šá‰È): Cornea
2010/11; 29 (11): 1256-60.

110233. [ŒŽ’˜] One-Year Follow-up of Posterior Chamber Toric Phakic Intraocular Lens Implantation
for Moderate to High Myopic Astigmatism. _’J˜aF1, Ž…Œö–ç1, ‘ŠàV‘å•ã1, ŒÜ\—’ÍŽj1, ¬Œ
^—1, ’†‘ºH•ä (1Šá‰È): Ophthalmology 2010/12; 117 (12): 2287-94.

110234. [ŒŽ’˜] Effect of motion stimulation without changing binocular disparity on stereopsis
in strabismus patients. ”Œ“c’m–ç1, Îì@‹Ï1, Œ–{_”V, ŒãŠÖ—˜–Ÿ2, Žs糋`Í2, Žs糍O”ü, ²
“¡M”V, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): Am Orthopt J 2010; 60: 87-94.

110235. [ŒŽ’˜] Modulation transfer function of intraocular collamer lens with a central artificial
hole. ‹›—¢@”Ž1, Ž…Œö–ç2, ìŽç“c‘ñŽu1, ‘å–{•¶Žq2 (1ˆã—Éq¶Šw•”, 2Šá‰È): Graefes Arch Clin
Exp Ophthalmol 2011/1; 249: 1081-5.

110236. [ŒŽ’˜] Evaluation of corneal biomechanical parameters after simultaneous
phacoemulsification with intraocular lens implantation and limbal relaxing incisions. _’J˜a
F1, Ž…Œö–ç1, ‘å–{•¶Žq1, “V–엝Œb1 (1Šá‰È): J Cataract Refract Surg 2011/2; 37 (2): 265-70.

120048. [ŒŽ’˜] ”’“àáŽèpŒã‚ÉŠá“àƒŒƒ“ƒY•ÎˆÊ‚𐶂¶‚œÇ—á‚ÌŒŸ“¢. ˆø“cŽj‰À1, Ž…Œö–ç2, _’J˜a
F2, “V–엝Œb2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È): IOL&RS 2010/6; 24 (2): 304-8.

120049. [ŒŽ’˜] —ôEŒŽ«–Ô–Œ”—£‚ɑ΂·‚é”’“àáŽèp•¹—pÉŽq‘ÌŽèpŒã‚Ì‹üÜŒë·. ”’’J@“O1, Ž…
Œö–ç1, ‚–ì‰ë•F1, –ö“c’q•F1, ’†Œ@Šî1, Š}ŒŽ³s1, ²“¡M”V2, ’J@ŒcŽq, ”‹“‡^“Þ (1Šá‰È, 2
‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): Šá‰È—Տ°‹I—v 2010/8; 3 (8): 818-22.

120050. [ŒŽ’˜] —ΓàáŠ³ŽÒ‚ɑ΂·‚é’YŽ_’E…y‘f‘jŠQ–ò‚Ì“_Šá‰ñ”‚ª‹y‚Ú‚·Šáˆ³‚ÌŒŸ“¢. ‘å’Î’qG1,
X“c“N–ç1, ¯ŽiMs2, •y‰ª•q–ç3, —L–{‚ ‚±4, ŒŽ@’Œl4, —é–؍G¹5, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Ã
‰q¶Šw•”, 3“ú—§‰¡•l•a‰@Šá‰È, 4_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 5ŽÐ‰ï•ÛŒ¯‘Š–Í–ì•a‰@Šá‰È):
‚ ‚œ‚炵‚¢Šá‰È 2010/10; 27 (10): 1435-8.

120051. [ŒŽ’˜] “µEƒTƒCƒY‚ª‚ŽŸ”g–ÊŽû·‚ÆŽ‹—Í‚É‹y‚Ú‚·‰e‹¿. ŽR–{^–ç1,3, ‹›—¢@”Ž2,3, ìŽç“c
‘ñŽu2,3, ’†ŽR“ށX”ü2, ’†’JŸŒÈ2, ‰¶“c@Œ’1 (1Ÿº–ì•Ó‘‡•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶
Šw•”): ‚ ‚œ‚炵‚¢Šá‰È 2010/10; 27 (10): 1473-7.

120052. [ŒŽ’˜] ‘œÅ“_Šá“àƒŒƒ“ƒY‚Ì–éŠÔŽ‹‹@”\‚Ì•]‰¿. ’·’JìˆŸ—¢1, ¬“‡—²Ži2, ŒŽ@CÆ1, ’†‘º
‰pŽ÷1, “Žˆä—¢ŠG2, ’†‘º—Fº2, Žsìˆê•v1,3 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È, 2–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 3Šá
‰È): IOL&RS 2010/12; 24 (4): 630-5.

120053. [ŒŽ’˜] ‰f‘œ‚É‚æ‚鎋Šo‹@”\‚ւ̉e‹¿‚Æ”]Šˆ“®?3D‰f‘œ‚Ì”]_ŒoŠˆ“®‚ւ̉e‹¿‚ÌŒŸ“¢?. ŒŽ@
’Œl1,2, ŒˆäNŽ÷3, ¬–ì‹|ŠG4 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰ÈŠwuÀ, 2Šá‰È, 3•œ¬ˆã
—Ðê–åŠw‰@Ž‹”\ŒP—ûŠw‰È, 4_“ސ쎕‰È‘åŠw¶‘Ì‹@”\ŠwuÀ¶—Šw•ª–ì): _ŒoŠá‰È 2010/12; 27 (4):
381-8.

120054. [ŒŽ’˜] 3D‰f‘œ‚ÆŽ‹Šo”œ‰ž. ”Œ“c’m–ç1, ¯ŽiMs1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): _
ŒoŠá‰È 2010/12; 27 (4): 389-98.

120055. [ŒŽ’˜] Šjã«Šá‹…‰^“®áŠQ‚ɑ΂·‚鎋”\‹ž³‚ÌŒø‰Ê. óì@Œ«1, Îì@‹Ï1, ¯ŽiMs1, Ž
…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): “ú–{Ž‹”\ŒP—ûŽm‹Š‰ïŽ 2010/12; 39: 87-92.

120056. [ŒŽ’˜] Alcohol-guided PRK (A-PRK) ‚É‚š‚¯‚éwavefrontcustomizedÆŽË‚Ì—LˆÓ«. ’†‘ºH•ä
1, ˆîˆä—²‘Ÿ1, ’·•l¬‰fŽq1, Îˆä—SŽq1, “ì‰_@Š²1, –xì—Ǎ‚1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1 (1ˆäã
Šá‰È•a‰@, 2Šá‰È): “ú–{Ž‹”\ŒP—ûŽm‹Š‰ïŽ 2010/12; 39: 173-9.

120057. [ŒŽ’˜] ‰ñÜŒ^‘œÅ“_Šá“àƒŒƒ“ƒYÇ—á‚Ì”N‘ã•Ê‚̐¬Ñ. ‹ß“¡—¢1, ŽðˆäKO1, “à“¡®‹v1, ‹Ê
’u–Ÿ–ì1, Žsìˆê•v2,3, ˆé’J®‹P4, ¬“‡—²Ži4, ’†‘º—Fº4, éŽRŒhN5 (1’†‹žŠá‰È, 2ŽÐ‰ï•ÛŒ¯’†‹ž
•a‰@, 3Šá‰È, 4–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 5•x“cŠá‰ÈƒNƒŠƒjƒbƒN): “ú–{Ž‹”\ŒP—ûŽm‹Š‰ïŽ 2010/12; 39;
181-90.

120058. [ŒŽ’˜] ˆäãŠá‰È•a‰@‚É‚š‚¯‚éŽÕŒõŠá‹Ÿ‚Ì‘I’è‚ɉe‹¿‚ð‹y‚Ú‚·ˆöŽq. žŸˆä‚µ‚Ì‚Ô1, “°ŽR‚©‚³‚Ë
1, ‘’J‹Å”ü1, ¬àV—D‹M1, Ÿ–”‚ ‚©‚Ë1, Îˆä—SŽq1, “ì‰_@Š²1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäã
Šá‰È•a‰@, 2Šá‰È): “ú–{Ž‹”\ŒP—ûŽm‹Š‰ïŽ 2010/12; 39: 217-23.

120059. [ŒŽ’˜] dÇt‹GƒJƒ^ƒ‹‚ɑ΂µƒ^ƒNƒƒŠƒ€ƒX“_Šá‰t‚ðŽg—p‚µ‚œ1—á. èè@—ߎq1, _’J˜aF1, Ž
…Œö–ç1 (1Šá‰È): Šá‰È—Տ°‹I—v 2011/1; 4 (1): 16-9.

120060. [ŒŽ’˜] ÔŠOü“dŽq“µEŒvIriscorder‚̗Տ°‰ž—p. óì@Œ«1, Îì@‹Ï1, ¯ŽiMs1, Ž…
Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): “ú–{‚ÌŠá‰È 2011/1; 82 (1): 45-6.

120061. [ŒŽ’˜] ³íŠáˆ³—ΓàáŠ³ŽÒ‚É‚š‚¯‚郌ƒ{ƒuƒmƒ[ƒ‹“_Šá5”NŠÔ“Š—^‚ÌŒø‰Ê. ˆäãŒ«Ž¡1, Žá‘q
‰ë“o1,2, •x“c„Ži3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3“Œ–M‘åŠwˆãŠw•”Šá‰ÈŠw‘æ“ñuÀ): Šá‰È—Տ°‹I—v 2011/2;
4 (2): 115-9.

120062. [ŒŽ’˜] ‹ßÔŠO•ªŒõ–@‚É‚æ‚éŒã“ª—tŽ‹Šo–ì”]ŒŒ—¬“®‘Ô‚ÌŠÏŽ@. ¬’¬—SŽq3, Vˆä“cF—T1,2, V
ˆä’qŠG3, ’JŒûŒh“¹3, •“cŒÎ‘Ÿ˜Y4 (3‘Ûˆã—ÕŸŽƒ‘åŠw•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 2Šá‰È, 3‘Û
ˆã—ÕŸŽƒ‘åŠw•ÛŒ¯ˆã—Êw•”ì‹Æ—Ö@Šw‰È, 4‘Û“d‹C’ʐMŠî‘b‹ZpŒ€‹†Š”]î•ñŒ€‹†Š‰^“®§ŒäE‹@”\‰ñ
•œŒ€‹†Žº): Šá‰È—Տ°‹I—v 2011/2; 4 (2): 180-5.

120063. [ŒŽ’˜] I/Aƒnƒ“ƒhƒs[ƒX‚Ö‚Ì•t’…Žc—¯•š‚É‚æ‚è”­¶‚µ‚œ‚ƍl‚Š‚ç‚ê‚éTASS‚Ìoutbreak. ì•”
Š²Žq1, ‹ß“¡•ô¶2, ‰Á‰ê’BŽu3,4, ó—˜œŽu5, ‘å‹Ž—Tˆê6 (1ƒRƒXƒ‚ƒXŠá‰È, 2–ŒŒÃ‰®‘åŠw‘åŠw‰@ˆãŠwŒn
Œ€‹†‰ÈŠŽŠoŠíáŠQ§ŒäŠw, 3ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È, 4Šá‰È, 5‘åã‘åŠwˆãŠw•”•t‘®•a‰@ŠŽõ§Œä•”, 6ˆ€
•Q‘åŠwˆãŠw•”Šá‰ÈŠw): Šá‰È—Տ°‹I—v 2011/3; 4 (3): 216-21.

120064. [ŒŽ’˜] ƒfƒBƒXƒ|ƒpƒNƒŒƒ“‚ð—p‚¢‚œŒ‹–Œ’oŠÉÇŽèp‚Ì’ZŠú¬Ñ. ’†Œ@Šî1,2, ŒÜ\—’ÍŽj1, ²
“¡M”V3, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È, 2‘å˜aŽs—§•a‰@, 3ˆã—ÃŒnŒ€‹†‰È): —Տ°Šá‰È 2011/3; 65 (3):
307-12.

120065. [ŒŽ’˜] ’PŠá‹Ÿ‚Ì“™‰¿‹üÜ—͂ƍì‹Æ‹——£—pƒXƒP[ƒ‹‚̍쐬?Calibration of Equivalent Viewing
Power and Working Distances of Adjustable Focus Telescopes for Near Vision?. “c糐³–Ÿ1, ‹›—¢@
”Ž2 (1“ú–{ƒ‰ƒCƒgƒnƒEƒX—{¬•”, 2ˆã—Éq¶Šw•”): “ú–{ƒ[ƒrƒWƒ‡ƒ“Šw‰ïŽ 2011/3; 10: 57-62.

120066. [ŒŽ’˜] Šá“àƒŒƒ“ƒY‚É‚æ‚郂ƒmƒrƒWƒ‡ƒ“–@‚Ì–ž‘«“x‚ɉe‹¿‚·‚éˆöŽq‚ÌŒŸ“¢. ‹Ž–{“Ä•¶1, ˆÉ“¡”ü
¹ŠG2, “V–엝Œb1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): IOL&RS 2011/3; 25 (1): 62-7.

220022. [€ŒŽ’˜] ƒ[ƒrƒWƒ‡ƒ“ŽÒ—pŽ‹Šo•â•‹ï‚Ì•Û—Ló‹µ‚Æ—LŒøŠˆ—p‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²ž. ŽOŽÄ
Œb”üŽq1, •œ’ˉpŽ¡2, ¬’¬—SŽq1, —é–ØŒ«Ž¡1, Vˆä“cF—T1,3 (1‘Ûˆã—ÕŸŽƒ‘åŠw, 2“ú–{–Ô–ŒF‘f•Ï
«Ç‹Š‰ï, 3Šá‰È): “ú–{Ž‹”\ŒP—ûŽm‹Š‰ïŽ 2010/12; 39: 233-8.

320040. [Ç—á•ñ] –³‹Û«‘–Œ‰ŠŒã‚É”­Ç‚µ‚œ—Œ‘€Ž‹_Œo‰Š‚Ì1—á. —`…@Šw1, Žs糋`Í1, Ž…Œö
–ç1 (1Šá‰È): _ŒoŠá‰È 2010/9; 27 (3): 295-300.

320041. [Ç—á•ñ] dÇt‹GƒJƒ^ƒ‹‚ɑ΂µƒ^ƒNƒƒŠƒ€ƒX“_Šá‰t‚ðŽg—p‚µ‚œ1—á. èè@—ߎq1, _’J˜aF
1, Ž…Œö–ç1 (1Šá‰È): Šá‰È—Տ°‹I—v 2011/1; 4 (1): 16-9.

320042. [Ç—á•ñ] ŠÔŸ[«ŠOŽÎŽ‹Š³ŽÒ‚É‚š‚¯‚éŠáˆÊ•Ï‰»‚É”º‚€’²ßE“µEŒa‚̕ω»‚ɂ‚¢‚Ä. åŒŽŽµd
1, Îì@‹Ï1, ŒãŠÖ—˜–Ÿ2, ŒèœA‰h2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): _ŒoŠá‰È 2010/12; 27 (4):
407-15.

320043. [Ç—á•ñ] ŠááÙáz¹‚É‚š‚¯‚éCES-D‚ð—p‚¢‚œ‹C•ªáŠQ‚Ì•]‰¿. ‘åÎŒb—Žq1, Žá‘q‰ë“o1,2 (1
ˆäãŠá‰È•a‰@, 2Šá‰È): _ŒoŠá‰È 2010/12; 27 (4): 422-8.

510008. [‘à]yREFRACTIVE SURGERYzFEATURE STORY: Surgically Induced Astigmatism After Visian
ICL Implantation. _’J˜aF1 (1Šá‰È): CRSTEurope 2010/11; 11: 33-5.

520075. [‘à] R‚ª‚ñÜ‚ÆŠááŠQ (Šá•”•›ì—p). ”–؍LÆ1,2 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[, 2Šá‰È): Šà
‚Ɖ»Šw—Ö@ 2010/9; 37 (9): 1639-44.

520076. [‘à] Refractive Lenticule Extraction (ReLEx)?ƒGƒLƒVƒ}ƒŒ[ƒU[‚ð•K—v‚Æ‚µ‚È‚¢V‚œ‚È‹ü
Ü‹ž³Žèp?. _’J˜aF (Šá‰È): IOL&RS 2010/12; 24 (4): 616-20.

520077. [‘à]y“W–]zŠáŽîᇂ̓W–]?2005?2006”N“x?. ’ҁ@‰p‹M1, —é–ؖΐM2, ”–؍LÆ3,4 (1
ŠàŒ€‹†‰ï—L–Ÿ•a‰@Šá‰È, 2‘—§‚ª‚ñŒ€‹†ƒZƒ“ƒ^[Šá‰È, 3Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 4Šá‰È): Šá‰È
2011/1; 53 (1): 3-48.

521020. [‰ðà]y”’“àáE‹üÜŽèp‚̘_“_zŠp–ŒØŠJ. Ž…Œö–ç (Šá‰È): IOL&RS 2010/6; 24 (2): 262-4.

521021. [‰ðà] ƒGƒLƒXƒp[ƒg‚É•·‚­. _’J˜aF (Šá‰È): IOL&RS 2010/9; 24 (3): 508.

521022. [‰ðà] Ž‹—Í•s—Ç‚ÍŠá‰Èˆã‚É‚æ‚éfŽ@‚ª‘åØ. ŒãŠÖ—˜–Ÿ1, Ží“c–F˜Y1 (1Šá‰È): Œ’N‚Ó‚µ‚¬”­
Œ©ƒjƒ…[ƒXu‚©‚ç‚Ÿ‚Ì•sŽv‹c‡Iv 2010/10; 18 (10): •t˜^.

521023. [‰ðà]yV‚µ‚¢Žž‘ã‚Ì”’“àáŽèpzƒgƒsƒbƒNƒX: ƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒY‚Ì“x”Œˆ’è. _’J˜aF
(Šá‰È): —Տ°Šá‰È 2010/11; 64 (11, ‘Š§): 138-40.

521024. [‰ðà]yŠá‰È‚̐V‚µ‚¢ŒŸž–@zI. ŠpŒ‹–Œ—ÜŠí@[¶‘Ì—ÍŠwŒŸž]@Ocular Response AnalyzerTM
‚ɂ‚¢‚Ä‹³‚Š‚Ä‚­‚Ÿ‚³‚¢. _’J˜aF (Šá‰È): ‚ ‚œ‚炵‚¢Šá‰È 2010/12; 27 (—Õ‘): 47-50.

521025. [‰ðà] ‰€Ž™‚Ì‚œ‚ß‚ÌŽ‹—ÍŒŸžƒ}ƒjƒ…ƒAƒ‹. ‰F’ÃŒ©‹`ˆê1,2,3, ‹{‰Y@“O2 (1‰F’ÃŒ©Šá‰Èˆã‰@,
2“ú–{Šá‰ÈˆãŽt‰ïí”C—Ž–, 3Šá‰È): “ú–{‚ÌŠá‰È 2011/3; 82 (3): 329-33.

522119. [uÀ]y“ÁWF ‰~Šp–Œz—L…»‘ÌŠá“àƒŒƒ“ƒY (Phakic IOL) ‚É‚æ‚é‹üÜ‹ž³. _’J˜aF (Šá
‰È): ‚ ‚œ‚炵‚¢Šá‰È 2010/4; 27 (4): 459-64.

522120. [uÀ]yV‚µ‚¢Žž‘ã‚Ì”’“àáŽèpzIII. ‚‹@”\Šá“àƒŒƒ“ƒY@ƒgƒsƒbƒNƒX: ƒ‚ƒmƒrƒWƒ‡ƒ“. Ž…
Œö–ç (Šá‰È): —Տ°Šá‰È 2010/10; 64 (11, ‘Š§): 211-3.

522121. [uÀ]yV‚µ‚¢Žž‘ã‚Ì”’“àáŽèpzII. –ž‘«“x‚̍‚‚¢Šá“àƒŒƒ“ƒY“x”Œˆ’è?ƒsƒM[ƒoƒbƒN‚Ì“x”
Œˆ’è?. _’J˜aF (Šá‰È): —Տ°Šá‰È 2010/11; 64 (11, ‘Š§)124-8.

522122. [uÀ]yV‚µ‚¢Žž‘ã‚Ì”’“àáŽèpzII. –ž‘«“x‚̍‚‚¢Šá“àƒŒƒ“ƒY“x”Œˆ’è?“x”‚ž‚ê‚ɑ΂·‚éƒC
ƒ“ƒtƒH[ƒ€ƒhEƒRƒ“ƒZƒ“ƒg?. ¬Œ^— (Šá‰È): —Տ°Šá‰È 2010/11; 64 (11, ‘Š§): 130-6.

522123. [uÀ]y“ÁWzLASIK‚ÌŽüpŠúŠÇ—. ŒÜ\—’ÍŽj (Šá‰È): IOL&RS 2010/12; 24 (4): 590-596.

522124. [uÀ]y“ÁWzRefractive Lenticule Extraction (ReLEx)?ƒGƒLƒVƒ}ƒŒ[ƒU[‚ð•K—v‚Æ‚µ‚È‚¢
V‚œ‚È‹üÜ‹ž³Žèp?. _’J˜aF (Šá‰È): IOL&RS 2010/12; 24 (4): 616-620.

522125. [uÀ]y“ÁW: ŽOŽŸŒ³‰f‘œ‚ÆŽ‹Šo‚̉Ȋwz˜˜_. ŒŽ@’Œl1, ŒˆäNŽ÷2, ¬–ì‹|ŠG3 (1Šá‰È,
2•œ¬ˆã—Ðê–åŠw‰@Ž‹”\ŒP—ûŠw‰È, 3_“ސ쎕‰È‘åŠw¶‘Ì‹@”\ŠwuÀ¶—Šw•ª–ì): _ŒoŠá‰È 2010/12; 27
(4): 351-2.

522126. [uÀ]y“ÁW: ŽOŽŸŒ³‰f‘œ‚ÆŽ‹Šo‚̉Ȋwz“µE‚̐_ŒoŠá‰È“ü–å‡C@“µE‚ÆŠáŒõŠw. ìŽç“c‘ñŽu
1, ‹›—¢@”Ž1, Îì@‹Ï1 (1ˆã—Éq¶Šw•”): _ŒoŠá‰È 2011/12; 27 (4): 436-40.

522127. [uÀ]y“ÁW: Œ•a‚ƐSˆö«Ž‹ŠoáŠQz1. Sˆö«Ž‹ŠoáŠQ‚̐f’f?Diagnosis of psychogenic
visual disturbance?. ÝŠy‹±Žq1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): Šá‰È 2011/3; 53 (3):
295-9.

522128. [uÀ]y“ÁW: ƒtƒFƒgƒ€ƒZƒJƒ“ƒhƒŒ[ƒU[‰ž—p‚ÌŽÀÛz¡Œã‚Ì“W–]. _’J˜aF (Šá‰È): IOL&RS
2011/3; 25 (1): 41-6.

540040. [‚»‚Ì‘Œ (V•·)]yŽ†ãf—ÃŽºzí‚É—Ü‚ª—¬‚ê—Ž‚¿‚é. ‰F’ÃŒ©‹`ˆê1,2 (1Šá‰È, 2‰F’ÃŒ©Šá‰È
ˆã‰@): “Œ‹žV•· 2010/4/1.

540041. [‚»‚Ì‘Œ (Šw‰ïˆóÛ‹L)]y‘æ63‰ñ“ú–{—Տ°Šá‰ÈŠw‰ïˆóÛ‹Lzˆê”ʍu‰‰uŠp–ŒŒŸžv. _’J˜aF (Šá
‰È): Šá‰È 2010/4; 52 (4): 478-9.

540042. [‚»‚Ì‘Œ (Q•A)]y‚Í‚¶‚߂ẴIƒ‹ƒ\ƒPƒ‰ƒgƒƒW[Q & Az‡•¹Ç‚Æ‚»‚̑Ώˆ–@. ‰F’ÃŒ©‹`ˆê1,2
(1Šá‰È, 2‰F’ÃŒ©Šá‰Èˆã‰@): Šá‰ÈƒPƒA 2010/9; 12 (10): 45-8.

540043. [‚»‚Ì‘Œ (•t˜^)] ‚ß‚ª‚Ë‚ð‚©‚¯‚œ‚Ù‚€‚ª‚¢‚¢‚Ì‚©‚È? ŒãŠÖ—˜–Ÿ (Šá‰È): Œ’N‚Ó‚µ‚¬”­Œ©ƒjƒ…[
ƒX 2010/10; 18 (10): ƒ|ƒXƒ^[.

540044. [‚»‚Ì‘Œ (•t˜^)] ³‚µ‚¢Žpš‚Å–{‚ð“ǂޏKŠµ‚ð‚‚¯‚æ‚€! ŒãŠÖ—˜–Ÿ (Šá‰È): Œ’N‚Ó‚µ‚¬”­Œ©ƒj
ƒ…[ƒX 2010/10; 18 (10): ƒ|ƒXƒ^[.

540045. [‚»‚Ì‘Œ (•t˜^)] ‚¢‚ë‚¢‚ë‚Ȗڂ̍öŠo‚ðŠy‚µ‚ñ‚Å‚Ý‚æ‚€! ŒãŠÖ—˜–Ÿ (Šá‰È): Œ’N‚Ó‚µ‚¬”­Œ©ƒj
ƒ…[ƒX 2010/10; 18 (10): ƒ|ƒXƒ^[.

540046. [‚»‚Ì‘Œ (V•·)] ”’“àáŽèp‚Ì•‹y‚ð. Ž…Œö–ç (Šá‰È): •ŸˆäV•· 2010/10/27.

540047. [‚»‚Ì‘Œ (ûŽq)] Simple¥¥¥, and Stable!?ƒAƒoƒ“ƒVƒBƒvƒŠƒZƒbƒg?. Ž…Œö–ç (Šá‰È): ƒƒf
ƒBƒJƒ‹Eƒrƒ…[ƒ|ƒCƒ“ƒg 2010/11; 31 (5): 2.

540048. [‚»‚Ì‘Œ (ƒgƒsƒbƒNƒX)] ‚±‚ñ‚É‚¿‚ÍCLŠO—ˆ@–k—¢‘åŠw•a‰@‚ÌŠª. ‰F’ÃŒ©‹`ˆê1,2, ŒF”WŒä“°—²
2,3 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È, 3ƒNƒ}ƒmƒ~ƒh[Šá‰È): ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ïŽ 2010/12; 52 (4): 302-3.

540049. [‚»‚Ì‘Œ (Vt‘z)] ‘Ì—Í‚ÆŒoŒ±. Îì@‹Ï (ˆã—Éq¶Šw•”): “ú–{‚ÌŠá‰È 2011/1; 82 (1):
11.

540050. [‚»‚Ì‘Œ (Vt‘z)] ŽŸ‚Ì–Ú•W‚Í? ¯ŽiMs (ˆã—Éq¶Šw•”): “ú–{‚ÌŠá‰È 2011/1; 82 (1):
12.

540051. [‚»‚Ì‘Œ (ˆóÛ‹L)] ‘æ41‰ñ‘S‘ŠwZ•ÛŒ’EŠwZˆã‘å‰ï‚̈óÛ‹L@3: •œ¬21”N“x‘S‘ŠwZ‚̃R
ƒ“ƒ^ƒNƒgƒŒƒ“ƒY‘•—p. ‰F’ÃŒ©‹`ˆê1,2 (1Šá‰È, 2‰F’ÃŒ©Šá‰Èˆã‰@): “ú–{‚ÌŠá‰È 2011/2; 82 (2): 185-6.

540052. [‚»‚Ì‘Œ (ˆóÛ‹L)] ‘æ41‰ñ‘S‘ŠwZ•ÛŒ’EŠwZˆã‘å‰ï‚̈óÛ‹L@4: ’†E‚Z¶‚̃Rƒ“ƒ^ƒNƒgƒŒ
ƒ“ƒY‚̃PƒAó‹µ. â–{‘¥•q (Šá‰È): “ú–{‚ÌŠá‰È 2011/2; 82 (2): 186.

540053. [‚»‚Ì‘Œ (Šw‰ïŽ˜^)] ‹ßÔŠO•ªŒõ–@ (NIRS) ‚ð—p‚¢‚œ3D‰f‘œ’Ž‹Žž‚Ì”]‹@”\‚ÌŒŸ“¢. ”Œ“c’m–ç
1, ¯ŽiMs1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): Šá‰È—Տ°‹I—v 2011/3; 4 (3): 260-1.

540054. [‚»‚Ì‘Œ (Šw‰ïŽ˜^)] ŽÎˆÊ‹ßŽ‹p‘OŒã‚É‚š‚¯‚é‘Š‘Îçt–©•Ï‰». åŒŽŽµd1, Îì@‹Ï1, ŒãŠÖ—˜
–Ÿ2, ’r“c“N–ç2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): Šá‰È—Տ°‹I—v 2011/3; 4 (3): 265.

540055. [‚»‚Ì‘Œ (Šw‰ïŽ˜^)] “œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éÉŽq‘ÌŽèp‚̏pŒãŒo‰ß. ŽRŒûŠG—¢1, ’†Œ@Šî
1, –ö“c’q•F1, Ž…Œö–ç1 (1Šá‰È): Šá‰È—Տ°‹I—v 2011/3; 4 (3): 279.

540056. [‚»‚Ì‘Œ (Šw‰ïŽ˜^)] ¬Ž™‚ÌŽ‹_ŒoŽŸŠ³. •û’qŒbŽq1, Žs糋`Í2, Ž…Œö–ç2 (1‘Š–Í–ì•a
‰@, 2Šá‰È): Šá‰È—Տ°‹I—v 2011/3.; 4 (3): 279.

540057. [‚»‚Ì‘Œ (Šw‰ïŽ˜^)] ƒ‰ƒ^ƒmƒvƒƒXƒg‚ƃ^ƒtƒ‹ƒvƒƒXƒg‚̊ሳ‰º~Œø‰Ê‚Ì”äŠrŒŸ“¢. ]•—Ft
1, Š}ŒŽ³s1, ¬Š}ŒŽƒŒb1, ŽRŒûŠG—¢1, ‘å’Î’qG1, X“c“N–ç1, ¯ŽiMs2, Ž…Œö–ç1 (1Šá‰È, 2
ˆã—Éq¶Šw•”): Šá‰È—Տ°‹I—v 2011/3; 4 (3): 279.

540058. [‚»‚Ì‘Œ (Šw‰ïŽ˜^)] •¡”‰ñˆÚA•Ð‹@”\•s‘S‚ɑ΂µ‚ĐlŒûŠp–ŒBoston K-proˆÚAp‚ðŽ{p‚µ‚œ
ˆê—á. ²“¡M”V1, ŒÜ\—’ÍŽj2, _’J˜aF2, Ž…Œö–ç2 (1ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È): Šá‰È—Տ°‹I—v
2011/3; 4 (3): 279.

540059. [‚»‚Ì‘Œ (Šw‰ïŽ˜^)] ‹üÜ‹ž³ŽèpŒã‚ÌŠá“àƒŒƒ“ƒY“x”ŒvŽZ. ”Ñ“c‰Ã•F1, Ž…Œö–ç1, “V–엝
Œb1 (1Šá‰È): Šá‰È—Տ°‹I—v 2011/3; 4 (3): 279.

540060. [‚»‚Ì‘Œ (Šw‰ïŽ˜^)] –k—¢‘åŠw•a‰@‚É‚š‚¯‚éŠá‰ÈŽÊ^‹Æ–±‚̏Љî. ŽRŒû@ƒ (Šá‰È): Šá‰È—Տ°
‹I—v 2011/3; 4 (3): 279.

540061. [‚»‚Ì‘Œ (u‰‰—vŽ|)] ƒ[ƒrƒWƒ‡ƒ“Š³ŽÒ‚ÌŽc‘¶Ž‹–ì‚ÆQuality of Life. –öàV”üˆßŽq1,2, ‰Á“¡@
‘1, ‘ŒŽu•Û1, “c‘º‚ß‚®‚Ý1, –kàV–œ—¢Žq1, —Ž‡áÁ‹IŽq1, ¯ŽiMs3 (1“Œ‹ž‘åŠw, 2‘åŠw‰@ˆã—ÃŒn
Œ€‹†‰È, 3ˆã—Éq¶Šw•”): “ú–{ƒ[ƒrƒWƒ‡ƒ“Šw‰ïŽ 2011/3; 10: S24.

540062. [‚»‚Ì‘Œ (u‰‰—vŽ|)] NEI VFQ-25‚ð—p‚¢‚œŠááÙáz¹Š³ŽÒ‚ÌŽ‹‹@”\ŠÖ˜AQOL‚Ì•]‰¿. ‹v•ÛŽá“Þ1,
ŒŽŒû@“µ1, •XŽº^‹Õ1, –{‘œ¹Žq1, Îˆä—SŽq1, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È):
“ú–{ƒ[ƒrƒWƒ‡ƒ“Šw‰ïŽ 2011/3; 10: S24.

540063. [‚»‚Ì‘Œ (u‰‰—vŽ|)] ’†Œ˜Eˆõ‚ɑ΂·‚郍[ƒrƒWƒ‡ƒ“‘ÌŒ±ŠwK‚ɂ‚¢‚Ä. •“c”ü’mŽq1, Îˆä
—SŽq1, â“cç]Žq1, ²“¡—T”üŽq1, “¡‰i–MŽq1, X@”ü‹I1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1 (1ˆäãŠá‰È•a
‰@, 2Šá‰È): “ú–{ƒ[ƒrƒWƒ‡ƒ“Šw‰ïŽ 2011/3; 10: S32.

[’˜@‘]

620113. [Šwp‘] (•ª’SŽ·•M)yŠá‚̃TƒCƒGƒ“ƒX@ŠáŽŸŠ³‚Ì“äzIII. ‘O–[E‹÷ŠpE…»‘́@˜VŽ‹‚ɑ΂·‚é
ŽèpŽ¡—Â͖{“–‚ɉ”\‚©? p.102-4. Ž…Œö–ç (Šá‰È), •Ò ª–؁@º, “c–ì•Û—Y, ‘å‹Ž—Tˆê, ’Ø“cˆê’j, ‘å
Ž­“N˜Y, •¶Œõ“°, “Œ‹ž, 2010/6”­s.

620114. [Šwp‘] (•ª’SŽ·•M)yŽ‹”\‹ž³Šw —pŒê‰ðàŽ«“TzƒAƒbƒx”, p.4-5. FŽû·, p.14. ƒKƒ“ƒ}
Šp, p.47-8. Å¬ö—‰~, p.81. Å“_, p.112-3. ‹›—¢@”Ž1 (1ˆã—Éq¶Šw•”), •Ò ŽR–{@ß1 (1_
ŒË‘åŠw–Œ—_‹³Žö), ƒƒfƒBƒJƒ‹ˆšo”Å, “Œ‹ž, 2010/10”­s.

620115. [Šwp‘] (•ª’SŽ·•M)y‹üÜˆÙí‚ÆŠá‹Ÿ‹ž³@ê–åˆã‚Ì‚œ‚ß‚ÌŠá‰Èf—ÃNƒIƒŠƒtƒ@ƒC 1z’²ß—Í
‚Ì‘ª’è, p.214-20. ìŽç“c‘ñŽu1, ‹›—¢@”Ž1 (1ˆã—Éq¶Šw•”), •Ò ‘厭“N˜Y2 (2’}”g‘åŠw), ’†ŽR‘
“X, “Œ‹ž, 2010/11”­s.

620116. [Šwp‘] (•ª’SŽ·•M)y‹üÜˆÙí‚ÆŠá‹Ÿ‹ž³@ê–åˆã‚Ì‚œ‚ß‚ÌŠá‰Èf—ÃNƒIƒŠƒtƒ@ƒC 1z’²ß‚Ì
ˆÙí‚Æ‚»‚ÌŽ¡—Ã, p.221-6. óì@Œ«1, ¯ŽiMs1, Îì@‹Ï1 (1ˆã—Éq¶Šw•”), •Ò ‘厭“N˜Y2 (2
’}”g‘åŠw), ’†ŽR‘“X, “Œ‹ž, 2010/11”­s.

620117. [Šwp‘] (•ª’SŽ·•M)y‹üÜˆÙí‚ÆŠá‹Ÿ‹ž³@ê–åˆã‚Ì‚œ‚ß‚ÌŠá‰Èf—ÃNƒIƒŠƒtƒ@ƒC 1zŠá‚Ì‹ü
Ü—v‘f, p.278-86. ‹›—¢@”Ž1 (1ˆã—Éq¶Šw•”), •Ò ‘厭“N˜Y2 (2’}”g‘åŠw), ’†ŽR‘“X, “Œ‹ž, 2010/11
”­s.

620118. [Šwp‘] (•ª’SŽ·•M)yƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒYz‘æ1Í —Ž‹‚ÌŽí—Þ, p.3-9. _’J˜aF1 (1Šá
‰È), •Ò’˜ ƒrƒbƒZƒ“‹{“‡OŽq2 (2“Œ‹žˆã‰È‘åŠw…“¹‹Ž•a‰@Šá‰È), “ìŽR“°, “Œ‹ž, 2010/11”­s.

620119. [Šwp‘] (•ª’SŽ·•M)yƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒYzƒRƒ‰ƒ€8 ƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒY‚̐¬Œ÷–@, p.114-5.
Ž…Œö–ç1 (1Šá‰È), •Ò’˜ ƒrƒbƒZƒ“‹{“‡OŽq2 (2“Œ‹žˆã‰È‘åŠw…“¹‹Ž•a‰@Šá‰È), “ìŽR“°, “Œ‹ž, 2010/11
”­s.

620120. [Šwp‘] (•ª’SŽ·•M)yƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒYz‘æ9Í pŒãŒŸž, p.117-25. _’J˜aF1 (1Šá
‰È), •Ò’˜ ƒrƒbƒZƒ“‹{“‡OŽq2 (2“Œ‹žˆã‰È‘åŠw…“¹‹Ž•a‰@Šá‰È), “ìŽR“°, “Œ‹ž, 2010/11”­s.

620121. [Šwp‘] (•ª’SŽ·•M)yƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒYzƒg[ƒŠƒbƒN—L…»‘ÌŠá“àƒŒƒ“ƒY‚©‚çŠw‚ñ‚Ÿ‚±‚Æ,
p.162-3. Žsìˆê•v1,2 (1Šá‰È, 2ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È), •Ò’˜ ƒrƒbƒZƒ“‹{“‡OŽq3 (3“Œ‹žˆã‰È‘åŠw
…“¹‹Ž•a‰@Šá‰È), “ìŽR“°, “Œ‹ž, 2010/11”­s.

620122. [Šwp‘] (•ª’SŽ·•M)yƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒYz—Ž‹‚Í‚Ç‚±‚Ü‚ÅŽ¡‚·‚ׂ«‚©H —Ž‹‚Əœ_[“x‚Æ
‚ÌŠÖŒW, p.170-1. ‹›—¢@”Ž1 (1ˆã—Éq¶Šw•”), •Ò’˜ ƒrƒbƒZƒ“‹{“‡OŽq2 (2“Œ‹žˆã‰È‘åŠw…“¹‹Ž•a‰@
Šá‰È), “ìŽR“°, “Œ‹ž, 2010/11”­s.

620123. [Šwp‘] (•ª’SŽ·•M)yŠá‰ÈŒŸž‚̃Oƒm[ƒeƒBEƒZƒAƒEƒgƒ“z1. Ž‹‹@”\EŽÎŽ‹ŽãŽ‹@ƒRƒJƒCƒ““_
ŠáŽŽŒ±ˆÈŠO‚É, HornerÇŒóŒQ‚̐f’f‚ª‚Å‚«‚é‚à‚Ì‚ª‚ ‚é, p.31-4. Îì@‹Ï1 (1ˆã—Éq¶Šw•”), ŽR‰º
‰pr2, ’JŒŽGM3 (2ŽRŒ`‘åŠw, 3ŒF–{‘åŠw), ƒVƒiƒW[o”Å, “Œ‹ž, 2010/11”­s.

620124. [Šwp‘] (•ª’SŽ·•M)yŠá‰ÈŒŸž‚̃Oƒm[ƒeƒBEƒZƒAƒEƒgƒ“z3. …»‘́@’m‚Á‚Ä‚¢‚é‚‚à‚è‚Å’m
‚ç‚È‚¢‚±‚Æ‚ª‘œ‚¢’²ßŒŸž, p.98-101. óì@Œ«1, Îì@‹Ï1, ¯ŽiMs1, Ž…Œö–ç2 (1ˆã—Éq¶Šw
•”, 2Šá‰È), ŽR‰º‰pr3, ’JŒŽGM4 (3ŽRŒ`‘åŠw, 4ŒF–{‘åŠw), ƒVƒiƒW[o”Å, “Œ‹ž, 2010/11”­s.

620125. [Šwp‘] (•ª’SŽ·•M)yŠá‰ÈŒŸž‚̃Oƒm[ƒeƒBEƒZƒAƒEƒgƒ“z4. —Γàá@Ž‹–쌟ž: ‘Šú—Γàá
f’f‚É—L—p‚ÈŽ‹–쌟ž‚ÌŽg‚¢•ª‚¯, p.148-152. ¯ŽiMs1 (1ˆã—Éq¶Šw•”), ŽR‰º‰pr2, ’JŒŽGM3 (2
ŽRŒ`‘åŠw, 3ŒF–{‘åŠw), ƒVƒiƒW[o”Å, “Œ‹ž, 2010/11”­s.

620126. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚ÌŽ¡—ÃŽnŽwj 2011”N“x”Å?Ž„‚Í‚±‚€Ž¡—µ‚Ä‚¢‚éz24 Šá‰ÈŽŸŠ³@‚u
‚c‚sì‹Æ‚É‚æ‚éáŠQ, p.892-3. Žs糋`Í (Šá‰È), ‘•ÒW ŽRŒû@“O, –kŒŽŒõ•v, •ŸˆäŽŸ–î, ˆãŠw‘‰@, “Œ
‹ž, 2011/1”­s.

620127. [Šwp‘] (•ª’SŽ·•M)yVES NOWõ5@Šá‰ÈŽèp‚̃ƒWƒbƒN: ‚±‚€l‚Š‚ê‚ÎŽèp‚͏ã’B‚·‚ézIII.
V‚µ‚¢ŽèpŠíŠB, Žè‹Z@ƒiƒCƒt, p.138-140. _’J˜aF1 (1Šá‰È), •Ò ŽR–{“N–ç2, ]ŒûGˆê˜Y3, ƒrƒb
ƒZƒ“‹{“‡OŽq4, –å”V‰€ˆê–Ÿ5 (2Šò•Œ‘åŠw, 3]ŒûŠá‰È•a‰@, 4“Œ‹žŽ•‰È‘åŠw, 5‰¡•lŽs—§‘åŠw), ƒƒWƒJ
ƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 2011/2”­s.

620128. [Šwp‘] (•ª’SŽ·•M)yˆãŽt‘ŽŽŠùo–â‘èWƒTƒNƒZƒXRED Minor '12 Level III zŠá‰È, p.235-74.
ŒãŠÖ—˜–Ÿ1, Ží“c–F˜Y1 (1Šá‰È), ˆãŠw•]˜_ŽÐ, 2011/3”­s.

622002. [Šwp‘] (–|–ó)yVISION TIMESz‘œÅ“_I‚nL‚Ö‚Ì’†•«‡‰ž: ƒgƒŒ[ƒjƒ“ƒO‚Í”]‚̏•‚¯‚Æ‚È‚é
‚Ì‚©? (Multifocal Neuroadaptation: Can Training Help the Brain?), ¬Œ^—1,2 (1ŽR‰€•a‰@Šá‰È,
2‘Ûˆã—ÕŸŽƒ‘åŠw—Տ°ˆãŠwŒ€‹†ƒZƒ“ƒ^[), ‰F–ìr•F3 (3ˆ€•Q‘åŠw‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È), ƒGƒ‹ƒ[ƒrƒAE
ƒWƒƒƒpƒ“, “Œ‹ž, 2010/11”­s.

622003. [Šwp‘] (–|–ó)yVISION TIMESzŠú‘҂̐¯, ƒtƒFƒCƒLƒbƒNIOL‚ɉœ‚ª‚ ‚Á‚œ? (What Happened to
the Promise of Phakic IOLs?), p.11-15. ¬Œ^—1,2 (1ŽR‰€•a‰@Šá‰È, 2‘Ûˆã—ÕŸŽƒ‘åŠw—Տ°ˆãŠw
Œ€‹†ƒZƒ“ƒ^[), ‰F–ìr•F3 (3ˆ€•Q‘åŠw‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È), ƒGƒ‹ƒ[ƒrƒAEƒWƒƒƒpƒ“, “Œ‹ž, 2010/11”­
s.

[Šw‰ïEŒ€‹†‰ï“™]

712053. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€ & Siencific Papers) Pseudophakic Monovision Using Monofocal
and Multifocal IOLs-Hybrid Monovision. ”Ñ“c‰Ã•F (Šá‰È): ASCRS¥ASOA Symposium & Congress
(2010/4/9-12), ƒAƒƒŠƒJEƒ{ƒXƒgƒ“.

712054. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€•Siencific Papers) Pseudophakic Monovision Using Pupil Size.
Ž…Œö–ç (Šá‰È): ASCRS¥ASOA Symposium & Congress (2010/4/9-12), ƒAƒƒŠƒJEƒ{ƒXƒgƒ“.

712055. [Šw‰ï (‘Û)] (ƒrƒfƒIƒVƒ“ƒ|ƒWƒEƒ€) International Video Symposium of Challenging Cases and
Complication Management in Cataract Surgery. Ž…Œö–ç (Šá‰È): ASCRS¥ASOA Symposium & Congress
(2010/4/9-12), ƒAƒƒŠƒJEƒ{ƒXƒgƒ“.

712056. [Šw‰ï (‘Û)] (ƒtƒBƒ‹ƒ€) Waxy Vision: Dissatisfaction After Multifocal IOL Implantation.
Ž…Œö–ç (Šá‰È): ASCRS¥ASOA Symposium & Congress (2010/4/9-12), ƒAƒƒŠƒJEƒ{ƒXƒgƒ“.

712057. [Šw‰ï (‘Û)] (µ‘ҍu‰‰“™) Monovison, ICL indication on diversity and evolution. Ž…
Œö–ç (Šá‰È): 7th International STAAR ICL Experts Symposium (2010/9/2), ƒtƒ‰ƒ“ƒXEƒpƒŠ.

712058. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) LASIK-current indications and contraindications. Ž…Œö
–ç (Šá‰È): The 25th Asia-Pacific Academy of Ophthalmology Congress (2010/9/16), ’†‘E–k‹ž.

712059. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Pseudophakic Monovision. Ž…Œö–ç (Šá‰È): The 25th
Asia-Pacific Academy of Ophthalmology Congress (2010/9/17), ’†‘E–k‹ž.

712060. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) LASIK-current indications and contraindications. Ž…Œö
–ç (Šá‰È): The 25th Asia-Pacific Academy of Ophthalmology Congress (2010/9/18), ’†‘E–k‹ž.

712061. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Pearls for Astigmatic Keratotomy. Ž…Œö–ç (Šá‰È): The
25th Asia-Pacific Academy of Ophthalmology Congress (2010/9/19), ’†‘E–k‹ž.

712062. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) ICL vs. LASIK: Efficiency and Safety. Ž…Œö–ç (Šá‰È): 19th
in the morning during the congress ICL Breakfast symposium (2010/9/19), ’†‘E–k‹ž.

712063. [Šw‰ï (‘Û)] (Scientific Session) Monovision or multifocal IOL? Ž…Œö–ç (Šá‰È): 23rd
International Congress of German Ophthalmic Surgeons (2010/10/23), ƒhƒCƒcEƒnƒ“ƒuƒ‹ƒN.

712064. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) HOYA Preloaded IOL. Ž…Œö–ç (Šá‰È): The 104th Annual
Meeting The Korean Ophthalmological Society (2010/11/5), ŠØ‘Eƒ\ƒEƒ‹.

712065. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) Corneal Hysteresis. _’J˜aF (Šá‰È): The 2nd Asia Cornea
Society Biennial Scientific Meeting (2010/12/2), ‹ž“s.

712066. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) 12-Year Follow-Up of ICL. Ž…Œö–ç (Šá‰È): The 2nd Asia
Cornea Society Biennial Scientific Meeting (2010/12/3), ‹ž“s.

712067. [Šw‰ï (‘Û)] (µ‘ҍu‰‰“™) Difficult Cases of Cataract Surgery. Ž…Œö–ç (Šá‰È): 69th
Annual Conference of All India Ophthalmological Society (2011/2/4), ƒCƒ“ƒhEƒA[ƒƒ_ƒo[ƒh.

712068. [Šw‰ï (‘Û)] (Instruction Courses)yƒpƒlƒŠƒXƒgzCurbside Consultation In Cataract Surgery.
Abhay Vasavada, Haldipurkar S S, Haripriya Aravind, Khiun Tjia, Ž…Œö–ç1, Minu Mathen M, Partha
Biswas, Purendra Bhasin, Sri Ganesh, Titiyal JS (1Šá‰È): 69th Annual Conference of All India
Ophthalmological Society (2011/2/4), ƒCƒ“ƒhEƒA[ƒƒ_ƒo[ƒh.

712069. [Šw‰ï (‘Û)] (ƒVƒ“ƒ|ƒWƒEƒ€) The Role of@Monovision. Ž…Œö–ç (Šá‰È): ASCRSEASOA
Symposium & Congress (2011/3/26), ƒAƒƒŠƒJEƒTƒ“ƒfƒBƒGƒS.

712070. [Šw‰ï (‘Û)] (ASCRS Course) International Video Symposium of Challenging Cases and
Complication Management. Osher RH (Ahmed IK, Trindade FC, Alio JL, Pckard RB, Assia EI, Little
BC, Vasavada AR, Agarwal A, Ž…Œö–ç1, Barrett GD, Tjia KF, Budo CR, Malyugin BE) (1Šá‰È): ASCRSE
ASOA Symposium & Congress (2011/3/28), ƒAƒƒŠƒJEƒTƒ“ƒfƒBƒGƒS.

713137. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Three-Dimensional Pupillography Using Optical Demultiplexer-OCT
at a Speed of 5,000,000 Axial Scans Per Second. ’†Œ@Šî1, D Choi2, H Hiro-oka2, H Furukawa2,
R Yoshimura2, ŒÜ\—’ÍŽj1, K Ohbayashi2, Ž…Œö–ç1 (1Šá‰È, 2Center for Natural Science): ARVO
2010 (2010/5/2), ƒAƒƒŠƒJEƒtƒƒŠƒ_.

713138. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Relationship between visual acuity, pupil size and refractive
difference in pseudophakic monovision. ìŽç“c‘ñŽu1, ‹›—¢@”Ž1, ’†ŽR“ށX”ü2, i“¡^‹I2, ”Œ“c
’m–ç1, ˆÉ“¡”ü¹ŠG1, Ž…Œö–ç3 (1ˆã—Éq¶Šw•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3Šá‰È): ARVO 2010
(2010/5/2-6), ƒAƒƒŠƒJEƒtƒƒŠƒ_.

713139. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Binocular interaction in visual evoked responses: a presbyopic
treatment study. Ž…Œö–ç1, ˆÉ“¡”ü¹ŠG2 (1Šá‰È, 2ˆã—Éq¶Šw•”): World Ophthalmology Congress
2010 (2010/6/6), ƒhƒCƒcEƒxƒ‹ƒŠƒ“.

713140. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Association between quality of life and changes in visual acuity
in Japanese patients with low vision. –öàV”üˆßŽq1, Satoshi Kato, Shiho Kunimatsu, Megumi Kobayashi,
Makiko Ochiai, ¯ŽiMs2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): World Ophthalmology Congress 2010
(2010/6/6), ƒhƒCƒcEƒxƒ‹ƒŠƒ“.

713141. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) An anti-aquaporin-4 antibody-positive optic neuropathy along
with several medical factors. ”–؍LÆ1, Hiroyuki Fukuda, Yoko Fujitani, Akiko Tamura, Hideo
Suyama (1Šá‰È): XVIII International Neuro-Ophthalmology Society Meeting (INOS2010) (2010/6/15-18),
ƒtƒ‰ƒ“ƒXEƒŠƒˆƒ“.

713142. [Šw‰ï (‘Û)] (Free Paper) Waxy vison: an electrophysiology study. Ž…Œö–ç1, ˆÉ“¡”ü
¹ŠG2, ”Ñ“c‰Ã•F1, ìŽç“c‘ñŽu2, ‘å–{•¶Žq1 (1Šá‰È, 2ˆã—Éq¶Šw•”): XXVIII Congress of the ESCRS
(2010/9/6), ƒpƒŠEƒtƒ‰ƒ“ƒX.

713143. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Short-term results of nasal-superior trabeculectomy. ¯ŽiM
s1, ìŽç“c‘ñŽu1, X“c“N–ç2, ”Ñ“‡@Œh2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): 9th Congress of The
European Glaucoma Society (2010/9/15), ƒXƒyƒCƒ“Eƒ}ƒhƒŠƒbƒh.

713144. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) The Long-term Safety of ICL and its Importance in Refractive
Surgery. Ž…Œö–ç (Šá‰È): STAAR Aier Group Users' Meeting (2010/9/16), ’†‘E–k‹ž.

713145. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Long-term Comparison of Implantable Collamer Lens Implantation
and Wavefront-guided Laser in Situ Keratomileusis for High Myopic Astigmatism. Ž…Œö–ç (Šá‰È):
The 25th Asia-Pacific Academy of Ophthalmology Congress (2010/9/16-17), ’†‘E–k‹ž.

713146. [Šw‰ï (‘Û)] (Paper Presentations) The effectiveness of proton beam therapy in rare
nasolacrimal duct cancers. ”–؍LÆ1,2, Teturo Onizuka, Hiroshi Fuji, Shigeyuki Murayama (1
Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È): APAO Sydney 2011 (2011/3/20), ƒI[ƒXƒgƒ‰ƒŠƒAEƒVƒhƒj[.

713147. [Šw‰ï (‘Û)] (Paper Session) Binocular Iinteraction in Visual Evoked Rresponses:
Effective IOL Exchange. Ž…Œö–ç1, ”Ñ“c‰Ã•F1, ˆÉ“¡”ü¹ŠG2 (1Šá‰È, 2ˆã—Éq¶Šw•”): ASCRSEASOA
Symposium & Congress (2011/3/28), ƒAƒƒŠƒJEƒTƒ“ƒfƒBƒGƒS.

713148. [Šw‰ï (‘Û)] (Free Paper) Correction of Rotation and Axial Length of Toric IOLs. ŽO
‘îr”V1, Ž…Œö–ç1, _’J˜aF1, ”Ñ“c‰Ã•F1, “V–엝Œb1 (1Šá‰È): ASCRSEASOA Symposium & Congress
(2011/3/29), ƒAƒƒŠƒJEƒTƒ“ƒfƒBƒGƒS.

721018. [Šw‰ï (‘S‘)] (“Á•Êu‰‰)yÀ’·z–]‰“‹Ÿ‚ÌŽ‹—Í‚ð10”{‚ɉü‘P‚·‚é•âžŒõŠw. ‹›—¢@”Ž (ˆã—Ã
‰q¶Šw•”): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

721019. [Šw‰ï (‘S‘)] (“Á•Êu‰‰)y‰ï’·u‰‰À’·z_ŒoŠá‰ÈŠw‚Ɛ_Œo‹ØÚ‡•”ŽŸŠ³Ú‡•”EœŠi‹ØŽŸŠ³.
Žá‘q‰ë“o1,2 (1Šá‰È, 2ˆäãŠá‰È•a‰@): ‘æ48‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/27), –ŒŒÃ‰®.

722159. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) yÀ’·zƒVƒ“ƒ|ƒWƒEƒ€1: Phakic IOL ‚ÌŽÀÛ. Ž…Œö–ç (Šá
‰È): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/25), ‘åã.

722160. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ICL‚Ì’·Šú—\Œã. Ž…Œö–ç (Šá‰È): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹ü
ÜŽèpŠw‰ï‘‰ï (2010/6/25), ‘åã.

722161. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Toric ICL (—Ž‹“x”“ü‚èŒã–[Œ^—L…»‘ÌŠá“àƒŒƒ“ƒY). ‘ŠàV‘å
•ã1,2 (1Šá‰È, 2ŠC˜V–Œ‘‡•a‰@): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/25), ‘åã.

722162. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) RK, PRKŒã‚Ì‹üÜˆÙí‚ɑ΂·‚éPhakic IOL‚É‚æ‚鎡—Ã. Ž…
Œö–ç (Šá‰È): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/25), ‘åã.

722163. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zí—ª“I”’“àáŽèp‚Ì‚œ‚ß‚É?IOL‚̃g[ƒ^ƒ‹ƒ\ƒŠ
ƒ…[ƒVƒ‡ƒ“ƒVƒXƒeƒ€IOLƒ}ƒXƒ^[ (ƒ‚ƒfƒ‹500) ‚Ö‚ÌŠú‘Ò?. Žsìˆê•v1,2 (1Šá‰È, 2ŽÐ‰ï•ÛŒ¯’†‹ž•a
‰@): ‘æ49‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2010/6/25), ‘åã.

722164. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zSimple¥¥¥, and Stable!?ƒAƒoƒ“ƒVƒBƒvƒŠƒZƒbƒg
?. Ž…Œö–ç (Šá‰È): ‘æ49‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2010/6/26),
‘åã.

722165. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) ‚à‚Á‚Æ‚í‚©‚éƒg[ƒŠƒbƒNIOL‚ÌŽÀÛ. Ž…Œö–ç (Šá‰È):
‘æ49‰ñ“ú–{”’“àáŠw‰ï‘‰ïE‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï (2010/6/26), ‘åã.

722166. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·zi‰»‚·‚闐Ž‹‹ž³. Ž…Œö–ç (Šá‰È): ‘æ25‰ñ“ú–{Šá
“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/27), ‘åã.

722167. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·zNew Device?ŒŸž‹@Ší‚̐i•à?. ‹›—¢@”Ž1, ‘O“c’Œ
”V2 (1ˆã—Éq¶Šw•”, 2‘åã‘å): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/27), ‘åã.

722168. [Šw‰ï (‘S‘)] (‡“¯Žs–¯ŒöŠJuÀ) ˜VŠá‚ÍŽ¡—Âł«‚é! Ž…Œö–ç (Šá‰È): ‘æ49‰ñ“ú–{”’“à
áŠw‰ï‘‰ïE‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï^‡“¯Žs–¯ŒöŠJuÀ (2010/6/27), ‘åã.

722169. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ƒJƒ‰[ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚ª•ø‚Š‚鏔–â‘è. ‰F’ÃŒ©‹`ˆê
1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): ‘æ53‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (2010/7/10), “Œ‹ž.

722170. [Šw‰ï (‘S‘)] (Šwp§—ãÜŽóÜu‰‰) “µEŒa‚ª’²®”÷“®‚Žü”g¬•ªoŒ»•p“x‚É‹y‚Ú‚·‰e‹¿. ’†
ŽR“ށX”ü (‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

722171. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šá‹…ŒõŠwŒn‚ÌŠî‘b’mŽ¯. ‹›—¢@”Ž (ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú
–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

722172. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) –Ÿ“ú‚©‚ç‚·‚®‚ɐ¶‚©‚¹‚鎋—ÍŒŸžƒeƒNƒjƒbƒN. åŒŽŽµd (ˆã—Ã
‰q¶Šw•”): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

722173. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŠeŽí‹üÜ‹ž³–@‚̃hƒ‰ƒCƒrƒ“ƒOƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“. ìŽç“c‘ñŽu
(ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

722174. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·zƒVƒ“ƒ|ƒWƒEƒ€3: ˜VŽ‹‚ðl‚Š‚é. ‹›—¢@”Ž1, ªŠÝˆê”T
2 (1ˆã—Éq¶Šw•”, 2Œc‰ž‘å): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

722175. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šá“àƒŒƒ“ƒY‚É‚æ‚郂ƒmƒrƒWƒ‡ƒ“–@. “V–엝Œb (Šá‰È): ‘æ46‰ñ
“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

722176. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·zƒVƒ“ƒ|ƒWƒEƒ€4: Ž‹”\‹ž³Šw‚ÆŠáŒõŠw‚Ì—Z‡. Vˆä“c
F—T1,2, ‰PˆäçŒb3 (1Šá‰È, 2‘Ûˆã—ÕŸŽƒ‘åŠw, 3’é‹ž‘å): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4),
_“ސì.

722177. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) 3D‰æ‘œ‚ÌŒ»ó‚ÆŠáŒõŠwEŽ‹”\‹ž³Šw“I‰Û‘è. ”Œ“c’m–ç (ˆã—Ã
‰q¶Šw•”): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

722178. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Ž‹”\‹ž³Šw‚É‚š‚¯‚é‹ßŒ©”œ‰ž‚̉ž—p. ŒŽ@’Œl1,2 (1Šá‰È, 2
_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

722179. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·z‘OŠá•”‰ðÍ‘ª’è‘•’uƒyƒ“ƒ^ƒJƒ€HR‚ÌŠî‘b‚©‚ç—Õ
°Šˆ—p‚Ü‚Å. ‹›—¢@”Ž (ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

722180. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ƒg[ƒŠƒbƒNIOL‚É‚æ‚闐Ž‹ŒyŒž‚ª‚à‚œ‚ç‚·—‡ŠáŽ‹—ÍŒüã
‚̈Ӌ`. ŽO‘îr”V (Šá‰È): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

722181. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ScheimpflugŽ®‘OŠá•”‰ðÍ‘•’uPentacam‚ÌŽÀ—Í. ìŽç
“c‘ñŽu (ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

722182. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) Elevation-based Topography‚Ö‚Ì‚¢‚Ž‚È‚¢. _’J˜aF
(Šá‰È): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/4), _“ސì.

722183. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y’N‚Å‚à‚í‚©‚éƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYuÀ (Šî‘b‚ÆŽÀ‘H)zƒRƒ“ƒ^ƒN
ƒgƒŒƒ“ƒY‚Æ–òŽ––@. ‰F’ÃŒ©‹`ˆê1,2 (1Šá‰È, 2‰F’ÃŒ©Šá‰È): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/5), _
“ސì.

722184. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ƒI[ƒgƒŒƒX‚É‚æ‚é’²ß‹@”\‘ª’è?“±“ü•Ò?. ’†ŽR“ށX”ü
(‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/5), _“ސì.

722185. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zuTrabectomev‚»‚Ì—˜_‚ÆŽÀÛ. ¯ŽiMs (ˆã—Ã
‰q¶Šw•”): ‘æ21‰ñ“ú–{—ΓàáŠw‰ï (2010/9/25), •Ÿ‰ª.

722186. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[)yÀ’·z ’m‚Á‚Ä‚Ä—Ç‚©‚Á‚œI—Γàáf—Â̂±‚ñ‚È‚±‚Æ, ‚ 
‚ñ‚È‚±‚Æ. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ21‰ñ“ú–{—ΓàáŠw‰ï (2010/9/26), •Ÿ‰ª.

722187. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŽi‰ïz3D‰f‘œŽ‹’®‚É‚æ‚鎩—¥_Œo‚ւ̉e‹¿. ŒŽ@’Œl1,2 (1
Šá‰È, 2_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È): ‘æ63‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2010/10/23), _“ސì.

722188. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) 3D‰f‘œ’Ž‹Žž‚̐¶‘Ì”œ‰ž‚ÆŠá‰ÈŒŸžEŒP—û‰ž—p. ”Œ“c’m–ç (ˆã
—Éq¶Šw•”): ‘æ63‰ñ“ú–{Ž©—¥_ŒoŠw‰ï‘‰ï (2010/10/23), _“ސì.

722189. [Šw‰ï (‘S‘)] (Šwp“WŽŠ—DGÜŽóÜu‰‰) ”’“àáŽèp‘O‚É‚š‚¯‚éŠp–Œ—Ž‹•ª•z. ŽO‘îr”V1,
_’J˜aF1, “V–엝Œb1, Ž…Œö–ç1 (1Šá‰È): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/11), •ºŒÉ.

722190. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Phakic IOL. _’J˜aF (Šá‰È): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï
(2010/11/11), •ºŒÉ.

722191. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[)yÀ’·z ˆã—Éž—pOCT‚ÌŒ»ó‚Ə«—ˆ“W–]. Ž…Œö–ç (Šá
‰È): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/11), •ºŒÉ.

722192. [Šw‰ï (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) ˆã—Éž—pOCT‚ÌŒ»ó‚Ə«—ˆ“W–]. ‘å—эN“ñ (‘åŠw‰@ˆã—Ã
ŒnŒ€‹†‰È): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/11), •ºŒÉ.

722193. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·z Šáˆ³‰º~–ò‚ÌŒ»ó‚Æ–¢—ˆ. ¯ŽiMs (ˆã—Éq¶Šw•”):
‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/12), •ºŒÉ.

722194. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) “œ”A•aŠ³ŽÒ‚ÌŽ¡—Õûj5?‚±‚ñ‚ÈŽž‚Ç‚€‚·‚é?.
‰Á“¡@‘1, ‚–ì‰ë•F2,3, ˆÀ“¡L˜N4, Œ‘º”ü‘ã5 (1“Œ‹ž‘å, 2‘Ûˆã—ÕŸŽƒ‘åE”MŠC, 3Šá‰È, 4Ï¶
‰ïVŠƒ‘æ“ñ•a‰@, 5‰i“cŠá‰È): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/12), •ºŒÉ.

722195. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ‘œÅ“_Šá“àƒŒƒ“ƒY“±“ü‚̃|ƒCƒ“ƒg: ¬Œ÷—á‚Æ•s¬
Œ÷—á‚ɂ‚¢‚Ä‚ÌŒŸ“¢. “¡–{‰Â–FŽq1, “¿“c–F_2, “¡“c‘PŽj3, ‹›—¢@”Ž4 (1ƒtƒWƒ‚ƒgŠá‰È, 2ˆäãŠá‰È,
3“¡“cŠá‰È, 4ˆã—Éq¶Šw•”): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/12), •ºŒÉ.

722196. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ‘œÅ“_Šá“àƒŒƒ“ƒY‚Ì—ðŽj‚ÆŒõŠw“I‹@”\. ‹›—¢@”Ž
(ˆã—Éq¶Šw•”): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/12), •ºŒÉ.

722197. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒNƒ‹ƒOƒX) ‚ß‚Ž‚Ü‚µ_ŒoŠá‰ÈII. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ64
‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

722198. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ”’“àáŽèp‚Æ—Ž‹‹ž³?ƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒY‚ð
Šw‚Ú‚€?. ƒrƒbƒZƒ“‹{“‡OŽq1, ‹{“c˜a“T2, _’J˜aF3, ’†‘º–M•F4 (1“Œ‹žŽ•‘åE…“¹‹Ž, 2‹{“cŠá‰È,
3Šá‰È, 4‚œ‚È‚µ’†‘ºŠá‰ÈƒNƒŠƒjƒbƒN): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

722199. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) FŠoƒƒJƒjƒYƒ€‚̉ðà‚ƐFŠoˆÙí‚̗Տ°f’f‚š‚æ
‚ÑŽw“±. Žsìˆê•v1,2, “c•ÓÙŽq3, ŽRoVˆê4, ‰ª“‡@C5, ’†‘º‚©‚š‚é6 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Šá
‰È, 3Ž‹ŠoŒ€‹†Š, 4Ž ‰êˆã‘å, 5ŽOŠy•a‰@, 6—Žqˆã‘å): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •º
΃.

722200. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ŠwZ•ÛŒ’‚̃GƒbƒZƒ“ƒX (¬Ž™‚ÌŠá‹Ÿ, ƒRƒ“ƒ^ƒNƒg
ƒŒƒ“ƒYŽÀ‘Ô’²ž, ŠwZ‚Å‚ÌŠáŠO). ‰F’ÃŒ©‹`ˆê1,2,3, ŒÎè@Ž4, ‹{‰Y@“O2,5, ‚‹Ž˜a”Ž2, •Ÿ‰ºŒö
Žq2, ‚–ì@”É2 (1‰F’ÃŒ©Šá‰È, 2“ú–{Šá‰Èˆã‰ï, 3Šá‰È, 4ŒÎèŠá‰È, 5‹{‰YŠá‰È): ‘æ64‰ñ“ú–{—Տ°Šá
‰ÈŠw‰ï (2010/11/14), •ºŒÉ.

722201. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ”’“àáƒT[ƒWƒƒƒ“‚à•KŒ©I—L…»‘ÌŠá“àƒŒƒ“ƒY‚ð
Žn‚ß‚æ‚€. Ž…Œö–ç1, _’J˜aF1, ¬Œ^—1,2, Žsìˆê•v1,3, ’†‘º—Fº4 (1Šá‰È, 2ŽR‰€•a‰@, 3
ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 4–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/14), •ºŒÉ.

722202. [Šw‰ï (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) ŠwZ‚ł̃Jƒ‰[CL‚̑Ήž. ‰F’ÃŒ©‹`ˆê1,2 (1Šá‰È, 2
“ú–{Šá‰Èˆã‰ï): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/14), •ºŒÉ.

722203. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yÀ’·z_ŒoŒnŽŸŠ³‚É‚š‚¯‚éŠá¥Ž‹—̈æ‚̏njó. Îì@‹Ï (ˆã—Ã
‰q¶Šw•”): ‘æ48‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/26), –ŒŒÃ‰®.

722204. [Šw‰ï (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) “µE‚©‚çl‚Š‚é”’“àáŽèp. Ž…Œö–ç1, ]ŒûG
ˆê˜Y2, ƒrƒbƒZƒ“‹{“‡OŽq3, _’J˜aF1, ˆÉ“¡”ü¹ŠG4 (1Šá‰È, 2]ŒûŠá‰È•a‰@, 3“Œ‹žŽ•‘åE…“¹‹Ž, 4
ˆã—Éq¶Šw•”): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/28), ‹ž“s.

722205. [Šw‰ï (‘S‘)] (ƒI[ƒKƒiƒCƒU[) —L…»‘ÌŠá“àƒŒƒ“ƒY‚ÌŒ»ó‚ƐV‚œ‚È“WŠJ. ‹{“c˜a“T1, _’J
˜aF2 (1‹{“cŠá‰È•a‰@, 2Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/28), ‹ž“s.

722206. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹U…»‘ÌŠá‚ւ̉ž—p. _’J˜aF (Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèp
Šw‰ï‘‰ï (2011/1/28), ‹ž“s.

722207. [Šw‰ï (‘S‘)] (ƒI[ƒKƒiƒCƒU[) ‹üÜ‹ž³Žèp‚ÌŠî–{. •B“c@–q1, _’J˜aF2 (1‹ž“s•{ˆã
‘å, 2Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

722208. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) pŒãŒŸž‚̃|ƒCƒ“ƒg. _’J˜aF (Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèp
Šw‰ï‘‰ï (2011/1/29), ‹ž“s.

722209. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒgƒ‰ƒxƒNƒŒƒNƒgƒ~[pŒã‚Ì”’“àáis. ¯ŽiMs (ˆã—Éq¶Šw
•”): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

722210. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[)yƒI[ƒKƒiƒCƒU[zpŒãŠá“à‰Š?f’f‚ÆŽ¡—Ã?. ¬Œ^—1,2,
ŽRì—ÇŽ¡3 (1Šá‰È, 2ŽR‰€•a‰@, 3‹v—¯•Ä‘å): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

722211. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) ƒgƒ‰ƒxƒNƒŒƒNƒgƒ~[Œã‚ÌŠá“à‰Š‚̐f’f‚ÆŽ¡—Ã. ¯ŽiMs (ˆã—Ã
‰q¶Šw•”): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

722212. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[) ‰ºŠááÙ“à”œÇ. Œ–{_”V1,2 (1‰¡{‰êŽs—§‚€‚í‚Ü‚¿•a‰@, 2
Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

722213. [Šw‰ï (‘S‘)] (‹³ˆçƒZƒ~ƒi[)yƒI[ƒKƒiƒCƒU[zˆã—Ï‘—Þ‚Ì‹LÚ‚ÆŠ³ŽÒ‘Ήž. ˆ»–؉ë•F1, Žá
‘q‰ë“o2,3 (1‘—§é‹Ê•a‰@Šá‰È, 2ˆäãŠá‰È•a‰@, 3Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29),
‹ž“s.

722214. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yÀ’·zSimplec, and Stable! II?ƒAƒoƒ“ƒVƒBƒvƒŠƒZƒb
ƒg Line Up?. Ž…Œö–ç (Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

722215. [Šw‰ï (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) Simplec, and Stable! II?ƒAƒoƒ“ƒVƒBƒvƒŠƒZƒbƒg Line
Up?. ”Ñ“c‰Ã•F (Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

722216. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[zŠá‰ÈŽèp: pŒãD‘i‚â•s–ž‚ւ̑Ήž. Žá‘q
‰ë“o1,2, Œ‘º”ü‘ã3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3‰i“cŠá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/30),
‹ž“s.

722217. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šp–Œ‚̃oƒCƒIƒƒJƒjƒNƒX. _’J˜aF (Šá‰È): ‘æ34‰ñŠp–ŒƒJƒ“
ƒtƒ@ƒ‰ƒ“ƒX^‘æ26‰ñ“ú–{Šp–ŒˆÚAŠw‰ï (2011/2/11), å‘ä.

723726. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰~Šp–ŒŠá‚É‚š‚¯‚éEnhanced Ectasia Display‚Ì—L—p«. Îˆä—œ
ŠG, _’J˜aF1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1, ‰F’ÃŒ©‹`ˆê1,2, ŒF”WŒä“°—²1,3 (1Šá‰È, 2‰F’ÃŒ©Šá‰Èˆã‰@,
3ƒNƒ}ƒmƒ~ƒh[Šá‰È): ‘æ114‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2010/4/15), –ŒŒÃ‰®.

723727. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) LASIKŒã‚Ì—Ž‹regression‚ÌŒŸ“¢. ŒÜ\—’ÍŽj (Šá‰È): ‘æ114‰ñ
“ú–{Šá‰ÈŠw‰ï‘‰ï (2010/4/15), –ŒŒÃ‰®.

723728. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) wavefront-guided LASIK5”NŒo‰ß. Œ‘ºˆêO1,2 (1ŽR‰€•a‰@, 2Šá
‰È): ‘æ114‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2010/4/15), –ŒŒÃ‰®.

723729. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ¿1-blockerš“µEŽU‘å‹Ø‚ւ̉e‹¿. ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2, ¬Š}
ŒŽŽuD3, ^‰º‹I”ü‘ã1, ’r“c“N–ç1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”, 3–òŠw•”): ‘æ114‰ñ“ú–{Šá
‰ÈŠw‰ï‘‰ï (2010/4/15), –ŒŒÃ‰®.

723730. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) LVŠ³ŽÒ‚ÌQOL‚ÆEsterman Disability Score ‚š‚æ‚ÑFunctional Field
Score‚Æ‚Ì”äŠr. –öàV”üˆßŽq1,2, ‰Á“¡@‘1, ‘ŒŽu•Û1, ¬—Ñ‚ß‚®‚Ý1, —Ž‡áÁ‹IŽq1, ¯ŽiMs3 (1
“Œ‹ž‘å, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ114‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2010/4/15), –ŒŒÃ‰®.

723731. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”ñ‹…–ÊŠá“àƒŒƒ“ƒY‚ÌŒõŠw“Á«‚ɉe‹¿‚ð—^‚Š‚éˆöŽq. ìŽç“c‘ñŽu1,
‹›—¢@”Ž1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ114‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2010/4/15), –ŒŒÃ‰®.

723732. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·z_ŒoŠá‰ÈE¬Ž™Šá‰È Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ114‰ñ“ú
–{Šá‰ÈŠw‰ï‘‰ï (2010/4/15), –ŒŒÃ‰®.

723733. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ”’“àáŽèp‘O‚É‚š‚¯‚éŠp–Œ—Ž‹•ª•z. ŽO‘îr”V1, _’J˜aF1, “V
–엝Œb1, Ž…Œö–ç1 (1Šá‰È): ‘æ114‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2010/4/15), –ŒŒÃ‰®.

723734. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šp–Œ—Ž‹—Ê‚Æ—Ž‹Ž²‚Ì”äŠr. ¬‹Ž‰p’· (‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ
114‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2010/4/15), –ŒŒÃ‰®.

723735. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) “ñŽí‚Ì‘•’uŠÔ‚É‚š‚¯‚éƒRƒ“ƒgƒ‰ƒXƒgŠŽ“x‚Ì”äŠr. ’†ŽR“ށX”ü1, ì
Žç“c‘ñŽu2, ‹›—¢@”Ž2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ114‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2010/4/16),
–ŒŒÃ‰®.

723736. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·z—Γàá (1). ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ114‰ñ“ú–{Šá‰È
Šw‰ï‘‰ï (2010/4/16), –ŒŒÃ‰®.

723737. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 4Ží‚ÌŽ‹–쑪’è‚É‚š‚¯‚鍬‘÷‚̉e‹¿. •œàVˆê–@1, ¯ŽiMs2, [
ˆä÷Žq2, Œ–ì@Œb2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ114‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2010/4/16),
–ŒŒÃ‰®.

723738. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) GoldmanŠáˆ³Œv‚ɉe‹¿‚ð‹y‚Ú‚·ˆöŽq‚ÌŒŸ“¢. _’J˜aF1, X“c“N–ç
1, Ž…Œö–ç1, ¯ŽiMs2 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ114‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2010/4/16), –ŒŒÃ‰®.

723739. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŒŽ”­ŠJ•ú‹÷Šp—Γàá‚Ɛ³íŠáˆ³—Γàá‚É‚š‚¯‚éŠp–Œ¶‘Ì—ÍŠw“Á«‚Ì
ŒŸ“¢. X“c“N–ç1, ¯ŽiMs2, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ114‰ñ“ú–{Šá‰È
Šw‰ï‘‰ï (2010/4/16), –ŒŒÃ‰®.

723740. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •Ð“ª’É‚É‚š‚¯‚鎋ŠoáŠQ‚ÌŒŸ“¢. —é–Ø—T”ü (_“ސ쎕‘åE‰¡•lƒNƒŠ
ƒjƒbƒN): ‘æ114‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ï (2010/4/17), –ŒŒÃ‰®.

723741. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‡•¹Ç‚ƑΏˆ–@. ‰F’ÃŒ©‹`ˆê1,2 (1Šá‰È, 2‰F’ÃŒ©Šá‰Èˆã‰@): ‘æ
114‰ñ“ú–{Šá‰ÈŠw‰ï‘‰ïE‘æ3‰ñƒIƒ‹ƒ\ƒPƒ‰ƒgƒƒW[uK‰ï (2010/4/18), –ŒŒÃ‰®.

723742. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Color Acuity Test‚ð—p‚¢‚œWaxy Vision‚ɑ΂·‚é•]‰¿. ’†‘º‰pŽ÷
1, Žsìˆê•v1,2, ‰¡ŽR@ãÄ1, “c糏َq3, “c’†@Ž4, “c’†–FŽ÷4 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Šá‰È, 3’†
‹žŠá‰È, 4MB‘åHŠw•”): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/25), ‘åã.

723743. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘OŠá•”Œv‘ª‚É‚š‚¯‚éÄŒ»«‚Ì”äŠr. –îƒm–Ú‹ž•œ1, ”Ñ“c‰Ã•F1, Ž
…Œö–ç1 (1Šá‰È): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/25), ‘åã.

723744. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šp–Œ—Ž‹‚ª”’“àáŽèpŒã‚Ì‹V’²®‚É‹y‚Ú‚·‰e‹¿‚ÌŠî‘b“IE—Տ°“IŒŸ
“¢. _’J˜aF1, t“úˆähŽq1, Ž…Œö–ç1, ìŽç“c‘ñŽu2, ‹›—¢@”Ž2 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ
25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/25), ‘åã.

723745. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œ’íŠá‚É‚š‚¯‚ékŠp‚ÌŒŸ“¢. ”~“c‹žŽq1, ˆÉ“¡”ü¹ŠG2, _’J˜aF
1, ìŽç“c‘ñŽu2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï
(2010/6/25), ‘åã.

723746. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒgƒ‰ƒxƒNƒg[ƒ€—¬o˜HÄŒšŽèp‚Ì”’“àá“¯ŽžŽèp‚Æ’P“ÆŽèp‚̏pŒã
6ƒ•ŒŽˆÈ~‚Ì‘Šú¬Ñ‚Ì”äŠr. “n•ÓŽOŒP1, ‘O“cªG2, Žsìˆê•v1,3, ŒìŽu•ä1, ‘åŠÑ˜a“¿1 (1ŽÐ‰ï
•ÛŒ¯’†‹ž•a‰@, 2Šò•ŒÔ\Žš•a‰@, 3Šá‰È): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/26), ‘å
ã.

723747. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z‹üÜŽèp2. _’J˜aF (Šá‰È): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹ü
ÜŽèpŠw‰ï‘‰ï (2010/6/26), ‘åã.

723748. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V‚µ‚¢Šp–ŒŒú‘ª’è‘•’u‚Ì‘ª’萞“xEÄŒ»«‚Æ‘Œ‹@Ží‚Ƃ̌݊·«. ŒË
’ˁ@Œå1, ŽžàV‚Š‚èŽq1, ìŽç“c‘ñŽu2, ‹›—¢@”Ž2, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”):
‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/26), ‘åã.

723749. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —L…»‘ÌŠá“àƒŒƒ“ƒY‚É‚š‚¯‚ékŠp‚ª‚ŽŸŽû·EƒRƒ“ƒgƒ‰ƒXƒgŠŽ“x‚É
‹y‚Ú‚·‰e‹¿. ˆÀ“¡˜a‰ÌŽq1, _’J˜aF1, ˆÉ“¡”ü¹ŠG2, ŒÜ\—’Íl1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶
Šw•”): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/26), ‘åã.

723750. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Ž‹‹ž³—L…»‘ÌŠá“àƒŒƒ“ƒY (Toric Implantable Collamer Lens) ‚Ì
‰ñù‚ɑ΂·‚鐮•œp‚ÌŒø‰Ê. ŒŽ@CÆ1, ’†‘º—Fº2, ‹g“c—zŽq2, ¬“‡—²Ži3, ’·’JìˆŸ—¢1, Žsìˆê•v
1,4 (1ŽÐ•Û’†‹ž•a‰@, 2–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 3Œc‰ž‘å, 4Šá‰È): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw
‰ï‘‰ï (2010/6/26), ‘åã.

723751. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —L…»‘ÌŒã–[ƒŒƒ“ƒY (ICL) pŒã10”N‚ÌŒo‰ß. ŒÜ\—’Íl1, _’J
˜aF1, Ž…Œö–ç1 (1Šá‰È): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/26), ‘åã.

723752. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”’“àá…»‘̂̏ã”ç×–E–§“x‚̍¶‰EŠá‚Å‚Ì”äŠr. ˆÀ—¢’“¿1, ”n“ˆ
Ž”@2, ŽR–{’ŒŽ÷3, “à“¡®‹v4, ‰¡ŽR@ãÄ1, Žsìˆê•v1,5 (1’†‹ž•a‰@, 2Šá‰È–ŸŠá‰@, 3“¡“c•ÛŒ’‰q¶
‘å‹€—˜Œ€, 4’†‹žŠá‰È, 5Šá‰È): ‘æ49‰ñ“ú–{”’“àáŠw‰ï‘‰ï (2010/6/26), ‘åã.

723753. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “œ”A•aœëŠ³‚Ì—L–³‚Ɛ…»‘̏ã”ç×–E–§“x‚Æ‚ÌŠÖŒW. ‹ß“¡“Þ’Ã1, ”n
“ˆŽ”@2, ŽR–{’ŒŽ÷3, ŽðˆäKO4, “à“¡®‹v4, Žsìˆê•v1,5 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Šá‰È–Ÿ•a‰@, 3“¡
“c•ÛŒ¯‰q¶‘å‹€—˜Œ€, 4’†‹žŠá‰È, 5Šá‰È): ‘æ49‰ñ“ú–{”’“àáŠw‰ï‘‰ï (2010/6/26), ‘åã.

723754. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒY‚ÌŽ²‚ž‚ê‚ÌŒoŽž“IŒŸ“¢. ŽO‘îr”V1, Ž…Œö
–ç1, _’J˜aF1, ”Ñ“c‰Ã•F1, “V–엝Œb1 (1Šá‰È): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/26),
‘åã.

723755. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·zˆê”ʍu‰‰15: ƒg[ƒŠƒbƒN2. Ž…Œö–ç (Šá‰È): ‘æ25‰ñ“ú
–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/26), ‘åã.

723756. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒY‚ÌŒõŠw“Á«‚ɉe‹¿‚ð—^‚Š‚éˆöŽq. ìŽç“c‘ñŽu
1, ‹›—¢@”Ž1, _’J˜aF2, ŽO‘îr”V2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY
‹üÜŽèpŠw‰ï‘‰ï (2010/6/26), ‘åã.

723757. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒg[ƒŠƒbƒN—L…»‘ÌŠá“àƒŒƒ“ƒY. _’J˜aF (Šá‰È): ‘æ25‰ñ“ú–{Šá
“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï (2010/6/27), ‘åã.

723758. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 2dj‚ð—˜—p‚µ‚œ…»‘Ì‘OùNõF‘Ì‚Ì—LŒø«. ‰Á‰ê’BŽu1,2, Žsì
ˆê•v1,2, ‹g“c‘¥•F1, ’†‘º‰pŽ÷1, ‘å–î‹g”ü1, ‰¡ŽR@ãÄ1, ˆÀ—¢’“¿1, Šâ²¹’š3, “¡–{@Šw3, •œŽR
šæ˜a3, ‘åìŠ°³3 (1’†‹ž•a‰@, 2Šá‰È, 3ƒjƒvƒŠ”Ž®‰ïŽÐ): ‘æ25‰ñ“ú–{Šá“àƒŒƒ“ƒY‹üÜŽèpŠw‰ï‘‰ï
(2010/6/27), ‘åã.

723759. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŽU“µ‚É”º‚€Šp–Œ‘O, Œã–ʂƐ…»‘Ì‘O–Ê‚Ì‹È—Š”ŒŒa‚̕ω». ”n“ˆŽ”@
1, ¬“‡—²Ži2, “à“¡®‹v3, ŽðˆäKO3, Žsìˆê•v4,5 (1Šá‰È–ŸŠá‰@, 2–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 3’†‹ž
Šá‰È, 4’†‹ž•a‰@Šá‰È, 5Šá‰È): ‘æ49‰ñ“ú–{”’“àáŠw‰ï‘‰ï (2010/6/27), ‘åã.

723760. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒŠƒtƒ@ƒuƒ`ƒ“‚ÉŠÖ˜A‚µ‚œ‘O–[’~”^‚𔺂€ƒuƒhƒE–Œ‰Š. ”Ñ“‡@Œh1,
Žs糋`Í1, Ž…Œö–ç1 (1Šá‰È): ‘æ44‰ñ“ú–{Šá‰ŠÇŠw‰ï (2010/7/9), “Œ‹ž.

723761. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·zƒVƒŠƒR[ƒ“ƒnƒCƒhƒƒQƒ‹ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY. ‰F’ÃŒ©‹`ˆê1,2
(1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): ‘æ53‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (2010/7/10), “Œ‹ž.

723762. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒn[ƒhƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYƒP[ƒX‚Ì”÷¶•š‰˜õ. A“cŠìˆê1, ‰F’ÃŒ©
‹`ˆê2,4, ’|“à—C‰î3, ŽRèŸG3 (1ƒEƒGƒ_Šá‰È, 2‰F’ÃŒ©Šá‰Èˆã‰@, 3Š”Ž®‰ïŽÐƒIƒtƒeƒNƒX_ŒËŒ€‹†Š,
4Šá‰È): ‘æ53‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (2010/7/10), “Œ‹ž.

723763. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •œ¬21”N“xŠwZŒ»ê‚ł̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—pó‹µ’²ž. ‰F’ÃŒ©
‹`ˆê1,2,3, A“cŠìˆê1, ‹{‰Y@“O1, ‹g“c@”Ž1, ŽO‘ì1 (1“ú–{Šá‰Èˆã‰ï, 2‰F’ÃŒ©Šá‰Èˆã‰@, 3Šá
‰È): ‘æ53‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (2010/7/10), “Œ‹ž.

723764. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘æ4‰ñƒIƒ‹ƒ\ƒPƒ‰ƒgƒƒW[uK‰ïu‡•¹Ç‚ƑΏˆ–@v. ‰F’ÃŒ©‹`ˆê
1,2 (1Šá‰È, 2‰F’ÃŒ©Šá‰Èˆã‰@): ‘æ53‰ñ“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ï‘‰ï (2010/7/11), “Œ‹ž.

723765. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”ñÚGŒ^Šáˆ³EŠp–ŒŒú‘ª’è‘•’u‚ÌŽg—pŒoŒ±. ŒË’ˁ@Œå1, ìŽç“c‘ñ
Žu2, ‹›—¢@”Ž2, _’J˜aF1, ¯ŽiMs2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw
‰ï‘‰ï (2010/9/5), _“ސì.

723766. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V‚µ‚¢ƒI[ƒgƒŒƒtƒ‰ƒNƒgƒ[ƒ^‚É‚æ‚é’²ß”÷“®‚Žü”g¬•ªoŒ»•p“x
‚Ì‘ª’è. ’†ŽR“ށX”ü1, i“¡^‹I1, ŽÄ“c—DŽq1, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È,
2ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/5), _“ސì.

723767. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) V‚µ‚¢—ŒŠáŽ‹‹@”\ŒŸž‚ÌŽg—pŒoŒ±. i“¡^‹I1, ’†ŽR“ށX”ü1, ŽÄ
“c—DŽq1, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú–{ŠáŒõŠw
Šw‰ï‘‰ï (2010/9/5), _“ސì.

723768. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œ’íŽÒ‚É‚š‚¯‚éÅ‚Ž‹—Í‚ÌŒŸ“¢. —é–ØŒ«Ž¡1,2, Vˆä“cF—T1,2,3,
ŽR“c“Ol1,2, Žl”V‹{—C”n1, ‘å’J‘Žq1 (1‘Ûˆã—ÕŸŽƒ‘åŠw•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 2‘Ûˆã—Ã
•ŸŽƒ‘åŠw‘åŠw‰@•ÛŒ’ˆã—ÊwêUŽ‹‹@”\—Ö@Šw•ª–ì, 3Šá‰È): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/5), _
“ސì.

723769. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž‹—͂ƃRƒ“ƒgƒ‰ƒXƒgŠŽ“x‚ɉe‹¿‚ð‹y‚Ú‚·ƒtƒŒƒlƒ‹–ŒƒvƒŠƒYƒ€“x”‚Ì
ŒŸ“¢. óì@Œ«1, ’†ŽR“ށX”ü2, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1ˆã—Éq¶Šw•”Ž‹Šo‹@”\—Ö@Šw, 2‘å
Šw‰@ˆã—ÃŒnŒ€‹†‰ÈŠá‰ÈŠw): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/5), _“ސì.

723770. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Ž‹Šá‚É‚š‚¢‚Ä“µEƒTƒCƒY‚ªŽ‹‹@”\‚É‹y‚Ú‚·‰e‹¿. ŽR–{^–ç1,2,
‹›—¢@”Ž2,3, ìŽç“c‘ñŽu2,3, ’†ŽR“ށX”ü3, ’†’JŸŒÈ3, ‰¶“c@Œ’1 (1ˆã—Ö@lŽÐ’c‘Š˜a‰ïŸº–ì•Ó‘
‡•a‰@Šá‰È, 2ˆã—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/5), _“ސì.

723771. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Ž‹“x”‚Æ“µEŒa‚̈Ⴂ‚É‚æ‚éƒRƒ“ƒgƒ‰ƒXƒgŽ‹—Í. ’†’JŸŒÈ1,4,
’†ŽR“ށX”ü1, “àŽRmŽu3, ‹gŒŽ_“ñ4, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3’¹Žæ‘å
Šw’nˆæŠw•”, 4Œ]‘‡ˆã—Ðê–åŠwZŽ‹”\ŒP—ûŽm‰È): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/5), _“ސì.

723772. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·zŽ‹—Í. ”Œ“c’m–ç (ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï
‘‰ï (2010/9/5), _“ސì.

723773. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·zŠá“àƒŒƒ“ƒY. —é–؉ëM (Šá‰È): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘
‰ï (2010/9/5), _“ސì.

723774. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) F‚ð—p‚¢‚œV‚µ‚¢Ž‹‹@”\ŒŸž‘•’u‚É‚æ‚鐳íŠá‚Æ‘œÅ“_Šá“àƒŒƒ“ƒY
‘}“üŠá‚Ì”äŠr. “c’†–FŽ÷1, “c’†@Ž1, ‰¡ŽR@ãÄ2,3, ’†‘º‰pŽ÷2,3, Žsìˆê•v2,3,4, “c糏َq3 (1
MB‘åŠwHŠw•”“d‹C“dŽqHŠw‰È, 2ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@Šá‰È, 3Ž‹ŠoŒ€‹†Š, 4Šá‰È): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw
‰ï‘‰ï (2010/9/5), _“ސì.

723775. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž©—¥_Œoƒoƒ‰ƒ“ƒX‚̕ω»‚Æ’²®‹@”\‚ւ̉e‹¿. –‘“c_ŽO1, ‹›—¢@
”Ž2 (1“Þ—ÇŒ§—§ˆã‰È‘åŠwŠá‰ÈŠw‹³Žº, 1ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/5), _“Þ
ì.

723776. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ‰ƒ“ƒ_ƒ€ƒhƒbƒgƒXƒeƒŒƒIƒOƒ‰ƒ€‚É‚æ‚é—§‘ÌŽ‹’mŠoŽž‚Ì’²ß”œ‰ž—Ê‚Ì
ŒŸ“¢. ŽÄ“c—DŽq1, i“¡^‹I1, ’†ŽR“ށX”ü1, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2
ˆã—Éq¶Šw•”): ‘æ46‰ñ“ú–{ŠáŒõŠwŠw‰ï‘‰ï (2010/9/5), _“ސì.

723777. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Visual Field Index‚ð‘g‚Ý“ü‚ê‚œV‚µ‚¢Hodapp-Anderson-Parrish
•ªÍ. •œàVˆê–@1, ¯ŽiMs2, ‹œ‰E‹ß”ŽN3, X“c“N–ç3, ¬£—ÁŽq3, ‘å’Î’qG3, Š}ŒŽ³s1, ]•
—Ft3, ŽRŒûŠG—¢3, Ž…Œö–ç3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3Šá‰È): ‘æ21‰ñ“ú–{—Γàá
Šw‰ï (2010/9/24), •Ÿ‰ª.

723778. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒãŠú—Γàá—á‚É‚š‚¯‚éVisual Field index (VFI) ‚ÆQuality of
Vision (QOV) ‚Ì‘ŠŠÖ. ‹œ‰E‹ß”ŽN1, ¯ŽiMs2, –ö‘ò”üˆßŽq3, X“c“N–ç1, Ž…Œö–ç1 (1Šá‰È, 2ˆã
—Éq¶Šw•”, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ21‰ñ“ú–{—ΓàáŠw‰ï (2010/9/24), •Ÿ‰ª.

723779. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ³íŠáˆ³—Γàá‚É‚š‚¯‚éŠp–Œ¶‘Ì—ÍŠw“Á«‚Ɛ_Œo‘@ˆÛ‘wŒú‚ÌŠÖŒW.
X“c“N–ç1, ¯ŽiMs2, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ21‰ñ“ú–{—ΓàáŠw‰ï
(2010/9/24), •Ÿ‰ª.

723780. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —§‘ÌŽ‹‚ð—p‚¢‚œŽ‹–ìˆÙíŒŸo‚ÌŽŽ‚Ý. –]ŒŽ_Žu1, ¯ŽiMs2, –ö
‘ò”üˆßŽq1, •œàVˆê–@1, •Ÿ“c^—1 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ21‰ñ“ú–{—ΓàáŠw‰ï
(2010/9/24), •Ÿ‰ª.

723781. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šáâ|“à—eœ‹Žp‚ðŽ{s‚µ‚œ, 39Î—«Œ‹–Œˆ««•FŽî‚Ì1—á. ”
–؍LÆ1,2, ’†ì‰ë—T3, ¬ò‘ñ–ç3, ‹gìŽü²4, •û@‘å4, ‹S’Ë“N˜Y5 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È,
2Šá‰È, 3Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[ÄŒšEŒ`¬ŠO‰È, 4“¯”畆‰È, 5“¯“ªèò‰È): ‘æ25‰ñ“ú–{Šáâ|ŽŸŠ³ƒVƒ“ƒ|
ƒWƒEƒ€ (2010/10/23), “‡ª.

723782. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒY‚ÌŽ²‚ž‚ê‚ɉe‹¿‚ð‹y‚Ú‚·ˆöŽq‚ÌŒŸ“¢. _’J˜a
F1, ŽO‘îr”V1, “V–엝Œb1, Ž…Œö–ç1 (1Šá‰È): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/11), •ºŒÉ.

723783. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Šp–Œ‘OŒã–ʏó‰ðÍ‚ð—p‚¢‚œ‰~Šp–ŒŠá‚Ìelevation•Ï‰»—ʂƏdÇ“x
‚ÌŠÖ˜A. Îˆä—œŠG1, ŒÜ\—’ÍŽj2, _’J˜aF2, Ž…Œö–ç2, ‰F’ÃŒ©‹`ˆê2,3, ŒF”WŒä“°—²2,4 (1‘åŠw
‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È, 3‰F’ÃŒ©Šá‰È, 4ƒNƒ}ƒmƒ~ƒh[Šá‰È): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/11),
•ºŒÉ.

723784. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Šáâ|ƒTƒ‹ƒRƒCƒh[ƒVƒX‚ƍl‚Š‚œ1—á. ”–؍LÆ1,2, “n粗íŽq3, ˆÉ
“¡ˆÈ’m˜Y3, ŒŽ“c—²•¶4, ŒˆäG–Ÿ5 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È, 3Œ§—§Ã‰ªƒKƒ“ƒZƒ“ƒ^[•a
—f’f‰È, 4Ä’±‚ª‚íŠá‰È, 5Œˆä“à‰Èˆã‰@): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/11), •ºŒÉ.

723785. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z_ŒoŠá‰È. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ64‰ñ“ú–{—Տ°Šá
‰ÈŠw‰ï (2010/11/12), •ºŒÉ.

723786. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z‹üÜ‹ž³EIOL. Ž…Œö–ç (Šá‰È): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw
‰ï (2010/11/12), •ºŒÉ.

723787. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‰“•ûŽ‹‚É‚š‚¯‚铵EŒa‚Ì“ú’†“ú“à•Ï“®‚ÌŒŸ“¢. ¬‹Ž‰p’·1, _’J˜a
F2, ŒãŠÖ—˜–Ÿ2, Îì@‹Ï3, Ž…Œö–ç2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È, 3ˆã—Éq¶Šw•”): ‘æ64‰ñ“ú
–{—Տ°Šá‰ÈŠw‰ï (2010/11/12), •ºŒÉ.

723788. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒg[ƒŠƒbƒNŠá“àƒŒƒ“ƒY‚̕ΐSEŒXŽÎ‚š‚æ‚ÑŠá‹…Ž²‚ª‘ŒŠo‹üÜ“x‚É—^
‚Š‚é‰e‹¿. ìŽç“c‘ñŽu1, ‹›—¢@”Ž1, _’J˜aF2, ŽO‘îr”V2, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ
64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/12), •ºŒÉ.

723789. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Toric Implantable Collamer Lens (T-ICL) ‚̉ñù’ö“x‚ÆŠÖ˜AˆöŽq
‚ɂ‚¢‚Ä‚ÌŒŸ“¢. X@r’j1, ‰¡ŽR@ãÄ1, ¬“‡—²Ži2, ŒŽ@CÆ1, ’†‘º‰pŽ÷1, ˆé’J®‹P2, ˆä“¡–ƒ—R
2, “Žˆä—ŠG2, ’†‘º—Fº2, Žsìˆê•v1,3 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 3Šá‰È): ‘æ
64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/12), •ºŒÉ.

723790. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘œ–Ú“IŽ‹‹@”\ŒŸž‘•’u‚ð—p‚¢‚œƒXƒNƒŠ[ƒjƒ“ƒOŒŸžƒAƒ‹ƒSƒŠƒYƒ€‚Ì
ŠJ”­. ”Œ“c’m–ç1, ‰Í‘º@—º2, Ž…‹I–F2, ¬ŠâOŽq2, àV“cˆêÆ2, ¯ŽiMs1, Îì@‹Ï1, ‹›—¢@”Ž
1, Ž…Œö–ç3 (1ˆã—Éq¶Šw•”, 2ƒpƒiƒ\ƒjƒbƒN“dH, 3Šá‰È): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/12),
•ºŒÉ.

723791. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) OCTOPUS G1ƒvƒƒOƒ‰ƒ€‚É‚š‚¯‚éVisual Field Index‚ÌŽZo. •œàV
ˆê–@1,3, ¯ŽiMs2, —é–؍Ž‘¥3, Monhart matthias4 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3‚·‚ž
‚«Šá‰ÈƒNƒŠƒjƒbƒN, 4Haag -Streit): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/12), •ºŒÉ.

723792. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Functional Field Score‚ð—p‚¢‚œŽ‹ŠoáŠQ“™‹‰‚ÆVFQ-25‚ÌŠÖŒW. –ö
àV”üˆßŽq1, ‰Á“¡@‘, ‘ŒŽu•Û, ¬—Ñ‚ß‚®‚Ý, –kàV–œ—¢Žq, —Ž‡áÁ‹IŽq (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ64
‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723793. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) F‚ð—p‚¢‚œV‚µ‚¢Ž‹‹@”\ŒŸž (Color Acuity Test) ‚É‚Ä•]‰¿‚µ‚œ³
íŠá‚̉Á—•Ï‰». ‰¡ŽR@ãÄ1, ’†‘º‰pŽ÷1, “ŽŒû—¢ŠG2, ŽðˆäKO2, Žsìˆê•v1,3, “c粏َq2, “c’†
–FŽ÷4, “c’†@Ž4 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2’†‹žŠá‰È, 3Šá‰È, 4MB‘åHŠw•”): ‘æ64‰ñ“ú–{—Տ°Šá‰È
Šw‰ï (2010/11/13), •ºŒÉ.

723794. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘OŠá•”Œ`ó‰ðÍ‘•’uTMS-5‚É‚æ‚é‘O–[[“x‘ª’è‚̍Č»«‚Æ‘Œ‹@Ží‚Æ
‚Ì”äŠrŒŸ“¢. “¡ŒŽ˜aŽq1, “¡‘º•‡²Žq2, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ64‰ñ“ú
–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723795. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒfƒBƒXƒ|ƒpƒNƒŒƒ“‚ð—p‚¢‚œŒ‹–Œ’oŠÉÇŽèp. ’†Œ@Šî1,2, ŒÜ\—’
ÍŽj1, ²“¡M”V3, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È, 2‘å˜aŽs—§•a‰@, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ64‰ñ
“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723796. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) DSAEKpŒãŽ‹—͂ɉe‹¿‚ð‹y‚Ú‚·ˆöŽq‚ÌŒŸ“¢. ²“¡M”V1, ŒÜ\—’Í
Žj2, _’J˜aF2, Ž…Œö–ç2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13),
•ºŒÉ.

723797. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 2ŒQ•Às”äŠr‚É‚æ‚郉ƒ^ƒmƒvƒƒXƒg‚ƃ^ƒtƒ‹ƒvƒƒXƒg‚̊ሳ‰º~Œø
‰Ê‚ÌŒŸ“¢. ]•—Ft1, Š}ŒŽ³s2, ¬Š}ŒŽƒŒb1, ŽRŒûŠG—1, ‘å’Î’qG1, X“c“N–ç1, ¯ŽiMs3, Ž
…Œö–ç1 (1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •º
΃.

723798. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) •â³Šáˆ³’l‚©‚ç‚Ý‚œ³íŠáˆ³—ΓàáŠá‚Ì•]‰¿. X“c“N–ç1, ¯ŽiM
s2, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723799. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒmƒ“ƒRƒ“ƒ^ƒNƒgƒgƒmEƒpƒLƒ[ƒ^NT-530P‚̍Č»«‚š‚æ‚ÑŠp–ŒŒú‚Æ
‚ÌŠÖ˜A‚ÌŒŸ“¢. “¡‘º•‡²Žq1, “¡ŒŽ˜aŽq2, _’J˜aF2, ¯ŽiMs1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá
‰È): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723800. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) —§‘ÌŽ‹‰f‘œŽ‹’®Žž‚Ìçt–©‰^“®‚Æ“µEŒa‚̕ω». ŽÄ“c—DŽq1, i“¡^
‹I1, ’†ŽR“ށX”ü1, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ64‰ñ
“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723801. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‹üÜ‹ž³Žèpp‘O‚É‚š‚¯‚éƒTƒCƒvƒŒƒWƒ“ŒŸž‚Ì—LŒø«. ˆÀ—¢’“¿
1, ¬“‡—²Ži2, “Žˆä—¢ŠG3, ’†‘º—Fº3, ²“¡—T–ç4, ”’ˆä—D‘Ÿ4, ²“¡’m”ü4, ‹Ê’u–Ÿ–ì1, Žsìˆê•v1,5
(1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Œcœä‘å, 3–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN, 4²“¡—T–çŠá‰È, 5Šá‰È): ‘æ64‰ñ“ú–{—Տ°Šá
‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723802. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) V‚µ‚¢ƒRƒ“ƒgƒ‰ƒXƒgƒOƒŒƒAƒeƒXƒ^[‚ð—p‚¢‚œŒŸž‹——£‚É‚æ‚éƒRƒ“ƒg
ƒ‰ƒXƒgŠŽ“x‚̕ω». ’†ŽR“ށX”ü1, i“¡^‹I1, ŽÄ“c—DŽq1, ìŽç“c‘ñŽu2, ‹›—¢@”Ž2 (1‘åŠw‰@ˆã—ÃŒn
Œ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723803. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šá’ꎋ–ìŒv‚ð—p‚¢‚œ–Ô–ŒŽü•ÓŽ‹—Í‘ª’è‚ÌŽŽ‚Ý. –‘“c_ŽO1, “’ì‰p
ˆê1, ‹›—¢@”Ž2 (1“Þ—ÇŒ§ˆã‘å, 2ˆã—Éq¶Šw•”): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723804. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ˆÙŒa“µE‚É‚š‚¯‚闐Ž‹‚ƍ‚ŽŸŽû·‚ªŽ‹‹@”\‚É‹y‚Ú‚·‰e‹¿. ŽR–{^–ç
1,2, ‹›—¢@”Ž3, ìŽç“c‘ñŽu3, ‰¶“c@Œ’1 (1•£–ì•Ó‘‡•a‰@, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”):
‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723805. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šá“àƒŒƒ“ƒY‘}“üŠá‚ÌSRK/TŽ®‚Å‚Ì—\‘ª‘O–[[“x‚ÆŽÀ‘ª‘O–[[“x‚ÌŠÖ
ŒW. ‹Ê’u–Ÿ–ì1, ¬“‡—²Ži2, ’·£—zŽq1, Žsìˆê•v1,3 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Œcœä‘å, 3Šá‰È): ‘æ
64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723806. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šá‹ŸŒ^LED’PŠá“|‘œ‹Ÿ (ƒtƒ@ƒ“ƒ_ƒXƒ{[ƒC) ‚ÌŽg—pŒoŒ±. “c’†rˆê
1,2 (1Šá‰È, 2•‘ –ìÔ\Žš•a‰@): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723807. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Œã–[Œ^—L…»‘ÌŠá“àƒŒƒ“ƒY‘}“üŒã‚É”­Ç‚µ‚œ”’“àá. ‹g“c—zŽq1,
“Žˆä—¢ŠG2, ˆé’J®‹P1, ˆä“¡–ƒ—R1, ’†‘º—Fº1, ‹g“c‘¥•F3, Žsìˆê•v3,4 (1–ŒŒÃ‰®ƒAƒCƒNƒŠƒjƒbƒN,
2’†‹žƒƒfƒBƒJƒ‹, 3ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 4Šá‰È): ‘æ64‰ñ“ú–{—Տ°Šá‰ÈŠw‰ï (2010/11/13), •ºŒÉ.

723808. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šá‹Ÿ‚ƃRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚ðŽg—p‚µ‚œŽ‹–ìáŠQƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚Ì”ä
ŠrŒŸ“¢. •Ÿ“c^—1, ‹›—¢@”Ž1,2, ¯ŽiMs1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ52‰ñ“ú
–{ŽY‹ÆE˜J“­EŒð’ÊŠá‰ÈŠw‰ï (2010/11/20), •Ÿ‰ª.

723809. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –¬—–ŒŒú‚Ì“ú“à•Ï“®. ˆÉ“¡ŽuD1, Žs糋`Í1, åŒŽŽµd2, Ž…
Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ49‰ñ“ú–{–Ô–ŒÉŽq‘ÌŠw‰ï‘‰ï (2010/11/26), ‘åã.

723810. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) RƒAƒNƒAƒ|ƒŠƒ“-4R‘Ì—z«Ž‹_Œo‰Š‚ÉŠÖ‚·‚é‘œŽ{ÝŒ€‹†‘æˆêƒvƒƒW
ƒFƒNƒg: —Տ°‘œ‚ÌŒŸ“¢‚Ì‘Š‡. ‚–Ø•ô•v1,2, “c’†œšŽq3, Žá‘q‰ë“o2,4,5, ŽO‘ºŽ¡2,6, Îì@‹Ï2,7, ù
ˆä@•×2,8, —é–Ø—˜ª2,9, ‹C‰ê‘òˆê‹P2,10, –ђˍ„Ži2,11, ‘å‹v•Û^Ži2,12, ’†”nGŽ÷2,13, ˆÀ“¡²
2,14, ‘åÎ–Ÿ¶2,15, V“c‘ì–ç2,16, ‘åo®˜N17, —é–؍N•v18, ŒàV³–L2,19, ˆ¢•”tŽ÷1,2 (1VŠƒ
‘åŠwŠá‰È, 2Japan anti-aquaporion-4 antibody-positive optic neuritis study group, 3‹à‘òˆã‰È‘åŠw
_Œo“à‰È, 4ˆäãŠá‰È•a‰@, 5Šá‰È, 6•ºŒÉˆã‰È‘åŠwŠá‰È, 7ˆã—Éq¶Šw•”, 8ŽœŒb‰ïˆã‰È‘åŠwŠá‰È, 9“Æ
‹Šˆã‰È‘åŠwŠá‰È, 10ˆÇ—Ñ‘åŠwŠá‰È, 11“Œ‹žˆã‰È‘åŠwŠá‰È, 12‹à‘ò‘åŠwŠá‰È, 13‹{è‘åŠwŠá‰È, 14ŠÖŒˆã
‰È‘åŠw‘êˆä•a‰@Šá‰È, 15_ŒË’†‰›Žs–¯•a‰@Šá‰È, 16–kŠC“¹‘åŠá‰È, 17Œcœä‘åŠwŠá‰È, 18ŽèˆîŒkm‰ï•a‰@
Šáâ|_ŒoŠá‰ÈƒZƒ“ƒ^[, 19VŠƒ‘åŠw_Œo“à‰È): ‘æ48‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/26), –ŒŒÃ‰®.

723811. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) RAQP4R‘̉A«‚ÌŽ©ŒÈ–Ɖu«Ž‹_Œo‰Š‚ƍRAQP4R‘Ì—z«Ž‹_Œo‰Š
‚Ì”äŠrŒŸ“¢. ŽRã–ŸŽq1, Žá‘q‰ë“o2,3, “c’†œšŽq4 (1“Œ‹ž’üM•a‰@Šá‰È, 2ˆäãŠá‰È•a‰@, 3Šá‰È, 4
‹à‘òˆã‰È‘åŠw_Œo“à‰È): ‘æ48‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/26), –ŒŒÃ‰®.

723812. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) OPA1ˆâ“`ŽqˆÙí‚ð”F‚ß‚œíõF‘Ì—D«ˆâ“`«Ž‹_ŒoˆÞk‚Ì1‰ÆŒn2
Ç—á. –ìŠÔŒª°1, Žá‘q‰ë“o1,2, ‘ºã@»3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3‡“V‘å): ‘æ48‰ñ“ú–{_ŒoŠá
‰ÈŠw‰ï‘‰ï (2010/11/26), –ŒŒÃ‰®.

723813. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠáŽ²’·‰„’·‚ªŒŽˆö‚ƍl‚Š‚ç‚ê‚éŠJŽU•s‘S. ŒãŠÖ—˜–Ÿ1, Îì@‹Ï2,
’r“c“N–ç1, óì@Œ«2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ48‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï
(2010/11/26), –ŒŒÃ‰®.

723814. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒqƒg‚É‚š‚¯‚郁ƒ‰ƒmƒvƒVƒ“ŠÜ—L–Ô–Œ_Œoß×–E‚̍œKŒõ”g’·‚ÌŒŸ“¢.
¬–쎛’©”ü1, Îì@‹Ï2, óì@Œ«2, ’‡”‘@‘3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3‘—§áŠQ
ŽÒƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[•a‰@‘æ“ñf—Õ”): ‘æ48‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/27), –ŒŒÃ‰®.

723815. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —LF‰Æ“e‚É‚š‚¯‚éF“Á«‚É‚æ‚é‘ÎŒõ”œŽË‚̍·ˆÙ. óì@Œ«1, Îì@
‹Ï1, ^‰º‹I”ü‘ã2, ŒãŠÖ—˜–Ÿ2, ’r“c“N–ç2, ŒiŽR—R‹M1, “‚–Ø—æŽq1, ì’[Ÿ©“l1, “¿¢—R—œ“Þ1, —с@—Ž
ˆê1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ48‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/27), –ŒŒÃ‰®.

723816. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”]Š²[Ç‚É‚æ‚閃ა«ã‰ºŽÎŽ‹‚ɑ΂·‚éŽÎŽ‹Žèp‚ÌŒø‰Ê?Vertical
one and a halfÇŒóŒQ4Ç—á‚È‚ÇŠá‹…‰^“®áŠQ‚Ìquality of life‚ÌŒüã‚ð–ÚŽw‚µ‚Ä?. ŒŽ@’Œl1,2,
¬Žèì‘׎}1, ŒN“‡^ƒ1, ‘å–ìWŽi1,2, —é–Ø—T”ü1,2, –]ŒŽ_Žu3, ’‡”‘@‘4, Œü–ì˜a—Y1,2 (1_“Þ
ìŽ•‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰ÈŠw, 2Šá‰È, 3ˆã—Éq¶Šw•”, 4‘—§áŠQŽÒƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^
[•a‰@): ‘æ48‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/27), –ŒŒÃ‰®.

723817. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬”]‹ŽŠp•”Žîᇂɍ‡•¹‚µ‚œ•Ð‘€Šç–Êáz¹‚Ì1—á. ‰ª“c“ñ—t1, Žá‘q
‰ë“o1,2 (1Œä’ƒƒm…ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ48‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/27), –ŒŒÃ‰®.

723818. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šááىº‚‚ÆŠá‹…‰^“®áŠQ‚ð’悵‚œˆ««ˆÞk«‹u]Ç (DegosÇ) ‚Ì1
—á. ’r“c“N–ç1, Îì@‹Ï2, ŒãŠÖ—˜–Ÿ1, ŒèœA‰h1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ48‰ñ
“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/27), –ŒŒÃ‰®.

723819. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠááÙáz¹Š³ŽÒ‚ɑ΂·‚éƒNƒ‰ƒbƒ`ƒƒKƒl‚ÌŒø‰Ê. ‰Í–{‚Ђë”ü, –ìŠÔŒª
°, ˆø“crˆê, —é–؉xŽq, ‹v•ÛŽá“Þ, ˆäãŒ«Ž¡, Žá‘q‰ë“o1,2 (1Šá‰È, 2ˆäãŠá‰È•a‰@): ‘æ48‰ñ“ú–{_
ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/27), –ŒŒÃ‰®.

723820. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ž‹—͒ቺ‚ðŽå‘i‚ÉŠá‰È‚ðŽóf‚µ‚œŠáâ|“àˆ««•FŽî‚̈ê—á. ]•—F
t1, Žs糋`Í1, Ž…Œö–ç1 (1Šá‰È): ‘æ48‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/27), –ŒŒÃ‰®.

723821. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒLƒ_ƒ`ƒ`ƒ‡ƒEƒZƒ“ƒAƒTƒKƒI (Šwp–ŒBrugmansia) ‚É‚æ‚è•ÐŠá‚Ì–ƒáƒ
«ŽU“µ‚ð‚«‚œ‚µ‚œ1—á. ×’J—R‹IŽq1, ŒŽ@’Œl1,2, ¬Žèì‘׎}1, –]ŒŽ_Žu3, ŒN“‡^ƒ1, —é–Ø—T”ü
1,2, Œü–ì˜a—Y1,2 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 2Šá‰È, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰ÈŠá‰È): ‘æ
48‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/27), –ŒŒÃ‰®.

723822. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 3ŽŸŒ³‰f‘œ‚É‚æ‚é”]Šˆ“®‚ւ̉e‹¿‚ÌŒ€‹†?‹ßÔŠO•ªŒõ–@ (NIRS) ‚É
‚æ‚é”]ŒŒ—¬‚Ì‘ª’è?. ŒˆäNŽ÷1, –쌎®”ü1, ŽR–{‹Ôˆê1, ¬–ì‹|ŠG2, ŒŽ@’Œl3,4 (1•œ¬ˆã—Ðê–å
Šw‰@Ž‹”\ŒP—ûŠw‰È, 2_“ސ쎕‰È‘åŠw¶‘Ì‹@”\ŠwuÀ¶—Šw•ª–ì, 3_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒN
Šá‰È, 4Šá‰È): ‘æ48‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï‘‰ï (2010/11/27), –ŒŒÃ‰®.

723823. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰ß‹Ž3”NŠÔ‚Ì—Õ’nŽÀKƒAƒ“ƒP[ƒgŒ‹‰Ê‚Ì•ñ?‚æ‚è—Ç‚¢—Õ’nŽÀK‚ð
–ÚŽw‚µ‚Ä?. ŽOŽÄŒb”üŽq1, Vˆä’qŒb1, ”Ÿº^‹I2, ŒÃìŽì‹I1, Vˆä“cF—T1,3 (1‘Ûˆã—ÕŸŽƒ‘åŠw
•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 2‘Ûˆã—ÕŸŽƒ‘å•a‰@, 3Šá‰È): ‘æ51‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2010/11/27),
_ŒË.

723824. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’nˆæ‚ƘAŒg‚µ‚œŽ‹”\ŒP—ûŽm‹³ˆç‚Ö‚ÌŽæ‚è‘g‚݁@1. Ž‹ŠoáŠQŽÒ’c‘Ì:
Žó‚¯“ü‚ê‘€‚Ì”œ‰ž. ¬’¬—SŽq1, ŽOŽÄŒb”üŽq1, —é–ØŒ«Ž¡1, Vˆä“cF—T1,2, •œ’ˉpŽ¡3 (1‘Ûˆã—ÕŸ
Žƒ‘åŠw•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 2Šá‰È, 3“ú–{–Ô–ŒF‘f•Ï«Ç‹Š‰ïˆï–ØŽx•”): ‘æ51‰ñ“ú–{Ž‹”\‹ž
³Šw‰ï (2010/11/27), _ŒË.

723825. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Ž‹‚Æ’²ß”÷“®‚Žü”g¬•ªoŒ»•p“x. ’†ŽR“ށX”ü1, i“¡^‹I1, ŽÄ
“c—DŽq1, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ51‰ñ“ú–{Ž‹”\‹ž
³Šw‰ï (2010/11/27), _ŒË.

723826. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒõŠwŽ®ŠáŽ²’·‘ª’èŠíLS900‚ð—p‚¢‚œŠá“àƒŒƒ“ƒY‘}“üŠá‚Ì‘O–[[“x.
’·£—zŽq1, ‹Ê–ì–Ÿ–ì1, ¬“‡—²Ži2,3, Žsìˆê•v1,4 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Œcœä‹`m‘åŠw, 3–ŒŒÃ‰®ƒA
ƒCƒNƒŠƒjƒbƒN, 4Šá‰È): ‘æ51‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2010/11/27), _ŒË.

723827. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Ž‹‚ª—§‘ÌŽ‹‹@”\‚É—^‚Š‚é‰e‹¿. i“¡^‹I1, ŽÄ“c—DŽq1, ’†ŽR“ށX
”ü1, ìŽç“c‘ñŽu1,2, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): ‘æ51‰ñ“ú–{Ž‹”\‹ž³Šw
‰ï (2010/11/27), _ŒË.

723828. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆäãŠá‰È•a‰@‚É‚š‚¯‚éSˆö« (”ñŠíŽ¿«) Ž‹ŠoáŠQ. ŒüˆäÍ‘Ÿ1, ŒŽ
Œû@“µ1, ŒŽ“c“Þ1, “cŒûˆŸŠóŽq1, Îˆä—SŽq1, ¬Œû–F‹v1, Žá‘q‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È):
‘æ51‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2010/11/27), _ŒË.

723829. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) 3D‰f‰æŠÓÜŒã, “àŽÎŽ‹‚𔭏ǂµ‚œ1—á. ‹Ž–{“Ä•¶1,2, –î–ì@—²
1,3, “¡ŒŽ˜aŽq2, ‘ŠàV‘å•ã1,2,3, Îì@‹Ï4 (1ŠC˜V–ŒƒƒfƒBƒJƒ‹ƒvƒ‰ƒU, 2Šá‰È, 3ŠC˜V–Œ‘‡•a‰@, 4
ˆã—Éq¶Šw•”): ‘æ51‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2010/11/27), _ŒË.

723830. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ‘Ûˆã—ÕŸŽƒ‘åŠw•a‰@‚É‚š‚¯‚鐅•œŽÎŽ‹Žèp‚̐¬Ñ. Vˆä’qŠG1,2,
ŽR“c“Ol1,2, Vˆä“cF—T1,2,3, ŽOŽÄŒb”üŽq1,2, ¬’¬—SŽq1,2, ¬–ì—¢‹KŽq2, Žl”V‹{—C”n1,2, —é–Ø
Œ«Ž¡1,2, ‰iˆäd”V2, ŒÃìŽì‹I1,2 (1‘Ûˆã—ÕŸŽƒ‘åŠw•ÛŒ’ˆã—Êw•”Ž‹‹@”\—Ö@Šw‰È, 2‘Ûˆã—ÕŸŽƒ
‘åŠw•a‰@, 3Šá‰È): ‘æ51‰ñ“ú–{Ž‹”\‹ž³Šw‰ï (2010/11/27), _ŒË.

723831. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ³íŽá”NŽÒ‚É‚š‚¯‚éFilling-inŒ»Û‚Ì•”ˆÊ•ÊŒŸ“¢. •Ÿ“c^—1, ¯
ŽiMs1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”): “ú–{Ž‹ŠoŠw‰ïE2011”N“~‹G‘å‰ï (2011/1/20), “Œ
‹ž.

723832. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ‚ƒmƒrƒWƒ‡ƒ“Ç—á‚É‚š‚¯‚é”’“àáŽèp‘OŒã‚Ì“µEŒa‚ÌŒoŽž“I•Ï‰».
”Ñ“c‰Ã•F1, Ž…Œö–ç1, ˆÉ“¡”ü¹ŠG2, “V–엝Œb1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw
‰ï‘‰ï (2011/1/28), ‹ž“s.

723833. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹­“xŠp–Œ—Ž‹Šá‚ւ̃g[ƒŠƒbƒNŠá“àƒŒƒ“ƒY‘}“üp‚ÆLRIs“¯ŽžŽèp‚Ì
—Տ°¬Ñ. ŽO‘îr”V1, Ž…Œö–ç1, _’J˜aF1, ”Ñ“c‰Ã•F1, “V–엝Œb1 (1Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽè
pŠw‰ï‘‰ï (2011/1/28), ‹ž“s.

723834. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) …»‘̕Έʂɂæ‚鎋‹@”\‚ÌŠáŒõŠwƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“. ŽÄ“c—DŽq1,
ìŽç“c‘ñŽu2, i“¡^‹I1, ’†ŽR“ށX”ü1, “c’†–ŸŽq3, ‹›—¢@”Ž1,2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶
Šw•”, 3“Œ‹žˆãŽ•‘å): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/28), ‹ž“s.

723835. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·z—Γàá2. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ34‰ñ“ú–{Šá‰ÈŽè
pŠw‰ï‘‰ï (2011/1/28), ‹ž“s.

723836. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Šá“àƒŒƒ“ƒY‹­–Œ–D’…Ç—á‚Ì3”NŠÔ‚É‚í‚œ‚éŒã‚ëŒü‚«ŒŸ“¢. ÝŠy‹±Žq
1, –ìŒû@Œ\1, “ì‰_‚Í‚é‚©1, “¿“c–F_1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1, ‹g•x•¶º3 (1ˆäãŠá‰È•a‰@, 2
Šá‰È, 3‘åÉ•{‹g•xŠá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/28), ‹ž“s.

723837. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”’“àáŽèpŽž‚̏Ɏq‘̂̈³•Ï“®. ‘å–쏮“o, ˆäãŒ«Ž¡1, Žá‘q‰ë“o
1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

723838. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) IOLƒ}ƒXƒ^[TM (ƒ‚ƒfƒ‹500) ‚̐V‹@”\‚Ì—L—p«?’Ž‰¹”g‘•’u‚Ƃ̃Š
ƒ“ƒN?. ”ä‰Ã—˜¹Žq1, ‹›—¢@”Ž2, ‘å“à‰ë”V3, ˆäãŒ«Ž¡1, Žá‘q‰ë“o1,4 (1ˆäãŠá‰È•a‰@, 2ˆã—Éq
¶Šw•”, 3‘å“àŠá‰È, 4Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

723839. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Ž‹û—Γàá‚ɑ΂·‚éƒgƒ‰ƒxƒNƒg[ƒ€—¬o˜HÄŒšŽèp‚̏pŒã6ƒ–ŒŽ¬
Ñ. “n•ÓŽO‘¥1, ‘O“cªG2, Žsìˆê•v1,3, ŒìŽu•ä1, ‘åŠÑ˜a“¿1 (1ŽÐ•Û’†‹ž, 2Šò•ŒÔ\Žš•a‰@, 3
Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

723840. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œã–[Œ^—L…»‘ÌŠá“àƒŒƒ“ƒY‘}“üpŒã‚É‚š‚¯‚é’²®—Í‚ÌŒoŽž“IŒŸ“¢.
_’J˜aF1, ŒÜ\—’ÍŽj1, Ž…Œö–ç1, Îì@‹Ï2 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw
‰ï‘‰ï (2011/1/29), ‹ž“s.

723841. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z‹üÜ‹ž³Žèp2. _’J˜aF (Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèp
Šw‰ï‘‰ï (2011/1/29), ‹ž“s.

723842. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹U…»‘ÌŠá‚ɑ΂·‚éƒsƒM[ƒoƒbƒN‚Æ‚µ‚Ä‚Ì—L…»‘ÌŒã–[ƒŒƒ“ƒY‘}“ü
p‚Ì—L—p«. ŒÜ\—’ÍŽj1, _’J˜aF1, Ž…Œö–ç1 (1Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29),
‹ž“s.

723843. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘ª’è•ûŒü‚̈Ⴂ‚ª–Ñ—laŠÔ‹——£ (Sulcus to Sulcus)‚É‹y‚Ú‚·‰e‹¿.
²“¡M”V1, _’J˜aF2, ŒÜ\—’ÍŽj2, Ž…Œö–ç2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È): ‘æ34‰ñ“ú–{Šá‰È
ŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

723844. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Ž‹Šá‚É‚š‚¯‚铵EŒa‚ª—‡ŠáŽ‹—Í‚É‹y‚Ú‚·‰e‹¿. ¬‹Ž‰p’·1,2, _
’J˜aF3, Ž…Œö–ç3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠC˜V–Œ‘‡, 3Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï
(2011/1/29), ‹ž“s.

723845. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰)yÀ’·z—ÜŠíE—Ü“¹. ‰Ã’¹M’‰1, ”–؍LÆ2,3 (1¹—ê•lŒ•a‰@E
ŠáŒ`¬Šáâ|ŠO‰È, 2Ã‰ªŒ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[, 3Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž
“s.

723846. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Ü“¹ƒtƒ@ƒCƒo[ƒXƒR[ƒv“±“üŒã‚̍R‚ª‚ñÜS1‚É‚æ‚é—Ü“¹áŠQ‚ÌŽ¡—Ã.
”–؍LÆ1,4, ˆÀˆä”ŽŽj2, •Ÿ•y@W2, ŽRø“@Ÿ2, ‘œ‹v‰À¬2, ŒË‚–ŸŽq2, Ž›“‡‰ë“T3 (1Œ§—§Ã‰ª‚ª
‚ñƒZƒ“ƒ^[Šá‰È, 2Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Á‰»Ší“à‰È, 3Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[ŠO‰È, 4Šá‰È): ‘æ34‰ñ“ú
–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

723847. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)yÀ’·z‹üÜ‹ž³Žèp —é–؉ëM (Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽè
pŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

723848. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Hole ICL‚É‚š‚¯‚é–[…‚Ì—¬‘Ì—ÍŠw“I‰ðÍ. ìŽç“c‘ñŽu1, ‹›—¢@”Ž
1, Ž…Œö–ç2 (1ˆã—Éq¶Šw•”, 2Šá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/29), ‹ž“s.

723849. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Šá“àƒŒƒ“ƒYŒðŠ·Žèp‚ÌŠO‰È“I¬Ñ. –ìŒû@Œ\1, “ì‰_‚Í‚é‚©1, Ý
Šy‹±Žq1, “¿“c–F_1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1, ‹g•x•¶º3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3‘ŸÉ•{‹g•xŠá
‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/30), ‹ž“s.

723850. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) …»‘ÌùN‚̐üˆÛ«‘B‚ÆùNØŠJ‘‹‚̘A‘±«. “ì‰_‚Í‚é‚©1, –ìŒû@
Œ\1, ÝŠy‹±Žq1, “¿“c–F_1, Žá‘q‰ë“o1,2, ˆäãŒ«Ž¡1, ‹g•x•¶º3 (1ˆäãŠá‰È•a‰@, 2Šá‰È, 3‘ŸÉ
•{‹g•xŠá‰È): ‘æ34‰ñ“ú–{Šá‰ÈŽèpŠw‰ï‘‰ï (2011/1/30), ‹ž“s.

723851. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) RŠàÜS-1“à•ž‚É‚æ‚éŠp–Œã”çáŠQ‚ÆŠpŒ‹–ŒF‘f’Ÿ’…‚Ì1—á. ¬‹Ž
‰p’·1, _’J˜aF2, Ž…Œö–ç2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2011/‘æ35‰ñ“ú
–{Šp–ŒŠw‰ï‘‰ïE‘æ27‰ñ“ú–{Šp–ŒˆÚAŠw‰ï (2011/2/17), “Œ‹ž.

723852. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) —Γàá‡•¹Ç—á‚ɑ΂·‚éBoston Keratoprosthesis. X@—mÄ1, Žq
“‡—Ç•œ1, ‹{“c˜a“T1, _’J˜aF2 (1‹{“cŠá‰Èˆã‰@, 2Šá‰È): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2011/‘æ35‰ñ“ú–{Šp
–ŒŠw‰ï‘‰ïE‘æ27‰ñ“ú–{Šp–ŒˆÚAŠw‰ï (2011/2/18), “Œ‹ž.

731107. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) —Γàá’·ŠúŠÇ—‚̃|ƒCƒ“ƒg. ¯ŽiMs (ˆã—Éq¶Šw•”):
Šò•Œ—Γàá‚̉ï (2010/5/9), Šò•Œ.

731108. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) —Γàá–ò•šŽ¡—Â̂±‚ê‚©‚ç‚̍l‚Š•û. ¯ŽiMs (ˆã—Éq
¶Šw•”): •œ¬22”N“x“¹–kŠá‰Èˆã‰ïŠwpu‰‰‰ï (2010/5/22), –kŠC“¹.

731109. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z“Á•Êu‰‰1. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ10
‰ñ_“ސìŠá‰ÈƒZƒ~ƒi[ (2010/6/3), _“ސì.

731110. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚̐V‚œ‚ȉ”\«. _’J˜aF
(Šá‰È): ‘æ4‰ñ‚³‚ª‚ÝŠá‰ÈŒ€‹†‰ï (2010/6/11), _“ސì.

731111. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z—ΓàáŽ¡—Ð헪‚̐V‚µ‚¢“WŠJ. ¯ŽiMs (ˆã—Ã
‰q¶Šw•”): ‘æ4‰ñ‚³‚ª‚ÝŠá‰ÈŒ€‹†‰ï (2010/6/11), _“ސì.

731112. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yƒ‚ƒfƒŒ[ƒ^[z‹üÜE˜VŽ‹‹ž³‚É‚š‚¯‚闐Ž‹. _’J˜a
F (Šá‰È): 14th The IRSJ 2010 (2010/9/5), _“ސì.

731113. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) IOL‚É‚æ‚闐Ž‹‹ž³‚ƘVŽ‹Ž¡—Ã. _’J˜aF (Šá‰È): 14th
The IRSJ 2010 (2010/9/5), _“ސì.

731114. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zŠá•”Žîᇐ«ŽŸŠ³‚ÉŠÖ‚·‚éŠî‘b“I‚È’mŽ¯. ‰F’ÃŒ©
‹`ˆê1,2 (1Šá‰È, 2‰F’ÃŒ©Šá‰Èˆã‰@): ‘æ12‰ñ‰¡•lŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2010/9/11), _“ސì.

731115. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z“œ”A•a–Ô–ŒÇ‚ɑ΂·‚é–Ô–ŒŒõ‹ÃŒÅp‚̐Ví—ª. Ž
…Œö–ç (Šá‰È): ‘æ46‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/10/7), _“ސì.

731116. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Šá‰ÈŠwZˆã‚Ì–ðŠ„‚Æ¬Ž™‚ÌŽ‹—Í. ‰F’ÃŒ©‹`ˆê1,2 (1Šá
‰È, 2“ú–{Šá‰Èˆã‰ï): ‘æ123‰ñ_“ސ쌧Šá‰ÈW’k‰ï (2010/10/16), _“ސì.

731117. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·zŠá‰ÈŠwZˆã‚Ì–ðŠ„‚Æ¬Ž™‚ÌŽ‹—Í. —é–؍‚‰“1,2 (1
Šá‰È, 2_“ސ쌧Šá‰Èˆã‰ï): ‘æ123‰ñ_“ސ쌧Šá‰ÈW’k‰ï (2010/10/16), _“ސì.

731118. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z‹üÜ‹ž³Žèp‚Ì—ðŽj‚ÆŒ»‹µ. Ží“c–F˜Y1,2 (1Šá
‰È, 2_“ސ쌧Šá‰Èˆã‰ï): ‘æ123‰ñ_“ސ쌧Šá‰ÈW’k‰ï (2010/10/16), _“ސì.

731119. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Šá‰ÈŽèpÅ‘Oü! Ž…Œö–ç (Šá‰È): –k—¢‘åŠw“¯‘‹‰ï•Ÿ
ˆäŒ§Žx•”Ý—§25Žü”N‹L”OŒöŠJu‰‰‰ï (2010/11/6), •Ÿˆä.

731120. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒ‚ƒmƒrƒWƒ‡ƒ“‚Æ‘œÅ“_IOL. Ž…Œö–ç (Šá‰È): ‘æ54‰ñ
ˆ€•QŒ§Šá‰ÈW’k‰ï (2010/12/12), ˆ€•Q.

731121. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z‰¡{‰ê‹€Ï•a‰@‚É‚š‚¯‚é‰Á—”Á•Ï«Ç‚ÌŽ¡—Ã.
—é–؍‚‰“1,2 (1Šá‰È, 2_“ސ쌧Šá‰Èˆã‰ï): ‘æ39‰ñ_“ސ쌧Šá‰Èˆã‰ïuK‰ï (2010/12/18), _“ސì.

731122. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yÀ’·z‰¡{‰ê‹€Ï•a‰@Šá‰È‚ÌŒ»‹µ‚ÆŽ¡—ÃŽÀÑ‚ɂ‚¢‚Ä.
Ží“c–F˜Y1,2 (1Šá‰È, 2_“ސ쌧Šá‰Èˆã‰ï): ‘æ39‰ñ_“ސ쌧Šá‰Èˆã‰ïuK‰ï (2010/12/18), _“ސì.

731123. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŠááÙáz¹Š³ŽÒ‚̓hƒ‰ƒCƒAƒCŠ³ŽÒ‚Ì’†‚É•Ž‚ê‚Ä‚¢‚é. Žá‘q
‰ë“o1,2 (1ˆäãŠá‰È•a‰@, 2Šá‰È): ‘æ5‰ñOcular Surface Symposium (2011/1/8), _“ސì.

731124. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) —Γàá–ò•šŽ¡—Â̂±‚ê‚©‚ç. ¯ŽiMs (ˆã—Éq¶Šw•”):
‘æ16‰ñH“cŒ§Šá‰ÈŠwpu‰‰‰ï (2011/1/15), H“c.

731125. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “úíf—ÂɕK—v‚È‹üÜ‹ž³Žèp‚Ì’mŽ¯. _’J˜aF (Šá
‰È): Šá‰ÈƒZƒ~ƒi[in‘œ–€ (2011/2/4), “Œ‹ž.

731126. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) 3D‰f‘œ‚Æð¡‚ÌŠáž”æ˜J. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ
7‰ñÃ“ìŠá‰È‹äŠy•” (2011/3/10), _“ސì.

732098. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (uK‰ïuŽt) ˆã—Ñ€‚©‚ç‚Ý‚œƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚̔̔„‚ɂ‚¢‚Ä. ‰F
’ÃŒ©‹`ˆê1,2 (1Šá‰È, 2‰F’ÃŒ©Šá‰Èˆã‰@): ˆã—Ë@ŠíƒZƒ“ƒ^[•œ¬22”N“xƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY”Ì”„‰c‹ÆŠÇ—
ŽÒuK‰ï (2010/6/24), “Œ‹ž.

732099. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ‰‚ß‚Ä‚ÌŽÎŽ‹EŽãŽ‹. ŒãŠÖ—˜–Ÿ (Šá‰È): ‘æ9‰ñBay Ocular
Club (2010/8/28), _“ސì.

732100. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yƒI[ƒKƒiƒCƒU[zClinical applications of power
vectors (Prof. Miller). ‹›—¢@”Ž (ˆã—Éq¶Šw•”): 14th The IRSJ 2010 (2010/9/5), _“ސì.

732101. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éŠá‰ÈŽÊ^‹Æ–±‚̏Љî. ŽRŒû@ƒ
(Šá‰È): ‘æ46‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/10/7), _“ސì.

732102. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰)yÀ’·z–k—¢‘åŠw•a‰@‚É‚š‚¯‚éŠá‰ÈŽÊ^‹Æ–±‚̏Љî. Žs
糋`Í (Šá‰È): ‘æ46‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/10/7), _“ސì.

732103. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—ጟ“¢) lHŠp–ŒBoston KproˆÚAp. _’J˜aF (Šá‰È): ‘æ9
‰ñBay Ophthalmic Surgical Seminar (2010/10/9), _“ސì.

732104. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒZƒbƒVƒ‡ƒ“) ƒg[ƒŠƒbƒNIOL‚Í‚Ç‚Ì‚æ‚€‚É“±“ü‚·‚ê‚Ηǂ¢‚Ì‚©? _
’J˜aF (Šá‰È): Ophthalmic Surgical Seminar (2010/10/23), “Œ‹ž.

732105. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (uK‰ïuŽt) Šá‰ÈŠwZˆã‚ƃRƒ“ƒ^ƒNƒgƒŒƒ“ƒY. ‰F’ÃŒ©‹`ˆê1,2 (1
Šá‰È, 2“ú–{Šá‰Èˆã‰ï): ’·–쌧•œ¬22”N“xˆã—Ë@ŠíE”Ì”„‹Æ“™ŠÇ—ŽÒŒp‘±Œ€C (2010/11/21), ’·–ì.

732106. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (uK‰ïuŽt) ƒ‚ƒmƒrƒWƒ‡ƒ“. Ž…Œö–ç (Šá‰È): ‘æ4‰ñŠáR‰Á—îˆã
ŠwŒ€‹†‰ïuK‰ï (2010/11/23), “Œ‹ž.

732107. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ~ƒjƒŒƒNƒ`ƒƒ[) ’²ß«“àŽÎŽ‹‚ƃŒ[ƒVƒbƒN. ˆÉ“¡”ü¹ŠG (ˆã—Éq
¶Šw•”): ‘æ19‰ñ¬Ž™Šá‰È (ŽÎŽ‹EŽãŽ‹) Ç—ጟ“¢‰ïE•×‹­‰ï (2011/2/24), _“ސì.

732108. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z¬Ž™‚ÌŠá’ꎟŠ³‚̃gƒsƒbƒNƒX. Ž…Œö–ç (Šá
‰È): ‘æ35‰ñÃŒŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2011/3/3), _“ސì.

732109. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™)yÀ’·z _“ސ쌧“à‰ÈEŠá‰È˜AŒg‹Š‹c‰ï‚Ì“œ”A•af—Ã
î•ñ’ñ‹Ÿ‘‚ð—p‚¢‚œŠˆ“®‚ɂ‚¢‚Ä. Ží“c–F˜Y (Šá‰È): _“ސ쓜”A•aŠáƒtƒH[ƒ‰ƒ€ (2011/3/5), _“ސì.

733335. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šp–ŒˆÚA‚ÌŽÀÛ. _’J˜aF (Šá‰È): Ã“ìƒAƒCƒoƒ“ƒNƒ`
ƒƒƒŠƒeƒB[ƒRƒ“ƒT[ƒg (2010/4/4), _“ސì.

733336. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “ñd–Œàh‰ß–@‚ª’˜Œø‚µ‚œRƒAƒNƒAƒ|ƒŠƒ“4R‘Ì—z«Ž‹_
Œo‰Š‚̈ê—á. ‚@ˆè‰Ã1, Žs糋`Í1, Îì@‹Ï2, ŒãŠÖ—˜–Ÿ1, Ž…Œö–ç1, ‚–Ø•ô•v3, “c’†ŒbŽq4 (1
Šá‰È, 2ˆã—Éq¶Šw•”, 3VŠƒ‘å, 4‹à‘òˆã‘å_Œo“à‰È): ‘æ2‰ñ_“ސ쌧Šá‰ÈŠw‰ï (2010/4/24), _“ސì.

733337. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È8”NŠÔ‚ÌŒoŒ±‚©‚ç“Ÿ‚œ‚à‚Ì.
”–؍LÆ1,2, Ž…Œö–ç2 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È): ‘æ2‰ñ_“ސ쌧Šá‰ÈŠw‰ï (2010/4/24),
_“ސì.

733338. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zˆê”ʉ‰‘è. Ž…Œö–ç (Šá‰È): ‘æ2‰ñ_“ސ쌧Šá
‰ÈŠw‰ï (2010/4/24), _“ސì.

733339. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šá‰ÈŠwZ•ÛŒ’‚̏”–â‘è. ‰F’ÃŒ©‹`ˆê1,2 (1Šá‰È, 2“ú
–{Šá‰Èˆã‰ï): Žw’è“sŽsŠá‰ÈŠwZˆãŒ€C‰ï (2010/5/15), ‘åã.

733340. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “úíf—ÂɕK—v‚È‹üÜ‹ž³Žèp‚Ì’mŽ¯. _’J˜aF (Šá
‰È): ’¬“cŽsˆãŽt‰ïŠwpu‰‰‰ï (2010/5/21), “Œ‹ž.

733341. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) —zŽqüŽ¡—ª’˜Œø‚µ‚Ä‚¢‚é•@—ÜŠÇ‘B—lùN–EŠà‚̈ê—á. ”
–؍LÆ1,2, ‹S’Ë“N˜Y3, ‘ºãds4, “¡@@_4, ì–쌒“ñ5 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È, 3
Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[“ªèò‰È, 4Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[—zŽqüŽ¡—ÉÈ, 5‡“V“°Ã‰ª•a‰@Žš•@‰È): ‘æ80
‰ñ‹ãBŠá‰ÈŠw‰ï (2010/5/28), ²‰ê.

733342. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒIƒ‹ƒ\ƒPƒ‰ƒgƒƒW[‚̍‡•¹Ç‚ɂ‚¢‚Ä. ‰F’ÃŒ©‹`ˆê1,2
(1Šá‰È, 2‰F’ÃŒ©Šá‰Èˆã‰@): ‘æ4‰ñ‰¡•lŠá‰ÈfX˜AŒg‚̉ï (2010/6/11), _“ސì.

733343. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˜VŠá‚ÍŽ¡—Âł«‚é! Ž…Œö–ç (Šá‰È): ‡“¯Žs–¯ŒöŠJu
À (2010/6/27), ‘åã.

733344. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·z‹ßŽ‹«Šá’ê•a•Ï‚ÌŒ©‚©‚œ‚ƐV•ª—Þ. Žs糋`Í (Šá
‰È): ‘æ33‰ñÃŒŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2010/7/1), _“ސì.

733345. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “œ”A•a‚ÆŠá‚Ì•a‹C‚ɂ‚¢‚Ä. Žs糋`Í (Šá‰È): –k—¢‘å
Šw•a‰@“œ”A•aŠ³ŽÒ‰ï@‚³‚ª‚݉ï (2010/7/3), _“ސì.

733346. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zu‰‰1: –Ô–ŒV¶ŒŒŠÇ‚ÆVEGF‚Ì–ðŠ„?Šî‘b–ò—
Šw“I—§ê‚©‚ç?. Žs糋`Í (Šá‰È): ‘æ8‰ñ_“ސ쌧Šá‰ÈDMƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/7/3), _“ސì.

733347. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šá’êŽÊ^ŽB‰e“ü–å. ‰i–ìKˆê (Šá‰È): ‘æ22‰ñŠá‰ÈŽÊ^
Œ€‹†‰ï (2010/7/4), “Œ‹ž.

733348. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ”­’BáŠQŽ™‚ÌŒŸž‘ÌŒ±. åŒŽŽµd (ˆã—Éq¶Šw•”): ‘æ
18‰ñ¬Ž™Šá‰È (ŽÎŽ‹EŽãŽ‹) Ç—ጟ“¢‰ïE•×‹­‰ï (2010/7/15), _“ސì.

733349. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) 3DŽž‘ã‚̊ᐞ”æ˜J. Îì@‹Ï (ˆã—Éq¶Šw•”): Pfizer
Ophthalmic Seminar (2010/7/31), L“‡.

733350. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’ŒŠáŽ²‚ªŒŽˆö‚ƍl‚Š‚ç‚ê‚éŠJŽU•s‘S. ŒãŠÖ—˜–Ÿ1, Îì@
‹Ï2, ’r“c“N–ç1, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ26‰ñ^’߃Zƒ~ƒi[ (2010/8/1), _“ސì.

733351. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) —ΓàáŽ¡—Öò, ”z‡Ü‚ɂ‚¢‚Ä. ¯ŽiMs (ˆã—Éq¶Šw
•”): ‘æ13‰ñ‘Š–ÍŒŽƒOƒ‰ƒR[ƒ}ƒ~[ƒeƒBƒ“ƒ“ƒO (2010/8/26), _“ސì.

733352. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) •œ¬21”N“x‘S‘ŠwZ‚ł̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒY‘•—p’²ž. ‰F
’ÃŒ©‹`ˆê1,2 (1‰F’ÃŒ©Šá‰Èˆã‰@, 2Šá‰È): _“ސ쌧Šá‰Èˆã‰ï@•œ¬22”N“xˆã—Ë@Ší”Ì”„‹Æ“™‚ÌŠÇ—ŽÒ‚É
‘΂·‚éŒp‘±“IŒ€C (2010/9/2), _“ސì.

733353. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yƒ‚ƒfƒŒ[ƒ^[z’YŽ_ƒKƒXƒŒ[ƒU[‚ÌŠá‰È‰ž—p. Îì@‹Ï
(ˆã—Éq¶Šw•”): ‘æ11‰ñŠá‰È—Տ°‹@ŠíŒ€‹†‰ï (2010/9/5), _“ސì.

733354. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yƒ‚ƒfƒŒ[ƒ^[zˆê”ʍu‰‰. Žs糋`Í (Šá‰È): ‘æ11‰ñ
Šá‰È—Տ°‹@ŠíŒ€‹†‰ï (2010/9/5), _“ސì.

733355. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yƒ‚ƒfƒŒ[ƒ^[zOCT‚̐V‚µ‚¢ŽŽ‚Ý. _’J˜aF (Šá‰È): ‘æ
11‰ñŠá‰È—Տ°‹@ŠíŒ€‹†‰ï (2010/9/5), _“ސì.

733356. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’Ž‚‘¬OCT‚É‚æ‚铵Eƒ_ƒCƒiƒ~ƒNƒX‚ÌŠÏŽ@. ’†Œ@Šî
1,2 (1Šá‰È, 2‘å˜aŽs—§•a‰@): ‘æ11‰ñŠá‰È—Տ°‹@ŠíŒ€‹†‰ï (2010/9/5), _“ސì.

733357. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’²ß•‰‰×Žž‚ÌSS-OCT‚ð—p‚¢‚œŠá‚̃oƒCƒIƒƒgƒŠ[. ŒÜ
\—’ÍŽj (Šá‰È): ‘æ11‰ñŠá‰È—Տ°‹@ŠíŒ€‹†‰ï (2010/9/5), _“ސì.

733358. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŠwZŒ»ê‚ł̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒY. ‰F’ÃŒ©‹`ˆê1,2 (1Šá
‰È, 2“ú–{Šá‰Èˆã‰ï): ìèŽsˆãŽt‰ïŠwZˆã•”‰ïŠwpu‰‰‰ï (2010/9/9), _“ސì.

733359. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Visual Field Index ‚ð‘g‚Ý“ü‚ê‚œV‚µ‚¢
Hodapp-Anderson-Parrish•ª—Þ. •œàVˆê–@1, ¯ŽiMs2, ‹œ‰E‹ß”ŽN3, X“c“N–ç3, ¬£—ÁŽq3, ‘å’Î
’qG3, Š}ŒŽ³s1, ]•—Ft3, ŽRŒûŠG—3, Ž…Œö–ç3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3Šá
‰È): ‘æ21‰ñNetwork of Glaucoma (2010/9/10), _“ސì.

733360. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž‹—Í’l‚É•\‚ê‚È‚¢gŒ©‚Š‚É‚­‚³h‚ɂ‚¢‚Ä. —é–؍‚‰“
1,2 (1Šá‰È, 2‚¿‚®‚³Šá‰È): ‘æ1‰ñ_“ސìŠá‰Èˆã—Ï]Ž–ŽÒ•×‹­‰ï (2010/9/12), _“ސì.

733361. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) 3DŽž‘ã‚Ì‚±‚Ç‚à‚ÌŠá‰ÈŒŸž. ”Œ“c’m–ç (ˆã—Éq¶Šw•”):
‘æ1‰ñ_“ސìŠá‰Èˆã—Ï]Ž–ŽÒ•×‹­‰ï (2010/9/12), _“ސì.

733362. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zƒNƒŒ[ƒ}[‚Ö‚ÌŽÀ‘H“I‘Ήž?—Í‚ð‡‚í‚¹‚Ĉã—ÂÆ
Œ»ê‚ðŽç‚ë‚€?. Ží“c–F˜Y (Šá‰È): ‘æ1‰ñ_“ސìŠá‰Èˆã—Ï]Ž–ŽÒ•×‹­‰ï (2010/9/12), _“ސì.

733363. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Œ©‚Š•û‚ɂ‚¢‚Ä. Vˆä“cF—T1,2 (1Šá‰È, 2‘Ûˆã—Ã
•ŸŽƒ‘åŠwŽ‹Šo‹@”\—Ö@Šw‰È): _“ސ샍[ƒrƒWƒ‡ƒ“ƒlƒbƒgƒ[ƒN‘æ23‰ñŒ€C‰ï (2010/10/2), _“ސì.

733364. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·z_“ސ샍[ƒrƒWƒ‡ƒ“ƒlƒbƒgƒ[ƒN‘æ23‰ñŒ€C‰ï.
Žs糋`Í (Šá‰È): _“ސ샍[ƒrƒWƒ‡ƒ“ƒlƒbƒgƒ[ƒN‘æ23‰ñŒ€C‰ï (2010/10/2), _“ސì.

733365. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹üÜˆÙí‚Æ‹üÜ‹ž³Žèp‚Æ‚Í. ŒÜ\—’ÍŽj (Šá‰È): –Ú
‚̈€Œìƒf[ (2010/10/3), _“ސì.

733366. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –Ô–Œ‚Ì•a‹C‚ɂ‚¢‚Ä?“œ”A•a–Ô–ŒÇ‚Æ‚»‚Ì‘Œ?. –ö“c’q
•F (Šá‰È): –ڂ̈€Œìƒf[ (2010/10/3), _“ސì.

733367. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zˆê”ʉ‰‘è. X“c“N–ç (Šá‰È): ‘æ46‰ñ–k—¢‘åŠwE
_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/10/7), _“ސì.

733368. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “œ”A•a‰©”Á•‚Žî‚ɑ΂·‚éÉŽq‘ÌŽèp‚̏pŒãŒo‰ß. ŽRŒûŠG
—1, ’†Œ@Šî1, –ö“c’q•F1, Ž…Œö–ç1 (1Šá‰È): ‘æ46‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`
ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/10/7), _“ސì.

733369. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™‚ÌŽ‹_ŒoŽŸŠ³. •û’qŒbŽq1, Žs糋`Í1, Ž…Œö
–ç1 (1Šá‰È): ‘æ46‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/10/7), _“ސì.

733370. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒ‰ƒ^ƒmƒvƒƒXƒg‚ƃ^ƒtƒ‹ƒvƒƒXƒg‚̊ሳ‰º~Œø‰Ê‚Ì”äŠr
ŒŸ“¢. ]•—Ft1, Š}ŒŽ³s2, ¬Š}ŒŽƒŒb1, ŽRŒûŠG—1, ‘å’Î’qG1, X“c“N–ç1, ¯ŽiMs3, Ž…
Œö–ç1 (1Šá‰È, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3ˆã—Éq¶Šw•”): ‘æ46‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT
[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/10/7), _“ސì.

733371. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) •¡”‰ñˆÚA•Ð‹@”\•s‘S‚ɑ΂µ‚ĐlHŠp–ŒBoston K-proˆÚ
Ap‚ðŽ{s‚µ‚œˆê—á. ²“¡M”V1, ŒÜ\—’ÍŽj2, _’J˜aF2, Ž…Œö–ç2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2Šá
‰È): ‘æ46‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/10/7), _“ސì.

733372. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹üÜ‹ž³ŽèpŒã‚ÌŠá“àƒŒƒ“ƒY“x”ŒvŽZ. ”Ñ“c‰Ã•F1, Ž
…Œö–ç1, “V–엝Œb1 (1Šá‰È): ‘æ46‰ñ–k—¢‘åŠwE_“ސ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX
(2010/10/7), _“ސì.

733373. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) 50Î‚ð‰ß‚¬‚œ‚ç‹C‚ð‚‚¯‚È‚¢‚Æ‚¢‚¯‚È‚¢Šá‚Ì•a‹C?ƒƒK
ƒl‚ª‡‚í‚È‚­‚È‚Á‚œ‚ÆŽv‚€‘O‚É?. Žs糋`Í (Šá‰È): ‘æ9‰ñŠ³ŽÒ‰ïƒ–k—¢‚ä‚€‚ä‚€ƒNƒ‰ƒu„
(2010/10/16), _“ސì.

733374. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šá‰È‰æ‘œf’fŠw?“à‰Èˆã‚É•K—v‚ÈŠá’ê‚ÌŒ©•û?. Žs糋`
Í (Šá‰È): ‘æ56‰ñ‚³‚ª‚Ý“œ”A•aƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/10/22), _“ސì.

733375. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “úíŒŸž‚̃Rƒc?‚Ç‚±‚ÉŽžŠÔ‚ð‚©‚¯‚é‚ׂ«‚È‚Ì‚©?. å
ŒŽŽµd (ˆã—Éq¶Šw•”): ÃŒŠá‰Èˆã‰ïŠwpu‰‰‰ï (2010/10/23), _“ސì.

733376. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zÅ‹ß‚̗Γàá–ò•š—Ö@‚ɂ‚¢‚Ä?ƒAƒhƒqƒAƒ‰ƒ“ƒX
‚ƍ‡Ü?. ¯ŽiMs (ˆã—Éq¶Šw•”): ‘æ1‰ñÃŒŠá‰ÈƒAƒJƒfƒ~[ (2010/10/27), _“ސì.

733377. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·z“úíf—Âɂš‚¯‚é—¬—܏ǂ̐f’f‚ÆŽ¡—Ã. Îì@‹Ï
(ˆã—Éq¶Šw•”): ‘æ1‰ñÃŒŠá‰ÈƒAƒJƒfƒ~[ (2010/10/27), _“ސì.

733378. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Žá”NŽÒ‚ÌNVG‚ɑ΂·‚éƒCƒ“ƒvƒ‰ƒ“ƒgŽèp‚ÌŒoŒ±. t–ؐ’
G1, ‚@ˆè‰Ã1, ‘å’Î’qG1, X“c“N–ç1, ¯ŽiMs2 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ22‰ñƒlƒIƒoƒX‚̉ï
(2010/10/29), “Œ‹ž.

733379. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zu‰‰1: R—Γàá“_Šá–ò‚ªŠp–Œ‚É‹y‚Ú‚·‰e‹¿. ¯
ŽiMs (ˆã—Éq¶Šw•”): ƒ~ƒPƒ‰ƒ“LA“_Šá‰t”­”„3Žü”N‹L”Ou‰‰‰ï (2010/10/30), _“ސì.

733380. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) •œ¬21”N“x‘S‘ŠwZ‚̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒY‘•—pó‹µ. ‰F
’ÃŒ©‹`ˆê1,2 (1Šá‰È, 2_“ސ쌧ˆãŽt‰ï): ‘æ41‰ñ‘S‘ŠwZ•ÛŒ’EŠwZˆã‘å‰ï (2010/11/20), ŒQ”n,

733381. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’†E‚Z¶‚̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚̃PƒAó‹µ. â–{‘¥•q (Šá
‰È): ‘æ41‰ñ‘S‘ŠwZ•ÛŒ’EŠwZˆã‘å‰ï (2010/11/20), ŒQ”n.

733382. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž‹—ÍŒŸž‚Å, •ª‚©‚邱‚Æ‚Æ, •ª‚©‚ç‚È‚¢‚±‚Æ?Ž‹—ÍŒŸžE
ŽófŠ©‚Ői‚߂鎋Ší‚ÆŽ‹—͂̐¶ŠU•ÛŒ’?. —é–؍‚‰“ (Šá‰È): ‘æ41‰ñ‘S‘ŠwZ•ÛŒ’EŠwZˆã‘å‰ï
(2010/11/20), ŒQ”n.

733383. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) —Γàáf—Âɂš‚¯‚é‰æ‘œf’f‚ÌŠˆ—p–@. ¯ŽiMs (ˆã—Ã
‰q¶Šw•”): ‘æ34‰ñÃŒŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2010/12/9), _“ސì.

733384. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) FÊ‚̉Á—î‚Æ”’“àáŽèp‘OŒã‚̐FŠo‚ɂ‚¢‚Ä. Žsìˆê•v
1,2 (1ŽÐ‰ï•ÛŒ¯’†‹ž•a‰@, 2Šá‰È): ‘æ34‰ñÃŒŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2010/12/9), _“ސì.

733385. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) PGŠÖ˜A–ò‚Æ”z‡“_Šá–ò‚̗Տ°ŒoŒ±. ¯ŽiMs (ˆã—Éq
¶Šw•”): _“ސìƒfƒ…ƒIƒgƒ‰ƒo”z‡“_Šá‰t”­”„‹L”Ou‰‰‰ï (2010/12/11), _“ސì.

733386. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) PGŠÖ˜A–ò‚Æ”z‡“_Šá–ò‚̗Տ°ŒoŒ±. Š}ŒŽ³s1,2 (1‘å
Šw‰@ˆã—ÃŒnŒ€‹†‰È, 2“Œ—ÑŠÔ•a‰@): _“ސìƒfƒ…ƒIƒgƒ‰ƒo”z‡“_Šá‰t”­”„‹L”Ou‰‰‰ï (2010/12/11), _“Þ
ì.

733387. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™‚ÌŽ‹—Í‚ÆŒ’f. ‰F’ÃŒ©‹`ˆê1,2 (1Šá‰È, 2‰¡•lŽs
Šá‰Èˆã‰ï): ‰¡•lŽsˆãŽt‰ï‘æ18‰ñ‰¡•l—Տ°ˆãŠw‰ïŠwpW’k‰ï (2010/12/11), _“ސì.

733388. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) V‚µ‚¢—Γàá•ª—Þ‚Ì’ñŽŠ‚Æ—L—p«. •œàVˆê–@1, ¯ŽiM
s2, X“c“N–ç3, Ž…Œö–ç3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3Šá‰È): ‘æ27‰ñ_“ސ쌧—Γà
á’k˜b‰ï (2011/2/5), _“ސì.

733389. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) PGŒø‰Ê•s\•ª—á‚©‚ç‚̍‡Ü‚ւ̐؂è‘Ö‚ŠŽŽŒ±. Š}ŒŽ³
s1, ¬£—ÁŽq1, t“úˆähŽq2, ŽRì–퐶3, X“c“N–ç4, ¯ŽiMs5, Ž…Œö–ç4 (1“ŒŽÅ—ÑŠÔ•a‰@, 2
‘Š–Í–ì•a‰@, 3‘å˜aŽs—§•a‰@, 4Šá‰È, 5ˆã—Éq¶Šw•”): ‘æ27‰ñ_“ސ쌧—Γàá’k˜b‰ï (2011/2/5), _
“ސì.

733390. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Trabectome҂̎g—pŒoŒ±. ‚@ˆè‰Ã1, t–ؐ’G1, ‘å
’Î’qG1, X“c“N–ç1, ¯ŽiMs2, Ž…Œö–ç1 (1Šá‰È, 2ˆã—Éq¶Šw•”): ‘æ27‰ñ_“ސ쌧—Γàá’k˜b
‰ï (2011/2/5), _“ސì.

733391. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚éŠp–ŒˆÚAŽèp‚ÌŒ»ó. ŒÜ\—’ÍŽj (Šá‰È):
‘æ8‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2011/2/10), _“ސì.

733392. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) 3D‰f‘œ‚ªŽ‹‹@”\‚É‹y‚Ú‚·‰e‹¿. ”Œ“c’m–ç (ˆã—Éq¶Šw
•”): ‘æ8‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2011/2/10), _“ސì.

733393. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zƒgƒsƒbƒNƒX1. _’J˜aF (Šá‰È): ‘æ8‰ñ–k—¢Šá
‰È•af˜AŒg‰ï (2011/2/10), _“ސì.

733394. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zƒgƒsƒbƒNƒX2. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ8
‰ñ–k—¢Šá‰È•af˜AŒg‰ï (2011/2/10), _“ސì.

733395. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šá‹…“Eop‚ɂ‚¢‚čl‚Š‚邱‚Æ. ”–؍LÆ1,2, ’†ì‰ë
—T3, ¬ò‘ñ–ç3, Œˆä‹M_3 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È, 3Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[ÄŒšEŒ`
¬ŠO‰È): ‘æ22‰ñŠááفE‹`Šá°ŽèpŒ€‹†‰ï (2011/2/11), “Œ‹ž.

733396. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—ጟ“¢) çt–©‰ß‘œŒ^“àŽÎŽ‹. ŒãŠÖ—˜–Ÿ (Šá‰È): ‘æ19‰ñ¬Ž™Šá‰È
(ŽÎŽ‹EŽãŽ‹) Ç—ጟ“¢‰ïE•×‹­‰ï (2011/2/24), _“ސì.

733397. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—ጟ“¢) •s“¯Ž‹‚ÌŠOŽÎŽ‹Žèp. Îì@‹Ï (ˆã—Éq¶Šw•”): ‘æ19
‰ñ¬Ž™Šá‰È (ŽÎŽ‹EŽãŽ‹) Ç—ጟ“¢‰ïE•×‹­‰ï (2011/2/24), _“ސì.

733398. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zƒx[ƒ`ƒFƒbƒg•a‚ɑ΂·‚éRTNFƒ¿R‘̗Ö@. Žs
糋`Í (Šá‰È): ‘Š–ÍŒŽäPŒŽ•aRAƒZƒ~ƒi[ (2011/2/24), _“ސì.

733399. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zu‰‰‰ï. Žs糋`Í (Šá‰È): ‘æ24‰ñ_“ސ샍[
ƒrƒWƒ‡ƒ“ƒlƒbƒgƒ[ƒNŒ€C‰ï (2011/2/26), _“ސì.

733400. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·z’m‚Á‚Ä‚š‚«‚œ‚¢Šá’ꎟŠ³. Žs糋`Í (Šá‰È): ‘æ
35‰ñÃŒŠá‰È—Տ°ƒtƒH[ƒ‰ƒ€ (2011/3/3), _“ސì.

733401. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yÀ’·zˆê”ʍu‰‰. “©ŽRG•v1,2 (1‚·‚â‚ÜŠá‰È, 2Šá‰È):
‘æ5‰ñ“ŒŠC“¹Šá‰ÈŒ€‹†‰ï (2011/3/12), _“ސì.

733402. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚â‚Á‚Ï‚è—\Œã•s—Ç‚Ÿ‚Á‚œ–Ô–Œ’†S“®–¬•ÂÇÇ‚Ì1Ç—á.
•y‰ª•q–ç1,2 (1“ú—§‰¡•l•a‰@, 2Šá‰È): ‘æ5‰ñ“ŒŠC“¹Šá‰ÈŒ€‹†‰ï (2011/3/12), _“ސì.

733403. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ’†E‚Z¶‚̃Rƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚̉˜õó‹µ‚ƏíÝD‹C«
‹Û‘p‚Æ‚Ì”äŠrŒŸ“¢. â–{‘¥•q1,2 (1â–{Šá‰ÈÃ“ìƒNƒŠƒjƒbƒN, 2Šá‰È): ‘æ5‰ñ“ŒŠC“¹Šá‰ÈŒ€‹†‰ï
(2011/3/12), _“ސì.

733404. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™‚ÌŽ‹_ŒoÇ. Žs糋`Í (Šá‰È): ‘æ5‰ñ“ŒŠC“¹Šá‰È
Œ€‹†‰ï (2011/3/12), _“ސì.

733405. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Monocular double depressor palsy (MDD) ‚̗Տ°‘œ‚Æ•a
‘ƒ‚̐_ŒoŠw“IlŽ@. ŒŽ@’Œl1,2 (1_“ސ쎕‰È‘åŠw•‘®‰¡•lƒNƒŠƒjƒbƒNŠá‰È, 2Šá‰È): ‘æ5‰ñ“ŒŠC“¹Šá
‰ÈŒ€‹†‰ï (2011/3/12), _“ސì.

733406. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Šá‹…“Eop‚ɂ‚¢‚čl‚Š‚邱‚Ɓ@ƒp[ƒgII. ”–؍LÆ
1,2 (1Œ§—§Ã‰ª‚ª‚ñƒZƒ“ƒ^[Šá‰È, 2Šá‰È): ‘æ5‰ñ“ŒŠC“¹Šá‰ÈŒ€‹†‰ï (2011/3/12), _“ސì.

733407. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“F2ƒ¿—U“±‘Ì“_Šá‰t. “©ŽRG•v1,2 (1
‚·‚â‚ÜŠá‰È, 2Šá‰È): ‘æ5‰ñ“ŒŠC“¹Šá‰ÈŒ€‹†‰ï (2011/3/12), _“ސì.

733408. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Ç—ጟ“¢u‰‰) Šp–Œ‘OŒã–ÊŒ`ó‰ðÍ‚ð—p‚¢‚œ‰~Šp–ŒŠá‚Ìelevation
•Ï‰»—ʂƏdÇ“x‚ÌŠÖ˜A. Îˆä—œŠG (‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ2‰ñ‚ß‚Ž‚¹IƒRƒ‹ƒlƒA‚Ì’Bl (2011/3/18),
“Œ‹ž.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-540020. [‚»‚Ì‘Œ]uVDTÇŒóŒQv‚ð’m‚Á‚Ä‚¢‚Ü‚·‚©? _’J˜aF (Šá‰È): WELL‚É•é‚ç‚»‚€
2010/3; Spring: 64-5.

[’˜@‘]

H21-620014. [Šwp‘] (•ª’SŽ·•M)yu’Ž“ü–åvŠá‰ÈŽèpŠî–{pŽ®50?DVD‚ƃVƒF[ƒ}‚ł܂邲‚Æ—
‰ðz5. …»‘́@…»‘Ì“û‰»‹zˆøp (PEA), P.104-11. Ž…Œö–ç (Šá‰È), ŠÄC ‰º‘º‰Ãˆê, •Ò Œ–{’·‘Ÿ,
žwŠ_Žj˜Y, ƒƒfƒBƒJo”Å, ‘åã, 2010/3”­s.


Žš•@ˆôA‰ÈŠw

[Šwp˜_•¶]

110237. [ŒŽ’˜] Inverted epiglottis: a postoperative complication of supracricoid laryngectomy
with cricohyoidoepiglottopexy. Nakayama M1, Okamoto M1, Seino Y1, Miyamoto S1, Hayashi S1, Masaki
T1, Yokobori S1, Takeda M1: Auris Nasus Larynx 2010/10; 37 (5): 609-14. (’†ŽR–Ÿm1, ‰ª–{–ql
1, Ž–ì—R”y1, ‹{–{r•ã1, —с@­ˆê1, ³˜Ò@—²1, ‰¡–x@Šw1, ’|“c¹•F1: 1Žš•@)

110238. [ŒŽ’˜] Phase l/ll Trial of Concurrent Use of S-1 and Radiation Therapy for T2 Glottic Cancer.
Nakayama M1, Hayakawa K2, Okamoto M1, Niibe Y2, Ishiyama H2, Kotani S2: Jpn J Clin Oncol 2010/10;
40 (10): 921-6. (’†ŽR–Ÿm1, ‘ì˜ad2, ‰ª–{–ql1, V•”@÷2, ÎŽR”ŽžŠ2, ¬’J³Žq2: 1Žš•@, 2
•úŽËü (Žîá‡))

110239. [ŒŽ’˜] High-speed digital imaging laryngoscopy of the neoglottis following supracricoid
laryngectomy with cricohyoidoepiglottopexy. Hayashi S1, Hirose H, Tayama N, Imagawa H, Nakayama
M1, Seino Y1, Okamoto M1: The Journal of Laryngology & Otology 2010/11; 124 (11): 1234-8. (—с@
­ˆê1, ’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{–ql1: 1Žš•@)

110240. [ŒŽ’˜] Delayed wound infection after supracricoid partial laryngectomy following failure
of high dose radiation. Nakayama M1, Okamoto M1, Seino Y1, Miyamoto S1, Mastuki T1, Ogawa A1:
Eur Arch Otorhinolaryngol 2011/2; 268 (2): 273-9. (’†ŽR–Ÿm1, ‰ª–{–ql1, Ž–ì—R”y1, ‹{–{r•ã
1, Œ–؁@’1, ¬ìˆŸŠóŽq1: 1Žš•@)

120067. [ŒŽ’˜] “Á”­«—Œ‘€«ŠŽ‰¹“ï’®‚ÌŒŸ“¢?is—lŽ®‚̍·‚É‚æ‚錟“¢?. ¬–ì—Yˆê, ²–ì@”£1, ã
žŠ‹M—T1, ’–@Œ’Žu, –q–슰”V1, ‰ª–{–ql1 (1Žš•@): AUDIOLOGY JAPAN 2010/4; 53 (2): 142-9.

120068. [ŒŽ’˜] ’·ŠúŠÏŽ@‚µ‚œ“Á”­«—Œ‘€«ŠŽ‰¹“ï’®‚ÌŒŸ“¢. ãžŠ‹M—T1, ²–ì@”£1, ¬–ì—Yˆê, ’–@Œ’
Žu, –q–슰”V1, ‰ª–{–ql1 (1Žš•@): Audiology Japan 2010/4; 53 (2):158-63.

120069. [ŒŽ’˜] ž__ŒoŒnŠù‰Ç‚ð—L‚·‚铪èò•”isŠàÇ—á‚ÌŽ¡—Ã. Ž–ì—R”y1, ’†ŽR–Ÿm1, —с@­
ˆê1, ’|“c¹•F1, ‹{–{r•ã1, Œ—tG‹N1, ‰ª–{–ql1 (1Žš•@): “ªèò•”Šà 2010/4; 36 (1): 119-24.

120070. [ŒŽ’˜] ŠO—ˆ”r”^ˆ’u‚ðdŽ‹‚µ‚œG“ŽüˆÍ”^ᇂւ̑Ήž. —é–Ø—§r1, ‰ª–{–ql1, ‰Á”[Fˆê1 (1
Žš•@): “úŽš•@ŠŽõŽ 2010/5; 28 (1): 115-8.

120071. [ŒŽ’˜] Žš•@ˆôA‰ÈŠO—ˆ‚É‚š‚¯‚éš‹‰ºáŠQƒXƒNƒŠ[ƒjƒ“ƒO€–Ú‚ÌŒŸ“¢. ŒŽRkˆê˜Y, ‰iˆä_–€
1, ‰Pˆä‘å—S1, ŒIŒŽ—¢‰À, ”ª”ö˜a—Y, œA£@”£ (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ïŽ 2010/6; 113 (6): 542-8.

120072. [ŒŽ’˜] š‹‰ºáŠQ‚ɑ΂·‚éŠO—ˆ‚ł̑Ήž–@‚ÌŽŽ‚Ý. ŒŽRkˆê˜Y, ‰iˆä_–€1, ‰Pˆä‘å—S1, ŒIŒŽ
—¢‰À, ”ª”ö˜a—Y, œA£@”£ (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ïŽ 2010/7; 113 (7): 587-92.

120073. [ŒŽ’˜] “Ë”­«“ï’®‚̎Љï“I–â‘è. ‰ª–{–ql1, ²–ì@”£1, ãžŠ‹M—T1, ¬–ì—Yˆê (1Žš•@):
Audiology Japan 2010/12; 53 (6): 682-6.

120074. [ŒŽ’˜] “Ë”­«“ï’®Ç—á‚ɑ΂·‚éƒoƒ‰ƒVƒNƒƒrƒ‹’ljÁ“Š—^‚ÌŒø‰Ê‚ɂ‚¢‚Ä. –q–슰”V1, ²–ì@
”£1, ãžŠ‹M—T1, ‰ª–{–ql1 (1Žš•@): Otology Japan 2010/12; 20 (5): 717-20.

120075. [ŒŽ’˜] •@’†Šuœ]‹ÈÇ‚ð‡•¹‚µ‚œƒAƒŒƒ‹ƒM[«•@‰Š‰º•@b‰î”S–Œ‚ÌTh2, Th1×–EZ‚ÌŒŸ“¢.
”ª”ö˜a—Y, ‰Pˆä‘å—S, ŒIŒŽ—¢‰À, ŒŽRkˆê˜Y, ˆäŒû–F–Ÿ, ŽR–{ˆê”Ž, ²“¡Œ«‘Ÿ˜Y, —é–Ø—§r1, ‰ª–{–ql
1 (1Žš•@): “ú–{•@‰ÈŠw‰ï‰ïŽ 2010/12; 49 (4): 507-12.

220023. [€ŒŽ’˜] ‚ß‚Ü‚¢‚̃ŠƒnƒrƒŠ. ’·À‰p–Ÿ1 (1Žš•@): ‘æ27‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ïˆãŽtuK‰ï
Ž˜^W 2010/6; p.54-9.

220024. [€ŒŽ’˜] —Šw—Ö@. ’·À‰p–Ÿ1 (1Žš•@): ‘æ27‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ïˆãŽtuK‰ïŽ˜^W
2010/6; p.68-70.

520078. [‘à] “Á”­«—Œ‘€«ŠŽ‰¹“ï’®‚ÌŽæ‚舵‚¢. ‰ª–{–ql (Žš•@): ê–åˆã’ʐM 2010/5; 130: 6-7.

520079. [‘à]y‚—îŽÒ‚Ì•â’®?ŽÀ’nf—Âɖ𗧂ŐV‚Ì’mŽ¯?z•â’®Žü•Ó‹@Ší, Žx‰‡‹@Ší. ²–ì@”£
(Žš•@): ENTONI 2010/5; 115: 52-7.

520080. [‘à]yŽš•ÂÇŠŽ‚̐f’f‚ÆŽ¡—ÁzŽš•ÂÇŠŽ‚ÆŽšŠÇ‹@”\ŒŸž. ²–ì@”£ (Žš•@): ENTONI 2010/9;
119: 17-21.

520081. [‘à] ƒƒjƒG[ƒ‹•a‚ɑ΂·‚鐅•ªÛŽæ—Ö@‚ƃJƒNƒeƒ‹—Ö@?‚ß‚Ü‚¢‚̃JƒNƒeƒ‹—Ö@?. ’·À
‰p–Ÿ (Žš•@): ENTONI 2010/10; 120: 74-80.

521026. [‰ðà]y‚ß‚Ü‚¢‚̗Տ°zƒƒjƒG[ƒ‹•a‚̐f’f‚ÆŽ¡—Ã. ’·À‰p–Ÿ (Žš•@): Medico 2010/5; 41 (5):
153-6.

522129. [uÀ]y•ê‚³‚ñ‚ւ̉ñ“šƒ}ƒjƒ…ƒAƒ‹@Žš•@ˆôA‰ÈQ•A 2010zŽš•Ò@•â’®Ší@•â’®Ší‚Ì‘•—p‚Æ‚±
‚Ƃ΂̃gƒŒ[ƒjƒ“ƒOŠJŽn‚ÌŽžŠú‚Í? ²–ì@”£ (Žš•@): JOHNS 2010/8; 26 (9, 9ŒŽ‘‘卆): 1266-7.

540064. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)uƒXƒeƒƒCƒhˆË
‘¶«ŠŽ‰¹“ï’®‚̐V‚µ‚¢f’f•û–@‚š‚æ‚ѐf’fŠî€‚ÉŠÖ‚·‚錟“¢vzŒp‘±“I‚Ü‚œ‚Í”œ•œ‚·‚éƒXƒeƒƒCƒh“Š—^‚ª
•K—v‚Å‚ ‚Á‚œ—Œ‘€is«ŠŽ‰¹“ï’®‚Ì4Ç—á. ²–ì@”£1, ‰ª–{–ql1, ‘å‹ŽŒ’‘Ÿ˜Y1 (1Žš•@): Œú¶˜J“­
‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)uƒXƒeƒƒCƒhˆË‘¶«ŠŽ‰¹“ï’®‚̐V‚µ‚¢f’f•û–@‚š‚æ‚ѐf’f
Šî€‚ÉŠÖ‚·‚錟“¢v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.22-4.

540065. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‹}«‚“x“ï’®
‚ÉŠÖ‚·‚é’²žŒ€‹†vz“Ë”­«“ï’®‚Ì”­Ç‘O‚̃XƒgƒŒƒXó‹µ, ”­¶ó‹µ‚ÉŠÖ‚·‚é—\”õ“I’²ž. ‰ª–{–ql1, ²
–ì@”£1, ‘å‹ŽŒ’‘Ÿ˜Y1, ’–@Œ’Žu (1Žš•@): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ‹}«‚
“x“ï’®‚ÉŠÖ‚·‚é’²žŒ€‹†•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.48-9.

540066. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠw‰ÈŒ€”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‹}«‚“x“ï’®
‚ÉŠÖ‚·‚é’²žŒ€‹†vz“Ë”­«“ï’®grede 4‚̏Ǘá‚ɑ΂·‚éƒXƒeƒƒCƒhŒÛŽº“à’“ü‚ÌŒŸ“¢. ‰ª–{–ql1, “n
•Ó—T”V1, ‘å‹ŽŒ’‘Ÿ˜Y1, ’–@Œ’Žu, ãžŠ‹M—T, ¬–ì—Yˆê, ²–ì@”£1 (1Žš•@): Œú¶˜J“­‰ÈŠw‰ÈŒ€”ï•â
•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²žŒ€‹†vz•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘
2011/3; p.57-8.

540067. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠw‰ÈŒ€”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‹}«‚“x“ï’®
‚ÉŠÖ‚·‚é’²žŒ€‹†vz–k—¢‘åŠw•a‰@‚É‚š‚¯‚é‰ß‹Ž16”NŠÔ‚Ì“Ë”­«“ï’®Ž¡—Â̑Š‡. ‰ª–{–ql1, ²–ì@”£
1, “n•Ó—T”V1, ’–@Œ’Žu1, ‘å‹ŽŒ’‘Ÿ˜Y1 (1Žš•@): Œú¶˜J“­‰ÈŠw‰ÈŒ€”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–
‹Æ)u‹}«‚“x“ï’®‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.59-62.

540068. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‹}«‚“x“ï’®
‚ÉŠÖ‚·‚é’²žŒ€‹†vz“«“àŽšŽŸŠ³‚̈â“`Žqƒoƒ“ƒN\’z?“Ë”­«“ï’®‚̈â“`Žqƒoƒ“ƒNƒvƒƒWƒFƒNƒg. ‰F
²”ü^ˆê, ¬ì@ˆè, ‰ª–{–ql1, Šì‘œ‘ºŒ’, ‹Å@Ž•¶, ²“¡G–Ÿ, ’†“‡@–±, •Ÿ“‡–M”Ž, ŽR‘d’B–ç, ‹S
“ª—Ç•ã, Œ”öMÆ, H@@õ (1Žš•@): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ‹}«‚“x“ï’®
‚ÉŠÖ‚·‚é’²žŒ€‹†•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.27-32.

540069. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙ
í‚ÉŠÖ‚·‚é’²žŒ€‹† (Œ€‹†‘ã•\ŽÒ: “n•Ós—Y)vzI. ƒƒjƒG[ƒ‹•a, ’x”­«“àƒŠƒ“ƒp…Žî‚ÉŠÖ‚·‚é‰uŠw‚š
‚æ‚їՏ°“I’²žŒ€‹†. II. R—˜”Aƒzƒ‹ƒ‚ƒ“‚Æ’E…•‰‰×‚É‚æ‚é嗋ŒŒŠÇð•Ï‰»‚ÉŠÖ‚·‚錀‹†. III. “
«“àŽšŽŸŠ³‚̈â“`Žqƒoƒ“ƒN\’z‚ÌŒ€‹†. IV. ’x”­«“àƒŠƒ“ƒp…Žî‚̉摜f’f‚ÉŠÖ‚·‚錀‹†. V. ƒƒjƒG
[ƒ‹•a (’x”­«“àƒŠƒ“ƒp…Žî‚ðŠÜ‚Þ) ‚ÌŽ¡—ÂɊւ·‚錀‹†. “n•Ós—Y1, Â–ØŒõL2, ‰F²”ü^ˆê3, ‚
‹Ž³h4, ’·À‰p–Ÿ5 (1•xŽR‘å, 2Šò•Œ‘å, 3MB‘å, 4‰¡•l’†‰›ƒNƒŠƒjƒbƒN‚ß‚Ü‚¢ƒƒjƒG[ƒ‹•aƒZƒ“ƒ^
[, 5Žš•@): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†v
•œ¬21”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2010/3; p.17-22.

540070. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙ
í‚ÉŠÖ‚·‚é’²žŒ€‹† (Œ€‹†‘ã•\ŽÒ: “n•Ós—Y)vz1. ƒƒjƒG[ƒ‹•af—ÃKƒCƒhƒ‰ƒCƒ“‚̍쐬. 2. ƒƒjƒG
[ƒ‹•a‚ÉŠÖ‚·‚é‰uŠw‚š‚æ‚їՏ°“I’²žŒ€‹†. 3. ƒƒjƒG[ƒ‹•a‚Ì”­Ç‚ÉŠÖ‚·‚鐅ƒ`ƒƒƒ“ƒlƒ‹, R—˜”Aƒzƒ‹
ƒ‚ƒ“‚ÉŠÖ‚·‚錀‹†. 4. ƒƒjƒG[ƒ‹•a‚É‚š‚¯‚é_Œo“à•ª”åƒzƒ‹ƒ‚ƒ““®‘Ô‚ÌŒŸ“¢. 5. ƒƒjƒG[ƒ‹•a‚̐V‚µ
‚¢ŽŸŠ³ŠT”O‚ÆŽ¡—Ö@‚ɂ‚¢‚Ä‚ÌŒ€‹†. 6. ƒƒjƒG[ƒ‹•a‚̉摜f’f‚ÉŠÖ‚·‚錀‹†. 7. “«“àƒŠƒ“ƒp…
ŽîŽŸŠ³ (ƒƒjƒG[ƒ‹•a, ’x”­«“àƒŠƒ“ƒp…Žî) ‚ɑ΂·‚éŒoŒÛ–Œ“I’†Žš‰Áˆ³Ž¡—Ã. 8. “«“àŽšŽŸŠ³‚̈â
“`Žqƒoƒ“ƒN\’z‚ÆŽŽ—¿•ªÍ. “n•Ós—Y1, Â–ØŒõL2, ‰F²”ü^ˆê3, ‚‹Ž³h4, ’·À‰p–Ÿ5 (1•xŽR‘å,
2Šò•Œ‘å, 3MB‘å, 4‰¡•l’†‰›ƒNƒŠƒjƒbƒN‚ß‚Ü‚¢ƒƒjƒG[ƒ‹•aƒZƒ“ƒ^[, 5Žš•@): Œú¶˜J“­È‰ÈŠwŒ€‹†
”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ
‘ 2011/3; p.19-22.

540071. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙ
í‚ÉŠÖ‚·‚é’²žŒ€‹† (Œ€‹†‘ã•\ŽÒ: “n•Ós—Y)vz1. ƒƒjƒG[ƒ‹•af—ÃKƒCƒhƒ‰ƒCƒ“‚̍쐬. 2. ƒƒjƒG
[ƒ‹•aE’x”­«“àƒŠƒ“ƒp…Žî‚̉uŠw“I’²ž. 3. ƒƒjƒG[ƒ‹•a‚̐_Œo“à•ª”åƒzƒ‹ƒ‚ƒ“, R—˜”Aƒzƒ‹ƒ‚ƒ“‚É
ŠÖ‚·‚éŠî‘b“IŒ€‹†. 4. ƒƒjƒG[ƒ‹•a‚É‚š‚¯‚é_Œo“à•ª”åƒzƒ‹ƒ‚ƒ““®‘Ô‚ÌŒŸ“¢. 5. “«ƒƒjƒG[ƒ‹•a
‚ɑ΂·‚鎡—ÃŒø‰ÊŒüã‚ÉŠÖ‚·‚錀‹†. 6. “«“àŽšŽŸŠ³‚̈â“`Žqƒoƒ“ƒNƒvƒƒWƒFƒNƒg‚É‚æ‚郁ƒjƒG[ƒ‹
•aˆâ“`Žq‰ðÍ. “n•Ós—Y1, Â–ØŒõL2, ‰F²”ü^ˆê3, ‚‹Ž³h4, ’·À‰p–Ÿ5 (1•xŽR‘å, 2Šò•Œ‘å, 3
MB‘å, 4‰¡•l’†‰›ƒNƒŠƒjƒbƒN‚ß‚Ü‚¢ƒƒjƒG[ƒ‹•aƒZƒ“ƒ^[, 5Žš•@):uŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“ï
Ž¡«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ), ‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬20”N“x?•œ¬22”N“x‘‡Œ€‹†•ñ‘
2011/3; p.57-64.

540072. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙ
í‚ÉŠÖ‚·‚é’²žŒ€‹†vz2010”N“àƒŠƒ“ƒp…ŽîŽŸŠ³‰uŠw’²žŒ‹‰Ê. «Ï“úo•v1, “n•Ós—Y1, \“ñ’¬^Ž÷
Žq1, Â–ØŒõL2, ’r‰€“N˜Y3, ˆÉ“¡Žõˆê4, ‰F²”ü^ˆê5, Š`–؏͐L6, ”ì’ˁ@ò7, —é–؁@‰q8, ‚‹Ž³
h9, ‚‹ŽŽ»10, H“c¹–ç11, •“cŒ›º12, “yˆäŸ”ü13, ’·À‰p–Ÿ14, ŽR‰º—TŽi15, ‚‹Ž@Žp16, ‘å
“‡L‰î17, ’Ø“c‰ëm18, ˆÀ‘º²“s‹I19 (1•xŽR‘å, 2Šò•Œ‘å, 3“ú–{ˆã‘å, 4‹ž“s‘å, 5MB‘å, 6“Œ‹ž‘å,
7¹ƒ}ƒŠƒAƒ“ƒiˆã‘å, 8“Œ‹žˆã‘å, 9‚ß‚Ü‚¢ƒƒjƒG[ƒ‹•aƒZƒ“ƒ^[, 10ŒQ”n‘å, 11L“‡‘å, 12,“¿“‡‘å, 13
‹ß‹E‘å, 14Žš•@, 15ŽRŒû‘å, 16VŠƒ‘å, 17²“n‘‡•a‰@, 18ã‰z‘‡•a‰@, 19Ž…‹›ì‘‡•a‰@): Œú¶
˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬21”N“x‘Š‡E
•ª’SŒ€‹†•ñ‘ 2011/3; p.67-70.

540073. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙ
í‚ÉŠÖ‚·‚é’²žŒ€‹†vzŽÀŒ±“IArg-Vasopressin “Š—^“®•šƒ‚ƒfƒ‹‚É‚š‚¯‚é嗋ŒŒŠÇð‚ÌŒ`‘ԕω»?
Vasopressin V2-receptorhR–ò‚̉e‹¿?. ’·À‰p–Ÿ1, ‰ÍŒŽŽ‰ë2, “¿‘Œú“ñ, ²“¡—º•œ2, —Ž‡@“Ö
1, ‰ª–{–ql1 (1Žš•@, 2¶—): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙ
í‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.77-80.

540074. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙ
í‚ÉŠÖ‚·‚é’²žŒ€‹†vzƒƒjƒG[ƒ‹•a‚Æ“Ë”­«“ï’®‚ÌŒŒˆ³’l‚ÌŒŸ“¢. ‰Á”[Fˆê1, ’·À‰p–Ÿ1, —Ž‡@“Ö
1, ‰ª–{–ql1 (1Žš•@): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·
‚é’²žŒ€‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.120.

54075. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙ
í‚ÉŠÖ‚·‚é’²žŒ€‹†vz––œ‘O’뎟Š³‚É‚š‚¯‚éComputerized Dynamic Posturography. —Ž‡@“Ö1, ’·À
‰p–Ÿ1, “¿‘Œú“ñ, ‰ª–{–ql1 (1Žš•@): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë
‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.134-5.

540076. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙ
í‚ÉŠÖ‚·‚é’²žŒ€‹†vzƒƒjƒG[ƒ‹•a‚ɑ΂·‚鐅•ªÛŽæ—Ö@‚É‚š‚¯‚éˆù…•û–@‚ÌŒŸ“¢. ¬“cŒŽ–Œ•à, Šâ‰º
—T—¢, ‚“c’qŽq, ’·À‰p–Ÿ1, —Ž‡@“Ö1, ‰ª–{–ql1, ”ª“c‹žŽq (1Žš•@): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â
•‹à“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ@‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹† •œ¬22”N“x@‘Š‡E•ª’SŒ€‹†•ñ‘
2011/3; p.158-60.

540077. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•¶•”‰ÈŠwÈŠî”ÕŒ€‹† (C) •œ¬22”N“x‰ÈŠwŒ€‹†”ï•â•‹àŽÀÑ•ñ‘z
R—˜”Aƒzƒ‹ƒ‚ƒ““Š—^‚É‚æ‚錌ŠÇð‚ÌŒ`‘ԕω»‚É”º‚€’®—͏áŠQ‚ÉŠÖ‚·‚錀‹†. ’·À‰p–Ÿ1, ‰ÍŒŽŽ‰ë2, ã
ã—ms3 (1Žš•@, 2¶—, 3‰ð–U): Œ€‹†ŽÀÑ•ñ‘ 2011/3.

[’˜@‘]

620129. [Šwp‘] (•ª’SŽ·•M)yŽš•@ˆôA‰ÈE“ªèò•”ŠO‰È‚ÌŒŸžƒ}ƒjƒ…ƒAƒ‹?•û–@EŒ‹‰Ê‚Æ‚»‚̉ðŽß (Žš
•@ˆôA‰ÈE“ªèò•”ŠO‰È@‘Š§†82 (5))zI. ’®ŠoŒŸž@1. ƒ‰¹’®—ÍŒŸž, p.7-12. ²–ì@”£ (Žš•@), ˆã
Šw‘‰@, “Œ‹ž, 2010/4”­s.

620130. [Šwp‘] (•ª’SŽ·•M)yEBM@Žš•@ˆôA‰ÈE“ªèò•”ŠO‰È‚ÌŽ¡—à 2010-2011zII. Žš—̈æ@E•â’®Ší,
lŒû’†Žš, lH“àŽš@1. •â’®Ší‚ÉEBM‚Í‚ ‚é‚©? p.168-70. ²–ì@”£ (Žš•@), •Ò ’r“cŸ‹v, ‘Œ, ’†ŠO
ˆãŠwŽÐ, “Œ‹ž, 2010/5”­s.

620131. [Šwp‘] (•ª’SŽ·•M)yEBM@Žš•@ˆôA‰ÈE“ªèò•”ŠO‰È‚ÌŽ¡—à 2010-2011zV. “ªèò•”Žîᇗ̈æ@B.
A“ª‚ª‚ñ@3. A“ªˆŸ‘S“Eop‚ÌEBM‚Æ‚Í?, p.458-63. ’†ŽR–Ÿm1, ‰ª–{–ql1 (1Žš•@), •Ò ’r“cŸ‹v,
‘Œ, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713149. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Delayed Wound Infection after Supracricoid@
Laryngectomy Following@Failure@of Higt Dose Radiation. Meijin Nakayaka1, Makito Okamoto1,
Yutomo Seino1, Shunsuke Miyamoto1, Seiichi Hayashi1, Takashi Matsuki1, Akiko Ogawa1: 4th World
Congress of International Federation of Head and Neck Oncologic Societies (2010/6/16), Korea. (’†
ŽR–Ÿm1, ‰ª–{–ql1, Ž–ì—R”y1, ‹{–{r•ã1, —с@­ˆê1, Œ–؁@’1, ¬ìˆŸŠóŽq1: 1Žš•@)

713150. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Treatment Indication for Advanced Head and Neck Cancer
Associated with Psychiatric Disease. Yutomo Seino1, Meijin Nakayama1, Makito Okamoto1, Masahiko
Takeda1, Syunsuke Miyamoto1, Seiichi Hayashi1, Takashi Matsuki1, Akiko Ogawa1, Hiroki Matuba1:
4th World Congress of International Federation of Head and Neck Oncologic Societies (2010/6/17),
Korea. (Ž–ì—R”y1, ’†ŽR–Ÿm1, ‰ª–{–ql1, ’|“c¹•F1, ‹{–{r•ã1, —с@­ˆê1, Œ–؁@’1, ¬ìˆŸ
ŠóŽq1, Œ—tG‹N1: 1Žš•@)

713151. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A Clinical Review of Thyroid Malignant Lymphome:
Diagnosis,Treatment,and Outcome. Seiichi Hayashi1, Meijin Nakayama1, Yutomo Seino1, Shunsuke
Miyamoto1, Makito Okamoto1: 4th World Congress of International Federation of Head and Neck
Oncologic Societies (2010/6/18), Korea. (—с@­ˆê1, ’†ŽR–Ÿm1, Ž–ì—R”y1, ‹{–{r•ã1, ‰ª–{–q
l1: 1Žš•@)

713152. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) CyberKnife Stereotactic Radiotherapy for Initial
Treatment of Head and Neck Malignancy. Takashi Matsuki1, Koichi Yamashita, Meijin Nakayama1, Akiko
Ogawa1, Yutomo Seino1, Seiichi Hayashi1, Makito Okamoto1: A Clinical Review of 12 Patients. 4th
World Congress of International Federation of Head and Neck Oncologic Societies (2010/619), Korea.
(Œ–؁@’1, ’†ŽR–Ÿm1, ¬ìˆŸŠóŽq1, Ž–ì—R”y1, —с@­ˆê1, ‰ª–{–ql1: 1Žš•@)

713153. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) CyberKnife Stereotactic Radiotherapy for Salvage
Treatment of Head and Neck Malignancy. Akiko Ogawa1, Koichi Yamashita, Meijin Nakayama1, Takashi
Matsuki1, Makito Okamoto1, Yutomo Seino1, Seiichi Hayashi1: A Clinical Review. 4th World Congress
of International Federation of Head and Neck Oncologic Societies (2010/6/19), Korea. (¬ìˆŸŠó
Žq1, ’†ŽR–Ÿm1, Œ–؁@’1, ‰ª–{–ql1, Ž–ì—R”y1, —с@­ˆê1: 1Žš•@)

713154. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The effect of newborn hearing screening on early
diagnosis and intervention on infants with moderage hearing loss. Rie Inoue, Sachie Onuma, Keiko
Suzuki, Hajime Sano1, Makito Okamoto1: 21st International Congress on the Education of the Deaf
Vancouver (2010/7/20), Canada. (²–ì@”£1, ‰ª–{–ql1: 1Žš•@)

713155. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Morphological changes in stria vascularis in
experimental animal models administered arginine vasopressin. Naganuma H1, Kawahara K2, Sato R2,
Tokumasu K, Ochiai A1, Makino H1, Okamoto M1: 26th Barany Society Meeting (2010/8/20), Reykjavik.
(’·À‰p–Ÿ1, ‰ÍŒŽŽ‰ë2, ²“¡—º•œ2, —Ž‡@“Ö1, –q–슰”V1, ‰ª–{–ql1: 1Žš•@, 2¶—)

713156. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) A research of disequilibrium disease at department of
Neurotology, Kitasato University Hospital. Makino H1, Naganuma H1, Ochiai A1, Tokumasu K, Okamoto
M1: 26th Barany Society Meeting (2010/8/20), Reykjavik. (–q–슰”V1, ’·À‰p–Ÿ1, —Ž‡@“Ö1, ‰ª
–{–ql1: 1Žš•@)

713157. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Vertigo and disequilibrium of SLE patients. Ochiai
A1, Naganuma H1, Tokumasu K, Okamoto M1: 26th Barany Society Meeting (2010/8/20), Reykjavik. (—Ž
‡@“Ö1, ’·À‰p–Ÿ1, ‰ª–{–ql1: 1Žš•@)

713158. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Flaccid neoglottis following supracricoid
laryngectomy: laryngoscopic revision assisted by navigation system. Nakayama M1, Seino Y1,
Okamoto M1, Matsuki T1: The 4th World Voice Congress (2010/9/8), Seoul, Korea. (’†ŽR–Ÿm1, Ž
–ì—R”y1, ‰ª–{–ql1, Œ–؁@’1: 1Žš•@)

713159. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Hydration Therapy for Patients with Meniere's Disease:
the second report. Naganuma H1, Kawahara K2, Tokumasu K, Ochiai A1, Okamoto M1: Sixth International
Symposium on Meniere's Disease and Inner Ear Disorders (2010/11/15), Kyoto. (’·À‰p–Ÿ1, ‰ÍŒŽŽ
‰ë2, —Ž‡@“Ö1, ‰ª–{–ql1: 1Žš•@, 2¶—)

713160. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Peak Audiogram of Meniere's Disease. Ochiai A1,
Naganuma H1, Tokumasu K, Okamoto M1: Sixth International Symposium on Meniere's Disease and Inner
Ear Disorders (2010/11/15), Kyoto. (—Ž‡@“Ö1, ’·À‰p–Ÿ1, ‰ª–{–ql1: 1Žš•@)

713161. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) An Inverstigation regarding the Drinking Method in
Hydration Therapy for Patients with Meniere's Disease. Odahara H, Iwashita K, Takeda T, Hatta
K, Naganuma H1: Sixth International Symposium on Meniere's Disease and Inner Ear Disorders
(2010/11/15), Kyoto. (’·À‰p–Ÿ1: 1Žš•@)

713162. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Clinical significance of positive Delphian node in
supracricoid laryngectomy with cricohyoidoepiglottopexy. Nakayama M1, Seino Y1, Okamoto M1,
Mikami T2, Okamoto T1, Miyamto S1: The 12th Asia-Oceania Otolaryngology Head and Neck Congress
(2011/3/3), Auckland, New Zealand. (’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{–ql1, ŽOã“N•v2, ‰ª–{—·l1, ‹{
–{r•ã1: 1Žš•@, 2•a—)

713163. [Šw‰ï (‘Û)] A Case of Recurrent Laryngeal Nerve Paralysis Due to Upper Mediastinal
Hematoma. Makino H1, Nakayama M1, Seino Y1, Okamoto T1: The 12th Asia-Oceania Otolaryngology Head
and Neck Congress (2011/3/1-4), Auckland, New Zealand. (–q–슰”V1, ’†ŽR–Ÿm1, Ž–ì—R”y1, ‰ª–{
—·l1: 1Žš•@)

713164. [Šw‰ï (‘Û)] FA preliminary report of phase I/II Trial of S-1 and Nedaplatin with
concurrent radiotherapy in locally advanced mesopharynx, hypopharynx cancer. Okamoto T1, Hayakawa
K2, Okamoto M1, Nakayama M1, Seino Y1, Miyamoto S1: The 12th Asia-Oceania Otolaryngology Head and
Neck Congress (2011/3/1-4), Auckland, New Zealand. (‰ª–{—·l1, ‘ì˜ad2, ‰ª–{–ql1, ’†ŽR–Ÿm
1, Ž–ì—R”y1, ‹{–{r•ã1: 1Žš•@, 2•úŽËü (Žîá‡))

722218. [Šw‰ï (‘S‘)] (‹L”Ou‰‰) ƒ‰ƒbƒg‚É‚š‚¯‚éˆê‘€«”œ‰ñ_Œo–ƒáƒ‚ɑ΂·‚鉖Šî«üˆÛ‰è×–E‘B
ˆöŽq (b-FGF) ‚ð—p‚¢‚œŽ©‰Æ‹Ø–ŒˆÚAp‚ÌŒø‰Ê. ‰iˆä_–€ (Žš•@): ‘æ21‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï”F’è‹CŠÇ
H“¹‰Èê–åˆã‘å‰ï (2011/2/27), ‘åã.

722219. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) uG“•a‘ƒŠŽõÇŒ€‹†‚̍őOüvG“‚É‚š‚¯‚é“œœ•s‘SIgA1‚Ì
ŽY¶‹@˜. ˆÉ“¡º•F, ‰ª–{–ql1 (1Žš•@): ‘æ23‰ñ“ú–{ŒûoEˆô“ª‰ÈŠw‰ï (2010/9/17), “Œ‹ž.

722220. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y“ªèò•”E‹CŠÇEH“¹—̈æ‚Ì‹@”\‰·‘¶ŽèpzA“ªŠà‚Ì‹@”\‰·‘¶
Ž¡—Âɂš‚¯‚éA“ªˆŸ‘S“Eop‚Ì–ðŠ„. ’†ŽR–Ÿm (Žš•@): ‘æ62‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï
(2010/11/4), ‘啪.

723853. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) š‹‰ºáŠQ‚̃XƒNƒŠ[ƒjƒ“ƒO€–Ú‚ÌŒŸ“¢. ŒŽRkˆê˜Y, ‰iˆä_–€1, ‰P
ˆä‘å—S1, ŒIŒŽ—¢‰À, ”ª”ö˜a—Y, œA£@”£ (1Žš•@): ‘æ111‰ñ“ú–{Žš•@ˆôA‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï
(2010/5/20), å‘ä.

723854. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘åŠw•a‰@Žš•@ˆôA‰ÈŠO—ˆ‚ł̐f—ÃŽx‰‡‚Ì—L—p«. —é–Ø—§r1, ‰ª–{
–ql1, —с@­ˆê1 (1Žš•@): ‘æ111‰ñ“ú–{Žš•@ˆôA‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/5/22), å‘ä.

723855. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) A“ªˆŸ‘S“EopSupracricoid Laryngectomy?p’†v‘¬•a—f’f‚Ì
ˆÓ‹`?. ’†ŽR–Ÿm1, Ž–ì—R”y1, —с@­ˆê1, ‹{–{r•ã1, ‰ª–{–ql1 (1Žš•@): ‘æ34‰ñ“ú–{“ªèò•”Šà
Šw‰ï (2010/6/11), “Œ‹ž.

723856. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •úŽËüŽ¡—Â𒆐S‚Æ‚µ‚œ‰ºˆô“ªŠà‚ÌŽ¡—ЬÑ. ‰ª–{—·l1, ’†ŽR–Ÿ
m1, Ž–ì—R”y1, —с@­ˆê1, ‰ª–{–ql1 (1Žš•@): ‘æ34‰ñ“ú–{“ªèò•”ŠàŠw‰ï (2010/6/11), “Œ‹ž.

723857. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) cŠuŒŒŽî‚ªŒŽˆö‚Æ‹^‚í‚ê‚œ”œ‰ñ_Œo–ƒáƒ‚Ì1—á. –q–슰”V1, ‰ª–{
–ql1 (1Žš•@): ‘æ72‰ñŽš•@ˆôA‰È—Տ°Šw‰ï (2010/7/2), ‘q•~.

723858. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”]_ŒoÇó‚𔺂€•›•@o^‹ÛÇ‚̍lŽ@. ‰Á”[Fˆê1, —é–Ø—§r1, —с@
­ˆê1, ‰ª–{–ql1 (1Žš•@): ‘æ49‰ñ“ú–{•@‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/8/27), ŽD–y.

723859. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –âf•\‚ðŽg—p‚µ‚œƒXƒM‰Ô•²ÇŽ¡—Â̌Ÿ“¢. —é–Ø—§r1, ‰ª–{–ql1,
—с@­ˆê1, ‰Á”[Fˆê1 (1Žš•@): ‘æ49‰ñ“ú–{•@‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/8/28), ŽD–y.

723860. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰È‚É‚š‚¯‚éŒûo—̈æ‚̐_ŒoâŽîá‡. “n•Ó—T”V1, ’†ŽR–Ÿm1, Ž
–ì—R”y1, ‰ª–{–ql1 (1Žš•@): ‘æ23‰ñ“ú–{ŒûoEˆô“ª‰ÈŠw‰ï (2010/9/16), “Œ‹ž.

723861. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‚—îŽÒŽ{Ý‚É‚š‚¯‚éš‹‰º“àŽ‹‹ŸŒŸž‚ÌŒŸ“¢. ŒŽRkˆê˜Y, ‰iˆä_–€
1, ‘åãŒ€“ñ, ”ª”ö˜a—Y, ”Ñ“c­O, ’ρ@@Žç, œA£@”£ (1Žš•@): ‘æ23‰ñ“ú–{ŒûoEˆô“ª‰ÈŠw‰ï
(2010/9/16), “Œ‹ž.

723862. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “Ë”­«“ï’®‚ÆŠÓ•Ê‚ð—v‚µ‚œŽšd‰»Ç‚ÌŒŸ“¢. ²–ì@”£1, ’–@Œ’Žu,
‹Ž–{‘å–å1, ãžŠ‹M—T1, ¬–ì—Yˆê, ‘å‹ŽŒ’‘Ÿ˜Y1, ‰ª–{–ql1 (1Žš•@): ‘æ20‰ñ“ú–{Žš‰ÈŠw‰ï‘‰ïEŠw
pu‰‰‰ï (2010/10/9), ŒŽR.

723863. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŽÀŒ±“IArg-Vasopressin“Š—^“®•šƒ‚ƒfƒ‹‚É‚š‚¯‚é嗋ŒŒŠÇð‚ÌŒ`‘Ô
•Ï‰»?VasopressinV2-receptohR–ò‚̉e‹¿?. ’·À‰p–Ÿ1, ‰ÍŒŽŽ‰ë2, “¿‘Œú“ñ, ²“¡—º•œ2, —Ž‡@
“Ö1, ‰ª–{–ql1 (1Žš•@, 2¶—): ‘æ20‰ñ“ú–{Žš‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/10/9), ŒŽR.

723864. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹}«“û—p“Ë‹N‰Š‚ª‹^‚í‚ê‚œŠOŽš“¹•ÂœŽ™‚̈ê—á. –q–슰”V1, ²–ì@
”£1, ˆÉ“¡º•F1, ‰ª–{–ql1 (1Žš•@): ‘æ20‰ñ“ú–{Žš‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/10/9), ŒŽR.

723865. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒsƒbƒ`§Œä‰Â”\‚È“d‹CŽ®lHA“ª‚É‚æ‚é3Ží—Þ‚Ì”­˜b‰Û‘è‚Ì’®ŠoS
—“I•]‰¿. ¬’rŽO“ÞŽq, –xŒû—˜”V, ””’J‰pŽ÷, ‹e’n‹`M, —é–Ø–q•F, ‰ª–{–ql1 (1Žš•@): ‘æ55‰ñ“ú–{
‰¹ºŒŸŒêˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/10/14), “Œ‹ž.

723866. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚é‹h‰¹Ž™‚ÌŒo‰ß?‘æˆê•ñ?. ‘åÀKŒb1, ‹ù“c
O”ü, ŒŽ@—R‹I (1Žš•@): ‘æ55‰ñ“ú–{‰¹ºŒŸŒêˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/10/14), “Œ‹ž.

723867. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰ºˆô“ªŠàN2aˆÈã‚ɑ΂·‚éèò•”ŠsŽpæsŒã‰»Šw•úŽËüŽ¡—Ö@‚Ì’Z
Šú“IŒŸ“¢. ‰ª–{—·l1, ’†ŽR–Ÿm1, Ž–ì—R”y1, ‘ì˜ad2, ‰ª–{–ql1 (1Žš•@, 2•úŽËü (Žîá‡)): ‘æ
62‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/4), ‘啪.

723868. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) º‘Ñ–ƒáƒ‚ɑ΂·‚ébasic-FGF‚ð™•ú‚³‚¹‚œŽ©‰Æ‹Ø–ŒˆÚAp?
basic-FGF‚Ì“Š—^—ʂɂ‚¢‚Ä?. ‰iˆä_–€1, ŒŽRkˆê˜Y, Ž–ì—R”y1, –Ø‘º@—S, “c”š‘וF, ‰ª–{–ql
1 (1Žš•@): ‘æ62‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/4), ‘啪.

723869. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ÄŽèp‚ðs‚Á‚œ‹C“¹ˆÙ•š3Ç—á. ³˜Ò@—²1, ‰ª–{–ql1, –xŒû—˜
”V (1Žš•@): ‘æ62‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/4), ‘啪.

723870. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹CŠÇŽxˆÙ•šœ‹Ž‚ɃtƒHƒKƒeƒB[ƒoƒ‹[ƒ“ƒJ[ƒeƒ‹‚ðŽg—p‚µ‚œ1—á.
’Óc•à”ü, ’|“c¹•F1, “n糌’ˆê, –{ŠÔ˜a•v (1Žš•@): ‘æ62‰ñ“ú–{‹CŠÇH“¹‰ÈŠw‰ï‘‰ïEŠwpu‰‰‰ï
(2010/11/4), ‘啪.

723871. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “Ë”­«“ï’®grade 4‚̏Ǘá‚ɑ΂·‚éƒXƒeƒƒCƒhŒÛŽº“à’“ü‚ÌŒŸ“¢.
“n•Ó—T”V1, ‘å‹ŽŒ’‘Ÿ˜Y1, ’–@Œ’Žu, ãžŠ‹M—T1, ¬–ì—Yˆê, ²–ì@”£1, ‰ª–{–ql1 (1Žš•@): ‘æ55
‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/11), “Þ—Ç.

723872. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰È‚ōs‚Á‚Ä‚«‚œ“Ë”­«“ï’®‚Ö‚ÌŽ¡—Ö@‚Æ‚»‚ÌŒø‰Ê. ²–ì@”£1,
“n•Ó—T”V1, ¬–ì—Yˆê, ’–@Œ’Žu, ‘å‹ŽŒ’‘Ÿ˜Y1, ãžŠ‹M—T1, ‰ª–{–ql1 (1Žš•@): ‘æ55‰ñ“ú–{’®Šoˆã
Šw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/11), “Þ—Ç.

723873. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –Ó˜WŠ³ŽÒ‚̐lH“àŽš–„‚ߍž‚ݏpŽ{s‘O‚̃Rƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“Žè’i‚Ì
Šm—§. ˆäã—ŠG, ‘åÀKŒb1, ŒŽ@—R‹I, —é–ØŒbŽq, ²–ì@”£1, ‰ª–{–ql1 (1Žš•@): ‘æ55‰ñ“ú–{’®
ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/11), “Þ—Ç.

723874. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) lŠÔƒhƒbƒNŽófŽÒ‚̏ƒ‰¹’®—Í?”N—î‚š‚æ‚Ñ“œ”A•a‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä
?. ‘å‹ŽŒ’‘Ÿ˜Y1, “n•Ó—T”V1, ’–@Œ’Žu, ¬–ì—Yˆê, ²–ì@”£1, ‰ª–{–ql1 (1Žš•@): ‘æ55‰ñ“ú–{’®
ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/11), “Þ—Ç.

723875. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) OTOFˆâ“`Žq•ÏˆÙ‚ð”F‚ß‚éAuditory neuropathy spectrum disorder
‚Ì“û—cŽ™—á‚É‚š‚¯‚élH“àŽš‘•—pŒø‰Ê. ‘匎‘ìÆ1, –{‘º•üŽq, Žç–{—ÏŽq, ‘×’nGM, Œ‰i’B—Y (1Žš•@):
‘æ55‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/11), “Þ—Ç.

723876. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •â’®Ší—Œ—p‘•—pŒø‰Ê‚ÌŒŸ“¢?ƒtƒBƒbƒeƒBƒ“ƒO’ŒŒã‚̉ۑ肚‚æ‚Ñ, ŽŽ
’®Œã‚ÌŽ¿–⎆‚É‚š‚¯‚é•]‰¿?. ‘åÀKŒb1, ˆäã—ŠG, ŒŽ@—R‹I, —é–ØŒbŽq, Œ•œ“oŽu³, “n•Ó—T”V1, ‘å
‹ŽŒ’‘Ÿ˜Y1, ’–@Œ’Žu, ²–ì@”£1, ‰ª–{–ql1 (1Žš•@): ‘æ55‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï
(2010/11/12), “Þ—Ç.

723877. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •â’®‚É‚æ‚é‰ï˜bƒŒƒxƒ‹‚̌ꉹ–Ÿ—Ä“x‚̉ü‘P. Œ•œ“oŽu³, ŒŽ@—R‹I,
—é–ØŒbŽq, ‘åÀKŒb1, ˆäã—ŠG, ‘å‹ŽŒ’‘Ÿ˜Y1, “n•Ó—T”V1, ²–ì@”£1, ‰ª–{–ql1 (1Žš•@): ‘æ55
‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/12), “Þ—Ç.

723878. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’®Šod•¡áŠQŽ™‚ÌŽw“±E—Èçæ‚ÉŠÖ‚·‚éŽÀ‘Ô’²ž. ¡ˆä—T–íŽq, ²
“¡—TŽq, ‘×’nGM, Žç–{—ÏŽq, –{‘º•üŽq, ‘匎‘ìÆ1 (1Žš•@): ‘æ55‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰
‰ï (2010/11/12), “Þ—Ç.

723879. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Œy“xE’†“™“x“ï’®Ç—á75—á‚ÌŒŸ“¢. Žç–{—ÏŽq, ²“¡—TŽq. –{‘º•ü
Žq, ¡ˆä—T–íŽq, ‘匎‘ìÆ1, ‘×’nGM (1Žš•@): ‘æ55‰ñ“ú–{’®ŠoˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/12),
“Þ—Ç.

723880. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒƒjƒG[ƒ‹•a‚Æ“Ë”­«“ï’®‚ÌŒŒˆ³’l‚ÌŒŸ“¢. ‰Á”[Fˆê1, ’·À‰p–Ÿ
1, —Ž‡@“Ö1, “¿‘Œú“ñ, ‰ª–{–ql1 (1Žš•@): ‘æ69‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï
(2010/11/18), ‹ž“s.

723881. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Ò‘¬”]•Ï«Ç‚É‚š‚¯‚éTRH-T—Ö@‚̏dS“®—hŒŸž‚É‚æ‚é’ZŠúŠÔ•]
‰¿. ‘ºŽR^‹|, ˆÉ•ÛŽŽq, ó–ì˜a], ¬”Š@i, –F“c‚ЂƂÝ, ˆ¢‹v’ÓñŽO•v2, ’·À‰p–Ÿ1, “¿‘Œú“ñ, ‰ª
–{–ql1 (1Žš•@, 2_Œo“à): ‘æ69‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/18), ‹ž“s.

723882. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™Langerhans cell histiocytosis (LCH) Ç—á‚É‚š‚¯‚é•œtáŠQ
‚ÌŒŸ“¢. ‘匎‘ìÆ1, ŒÜ“‡Žjs, Žç–{—ÏŽq, –{‘º•üŽq, ‘×’nGM (1Žš•@): ‘æ69‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw
‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/18), ‹ž“s.

723883. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ãŠááٌü‚«ŠáU‚ðŽŠ‚µ‚œWernicke”]Ç—á. —Ž‡@“Ö1, ’·À‰p–Ÿ
1, “¿‘Œú“ñ, ‰Á”[Fˆê1, ‰ª–{–ql1 (1Žš•@): ‘æ69‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï
(2010/11/18), ‹ž“s.

723884. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒƒjƒG[ƒ‹•a‚ɑ΂·‚鐅•ªÛŽæ—Ö@‚É‚š‚¯‚éˆù…•û–@‚ÌŒŸ“¢?ˆù…
Œv‰æƒpƒ“ƒtƒŒƒbƒg‚Ì—LŒø«?. Šâ‰º—T—¢, ¬“cŒŽ–Œ•à, ‚“c’qŽq, ’·À‰p–Ÿ1, —Ž‡@“Ö1, ‰ª–{–ql
1, ”ª“c‹žŽq (1Žš•@): ‘æ69‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/18), ‹ž“s.

723885. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒƒjƒG[ƒ‹•a‚ɑ΂·‚鐅•ªÛŽæ—Ö@‚É‚š‚¯‚éˆù…•û–@‚ÌŒŸ“¢. ¬“c
ŒŽ–Œ•à, Šâ‰º—T—¢, ‚“c’qŽq, ’·À‰p–Ÿ1, —Ž‡@“Ö1, ‰ª–{–ql1, ”ª“c‹žŽq (1Žš•@): ‘æ69‰ñ“ú–{
‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/18), ‹ž“s.

723886. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŽÀŒ±“IArg-Vasopressin“Š—^“®•šƒ‚ƒfƒ‹‚É‚š‚¯‚é嗋ŒŒŠÇð‚ÌŒ`‘Ô
•Ï‰»?¶‰E·‚ÌŒŸ“¢?. ’·À‰p–Ÿ1, ‰ÍŒŽŽ‰ë2, ²“¡—º•œ2, “¿‘Œú“ñ, —Ž‡@“Ö1, ‰Á”[Fˆê1, ‰ª–{
–ql1 (1Žš•@, 2¶—): ‘æ69‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ïEŠwpu‰‰‰ï (2010/11/18), ‹ž“s.

723887. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) A“ªˆŸ‘S“EoÇ—á‚É‚š‚¯‚éDelphian nodeŒŸõ‚̈Ӌ`. ’†ŽR–Ÿm
1, ‰ª–{—·l1, Ž–ì—R”y1, ‹{–{r•ã1, ‰ª–{–ql1 (1Žš•@): ‘æ21‰ñ“ú–{“ªèò•”ŠO‰ÈŠw‰ï‚È‚ç‚Ñ‚ÉŠwp
u‰‰‰ï (2011/1/27), ‰F“s‹{.

723888. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒoŒûäS–@ (Transoral Lateral Oropharyngectomy) ‚É‚æ‚é‘€•ÇŒ^’†
ˆô“ªŠà‚ÌŽèpŽ¡—Â̗˜“_‚Æ–â‘è“_. Ž–ì—R”y1, ’†ŽR–Ÿm1, ’|“c¹•F1, ‰ª–{—·l1, ‰ª–{–ql1 (1Žš
•@): ‘æ21‰ñ“ú–{“ªèò•”ŠO‰ÈŠw‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2011/1/27), ‰F“s‹{.

723889. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) œ‰sú‚𑜗p‚µ‚œ•@“à‘O“ª“ŽŽèp. —é–Ø—§r1, ‰ª–{–ql1, —с@­
ˆê1, ‰Á”[Fˆê1, ’†ì‹Mm1 (1Žš•@): ‘æ21‰ñ“ú–{“ªèò•”ŠO‰ÈŠw‰ï‚È‚ç‚Ñ‚ÉŠwpu‰‰‰ï (2011/1/28), ‰F
“s‹{.

731127. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒAƒŒƒ‹ƒM[«•@‰Š‚Ì“®Œü‚ɂ‚¢‚Ä. Îˆä–L‘Ÿ (Žš•@): ‘Š
Žš‰ï‹L”Ou‰‰‰ï (2010/4/11), “Œ‹ž.

731128. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) “Ë”­«“ï’®‚ÆŽü•ÓŽŸŠ³. ‰ª–{–ql (Žš•@): •œ¬21”N“x
“¿“‡Œ§Žš•@ˆôA‰Èˆã‰ï‘‰ï‹y‚Ñ‘æ113‰ñˆã‰ïŒ€C‰ï (2010/4/18), “¿“‡.

731129. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) lŠÔƒhƒbƒOŽófŽÒ‚̏ƒ‰¹’®—Í?‰Á—î•Ï‰»‚âHbA1C‚Æ‚ÌŠÖ
ŒW‚ɂ‚¢‚Ä?. ‘å‹ŽŒ’‘Ÿ˜Y (Žš•@): ‘Š–ÍŒŽŽsˆãŽt‰ïŽš•@‰Èˆã‰ïu‰‰‰ï (2010/6/24), ‘Š–ÍŒŽ.

731130. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‰‰ñŽ¡—ÂƂµ‚ăTƒCƒo[ƒiƒCƒt—Ö@‚ðŽ{s‚µ‚œ“ªèò•”ˆ«
«Žîá‡12Ç—á (13•a•Ï) ‚ÌŒŸ“¢. Œ–؁@’ (Žš•@): ‘æ19‰ñ–k—¢Žš•@ˆôA‰ÈŒ€‹†‰ï (2010/10/23), ‘Š
–ÍŒŽ.

731131. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒTƒ‹ƒx[ƒWŽ¡—ÂƂµ‚ẴTƒCƒo[ƒiƒCƒtŽ¡—Â̌Ÿ“¢. ¬
ìˆŸŠóŽq (Žš•@): ‘æ19‰ñ–k—¢Žš•@ˆôA‰ÈŒ€‹†‰ï (2010/10/23), ‘Š–ÍŒŽ.

731132. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Žš‰È—̈æ‚̉ð–U‚ƃƒjƒG[ƒ‹•a‚ɂ‚¢‚Ä?ÅVŽ¡—Ã?.
’·À‰p–Ÿ (Žš•@): •œ¬22”N“x_“ސ쌧—Տ°‰q¶ŒŸž‹ZŽt‰ï¶—Œ€‹†”Ç•œt’®Šoê–åƒOƒ‹[ƒvuK‰ï
(2010/11/25) ‰¡•l.

731133. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •â’®Ší“K‡ŒŸž‚ÌŽwj. ‰ª–{–ql (Žš•@): •â’®Ší‘Š’k
ˆãXV‚Ì‚œ‚߂̍uK‰ï (2010/10/30), ‹{è.

731134. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒAƒŒƒƒbƒNODù”­”„‹L”Ou‰‰. —é–Ø—§r (Žš•@): ƒAƒŒ
ƒƒbƒNODù”­”„‹L”Ou‰‰‰ï (2011/2/3) ‚Œ.

731135. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚铪èò•”Šàf—Ã?‚Æ‚­‚ɉºˆô“ªŠà‚É
‚‚¢‚Ä?. ‰ª–{–ql (Žš•@): ‘æ10‰ñŽO‰Y˜A‡Žš•@ˆôA‰Èˆã‰ï (2011/2/19), ‰¡{‰ê.

732110. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Žs–¯ŒöŠJuÀ)yŠŽŠoŠíuŽ‹Šo‚Æ’®Šov‚ƎЉï‚̂‚Ȃª‚èz•â’®Ší?
’²®‚ƍw“ü‚ð‚ß‚®‚Á‚Ä?. ‰ª–{–ql (Žš•@):Žs–¯ŒöŠJuÀ (2010/8/10), “Œ‹ž.

732111. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€) –k—¢‘åŠw‚É‚š‚¯‚éuƒI[ƒ‹–k—¢ƒ`[ƒ€ˆã—ɉKv‚Ì
ŠT—e. ‰ª–{–ql (Žš•@): ‘œEŽí˜AŒg‹³ˆçƒVƒ“ƒ|ƒWƒEƒ€ (2011/3/12), “Œ‹ž.

733409. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰–Šî«üˆÛ‰è×–E‘BˆöŽq (b-FGF) ‚ð—p‚¢‚œŽ©‰Æ‹Ø–ŒˆÚ
A‚Ì‘gDŠw“IŒŸ“¢?ƒ‰ƒbƒg‚̉ºŽˆ‹Ø‚ð—p‚¢‚Ä?. ‰iˆä_–€ (Žš•@):‘ŠŽš‰ï‹L”Ou‰‰‰ï2010/4/11), “Œ‹ž.

733410. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) —‘z“I‚ȍRƒqƒXƒ^ƒ~ƒ“–ò‚ðl‚Š‚é. —é–Ø—§r (Žš•@): ƒA
ƒŒƒ‹ƒM[«ŽŸŠ³Ž¡—Êwpu‰‰‰ï(2010/4/22), ‘Š–ÍŒŽ.

733411. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —‘z“I‚ȍRƒqƒXƒ^ƒ~ƒ“–ò‚ðl‚Š‚é. —é–Ø—§r
(Žš•@): ƒAƒŒƒOƒ‰”­”„10Žü”N‹L”Ou‰‰‰ï (2010/4/22), ‘Š–ÍŒŽ.

733412. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆ««Žîᇂª‹^‚í‚ê‚œèò•”•úŽË‹ÛÇ‚̈ê—á. ‰Á”[Fˆê1, Ž
–ì—R”y1, –q–슰”V1, ‰ª–{–ql1 (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ152‰ñŽš•@ˆôA‰ÈE
“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2010/6/12), ‰¡•l.

733413. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Narrow Band Imaging “àŽ‹‹Ÿ‚ōA“ª“û“ªŽî‚ðŠg‘åŠÏŽ@‚µ
‚œ2—á. ³˜Ò@—² (Žš•@): ‘æ7‰ñ“ªèò•”•\ÝŠàŒ€‹†‰ï (2010/6/12), “Œ‹ž.

733414. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒŒƒ‹ƒM[«•@‰Š‚ÌŽ¡—Ð헪. —é–Ø—§r (Žš
•@): ‘æ17‰ñ•œ’ËŽsE’†ŒSŽš•@ˆôA‰Èˆã‰ïŠwpu‰‰‰ï (2010/6/19), •œ’Ë.

733415. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒKƒCƒhƒ‰ƒCƒ“‚ɏ€‚¶‚œ¬Ž™‹}«’†Žš‰ŠŽ¡—ÂÌ
ŽÀÛ. —é–Ø—§r (Žš•@): ‘æ4‰ñ‘Š–ÍŒŽ@DRIAOMSu‰‰‰ï (2010/6/29), ‘Š–ÍŒŽ.

733416. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒKƒCƒhƒ‰ƒCƒ“‚ɏ€‚¶‚œ¬Ž™‹}«’†Žš‰ŠŽ¡—Â̎ÀÛ. —é–Ø
—§r1, ‰ª–{–ql1 (1Žš•@): ‘æ4‰ñ‘Š–ÍŒŽDRIAMOSŒ€‹†‰ï (2010/6/29), ‘Š–ÍŒŽ.

733417. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) A“ªŠà‚ɑ΂·‚éA“ªˆŸ‘S“EpŒã‚Ì‹@”\•]‰¿?3ŽŸŒ³CT‚É
‚æ‚é•]‰¿‚𒆐S‚É?. Ž–ì—R”y (Žš•@): ‘æ74‰ñ‘Š•Žš•@‰ÈŒ€‹†‰ï (2010/7/10), ‘Š–ÍŒŽ.

733418. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) š‹‰ºáŠQ‚̗Տ°?f’f‚ƃŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“?. —é–Ø—§
r1, ‰ª•”‘•c (1Žš•@): ‘æ74‰ñ‘Š•Žš•@‰ÈŒ€‹†‰ï (2010/7/10), ‘Š–ÍŒŽ.

733419. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) •›•@opŒãœ«•ÂœÇ—á‚É‚š‚¯‚éƒiƒrƒQ[ƒVƒ‡ƒ“‰ºŽèp.
—é–Ø—§r (Žš•@): ‘æ23‰ñ_“ސ쌧Žš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŽèpŽè‹ZŒ€‹†‰ï (2010/7/15), ‰¡•l.

733420. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹}«’†Žš‰Šf—Âɑ΂·‚錻ó’²ž. —é–Ø—§r1, ‰ª–{–q
l1 (1Žš•@): ‘æ40‰ñ“ú–{Žš•@ˆôA‰ÈŠŽõÇŒ€‹†‰ïEŠwpu‰‰‰ï, ‘æ34‰ñ“ú–{ˆã—pƒGƒAƒƒ]ƒ‹Œ€‹†‰ï
(2010/9/3), –ŒŒÃ‰®.

733421. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) •@’†Šu‘œŒ`üŽî‚Ì1—á. ‰Pˆä‘å—S1, ”ª”ö˜a—Y, ŒIŒŽ—¢
‰À (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ153‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï
(2010/9/11), ‰¡•l.

733422. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “ûŽ™ãªùN–E‚Ì1—á. ×–ì_Žj1, ³˜Ò@—²1, –q–슰
”V1, ‰ª–{–ql1 (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï‘æ153‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwp
u‰‰‰ï (2010/9/11), ‰¡•l.

733423. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ÆŽËŒãÄ”­A“ªŠà‚ɑ΂·‚éA“ªˆŸ‘S“Eop. ’†ŽR–Ÿm
1, ‰ª–{—·l1, Ž–ì—R”y1, ‹{–{r•ã1, ‰ª–{–ql1 (1Žš•@): ‘æ3‰ñA“ª‹@”\‰·‘¶Ž¡—ÃŒ€‹†‰ï (2010/9/18),
“Œ‹ž.

733424. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) u‚«‚±‚Š‚ɂ‚¢‚Ä‚ÌŽ¿–⎆2002v‚É‚æ‚é’®ŠoáŠQ‚ÌŽåŠÏ
•]‰¿. —é–ØŒbŽq, ŒŽ@—R‹I, ‰ª–{–ql1, ²–ì@”£1, —é–Ø–q•F, ˆäã—ŠG, ‘åÀKŒb1 (1Žš•@): “ú–{
’®ŠoˆãŠw‰ï‘æ33‰ñ•â’®Œ€‹†‰ï (2010/11/12), “Þ—Ç.

733425. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŒoŒûo–@ (Transoral Lateral Oropharyngectomy) ‚É‚æ
‚é‘€•ÇŒ^’†ˆô“ªŠà‚ÌŽèpŽ¡—Ã. Ž–ì—R”y (Žš•@): ‘æ50‰ñ“ªèò•”ŠàŽ¡—ÃJƒ“ƒtƒ@ƒŒƒ“ƒX (2010/11/19),
‰¡•l.

733426. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Œ‹ãF–@‚É‚ÄŽ¡—µ‚œ¬Ž™ã‰»”^«“÷‰èŽî‚Ì1—á. ’†ì‹M
m1, ’†ŽR–Ÿm1, ‰ª–{—·l1, ‰Á”[Fˆê1, ‰ª–{–ql1 (1Žš•@): “ú–{Žš•@ˆôA‰ÈŠw‰ï_“ސ쌧’n•û•”‰ï
‘æ154‰ñŽš•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŠwpu‰‰‰ï (2010/12/4), ‰¡•l.

733427. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •@ƒAƒŒƒ‹ƒM[Ž¡—Öò‚̍ŋ߂̍l‚Š•û. —é–Ø—§
r (Žš•@): ìèŽsŽš•@ˆôA‰ÈƒZƒ~ƒi[ (2010/12/4), ìè.

733428. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •@ƒAƒŒƒ‹ƒM[Ž¡—Öò‚̍ŋ߂̍l‚Š•û. —é–Ø—§
r (Žš•@): Šƒ–èŽš•@ˆôA‰Èˆã‰ï (2010/12/12), ’Ò“°.

733429. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚ß‚Ü‚¢‚̗Տ°. —Ž‡@“Ö (Žš•@): ¶ŠˆKŠµ
•a‚ðl‚Š‚é‰ï (2011/1/13), ‘Š–ÍŒŽ.

733430. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ªèò•”•\ÝŠà‚̍ŋ߂̓®Œü. Œ—tG‹N (Žš•@):
‘Š–ÍŒŽŽsˆãŽt‰ïŽš•@‰Èˆã‰ï (2011/1/20), ’¬“c.

733431. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Ë”­«“ï’®grade4‚̏Ǘá‚ɑ΂·‚éƒXƒeƒƒCƒh
ŒÛŽº“à’“ü‚ÌŒŸ“¢. “n•Ó—T”V (Žš•@): ‘Š–ÍŒŽŽsˆãŽt‰ïŽš•@‰Èˆã‰ï (2011/1/20), ’¬“c.

733432. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽÀŒ±“IAeg-Vasopressin“Š—^“®•šƒ‚ƒfƒ‹‚É‚š
‚¯‚é嗋ŒŒŠÇð‚ÌŒ`‘ԕω»D?Vasopressin V2-receptorhR–ò‚̉e‹¿?. ’·À‰p–Ÿ1, ‰ÍŒŽŽ‰ë2, “¿
‘Œú“ñ, ²“¡—º•œ2, —Ž‡@“Ö1, ‰ª–{–ql1 (1Žš•@, 2¶—):uŒú¶˜J“­È@“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æv
‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†”Ç•œ¬22”N“x•ñ‰ï (2011/1/22), “Œ‹ž.

733433. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒjƒG[ƒ‹•a‚Æ“Ë”­«“ï’®‚ÌŒŒˆ³’l‚ÌŒŸ“¢. ‰Á
”[Fˆê1, ’·À‰p–Ÿ1, —Ž‡@“Ö1, “¿‘Œú“ñ, ‰ª–{–ql1 (1Žš•@):uŒú¶˜J“­È@“«ŽŸŠ³Ž•žŒ€‹†
Ž–‹Æv‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†”Ç•œ¬22”N“x•ñ‰ï (2011/1/22), “Œ‹ž.

733434. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ––œ‘O’됫ŽŸŠ³‚É‚š‚¯‚éComputerized Dynamic
Posturography. —Ž‡@“Ö1, ’·À‰p–Ÿ1, “¿‘Œú“ñ, ‰ª–{–ql1 (1Žš•@):uŒú¶˜J“­È@“«ŽŸŠ³Ž
•žŒ€‹†Ž–‹Æv‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†”Ç•œ¬22”N“x•ñ‰ï (2011/1/22), “Œ‹ž.

733435. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒjƒG[ƒ‹•a‚ɑ΂·‚鐅•ªÛŽæ–@‚É‚š‚¯‚éˆù
…•û–@‚ÌŒŸ“¢. ¬“cŒŽ–Œ•à, Šâ‰º—T—¢, ‚“c’qŽq, ’·À‰p–Ÿ1, —Ž‡@“Ö1, ‰ª–{–ql1, ”ª“c‹žŽq (1
Žš•@):uŒú¶˜J“­È@“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æv‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†”Ç•œ¬22”N“x•ñ‰ï
(2011/1/22), “Œ‹ž.

733436. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŒoŒûäS–@ (Transoral Lateral Oropharyngectomy) ‚É‚æ
‚é‘€•ÇŒ^’†ˆô“ªŠà‚ÌŽèpŽ¡—Ã. Ž–ì—R”y (Žš•@): ‘æ20‰ñ–k—¢ŽîᇃtƒH[ƒ‰ƒ€ (2011/1/28), –k—¢.

733437. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “«“àŽšŽŸŠ³‚̈â“`Žqƒoƒ“ƒN\’z?“Ë”­«
“àŽš“ï’®‚̈â“`Žqƒoƒ“ƒNƒvƒƒWƒFƒNƒg?. Œ”öMÆ, ‹S“ª—Ç•ã, H@@õ, ‰F²”ü^ˆê, ¬ì@ˆè, ‰ª
–{–ql1, Šì‘œ‘ºŒ’, ‹Å@Ž•¶, ²“¡Gº, ’†“‡@–±, •Ÿ“‡–M”Ž, •Ÿ“c@—@, …“c–M”Ž, ŽR‘Z’B–ç (1Žš
•@): •œ¬22”N“x‘æ2‰ñŒú¶˜J“­È‹}«‚“x“ï’®’²žŒ€‹†”ljï‹c (2011/2/12), “Œ‹ž.

733438. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Ë”­«“ï’®‚Ì”­¶ó‹µ‚Æ”­Ç‘O‚̃XƒgƒŒƒXó
‹µ‚ÉŠÖ‚·‚é—\”õ’²ž. ²–ì@”£1, ‘å‹ŽŒ’‘Ÿ˜Y1, ’–@Œ’Žu, ‰ª–{–ql1 (1Žš•@): •œ¬22”N“x‘æ2‰ñ
Œú¶˜J“­È‹}«‚“x“ï’®’²žŒ€‹†”ljï‹c (2011/2/12), “Œ‹ž.

733439. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “Ë”­«“ï’®‚̏Ǐó, QOL, ƒnƒ“ƒfƒBƒLƒ…ƒbƒv’²
ž‚Ì‹€“¯Œ€‹†. ‘å‹ŽŒ’‘Ÿ˜Y1, ²–ì@”£1, ’–@Œ’Žu, ¬–ì—Yˆê, ‰ª–{–ql1 (1Žš•@): •œ¬22”N“x‘æ2
‰ñŒú¶˜J“­È‹}«‚“x“ï’®’²žŒ€‹†”ljï‹c (2011/2/12), “Œ‹ž.

733440. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹}«’ቹáŠQŒ^ŠŽ‰¹“ï’®‚Ì’PÜŽ¡—ÃŽ¡Œ±‚ÌŒ‹
‰Ê. ˆäã‘׍G, ¬ì@ˆè, ‰F²”ü^ˆê, ‰ª–{–ql1, Šì‘œ‘ºŒ’, ‹Å@Ž•¶, ²“¡Gº, ’†“‡@–±, •Ÿ“‡–M
”Ž, •Ÿ“c@—@, …“c–M”Ž, ŽR‘Z’B–ç (1Žš•@): •œ¬22”N“x‘æ2‰ñŒú¶˜J“­È‹}«‚“x“ï’®’²žŒ€‹†”ljï
‹c (2011/2/12), “Œ‹ž.

733441. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒŒƒ‹ƒM[«•@‰Š‚ɑ΂·‚é‘æ2¢‘ãRƒqƒXƒ^
ƒ~ƒ“–ò‚ÌŽg—p–@‚ɂ‚¢‚Ä?ƒAƒŒƒOƒ‰‚𒆐S‚É?. ’|“c¹•F (Žš•@): ƒAƒŒƒ‹ƒM[ŽŸŠ³‚É‚š‚¯‚鎡—Ð헪‚É
ŠÖ‚·‚éÀ’k‰ï (2011/2/17), ‰¡•l.

733442. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰)yŽš‚©‚ç‚­‚é‚ß‚Ü‚¢, ‚Ó‚ç‚‚«, Žš–Â?¶ŠˆKŠµ‚Æ‚ÌŠÖ˜A
?zƒƒjƒG[ƒ‹•aƒRƒ“ƒgƒ[ƒ‹‚Ì‚œ‚߂̐…•ªÛŽæ—Ö@. ’·À‰p–Ÿ (Žš•@): Œú¶˜J“­‰ÈŠwŒ€‹†EŒ€‹†¬‰Ê
“™•‹yŒ[”­Ž–‹Æ‚É‚æ‚鐬‰Ê”­•\‰ï (2011/2/18), –ŒŒÃ‰®.

733443. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ï’®‚̈â“`Žqf’f‚ÌŒ»ó‚š‚æ‚ÑŽÀÛ‚̏Ǘá‚É
‚‚¢‚Ä. ²–ì@”£ (Žš•@): ‘æ117‰ñ“ï’®ŒŸŒêáŠQŒ€‹†‰ï (2011/2/26), ‰¡•l.

733444. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒjƒG[ƒ‹•a‚ɑ΂·‚鐅•ªÛŽæ—Ö@‚ɂ‚¢‚Ä.
’·À‰p–Ÿ (Žš•@): ˆ€’mŒ§Žš•@ˆôA‰Èˆã‰ï“ŒŒŽO‰Í’n‹æŒ€C‰ï (2011/3/19), –L‹ŽŽs.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-540021. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O
’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²žŒ€‹†vz“«“àŽšŽŸŠ³‚̈â“`Žqƒoƒ“ƒN\’z. ‰F²”ü^ˆê1, H@@õ1, ‹S“ª
—Ç•ã1, Œ”öMÆ1, ¬ì@ˆè2, “n•Ós—Y3, Šì‘œ‘ºŒ’4, ’†“‡@–±5, ‰ª–{–ql6, ‹Å@Ž•¶7, •Ÿ“c@˜_
8, ²“¡Gº9, ŽR‘Z’B–ç10, •Ÿ“‡–M”Ž11, …“c–M”Ž12, ’r‰€“N˜Y13, ˆÉ“¡Žõˆê14, Š`–؏͐L10, ”ì’ˁ@
ò15, —é–؁@‰q16, ‚‹ŽŽ¹17, H“c¹–ç18, •“cŒ›º19, “yˆäŸ”ü20, ŽR‰º—TŽi21, ‚‹Ž³h22, Â
–ØŒõL23, ’·À‰p–Ÿ6 (1MB‘å, 2Œcœä‘å, 3•xŽR‘å, 4“Œ‹žˆãŽ•‘å, 5–ŒŒÃ‰®‘å, 6Žš•@, 7ˆ€•Q‘å, 8
–kŠC“¹‘å, 9ŠâŽèˆã‘å, 10“Œ‹ž‘å, 11‰ªŽR‘å, 12•lŒˆã‘å, 13“ú–{ˆã‘å, 14‹ž“s‘å, 15¹ƒ}ƒŠƒAƒ“ƒiˆã
‘å, 16“Œ‹žˆã‘å, 17ŒQ”n‘å, 18L“‡‘å, 19“¿“‡‘å, 20‘åã‘å, 21ŽRŒû‘å, 22‚ß‚Ü‚¢ƒƒjƒG[ƒ‹•aƒZƒ“
ƒ^[, 23Šò•Œ‘å): Œú¶˜J“­È‰ÈŠwŒ€‹†”ï•â•‹à (“«ŽŸŠ³Ž•žŒ€‹†Ž–‹Æ)u‘O’ë‹@”\ˆÙí‚ÉŠÖ‚·‚é’²ž
Œ€‹†v•œ¬21”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2010/3; p.108-11.


ž_‰ÈŠw

[Šwp˜_•¶]

110241. [ŒŽ’˜] Association between autism and variants in the wingless-type MMTV integration site
family member2 (WNT2) gene. Marui T, Funatogawa I, Koishi S, Yamamoto K1, Matsumoto H, Hashimoto
O, Jinde S, Nishida H, Sugiyama T, Kasai K, Watanabe K, Kano Y, Kato N: Int J Neuropsychopharmacol
2010/5; 13 (4): 443-9. (ŽR–{Œ«Ži1: 1ž_)

110242. [ŒŽ’˜] Similarity in predictors between near miss and adverse event among Japanese nurses
working at teaching hospitals. Tanaka K1, Otsubo T, Tanaka M, Kaku A, Nishinoue N, Takanao T,
Kamata N, Miyaoka H2: Ind Health 2010/6; 48 (6): 775-82. (“c’†Žr1, ‹{‰ª@“™2: 1‘åŠw‰@ˆã—ÃŒn
Œ€‹†‰È, 2ž_)

110243. [ŒŽ’˜] Exploration of factors related to hara-kiri as a method of suicide and suicidal
behavior. Takai M, Yamamoto K1, Iwamitsu Y2, Miyaji S, Yamamoto H1, Tatematsu S1, Yukawa M1, Ide
A1, Kamijo Y3, Soma K3, Miyaoka H1: Eur Psychiatry 2010/11; 25 (7): 409-13. (ŽR–{Œ«Ži1, Šâ–ž—D
”ü2, ŽR–{G–Ÿ1, —§Œ¹ˆê1, “’ì^”ü1, ˆäo•¶Žq1, ãžŠ‹gl3, ‘Š”nˆêˆå3, ‹{‰ª@“™1: 1ž_, 2
‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3‹~–œ)

110244. [ŒŽ’˜] The Effect of Interpersonal Touch During Childhood on Adult Attachment and
Depression: A Neglected Area of Family and Developmental Psychology ?. Takeuchi M.S, Miyaoka H1,
Tomoda A, Suzuki M, Liu Q, Kitamura T: J Child Fam Stud 2010; 19 (1): 109-17. (‹{‰ª@“™1: 1ž
_)

110245. [ŒŽ’˜] Predictors of psychological distress after diagnosis in breast cancer patients and
patients with benign breast problems. Ando N, Iwamitsu Y1, Kuranami M2, Okazaki S, Nakatani Y,
Yamamoto K3, Watanabe M2, Miyaoka H3: Psychosomatics 2011/1-2; 52 (1): 56-64. (Šâ–ž—D”ü1, ‘ •À@
Ÿ2, ŽR–{Œ«Ži3, “n粏¹•F2, ‹{‰ª@“™3: 1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 3ž_)

110246. [ŒŽ’˜] Validity and reliability of the Japanese version of the Temperament and Character
Inventory: a studyof university and college students. Takeuchi M, Miyaoka H1, Atsuko Tomoda A,
Suzuki M, Xi Lu, Kitamura T: Compr Psychiatry 2011/1-2; 52 (1): 109-17. (‹{‰ª@“™1: 1ž_)

110247. [ŒŽ’˜] The NADH-ubiquinone oxidoreductase 1 alpha subcomplex 5 (NDUFA5) gene variants are
associated with autism. Marui T, Funatogawa I, Koishi S, Yamamoto K1, Matsumoto H, Hashimoto O,
Jinde S, Nishida H, Sugiyama T, Kasai K, Watanabe K, Kano Y, Kato N: Acta Psychiatr Scand 2011/2;
123 (2): 118-24. (ŽR–{Œ«Ži1: 1ž_)

110248. [ŒŽ’˜] The subtype classifications and characteristics of chronic depression. Hisamura
M1, Yamaguchi S1, Maruta S1, Yoshimura Y1, Tanaka K2, Miyaoka H1: The Kitasato Medical Journal
2011/3; 41 (1): 1-9. (‹v‘º³Ž÷1, ŽRŒû¹Žq1, ŠÛ“cCŽj1, ‹g絋`F1, “c’†Žr2, ‹{‰ª@“™1: 1ž
_, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

120076. [ŒŽ’˜] ‡–°‚ƃXƒgƒŒƒXƒR[ƒsƒ“ƒO?‘åŠw¶‚ÌŒ’N’²ž‚©‚ç?. ’†‘º—F”ü, ‘ºŒŒö”üŽq, ‹{‰ª@
“™1 (1ž_): ˆãŠw‚Ɛ¶•šŠw 2011/1; 155 (1): 48-52.

320044. [Ç—á•ñ] ƒlƒtƒ[ƒ[ÇŒóŒQ‚ÌŽ¡—Ã’†‚ɃXƒeƒƒCƒhž_•a‚𔭏ǂµ‚œŽ™“¶‚̈ê—á. H—t‘å•ã,
ˆäãŸ•v1, ‰ª“c¹•F, ˆÉ“¡³® (1ž_): ž_‰ÈŽ¡—Êw 2011/1; 26 (1): 95-8.

521027. [‰ðà] ƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“EƒŠƒGƒ]ƒ“EƒT[ƒrƒX (CLS) ‚É‚š‚¯‚éƒ`[ƒ€ˆã—ƒnˆæ˜AŒg. ŽR
–{Œ«Ži (ž_): _“ސìˆãŠw‰ïŽGŽ 2010/7; 37 (2): 165-9.

522130. [uÀ]y3. ”]”gŒŸžŽÀ’nƒR[ƒXzŠî‘b”g‚Ì”»“Ç. âV“¡³”Í (ž_): —Տ°_Œo¶—Šw 2010/4; 38
(2): 121-3.

522131. [uÀ]y“ÁW: ADHD—Տ°‚̐V“WŠJIzADHD‚͉ߏèf’f‚³‚ê‚Ä‚¢‚È‚¢‚©? ˆäãŸ•v (ž_): ž
_‰ÈŽ¡—Êw 2010/6; 25 (6): 757-64.

522132. [uÀ]yDSM-5ƒhƒ‰ƒtƒg‚ð‚Ç‚€l‚Š‚é‚©zDSM-5 ƒhƒ‰ƒtƒg‚É‚š‚¯‚éƒpƒjƒbƒNáŠQ, GAD, PTSD. ‘º
ŒŒö”üŽq, ‹{‰ª@“™1 (1ž_): ž_‰ÈŽ¡—Êw 2010/8; 25 (8): 1033-40.

522133. [uÀ]y“ÁW: •s’èD‘i‚ÌŽq‚Ç‚à‚ðf‚é‚œ‚߂ɁzII Çó‚ɉž‚¶‚œƒAƒvƒ[ƒ`@‘œÊ‚Ȑg‘̏D‘i
‚ª‘O–Ê‚ÉŒ»‚ê‚鐞_ŽŸŠ³. ˆäãŸ•v (ž_): ¬Ž™‰Èf—à 2011/1; 74 (1): 76-81.

530009. [‚»‚Ì‘Œ (’²ž•ñ)] The Relationship of Temperament and Character Dimensions to Perceived
Parenting Styles in Childhood: A Study of a Japanese University Student Population. Takeuchi,
MS, Miyaoka H1, Suzuki M, Tomoda A, Yokoo AI, Tsutsumida R, Kitamura T: The Open Family Studies
Journal 2011/2; 4: 9-14. (‹{‰ª@“™1: 1ž_)

540078. [‚»‚Ì‘Œ (‘“àŠw‰ïƒjƒ…[ƒX)] ‘æ25‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ïŠwp‘‰ï (‘æ27‰ñ“ú–{Â”NŠúž_—Ö@
Šw‰ï‘‰ï‡“¯‘å‰ï). ‹{‰ª@“™ (ž_): ŽY‹ÆˆãŠwƒWƒƒ[ƒiƒ‹ 2010/7; 33 (4): 39-41.

540079. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yž_E_Œo‰ÈŠwU‹»à’c•â•‹àzŽ©ŽEŠé}‚̍Ĕ­–hŽ~‚ɑ΂·‚é•¡‡“I
ƒP[ƒXEƒ}ƒlƒWƒƒ“ƒg‚ÌŒø‰Ê: ‘œŽ{Ý‹€“¯‚É‚æ‚é–³ìˆ×‰»”äŠrŽŽŒ±. •œˆÀ—Ç—Y, —L‰ê@“O, ‰ÍŒçH, “c
’†Ž–Ÿ, Žðˆä–Ÿ•v, œAíGl, ‹{‰ª@“™1, ’©“c@—², ŠÝ–{”NŽj, ‘å‹v•Û‘P˜N, ˆª‹gžŠ‘Ÿ˜Y, ™–{’BÆ, l
Œ©‰ÀŽ}, •–Ø‘¥b, –xì’ŒŽj, ŽO‘º@›’, ‘å’ˍk‘Ÿ˜Y, ŠâŒFº—m, åʓ¡’š–Ÿ, Šâ“c’‡¶, ‰Í–쌳Žk, ˆäã@
áÁ, ¬ì’©¶, ‰Á“¡‘厜, ì–쌒Ž¡ , â–{”ŽŽq, ²“¡—æŽq, ‘Ÿ“ìO˜a, ŽR–{Œ«Ži1, ãžŠ‹gl2, ’r‰º
ŽŽÀ, ˆÉ“¡Œh—Y, ’q“c•¶“¿, Œ‰ª@–L, ŽR“c•üŽ÷, ‰¡“c—Ts, Î’Ë’ŒŽ÷, ŽðˆäOŒ›, •Ä–{’Œ—T (1ž_, 2
‹~–œ): •œ¬21”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2010; p.28-40.

540080. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yž_E_Œo‰ÈŠwU‹»à’c•â•‹àuŽ©ŽE‘΍ô‚Ì‚œ‚߂̐헪Œ€‹†?Ž©ŽEŠé
}‚̍Ĕ­–hŽ~‚ɑ΂·‚é•¡‡“IƒP[ƒXEƒ}ƒl[ƒWƒƒ“ƒg‚ÌŒø‰Ê: ‘œŽ{Ý‹€“¯‚É‚æ‚é–³ìˆ×‰»”äŠrŒ€‹†vz‰î
“üƒvƒƒOƒ‰ƒ€ˆÏˆõ‰ïS—‹³ˆçƒvƒƒOƒ‰ƒ€ì¬‚Æ•W€‰»‚ÉŠÖ‚·‚é•ñ. ‘å’ˍk‘Ÿ˜Y, ‘Ÿ“ìO˜a, ŽR–{Œ«
Ži1, ì–쌒Ž¡, â–{”ŽŽq, ‘¥–{˜aL, ‰Á“¡‘厜, ™–{’BÆ, ‹g“c’q”V, ²“¡—æŽq, ª–{Ž‹M, lŒ©‰ÀŽ},
•œ—ÑŒcŽj, _’J”ü’qŽq, ì‘ºË‘ã, ‰º“cd˜N, ’†‘º@Œõ, •œ–ì‚Ý‚¬‚í, ŽR“c‘f•üŽq, ŽR“c”܍¹Žq, “yˆäŒŽ
ç•ä, ‰ÍŒçH (1ž_): uŽ©ŽE‘΍ô‚Ì‚œ‚߂̐헪Œ€‹†?Ž©ŽEŠé}‚̍Ĕ­–hŽ~‚ɑ΂·‚é•¡‡“IƒP[ƒXEƒ}
ƒl[ƒWƒƒ“ƒg‚ÌŒø‰Ê: ‘œŽ{Ý‹€“¯‚É‚æ‚é–³ìˆ×‰»”äŠrŒ€‹†vz•œ¬17-21”N“x‘‡Œ€‹†•ñ‘ 2010;
p.293-302.

540081. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yž_E_Œo‰ÈŠwU‹»à’c•â•‹àuŽ©ŽE‘΍ô‚Ì‚œ‚߂̐헪Œ€‹†?Ž©ŽEŠé
}‚̍Ĕ­–hŽ~‚ɑ΂·‚é•¡‡“IƒP[ƒXEƒ}ƒl[ƒWƒƒ“ƒg‚ÌŒø‰Ê: ‘œŽ{Ý‹€“¯‚É‚æ‚é–³ìˆ×‰»”äŠrŒ€‹†vz–k
—¢‘åŠw•a‰@. ‹{‰ª@“™1, ‘Š”nˆêˆå2, ãžŠ‹gl2, _œä’m“¹2, Šâ–ž—D”ü3, ŽR–{Œ«Ži1, ‹{’nLŒá1, ˆä
o•¶Žq1, âˆäŠì˜N3, ŽR–{G–Ÿ3, ¯–ìr–í3, “’ì^”ü3, ‚ˆä (_’J) ”ü’qŽq, —§Œ¹ˆê3 (1ž_, 2
‹~–œ, 3‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È):uŽ©ŽE‘΍ô‚Ì‚œ‚߂̐헪Œ€‹†?Ž©ŽEŠé}‚̍Ĕ­–hŽ~‚ɑ΂·‚é•¡‡“IƒP[ƒXE
ƒ}ƒl[ƒWƒƒ“ƒg‚ÌŒø‰Ê: ‘œŽ{Ý‹€“¯‚É‚æ‚é–³ìˆ×‰»”äŠrŒ€‹†v•œ¬17-21”N“x‘‡Œ€‹†•ñ‘ 2010;
p.367-73.

540082. [‚»‚Ì‘Œ (‘•])]uƒCƒ‰ƒXƒg”ÅŽ©•ÂÇ‚Ì‚Æ‚à‚Ÿ‚¿‚ð—‰ð‚·‚é–{?‚¢‚Á‚µ‚å‚ÉŠw‚Ô‚È‚©‚悵‰ž‰‡’c
?. ŒŽ@@m, ‚‹Ž‚ ‚ÂŽq (•Ò’˜), ‡“¯o”Łv. ˆäãŸ•v (ž_): Ž™“¶Â”Nž_ˆãŠw‚Æ‚»‚̋ߐڗ̈æ
2011/2; 52 (1): 81-2.

540083. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­È ž_E_ŒoŽŸŠ³Œ€‹†ŠJ”­”ï 20ˆÏ-5už_‰Èˆã—Âɂš‚¯‚é
”­’Bž_ˆãŠw“IŽx‰‡‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: _”ö—zŽq)vzˆê”ʐž_‰È‚ł̐¬l”­’BáŠQ—Տ°‚É‚š‚¯‚é
Ž™“¶ž_‰Èˆã‚É‚æ‚éf—ÃŽx‰‡‚ÉŠÖ‚·‚錀‹†. ˆäãŸ•v (ž_):yŒú¶˜J“­È ž_E_ŒoŽŸŠ³Œ€‹†ŠJ”­”ï
20ˆÏ-5už_‰Èˆã—Âɂš‚¯‚é”­’Bž_ˆãŠw“IŽx‰‡‚ÉŠÖ‚·‚錀‹†vz•œ¬20-22”N“x‘Š‡Œ€‹†•ñ‘ 2011/3;
p.68-70.

540084. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yž_E_ŒoŽŸŠ³Œ€‹†ŠJ”­”ïu‹C•ªáŠQ‚ÌŽ¡—ÃVƒXƒeƒ€‚ÌŠJ”­‚ÆŒŸØ‚É
ŠÖ‚·‚錀‹† (20ˆÏ-1 (_’ë”Ç))vz”]ŠíŽ¿«•Ï‰»‚𔺂€‚—îŽÒ‚Ì‚€‚•a‚̐f’f‚ÆŽ¡—ÂɊւ·‚éƒKƒCƒhƒ‰ƒC
ƒ“‚̍쐬. ‚‹Ž@Œb1, ’r“c‘Ÿˆê˜Y2, “cÀ—Ž‘Ÿ˜Y1, ‹{‰ª@“™1 (1ž_, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ž
_E_ŒoŽŸŠ³Œ€‹†ŠJ”­”ïu‹C•ªáŠQ‚ÌŽ¡—ÃVƒXƒeƒ€‚ÌŠJ”­‚ÆŒŸØ‚ÉŠÖ‚·‚錀‹†v•œ¬20-22”N“x‘Š‡Œ€‹†
•ñ‘ 2011/3; p.93-8.

540085. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yž_E_ŒoŽŸŠ³Œ€‹†ŠJ”­”ïuÛHáŠQ‚̉uŠw, •a‘ԂƐf’f, Ž¡—Ö@, “]
‹A‚Æ—\Œã‚ÉŠÖ‚·‚鑍‡“IŒ€‹† (20ˆÏ-2 (Ø’r”Ç))vzdÇ_Œo«–³H—~Ç‚Ì•W€“IŽ¡—ÂɊւ·‚錀‹†. ‚
‹ŽŒb—1, ‹{‰ª@“™1 (1ž_):uÛHáŠQ‚̉uŠw, •a‘ԂƐf’f, Ž¡—Ö@, “]‹A‚Æ—\Œã‚ÉŠÖ‚·‚鑍‡“IŒ€‹†v
•œ¬20-22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.49-51.

540086. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†•â•‹à@–ƉuƒAƒŒƒ‹ƒM[ŽŸŠ³—\–hEŽ¡—ÃŒ€‹†Ž–‹Æ (–Æ
‰uƒAƒŒƒ‹ƒM[•ª–ì)uüˆÛ‹Ø’ɏǂ̔­Ç—vˆö‚̉𖟋y‚ÑŽ¡—ÃVƒXƒeƒ€‚ÌŠm—§‚Æ•]‰¿‚ÉŠÖ‚·‚錀‹†vzg‘̏Š
Œ©‚ÉŒ©‡‚í‚È‚¢’É‚Ý‚ð‘i‚Š‚éÇ—á‚̐ž_‰Èf’f‚ÆŒüž_–ò‚ÌŒø‰Ê. ‹{‰ª@“™1, ‹{’n‰p—Y1, —«@Œ[Ž÷1,
Vˆäh‘Ÿ˜Y1 (1ž_): Œú¶˜J“­‰ÈŠwŒ€‹†•â•‹à@–ƉuƒAƒŒƒ‹ƒM[ŽŸŠ³—\–hEŽ¡—ÃŒ€‹†Ž–‹Æ (–ƉuƒAƒŒƒ‹
ƒM[•ª–ì)uüˆÛ‹Ø’ɏǂ̔­Ç—vˆö‚̉𖟋y‚ÑŽ¡—ÃVƒXƒeƒ€‚ÌŠm—§‚Æ•]‰¿‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“xŒ€‹†
•ñ‘ 2011/3; p.30-4.

540087. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†•â•‹à@–ƉuƒAƒŒƒ‹ƒM[ŽŸŠ³—\–hEŽ¡—ÃŒ€‹†Ž–‹Æ (–Æ
‰uƒAƒŒƒ‹ƒM[•ª–ì)uüˆÛ‹Ø’ɏǂ̔­Ç—vˆö‚̉𖟋y‚ÑŽ¡—ÃVƒXƒeƒ€‚ÌŠm—§‚Æ•]‰¿‚ÉŠÖ‚·‚錀‹†vzüˆÛ‹Ø
’ɏNJT”O‚̐ž_ˆãŠw‚Ƃ̐®‡«‚ÉŠÖ‚·‚錀‹†. ‹{‰ª@“™ (ž_): Œú¶˜J“­‰ÈŠwŒ€‹†•â•‹à@–ƉuƒAƒŒƒ‹
ƒM[ŽŸŠ³—\–hEŽ¡—ÃŒ€‹†Ž–‹Æ (–ƉuƒAƒŒƒ‹ƒM[•ª–ì)uüˆÛ‹Ø’ɏǂ̔­Ç—vˆö‚̉𖟋y‚ÑŽ¡—ÃVƒXƒeƒ€‚Ì
Šm—§‚Æ•]‰¿‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“xŒ€‹†•ñ‘ 2011/3; p.35-8.

540088. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†•â•‹à@–ƉuƒAƒŒƒ‹ƒM[ŽŸŠ³—\–hEŽ¡—ÃŒ€‹†Ž–‹Æ (–Æ
‰uƒAƒŒƒ‹ƒM[•ª–ì)uüˆÛ‹Ø’ɏǂ̔­Ç—vˆö‚̉𖟋y‚ÑŽ¡—ÃVƒXƒeƒ€‚ÌŠm—§‚Æ•]‰¿‚ÉŠÖ‚·‚錀‹†vzüˆÛ‹Ø
’ɏǂ𐞐_‰Èˆã‚Í‚Ç‚€—‰ð‚µ‚Ä‚¢‚é‚©. ‹{‰ª@“™1, ‹{’n‰p—Y1, ‘åÎ@’q1 (1ž_): Œú¶˜J“­‰ÈŠwŒ€
‹†•â•‹à@–ƉuƒAƒŒƒ‹ƒM[ŽŸŠ³—\–hEŽ¡—ÃŒ€‹†Ž–‹Æ (–ƉuƒAƒŒƒ‹ƒM[•ª–ì)uüˆÛ‹Ø’ɏǂ̔­Ç—vˆö‚̉ð
–Ÿ‹y‚ÑŽ¡—ÃVƒXƒeƒ€‚ÌŠm—§‚Æ•]‰¿‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“xŒ€‹†•ñ‘ 2011/3; p.62-5.

540089. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†•â•‹à@–ƉuƒAƒŒƒ‹ƒM[ŽŸŠ³—\–hEŽ¡—ÃŒ€‹†Ž–‹Æ (–Æ
‰uƒAƒŒƒ‹ƒM[•ª–ì)uüˆÛ‹Ø’ɏǂ̔­Ç—vˆö‚̉𖟋y‚ÑŽ¡—ÃVƒXƒeƒ€‚ÌŠm—§‚Æ•]‰¿‚ÉŠÖ‚·‚錀‹†vz•ª’S‰Û
‘è–Œ: g‘̏ŠŒ©‚ÉŒ©‡‚í‚È‚¢’É‚Ý‚ð‘i‚Š‚éÇ—á‚̐ž_‰Èf’f‚ÆŒüž_–ò‚ÌŒø‰Ê. ‹{‰ª@“™1, ‹{’n‰p—Y
1, —«@Œ[Ž÷1, Vˆäh‘Ÿ˜Y1 (1ž_): Œú¶˜J“­‰ÈŠwŒ€‹†•â•‹à@–ƉuƒAƒŒƒ‹ƒM[ŽŸŠ³—\–hEŽ¡—ÃŒ€‹†Ž–
‹Æ (–ƉuƒAƒŒƒ‹ƒM[•ª–ì)uüˆÛ‹Ø’ɏǂ̔­Ç—vˆö‚̉𖟋y‚ÑŽ¡—ÃVƒXƒeƒ€‚ÌŠm—§‚Æ•]‰¿‚ÉŠÖ‚·‚錀‹†v
•œ¬22”N“xŒ€‹†•ñ‘ 2011/3; p.94-7.

540090. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à@áŠQŽÒ‘΍ô‘‡Œ€‹†Ž–‹Æ (ž_áŠQ•ª–ì)
u—lX‚Ȉˑ¶Ç‚š‚¯‚éˆã—ÁE•ŸŽƒ‚̉ñ•œƒvƒƒOƒ‰ƒ€‚̍ô’è‚ÉŠÖ‚·‚錀‹†vz‹{‰ª@“™1, ”óŒû@i, Œ–{r
•F, ¬ò“TÍ, ‘åÎ@’q1 (1ž_): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à@áŠQŽÒ‘΍ô‘‡Œ€‹†Ž–‹Æ (ž_áŠQ•ª
–ì)u—lX‚Ȉˑ¶Ç‚š‚¯‚éˆã—ÁE•ŸŽƒ‚̉ñ•œƒvƒƒOƒ‰ƒ€‚̍ô’è‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†
•ñ‘ 2011/3; p.7-15.

540091. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à@áŠQŽÒ‘΍ô‘‡Œ€‹†Ž–‹Æ (ž_áŠQ•ª–ì)
u—lX‚Ȉˑ¶Ç‚š‚¯‚éˆã—ÁE•ŸŽƒ‚̉ñ•œƒvƒƒOƒ‰ƒ€‚̍ô’è‚ÉŠÖ‚·‚錀‹†vz•a“IƒMƒƒƒ“ƒuƒŠƒ“ƒO (‚¢‚í‚ä
‚éƒMƒƒƒ“ƒuƒ‹ˆË‘¶) ‚ÌŠT”O‚ÌŒŸ“¢‚ÆŠeŠÖ˜A‹@ŠÖ‚Ì“KØ‚ȘAŒg‚ÉŠÖ‚·‚錀‹†. ‹{‰ª@“™1, ‘åÎ@’q1, “c
•Ó@“™, ˆÉ”g^——Y, Šâè³l, ˆî‘º@Œú, ²“¡@‘ñ1, ‰Í–{‘אM, XŽR¬•j, Ô–ØŒ’—˜, Œ‘º’Œ”V (1
ž_): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à@áŠQŽÒ‘΍ô‘‡Œ€‹†Ž–‹Æ (ž_áŠQ•ª–ì)u—lX‚Ȉˑ¶Ç‚š‚¯‚éˆã
—ÁE•ŸŽƒ‚̉ñ•œƒvƒƒOƒ‰ƒ€‚̍ô’è‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x•ª’SŒ€‹†•ñ‘•Êû 2011/3; p.7-80.

540092. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à@áŠQŽÒ‘΍ô‘‡Œ€‹†Ž–‹Æ (ž_áŠQ•ª–ì)
u—lX‚Ȉˑ¶Ç‚š‚¯‚éˆã—ÁE•ŸŽƒ‚̉ñ•œƒvƒƒOƒ‰ƒ€‚̍ô’è‚ÉŠÖ‚·‚錀‹†vz•a“IƒMƒƒƒ“ƒuƒŠƒ“ƒO (‚¢‚í‚ä
‚éƒMƒƒƒ“ƒuƒ‹ˆË‘¶) ‚ÌŠT”O‚ÌŒŸ“¢‚ÆŠeŠÖ˜A‹@ŠÖ‚Ì“KØ‚ȘAŒg‚ÉŠÖ‚·‚錀‹†. ‹{‰ª@“™1, ‘åÎ@’q1 (1
ž_): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à@áŠQŽÒ‘΍ô‘‡Œ€‹†Ž–‹Æ (ž_áŠQ•ª–ì)u—lX‚Ȉˑ¶Ç‚š‚¯‚éˆã
—ÁE•ŸŽƒ‚̉ñ•œƒvƒƒOƒ‰ƒ€‚̍ô’è‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.115-79.

[’˜@‘]

620132. [Šwp‘] (•ª’SŽ·•M)yÅV@ŒŸžE‰æ‘œf’fŽ–“T@2010-11”Łz‘æ15Í —Տ°S—E_ŒoS—
ŒŸž, p.236-46. ‹{‰ª@“™ (ž_), •Ò’˜ “ú–{—Տ°ŒŸžˆãŠw‰ï, ˆãŠw’ʐMŽÐ, “Œ‹ž, 2010/5”­s.

620133. [Šwp‘] (•ª’SŽ·•M)y“«áu’É‚Ì–ò•š—Ö@zR‚€‚–ò, R•sˆÀ–ò, p.171-81. ŸŒ©ç»1, ŽR
–{Œ«Ži1, ‹{‰ª@“™1 (1ž_), •Ò ”óŒû”ä“oŽÀ, “ìŽR“°, “Œ‹ž, 2010/6”­s.

620134. [Šwp‘] (•ª’SŽ·•M)y“«áu’É‚Ì–ò•š—Ö@zR‚Ä‚ñ‚©‚ñ–ò, p.181-90. “ñ•r@‚1, ŽR–{Œ«
Ži1, ‹{‰ª@“™1 (1ž_), •Ò ”óŒû”ä“oŽÀ, “ìŽR“°, “Œ‹ž, 2010/6”­s.

620135. [Šwp‘] (•ª’SŽ·•M)yž_‰ÈŽ¡—Öòƒnƒ“ƒhƒuƒbƒN ‰ü’ù6”ŁzŠe˜_@2. ‹C•ªˆÀ’è–ò, p.233-54.
‘哈–Ÿ•F (ž_), •Ò’˜ ã“‡‘—˜, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/7”­s.

620136. [Šwp‘] (•ª’SŽ·•M)yž_‰ÈŽ¡—Öòƒnƒ“ƒhƒuƒbƒN ‰ü’ù6”Łz‘˜_@III. Žå‚ÈŒüž_–ò@B. ‹C
•ªˆÀ’è–ò, p.45-52. ‘哈–Ÿ•F (ž_), •Ò’˜ ã“‡‘—˜, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/7”­s.

620137. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚̐ž_‰ÈŽ¡—ÃKƒCƒhƒ‰ƒCƒ“2010”N”Å (ž_‰ÈŽ¡—Êw‘æ25Šª‘Š§†)z
‘æ7Í ¬l‚̃p[ƒ\ƒiƒŠƒeƒB‚š‚æ‚эs“®‚̏áŠQ@10. •a“IƒMƒƒƒ“ƒuƒŠƒ“ƒO (‚¢‚í‚ä‚éƒMƒƒƒ“ƒuƒ‹ˆË‘¶) ‚Ì
‰ñ•œŽx‰‡, p.240-1. ²“¡@‘ñ1, ‹{‰ª@“™1 (1ž_), •Ò už_‰ÈŽ¡—Êwv•ÒWˆÏˆõ‰ï, ¯˜a‘“X, “Œ
‹ž, 2010/10”­s.

620138. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚̐ž_‰ÈŽ¡—ÃKƒCƒhƒ‰ƒCƒ“2010”N”Å (ž_‰ÈŽ¡—Êw‘æ25Šª‘Š§†)z
‘æ5Í _ŒoÇ«áŠQ, ƒXƒgƒŒƒXŠÖ˜AáŠQ‚š‚æ‚ѐg‘Ì•\Œ»«áŠQ@13. Ž‘±«g‘Ì•\Œ»«áu’ɏáŠQ,
p.184-5. ‹{‰ª@“™1, ‹{’n‰p—Y1 (1ž_), •Ò už_‰ÈŽ¡—Êwv•ÒWˆÏˆõ‰ï, ¯˜a‘“X, “Œ‹ž, 2010/10
”­s.

620139. [Šwp‘] (•ª’SŽ·•M)y”]‚Æ‚±‚±‚ë‚̃vƒ‰ƒCƒ}ƒŠƒPƒA ‘æ4Šª@Žq‚Ç‚à‚Ì”­’B‚ƍs“®zVIÍ Ž™“¶
Šú‚É‚š‚¯‚éS‚Ì–â‘è@¬Ž™‚̐SgÇ, p.409-17. ŸŒ©ç»1, ˆäãŸ•v1 (1ž_), •Ò ”Ñ“c‡ŽO, ƒVƒi
ƒW[, 2010/10”­s.

620140. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚ÌŽ¡—ÃŽnŽwj 2011”N“x”Å?Ž„‚Í‚±‚€Ž¡—µ‚Ä‚¢‚éz16 ž_ŽŸŠ³@‚€
‚•a«áŠQ, p.865-6. ‹{‰ª@“™ (ž_), ‘•ÒW ŽRŒû@“O, –kŒŽŒõ•v, •ŸˆäŽŸ–î, ˆãŠw‘‰@, “Œ‹ž,
2011/1”­s.

620141. [Šwp‘] (•ª’SŽ·•M)y‚€‚•aŽ¡—Ãnƒ“ƒhƒuƒbƒN@f—ẪRƒcz‘æII•” ‚€‚•aŠe˜_@ƒRƒ‰ƒ€: ”ñ
ê–åˆã‚ª‚€‚•a‚ðŽ¡—Ã‚·‚鎞‚Ì’ˆÓ, p.169-71. ‹{‰ª@“™1, ‘åÎ@’q1 (1ž_), •Ò ‘å–ì@—T, ‹à„
o”Å, “Œ‹ž, 2011/1”­s.

620142. [Šwp‘] (•ª’SŽ·•M)yŒú¶˜J“­È@ž_E_ŒoŽŸŠ³Œ€‹†ŠJ”­”ïuž_‰Èˆã—Âɂš‚¯‚é”­’Bž_
ˆãŠwŽx‰‡‚ÉŠÖ‚·‚錀‹†vz‰ðà‚ÆŽ–—á‚Å—‰ð‚·‚é@Ž©•ÂÇƒXƒyƒNƒgƒ‰ƒ€áŠQ‚Ì‚ ‚鐞_‰ÈŠ³ŽÒ‚ւ̑Ήž@
ž_‰Èˆã‚Ì‚œ‚߂̗Տ°ŽÀ‘Hƒ}ƒjƒ…ƒAƒ‹. ”Ñ“c‡ŽO, ”Š_r‘Ÿ˜Y, ˆäãŸ•v1, ˆäŒû‰pŽq, ‘Ÿ“c–Lì, ‰œŽ›@
’, ¬–ì˜aÆ, •“c”ü•Û, ¬Îœ“ñ, ¬ŽR’q“T, [’×æŽq, ‹{”ö‰v’m (1ž_), ŠÄC _”ö—zŽq, Œú¶˜J
“­È@ž_E_ŒoŽŸŠ³Œ€‹†ŠJ”­”ï, 2011/2”­s.

622004. [Šwp‘] (–|–ó)y”­’BáŠQŽ–“T (Dictionay of Developmental Disabilities Terminology)z
•Ò ƒpƒXƒJƒ‹EJEƒAƒJƒ‹ƒh, ƒo[ƒoƒ‰EYEƒzƒCƒbƒgƒ}ƒ“, ŠÄC ã—Ñ–õŽq, ‰Á‰ä–qŽq, –|–ó‹Š—Í ˆäãŸ
•v1, ˆäã—S‹I (1ž_), –ó X“c—R”ü, ŒÃ‰êËŽq, ‰Á“¡‘œ‰ÀŽq, –ŸÎ‘“X, “Œ‹ž, 2011/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713165. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Recent characteristics of suicide and suicidal behavior
in patient with schizophrenia. Yamamoto K1, Takai-Kamiya M, Yamamoto H1, Tatematsu S, Yukawa-Inui
M1, Miyaji S, Iwamitsu Y2, Miyaoka H1: 2nd Schizophrenia International Research Society Conference
(2010/4/12), Florence. (ŽR–{Œ«Ži1, ŽR–{G–Ÿ1, Š£@^”ü1, Šâ–ž—D”ü2, ‹{‰ª@“™1: 1ž_, 2‘åŠw
‰@ˆã—ÃŒnŒ€‹†‰È)

713166. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Physical activity of daily living in patients with
Schizophrenia. Yamamoto H1, Yamamoto K2, Miyaji S, Inui M2, Kamiya M, Tatematsu S1, Yutani M1,
Miyaoka H2: 2nd Schizophrenia International Research Society Conference (2010/4/12), Florence.
(ŽR–{G–Ÿ1, ŽR–{Œ«Ži2, Š£@^”ü2, —§Œ¹ˆê1, –û’JŒ³‹K1, ‹{‰ª@“™2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2
ž_)

713167. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Preliminary study on quantification of improper error
style inconsistent with the order of difficulty in WISC-third Japanese version. Inoue K1, Katsumi
C1, Obara M1, Miyaoka H1, Oiji A2: 19th World Congress of the International Association for Child
and Adolescent Psychiatry and Allied Professions (2010/6/4), Beijing. (ˆäãŸ•v1, ŸŒ©ç»1, ¬
ŒŽŽOŽ}1, ‹{‰ª@“™1, ¶’n@V2: 1ž_, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È)

713168. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Emotional suppression and psychological responses in
breast cancer patients after surgery. Nakatani Y, Iwamitsu Y1, Kuranami M2, Okazaki S, Yamamoto
K3, Watanabe M2, Miyaoka H3: The International Conference of 4th Asian Congress of Health Psychology
(2010/8/27-31), Taipei, Taiwan. (Šâ–ž—D”ü1, ‘ •À@Ÿ2, ŽR–{Œ«Ži3, “n粏¹•F2, ‹{‰ª@“™3: 1‘å
Šw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 3ž_)

713169. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Elderly people using psychiatric emergency system in
suburban area in Japan. Takahashi M1, Sawayama E1, Miyaoka H1: International Psychogeriatric
Association (2010/9/28), Santiago de Compostela, Spain. (‚‹Ž@Œb1, àVŽRŒb”g1, ‹{‰ª@“™1: 1
ž_)

713170. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The EEG patterns of drowsiness that are related to
abnormal cognitive decline in elderly. Saito M1, Takahashi M1, Suzuki J2, Himeda K2, Oshida Y2,
Yoshimoto K2, Tagaya H3, Miyaoka H1: 29th international congress of clinical neurophysiology
(2010/11/1), Kobe. (âV“¡³”Í1, ‚‹Ž@Œb1, —é–؏~Žq2, •P“c‹v”ü2, ‰Ÿ“cD”ü2, ‹g–{gŽq2, “cƒ–
’J_–M3, ‹{‰ª@“™1: 1ž_, 2“Œ•a‰@—Տ°ŒŸž•”, 3ˆã—Éq¶Šw•”)

722221. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) 5. üˆÛ‹Ø’ɏǂƐž_ŽŸŠ³‚̊ӕʂƍ‡•¹. ‹{‰ª@“™
(ž_): “ú–{üˆÛ‹Ø’ɏNJw‰ï‘æ2‰ñŠwpW‰ï (2010/11/13), “Œ‹ž.

722222. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‹Z”\K“Ÿ‚Ì‘€–Ê‚©‚ç (1): Ï
‹É“IŒX’®‚Æ‹€ŠŽ. ‚‹Ž@Œb (ž_): ‘æ106‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2010/5/21), L“‡.

722223. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “ú–{‚̐ž_‰Èˆã—Âð“W–]‚·‚é?ž_‰È‹~‹}‚Ì—§ê
‚©‚ç?. ‹g絑PF (ž_): ‘æ106‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2010/5/21), L“‡.

723890. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚€‚•a‚Ɛg‘̏Ǐó‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä. Š£@^”ü1, ŽR–{
Œ«Ži1, ‹{’n‰p—Y1, ‹{’nLŒá, ŽR–{G–Ÿ2, “’ì‘׈ê, ‹{‰ª@“™1 (1ž_, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ
106‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2010/5/20), L“‡.

723891. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å”]”’Ž¿•a•Ï‚ð‚Æ‚à‚È‚€‚€‚•a‚Æ”º‚í‚È‚¢‚€‚•a‚Ì”äŠr
ŒŸ“¢. ‚‹Ž@Œb1, ’r“c‘Ÿˆê˜Y2, ŠÌ•t@—m1, ‹{‰ª@“™1 (1ž_, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ106‰ñ
“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2010/5/20), L“‡.

723892. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) g‘̍‡•¹Ç•a“‚É“ü‰@‚µ‚œ–òÜ«ƒCƒŒƒEƒXÇ—á‚ɂ‚¢‚Ä.
Vˆä‹v–«, ŽR–{Œ«Ži1, ˆäãŸ•v1, ŠÛ“ÞŒb, ’ËŒŽ“ÖŽq1, ‹Ž–{Mˆê˜Y1, ’†‘ºŒ³”ü1, ‹{‰ª@“™1 (1ž
_): ‘æ106‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2010/5/21), L“‡.

723893. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬l”­’BáŠQŠ³ŽÒ‚̈ê”ʐž_‰Èˆã‚É‚æ‚éf—Âւ̎™“¶ž
_‰Èˆã‚É‚æ‚éŽx‰‡•û–@‚ÌŠJ”­. ˆäãŸ•v1, ¬ŒŽŽOŽ}1, –ö‚©‚š‚è1, àVŽRŒb”g1, ‚‹ŽŒb—1, ‰Ã”[–ŸŽq
1, ‹g“c–FŽq1, ‹{‰ª@“™1 (1ž_): ‘æ106‰ñ“ú–{ž__ŒoŠw‰ïŠwp‘‰ï (2010/5/21), L“‡.

723894. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŸŒê”­’B‚É’x‚ê‚ðŽŠ‚·Ž™‚Ì”ñŒŸŒê“I—v‹s“®‚ÉŠÖ‚·‚錀
‹† (‚»‚Ì1)?‘S‘Ì”­’BAŒŸŒê”­’B‚Æ”ñŒŸŒê“I—v‹s“®‚ÌŠÖ˜A?. ˆäã—ŠG, ‹ù“cO”ü, ‘åÀKŒb, ˆäã
Ÿ•v1, ŽÄ@—æŽq, Î“cG‘ã (1ž_): ‘æ36‰ñ“ú–{ƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“áŠQŠw‰ïŠwpu‰‰‰ï (2010/5/30),
•P˜H.

723895. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŸŒê”­’B‚É’x‚ê‚ðŽŠ‚·Ž™‚Ì”ñŒŸŒê“I—v‹s“®‚ÉŠÖ‚·‚錀
‹† (‚»‚Ì2)?ƒNƒŒ[ƒ“‚Ì—L–³‚Æ‘Œ‚Ì—vˆö‚Æ‚ÌŠÖ˜A?. ‹ù“cO”ü, ˆäã—ŠG, ‘åÀKŒb, ˆäãŸ•v1, ŽÄ@
—æŽq, Î“cG‘ã (1ž_): ‘æ36‰ñ“ú–{ƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“áŠQŠw‰ïŠwpu‰‰‰ï (2010/5/30), •P˜H.

723896. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”Ó”­«ƒAƒ‹ƒcƒnƒCƒ}[Œ^”F’mÇ‚É‚š‚¯‚é”]ŒŒŠÇ«áŠQ‚Æ
“®–¬d‰»E¶ŠˆKŠµ‚ÌŠÖ˜A. Vˆä‹v–«, ‚‹Ž@Œb1, ’†“‡Œ[‰î1, ‘åÎ@’q1, ‰Y‹v•ÛˆÀ‹PŽq, ‹{‰ª@“™
1, ]‘º@‘å1 (1ž_): ‘æ25‰ñ“ú–{˜V”Nž_ˆãŠw‰ï (2010/6/25), ŒF–{.

723897. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”F’mÇŠ³ŽÒ‚ð‰îŒì‚·‚é‰Æ‘°‚ÌQuality of life‚ÌŠÖ˜A—v
ˆö‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ‚ˆä”ü’qŽq, ‚‹Ž@Œb1, Šâ–ž—D”ü2, –û’JŒ³‹K2, ŠÌ•t@—m1, ‘åÎ@’q1, ‹{‰ª@“™
1 (1ž_, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): ‘æ25‰ñ“ú–{˜V”Nž_ˆãŠw‰ï (2010/6/25), ŒF–{.

723898. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž©ŒÈ’†“Å‚É‚æ‚鎩ŽEŠé}Š³ŽÒ‚Ì‹Gß«‚ɂ‚¢‚Ä‚ÌŒŸ“¢: ž
_áŠQ‚Æ‚ÌŠÖ˜A‚©‚ç. ‚ˆä”ü’qŽq1, ãžŠ‹gl2, ˆäo•¶Žq2, —§Œ¹ˆê1, –x@’qŽq, ŽR–{Œ«Ži1, ‹{‰ª@
“™1, ‘Š”nˆêˆå2 (1ž_, 2‹~–œ): ‘æ34‰ñ“ú–{Ž©ŽE—\–hŠw‰ï‘‰ï (2010/9/9), “Œ‹ž.

723899. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t‘ŸˆÚA‚ðŽó‚¯‚銳ŽÒ‚ɏp‘OS—”œ‰ž‚Æ“Á«•sˆÀ‚ÌŠÖŒW.
—§Œ¹ˆê1, Šâ–ž—D”ü1, ŽR–{Œ«Ži2, ‹{‰ª@“™2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ž_): “ú–{Œ’NS—Šw‰ï ‘æ
23‰ñ‘å‰ï (2010/9/11), —¬ŽR.

723900. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t‘ŸˆÚA‚ðŽó‚¯‚銳ŽÒ‚̏p‘O‹C•ª‚ƏpŒã¶ŠˆƒCƒ[ƒW‚É
‚‚¢‚Ä?“Á«•sˆÀ‚Æ‚ÌŠÖŒW‚©‚ç?. —§Œ¹ˆê1, Šâ–ž—D”ü1, ŽR–{Œ«Ži2, ‹g“cˆê¬3, ‹{‰ª@“™2 (1‘å
Šw‰@ˆã—ÃŒnŒ€‹†‰È, 2ž_, 3”å”AŠí): “ú–{S—Šw‰ï@‘æ74‰ñ‘å‰ï (2010/9/20), ‘åã.

723901. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘Þ‰@1”NŒã‚Ì“û‚ª‚ñŠ³ŽÒ‚̐S—“IƒXƒgƒŒƒX‚ƃR[ƒsƒ“ƒO
‚ɂ‚¢‚Ä?ŠŽî—}§ŒXŒü‚Æ‚ÌŠÖ˜A‚©‚ç?. ’†’J—LŠó1, Šâ–ž—D”ü1, ‘ •À@Ÿ2, ‰ªè‰ê”ü, ˆÀ“c—TŒb, ŽR
–{Œ«Ži3, “n粏¹•F2, ‹{‰ª@“™3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 3ž_): ‘æ23‰ñ“ú–{ƒTƒCƒRƒIƒ“ƒR
ƒƒW[Šw‰ïE‘æ10‰ñ“ú–{”F’m—Ö@Šw‰ï@‡“¯‘å‰ï (2010/9/24), –ŒŒÃ‰®.

723902. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) SNAP-25•ÏˆÙƒ}ƒEƒX‚̍s“®ˆÙí‚ɑ΂·‚éŠeŽíŒüž_–ò‚ÌŒø‰Ê. —é–Ø
‰f“ñ, ‹{‰ª@“™1, “Œ@’åG2, “n•Ó@Ž 1, •Ð‰ª³˜a, ‚‹Ž³g3, ŽRX‘D3, ¬‹v•ÛGr, ‘å’ːM‘Ÿ
˜N (1ž_, 2ŽÀ“®, 3¶‰»): ‘æ20‰ñ—Տ°ž__Œo–ò—Šw‰ïE‘æ40‰ñ“ú–{_Œož_–ò—Šw‰ï‡“¯”N‰ï
(2010/9/25), å‘ä.

723903. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆã—Õیì“ü‰@‚É‚æ‚Á‚ÄŽ¡—µ‚œ_Œo«–³H—~Ç‚̈ê—á. Vˆäh‘Ÿ˜Y
1, d“cçŽÑŽq1, ‚‹ŽŒb—1, ‹{‰ª@“™1 (1ž_): ‘æ14‰ñ“ú–{ÛHáŠQŠw‰ïŠwpW‰ï (2010/10/3), “Œ
‹ž.

723904. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ž_‰È‹~‹}E‡•¹Ç“ü‰@—¿ŽZ’蓱“üŒã‚̐f—Ï󋵂̕ω».
‰Á“¡—ŠŽq1, ˆä“‡Œ³Žq1, ‘ºãmˆê1, ’†àVG–Ÿ1, ‰¡ŽR³@1, —é–Ø—Eˆê1, ‹g絑PF1 (1ž_): ‘æ18
‰ñ“ú–{ž_‰È‹~‹}Šw‰ï (2010/10/14), ‘åã.

723905. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬l”­’BáŠQ—Տ°‚ł̈ê”ʐž_ˆã‚ÆŽ™“¶ž_‰Èˆã‚Ì‹Š“­.
ˆäãŸ•v1, ¬ŒŽŽOŽ}1, ‹{‰ª@“™1 (1ž_): ‘æ51‰ñ“ú–{Ž™“¶Â”Nž_ˆãŠw‰ï‘‰ï (2010/10/30), ‘O
‹Ž.

723906. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ž_ˆãŠw“I‚ÈŠÖ—^‚ª•K—v‚Å‚ ‚Á‚œŒŒ‰t“§ÍÇ—á‚ɂ‚¢‚Ä:
“ü‰@Ž¡—ÏǗá‚̍ŋ߂̖â‘è“_. Vˆä‹v–«, ŽR–{Œ«Ži1, ˆäãŸ•v1, ŠÛ“ÞŒb, ’ËŒŽ“ÖŽq1, ‹{‰ª@“™1 (1
ž_): ‘æ23‰ñ“ú–{‘‡•a‰@ž_ˆãŠw‰ï‘‰ï (2010/11/26), “Œ‹ž.

723907. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “d‹C‚¯‚¢‚ê‚ñ—Ö@‚É‚š‚¯‚éBIS (Bispectral Index) ƒ‚
ƒjƒ^[‚̈Ӌ`. àVŽRŒb”g1, ‚‹Ž@Œb1, “c’†Žr2, àVŽR@“§1, ‰œ•xr”V3, ‹{‰ª@“™1 (1ž_, 2
‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 3–ƒŒ): ‘æ23‰ñ“ú–{‘‡•a‰@ž_ˆãŠw‰ï‘‰ï (2010/11/26), “Œ‹ž.

723908. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒNƒŒ[ƒ“Œ»ÛÄl?ŒŸŒê”­’BE”ñŒŸŒê“I—v‹s“®‚Æ‚ÌŠÖ
˜A‚©‚ç?. ˆäãŸ•v (ž_): ‘æ20‰ñ“ú–{“û—cŽ™ˆãŠwES—Šw‰ï (2010/12/4), –ŒŒÃ‰®.

731136. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) S—Žm‚ɖ𗧂g‚€‚h‚Ì’mŽ¯?‚€‚•a‚Í–{“–‚É‘‚Š‚œ
‚Ì‚©? ‹{‰ª@“™ (ž_): _“ސ쌧—Տ°S—Žm‰ï@‘æ1‰ñŒ€C‰ïE‘‰ï (2010/7/4), ‰¡•l.

731137. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ž_ˆã—©‚çuEê‚̃ƒ“ƒ^ƒ‹ƒwƒ‹ƒXv‚ð–â‚€. ‹{‰ª@“™
(ž_): ‘æ32‰ñƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘å‰ï (2010/9/2), “Œ‹ž.

731138. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) Ž©ŽE‘΍ô‚Ì‚œ‚߂̐헪Œ€‹† (ACTION-J) ‚ɂ‚¢‚Ä?–k—¢
‘åŠwž_‰È‚É‚š‚¯‚éŽæ‚è‘g‚ݏó‹µ?. ŽR–{Œ«Ži (ž_): ‘Š–ÍŒŽŽs‹³ˆçŒ€CŽ–‹Æ (2010/9/24), ‘Š–ÍŒŽ.

731139. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‚ª‚ñŠ³ŽÒ‚³‚ñ‚Ì‚±‚±‚ë‚ւ̃Aƒvƒ[ƒ`?–k—¢‘åŠw•a‰@‚Å
‚ÌŽæ‚è‘g‚Ý?. ŽR–{Œ«Ži (ž_): ‹›À’n‹æŠwpu‰‰‰ï (2011/3/5), “ì‹›À.

733445. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) t‘ŸˆÚA‘O‚ÌŠ³ŽÒ‚ª•ø‚­lH“§Í‚Ì‹ê’É‚Æ“Á
«•sˆÀ‚ÌŠÖŒW. —§Œ¹ˆê1, Šâ–ž—D”ü1, ŽR–{Œ«Ži2, ‹g“cˆê¬3, ‹{‰ª@“™2 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2
ž_, 3”å”AŠí): ‘æ21‰ñ“ú–{ƒTƒCƒRƒlƒtƒƒƒW[Œ€‹†‰ï (2010/6/5), ‰ªŽR.

733446. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹~‹}ˆã—ÃŒ»ê‚Å‹@”\‚·‚鎩ŽE‘΍ô‚ɂ‚¢‚Ä. ‹v
‘º³Ž÷1, ³‘ºŒª“ñ, ‹{‰ª@“™1 (1ž_): “Œ‹žž_ˆãŠw‰ï‘æ89‰ñŠwpW‰ï (2010/7/10), “Œ‹ž.

733447. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‡–°’†‚ÌŽ©—§_ŒoŠˆ“®‚Ɛ¶ŠˆKŠµ•a‚ÌŠÖŒW. Š™
“c’ŒŽ÷1, “c’†Žr1, “cƒP’J_–M2, ‹{‰ª@“™3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ˆã—Éq¶Šw•”, 3ž_): “Œ
‹žž_ˆãŠw‰ï@‘æ89‰ñŠwpW‰ï (2010/7/10), “Œ‹ž.

733448. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) S‘ŸƒJƒe[ƒeƒ‹ŒŸžŽž‚ÉŒ°Ý‰»‚µ‚œ•sˆÀáŠQ
‚̈ê—á. •œìk‘å1, d“cçŽÑŽq1, ‹{’n‰p—Y1, ˆäãŸ•v1, ŽR–{Œ«Ži1, ‹{‰ª@“™1 (1ž_): ‘æ32
‰ñ_“ސìSgˆãŠw‰ï‘‰ïEŠwpW‰ï (2010/9/11), ‰¡•l.

733449. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “û‚ª‚ñŠ³ŽÒ‚Ì‘Þ‰@1”NŒã‚É‚š‚¯‚éS—“I‹ê’É
‚ƃR[ƒsƒ“ƒO‚ɂ‚¢‚Ä?ŠŽî—}§ŒXŒü‚Æ‚ÌŠÖŒW‚©‚ç?. ’†’J—LŠó1, Šâ–ž—D”ü1, ‘ •À@Ÿ2, ˆÀ“c—TŒb
1, ŽR–{Œ«Ži3, “n粏¹•F2, ‹{‰ª@“™3 (1‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È, 2ŠO‰È, 3ž_): ‘æ32‰ñ_“ސìSgˆã
Šw‰ï‘‰ïEŠwpW‰ï (2010/9/11), ‰¡•l.

733450. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 20ˆÏ-1u‹C•ªáŠQ‚ÌŽ¡—ÃVƒXƒeƒ€‚ÌŠJ”­‚ÆŒŸ
Ø‚ÉŠÖ‚·‚錀‹†v”ǁ@•ª’SŒ€‹†u”]ŠíŽ¿«•Ï‰»‚𔺂€‚—îŽÒ‚Ì‚€‚•a‚̐f’f‚ÆŽ¡—ÂɊւ·‚éƒKƒCƒhƒ‰ƒCƒ“
‚̍쐬v. ‚‹Ž@Œb1, ’r“c‘Ÿˆê˜Y2, “cÀ—Ž‘Ÿ˜Y1, ‹{‰ª@“™1 (1ž_, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰È): •œ
¬22”N“xž_E_ŒoŽŸŠ³Œ€‹†ŠJ”­”ï@ž_ŽŸŠ³ŠÖ˜AŒ€‹†”ǁ@Œ€‹†•ñ‰ï (2010/12/1), “Œ‹ž.

733451. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆê”ʐž_‰È‚ł̐¬l”­’BáŠQ—Տ°‚É‚š‚¯‚鎙
“¶ž_‰Èˆã‚É‚æ‚éf—ÃŽx‰‡‚ÉŠÖ‚·‚錀‹†. ˆäãŸ•v (ž_): •œ¬22”N“xž_E_ŒoŽŸŠ³Œ€‹†ŠJ”­”ï@ž
_ŽŸŠ³ŠÖ˜AŒ€‹†”ǁ@Œ€‹†•ñ‰ï (2010/12/1), “Œ‹ž.

733452. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 20ˆÏ-5uÛHáŠQ‚̉uŠw, •a‘ԂƐf’f, Ž¡—Ã
–@, “]‹A‚Æ—\Œã‚ÉŠÖ‚·‚鑍‡“IŒ€‹†v”ǁ@•ª’SŒ€‹†udÇ_Œo«–³H—~Ç‚Ì•W€“IŽ¡—ÂɊւ·‚錀‹†v. ‚
‹ŽŒb—1, d“cçŽÑŽq1, Vˆäh‘Ÿ˜Y1, ‹{‰ª@“™1 (1ž_): •œ¬22”N“xž_E_ŒoŽŸŠ³Œ€‹†ŠJ”­”ï@ž
_ŽŸŠ³ŠÖ˜AŒ€‹†”ǁ@Œ€‹†•ñ‰ï (2010/12/2), “Œ‹ž.

733453. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘Š–ÍŒŽŽs‚É‚š‚¯‚鎩ŽE‚ÌŽÀ‘Ô. àVŽRŒb”g1, Œ
‘º@œ, ¬—э—¢, ‘å’|ŽOç‘ã, ¬’r®Žu, “c’†Žr2, ‹{‰ª@“™1, —é–ØŽu–ƒŽq1 (1ž_, 2‘åŠw‰@ˆã
—ÃŒnŒ€‹†‰È): _“ސ쐞_ˆãŠw‰ï‘æ161‰ñ—á‰ï (2011/2/19), ‰¡•l.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H18-522001. [uÀ]y“ÁW: Vl‚ª’m‚Á‚Ä‚š‚«‚œ‚¢‹~‹}ˆã—Â̐¢ŠEz6. ‹~‹}Œ»ê‚É‚š‚¯‚é—Տ°—Ï—.
‹v‘º³Ž÷1, ‹{‰ª@“™1 (1ž_): ƒGƒ}[ƒWƒFƒ“ƒV[EƒPƒA 2006/5; 19 (5): 51-4.

H21-320007. [Ç—á•ñ] “ª•”ŠOŒã‚É”­Ç‚µ‚œ‹­”—«áŠQŠ³ŽÒ‚ɑ΂·‚é”F’ms“®—Ö@?Š³ŽÒ‚Ì”F’m
‹@”\‚ɍ‡‚킹‚œ‰î“ü•û–@‚ÌŒŸ“¢?. Ž³‘q‹v—¢]1, ®–ìç’ÃŒb1, ¶’n@V1, ‹{‰ª@“™2 (1‘åŠw‰@ˆã—Ã
ŒnŒ€‹†‰È, 2ž_): –k—¢ˆãŠw 2009/6; 39 (1): 29-34.

H21-522009. [uÀ]y“ÁW: Ž•‰È E ŒûoŠO‰È‚ð‚ß‚®‚éSgˆãŠwzuŽ•‰ÈSgÇv‚ƐSgˆãŠw / ž
_ˆãŠw. ‹{’n‰p—Y1, ‹{‰ª@“™1 (1ž_): SgˆãŠw 2009/10; 49 (10): 1063-6.

H21-522010. [uÀ]y“ÁW:u“ª’ɂƍ˜’Ɂv’ɂ݂̍ŐV‰ÈŠwzu’ɂ݁v‚ւ̐ž_‰Èˆã“IƒAƒvƒ[ƒ`. ‹{
‰ª@“™ (ž_): iliholi 2010/3; 03: 64-8.

H21-530004. [‚»‚Ì‘Œ (’²ž•ñ)] A randomized controlled multicenter trial of post-suicide
attempt case management for the prevention of further attempts in Japan (ACTION-J). Hirayasu Y,
Kawanishi C, Yonemoto N, Ishizuka N, Okubo Y, Sakai A, Kishimoto T, Miyaoka H1, Otsuka K, Kamijo
Y, Matsuoka Y, Aruga T: BMC Public Health 2009/9; 9: 364. (‹{‰ª@“™1: 1ž_)

[’˜@‘]

H21-620015. [Šwp‘] (•ª’SŽ·•M)yŠ³ŽÒ‚³‚ñ‚Ì”wŒiE•a‘Ԃōl‚Š‚é@–ò‚Ì‘I‚Ñ•ûEŽg‚¢•û‚̃GƒbƒZ
ƒ“ƒX (Ž¡—à 91 (‘Š§†))zSgEž_@S‹CÇEg‘Ì•\Œ»«áŠQ, p.1282-5. ‹{‰ª@“™ (ž_), Šé‰æ ‰J
X³—m, “ìŽR“°, “Œ‹ž, 2009/4”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H21-733014. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹­”—Çó‚ª’˜–Ÿ‚Ȃ₹‚ÉŠÖ˜A‚µ‚œ_
Œo«–³H—~Ç‚Ì“ü‰@Ž¡—Ã. ‘å—Ñ‘ñŽ÷1, d“cçŽÑŽq1, ‰Ã”[–ŸŽq1, ‚‹ŽŒb—1, ‚‹Ž@Œb1, ‹{‰ª@“™1
(1ž_): ‘æ30‰ñ_“ސ쌧SgˆãŠw‘‰ï (2010/3/13), ‰¡•l.


•úŽËü‰ÈŠw (‰æ‘œf’fŠw)

[Šwp˜_•¶]

110249. [ŒŽ’˜] Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment
of apparent diffusion coefficient in histologic subtypes. Gill RR, Umeoka S, Mamata H, Tilleman
TR, Stanwell P, ƒEƒbƒhƒnƒ€ƒX—æŽq1, Padera RF, Sugarbaker DJ, Hatabu H (1•úŽËü (‰æ‘œ), Department
of Radiology, Brigham and Women's Hospital): AJR AM J Roentgenol (American journal of roentgenology)
2010/8; 195 (2): 125-30.

110250. [ŒŽ’˜] Phase I clinical trial of the vaccination for the patients with metastatic melanoma
using gp100-derived epitope peptide restricted to HLA-A*2402. Baba T, Sato-Matsushita M, Kanamoto
A, Itoh A, Oyaizu N, ˆäã—D‰î1, Kawakami Y, Tahara H (1•úŽËü (‰æ‘œ), Department of Surgery and
Bioengineering, Advanced Clinical Research Center, Institute of Medical Science, The University
of Tokyo): J TRANSL Med (JOURNAL OF TRANSLATIONAL MEDICINE) 2010/9; 8: 84 (12 pages).

110251. [ŒŽ’˜] Usefulness of multidetector-row CT (MDCT) for the diagnosis of non-occlusive
mesenteric ischemia (NOMI): assessment of morphology and diameter of the superior mesenteric artery
(SMA) on multi-planar reconstructed (MPR) images. ƒEƒbƒhƒnƒ€ƒX—æŽq1, ŒŠª@”Ž2, “¡ˆä@Š]1, Š`
“c‘Žq1, ‘ì˜ad3 (1•úŽËü (‰æ‘œ), 2‹~–œ, 3•úŽËü (Žîá‡)): Eur J Radiol (European Journal of
RADIOLOGY) 2010/10; 76 (1): 96-102.

110252. [ŒŽ’˜] Interstitial MR lymphography in mice with gadopentetate dimeglumine and gadoxetate
disodium. Sheng F, Inoue Y1, Kiryu S, Watanabe M, Ohtomo K: J Magn Reson Imaging 2011/2; 33 (2):
490-7. (ˆäã—D‰î1: 1•úŽËü (‰æ‘œ))

310017. [Ç—á•ñ] Gastrointestinal bleeding during the anti-angiogenic peptide vaccination in
combination with gemcitabine for advanced pancreatic cancer. Nagayama H, Matsumoto K, Isoo N,
Ohno H, Takahashi N, Nakaoka T, Shinozaki M, Watanabe M, ˆäã—D‰î1, Nagamura F, Oyaizu N, Yamashita
N (1•úŽËü (‰æ‘œ), Depertment of clinical trial safety management, depertment of surgery, division
of radiololgy,division of pathologyDivision of Advanced Medical Science, Research Hospital, The
Institute of Medical Science, The University of Tokyo): Clin J Gastroenterol 2010/12; 3 (6): 307-17.

320045. [Ç—á•ñ] ¬’°Ã–¬ŠïŒ`‚Ì1—á. ‘åX’qŽq1, ‘êì­˜a1, ‘åÀ—Yˆê˜Y1,2, –k–ì‰ëŽj1, ŽO•x
O”V3, ó–ì—Y“ñ4, ²X–ؐ^‹|5, ˆé•”‹`Œ›6 (1‘—§•a‰@‹@\‘Š–ÍŒŽ•a‰@•úŽËü‰È, 2•úŽËü (‰æ‘œ), 3
‘—§•a‰@‹@\‘Š–ÍŒŽ•a‰@•a—, 4•úŽËü (Žîá‡), 5ŽŠœ‰ï‘æ“ñ•a‰@•úŽËü‰È, 6‘—§•a‰@‹@\“Œ‹žˆã—ÃZ
ƒ“ƒ^[•úŽËü‰È): —Տ°•úŽËü 2011/2; 56 (2): 229-34.

520082. [‘à] •ªŽqƒCƒ[ƒWƒ“ƒO‚̐i•à: ¬“®•šŽÀŒ±—pŒõƒCƒ[ƒWƒ“ƒO‘•’uE‹Z–@‚̐i•à. ˆäã—D‰î
(•úŽËü (‰æ‘œ)): PET Journal 2010/12; 12: 21-3.

521028. [‰ðà]yPicked-up Knowledge from Foreign Journalsz_Œo•úŽËü. ›@Mˆê (•úŽËü (‰æ‘œ)):
‰æ‘œf’f 2010/5; 30 (7): 724-5.

521029. [‰ðà]yPicked-up Knowledge from Foreign Journalsz_Œo•úŽËü. ›@Mˆê (•úŽËü (‰æ‘œ)):
‰æ‘œf’f 2010/11; 30 (14): 1498-500.

522134. [uÀ]yRefresher CoursezŽ€á‘‚ÌMRI. ‹Ë¶@–Î1, ²ŒŽ—ÍŽO˜Y2, ˆäã—D‰î1,3, “Ž“cŠÑŒ[
ˆê4, ŠÙ–ì@‰~4, ‘å—F@–M5 (1“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•úŽËü‰È, 2ŽÐ‰ï•ÛŒ¯’†‰›‘‡•a‰@‘å’°ãè–å•aƒZ
ƒ“ƒ^[, 3•úŽËü (‰æ‘œ), 4ŽÐ‰ï•ÛŒ¯’†‰›‘‡•a‰@•úŽËü‰È, 5“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰È•úŽËü‰È): ‰æ
‘œf’f 2010/6; 30 (8): 854-62.

522135. [uÀ]yˆâ“`«“ûŠà‡Azˆâ“`«“ûŠà‚̐f’f. â–{‘Žq1, ƒEƒbƒhƒnƒ€ƒX—æŽq1 (1•úŽËü (‰æ‘œ)):
“ûŠà‚̗Տ° 2010/7; 25 (3): 295-8.

522136. [uÀ]yPicked-up Knowledge from Foreign Journalsz_Œo•úŽËü. ›@Mˆê (•úŽËü (‰æ
‘œ))): ‰æ‘œf’f 2010/7; 30 (7): 724-5.

522137. [uÀ]y‘nŠ§30Žü”N“Á•ÊŠé‰æz_Œo•úŽËü30”N. ›@Mˆê (•úŽËü (‰æ‘œ)): ‰æ‘œf’f
2010/10; 30 (13): 1380-90.

522138. [uÀ]y“ÁW1: PACS‚͉œ‚ð‚ß‚Ž‚·@i‰»‚𑱂¯‚éPACS‚ð‚Ç‚€Žg‚¢‚±‚È‚·‚©zŒã‰÷‚µ‚È‚¢‚œ‚ß
‚ÌPACS“±“üEXV‚̍l‚Š•û. ‘º“cWˆê˜Y (•úŽËü (‰æ‘œ)): ƒCƒ“ƒi[ƒrƒWƒ‡ƒ“•Êû@IT Vision 2011/1;
23 (1): 33-5.

522139. [uÀ]y“ÁW: ‹~‹}—̈æ‚̃}ƒ‹ƒ`ƒXƒ‰ƒCƒXCTƒ}ƒjƒ…ƒAƒ‹z3. • •”@4) ”ñ•ÂÇ«’°ŠÔ–Œ‹•ŒŒ; NOMI.
ƒEƒbƒhƒnƒ€ƒX—æŽq1, ŒŠª@”Ž1,2, •Ð‰ª—Sˆê2, Š~Œ©•¶Ž}2 (1•úŽËü (‰æ‘œ), 2‹~–œ): ‹~‹}ˆãŠw 2011/2;
35 (2): 179-83.

540093. [‚»‚Ì‘Œ] ŽY‰ÈoŒŒ‚ɑ΂·‚éIVR‚ɂ‚¢‚ẴAƒ“ƒP[ƒg’²ž•ñ. ‘]ª”üá1, ’†“‡N—Y1, ƒE
ƒbƒhƒnƒ€ƒX—æŽq2, ‰ÁŽR‰p•v3, ‰–ŽR–õ˜a4, ’ߍ萳Ÿ5, •œ–Ø—²•v6, ‹gŒ”ü²Žq1 (1ŠâŽèˆã‰È‘åŠwE¹
ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw, 2•úŽËü (‰æ‘œ), 3‘Ûe‘P‘‡•a‰@, 4àՋŠˆã‰È‘åŠw, 5“‡ª‘åŠw, 6‰ªŽR‘åŠw):
Intervenntional Radiology 2010/7; 25 (3): 359-62.

[’˜@‘]

620143. [Šwp‘]y¬Ž™_Œo‚̉摜f’f?”]Ò‘‚©‚瓪èò•”Eœ“î•”‚܂ŁzÒ‘EÒ’Å‚Ì”­’B, p.39-48.
›@Mˆê1 (1•úŽËü (‰æ‘œ)), •Ò ‘åê@—m2 (2’é‹ž‘åŠwˆãŠw•”•úŽËü‰ÈŠw), ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ,
2010/4”­s.

620144. [Šwp‘]y—Տ°ˆã‚ƃRƒƒfƒBƒJƒ‹‚Ì‚œ‚߂̍ŐVƒNƒŠƒjƒJƒ‹PETz¬“®•š—pŒõƒCƒ[ƒWƒ“ƒO‘•’u,
p.243-6. ˆäã—D‰î (•úŽËü (‰æ‘œ)), •ÒWŽåŠ² •Ä‘q‹`°, æ’[ˆã—ËZpŒ€‹†Š, 2010”­s.

[Šw‰ïEŒ€‹†‰ï“™]

712071. [Šw‰ï (‘Û)] (µ‘ҍu‰‰) DWI to monitor the therapy ƒEƒbƒhƒnƒ€ƒX—æŽq (•úŽËü (‰æ‘œ)):
Breast MR Imaging and Spectroscopy (2010 /10/1-3), Boston.

713171. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) MR imaging in intramedullary spinal cord metastasis. ›@M
ˆê1, Ohnuma Y, ‘ì˜ad2 (1•úŽËü (‰æ‘œ), 2•úŽËü (Žîá‡)): ASNR 48th Annual Meeting (2010 5/10-15),
Boston, USA, AMERICAN SOCIETY OF NEURORADIOLOGY 2010; p.409.

713172. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MR imaging in spinal cord metastasis. ›@Mˆê1, ‘å
À—Yˆê˜Y, ‘ì˜ad2 (1•úŽËü (‰æ‘œ), 2•úŽËü (Žîá‡)): ‘æ48‰ñ•Ä‘_Œo•úŽËüŠw‰ï (2010/5/17), ƒ{
ƒXƒgƒ“, •Ä‘.

713173. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Gaussia Luciferase for bioluminescence tumor monitoring in
comparison with firefly luciferase. ˆäã—D‰î1, Sheng F, Kiryu S, Watanabe M, Ratanakanit H, Izawa
K, Tojo A, Ohtomo K (1•úŽËü (‰æ‘œ)): World Molecular Imaging Congress (2010/9/8-11), Kyoto, Japan.

713174. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effect of anesthesia and hypothermia on the hepatic kinetics of
Gd-EOB-DTPA. ‹Ë¶@–Î1, ˆäã—D‰î2, Watanabe M, ‘å—F@–M1 (1Radiology,institute of Medical
Science, University of Tokyo, 2•úŽËü (‰æ‘œ)): Evaluation using MR imaging of conscious mice. World
Molecular Imaging Congress (2010/9/8-10), Kyoto.

713175. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Effective Connectivity of the Right Anterior Insular Cortex in
Anticipation of Feedback Stimulus. Kotani Y, Ohgami Y, Tsukamoto T, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ)):
50th Annual Meeting of Society for Psyhological Research (2010/9/29-10/3), Portland,
Psychophysiology 2010; 47: S60.

713176. [Šw‰ï (‘Û)] (ƒ|ƒXƒ^[) Stimulus-Preceding Negativity (SPN) prior to Unilateral Visual
Feedback Stimulus. Ohgami Y, Kotani Y, Tsukamoto T, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ)): a Combined
EEG/fMRI Study, 50th Annual Meeting of Society for Psyhological Research (2010/9/29-10/3), Portland,
Psychophysiology 2010; 47: S60.

713177. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MR imaging in spinal cord metastasis. ›@Mˆê1, ‘å
À—Yˆê˜Y, ‘ì˜ad2 (1•úŽËü (‰æ‘œ), 2•úŽËü (Žîá‡)): ‘æ19‰ñ_Œo•úŽËüƒVƒ“ƒ|ƒWƒEƒ€ (2010/10/4),
ƒ{ƒ[ƒjƒA, ƒCƒ^ƒŠƒA.

722224. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒ“ƒ|ƒWƒEƒ€: ŠjŽ¥‹C‹€–ˆãŠwzMRI‰æ‘œf’f‚ÌŒ»ó. ˆäã
—D‰î (•úŽËü (‰æ‘œ)): ‘æ100‰ñ“ú–{ˆãŠw•š—Šw‰ïŠwp‘å‰ï (2010/9/23-25), “Œ‹ž, ˆãŠw•š— 2010; 30:
52-3.

722225. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Ò‘Žîᇂ̉摜f’f. ›@Mˆê (•úŽËü (‰æ‘œ)): ‘æ45‰ñ“ú
–{Ò‘áŠQˆãŠw‰ï (2010/10/21-22), Œ–{.

723909. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‰º•”Á‰»ŠÇoŒŒ‚ɑ΂·‚éƒ}ƒ‹ƒ`ƒXƒ‰ƒCƒXCT‚Ì—L—p«?“–‹~–œ‹~‹}ƒZ
ƒ“ƒ^[‚É‚š‚¯‚錟“¢?. ¬Š}ŒŽ‹1, ŒŠª@”Ž1, â–{‘Žq1, Š~Œ©•¶Ž}2, _œä’m“¹2, ‹e’nG•F3, ƒE
ƒbƒhƒnƒ€ƒX—æŽq1, Œ‰iŒh“ñ1, ˆäã—D‰î1, ‘Š”nˆêˆå2 (1•úŽËü (‰æ‘œ), 2‹~–œ, 3Á‰»Ší“à): ‘æ70
‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠwpW‰ïŽ˜^W (2011/4/8), ‰¡•l, ‘æ70‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïŠwpW‰ïŽ˜^W
2011/2; S322.

723910. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –ü’…‘ٔՂɑ΂·‚é—\–h“Ip‘O—Œ‘€“à’°œ“®–¬ƒoƒ‹[ƒ“—¯’u‚š‚æ‚ÑŽ™
•ØoŒãTAE ‚Ì—L—p«‚ÌŒŸ“¢. ƒEƒbƒhƒnƒ€ƒX—æŽq1, ŒŠª@”Ž1,2, â–{‘Žq1, “¡ˆä@Š]1, ¬Š}ŒŽ‹1,
Š~Œ©•¶Ž}2, _œä’m“¹2, “‡‰ª‹¶3, Œ‰iŒh“ñ1, “V–ì@Š®3, ‘Š”nˆêˆå2, ›@Mˆê1, ‘ì˜ad4 (1
•úŽËü (‰æ‘œ), 2‹~–œ, 3ŽY•w, 4•úŽËü (Žîá‡)): ‘æ39‰ñ“ú–{IVRŠw‰ï‘‰ï (2010/5/20-22), “Œ‹ž, “ú
–{IVRŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2010; p.132.

723911. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŽüŽYŠúoŒŒ‚ɑ΂·‚éŒoƒJƒe[ƒeƒ‹“I“®–¬Çðp. â–{‘Žq (•úŽËü
(‰æ‘œ)): ‘æ39‰ñ“ú–{IVRŠw‰ï‘‰ï (2010/5/20-22), “Œ‹ž.

723912. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‹H‚È”rŒŒ˜HŒ`‘Ô‚ð’悵‚œ\“ñŽw’°Ã–¬áŽ‚ɑ΂µ‚ÄB-RTO‚ðŽ{s‚µ‚œ
1—á. ¬Š}ŒŽ‹1, ‘ëì­˜a, ‘åX’qŽq, ²X–ؐ^‹|, –î“àŒŽ‹v, “¡ˆä@Š]1, Œ‰iŒh“ñ1 (1•úŽËü (‰æ
‘œ)): ‘æ39‰ñ“ú–{IVRŠw‰ï‘‰ï (2010/5/20-22), “Œ‹ž.

723913. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Gd-EOB-DTPA‚ÌŠÌ“®‘Ô‚É‚š‚¯‚é–ƒŒ‚š‚æ‚Ñ’á‘̉·‚̉e‹¿?ŠoÁ‰ºƒ}
ƒEƒXMRI‚ð—p‚¢‚œŒŸ“¢?. ‹Ë¶@–Î1, ˆäã—D‰î2, “n•Ó@T, ‘å—F@–M (1“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•úŽË
ü‰È, 2•úŽËü (‰æ‘œ)): ‘æ5‰ñ“ú–{•ªŽqƒCƒ[ƒWƒ“ƒOŠw‰ï‘‰ïEŠwpW‰ï (2010/5/22-23), ‘å’Ã, JSMI
Report 2010/5; 3 (2): 96.

723914. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒCƒ“ƒrƒ{ŒuŒõƒCƒ[ƒWƒ“ƒO‚ð—p‚¢‚œƒ}ƒEƒXƒŠƒ“ƒp—¬˜H‚̉ðÍ. ˆäã
—D‰î1, ‹Ë¶@–Î2, ‘’J‰ÀF, “n•Ó@T, ”qŽt’q”V, ‹gìG‹N, “ˆ“cŽç’j, ¬–ö’Ã’ŒŽ÷, ‘å—F@–M (1•ú
ŽËü (‰æ‘œ), 2“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š•úŽËü‰È): ‘æ5‰ñ“ú–{•ªŽqƒCƒ[ƒWƒ“ƒOŠw‰ï‘‰ïEŠwpW‰ï
(2010/5/22-23), ‘å’Ã, JSMI Report 2010/5; 3 (2): 153.

723915. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) œ”Õ“àÃ–¬‘¹‚ɑ΂·‚éƒXƒeƒ“ƒg—¯’u‚Ì—L—p«. “®•šŽÀŒ±‚Æ1—Տ°
—á. ƒEƒbƒhƒnƒ€ƒX—æŽq1, ŒŠª@”Ž1,2, Š~Œ©•¶Ž}2, ‘ëì­˜a, “c‘ºK•ä3, •Ð‰ª—Sˆê2, ‘Š”nˆêˆå2 (1
•úŽËü (‰æ‘œ), 2‹~–œ, 3ŠO‰È): ‘æ30‰ñ“ú–{Ã–¬Šw‰ï‘‰ï (2010/6/17-18), ‹{è, Ã–¬Šw 2010; 21: 219.

723916. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘œ”­«ŠÌ×–EŠà, ŠÌ«”]Ç‚𔺂€ŒÇ—§«ˆÝÃ–¬áŽ‚ɑ΂µ‚Ä, ŠÌ—\”õ
”\‚ðl—¶‚µ, ƒVƒƒƒ“ƒg‚ð‰·‘¶‚µ‚Đ֬ᎂɂ̂ÝBRTO‚ðŽ{s‚µ‚œ1—á. “¡ˆä@Š]1, Œ‰iŒh“ñ1, ‘ëì­
˜a2, ¬Š}ŒŽ‹1, “ü]‚‚®‚Ý1, “cŒû’qŽq1, ‰œ˜e—T‰î3, ‘ì˜ad4 (1•úŽËü (‰æ‘œ), 2‘—§•a‰@
‹@\‘Š–ÍŒŽ•a‰@•úŽËü‰È, 3Á‰»Ší“à, 4•úŽËü (Žîá‡)): ‘æ17‰ñ“ú–{–å–¬ˆ³˜ŽiÇŠw‰ï‘‰ï
(2010/9/9-10), •xŽR, “ú–嘎‰ïŽ 2010; 16: 93.

723917. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹¹•”‘¢‰eCT‚ō¶Žº•Ç‚Ɉُ킪‹^‚í‚ê, S‘ŸCT‚É‚ÄŠm’èf’f‚ÉŽŠ‚Á
‚œŠO«S‘¹‚̈ê—á. â–{‘Žq1, ŒŠª@”Ž1,2, •ž•”@2, Š~Œ©•¶Ž}2, ˆäãMK3, ¬ŒŽ–M‹`3, ‘Š
”nˆêˆå2, ƒEƒbƒhƒnƒ€ƒX—æŽq1, ›@Mˆê1, ‘ì˜ad4 (1•úŽËü (‰æ‘œ), 2‹~–œ, 3S‘ŸŒŒŠÇŠO, 4•ú
ŽËü (Žîá‡)): ‘æ46‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ï (2010/9/18-20), ‰¡•l, ‘æ46‰ñ“ú–{ˆãŠw•úŽË
üŠw‰ïH‹G—Տ°‘å‰ïŽ˜^W 2010/8; p.507.

723918. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰óŽ€«‹Ø–Œ‰Š‚ª‰”­Çó‚Å‚ ‚Á‚œ‹}«äX‰Š‚̏Ǘá. “cŒû’qŽq1,
ƒEƒbƒhƒnƒ€ƒX—æŽq1, “¡ˆä@Š]1, â–{‘Žq1, ŒŽ@•q«1, ¬Š}ŒŽ‹1, “ü]‚‚®‚Ý1, “Œ“c®Ž÷, ›@M
ˆê1 (1•úŽËü (‰æ‘œ): ‘æ46‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ï (2010/9/18-20), ‰¡•l, ‘æ46‰ñ“ú–{
ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ïŽ˜^W 2010/8; p.512.

723919. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) • …úŽh‚É‚æ‚鉺• •Ç“®–¬‘¹‚ÉTAE‚ðŽ{s‚µ‚œˆê—á. ¬Š}ŒŽ‹
1, ‘ëì­˜a2, ‘åX’qŽq2, ²X–ؐ^‹|3, –î“àŒŽ‹v4, “¡ˆä@Š]1, Œ‰iŒh“ñ1 (1•úŽËü (‰æ‘œ), 2‘
—§•a‰@‹@\‘Š–ÍŒŽ•a‰@•úŽËü‰È, 3ŽŠœ‰ï‘æ“ñ•a‰@•úŽËü‰È, 4–k—¢Œ€‹†Š•a‰@•úŽËü‰È): ‘æ46‰ñ“ú–{
ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ï (2010/9/18-20), ‰¡•l, ‘æ46‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ïŽ˜^W
2010/8; p.576.

723920. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘gŠ·‚Š–ƒ]ƒEƒCƒ‹ƒX‚ð—p‚¢‚œ“ûŠàŽ¡—Ö@ŠJ”­‚ÌŠî‘b“IŒ€‹†. ™ŽR‹M
Ð1, •Ä“c”ü²Žq1, ‘qÎ@•2, •ž•”³ô2, ˆäã—D‰î3, ²“¡GŽ÷1, b”ã’mŒbŽq1 (1“Œ‹ž‘åŠwˆã‰ÈŠw
Œ€‹†ŠŽÀŒ±“®•šŒ€‹†Ž{Ý, 2“Œ‹ž‘åŠwˆã‰ÈŠwŒ€‹†Š‰‚”ü•aŠQ“®•šŒ€‹†Ž{Ý, 3•úŽËü (‰æ‘œ)): ‘æ58‰ñ“ú
–{ƒEƒBƒ‹ƒXŠw‰ïŠwpW‰ï (2010/11/7-9), “¿“‡, ‘æ58‰ñ“ú–{ƒEƒBƒ‹ƒXŠw‰ïŠwpW‰ïŽ˜^W 2010; p.62.

723921. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) œƒVƒ“ƒ`‚âFDG-PET/CT‚Å‘œ”­«œ“]ˆÚ‚É—ÞŽ—‚µ‚œŠŒ©‚ð’悵‚œ”ñŽî
ᇐ«•a•Ï‚Ì1Ç—á. ŒŽ@•q«1, ó–ì—Y“ñ2, “cŒû’qŽq1, “ü]‚‚®‚Ý1, ‹e’r@Œh, •“c@“O, ›@M
ˆê1, ‘ì˜ad2, ˆäã—D‰î1 (1•úŽËü (‰æ‘œ), 2•úŽËü (Žîá‡)): ‘æ50‰ñ“ú–{ŠjˆãŠw‰ïŠwp‘‰ï
2010/11/11-13), ‘å‹{, ŠjˆãŠw 2010/9; 47 (3): S46.

723922. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[)yƒ`ƒ…[ƒgƒŠƒAƒ‹4zˆã—Ïî•ñ•W€‰»‚ÌŠî”Õ‚ð¡ˆê“xl‚Š
‚é. ‘º“cWˆê˜Y (•úŽËü (‰æ‘œ)): ‘æ30‰ñ“ú–{ˆã—Ïî•ñŠw‰ï (2010/11/18), •lŒ.

723923. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[)y‹€“¯Šé‰æ •Ä‘PMI“ú–{Žx•” ƒ`ƒ…[ƒgƒŠƒAƒ‹1zˆã—ÃIT
í—ª‚ƃvƒƒWƒFƒNƒgƒ}ƒlƒWƒƒ“ƒgƒIƒtƒBƒX (PMO). ‘º“cWˆê˜Y (•úŽËü (‰æ‘œ)): ‘æ30‰ñ“ú–{ˆã—Ïî•ñ
Šw‰ï‘‰ï (2010/11/18), •lŒ.

723924. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒXƒeƒŒƒIƒKƒCƒh‰ºƒ}ƒ“ƒ‚ƒg[ƒ€¶ŒŸ‚É‚š‚¯‚éƒ}ƒCƒNƒƒ}[ƒJ[—¯’u
ž“x‚ÌŒŸ“¢. “cã_ˆê1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, ™ŽR’ŒŽq3, šâì‹MŽq4, ŠÖŒûˆ€Žq5, —§ì—T”ü6, ‘ •À@
Ÿ3 (1–k—¢‘åŠw“Œ•a‰@•úŽËü•”, 2•úŽËü (‰æ‘œ), 3ŠO‰È, 4‰¡{‰ê‹€Ï•a‰@, 5–k—¢‘åŠw•a‰@, 6‹€Ï
—§ì•a‰@): ‘æ20‰ñ“ú–{“ûŠàŒŸfŠw‰ï‘‰ï (2010/11/19-20), •Ÿ‰ª, “ú–{“ûŠàŒŸfŠw‰ïŽ 2010/10; 19
(3): 343.

723925. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 2Ž{Ý‹€“¯‚ÅŽÀŽ{‚µ‚œV‹KPET—p•úŽË«f’fÜ‚Ì‘æ1‘ŠŽŽŒ±‚̉ۑè
‚ƑΉž. ’†‘º’q”ü, ‚‹ŽŒ«¬, “üŒË–ì˜a‘ã, ’†ŒŽ‚¢‚¿‚Ý, ‹e’r@Œh, ‰¡“cœÄˆê, ŒŽ@•q«1, ó–ì—Y“ñ
2, ’r“cN•F, ŒF’J—YŽ¡ (1•úŽËü (‰æ‘œ), 2•úŽËü (Žîá‡)): ‘æ31‰ñ“ú–{—Տ°–ò—Šw‰ï (2010/12/1-3),
‹ž“s, —Տ°–ò— 2010/11; 41 (Suppl): S245.

723926. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) FRS2beta ‚Í, ErbB2 ‰ßè”­Œ»‚É‚æ‚è—U“±‚³‚ê‚é“ûŠà‚ÌŠà—}§ˆöŽq‚Å
‚ ‚é. ‰Æ“‡‘å•ã1, â–{—åŽq2, ˆäã—D‰î3, ¬—ѐ闲4, ”–쒌Ž÷4, ‹g“ciº2, Œã“¡“TŽq1 (1“Œ‘å
ˆã‰ÈŒ€ƒVƒXƒeƒ€¶–œˆã‰ÈŠw, 2“Œ‘åˆã‰ÈŒ€”­¶HŠw, 3•úŽËü (‰æ‘œ), 4MB‘åˆãŠw): ‘æ33‰ñ“ú–{•ªŽq
¶•šŠw‰ï”N‰ïE‘æ83‰ñ“ú–{¶‰»Šw‰ï‘å‰ï‡“¯‘å‰ï (2010/12/7-10), _ŒË, Ž˜^W 2010; 246.

731140. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŠjˆãŠw‚ð—p‚¢‚œ’è—Ê“I‹@”\‰ðÍ. ˆäã—D‰î (•úŽËü (‰æ
‘œ)): ‘æ1‰ñ–k—¢‹@”\‰æ‘œƒZƒ~ƒi[ (2010/11/30), ‘Š–ÍŒŽ.

731141. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŠjˆãŠwŒŸž‹ZpŠJ”­: ’è—ʐ«Œüã‚ÉŒü‚¯‚Ä. ˆäã—D‰î
(•úŽËü (‰æ‘œ)): ‘æ334‰ñ_“ސìŠjˆãŠw‹ZpŒ€‹†‰ï (2010/12/18), ‰¡•l.

733454. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ‰ñ’°––’[•œŠŠ‹Ø“÷Žî‚Ì1—á. ¬Š}ŒŽ‹1, ‘ëì­˜a2, ‘å
ê—Y”V2, ‘åX’qŽq2, –x“cˆ»Žq3, âV“¡¶˜N3, ‹ààVG‹I4 (1•úŽËü (‰æ‘œ), 2‘—§•a‰@‹@\‘Š–ÍŒŽ•a
‰@•úŽËü‰È, 3•a—, 4ŠO‰È): ‘æ24‰ñ• •”•úŽËüŒ€‹†‰ï (2010/6/11-12), ’·–ì.

733455. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) äX“à•›äB‚ɐ¶‚¶‚œùN–E‚ƍl‚Š‚ç‚ê‚œ1—á. â–{‘Žq1, Œ
‰iŒh“ñ1, ¬Š}ŒŽ‹1, “¡ˆä@Š]1, “ü]‚‚®‚Ý1, “cŒû’qŽq1, ˆÉ“¡—IŽq1, –Ø“cŒõL2, ‘ì˜ad3 (1
•úŽËü (‰æ‘œ), 2Á‰»Ší“à, 3•úŽËü (Žîá‡)): ‘æ24‰ñ• •”•úŽËüŒ€‹†‰ï (2010/6/11-12), ’·–ì, ‘æ24
‰ñ• •”•úŽËüŒ€‹†‰ïŽ˜^W 2010; p.94.

733456. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆÝÃ–¬áŽ‚ɑ΂µ‚ă_ƒuƒ‹ƒoƒ‹[ƒ“ƒJƒe[ƒeƒ‹‚ð—p‚¢, NBCA
‚𕹗p‚µ‚ÄB-RTO‚ðŽ{s‚µ‚œˆê—á. ¬Š}ŒŽ‹1, ‘ëì­˜a, ‘åX’qŽq1, ²X–ؐ^‹|1, –î“àŒŽ‹v1, “¡
ˆä@Š]1, Œ‰iŒh“ñ1 (1•úŽËü (‰æ‘œ) ‘æ5‰ñ“ú–{IVRŠw‰ïŠÖ“Œ’n•û‰ï (2010/7/10), “Œ‹ž, ‘æ5
‰ñ“ú–{IVRŠw‰ïŠÖ“Œ’n•û‰ïŽ˜^W 2010; p.27.

733457. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Measles virus selectively blind to signaling lymphocyte
activation molecule (SLAM) is safe and shows potent antitumor activity against breast cancer.
Sugiyama T, Yoneda M, Kuraishi T, Hattori S, ˆäã—D‰î1, Sato H, Kai C (1•úŽËü (‰æ‘œ)
‘æ10‰ñ‚ ‚킶‚µ‚ÜŠŽõÇE–ƉuƒtƒH[ƒ‰ƒ€ (2010/9/7-10), ’W˜H.

733458. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) • …úŽh‚É‚æ‚鉺• •Ç“®–¬‘¹‚ÉTAE‚ðŽ{s‚µ‚œˆê—á.
¬Š}ŒŽ‹ (•úŽËü (‰æ‘œ)): ‘æ20‰ñ‹~‹}•úŽËüŒ€‹†‰ï (2010/9/20), ‰¡•l.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-110022. [ŒŽ’˜] Identification of residual breast carcinoma following neoadjuvant
chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and
pathologic findings. Woodhams R1, Kakita S1, Hata H, Iwabuchi K2, Kuranami M3, Gautam S, Hatabu
H, Kan S1, Mountford C: Radiology 2010/2; 254 (2): 357-66. (ƒEƒbƒhƒnƒ€ƒX—æŽq1, Š`“c‘Žq1, Šâ
ŸºŒ[ˆê2, ‘ •À@Ÿ3, ›@Mˆê1: 1•úŽËü (‰æ‘œ), 2•a—, 3ŠO‰È)


•úŽËü‰ÈŠw (•úŽËüŽîᇊw)

[Šwp˜_•¶]

110253. [ŒŽ’˜] Differences between intraoperative ultrasound-based dosimetry and postoperative
computed tomography-based dosimetry for permanent interstitial prostate brachytherapy. Ishiyama
H1, Nakamura R, Sato T2, Tanji S, Uemae M3, Baba S2, Hayakawa K1: Brachytherapy 2010/7; 9 (3):
219-23. (ÎŽR”ŽžŠ1, ²“¡ˆÐ•¶2, ã‘O•ôŽq3, ”nêŽu˜Y2, ‘ì˜ad1: 1•úŽËü (Žîá‡), 2”å”AŠí, 3
•úŽËü•”)

110254. [ŒŽ’˜] High-dose-rate intracavitary brachytherapy combined with external beam
radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional
study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO
2006-2007). Niibe Y1, Kenjo M, Onishi H, Ogawa Y, Kazumoto T, Ogino I, Tsujino K, Harima Y,
Takahashi T, Anbai A, Tsuchida E, Toita T, Takemoto M, Yamashita H, Hayakawa K1: Jpn J Clin Oncol
2010/8; 40 (8): 795-9. (V•”@÷1, ‘ì˜ad1: 1•úŽËü (Žîá‡))

110255. [ŒŽ’˜] Concomitant expression of HER2 and HIF-1ƒ¿ is a predictor of poor prognosis in
uterine cervical carcinoma treated wiht concurrent chemoradiotherapy: prospective analysis
(KGROG0501). Niibe Y1, Watanabe J2, Tsunoda S3, Arai M3, Arai T3, Kawaguchi M3, Matsuo K, Jobo
T, Ono S3, Numata A3, Unno N3, Hayakawa K1: Eur J Gynaecol Oncol 2010/10; 31 (5): 491-6. (V•”@
÷1, “n糁@ƒ2, Šp“cV•œ3, Vˆä³G3, Vˆä@“w3, ìŒû”ü˜a3, Œ”öŒb‘Ÿ˜Y, ã–V•qŽq, ¬–ìd–ž
3, À“c@Ê3, ŠC–ìM–ç3, ‘ì˜ad1: 1•úŽËü (Žîá‡), 2•a—, 3ŽY•w)

120077. [ŒŽ’˜] FIGO•aŠú•ª—ÞIbŠú‚ÌŽq‹{èòŠà‚ɑ΂·‚鍪Ž¡“I•úŽËüŽ¡—ЬÑ. V•”@÷1, ŒŽ@•q«
2, ¬’J³Žq1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, Šp“cV•œ3, Vˆä³G3, Vˆä@“w3, ìŒû”ü˜a3, ¬–ìd–ž3, À
“c@Ê3, ŠC–ìM–ç3, ‘ì˜ad1 (1•úŽËü (Žîá‡), 2•úŽËü (‰æ‘œ), 3ŽY•w): —Տ°•úŽËü 2010/7; 55
(7): 901-3.

520083. [‘à] ­”“]ˆÚE­”Ä”­ (oligometastases, oligo-recurrence) ‚ɑ΂·‚é•úŽËüŽ¡—Ã. V
•”@÷1, ¬’J³Žq1, ‘“c@Ši1, ‘ì˜ad1 (1•úŽËü (Žîá‡)): “úàՈã•ñ 2011/2; 55 (3¥4): 266-70.

522140. [uÀ]y“ÁW: ‚ª‚ñŽ¡—ÃKƒCƒhƒ‰ƒCƒ“‚ÌŒŸØz”xŠà?EBM‚ÌŽè–@‚É‚æ‚é”xŠàf—ÃKƒCƒhƒ‰ƒCƒ“2005
”N”Å?. ‘ì˜ad1, ’؈䐳”Ž (1•úŽËü (Žîá‡)): Šà‚Ɖ»Šw—Ö@ 2010/4; 37 (4): 609-12.

522141. [uÀ]y“ÁW1. ‚—ŽÐ‰ï‚É‚š‚¯‚éŠàŽ¡—ÍőOüzV‚µ‚¢•úŽËüŽ¡—Ã. ‘ì˜ad (•úŽËü (Žî
á‡)): ¬l•a‚Ɛ¶ŠˆKŠµ•a 2010/5; 40 (5): 484-9.

522142. [uÀ]y‚±‚ê‚Ÿ‚¯‚Í’m‚Á‚Ä‚š‚«‚œ‚¢I•úŽËü—Ö@Q&A?Šî–{’mŽ¯‚ƍőOü?zII. ‘ŸŠí•Ê‚Ì•úŽË
üŽ¡—Á@”x‚ª‚ñ (”ñ¬×–E”x‚ª‚ñ). ‘ì˜ad (•úŽËü (Žîá‡)): ‚ª‚ñŽ¡—ÃŒƒNƒ`ƒƒ[ 2011/1; 2 (1):
103-7.

522143. [uÀ]y“ÁW: i‰»‚·‚é”xŠàf—ÃKƒCƒhƒ‰ƒCƒ“ (“ú–{”xŠàŠw‰ï)?‰ü’ù‚ð‚ß‚®‚é“®Œü?z1. ”xŠà
f—ÃKƒCƒhƒ‰ƒCƒ“‰ü’ù‚ÌŠT—v. ‘ì˜ad1, ’؈䐳”Ž (1•úŽËü (Žîá‡)): “ú–{‹¹•”—Տ° 2011/2; 70 (2):
109-17.

[’˜@‘]

620145. [Šwp‘] (•ª’SŽ·•M)y‚ª‚ñE•úŽËü—Ö@2010z‘æ7Í Še—̈æ‚ÌŽ¡—Á@‹¹•”Žîᇁ@7-25 ”xŠàE
cŠuŽîᇁE‹¹–ŒŽîá‡, p.764-8. ‘ì˜ad (•úŽËü (Žîá‡)), •Ò ‘同@—m, “‚àV‹v”üŽq, “‚àVŽ”V, ŽÂ
ŒŽo”ŐVŽÐ, “Œ‹ž, 2010/11”­s.

[Šw‰ïEŒ€‹†‰ï“™]

721020. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) ‘˜_E‚ª‚ñf—Ã: ‚ª‚ñ‚Ì•úŽËüŽ¡—Âɂ‚¢‚Ä: ‚ª‚ñ•úŽËüŽ¡—Â̊î
‘b’mŽ¯. ‘ì˜ad (•úŽËü (Žîá‡)): ‘æ65‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ïE‹³ˆçW‰ï (2010/7/16), ‰ºŠÖ.

722226. [Šw‰ï (‘S‘)] (ƒ~ƒjƒ[ƒNƒVƒ‡ƒbƒv) IbŠú‚ÌŽq‹{èòŠà‚ɑ΂·‚鍪Ž¡“I•úŽËüŽ¡—ЬÑ. V•”@
÷1, ¬’J³Žq1, ŒŽ@•q«2, Šp“cV•œ3, Vˆä³G3, Vˆä@“w3, ìŒû”ü˜a3, ¬–ìd–ž3, À“c@Ê
3, ŠC–ìM–ç3, ‘ì˜ad1 (1•úŽËü (Žîá‡), 2•úŽËü (‰æ‘œ), 3ŽY•w): ‘æ48‰ñ“ú–{•wl‰ÈŽîᇊw‰ï
(2010/7/9), ‚‚­‚΍‘Û‰ï‹cê, “ú–{•wl‰ÈŽîᇊw‰ïŽGŽ 2010; 28 (3): 290.

722227. [Šw‰ï (‘S‘)] (‹³ˆçu‰‰) (‹³ˆçu‰‰)yŠjˆãŠwz‘ÌŠ²•”‚Å‚ÌSPECT-CT ‚̗Տ°“I—L—p«. ó–ì
—Y“ñ (•úŽËü (Žîá‡)): ‘æ46‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ï (2010/9/18-20), ‰¡•l, ‘æ46‰ñ“ú–{
ˆãŠw•úŽËüŠw‰ïH‹G—Տ°‘å‰ïŽ˜^W 2010/8; p.447-8.

723927. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Ib1ŠúŽq‹{èòŠà‚ɑ΂·‚鍪Ž¡“I•úŽËü’P“ƗÖ@‚ÌŽ¡—ЬÑ. V•”@
÷1, ŒŽ@•q«2, ¬’J³Žq1, ƒEƒbƒhƒnƒ€ƒX—æŽq2, Šp“cV•œ3, Vˆä³G3, ŠC–ìM–ç3, ‘ì˜ad1 (1
•úŽËü (Žîá‡), 2•úŽËü (‰æ‘œ), 3ŽY•w): ‘æ69‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ï (2010/4/9), ‰¡•l, ‘æ69
‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï‘‰ïŽ˜^ 2010/2; p.230.

723928. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) œ“]ˆÚ‚ÌŽ¡—à “ûŠàœoligo-recurrenceÇ—á‚ɑ΂·‚é•ú
ŽËüŽ¡—Â̈Ӌ`: 4Ž{Ý‹€“¯Œ€‹†. V•”@÷1, ”’ÎŒ›Žj˜Y, •–{[L, Œ“ˆÀ—SŽq, ¬’J³Žq1, ’†ìŒb
ˆê, ‹ààV@‰E, ‰i“c@–õ, ‘ì˜ad1 (1•úŽËü (Žîá‡)): “ú–{ŠàŽ¡—Êw‰ï‘æ48‰ñŠwpW‰ï (2010/10/29),
‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ 2010/9; 45 (2)F448.

723929. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”ñ“V‘RŒ^ƒAƒ~ƒmŽ_‚ð—LŒø¬•ª‚Æ‚·‚éV‹KPETf’fÜ (NMK36) ‚̍‘“à
‘æ1‘Š—Տ°ŽŽŒ±. ó–ì—Y“ñ1, ’r“cN•F, ‹e’n@Œh, ŒŽ@•q«2, “cŒû’qŽq2, “¿d‘žé, ŠÛ”öGŽ÷, •
“c@“O, ’†‘º’q”ü, ŒF’J—YŽ¡, ‘ì˜ad1 (1•úŽËü (Žîá‡), 2•úŽËü (‰æ‘œ)): ‘æ50‰ñ“ú–{ŠjˆãŠw‰ïŠw
p‘‰ï (2010/11/11-13), ‘å‹{, ŠjˆãŠw 2010/9; 47 (3): 389.

731142. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”xŠà•úŽËüŽ¡—Â̐i•à‚Ɖۑè. ‘ì˜ad (•úŽËü (Žî
á‡)): ‘æ92‰ñ“ú–{”xŠàŠw‰ïŠÖŒŽx•”‰ï (2010/7/10), ‘åã.

731143. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) •úŽËüŽîᇊwF•úŽËüŽ¡—Â̎ÀÛ. ‘ì˜ad (•úŽËü (Žî
á‡)): “ú–{—Տ°Žîᇊw‰ï‘æ14‰ñ‹³ˆçƒZƒ~ƒi[FAƒZƒbƒVƒ‡ƒ“ (2010/8/21), ‰¡•l.

731144. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) AƒZƒbƒVƒ‡ƒ“?•úŽËüŽîᇊw: •úŽËüŽ¡—Â̎ÀÛ. ‘ì
˜ad (•úŽËü (Žîá‡)): “ú–{—Տ°Žîᇊw‰ï‘æ17‰ñ‹³ˆçƒZƒ~ƒi[ (2011/3/5), ‰¡•l.

H21”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H21-731010. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ”xŠà•úŽËüŽ¡—Â̌»ó‚Ɖۑè. ‘ì˜ad (•ú
ŽËü (Žîá‡)): L“‡”x‚ª‚ñŒ€‹†‰ïŠwpu‰‰‰ï (2010/2/18), L“‡.


–ƒŒ‰ÈŠw

[Šwp˜_•¶]

110256. [ŒŽ’˜] Effects of Intravenous Prostaglandin E1 on Pain and Body Temperature in Patients
with Post-Herpetic Neuralgia. Kanai A1, Wang G2, Hoshi K3, Okamoto H1: Pain Med 2010/4; 11 (4):
609-16. (‹àˆäº•¶1, ‰€@‘‹Õ2, ¯@‰À–F3, ‰ª–{_Žk1: 1–ƒŒ, 2’nˆæŽüŽYŠúE‹~‹}ˆã—Ã, 3‰q¶E
ŒöO‰q¶)

110257. [ŒŽ’˜] Lidocaine eyedrops attenuate pain associated with ophthalmic post-herpetic
neuralgia. Kanai S1, Okamoto T1, Suzuki K, Niki Y, Okamoto H1: Anesth Analg 2010/5; 110 (5): 1457-60.
(‹àˆäº•¶1, ‰ª–{@‹M1, ‰ª–{_Žk1: 1–ƒŒ)

120078. [ŒŽ’˜] ’鉀ØŠJpŒã’Á’É–@‚Æ‚µ‚Ä‚Ìtransverse abdominis plane block‚̉”\«?Œã•ûŽ‹“IŒ€
‹†?. ‰ª“c®Žq, ‰œ•xr”V1, ‘同—fŽq2, “V–ì@Š®2, ŠC–ìM–ç2 (1–ƒŒ, 2ŽY•w): •ª•Ø‚Æ–ƒŒ 2010;
92: 25-31.

120079. [ŒŽ’˜] ƒuƒhƒE“œ‚͏ö—¯…‚æ‚èƒeƒgƒ‰ƒJƒCƒ“‚̐_Œo“Ő«‚ðŒyŒž‚·‚é. •Ÿ“‡¹–é”T, ’|˜Q–¯]1,
–ö‰ºŽO˜Y, “ޗljÀ—m, ‰ª–{_Žk1 (1–ƒŒ): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ 2011/2; 18 (2): 34-9.

220025. [€ŒŽ’˜] 2008”NŽüpŠú”xŒŒðÇðÇ”­Ç’²žŒ‹‰Ê‚©‚猩‚œ–{–M‚É‚š‚¯‚éŽüpŠú”xŒŒðÇðÇ‚Ì
“Á’¥?(ŽÐ)“ú–{–ƒŒ‰ÈŠw‰ïˆÀ‘SˆÏˆõ‰ï”xŒŒðÇðÇƒ[ƒLƒ“ƒOƒOƒ‹[ƒv•ñ?. •Šâ­”V1, ŒÃ‰Æ@m,
£”öŒ›³, –kŒûŸN, ’†‘º^’ª, ²‹vŠÔ¹m, ’†”n—ˆê˜Y (1–ƒŒ): –ƒŒ 2010/5; 59 (5): 667-73.

520084. [‘à]y“ú–{—Տ°–ƒŒŠw‰ï‘æ29‰ñ‘å‰ï ƒVƒ“ƒ|ƒWƒEƒ€?ŽüpŠúÃ–¬ŒŒðÇðÇ‚ɑ΂·‚é–ò•š“I—\
–h–@?zŽüpŠúÃ–¬ŒŒðÇðÇ‚É‚š‚¯‚é–ò•š—\–h?–ƒŒ‰Èˆã‚Ì—§ê‚©‚ç?ƒ“ú–{–ƒŒ‰ÈŠw‰ïŽüpŠú”xÇð
Ç’²žŒ‹‰Ê‚æ‚聄. •Šâ­”V (–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ïŽ 2010/11; 30 (7): 996-1001.

520085. [‘à] œ”ՈʔDP‚ɑ΂·‚éŠO‰ñ“]p‚Ì–ƒŒ–@. •Šâ­”V1, ‰œ•xr”V1 (1–ƒŒ): •ª•Ø‚Æ–ƒŒ
2010/12; 92: 41-5.

521030. [‰ðà]yŽ¿‹^‰ž“š: ”D•w‚Ì‹Ø’oŠÉ–ò‚̍ì—p”­Œ»‚ɂ‚¢‚āzu”D•w‚Ì‘Sg–ƒŒ‚̍Û, ‹Ø’oŠÉ–ò‚̏\
•ª‚ÈŒø‰Ê‚ª“Ÿ‚ç‚ê‚é‚Ü‚Å‚ÉŽžŠÔ‚ª’·‚­‚©‚©‚é‚æ‚€‚ÉŽv‚¢‚Ü‚·, ‹Ø’oŠÉ–ò‚Ÿ‚¯‚È‚Ì‚©”D•w‚É“Š—^‚³‚ê‚é–ò•š
‚͈ê”ʂɍì—p”­Œ»‚Ü‚Å‚ÉŽžŠÔ‚ª’·‚­‚È‚é‚Ì‚© (–ò•š“®‘ÔŠw“I–â‘è?) ‚»‚Ì‹@˜‚ɂ‚¢‚Ä‚š‹³‚Š‚­‚Ÿ‚³‚¢.
‰œ•xr”V1, ‰Á“¡—¢ŠG1 (1–ƒŒ): —Տ°–ƒŒ 2011/2; 35 (2): 257-8.

522144. [uÀ] ”ì–žŠ³ŽÒ‚Æ—]è”畆Øœp‚ÌŽüpŠúŠÇ—. Vˆä³N (–ƒŒ): —Տ°–ƒŒ 2010/7; 34 (7):
1153-65.

522145. [uÀ]yƒCƒŒƒMƒ…ƒ‰[‚É‹­‚­‚È‚éI‹CŠÇ‘}ŠÇ‚̃oƒŠƒG[ƒVƒ‡ƒ“ƒpƒ^[ƒ“21zƒKƒ€ƒGƒ‰ƒXƒeƒBƒb
ƒNƒuƒW[‚ðŽg—p‚µ‚œ‹CŠÇ‘}ŠÇ. •Šâ­”V (–ƒŒ): ƒIƒyƒi[ƒVƒ“ƒO 2011/1; 26 (1): 85-8.

522146. [uÀ]yƒCƒŒƒMƒ…ƒ‰[‚É‹­‚­‚È‚éI‹CŠÇ‘}ŠÇ‚̃oƒŠƒG[ƒVƒ‡ƒ“ƒpƒ^[ƒ“21zèò•”L“W/ Œã‹ü‚ª
‚Å‚«‚È‚¢Ž–—á (—\‘ª‚³‚ê‚œ‘}ŠÇ¢“ï). •Šâ­”V (–ƒŒ): ƒIƒyƒi[ƒVƒ“ƒO 2011/1; 26 (1): 89-92.

522147. [uÀ]yƒCƒŒƒMƒ…ƒ‰[‚É‹­‚­‚È‚éI‹CŠÇ‘}ŠÇ‚̃oƒŠƒG[ƒVƒ‡ƒ“ƒpƒ^[ƒ“21zŠJŒû‚Å‚«‚È‚¢Ž–—á
(—\‘ª‚³‚ê‚œ‘}ŠÇ¢“ï). •Šâ­”V (–ƒŒ): ƒIƒyƒi[ƒVƒ“ƒO 2011/1; 26 (1): 93-5.

522148. [uÀ]yƒCƒŒƒMƒ…ƒ‰[‚É‹­‚­‚È‚éI‹CŠÇ‘}ŠÇ‚̃oƒŠƒG[ƒVƒ‡ƒ“ƒpƒ^[ƒ“21zã‹C“¹è‹’«•a•Ï
(—\‘ª‚³‚ê‚œ‘}ŠÇ¢“ï). •Šâ­”V (–ƒŒ): ƒIƒyƒi[ƒVƒ“ƒO 2011/1; 26 (1): 96-8.

522149. [uÀ]yÇ—ጟ“¢z”D•w‚ÌŒŒ¬”ÂŒž­Ç: ³Šm‚Ȑf’f‚É‚à‚Ƃ¢‚Ē鉀ØŠJ‚É•K—v‚ÈŒŒ¬””‚ð
Šm•Û‚·‚é. ‰Á“¡—¢ŠG (–ƒŒ): LiSA 2011/1; 18 (1): 36-41.

522150. [uÀ]ypŒã’Á’Ɂz‘Sg–ƒŒ‚É‚æ‚é’鉀ØŠJp: ”D•w‚Ì“Á«‚𓥂܂Š‚čאS‚Ì’ˆÓ‚𕥂¢, pŒã
‚̈玙‚܂ŐS”z‚è‚ð! ‰œ•xr”V1, ‰Á“¡—¢ŠG1 (1–ƒŒ): LiSA 2011/3; 18 (3): 270-3.

540094. [‚»‚Ì‘Œ (’²ž•ñ)] 2008”N“ú–{–ƒŒ‰ÈŠw‰ïEŽüpŠú”xŒŒðÇðÇ”­Ç’²žŒ‹‰Ê‚Ì•ñ. •Šâ
­”V1, –kŒûŸN, £”öŒ›³, ŒÃ‰Æ@m, ’†‘º^’ª, ²‹vŠÔ¹m, ’†”n—ˆê˜Y, ‰¡“c”üK (1–ƒŒ): S‘Ÿ
2010/7; 42 (7): 988-9.

540095. [‚»‚Ì‘Œ (to the Editor)] iPad: –ƒŒ‰Èˆã‚ÌŽ —{‹­‘s‚É, ‚±‚Ì1ù (tablet) ‚Í‚æ‚­Œø‚«‚Ü‚·.
•Šâ­”V (–ƒŒ): LiSA 2010/8; 17 (8): 832-4.

[’˜@‘]

620146. [Šwp‘] (•ª’SŽ·•M)yJSAƒŠƒtƒŒƒbƒVƒƒ[ƒR[ƒX2008zŠë‹@ŠÇ—E–ƒŒ‚̈À‘S@”xŒŒðÇðÇ@
ŽüpŠú‚̃TƒCƒŒƒ“ƒgEƒLƒ‰[‘΍ô, p.1-10. •Šâ­”V (–ƒŒ), •Ò (ŽÐ) “ú–{–ƒŒ‰ÈŠw‰ï ‹³ˆçˆÏˆõ‰ïE
ˆÀ‘SˆÏˆõ‰ï, ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 2010/5”­s.

620147. [Šwp‘] (•ª’SŽ·•M)yÃ–¬ŒŒðÇðÇƒKƒCƒhƒuƒbƒN (‰ü’ù‘æ2”Å)zII. ”xŒŒðÇðÇ@3. Å
‹ß‚Ì“®Œü, p.35-44. •Šâ­”V (–ƒŒ), •Ò’˜ ¬—Ñ—²•v, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2010/4”­s.

620148. [Šwp‘] (•ª’SŽ·•M)yÃ–¬ŒŒðÇðÇ—\–hƒKƒCƒhƒuƒbƒN@ƒGƒLƒXƒp[ƒgƒIƒsƒjƒIƒ“zIÍ ‘˜_@
Ã–¬ŒŒðÇðÇ‚̉uŠw, p.1-7. •Šâ­”V (–ƒŒ), •Ò •yŽm•Žj, ¶‹ßŒ«l, “ì]“°, “Œ‹ž, 2010/4”­s.

620149. [Šwp‘] (•ª’SŽ·•M)y–ƒŒ‰Èƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOAtoZz‘æ1•” p‘O@‘æIIÍ zŠÂŠí@o
ŒŒ‚µ‚Ä‚¢‚ÄŒŒˆ³‚ª’á‚¢, p.109-10. •Šâ­”V1 (1–ƒŒ), •Ò ‚èáÁ‹|, ‰Í–{¹Žu, ì^“cŽ÷l, ‰ª–{_
Žk1, •¶Œõ“°, “Œ‹ž, 2010/10”­s.

620150. [Šwp‘] (•ª’SŽ·•M)y–ƒŒ‰Èƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOAtoZz‘æ1•” p‘O@‘æIIÍ zŠÂŠí @Ã
–¬ŒŒðÇðÇ‚ª‚ ‚é, p.112-3. •Šâ­”V1 (1–ƒŒ), •Ò ‚èáÁ‹|, ‰Í–{¹Žu, ì^“cŽ÷l, ‰ª–{_Žk
1, •¶Œõ“°, “Œ‹ž, 2010/10”­s.

620151. [Šwp‘] (•ª’SŽ·•M)y–ƒŒ‰Èƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOAtoZz‘æ1•” p‘O@‘æXÍ ŽY•wl‰È@’é
‰€ØŠJ‚ÌŠ³ŽÒ‚ª‘Sg–ƒŒ‚ðŠó–]‚µ‚Ä‚¢‚é, p.286-7. ‰œ•xr”V1 (1–ƒŒ), •Ò ‚èáÁ‹|, ‰Í–{¹Žu, ì
^“cŽ÷l, ‰ª–{_Žk1, •¶Œõ“°, “Œ‹ž, 2010/10”­s.

620152. [Šwp‘] (•ª’SŽ·•M)y–ƒŒ‰Èƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOAtoZz‘æ1•” p‘O@‘æXÍ ŽY•wl‰È@”D
P‚ŒŒˆ³ÇŒóŒQ‚ª‚ ‚é, p.289-91. ‰œ•xr”V1 (1–ƒŒ), •Ò ‚èáÁ‹|, ‰Í–{¹Žu, ì^“cŽ÷l, ‰ª–{_
Žk1, •¶Œõ“°, “Œ‹ž, 2010/10”­s.

620153. [Šwp‘] (•ª’SŽ·•M)y–ƒŒ‰Èƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOAtoZz‘æ2•” p’†EpŒã@‘æIIÍ z
ŠÂŠí@”xŒŒðÇðÇ‚ª‹^‚í‚ê‚é, p.431-3. •Šâ­”V1 (1–ƒŒ), •Ò ‚èáÁ‹|, ‰Í–{¹Žu, ì^“cŽ÷l,
‰ª–{_Žk1, •¶Œõ“°, “Œ‹ž, 2010/10”­s.

620154. [Šwp‘] (•ª’SŽ·•M)y–ƒŒ‰Èƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOAtoZz‘æ2•” p‘OEpŒã@‘æVÍ ŒŒ‰tE
Ž~ŒŒ‹ÃŒÅŒn‹@”\@ŒŒ‰t»Ü‚ªÃ–¬ƒ‹[ƒg‚©‚ç˜R‚ê‚œ, p.472. •Šâ­”V1 (1–ƒŒ), •Ò ‚èáÁ‹|, ‰Í–{
¹Žu, ì^“cŽ÷l, ‰ª–{_Žk1, •¶Œõ“°, “Œ‹ž, 2010/10”­s.

620155. [Šwp‘] (•ª’SŽ·•M)y–ƒŒ‰Èƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOAtoZz‘æ2•” p‘OEpŒã@‘æVÍ ŒŒ‰tE
Ž~ŒŒ‹ÃŒÅŒn‹@”\@d–ŒŠOƒJƒe[ƒeƒ‹—¯’uŠ³ŽÒ‚ɍR‹ÃŒÅ–ò‚ð“Š—^‚µ‚œ, p.490-1. •Šâ­”V1 (1–ƒŒ), •Ò
‚èáÁ‹|, ‰Í–{¹Žu, ì^“cŽ÷l, ‰ª–{_Žk1, •¶Œõ“°, “Œ‹ž, 2010/10”­s.

620156. [Šwp‘] (–|–ó)yÅV ŽY‰È–ƒŒƒnƒ“ƒhƒuƒbƒN@‰ü’ù‘æ2”Łz‰œ•xr”V (–ƒŒ), ƒƒWƒJƒ‹ƒrƒ…
[ŽÐ, “Œ‹ž, 2011/2”­s.

[Šw‰ïEŒ€‹†‰ï“™]

711003. [Šw‰ï (‘Û)] (“Á•Êu‰‰) General anesthesia for cesarean delivery; indications, risks and
benefits. Okutomi T1: 2nd International Congress of the Society of Anesthesiology and Perinatal
Medicine (2010/10/5), Poznan, Poland. (‰œ•xr”V1: 1–ƒŒ)

713178. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Localization and high-potassium intake-induced
expression of mineralcorticoid receptor (MR) mRNA in mouse kidney nephron. Kobayashi M1, Yasuoka
Y2, Okamoto H1, Kawahara K2: ISN NEXUS Symposium Kidney and Vascular system:Emerging Culprits in
pathogenesis and advances inTherapy (2010/4/16), Kyoto. (¬—ѐ‰À1, ˆÀ‰ª—L‹IŽq2, ‰ª–{_Žk1, ‰Í
ŒŽŽ‰ë2: 1–ƒŒ, 2¶—)

713179. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Neurotropin attenuates pain associated with trigeminal
neuralgia refractory to treatment. Ogoshi K1, Kanai A1, Okamoto H1: American Society of
Anesthesiologists (2010/10/18), San Diego, USA. (¶‰zŽq1, ‹àˆäº•¶1, ‰ª–{_Žk1: 1–ƒŒ)

713180. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Oral application of 8% lidocaine spray for patients
with trigeminal neuralgia. Konndo Y1, Niki Y, Kanai A1, Okamoto H1: American Society of
Anesthesiologists (2010/10/18), San Diego, USA. (‹ß“¡—S‰î1, m–Ø—L—Žq, ‹àˆäº•¶1, ‰ª–{_Žk1:
1–ƒŒ)

713181. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The segmental level of initial warm sensation during
intrathecal injection of isobaric bupivacaine. Kanai A1, Ogoshi K1, Okamoto H1: American Society
of Anesthesiologists (2010/10/18), San Diego, USA. (‹àˆäº•¶1, ¶‰zŽq1, ‰ª–{_Žk1: 1–ƒŒ)

713182. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Incedence and Risk Factors for perioperative Pulmonary
Thromboembolism in Japan. Kuroiwa M1: American Association of Anesthesiologists Anual meeting
2010 (2010/10/21), San Diego, USA. (•Šâ­”V1: 1–ƒŒ)

713183. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Lower Incidence of Spinal Tetracaine Neurotoxicity
Dissolved in 10% Glucose Than in Distilled Water. Fukushima S, Takenami T1, Nara Y, Hiruma H2,
Kawakami T2: Anesthesiology 2010 (2010/10/19), ƒVƒJƒS, •Ä‘. (’|˜Q–¯]1, ”ä—¯ŠÔO”ü2, ìã@—Ï
2: 1–ƒŒ, 2¶—)

713184. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Reduced Incidence of Tetracaine Neurotoxicity in
Glucose Solution Is Independent of Hyperosmolarity. Takenami T1, Fukushima S, Nara Y, Hiruma H2,
Okamoto H1: Anesthesiology 2010 (2010/10/19), ƒVƒJƒS, •Ä‘. (’|˜Q–¯]1, ”ä—¯ŠÔO”ü2, ‰ª–{_Žk
1: 1–ƒŒ, 2¶—)

713185. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Safety of Intrathecally Administered High-Dose
Clonidine in Rats. Takenami T1, Fukushima S, Nara Y, Hiruma H2, Kawakami T2: Anesthesiology 2010
(2010/10/19), ƒVƒJƒS, •Ä‘. (’|˜Q–¯]1, ”ä—¯ŠÔO”ü2, ìã@—Ï2: 1–ƒŒ, 2¶—)

713186. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) S-Form Ropivacaine and Levobupivacaine Are Less
Neurotoxic Than Procaine and Bupivacaine in Rat. Takenami T1, Nara Y, Hiruma H2, Fukushima S,
Kawakami T2: Anesthsiology 2010 (2010/10/19), ƒVƒJƒS, •Ä‘. (’|˜Q–¯]1, ”ä—¯ŠÔO”ü2, ìã@—Ï
2: 1–ƒŒ, 2¶—)

721021. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) S‘ŸŽèp‚É‚š‚¯‚éTEE‚Ì–ðŠ„. ‰ª–{_Žk (–ƒŒ): “ú–{S‘ŸŒŒŠÇ–ƒ
ŒŠw‰ï‘æ15‰ñŠwp‘å‰ï (2010/10/8), “Œ‹ž.

722228. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ŽüpŠú”xŒŒðÇðÇ. •Šâ­”V (–ƒŒ): “ú–{–ƒ
Œ‰ÈŠw‰ï@‘æ58‰ñŠwpW‰ïE‘‰ï (2011/5/21), _ŒË.

722229. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –¢—ˆ‚̏p’†zŠÂ§Œä–ƒŒŠÇ—@ƒ‚ƒjƒ^[‚Æ‚µ‚Ä‚Ì
3ŽŸŒ³S‘Ÿƒ‚ƒfƒ‹. ‰ª–{_Žk (–ƒŒ): ‘æ31‰ñ“ú–{zŠÂ§ŒäˆãŠw‰ï‘‰ï (2010/5/28), ‘åã.

722230. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ”ñS‘ŸŽèp‚ÆTEE. ‰ª–{_Žk (–ƒŒ): “ú–{–ƒŒ
‰ÈŠw‰ï‘æ57‰ñŠwpW‰ï (2010/6/3), •Ÿ‰ª.

722231. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) PBLD ‹ÇŠ–ƒŒ‚ƍR‹ÃŒÅ—Ö@. •Šâ­”V (–ƒŒ): “ú
–{–ƒŒ‰ÈŠw‰ï‘æ57‰ñŠwpW‰ï (2010/6/4), •Ÿ‰ª.

722232. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Šé‹Æ‹€ÏƒZƒ~ƒi[ ŽüpŠú”xŒŒðÇðÇ—\–h‚̃lƒN
ƒXƒgƒXƒe[ƒW. •Šâ­”V (–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ57‰ñŠwpW‰ï (2010/6/5), •Ÿ‰ª.

722233. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) –ƒŒ‰Èˆã‚©‚猩‚œÃ–¬ŒŒðÇðÇ. •Šâ­”V (–ƒ
Œ): ‘æ37‰ñ“ú–{ŒÒŠÖßŠw‰ïŠwpW‰ï (2010/10/2), •Ÿ‰ª.

722234. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ’鉀ØŠJp‚É‚š‚¯‚éÒ‘‚­‚à–Œ‰º–ƒŒ‚̃Xƒ^ƒ“ƒ_
[ƒh. ‰Á“¡—¢ŠG (–ƒŒ): ‘æ114‰ñ“ú–{ŽY‰È–ƒŒŠw‰ï (2010/12/4), ‰¡•l.

723930. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Histological analysis of Cauda equina syndrome after
intrathecal lidocain neurotoxicity in rat. ’|˜Q–¯]1, “ޗljÀ—m, ”ä—¯ŠÔO”ü2, ìã@—Ï2 (1–ƒ
Œ, 2¶—): ‘æ87‰ñ“ú–{¶—Šw‰ï‘å‰ï (2010/5/19), ·‰ª.

723931. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒNƒƒjƒWƒ“‚̐_Œo“Ő«Œ€‹†. •Ÿ“‡¹–é”T, ’|˜Q–¯]1, ŽR
“c—R1, ’·ŒŽ—R‹M1, ¶‰zŽq1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ57‰ñŠwpW‰ï (2010/6/3), •Ÿ
‰ª.

723932. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰ºŽˆŒŒŠÇV¶Ž¡—Âɑ΂·‚鎝‘±Ò‘‚­‚à–Œ‰º–ƒŒŠÇ—.
‹ß“¡—S‰î1, ‰ª–{@‹M1, m–Ø—L—Žq, —é–Ø–ƒ—t1, ‹àˆäº•¶1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ
57‰ñŠwpW‰ï (2010/6/4), •Ÿ‰ª.

723933. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ò‘‚­‚à–Œ‰º–ƒŒ‚É‚š‚¯‚鉷ŠŽ”­¶ŠJŽn•”ˆÊ‚ÆŠŽŠoŽÕ’f
ˆæ‚ÌŠÖŒW. ‰ª–{@‹M1, ‹àˆäº•¶1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï‘æ57‰ñŠwpW‰ï (2010/6/4),
•Ÿ‰ª.

723934. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒeƒƒCƒh’ZŠú“Š—^‚É‚æ‚è‰ü‘P‚µ‚œŒz•”’ŊԔƒwƒ‹ƒjƒA
‚É”º‚€Œƒ’É. —с@Œol1, ‹àˆäº•¶1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ44‰ñ‘å‰ï
(2010/7/2), ‹ž“s.

723935. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) å’°ŠÖß‰Š‚ɑ΂·‚éå’°ŠÖß“à’ŽË‚Ì—LŒø«‚ÌŒŸ“¢. ’·
ŒŽ—R‹M1, ‰ª–{@‹M1, ‹àˆäº•¶1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ44‰ñ‘å‰ï
(2010/7/2), ‹ž“s.

723936. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«˜‰ºŽˆ’ÉŠ³ŽÒ‚ɑ΂·‚éÒ‘‚­‚à–Œ‰º_ŒoƒuƒƒbƒN.
‰ª–{@‹M1, ’·ŒŽ—R‹M1, ‹àˆäº•¶1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ44‰ñ‘å‰ï
(2010/7/2), ‹ž“s.

723937. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒuƒhƒE“œ‚͐Z“§ˆ³‚ÉŠÖ‚í‚ç‚žƒeƒgƒ‰ƒJƒCƒ“‚̐_Œo“Ő«‚ð
ŒyŒž‚·‚é. •Ÿ“‡¹–é”T, ’|˜Q–¯]1, “ޗljÀ—m, ¶‰zŽq1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒb
ƒNŠw‰ï‘æ44‰ñ‘å‰ï (2010/7/3), ‹ž“s.

723938. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž‘±––œ_ŒoƒuƒƒbƒN‚É‚æ‚è‰ü‘P‚µ‚œ“«Œz•”‘яóáv
]ŠÖ˜A’É‚Ì2Ç—á. m–Ø—L—Žq, ‹àˆäº•¶1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ44‰ñ
‘å‰ï (2010/7/3), ‹ž“s.

723939. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 3ŽŸŒ³ŒoH“¹SƒGƒR[‚ÅŒŸo‚³‚ê‚œ‘•’…lH•Ù—Ö‚É‚æ‚é
‘m–X•Ù—ÖŒ`‘Ԃ̍·ˆÙ. ‰ª–{_Žk1, ŒË“c‰ë–ç1, •º“ªˆŸ‹IŽq (1–ƒŒ): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ15‰ñŠw
p‘å‰ï (2010/10/9), “Œ‹ž.

723940. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Fontan pŒãŠ³ŽÒ‚̉¡Šu–Œ–Dkp‚Ì–ƒŒŠÇ—. •º“ªˆŸ‹I
Žq, ŒË“c‰ë–ç1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ15‰ñŠwp‘å‰ï (2010/10/9), “Œ‹ž.

723941. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚ð‡•¹‚µdÇS•s‘S‚ð’悵‚œ‘å“®–¬
•Ù•Âœ•s‘SÇ‚Ì–ƒŒŒoŒ±. ŒË“c‰ë–ç1, •º“ªˆŸ‹IŽq, ¬â‹Žr”ü2, ‰ª–{_Žk1 (1–ƒŒ, 2zŠÂŠí“à): “ú
–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ15‰ñŠwp‘å‰ï (2010/10/9-10), “Œ‹ž.

723942. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) iPad‚ð—p‚¢‚œ“®‰æ‚É‚æ‚ép‘O–ƒŒ–@à–Ÿ‚Ì—L—p«. Ž
–쏃Žq1, Š‰Y’ŒŽq1, Œ“cO”ü1, •Šâ­”V1, Vˆä­”V1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ
30‰ñ‘å‰ï (2010/11/4), “¿“‡.

723943. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) pŒã‰ñ•œŽº‚ňӎ¯’ቺ‚ƌċz—}§‚𗈂µ‚œ8—á‚ÌŒŸ“¢.
‘å’Ë’q‹v1, Vˆä³N1, ¬—ѐ‰À1, •Ÿ“‡¹–é”T, ˆé–ì‰ëŽq, •Šâ­”V1, ‹àˆäº•¶1, ‰ª–{_Žk1 (1–ƒ
Œ): “ú–{—Տ°–ƒŒŠw‰ï‘æ30‰ñ‘å‰ï (2010/11/4), “¿“‡.

723944. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é‹Ù‹}ƒR[ƒ‹1”NŠÔ‚̏WŒv. Vˆä³N1, ’·
ŒŽ—R‹M1, ‹ß“¡—S‰î1, ‰ª–{@‹M1, ŒÃ“¡³“T, åUdçŠG, •Šâ­”V1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒ
ŒŠw‰ï‘æ30‰ñ‘å‰ï (2010/11/4), “¿“‡.

723945. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ò‘‚­‚à–Œ‰º–ƒŒŽ{sŽž‚ɋǏŠ–ƒŒ–ò‚̍L‚ª‚è‚ð‹K’è‚·
‚éˆöŽq‚ª‚ ‚é‚©? Œ“cO”ü1, ‰ª“c®Žq, ‰œ•xr”V1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ï‘æ30‰ñ
‘å‰ï (2010/11/5), “¿“‡.

723946. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Neurotoxicity of intrathecal clonidine in rats. ’|
˜Q–¯]1, ”ä—¯ŠÔO”ü2, ìã@—Ï2 (1–ƒŒ, 2¶—): ‘æ88‰ñ“ú–{¶—Šw‰ï‘å‰ï (2011/3/30), ‰¡•l. Š
kÐ‚Ì‚œ‚ß‘å‰ïŠJÃ’†Ž~ (The Journal of Physiological SciencesŽã‚Å”­•\)

731145. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒGƒrƒfƒ“ƒX‚ÉŠî‚¢‚œ’鉀ØŠJp‚Ì–ƒŒŒv‰æ (Šî‘b•Ò).
‰œ•xr”V (–ƒŒ): ‘æˆê‰ñŽáŽè–ƒŒˆãŽt‚Ì‚œ‚ß‚Ì–ƒŒ‰Èf—ÍőOüƒZƒ~ƒi[ (2009/11/21), ‘åã.

731146. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’鉀ØŠJp‚Ì–ƒŒ‚ÌŠî‘b‚ƍŋ߂̍l‚Š•û. ‰œ•xr”V (–ƒ
Œ): Ã‰ª–ƒŒˆã‰ï (2010/5/29), Ã‰ª.

731147. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ŽOŽŸŒ³ŒoH“¹SƒGƒR[‚ÌŒ»‹µ‚Æ–¢—ˆ. ‰ª–{_Žk (–ƒŒ):
‘æ3‰ñé‹ÊS‘ŸŒŒŠÇŠO‰ÈŽüpŠúŠÇ—ƒtƒH[ƒ‰ƒ€ (2010/6/19), ‘å‹{.

731148. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ’鉀ØŠJp‚Ì–ƒŒ–@‚ÌŠî‘b‚Æ‚»‚Ì•›ì—p‘΍ô. ‰œ•xr”V
(–ƒŒ): ‹ãB–ƒŒ‰ÈŠw‰ï‘æ48‰ñ‘å‰ï (2010/9/25), ”Ž‘œ.

733459. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é—\Šú‚¹‚Ê‘}ŠÇ¢“ïÇ—á‚ÌŒŸ“¢. ŒÃ
“¡³“T, •Šâ­”V1, VˆäŠìN, ’J@«¯, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï ŠÖ“ŒbM‰zE“Œ‹žŽx•”
‘æ50‰ñ ‡“¯ŠwpW‰ï (2010/9/11), “Œ‹ž.

733460. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) _Œo«HŽv•sUÇ‡•¹‹‘å—‘‘ƒŽîᇓEoŒã‚É
”­¶‚µ‚œÄ–c’£«”x…Žî‚̈ê—á. Ž–쏃Žq1, Vˆä³N1, •º“ªˆŸ‹IŽq, ŒË“c‰ë–ç1, ‰ª–{_Žk1 (1–ƒŒ):
“ú–{–ƒŒ‰ÈŠw‰ï ŠÖ“ŒbM‰zE“Œ‹žŽx•”‘æ50‰ñ ‡“¯ŠwpW‰ï (2010/9/11), “Œ‹ž.

733461. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tŠà“Eop’†‚É”x“]ˆÚ‘ƒ‚©‚ç‹C“¹“àoŒŒ‚µ‚œ
ˆê—á. ŽRèGŒp, Vˆä³N1, ‘ dçŠG, ŒÃ“¡³“T, •Šâ­”V1, ‰ª–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ÈŠw‰ï
ŠÖ“ŒbM‰zE“Œ‹žŽx•”‘æ50‰ñ‡“¯ŠwpW‰ï (2010/9/11), “Œ‹ž.

733462. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ”²ŠÇŒã‚̏ã‹C“¹•ÂÇ‚Ɉø‚«‘±‚¢‚ĉAˆ³«”x…
Žî‚𗈂µ‚œˆê—á. Š‰Y’ŒŽq1, Vˆä³N1, ’·ŒŽ—R‹M1, —é–Ø–ƒ—t1, •Šâ­”V1, ‰ª–{_Žk1 (1–ƒŒ): “ú
–{–ƒŒ‰ÈŠw‰ï ŠÖ“ŒbM‰zE“Œ‹žŽx•”‘æ50‰ñ ‡“¯ŠwpW‰ï (2010/9/11), “Œ‹ž.

H21”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H21-713007. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) THE EFFECT OF ULTRASOUND GUIDED TRANSVERSUS
ABDOMINIS PLANE BLOCKS ON THE DURATION OF THE FIRST ANALGESIC REQUIREMENT FOLLOWING CESAREAN
DELIVERY. Okutomi T1, Okada H, Ohnishi Y, Amano K2, Unno N2: 84th International Anesthesia Research
Society (2010/3/20), Honolulu, Hawaii. (‰œ•xr”V1, “V–ì@Š®2, ŠC–ìM–ç2: 1–ƒŒ, 2ŽY•w)

H21-713008. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) THE FACTORS ON INTRATHECAL DRUG SPREAD AT THE
INITIATION OF LABOR ANALGESIA. Okada H, Okutomi T1, Amano K2, Unno N2: 84th International
Anesthesia Research Society (2010/3/21), Honolulu, Hawaii. (‰œ•xr”V1, “V–ì@Š®2, ŠC–ìM–ç2: 1
–ƒŒ, 2ŽY•w)


—Տ°ŒŸžf’fŠw

[Šwp˜_•¶]

110258. [ŒŽ’˜] Acute inflammatory biomarkers in cerebrospinal fluid as indicator of blood
cerebrospinal fluid barrier damage in Japanese subjects with infectious meningitis. Kanoh Y1,
Ohara T, Akahoshi T2: Clin Lab 2011/1-2; 57 (1-2): 37-46. (Žë–ì—Lì1, ‘匎³Žu, Ô¯@“§2: 1
—ÕŒŸŠw, 2‘‡f—Ã)

110259. [ŒŽ’˜] Cognate interaction plays a key role in the surveillance of autoreactive B cells
in induced mixed bone marrow chimerism in BXSB lupus mice? Takeuchi E1, Takeuchi Y2: Autoimmunity
2011/1; 19 (Epub ahead of print). (’|“àŒb”üŽq1, ’|“àN—Y2: 1—ÕŒŸŠw, 2t‘Ÿ“à)

220026. [€ŒŽ’˜]y‘æ67‰ñŠÖ“ŒEbM‰zŽx•”—á‰ïz“®–¬d‰»‚̐¶‰»Šwƒ}[ƒJ[‚Ɛ¶—ŒŸž?R“®–¬d‰»
—Ö@‚É‚š‚¯‚é•Ï“®‚Æ‚»‚Ì—L—p«‚ɂ‚¢‚Ä?. Žë–ì—Lì (—ÕŒŸŠw): —Տ°•a— 2011/1; 59 (1): 80-8.

[Šw‰ïEŒ€‹†‰ï“™]

723947. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) MHCŠ®‘S•sˆê’vƒhƒi[‚©‚ç‚̍œ‘ˆÚA‚É‚æ‚鎩ŒÈ–ƉuŒŒ
¬”ÂŒž­Ç‚ÌŠ®‘S‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ’|“àŒb”üŽq1, Žë–ì—Lì1 (1—ÕŒŸŠw): ‘æ57‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ï
ŠwpW‰ï (2010/9/10), “Œ‹ž.

732112. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) “®–¬d‰»‚̐¶‰»Šwƒ}[ƒJ[‚Ɛ¶—ŒŸž
?R“®–¬d‰»—Ö@‚É‚š‚¯‚é•Ï“®‚Æ‚»‚Ì—L—p«‚ɂ‚¢‚Ä?. Žë–ì—Lì (—ÕŒŸŠw): ‘æ67‰ñ“ú–{—Տ°ŒŸžˆã
Šw‰ïŠÖ“ŒbM‰zŽx•”—á‰ï (2010/5/29), _“ސì.


—AŒŒE×–EˆÚAŠw

[Šwp˜_•¶]

110260. [ŒŽ’˜] CD3- and CD4-positive plasmablastic lymphoma: A literature review of Japanese
plasmablastic lymphoma cases. Suzuki Y1, Yoshida T2, Nakamura N, Kamata H3, Kotani S4, Ohsaka
M3, Kajita S2, Miyazaki K3, Ohtani S1, Nakayama M5, Horie R3, Hayakawa K4, Niitsu N, Higashihara
M3: Intern Med 2010; 49 (16): 1801-5. (—é–Ø—TŽq1, ‹g“c@Œ÷2, Š™“c_–«3, ¬’J³Žq4, ‘åâ@Šw
3, Š“cç”ü”T2, ‹{è_“ñ3, ‘å’JTˆê1, ’†ŽR–Ÿm5, –x]—Ljê3, ‘ì˜ad4, “ŒŒŽ³–Ÿ3: 1—AŒŒE
×–EˆÚA, 2•a—, 3ŒŒ‰t“à, 4•úŽËü (Žîá‡), 5Žš•@)

110261. [ŒŽ’˜] Constitutive activity of nuclear transcription factor kappaB is observed in
follicular lymphoma. Suzuki Y1, Yoshida T2, Horie R3, Tsuruta T, Togano T3, Ohsaka M3, Miyazaki
K3, Danbara M3, Ohtani S1, Okayasu I2, Higashihara M3: J Clin Exp Hematop 2010; 50 (1): 45-50.
(—é–Ø—TŽq1, ‹g“c@Œ÷2, –x]—Ljê3, ’Ì–ì•x‹P3, ‘åâ@Šw3, ‹{è_“ñ3, ’hŒŽŠ²¶3, ‘å’JTˆê1, ‰ª
ˆÀ@ŒM2, “ŒŒŽ³–Ÿ3: 1—AŒŒE×–EˆÚA, 2•a—, 3ŒŒ‰t“à)

310018. [Ç—á•ñ] Schnitzler's syndrome with prominent neutrophil infiltration misdiagnosed as
Sweet's syndrome: a typical example of urticarial neutrophilic dermatosis. Asahina A, Sakurai
N, Suzuki Y1, Narushima K: Clin Exp Dermatol 2010/6; 35 (4): e123-6. (—é–Ø—TŽq1: 1—AŒŒE×–E
ˆÚA)

310019. [Ç—á•ñ] A case of giardiasis expressing severe systemic symptoms and marked
hypereosinophillia. Suzuki Y1, Nakamura T, Tokoro M, Togano T2, Ohsaka M2, Kohri M, Hirata Y,
Miyazaki K2, Danbara M2, Horie R2, Miura I, Sunakawa K, Higashihara M2: Parasitol Int 2010/9; 59
(3): 487-9. (—é–Ø—TŽq1, ’Ì–ì•x‹P2, ‘åâ@Šw2, ‹{è_“ñ2, ’hŒŽŠ²¶2, –x]—Ljê2, “ŒŒŽ³–Ÿ2: 1
—AŒŒE×–EˆÚA, 2ŒŒ‰t“à)

320046. [Ç—á•ñ] ’˜‚µ‚¢DŽ_‹…‘‘œ‚Æ‘œÊ‚È‘SgÇó‚𔺂Á‚œƒWƒAƒ‹ƒWƒAÇ‚̈ê—á. —é–Ø—TŽq1, ’Ì
–ì•x‹P2, ‘åâ@Šw2, ŒS@”ü‰À, ‹{è_“ñ2, –x]—Ljê2, “ŒŒŽ³–Ÿ2, ’†‘º@Œ’3, Š@³Ž¡ (1—AŒŒE
×–EˆÚA, 2ŒŒ‰t“à, 3Šñ¶’Ž): “ú–{—Տ°Šñ¶’ŽŠwŽGŽ 2011/2; 21 (1): 12-5.

530010. [‚»‚Ì‘Œ (Letters to the Editor)] Bullous amyloidosis mimicking bullous pemphigoid:
usefulness of electron microscopic examination. Asahina A, Hasegawa K, Ishiyama M, Miyagaki T,
Tada Y, Suzuki Y1, Kanabe T, Saito I: Acta Derm Venereol 2010/7; 90 (4): 427-8. (—é–Ø—TŽq1: 1
—AŒŒE×–EˆÚA)

540096. [‚»‚Ì‘Œ (’²ž•ñ)]y•œ¬22”N“x_“ސ쌧‡“¯—AŒŒ—Ö@ˆÏˆõ‰ïŒŒ‰t»Ü‚Ì“K³Žg—p‚ði‚ß‚é‚œ
‚ß‚É?“K³Žg—pŽÀ‘H‚Ì‚œ‚ß‚ÌŽÀ‘Ô’²žŒ‹‰Ê•ñzS‘ŸŒŒŠÇŠO‰È—̈æ. ‘å’JTˆê (—AŒŒE×–EˆÚA): _“Þ
ìŒ§‡“¯—AŒŒ—Ö@ˆÏˆõ‰ï 2011/3; p.42-56.

[Šw‰ïEŒ€‹†‰ï“™]

723948. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž©ŒÈ––œŒŒŠ²×–EÌŽæŽž‚ɃAƒiƒtƒBƒ‰ƒLƒV[‚𗈂µ‚œˆê
—á. Šp“c—TŽq1, ¬–{”ü“Þ, •—ŠÔ‚ ‚«‚Ý, ‚–ì”g—¯”ü, ”ª–ؘa¢, •œ“c‘×—Ç, ‹{è_“ñ2, ‘å’JTˆê1, “Œ
ŒŽ³–Ÿ2, ¬ŒŽ–M‹` (1—AŒŒE×–EˆÚA, 2ŒŒ‰t“à): ‘æ58‰ñ“ú–{—AŒŒE×–EŽ¡—Êw‰ï‘‰ï (2010/5/30), –Œ
ŒÃ‰®.

723949. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) DŽ_‹…‘‘œ‚Æ‘œÊ‚È‘SgÇó‚𔺂Á‚œƒWƒAƒ‹ƒWƒAÇ‚̈ê
—á. Šp“c—TŽq1, ’†‘º@Œ’2 (1—AŒŒE×–EˆÚA, 2Šñ¶’ŽŠw): —Տ°Šñ¶’ŽŠw‰ï (2010/6/19), “È–Ø.

723950. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Affect of aberrant T cell antigen expression on DLBCL
patients' background and prognosis. Šp“c—TŽq1, ‹g“c@Œ÷2, ‰€@‘‹Õ3, Aoki T, Š™“c_–«4, ‰¥@
‘cœ4, –Ø‘º—T˜a4, Îˆä—²Ži4, Katayama T, ‘åâ@Šw4, ‹{è_“ñ4, ’hŒŽŠ²¶4, ‘å’JTˆê1, ŠâŸºŒ[
ˆê2, –x]—Ljê4, “ŒŒŽ³–Ÿ4 (1—AŒŒE×–EˆÚA, 2•a—, 3’nˆæŽüŽYŠúE‹~‹}, 4ŒŒ‰t“à): ‘æ72‰ñ“ú–{
ŒŒ‰tŠw‰ï‘‰ï (2010/9/25), ‰¡•l.


‹~–œ‹~‹}ˆãŠw

[Šwp˜_•¶]

110262. [ŒŽ’˜] Postoperative surgical site infection following acetabular fracture fixation.
Suzuki T1, Morgan SJ, Smith WR, Stahel PF, Gillani SA, Hak DJ: Injury 2010/4; 41 (4): 396-9. (—é
–؁@‘ì1: 1‹~–œ)

110263. [ŒŽ’˜] Combined Injuries of the Pelvis and Acetabulum: Nature of a Devastating Diad.
Suzuki T1, Smith WR, Hak DJ, Stahel PF, Baron AJ, Gillani SA, Morgan SJ: J Orthop Trauma 2010/5;
24 (5): 303-8. (—é–؁@‘ì1: 1‹~–œ)

110264. [ŒŽ’˜] Neurocysticercosis: Assessing where the infection was acquired form. Yanagida T,
Yuzawa I1, Fujii K2, Ito A: JOURNAL OF TRAVEL MEDICINE 2010/5,6; 17 (3): 206-8. (“’àV@ò1, “¡
ˆäŽF2: 1‹~–œ, 2”]ŠO)

110265. [ŒŽ’˜] Technical problems and complications in the removal of the less invasive
stabilization system. Suzuki T1, Smith WR, Stahel PF, Morgan SJ, Baron AJ, Hak DJ: J Orthop Trauma
2010/6; 24 (6): 369-73. (—é–؁@‘ì1: 1‹~–œ)

110266. [ŒŽ’˜] Safety and efficacy of conversion from external fixation to plate fixation in
humeral shaft fractures. Suzuki T1, Hak DJ, Stahel PF, Morgan SJ, Smith WR: J Orthop Trauma 2010/7;
24 (7): 414-9. (—é–؁@‘ì1: 1‹~–œ)

110267. [ŒŽ’˜] Stress radiograph to detect true extent of symphyseal disruption in presumed
anteroposterior compression type I pelvic injuries. Suzuki T1, Morgan SJ, Smith WR, Stahel PF,
Flierl MA, Hak DJ: J Trauma 2010/10; 69 (4): 880-5. (—é–؁@‘ì1: 1‹~–œ)

110268. [ŒŽ’˜] MRI is useful for diagnosis of H1N1 fulminant myocarditis. Takeuchi I1, Imaki R1,
Inomata T2, Soma K1, Izumi T2: Circ J 2010/11; 74 (12): 2758-9. (’|“àˆê˜Y1, ¡–Ø—²‘Ÿ1, ’––”F
Œ³2, ‘Š”nˆêˆå1, ˜aò@“O2: 1‹~–œ, 2zŠÂŠí“à)

110269. [ŒŽ’˜] Hemodialysis is an independent predictor of coronary in-stent restenosis after
paclitaxel eluting stent implantation. Takeuchi I1, Moriguchi M, Imaki R1, Fukaya H2, Shinagawa
H2, Shimohama T2, Tojo T2, Fukuda N, Inomata T2, Aoyama N2, Soma K1, Izumi T2: Intern Med 2010;
49 (22): 2379-84. (’|“àˆê˜Y1, ¡–Ø—²‘Ÿ1, [’J‰p•œ2, •iì–íl2, ‰º•lF˜Y2, “ŒžŠ‘å‹P2, ’––”F
Œ³2, ÂŽR’Œ‘P2, ‘Š”nˆêˆå1, ˜aò@“O2: 1‹~–œ, 2zŠÂŠí“à)

120080. [ŒŽ’˜] –{–M‚É‚š‚¯‚é”M’†Ç‚ÌŽÀ‘Ô?Heatstroke STUDY2008ÅI•ñ?. ŽO‘îNŽj, —L‰ê@“O,
ˆäãŒ’ˆê˜Y, ‰œŽ›@Œh, –kŒŽF—Y1, “‡èCŽŸ, ’ß“c—ljî, ‰¡“c—Ts (1‹~–œ): “ú–{‹~‹}ˆãŠw‰ïŽGŽ
2010/5; 21 (5): 230-44.

120081. [ŒŽ’˜] 1998”N“x‚ÉŒú¶È (Œ»Œú¶˜J“­È) ‚©‚ç“Å–ò•š•ªÍ‹@Ší‚ª”z”õ‚³‚ê‚œ‹~‹}ˆã—ÃŽ{Ý‚É‚š
‚¯‚镪Í‹Æ–±‚ÌŽÀ‘Ô’²ž. –x@@”J1, ˆÉŠÖ@Œ›1, —é–؍Kˆê˜Y1, “ޏ——Ǐº1, •Ÿ–{^—Žq1, •Ÿ‰Æçº
1, X@”Ž”ü1, ‘Š”nˆêˆå1,2 (1“ú–{’†“ÅŠw‰ï•ªÍˆÏˆõ‰ï, 2‹~–œ): ’†“ÅŒ€‹† 2010/9; 23 (3): 224-31.

120082. [ŒŽ’˜] ‹~–œ‹~‹}ƒZƒ“ƒ^[ŽOŽŸ”À‘—Š³ŽÒ‚Ì—ˆ‰@ŽžƒoƒCƒIƒ}[ƒJ[ (B Œ^ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh
‚ƃgƒƒ|ƒjƒ“I, D-dimer) ‚É‚æ‚é—\Œã—\‘ª. ‹g“c@“O1, •ž•”@2, _œä’m“¹2, •Ð‰ª—Sˆê2, ãžŠ‹g
l2, ¡ˆä@Š°2, –kŒŽF—Y2, ‘Š”nˆêˆå2 (1¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw‹~‹}ˆãŠw, 2‹~–œ): ICU‚ÆCCU 2011/1;
35 (1): 77-83.

310020. [Ç—á•ñ] Aseptic meningitis in association with glyphosate-surfactant herbicide
poisoning. Sato C1, Kamijo Y1, Yoshimura K, Ide T1: Clin Toxicol (Phila) 2011/2; 49 (2): 118-20.
(²“¡çŒb1, ãžŠ‹gl1, ˆäorŒõ1: 1‹~–œ)

310021. [Ç—á•ñ] Severe carbon monoxide poisoning complicated by hypothermia: a case report.
Kamijo Y1, Ide T1, Ide A2, Soma K1: Am J Emerg Med 2011/3; 29 (3): 357.e5-7. (ãžŠ‹gl1, ˆäo
rŒõ1, ˆäo•¶Žq2, ‘Š”nˆêˆå1: 1‹~–œ, 2ž_)

320047. [Ç—á•ñ] èò•”Ø‘n‚É‚æ‚éoŒŒ«ƒVƒ‡ƒbƒN‚É‚æ‚èÒ‘[Ç‚𕹔­‚µ‚œ1—á. ”~’ײ‘Ÿ1, ŽÄ“c
’m‹`1, ˆäorŒõ1, ‹Ž–{­•q1, XŽRŒc‘Ÿ1, ˆêŽr¢1, “c‘º—Ll1, ãžŠ‹gl1, ‘Š”nˆêˆå1 (1‹~–œ):
“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽGŽ 2010/12; 31: 2.

522151. [uÀ]y“ÁW: ¡“ú‚̐ž_‰ÈŽ¡—ÃKƒCƒhƒ‰ƒCƒ“z‘æ11Í ž_‚š‚æ‚эs“®‚̏áŠQ‚É‚µ‚΂µ‚ΐ”º
‚·‚é‘Œ‚̏áŠQ@12. ’†“Å•šŽ¿‚É‚æ‚鎩ŽEŠé}?Œüž_–ò‚š‚æ‚ÑŽs”Ì–ò‚É‚æ‚é‹}«’†“ł𒆐S‚É?. ãžŠ
‹gl (‹~–œ): ž_‰ÈŽ¡—Êw 2010/10; 25 (‘Š§): 334-7.

522152. [uÀ]y“ÁW: –«ŽŸŠ³‚Ì‹}«‘ˆ«?•a‘Ô‚Ì—‰ð‚ÆŽ¡—Â̎ÀÛz18. ž_ŽŸŠ³‚Ì‹}«‘ˆ«. V
ˆä‹v–«, ãžŠ‹gl1 (1‹~–œ): ‹~‹}ˆãŠw 2011/1; 35 (1): 101-5.

522153. [uÀ]y“ÁW: ‘ŸŠí’ñ‹ŸŽ{Ý‚©‚ç‚Ý‚œ‰ü³‘ŸŠíˆÚA–@‚̉ۑè‚ƑΉžz‘ŸŠí’ñ‹ŸŽ{Ý‚Ì•‰’S‚Ɖü‘P
ô. –kŒŽF—Y (‹~–œ): “ú–{ˆãŽt‰ïŽGŽ 2011/3; 139 (12): 2562-5.

[’˜@‘]

610008. [Šwp‘] (•ª’SŽ·•M)yOrthopaedic Knowledge Update, Trauma 4zPelvic Fractures: Evaluation
and Acute Management, p.279-92. Smith WR, Suzuki T1, Tornetta P, III, Eds. Schmidt AH, Teague
DC, American Academy of Orthopaedic Surgeons, 2010/10”­s. (—é–؁@‘ì1: 1‹~–œ)

620157. [Šwp‘] (•ª’SŽ·•M)yƒJƒ‹ƒoƒyƒlƒ€‚ð‚Ç‚€Žg‚€‚©H?“K³Žg—p‚Ì‚œ‚ß‚ÌŠî‘b‚ƗՏ°?zII. —Õ
°•Ò@5. ‹~‹}‹~–œ—̈æ, p.116-23. ‘Š”nˆêˆå (‹~–œ), •Ò ‰Í–ì@–Î, ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, ‘åã, 2010/8
”­s.

620158. [Šwp‘] (•ª’SŽ·•M)ylHŒÄ‹zŠíŠÖ˜A”x‰Š‚Ì‚·‚ׂā@ƒGƒrƒfƒ“ƒX‚ÉŠî‚­—\–hEf’fEŽ¡—Áz
‘æIÍ ”wŒi@1. ƒI[ƒo[ƒrƒ…[?’è‹`‚ƉuŠw, ŠëŒ¯ˆöŽq?, p.2-8. ‘Š”nˆêˆå (‹~–œ), •Ò Žu”nL˜N,
“ì]“°, “Œ‹ž, 2010/7”­s.

620159. [Šwp‘] (•ª’SŽ·•M)y‰ü’ù‘æ4”Å ‹~‹}f—ÃŽwjzž_áŠQ, p.564-9. ãžŠ‹gl (‹~–œ), ŠÄ
C “ú–{‹~‹}ˆãŠw‰ï, •Ò “ú–{‹~‹}ˆãŠw‰ïê–åˆã”F’èˆÏˆõ‰ï, ‚Ö‚é‚·o”Å, “Œ‹ž, 2011/1”­s.

620160. [Šwp‘] (•ª’SŽ·•M)y¡“ú‚ÌŽ¡—Öò2011z’†“ÅŽ¡—Öò, p.1061-71. ãžŠ‹gl (‹~–œ), •Ò ‰Y
•”»•v, “‡“c˜aK, ì‡áÁˆê, “ì]“°, “Œ‹ž, 2011/1”­s.

620161. [Šwp‘] (•ª’SŽ·•M)yŠO‰ÈE‹~‹}W’†Ž¡—Âɂš‚¯‚銎õÇ‘΍ô@¡‚·‚®ŽÀ‘H‚µ‚œ‚¢ŽüpŠúŠÇ—
‚ƍR‹Û–ò“K³Žg—pz‘æ5Í W’†Ž¡—ÃŽº (ICU) ‚É‚š‚¯‚éŠÇ—EŽ¡—Á@2. lHŒÄ‹zŠíŠÇ—”x‰Š‚̐f’f,
p.171-6. ‘Š”nˆêˆå (‹~–œ), •Ò ’|–––F¶, ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, ‘åã, 2011/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713187. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Treatment strategy of open long bone fractures for the
patients with head injuries. Minehara H1, Konno S1, Uchino M2, Ohkawa T, Boku T2, Toyama M2, Itoman
M2: 11th European Congress of Trauma & Emergency Surgery (2010/5/16), Brussels, Belgium. (•ôŒŽ
G¹1, ¡–ìTŒá1, “à–쐳—²2, –p@W³2, “hŽR³G2, Ž…–ž·Œ›2: 1‹~–œ, 2®ŠO)

713188. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) The S-100B levels in the cerebrospinal fluid and
clinical prognosis in carbon monoxide poisoning. Ide T1, Kamijo Y1, Yoshimura K, Ide A1, Nishikawa
T, Soma K1, Mochizuki H2: International Congress of Toxicology (2010/7/21), Barcelona. (ˆäor
Œõ1, ãžŠ‹gl1, ˆäo•¶Žq1, ‘Š”nˆêˆå1, –]ŒŽGŽ÷2: 1‹~–œ, 2_Œo“à)

713189. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Stress Radiograph to Detect True Extent of Symphyseal
Disruption in Presumed Anteroposterior Compression Type I Pelvic Injuries. Suzuki T1, Morgan SJ,
Smith WR, Stahel PF, Hak DJ: 26th annual meeting of Orthopaedic Trauma Association (2010/10/14),
Baltimore, USA. (—é–؁@‘ì1: 1‹~–œ)

722235. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) LISS”²‹Ž¢“ïÇ—á‚̗Տ°“IŒŸ“¢. —é–؁@‘ì (‹~
–œ): ‘æ36‰ñœÜŽ¡—Êw‰ï (2010/7/2), ç—t.

722236. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ƒVƒ“ƒ|ƒWƒEƒ€uVAD‚Æ‚Ç‚€‘Λ³‚·‚é‚©F‚»‚Ì“K‰ž
‚Ɖ^—pvPCPS‚ð‘}“üŒãS‘ŸˆÚA‘Ò‹@Ç—á‚Æ‚È‚Á‚œÇ—á‚ɂ‚¢‚Ä“à‰È‘€‚©‚ç‚Ì’ñŒŸ. ’|“àˆê˜Y (‹~–œ): ‘æ
14‰ñ“ú–{S•s‘SŠw‰ï‘‰ïƒVƒ“ƒ|ƒWƒEƒ€ 2010 (2010/10/7-9), “Œ‹ž.

722237. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y‹~‹}ˆã—Âɂš‚¯‚éPCPS‚ÌŒ»ó: “K‰ž‚Æ—£’EzŒ€ÇŒ^S‹Ø‰Š‚ð
‚¢‚©‚É‚Ì‚è‚«‚é‚©: PCPS“±“ü‚̃^ƒCƒ~ƒ“ƒO. ’|“àˆê˜Y (‹~–œ): ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ïƒVƒ“ƒ|ƒWƒE
ƒ€, 2010 (2010/10/9-11), “Œ‹ž.

722238. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yJƒ^[ƒ“‚É‚š‚¯‚éŽó‚¯“ü‚êˆã—Ë@ŠÖ‚©‚猩‚œƒhƒNƒ^[ƒwƒŠ‚̉Û
‘èzJƒ^[ƒ“Žó‚¯“ü‚ê•a‰@‚©‚ç‚Ý‚œƒhƒNƒ^[ƒwƒŠ‚Ì—L—p«. ’|“àˆê˜Y (‹~–œ): ‘æ17‰ñq‹óˆã—Êw‰ï‘‰ï
ƒVƒ“ƒ|ƒWƒEƒ€ 2010 (2010/11/14), ŽD–y.

722239. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) dÇ‹~‹}Š³ŽÒ‚ɑ΂·‚ésynbiotics‚Ì—L—p«‚ÉŠÖ‚·
‚錀‹†. •Ð‰ª—Sˆê1, _œä’m“¹1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ26‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï (2011/2/17), –Œ
ŒÃ‰®.

722240. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ICUE‹~‹}•a“‚É‚š‚¯‚éŠÅŒìŽt‚ÌNSTŠˆ“®‚ƍ¡Œã‚Ì
‰Û‘è. Šâ‘º‹M”ü, •Ð‰ª—Sˆê1, _œä’m“¹1 (1‹~–œ): ‘æ38‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï (2011/2/24), ‰¡
•l.

723951. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Technical Problems and Complications in the Removal
of the Less Invasive Stabilization System. —é–؁@‘ì1, Morgan SJ, Smith WR, Stahel PF, Hak DJ (1
‹~–œ): ‘æ83‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (2010/5/14), “Œ‹ž.

723952. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Ž©ŽEŠé}‚É‚æ‚éˆêŽ_‰»’Y‘f’†“Å‚É”º‚€’x”­«”]Ç8—á‚Ì
—Տ°“IŒŸ“¢. ˆäorŒõ1, ãžŠ‹gl1, ˆäo•¶Žq1, ‘Š”nˆêˆå1, –]ŒŽGŽ÷2 (1‹~–œ, 2_Œo“à): “ú–{_
ŒoŠw‰ï‘‰ï (2010/5/22), “Œ‹ž.

723953. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠJ• ’x‰„‚Æ‚È‚Á‚œŠOÇ—á‚ÌŒŸ“¢. •Ð‰ª—Sˆê1, “‡“c@Œª
1, ŒŠª@”Ž1, _œä’m“¹1, Š~Œ©•¶Ž}1, •ž•”@1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ24‰ñ“ú–{ŠOŠw‰ï
(2010/5/28), –‹’£.

723954. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇ”MŠ³ŽÒ‚É‚š‚¯‚é“Œ—mˆãŠw“IƒAƒvƒ[ƒ`‚Ì•¹—p‚Æ‚»
‚ÌŒø‰Ê. _œä’m“¹1, •Ð‰ª—Sˆê1, •ž•”@1, Š~Œ©•¶Ž}1, ˆêŽr¢, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ):
‘æ24‰ñ“ú–{ŠOŠw‰ï (2010/5/28), –‹’£.

723955. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™dÇŠÌ‘¹‚ɑ΂·‚éTAE‚Ì—L—p«. Š~Œ©•¶Ž}1, •Ð
‰ª—Sˆê1, •ž•”@1, _œä’m“¹1, “‡“c@Œª1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ24‰ñ“ú–{ŠOŠw‰ï
(2010/5/28), –‹’£.

723956. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) S‘Ÿ’Ž‰¹”gŒŸžA‹¹•”‘¢‰eCT‚Å‘¹•”ˆÊ‚ª“¯’è‚Å‚«‚œŠO
«S‘¹‚̈ê—á. •ž•”@1, •Ð‰ª—Sˆê1, ¡ˆä@Š°1, ’|“àˆê˜Y1, Š~Œ©•¶Ž}1, ‘Š”nˆêˆå1 (1‹~–œ):
‘æ24‰ñ“ú–{ŠOŠw‰ï (2010/5/28), –‹’£.

723957. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘OŒãˆ³”—(APC)-IŒ^œ”՗֍œÜ‚ɑ΂·‚éƒXƒgƒŒƒXXüŽB
‰eŽ{s‚Ì—LŒø«‚ÌŒŸ“¢. —é–؁@‘ì (‹~–œ): ‘æ36‰ñœÜŽ¡—Êw‰ï (2010/7/1), ç—t.

723958. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰ºŽˆœÜŠO‚ð‡•¹‚µ‚œ“ª•”ŠO‚ÌŽ¡—Ã. ¡–ìTŒá1, •ôŒŽG¹1,
Œ¢Ž”@‰~2, ’†ŒŽ–M»2, ŽÄ“c^—RŽq1, ‰““¡¹F2, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ, 2”]ŠO): ‘æ13‰ñ
“ú–{”]’ቷ—Ö@Šw‰ï (2010/7/2), ‘åã.

723959. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ã˜rœœŠ²•”œÜŠ³ŽÒ‚ɑ΂·‚é‘nŠOŒÅ’èŒã‚Ì“ñŠú“IƒvƒŒ
[ƒgŒÅ’è–@‚Ì—LŒø«‚ÉŠÖ‚·‚錟“¢. —é–؁@‘ì (‹~–œ): ‘æ36‰ñœÜŽ¡—Êw‰ï (2010/7/2), ç—t.

723960. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ’iŠK“INorwood-RastelliŽèppŒã‚Ì”x“®–¬‹·ó‚ɑ΂·‚錟“¢. —F
•Û‹M”Ž1, ‹{’n@ŠÓ2, ”Â’JŒcˆê2, “c’†—C‹M2, ’¹ˆäWŽO2, {“¡‹±ˆê2, ŽÄ“c@u2, ˆäãMK2, ”g—¢
—z‰î2 (1‹~–œ, 2S‘ŸŒŒŠÇŠO): ‘æ46‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï (2010/7/7-9), ‰YˆÀ, “ú–{¬Ž™zŠÂŠíŠw‰ï
ŽGŽ 2010/6; 26: 274.

723961. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Necrotizing soft tissue infectionÇ—á‚ÌŒŸ“¢. ’©ŒG
’õ—²1, •Ð‰ª—Sˆê1, _œä’m“¹1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï
(2010/10/9), “Œ‹ž.

723962. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —ˆ‰@ŽžŒŒ‰tƒ}[ƒJ[‚É‚æ‚édÇ‹~‹}Š³ŽÒ‚Ì—\Œã—\‘ª. ‹g
“c@“O, •Ð‰ª—Sˆê1, ãžŠ‹gl1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï
(2010/10/10), “Œ‹ž.

723963. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚éˆâ“`Žq‘gŠ·‚ŠŠˆ«Œ^ŒŒ‰t‹ÃŒÅ‘æVIIˆöŽq»
Ü‚ÌŽg—p¬Ñ. —é–؁@‘ì1, _œä’m“¹1, ²“¡çŒb1, •ž•”@1, Š~Œ©•¶Ž}1, ¡–ìTŒá1, •ôŒŽG¹1,
•Ð‰ª—Sˆê1, ¡ˆä@Š°1, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ38‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (2010/10/9-11),
“Œ‹ž.

723964. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘ŸŠí’ñ‹Ÿ‚É‚š‚¯‚é–@ˆãŠwEŒxŽ@‚Ƃ̘A—˜AŒg‘̐§‚ɂ‚¢
‚Ä. ‚‹Ž@Œb, ’[ŽR˜a”ü, rì–@Žq, –kŒŽF—Y1, ‹g“cˆê¬2, ‘ì˜ad3, ŒIŒŽŽ—R4 (1‹~–œ, 2”å”A
Ší, 3•úŽËü (Žîá‡), 4–@ˆã): ‘æ44‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2011/1/28), •ºŒÉ.

723965. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘‰tƒ~ƒGƒŠƒ“‰–Šî«’`”’‚̍ď㏞‚ð”F‚ß‚œˆêŽ_‰»’Y‘f’†
“Å‚É‚æ‚é‘J‰„«ˆÓŽ¯áŠQ‚̈ê—á. ˆäo•¶Žq1, ˆäorŒõ1, ãžŠ‹gl1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ61‰ñ“ú
–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2011/2/5), ‰¡•l.

723966. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‰h—{ƒTƒ|[ƒgƒ`[ƒ€‰ÁŽZVÝ‚É”º‚€NSTŠˆ“®‚̐V‚µ‚¢“W
ŠJ?NSTŽx‰‡ƒVƒXƒeƒ€‚̍\’z?. ‰¡‘K—TŽq, •Ð‰ª—Sˆê1, _œä’m“¹1 (1‹~–œ): ‘æ26‰ñ“ú–{Ã–¬Œo’°‰h
—{Šw‰ï (2011/2/17), –ŒŒÃ‰®.

723967. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆãŠw•”—Տ°ŽÀK¶‚ɑ΂·‚é‰h—{‹³ˆçF‹~‹}NSTŠˆ“®ŽQ‰Á‚ÌŒø‰Ê?‹}
«ŠúdÇŠ³ŽÒ‚̉h—{ŠÇ—‚ÉŠÖ‚·‚錟“¢?. _œä’m“¹1 •Ð‰ª—Sˆê1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ26‰ñ“ú–{Ã
–¬Œo’°‰h—{Šw‰ï (2011/2/18), –ŒŒÃ‰®.

723968. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‹~–œ‹~‹}ƒZƒ“ƒ^[‚É‚š‚¯‚éš‹‰ºáŠQŠ³ŽÒ‚ÌŒ»ó. ‰ª“cŽ‡
•ä, •Ð‰ª—Sˆê1, _œä’m“¹1 (1‹~–œ): ‘æ26‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï (2011/2/18), –ŒŒÃ‰®.

723969. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) dÇ‹}«äX‰Š‚É‚š‚¯‚é7“úˆÈ“à‚ÌŒo’°‰h—{ŠJŽn‚ÌŒø‰Ê.
HŽR—SŽq, •Ð‰ª—Sˆê1, _œä’m“¹1 (1‹~–œ): ‘æ26‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï (2011/2/18), –ŒŒÃ‰®.

723970. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@ICU‚É‚š‚¯‚é‹CŠÇ‘}ŠÇŠ³ŽÒ‚Ìš‹‰ºáŠQ‚ÉŠÖ‚·‚錟“¢.
•ÐŽRˆŸŽ÷, •Ð‰ª—Sˆê1, _œä’m“¹1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ38‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï (2011/2/25),
‰¡•l.

723971. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚š‚¯‚é4‘ŸŠíˆÈã‚Ì‘œ‘ŸŠí•s‘S‚ð’æ‚·‚é‹~‹}ŠO‰È
ŽŸŠ³‚ÌŽ¡—ЬÑ. •Ð‰ª—Sˆê1, “‡“c@Œª1, _œä’m“¹1, Š~Œ©•¶Ž}1, •ž•”@1, ²“¡çŒb1, —é–؁@‘ì
1, ¡ˆä@Š°, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ): ‘æ38‰ñ@“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï (2011/2/25), ‰¡•l.

731149. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰)yzŠÂŠí—̈æ‚̍ŐVŽ¡—Ã?2010z‹~–œ‹~‹}ƒZƒ“ƒ^[@zŠÂ
Ší•ª–ì‚ÉŠÖ‚·‚éÅV‚̘b‘è. ’|“àˆê˜Y (‹~–œ): Œ§‰›ˆãŽt‰ïu‰‰‰ï@zŠÂŠí—̈æMeeting (2010/5), _“Þ
ì.

731150. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ­—ߎw’è“sŽs‚³‚ª‚Ý‚Í‚ç‚É‚àƒwƒŠ‚ð—p‚¢‚œ˜AŒg‚ð?ŒQ”n
Œ§ƒhƒNƒ^[ƒwƒŠ‚©‚ç‚Ý‚œ‘Š–ÍŒŽ‚Ì•ûŒü«‚ðl‚Š‚é?. ’|“àˆê˜Y (‹~–œ): ‘æ3‰ñ‘Š–͐St˜AŒg‚̉ï
(2010/10), _“ސì.

732113. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) SŒŒŠÇƒCƒxƒ“ƒg—}§‚ð–ÚŽw‚µ‚œŒŒ“œŠÇ
—@‹~‹}”À‘—‚³‚ê‚œÇ—á‚©‚ç‚Ì’ñŒŸ. ’|“àˆê˜Y (‹~–œ): 2‰ñ“œ”A•a‚̍‡•¹Ç‚ðl‚Š‚é‰ï (2010/5).

733463. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@ICU‚ł̉h—{ŠÇ—‚ƐV‚µ‚¢ƒKƒCƒhƒ‰ƒCƒ“
‚Æ‚Ì‘Šˆá‚ÉŠÖ‚·‚錟“¢. •Ð‰ª—Sˆê1, _œä’m“¹1, ’©ŒG’õ—²1 (1‹~–œ): ‘æ2‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ïŽñ
“sŒ—Žx•”ŠwpW‰ï (2010/5/22), “Œ‹ž.

733464. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •‘“¥‰^“®‚ð”F‚ß‚œˆêŽ_‰»’Y‘f’†“Å‚É‚æ‚é’x”­
«”]Ç‚̈ê—á. ˆäorŒõ1, ˆäo•¶Žq1, ãžŠ‹gl1, _œä’m“¹1, ²“¡çŒb1, ‹g‘º‹vmŽq, ‘Š”nˆêˆå1
(1‹~–œ): ‘æ25‰ñ“ú–{’†“ÅŠw‰ï“Œ“ú–{’n•û‰ï (2011/1/8), ŽD–y

733465. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Streptococcus oralis‚É‚æ‚鐑–Œ‰Š‚Ì1—á. ˆä
orŒõ1, ”~’ײ‘Ÿ1, ˆîŠ_‘דl1, ŽR’J—§‘å1, ŽÄ“c^—RŽq1, ¡ˆä@Š°, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~
–œ): ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2011/2/5), ‰¡•l.

733466. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒ‰ƒt[ƒv‚ÌŽg—p‚É‚æ‚艺• •Ç“®–¬‘¹‚ð—ˆ
‚µ‚œˆê—á. ”~’ײ‘Ÿ1, •Ð‰ª—Sˆê1, Š~Œ©•¶Ž}1, ’©ŒG’õ—²1, ŽR’J—§‘å1, ˆîŠ_‘דl1, –kŒŽF—Y1, ‘Š
”nˆêˆå1 (1‹~–œ): ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2011/2/5), ‰¡•l.

733467. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‘å‘ڍœœÜ‚ɑ΂·‚éŽæ‚è‘g‚Ý ?’Œ’BŒ¡ˆøƒ[ƒ
‚ð–ÚŽw‚µ‚Ä?. —é–؁@‘ì1, •ôŒŽG¹1, –p@W³2, •ž•”@1, Š~Œ©•¶Ž}1, _œä’m“¹1, ²“¡çŒb1,
•Ð‰ª—Sˆê1, ¡ˆä@Š°, –kŒŽF—Y1, ‘Š”nˆêˆå1 (1‹~–œ, 2®ŠO): ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï
(2011/2/5), ‰¡•l.

733468. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ’Œ’°úE‚É‚æ‚éúE«• –Œ‰Š‚𓯎ž”­Ç‚µ‚œ
ŠÌŒŒŠÇ“÷Žî”j—ô‚̈ê—á. “n糍WŽ¯, •Ð‰ª—Sˆê1, ‹{àVŽu˜N2, ’†’JŒ€“l1, Š~Œ©•¶Ž}1, ƒEƒbƒhƒnƒ€ƒX—æ
Žq3, ‘Š”nˆêˆå1 (1‹~–œ, 2Á‰»Ší“à, 3•úŽËü (‰æ‘œ)): ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2011/2/5),
‰¡•l.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-522011. [uÀ]yäPŒŽ•a‚Ɛ_ŒoŽŸŠ³?Šî‘b‚©‚ç—Տ°‚܂Łz_ŒoäPŒŽ•aŠe˜_: _Œo“à‰Èˆã‚©‚ç, äP
ŒŽ•a‰Èˆã‚©‚ç@SjogrenÇŒóŒQ: _Œo“à‰È‚©‚ç. ˆäorŒõ (‹~–œ): Clinical Neuroscience 2010/2; 28
(2): 184-5.

[’˜@‘]

H21-620016. [Šwp‘] (•ª’SŽ·•M)ydÇS•s‘S‚ÌŽ¡—ÁzImpella?IABP, PCPSˆÈŠO‚̕⏕zŠÂ‘•’u
?I, p.45-53. ’|“àˆê˜Y (‹~–œ), ŠÄC àV@–FŽ÷, ŠwŒ€ƒƒfƒBƒJƒ‹GŽÐ, “Œ‹ž, 2010/3”­s.

H21-620017. [Šwp‘] (•ª’SŽ·•M)y”]‘²’†ÇŒóŠwz”]ŒŒŠÇáŠQ‚Æ“ª’É, p.530-7. ˆäorŒõ1, â
ˆä•¶•F (1‹~–œ), •Ò’˜ “cìᩈê, Œ‘º‘“X, VŠƒ, 2010/3”­s.

[Šw‰ïEŒ€‹†‰ï“™]

H21-733015. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ×‹Û«‘–Œ‰ŠA”sŒŒÇ‚ÉŽŠ‚Á‚œƒtƒ]
ƒoƒNƒeƒŠƒEƒ€ŠŽõÇ‚ÌŽá”N’j«—á. ŽÄ“c^—RŽq1, ˆäorŒõ1, ²“¡çŒb1, ¡ˆä@Š°, –kŒŽF—Y1, ‘Š
”nˆêˆå1 (1‹~–œ): ‘æ60‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2010/2/6), “Œ‹ž.


‘‡f—ÈãŠw

[Šwp˜_•¶]

120083. [ŒŽ’˜] –â‘è‰ðŒˆ”\—͂̈琬‚ð–ÚŽw‚µ‚œƒ`[ƒ€Šî”ÕŒ^ŠwK‚ÌŽŽ‚Ý. ’|–{@‹B1, Ô¯@“§1 (1
‘‡f—Ã): –k—¢ˆãŠw 2010/6; 40 (1): 19-23.

520086. [‘à] ƒCƒ“ƒ^[ƒƒCƒLƒ“1. Ô¯@“§ (‘‡f—Ã): “ú–{—Տ° 2010/5; 68 (‘Š§†5): 105-9.

520087. [‘à] ‚±‚̐l‚ɐ[•”Ã–¬ŒŒð‚Í‚ ‚é? ’|–{@‹B (‘‡f—Ã): “úŒoƒƒfƒBƒJƒ‹ 2010/5;
p.38-56.

522154. [uÀ]y“ÁW: –Ɖu”œ‰ž‚ƗՏ°ŒŸž2010zV ¶‰»Šw@D V‚µ‚¢‰ŠÇƒ}[ƒJ[. Ô¯@“§1, ˜a
“c’B•F1 (1‘‡f—Ã): ŒŸž‚Æ‹Zp 2010/9; 38 (10, ‘Š§): 916-20.

522154. [uÀ]yÀ’k‰ï: ƒgƒVƒŠƒYƒ}ƒu‚̏ãŽè‚ÈŽg‚¢•ûz5. Cutting Edge@’É•—‚ɑ΂·‚éIL-1—}§—Ö@.
Ô¯@“§ (‘‡f—Ã): Frontiers in Rheumatology & Clinical Immunology 2010/11; 4 (4): 33-6.

540097. [‚»‚Ì‘Œ (’²ž•ñ)] ‘Š–ÍŒŽ’nˆæZ–¯‚ÌŽófs“®‚ÉŠÖ‚·‚銳ŽÒˆÓŽ¯’²ž. ’|–{@‹B1, Ô¯@“§
1 (1‘‡f—Ã): –k—¢ˆãŠw 2010/6; 40 (1): 25-31.

[’˜@‘]

620162. [Šwp‘] (•ª’SŽ·•M)y“ú–{—Õ଑Š§@ŠÖßƒŠƒEƒ}ƒ` (‘æ2”Å)?Š°‰ð‚ð–ÚŽw‚·Ž¡—Â̐VŽž‘ã?z
III. ŠÖßƒŠƒEƒ}ƒ`‚̐¬ˆö‚Æ•a‘Ԑ¶—@4. ‰ŠÇƒƒfƒBƒG[ƒ^[@3) Žå‚ȃTƒCƒgƒJƒCƒ“@b. ƒCƒ“ƒ^[ƒƒC
ƒLƒ“1, p.105-9. Ô¯@“§ (‘‡f—Ã), “ú–{—Õ଎Ð, ‘åã, 2010/5”­s.

622005. [Šwp‘] (–|–ó)yJAMA”Å ˜_—“IfŽ@‚Ì‹Zp?ƒGƒrƒfƒ“ƒX‚ÉŠî‚­f’f‚̃mƒEƒnƒE?zThe
Rational Clinical Examination: The Evidence-Based Clinical Diagnosis. ’|–{@‹B (‘‡f—Ã), •Ò
Simel DL, Drummond Rennie, “úŒoBPŽÐ, “Œ‹ž, 2010/5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722241. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) ’É•—”­ì‚Ì•ªŽq•a‘Ô. Ô¯@“§ (‘‡f—Ã): ‘æ
44‰ñ“ú–{’É•—EŠjŽ_‘ãŽÓŠw‰ï (2011/2/17), Vh.


ˆãŠw•”•‘®ˆãŠw‹³ˆçŒ€‹†ŠJ”­ƒZƒ“ƒ^[

ˆãŠw‹³ˆçŒ€‹†•”–å

[’˜@‘]

620163. [Šwp‘] (•ª’SŽ·•M)yˆãŠw‹³ˆç•Êû@ˆãŠw‹³ˆç”’‘2010”N”Å ('07?'10)z—«ˆãŽt‚̃LƒƒƒŠ
ƒA, p.159-63. Žç‰®—˜‰À (ˆãŠw‹³ˆç), •Ò “ú–{ˆãŠw‹³ˆçŠw‰ï, ŽÂŒŽo”ŐVŽÐ, “Œ‹ž, 2010/7”­s.

620164. [Šwp‘] (•ª’SŽ·•M)yˆãŠw‚̍u‹`ƒXƒLƒ‹ƒAƒbƒv‚Ì‚œ‚߂̃}ƒCƒNƒƒeƒB[ƒ`ƒ“ƒO‚ÌŽÀ‘Hz–k—¢‘å
ŠwˆãŠw•”‚É‚š‚¯‚éƒ}ƒCƒNƒƒeƒB[ƒ`ƒ“ƒO‚ÌŽÀ‘H–@‚ÆŒ‹‰Ê, p.26-31. Žç‰®—˜‰À (ˆãŠw‹³ˆç), •Ò “Œ‹ž—Žq
ˆã‰È‘åŠw‹³ˆçŠw, “Œ‹ž, 2011/3”­s.


ŠwKŽx‰‡Œ€‹†•”–å


ˆãŠwŒŽ˜_Œ€‹†•”–å

[Šwp˜_•¶]

520088. [‘à]y“ÁW: ŠO‚ƍHŠw?ŠO—\–hEŒ€‹†zHŠw‚ƈãŠw˜AŒg‚Ì‚œ‚߂̐l‘̏ŠQƒf[ƒ^ŽûW‚É‚š
‚¯‚é–@“IE—Ï—“I–â‘è. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_): ‹~‹}ˆãŠw 2010/5; 34 (5): 605-8.

540098. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]y•œ¬22”N“xƒ^ƒJƒ^à’c•¬Œ€‹†uŽ–ŒÌŽ©“®’Ê•ñƒVƒXƒeƒ€ (CAN) ‚ª‹N
“®‚·‚éƒhƒNƒ^[ƒwƒŠƒVƒXƒeƒ€‚É‚æ‚éŒð’ÊŽ–ŒÌŽ€–SíŒžŒø‰Ê‚ÌŒ€‹†vzACNƒVƒXƒeƒ€\’z‚ÉŒW‚é–@“IE—Ï—
“IEŽÐ‰ï“I‰Û‘è‚ÌŒ€‹†. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_): uŽ–ŒÌŽ©“®’Ê•ñƒVƒXƒeƒ€ (ACN)‚ª‹N“®‚·‚éƒhƒNƒ^[ƒw
ƒŠƒVƒXƒeƒ€‚É‚æ‚éŒð’ÊŽ–ŒÌŽ€–SíŒžŒø‰Ê‚ÌŒ€‹†v•œ¬22”N“xƒ^ƒJƒ^à’c•¬Œ€‹†ŽÀŽ{•ñ‘ 2011/3;
p.54-6.

[Šw‰ïEŒ€‹†‰ï“™]

722242. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eµ‘ҍu‰‰“™) Š³ŽÒ‚̐lŒ ‚Ɛ¶–œ—Ï—. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_):
‘æ3‰ñ“ú–{ƒTƒCƒRƒIƒ“ƒRƒƒW[Šw‰ï (2010/9/23), –ŒŒÃ‰®.

733469. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) —«‚ÌŽ©ŒÈŒˆ’茠‚Æ—Ï—. âV“¡—L‹IŽq (ˆãŠw
ŒŽ˜_): ¶BƒeƒNƒmƒƒW[‚ƃwƒ‹ƒXƒPƒA‚ðl‚Š‚錀‹†‰ï (2010/6/19), ‹à‘ò.

733470. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “nqˆÚA‚ƈã—×ϗ. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_):
“nqˆÚA‚ðl‚Š‚錀‹†‰ï (2010/7/16), “Œ‹ž.

733471. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ˆãŽt‚ÌŽg–œ‚ðl‚Š‚é. âV“¡—L‹IŽq (ˆãŠwŒŽ˜_):
ˆã—×ϗŒ€‹†‰ï (2011/1/18), “Œ‹ž.


ˆã—ÈÀ‘SEŠÇ—ŠwŒ€‹†•”–å


ˆã—ËZp‹³ˆçŒ€‹†•”–å


ˆãŠw•”•‘®—Տ°Œ€‹†ƒZƒ“ƒ^[

Šé‰æŠJ”­•”–å

[Šwp˜_•¶]

110270. [ŒŽ’˜] Acute decompensated heart failure syndromes ( ATTEND)registry. A prospective
observational multicenter cohort study: Rationale, design, and preliminary data. Sato N, Kajimoto
K, Asai K, Mizuno M, Minami Y, Nagashima M, Murai K, Muanakata R, Yumino D, Meguro T, Kawana M,
Nejima J, Satoh T1, Mizuno K, Tanaka K, Kasanuki H, Takano T: Am Heart J 2010/6; 159 (6): 949-55.e1.
(²“¡•q•F1: 1—Տ°Œ€‹†EŠé‰æ)

110271. [ŒŽ’˜] Development of a database of health insurance claims: standardization of disease
classifications and anonymous record linkage. Kimura S, Sato T1, Ikeda S, Noda M, Nakayama T:
J Epidemiol 2010/8; 20 (5): 413-9. (²“¡•q•F1: 1—Տ°Œ€‹†EŠé‰æ)

110272. [ŒŽ’˜] Echocardiography for the detection of valvulopathy associated with the use of
ergot-derived dopamine agonists in patients with Parkinson's disease. Nakaoka S, Ishizaki T,
Urushihara H, Satoh T1, Ikeda S, Morikawa K, Nakayama T: Intern Med 2011; 50 (7): 687-94. (²
“¡•q•F1: 1—Տ°Œ€‹†EŠé‰æ)

120084. [ŒŽ’˜] f—ÕñV–Ÿ×‘ (ƒŒƒZƒvƒg) ƒf[ƒ^ƒx[ƒX‚©‚ç2Œ^“œ”A•a‡•¹Ç‚š‚æ‚ё匌ŠÇÇ‚Ì•aŠú
i“W‚ƈã—Ôï‚ÌŠÖŒW‚ð–Ÿ‚ç‚©‚É‚·‚é‚œ‚ß‚ÌŠ³ŽÒî•ñ‚𒊏o‚·‚é•û–@‚ÌŒŸ“¢. –k—¢”Žm, ’r“cr–ç, ò@
˜a³, ‰ª”šƒ], –å˜e@F, ’†ŽRŒ’•v, –ì“cŒõ•F, ²“¡•q•F1 (1—Տ°Œ€‹†EŠé‰æ): Q&A‚Å‚í‚©‚é”ì–ž‚Æ
“œ”A•a 2010/8; 9 (9): 48-64.

520089. [‘à] ˆã—Ãf[ƒ^ƒx[ƒX‚Ì–òÜŒoÏ•]‰¿‚ւ̉ž—p. ’r“cr–ç, –k—¢”Žm, –ì“cŒõ•F, ’†ŽRŒ’•v,
²“¡•q•F1 (1—Տ°Œ€‹†EŠé‰æ): —Տ°–ò— 2010/11; 41 (6): 281-6.

540099. [‚»‚Ì‘Œ (–|–ó)]yˆã—Ïî•ñƒT[ƒrƒX Minds (ƒ}ƒCƒ“ƒY)^ˆã—Ã’ñ‹ŸŽÒŒü‚¯^ƒRƒNƒ‰ƒ“EƒŒƒrƒ…[z
‹Ö‰Œ‘£i‚Ì‚œ‚߂̃p[ƒgƒi[‚É‚æ‚éŽx‰‡‚Ì‹­‰» (2008 issue 3, Updated) (CitationFPark EW, Schultz
JK, Tudiver FG, Campbell T, Becker LA. Enhancing partner support to improve smoking cessation.
Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD002928. DOI:
10.1002/14651858.CD002928.pub2). –|–ó â–{‘×—1, ¯@‰À–F2EŠÄ–ó ’†‘º³˜a; JCOHR (1—Տ°Œ€‹†E
Šé‰æ, 2‰q¶EŒöO‰q¶): à’c–@l“ú–{ˆã—Ë@”\•]‰¿‹@\, Minds (“dŽqo”Åhttp://minds.jcqhc.or.jp)
2010/7. http://minds.jcqhc.or.jp/stc/0075/4/0075_G0000209_T0004172.html

540100. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­
‚ðæ“±‚·‚鎡Œ±—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vzŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±
—Տ°Œ€‹†’†Šj‹’“_®”õ. ‘ŠàVDŽ¡2, ”n“ˆ³—²4, ˜aò@“O5, ‰v“c“TK6, “n粏¹•F7, ²“¡•q•F1, ŒF
’J—YŽ¡4, ’|“à³O, ¯@‰À–F2, ‰€@‘‹Õ3, ˆíŒ©@Ž¡1, â–{‘×—1, Ä“¡Žj˜N1, ŽŒŽ@~, ˆÉ“¡Ÿ
•F, Frank Arnold, •P–ìG•ã, “n粒B–ç, Œ‘ºGŒ› (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶EŒöO‰q¶, 3’nˆæŽüŽYŠúE
‹~‹}ˆã—Ã, 4–ò—, 5zŠÂŠí“à, 6ŒÄ‹zŠí“à, 7ŠO‰È): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡
Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­‚ðæ“±‚·‚鎡Œ±—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹†v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ
‘ 2011/3; p.1-5.

540101. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­
‚ðæ“±‚·‚鎡Œ±—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vz—Տ°Œ€‹†‘Š’k‚Ì‚ ‚è•û‚É
‚‚¢‚Ä. ‰€@‘‹Õ3, â–{‘×—1, ²“¡•q•F1, ¯@‰À–F2, ˆíŒ©@Ž¡1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ,
2‰q¶EŒöO‰q¶, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)
u—Տ°Œ€‹†Žx‰‡‚ÉŠÖ‚·‚錟“¢v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.147-54.

540102. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­
‚ðæ“±‚·‚鎡Œ±—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vzŽ¡Œ±‹y‚їՏ°Œ€‹†‚ðŽx‰‡
‚·‚é‚œ‚߂̃f[ƒ^ƒx[ƒX‚̍\’z‚Ɖ^—p‚ÉŠÖ‚·‚錀‹†. ˆíŒ©@Ž¡1, ²“¡@•q•F1, Frank Arnold, â–{‘×
—1, ¯@‰À–F2, ‰€@‘‹Õ3, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶EŒöO‰q¶, 3’nˆæŽüŽYŠúE‹~‹}ˆã
—Ã):uŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘
2011/3; p.155-7.

540020. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­
‚ðæ“±‚·‚鎡Œ±—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)vz—Տ°Œ€‹†‚ÉŠÖ‚·‚鏉ŠwŽÒ
‚Ì‚œ‚ß‚Ì‹³ˆçƒvƒƒOƒ‰ƒ€‚Ì‚ ‚è•û‚ɂ‚¢‚Ä. ¯@‰À–F2, ‰€@‘‹Õ3, â–{‘×—1, ˆíŒ©@Ž¡1, ²“¡•q
•F1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶EŒöO‰q¶, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï
•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)u—Տ°Œ€‹†Žx‰‡‚ÉŠÖ‚·‚錟“¢v•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘
2011/3; p.159-84.

540103. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­
‚ðæ“±‚·‚鎡Œ±—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)v z—Տ°Œ€‹†‚ÉŠÖ‚·‚鋳ˆç
ƒvƒƒOƒ‰ƒ€‚ðŠJ”­‚·‚é‚œ‚ß‚Ì’²ž (—Տ°Œ€‹†‚Ì‚œ‚߂̃f[ƒ^ƒ}ƒlƒWƒƒ“ƒgƒZƒ~ƒi[‚ɂ‚¢‚Ä‚ÌŒŸ“¢).
‰€@‘‹Õ3, â–{‘×—1, ²“¡r•F1, ¯@‰À–F2, ˆíŒ©@Ž¡1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶E
ŒöO‰q¶, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)u—Տ°
Œ€‹†‚ÉŠÖ‚·‚鋳ˆçƒvƒƒOƒ‰ƒ€‚ðŠJ”­‚·‚é‚œ‚ß‚Ì’²žv•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3;
p.185-97.

540104. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)uŒ€‹†ŠJ”­
‚ðæ“±‚·‚鎡Œ±—Տ°Œ€‹†’†Šj‹’“_®”õ‚ÉŠÖ‚·‚錀‹† (Œ€‹†‘ã•\ŽÒ: ‘ŠàVDŽ¡)v z—Տ°Œ€‹†‚ÉŠÖ‚·‚鋳ˆç
ƒvƒƒOƒ‰ƒ€‚ðŠJ”­‚·‚é‚œ‚ß‚Ì’²ž (¶•š“ŒvŠwƒ[ƒNƒVƒ‡ƒbƒvã‹‰ƒZƒ~ƒi[‚ɂ‚¢‚Ä‚ÌŒŸ“¢). ‰€@‘
‹Õ3, â–{‘×—1, ²“¡r•F1, ¯@‰À–F2, ˆíŒ©@Ž¡1, ‘ŠàVDŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶EŒöO‰q
¶, 3’nˆæŽüŽYŠúE‹~‹}ˆã—Ã): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (ˆã—ËZpŽÀ—p‰»‘‡Œ€‹†Ž–‹Æ)u—Տ°Œ€‹†‚É
ŠÖ‚·‚鋳ˆçƒvƒƒOƒ‰ƒ€‚ðŠJ”­‚·‚é‚œ‚ß‚Ì’²žv•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.199-214.

540105. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘΍ô‘‡Œ€‹†Ž–
‹Æ)zŠeŽíŒŸfƒf[ƒ^‚ƃŒƒZƒvƒgƒf[ƒ^“™‚É‚æ‚é•ÛŒ’Ž–‹Æ‚Ì•]‰¿‚ÉŠÖ‚·‚錀‹†. …“ˆtñ, ‘ådŒ«Ž¡, ²
“¡•q•F1, “‡@Œ’“ñ, “‡‘܏[¶, ‰¡ŽR“OŽ¢, Ô—ä@—º, ”Ñ–ì’ŒŽq, ’r“cr–ç, ˆÉW‹ž”ü, ˆäã—DŽq, ¬–ì
“ÞŽq, Šì‰®•NŽj, ‹ïŽuŒ˜Žu•Û, V—¢¬”ü, “c’†@“O, ’†ŽRŒ’•v, “¡ˆä@m, “¡ì“N–ç, ¯@‰À–F2, ^
ŽÓ‰ë‘ã, Œ–{GŽq, Xì@Šó, ‹gŒ©ˆí˜Y, —^“ß”eŒb (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶EŒöO‰q¶): Œú¶˜J“­‰È
ŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘΍ô‘‡Œ€‹†Ž–‹Æ) •œ¬20?22”N“x‘‡Œ€‹†•ñ‘ 2011/3;
p.1-36.

540106. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘΍ô‘‡Œ€‹†Ž–
‹Æ)zŠeŽíŒŸfƒf[ƒ^‚ƃŒƒZƒvƒgƒf[ƒ^“™‚É‚æ‚é•ÛŒ’Ž–‹Æ‚Ì•]‰¿‚ÉŠÖ‚·‚錀‹†. …“ˆtñ, ²“¡•q•F1, “‡@
Œ’“ñ, “‡‘܏[¶, ‰¡ŽR“OŽ¢, Ô—ä@—º, ’r“cr–ç, ’†ŽRŒ’•v, “¡ˆä@m, “¡ì“N–ç, ¯@‰À–F2, ^ŽÓ‰ë
‘ã, Œ–{GŽq, Xì@Šó, —^“ß”eŒb (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶EŒöO‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à
(zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘΍ô‘‡Œ€‹†Ž–‹Æ) •œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.1-18.

540107. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (zŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘΍ô‘‡Œ€‹†Ž–
‹Æ)zŒ’•Û‘g‡ƒŒƒZƒvƒgƒf[ƒ^ƒx[ƒX‚ð—p‚¢‚œ“Á’茟fE•ÛŒ’Žw“±‚Ì•]‰¿‚̉”\«‚Ɖۑè. ²“¡•q•F1, ’†
ŽRŒ’•v, ’r“cr–ç, ¯@‰À–F2 (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶EŒöO‰q¶): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (z
ŠÂŠíŽŸŠ³“™¶ŠˆKŠµ•a‘΍ô‘‡Œ€‹†Ž–‹Æ)•œ¬22”N“x‘Š‡E•ª’SŒ€‹†•ñ‘ 2011/3; p.19-22.

540108. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)] ‘—§ˆã–ò•iH•i‰q¶Œ€‹†ŠuH•i‰˜õƒJƒr“Å‚ÌŽÀ‘Ô’²ž‚È‚ç‚тɐ¶‘Ì“Å
«‰e‹¿‚ÉŠÖ‚·‚錀‹†v. ‹Ç@”Žˆê, ¬Œ—ÇŽq, a’J@~, ²“¡•q•F1, Ä“¡Žj˜N, ™ŽRŒ\ˆê (1—Տ°Œ€‹†E
Šé‰æ): ‘—§ˆã–ò•iH•i‰q¶Œ€‹†ŠuH•i‰˜õƒJƒr“Å‚ÌŽÀ‘Ô’²ž‚È‚ç‚тɐ¶‘̓Ő«‰e‹¿‚ÉŠÖ‚·‚錀‹†vH22
”N“xŒ€‹†•ñ‘ 2011/3.

[Šw‰ïEŒ€‹†‰ï“™]

723972. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒwƒ‚ƒtƒBƒ‹ƒXƒCƒ“ƒtƒ‹ƒGƒ“ƒU‹ÛbŒ^ (Hib) ƒƒNƒ`ƒ“‚̈ã—ÃŒoÏ•]‰¿.
²“¡•q•F1, ˜a“ckŽ¡2, ™X—TŽ÷, {‰ê–œ’q, •œ”ö’qL, ’r“cr–ç (1—Տ°Œ€‹†EŠé‰æ, 2‰q¶EŒöO‰q
¶): ‘æ81‰ñ“ú–{‰q¶Šw‰ï (ŽãŠJÃ), “ú–{‰q¶ŠwŽGŽ 2011; 66 (2); 438.

723973. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) 75ÎˆÈã‚—îŽÒ”ñ¬×–E”xŠà‚ɑ΂·‚éŽèpŽ¡—Â̌Ÿ“¢.
‰€@‘‹Õ1, ¬ìŽj—m2, ŒˆäŒ[•v2, “V–ì‰pŽ÷2, ŒŽ@‰p‘¥2, ª’ÃŒ«Ži2, ˆÉ˜¬“c–Ÿ2, ƒŒƒIƒ“EƒoƒbƒN
ƒX1, ²“¡•q•F1, ‹g‘º”Ž–M2, ²“¡”Vr2 (1—Տ°Œ€‹†EŠé‰æ, 2ŒÄ‹zŠíŠO): ‘æ27‰ñ“ú–{ŒÄ‹zŠíŠO‰ÈŠw
‰ï (2010/5/13), å‘ä.

723974. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) …“—ƒƒNƒ`ƒ“‚Ì’èŠúÚŽí‰»‚Ì”ï—p‘ÎŒø‰Ê. ²“¡•q•F1, {
‰ê–œ’q, ’r“cr–ç, ŒÜ\—’’†, ¬—Ñ”üˆŸ, ™X—TŽ÷, ŽíŽsÛŽq, “c‘q’q”V, •œ”ö’qL, ˜a“ckŽ¡2 (1—Õ
°Œ€‹†EŠé‰æ, 2‰q¶EŒöO‰q¶): ‘æ48‰ñ“ú–{ˆã—ÁE•a‰@ŠÇ—Šw‰ïŠwp‘‰ï (2010/10/16), L“‡.

723975. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ú–{l‹y‚Ñ’†‘l (Š¿–¯‘°) ‚ł̃AƒZƒgƒAƒ~ƒmƒtƒFƒ“–ò
•š“®‘Ô‚Ì”äŠr. ˜eâ^”ü1, ]@@ß, ’r“cN•F, “¡“c•üŒb2, ‚‹ŽŒ«¬, ’†‘º’q”ü, âV“¡—R”üŽq, ‘O“c
ŽÀ‰Ô, ‰€@‘‹Õ3, ²“¡”ü•äŽq, ˜@À’qŽq, ŒF’J—YŽ¡2 (1—Տ°Œ€‹†EŠé‰æ, 2–ò—, 3’nˆæŽüŽYŠúE‹~‹}
ˆã—Ã): ‘æ31‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2010/12/1), ‹ž“s.

723976. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) An international program for clinical research at
Kitasato University. ²“¡•q•F1, ‰€@‘‹Õ2, ƒŒƒIƒ“EƒoƒbƒNƒX1, ¯@‰À–F3, ˆíŒ©@Ž¡1, â–{‘×
—, ‘ŠàVDŽ¡3 (1—Տ°Œ€‹†EŠé‰æ, 2’nˆæŽüŽYŠúE‹~‹}ˆã—ØAŒg‹³Žº, 3‰q¶EŒöO‰q¶): ‘æ21‰ñ“ú–{
‰uŠw‰ïŠwp‘‰ï (2011/1/21), ŽD–y, ‘æ21‰ñ“ú–{‰uŠw‰ïŠwp‘‰ïu‰‰W 2011; p.169.

733472. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) “ú–{lŒ’NŽá”N’jŽq‚̈ÀÃŽžS“d}‚É‚š‚¯‚é
QTŠî€’l‚̉ºŒÀ. ˆíŒ©@Ž¡1, ‹{ŒŽ‰p•v, Œã“¡Š°Ži, ’r“cŒ›º, Žç“cŒ›’, ¬Œè“O–ç (1—Տ°Œ€‹†EŠé
‰æ): ‘æ26‰ñS“dî•ñˆ—ƒ[ƒNƒVƒ‡ƒbƒv (2010/10/23), ’–•c‘ã, S“d} 2011; 31 (Suppl 1): S-1-4.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H20-110004. [ŒŽ’˜] Aflatoxin and ochratoxin A contamination of retail foods and intake of
these mycotoxins in Japan. Kumagai S, Nakajima M, Tabata S, Ishikuro E, Tanaka T, Norizuki H,
Itoh Y, Aoyama K, Fujita K, Kai S, Sato T1, Saito S, Yoshiike N, Sugita-Konishi Y: Food Addit Contam
Part A Chem Anal Control Expo Risk Assess. 2008 Sep;25(9): 2008/9; 25 (9): 1101-6. (²“¡•q•F1:
1—Տ°Œ€‹†EŠé‰æ)

H21-110023. [ŒŽ’˜] Exposure to aflatoxins in Japan: risk assessment for aflatoxin B1.
Sugita-Konishi Y, Sato T1, Saito S, Nakajima M, Tabata S, Tanaka T, Norizuki H, Itoh Y, Kai S,
Sugiyama K, Kamata Y, Yoshiike N, Kumagai S: Food Addit Contam Part A Chem Anal Control Expo Risk
Assess 2010/3; 27 (3): 365-72. (²“¡•q•F1: 1—Տ°Œ€‹†EŠé‰æ)

H21-540022. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (H•i‚̈ÀSEˆÀ‘SŠm•Û„iŒ€‹†
Ž–‹Æ)zƒJƒr“Å‚ðŠÜ‚ސH•i‚̈À‘S«‚ÉŠÖ‚·‚錀‹†. ¬Œ—ÇŽq, ŒF’J@i, ²“¡•q•F1, Ä“¡Žj˜N1, ™ŽR
Œ\ˆê, “c’†•qŽk (1—Տ°Œ€‹†EŠé‰æ): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (H•i‚̈ÀSEˆÀ‘SŠm•Û„iŒ€‹†Ž–‹Æ) •œ
¬19?21”N“x‘‡Œ€‹†•ñ‘ 2010/5; p.3-39, p.63-87.

H21-540023. [‚»‚Ì‘Œ (Œ€‹†•ñ‘)]yŒú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (’nˆæˆã—Êî”ÕŠJ”­„iŒ€‹†Ž–
‹Æ)zˆã—ËZp‚̎Љï“I–ðŠ„‚ÆŒoÏ«‚Ì•]‰¿‚ÉŠÖ‚·‚錀‹†. ²“¡•q•F1, ’r“cr–ç, {‰ê–œ’q, ™X—TŽ÷,
•œ”ö’qL (1—Տ°Œ€‹†EŠé‰æ): Œú¶˜J“­‰ÈŠwŒ€‹†”ï•â•‹à (’nˆæˆã—Êî”ÕŠJ”­„iŒ€‹†Ž–‹Æ) •œ¬21”N
“x‘‡Œ€‹†•ñ‘ 2010/5; p.1-3.

H21-540024. [‚»‚Ì‘Œ (u‰‰‰ï‹L˜^W)]yƒwƒ‹ƒXƒPƒAEƒ\ƒŠƒ…[ƒVƒ‡ƒ“Œ€‹†u•a‰@‚ÌŒŸ—t‚ð‚í‚©‚è‚â
‚·‚­vu‰‰‰ïzˆãŠw•”‹³ˆç‚É‚š‚¯‚銳ŽÒƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“. ²“¡•q•F1, Žç‰®—˜‰À2 (1—Տ°Œ€‹†EŠé
‰æ, 2ˆãŠw‹³ˆç): ƒwƒ‹ƒXƒPƒAEƒ\ƒŠƒ…[ƒVƒ‡ƒ“Œ€‹†u•a‰@‚ÌŒŸ—t‚ð‚í‚©‚è‚â‚·‚­vu‰‰‰ï‹L˜^W 2010/3;
p.97-110.

[’˜@‘]

H21-620018. [Šwp‘] (•ª’SŽ·•M)yƒTƒuƒm[ƒg@•ÛŒ’ˆã—Ø_EŒöO‰q¶Šw (2010”N”Å) ‘æ33”Łz
‘æ3Í ‰uŠw, ‘æ4Í “Œv, p.117-82. ²“¡•q•F (—Տ°Œ€‹†EŠé‰æ), ƒƒfƒBƒbƒNƒƒfƒBƒA, “Œ‹ž, 2009/10
”­s.


ƒoƒCƒIƒGƒVƒbƒNƒX•”–å


ƒvƒƒWƒFƒNƒg„i•”–å


Œ’NŠÇ—ƒZƒ“ƒ^[


–k—¢‘åŠw•a‰@

ŠÅŒì•”

[Šwp˜_•¶]

120085. [ŒŽ’˜] SŒŒŠÇ•aŠ³ŽÒ‚É‚š‚¯‚é‹Ö‰ŒéŒŸ‚ÌŽó—e‚Í‘Þ‰@Œã‚̍ċi‰Œ—\–h‚É‚š‚¢‚ďd—v‚ȈöŽq‚Æ‚È‚é.
‰Í–ì^—1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y3, ‚‹Ž—R”ü1, Œ©ˆä“c˜a³3, ŽR–{Žü•œ4, –x“cˆêŽ÷4, –Ø‘º‰ë•F
2, Œ‰i“Ä•F2, –ì“cçt5, ˜aò@“O5 (1ŠÅŒì•”, 2ˆã—Éq¶Šw•”, 3ƒŠƒnƒrƒŠ•”, 4‘åŠw‰@ˆã—ÃŒnŒ€‹†
‰È, 5zŠÂŠí“à): S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ 2010/6; 15 (2): 301-5.

220027. [€ŒŽ’˜] tˆÚAˆã—Âɂš‚¯‚éŠÅŒì‚Ì‹@”\‚Æ–ðŠ„. –ìŒû•¶”T1, ’r“c¬]2, “c’†”üŽ÷1, •œ“‡
—DŽq1, •œ‰ª’qŒb1, ’†“‡ßŽq1, ‹g“cˆê¬2 (1ŠÅŒì•”, 2”å”AŠí): tˆÚAÇ—áW2010 (‘æ43‰ñ“ú–{—Õ
°tˆÚAŠw‰ï‹L˜^W) 2010/9; p.386-8.

520090. [‘à]yŒ©‚Ä‚í‚©‚é—Տ°ŠÅŒì‹Zpz‘n•”‚̏Á“łƃK[ƒ[ŒðŠ·. ì‘º”ü‹IŽq1 (ŠÄC ’––”ŽŽq1,
Ž…@–F1) (1ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2010/4; 14 (5): 40833.

520091. [‘à]yÀ’k‰ïz–\—Í‚ð–„‚à‚ꂳ‚¹‚È‚¢‚œ‚ß‚ÉŠÇ—E‚ª‚Å‚«‚邱‚Æ. ì’JOŽq (ŠÅŒì•”): ŠÅŒì
ŠÇ— 2010/5; 20 (5): 401-5.

520092. [‘à] ‘å’°‚ª‚ñ“àŽ‹‹ŸŒŸž¥Ž¡—ÑOŒã‚̃PƒA. ’·’Jì“ÞŽq1, çø“”ü“oŽq1 (1ŠÅŒì•”): ‚ª
‚ñŠÅŒì 2010/5: 15 (4): 396-400.

520093. [‘à] ¬Ž™‚̃oƒCƒ^ƒ‹ƒTƒCƒ“. ‘å’J®–ç (ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2010/6; 14 (6):
10-7.

520094. [‘à]y—Տ°ŠÅŒì‹Zpzí‚Ɋ댯‚ð—\‘ª‚µ‚È‚ª‚çs‚€u¬Ž™‚Ì“úí¶Šˆ‰‡•v. ‘å’ˁ@1 (ŠÄ
C ’––”ŽŽq1, ‰Pˆä‚ä‚©‚è1) (1ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2010/7; 14 (8): 10-7.

520095. [‘à]y—Տ°ŠÅŒì‹ZpzƒŠƒXƒN‚ðŠÇ—‚µ‚È‚ª‚çs‚€’iŠK“I—£°‚Æ•às‰î•. ‹àŒŽƒŽi1 (ŠÄC ’–
–”ŽŽq1, ‰Pˆä‚ä‚©‚è1) (1ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2010/8; 14 (9): 10-7.

520096. [‘à]y¶ŠˆKŠµ•a‚ð‚ß‚®‚é‰Æ‘°‚ÌŽx‰‡zƒAƒvƒ[ƒ`•Ò@‰Æ‘°’²®‚ª•K—v‚ÈŠ³ŽÒ‚Æ‚»‚̃Aƒvƒ[
ƒ`. ‚Œ©‹IŽq (ŠÅŒì•”): ‰Æ‘°ŠÅŒì 2010/8; 8 (2): 85-90.

520097. [‘à]y—Տ°ŠÅŒì‹Zpz“_“HŽ¡—Ã’†‚ÌŽÔ‚¢‚·‚̈ڏæ‚ƈڑ—. ‰Á“¡@Œi1 (ŠÄC ’––”ŽŽq1, ‰P
ˆä‚ä‚©‚è1) (1ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2010/9; 14 (10): 10-7.

520098. [‘à] H‚̗Տ°ŠÅŒì—ÍŒŸ’è(¬Ž™•Ò). ‘å’J®–ç (ŠÅŒì•”): smart nurse 2010/10; 10ŒŽ†:
20-5.

520099. [‘à]y—Տ°ŠÅŒì‹Zpz“_“HŽ¡—Ã’†‚̐QˆßŒðŠ·. ì‘º’q”ü1 (ŠÄC ’––”ŽŽq1, ‰Pˆä‚ä‚©‚è1)
(1ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2010/10; 14 (11): 10-7.

520100. [‘à]y•a‰@ƒgƒCƒŒ‚Ì‹€“¯Œ€‹† (‘æ1•ñ)zˆÀ‘S‚ʼnõ“K, ŠÂ‹«‚ɂ₳‚µ‚¢ƒgƒCƒŒ‹óŠÔ‚ÌŒ€‹†. ‰ê
—ˆ®F1, ÀŠÔO˜a2, —é–Ø”üŽ}Žq3, ’†“‡“¿“ñ4, —é–؍Nm5, —é–؏ºŽq1 (1TOTO (Š”) ƒŠƒ‚ƒfƒ‹‰c‹Æ„
i•”ƒpƒuƒŠƒbƒNƒ‚ƒfƒ‹‰c‹Æ„iƒOƒ‹[ƒv, 2–k—¢‘åŠw•a‰@ŠÂ‹«®”õ‰Û, 3ŠÅŒì•”, 4(Š”) ‰ª‘º»ìŠƒ}[
ƒPƒeƒBƒ“ƒO•”, 5ƒAƒCƒJH‹Æ (Š”) “Á”Ì•”): •a‰@Ý”õ 2010/11; 52 (6): 156-7.

520101. [‘à]y—Տ°ŠÅŒì‹ZpzˆÀÃ‰ç°Š³ŽÒ‚ð‘Ώۂɂµ‚œ‰A•”ôò. ²“¡—ÇŽq1 (ŠÄC ’––”ŽŽq1, ‰P
ˆä‚ä‚©‚è1) (1ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2010/11; 14 (13): 10-7.

520102. [‘à]y—Տ°ŠÅŒì‹Zpz‘S‰î•‚ð•K—v‚Æ‚·‚銳ŽÒ‚ÌŒûoƒPƒA. ‹{ø“—FŒb1 (ŠÄC ’––”ŽŽq1, ‰P
ˆä‚ä‚©‚è1) (1ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2010/12; 14 (14): 10-7.

520103. [‘à]y‚±‚ê‚͉Ÿ‚³‚Š‚Ä‚š‚«‚œ‚¢pŒãƒPƒAŽ–—áWzpŒãƒPƒA‚Ì•Ï‘J; pŒãƒPƒA. ‘å’J®–ç (ŠÅ
Œì•”): —Տ°ŠÅŒì 2011/1; 37 (1): 18-22.

520104. [‘à]y‚±‚ê‚͉Ÿ‚³‚Š‚Ä‚š‚«‚œ‚¢pŒãƒPƒAŽ–—áWzpŒã‚̌ċzŠÇ—‚ª•K—v‚ÈŠ³ŽÒ. ‘å’J®–ç (ŠÅ
Œì•”): —Տ°ŠÅŒì 2011/1; 37 (1): 49-52.

520105. [‘à]y—Տ°ŠÅŒì‹ZpzƒtƒBƒWƒJƒ‹ƒAƒZƒXƒƒ“ƒg. –x]çŒbŽq1 (ŠÄC ’––”ŽŽq1, ‰Pˆä‚ä‚©
‚è1) (1ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2011/1; 15 (1): 10-7.

520106. [‘à] Ý‘î—×{‚̐…æˆÄ“à‚Æ‚È‚éu‘Þ‰@‘O–K–âŽw“±v‚ÅŠÅŒìŽt‚͉œ‚ð‚·‚é‚Ì‚©. Ž…”ü²Žq
(ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2011/1; 15 (1): 48-53.

520107. [‘à] ‹CŠÇ‹zˆø‚̉ð–UE¶—Šw“I—‰ð. ‘å’J®–ç (ŠÅŒì•”): —Šw—Ö@ 2011/2; 28 (2): 321-8.

520108. [‘à]y—Տ°ŠÅŒì‹ZpzŠëŒ¯‚ð—\‘ª‚µ‚È‚ª‚çs‚€“ü—‰î•. –x“cÊŽq1 (ŠÄC ’––”ŽŽq1, ‰P
ˆä‚ä‚©‚è1) (1ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2011/2; 15 (2): 10-7.

520109. [‘à] ˆê”Ê•a“‚Å‚Ì‚ª‚ñI––Šú‚̉Ƒ°ƒPƒA‚ÌŒ»ó. ‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): ‰Æ‘°ŠÅŒì 2011/2;
9 (1): 52-7.

520110. [‘à]y‚ª‚ñI––Šú‚̉Ƒ°ƒPƒAzŽãƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“?Š³ŽÒ‚É•a–ŒE•aó’m‚ð‚µ‚œ‚ª‚ç‚È
‚¢‰Æ‘°?. ‚Œ©‹IŽq (ŠÅŒì•”): ‰Æ‘°ŠÅŒì 2011/2; 9 (1): 108-16.

520111. [‘à]y—Տ°ŠÅŒì‹ZpzŽèpŠÅŒì?Žèp‚Ì—¬‚ê‚ÆŠÅŒìŽt‚Ì–ðŠ„‚ð—‰ð‚·‚é‚œ‚ß‚É?. œA–ìŒbŽq
1 (ŠÄC ’––”ŽŽq1, ‰Pˆä‚ä‚©‚è1) (1ŠÅŒì•”): ƒi[ƒVƒ“ƒOƒJƒŒƒbƒW 2011/3; 15 (3): 10-7.

521031. [‰ðà] ‘ŽYŽ™‚̏o¶’·Œã‚̃PƒA. ›–삳‚â‚© (ŠÅŒì•”): NEONATAL CARE 2011/2; 24 (2): 30-6
(140-6).

522155. [uÀ] VlŠÅŒìEˆõŒ€CƒvƒƒOƒ‰ƒ€\’z–@. •Ê•{çŒb1, ’––”ŽŽq1 (1ŠÅŒì•”): ŠÅŒì 2010/5;
62 (7): 28-33.

522156. [uÀ] ‚ ‚È‚œ‚ÌŽÀ—Í‚ð˜rŽŽ‚µIH‚̗Տ°ŠÅŒì—ÍŒŸ’è 2 ŠŽõŠÇ——Í‚ðƒ`ƒFƒbƒN. ’†–ì—R‹IŽq
1, ‚é—R”üŽq2 (1ŠÅŒì•”, 2ŠŽõŠÇ—Žº): smart nurse 2010/10; 12 (10: 26-33.

540109. [‚»‚Ì‘Œ] (ƒCƒ“ƒ^ƒrƒ…[) ƒLƒƒƒŠƒAƒrƒWƒ‡ƒ“‚ð•`‚¯‚é‘gD‚ÍŠwK‚·‚é?‘gD‚ÌŠJ•ú«, ƒXƒ^ƒbƒt
‚ªƒRƒ~ƒbƒg‚Å‚«‚éŠÂ‹«‚ð–ÚŽw‚µ‚Ä?. •Ê•{çŒb (ŠÅŒì•”): ŠÅŒìŠÇ— 2010/5; 20 (5): 376-9.

540110. [‚»‚Ì‘Œ] (Œ€‹†•ñ) •œ¬18”N‚ª‚ñŠÅŒì‚ÉŒg‚í‚éê–åŠÅŒìŽt‚ÌŠˆ“®ó‹µ’²ž•ñ. çø“”ü“oŽq
1, ²“¡âXŽq1, ¬Œ_Žq1, à_ŒûŒbŽq1, ¬”—•y”ü]1, ‚‹Ž”ü‰êŽq1, Šp“c’ŒŽ}1, ŽËê“TŽq1, ‚ŽR‹ž
Žq1, ×’J”ü‹I1, ’·’Jì‹v–€1, ¬“‡‘€Žq1 (1ŠÅŒì•”): “ú–{‚ª‚ñŠÅŒìŠw‰ïŽ 2010/9; 24 (2): 41-8.

540111. [‚»‚Ì‘Œ] (ŽÀ‘H•ñ) ¬Ž™ŠÅŒì‚ÉŠÖ‚·‚éƒP[ƒXƒŒƒrƒ…[Œã‚̃P[ƒX’ñ‹ŸŽÒ‚É‚æ‚é—Տ°‚ւ̃tƒB[
ƒhƒoƒbƒN. [’JŠî—T1, Œ“cŽuân2, ˆÉ“¡FŽq3, Œ‘ºŽÀŠóŽq4, Œ”ö”ü’qŽq5, “›ˆä^—D”ü6, ŽR“à•üŽq
6, ’·’JìF‰¹7, ]–{ƒŠƒi6, ’†àV~Žq8, ì–Œ‚é‚è6, •œŽRŒbŽq6 (1“ú–{Ô\ŽšŠÅŒì‘åŠw‘åŠw‰@”ŽŽm‰Û
’ö, 2“ú–{ŠÅŒì‹Š‰ïŠÅŒìŒ€CŠwZ, 3ŠÅŒì•”, 4Œcœä‹`m‘åŠw•a‰@, 5‘O“ú–{Ô\ŽšŠÅŒì‘åŠw, 6“ú–{Ô\
ŽšŠÅŒì‘åŠw, 7‘O“ú–{Ô\ŽšŠÅŒì‘åŠw‘åŠw‰@CŽm‰Û’ö, 8¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw‰¡•lŽsŒ•”•a‰@): ¬Ž™ŠÅ
ŒìŠw‰ïŽ 2010; 19 (2): 25-31.

540112. [‚»‚Ì‘Œ] (Œ€‹†•ñ) ŠÅŒìŽt‚ªu¢‚Á‚œvŽ–—á‚ÌŒŸ“¢‚ð’Ê‚µ‚Ä‚Ý‚Š‚鏬Ž™ŠÅŒìŽÀ‘H‚ð‘j‚ޗՏ°‚Ì
Œ»ó. Œ“cŽuân1, ˆÉ“¡FŽq2, [’JŠî—T3, ŽR“à•üŽq4, ’†àV~Žq5, ”Ñ‘º’ŒŽq6, ]–{ƒŠƒi4, “›ˆä^
—D”ü4, Œ”ö”ü’qŽq7, Œ‘ºŽÀŠóŽq8, ’·’JìF‰¹9 (1“ú–{ŠÅŒì‹Š‰ïŠÅŒìŒ€CŠwZ, 2ŠÅŒì•”, 3“ú–{Ô\
ŽšŠÅŒì‘åŠw‘åŠw‰@”ŽŽm‰Û’ö, 4“ú–{Ô\ŽšŠÅŒì‘åŠw, 5¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw‰¡•lŽsŒ•”•a‰@, 6“Œ–M‘åŠw
ˆãŠw•”ŠÅŒìŠw‰È, 7‘O“ú–{Ô\ŽšŠÅŒì‘åŠw, 8Œcœä‹`m‘åŠw•a‰@, 9‘O“ú–{Ô\ŽšŠÅŒì‘åŠw‘åŠw‰@CŽm‰Û
’ö): ¬Ž™ŠÅŒì 2010; 33 (11): 1587-93.

540113. [‚»‚Ì‘Œ] (Œ€‹†•ñ) ‹~‹}EW’†Ž¡—Âð—v‚·‚édÇˆÓŽ¯áŠQŠ³ŽÒ‚ɑ΂·‚é‰Æ‘°¬ˆõ‚Ì”FŽ¯ƒvƒƒZ
ƒX‚ÆŠÅŒìŽx‰‡‚Ì’T‹. žÒŒ‹v”üŽq (ŠÅŒì•”): “ú–{ŠÅŒì‰ÈŠw‰ïŽ 2011/3; 31 (1): 36-45.

[’˜@‘]

620165. [Šwp‘] (•ª’SŽ·•M)y‘ΏۑrŽž‚ÌŠÅŒìzƒ}[ƒKƒŒƒbƒgEAEƒjƒ…[ƒ}ƒ“‚Ì—˜_, p.73-5. ‹ß“¡
‚Ü‚ä‚Ý (ŠÅŒì•”), •Ò Ž›è–Ÿ”ü (•Ÿ‰ª‘åŠwˆãŠw•”), ’†‰›–@‹K, 2010/4/20”­s.

620166. [Šwp‘] (•ª’SŽ·•M)y‘ΏۑrŽž‚ÌŠÅŒìz“û‚ª‚ñ‚É‚æ‚é“û–[‚ð‘rŽž‚µ‚œl‚ւ̃PƒA, p.140-9. ‹ß
“¡‚Ü‚ä‚Ý (ŠÅŒì•”), •Ò Ž›è–Ÿ”ü (•Ÿ‰ª‘åŠwˆãŠw•”), ’†‰›–@‹K, 2010/4/20”­s.

620167. [Šwp‘] (•ª’SŽ·•M)yŽ–—á‚ÅŠw‚Ôƒ}ƒ“ƒK‚Å‚í‚©‚é@ž_‰ÈŠÅŒì‚Ì”ñŒŸŒê“IƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“
UPpzE”F’mÇŠ³ŽÒ‚̏ꍇ@‹óŠÔ‹——£‚ðŠˆ—p‚µ‚œ‚©‚©‚í‚è, p.231-5. ¬—Ñ•x‹MŽq (ŠÅŒì•”), ŠÄC •œàV
‹vˆê (ŠÖŒˆã—ÑåŠw•ÛŒ’ŠÅŒìŠw•”), ƒƒfƒBƒJo”Å, ‘åã, 2010/6/10”­s.

620168. [Šwp‘] (•ª’SŽ·•M)yDMAT•W€ƒeƒLƒXƒgzDMAT‚ªŽÀŽ{‚·‚éf—Á@ŠÅŒì‚ÌŽÀÛ@SCU, p.245-8.
ŠŽR˜a”ü (ŠÅŒì•”): •Ò “ú–{W’cÐŠQˆãŠw‰ïDMATƒeƒLƒXƒg•ÒWˆÏˆõ‰ï, ŠÄC “ú–{W’cÐŠQˆãŠw‰ï, ‚Ö‚é
‚·o”Å, 2011/2/21”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722243. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) —Տ°‰Æ‚ƊŌ쌀‹†. •Ê•{çŒb (ŠÅŒì•”): ‘æ47‰ñ“ú–{ˆã—ÁE•a
‰@ŠÇ—Šw‰ïŠwp‘‰ï (2009/10/17-18), “Œ‹ž, “ú–{ˆã—ÁE•a‰@ŠÇ—Šw‰ïŽ 2010/4; 47 (2): 122-3.

722244. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‰ñ•œŠúS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚É‚š‚¯‚éŠÅŒìŽt‚Ì–ðŠ„‚É‚Â‚¢‚Ä.
‚‹Ž—R”ü1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y3, ‰Í–ì^—1, ‘q“‡^‹I1, Œ©ˆä“c˜a³3, –ì“cçt4, ˜aò@“O4
(1ŠÅŒì•”, 2ˆã—Éq¶Šw•”, 3ƒŠƒnƒrƒŠ•”, 4zŠÂŠí“à): ‘æ14‰ñ“ú–{S•s‘SŠw‰ïŠwpW‰ï (2010/10/9),
“Œ‹ž.

722245. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‚ª‚ñ‘ÌŒ±ŽÒ‚Æ‚»‚̉Ƒ°‚ªŽ‚—͂ðM‚¶‚ÄŒü‚«‡‚€.
‹ß“¡‚Ü‚ä‚Ý (ŠÅŒì•”): ‘æ48‰ñ“ú–{ŠàŽ¡—Êw‰ïŠwpW‰ï (2010/10/28), ‹ž“s, “ú–{ŠàŽ¡—Êw‰ïŽ
2010/9/21; 45 (2): 424.

723977. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) tˆÚAˆã—Âɂš‚¯‚éŠÅŒì‚Ì‹@”\‚Æ–ðŠ„. –ìŒû•¶”T1, ’r“c¬]2, “c
’†”üŽ÷1, •œ“‡—DŽq1, •œ‰ª’qŒb1, ’†“‡ßŽq1, ‹g“cˆê¬2 (1ŠÅŒì•”, 2”å”AŠí): ‘æ43‰ñ“ú–{—Տ°tˆÚ
AŠw‰ï (2010/1/30), ‚’m ‘æ43‰ñ“ú–{—Տ°tˆÚAŠw‰ïtˆÚAÇ—áW2010 2011; p.386-8.

723978. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •a““à‚Ì‚É‚š‚¢‚ɑ΂·‚éŠÅŒìŽt‚̈ӎ¯’²ž. ²X–Ø—º (ŠÅŒì•”):
‘æ23‰ñ“ú–{˜V”N”å”AŠí‰ÈŠw‰ï (2010/5/14-15), “Œ‹ž.

723979. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) •s”DŽ¡—ÃŒã‚Ì”D•w‚Ö‚Ì”DP“K‰žŽx‰‡ƒvƒƒOƒ‰ƒ€‚É‚æ‚é‰î“ü‘OŒã‚Ì•s
ˆÀ‚𕪐͂µ‚Ä. —V²_Žq1, ˆé’J‘•c1, ãàV‰xŽq2, ‚‹Ž^—2 (1ŠÅŒì•”, 2ŠÅŒìŠw•”): ‘æ9‰ñ“ú–{
•s”DƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ïŠwpW‰ï (2010/6/4), “Œ‹ž, “ú–{•s”DƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ïŽ 2010/4; 9 (1):
47-8.

723980. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) •s”DƒJƒEƒ“ƒZƒŠƒ“ƒOƒXƒLƒ‹ƒAƒbƒvƒZƒ~ƒi[2010‚Ì•ñ‚ƍ¡Œã‚̉ۑè
(ŽÀ‘H•ñ). —V²_Žq1,2, •lè‹žŽq2, •Ÿ“c‹M”üŽq2, Ž}Œ³’ŒŽq2, ‹Ž‘º•xŽq2, Œã“¡’qŽq2, –î–윚Žq
2, ãàV‰xŽq2, ²“¡F“¹2, Š„“cC•œ3, Š„“cßŽq3 (1ŠÅŒì•”, 2“ú–{•s”DƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ïŒ€CˆÏˆõ
‰ï¥”F’èˆÏˆõ, 3ƒg[ƒ^ƒ‹ƒ‰ƒCƒtƒPƒAƒTƒ|[ƒg‚Ç‚è‚¢‚Þ): ‘æ9‰ñ“ú–{•s”DƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ïŠwpW‰ï
(2010/6/4), “Œ‹ž, “ú–{•s”DƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ïŽ 2010/4; 9 (1): 81-2.

723981. [Šw‰ï (‘S‘)] (ŽŠà“¢˜_) “–‰È‚ł̍ݑî‰îŒì‚ÉŒü‚¯‚œgTeam Coordinator Nurse‘åbh“±“ü‚É
‚æ‚è‚Ý‚Š‚œ‰Û‘è. ‰iˆäˆê”ü1, ‰Á“¡–qŽq1, “ŒŠC—Ñ‚¿‚Š‚Ý1, ‹g“cG”ü1, ¬â–ùŒ«2, ‰Á“¡@O2, —с@‹ž
Žq2, ‰|–{‘ñ–Î2, åÎ‹I•F2, ‘ •À@Ÿ2, “n粏¹•F2 (1ŠÅŒì•”, 2ŠO‰È): ‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘
‰ï (2010/6/24), ŽD–y, ‘æ18‰ñ“ú–{“ûŠàŠw‰ïŠwp‘‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2010; p.504.

723982. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ä‹i‰Œ‚̊댯ˆöŽq‚âs“®•Ï—eƒXƒe[ƒW‚ðl—¶‚µ‹Ö‰ŒŽx‰‡‚ðs‚Á‚œ3
Ç—á. ‰Í–ì^—1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y3, ‚‹Ž—R”ü1, Œ©ˆä“c˜a³3, ŽR–{Žü•œ4, –x“cˆêŽ÷4, –Ø
‘º‰ë•F2, Œ‰i“Ä•F2, –ì“cçt5, ˜aò@“O5 (1ŠÅŒì•”, 2ˆã—Éq¶Šw•”, 3ƒŠƒnƒrƒŠ•”, 4‘åŠw‰@ˆã—Ã
ŒnŒ€‹†‰È, 5zŠÂŠí“à): ‘æ16‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï 2010/7/18), Ž­Ž™“‡.

723983. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠÅŒìŠw¶‚ªŽÀKƒOƒ‹[ƒv‚É‹‚ß‚é‚à‚Ì. ‘å‹v•Û–Ÿ”ü (ŠÅŒì•”): ‘æ
41‰ñ“ú–{ŠÅŒìŠw‰ï?ŠÅŒì‹³ˆç?ŠwpW‰ï (2010/@8/19-20), ’·è.

723984. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) —˜•Ö«‚Æ‹ï‘̐«‚ð”õ‚Š‚œƒAƒNƒVƒ‡ƒ“ƒJ[ƒh‚ÌŒŸ“¢. ŠŽR˜a”ü1, Šâ
é_“ñ1, ŽR–ì•Ó‚Ý‚¿Žq (1ŠÅŒì•”): ‘æ12‰ñ“ú–{ÐŠQŠÅŒìŠw‰ï”NŽŸ‘å‰ï (2010/8/28), •Ÿˆä.

723985. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠO—ˆ‚ʼn»Šw—Ö@‚ðŽó‚¯‚éÄ”­“û‚ª‚ñŠ³ŽÒ‚̈ӎvŒˆ’è‚̉ߒö?Ä”­
’m‚©‚玡—Â܂Å?. ‚‹Ž–ƒ—¢Žq1, ”ԏ ÍŽq1 (1ŠÅŒì•”): ‘æ41‰ñ“ú–{ŠÅŒìŠw‰ï?¬lŠÅŒìˆçII?Šwp
W‰ï (2010/8/31), •Ÿ‰ª, ‘æ41‰ñ“ú–{ŠÅŒìŠw‰ïŽ˜^W 2010/8; p.44.

723986. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) •s”DŽ¡—ÃŒã‚Ì”D•w‚Ö‚Ì”DP“K‰žŽx‰‡ƒvƒƒOƒ‰ƒ€‚É‚æ‚é‰î“ü‘OŒã‚̈€
’…‚𕪐͂µ‚Ä. —V²_Žq1, ãàV‰xŽq2 (1ŠÅŒì•”, 2ŠÅŒìŠw•”): ‘æ8‰ñ“ú–{¶BŠÅŒìŠw‰ïŠwpW‰ï
(2010/9/12), “¿“‡, ‘æ8‰ñ“ú–{¶BŠÅŒìŠw‰ïŠwpW‰ï^ƒvƒƒOƒ‰ƒ€Eu‰‰W 2010/8; p.87.

723987. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ƒtƒFƒ“ƒ^ƒjƒ‹ƒpƒbƒ`‚Ì“\•z•”ˆÊ•Ê”—£–ÊዂƔ—£‚Ì—vˆöŒŸõ. ŒI“c
‚©‚Ù‚é1, ‘•ªG–ç2, ŽO‰Y•S‡3 (1ŠÅŒì•”, 2–òÜ•”, 3–òŠw•”): ‘æ4‰ñŠÉ˜aˆã—ÖòŠw‰ï (2010/9/26),
Ž­Ž™“‡, ‘æ4‰ñŠÉ˜aˆã—ÖòŠw‰ïŽ˜^W 2010; p.232.

723988. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘ŸŠí’ñ‹Ÿ‚ÉŠÖ‚·‚éˆÓŽv’Šo‚ÌŒ»ó‚Ɖۑè. ‚‹Ž@Œb1, rì–@Žq1
(1ŠÅŒì•”) : ‘æ6‰ñ“ú–{ˆÚAEÄ¶ˆã—ÊŌìŠw‰ïŠwpW‰ï (2010/10/2), å‘ä.

723989. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆê”Ê•a“‚É‚š‚¯‚é‘ŸŠíE‘gD’ñ‹ŸˆÓŽv‚Ì”cˆ¬‚Æ‘žd‚ÉŒü‚¯‚œŽæ‚è‘g
‚Ý. ŽO‰Y‚µ‚ž‚©1, rì–@Žq1, žÒŒ‹v”üŽq1, –x]”ü—R‹I1, ’r“cKŽq1, ’†àVŒúŽq1, —é–Ø”üŽ}Žq1 (1
ŠÅŒì•”): ‘æ46‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (2010/10/22), ‹ž“s.

723990. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@EˆÚAˆã—ÃŽx‰‡ŽºÝ’u‚æ‚è4”NŠÔ‚ÌŠˆ“®‚Æ•à‚Ý. ’[ŽR
˜a”ü1, rì–@Žq1, ‚‹Ž@Œb2, žÒŒ‹v”üŽq2, ‰Pˆä‚ä‚©‚è2, ’†“‡ßŽq2, “ü–Ø‹GŒb2, —é–Ø”üŽ}Žq2, ¬
‰z–Ÿ”ü2, ‹g“cˆê¬3, –kŒŽF—Y4, ‘ì˜ad5 (1ˆÚAˆã—ÃŽx‰‡Žº, 2ŠÅŒì•”, 3”å”AŠí, 4‹~–œ, 5•úŽË
ü (Žîá‡)): ‘æ46‰ñ“ú–{ˆÚAŠw‰ï (2011/10/22), ‹ž“s.

723991. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒƒjƒG[ƒ‹•a‚ɑ΂·‚鐅•ªÛŽæ—Ö@‚É‚š‚¯‚éˆù…•û–@‚ÌŒŸ“¢?ˆù…
Œv‰æƒpƒ“ƒtƒŒƒbƒg‚Ì—LŒø«?. Šâ‰º—T—¢1, ‚“c’qŽq1, ’·À‰p–Ÿ2, —Ž‡@“Ö2, ‰ª–{–ql2 (1ŠÅŒì
•”, 2Žš•@): ‘æ69‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï‘‰ï (2011/11/18), ‹ž“s, Šwpu‰‰‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W
2010/10; 69 (5): 363.

723992. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒƒjƒG[ƒ‹•a‚ɑ΂·‚鐅•ªÛŽæ—Ö@‚É‚š‚¯‚éˆù…•û–@‚ÌŒŸ“¢. Šâ‰º
—T—¢1, ‚“c’qŽq1, ’·À‰p–Ÿ2, —Ž‡@“Ö2, ‰ª–{–ql2 (1ŠÅŒì•”, 2Žš•@): ‘æ69‰ñ“ú–{‚ß‚Ü‚¢•œt
ˆãŠw‰ï‘‰ï (2010/11/18), ‹ž“s, Šwpu‰‰‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010/10; 69 (5): 364.

723993. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éHIVŠŽõ”D•w‚̃`[ƒ€ˆã—Âɑ΂·‚éƒj[ƒY?
ŽüŽYŠú‚ð’Ê‚µ‚Ä”D•w‚ª–]‚Þƒ`[ƒ€‘̐§‚ÌŒŸ“¢?. ŒŽRW‘ã (ŠÅŒì•”): ‘æ24‰ñ“ú–{ƒGƒCƒYŠw‰ïŠwpW‰ï
(2010/11/25), “Œ‹ž, “ú–{ƒGƒCƒYŠw‰ïŽ 2010/11; 12 (4): 464.

723994. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘ŸŠíE‘gD’ñ‹Ÿ‚É‚š‚¯‚éŒxŽ@E–@ˆãŠw‚Ƃ̘A—˜AŒg‘̐§. ‚‹Ž@Œb
1, ’[ŽR˜a”ü1, žÒŒ‹v”üŽq1, rì–@Žq1, –kŒŽF—Y2, ‹g“cˆê¬3, ‘ì˜ad4, ŒIŒŽŽ—R5 (1ŠÅŒì•”,
2‹~–œ, 3”å”AŠí, 4•úŽËü (Žîá‡), 5–@ˆã): ‘æ44‰ñ“ú–{—Տ°tˆÚAŠw‰ï (2011/1/28), •ó’Ë.

723995. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‚ª‚ñŠÅŒìê–åŠÅŒìŽt‚ªs‚€—Ï—’²®‚ÌŽ‹“_‚Æ•û—ª?ŠO—ˆ‚ŐS”x‘h¶
‚ðs‚Á‚œis‚ª‚ñŠ³ŽÒ‚̃P[ƒX‚ð’Ê‚µ‚Ä?. ‘ì–ž—˜Žq1, çø“”ü“oŽq2, ‹v•ÄŒb]2, Ž™‹Ê”ü—R‹I2, —é
–Ø‹M”ü3, ŒK–ŒŽõ”ü2, Ž…—TŽq4, ‰ª@‘œŒb3, –]ŒŽ”ü•ä2, ¬‘ò@3, Žt‰ªŒbŽq2, ²“¡”ü‹I2, Šâ–{
ƒŽq2, ’·’Jì“ÞŽq3 (1“Œ‹žŽœŒb‰ïˆã‰È‘åŠw•‘®•a‰@, 2ŠÅŒì•”, 3“Œ•a‰@ŠÅŒì•”, 4Œö—§•x‰ª‘‡•a
‰@): ‘æ25‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2011/2/12), _ŒË, “ú–{‚ª‚ñŠÅŒìŠw‰ïŽ 2011/2; 25 (“Á•Ê†):
110.

723996. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) “ªèò•”‚ª‚ñŠ³ŽÒ‚ª’m‚©‚珉”­Ž¡—Ẩߒö‚É•ø‚¢‚œŽv‚¢. Žt‰ªŒbŽq
1, —äŠÝGŽq2 (1ŠÅŒì•”, 2ŠÅŒìŠw•”): ‘æ25‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2011/2/12), _ŒË, “ú–{‚ª
‚ñŠÅŒìŠw‰ïŽ 2010/2; 25 (“Á•Ê†): 124.

723997. [Šw‰ï (‘S‘)] (ŽŠà“¢˜_) M. ƒjƒ…[ƒ}ƒ“‚ÌŒ’N—˜_‚ÉŠî‚­Šñ‚è“Y‚¢‚̃PƒA‚Å•\‚ê‚œŠ³ŽÒ‚ÆŠÅ
ŒìŽt‚̐¬’·?eŽqŠÖŒW‚É”Y‚ÞŠ³ŽÒ‚ªŠÖŒWC•œ‚µ‚œƒP[ƒX?. ‰ª@‘œŒb1, çø“”ü“oŽq2, —äŠÝGŽq3 (1
“Œ•a‰@ŠÅŒì•”, 2ŠÅŒì•”, 3ŠÅŒìŠw•”): ‘æ25‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2010/2/12), _ŒË, “ú–{‚ª
‚ñŠÅŒìŠw‰ïŽ 2010/2; 25 (“Á•Ê†): 202.

723998. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Ž–—ጟ“¢‰ï‚Å‚ÌŠw‚Ñ‚Ì’†‚©‚çŠÅŒìŽt‚ç‚ɐ¶‚Ü‚ê‚œ•Ï‰»‚̉ߒö?M. ƒj
ƒ…[ƒ}ƒ“‚́uŒ’N‚Ì—˜_v‚ÉŠî‚­Šñ‚è“Y‚¢‚̃PƒA‚ÉŠî‚¢‚Ä?. çø“”ü“oŽq1, —äŠÝGŽq2, ì˜eç
3, ¬ŠÑ‰ÄŽq3, ‰ª@‘œŒb3, Œ‘ºçt3, ŒŽŽq“à¹D3 (1ŠÅŒì•”, 2ŠÅŒìŠw•”, 3“Œ•a‰@ŠÅŒì•”): ‘æ25
‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2011/2/13), _ŒË, “ú–{‚ª‚ñŠÅŒìŠw‰ïŽ 2010/2; 25 (“Á•Ê†): 233.

723999. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠÅŒìŽt‚Ì‹³ˆç‚ð–Ú“I‚Æ‚µ‚œƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚Ì—\–hÚŽí‚ÉŠÖ‚·‚éƒvƒŠ
ƒ“ƒg‹³Þ‚̍쐬‚ÌŒŸ“¢. ’†–ì—R‹IŽq (ŠÅŒì•”): ‘æ26‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï (2011/2/9), ‰¡•l, ‘æ26
‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ï^ƒvƒƒOƒ‰ƒ€EŽ˜^W (CD-ROM) 2011/2; 2-0-17-3.

732114. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) “ú–{DMAT‚É‚š‚¯‚é–òÜŽt‚Ì–ðŠ„. ŠŽR˜a”ü
(ŠÅŒì•”): ‘æ49‰ñ“ú–{–òŠw‰ïE“ú–{–òÜŽt‰ïE“ú–{•a‰@–òÜŽt‰ï^’†‘Žl‘Žx•”Šwp‘å‰ï (2010/11/7),
•ÄŽq.

732115. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçƒZƒ~ƒi[) ‘Þ‰@’²®ŠÅŒì‚ÌŽÀÛ. 傖Œ—R‰Á—¢ (ŠÅŒì•”): ‘æ9
‰ñ“ú–{zŠÂŠíŠÅŒìŠw‰ï‹³ˆçƒZƒ~ƒi[’†‹‰•Ò (ŠÖ“Œ) (2011/1/22), “Œ‹ž.

732116. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçƒZƒ~ƒi[) Œp‘±ŠÅŒì (SƒŠƒn‚ðŠÜ‚Þ). ‚‹Ž—R”ü (ŠÅŒì•”): ‘æ
9‰ñ“ú–{zŠÂŠíŠÅŒìŠw‰ï‹³ˆçƒZƒ~ƒi[’†‹‰•Ò (ŠÖ“Œ) (2011/1/22), “Œ‹ž.

732117. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (‹³ˆçu‰‰) ŠÅŒìŒ€‹†‚ÉŠÖ‚·‚é—Ï—“I”z—¶‚ɂ‚¢‚Ä. ‹ß“¡‚Ü‚ä‚Ý (ŠÅ
Œì•”): _“ސ쌧ŠÅŒì‹Š‰ï‘Š–ÍŒŽŽx•”ŠÅŒìŒ€‹†”­•\‰ï (2011/1/27), _“ސì.

733473. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž©•ÂÇŠ³ŽÒ: Œp‘±ŠÅŒì‚̃L[ƒ[ƒh‚́g¶Šˆs“®‚̏KŠµ
‰»h. •œ“‡—DŽq1, –ìŒû•¶”T1, ‹g“cˆê¬2, ŽR–{Œ«Ži3, Îˆä‘å•ã2 (1ŠÅŒì•”, 2”å”AŠí, 3ž_): ‘æ
21‰ñ“ú–{ƒTƒCƒRƒlƒtƒƒƒW[Œ€‹†‰ï (2010/6/5-6), ‰ªŽR.

733474. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Šá‰È•a“‚Å‚Ì“]“|E“]—ŽEÕ“Ë‚ÉŠÖ‚·‚éƒCƒ“ƒVƒfƒ“ƒg‘Î
ô. –x]”ü—R‹I (ŠÅŒì•”): ‘æ24‰ñ“ú–{Šá‰ÈŠÅŒìŒ€‹†‰ï (2008/9/20), “Œ‹ž, ‘æ24‰ñ“ú–{Šá‰ÈŠÅŒìŒ€‹†
”­•\Žû˜^ 2010/10/16; ‘æ24‰ñ: 76.

733475. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) lHŽºŠÖß‘S’uŠ·p‚É‚š‚¯‚鎝‘±‘å‘ڐ_ŒoƒuƒƒbƒN‚ÌŒø
‰Ê. ’·’Jì—TŽq (ŠÅŒì•”): “Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2010/9/17-18), ŠâŽè.

733476. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ|ƒXƒ^[) ‘ŸŠíE‘gD’ñ‹Ÿ‚É‚š‚¯‚éŒxŽ@E–@ˆãŠw‚Ƃ̘A—˜AŒg‘̐§
‚ÌŒŸ“¢. ‚‹Ž@Œb1, ’[ŽR˜a”ü1, žÒŒ‹v”üŽq1, rì–@Žq1, –kŒŽF—Y2, ‹g“cˆê¬3, ‘ì˜ad4, ŒI
ŒŽŽ—R5 (1ŠÅŒì•”, 2‹~–œ, 3”å”AŠí, 4•úŽËü (Žîá‡), 5–@ˆãŠw): ‘æ79‰ñ“ú–{–@ˆãŠw‰ïŠÖ“Œ’n•û‰ï
(2010/10/30), “Œ‹ž, ‘æ79‰ñ“ú–{–@ˆãŠw‰ïŠwpŠÖ“Œ’n•ûW‰ïu‰‰—vŽ|W 2010; p.53.

733477. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) • •ÇƘIo‚µ‚œŽîᇂɂæ‚èƒXƒg[ƒ}ƒPƒA‚É“ïa‚µ‚œˆê—á.
Vˆä—¢‰À1, ¬–ì˜H‘ã1, ¬—я»Žq1 (1ŠÅŒì•”): ‘æ33‰ñ_“ސìƒXƒg[ƒ}Œ€‹†‰ï (2010/12/4), ìè.

733478. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) CTŒ©Šw‰ï‚̌㉺‚ɂ‚¢‚Ä. Œ‰º”ü‹M1, —é–Ø’qŽq1, ‹Ê
ì’ŒŽq1, ‰Í“c‘œ‰Á1, Ž…@–F1, –ììŒhŽq1, ‘å’ˁ@Œb1, ŽRŒû–­Žq1, •zì–­Žq1, ‚–Ø—R—1 (1
ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰ƒ€EŽ˜^
2010/11; ‘æ10‰ñ: 44.

733479. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “]“|“]—Ž–hŽ~—p‹ï‚Ì‘I‘ð–ÚˆÀ. –îŒûKŽq1, –Ÿ_“N–ç2 (1
ŠÅŒì•”, 2ŠÅŒìŠw•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ11‰ñ–k—¢ŠÅŒìŒ€‹†‰ïƒvƒƒOƒ‰
ƒ€EŽ˜^ 2010/11; ‘æ10‰ñ: 67.

733480. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬lˆÚsŠúŽx‰‡‚ÉŠÖ‚·‚鏬Ž™‰È‚Å‚ÌŽæ‚è‘g‚Ý?¬Ž™ˆã—Ã
ŽÒ‚̈ӎ¯’²ž‚ð‚à‚Æ‚É?. ²X–Ø”ü˜aŽq (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733481. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) –ƒŒ•ª•Ø‚ðŠó–]‚·‚é”D•w‚Ö‚Ì•ê“ûˆçŽ™„i‚Ì‚œ‚߂̍čl
?ƒ[ƒŠƒXƒN‚ð‘ΏۂƂµ‚œ–ƒŒ•ª•Ø‚ÆŽ©‘R•ª•Ø‚Ì”äŠr‚©‚ç?. ’©ŒG”ü•ä (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€
‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733482. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™‚É‚š‚¯‚éƒoƒCƒhƒuƒƒbƒNŽg—p‚É‚æ‚éåñጔ­¶‚ɂ‚¢
‚Ă̍lŽ@?[’ÁÃ‰º‚Å‚Ì“K³Žg—p‚ɂ‚¢‚Ä?. ¬ŽR@ˆ€ (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï
(2011/12/18), ‘Š–ÍŒŽ.

733483. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™•a“‚É‚š‚¯‚é–ʉï‚ÌŒŸ“¢?–ʉŠÔ‚̉„’·‚ðŽŽ‚Ý‚Ä
?. Œ“à‰ÀŽq (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733484. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™•a“‚É‚š‚¯‚éVlŠÅŒìŽt‚Ö‚Ì‹~‹}‘h¶–@‚̉‰K‚É‚Â
‚¢‚Ä?BLS‚ÌŽè‹ZK“Ÿ‚ð–ÚŽw‚µ‚Ä‚Ì‹³ˆç“IŽæ‚è‘g‚Ý?. ìã‘å•ã (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï
(2011/12/18), ‘Š–ÍŒŽ.

733485. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆã—ÓIƒPƒA‚ð‚à‚ÂŽq‚Ç‚à‚ÌŒ»ó‚Ɖۑè?AŠw‚܂ł̍ݑî
ƒPƒA‚ÉŠÖ‚·‚é•êe‚ÌŒê‚è‚©‚ç?. –îàV^Ž} (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733486. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Š³ŽÒ‚ƈӐ}“IlŠÔŠÖŒW\’z‚ð}‚鎖‚̈Ӌ`?ƒgƒ‰ƒxƒ‹ƒr
[—˜_‚ð—p‚¢‚Ä?. ²“¡Ø (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733487. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒgƒ‰ƒxƒ‹ƒr[‚Ì—˜_‚ÉŠî‚­ŠÖŒW«‚̍\’z?Š³ŽÒ‚Æ‘ÌŒ±
‚ð‹€‚É‚µ‚Ä?. H“c]—œŽq (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733488. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŒÂ•Ê“I‚ȃŠ[ƒ_[ˆç¬‚ÌŽŽ‚Ý?Œø‰Ê“I‚ȃŠ[ƒ_[ˆç¬‚Ì
ŽŽ‚Ý‘æ2•ñEƒŠ[ƒ_[ˆç¬ƒvƒƒOƒ‰ƒ€‚ÌŠˆ—p?. ˆ°àVŒ\Žq (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï
(2011/12/18), ‘Š–ÍŒŽ.

733489. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆê”Ê•a“‚É‚š‚¯‚é‘ŸŠíE‘gD’ñ‹ŸˆÓŽv‚Ì”cˆ¬‚ƍ¡Œã‚̉Û
‘è?’ñ‹ŸˆÓŽv‚Ì‘žd‚ÉŒü‚¯‚œŽæ‚è‘g‚Ý?. ŽO‰Y‚µ‚ž‚© (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18),
‘Š–ÍŒŽ.

733490. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “]“|“]—Ž–hŽ~—p‹ï‚Ì‘I‘ð–ÚˆÀ‚Ì–ŸŠm‰». –îŒûKŽq (ŠÅŒì
•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733491. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Ž–—ጟ“¢‰ï‚Å‚ÌŠw‚Ñ‚Ì’†‚©‚çŠÅŒìŽt‚ç‚ɐ¶‚Ü‚ê‚œ•Ï‰»‚Ì
‰ß’ö?M. ƒjƒ…[ƒ}ƒ“‚́uŒ’N—˜_v‚ÉŠî‚­Šñ‚è“Y‚¢‚̃PƒA‚ÉŠî‚¢‚Ä?. çø“”ü“oŽq (ŠÅŒì•”): ‘æ
10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733492. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒgƒ‰ƒxƒ‹ƒr[‚Ì—˜_‚ðŽÀ‘H‚µ‚Ä‚Ý‚Ä?lŠÔ‘ΐlŠÔ‚ÌŠÅŒì
‚ð’Ê‚µ‚œŠw‚Ñ?. ˆÀ’B—R”üŽq (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733493. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘¢ŒŒŠíŽîᇊ³ŽÒ‚̍D’†‹…Œž­Žž‚É‚š‚¯‚éHŽ–Žw“±—pƒpƒ“
ƒtƒŒƒbƒgì¬‚ÉŒü‚¯‚Ä?ŠÅŒìŽt‚̈ӎ¯’²ž?. ŒŒŽ’mŽ} (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï
(2011/12/18), ‘Š–ÍŒŽ.

733494. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŠÅŒìŽt‚̍R‚ª‚ñÜ‚É‚æ‚锘˜I–hŽ~‚ɑ΂·‚é•a“ŠÔ‚Ì”FŽ¯
‚̈Ⴂ. rˆä”üŽq (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733495. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) B•a“‚É‚š‚¯‚é’iŠK“IƒŠ[ƒ_[ƒIƒŠƒGƒ“ƒe[ƒVƒ‡ƒ“‚ÌŒø
‰Ê‚ƍ¡Œã‚̉ۑè. ‰Á‰ê”üˆÓ (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733496. Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚؃vƒƒE‚̊Ō엝˜_‚ð—p‚¢‚œ‡•¹Ç‚ð—L‚·‚é“œ”A•aŠ³ŽÒ‚Ì
ŠÅŒì. ç–Ø—Ç“Þ‰› (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733497. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Œûo•ÛŽŒÜ‚Ì’è’…‚ÉŒü‚¯‚Ä?•ÛŽŒEŽŒƒWƒFƒ‹‚ðŽg—p‚µ
‚œŠÅŒìŽt‚ւ̃Aƒ“ƒP[ƒg’²ž‚©‚ç?. Î‘q@ˆ€ (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–Í
ŒŽ.

733498. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‹~‹}‹~–œƒZƒ“ƒ^[‚É‚š‚¯‚éš‹‰ºáŠQŠ³ŽÒ‚ÌŒ»ó. ‰ª“cŽ‡
•ä (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733499. Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “à‚È‚éˆÓŽ¯‚ÌŠoÁ‚ð–ÚŽw‚µ‚Ä?dÇ“ª•”ŠOŠ³ŽÒ‚ÌŠÏŽ@‹L
˜^‚Æ‘J‰„«ˆÓŽ¯áŠQ‚̈ӎ¯‰ü‘P‚ÌŽ–—á‚𓥂܂Š‚Ä?. dM@—º (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï
(2011/12/18), ‘Š–ÍŒŽ.

733500. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–ICU‚É‚š‚¯‚é‹CŠÇ“à‘}ŠÇŠ³ŽÒ‚Ìš‹‰ºáŠQ‚ÉŠÖ‚·‚錟“¢.
•ÐŽRˆŸŽ÷ (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733501. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‰º—Ÿ‚É‚æ‚é”畆ƒgƒ‰ƒuƒ‹—\–h‚Ì‚œ‚ß‚Ì”r•Ö—¯’uƒJƒe[ƒe
ƒ‹‘}“üŽžŠú‚ÌŒŸ“¢. ŒÑ“c«Žk (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733502. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “–‰@ŠÅŒìŽt‚Ì”MŠÇ—‚ɑ΂·‚éˆÓŽ¯‚ƍs“®‚ÌŽÀÛ. ‰Á“¡
¬”ü (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733503. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “ûŽ™—h‚³‚Ô‚ç‚êÇŒóŒQ (SBS)—\–h‚ÉŒü‚¯‚Ä‚ÌŽæ‚è‘g‚Ý?
‰Æ‘°‚ÖŒü‚¯‚Ä“ˆê‚µ‚œŽw“±‚ɂ‚¢‚Ä?. ”’–؍²’mŽq (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18),
‘Š–ÍŒŽ.

733504. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) CTŒ©Šw‰ï‚ÌŒø‰Ê‚ɂ‚¢‚Ä?Ž–‘O€”õ•s‘«‚ÍŒyŒž‚µ‚œ‚©?.
Œ‰º”ü‹M (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733505. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™—̈æ‚É‚š‚¯‚éÝ‘îlHŒÄ‹zŠí“±“üƒ}ƒjƒ…ƒAƒ‹ì¬?
‰Æ‘°‚ðŠÜ‚ß‚œ‰~ŠŠ‚ȃ`[ƒ€ˆã—Âð–ÚŽw‚µ‚Ä?. –Ø‘º‚ä‚ÝŽq (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï
(2011/12/18), ‘Š–ÍŒŽ.

733506. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ¬Ž™•a“‚É‚š‚¯‚élHŒÄ‹zŠíŠÖ˜A‚̃Cƒ“ƒVƒfƒ“ƒg‚Ì•ªÍ.
’·“‡‹Žj (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733507. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) V¶Ž™Ž¡—Âɑ΂·‚ée‚̈ӎvŒˆ’è‚ðŽx‚Š‚é”DPŠú‚©‚ç‚Ì
ŠÖ‚í‚è. ‰º‰’@ˆ» (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733508. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) Š³ŽÒ‚Ì?‰Æ‘°‚̈ӎvŒˆ’è‚Ö‚ÌŽx‰‡?. Šâ“c‚È‚È (ŠÅŒì
•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹† (2011/12/18), ‘Š–ÍŒŽ.

733509. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “ªŒz•”Žîᇊ³ŽÒ‚Ì•úŽËü«Œûo”S–Œ‰Š‚ɑ΂·‚éŠÅŒìŽt‚Ì
ˆÓŽ¯’²ž. ŒÃ“¡@Œb (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733510. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŽžºEHŽ–‚ւ̉‡•‚ɂ‚¢‚ÄŠw‚ñ‚Ÿ‚±‚Æ?‚؃vƒƒE‚̐l
ŠÔŠÖŒW‚̊Ō엝˜_‚ð—p‚¢‚Ä?. ŽR“c—F”ü (ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733511. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒtƒBƒWƒJƒ‹ƒAƒZƒXƒƒ“ƒgŒ€C‚ÌŠˆ“®•ñ. –x]çŒbŽq
(ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2011/12/18), ‘Š–ÍŒŽ.

733512. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒeƒ“ƒOƒ^ƒP’†“Å‚É‚æ‚é‘œÊ‚Ȑž_Çó‚ð‚«‚œ‚µ‚œŠ³ŽÒ‚Ì
Ç—á•ñ. ˜a’m—ÉŽq1, —é–Ø–M•F1 (1ŠÅŒì•”): ‘æ25‰ñ“ú–{’†“ÅŠw‰ï“Œ“ú–{’n•û‰ï (2011/1/8), –kŠC“¹.

733513. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “‡Žž’²Ç‚ð‡•¹‚µ‚œ‡TŒ^“œ”A•a”D•w‚̗×{Žw“±. ”‹ŒŽ
ºŽq (ŠÅŒì•”): ‘æ48‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2011/1/29), “Œ‹ž, ‘æ48‰ñ“ú–{“œ”A•aŠw‰ï
ŠÖ“ŒbM‰z’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/1; p.73.

733514. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‹~‹}•a“‚É‚š‚¯‚éŠàŠÅŒì‚̈êlŽ@. ‹àˆä‘Žq1, “y‰®Žu
•Û1, XˆÀŒb”ü1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2011/2/5), ‰¡•l, ‘æ
61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€W 2011/2; p.94.

733515. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‘J‰„«ˆÓŽ¯áŠQ‚ÌŠÅŒì‰î“ü‚ɂ‚¢‚Ä?d“ª•”ŠOŠ³ŽÒ
‚̈ӎ¯‰ü‘P‚ÌŽ–—á‚ðU‚è•Ô‚Á‚Ä?. dM@—º1, ’·–ì—F‹IŽq1, ¡ˆä¹Œb1, ¬oŒb”ü1, ”‘qMŽq1, ’†
’JG”ü1, Œ“cŒb”ü1, •Ð‘q—TŽq1, _•Û•‘¥2 (1ŠÅŒì•”, 2ƒŠƒnƒrƒŠ•”): ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ
’n•û‰ï (2011/2/5), ‰¡•l, ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€W 2011/2; p.95.

733516. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Œûo•ÛŽŒÜ‚ð—p‚¢‚œƒPƒA‚Ì’è’…‚ÉŒü‚¯‚Ä?“±“ü‘OŒã‚ÌŠÅ
ŒìŽt‚̈ӎ¯•Ï‰»‚ɂ‚¢‚Ä?. Î‘q@ˆ€1, –î•”hŽu1, ‚–؁@ˆ²1, XˆÀŒb”ü1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì
•”): ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2011/2/5), ‰¡•l, ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰
ƒ€W 2011/2; p.96.

733517. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) VAPƒT[ƒxƒCƒ‰ƒ“ƒXŒ‹‰Ê‚ÆŒŽˆö‚Ì’²ž. d‰ªŽu’ÉÀ1, ŒŽ
“cˆŸŠó1, “ŒŒb—œ‰Ø1, XˆÀŒb”ü1, ŽR–ì•Ó‚Ý‚¿Žq1 (1ŠÅŒì•”): ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï
(2011/2/5), ‰¡•l, ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€W 2011/2; p.96.

733518. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘ŸŠí’ñ‹ŸˆÓŽv‚Ì‘žd‚É‚š‚¯‚éˆã—Ã`[ƒ€‚ÌŠÖ‚í‚è‚ÉŠÖ‚·
‚éˆêlŽ@. žÒŒ‹v”üŽq1, ‚‹Ž@Œb1, •ž•”@2, _œä’m“¹2, –kŒŽF—Y2, ‹g“cˆê¬3, ŽR–ì•Ó‚Ý‚¿Žq
1, ‘Š”nˆêˆå2 (1ŠÅŒì•”, 2‹~–œ, 3”å”AŠí): ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (2011/2/5): ‰¡•l, ‘æ
61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïƒvƒƒOƒ‰ƒ€W 2011/2; p.97.

733519. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘O’uŒŒŠÇ‚ÌŠ³ŽÒ‚Æ‚ÌŠÖ‚í‚è‚ðU‚è•Ô‚Á‚ā[‚؃vƒ-‚Ì—˜_
‚ð—p‚¢‚ÄŠ³ŽÒ?ŠÅŒìŽtŠÖŒW‚ðU‚è•Ô‚é?. ¬ŒŒbŽq (ŠÅŒì•”): ‘æ24‰ñ_“ސì•ê«‰q¶Šw‰ïŠwpW‰ï
(2011/2/5), _“ސì.

733520. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‹~–œ‹~‹}ƒZƒ“ƒ^[‚É‚š‚¯‚é‰@“àƒhƒi[ƒR[ƒfƒBƒl[ƒ^[
‚Ì–ðŠ„?‘ŸŠíE‘gD’ñ‹ŸŠó–]‚ÌŠ³ŽÒE‰Æ‘°‚̈ӎv‘žd‚ÉŒü‚¯‚œŽæ‚è‘g‚Ý?. ’[ŽR˜a”ü1, rì–@Žq1, ‚
‹Ž@Œb1, žÒŒ‹v”üŽq1, •œ@KŒb1, Šâ‘º‹M”ü1 (1ŠÅŒì•”): ‘æ61‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï
(2011/2/5), ƒpƒVƒtƒBƒR‰¡•l.

H21”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H21-723019. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‹~–œ‹~‹}ƒZƒ“ƒ^[‚É‚š‚¯‚éš‹‰ºáŠQ‚ÌŒ»ó. ‰ª“cŽ‡•ä1,
“y‰®Žu•Û1 (1ŠÅŒì•”): ‘æ26‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï (2010/2/18), –ŒŒÃ‰®, ‘æ26‰ñ“ú–{Ã–¬Œo’°‰h—{
Šw‰ïŽ˜^W 2010/1; 26: 389.


—Տ°ŒŸž•”

[Šwp˜_•¶]

110273. [ŒŽ’˜] The role of the genetic test of verotoxin for bacterial carrier investigation of
cooking staff:detection of enterohemorrhagic Escherichia coli. Shin Nihonyanagi1,2, Nobuhiko
Nakazaki1,2, Yasuyoshi Hirata1,2,3, Shinichi Munekata1, Shinichi Ohtani4, Tsuyoshi Takemoto5,
Yuhsaku Kanoh6, Tohru Akahoshi5 (1Department of Medical Laboratory, Kitasato University Hospital,
2Infection Control Team, Kitasato University Hospital, 3Department of Infection Control and
Prevention, Kitasato University Hospital, 4Department of Transfusion and Cell Transplantation
Medicine, Kitasato University School of Medicine, 5Department of General Medicine, Kitasato
University School of Medicine, 6Department of Laboratory Medicine, Kitasato University School of
Medicine): The Kitasato Medical Journal 2010/9; 40 (2): 129-34. (“ñ–{–öL1,2, ’†èM•F1,2, •œ
“c‘×—Ç1,2,3, “•ûLˆê1, ‘å’JTˆê4, ’|–{@‹B5, Žë–ì—Lì6, Ô¯@“§5: 1—ÕŒŸ•”, 2–k—¢‘åŠw•a‰@
ŠŽõ‘΍ôƒ`[ƒ€, 3ŠŽõŠÇ—Žº, 4—AŒŒE×–EˆÚA, 5‘‡f—Ã, 6—ÕŒŸŠw)

120086. [ŒŽ’˜] ŠeŽí•Û‘¶ðŒ‚É‚š‚¯‚éNeisseria gonorrhoeae‚ÌŒoŽž“I¶‹Û”‚ÉŠÖ‚·‚錟“¢. “ñ–{–öL
1, “c•”—T“ñ1, ˆÀ’B@÷1, ¬ŠÑ’q¢1, ŸNˆäŒc‘¢1, “•ûLˆê1, Žë–ì—Lì2, ²X–؉ëˆê3, ‹{–{–Lˆê
4 (1—ÕŒŸ•”, 2—ÕŒŸŠw, 3ŠÖ“Œ˜JÐ•a‰@—Տ°ŒŸž‰È, 4ìèŽs—§‘œ–€•a‰@—Տ°ŒŸž•”): _“ސ쌧—Տ°‰q¶
ŒŸž‹ZŽt‰ïŽGŽ 2011/3; 45 (2): 11-6.

120087. [ŒŽ’˜] lH“§Í“±“üŒã‚Ì–«t•s‘SŠ³ŽÒ‚É‚š‚¯‚é”]”gŠî‘b—¥“®‚ÆŒŒ‰t¶‰»Šwƒf[ƒ^‚Æ‚ÌŠÖ˜A«
‚ɂ‚¢‚Ä. ¬–ìàV—T–ç1,2, Šâ‹Ž˜a•F2, ‹g–{gŽq1, “•ûLˆê1, ‹gŒŽ‰pŽ™2, Â–؁@~2, Žë–ì—Lì3,
Ô¯@“§4 (1—ÕŒŸ•”, 2–ƒ•z‘åŠw‘åŠw‰@ŠÂ‹«•ÛŒ’ŠwŒ€‹†‰ÈŠÂ‹«•ÛŒ’‰ÈŠwêU•ÛŒ¯¶–œŒn_Œo¶—Šw•ª–ì, 3
—ÕŒŸŠw, 4‘‡f—Ã): —Տ°•a— 2010/12; 58 (12): 1169-75.

220028. [€ŒŽ’˜] ’²—]Ž–ŽÒ‚Ì•Û‹Û’²ž‚É‚š‚¯‚éƒxƒƒgƒLƒVƒ“ˆâ“`ŽqŒŸž‚Ì–ðŠ„?’°ŠÇoŒŒ«‘å’°‹Û‚Ì
ŒŸo?. “ñ–{–öL (—ÕŒŸ•”): —Տ°•a— 2011/1; 59 (1): 75-6.

520112. [‘à] •W€—Տ°”]”gŒŸž–@. ¬–ìàV—T–ç (—ÕŒŸ•”): _“ސ쌧—Տ°‰q¶ŒŸž‹ZŽt‰ïŽGŽ
2010/6; 45 (1): 17-41.

520113. [‘à] –k—¢‘åŠw•a‰@‚É‚š‚¯‚é“œ”A•af—ÃŒ»ê‚ł̗Տ°ŒŸž‹ZŽt‚ÌŠˆ–ô‚ÆŠˆ“®‚̏ê. ŽO‰Y–F“T
1, ‘å–ì‹v”üŽq1, ‰Í“‡]”ü1, “y•M’q»1, Žç‰®’B”ü2 (1—ÕŒŸ•”, 2“à•ª”å‘ãŽÓ“à): Diabetes Frontier
2010/12; 21 (6): 738.

540114. [‚»‚Ì‘Œ]yÀ’k‰ïzæ”y‚©‚çŠw‚Ԑ¶—‹@”\ŒŸž?‰ß‹Ž‚©‚ç–¢—ˆ?. ’‡L@Žu1, ŽO‰YƒŽq2, Î
‹œŒiŽq3, “•ûLˆê4, M‰ª—S•F5, ‰i]@Šw6 (1_“ސ쌧Œú¶˜A‘Š–ÍŒŽ‹Š“¯•a‰@ŒŸž•”, 2ŒÕ‚Ì–å•a‰@
—Տ°¶—ŒŸž•”, 3‘åŠ_Žs–¯•a‰@ŒŸž•”, 4—ÕŒŸ•”, 5¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åŠw—Տ°ŒŸžˆãŠwuÀ, 6‰i]•â
Š®ˆã—ÃŒ€‹†Š•‘®èI‹„‰@): ŒŸž‚Æ‹Zp 2010/11; 38 (12): 1176-85.

540115. [‚»‚Ì‘Œ] ‘åŠw•a‰@E“Œ•a‰@—Տ°ŒŸž•”‚É‚š‚¯‚é‹@”\“I‘gD“‡‚©‚çˆê”N‚ðU‚è•Ô‚Á‚Ä. “•ûL
ˆê (—ÕŒŸ•”): –k—¢‘åŠw•a‰@ƒjƒ…[ƒX, “Œ•a‰@‚ ‚¢‚ ‚¢ 2010/5; No.448: 6.

[’˜@‘]

620169. [Šwp‘] (•ª’SŽ·•M)yu‚š‚Áv‚ÆŽv‚킹‚éI@’Ž‰¹”gŒŸž•ñ‘‚̏‘‚«•û@S‘Ÿ^ŒŒŠÇzèò“®–¬,
p.118-151. ’†“‡@“N1, ’†Œ‹vK2, “¡ˆä@Ž 3, ‰FŽ¡‹Ž‘PŸ2 (1‘—§•a‰@‹@\…ŒËˆã—ÃZƒ“ƒ^[—Տ°
ŒŸž‰È, 2—ÕŒŸ•”, 3“Œ•a‰@—ÕŒŸ•”), •Ò’˜ Ž›“‡@–Î4 (4_“ސ쌧Œú¶˜AˆÉšŒŽ‹Š“¯•a‰@ˆã—ËZp•”), (Š”)
ƒxƒNƒgƒ‹ƒRƒA, 2010/5”­s.

620170. [Šwp‘] (•ª’SŽ·•M)yu‚š‚Áv‚ÆŽv‚킹‚éI@’Ž‰¹”gŒŸž•ñ‘‚̏‘‚«•û@S‘Ÿ^ŒŒŠÇz• •”‘å
“®–¬, p.152-93. ’†“‡@“N1, ’†Œ‹vK2, “¡ˆä@Ž 3, ‰FŽ¡‹Ž‘PŸ2 (1‘—§•a‰@‹@\…ŒËˆã—ÃZƒ“ƒ^[
—Տ°ŒŸž‰È, 2—ÕŒŸ•”, 3“Œ•a‰@—ÕŒŸ•”), •Ò’˜ Ž›“‡@–Î4 (4_“ސ쌧Œú¶˜AˆÉšŒŽ‹Š“¯•a‰@ˆã—ËZp•”),
(Š”) ƒxƒNƒgƒ‹ƒRƒA, 2010/5”­s.

620171. [Šwp‘] (•ª’SŽ·•M)yu‚š‚Áv‚ÆŽv‚킹‚éI@’Ž‰¹”gŒŸž•ñ‘‚̏‘‚«•û@S‘Ÿ^ŒŒŠÇz‰ºŽˆ“®
Ã–¬, p.194-225. ’†“‡@“N1, ’†Œ‹vK2, “¡ˆä@Ž 3, ‰FŽ¡‹Ž‘PŸ2 (1‘—§•a‰@‹@\…ŒËˆã—ÃZƒ“ƒ^
[—Տ°ŒŸž‰È, 2—ÕŒŸ•”, 3“Œ•a‰@—ÕŒŸ•”), •Ò’˜ Ž›“‡@–Î4 (4_“ސ쌧Œú¶˜AˆÉšŒŽ‹Š“¯•a‰@ˆã—ËZp
•”), (Š”) ƒxƒNƒgƒ‹ƒRƒA, 2010/5”­s.

620172. [Šwp‘] (•ª’SŽ·•M)yu‚š‚Áv‚ÆŽv‚킹‚éI@’Ž‰¹”gŒŸž•ñ‘‚̏‘‚«•û@ŒŸf^”å”AŠí^ŽY•w
l‰È^‘Ì•\‘ŸŠíz”å”AŠí, p.64-125. •œŽRŒ»¶1, “¡ˆä@Ž 2, ‰FŽ¡‹Ž‘PŸ3, ’†Œ‹vK3 (1]ŒËì‹æˆã
Žt‰ïˆã—ÃŒŸžƒZƒ“ƒ^[¶—ŒŸžŽº, 2“Œ•a‰@—ÕŒŸ•”, 3—ÕŒŸ•”), •Ò Ž›“‡@–Î4 (4_“ސ쌧Œú¶˜AˆÉšŒŽ
‹Š“¯•a‰@ˆã—ËZp•”), (Š”) ƒxƒNƒgƒ‹ƒRƒA, 2010/5”­s.

620173. [Šwp‘] (•ª’SŽ·•M)yu‚š‚Áv‚ÆŽv‚킹‚éI@’Ž‰¹”gŒŸž•ñ‘‚̏‘‚«•û@ŒŸf^”å”AŠí^ŽY•w
l‰È^‘Ì•\‘ŸŠízŽY•w•wl‰È, p.126-81. •œŽRŒ»¶1, “¡ˆä@Ž 2, ‰FŽ¡‹Ž‘PŸ3, ’†Œ‹vK3 (1]ŒËì
‹æˆãŽt‰ïˆã—ÃŒŸžƒZƒ“ƒ^[¶—ŒŸžŽº, 2“Œ•a‰@—ÕŒŸ•”, 3—ÕŒŸ•”), •Ò’˜ Ž›“‡@–Î4 (4_“ސ쌧Œú¶˜A
ˆÉšŒŽ‹Š“¯•a‰@ˆã—ËZp•”), (Š”) ƒxƒNƒgƒ‹ƒRƒA, 2010/5”­s.

620174. [Šwp‘] (•ª’SŽ·•M)yu‚š‚Áv‚ÆŽv‚킹‚éI@’Ž‰¹”gŒŸž•ñ‘‚̏‘‚«•û@ŒŸf^”å”AŠí^ŽY•w
l‰È^‘Ì•\‘ŸŠíz‘Ì•\‘ŸŠí, p.182-225. •œŽRŒ»¶1, “¡ˆä@Ž 2, ‰FŽ¡‹Ž‘PŸ3, ’†Œ‹vK3 (1]ŒËì
‹æˆãŽt‰ïˆã—ÃŒŸžƒZƒ“ƒ^[¶—ŒŸžŽº, 2“Œ•a‰@—ÕŒŸ•”, 3—ÕŒŸ•”), •Ò’˜ Ž›“‡@–Î4 (4_“ސ쌧Œú¶˜A
ˆÉšŒŽ‹Š“¯•a‰@ˆã—ËZp•”), (Š”) ƒxƒNƒgƒ‹ƒRƒA, 2010/5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

7231000. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ”|—{ŽžŠÔ‰„’·‚É‚æ‚èLinezolid‚ÌMICãž‚ðŽŠ‚µ‚œMRSA‚ÉŠÖ‚·‚錟
“¢. ˆÀ’B@÷1, “ñ–{–öL1, ÷ˆäŒc‘¢1, “•ûLˆê1, ‘å’JTˆê2, Žë–ì—Lì3, •l“cKG4, ‰Ô–؏G–Ÿ
5 (1—ÕŒŸ•”, 2—AŒŒE×–EˆÚA, 3—ÕŒŸŠw, 4“Œ•a‰@–òÜ•”, 5–k—¢Œ€‹†ŠRŠŽõÇ–òŒ€‹†ƒZƒ“ƒ^[): ‘æ
59‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2010/4/25), “Œ‹ž, ˆãŠwŒŸž 2010/4; 59 (4): 572.

7231001. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) S–[’†Šu¶–[‘€‚É”­¶‚µ‚œS‘ŸŒŒŠÇŽî‚̈ê—á. ‰““¡—¯”üŽq1, –Š“c
Šì”V1, ‰FŽ¡‹Ž‘PŸ1, –F“c@v1, •œ–{—T”ü1, â–{˜a‘ã1, Žë–ì—Lì2 (1—ÕŒŸ•”, 2—ÕŒŸŠw): ‘æ35‰ñ
“ú–{’Ž‰¹”gŒŸžŠw‰ï (2010/5/8), ‘åã, ’Ž‰¹”gŒŸž‹Zp 2010/4; 2: 213.

7231002. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘ÙŽ™ƒGƒR[‚ÅŒŸo‚³‚ê‚œo¶ŒãŽèp‚ÉŽŠ‚Á‚œùN–E«_Œo‰èŽî‚Ì1Ç
—á. ’†Œ‹vK1, ‰FŽ¡‹Ž‘PŸ1, “•ûLˆê1, “¡ˆä@Ž 2, “c’†@Œ‰3, Žë–ì—Lì4 (1—ÕŒŸ•”, 2“Œ•a‰@
—ÕŒŸ•”, 3ŠO‰È, 4—ÕŒŸŠw): ‘æ35‰ñ“ú–{’Ž‰¹”gŒŸžŠw‰ï (2010/5/8), ‘åã, ’Ž‰¹”gŒŸž‹Zp 2010/4; 2:
246.

7231003. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ú“–’Œ•\ì¬ƒVƒXƒeƒ€‚Ì“±“ü‚É‚š‚¯‚éŠÇ—‹Æ–±‚ÌŒø—Š‰»‚ɂ‚¢‚Ä.
•œˆä@œ1, “ñ–{–öL1, Žu‘º‰Ã•F1, “à“cˆêO1, “•ûLˆê1, Žë–ì—Lì2 (1—ÕŒŸ•”, 2—ÕŒŸŠw): ‘æ59
‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2010/5/22), _ŒË, ‘æ59‰ñ“ú–{ˆãŠwŒŸžŠw‰ïŽ˜^W 2010/4; 59 (4): 623.

7231004. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚錌‰t‹ÃŒÅ•ªÍ‘•’uXVŽž‚ÌŽæ‚è‘g‚Ý•û‚ɂ‚¢
‚Ä. ’†Œ@ŒO1, ãŒŽ—R‰À—1, ãˆä˜aŽq1, Žu‘º‰Ã•F1, ‘O“c’‰L1, •œˆä@œ1, “•ûLˆê1, Žë–ì—L
ì2 (1—ÕŒŸ•”, 2—ÕŒŸŠw): ‘æ59‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2010/5/23), _ŒË, ‘æ59‰ñ“ú–{ˆãŠwŒŸžŠw‰ïŽ
˜^W 2010/4; 59 (4): 545.

7231005. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@EˆõŒ’f‚É‚š‚¯‚é“Á’è•ÛŒ’Žw“±‘Ώێ҂̓Á’¥. ¬—ѐŽ}1, ‘
“ãç»1, ŒN’ˈè‘ã1, ‰ª“c@ƒ2 (1—ÕŒŸ•”, 2Œ’NŠÇ—ƒZ): “ú–{lŠÔƒhƒbƒNŠw‰ïŠwp‘å‰ï (2010/8/26),
ˆ®ì, lŠÔƒhƒbƒN 2010/8; 25 (2): 316 (446).

7231006. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éƒmƒƒEƒCƒ‹ƒX‚ÌŒŸoó‹µ‚š‚æ‚ÑŠŽ
õ‘΍ô‚ɂ‚¢‚Ä. ’†èM•F1, ‹vŒ’mŽq, ŽR•Ó°”ü, ŸNˆäŒc‘¢1, “•ûLˆê1, Žë–ì—Lì2 (1—ÕŒŸ•”, 2
—ÕŒŸŠw): ‘æ57‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ïŠwpW‰ï (2010/9/10), “Œ‹ž.

7231007. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Տ°‰»ŠwŽ©“®•ªÍ‘•’uuƒfƒBƒƒ“ƒVƒ‡ƒ“EXLLMv‚ÌŠî‘b“I«”\•]‰¿
‚ɂ‚¢‚Ä. ¬ŽRhŽq1, “¡‘º‘Ps1, ’†ø“LŽq1, ‘åê—Y‹g1, ‰““¡¬Žq1, •œˆä@œ1, “à“cˆêO1, ‘å
’JTˆê2, Žë–ì—Lì3 (1—ÕŒŸ•”, 2—AŒŒE×–EˆÚA, 3—ÕŒŸŠw): “ú–{—Տ°ŒŸžŽ©“®‰»Šw‰ï‘æ42‰ñ‘å‰ï
(2010/10/9), _ŒË, “ú–{—Տ°ŒŸžŽ©“®‰»Šw‰ï‰ïŽ 2010/9; 35 (4): 620.

7231008. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 21-hydroxylase deficiency‚̐f’f‚É‚š‚¯‚éˆâ“`ŽqŒ^‚Æ•\Œ»Œ^‚Ì–µ
‚—á?PCR‚É‚š‚¯‚éallele dropout?. ˆÀ–{—Ž”n1,2, ‚ŽR‹g‰i3, ‘唚®Žq1,4,5, ‹{‰ºr”V3, ‚“c
Žj’j1,4 (1ˆã—ÃŒnŒ€‹†‰È—Տ°ˆâ“`ˆãŠw, 2—ÕŒŸ•”, 3•ªŽqˆâ“`, 4ˆâ“`f—Õ”, 5‰«“ꌧ—§’†•”•a‰@ŽY•w
l‰È): “ú–{l—Þˆâ“`Šw‰ï (2010/10/29), ‘å‹{.

7231009. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU (H1N1) —z«‚Ì”]”gŠŒ©‚ÌŒŸ“¢. ‹“‡@m1, –ì
àV»Žq1, ¬–ìàV—T–ç1, ‰Ÿ“cD”ü1, ‰Í“‡]”ü1, ‹g–{gŽq2, –ìX“c–L3, Šâèr”V3 (1—ÕŒŸ•”, 2“Œ
•a‰@—ÕŒŸ•”, 3¬Ž™): ‘æ40‰ñ“ú–{—Õଐ_Œo¶—Šwp‘å‰ï (2010/11/2), _ŒË, —Տ°_Œo¶—Šw 2010; 38:
338.

7231010. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) èò“®–¬“à–Œ’†–Œ•¡‡‘Ì”ìŒú“x (IMT) ‚Æ“®–¬d‰»ƒŠƒXƒNˆöŽq‚Æ‚ÌŠÖŒW.
‘“ãç»1, ¬—ѐŽ}1, ŒN’ˈè‘ã1, ‰ª“c@ƒ2 (1—ÕŒŸ•”, 2Œ’NŠÇ—ƒZ): “ú–{‘‡Œ’fˆãŠw‰ï
(2011/1/28), “Œ‹ž.

7231011. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) ’²—]Ž–ŽÒ‚Ì•Û‹Û’²ž‚É‚š‚¯‚éˆâ“`ŽqŒŸž‚Ì–ðŠ„?’°ŠÇ
oŒŒ«‘å’°‹Û‚ÌŒŸo?. “ñ–{–öL (—ÕŒŸ•”): ‘æ67‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ïŠÖ“ŒbM‰zŽx•”—á‰ï^‘æ21‰ñ
_“ސ쌧—Տ°ŒŸžˆãŠw‰ï (2010/5/29), _“ސ쌧‘‡ˆã—ÉïŠÙ7ŠK‘åu“°, ‘æ67‰ñ“ú–{—Տ°ŒŸžˆãŠw‰ï
ŠÖ“ŒbM‰zŽx•”—á‰ï^‘æ21‰ñ_“ސ쌧—Տ°ŒŸžˆãŠw‰ïŠwpu‰‰Ž˜^W2010; p.2.

732118. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚鍜“±ƒ}ƒXƒLƒ“ƒO–@ (ABC–@) ‚É‚Â
‚¢‚Ä. ¬”Š@i (—ÕŒŸ•”): _“ސ쌧—Տ°ŒŸž‹ZŽt‰ï¶—ŒŸžŒ€‹†”Ç (2010/7/8), _“ސ쌧Œ§–¯ƒTƒ|[
ƒgƒZƒ“ƒ^[.

732119. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (Šî’²u‰‰) –k—¢‘åŠw•a‰@—Տ°ŒŸž•”‚É‚š‚¯‚éˆÓŽ¯‰üŠv‚ƐlÞˆç¬‚Ì
Žæ‚è‘g‚Ý. “•ûLˆê (—ÕŒŸ•”): é‹ÊŒ§—Տ°ŒŸž‹ZŽt‰ïŒŸžŽºŠÇ—‰^‰cˆÏˆõ‰ïŒ€C‰ï (2011/1/28), ‘å
‹{.

733521. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ƒ`[ƒ€ˆã—à –k—¢‘åŠw•a‰@‚É‚š‚¯‚é“œ”A•af—ÃŒ»ê‚Å‚Ì—Õ
°ŒŸž‹ZŽt‚ÌŠˆ–ô‚ÆŠˆ“®‚̏ê. ŽO‰Y–F“T1, ŽRŠÝ‹v”üŽq, ‰Í“‡]”ü1, ˆŸ–앶„, “y•M’q»1, Žç‰®’B”ü
2 (1—ÕŒŸ•”, 2“à•ª”å‘ãŽÓ“à): ‘æ22‰ñ“œ”A•a«tÇŒ€‹†‰ï (2010/12/4-5), “Œ‹ž, Diabetes Frontier
2010; 21 (6): 738.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-522012. [uÀ]y“ÁWz“ú—Õ‹Z•W€‰»Ž–‹Æ‚ÌŠT—v‚Ɛ_—Õ‹Z‚ł̃f[ƒ^•W€‰»‚ÌŽæ‚è‘g‚Ý. •œˆä@
œ1, –{‘ºŒõ˜Y2, ¬ì@“o3, ŠÖ‘ò•x]4, Œ‰ºKN5, ”ó“nPŒ›6, ‰Í–ìˆê˜Y7 (1—ÕŒŸ•”, 2“ŒŠC‘åŠw
ˆãŠw•”•‘®•a‰@, 3‰¡•lŽs—§‘åŠw•‘®•a‰@, 4‰¡{‰ê‹€Ï•a‰@, 5¬“cŒŽŽs—§•a‰@, 6Š”Ž®‰ïŽÐ•ÛŒ’‰ÈŠwŒ€
‹†Š, 7“ú—§‰¡•l•a‰@): _“ސ쌧—Տ°‰q¶ŒŸž‹ZŽt‰ïŽGŽ 2010/3; 45 (2): 1-10.


•úŽËü•”

[Šwp˜_•¶]

522157. [uÀ]y‘æ38‰ñH‹GŠwp‘å‰ïE‘æ16‰ñˆã—Ïî•ñ•ª‰È‰ï•ñ: •ª‰È‰ïƒVƒ“ƒ|ƒWƒEƒ€u•úŽËü•”–å
‚É‚š‚¯‚éˆã—p‰æ‘œî•ñê–å‹ZŽt‚Ì–ðŠ„?ƒVƒXƒeƒ€ƒŠƒvƒŒƒCƒX‚ðŒ©˜‚Š‚œ‹Æ–±•ªÍ?vzŠjˆãŠwŒŸž‚Ì–â‘è
“_‚ð‰ü‘P‚·‚é‚œ‚߂̃[ƒNƒtƒ[•ªÍ—á. _‹{ŽiŒö“ñ (•úŽËü•”): “ú–{•úŽËü‹ZpŠw‰ïˆã—Ïî•ñ•ª‰È‰ï
ŽGŽ 2010/10; 16: 27-32.

[Šw‰ïEŒ€‹†‰ï“™]

722246. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y•úŽËü•”–å‚É‚š‚¯‚éˆã—p‰æ‘œî•ñê–å‹ZŽt‚Ì–ðŠ„?ƒVƒXƒeƒ€ƒŠ
ƒvƒŒƒCƒX‚ðŒ©˜‚Š‚œ‹Æ–±•ªÍ?zŠjˆãŠwŒŸž‚Ì–â‘è“_‚ð‰ü‘P‚·‚é‚œ‚߂̃[ƒNƒtƒ[•ªÍ—á. _‹{ŽiŒö
“ñ (•úŽËü•”): ‘æ16‰ñ“ú–{•úŽËü‹ZpŠw‰ïˆã—Ïî•ñ•ª‰È‰ï (2010/10/15), å‘ä, “ú–{•úŽËü‹ZpŠw‰ï
ˆã—Ïî•ñ•ª‰È‰ïŽGŽ 2010/9; 15: 12.

7231012. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) IDEAL-FSE–@‚É‚š‚¯‚鐅^Ž‰–b•ª—£ƒGƒ‰[‚ÉŠÖ‚·‚éŠî‘b“IŒŸ“¢. ¬
Œ©³‘Ÿ˜Y1, `@”Ž•¶1, ”öè³‘¥2, …ãT–ç1, ²“¡^—R”ü1 (1•úŽËü•”, 2ˆã—Éq¶Šw•”): ‘æ66‰ñ
“ú–{•úŽËü‹ZpŠw‰ï‘‰ïŠwp‘å‰ï (2010/4/8), ‰¡•l, “ú–{•úŽËü‹ZpŠw‰ïŽGŽ‘æ66‰ñ‘‰ïŠwp‘å‰ï—\e
W 2010/2; p.110.

7231013. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Flow saturation preparation–@MR-Angiography‚É‚š‚¯‚é
2D-thickslise-test scan‚ÌŠî‘b“IŒŸ“¢. `@”Ž•¶1, …ãT–ç1, ¬Œ©³‘Ÿ˜Y1, ²“¡^—R”ü1, ”öè³
‘¥2, ›@Mˆê3, ŽODŒõ°4, ’ËŒ³“S“ñ4 (1•úŽËü•”, 2ˆã—Éq¶Šw•”, 3•úŽËü (‰æ‘œ), 4GEƒwƒ‹ƒX
ƒPƒA[ƒWƒƒƒpƒ“): ‘æ38‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2010/10/1), ‚‚­‚Î, ‘æ38‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï
u‰‰Ž˜^W 2010/9; p.372.

7231014. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) IDEAL•¹—p3D FSPGR–@‚É‚š‚¯‚鐅^Ž‰–b•ª—£ƒGƒ‰[‚ÉŠÖ‚·‚éŠî‘b“I
ŒŸ“¢. ¬Œ©³‘Ÿ˜Y1, `@”Ž•¶1, ”öè³‘¥2, …ãT–ç1, ²“¡^—R”ü1, ‘ŠàV@^1, ›@Mˆê3 (1
•úŽËü•”, 2ˆã—Éq¶Šw•”, 3•úŽËü (‰æ‘œ)): ‘æ38‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ï‘å‰ï (2010/10/1), ‚‚­‚Î, ‘æ
38‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ïu‰‰Ž˜^W 2010/9; p.377.

7231015. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠgŽU‹­’²‰æ‘œ‚É‚š‚¯‚é‰æ‘œ‰ÁŽZˆ—‚ªSNR‚É—^‚Š‚é‰e‹¿. …ãT–ç
1, ”öè³‘¥2, `@”Ž•¶1, ²“¡^—R”ü1, ¬Œ©³‘Ÿ˜Y1 (1•úŽËü•”, 2ˆã—Éq¶Šw•”): ‘æ38‰ñ“ú–{Ž¥
‹C‹€–ˆãŠw‰ï‘å‰ï (2010/10/1), ‚‚­‚Î, ‘æ38‰ñ“ú–{Ž¥‹C‹€–ˆãŠw‰ïu‰‰Ž˜^W 2010/9; p.384.

7231016. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠgŽU‹­’²‰æ‘œ‚É‚š‚¯‚éŽB‘œƒpƒ‰ƒ[ƒ^‚ªSNR, CNR‚É—^‚Š‚é‰e‹¿. ²
“¡^—R”ü1, ”öè³‘¥2, …ãT–ç1, ˆéè—R”T2, ¬—Ñ–ƒˆßŽq2, “c‘º”ü¹Žq2, “’“cŽÑD2, `@”Ž•¶1
(1•úŽËü•”, 2ˆã—Éq¶Šw•”): ‘æ38‰ñ“ú–{•úŽËü‹ZpŠw‰ïH‹GŠwp‘å‰ï (2010/10/14), å‘ä, “ú–{•ú
ŽËü‹ZpŠw‰ïŽGŽ 2010/9; 66 (9): 1148.

7231017. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “®‘̒ǐՑ•’u‚ð—p‚¢‚œ‘O—§‘B“à‹à‘®ƒ}[ƒJ‚̈ʒu•Ï“®‚ÌŒŸ“¢. Žñ“¡
éº1, ˆüŽR‹IŽq1, `@ç“s1, ‰ª–{Œ[Œö1, í–Ø•Žm1, ˆî“c—ŽŽi1, –ì“c–Η˜1, ã‘O•ôŽq1 (1•úŽË
ü•”): ‘æ38‰ñ“ú–{•úŽËü‹ZpŠw‰ïH‹GŠwp‘å‰ï (2010/10/14), å‘ä, “ú–{•úŽËü‹ZpŠw‰ïŽGŽ 2010/9;
66 (9): 273.

7231018. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) JJ1017ŠjˆãŠw—̈æŠg’£”ł̍ô’è. _‹{ŽiŒö“ñ1, ŸNˆä@ŽÀ2, •“c@
Œå3, ‰Á“¡œ“ñ4, ›”ŠÔ”Ž”V5, Ž…Œh“ñ6, ‰Ô‰ªG•œ7, àF’JFs8, Œ“cŒb—Y9, ‰œ“c•Û’j10, šú@^
–ç11 (1•úŽËü•”, 2“ú–{ˆã‰È‘åŠwŒ’fˆã—ÃZƒ“ƒ^[, 3ˆã—Ö@lŽÐ’c“ú‚‰ï“ú‚•a‰@, 4“Œ‹ž‘åŠwˆãŠw•”
•‘®•a‰@, 5‘åãŽs—§‘åŠwˆãŠw•”•‘®•a‰@, 6æ’[ˆã—ÃZƒ“ƒ^[, 7‹ß‹E‘åŠwˆãŠw•”•‘®•a‰@, 8Žs—§ŠÝ˜a
“cŽs–¯•a‰@, 9é‹Êˆã‰È‘åŠw‘‡ˆã—ÃZƒ“ƒ^[, 10‰ªèŽs–¯•a‰@, 11‰ï’ÑåŠw): ‘æ30‰ñ“ú–{ŠjˆãŠw‹Zp
Šw‰ï‘‡Šwp‘å‰ï (2010/11/11), ‘å‹{, “ú–{ŠjˆãŠw‹ZpŠw‰ïŽŠjˆãŠw‹Zp 2010/9; 30 (—\eW): 330.

7231019. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) •úŽË«ˆã–ò•i‚Ì•iŽ¿ŠÇ—?‘æ2•ñ. “n•Ó‚ ‚ä‚Ý1, ‹e’r@Œh1, ‹{
•”ä˜CŽ÷1, “¿d‘žé1, ŠÛ”öGŽ÷1, Ž›è„Žj1, ˆ¢•”@–L1 (1•úŽËü•”): ‘æ30‰ñ“ú–{ŠjˆãŠw‹ZpŠw
‰ï‘‡Šwp‘å‰ï (2010/11/12), ‘å‹{, “ú–{ŠjˆãŠw‹ZpŠw‰ïŽŠjˆãŠw‹Zp 2010/9; 30 (—\eW): 347.

733522. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) S‹ØSPECT‚É‚š‚¯‚éƒRƒŠƒ[ƒ^ŠJŒûŒa•â³•t’€ŽŸ‹ßŽ—–@
‚ÌŒŸ“¢. ˆ¢•”@–L1, ‹e’r@Œh1, “¿d‘žé1, ŠÛ”öGŽ÷1, ‘åŠÖ—T‰î1, Ž›è„Žj1, ‹{•”ä˜CŽ÷1 (1
•úŽËü•”): “ú–{•úŽËü‹ZpŠw‰ï‘æ57‰ñŠÖ“Œ•”‰ïŒ€‹†”­•\‘å‰ï (2011/2/5), ‘å‹{, “ú–{•úŽËü‹ZpŠw‰ï
‘æ57‰ñŠÖ“Œ•”‰ïŒ€‹†”­•\‘å‰ïŽ˜^W 2011/2; p.201.

733523. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ˆê”ÊŽB‰e—pŠÔÚ•ÏŠ·Œ^FPDƒVƒXƒeƒ€‚Ì•š—“Á«‚ÌŒŸ“¢.
ˆÉ“¡Š°‘×1, ŠÖ@«Žu1, ŽR–{˜a³1, ‘å–쐳’q1, ’†“ˆ‹K—e1, ŒÜ–¡@•×2, _‹{ŽiŒö“ñ1 (1•úŽËü•”, 2
ˆã—Éq¶Šw•”): “ú–{•úŽËü‹ZpŠw‰ï‘æ57‰ñŠÖ“Œ•”‰ïŒ€‹†”­•\‘å‰ï (2011/2/6), ‘å‹{, “ú–{•úŽËü‹Zp
Šw‰ï‘æ57‰ñŠÖ“Œ•”‰ïŒ€‹†”­•\‘å‰ïŽ˜^W 2011/2: p.267.


–òÜ•”

[Šwp˜_•¶]

110274. [ŒŽ’˜] Innitial analysis of relationship between plasma platinum consentration and
hematological adverse reaction associated with weekly chemothe. Hamada Y1, Naitoh H2, Niibe Y3,
Kotani A3, Takayanagi R2, Tsunoda S4, Unno N4, Hayakawa K3, Kusu F2, Yago K1,5, Yamada Y2 (1–ò
Ü•”, 2“Œ‹ž–ò‰È‘åŠw, 3•úŽËü (Žîá‡), 4ŽY•w, 5–òŠw•”): Eur J Gynaec Oncol 2010; 31 (5): 517-21.
(•l“cKG1, V•”@÷3, ¬’J³Žq3, Šp“cV•œ4, ŠC–ìM–ç4, ‘ì˜ad3, –îŒã˜a•v1,5)

120088. [ŒŽ’˜] ‚킪‘‚Ì‚ª‚ñáu’É–ò‚É‚š‚¯‚é–â‘è“_‚Æ‚»‚Ì‰ðŒˆ–@. ‘•ªG–ç1, “IêŒ³O2, ŽR“cˆÀ•F
3, –îŒã˜a•v1,4 (1–òÜ•”, 2‘—§‚ª‚ñƒZƒ“ƒ^[‚ª‚ñ‘΍ôî•ñƒZƒ“ƒ^[, 3“Œ‹ž–ò‰È‘åŠw–òŠw•”, 4–òŠw•”):
YAKUGAKU ZASSHI 2011/1; 131 (1): 113-27.

120089. [ŒŽ’˜] 10%ƒVƒNƒƒzƒXƒtƒ@ƒ~ƒhŽU‚Ì’²»•û–@‚Æ’·ŠúˆÀ’萫‚ÌŒŸ“¢. ‚Æ‚š‚µKŽs˜N1, ‘•ªG–ç
2, •l“cKG3, ‹ß“¡—¯”üŽq2, ŒŒŽ@”£2, –îŒã˜a•v2 (1‰ñS“°‘æ“ñ•a‰@–òÜ‰È, 2–òÜ•”, 3“Œ•a‰@–ò
Ü•”): “ú–{•a‰@–òÜŽt‰ïŽGŽ 2011/1; 47 (1): 90-3.

520114. [‘à] ‚킪‘‚Ì‚ª‚ñáu’ÉŽ¡—Öò‚É‚š‚¯‚é–â‘è“_‚Æ‚»‚Ì‰ðŒˆ•û–@. ‘•ªG–ç1, “IêŒ³O2, ŽR
“cˆÀ•F3, –îŒã˜a•v1 (1–òÜ•”, 2“Æ—§s­–@l‘—§‚ª‚ñŒ€‹†ƒZƒ“ƒ^[’†‰›•a‰@ŠÉ˜aˆã—ÉȁEž_ŽîᇉÈ,
3“Œ‹ž–ò‰È‘åŠw–òŠw•”—Տ°–òŒø‰ðÍŠw‹³Žº ): –òŠwŽGŽ 2011/1; 131: 113-27.

521032. [‰ðà] ‘æ1‰ñ_“ސ쌧‚ª‚ñê–å–ò•š—Ö@”F’è–òÜŽt—{¬ƒ[ƒNƒVƒ‡ƒbƒv•ñ. ²X–ØŽõŽq (–ò
Ü•”): _“ސ쌧•a‰@–òÜŽt‰ï‰ïŽ 2010/5; 124: 37-9.

521033. [‰ðà]y–òÜŽt‚©‚ç”­MIŠŽõ‘΍ô‚ÉŒø‚­ƒNƒXƒŠzÇ—á•ñ‘‚ÌŒø‰Ê“I‚ȏ‘‚«•û. ¬—я¹G (–ò
Ü•”, “ú–{‰»Šw—Ö@Šw‰ï): ƒCƒ“ƒtƒFƒNƒVƒ‡ƒ“ƒRƒ“ƒgƒ[ƒ‹ 2010/7; 19 (7): 696.

521034. [‰ðà] ŠŽõ‘΍ô‚̏[ŽÀ‚Ì‚œ‚ß‚É?ê–剻‚ƈê”ʉ»?. ¬—я¹G1,2 (1–òÜ•”, 2“ú–{‰»Šw—Ã
–@Šw‰ï): ƒCƒ“ƒtƒFƒNƒVƒ‡ƒ“ƒRƒ“ƒgƒ[ƒ‹ 2011/7; 19 (8): 798.

521035. [‰ðà] ƒXƒyƒVƒƒƒ‹ƒ|ƒsƒ…ƒŒ[ƒVƒ‡ƒ“‚Ö‚Ì•›ì—pŠÇ—. ‘•ªG–ç1, –îŒã˜a•v1,2 (1–òÜ•”, 2
–òŠw•”): –ò‹Ç 2010/9; 61 (10): 3123-30.

521036. [‰ðà] Žèp•”‚É‚š‚¯‚é–òÜŽt‹Æ–±?ŽèpŽº‚É‚š‚¯‚é–òÜŽt‚Ì–ðŠ„?. •yàV@~1, –îŒã˜a•v
1,2 (1–òÜ•”, 2–òŠw•”): –òŽ–V•ñ 2011/1; No,2663: 50-4.

522158. [uÀ] ‚æ‚­‚ ‚éw‹^–⎖—áx‚ÉŠw‚ԍR‹Û–òƒ}ƒlƒWƒƒ“ƒg‚̔錍 ŠŽõÇf—Â̍l‚Š•û‚©‚ç‚Ý‚œR
‹Û–òƒ}ƒlƒWƒƒ“ƒg Œo‰ßŠÏŽ@ (Œø‰Ê”»’襕›ì—p) 1 Œø‰Ê¥•›ì—p‚Ì–Ê‚©‚ç‚Ý‚œ“KØ‚ȍR‹Û–òŽ¡—ÊúŠÔ‚̍l
‚Š•û?R‹Û–ò“Š—^‚Ì—LŒø«”»’f‚â’†Ž~ƒŒƒxƒ‹‚Ì•›ì—p‚ð–òÜŽt‚Í‚Ç‚€‚Ý‚é‚ׂ«‚©?. ¬—я¹G1, –îŒã˜a
•v1,2 (1–òÜ•”, 2–òŠw•”): –ò‹Ç 2010/6; 61 (7): 2634-9.

522159. [uÀ] 1“ú1‰ñ“Š—^Žž‘ã‚̍R‹Û‰»Šw—Ö@ 2.uPK-PDv‚Í‚æ‚è—LŒø‚ňÀ‘S,ŠmŽÀ‚ȍR‹Û‰»Šw—Ö@‚ð
ŽÀŒ»‚·‚é. ¬—я¹G (–òÜ•”): ‰»Šw—Ö@‚̗̈æ 2010/6; 26 (7): 1367-72.

522160. [uÀ] ƒOƒŠƒRƒyƒvƒ`ƒhŒn–ò‚ÌTDM‚Ì•W€‰». ¬—я¹G1,2 (1–òÜ•”, 2“ú–{‰»Šw—Ö@Šw‰ï): ŠŽ
õÇ 2010/7; 40 (4): 140-7.

522161. [uÀ] ‘ϐ«‰»—}§‚ðl—¶‚µ‚œR‹Û‰»Šw—Ö@ 2.–ò•š“®‘Ô‚Æ–ò—ÍŠw‚ÉŠî‚¢‚œR‹Û–ò‚Ì“K³Žg—p
2-3 ƒOƒŠƒRƒyƒvƒ`ƒhŒn–ò. ¬—я¹G1, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”): ŒŽŠ§–òŽ– 2010/8; 52 (9):
1407-12.

522162. [uÀ]y‚ª‚ñáu’ɃRƒ“ƒgƒ[ƒ‹‚Æ–òŠw“IŠÇ—z ‚ª‚ñáu’ÉŽ¡—Öò‚Ì•›ì—pƒ}ƒlƒWƒƒ“ƒg@ƒXƒyƒV
ƒƒƒ‹ƒ|ƒsƒ…ƒŒ[ƒVƒ‡ƒ“‚Ö‚Ì•›ì—pŠÇ—. ‘•ªG–ç1, –îŒã˜a•v1 (1–òÜ•”): –ò‹Ç 2010/9; 61: 3123-30.

522163. [uÀ]yJCNƒZƒŒƒNƒg 4@ƒƒ“ƒXƒeƒbƒvƒAƒbƒvÃ–¬‰h—{z“K³‚È”÷—ÊŒ³‘f“Š—^—Ê‚Æ‚Í. ŒŒŽ@”£
1, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”): —Տ°‰h—{ 2010/10; •Êû: 104-8.

522164. [uÀ] ”x‰Š2010 R‹Û–òŽ¡—à RMRSA–ò‚ÌTDM‚ɂ‚¢‚Ä. ¬—я¹G (–òÜ•”): ‘Ž‡—Տ°
2010/10; 59 (10): 2090-5.

[’˜@‘]

620175. [Šwp‘] (•ª’SŽ·•M)y‚ª‚ñáu’É‚Ì–ò•š—Ö@‚ÉŠÖ‚·‚éƒKƒCƒhƒ‰ƒCƒ“ (‘æ1”Å)z”wŒi’mŽ¯, p.43-7.
‘•ªG–ç (–òÜ•”), •Ò “ú–{ŠÉ˜aˆã—Êw‰ï, ‹àŒŽo”Å (Š”), 2010/6”­s.

620176. [Šwp‘] (•ª’SŽ·•M)yƒJƒ‹ƒoƒyƒlƒ€‚ð‚Ç‚€Žg‚€‚©??“K³Žg—p‚Ì‚œ‚ß‚ÌŠî‘b‚ƗՏ°?zII. —Տ°
•Ò@5. ‹~‹}‹~–œ—̈æ. ¬—я¹G (–òÜ•”), •Ò ‰Í–ì@–Î, ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, ‘åã, 2010/8”­s.

620177. [Šwp‘] (•ª’SŽ·•M)yR‹Û‰»Šw—Ö@”F’è–òÜŽtƒeƒLƒXƒg@–òÜŽt‚ª’m‚Á‚Ä‚š‚«‚œ‚¢ŠŽõÇ‚ƍR
‹Û‰»Šw—Ö@zR‹Û–ò‚ÌTDM, p.31-44. ¬—я¹G1,2 (1–òÜ•”, 2“ú–{‰»Šw—Ö@Šw‰ï), •Ò “ú–{‰»Šw—Ö@
Šw‰ïR‹Û‰»Šw—Ö@”F’è–òÜŽt”F’èˆÏˆõ‰ï, “ú–{‰»Šw—Ö@Šw‰ï, 2010/10”­s.

620178. [Šwp‘] (•ª’SŽ·•M)yR‹Û‰»Šw—Ö@”F’è–òÜŽtƒeƒLƒXƒg@–òÜŽt‚ª’m‚Á‚Ä‚š‚«‚œ‚¢ŠŽõÇ‚ƍR
‹Û‰»Šw—Ö@zR—Δ^‹Û–ò, p.159-69. ¬—я¹G1,2 (1–òÜ•”, 2“ú–{‰»Šw—Ö@Šw‰ï), •Ò “ú–{‰»Šw—Ö@
Šw‰ïR‹Û‰»Šw—Ö@”F’è–òÜŽt”F’èˆÏˆõ‰ï, “ú–{‰»Šw—Ö@Šw‰ï, 2010/10”­s.

620179. [Šwp‘] (•ª’SŽ·•M)y‹~–œ‹~‹}Žž‚̃XƒLƒ‹&–òƒnƒ“ƒhƒuƒbƒN?‚»‚Ì’mŽ¯‚ª–œ‚ð‹~‚€?z1. ŠOE
Ž–ŒÌ, Ž–Œ, ÐŠQ‚É‚æ‚éŠO, p.90-7. ¬—я¹G1, ‘Š”nˆêˆå2 (1–òÜ•”, 2‹~–œ), •Ò ²“¡@”Ž, ˆã
–òƒWƒƒ[ƒiƒ‹ŽÐ, ‘åã, 2010/12”­s.

620180. [Šwp‘] (•ª’SŽ·•M)y‹~–œ‹~‹}Žž‚̃XƒLƒ‹&–òƒnƒ“ƒhƒuƒbƒN?‚»‚Ì’mŽ¯‚ª–œ‚ð‹~‚€?z‹~–œ‹~‹}
‚Å–òÜŽt‚ª•K—v‚Æ‚È‚éî•ñ‚ÌŒŸõ‰Â”\‚ȃz[ƒ€ƒy[ƒW, p.425-38. ‹ß“¡—¯”üŽq (–òÜ•”), •Ò ²“¡@”Ž,
ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, ‘åã, 2010/12”­s.

620181. [Šwp‘] (•ª’SŽ·•M)yŠO‰ÈE‹~‹}W’†Ž¡—Âɂš‚¯‚銎õÇ‘΍ô@¡‚·‚®ŽÀ‘H‚µ‚œ‚¢ŽüpŠúŠÇ—
‚ƍR‹Û–ò“K³Žg—pzII•” ŠO‰ÈE‹~‹}—̈æ‚É‚š‚¯‚éR‹Û–ò‚Ì“K³Žg—p@‘æ4Í pŒãŠŽõ‚É‚š‚¯‚éR‹Û–òŽ¡
—Á@1. MRSAŠŽõ‚ɑ΂·‚éR‹Û–òŽ¡—Ã, p.337-45. ¬—я¹G (–òÜ•”), ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, ‘åã, 2011/3
”­s.

[Šw‰ïEŒ€‹†‰ï“™]

713190. [Šw‰ï (‘Û)] (ˆê”ÊŒû‰‰) Population pharmacokinetic analysis of transdermal fentanyl in
Japanese patients with cancer pain. Hideya Kokubun1, Keniti Ebinuma2, Motohiro Matoba3, Misako
Fukawa1, Hajime Mastubara1, Kazuo Yago1 (1Department of Pharmacy, Kitasato University Hospital,
2Department of Pharmacy, Jichi Medical University Hospital, 3Department of Palliative Medicine,
National Cancer Center): ‘æ6‰ñ‰¢BŠÉ˜aƒPƒAŠw‰ï (—Տ°Œ€‹†•”‰ï) (2010/6/10-12), Glasgow, ‘æ6‰ñ
‰¢BŠÉ˜aƒPƒAŠw‰ï (—Տ°Œ€‹†•”‰ï) —vŽ|W 2010/6; p.116. (‘•¶G–ç1, •{ì”ü¹Žq1, ŒŒŽ@”£1, –î
Œã˜a•v1: –òÜ•”)

721022. [Šw‰ï (‘S‘)] (“Á•Êu‰‰) PC‚ðŽg—p‚µ‚È‚¢–ò•š“®‘Ô‰ðÍ. ¬—я¹G (–òÜ•”): ‘æ49‰ñ–ò•š
Ž¡—ƒjƒ^ƒŠƒ“ƒOŒ€‹†‰ï“Á•Êƒ[ƒ~ (2011/1/22-23), “Œ‹ž.

7231020. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Œ‹’°E’Œ’°ŠàŽèp‚É‚š‚¯‚épŒãŠŽõ—\–hR‹Û–ò‚ÉŠÖ‚·‚錟“¢. ˆî–ì@
Š°1, ˆäŒŽ@Œú2, •yàV@~1, ¬–ì—¢q2, ’†‘º—²r2, ‹ß“¡—¯”üŽq1, ‰ª–{_Žk3, –îŒã˜a•v1,4, “nç²
¹•F2 (1–òÜ•”, 2ŠO‰È, 3–ƒŒ, 4–òŠw•”): ‘æ110‰ñ“ú–{ŠO‰ÈŠw‰ï’èŠúŠwpW‰ï (2010/4/10), –ŒŒÃ‰®,
“ú–{ŠO‰ÈŠw‰ïŽGŽ 2010/3; 111 (2, —ÕŽž‘Š§†): 711.

7231021. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) tˆÚAŠ³ŽÒ‚É‚š‚¯‚éƒOƒ‰ƒZƒvƒ^[‚ÌTDM?pŒã“ú”‚ÆPKƒvƒƒtƒ@ƒC
ƒ‹‚©‚ç‚̍lŽ@?. •yàV@~1, ‹g“cˆê¬2, Ä‹ž–ŸŽq1, ’†‘º@—D1, ¬—я¹G1, ‹ß“¡—¯”üŽq1, ŒŒŽ@”£
1, –îŒã˜a•v1,3, –]ŒŽN•œ2, ‘OŽR—Ç‘Ÿ2, “y‹Ž³l2, Îˆä‘å•ã2, ‰““¡’‰—Y2, ”nêŽu˜Y2 (1–òÜ•”,
2”å”AŠí, 3–òŠw•”): ‘æ16‰ñ“ú–{ˆÚAˆã—Öò•š—Ö@Œ€‹†‰ï (2010/6/5), “Œ‹ž, ¡“ú‚̈ڐA 2010/7; 23
(6): 745-8.

7231022. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒ’†”Z“xƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚ð—p‚¢‚œƒƒƒyƒlƒ€‘å—Ê“Š—^
Žž‚Ì—LŒø«‚š‚æ‚шÀ‘S«‚ÉŠÖ‚·‚錟“¢. ‰“ŽR‰Á“ÞŽq1, ¬Œ•q²1, ’†‘º³Ž÷2, ²X–ØŽõŽq1, â‘q’q
Žq1, ‹ß“¡—¯”üŽq1, ŒŒŽ@”£1, »ìŒc‰î3, –îŒã˜a•v1,4 (1–òÜ•”, 2‘åŠw‰@ˆã—ÃŒnŒ€‹†‰ÈŠÂ‹«”÷¶•š
Šw, 3–k—¢¶–œ‰ÈŠwŒ€‹†Š“Á•ÊŒ€‹†•”–å, 4–òŠw•”): “ú–{TDMŠw‰ï (2010/6/26-27), ŽD–y, TDMŒ€‹†
2010/6; 27 (3): s176.

7231023. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠŽõ«S“à–Œ‰ŠŠ³ŽÒ‚É‚š‚¯‚éƒxƒ“ƒWƒ‹ƒyƒjƒVƒŠƒ“ƒJƒŠƒE
ƒ€‚Ì•êW’c–ò•š“®‘Ô‰ðÍ. ¬Œ•q²1, ¬—я¹G1, ‘•ªG–ç1, Žç‰®‰Ä”ü1, â‘q’qŽq1, ‹ß“¡—¯”üŽq
1, ŒŒŽ@”£1, ’––”FŒ³2, ˜aò@“O2, –îŒã˜a•v1,3 (1–òÜ•”, 2zŠÂŠí“à, 3–òŠw•”): ‘æ26‰ñ“ú–{
TDMŠw‰ïEŠwp‘å‰ï (2010/6/13-14), ŽD–y, TDMŒ€‹† 2010/6; 27 (3): s178.

7231024. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) V¶Ž™‚É‚š‚¯‚éƒtƒFƒmƒoƒ‹ƒrƒ^[ƒ‹Ã’»Ü‚ÌŽg—pŒoŒ±.
Ä‹ž–ŸŽq1, •yàV@~1, ’†‘º@—D1, ¬—я¹G1, Žç‰®‰Ä”ü1, ‹ß“¡—¯”üŽq1, ŒŒŽ@”£1, –ì“n³•F2, –î
Œã˜a•v1,3 (1–òÜ•”, 2¬Ž™, 3–òŠw•”): ‘æ27‰ñ“ú–{TDMŠw‰ïEŠwp‘å‰ï (2010/6/26-27), ŽD–y, ‘æ
27‰ñ“ú–{TDMŠw‰ïEŠwp‘å‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2010/6; 27 (3): s190.

7231025. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒVƒ‹Ž_ƒCƒ}ƒ`ƒjƒu‚ÌŒŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚̈Ӌ`:
meta-analysis. Î“c—L1, ¬Œ•q²2, ”ö’¹Ÿ–ç1, ‹ß“¡—¯”üŽq2, ŒŒŽ@”£2, –îŒã˜a•v1,2 (1–òŠw
•”, 2–òÜ•”): ‘æ27‰ñ“ú–{TDMŠw‰ïEŠwp‘å‰ï (2010/6/26-27), ŽD–y, TDMŒ€‹† 2010/6; 27 (3): s211

7231026. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬ltˆÚAŠ³ŽÒ‚É‚š‚¯‚éƒ~ƒRƒtƒFƒm[ƒ‹Ž_‚Ì•êW’c–ò•š
“®‘Ô‰ðÍ. —é–Ø—œ1, ¬—я¹G2, ‹g“cˆê¬3, Îˆä‘å•ã3, ”ö’¹Ÿ–ç1, ‹ß“¡—¯”üŽq2, ŒŒŽ@”£2, –î
Œã˜a•v1,2 (1–òŠw•”, 2–òÜ•”, 3”å”AŠí): ‘æ27‰ñ“ú–{TDMŠw‰ïEŠwp‘å‰ï (2010/6/26-27), ŽD–y, TDM
Œ€‹† 2010/6; 27 (3): s228.

7231027. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) tˆÚAŒãˆÀ’èˆÛŽŠú‚É‚š‚¯‚éƒ~ƒRƒtƒFƒm[ƒ‹Ž_‚ÌAUC„
’è. ¬ŽRˆè”ü1, ¬—я¹G2, ‹g“cˆê¬3, Îˆä‘å•ã3, ‘OŽR—Ç‘Ÿ3, ”ö’¹Ÿ–ç1, ŒŒŽ@”£2, –îŒã˜a•v
1,2 (1–òŠw•”, 2–òÜ•”, 3”å”AŠí): ‘æ27‰ñ“ú–{TDMŠw‰ïEŠwp‘å‰ï (2010/6/26-27), ŽD–y, TDMŒ€‹†
2010/6; 27 (3): s230.

7231028. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŽüpŠú‚É‚š‚¯‚é“K³‚Ȉã–ò•iî•ñ‚ÉŒü‚¯‚Ä(‘æ1•ñ)?“–
‰@‚Å‚ÌŽ¿‹^•ªÍ‚𒆐S‚É?. •yàV@~1, Ä‹ž–ŸŽq1, ¬Œ•q²1, ‹ß“¡—¯”üŽq1, ŒŒŽ@”£1, –îŒã˜a•v
1,2 (1–òÜ•”, 2–òŠw•”): ‘æ18‰ñ“ú–{ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€ (2010/7/10-11), L“‡, ‘æ18‰ñ“ú–{ˆã—Öò
ŠwƒtƒH[ƒ‰ƒ€—vŽ|W 2010/7; p.132.

7231029. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) RMRSA–òŽg—pŠ³ŽÒ”‚š‚æ‚ÑMRSAŒŸoŠ³ŽÒ”‚ɉe‹¿‚ð‹y
‚Ú‚·ˆöŽq‚ÌŒŸ“¢. {“c“NŽj1, “‡èM•v1, ”~“cŽ—²1 (1‘Ûe‘P‘‡•a‰@–òÜ•”): ˆã—ÖòŠwƒtƒH[ƒ‰
ƒ€2010^‘æ18‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ (2010/7/10-11), L“‡, ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2010
^‘æ18‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€u‰‰—vŽ|W 2010/7; p.187.

7231030. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒ“ƒ`Eƒh[ƒsƒ“ƒOƒf[ƒ^ƒx[ƒX‚̍\’z. ŠLÀ@1, ”–
ˆäŒ’‰î2, ¬ŽºŽ¡F3, Vˆä–œ—Žq1, ŽŒŽ@~4, ŒŒŽ@”£1, Œú“cKˆê˜Y2,4, –îŒã˜a•v1,2 (1–òÜ•”,
2–òŠw•”, 3“¡‘òŽs–¯•a‰@–ò‹Ç, 4–k—¢Œ€‹†Š•a‰@Ž¡Œ±): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2010^‘æ18‰ñƒNƒŠƒjƒJƒ‹
ƒVƒ“ƒ|ƒWƒEƒ€ (2011/7/10-11), L“‡, ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2010^‘æ18‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|
ƒWƒEƒ€u‰‰—vŽ|W 2010/7; p.195.

7231031. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ‚ª‚ñƒTƒƒ“‚É‚š‚¯‚é–òÜŽt‚ÌŠÖ—^. –k–ì’qŽq1, Vˆä–œ
—Žq1, ‘O“cŒiŽq2, ‹ß“¡‚Ü‚ä‚Ý2, ŒŒŽ@”£1, –îŒã˜a•v1 (1–òÜ•”, 2•a‰@Š³ŽÒŽx‰‡ƒZƒ“ƒ^[•”): “ú
–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ40‰ñŠwp‘å‰ï (2010/8/28-29), “Œ‹ž, “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ
40‰ñŠwp‘å‰ïu‰‰—vŽ|W 2010/8; p.354.

7231032. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒFƒ“ƒ^ƒjƒ‹ƒpƒbƒ`‚É‚æ‚éŒÄ‹z—}§‚ÌŽÀ‘Ô’²ž‚š‚æ‚Ñ—v
ˆö’Tõ. ‘•ªG–ç1, ŽO‰Y•S‡2, “IêŒ³O3, Vˆä–œ—Žq1, ŒŒŽ@”£1, –îŒã˜a•v1,2 (1–òÜ•”, 2
–òŠw•”, 3“Æ—§s­–@l‘—§‚ª‚ñŒ€‹†ƒZƒ“ƒ^[’†‰›•a‰@ŠÉ˜aˆã—ÉȁEž_ŽîᇉÈ): ‘æ4‰ñ“ú–{ŠÉ˜aˆã—Öò
Šw‰ï (2010/9/25-26), Ž­Ž™“‡, ‘æ4‰ñ“ú–{ŠÉ˜aˆã—ÖòŠw‰ï—vŽ|W 2010/9; p.221.

7231033. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ŠÈˆÕŒœ‘÷–@‚É‚š‚¯‚éùÜ”jÓŠí‹ï‚ÌŒŸ“¢. ””’J—DŽq1, –Ø
‘ºŒö”ü2, ŽO‹Ž^—R”ü2, ”’‘ò˜aŽq1, ‘•ªG–ç1, Vˆä–œ—Žq1, ŒŒŽ@”£1, –îŒã˜a•v1,2 (1–òÜ•”, 2
–òŠw•”): ‘æ20‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2010/11/13-14), –‹’£, ‘æ20‰ñ“ú–{ˆã—ÖòŠw‰ïu‰‰—vŽ|W
2010/11; p.290.

7231034. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) pŒãƒVƒoƒŠƒ“ƒO”­¶—vˆö‚ÌŒŸ“¢. ÔÎŽÑŠó1, •yàV@~
2, ¬Œ•q²2, ‹ß“¡—¯”üŽq2, ŒŒŽ@”£2, ”ö’¹Ÿ–ç2,3, –îŒã˜a•v2,3 (1–òŠw•”—Տ°–òŠwŒ€‹†‹³ˆçƒZƒ“
ƒ^[, 2–òÜ•”, 3–òŠw•”): ‘æ20‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2010/11/13-14), –‹’£, ‘æ20‰ñ“ú–{ˆã—ÖòŠw
‰ïu‰‰—vŽ|W 2010/11; p.415.

7231035. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) zŠÂŠí—̈æ‚É‚š‚¯‚éR‹Û–ò‚Ì“K³Žg—p‚Æ–òÜŽt‚ÌŠÖ‚í‚è. ¬—я¹G
(–òÜ•”): ‘æ24‰ñ“ú–{Š¥ŽŸŠ³Šw‰ï (2010/12/11), “Œ‹ž, “ú–{Š¥ŽŸŠ³Šw‰ïŽGŽ 2010/11; 16 (4): 328.

7231036. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw‚É‚š‚¯‚鏉”N“xŽÀ–±ŽÀK‚ÌŽÀŽ{ó‹µ. –îŒã˜a•v
1,2, ”ö’¹Ÿ–ç1,2 (1–òŠw•”, 2–òÜ•”): –òŠw‹³ˆç‹Š‹c‰ïƒtƒH[ƒ‰ƒ€2011 (2011/2/12), “Œ‹ž.

7231037. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –k—¢‘åŠw•a‰@‚É‚š‚¯‚é‘åŠw?–òÜ•”‚Ì‹Š“­‚É‚æ‚éŽÀ–±ŽÀ
K. “cŒû—SŽq1, ”ö’¹Ÿ–ç1,2, –Ø‘ºŒö”ü1, –Ñ—˜‡ˆê1, Î“c—L1, “n糐ç’ß1, ‹ß“¡—¯”üŽq2, ŒŒŽ@
”£2, –îŒã˜a•v1,2 (1–òŠw•”, 2–òÜ•”): “ú–{–òŠw‰ï‘æ131”N‰ï (2011/3/28-31), Ã‰ª, “ú–{–òŠw‰ï‘æ
131”N‰ï—vŽ|W4 2011/3; 4: 358.

7231038. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) •a‰@ŽÀ–±ŽÀK‚É‚š‚¯‚éŽÀKŽ{Ýí’“‹³ˆõ‚Ì•K—v«. –Ñ—˜
‡ˆê1, ”ö’¹Ÿ–ç1,2, “cŒû—SŽq1, –Ø‘ºŒö”ü1, Î“c—L1, “n糐ç’ß1, ‹ß“¡—¯”üŽq2, ŒŒŽ@”£2, –î
Œã˜a•v1,2 (1–òŠw•”, 2–òÜ•”): “ú–{–òŠw‰ï‘æ131”N‰ï (2011/3/28-31), Ã‰ª, “ú–{–òŠw‰ï‘æ131”N‰ï
—vŽ|W4 2011/3; 4: 358.

731151. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) RMRSA–ò‚ÌTDM‚ÉŠÖ‚·‚éÅV‚ÌŒ©‰ð. ¬—я¹G (–òÜ
•”): ‘æ2‰ñÎìŒ§•a‰@–òÜŽt‰ïŠŽõ§Œä–òÜŽtƒZƒ~ƒi[ (2010/9/5), ‹à‘ò.

733524. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) –«áu’ɂɑ΂·‚éƒtƒFƒ“ƒ^ƒjƒ‹“\•tÜ‚ÌŽg—p
ó‹µ‚Æ–â‘è“_‚Ì’Šo. ²X–ØŽõŽq1, â‘q’qŽq1, ‰“ŽR‰Á“ÞŽq1, ‹ß“¡—¯”üŽq1, ŒŒŽ@”£1, –îŒã˜a•v
1,2 (1–òÜ•”, 2–òŠw•”): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ40‰ñŠwp‘å‰ï (2010/8/28-29), “Œ‹ž, “ú
–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ40‰ñŠwp‘å‰ï—pŽ† 2010/8; p.358.


ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”

[Šw‰ïEŒ€‹†‰ï“™]

713191. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) Decreased strength of Quadriceps increases the risk of mortality
in patients with chronic heart failure. Kamiya K1, Masuda T2, Matsunaga A2, Miida K1, Ogura MN2,
Kimura M2, Noda C3, Yamaoka-Tojo M2, Inomata T3, Izumi T3 (1Rehabilitation center, Kitasato
University Hospital, 2Department of allied health sciences, Kitasato University, 3Department of
Cardio-angiology, Kitasato University School of Medicine): American Heart Association (AHA) 2010
Scientific Sessions (2010/11/13-17), Chicago. (_’JŒ’‘Ÿ˜Y1, ‘“c@‘ì2, Œ‰i“Ä•F2, Œ©ˆä“c˜a³
1, ¬‘q@Ê2, –Ø‘º‰ë•F2, –ì“cçt3, “ŒžŠ”ü“ÞŽq2, ’––”FŒ³3, ˜aò@“O3: 1ƒŠƒnƒrƒŠ•”, 2ˆã—Ã
‰q¶Šw•”, 3zŠÂŠí“à)

7231039. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠÖßƒŠƒEƒ}ƒ`•I‚É‚š‚¯‚élH•IŠÖß‘S’uŠ·pŒã‚ɍð“ú‰ü‘P‚ª¢“ï‚Ÿ
‚Á‚œˆêÇ—á. ²X–؏Gˆê1, ²“¡ˆŸ—¢1, _•Û•‘¥1, “¡“c@Œì2 (1ƒŠƒnƒrƒŠ•”, 2®ŠO): ‘æ44‰ñ“ú
–{ì‹Æ—Ö@ŽmŠw‰ï (2010/6/11-13), å‘ä, 2010; 44: 31.

7231040. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “à‚È‚éˆÓŽ¯‚ð‚¢‚©‚É‘£‚¹‚é‚©?dÇ“ª•”ŠOŠ³ŽÒ‚Ìretrospective
ŠÏŽ@‹L˜^‚©‚ç‚Ì•ñ?. _•Û•‘¥1, ‰“ŒŽ‚Ü‚è‚Š1, ’·–ì—F‹IŽq2, dM@—º2, –kŒŽF—Y3 (1ƒŠƒnƒrƒŠ
•”, 2ŠÅŒì•”, 3‹~–œ): ‘æ44‰ñ“ú–{ì‹Æ—Ö@ŽmŠw‰ï (2010/6/11-13), å‘ä, 2010; 44: 93.

7231041. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) HFO‚É‚æ‚éŒÄ‹zŠÇ—‚É“ïa‚µ‚œdÇŒÄ‹z•s‘S‚ɑ΂µŒÄ‹z—Šw—Ö@‚ª
—L—p‚Å‚ ‚Á‚œV¶Ž™‚̈ê—á. à_èL–Ÿ1, ¬’r•üF1, ‰¡ŽR”ü²Žq2, ‘剪–ƒ—¢3, ŒÏè‰ëŽq3, –ì“n‰ë•F
3, Îˆä³_3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3¬Ž™): ‘æ46‰ñ“ú–{ŽüŽYŠúEV¶Ž™Šw‰ïŠwpW‰ï
(2010/7/11-13), _ŒË, 2010; 46 (2): 551.

7231042. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) _Œo‹Ø“d‹CŽhŒƒ‚ðs‚¢‹Ø—Í‚š‚æ‚уoƒ‰ƒ“ƒX‹@”\‚ÌŒüã‚ª“Ÿ‚ç‚ê‚œƒJ
ƒeƒRƒ‰ƒ~ƒ“ˆË‘¶«S•s‘S‚̈êÇ—á. _’JŒ’‘Ÿ˜Y1, ‘“c@‘ì2, ’––”FŒ³3, Œ©ˆä“c˜a³1, ‰Í–ì^—1, ‚
‹Ž—R”ü1, ‘q“‡^‹I1, ¬‘q@Ê2, –Ø‘º‰ë•F2, ¬™—Œb3, –ì“cçt3, Œ‰i“Ä•F2, ˜aò@“O3 (1ƒŠ
ƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à): ‘æ16‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï
(2010/7/17-18), Ž­Ž™“‡.

7231043. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –«S•s‘SŠ³ŽÒ‚É‚š‚¯‚é”]«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh‚Æ•às§ŒÀ‚Í
‘Þ‰@‘Šú‚ÌŒ’NŠÖ˜AQOL‚ɉe‹¿‚·‚é. Œ©ˆä“c˜a³1, ‘“c@‘ì2, _’JŒ’‘Ÿ˜Y1, ‘q“‡^‹I1, ‰Í–ì^—
1, ‚‹Ž—R”ü1, ¬‘q@Ê2, –Ø‘º‰ë•F2, Œ‰i“Ä•F2, –ì“cçt3, ˜aò@“O3 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq
¶Šw•”, 3zŠÂŠí“à): ‘æ16‰ñ“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŠwpW‰ï (2010/7/17-18), Ž­Ž™“‡.

7231044. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Neuromuscular electrical stimulation improved muscle strength
and balance function in elderly patient with severe aortic stenosis. Kamiya K1, Masuda T2, Inomata
T3, Kawano M1, Takahashi Y1, Kurashima M1, Noda C3, Matsunaga A2, Izumi T3 (1Rehabilitation center,
Kitasato University Hospital, 2Department of allied health sciences, Kitasato University,
3Department of Cardio-angiology, Kitasato University School of Medicine): ‘æ14‰ñ“ú–{S•s‘SŠw
‰ïŠwpW‰ï (2010/10/7-9), “Œ‹ž. (_’JŒ’‘Ÿ˜Y1, ‘“c@‘ì2, ’––”FŒ³3, ‰Í–ì^—1, ‚‹Ž—R”ü1, ‘q
“‡^‹I1, –ì“cçt3, Œ‰i“Ä•F2, ˜aò@“O3: 1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3zŠÂŠí“à)

7231045. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Žc‘¶”x‘gD‚ÌIntact Lung Survival‚ðl—¶‚µ‚œŒÄ‹z—Šw—Ö@‚ª—L—p
‚Å‚ ‚Á‚œdÇŒÄ‹z•s‘S‚̐V¶Ž™—á. à_èL–Ÿ1, ã“cN‹v2, ¬’r•üF1, ‰¡ŽR”ü²Žq3, ‹àŽq’‰O2, —с@
‰2, •Ÿ“‡’‹`2, ŒŽ@^l2, ”~ŒŽ@ŽÀ2, Îˆä³_2 (1ƒŠƒnƒrƒŠ•”, 2¬Ž™, 3ˆã—Éq¶Šw•”): ‘æ
43‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ï (2010/10/29-30), •Ÿ‰ª, 2010; 21: 79.

7231046. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Electrical Impedance Tomography (EIT) ‚É‚æ‚鏬Ž™”x
‚Ì”x–§“x‘ª’è‚ÌŽŽ‚Ý. ¬’r•üF1, ª•’JŒá2, ¡ˆä@Š°3, à_èL–Ÿ1, ‹àŽq’‰O4, —с@‰4, •Ÿ“‡
’‹`4, ã“cN‹v4, ŒŽ@^l4, ”~ŒŽ@ŽÀ4, Îˆä³_4 (1ƒŠƒnƒrƒŠ•”, 2ˆã—Éq¶Šw•”, 3‹~–œ, 4¬
Ž™): ‘æ43‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽŸŠ³Šw‰ï (2010/10/29-30), •Ÿ‰ª.

733525. [Šw‰ï (Œ€‹†‰ïE’n•û‰ï) lHŒÒŠÖß‘S’uŠ·pŒã4“ú–Ú‚Ì‹Ø—Í‚©‚ç‘Þ‰@Žž‚Ì•às‘¬“x‚ª—\‘ª‚Å‚«
‚é‚©. ŒŠÛƒ‰À1, ‰“ŒŽ^ˆê1, _’JŒ’‘Ÿ˜Y1, Œ©ˆä“c˜a³1, •Ó“y–Œ—²1, “à–쐳—²2, •Ÿ“‡Œ’‰î2, “à
ŽRŸ•¶2, ‚•œ®L3, Ž…–ž·Œ›4 (1ƒŠƒnƒrƒŠ•”, 2®ŠO, 3ˆã—Éq¶Šw•”, 4‹ãB˜JÐ•a‰@): ‘æ59‰ñ“Œ
“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2010/9/17-18), ·‰ª, 2010; 22 (3): 306.

733526. [Šw‰ï (Œ€‹†‰ïE’n•û‰ï)] (ˆê”ʍu‰‰) lH•IŠÖß‘S’uŠ·pŒã‚̊֐߉“®ˆæ§ŒÀ‚ɑ΂µ‚ďã˜r“ñ
“ª‹Ø‰„’·p‚ðs‚Á‚œ1—á. ²X–؏Gˆê1, “¡“c@Œì2, ¬ÀŒ«Ž¡2, ²“¡ˆŸ—¢1, _•Û•‘¥1, •Ó“y–Œ—²
1, è•”@Œ›2 (1ƒŠƒnƒrƒŠ•”, 2®ŠO): ‘æ59‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2010/9/17-18), ·‰ª, 2010; 22
(3): 443.

733527. [Šw‰ï (Œ€‹†‰ïE’n•û‰ï) “–‰@‚É‚š‚¯‚éƒAƒLƒŒƒXäF”牺’f—ô–D‡pŒã‚Ì‘«ŠÖß’ê‹ü‹Ø—͐„ˆÚ‚É‚Â
‚¢‚Ä‚ÌŒŸ“¢. ‰“ŒŽ^ˆê1, è•”@Œ›2, ¬£NŽ¡2, ŒŠÛƒ‰À1, Œ©ˆä“c˜a³1, •Ó“y–Œ—²1, “à–쐳—²2,
Ž…–ž·Œ›3 (1ƒŠƒnƒrƒŠ•”, 2®ŠO, 3‹ãB˜JÐ•a‰@): ‘æ59‰ñ“Œ“ú–{®Œ`ÐŠQŠO‰ÈŠw‰ï (2010/9/17-18),
·‰ª, 2010; 22 (3): 446.


‰h—{•”

[’˜@‘]

620182. [Šwp‘] (•ª’SŽ·•M)y‚¢‚ŽŽÀ‘HI–«t‘Ÿ•a (CKD) ‚̉h—{ŠÇ—?‹ï‘Ì“IƒAƒvƒ[ƒ`‚Æ‚»‚̃Rƒc
?z4; Œ’f‚Ŕ얞‚ðŽw“E‚³‚ê‚œCKDŠ³ŽÒ, p.108-12. p.165. ‹g“c•üŽq (‰h—{•”), ŠÄC ‰Á“¡–Ÿ•F, •Ò
Žsì˜aŽq, •­–rŽq, •¶Œõ“°, 2010/6”­s.

620183. [Šwp‘] (•ª’SŽ·•M)y‚±‚ê‚Ÿ‚¯‚Í’m‚Á‚Ä‚š‚«‚œ‚¢“œ”A•a‚̐HŽ–—Ö@: “œ”A•aHŽ–—Ö@Q&A@“œ
”A•aƒŒƒNƒ`ƒƒ[2Šª1†zQ.11 HŽ–ƒoƒ‰ƒ“ƒXƒKƒCƒh‚ÆŽlŒQ“_”–@‚Æ‚Í, p.83-9. lŒ©–ƒ”üŽq1, ²“¡Æ
Žq1 (1‰h—{•”), •Ò ‹M“c‰ª³Žj, Œ‘ºˆêO, ‘Ž‡ˆãŠwŽÐ, 2011”­s.

[Šw‰ïEŒ€‹†‰ï“™]

7231047. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‘Ï“œ”\ˆÙí‚ð—L‚·‚é”ì–ž”D•w4Ç—á‚É‚š‚¯‚郁ƒ^ƒ{ƒŠƒbƒNƒAƒiƒ‰ƒC
ƒU[‚ð—p‚¢‚œ•K—vƒGƒlƒ‹ƒM[—Ê‚ÌŒŸØ. lŒ©–ƒ”üŽq1, ’†“ˆ‚Æ‚µ‚Ý1, ìã—IŽq1, —с@“N”Í2, Žsì—‹
Žt2, Žç‰®’B”ü2 (1‰h—{•”, 2“à•ª”å‘ãŽÓ“à): ‘æ53‰ñ“ú–{“œ”A•aŠw‰ï”NŽŸŠwpW‰ï (2010/5/27-29), ‰ª
ŽR, “œ”A•a 2010; 53: S-190.

7231048. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) t‘Ÿ•a‹³Žº‚ª•Û‘¶ŠúHŽ–—Ö@‚Æ“§Í“±“üŽž‚Ì•a‘Ô‚É‹y‚Ú‚·‰e‹¿. ‹g
“c•üŽq1, [‘ò²ŒbŽq1, ‘ŠŒŽ–ŸŽq1, ¶‹î^—Žq1, ²“¡ÆŽq1, Žç‰®—˜‰À2, Š™“cvšæ3 (1‰h—{•”, 2
ˆãŠw‹³ˆç, 3t‘Ÿ“à): ‘æ55‰ñ“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/18), _ŒË, “§Í‰ïŽ 2010/5; 43 (S1):
398.

7231049. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘Ï“œ”\ˆÙí‚ð—L‚·‚é”ì–ž”D•w‚É‚š‚¯‚é•K—vƒGƒlƒ‹ƒM[—Ê‚ÌŒŸØ. l
Œ©–ƒ”üŽq1, ’†“ˆ‚Æ‚µ‚Ý1, ìã—IŽq1, ²“¡ÆŽq1, Žsì—‹Žt2, Žç‰®’B”ü2 (1‰h—{•”, 2“à•ª”å‘ãŽÓ“à):
‘æ26‰ñ“ú–{“œ”A•aE”DPŠw‰ïŠwpW‰ï (2010/11/26-27), ‚³‚¢‚œ‚ÜŽs, “œ”A•a‚Æ”DP 2010; 10 (2): S-70.

7231050. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) dÇ‹}«äX‰Š‚É‚š‚¯‚é7“úˆÈ“à‚ÌŒo’°‰h—{ŠJŽn‚ÌŒø‰Ê. HŽR—SŽq
1, ²“¡ÆŽq1, ‰¡‘K—SŽq1, ‹gˆä‹vŽq1, ‰ï“c—D”ü1, •Ð‰ª—Sˆê2, _œä’m“¹2, Šâ‘º‹M”ü3, •ÐŽRˆŸŽ÷3,
•{ì”ü¹Žq4, ‰““¡¬Žq5 (1‰h—{•”, 2‹~–œ, 3ŠÅŒì•”, 4–òÜ•”, 5—ÕŒŸ•”): ‘æ25‰ñ“ú–{Ã–¬Œo’°‰h—{
Šw‰ï (2011/2/17-18), –ŒŒÃ‰®.

7231051. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‰h—{ƒTƒ|[ƒgƒ`[ƒ€‰ÁŽZVÝ‚É”º‚€NSTŠˆ“®‚̐V‚µ‚¢“WŠJ?NSTŽx
‰‡ƒVƒXƒeƒ€‚̍\’z?. ‰¡‘K—SŽq1, ²“¡ÆŽq1, ‹ß“¡‰{Žq1, HŽR—SŽq1, •Ð‰ª—Sˆê2, _œä’m“¹2, Šâ‘º
‹M”ü3, •ÐŽRˆŸŽ÷3, •{ì”ü¹Žq4, ‰““¡¬Žq5 (1‰h—{•”, 2‹~–œ, 3ŠÅŒì•”, 4–òÜ•”, 5—ÕŒŸ•”): ‘æ
25‰ñ“ú–{Ã–¬Œo’°‰h—{Šw‰ï (2011/2/17-18), –ŒŒÃ‰®.

733528. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) æ“V«‘œ”­«¬’°•ÂœÇ‚ÌŠ³Ž™‚ªŒoŒûÛŽæ‚ÉŽŠ‚é‚Ü‚Å‚Ì
‘œEŽí‚É‚æ‚éŽæ‚è‘g‚Ý. “©ŽR‹IŽq1, lŒ©–ƒ”üŽq1, ¬—Ñ—ÇŽq1, ìã—IŽq1, —é–؃qƒTŽq, “c’†@Œ‰2, Šâ
èr”V3, ²X–Ø”ü˜aŽq4, ’·–ìm”ü5, ‰““¡¬Žq6, Vˆä–œ—¢Žq5, ‘åÀKŒb, –Ø‘º”ü•ä, –Ø‘º—F”ü, ²
“¡ÆŽq1 (1‰h—{•”, 2ŠO‰È, 3¬Ž™, 4ŠÅŒì•”, 5–òÜ•”, 6—ÕŒŸ•”): ‘æ35‰ñ_“ސ쌧‰h—{‰ü‘PŠw‰ï
(2011/3/22), _“ސì.

733529. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‚€‚ÁŒŒ«S•s‘SŠ³ŽÒ‚̑̏dŠÇ—‚ɂ‚¢‚Ă̈êlŽ@. ¶‹î
^—Žq1, ŽÂèŒb—¢1, ‘ŠŒŽ–ŸŽq1, ‹g“c•üŽq1, ‹ß“¡‰{Žq1, ²“¡ÆŽq1, ”©ŽR—SŽq2 (1‰h—{•”, 2zŠÂ
Ší“à): ‘æ35‰ñ_“ސ쌧‰h—{‰ü‘PŠw‰ï (2011/3/22), _“ސì.


•a‰@•a—•”

[Šwp˜_•¶]

521037. [‰ðà] PCR-SSCP–@‚ÆDirect-Sequencing–@‚ð—p‚¢‚œˆâ“`Žq•ÏˆÙ‚ÌŒŸo. ‹vê@Ž÷1, ŽR‰º˜a–ç
2, ‹g“c@Œ÷3, ŽOã“N•v3, ŽOŽ}@M3, ‰ªˆÀ@ŒM3 (1“Œ•a‰@•a—•”, 2•a‰@•a—•”, 3•a—): •a—‹Zp
2011/1; 74 (1): 24-8.

521038. [‰ðà]y‹ZpuÀzƒTƒCƒgƒPƒ‰ƒ`ƒ“–Ɖu‘gD‰»ŠwõF‚É‚æ‚é“ûŠàƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpß“]ˆÚ‚ÌŒŸo.
âŒû@”E1, ŽR‰º˜a–ç1, ‘ •À@Ÿ2, ‰ªˆÀ@ŒM3, ŽOã“N•v3, ŽOŽ}@M3 (1•a—•”, 2ŠO‰È, 3•a—):
Medical technology 2011/2; 39 (2): 165-72.

540116. [‚»‚Ì‘Œ]y•œ¬21”N“xEˆõŒ€‹†: 2009-06zThinlayer•W–{‚É‚š‚¯‚éŽq‹{“à–Œ×–Ef‚Ì•]‰¿?“à
–ŒThinlayer•W–{‚Ì“Á«‚Æ, ŽèpÞ—¿‚É‚š‚¯‚é×–E‘œ‚ÌŒŸ“¢?. ’¬“c‘å•ã1, ‰¡ŽR@‘å1, –L‰i^Ÿ1, Š`
ÀœA–M1, •ž•”@Šw2, ŽR‰º˜a–ç1, “n糁@ƒ3, ‰ªˆÀ@ŒM3 (1•a‰@•a—•”, 2ˆã—Éq¶Šw•”, 3•a—): –k
—¢‘åŠw•a‰@EˆõŒ€‹† 2010/6.

[’˜@‘]

620184. [Šwp‘] (•ª’SŽ·•M)yˆã—p‰æ‘œƒnƒ“ƒhƒuƒbƒNz‘æ9•Ò ‚³‚Ü‚Ž‚܂Ȉã—p‰æ‘œ@‘æ8Í ÅV‚̃g
ƒsƒbƒNƒX: ×–Ef, p.1383-9. Š`ÀœA–M1, ²“¡”Vr2 (1•a—•”, 2ŒÄ‹zŠíŠO), ŠÄC “¡“cLŽu, ƒI[
ƒ€ŽÐ, 2010/11/25”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722247. [Šw‰ï (‘S‘)] (µ‘ҍu‰‰) PCR-SSCP–@‚ÆDirect-Sequencing–@‚ð—p‚¢‚œˆâ“`Žq•ÏˆÙ‚ÌŒŸo. ‹v
ê@Ž÷1, ŽR‰º˜a–ç2, ‹g“c@Œ÷3, ŽOã“N•v3, ŽOŽ}@M3 (1“Œ•a‰@•a—•”, 2•a‰@•a—•”, 3•a—): ‘æ
82‰ñ“ú–{•a—‹Zp‘gD‹ZpŠw‰ï (2010/8/8), “Œ‹ž.

7231052. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒTƒCƒgƒPƒ‰ƒ`ƒ“–ƉuõF‚É‚æ‚é“ûŠàƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpß“]ˆÚŒŸo—Š
‚ÌŒüã. âŒû@”E1, ŽR‰º˜a–ç1, ‘ •À@Ÿ2, ŽOã“N•v3, ‰ªˆÀ@ŒM3 (1•a‰@•a—•”, 2ŠO‰È, 3•a—):
‘æ59‰ñ“ú–{ˆãŠwŒŸžŠw‰ï (2010/5/22), _ŒË.

731152. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘̍o‰t-p’†v‘¬‘̍o‰t×–Ef. ŽR‰º˜a–ç1, ŽOã“N•v
2, ŽOŽ}@M2 (1•a‰@•a—•”, 2•a—): •œ¬22”N“x_“ސ쌧¶ŠˆKŠµ•aŒŸf]Ž–ŽÒŒ€C (2010/10/24), _
“ސì.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-540025. [‚»‚Ì‘Œ]y•œ¬20”N“xEˆõŒ€‹†: 2008-04z–Ɖu‘gD‰»ŠwõF‚É‚š‚¯‚錟‘Ì‚Ì•Û‘¶ð
Œ?R‘Ì‚Æ‚Ì”œ‰ž«‚ɂ‚¢‚Ä?. ‹{èœŽq1, ŽR‰º˜a–ç1, ”\š•x²Žq1, Šp“c”ü“ÞŽq1, ‹g“c²“yŽq1, Œ
àV•qs1 (1•a‰@•a—•”): –k—¢‘åŠw•a‰@EˆõŒ€‹† 2009/5.


MEƒZƒ“ƒ^[EŒŒ‰tò‰»ƒZƒ“ƒ^[

[Šwp˜_•¶]

522165. [uÀ]y¬Ž™‚̏W’†Ž¡—ÃPƒA‚É‚š‚¯‚éŠÅŒìŽÀ‘HzŠî‘b’mŽ¯@(5) ¬Ž™W’†Ž¡—×̈æ‚É‚š‚¯‚éME
‹@ŠíŠÇ—. “ŒžŠŒ\ˆê (MEƒZ): ¬Ž™ŠÅŒì 2010/7; 33 (7): 865-71.

522166. [uÀ]y“ÁWI@—Տ°HŠw‹ZŽm‹Æ–±“úŽz‹~–œ‹~‹}ƒZƒ“ƒ^[‹Æ–±‚̈ê“ú. ‘‘¬TŒá (MEƒZ):
Clinical Engineering 2010/6; 21 (7): 670-3.

540117. [‚»‚Ì‘Œ] ¬Ž™ŠJSp‚É‚š‚¯‚éÔŒŒ‹…»Ü•ÏX‚É‚æ‚é‰e‹¿‚ÉŠÖ‚·‚錟“¢. ŒÃ•œ@‘1, “¡ˆä³ŽÀ
1, “ŒžŠŒ\ˆê1, ‹{’n@ŠÓ2, ¬ŒŽ–M‹`3 (1MEƒZ, 2S‘ŸŒŒŠÇŠO, 3ŠC˜V–Œ‘‡•a‰@): ‘ÌŠOzŠÂ‹Zp 2010/6;
37 (2): 104-6.

540118. [‚»‚Ì‘Œ] Ši”[‰Â”\Œ^IABPƒJƒe[ƒeƒ‹‚ÉŠÖ‚·‚錟“¢?ƒV[ƒX‚ð—¯’u‚µ‚œ‚Ü‚Ü”²‹Ž‰Â”\‚©?. “Œ
žŠŒ\ˆê1, “¡ˆä³ŽÀ1, –؉ºt“Þ1, •“cÍ”1, ‘‘¬TŒá1, ¬ŒŽ–M‹`2 (1MEƒZ, 2ŠC˜V–Œ‘‡•a‰@): ‘Ì
ŠOzŠÂ‹Zp 2010/6; 37 (2): 107-10.

540119. [‚»‚Ì‘Œ] “–ƒZƒ“ƒ^[ŠŽõ‘΍ô‚ÌŽæ‚è‘g‚Ý?ŠŽõ‘΍ô”ï—p‚ɂ‚¢‚Ä?. ”’ˆä“ÖŽj1, ‘‘¬TŒá1,
“ŒžŠŒ\ˆê1, ˆî–с@”Ž1, ”Ñ“‡Œõ—Y1, –؉ºt“Þ1, š ³Œ©1, Œ“cç‰À1 (1MEƒZ): _“ސ쌧—Տ°HŠw
‹ZŽm‰ïŽ 2010; 22: 41-3.

540120. [‚»‚Ì‘Œ] —Տ°ŽÀKŽó‚¯“ü‚êŽ{Ý‚É‚š‚¯‚銎õ‘΍ô‚ɂ‚¢‚Ä. š ³Œ©1, “ŒžŠŒ\ˆê1, ”’ˆä“Ö
Žj1, ‘‘¬TŒá1, ˆî–с@”Ž1, ”Ñ“‡Œõ—Y1, ŒÃ•œ@‘1, –؉ºt“Þ1 (1MEƒZ): _“ސ쌧—Տ°HŠw‹ZŽm‰ï
Ž 2010; 22: 49-51.

540121. [‚»‚Ì‘Œ] ƒA[ƒXƒ`ƒFƒbƒJ‚Ì—L—p«‚ÌŒŸ“¢. ‘哇O”V1, “ŒžŠŒ\ˆê1, ”’ˆä“ÖŽj1, –쑺’q”V1, •
“cÍ”1, ‘‘¬TŒá1 (1MEƒZ): ˆã—Ë@ŠíŠw 2010/10; 80 (5): 536-7.

[Šw‰ïEŒ€‹†‰ï“™]

722248. [Šw‰ï (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yŽüpŠú‚É‚š‚¯‚é‘œEŽíŠÔ‚̘AŒgzŽèpŒãŠ³ŽÒ‚̌ċz
ŠÇ—‚É‚š‚¯‚é—Տ°HŠw‹ZŽm‚Ì–ðŠ„. “ŒžŠŒ\ˆê (MEƒZ): ‘æ35‰ñ“ú–{ŠO‰ÈŒn˜A‡Šw‰ïŠwpW‰ï
(2010/6/18), ‰YˆÀ, “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ 2010/5; 35 (3): 431.

7231053. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŒŒ‰t“§Í‘•’u (DCS-27) •t‘®BVŒv‚ð—p‚¢‚œƒoƒXƒLƒ…ƒ‰[ƒAƒNƒZƒXÄ
zŠÂ—Š‚ÌŒŸ“¢. ²“¡‰hŽ¡1, ¬ŽR@œ1, “Œ@Œ«ˆê1, –ìì—²ˆê˜Y1, “¡ŒŽNì1, “ŒžŠŒ\ˆê1, Š™“cvšæ
2 (MEƒZ, 2t‘Ÿ“à): ‘æ37‰ñ“ú–{ŒŒ‰tò‰»‹ZpŠw‰ï (2010/4/18), ŽRŒ`, “ú–{ŒŒ‰tò‰»‹ZpŠw‰ï‰ïŽ
2011/1; 18 (3): 61-4.

7231054. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ASO‰ºŽˆƒoƒCƒpƒXpŽ{sŒã‚Ì“§Í¢“ïÇ—á‚ðŒoŒ±‚µ‚Ä. “¡ŒŽNì1,
ŠÄ•šNO2, ²“¡‰h–è2, –ìì—²ˆê˜Y1, “Œ@Œ«ˆê1, ¬ŽR@œ1, “ŒžŠŒ\ˆê2, “n‰ï—œŽÑŽq3, “à“¡³‹g
3, Š™“cvšæ3 (1ŒŒ‰tò‰»ƒZ, 2MEƒZ, 3t‘Ÿ“à): ‘æ37‰ñ“ú–{ŒŒ‰tò‰»‹ZpŠw‰ï (2010/4/18), ŽRŒ`.

7231055. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆã—ÈÀ‘SuK‰ï (Ž‘±ŠÉ™Ž®ŒŒ‰tàh‰ß) ‚ÌŒø‰Ê‚ƍ¡Œã‚Ì‚ ‚è•û. “¡
ŒŽNì1, ŠÄ•šNO1, ²“¡‰h–è1, –ìì—²ˆê˜Y1, “Œ@Œ«ˆê1, ¬ŽR@œ1, “ŒžŠŒ\ˆê1, Ž…Œ’Žj2, Š™
“cvšæ2 (1MEƒZ, 2t‘Ÿ“à): ‘æ37‰ñ“ú–{ŒŒ‰tò‰»‹ZpŠw‰ï (2010/4/18), ŽRŒ`.

7231056. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‰@“à‚ɐݒu‚³‚ê‚œœ×“®Ší‚ÌŽg—pó‹µ‚ÌŒŸØ. ¡•ª@—m1, “ŒžŠŒ\
ˆê2 (1“ú–{Œõ“dH‹Æ, 2MEƒZ): ‘æ85‰ñ“ú–{ˆã—Ë@ŠíŠw‰ï (2010/5/15), •Ÿ‰ª, ˆã—Ë@ŠíŠw 2010/4; 80 (2):
153.

7231057. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒA[ƒXƒ`ƒFƒbƒJ‚Ì—L—p«‚ÌŒŸØ. ‘哇O”V1, “ŒžŠŒ\ˆê1, ”’ˆä“Ö
Žj1, –쑺’q”V1, •“cÍ”1, ‘‘¬TŒá1 (1MEƒZ): ‘æ85‰ñ“ú–{ˆã—Ë@ŠíŠw‰ï (2010/5/15), •Ÿ‰ª, ˆã
—Ë@ŠíŠw 2010/4; 80 (2): 157.

7231058. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Տ°ŽÀK¶Žó‚¯“ü‚êŽ{Ý‚É‚š‚¯‚銎õ‘΍ô‚ɂ‚¢‚Ä. š ³Œ©1,
“ŒžŠŒ\ˆê1, ”’ˆä“ÖŽj1, ‘‘¬TŒá1, ˆî–с@”Ž1, ”Ñ“‡Œõ—Y1, ŒÃ•œ@‘1, –؉ºt“Þ1, Œ“cç‰À1 (1ME
ƒZ): ‘æ20‰ñ“ú–{—Տ°HŠw‰ï (2010/5/22), ‰¡•l, “ú–{—Տ°HŠw‹ZŽm‰ï‰ïŽ 2010/4; 39: 97.

7231059. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Տ°HŠw‹ZŽm—{¬Z‚É‚š‚¯‚éŽèpŽº‹Æ–±ŽÀK‚ÉŠÖ‚·‚錟“¢. ŒÃ•œ@
‘1, “ŒžŠŒ\ˆê1, œA£@–«2, V•Û”NO2 (1MEƒZ, 2ˆã—Éq¶Šw•”): ‘æ20‰ñ“ú–{—Տ°HŠw‰ï (2010/5/22),
‰¡•l, “ú–{—Տ°HŠw‹ZŽm‰ï‰ïŽ 2010/4; 39: 98.

7231060. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–ƒZƒ“ƒ^[‚ÌŠŽõ‘΍ô‚ÌŽæ‚è‘g‚Ý?ŠŽõ‘΍ô”ï—p‚ɂ‚¢‚Ä?. ”’ˆä
“ÖŽj1, ‘‘¬TŒá1, “ŒžŠŒ\ˆê1, ˆî–с@”Ž1, ”Ñ“‡Œõ—Y1, –؉ºt“Þ1, š ³Œ©1, Œ“cç‰À1 (1MEƒZ):
‘æ20‰ñ“ú–{—Տ°HŠw‰ï (2010/5/22), ‰¡•l, “ú–{—Տ°HŠw‹ZŽm‰ï‰ïŽ 2010/4; 39: 116.

7231061. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒy[ƒXƒ[ƒJŠÖ˜A‹Æ–±‚É‚š‚¯‚éˆã—ÈÀ‘S‚ÉŠÖ‚·‚錟“¢. •“cÍ”
1, “ŒžŠŒ\ˆê1, ‘‘¬TŒá1, ŠOŠÔMl1, š ³Œ©1, ‘哇O”V1 (1MEƒZ): ‘æ20‰ñ“ú–{—Տ°HŠw‰ï
(2010/5/22), ‰¡•l, “ú–{—Տ°HŠw‹ZŽm‰ï‰ïŽ 2010/4; 39: 135.

7231062. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) • o‹Ÿ‰º’Œ’°ŠàØœp‚ɑ΂µ¶ã˜r“®–¬‚æ‚èIABP‚ðŽ{s‚µ‚œ1Ç—á.
‘‘¬TŒá1, “ŒžŠŒ\ˆê1, “¡ˆä³ŽÀ1, –؉ºt“Þ1, •“cÍ”1, ŒÃ•œ@‘1, ŠOŠÔMl1, š ³Œ©1, ’·
‘º–ΑŸ1 (1MEƒZ): ‘æ20‰ñ“ú–{—Տ°HŠw‰ï (2010/5/22), ‰¡•l, “ú–{—Տ°HŠw‹ZŽm‰ï‰ïŽ 2010/4; 39:
144.

7231063. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) PCIŒã‚Ì“§Í‚Å‚ÌŒŒˆ³’ቺ—vˆö‚ÌŒŸ“¢. ŠOŠÔMl1, ¬ŽR@œ1, “¡
ŒŽNì1, –ìì—²ˆê˜Y1, “Œ@Œ«ˆê1, “ŒžŠŒ\ˆê1, â–{®“o2, Š™“cvšæ2 (1MEƒZ, 2t‘Ÿ“à): ‘æ55‰ñ
“ú–{“§ÍˆãŠw‰ïŠwpW‰ï (2010/6/19), _ŒË, “§Í‰ïŽ 2010/5; 43 (S1): 493.

7231064. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ¬Ž™ŠJSp‚É‚š‚¯‚éD’†‹…ƒGƒ‰ƒXƒ^[ƒ[‘jŠQÜ‚Ì—\–h“I“Š—^‚ÉŠÖ‚·
‚錟“¢. ŒÃ•œ@‘1, “¡ˆä³ŽÀ1, •“cÍ”1, “ŒžŠŒ\ˆê1, ˆäãMK2, ‹{’n@ŠÓ2 (1MEƒZ, 2S‘ŸŒŒ
ŠÇŠO): ‘æ36‰ñ‘ÌŠOzŠÂ‹ZpˆãŠw‰ï (2010/10/31), å‘ä, ‘ÌŠOzŠÂ‹Zp 2010/9; 37 (3): 300.

7231065. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ[ƒNƒVƒ‡ƒbƒv) ¬Ž™‚É‚š‚¯‚éECMO. “ŒžŠŒ\ˆê1, “¡ˆä³ŽÀ1, •
“cÍ”1, ‘‘¬TŒá1, ’†‘º‹±Žq1 (1MEƒZ): ‘æ19‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2010/8/28),
“Œ‹ž, “ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“ŒbM‰z’n•û‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2010/8; p.53.

732120. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) i‰»‚·‚éƒpƒ‹ƒXƒIƒLƒVƒ[ƒ^: ƒpƒ‹ƒXƒIƒLƒV
ƒ[ƒ^‚Ì‘ª’茎—‚ƈÀ‘SŠÇ—. “ŒžŠŒ\ˆê (MEƒZ): ‘æ19‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï
(2010/8/28), “Œ‹ž, “ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“ŒbM‰z’n•û‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2010/8; p.58.

733530. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) W’†Ž¡—ÃŽº‚É‚š‚¯‚éˆã—Ë@ŠíƒAƒ‰[ƒ€”­¶‚ÌŒ»ó‚ɂ‚¢
‚Ä‚ÌŒŸ“¢. ’†‘º‹±Žq1, “ŒžŠŒ\ˆê1, “¡ˆä³ŽÀ1, •“cÍ”1, ‘‘¬TŒá1, œA£@–«2 (1MEƒZ, 2ˆã—Ã
‰q¶Šw•”): ‘æ19‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (2010/8/28), “Œ‹ž, “ú–{W’†Ž¡—ÈãŠw‰ïŠÖ“Œ
bM‰z’n•û‰ïƒvƒƒOƒ‰ƒ€Ž˜^W 2010/8; p.137.

733531. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) ¬Ž™ŠJSp‚É‚š‚¯‚éD’†‹…ƒGƒ‰ƒXƒ^[ƒ[‘jŠQÜ‚Ì—\–h“Š
—^‚ÉŠÖ‚·‚錀‹†. ŒÃ•œ@‘1, “ŒžŠŒ\ˆê1, ‹{’n@ŠÓ2, ˆäãMK2, ’¹ˆäW‘¢2, ŽÄ“c@u2, {“¡‹±ˆê
2, ‹gˆä@„2, —F•Û‹M”Ž2, ùŒŽ‘–L2, “c‘º’q‹I2 (1MEƒZ, 2S‘ŸŒŒŠÇŠO): ‘æ63‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï
’èŠúŠwpW‰ï (2010/10/26), ‘åã.


Ž¡Œ±ŠÇ—Žº


ˆã—ÈÀ‘SŠÇ—Žº


ŠŽõŠÇ—Žº

[Šwp˜_•¶]

110275. [ŒŽ’˜] Definite infective endocarditis: clinical and microbiological features of 155
episodes in one Japanese university hospital. Takayama Y1, Okamoto R2, Sunakawa K3 (1Department
of Infection Control and Prevention, Kitasato University School of Medicine, 2Department of
Microbiology, Kitasato University School of Medicine, 3Graduate School of Infection Control
Sciences, Kitasato University): J Formos Med Assoc 2010/11; 109 (11): 788-99. (‚ŽR—zŽq1, ‰ª–{
—¹ˆê2, »ìŒc‰î3: 1ŠŽõŠÇ—Žº, 2”÷¶•š, 3‘åŠw‰@ŠŽõ§Œä‰ÈŠw•{)

520115. [‘à] ‘‰t”|—{ŒŸž. •œ“c‘×—Ç1, –ìXŽRŸl2, »ìŒc‰î1 (1ŠŽõŠÇ—Žº, 2ŠC˜V–Œ‘‡•a
‰@¬Ž™‰È): medicina 2010/10; 47(11): 571-3.

522167. [uÀ] ƒXƒ}[ƒgƒi[ƒXŒŸ’è–â‘è. “¡–Ø‚­‚ÉŽq (ŠŽõŠÇ—Žº): smart nurse 2010/10; 12 (10):
2-3.

[’˜@‘]

620185. [Šwp‘] (•ª’SŽ·•M)y—Տ°‚Å‚·‚®Žg‚Š‚銎õ‘΍ôƒGƒrƒfƒ“ƒXW+Œ»êŠˆ—pp@INFECTION CONTROL
t‹G‘Š§z‘æ1Í ‚š‚³‚Š‚Ä‚š‚«‚œ‚¢ Šî–{‚̃Gƒrƒfƒ“ƒX@28. ƒƒ^ƒEƒCƒ‹ƒX‘΍ô, p.123-6. “¡–Ø‚­‚ÉŽq
(ŠŽõŠÇ—Žº), •Ò –î–ì–M•v, XŒ“Œ[‘Ÿ, ƒƒfƒBƒJo”Å, 2010/4”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722249. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) IL-13‚Ɉˑ¶‚µ‚œB-1×–E‹@”\‚Ɖt«ˆöŽq‚É‚æ‚é‹}«ŠŽõÇ
ŠŽŽó«§Œä‹@\. ŽR–{‰Ä’j, Â–ö“NŽj, š “‡L”V, ‹{â’q[, Î‹Ž—ߐb, ŽR“c[Œ[, ”ª“c‰v[, –kì”ü
•ä, ‚ŽR—zŽq*, ŒŠª—YŽi, –î–ìŽõˆê, •œŠƒ—mˆê, ìã˜a‹`, ‰ê—ˆ–ž•v (“Œ–k‘åŠw‘åŠw‰@“à‰È•a‘ÞŠw•ª–ì
ŠŽõ§ŒäEŒŸžf’fŠw, *ŠŽõŠÇ—Žº): ‘æ84‰ñ“ú–{ŠŽõÇŠw‰ï‘‰ï (2010/4/5-6), ‹ž“s.

7231066. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚錌‰t”|—{—z«—á‚̗Տ°“IŒŸ“¢. ‚ŽR—zŽq*, Î‹Ž—ߐb,
‹àX@”£, ‰““¡Žj˜Y, Â–ö“NŽj, ¬ŒF–­Žq, ”ª“c‰v[, ŽR“c[Œ[, ŒŠª—YŽi, ŽR–{‰Ä’j, –kì”ü•ä, š “‡
L”V, Vˆä˜a–Ÿ, –î–ìŽõˆê, •œŠƒ—mˆê, ‰ê—ˆ–ž•v (“Œ–k‘åŠw‘åŠw‰@“à‰È•a‘ÞŠw•ª–슎õ§ŒäEŒŸžf’fŠw,
*ŠŽõŠÇ—Žº): ‘æ84‰ñ“ú–{ŠŽõÇŠw‰ï‘‰ï (2010/4/5-6), ‹ž“s.

7231067. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚銎õÇƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“‚ÌŒ»ó. ‹àX@”£, ”ª“c‰v
[, ŽR“c[Œ[, ŒŠª—YŽi, ‚ŽR—zŽq*, ŽR–{‰Ä’j, š “‡L”V, –î–ìŽõˆê, •œŠƒ—mˆê, ‰ê—ˆ–ž•v (“Œ–k‘åŠw
‘åŠw‰@“à‰È•a‘ÞŠw•ª–슎õ§ŒäEŒŸžf’fŠw, *ŠŽõŠÇ—Žº): ‘æ84‰ñ“ú–{ŠŽõÇŠw‰ï‘‰ï (2010/4/5-6),
‹ž“s.

7231068. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Žs’†ŠŽõŒ^MRSA‚Ì‹C“¹ã”ç”|—{×–E‚ւ̐N“ü«‚ÉŠÖ‚·‚錟“¢. ‚
ŽR—zŽq*, –î–ìŽõˆê, ‰““¡Žj˜Y, Vˆä˜a–Ÿ, Î‹Ž—ߐb, ‹àX@”£, Â–ö“NŽj, ”ª“c‰v[, ŽR“c[Œ[, ŒŠª
—YŽi, ŽR–{‰Ä’j, –kì”ü•ä, š “‡L”V, •œŠƒ—mˆê, ‰ê—ˆ–ž•v (“Œ–k‘åŠw‘åŠw‰@“à‰È•a‘ÞŠw•ª–슎õ§ŒäE
ŒŸžf’fŠw, *ŠŽõŠÇ—Žº): ‘æ58 ‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2010/6/2-4), ’·è.

7231069. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ˆô“ª‚æ‚蕪—£‚³‚ê‚œGyrA‚Ì85‚ɃAƒ~ƒmŽ_’uŠ·‚ð‚à‚ƒtƒ‹ƒIƒƒLƒm
ƒƒ“‘ϐ«Streptococcus pyogenes‚Ì•ªŽq‰uŠw“IŒŸ“¢. Vˆä˜a–Ÿ, –î–ìŽõˆê, •“c@m, ‹àX@”£, ‰““¡
Žj˜Y, Â–ö“NŽj, Î‹Ž—ߐb, ˆ¢•”—TŽq, ’·‘òŒõÍ, –kì”ü•ä, ”ª“c‰v[, ŽR“c[Œ[, ŒŠª—YŽi, ‚ŽR—zŽq
*, ŽR–{‰Ä’j, š “‡L”V, •œŠƒ—mˆê, ‰ê—ˆ–ž•v (“Œ–k‘åŠw‘åŠw‰@“à‰È•a‘ÞŠw•ª–슎õ§ŒäEŒŸžf’fŠw, *
ŠŽõŠÇ—Žº): ‘æ58 ‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2010/6/2-4), ’·è.

7231070. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Տ°•ª—£Acinetobacter baumannii‚̍זEN“ü«‚ÉŠÖ‚·‚錟“¢. ‰“
“¡Žj˜Y, –î–ìŽõˆê, ‹àX@”£, Vˆä˜a–Ÿ, ‚ŽR—zŽq*, Î‹Ž—ߐb, Â–ö“NŽj, ”ª“c‰v[, ŽR“c[Œ[, ŒŠª
—YŽi, ŽR–{‰Ä’j, –kì”ü•ä, š “‡L”V, •œŠƒ—mˆê, ‰ê—ˆ–ž•v (“Œ–k‘åŠw‘åŠw‰@“à‰È•a‘ÞŠw•ª–슎õ§ŒäE
ŒŸžf’fŠw, *ŠŽõŠÇ—Žº): ‘æ58 ‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2010/6/2-4), ’·è.

7231071. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “–‰@‚É‚š‚¯‚éjŽh‚µEØ‘n˜J“­ÐŠQ‘΍ô‚Ɖü‘P‚ɂ‚¢‚Ä. “¡–Ø‚­‚É
Žq1, ‚é—R”üŽq1, ‚‹Ž—R”üŽq1, •œ“c‘×—Ç1, ‚ŽR—zŽq1, »ìŒc‰î1 (1ŠŽõŠÇ—Žº): ‘æ26‰ñ“ú–{ŠÂ
‹«ŠŽõŠw‰ï‘‰ï (2011/2/19), ‰¡•l.

731153. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ƒvƒŒƒzƒXƒsƒ^ƒ‹EƒPƒA‚ÉŠÖ˜A‚·‚銎õÇ‚Æ‚»‚̑΍ô. ‚
ŽR—zŽq (ŠŽõŠÇ—Žº): ‘æ49‰ñƒvƒŒƒzƒXƒsƒ^ƒ‹Œ€‹†‰ï (2010/11/25), –k—¢‘åŠw.

H21”N“xˆÈ‘O•ª

[Šw‰ïEŒ€‹†‰ï“™]

H21-713009. [Šw‰ï (‘Û)] (ˆê”ʍu‰‰) ESBL active surveillance culture in patients
rehospitalized from oyher facilities. Kunishima H, Minegishi M, Chiba J, Nakajima S, Nishimaki
Y, Takayama Y, Yamamoto N, Kitagawa M, Yano H, Hirakata Y, Honda Y, Kaku M (Department in Infectious
Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Graduate School of
Medicine): SHEA (Society for Healthcare Epidemiology of America) 2010 Annual Meeting
(2010/3/18-22), USA. (‚ŽR—zŽq)


–k—¢‘åŠw“Œ•a‰@

“Œ•a‰@ŠÅŒì•”

[Šwp˜_•¶]

520116. [‘à]y‘å’°‚ª‚ñ‚̍ŐVƒgƒsƒbƒN‚ÆŠÅŒìz’Œ’°‚ª‚ñ‚É‚š‚¯‚éƒXƒg[ƒ}‘¢Ýp‚ƃXƒg[ƒ}•Âœp‚Ì
ŽüŽèpŠúƒPƒA. ŒŒŽN”ü (“Œ•a‰@ŠÅŒì•”): ‚ª‚ñŠÅŒì 2010/5; 15 (4): 404-6.

522168. [uÀ]y“ÁW: ŠO—ˆŠÅŒìŽtEƒp[ƒgEˆõEƒNƒ‰[ƒN‚̐ڋö‚ƐlÞˆç¬zŠÅŒì•â², ƒNƒ‰[ƒN‚ÌŒp
‘±“I‚È‹³ˆçŽx‰‡‘̐§. –Ñ’Ë—R”üŽq1, ^–ì“oŠìŽq1, “¡“c’q‘ãŽq1 (1“Œ•a‰@ŠÅŒì•”): ŠO—ˆŠÅŒì 2010/4;
4E5ŒŽ†: 45-56.

522169. [uÀ]y“ÁW: ¬Ž™–«ŽŸŠ³Š³ŽÒ‚Ì‚œ‚߂̐¬lˆÚsŠúŽx‰‡z¬lˆÚsŠúŽx‰‡‚ÌŽÀÛ@(2) ¬lˆÚ
sŠúŽx‰‡‚ÉŠÖ‚·‚é‰@“àƒVƒXƒeƒ€‚­‚è; ¬Ž™ˆã—Î҂̈ӎ¯’²ž‚ð‚à‚Æ‚É. –û’J˜aŽq (“Œ•a‰@ŠÅŒì•”): ¬
Ž™ŠÅŒì 2010/8; 33 (9): 1269-74.

522170. [uÀ]y“ÁW2: ‚à‚Á‚Æ—Ç‚­‚·‚éI@‚à‚Á‚ÆŒø‰Ê‚ª‚Å‚éI@VlE•”“à‚Å‚Ì‹³ˆçEŒ€Cƒvƒ‰ƒ“z
p‘OpŒãŠÅŒì‚Ȃǂɖ𗧂Â?®Œ`ŠO‰È•a“ŠÅŒìŽt‚ÌŽèpŽºŒ©ŠwŒ€C?. –ìàV‚©‚Ù‚é1, ‹gŒŽçŒb1, ’†ŽR
‰hƒ2 (1“Œ•a‰@ŠÅŒì•”, 2ŠÅŒìŠw•”): Žå”C•’†Œ˜ + ‚±‚±‚ëƒTƒ|[ƒg 2011/1; 1E2ŒŽ†: 86-9.

522171. [uÀ]yƒGƒ“ƒhƒIƒuƒ‰ƒCƒt‚É‚š‚¯‚éŠÉ˜aƒPƒA?l¶‚ÌŠ®Œ‹Šú‚ª[ŽÀ‚µ‚œŽžŠÔ‚Æ‚È‚é‚æ‚€‚É?zƒG
ƒ“ƒhƒIƒuƒ‰ƒCƒtŠ³ŽÒ‚̈ÀŠy‚ւ̃PƒA@‡B‚É‚š‚¢‚̃PƒA. ŒŒŽN”ü (“Œ•a‰@ŠÅŒì•”): ‚ª‚ñŠÅŒì 2011/3;
16 (3): 374-6.

[’˜@‘]

620186. [Šwp‘] (•ª’SŽ·•M)yŽ©ŽE—\–hEŽ–Œã‘Ήž‚ÉŠÖ‚·‚éEˆõŒ€CƒeƒLƒXƒgz•a‰@“à‚ÌŽ©ŽE‘΍ô‚Ì‚·
‚·‚ß•û, p.40-2, p.50-5. ‰ÔˆäŒbŽq (“Œ•a‰@ŠÅŒì•”), •Ò ‰ÍŒçH (‰¡•lŽs—§‘åŠw), ‘Œ, “ú–{ˆã—Ë@”\
•]‰¿‹@\, 2011/1”­s.

620187. [Šwp‘] (•ª’SŽ·•M)y‚ª‚ñŠÅŒìƒVƒŠ[ƒY@ƒi[ƒX‚Ÿ‚©‚ç‚Å‚«‚éáu’Ƀ}ƒlƒWƒƒ“ƒgz‚ª‚ñŠÅŒìƒg
ƒsƒbƒNƒX@‚ª‚ñI––ŠúŠ³ŽÒ‚̈««‘n‚ւ̃PƒA‚ÌŽÀÛ, p.98-102. ŒŒŽN”ü (“Œ•a‰@ŠÅŒì•”), •ÒWEƒG
ƒLƒXƒp[ƒgƒi[ƒX•ÒW•”, Æ—ÑŽÐ, 2011/2”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722250. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒNƒ‰ƒCƒVƒXƒ}ƒlƒWƒƒ“ƒg. ‰ÔˆäŒbŽq (“Œ•a‰@ŠÅŒì•”): ‘æ12‰ñ
ˆã—Ã}ƒlƒWƒƒ“ƒgŠw‰ï (2010/6/12), ŽD–y, ˆã—Ã}ƒlƒWƒƒ“ƒgŠw‰ïŽ 2010/6; 11: 149.

722251. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Žèp’†‚ÌŠÅŒì (Žèpˆã—Â̎À‘HƒKƒCƒhƒ‰ƒCƒ“5Í)?ƒKƒCƒhƒ‰ƒC
ƒ“‚ÌŠˆ—p‚ɂ‚¢‚Ä. ”ª“c‹žŽq (“Œ•a‰@ŠÅŒì•”): ‘æ32‰ñ“ú–{ŽèpˆãŠwŠw‰ï (2010/10/1), ‰¡•l, “ú–{Žè
pˆãŠwŠw‰ïŽ 2011/5; 32 (2): 129-31.

722252. [Šw‰ï (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ’nˆæ˜AŒgƒpƒX‚Ì“±“ü‚É‚æ‚éSŒŒŠÇ•aŠ³ŽÒ‚Ö‚ÌŠÅŒìŽx‰‡. ŽR‰º@
’q1, ^–ì“oŠìŽq1, ì‡—R‰Í1, ˜aòK‘ã1, ’¬“c—z“ñ2, ‹g“c—F‹I2, ˜aò@“O2 (1“Œ•a‰@ŠÅŒì•”, 2
zŠÂŠí“à): ‘æ33‰ñ“ú–{‚ŒŒˆ³Šw‰ï (2010/10/16), •Ÿ‰ª.

722253. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒXƒLƒ“ƒPƒAŠO—ˆ‚ÌŒ»ó‚ƍ¡Œã‚ÌŽæ‚è‘g‚Ý. ŒŒŽN”ü (“Œ•a‰@ŠÅ
Œì•”): ‘æ25‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ïŠwpW‰ï (2011/2/11), _ŒË, “ú–{‚ª‚ñŠÅŒìŠw‰ïŽ 2011/1; 25 (“Á•Ê
†): 75.

722254. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”F’èŠÅŒìŽt‚̃LƒƒƒŠƒAƒAƒbƒvŽx‰‡Ž–‹Æ?‚È‚º¡”F’èŠÅŒìŽt‚ÉŠÅ
ŒìŠÇ—‚ª•K—v‚È‚Ì‚©?. ŒºŠC‘׎q (“Œ•a‰@ŠÅŒì•”): ‘æ25‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ï (2011/2/12), _ŒË.

722255. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŠO—ˆ‚É‚š‚¯‚éƒXƒg[ƒ}‘¢Ý‚̏p‘O‹³ˆç‚Ì—LŒø«. ŒŒŽN”ü (“Œ
•a‰@ŠÅŒì•”): ‘æ27‰ñ“ú–{ƒXƒg[ƒ}E”rŸ•ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ï (2011/2/5), •Ÿ‰ª, “ú–{ƒXƒg[ƒ}E
”rŸ•ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ïŽ 2011/1; 127 (1): 63.

7231072. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‚€‚•aŠ³ŽÒ‚Ì–«“I‚ɒቺ‚µ‚œŽ©ŒÈ‘žd‚É‚š‚¯‚éˆêlŽ@?
NANDA-NIC-NOC‚ð—p‚¢‚Ä?. —é–Ø–ƒ—Žq (“Œ•a‰@ŠÅŒì•”): ‘æ16‰ñ“ú–{ŠÅŒìf’fŠw‰ï (2010/6/5), _ŒË.

7231073. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒXƒg[ƒ}ŽüŽèpŠú‚É‚š‚¯‚郊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Ì”­“W‚ð–ÚŽw‚·Žæ‚è
‘g‚Ý?ƒAƒNƒVƒ‡ƒ“ƒŠƒT[ƒ`“±“ü‚É‚æ‚éˆã—Ã`[ƒ€‚̕ω»‚̃vƒƒZƒX. ŒŒŽN”ü (“Œ•a‰@ŠÅŒì•”): ‘æ19
‰ñ“ú–{‘nEƒIƒXƒgƒ~[EŽž‹ÖŠÇ—Šw‰ï (2010/5/9), “Œ‹ž, “ú–{‘nEƒIƒXƒgƒ~[EŽž‹ÖŠÇ—Šw‰ïŽ
2010/4; 14 (1): 120.

7231074. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)u‚É‚š‚¢‚É”z—¶‚µ‚œƒXƒg[ƒ}ƒPƒAƒ}ƒjƒ…ƒAƒ‹v‚̗Տ°ŠÅŒìŽt‚É‚æ‚é•]
‰¿. V“‡‘•c1, ŒŒŽN”ü2, ‹g‘º@–«3, ‚‹Ž@ƒ4, •i“c‚ЂƂÝ4 (1‰¡•l‘Dˆõ•ÛŒ¯•a‰@, 2“Œ•a‰@ŠÅ
Œì•”, 3“ŒŠC‘åŠwˆãŠw•”•t‘®•a‰@, 4ƒRƒ“ƒoƒeƒbƒN): ‘æ19‰ñ“ú–{‘nEƒIƒXƒgƒ~[EŽž‹ÖŠÇ—Šw‰ï
(2010/5/9), “Œ‹ž, “ú–{‘nEƒIƒXƒgƒ~[EŽž‹ÖŠÇ—Šw‰ïŽ 2010/4; 14 (1): 167.

7231075. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ˆã—ÃPƒA‚ð•K—v‚Æ‚·‚éŽq‚Ç‚à‚Ì’nˆæŽx‰‡‚ÌŒ»ó‚Ɖۑè. –û’J˜aŽq
1, ¬“‡‚ЂŎq2, ²âٍ²“s”ü3, ‘Œ (1“Œ•a‰@ŠÅŒì•”, 2ŠÅŒìŠw•”, 3ŠÅŒì•”): ‘æ20‰ñ“ú–{¬Ž™ŠÅŒì
(2010/6/26), _ŒË.

7231076. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ž_‰È•ÛŒìŽº‚É‚š‚¯‚é’†Œ˜ŠÅŒìŽt‚̈ӎ¯’²ž. ‚‹Ž‰p—Y1, Îì”ü
á1 (1“Œ•a‰@ŠÅŒì•”): ‘æ41‰ñ“ú–{ŠÅŒìŠw‰ï: ž_ŠÅŒì (2010/7/22), ‹{è.

7231077. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ®Œ`ŠO‰È•a“ŠÅŒìŽt‚ɑ΂·‚éŽèpŽºŒ€C‚ÌŒø‰Ê. –ìàV‚©‚Ù‚é1, ‹g
ŒŽçŒb1, ’†ŽR‰hƒ2 (1“Œ•a‰@ŠÅŒì•”, 2ŠÅŒìŠw•”): ‘æ41‰ñ“ú–{ŠÅŒìŠw‰ï: ŠÅŒì‹³ˆç (2010/8/19), ’·
è, ‘æ41‰ñ“ú–{ŠÅŒìŠw‰ïŽ˜^WŠÅŒì‹³ˆç 2010/8; p.182.

7231078. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ’·ŠúÝ‘î—×{’†‚̋؃WƒXƒgƒƒtƒB[Š³ŽÒ‚̐¬’·”­’B‚𑣂·ŠÅŒì?ƒy
ƒvƒƒE‚̊Ō엝˜_‚ð—p‚¢‚Ă̐U‚è•Ô‚è?. ìŒŽ“cÊ1, ‘Oì‹±Žq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ15‰ñ“ú–{“ï•a
ŠÅŒìŠw‰ï (2010/8/27), ŽRŒ`, “ú–{“ï•aŠÅŒìŠw‰ïŽ 2010/7; 15 (1): 60.

7231079. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) lHŒÄ‹zŠí‚©‚ç—£’E‚µ‚ж‚«‚邱‚Æ‚ð‘I‘ð‚µ‚œALSŠ³ŽÒ‚Ì1Ç—á?
ƒ`[ƒ€ˆã—Â̎‹“_‚©‚ç?. “n•””ü˜a1, ‘Oì‹±Žq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ15‰ñ“ú–{“ï•aŠÅŒìŠw‰ï
(2010/8/27), ŽRŒ`, “ú–{“ï•aŠÅŒìŠw‰ïŽ 2010/7; 15 (1): 70.

7231080. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‘Þ‰@Žw“±‚ÉŠÖ‚·‚鐮Œ`ŠO‰ÈŠÅŒìŽt‚̈ӎ¯’²ž?–ž‘«ŠŽ‚̍‚‚Ü‚éŽw“±
‚ð–ÚŽw‚µ‚Ä?. •ì–ƒŽÀ1, Œ¢ŠÛçŠG1, ‹gŒŽçŒb1, –ìàV‚©‚Ù‚é1, ’†ŽR‰hƒ2 (1“Œ•a‰@ŠÅŒì•”, 2ŠÅ
ŒìŠw•”): ‘æ41‰ñ“ú–{ŠÅŒìŠw‰ï: ¬lŠÅŒìII (2010/8/31), •Ÿ‰ª, ‘æ41‰ñ“ú–{ŠÅŒìŠw‰ïŽ˜^W¬lŠÅŒì
II 2010/8; p.189.

7231081. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŽèpŠÅŒì—vˆöŽZ’è’²žŒ‹‰Ê•ñ. ã–쐳•¶, ”ª“c‹žŽq1 (1“Œ•a‰@
ŠÅŒì•”): ‘æ24‰ñ“ú–{ŽèpŠÅŒìŠw‰ï (2010/9/17), ‹ž“s.

7231082. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) g‘̍‡•¹Ç‚ð‚à‚ž_‰È“ü‰@Š³ŽÒ‚ÌŠÅŒì•K—v“x‚ƃPƒA‚ÌŽÀÛ (‚»‚Ì
1)?Ý“Š³ŽÒ‚ÌŠT—v‚ÆŠÅŒì•K—v“x‚ÌŽÀÛ?. ˆäã—L”üŽq1, ‘同‚ЂƂÝ2, ¬–ì“cˆêŽ}3, ‘å’|áÁ—R”ü4 (1
‹ž“s‘åŠwˆãŠw•”•t‘®•a‰@, 2“Œ•a‰@ŠÅŒì•”, 3“Œ‹ž“s—§‹îž•a‰@, 4•Ÿ“‡Œ§—§ˆã‰È‘åŠw): ‘æ41‰ñ“ú–{ŠÅŒì
Šw‰ï: ŠÅŒìŠÇ— (2010/10/26), VŠƒ, ‘æ41‰ñ“ú–{ŠÅŒìŠw‰ïŽ˜^W: ŠÅŒìŠÇ— 2010/10; p.102.

7231083. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) g‘̍‡•¹Ç‚ð‚à‚ž_‰È“ü‰@Š³ŽÒ‚ÌŠÅŒì•K—v“x‚ƃPƒA‚ÌŽÀÛ (‚»‚Ì
2)?ŠÅŒìŽt‚ª‘ÌŒ±‚·‚鐞_‰ÈŠ³ŽÒ‚̐g‘̍‡•¹ÇƒPƒA‚ÌŽÀÛ?. ‘å’|áÁ—R”ü1, ‘同‚ЂƂÝ2, ¬–ì“cˆêŽ}
3, ˆäã—L”üŽq4 (1•Ÿ“‡Œ§—§ˆã‰È‘åŠw, 2“Œ•a‰@ŠÅŒì•”, 3“Œ‹ž“s—§‹îž•a‰@, 4‹ž“s‘åŠwˆãŠw•”•t‘®•a‰@):
‘æ41‰ñ“ú–{ŠÅŒìŠw‰ï: ŠÅŒìŠÇ— (2010/10/26), VŠƒ, ‘æ41‰ñ“ú–{ŠÅŒìŠw‰ïŽ˜^W: ŠÅŒìŠÇ— 2010/10;
p.103.

7231084. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) g‘̍‡•¹Ç‚ð‚à‚ž_‰È“ü‰@Š³ŽÒ‚ÌŠÅŒì•K—v“x‚ƃPƒA‚ÌŽÀÛ (‚»‚Ì
3)?ŠÅŒìŽt‚̋Ζ±ŽÀ‘Ô‚ÉŠî‚­ŠÅŒìEˆõ”z’u”‚ÌŒŸ“¢?. ‘å’|áÁ—R”ü1, ‘同‚ЂƂÝ2, ¬–ì“cˆêŽ}3, ˆä
ã—L”üŽq4 (1•Ÿ“‡Œ§—§ˆã‰È‘åŠw, 2“Œ•a‰@ŠÅŒì•”, 3“Œ‹ž“s—§‹îž•a‰@, 4‹ž“s‘åŠwˆãŠw•”•t‘®•a‰@): ‘æ
41‰ñ“ú–{ŠÅŒìŠw‰ï: ŠÅŒìŠÇ— (2010/10/26), VŠƒ, ‘æ41‰ñ“ú–{ŠÅŒìŠw‰ïŽ˜^W: ŠÅŒìŠÇ— 2010/10;
p.104.

7231085. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[)u‚«‚å‚€‚Ÿ‚¢‚̉ï?•a‰@‚Á‚Ăȁ[‚ɁH?v‚ÌŠˆ“®‚Ì•]‰¿?e‚©‚ç‚̃A
ƒ“ƒP[ƒg’²ž‚ð’Ê‚¶‚Ä?. •œŒS^—R”ü1, –û’J˜aŽq1, “à“¡–΍K2, ‘å’ˁ@3 (1“Œ•a‰@ŠÅŒì•”, 2ŠÅŒì
Šw•”, 3ŠÅŒì•”): ‘æ41‰ñ“ú–{ŠÅŒìŠw‰ï: ¬Ž™ŠÅŒì (2010/11/5), ’Ã.

7231086. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) ŠÅŒìŽt‚Ìà–Ÿ‚É‚æ‚èŽq‚Ç‚à‚́u‰œ‚ðvu‚Ç‚Ì‚æ‚€‚ɁvŒ©‚Ä‚¢‚é‚́H?
ƒAƒCƒ}[ƒNƒJƒƒ‰‚ª‘š‚Š‚œŽ‹ü‚Ì•ªÍ‚ð’Ê‚µŽx‰‡‚ðl‚Š‚é?. “à“¡–΍K1, –û’J˜aŽq2, ‰ªè@Í3 (1
ŠÅŒìŠw•”, 2“Œ•a‰@ŠÅŒì•”, 3‘ñB‘åŠwHŠw•”ƒfƒUƒCƒ“Šw‰È): ‘æ41‰ñ“ú–{ŠÅŒìŠw‰ï: ¬Ž™ŠÅŒì
(2010/11/6), ’Ã.

7231087. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) –«Šú‚É‚ ‚é‹•ŒŒ«SŽŸŠ³Š³ŽÒ‚̐¶ŠˆŽw“±‚ɑ΂·‚éƒiƒ‰ƒeƒBƒ”EƒA
ƒvƒ[ƒ`‚Ì“±“ü‚Æ‚»‚ÌŒø‰Ê. ˜aòK‘ã1, ŽR‰º@’q1, ^–ì“oŠìŽq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ7‰ñ“ú–{zŠÂ
ŠíŠÅŒìŠw‰ï (2010/11/20), L“‡, ‘æ7‰ñ“ú–{zŠÂŠíŠÅŒìŠw‰ïŠwpW‰ïŽ˜^W 2010/11; p.115.

7231088. [Šw‰ï (‘S‘)] (ƒfƒWƒ^ƒ‹ƒ|ƒXƒ^[) g‘̍S‘©ƒNƒŠƒjƒJƒ‹ƒpƒXì¬‚ÌŽÀÛ. “c‘º‘ñ–²1, sr‰Â
ˆ€1 (1“Œ•a‰@ŠÅŒì•”): ‘æ11‰ñ“ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ï (2010/12/3), ˆ€•Q, “ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ï
Ž 2010/12; 12 (4): 494.

7231089. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ‚ª‚ñŠÅŒìê–åŠÅŒìŽt‚ªs‚€—Ï—’²®‚ÌŽ‹“_‚Æ•û—ª?ŠO—ˆ‚ŐS”x‘h¶
‚ðs‚Á‚œis‚ª‚ñŠ³ŽÒ‚̃P[ƒX‚ð’Ê‚µ‚Ä?. ‘ì–ž—˜Žq1, ’·’Jì“ÞŽq2, —é–Ø‹M”ü2, ¬‘ò@2, ‰ª@
‘œŒb2, Ž…—TŽq3, çø“”ü“oŽq4, ‹v•ÄŒb]4, ŒK–ŒŽõ”ü4, –]ŒŽ”ü•ä4, Ž™‹Ê”ü‹I4, Žt‰ªŒbŽq4, ²“¡
”ü‹I4, Šâ–{ƒŽq4 (1“Œ‹žŽœŒbˆã‰È‘åŠw•t‘®•a‰@, 2“Œ•a‰@ŠÅŒì•”, 3Œö—§•x‰ª‘‡•a‰@, 4ŠÅŒì•”): ‘æ
25‰ñ“ú–{‚ª‚ñŠÅŒì (2011/2/11), _ŒË, “ú–{‚ª‚ñŠÅŒìŠw‰ïŽ 2011/1; 25 (“Á•Ê†): 110.

721090. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) M. ƒjƒ…[ƒ}ƒ“‚ÌŒ’N—˜_‚ÉŠî‚­Šñ‚è“Y‚¢‚̃PƒA‚Å•\‚ê‚œŠ³ŽÒ‚ÆŠÅ
ŒìŽt‚̐¬’·?eŽqŠÖŒW‚É”Y‚ÞŠ³ŽÒ‚ªŠÖŒWC•œ‚µ‚œƒP[ƒX?. ‰ª@‘œŒb1, çø“”ü“oŽq2, —äŠÝGŽq3 (1
“Œ•a‰@ŠÅŒì•”, 2ŠÅŒì•”, 3ŠÅŒìŠw•”): ‘æ25‰ñ“ú–{‚ª‚ñŠÅŒì (2011/2/12), _ŒË, “ú–{‚ª‚ñŠÅŒìŠw‰ïŽ
2011/1; 25 (“Á•Ê†): 202.

7231091. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ƒXƒg[ƒ}‘¢Ý—\’芳ŽÒ‚ւ̏p‘O‹³ˆçŠO—ˆ‚ÌŽŽ‚Ý?ƒAƒNƒVƒ‡ƒ“ƒŠƒT[
ƒ`ƒvƒƒWƒFƒNƒg?. ŒŒŽN”ü1, ˆî‹gŒõŽq2 (1“Œ•a‰@ŠÅŒì•”, 2ŠÅŒìŠw•”): ‘æ25‰ñ“ú–{‚ª‚ñŠÅŒìŠw‰ï
ŠwpW‰ï (2011/2/12), _ŒË, “ú–{‚ª‚ñŠÅŒìŠw‰ïŽ 2011/1; 25 (“Á•Ê†): 229.

7231092. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ŠÅŒìŽt‚ÌŠñ‚è“Y‚¢‚É‚æ‚芳ŽÒ‚ƃi[ƒX—ŒŽÒ‚Ì•Ï—e‚𐶂ݏo‚µ‚œŽ–—á
‚̈êlŽ@?M. ƒjƒ…[ƒ}ƒ“—˜_‚ð—p‚¢‚œŠÅŒì‚̐U‚è•Ô‚è?. Œ‘ºçt1, ŒŽŽq“à¹D1, çø“”ü“oŽq2, —ä
ŠÝGŽq3 (1“Œ•a‰@ŠÅŒì•”, 2ŠÅŒì•”, 3ŠÅŒìŠw•”): ‘æ25‰ñ“ú–{‚ª‚ñŠÅŒì (2011/2/12), _ŒË, “ú–{‚ª‚ñ
ŠÅŒìŠw‰ïŽ 2011/1; 25 (“Á•Ê†): 233.

7231093. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) œ“]ˆÚ‚̐f’f‚ðŽó‚¯‚œ‚ª‚ñŠ³ŽÒ‚ª—×{¶Šˆ‚Ì’†‚ōs‚Á‚Ä‚¢‚éŽå‘Ì“I
‚ÈŽæ‘g‚Ý. ¬‘ò@1, —äŠÝGŽq2 (1“Œ•a‰@ŠÅŒì•”, 2ŠÅŒìŠw•”): ‘æ25‰ñ“ú–{‚ª‚ñŠÅŒì (2011/2/12),
_ŒË, “ú–{‚ª‚ñŠÅŒìŠw‰ïŽ 2011/1; 25 (“Á•Ê†): 259.

7231094. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) ICT‚É‚æ‚éŠÂ‹«ƒ‰ƒEƒ“ƒh‚Æ‚»‚ÌŒø‰Ê‚ÉŠÖ‚·‚élŽ@. –k“‡_”ü1, –ì
àV‚©‚Ù‚é1, [–xMŽq1, –û’J˜aŽq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ26‰ñ“ú–{ŠÂ‹«ŠŽõ (2011/2/18), ‰¡•l, ‘æ26
‰ñ“ú–{ŠÂ‹«ŠŽõŠw‰ï‘‰ïŽ˜^W 2011/2; p.88.

731154. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (“Á•Êu‰‰) ‚ª‚ñŠ³ŽÒ‚̃XƒLƒ“ƒPƒA. ŒŒŽN”ü (“Œ•a‰@ŠÅŒì•”): ‘æ
10‰ñ•ºŒÉåñጁE”畆’×ᇌ€‹†‰ï (2010/7/3), _ŒË.

733532. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ‹Ù‹}Žèp‚ŃXƒg[ƒ}‚𑢐݂µ‚œ‚—ŽÒ‚Ö‚ÌŠÅŒìƒPƒA.
Î’Ë—T”ü1, ’·’Jì“ÞŽq1, ŽR–{]gŽq1, Œ‘º¡“úŽq1, ŒŒŽN”ü1 (1“Œ•a‰@ŠÅŒì•”): ‘æ33‰ñ_“Þ
ìƒXƒg[ƒ}Œ€‹†‰ï (2010/12/4), _“ސì, ‘æ33‰ñ_“ސìƒXƒg[ƒ}Œ€‹†‰ïŽ˜^W 2010/12; p.16.

733533. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) pŒã3ƒ–ŒŽ‚̏Á‰»ŠÇƒXƒg[ƒ}•Û—LŽÒ‚É‚š‚¯‚éQOL‚Ì”äŠr
ŒŸ“¢. ŒŒŽN”ü1, ²“¡•˜Y2 (1“Œ•a‰@ŠÅŒì•”, 2ŠO‰È): ‘æ33‰ñ_“ސìƒXƒg[ƒ}Œ€‹†‰ï (2010/12/4),
_“ސì, ‘æ33‰ñ_“ސìƒXƒg[ƒ}Œ€‹†‰ïŽ˜^W 2010/12; p.23.

733534. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Ž©sˆ×‚É‚æ‚éÒ‘‘¹Š³ŽÒ‚̏áŠQŽó—e‚ɑ΂·‚éŠÖ‚í‚è
‚ɂ‚¢‚Ă̈êlŽ@?ƒtƒBƒ“ƒN‚ÌŠë‹@ƒ‚ƒfƒ‹‚ð—p‚¢‚Ä?. ŽÄ“c@Œb1, ‹gŒŽçŒb1, ’†ŽR‰hƒ2 (1“Œ•a‰@
ŠÅŒì•”, 2ŠÅŒìŠw•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ïŽ˜^W
2010/12; p.28.

733535. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ’mŒã‚¹‚ñ–ςɈڍs‚µ‚œŠ³ŽÒ‚̐^ˆÓ‚Ö‚Ì‹C‚«. âV“¡–ƒ
ˆË1, ˜a“c‚³‚­‚ç1 (1“Œ•a‰@ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k—¢ŠÅŒì
Œ€‹†‰ïŽ˜^W 2010/12; p.29.

733536. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŠÌd•Ï––Šú‚ÌŠ³ŽÒ‚ª¶Šˆ•Ï—e‚ÉŽŠ‚é‚Ü‚Å‚ÌŠÖ‚í‚è‚©‚çŠw
‚ñ‚Ÿ‚±‚Æ?ƒyƒvƒƒE‚̊Ō엝˜_‚ð—p‚¢‚Ä?. ŠÃ—˜‹žŽq1, â‰º’qŽìŽq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ10‰ñ–k—¢
ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ïŽ˜^W 2010/12; p.32.

733537. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) p‘O‚̕ېŽ•û–@‚ɑ΂·‚鐮Œ`ŠO‰È•a“ŠÅŒìŽt‚̈ӎ¯‚É‚Â
‚¢‚Ä. ‘O“c^¶1, ’†—F—¢1, ‹gŒŽçŒb1, ’†ŽR‰hƒ2, [–xMŽq1 (1“Œ•a‰@ŠÅŒì•”, 2ŠÅŒìŠw•”): ‘æ
10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ïŽ˜^W 2010/12; p.35.

733538. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ŒoŠÇ‰h—{Š³ŽÒ‚É‚š‚¯‚é•Ö•]‰¿ƒc[ƒ‹Žg—pŽž‚Ì•Ö•]‰¿‚ÉŠÖ
‚·‚éƒXƒ^ƒbƒt‚Ì”FŽ¯’²ž. ŽR‰º@•‘1, ˜a‰Æ•‚Šó1, “yˆäP“ñ1, Ÿ–””üç1, ‘Oì‹±Žq1 (1“Œ•a‰@ŠÅŒì
•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ïŽ˜^W 2010/12; p.37.

733539. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) S‘Ÿ“ñŽŸ—\–hƒZƒ“ƒ^[‚É‚š‚¯‚é–k—¢‘åŠwzŠÂŠí’nˆæ˜AŒg
ƒpƒX‚ÌŽÀÛ?“dŽq‰»ƒpƒX“±“ü‚ÉŒü‚¯‚Ä?. ˜aòK‘ã1, ŽR‰º@’q1, ^–ì“oŠìŽq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ
10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ïŽ˜^W 2010/12; p.40.

733540. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ƒqƒ‹ƒfƒK[ƒhEEEƒyƒvƒƒE‚Ì—˜_‚ð—p‚¢‚œŠÅŒìŽt?Š³ŽÒ
ŠÖŒW‚Ì•ªÍ?“¯ˆê‰»‚Ì’iŠK‚ֈڍs‚·‚é‚œ‚ß‚ÉŠÅŒìŽt‚É‹‚ß‚ç‚ê‚Ä‚¢‚é‚à‚Ì?. ¬“‡’mŽÀ1, ŒF’J‰xŽq1 (1
“Œ•a‰@ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ïŽ˜^W 2010/12;
p.41.

733541. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ICU‚É‚š‚¯‚é”z‡•Ï‰»ƒf[ƒ^ƒx[ƒX‚̍\’z. ’†‘ä@•à1,
‚‘q‰Â“ÞŽq, âˆä’q”ü1, …‹ŽŒbŽq1, •l“cKG2, ‘O“c˜aÍ3 (1“Œ•a‰@ŠÅŒì•”, 2–òÜ•”, 3î•ñˆ—‰Û):
‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ïŽ˜^W 2010/12; p.53.

733542. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ICU‚É‚š‚¯‚邹‚ñ–σPƒA‚Ö‚ÌŽæ‚è‘g‚Ý?ICU‚¹‚ñ–σAƒZƒX
ƒƒ“ƒg—pŽ†‚ðŠˆ—p‚µ‚Ä?. Œ–{@Šó1, ‚‘q‰Â“ÞŽq1, …–ì^”üŽq1, ’†‘ä@•à1, …‹ŽŒbŽq1 (1“Œ•a‰@
ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ïŽ˜^W 2010/12; p.58.

733543. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) Ž{Ý‚É‚š‚¯‚éŠÅŒìŽt‚Ì–ðŠ„‚ÌˆêlŽ@. ‰œ“cƒ†ƒJƒŠ1, ×
ì–퐶1, ²“¡’qŽq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k—¢ŠÅ
ŒìŒ€‹†‰ïŽ˜^W 2010/12; p.71.

733544. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) I––Šú‚ɍݑî‚ʼn߂²‚·Š³ŽÒ‚ƉƑ°‚ÌŽv‚¢‚𑞏d‚µ‚œŽx‰‡
‚ðU‚è•Ô‚Á‚Ä. ‚ˆä‰À¢1, •Ð‰–@K1, ^–ì“oŠìŽq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï
(2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ïŽ˜^W 2010/12; p.73.

733545. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ŠÅŒìŽt‚Æ–ƒŒ‰Èˆã‚̘AŒg‚Ì‚«‚Á‚©‚¯‚Æ‚È‚Á‚œˆêŽ–—á?‘Ì
‰·ŠÇ—‚ð’Ê‚µ‚ÄŠw‚ñ‚Ÿ‚±‚Æ?. ’Ë“c—S—1, ‘Š“cŒbŽq1, ”ª“c‹žŽq1, ‰º‘ºŽ”ü1, –ìàV‚©‚Ù‚é1 (1“Œ•a
‰@ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ïŽ˜^W 2010/12;
p.80.

733546. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‘gD‚Æ‚µ‚ÄŽæ‚è‘g‚ñ‚ŸƒIƒ€ƒcƒvƒƒWƒFƒNƒg‚©‚ç‚̈êlŽ@.
ŽRè”ü’qŽq1, ²“¡’qŽq1 (1“Œ•a‰@ŠÅŒì•”): ‘æ10‰ñ–k—¢ŠÅŒìŒ€‹†‰ï (2010/12/18), ‘Š–ÍŒŽ, ‘æ10‰ñ–k
—¢ŠÅŒìŒ€‹†‰ïŽ˜^W 2010/12; p.81.


“Œ•a‰@—Տ°ŒŸž•”

[’˜@‘]

620188. [Šwp‘] (•ª’SŽ·•M)yu‚š‚Áv‚ÆŽv‚킹‚éI@’Ž‰¹”gŒŸž•ñ‘‚̏‘‚«•û@S‘Ÿ^ŒŒŠÇz’†“‡@“N
1, “¡ˆä@Ž 2, ‰FŽ¡‹Ž‘PŸ3, ’†Œ‹vK3 (1‘—§•a‰@‹@\…ŒËˆã—ÃZƒ“ƒ^[—Տ°ŒŸž‰È, 2“Œ•a‰@—Տ°ŒŸ
ž•”, 3—ÕŒŸ•”), •Ò Ž›“‡@–Î4 (4_“ސ쌧Œú¶˜AˆÉšŒŽ‹Š“¯•a‰@ˆã—ËZp•”), (Š”) ƒxƒNƒgƒ‹ƒRƒA,
2010/5”­s.

620189. [Šwp‘] (•ª’SŽ·•M)yu‚š‚Áv‚ÆŽv‚킹‚éI@’Ž‰¹”gŒŸž•ñ‘‚̏‘‚«•û@ŒŸf^”å”AŠí^ŽY•w
l‰È^‘Ì•\‘ŸŠíz•œŽRŒ»¶1, “¡ˆä@Ž 2, ‰FŽ¡‹Ž‘PŸ3, ’†Œ‹vK3 (1]ŒËì‹æˆãŽt‰ïˆã—ÃŒŸžƒZƒ“ƒ^
[¶—ŒŸžŽº, 2“Œ•a‰@—ÕŒŸ•”, 3—ÕŒŸ•”), •Ò Ž›“‡@–Î4 (4_“ސ쌧Œú¶˜AˆÉšŒŽ‹Š“¯•a‰@ˆã—ËZp•”),
(Š”) ƒxƒNƒgƒ‹ƒRƒA, 2010/5”­s.

[Šw‰ïEŒ€‹†‰ï“™]

7231095. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) Ò‘¬”]•Ï«Ç‚É‚š‚¯‚éTRH-T—Ö@‚̏dS“®—hŒŸž‚É‚æ‚é’ZŠúŠÔ•]
‰¿. ‘ºŽR^‹|1, ˆÉ•ÛŽŽq2, ó–ì˜a]3, –F“c‚ЂƂÝ3, ¬”Š@i3, ˆ¢‹v’Óñ•v4, ’·À‰p–Ÿ5, “¿‘
Œú“ñ5, ‰ª–{–ql5 (1“Œ•a‰@—ÕŒŸ•”, 2‰¡•lŽs—§‚݂ȂƐԏ\Žš•a‰@, 3—ÕŒŸ•”, 4_Œo“à, 5Žš•@): ‘æ69
‰ñ“ú–{‚ß‚Ü‚¢•œtˆãŠw‰ï (2010/11/18), ‹ž“s (‘—§‹ž“s‘Û‰ïŠÙ), Equilibrium Research 2010/10; 69
(5): 329.

733547. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ÊŒû‰‰) ã’°ŠÔ–ŒÃ–¬‚Ì”P“]‚𔺂Á‚œ“àƒwƒ‹ƒjƒA‚Ì1—á. “¡ˆä@
Ž 1, ŒFâ@L1, ‰““¡@—m1, –öŒŽ”ü’qŽq1, “ú‚@‰›2, Žë–ì—Lì3 (1“Œ•a‰@—ÕŒŸ•”, 2Á‰»Ší“à, 3
—ÕŒŸŠw): “ú–{’Ž‰¹”gˆãŠw‰ï‘æ22‰ñŠÖ“ŒbM‰z’n•û‰ï (2010/10/30), “Œ‹žƒtƒ@ƒbƒVƒ‡ƒ“ƒ^ƒEƒ“TFTƒz[
ƒ‹, ’Ž‰¹”gˆãŠw 2011/5; 38 (3): 321.


“Œ•a‰@–òÜ•”

[Šwp˜_•¶]

110276. [ŒŽ’˜] Microdose study of a P-glucoprotein substrate, fexofenadine, using a
non-radioisotope-labelled drug and LC/MS/MS. Yamazaki A1,2, Kumagai Y1,3, Yamane N3, Tozuka Z4,
Sugiyama Y5, Fujita T1,3, Yokota S1, Maeda M1 (1Clinical Trial Center, Kitasato University East
Hospital, 2Graduate School of Business, Tokyo Metropolitan University, 3Department of Pharmacology,
Kitasato University School of Medicine, 4JCL Bioassay Corporation, 5The University of Tokyo,
6Graduate School of Pharmaceutical Sciences): JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 2010/4;
35 (2): 169-75. (ŒF’J—YŽ¡1,3, “¡“c•üŒb1,3, ‰¡“cœÄˆê1, ‘O“cŽÀ‰Ô1: 3–ò—, 1“Œ•a‰@Ž¡Œ±ŠÇ—ƒZƒ“
ƒ^[)

110277. [ŒŽ’˜] Dose Conversion in Opioid Rotation from Continuous Intravenous of Morphine
Hydrochloride Injection to Fentanyl Patch in the Management of cancer Pain. Chihiro Kawano1,
Takeshi Hirayama1, Masakazu Kuroyama1 (1“Œ•a‰@–òÜ•”): YAKUGAKU ZASSHI 2011/3; 131: 463-7. (ì
–ìçq1, •œŽR•Ži1, •ŽR­ˆê1)

120090. [ŒŽ’˜] “ú–{•a‰@–òÜŽt‰ïŽGŽ‚Ö‚Ì“Še˜_•¶‚©‚ç‚Ý‚œ•a‰@–òÜŽt‚ÌŠŽõ§Œä‚ÉŠÖ‚í‚錀‹†‚̐„ˆÚ.
•ŽR­ˆê1,2, •œŽR•Ži1,2, ‚‹Ž¹Ž÷2, ‹ÊˆäTˆê˜Y2 (1“Œ•a‰@–òÜ•”, 2–òŠw•”): “ú–{•a‰@–òÜŽt‰ï
ŽGŽ 2010/11; 46 (11): 1541-4.

120091. [ŒŽ’˜] ƒvƒŒƒtƒBƒ‹ƒhƒVƒŠƒ“ƒW»Ü‚É‚æ‚éƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒƒNƒ`ƒ“ÚŽí‚Ì•Ö‰v‚ɑ΂·‚éˆê”ÊŽs–¯
‚ÌŽx•¥ˆÓŽvŠz‚ÉŠÖ‚·‚錀‹†. ¬‹v•Û‹ÓÆ1,2, ‘å•l@‘1, H“¡Œ›ˆê1, •œŽR•Ži3 (1–쑺‘Œ€, 2–Ÿ¯
‘åŒoÏ, 3“Œ•a‰@–òÜ•”): –ò—‚ÆŽ¡—à 2011/2; 39 (2): 189-97.

120092. [ŒŽ’˜] Ž¡—Âɓïa‚µ‚œ‘œŒn“ˆÞkÇ‚ɐ^‹Û«Šá“à‰Š‚ð‡•¹‚µ‚œ1—á?•¶Œ£“IlŽ@‚𓥂܂Š?.
•l“cKG1, ‹{ì¹D2, “c’†—R3, Žs糋`Í3, “ñ–{–öL4, Žë–ì—Lì5, –]ŒŽGŽ÷2, ‹v•Ä@Œõ, •ŽR
­ˆê1 (1“Œ•a‰@–òÜ•”, 2_Œo“à, 3Šá‰È, 4—ÕŒŸ•”, 5—ÕŒŸŠw): ‰»Šw—Ö@‚̗̈æ 2011/3; 27 (3): 100-8.

520117. [‘à] •a‰@ŠŽõƒT[ƒxƒCƒ‰ƒ“ƒX‚Æ‚Í. •l“cKG1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”): ŒŽŠ§–òŽ–
2010/8; 52: 1319-22.

[’˜@‘]

620190. [Šwp‘] (•ª’SŽ·•M)y‹Ö‰ŒŠw@‰ü’ù2”ŁzII ‹Ö‰Œ‚̈ãŠw@2 –ò‹ÇE–ò“X‚Å‚Ì‹Ö‰ŒŽw“±EŽx‰‡@A.
–ò‚ÌŽí—Þ, •›E‘ŠŒÝì—p@1. –ò‹ÇE–ò“X‚É‚š‚¯‚é–òÜŽt‚Ì‹Ö‰ŒŽw“±, p115-9. 3 ˆã—Ë@ŠÖ‚Å‚Ì‹Ö‰ŒŽw“±E
Žx‰‡@M. •a‰@Ef—ÏŠ‚Ì–òÜŽt‚Ì–ðŠ„, p187-9. ‘Š‘ò­–Ÿ (“Œ•a‰@–òÜ•”), •Ò “ú–{‹Ö‰ŒŠw‰ï, “ìŽR“°,
“Œ‹ž, 2010/4”­s.

620191. [Šwp‘] (•ª’SŽ·•M)y–òŠw‹³ˆçƒ‚ƒfƒ‹EƒRƒAƒJƒŠƒLƒ…ƒ‰ƒ€@C17•ª–썑‰ÆŽŽŒ±o‘è”͈͑Ήžƒe
ƒLƒXƒg@ˆã–ò•i‚ÌŠJ”­‚Ɛ¶ŽY@ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‚ÌŠî‘bzŽs”̌㒲ž‚̐§“x‚Æ‚»‚̈Ӌ`, p44-9,
p266. •œŽR•Ži1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”), ‚¶‚Ù‚€, “Œ‹ž, 2010/7”­s.

620192. [Šwp‘] (•ª’SŽ·•M)y‚æ‚­‚í‚©‚鏈•û‚¹‚ñ‚ÌŠî–{‚Ì“Ç‚Ý•û@‘æ2”ŁzChapter 4 ’ŽË–ò‚̏ˆ•û
‚¹‚ñ‚ð‚š‚Ú‚Š‚æ‚€!@4-1 ’ŽË–ò’²Ü‚ð‚µ‚ë‚€!. •ŽR­ˆê (“Œ•a‰@–òÜ•”), ŠÄC –öì’‰“ñ (“Œ–M‘åŠw
–òŠw•”), G˜aƒVƒXƒeƒ€, “Œ‹ž, 2010/8”­s.

620193. [Šwp‘] (•ª’SŽ·•M)yˆá‚¢‚ª‚í‚©‚é! “¯ŽíE“¯Œø–òz8Í Á‰»«’×ᇎ¡—Öò, p69-94. óˆä
”ü—R‹I1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”), •Ò •ŽR­ˆê1, ‘å’J“¹‹P2 (2“Œ‹ž’üM•a‰@–òÜ•”), “ì]“°, “Œ
‹ž, 2010/10”­s.

620194. [Šwp‘] (•ª’SŽ·•M)yˆá‚¢‚ª‚í‚©‚é! “¯ŽíE“¯Œø–òz10Í ‡–°–ò, p107-24. •“c‚¿‚©]1, •
ŽR­ˆê1 (1“Œ•a‰@–òÜ•”), •Ò •ŽR­ˆê1, ‘å’J“¹‹P2 (2“Œ‹ž’üM•a‰@–òÜ•”), “ì]“°, “Œ‹ž, 2010/10
”­s.

620195. [Šwp‘] (•ª’SŽ·•M)yˆá‚¢‚ª‚í‚©‚é! “¯ŽíE“¯Œø–òz11Í R‚€‚–ò, p125-42. •ŽR­ˆê1, ó
ˆä”ü—R‹I1 (1“Œ•a‰@–òÜ•”), •Ò •ŽR­ˆê1, ‘å’J“¹‹P2 (2“Œ‹ž’üM•a‰@–òÜ•”), “ì]“°, “Œ‹ž, 2010/10
”­s.

620196. [Šwp‘] (•ª’SŽ·•M)yŽ¡—Öòƒnƒ“ƒhƒuƒbƒN2011@–òÜ‘I‘ð‚Əˆ•û‚̃|ƒCƒ“ƒgz–òÜƒŠƒXƒg•Ò,
p1-1426. •ŽR­ˆê1, ‘Œ32–Œ (1“Œ•a‰@–òÜ•”), ŠÄC ‚‹vŽj–›2 (2Ž©Ž¡ˆã‰È‘åŠw), •Ò –x@³“ñ3, ›
–쌒‘Ÿ˜Y2, –å˜e@F4, Š£@Œ«ˆê5, —с@¹—m6 (3‘åã•{—§¬l•aƒZƒ“ƒ^[, 4“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒn
Œ€‹†‰È, 5‹ž“s–ò‰È‘åŠw, 6ŒÕƒm–å•a‰@), ‚¶‚Ù‚€, “Œ‹ž, 2011/1”­s.

620197. [Šwp‘] (•ª’SŽ·•M)yŽ¡—Öòƒnƒ“ƒhƒuƒbƒN2011@–òÜ‘I‘ð‚Əˆ•û‚̃|ƒCƒ“ƒgz–òÜƒŠƒXƒg•Ò: –ò
Œø•Êˆã–ò•i”äŠrˆê——•\, Šª“ªp7-37. •ŽR­ˆê1, óˆä”ü—R‹I1, •œŽR•Ži1, ¬ŒŽ”ü]1, •“c‚¿‚©]
1, –{ŠÔ‰ëŽm1 (1“Œ•a‰@–òÜ•”), ŠÄC ‚‹vŽj–›2 (2Ž©Ž¡ˆã‰È‘åŠw), •Ò –x@³“ñ3, ›–쌒‘Ÿ˜Y2, –å
˜e@F4, Š£@Œ«ˆê5, —с@¹—m6 (3‘åã•{—§¬l•aƒZƒ“ƒ^[, 4“Œ‹ž‘åŠw‘åŠw‰@ˆãŠwŒnŒ€‹†‰È, 5‹ž“s
–ò‰È‘åŠw, 6ŒÕƒm–å•a‰@), ‚¶‚Ù‚€, “Œ‹ž, 2011/1”­s.

620198. [Šwp‘] (•ª’SŽ·•M)yƒRƒ“ƒpƒNƒgˆã–ò•iî•ñW@ƒnƒCƒŠƒXƒNŽ¡—Öò2011zp1-1276, •ŽR­ˆê
1, ‘Œ19–Œ (1“Œ•a‰@–òÜ•”), ŠÄC ŒŽRŒ«–è2, ˆ¢“ìßŽq3 (2‹ß‹E‘åŠw–òŠw•”, 3“¯ŽuŽÐ—Žq‘åŠw–òŠw
•”), •Ò ˆ¢“ìßŽq3, ŸNˆä”ü—R‹I4, “¿“‡—TŽq5, ‰Í–ì‚Š‚ÝŽq6, •ŽR­ˆê1, –Ø‘º@Œ’7, •œ“cƒ¶8 (4
•ºŒÉŒ§—§“òè•a‰@–òÜ•”, 5‘åãƒuƒŒƒXƒgƒNƒŠƒjƒbƒN–òÜ•”, 6ŠÖŒˆã‰È‘åŠw—¢•a‰@–òÜ•”, 7•ºŒÉˆã‰È
‘åŠw•a‰@–òÜ•”, 8ŒF–{‘åŠw–òŠw•”), ‚¶‚Ù‚€, “Œ‹ž, 2011/1”­s.

[Šw‰ïEŒ€‹†‰ï“™]

722256. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) R‹Û–ò‚Ì‚æ‚è—Ç‚¢“Š—^–@‚̐ݒè‚ð–ÚŽw‚µ‚Ä. •l“cKG (“Œ•a‰@
–òÜ•”): ‘æ58‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (2010/4/28), ’·è, “ú–{‰»Šw—Ö@Šw‰ïŽGŽ 2010/4; 58: 145.

722257. [Šw‰ï (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’ŽË—pƒLƒbƒg»Ü‚Ì—L—p«?Œ»ê‚©‚ç‚Ì•]‰¿. •ŽR­ˆê (“Œ•a
‰@–òÜ•”): “ú–{•ï‘•Šw‰ï‘æ52‰ñƒVƒ“ƒ|ƒWƒEƒ€ (2010/6/14), “Œ‹ž, “ú–{•ï‘•Šw‰ï‘æ52‰ñƒVƒ“ƒ|ƒWƒEƒ€
—vŽ|W 2010/6; p.1-31.

7231096. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ‹ÇŠisŽq‹{èòŠà‚ɑ΂·‚éNedaplatin Weekly“Š—^‚Ì•êW’c–ò•š“®
‘Ô‰ðÍ?—Տ°‘æ2‘ŠŽŽŒ± (KGROG0501) ’†ŠÔ‰ðÍ?. •l“cKG1, £ŒË—Ç‹³2, V•”@÷3, Šp“cV•œ4, V
ˆä³G4, Vˆä@“w4, ìŒû”ü˜a4, ¬–ìd–ž4, À“c@Ê4, ŠC–ìM–ç4, ‘ì˜ad3, –îŒã˜a•v1,2 (1
–òÜ•”, 2–òŠw•”, 3•úŽËü (Žîá‡), 4ŽY•w): ‘æ27‰ñ“ú–{TDMŠw‰ï (2010/6/26), ŽD–y, ‘æ27‰ñ“ú–{
TDMŠw‰ï—vŽ|W 2010/6; 27(3): 214.

7231097. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒAƒ“ƒ`Eƒh[ƒsƒ“ƒOƒf[ƒ^[ƒx[ƒX‚̍\’z. ŠLÀ@1, ”–ˆäŒ’‰î
2, ¬ŽºŽ¡F2, Vˆä–œ—Žq1, ŒŒŽ@”£1, Œú“cKˆê˜Y2,3, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”, 3–k—¢
Œ€‹†Š•a‰@–òÜ•”): ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2010‘æ18‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ (2010/7/10),
L“‡, ˆã—ÖòŠwƒtƒH[ƒ‰ƒ€2010‘æ18‰ñƒNƒŠƒjƒJƒ‹ƒtƒ@[ƒ}ƒV[ƒVƒ“ƒ|ƒWƒEƒ€ 2010/7; p.195.

7231098. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ}ƒ“ƒK‚š‚æ‚уeƒŒƒrƒhƒ‰ƒ}‚Ì‹i‰Œ•`ŽÊ‚ÉŠÖ‚·‚é’²ž. ‘Š‘ò­–Ÿ1,
•ŽR­ˆê1 (1“Œ•a‰@–òÜ•”): ‘æ5‰ñ“ú–{‹Ö‰ŒŠw‰ïŠwp‘‰ï (2010/9/20), ˆ€•Q, ‘æ5‰ñ“ú–{‹Ö‰ŒŠw‰ïŠw
p‘‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010/9; p.151.

7231099. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Å‹ß‚Ì“àˆö«^‹Û«Šá“à‰Š‚Ì•¶Œ£“I’²ž. ‚‹Ž¹Ž÷1, •l“cKG2,
•œŽR•Ži1,2, •ŽR­ˆê1,2 (1‘åŠw‰@–òŠwŒ€‹†‰È, 2“Œ•a‰@–òÜ•”): ‘æ59‰ñ“ú–{ŠŽõÇŠw‰ï“Œ“ú–{Šwp
W‰ïE‘æ57‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï (2010/10/21), “Œ‹ž, ‘æ59‰ñ“ú–{ŠŽõÇŠw‰ï“Œ“ú–{Šw
pW‰ïE‘æ57‰ñ“ú–{‰»Šw—Ö@Šw‰ï“Œ“ú–{Žx•”‘‰ï—vŽ|W 2010/9; p.141.

7231100. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ŠÈˆÕŒœ‘÷–@‚É‚š‚¯‚éùÜ•²ÓŠí‹ï‚ÌŒŸ“¢. ””’J—DŽq1, –Ø‘ºŒö”ü2,
ŽO‹Ž^—R”ü2, ”’‘ò˜aŽq1, ‘•ªG–ç1, Vˆä–œ—Žq1, ŒŒŽ@”£1, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”):
‘æ20‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2010/11/13), ç—t, ‘æ20‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïu‰‰—vŽ|W 2010/10;
p.290.

7231101. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒ\ƒ‰ƒtƒFƒjƒu•ž—p’†‚ɍœ‘—}§‚ð‹N‚±‚µ‚œˆê—á. –{ŠÔ‰ëŽm1, •l“c
KG1, ‘å–ì™z‘Ÿ˜Y2, •œŽR•Ži1,2, ŒÃ“cˆê“¿3, “n粏¹•F3, •ŽR­ˆê1,2 (1“Œ•a‰@–òÜ•”, 2–òŠw•”,
3ŠO‰È): ‘æ20‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ï (2010/11/13), ç—t, ‘æ20‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïu‰‰—vŽ|W
2010/10; p.312.

7231102. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Á‰»Ší‚ª‚ñŠ³ŽÒ‚É‚š‚¯‚邪‚ñ‰»Šw—Ö@‚É—U”­‚³‚ê‚鈫SEšq“f‚É‘Î
‚·‚鐧“f—Ö@‚̗Տ°¬Ñ‚š‚æ‚ÑQOL‚ւ̉e‹¿‚ÉŠÖ‚·‚錀‹†. ¬X’q–ç1, ì–ìçq1,2, ”ò“c—[‹I1,2, •œ
ŽR•Ži1,2, ¬ò˜aŽO˜Y3, •ŽR­ˆê1,2 (1‘åŠw‰@–òŠwŒ€‹†‰È, 2“Œ•a‰@–òÜ•”, 3Á‰»Ší“à): ‘æ20‰ñ
“ú–{ˆã—ÖòŠw‰ï (2010/11/13), ç—t, ‘æ20‰ñ“ú–{ˆã—ÖòŠw‰ïu‰‰—vŽ|W 2010/11; p.339.

7231103. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw“Œ•a‰@ICU•a“‚É‚š‚¯‚é”z‡•Ï‰»ƒf[ƒ^ƒx[ƒX‚̍\’z. ‘ê
“‡˜aW1, •l“cKG1, ‘Š‘ò­–Ÿ1, ¬ìK—Y1, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”): ‘æ20‰ñ“ú–{ˆã—ÖòŠw‰ï
”N‰ï (2010/11/13), ç—t, ‘æ20‰ñ“ú–{ˆã—ÖòŠw‰ï”N‰ïu‰‰—vŽ|W 2010/10; p.405.

7231104. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) –k—¢‘åŠw•a‰@‚É‚š‚¯‚éHIVŠŽõ”D•w‚̃`[ƒ€ˆã—Âɑ΂·‚éƒj[ƒY?
ŽüŽYŠú‚ð’Ê‚µ‚Ä”D•w‚ª–]‚Þƒ`[ƒ€‘̐§‚ÌŒŸ“¢?. ŒŽRW‘ã1, •œ—с@“Þ1, ‘O“cŒiŽq2, “c’†”Ž”V3, V
ˆä–œ—Žq3, ˜a“c’B•F4, “V–ì@Š®5 (1ŠÅŒì•”, 2Š³ŽÒŽx‰‡ƒZƒ“ƒ^[•”, 3–òÜ•”, 4‘‡f—Ã, 5ŽY•w):
‘æ24‰ñ“ú–{ƒGƒCƒYŠw‰ïŠwpW‰ïE‘‰ï (2010/11/25), “Œ‹ž, “ú–{ƒGƒCƒYŠw‰ïŽ 2010/11; 12 (4): 464
(256).

7231105. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) 2Ž{Ý‹€“¯‚ÅŽÀŽ{‚µ‚œV‹KPET—p•úŽË«f’fÜ‚Ì‘æ1‘ŠŽŽŒ±‚̉ۑè
‚ƑΉž. ’†‘º’q”ü1,2, ‚‹ŽŒ«¬1,2, “üŒË–ì˜a‘ã1, ’†ŒŽ‚¢‚¿‚Ý1, ‹e’r@Œh3, ‰¡“cœÄˆê4, ŒŽ@•q«
5, ó–ì—Y“ñ6, ’r“cN•F1, ŒF’J—YŽ¡1 (1“Œ•a‰@Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[, 2“Œ•a‰@–òÜ•”, 3•úŽËü•”, 4Ž¡
Œ±ŠÇ—Žº, 5•úŽËü (‰æ‘œ), 6•úŽËü (Žîá‡)): ‘æ31‰ñ“ú–{—Տ°–ò—Šw‰ï”N‰ï (2010/12/1), ‹ž“s, —Õ
°–ò— 2010/11; 41 (Suppl): S245.

7231106. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) —Տ°–ò—ŽŽŒ±ŽQ‰ÁŠó–]ŽÒ‚ÌŒŸžƒf[ƒ^‚Ì”NŽŸ’²žI?ŒŒŽZ?. ’†‘º
’q”ü1,2, Îè¹D3, ‚‹ŽŒ«¬1,2, ‘O“cŽÀ‰Ô1,2, •ŽR­ˆê2, “c‰ê’J_–M3, ’r“cN•F1, “¡“c•üŒb
1, ŒF’J—YŽ¡1 (1“Œ•a‰@Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[, 2“Œ•a‰@–òÜ•”, 3ˆã—Éq¶Šw•”): ‘æ31‰ñ“ú–{—Տ°–ò—Šw
‰ï”N‰ï (2010/12/1), ‹ž“s, —Տ°–ò— 2010/11; 41 (Suppl): S247.

7231107. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) “ú–{l‚š‚æ‚Ñ’†‘l (Š¿–¯‘°) ‚ð‘ΏۂƂµ‚œ1Ž{Ý‚É‚æ‚é–ò•š“®‘Ô
”äŠrŽŽŒ±‚ÌŽÀŽ{‘̐§‚ÌŒŸ“¢?Šé‰æE—§ˆÄ‚©‚çŽÀŽ{‚܂ł̉ۑè?. ‘O“cŽÀ‰Ô1,2, –쑺¡“úŽq1, ˜eâ^”ü
3, ]@@ß1, ‰€@‘‹Õ4, ¬—ѐ^”ü1, ‚‹ŽŒ«¬1,2, “¡“c•üŒb1, ’r“cN•F1, •ŽR­ˆê2, ŒF’J—YŽ¡
1,3 (1“Œ•a‰@Ž¡Œ±ŠÇ—ƒZƒ“ƒ^[, 2“Œ•a‰@–òÜ•”, 3ˆãŠw•”•‘®—Տ°Œ€‹†ƒZƒ“ƒ^[, 4’nˆæŽüŽYŠúE‹~‹}
ˆã—Ã): ‘æ31‰ñ—Տ°–ò—Šw‰ï (2010/12/3), ‹ž“s, —Տ°–ò—, 2010/11; 41 (Suppl): S229.

7231108. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) Á‰»Ší‚ª‚ñŠ³ŽÒ‚É‚š‚¯‚邪‚ñ‰»Šw—Ö@—U”­ˆ«SEšq“f‚ɑ΂·‚éƒAƒv
ƒŒƒsƒ^ƒ“ƒg‚ðŠÜ‚ß‚œ—Տ°¬Ñ‹y‚ÑQOL‚ւ̉e‹¿‚ÉŠÖ‚·‚錀‹†. ¬X’q–ç1, ì–ìçq1,2, ”ò“c—[‹I1,2,
•œŽR•Ži1,2, ¬ò˜aŽO˜Y3, •ŽR­ˆê1,2 (1‘åŠw‰@–òŠwŒ€‹†‰È, 2“Œ•a‰@–òÜ•”, 3Á‰»Ší“à): “ú–{–ò
Šw‰ï‘æ131”N‰ï (2011/3/29), Ã‰ª, DVD—vŽ|W 2011/3; 29P-0819.

7231109. [Šw‰ï (‘S‘)] (ˆê”ʍu‰‰) ƒIƒLƒVƒRƒhƒ“™•úù1“ú2‰ñ•ªŠ„“Š—^ŒQ‚É‚š‚¯‚é’Á’ÉŒø‰Ê‚ÌŽ‘±«
‚š‚æ‚Ñ•›ì—p‚ÉŠÖ‚·‚錀‹†. ‘å–ì꣑Ÿ˜Y1, •œŽR•Ži1,2, ì–ìçq1,2, ”ò“c—[‹I1,2, •ŽR­ˆê1,2 (1
‘åŠw‰@–òŠwŒ€‹†‰È, 2“Œ•a‰@–òÜ•”): “ú–{–òŠw‰ï‘æ131”N‰ï (2011/3/29), Ã‰ª, DVD—vŽ|W 2011/3;
29P-0820.

7231110. [Šw‰ï (‘S‘)] (ˆê”ÊŒû‰‰) Tazobactam/Piperacillin (”z‡”ä1:8»Ü) ‚Ì•êW’c–ò•š“®‘Ô‰ðÍ.
‚‹Ž¹Ž÷1, •l“cKG2, •œŽR•Ži1,2, •ŽR­ˆê1,2 (1‘åŠw‰@–òŠwŒ€‹†‰È, 2“Œ•a‰@–òÜ•”): “ú–{–òŠw
‰ï‘æ131”N‰ï (2011/3/29), Ã‰ª, DVD—vŽ|W 2011/3; p.177.

732121. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) ‹Ö‰ŒŽ¡—Âð–òŠw‚ÌŽ‹“_‚©‚çl‚Š‚é. ‘Š‘ò­–Ÿ (“Œ•a‰@
–òÜ•”): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ40‰ñŠwp‘å‰ï (2010/8/29), “Œ‹ž, “ú–{•a‰@–òÜŽt‰ïŠÖ“Œƒu
ƒƒbƒN‘æ40‰ñŠwp‘å‰ïu‰‰—vŽ|W 2010/8; p.87.

732122. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰“™) –ò•š“®‘ÔŠw“IŽ‹“_‚©‚ç‚Ý‚œƒIƒsƒIƒCƒh‚Ì“K³Žg—p. •œ
ŽR•Ži (“Œ•a‰@–òÜ•”): ‘æ32‰ñ“ú–{•a‰@–òÜŽt‰ï‹ß‹EŠwp‘å‰ï (2011/1/22), _ŒË, ‘æ32‰ñ“ú–{•a‰@
–òÜŽt‰ï‹ß‹EŠwp‘å‰ïu‰‰—vŽ|W 2011/1; p.82.

733548. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) ‚ª‚ñƒTƒƒ“‚É‚š‚¯‚é–òÜŽt‚ÌŠÖ—^. –k–ì’qŽq1, Vˆä–œ
—Žq1, ‘O“cŒiŽq3, ‹ß“¡‚Ü‚ä‚Ý3, ŒŒŽ@”£1, –îŒã˜a•v1,2 (1–òÜ•”, 2–òŠw•”, 3Š³ŽÒŽx‰‡ƒZƒ“ƒ^[
•”): “ú–{•a‰@–òÜŽt‰ïŠÖ“ŒƒuƒƒbƒN‘æ40‰ñŠwp‘å‰ï (2010/8/29), “Œ‹ž, “ú–{•a‰@–òÜŽt‰ïŠÖ“Œƒuƒƒb
ƒN‘æ40‰ñŠwp‘å‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2010/8; p.354.

733549. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰) “œ”A•aŠO—ˆ‚É‚š‚¯‚é5EŽí‚̐f—Ãu[ƒX‚ðŽg—p‚µ‚œƒŠƒA
ƒ‹ƒ^ƒCƒ€ƒ`[ƒ€ˆã—Â̗L—p«. ‘Š‘ò­–Ÿ1, Žç‰®’B”ü2, ‘êìˆŸ–í1, •ŽR­ˆê1, •P“c‹v”ü3, â–{’q”ü
3, Ž‰Æ—R”üŽq4, ŽR‰º@’q5, ^–ì“oŠìŽq5, Žµ—¢áÁ‹`2, “c糁@‘6 (1“Œ•a‰@–òÜ•”, 2“à•ª”å‘ãŽÓ“à,
3“Œ•a‰@—ÕŒŸ•”, 4“Œ•a‰@‰h—{•”, 5“Œ•a‰@ŠÅŒì•”, 6Á‰»Ší“à): ‘æ48‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û
‰ï (2011/1/29), “Œ‹ž, ‘æ48‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ïƒvƒƒOƒ‰ƒ€EŽ˜^W 2011/1; p.35.

733550. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (ˆê”ʍu‰‰Eƒ|ƒXƒ^[) Voriconazole‚É‚æ‚莋ŠoˆÙí‚ð”F‚ߌŒ’†”Z“x
‘ª’è‚É‚æ‚荂’l‚ðŽŠ‚µ‚œ1Ç—á. •l“cKG1, ¬ò—º•ã1, £ŒË—Ç‹³2, ¬ŒŽ”ü]1, ‰¬–ì”üŒbŽq3, ‹v•Ä@
Œõ4, •ŽR­ˆê1 (1“Œ•a‰@–òÜ•”, 2–òÜ•”, 3_Œo“à, 4•a‰@•a—•”): ^‹ÛÇƒtƒH[ƒ‰ƒ€‘æ12‰ñŠwp
W‰ï (2011/2/5), “Œ‹ž, ^‹ÛÇƒtƒH[ƒ‰ƒ€‘æ12‰ñŠwpW‰ï—vŽ|W 2011/2; p.59.

H21”N“xˆÈ‘O•ª

[Šwp˜_•¶]

H21-110024. [ŒŽ’˜] Initial analysis of relationship between plasma platinum concentration
and hematological adverse reaction associated with weekly chemotherapy using nedaplatin in
combination with radiotherapy for cervical carcinoma. Hamada Y1, Naitoh H2, Niibe Y3, Kotani A2,
Takayanagi R2, Tsunoda S4, Unnno N4, Hayakawa K3, Kusu F2, Yago K1, Yamada Y2 (1–òÜ•”, 2School
of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 3•úŽËü (Žîá‡), 4ŽY•w): Eur J Gynaec
Oncol 2010/2; 5: 517-21. (•l“cKG1, V•”@÷3, Šp“cV•œ4, ŠC–ìM–ç4, ‘ì˜ad3, –îŒã˜a•v1)


“Œ•a‰@ˆã—Ïî•ñŠÇ—•”f—Ïî•ñŠÇ—‰Û

[Šw‰ïEŒ€‹†‰ï“™]

7231111. [Šw‰ï (‘S‘)] (ƒ|ƒXƒ^[) DPC‚ð—p‚¢‚œƒNƒŠƒjƒJƒ‹ƒpƒX“K—p‚̉e‹¿•]‰¿‚ɂ‚¢‚Ä. rˆäN•v1,
¬ŽRƒAƒ„1, ²“¡•˜Y2 (1“Œ•a‰@f—Ïî•ñŠÇ—, 2ŠO‰È): ‘æ36‰ñ“ú–{f—Ïî•ñŠÇ—Šw‰ïŠwp‘å‰ï
(2010/9/16-17), ’·–ì (ƒzƒNƒg•¶‰»ƒz[ƒ‹), f—Ïî•ñŠÇ— 2010/8; 22 (2): 140.

732123. [Šw‰ï (’n•û‰ïEŒ€‹†‰ï)] (µ‘ҍu‰‰) “–‰@‚É‚š‚¯‚éDPC‚ÌŽÀ–±‚ƑΉž‚ɂ‚¢‚Ä. rˆäN•v (“Œ
•a‰@f—Ïî•ñŠÇ—): ‘S‘ŒöŽ„•a‰@˜A–¿‘æ7‰ñDPCƒZƒ~ƒi[ (2010/11/18), “Œ‹ž (‘åŽè’¬ƒTƒ“ƒPƒCƒvƒ‰
ƒU).